Citrus Sinensis ID: 048280
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 381 | 2.2.26 [Sep-21-2011] | |||||||
| Q8GYA4 | 669 | Cysteine-rich receptor-li | no | no | 0.748 | 0.426 | 0.456 | 1e-73 | |
| Q8GWJ7 | 645 | Cysteine-rich receptor-li | no | no | 0.816 | 0.482 | 0.454 | 1e-72 | |
| Q9C5S9 | 674 | Cysteine-rich receptor-li | no | no | 0.774 | 0.437 | 0.445 | 2e-72 | |
| Q8S9L6 | 679 | Cysteine-rich receptor-li | no | no | 0.779 | 0.437 | 0.459 | 7e-72 | |
| Q9LDQ3 | 669 | Putative cysteine-rich re | no | no | 0.745 | 0.424 | 0.453 | 1e-71 | |
| O65482 | 830 | Putative cysteine-rich re | no | no | 0.753 | 0.345 | 0.452 | 3e-71 | |
| O65468 | 676 | Cysteine-rich receptor-li | no | no | 0.774 | 0.436 | 0.439 | 3e-71 | |
| O65472 | 690 | Putative cysteine-rich re | no | no | 0.858 | 0.473 | 0.412 | 8e-71 | |
| Q3E9X6 | 690 | Cysteine-rich receptor-li | no | no | 0.868 | 0.479 | 0.419 | 2e-70 | |
| O65405 | 683 | Cysteine-rich receptor-li | no | no | 0.706 | 0.393 | 0.466 | 2e-70 |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 277 bits (708), Expect = 1e-73, Method: Compositional matrix adjust.
Identities = 142/311 (45%), Positives = 199/311 (63%), Gaps = 26/311 (8%)
Query: 30 EKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQG 89
+ I + + + +AT +F SNK+G+GGFG V+KG L DG E+AVK+LS SS QG
Sbjct: 326 DDITTADSLQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQG 385
Query: 90 KKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQ---- 145
+ EF+NE L+A++QHRN+V LLG+C G E++L+YEYV N+SLD LF K Q
Sbjct: 386 EVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWT 445
Query: 146 ------------ILFRKKKT-------DIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186
IL+ + + D+KASNILLD PKIADFGMAR+F DQT
Sbjct: 446 RRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEE 505
Query: 187 NT-RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWA 245
NT R+ GT GYM+PEY MHG S+K+DV+SFGV++LE+ISG++NSSF A +L+ +A
Sbjct: 506 NTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYA 565
Query: 246 YKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKPGP 305
+ L+ + LE+VDP++ + +++ C+ IGLLC Q DP RPT+ +V+ML+
Sbjct: 566 WGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSN--T 623
Query: 306 GNLEEPTRPGV 316
L P +PG+
Sbjct: 624 VTLPVPRQPGL 634
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q8GWJ7|CRK19_ARATH Cysteine-rich receptor-like protein kinase 19 OS=Arabidopsis thaliana GN=CRK19 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 274 bits (700), Expect = 1e-72, Method: Compositional matrix adjust.
Identities = 156/343 (45%), Positives = 209/343 (60%), Gaps = 32/343 (9%)
Query: 27 EDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSS 86
ED I F F+A+ +AT F P NKLG+GGFG V+KG L G ++AVK+LS +S
Sbjct: 301 EDGNDITTAGSLQFDFKAIEAATNCFLPINKLGQGGFGEVYKGTLSSGLQVAVKRLSKTS 360
Query: 87 NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFS------- 139
QG+KEFENE ++A++QHRN+V LLGYC G EK+L+YE+V N+SLD LF
Sbjct: 361 GQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDSTMKMKL 420
Query: 140 -------LIKDIQ--ILFRKKKT-------DIKASNILLDDKWIPKIADFGMARLFPEDQ 183
+I I IL+ + + D+KA NILLDD PKIADFGMAR+F DQ
Sbjct: 421 DWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMDQ 480
Query: 184 THVNT-RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSS-FNLDVDAQNL 241
T T RV GT GYM+PEY M+G S+K+DV+SFGV++LE+ISG +NSS + +D NL
Sbjct: 481 TEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQMDESVGNL 540
Query: 242 LDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
+ + ++L+ E+VDPS + +I CI I LLC Q D + RPTM +V ML+
Sbjct: 541 VTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCVQEDAEDRPTMSSIVQMLTT 600
Query: 302 KPGPGNLEEPTRPGVPGSRYRRARRPA--ALSSSTAGSSGESN 342
L EP RP PG +R + A ++ SST S E++
Sbjct: 601 SLIA--LAEP-RP--PGFFFRSKQEQAGPSIDSSTHCSVDEAS 638
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 273 bits (698), Expect = 2e-72, Method: Compositional matrix adjust.
Identities = 146/328 (44%), Positives = 205/328 (62%), Gaps = 33/328 (10%)
Query: 13 KHFNLGSSRE-GDNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKL 71
K F+ S+ E GD+ +A + + + +AT +F SNK+G GGFG V+KG
Sbjct: 317 KTFDTASASEVGDD------MATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTF 370
Query: 72 DDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINE 131
+G+E+AVK+LS +S QG+ EF+ E ++A++QHRN+V LLG+ G E++L+YEY+ N+
Sbjct: 371 SNGKEVAVKRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNK 430
Query: 132 SLDKVLFSLIKDIQ----------------ILFRKKKT-------DIKASNILLDDKWIP 168
SLD +LF K IQ IL+ + + D+KASNILLD P
Sbjct: 431 SLDCLLFDPTKQIQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINP 490
Query: 169 KIADFGMARLFPEDQTHVNT-RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQ 227
KIADFGMAR+F DQT NT R+ GT GYMAPEY MHG S+K+DV+SFGV++LE+ISG+
Sbjct: 491 KIADFGMARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGR 550
Query: 228 RNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQ 287
+NSSF AQ+LL A++L+ K+L++VDP +A + ++ CI IGLLC Q DP
Sbjct: 551 KNSSFGESDGAQDLLTHAWRLWTNKKALDLVDPLIAENCQNSEVVRCIHIGLLCVQEDPA 610
Query: 288 LRPTMRRVVVMLSKKPGPGNLEEPTRPG 315
RP + V +ML+ L P +PG
Sbjct: 611 KRPAISTVFMMLTSN--TVTLPVPRQPG 636
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8S9L6|CRK29_ARATH Cysteine-rich receptor-like protein kinase 29 OS=Arabidopsis thaliana GN=CRK29 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 271 bits (692), Expect = 7e-72, Method: Compositional matrix adjust.
Identities = 153/333 (45%), Positives = 202/333 (60%), Gaps = 36/333 (10%)
Query: 42 FEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLA 101
FE L +AT NF N+LG GGFG V+KG G+EIAVK+LS +S QG EF+NE LLA
Sbjct: 347 FETLKTATDNFSSENELGRGGFGSVYKGVFPQGQEIAVKRLSGNSGQGDNEFKNEILLLA 406
Query: 102 RVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQIL-------------- 147
++QHRN+V L+G+C G E+LL+YE++ N SLD+ +F K Q+L
Sbjct: 407 KLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFIFDTEKR-QLLDWVVRYKMIGGIAR 465
Query: 148 ----------FRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN---TRVAGTN 194
FR D+KASNILLD + PKIADFG+A+LF QT + +R+AGT
Sbjct: 466 GLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFGLAKLFDSGQTMTHRFTSRIAGTY 525
Query: 195 GYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSS--FNLDVDAQNLLDWAYKLYKKD 252
GYMAPEY MHG SVK DVFSFGV+++E+I+G+RN++ N D DA++LL W ++ +++D
Sbjct: 526 GYMAPEYAMHGQFSVKTDVFSFGVLVIEIITGKRNNNGGSNGDEDAEDLLSWVWRSWRED 585
Query: 253 KSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKPGPGNLEEPT 312
L ++DPSL A S ++I CI IGLLC Q RPTM V +ML+ L P
Sbjct: 586 TILSVIDPSLTAG-SRNEILRCIHIGLLCVQESAATRPTMATVSLMLNSY--SFTLPTPL 642
Query: 313 RPGVPGSRYRRARRPAALSSSTAGSSGESNSRT 345
RP P+ +SSST G SN T
Sbjct: 643 RPAFV---LESVVIPSNVSSSTEGLQMSSNDVT 672
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LDQ3|CRK35_ARATH Putative cysteine-rich receptor-like protein kinase 35 OS=Arabidopsis thaliana GN=CRK35 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 270 bits (691), Expect = 1e-71, Method: Compositional matrix adjust.
Identities = 141/311 (45%), Positives = 198/311 (63%), Gaps = 27/311 (8%)
Query: 30 EKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQG 89
++I F F+ + +AT F SN +G GGFG V++GKL G E+AVK+LS +S QG
Sbjct: 323 DEITTTHSLQFSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKTSGQG 382
Query: 90 KKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLF----------- 138
+EF+NEA L++++QH+N+V LLG+C G EK+L+YE+V N+SLD LF
Sbjct: 383 AEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQGELDWT 442
Query: 139 ---SLIKDIQ--ILFRKKKT-------DIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186
++I I IL+ + + D+KASNILLD PKIADFGMAR+F DQ+
Sbjct: 443 RRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVDQSQA 502
Query: 187 NT-RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSF-NLDVDAQNLLDW 244
NT R+AGT GYM+PEY M GH S+K+DV+SFGV++LE+ISG++NSSF N+D NL+
Sbjct: 503 NTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDDSGSNLVTH 562
Query: 245 AYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKPG 304
A++L++ LE+VDP++ S + CI I LLC Q DP RP + +++ML+
Sbjct: 563 AWRLWRNGSPLELVDPTIGESYQSSEATRCIHIALLCVQEDPADRPLLPAIIMMLTSS-- 620
Query: 305 PGNLEEPTRPG 315
L P PG
Sbjct: 621 TTTLHVPRAPG 631
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65482|CRK23_ARATH Putative cysteine-rich receptor-like protein kinase 23 OS=Arabidopsis thaliana GN=CRK23 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 269 bits (688), Expect = 3e-71, Method: Compositional matrix adjust.
Identities = 142/314 (45%), Positives = 191/314 (60%), Gaps = 27/314 (8%)
Query: 27 EDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSS 86
E+ + I F F+A+V+AT NF P NKLG+GGFG V+KG G ++AVK+LS +S
Sbjct: 483 ENGDSITTAGSLQFDFKAIVAATNNFLPINKLGQGGFGEVYKGTFPSGVQVAVKRLSKTS 542
Query: 87 NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQ- 145
QG++EFENE ++A++QHRN+V LLGYC G EK+L+YE+V N+SLD LF Q
Sbjct: 543 GQGEREFENEVVVVAKLQHRNLVRLLGYCLEGEEKILVYEFVHNKSLDYFLFDTTMKRQL 602
Query: 146 ---------------ILFRKKKT-------DIKASNILLDDKWIPKIADFGMARLFPEDQ 183
IL+ + + D+KA NILLD PK+ADFGMAR+F DQ
Sbjct: 603 DWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFGMDQ 662
Query: 184 THVNT-RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSS-FNLDVDAQNL 241
T NT RV GT GYMAPEY M+G S+K+DV+SFGV++ E+ISG +NSS + +D NL
Sbjct: 663 TEANTRRVVGTYGYMAPEYAMYGQFSMKSDVYSFGVLVFEIISGMKNSSLYQMDDSVSNL 722
Query: 242 LDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
+ + ++L+ L++VDPS + I CI I LLC Q D RP M +V ML+
Sbjct: 723 VTYTWRLWSNGSQLDLVDPSFGDNYQTHDITRCIHIALLCVQEDVDDRPNMSAIVQMLTT 782
Query: 302 KPGPGNLEEPTRPG 315
L P +PG
Sbjct: 783 SSIV--LAVPKQPG 794
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 269 bits (687), Expect = 3e-71, Method: Compositional matrix adjust.
Identities = 144/328 (43%), Positives = 204/328 (62%), Gaps = 33/328 (10%)
Query: 13 KHFNLGSSRE-GDNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKL 71
K F+ S+ E GD+ +A + + + +AT +F SNK+G GGFG V+KG
Sbjct: 319 KTFDTASASEVGDD------MATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTF 372
Query: 72 DDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINE 131
+G+E+AVK+LS +S QG+ EF+ E ++A++QHRN+V LLG+ G E++L+YEY+ N+
Sbjct: 373 SNGKEVAVKRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNK 432
Query: 132 SLDKVLFSLIKDIQ----------------ILFRKKKT-------DIKASNILLDDKWIP 168
SLD +LF K Q IL+ + + D+KASNILLD P
Sbjct: 433 SLDCLLFDPTKQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINP 492
Query: 169 KIADFGMARLFPEDQTHVNT-RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQ 227
KIADFGMAR+F DQT NT R+ GT GYMAPEY MHG S+K+DV+SFGV++LE+ISG+
Sbjct: 493 KIADFGMARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGR 552
Query: 228 RNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQ 287
+NSSF+ AQ+LL ++L+ +L++VDP +A + ++ CI IGLLC Q DP
Sbjct: 553 KNSSFDESDGAQDLLTHTWRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPA 612
Query: 288 LRPTMRRVVVMLSKKPGPGNLEEPTRPG 315
RPT+ V +ML+ L P +PG
Sbjct: 613 KRPTISTVFMMLTSN--TVTLPVPRQPG 638
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65472|CRK12_ARATH Putative cysteine-rich receptor-like protein kinase 12 OS=Arabidopsis thaliana GN=CRK12 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 267 bits (683), Expect = 8e-71, Method: Compositional matrix adjust.
Identities = 148/359 (41%), Positives = 220/359 (61%), Gaps = 32/359 (8%)
Query: 21 REGDNEEDLEK--IAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIA 78
R+ E DL++ I + F+ + AT+NF +NKLG+GGFG V+KG L +G E+A
Sbjct: 334 RKSYQEIDLDQSGITTLHFQQLDFKTIEVATENFAKTNKLGQGGFGEVYKGTLVNGTEVA 393
Query: 79 VKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLF 138
VK+LS +S QG +EF+NE L+A++QHRN+V LLGYC EK+L+YE+V N+SLD LF
Sbjct: 394 VKRLSKTSEQGAQEFKNEVVLVAKLQHRNLVKLLGYCLEPEEKILVYEFVPNKSLDYFLF 453
Query: 139 SLIKDIQILFRKKKT-----------------------DIKASNILLDDKWIPKIADFGM 175
K Q+ + K+ D+KASNILLD IPKIADFGM
Sbjct: 454 DPTKQGQLDWTKRYNIIGGITRGILYLHQDSRLTIIHRDLKASNILLDADMIPKIADFGM 513
Query: 176 ARLFPEDQTHVNT-RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSF-N 233
AR+ DQ+ NT R+AGT GYM PEYV+HG S+K+DV+SFGV+ILE+I G++N SF
Sbjct: 514 ARISGIDQSVANTKRIAGTFGYMPPEYVIHGQFSMKSDVYSFGVLILEIICGKKNRSFYQ 573
Query: 234 LDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMR 293
D A+NL+ + ++L+ LE+VD +++ + +++ CI I LLC Q DP+ RP +
Sbjct: 574 ADTKAENLVTYVWRLWTNGSPLELVDLTISENCQTEEVIRCIHIALLCVQEDPKDRPNLS 633
Query: 294 RVVVMLSKKPGPGNLEEPTRPGVPGSRYRRARRPAALSSS-TAGSSGESNSRTYTSSLN 351
+++ML+ ++ +P VP ++ R + LSS T G + ++ + ++L+
Sbjct: 634 TIMMMLTNSSLILSVPQPPGFFVPQNK----ERDSFLSSQFTMGCTSQTKNDVTITNLD 688
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q3E9X6|CRK21_ARATH Cysteine-rich receptor-like protein kinase 21 OS=Arabidopsis thaliana GN=CRK21 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 266 bits (680), Expect = 2e-70, Method: Compositional matrix adjust.
Identities = 153/365 (41%), Positives = 216/365 (59%), Gaps = 34/365 (9%)
Query: 18 GSSREGDNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREI 77
G++ D +DL A+ F F A+ +AT NFH SNKLG GGFG V+KG +G E+
Sbjct: 331 GTASPDDATDDLT--ASSGSLRFDFRAIKAATSNFHKSNKLGHGGFGAVYKGMFPNGTEV 388
Query: 78 AVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVL 137
A K+LS S+QG+ EF+NE L+AR+QH+N+V LLG+ G EK+L+YE+V N+SLD L
Sbjct: 389 AAKRLSKPSDQGEPEFKNEVLLVARLQHKNLVGLLGFSVEGEEKILVYEFVPNKSLDHFL 448
Query: 138 FSLIKDIQILFRKKKT-----------------------DIKASNILLDDKWIPKIADFG 174
F IK +Q+ + ++ D+KASNILLD + PKIADFG
Sbjct: 449 FDPIKRVQLDWPRRHNIIEGITRGILYLHQDSRLTIIHRDLKASNILLDAEMNPKIADFG 508
Query: 175 MARLFPEDQTHVNT-RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFN 233
+AR F +QT NT RV GT GYM PEYV +G S K+DV+SFGV+ILE+I G++NSSF+
Sbjct: 509 LARNFRVNQTEANTGRVVGTFGYMPPEYVANGQFSTKSDVYSFGVLILEIIGGKKNSSFH 568
Query: 234 -LDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTM 292
+D NL+ ++L LE+VDP++ + D++ CI IGLLC Q +P RP+M
Sbjct: 569 QIDGSVSNLVTHVWRLRNNGSLLELVDPAIGENYDKDEVIRCIHIGLLCVQENPDDRPSM 628
Query: 293 RRVVVMLSKKPGPGNLEEPTRPGVPGSRYRRARRPAALSSSTAGSSGESNSRTYTSSLNT 352
+ ML+ ++ P P PG +R P L+ G S S ++T S++
Sbjct: 629 STIFRMLTNV----SITLPV-PQPPGFFFRERSEPNPLAERLL--PGPSTSMSFTCSVDD 681
Query: 353 NTGTA 357
+ T+
Sbjct: 682 ASITS 686
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65405|CRK28_ARATH Cysteine-rich receptor-like protein kinase 28 OS=Arabidopsis thaliana GN=CRK28 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 266 bits (680), Expect = 2e-70, Method: Compositional matrix adjust.
Identities = 141/302 (46%), Positives = 193/302 (63%), Gaps = 33/302 (10%)
Query: 42 FEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLA 101
FE L +AT NF P N+LG GGFG V+KG G+EIAVK+LS +S QG EF+NE LLA
Sbjct: 351 FETLKAATDNFSPENELGRGGFGSVYKGVFSGGQEIAVKRLSCTSGQGDSEFKNEILLLA 410
Query: 102 RVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQIL-------------- 147
++QHRN+V LLG+C G E++L+YE++ N SLD +F L K Q+L
Sbjct: 411 KLQHRNLVRLLGFCIEGQERILVYEFIKNASLDNFIFDL-KKRQLLDWGVRYKMIGGVAR 469
Query: 148 ----------FRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN---TRVAGTN 194
+R D+KASNILLD + PKIADFG+A+L+ DQT + +++AGT
Sbjct: 470 GLLYLHEDSRYRIIHRDLKASNILLDQEMNPKIADFGLAKLYDTDQTSTHRFTSKIAGTY 529
Query: 195 GYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSS--FNLDVDAQNLLDWAYKLYKKD 252
GYMAPEY ++G SVK DVFSFGV+++E+I+G+ N++ N D +A+NLL W ++ +++D
Sbjct: 530 GYMAPEYAIYGQFSVKTDVFSFGVLVIEIITGKGNNNGRSNDDEEAENLLSWVWRCWRED 589
Query: 253 KSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKPGPGNLEEPT 312
L ++DPSL + S +I CI IGLLC Q P RPTM V +ML+ L P+
Sbjct: 590 IILSVIDPSL-TTGSRSEILRCIHIGLLCVQESPASRPTMDSVALMLNSY--SYTLPTPS 646
Query: 313 RP 314
RP
Sbjct: 647 RP 648
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 381 | ||||||
| 359472840 | 402 | PREDICTED: cysteine-rich receptor-like p | 0.965 | 0.915 | 0.688 | 1e-153 | |
| 224111480 | 383 | predicted protein [Populus trichocarpa] | 0.926 | 0.921 | 0.712 | 1e-150 | |
| 356528198 | 405 | PREDICTED: cysteine-rich receptor-like p | 0.965 | 0.908 | 0.665 | 1e-148 | |
| 147805802 | 437 | hypothetical protein VITISV_016299 [Viti | 0.965 | 0.842 | 0.642 | 1e-147 | |
| 255573728 | 411 | Serine/threonine-protein kinase PBS1, pu | 0.986 | 0.914 | 0.676 | 1e-145 | |
| 356521131 | 410 | PREDICTED: putative cysteine-rich recept | 0.984 | 0.914 | 0.631 | 1e-140 | |
| 449449046 | 412 | PREDICTED: cysteine-rich receptor-like p | 0.984 | 0.910 | 0.649 | 1e-139 | |
| 356510843 | 400 | PREDICTED: cysteine-rich receptor-like p | 0.952 | 0.907 | 0.630 | 1e-138 | |
| 30698743 | 425 | protein kinase domain-containing protein | 0.973 | 0.872 | 0.583 | 1e-129 | |
| 351724569 | 413 | protein kinase family protein [Glycine m | 0.989 | 0.912 | 0.587 | 1e-129 |
| >gi|359472840|ref|XP_003631201.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Vitis vinifera] gi|297737665|emb|CBI26866.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 546 bits (1406), Expect = e-153, Method: Compositional matrix adjust.
Identities = 276/401 (68%), Positives = 321/401 (80%), Gaps = 33/401 (8%)
Query: 1 MTKPKKFFDGLLKHFNLGSSREGDNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGE 60
M KPK F ++K F SS+EG EEDLEKIAA+EQK FPFE LV+ATKNFH KLGE
Sbjct: 11 MMKPKNFLQNIMKPFKFSSSKEGQKEEDLEKIAAQEQKLFPFETLVAATKNFH--QKLGE 68
Query: 61 GGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAE 120
GGFGPVFKG+L+DGREIAVKKLS +SNQGKKEFENEAKLLARVQHRNVVNLLGYC GAE
Sbjct: 69 GGFGPVFKGRLEDGREIAVKKLSQNSNQGKKEFENEAKLLARVQHRNVVNLLGYCTRGAE 128
Query: 121 KLLIYEYVINESLDKVLFSLIKDIQILFRKK-----------------------KTDIKA 157
KLL+YEY+ NESLDK LF + ++ ++++ DIKA
Sbjct: 129 KLLVYEYISNESLDKFLFKTGRREELDWKRRYDIVGGIARGLLYLHEDSHSCIIHRDIKA 188
Query: 158 SNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFG 217
SN+LLDDKW PKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFG
Sbjct: 189 SNVLLDDKWAPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFG 248
Query: 218 VVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQI 277
V+ILELISGQ+NS+F++++DAQNLL+WA+KLYKK +SLE++DPSLA+S +Q+AMC+QI
Sbjct: 249 VLILELISGQKNSTFDVNLDAQNLLEWAWKLYKKGRSLEVLDPSLASSAVAEQVAMCVQI 308
Query: 278 GLLCTQGDPQLRPTMRRVVVMLSKKPGPGNLEEPTRPGVPGSRYRRARRPAALSSSTAGS 337
GLLCTQ DPQ RP MRRVVVMLSKK PG LEEPTRPG PGSRYRR+RRP S+STAG+
Sbjct: 309 GLLCTQADPQSRPNMRRVVVMLSKK--PGTLEEPTRPGYPGSRYRRSRRPTT-SASTAGT 365
Query: 338 SGESNSRTYTSSLNTNTGTASASTSALASPRQDKRGKRPVE 378
SGES + + + T +A+A+TS +ASPR D RGKRPV+
Sbjct: 366 SGES-----SHTFESTTNSATATTSGVASPRLDSRGKRPVQ 401
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224111480|ref|XP_002315871.1| predicted protein [Populus trichocarpa] gi|222864911|gb|EEF02042.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 536 bits (1381), Expect = e-150, Method: Compositional matrix adjust.
Identities = 275/386 (71%), Positives = 309/386 (80%), Gaps = 33/386 (8%)
Query: 1 MTKPKKFFDGLLKHFNLGSSREGDNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGE 60
MTK K LLK F SS+E EED+E IAAREQK F FE LVSATK+FH ++KLGE
Sbjct: 1 MTKLKNCLKSLLKPFKFNSSKERLGEEDMETIAAREQKQFSFETLVSATKDFHLTHKLGE 60
Query: 61 GGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAE 120
GGFGPV+KGKLDDGREIAVKKLSHSSNQGKKEF NEAKLL+RVQHRNVVNLLGYCAHG E
Sbjct: 61 GGFGPVYKGKLDDGREIAVKKLSHSSNQGKKEFTNEAKLLSRVQHRNVVNLLGYCAHGVE 120
Query: 121 KLLIYEYVINESLDKVLFSLIK----------DIQI------LFRKKKT-------DIKA 157
KLL+YEYV NESLDK+LF K DI I L+ + + DIKA
Sbjct: 121 KLLVYEYVANESLDKLLFKSDKRQLLDWNRRYDILIGIARGLLYLHEDSHNCIIHRDIKA 180
Query: 158 SNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFG 217
SNILLDDKW+PKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFG
Sbjct: 181 SNILLDDKWVPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFG 240
Query: 218 VVILELISGQRNSSFNLD-VDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQ 276
V++LELISGQRNS+F+ DAQNLLDWAYKL+KK++SLEI+DP LA+S + +Q+ C+
Sbjct: 241 VLVLELISGQRNSTFSQQHADAQNLLDWAYKLHKKNRSLEIMDPVLASSAAAEQVKTCVH 300
Query: 277 IGLLCTQGDPQLRPTMRRVVVMLSKKPGPGNLEEPTRPGVPGSRYRRARRPAALSSSTAG 336
+GLLCTQGDPQLRP MRR+VV+LSKK +LEEPTRPGVPGSRYRRARRPA + SSTAG
Sbjct: 301 LGLLCTQGDPQLRPDMRRIVVLLSKK--TCSLEEPTRPGVPGSRYRRARRPAGM-SSTAG 357
Query: 337 SS------GESNSRTYTSSLNTNTGT 356
+S GES+SRT+ SS NTNT T
Sbjct: 358 TSDTARTFGESDSRTFDSSSNTNTAT 383
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356528198|ref|XP_003532692.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 531 bits (1369), Expect = e-148, Method: Compositional matrix adjust.
Identities = 263/395 (66%), Positives = 316/395 (80%), Gaps = 27/395 (6%)
Query: 7 FFDGLLKHFNLGSSREGDNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPV 66
F ++KHF GS +E +NE D++++AA+EQK F +E L +ATKNF +KLGEGGFGPV
Sbjct: 11 FLHSIVKHFKFGSPKERNNEADIQQMAAQEQKIFAYETLAAATKNFSAIHKLGEGGFGPV 70
Query: 67 FKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126
+KGKL+DGREIAVKKLSH+SNQGKKEF NEAKLLARVQHRNVVNL+GYC HG EKLL+YE
Sbjct: 71 YKGKLNDGREIAVKKLSHTSNQGKKEFMNEAKLLARVQHRNVVNLVGYCVHGTEKLLVYE 130
Query: 127 YVINESLDKVLFSLIKDIQILFRKK-----------------------KTDIKASNILLD 163
YV +ESLDK+LF K Q+ ++++ DIKASNILLD
Sbjct: 131 YVAHESLDKLLFKSQKREQLDWKRRIGIITGVAKGLLYLHEDSHNCIIHRDIKASNILLD 190
Query: 164 DKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILEL 223
DKW PKIADFGMARLFPEDQ+ V+TRVAGTNGYMAPEYVMHG+LSVKADVFS+GV++LEL
Sbjct: 191 DKWTPKIADFGMARLFPEDQSQVHTRVAGTNGYMAPEYVMHGNLSVKADVFSYGVLVLEL 250
Query: 224 ISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQ 283
I+GQRNSSFNLDVDAQNLLDWAYK+YKK KSLEIVD +LA++ +++AMC+Q+GLLCTQ
Sbjct: 251 ITGQRNSSFNLDVDAQNLLDWAYKMYKKGKSLEIVDSALASTIVAEEVAMCVQLGLLCTQ 310
Query: 284 GDPQLRPTMRRVVVMLSKKPGPGNLEEPTRPGVPGSRYRRARRPAALSSSTAGSSGESNS 343
GDPQLRPTMRRVVVMLS+K PGN++EPTRPGVPGSRYRR RR +AL SST G+SG S+S
Sbjct: 311 GDPQLRPTMRRVVVMLSRK--PGNMQEPTRPGVPGSRYRRPRRHSAL-SSTVGTSGASDS 367
Query: 344 RTYTSSLNTNTGTASASTSAL-ASPRQDKRGKRPV 377
T SS N NT +++T + A+ D +GKRP+
Sbjct: 368 HTSDSSNNYNTTVTTSATGTISATAETDPKGKRPI 402
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147805802|emb|CAN71621.1| hypothetical protein VITISV_016299 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 528 bits (1359), Expect = e-147, Method: Compositional matrix adjust.
Identities = 280/436 (64%), Positives = 324/436 (74%), Gaps = 68/436 (15%)
Query: 1 MTKPKKFFDGLLKHFNLGSSREGDNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGE 60
M KPK F ++K F SS+EG EEDLEKIAA+EQK FPFE LV+ATKNFH KLGE
Sbjct: 11 MMKPKNFLQNIMKPFKFSSSKEGQKEEDLEKIAAQEQKLFPFETLVAATKNFH--QKLGE 68
Query: 61 GGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAE 120
GGFGPVFKG+L+DGREIAVKKLS +SNQGKKEFENEAKLLARVQHRNVVNLLGYC GAE
Sbjct: 69 GGFGPVFKGRLEDGREIAVKKLSQNSNQGKKEFENEAKLLARVQHRNVVNLLGYCTRGAE 128
Query: 121 KLLIYEYVINESLDKVLFS--------------------------------LIKDIQ--I 146
KLL+YEY+ NESLDK LF+ +I I +
Sbjct: 129 KLLVYEYISNESLDKFLFNWEEIDSNIDGDCDGLDSETGRREELDWKRRYDIIGGIARGL 188
Query: 147 LFRKKKT-------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAP 199
L+ + + DIKASN+LLDDKW PKIADFGMARLFPEDQTHVNTRVAGTNGYMAP
Sbjct: 189 LYLHEDSHSCIIHRDIKASNVLLDDKWAPKIADFGMARLFPEDQTHVNTRVAGTNGYMAP 248
Query: 200 EYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDW--------------- 244
EYVMHGHLSVKADVFSFGV+ILELISGQ+NS+F++++DAQNLL+W
Sbjct: 249 EYVMHGHLSVKADVFSFGVLILELISGQKNSTFDVNLDAQNLLEWEKRDGMASFCDYCRL 308
Query: 245 --AYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302
A+KLYKK +SLE++DPSLA+S +Q+AMC+QIGLLCTQ DPQ RP MRRVVVMLSKK
Sbjct: 309 LQAWKLYKKGRSLEVLDPSLASSAVAEQVAMCVQIGLLCTQADPQSRPNMRRVVVMLSKK 368
Query: 303 PGPGNLEEPTRPGVPGSRYRRARRPAALSSSTAGSSGESNSRTYTSSLNTNTGTASASTS 362
PG LEEPTRPG PGSRYRR+RRP A S+STAG+SGES + + + T +A+A+TS
Sbjct: 369 --PGTLEEPTRPGYPGSRYRRSRRPTA-STSTAGTSGES-----SHTFESTTNSATATTS 420
Query: 363 ALASPRQDKRGKRPVE 378
+ASPR D RGKRPV+
Sbjct: 421 GVASPRLDSRGKRPVQ 436
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255573728|ref|XP_002527785.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223532820|gb|EEF34595.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 519 bits (1337), Expect = e-145, Method: Compositional matrix adjust.
Identities = 280/414 (67%), Positives = 327/414 (78%), Gaps = 38/414 (9%)
Query: 1 MTKPKKFFDGLLKHFNLGSSREGDNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGE 60
MTK K FF L K FN S REG EEDL+KIAA+EQKHF F+ L SATK+FHP++KLGE
Sbjct: 1 MTKSKNFFLNLFKPFNFNSKREGQTEEDLDKIAAQEQKHFTFDTLASATKDFHPTHKLGE 60
Query: 61 GGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAE 120
GGFGPV++GKL+DGR+IAVKKLSHSSNQGKKEF NEAKLLARVQHRNVVNLLGYC HG E
Sbjct: 61 GGFGPVYRGKLNDGRDIAVKKLSHSSNQGKKEFMNEAKLLARVQHRNVVNLLGYCTHGME 120
Query: 121 KLLIYEYVINESLDKVLFSLIKDIQILFRKK-----------------------KTDIKA 157
KLL+YEYV NESLDK+LF K Q+ ++++ DIKA
Sbjct: 121 KLLVYEYVSNESLDKLLFKSNKREQLDWKRRYDIITGIARGLLYLHEDSHNCIIHRDIKA 180
Query: 158 SNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFG 217
SNILLDDKW+PKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFG
Sbjct: 181 SNILLDDKWVPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFG 240
Query: 218 VVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQI 277
V++LELI+GQRNS+FN ++AQNLL+WAYKL+KKD+SLEI+D +LA+S + DQ+ MCI I
Sbjct: 241 VLVLELITGQRNSTFNQSLEAQNLLEWAYKLHKKDRSLEIMDSTLASSAAIDQVKMCIHI 300
Query: 278 GLLCTQGDPQLRPTMRRVVVMLSKKPGPGNLEEPTRPGVPGSRYRRARRPAALSSSTAGS 337
GLLCTQGDPQLRP MRRVV++LSK+ PGNLEEP+RPGVPGSRYRR+RRP + +ST G+
Sbjct: 301 GLLCTQGDPQLRPNMRRVVILLSKR--PGNLEEPSRPGVPGSRYRRSRRPPGM-TSTGGT 357
Query: 338 SGESNSRTYTSSLNTNTGTASASTSAL------------ASPRQDKRGKRPVES 379
SG+ +SRT+ SS N+NT TAS S + + PR D RGKRP+ S
Sbjct: 358 SGDCDSRTFNSSSNSNTATASTSAATASTSTATVSTSIPSKPRSDPRGKRPMGS 411
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521131|ref|XP_003529211.1| PREDICTED: putative cysteine-rich receptor-like protein kinase 20-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 504 bits (1299), Expect = e-140, Method: Compositional matrix adjust.
Identities = 257/407 (63%), Positives = 312/407 (76%), Gaps = 32/407 (7%)
Query: 1 MTKPKKFFDGLLKHFNLGSSREGDNEE-DLEKIAAREQKHFPFEALVSATKNFHPSNKLG 59
MTKP FF L+K F SS+EG EE +++ +AA+EQK FP+E LV+AT FH NKLG
Sbjct: 1 MTKPNTFFHNLIKPFKFSSSKEGQTEENEIQNLAAQEQKIFPYETLVAATNKFHILNKLG 60
Query: 60 EGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA 119
EGGFGPV+KGKL+DGREIAVKKLSH SNQGK +F NEAKLLARVQHRNVVNL GYC HG+
Sbjct: 61 EGGFGPVYKGKLNDGREIAVKKLSHRSNQGKTQFVNEAKLLARVQHRNVVNLFGYCTHGS 120
Query: 120 EKLLIYEYVINESLDKVLFSLIKDIQILFRKK-----------------------KTDIK 156
EKLL+YEYV ESLDK+LF K Q+ ++++ DIK
Sbjct: 121 EKLLVYEYVRRESLDKLLFKSQKKEQLDWKRRFDIITGVARGLLYLHEDSHNCIIHRDIK 180
Query: 157 ASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSF 216
ASNILLD+KW+PKIADFG+ARLFPEDQTHVNTRVAGTNGY+APEY+MHGHLSVKADVFS+
Sbjct: 181 ASNILLDEKWVPKIADFGLARLFPEDQTHVNTRVAGTNGYLAPEYLMHGHLSVKADVFSY 240
Query: 217 GVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQ 276
GV++LEL+SG RNSSF++DV AQNLLDWAY+LYKK ++LEIVDP+LA++ +Q MCIQ
Sbjct: 241 GVLVLELVSGLRNSSFDMDVSAQNLLDWAYRLYKKGRALEIVDPTLASTAVTEQAEMCIQ 300
Query: 277 IGLLCTQGDPQLRPTMRRVVVMLSKKPGPGNLEEPTRPGVPGSRYRR-ARRPAALSSSTA 335
+GLLCTQGD LRPTM RV+V+LSKKP PG++EEPTRPG+PGSRYRR +RRP A+SS
Sbjct: 301 LGLLCTQGDLNLRPTMGRVIVVLSKKP-PGHMEEPTRPGIPGSRYRRVSRRPYAMSSGEV 359
Query: 336 GSSGESNSRTYTSSLNTNTGTASASTSALASPRQ----DKRGKRPVE 378
+SN T+ SS N T T +++T+ S D+RGKRP++
Sbjct: 360 --DDDSNLHTFDSSRNCGTNTTTSATTPTTSSNTTAEVDRRGKRPMQ 404
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449449046|ref|XP_004142276.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Cucumis sativus] gi|449527341|ref|XP_004170670.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 502 bits (1292), Expect = e-139, Method: Compositional matrix adjust.
Identities = 269/414 (64%), Positives = 312/414 (75%), Gaps = 39/414 (9%)
Query: 1 MTKPKKFFDGLLKHFNLGSSREGDNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGE 60
MTK K F L+K F GSSR+ E+DLE+IAA+EQK F+ALV AT NFH +NKLG+
Sbjct: 1 MTKSKSFVQNLIKQFRFGSSRDRQGEDDLEEIAAKEQKLIQFDALVEATNNFHSTNKLGQ 60
Query: 61 GGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAE 120
GGFGPV+KGKL DGR IAVKKLS S QG+KEF EAKLLARVQHRNVVNLLGYC HGAE
Sbjct: 61 GGFGPVYKGKLKDGRVIAVKKLSLYSKQGRKEFMTEAKLLARVQHRNVVNLLGYCVHGAE 120
Query: 121 KLLIYEYVINESLDKVLFSLIKDIQILFRKK-----------------------KTDIKA 157
KLL+YEYV+NESLDK+LF + ++ ++++ DIKA
Sbjct: 121 KLLVYEYVMNESLDKLLFKSSRRGELDWKRRYDIIFGVARGLQYLHVDSHNVIIHRDIKA 180
Query: 158 SNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFG 217
SNILLDDKW+PKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFG
Sbjct: 181 SNILLDDKWVPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFG 240
Query: 218 VVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQI 277
V++LELISGQRNSSF +DA+NLLDWAYKLYKK +SLEI+DP+LA+S DQ+ MCIQI
Sbjct: 241 VLVLELISGQRNSSFTSFMDAENLLDWAYKLYKKGRSLEIMDPTLASSAVPDQVTMCIQI 300
Query: 278 GLLCTQGDPQLRPTMRRVVVMLSKKPGPGNLEEPTRPGVPGSRYRRARRPAALSSSTAGS 337
GLLCTQGD LRPTM RVV++LSK+ PGNLEEPTRPG+PGSRYRR RR +A SSS G+
Sbjct: 301 GLLCTQGDSHLRPTMPRVVLILSKR--PGNLEEPTRPGMPGSRYRRTRRTSA-SSSIVGT 357
Query: 338 SGESNSRTYTSSLNTNTGTAS-------------ASTSALASPRQDKRGKRPVE 378
SG S+ + + +L TNT AS+S+ S R D RGKRP+E
Sbjct: 358 SGTSSGVSDSYALTTNTTGTITATATATATANEVASSSSPISRRYDTRGKRPIE 411
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356510843|ref|XP_003524143.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 496 bits (1278), Expect = e-138, Method: Compositional matrix adjust.
Identities = 249/395 (63%), Positives = 305/395 (77%), Gaps = 32/395 (8%)
Query: 7 FFDGLLKHFNLGSSREGDNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPV 66
F ++KHF GS +E +NE D+ ++AA+EQK F +E L +ATKNF +KLGEGGFGPV
Sbjct: 11 FLHSIVKHFKFGSPKERNNEADVHQMAAQEQKIFAYETLTAATKNFSAIHKLGEGGFGPV 70
Query: 67 FKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126
+KGKL+DGREIAVKKLSH+SNQGKKEF NEAKLLARVQHRNVVNL+GYC +G EKLL+YE
Sbjct: 71 YKGKLNDGREIAVKKLSHTSNQGKKEFMNEAKLLARVQHRNVVNLVGYCVYGTEKLLVYE 130
Query: 127 YVINESLDKVLFSLIKDIQILFRKK-----------------------KTDIKASNILLD 163
YV +ESLDK+LF K ++ ++++ DIKASNILLD
Sbjct: 131 YVAHESLDKLLFKSEKREELDWKRRVGIITGVAKGLLYLHEDSHNCIIHRDIKASNILLD 190
Query: 164 DKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILEL 223
+KW PKIADFGMARLFPEDQT VNTRVAGTNGYMAPEYVMHG+LSVKADVFS+GV++LEL
Sbjct: 191 EKWTPKIADFGMARLFPEDQTQVNTRVAGTNGYMAPEYVMHGNLSVKADVFSYGVLVLEL 250
Query: 224 ISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQ 283
I+GQRNSSFNLDVDAQNLLDWAYK++KK KSLE+VD +LA+ +++AMC+++GLLCTQ
Sbjct: 251 ITGQRNSSFNLDVDAQNLLDWAYKMFKKGKSLELVDSALASRMVAEEVAMCVRLGLLCTQ 310
Query: 284 GDPQLRPTMRRVVVMLSKKPGPGNLEEPTRPGVPGSRYRRARRPAALSSSTAGSSGESNS 343
GDPQLRPTMRRVV MLS+K GN++EPTRPG+PGSRYRR R + SST G+SG
Sbjct: 311 GDPQLRPTMRRVVAMLSRK--QGNMQEPTRPGIPGSRYRRPPRRHSALSSTLGTSGSD-- 366
Query: 344 RTYTSSLNTNTGTASASTSALASPRQ-DKRGKRPV 377
SS N NT +++T ++ + D +GKRP+
Sbjct: 367 ----SSNNDNTTVTTSATGTSSATAETDPKGKRPM 397
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30698743|ref|NP_177231.2| protein kinase domain-containing protein [Arabidopsis thaliana] gi|193870477|gb|ACF22895.1| At1g70740 [Arabidopsis thaliana] gi|332196987|gb|AEE35108.1| protein kinase domain-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 469 bits (1207), Expect = e-129, Method: Compositional matrix adjust.
Identities = 241/413 (58%), Positives = 299/413 (72%), Gaps = 42/413 (10%)
Query: 1 MTKPKKFFDGLLKHFNLGSSREGDNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGE 60
MTK FF ++K F S+R E+D+E+IAA EQK FPF+ LVSATK+FHP++KLGE
Sbjct: 13 MTKSMNFFQNIIKPFKRSSNR--GLEDDIERIAAMEQKVFPFQVLVSATKDFHPTHKLGE 70
Query: 61 GGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAE 120
GGFGPVFKG+L DGR+IAVKKLS S QGK EF NEAKLLA+VQHRNVVNL GYC HG +
Sbjct: 71 GGFGPVFKGRLPDGRDIAVKKLSQVSRQGKNEFVNEAKLLAKVQHRNVVNLWGYCTHGDD 130
Query: 121 KLLIYEYVINESLDKVLFSLIKDIQILFRKK-----------------------KTDIKA 157
KLL+YEYV+NESLDKVLF + +I ++++ DIKA
Sbjct: 131 KLLVYEYVVNESLDKVLFKSNRKSEIDWKQRFEIITGIARGLLYLHEDAPNCIIHRDIKA 190
Query: 158 SNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFG 217
NILLD+KW+PKIADFGMARL+ ED THVNTRVAGTNGYMAPEYVMHG LSVKADVFSFG
Sbjct: 191 GNILLDEKWVPKIADFGMARLYQEDVTHVNTRVAGTNGYMAPEYVMHGVLSVKADVFSFG 250
Query: 218 VVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQI 277
V++LEL+SGQ+NSSF++ Q LL+WA+KLYKK +++EI+D +AAS DQ+ +C+QI
Sbjct: 251 VLVLELVSGQKNSSFSMRHPDQTLLEWAFKLYKKGRTMEILDQDIAASADPDQVKLCVQI 310
Query: 278 GLLCTQGDPQLRPTMRRVVVMLSKKPGPGNLEEPTRPGVPGSRY-RRARRPAALSSSTAG 336
GLLC QGDP RP+MRRV ++LS+K PG+LEEP PGVPGSRY RR +RP+ +S
Sbjct: 311 GLLCVQGDPHQRPSMRRVSLLLSRK--PGHLEEPDHPGVPGSRYRRRTQRPSGAASLGTL 368
Query: 337 SSGESNSRTYTSSLNTNTGT--------------ASASTSALASPRQDKRGKR 375
S+ S++ ++ S+LNTNTGT ++A+ SA S D GKR
Sbjct: 369 STTGSSTDSFGSNLNTNTGTGVRGTPASSKASTRSNATRSAGQSSSSDPHGKR 421
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351724569|ref|NP_001237574.1| protein kinase family protein [Glycine max] gi|223452284|gb|ACM89470.1| protein kinase family protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 467 bits (1202), Expect = e-129, Method: Compositional matrix adjust.
Identities = 242/412 (58%), Positives = 304/412 (73%), Gaps = 35/412 (8%)
Query: 1 MTKPKKFFDGLLKHFNLGSSREGDNE-EDLEKIAAREQKHFPFEALVSATKNFHPSNKLG 59
M+K FF L+K F S+EG +E E+++ +AA+EQK FP+E LV+AT FH NKLG
Sbjct: 1 MSKRNTFFHNLIKPFKFSPSKEGQSEVEEIKNLAAQEQKIFPYETLVAATNKFHILNKLG 60
Query: 60 EGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA 119
EGGFGPV+KGKL+DGREIAVKKLSH SNQGK +F NEAKLLARVQHRNVV+L GYC HG
Sbjct: 61 EGGFGPVYKGKLNDGREIAVKKLSHRSNQGKTQFVNEAKLLARVQHRNVVSLFGYCTHGF 120
Query: 120 EKLLIYEYVINESLDKVLFSLIKDIQILFRKK-----------------------KTDIK 156
EKLL+YEYV++ESLDK+LF K Q+ ++++ DIK
Sbjct: 121 EKLLVYEYVLHESLDKLLFKSHKKEQLDWKRRFDIINGVARGLLYLHEDSHNCIIHRDIK 180
Query: 157 ASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSF 216
ASNILLD+ W+PKIADFG+ARLFPEDQTHVNTRVAGTNGY+APEY+MHGHL+VKADVFS+
Sbjct: 181 ASNILLDENWVPKIADFGLARLFPEDQTHVNTRVAGTNGYLAPEYLMHGHLTVKADVFSY 240
Query: 217 GVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQ 276
GV++LEL+SGQRNSSF++DV AQNL+DWAY+LYKK ++LEIVDP+LA+S +Q MCIQ
Sbjct: 241 GVLVLELVSGQRNSSFDMDVSAQNLVDWAYRLYKKGRALEIVDPTLASSVVAEQAEMCIQ 300
Query: 277 IGLLCTQGDPQLRPTMRRVVVMLSKKPGPGNLEEPTRPGVP----GSRYRRARRPAALSS 332
+GLLCTQG+ LRP+M RV+V+LSKKP P ++EEPTRPG+ R R RRP+A +S
Sbjct: 301 LGLLCTQGNQDLRPSMGRVMVILSKKP-PCHMEEPTRPGIAGSRYRRRVSRGRRPSATTS 359
Query: 333 STAGSSGESNSRTYTSSLNTNTGTASASTSALASPRQ------DKRGKRPVE 378
NS+T+ SS N T T +++T+ D+RGKRP++
Sbjct: 360 GEVDDDSSVNSQTFDSSSNYGTNTTTSATTPTTRSSNTTAEVVDRRGKRPMQ 411
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 381 | ||||||
| TAIR|locus:2033577 | 425 | AT1G70740 [Arabidopsis thalian | 0.427 | 0.383 | 0.709 | 1.4e-112 | |
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.422 | 0.240 | 0.5 | 5.3e-68 | |
| TAIR|locus:2121686 | 645 | CRK19 "cysteine-rich RLK (RECE | 0.419 | 0.248 | 0.5 | 1.2e-66 | |
| TAIR|locus:2141201 | 679 | CRK29 "cysteine-rich RLK (RECE | 0.430 | 0.241 | 0.511 | 3.5e-66 | |
| TAIR|locus:2121651 | 676 | CRK8 "cysteine-rich RLK (RECEP | 0.419 | 0.236 | 0.521 | 1.3e-65 | |
| TAIR|locus:2123071 | 636 | CRK33 "cysteine-rich RLK (RECE | 0.385 | 0.231 | 0.496 | 2.4e-65 | |
| TAIR|locus:2121626 | 830 | CRK23 "cysteine-rich RLK (RECE | 0.419 | 0.192 | 0.481 | 6e-65 | |
| TAIR|locus:2123116 | 700 | CRK30 "cysteine-rich RLK (RECE | 0.419 | 0.228 | 0.512 | 1.3e-64 | |
| TAIR|locus:2141762 | 665 | CRK26 "cysteine-rich RLK (RECE | 0.417 | 0.239 | 0.496 | 4.3e-64 | |
| TAIR|locus:2095334 | 393 | AT3G09010 [Arabidopsis thalian | 0.425 | 0.412 | 0.478 | 6.1e-64 |
| TAIR|locus:2033577 AT1G70740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 629 (226.5 bits), Expect = 1.4e-112, Sum P(2) = 1.4e-112
Identities = 117/165 (70%), Positives = 141/165 (85%)
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADV 213
DIKA NILLD+KW+PKIADFGMARL+ ED THVNTRVAGTNGYMAPEYVMHG LSVKADV
Sbjct: 187 DIKAGNILLDEKWVPKIADFGMARLYQEDVTHVNTRVAGTNGYMAPEYVMHGVLSVKADV 246
Query: 214 FSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAM 273
FSFGV++LEL+SGQ+NSSF++ Q LL+WA+KLYKK +++EI+D +AAS DQ+ +
Sbjct: 247 FSFGVLVLELVSGQKNSSFSMRHPDQTLLEWAFKLYKKGRTMEILDQDIAASADPDQVKL 306
Query: 274 CIQIGLLCTQGDPQLRPTMRRVVVMLSKKPGPGNLEEPTRPGVPG 318
C+QIGLLC QGDP RP+MRRV ++LS+KPG +LEEP PGVPG
Sbjct: 307 CVQIGLLCVQGDPHQRPSMRRVSLLLSRKPG--HLEEPDHPGVPG 349
|
|
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 415 (151.1 bits), Expect = 5.3e-68, Sum P(2) = 5.3e-68
Identities = 82/164 (50%), Positives = 114/164 (69%)
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT-RVAGTNGYMAPEYVMHGHLSVKAD 212
D+KASNILLD PKIADFGMAR+F DQT NT R+ GT GYM+PEY MHG S+K+D
Sbjct: 473 DLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSD 532
Query: 213 VFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIA 272
V+SFGV++LE+ISG++NSSF A +L+ +A+ L+ + LE+VDP++ + +++
Sbjct: 533 VYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYAWGLWSNGRPLELVDPAIVENCQRNEVV 592
Query: 273 MCIQIGLLCTQGDPQLRPTMRRVVVMLSKKPGPGNLEEPTRPGV 316
C+ IGLLC Q DP RPT+ +V+ML+ L P +PG+
Sbjct: 593 RCVHIGLLCVQEDPAERPTLSTIVLMLTSNTV--TLPVPRQPGL 634
|
|
| TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 389 (142.0 bits), Expect = 1.2e-66, Sum P(2) = 1.2e-66
Identities = 82/164 (50%), Positives = 106/164 (64%)
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR-VAGTNGYMAPEYVMHGHLSVKAD 212
D+KA NILLDD PKIADFGMAR+F DQT TR V GT GYM+PEY M+G S+K+D
Sbjct: 451 DLKAGNILLDDDMNPKIADFGMARIFGMDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSD 510
Query: 213 VFSFGVVILELISGQRNSS-FNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271
V+SFGV++LE+ISG +NSS + +D NL+ + ++L+ E+VDPS + +I
Sbjct: 511 VYSFGVLVLEIISGMKNSSLYQMDESVGNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEI 570
Query: 272 AMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKPGPGNLEEPTRPG 315
CI I LLC Q D + RPTM +V ML+ L EP PG
Sbjct: 571 TRCIHIALLCVQEDAEDRPTMSSIVQMLTTSLIA--LAEPRPPG 612
|
|
| TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 409 (149.0 bits), Expect = 3.5e-66, Sum P(2) = 3.5e-66
Identities = 88/172 (51%), Positives = 115/172 (66%)
Query: 148 FRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQT--H-VNTRVAGTNGYMAPEYVMH 204
FR D+KASNILLD + PKIADFG+A+LF QT H +R+AGT GYMAPEY MH
Sbjct: 476 FRIIHRDLKASNILLDQEMNPKIADFGLAKLFDSGQTMTHRFTSRIAGTYGYMAPEYAMH 535
Query: 205 GHLSVKADVFSFGVVILELISGQRNSS--FNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262
G SVK DVFSFGV+++E+I+G+RN++ N D DA++LL W ++ +++D L ++DPSL
Sbjct: 536 GQFSVKTDVFSFGVLVIEIITGKRNNNGGSNGDEDAEDLLSWVWRSWREDTILSVIDPSL 595
Query: 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKPGPGNLEEPTRP 314
A S ++I CI IGLLC Q RPTM V +ML+ L P RP
Sbjct: 596 TAG-SRNEILRCIHIGLLCVQESAATRPTMATVSLMLNSYSF--TLPTPLRP 644
|
|
| TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 413 (150.4 bits), Expect = 1.3e-65, Sum P(2) = 1.3e-65
Identities = 85/163 (52%), Positives = 112/163 (68%)
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT-RVAGTNGYMAPEYVMHGHLSVKAD 212
D+KASNILLD PKIADFGMAR+F DQT NT R+ GT GYMAPEY MHG S+K+D
Sbjct: 478 DLKASNILLDADINPKIADFGMARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSD 537
Query: 213 VFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIA 272
V+SFGV++LE+ISG++NSSF+ AQ+LL ++L+ +L++VDP +A + ++
Sbjct: 538 VYSFGVLVLEIISGRKNSSFDESDGAQDLLTHTWRLWTNRTALDLVDPLIANNCQNSEVV 597
Query: 273 MCIQIGLLCTQGDPQLRPTMRRVVVMLSKKPGPGNLEEPTRPG 315
CI IGLLC Q DP RPT+ V +ML+ L P +PG
Sbjct: 598 RCIHIGLLCVQEDPAKRPTISTVFMMLTSNTV--TLPVPRQPG 638
|
|
| TAIR|locus:2123071 CRK33 "cysteine-rich RLK (RECEPTOR-like protein kinase) 33" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 397 (144.8 bits), Expect = 2.4e-65, Sum P(2) = 2.4e-65
Identities = 74/149 (49%), Positives = 110/149 (73%)
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR-VAGTNGYMAPEYVMHGHLSVKAD 212
D+KASNILLD + PK+ADFGMAR+F DQ+ +TR V GT+GY++PEY+MHG SVK+D
Sbjct: 446 DLKASNILLDAEMEPKVADFGMARIFRVDQSRADTRRVVGTHGYISPEYLMHGQFSVKSD 505
Query: 213 VFSFGVVILELISGQRNSSFN-LDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271
V+SFGV++LE+ISG+RNS+F+ D +NL+ +A++ ++ LE+VD L + +++
Sbjct: 506 VYSFGVLVLEIISGKRNSNFHETDESGKNLVTYAWRHWRNGSPLELVDSELEKNYQSNEV 565
Query: 272 AMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300
CI I LLC Q DP+ RP + +++ML+
Sbjct: 566 FRCIHIALLCVQNDPEQRPNLSTIIMMLT 594
|
|
| TAIR|locus:2121626 CRK23 "cysteine-rich RLK (RECEPTOR-like protein kinase) 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 378 (138.1 bits), Expect = 6.0e-65, Sum P(2) = 6.0e-65
Identities = 79/164 (48%), Positives = 103/164 (62%)
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR-VAGTNGYMAPEYVMHGHLSVKAD 212
D+KA NILLD PK+ADFGMAR+F DQT NTR V GT GYMAPEY M+G S+K+D
Sbjct: 633 DLKAGNILLDADMNPKVADFGMARIFGMDQTEANTRRVVGTYGYMAPEYAMYGQFSMKSD 692
Query: 213 VFSFGVVILELISGQRNSS-FNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271
V+SFGV++ E+ISG +NSS + +D NL+ + ++L+ L++VDPS + I
Sbjct: 693 VYSFGVLVFEIISGMKNSSLYQMDDSVSNLVTYTWRLWSNGSQLDLVDPSFGDNYQTHDI 752
Query: 272 AMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKPGPGNLEEPTRPG 315
CI I LLC Q D RP M +V ML+ L P +PG
Sbjct: 753 TRCIHIALLCVQEDVDDRPNMSAIVQMLTTSSIV--LAVPKQPG 794
|
|
| TAIR|locus:2123116 CRK30 "cysteine-rich RLK (RECEPTOR-like protein kinase) 30" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 403 (146.9 bits), Expect = 1.3e-64, Sum P(2) = 1.3e-64
Identities = 84/164 (51%), Positives = 111/164 (67%)
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT-RVAGTNGYMAPEYVMHGHLSVKAD 212
DIKASNILLD PKIADFGMAR F + QT +T RV GT GYM PEYV HG S K+D
Sbjct: 474 DIKASNILLDADMNPKIADFGMARNFRDHQTEDSTGRVVGTFGYMPPEYVAHGQFSTKSD 533
Query: 213 VFSFGVVILELISGQRNSSF-NLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271
V+SFGV+ILE++SG++NSSF +D NL+ + ++L+ D SLE+VDP+++ S D++
Sbjct: 534 VYSFGVLILEIVSGRKNSSFYQMDGSVCNLVTYVWRLWNTDSSLELVDPAISGSYEKDEV 593
Query: 272 AMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKPGPGNLEEPTRPG 315
CI IGLLC Q +P RP + + ML+ N+ +P PG
Sbjct: 594 TRCIHIGLLCVQENPVNRPALSTIFQMLTNSSITLNVPQP--PG 635
|
|
| TAIR|locus:2141762 CRK26 "cysteine-rich RLK (RECEPTOR-like protein kinase) 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 376 (137.4 bits), Expect = 4.3e-64, Sum P(2) = 4.3e-64
Identities = 82/165 (49%), Positives = 109/165 (66%)
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQT--HVNTRVAGTNGYMAPEYVMHGHLSVKA 211
D+KASNILLD++ PKIADFGMARLF D T R+ GT GYMAPEYVMHG S K
Sbjct: 469 DLKASNILLDEEMTPKIADFGMARLFDIDHTTQRYTNRIVGTFGYMAPEYVMHGQFSFKT 528
Query: 212 DVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA--ASDSGD 269
DV+SFGV++LE+ISG++NS F+ + +L+ +A++ +K+ +L +VD L +S S +
Sbjct: 529 DVYSFGVLVLEIISGKKNSGFSSEDSMGDLISFAWRNWKEGVALNLVDKILMTMSSYSSN 588
Query: 270 QIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKPGPGNLEEPTRP 314
I CI IGLLC Q RP+M VV+ML L EP++P
Sbjct: 589 MIMRCINIGLLCVQEKVAERPSMASVVLMLDGHTIA--LSEPSKP 631
|
|
| TAIR|locus:2095334 AT3G09010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 387 (141.3 bits), Expect = 6.1e-64, Sum P(2) = 6.1e-64
Identities = 78/163 (47%), Positives = 111/163 (68%)
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADV 213
DIKASNILLD + PKI DFG+A+LFP++ THV+TRVAGT GY+APEY + G L+ KADV
Sbjct: 172 DIKASNILLDSNFSPKIGDFGLAKLFPDNVTHVSTRVAGTVGYLAPEYALLGQLTKKADV 231
Query: 214 FSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAM 273
+SFG+++LE+ISG ++ + L++W +KL ++ + LE VDP L + D++
Sbjct: 232 YSFGILVLEVISGNSSTRAAFGDEYMVLVEWVWKLREERRLLECVDPELTKFPA-DEVTR 290
Query: 274 CIQIGLLCTQGDPQLRPTMRRVVVMLSKKPGPGNLEEPTRPGV 316
I++ L CTQ Q RP M++V+ ML +K N + T PGV
Sbjct: 291 FIKVALFCTQAAAQKRPNMKQVMEMLRRKELNLNEDALTEPGV 333
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 381 | |||
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-41 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-39 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-39 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-36 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-23 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-21 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-19 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-12 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-10 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.001 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.001 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.001 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 0.002 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.003 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.003 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-41
Identities = 78/281 (27%), Positives = 126/281 (44%), Gaps = 57/281 (20%)
Query: 56 NKLGEGGFGPVFKGKLDDG----REIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVN 110
KLGEG FG V+KGKL E+AVK L S + +K+F EA+++ ++ H NVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 111 LLGYCAHGAEKLLIYEYVINESLDKVL------FSLIKDIQILFRKKKT----------- 153
LLG C L+ EY+ L L F + + + +
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 154 ---------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-----YMAP 199
D+ A N L+ + + KI+DFG++R +D + T G +MAP
Sbjct: 121 LASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPIRWMAP 176
Query: 200 EYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIV 258
E + G + K+DV+SFGV++ E+ + G + + + + +L++ +K L
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGA--TPYP-GLSNEEVLEY----LRKGYRLPK- 228
Query: 259 DPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299
P D++ ++ L C Q DP+ RPT +V L
Sbjct: 229 -PEYC----PDELY---ELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-41
Identities = 78/275 (28%), Positives = 120/275 (43%), Gaps = 55/275 (20%)
Query: 57 KLGEGGFGPVFKGKLDD-----GREIAVKKL-SHSSNQGKKEFENEAKLLARVQHRNVVN 110
KLGEG FG V+KGKL E+AVK L +S Q +EF EA+++ ++ H NVV
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 111 LLGYCAHGAEKLLIYEYVINESLDKVL------FSLIKDIQILF---------------- 148
LLG C ++ EY+ L L SL +
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIH 125
Query: 149 RKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG---YMAPEYVMHG 205
R D+ A N L+ + + KI+DFG++R +D + R G +MAPE + G
Sbjct: 126 R----DLAARNCLVGENLVVKISDFGLSRDLYDDDYY---RKRGGKLPIRWMAPESLKEG 178
Query: 206 HLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264
+ K+DV+SFGV++ E+ + G+ + + +L++ K L P
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGE---QPYPGMSNEEVLEYL----KNGYRLPQ--PPNCP 229
Query: 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299
+ + L C DP+ RPT +V +L
Sbjct: 230 PE-------LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-39
Identities = 76/276 (27%), Positives = 122/276 (44%), Gaps = 56/276 (20%)
Query: 57 KLGEGGFGPVFKGKLDDG-----REIAVKKLSHSSN-QGKKEFENEAKLLARVQHRNVVN 110
KLGEG FG V+KG L E+AVK L ++ Q +EF EA+++ ++ H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 111 LLGYCAHGAEKLLIYEYVINESLDKVL-------FSLIKDIQILF--------------- 148
LLG C +++ EY+ L L SL +
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFI 125
Query: 149 -RKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG---YMAPEYVMH 204
R D+ A N L+ + + KI+DFG++R +D + +V G +MAPE +
Sbjct: 126 HR----DLAARNCLVGENLVVKISDFGLSRDLYDDDYY---KVKGGKLPIRWMAPESLKE 178
Query: 205 GHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263
G + K+DV+SFGV++ E+ + G+ + +L++ KK L P
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGE---EPYPGMSNAEVLEYL----KKGYRLPK--PPNC 229
Query: 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299
+ ++ L C DP+ RPT +V +L
Sbjct: 230 PPE-------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 3e-39
Identities = 58/188 (30%), Positives = 91/188 (48%), Gaps = 23/188 (12%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKE-FENEAKLLARVQHRNVVNLLGYC 115
LGEGGFG V+ + G+++A+K + + E E ++L ++ H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 116 AHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT------------------DIKA 157
L+ EY SL +L + + D+K
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 158 SNILLD-DKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMH-GHLSVKADVFS 215
NILLD D K+ADFG+++L D++ + T V GT YMAPE ++ G+ S K+D++S
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKSDIWS 179
Query: 216 FGVVILEL 223
GV++ EL
Sbjct: 180 LGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 3e-37
Identities = 78/267 (29%), Positives = 116/267 (43%), Gaps = 44/267 (16%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKE--FENEAKLLARVQHRNVVNLLG 113
KLG G FG V+K K G+ +AVK L S + KK+ E ++L R+ H N+V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 114 YCAHGAEKLLIYEYVINESLDKVLFS-------LIKDI--QIL------------FRKKK 152
L+ EY L L K I QIL R
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHR--- 122
Query: 153 TDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG-HLSVKA 211
D+K NILLD+ + KIADFG+A+ + + + T V GT YMAPE ++ G K
Sbjct: 123 -DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPKV 180
Query: 212 DVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271
DV+S GV++ EL++G + ++ Q +L ++ ++ SG +
Sbjct: 181 DVWSLGVILYELLTG-KPPFSGENILDQ------LQLIRRILG-PPLEFDEPKWSSGSE- 231
Query: 272 AMCIQI--GLLCTQGDPQLRPTMRRVV 296
+ L DP RPT ++
Sbjct: 232 -EAKDLIKKCLNK--DPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-36
Identities = 75/283 (26%), Positives = 116/283 (40%), Gaps = 70/283 (24%)
Query: 57 KLGEGGFGPVFKGKLDD-----GREIAVKKL-SHSSNQGKKEFENEAKLLARVQHRNVVN 110
KLGEG FG V+KG L ++AVK L +S + ++EF EA ++ ++ H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 111 LLGYCAHGAEKLLIYEYVINESLDKVL------------FSLIKDI----------QILF 148
LLG C G ++ EY+ L L + I +
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVH 125
Query: 149 RKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGY-----MAPEYVM 203
R D+ A N L+ + + KI+DFG++R ED + G MAPE +
Sbjct: 126 R----DLAARNCLVTENLVVKISDFGLSRDIYEDDYYR----KRGGGKLPIKWMAPESLK 177
Query: 204 HGHLSVKADVFSFGVVILELIS-------GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLE 256
G + K+DV+SFGV++ E+ + G N +L + L
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV-------------LELLEDGYRLP 224
Query: 257 IVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299
P D++ ++ L C DP+ RPT +V L
Sbjct: 225 R--PENCP----DELY---ELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 4e-36
Identities = 72/261 (27%), Positives = 109/261 (41%), Gaps = 34/261 (13%)
Query: 52 FHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKE-FENEAKLLARVQHRNVV 109
+ KLGEG FG V+ + G+ +A+K + + +E E K+L +++H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 110 NLLGYCAHGAEKLLIYEYVINESLDKVL-----FSL--IKDI--QIL-----FRKKK--- 152
L + L+ EY L +L S + QIL K
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120
Query: 153 TDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKAD 212
D+K NILLD+ K+ADFG+AR + T GT YMAPE ++ D
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAPEVLLGKGYGKAVD 178
Query: 213 VFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIA 272
++S GV++ EL++G+ F + L +K K K P S +
Sbjct: 179 IWSLGVILYELLTGK--PPF----PGDDQLLELFKKIGKPK-PPFPPPEWDISPEAKDL- 230
Query: 273 MCIQIGLLCTQGDPQLRPTMR 293
I+ LL DP+ R T
Sbjct: 231 --IR-KLLVK--DPEKRLTAE 246
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 79/268 (29%), Positives = 119/268 (44%), Gaps = 45/268 (16%)
Query: 51 NFHPSNKLGEGGFGPVFKGK-LDDGREIAVKK--LSHSSNQGKKEFENEAKLLARVQHRN 107
+ LG G FG V+ D G +AVK LS S + + E E ++L+ +QH N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 108 VVNLLGYCAHGAEK-LLIY-EYVINESLDKVL--F-----SLIKD--IQIL--------- 147
+V G + L I+ EYV SL +L F +I+ QIL
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120
Query: 148 ---FRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR-VAGTNGYMAPEYVM 203
R DIK +NIL+D + K+ADFG A+ + +T T V GT +MAPE +
Sbjct: 121 GIVHR----DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 204 HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263
AD++S G ++E+ +G+ S L L YK+ + EI P
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPPWS-ELGNPMAAL----YKIGSSGEPPEI--PEHL 229
Query: 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPT 291
+ ++ D + C++ DP+ RPT
Sbjct: 230 SEEAKDFLRKCLRR-------DPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 62/195 (31%), Positives = 98/195 (50%), Gaps = 21/195 (10%)
Query: 52 FHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVN 110
F K+G+GGFG V+K + G+E+A+K + S + K++ NE ++L + +H N+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 111 LLG-------------YCAHGAEKLLI--YEYVINES-LDKVLFSLIKDIQILFRKKKT- 153
G +C+ G+ K L+ + ES + V L+K ++ L
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121
Query: 154 -DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKAD 212
DIKA+NILL K+ DFG++ D NT V GT +MAPE + KAD
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQL-SDTKARNTMV-GTPYWMAPEVINGKPYDYKAD 179
Query: 213 VFSFGVVILELISGQ 227
++S G+ +EL G+
Sbjct: 180 IWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-26
Identities = 64/211 (30%), Positives = 95/211 (45%), Gaps = 47/211 (22%)
Query: 58 LGEGGFGPVFKGKL------DDGREIAVKKLSH-SSNQGKKEFENEAKLLARVQHRNVVN 110
LGEG FG VF G+ +D +AVK L +SN +K+FE EA+LL QH N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 111 LLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT----------------- 153
G C G ++++EY+ + L+K L S D L
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 154 --------------DIKASNILLDDKWIPKIADFGMAR-LFPEDQTHVNTRVAGTN---- 194
D+ N L+ + KI DFGM+R ++ D RV G
Sbjct: 133 SGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY----YRVGGHTMLPI 188
Query: 195 GYMAPEYVMHGHLSVKADVFSFGVVILELIS 225
+M PE +M+ + ++DV+SFGVV+ E+ +
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 64/267 (23%), Positives = 118/267 (44%), Gaps = 47/267 (17%)
Query: 56 NKLGEGGFGPVFKGK-LDDGREIAVKK--LSHSSNQGKKEFENEAKLLARVQHRNVVNLL 112
++G+G FG V+ + DG+ +K+ LS+ S + +++ NE K+L ++ H N++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK-- 63
Query: 113 GYCAHGAEKLLIY---EYVINESLDKVLFSLIKD-------------IQILF-----RKK 151
Y EK + EY L + + K+ +Q+ +
Sbjct: 64 -YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122
Query: 152 KT---DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLS 208
K DIK NI L + K+ DFG++++ T V GT Y++PE + +
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNKPYN 181
Query: 209 VKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268
K+D++S G V+ EL + + F + +NLL+ A K+ K P + + S
Sbjct: 182 YKSDIWSLGCVLYELCTLKH--PF----EGENLLELALKILKGQY------PPIPSQYSS 229
Query: 269 DQIAMCIQIGLLCTQGDPQLRPTMRRV 295
+ + Q DP+ RP++ ++
Sbjct: 230 ELRNLV----SSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 69/275 (25%), Positives = 117/275 (42%), Gaps = 39/275 (14%)
Query: 51 NFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKE---FENEAKLLARVQH-R 106
++ KLGEG FG V+ + D + +A+K L+ KE F E ++LA + H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 107 NVVNLLGYCAHGAEKLLIYEYVINESLDKVL------------------FSLIKDIQIL- 147
N+V L + L+ EYV SL+ +L ++ ++ L
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 148 -FRKKKTDIKASNILLD-DKWIPKIADFGMARLFPEDQTHVNTR-----VAGTNGYMAPE 200
DIK NILLD D + K+ DFG+A+L P+ + + GT GYMAPE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 201 YVMH---GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEI 257
++ + S +D++S G+ + EL++G F + ++ + +
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGL--PPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 258 VDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTM 292
S + + + A + LL DP+ R +
Sbjct: 237 SPLSPSNPELISKAASDLLKKLL--AKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 36/203 (17%)
Query: 55 SNKLGEGGFGPVFKGKLD-----DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNV 108
+LGEG FG V + D G ++AVK L+HS Q + +FE E ++L + H N+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 109 VNLLGYC--AHGAEKLLIYEYVINESLDK--------------VLFSL--------IKDI 144
V G C G LI EY+ + SL +LFS +
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 145 QILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG--YMAPEYV 202
+ + R D+ A NIL++ + + KI+DFG+A++ PED+ + + G + + APE +
Sbjct: 129 RYIHR----DLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184
Query: 203 MHGHLSVKADVFSFGVVILELIS 225
S +DV+SFGV + EL +
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 2e-23
Identities = 55/191 (28%), Positives = 94/191 (49%), Gaps = 26/191 (13%)
Query: 57 KLGEGGFGPVFKG-KLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLG-- 113
KLGEG +G V+K + G+ +A+K + + +E E +L + +V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 114 -----------YCAHGAEKLLIYEYVINESLDK-----VLFSLIKDIQILFRKKKT--DI 155
YC G+ ++ + N++L + +L+ +K ++ L KK DI
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMK--ITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDI 125
Query: 156 KASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFS 215
KA NILL+++ K+ADFG++ + NT V GT +MAPE + + KAD++S
Sbjct: 126 KAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYNNKADIWS 184
Query: 216 FGVVILELISG 226
G+ +E+ G
Sbjct: 185 LGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 5e-23
Identities = 80/265 (30%), Positives = 116/265 (43%), Gaps = 43/265 (16%)
Query: 55 SNKLGEGGFGPVFKG-KLDDGREIAVKKLSHSSNQGK--KEFENEAKLLARVQHRNVVNL 111
NK+G G FG V+ LD G +AVK++ N K KE +E K+L ++H N+V
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 112 LGYCAHGAEKLLIY-EYVINESLDKVL---------------FSLIKDIQILFRKK--KT 153
G H EK+ I+ EY +L+++L L++ + L
Sbjct: 65 YGVEVH-REKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHR 123
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV---AGTNGYMAPEYV----MHGH 206
DIK +NI LD + K+ DFG A + T + V AGT YMAPE + GH
Sbjct: 124 DIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGH 183
Query: 207 LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266
AD++S G V+LE+ +G+R S LD N + + K P + S
Sbjct: 184 GRA-ADIWSLGCVVLEMATGKRPWSE-LD----NEFQIMFHVGAGHK------PPIPDSL 231
Query: 267 SGDQIAMCIQIGLLCTQGDPQLRPT 291
C + DP+ RPT
Sbjct: 232 QLSP--EGKDFLDRCLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 6e-23
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 23/198 (11%)
Query: 51 NFHPSNKLGEGGFGPVFKG-KLDDGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRN 107
N+ + +G G FG V+KG L+ G +A+K++S + K E LL ++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 108 VVNLLGYCAHGAEKLLIY-EYVINESLDKVL--F-----SLIKD--IQIL-----FRKKK 152
+V +G ++ L I EY N SL +++ F SL+ Q+L ++
Sbjct: 61 IVKYIG-SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 153 T---DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSV 209
DIKA+NIL + K+ADFG+A + + V GT +MAPE + S
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS-VVGTPYWMAPEVIEMSGAST 178
Query: 210 KADVFSFGVVILELISGQ 227
+D++S G ++EL++G
Sbjct: 179 ASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 7e-22
Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 30/200 (15%)
Query: 50 KNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVV 109
+ F KLG G FG V++G + +A+K L +++F+ E + L R++H++++
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 110 NLLGYCAHGAEKLLIYEYVINESLDKVL-----------------------FSLIKDIQI 146
+L C+ G +I E + SL L + +++
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNS 125
Query: 147 LFRKKKTDIKASNILLDDKWIPKIADFGMARLFPED-QTHVNTRVAGTNGYMAPEYVMHG 205
+ R D+ A NIL+ + + K+ADFG+ARL ED + ++ + APE HG
Sbjct: 126 IHR----DLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK--WTAPEAASHG 179
Query: 206 HLSVKADVFSFGVVILELIS 225
S K+DV+SFG+++ E+ +
Sbjct: 180 TFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-21
Identities = 84/262 (32%), Positives = 124/262 (47%), Gaps = 49/262 (18%)
Query: 58 LGEGGFGPVFKG-KLDDGREIAVKKLSHSSNQGK-----KEFENEAKLLARVQHRNVVNL 111
LG G FG V++G LDDG AVK++S + + K+ E E LL+++QH N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 112 LGYCAHGAEKLLIY-EYVINESLDKVL--FSLIKDI-------QIL-----FRKKKT--- 153
LG + L I+ E V SL K+L + + QIL + T
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHR 126
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM--HGHLSVKA 211
DIK +NIL+D + K+ADFGMA+ E G+ +MAPE + G+ + A
Sbjct: 127 DIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEVIAQQGGY-GLAA 183
Query: 212 DVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYK--KDKSLEIVDPSLAASDSGD 269
D++S G +LE+ +G+ S V A ++K + K L + L+ ++ D
Sbjct: 184 DIWSLGCTVLEMATGKPPWSQLEGVAA---------VFKIGRSKELPPIPDHLSD-EAKD 233
Query: 270 QIAMCIQIGLLCTQGDPQLRPT 291
I L C Q DP LRPT
Sbjct: 234 FI-------LKCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-21
Identities = 55/192 (28%), Positives = 95/192 (49%), Gaps = 28/192 (14%)
Query: 57 KLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCA 116
KLG G FG V+ G + ++AVK L + F EA+++ +++H +V L C+
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 117 HGAEKLLIYEYVINESL---------DKVLFSLIKDI--QI------LFRKK--KTDIKA 157
++ EY+ SL K+ + D+ QI L + D+ A
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAA 131
Query: 158 SNILLDDKWIPKIADFGMARLFPEDQ--THVNTR--VAGTNGYMAPEYVMHGHLSVKADV 213
NIL+ + + KIADFG+ARL +D+ + + T APE +G ++K+DV
Sbjct: 132 RNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANYGRFTIKSDV 187
Query: 214 FSFGVVILELIS 225
+SFG+++ E+++
Sbjct: 188 WSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 9e-21
Identities = 68/263 (25%), Positives = 106/263 (40%), Gaps = 49/263 (18%)
Query: 57 KLGEGGFGPVFKGKLD-DGREIAVKK--LSHSSNQGKKEFENEAKLLARVQHRNVVNLLG 113
LG+G G V+K + G+ A+KK + +K+ E K L + VV G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEF-RKQLLRELKTLRSCESPYVVKCYG 66
Query: 114 YCAHGAEKLLIYEYV--------------INES-LDKVLFSLIKDIQILFRKKKT---DI 155
E ++ EY+ I E L + ++K + L K+ DI
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDI 126
Query: 156 KASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFS 215
K SN+L++ K KIADFG++++ NT V GT YM+PE + S AD++S
Sbjct: 127 KPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYAADIWS 185
Query: 216 FGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVD------PSLAASDSGD 269
G+ +LE G+ F + + I D P+ S
Sbjct: 186 LGLTLLECALGK----FPF--LPPGQPSFFELMQ------AICDGPPPSLPAEEFSPEFR 233
Query: 270 Q-IAMCIQIGLLCTQGDPQLRPT 291
I+ C+Q DP+ RP+
Sbjct: 234 DFISACLQK-------DPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 83/275 (30%), Positives = 130/275 (47%), Gaps = 48/275 (17%)
Query: 58 LGEGGFGPVFK------GKLDDGREIAVKKLSHSSNQGKKE-FENEAKLLARV-QHRNVV 109
LG G FG V + K D ++AVK L +++ ++E +E K+++ + H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 110 NLLGYCAHGAEKLLIYEY-----VIN------ESL----DKVLFS--LIKDIQILFRKK- 151
NLLG C G L+I EY ++N ES D + FS + K + L K
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC 162
Query: 152 -KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV---NTRVAGTNGYMAPEYVMHGHL 207
D+ A N+LL I KI DFG+AR D +V N R+ +MAPE + +
Sbjct: 163 IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK--WMAPESIFNCVY 220
Query: 208 SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKS-LEIVDPSLAASD 266
+ ++DV+S+G+++ E+ S N + VD+ K YK K + P A ++
Sbjct: 221 TFESDVWSYGILLWEIFSLGSNPYPGMPVDS--------KFYKLIKEGYRMAQPEHAPAE 272
Query: 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
D I C DP RPT +++V ++ K
Sbjct: 273 IYD-------IMKTCWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-20
Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 33/200 (16%)
Query: 58 LGEGGFGPVFKG--KLDDGREI--AVKKL-SHSSNQGKKEFENEAKLLARVQHRNVVNLL 112
+G G FG V +G KL +EI A+K L + SS++ + +F EA ++ + H N++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 113 GYCAHGAEKLLIYEYVINESLDKVL------FSLIKDIQILFRKKK------------TD 154
G ++I EY+ N SLDK L F++ + + +L D
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRD 131
Query: 155 IKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-----YMAPEYVMHGHLSV 209
+ A NIL++ + K++DFG++R + + T+ G + APE + + +
Sbjct: 132 LAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK----GGKIPIRWTAPEAIAYRKFTS 187
Query: 210 KADVFSFGVVILELIS-GQR 228
+DV+SFG+V+ E++S G+R
Sbjct: 188 ASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 3e-20
Identities = 53/195 (27%), Positives = 81/195 (41%), Gaps = 27/195 (13%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKL--SHSSNQGKKEFENEAKLLARVQHRNVVNLLG 113
+GEG +G V K + G +A+KK S KK E K+L +++H N+VNL
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 114 YCAHGAEKLLIYEYVINESLD---------------KVLFSLIKDIQILFRKK--KTDIK 156
L++EYV L+ ++ L++ I DIK
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIK 127
Query: 157 ASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPE----YVMHGHLSVKAD 212
NIL+ + + K+ DFG AR T T Y APE +G D
Sbjct: 128 PENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGK---PVD 184
Query: 213 VFSFGVVILELISGQ 227
V++ G ++ EL+ G+
Sbjct: 185 VWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 4e-20
Identities = 77/272 (28%), Positives = 123/272 (45%), Gaps = 45/272 (16%)
Query: 58 LGEGGFGPVFKGKLD-----DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLL 112
LG+G FG V + D G +AVKKL HS+ + ++FE E ++L +QH N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 113 GYC-AHGAEKL-LIYEYVINESLDK--------------VLFS--LIKDIQILFRKK--K 152
G C + G L L+ EY+ SL +L++ + K ++ L K+
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVH 131
Query: 153 TDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG--YMAPEYVMHGHLSVK 210
D+ NIL++ + KI DFG+ ++ P+D+ + R G + + APE + SV
Sbjct: 132 RDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVA 191
Query: 211 ADVFSFGVVILELIS-GQRNSS--------FNLDVDAQNLLDWAYKLYKKDKSLEIVDPS 261
+DV+SFGVV+ EL + ++ S D Q ++ +L K + L
Sbjct: 192 SDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLP----- 246
Query: 262 LAASDSGDQIAMCIQIGLLCTQGDPQLRPTMR 293
A +I I C DP RP+
Sbjct: 247 -APPGCPAEIYA---IMKECWNNDPSQRPSFS 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 5e-20
Identities = 69/270 (25%), Positives = 111/270 (41%), Gaps = 62/270 (22%)
Query: 58 LGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAH 117
LG G FG V GK ++A+K + + +F EAK++ ++ H N+V L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 118 GAEKLLIYEYVINESL------------DKVLFSLIKDI----------QILFRKKKTDI 155
++ EY+ N L + L + D+ + R D+
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHR----DL 126
Query: 156 KASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN---GYMAPEYVMHGHLSVKAD 212
A N L+ + + K++DFG+AR +DQ T GT + PE + S K+D
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLDDQY---TSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 213 VFSFGVVILELISGQR-------NSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265
V+SFGV++ E+ S + NS V A Y+LY+ P LA +
Sbjct: 184 VWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA------GYRLYR---------PKLAPT 228
Query: 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMRRV 295
+ M C P+ RP +++
Sbjct: 229 EVYT--IMY-----SCWHEKPEDRPAFKKL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 5e-20
Identities = 80/280 (28%), Positives = 116/280 (41%), Gaps = 56/280 (20%)
Query: 56 NKLGEGGFGPVFKG--KLDDGREI--AVKKLSHSSNQ-GKKEFENEAKLLARVQHRNVVN 110
+LG G FG V KG + G+E+ AVK L GKKEF EA ++A++ H +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 111 LLGYCAHGAEKLLIYEYVINESLDKVL--FSLIKDIQIL------------FRKKK---T 153
L+G C G +L+ E L K L I + K
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT--NGYMAPEYVMHGHLSVKA 211
D+ A N+LL ++ KI+DFGM+R + AG + APE + +G S K+
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKS 179
Query: 212 DVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG-- 268
DV+S+GV + E S G K Y + K E++ A +SG
Sbjct: 180 DVWSYGVTLWEAFSYGA-------------------KPYGEMKGAEVI----AMLESGER 216
Query: 269 -DQIAMCIQ----IGLLCTQGDPQLRPTMRRVVVMLSKKP 303
+ C Q I L C + P+ RPT + + P
Sbjct: 217 LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 9e-20
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 40/207 (19%)
Query: 56 NKLGEGGFGPVFKGK-LDDGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLL 112
+G+G FG V K + DG+ + K++ + + + K++ +E +L ++H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 113 G---------------YCAHG----------AEKLLIYEYVINESLDKVLFSL------- 140
YC G E+ I E I L ++L +L
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 141 IKDIQILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPE 200
+L R D+K +NI LD K+ DFG+A++ D + T V GT YM+PE
Sbjct: 126 DPGNTVLHR----DLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPE 180
Query: 201 YVMHGHLSVKADVFSFGVVILELISGQ 227
+ H K+D++S G +I EL +
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 9e-20
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 39/208 (18%)
Query: 57 KLGEGGFGPVFKGKL------DDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVN 110
+LGEG FG VF + D +AVK L +S +++F+ EA+LL +QH+++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 111 LLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT----------------- 153
G C G L+++EY+ + L++ L S D +IL +
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 154 ---------------DIKASNILLDDKWIPKIADFGMAR-LFPEDQTHVNTRVAGTNGYM 197
D+ N L+ + KI DFGM+R ++ D V R +M
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM 191
Query: 198 APEYVMHGHLSVKADVFSFGVVILELIS 225
PE +++ + ++D++SFGVV+ E+ +
Sbjct: 192 PPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 9e-20
Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 25/199 (12%)
Query: 50 KNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVV 109
K +G+G FG V G G+++AVK L S + F EA ++ ++H N+V
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLV 63
Query: 110 NLLGYCAHGAEKLLIYEYVINESLDKVLFS-----LIKDIQILF-----------RKKK- 152
LLG G ++ EY+ SL L S + Q+ F +K
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF 123
Query: 153 --TDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVK 210
D+ A N+L+ + + K++DFG+A+ + Q V T APE + S K
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTK 179
Query: 211 ADVFSFGVVILELISGQRN 229
+DV+SFG+++ E+ S R
Sbjct: 180 SDVWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 45/211 (21%)
Query: 58 LGEGGFGPVFKGKL------DDGREIAVKKLSHSSN-QGKKEFENEAKLLARVQHRNVVN 110
LGEG FG V+KG+L +A+K L ++ + ++EF EA+L++ +QH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 111 LLGYCAHGAEKLLIYEYVINESLDKVLFS--------------LIKD-----------IQ 145
LLG C +++EY+ + L + L +K IQ
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 146 IL----------FRKKKTDIKASNILLDDKWIPKIADFGMARL-FPEDQTHVNTRVAGTN 194
I F + D+ A N L+ + KI+DFG++R + D V ++
Sbjct: 133 IAAGMEYLSSHHFVHR--DLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV 190
Query: 195 GYMAPEYVMHGHLSVKADVFSFGVVILELIS 225
+M PE +++G + ++D++SFGVV+ E+ S
Sbjct: 191 RWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (218), Expect = 1e-19
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 48/210 (22%)
Query: 52 FHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN---------EAKLLA 101
+ KLGEG +G V+K + G +A+KK+ + + E E LL
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-------RLDNEEEGIPSTALREISLLK 53
Query: 102 RVQHRNVVNLLGYCAHGAEKL-LIYEYV--------------INESLDK-VLFSLIKDI- 144
++H N+V LL H KL L++EY ++ +L K +++ L++ +
Sbjct: 54 ELKHPNIVKLLDVI-HTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLA 112
Query: 145 -----QILFRKKKTDIKASNILLDDKWIPKIADFGMARLF-PEDQTHVNTRVAGTNGYMA 198
+IL R D+K NIL++ + K+ADFG+AR F +T+ + V T Y A
Sbjct: 113 YCHSHRILHR----DLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRA 166
Query: 199 PEYVMHGHL-SVKADVFSFGVVILELISGQ 227
PE ++ S D++S G + E+I+G+
Sbjct: 167 PEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 43/203 (21%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN-------EAKLLARVQHRNV 108
++GEG G VFK K + G +A+KK++ ++ E K L QH V
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVA-----LRRLEGGIPNQALREIKALQACQHPYV 61
Query: 109 VNLLGYCAHGAEKLLIYEYVINESLDKVLFS----------------LIKDIQ------I 146
V LL HG+ +L+ EY+ L +VL L+K + I
Sbjct: 62 VKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGI 120
Query: 147 LFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG- 205
+ R D+K +N+L+ + KIADFG+ARLF E++ + + T Y APE +++G
Sbjct: 121 MHR----DLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE-LLYGA 175
Query: 206 -HLSVKADVFSFGVVILELISGQ 227
D+++ G + EL++G
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 56/193 (29%), Positives = 91/193 (47%), Gaps = 26/193 (13%)
Query: 57 KLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKE-FENEAKLLARVQHRNVVNLLGYC 115
K+G+G FG V+KG L E+AVK + K F EA++L + H N+V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 116 AHGAEKLLIYEYVINESLDKVL--------------FSLIKDIQILFRKKKT----DIKA 157
++ E V SL L SL + + + K D+ A
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAA 121
Query: 158 SNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN----GYMAPEYVMHGHLSVKADV 213
N L+ + + KI+DFGM+R E++ + T G + APE + +G + ++DV
Sbjct: 122 RNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178
Query: 214 FSFGVVILELISG 226
+S+G+++ E S
Sbjct: 179 WSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 50/188 (26%), Positives = 94/188 (50%), Gaps = 20/188 (10%)
Query: 57 KLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCA 116
KLG G FG V++G ++ +AVK L + K+F EA+++ +++H ++ L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 117 HGAEKLLIYEYVINESLDKVL----FSLIKDIQIL-----------FRKKKT----DIKA 157
++ E + SL + L +K Q++ + + + D+ A
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAA 131
Query: 158 SNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFG 217
N+L+ + I K+ADFG+AR+ ED + APE ++ S+K+DV+SFG
Sbjct: 132 RNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFG 191
Query: 218 VVILELIS 225
+++ E+++
Sbjct: 192 ILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 54/191 (28%), Positives = 93/191 (48%), Gaps = 23/191 (12%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLG-- 113
K+GEG G V+K G+E+A+KK+ Q K+ NE ++ +H N+V+
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDYYDSY 84
Query: 114 -----------YCAHGAEKLLIYEYVI--NES-LDKVLFSLIKDIQILFRKKKT--DIKA 157
Y G+ +I + + NE + V +++ ++ L + DIK+
Sbjct: 85 LVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKS 144
Query: 158 SNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHL-SVKADVFSF 216
NILL K+ADFG A ++++ N+ V GT +MAPE V+ K D++S
Sbjct: 145 DNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPE-VIKRKDYGPKVDIWSL 202
Query: 217 GVVILELISGQ 227
G++ +E+ G+
Sbjct: 203 GIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 5e-19
Identities = 60/202 (29%), Positives = 89/202 (44%), Gaps = 44/202 (21%)
Query: 58 LGEGGFGPVFK-GKLDDGREIAVKKLSHSSNQGKKEFE---NEAKLLARVQHRNVVNLLG 113
LG+G FG V K D G+ A+K L +KE E E +L+R+ H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 114 YCA-HGAEKL-LIYEYVI-NESLDKVLFSLIKDIQ------------------------- 145
+ A EKL L+ EY E LFS +
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGE-----LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG 113
Query: 146 ILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG 205
I++R D+K NILLD K+ DFG+A+ + + NT GT Y+APE ++
Sbjct: 114 IIYR----DLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGK 168
Query: 206 HLSVKADVFSFGVVILELISGQ 227
D +S GV++ E+++G+
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 6e-19
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 40/218 (18%)
Query: 57 KLGEGGFGPVFKGK------LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVN 110
+LGEG FG VF + D +AVK L + +K+F+ EA+LL +QH ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 111 LLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILF----RKKK-------------- 152
G C G ++++EY+ + L+K L + D IL R+ K
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 153 ---------------TDIKASNILLDDKWIPKIADFGMAR-LFPEDQTHVNTRVAGTNGY 196
D+ N L+ + KI DFGM+R ++ D V +
Sbjct: 132 IASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 191
Query: 197 MAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNL 234
M PE +M+ + ++DV+SFGV++ E+ + + F L
Sbjct: 192 MPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 65/223 (29%), Positives = 96/223 (43%), Gaps = 45/223 (20%)
Query: 46 VSATKNFHPSNKLGEGGFGPVFKG-KLDDGREIAVKK-LSHSSNQGKKEFE----NEAKL 99
S +++ KLGEG FG V+K ++ GR +A+KK L H+ G F E K+
Sbjct: 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKI 60
Query: 100 LARVQHRNVVNLLG---------------------YCAHGAEKLLIYEYV-INESLDK-V 136
L +++H NVV L+ Y H LL V + ES K
Sbjct: 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCY 120
Query: 137 LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAG-- 192
+ L++ I L DIKA+NIL+D++ I KIADFG+AR + + G
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGT 180
Query: 193 --------TNGYMAPEYVMHGHLSVKA-DVFSFGVVILELISG 226
T Y PE ++ A D++ G V E+ +
Sbjct: 181 RKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 37/215 (17%)
Query: 57 KLGEGGFGPVFKGKL------DDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVN 110
+LGEG FG VF + D +AVK L +S+ +K+F EA+LL +QH ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 111 LLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDI---------------QILFRKKKT-- 153
G C G ++++EY+ + L+K L + D Q+L ++
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 154 -------------DIKASNILLDDKWIPKIADFGMAR-LFPEDQTHVNTRVAGTNGYMAP 199
D+ N L+ + + KI DFGM+R ++ D V +M P
Sbjct: 132 GMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 191
Query: 200 EYVMHGHLSVKADVFSFGVVILELISGQRNSSFNL 234
E +M+ + ++DV+S GVV+ E+ + + + L
Sbjct: 192 ESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 57/198 (28%), Positives = 89/198 (44%), Gaps = 34/198 (17%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKLS--HSSNQGKKEFENEAKLLARVQHRNVVNLLG 113
K+GEG +G V+K + G +A+KK+ S K E KLL + H N++ LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 114 YCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT-------------------- 153
H + L++E+ +D L+ LIKD Q +
Sbjct: 66 VFRHKGDLYLVFEF-----MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120
Query: 154 --DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG--HLSV 209
D+K N+L++ + + K+ADFG+AR F V T Y APE ++ G S
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPE-LLLGDKGYST 178
Query: 210 KADVFSFGVVILELISGQ 227
D++S G + EL+S +
Sbjct: 179 PVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 5e-18
Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 35/201 (17%)
Query: 58 LGEGGFGPVFKGK-LDDGR----EIAVKKL-SHSSNQGKKEFENEAKLLARVQHRNVVNL 111
LG G FG V+KG + +G +A+K L +S + KE +EA ++A V H +VV L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 112 LGYCAHGAEKLLIYEYVINESLDKVL----------------------FSLIKDIQILFR 149
LG C ++ LI + + L + S +++ +++ R
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHR 133
Query: 150 KKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN-GYMAPEYVMHGHLS 208
D+ A N+L+ KI DFG+A+L D+ + +MA E ++H +
Sbjct: 134 ----DLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYT 189
Query: 209 VKADVFSFGVVILELIS-GQR 228
K+DV+S+GV + EL++ G +
Sbjct: 190 HKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 6e-18
Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 37/199 (18%)
Query: 56 NKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN-----EAKLLARVQHRNVV 109
KLGEG + V+K + + GR +A+KK+ + K+ N E KLL ++H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 110 NLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT---------------- 153
LL H + L++E+ ++ L +IKD I+
Sbjct: 66 GLLDVFGHKSNINLVFEF-----METDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120
Query: 154 ------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG-- 205
D+K +N+L+ + K+ADFG+AR F + +V T Y APE + G
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLF-GAR 178
Query: 206 HLSVKADVFSFGVVILELI 224
H V D++S G + EL+
Sbjct: 179 HYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 2e-17
Identities = 72/271 (26%), Positives = 125/271 (46%), Gaps = 44/271 (16%)
Query: 58 LGEGGFGPVFKG--KLDDGREIAVK----KLSHSSNQGKKEFENEAKLLARVQHRNVVNL 111
+G G FG V G KL REI V K ++ Q +++F +EA ++ + H N+++L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQFDHPNIIHL 70
Query: 112 LGYCAHGAEKLLIYEYVINESLDKVL------FSLIKDIQIL------------FRKKKT 153
G +++ EY+ N SLD L F++I+ + +L
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHR 130
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG--YMAPEYVMHGHLSVKA 211
D+ A NIL++ + K++DFG++R+ +D T G + APE + + + +
Sbjct: 131 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSAS 190
Query: 212 DVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQ 270
DV+S+G+V+ E++S G+R + D ++ Y+L P+ D
Sbjct: 191 DVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL-----------PA-----PMDC 234
Query: 271 IAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
A Q+ L C Q D RP ++V +L K
Sbjct: 235 PAALHQLMLDCWQKDRNERPKFEQIVSILDK 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 53/188 (28%), Positives = 94/188 (50%), Gaps = 20/188 (10%)
Query: 57 KLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCA 116
KLG G FG V+ G ++ ++AVK L + + F EA L+ +QH +V L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 117 HGAEKLLIYEYVINESL---------DKVLFSLIKDIQ------ILFRKKKT----DIKA 157
+I EY+ SL KVL + D + + ++K D++A
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRA 131
Query: 158 SNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFG 217
+N+L+ + + KIADFG+AR+ +++ + APE + G ++K+DV+SFG
Sbjct: 132 ANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFG 191
Query: 218 VVILELIS 225
+++ E+++
Sbjct: 192 ILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 29/201 (14%)
Query: 52 FHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFE----NEAKLLARVQHR 106
+ ++GEG +G V+K + G +A+KK+ K+ F E KLL +++H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHP 58
Query: 107 NVVNL---------------LGYCAHGAEKLLI-YEYVINESLDKVLFS-LIKDIQILFR 149
N+V L Y H LL E ES K L++ +Q L
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 150 KK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT-RVAGTNGYMAPEYVMHG- 205
DIK SNIL+++ + K+ADFG+AR + + + T RV T Y PE ++
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGAT 177
Query: 206 HLSVKADVFSFGVVILELISG 226
+ D++S G ++ EL G
Sbjct: 178 RYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 3e-17
Identities = 51/200 (25%), Positives = 95/200 (47%), Gaps = 32/200 (16%)
Query: 53 HPSN-----KLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRN 107
HPS ++G G FG V+ G + R++A+K + + +++F EA+++ ++ H
Sbjct: 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPK 60
Query: 108 VVNLLGYCAHGAEKLLIYEYVINESLD------------KVLFSLIKDI----------Q 145
+V L G C + L++E++ + L + L + D+
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120
Query: 146 ILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG 205
++ R D+ A N L+ + + K++DFGM R +DQ +T + +PE
Sbjct: 121 VIHR----DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS 176
Query: 206 HLSVKADVFSFGVVILELIS 225
S K+DV+SFGV++ E+ S
Sbjct: 177 KYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 3e-17
Identities = 62/268 (23%), Positives = 101/268 (37%), Gaps = 73/268 (27%)
Query: 50 KNFHPSNKLGEGGFGPVFKGKL-DDGREIAVKKLSHSS-NQGKKEFE--NEAKLLARV-Q 104
+F +GEG F V K + +E A+K L + KK E ++L R+
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 105 HRNVVNLLGYCAHGAEKL-LIYEYVIN-ESLDKVLF--SL-IKDIQ-------------- 145
H ++ L Y E L + EY N E L + SL K +
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH 119
Query: 146 ---ILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVA----------- 191
I+ R D+K NILLD KI DFG A++ + + + +
Sbjct: 120 SKGIIHR----DLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 192 --------GTNGYMAPEYVMHGHLSVKADVFSFGVVILELISG----------------- 226
GT Y++PE + +D+++ G +I ++++G
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235
Query: 227 QRNSSF--NLDVDAQNLLDWAYKLYKKD 252
+ SF N DA++L++ KL D
Sbjct: 236 KLEYSFPPNFPPDAKDLIE---KLLVLD 260
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 5e-17
Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 29/192 (15%)
Query: 56 NKLGEGGFGPVFKGKLDD-GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGY 114
+KLG G +G V++G +AVK L +EF EA ++ ++H N+V LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 115 CAHGAEKLLIYEYVIN------------ESLDKVLFSLIKDIQILFR----KKKT----D 154
C +I E++ + ++ V+ L QI +KK D
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-LYMATQISSAMEYLEKKNFIHRD 129
Query: 155 IKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN---GYMAPEYVMHGHLSVKA 211
+ A N L+ + + K+ADFG++RL D T AG + APE + + S+K+
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 212 DVFSFGVVILEL 223
DV++FGV++ E+
Sbjct: 187 DVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 7e-17
Identities = 70/268 (26%), Positives = 120/268 (44%), Gaps = 44/268 (16%)
Query: 50 KNFHPSNKLGEGGFGPVFKGKLDDGREI-AVKKLSHSSNQGKKEFEN---EAKLLARVQH 105
K F ++G G FG V+ + E+ A+KK+S+S Q +++++ E + L +++H
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 106 RNVVNLLGYCAHGAEKLLIYEYVINESLD--KVLFSLIKDIQIL---------------F 148
N + G L+ EY + + D +V +++++I
Sbjct: 75 PNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 149 RKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM---HG 205
+ DIKA NILL + K+ADFG A L + V GT +MAPE ++ G
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEG 189
Query: 206 HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265
K DV+S G+ +EL + ++ FN+ N + Y + + D P+L+++
Sbjct: 190 QYDGKVDVWSLGITCIEL-AERKPPLFNM-----NAMSALYHIAQNDS------PTLSSN 237
Query: 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMR 293
D D + C Q PQ RP+
Sbjct: 238 DWSDYFRNFVD---SCLQKIPQDRPSSE 262
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-16
Identities = 72/273 (26%), Positives = 129/273 (47%), Gaps = 46/273 (16%)
Query: 58 LGEGGFGPVFKGKLD-DGRE---IAVKKL-SHSSNQGKKEFENEAKLLARVQHRNVVNLL 112
+G G FG V +G+L G+ +A+K L S + + +++F +EA ++ + H N+++L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 113 GYCAHGAEKLLIYEYVINESLDKVL------FSLIKDIQIL------------FRKKKTD 154
G ++I E++ N +LD L F++I+ + +L D
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRD 131
Query: 155 IKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-----YMAPEYVMHGHLSV 209
+ A NIL++ + K++DFG++R F ED T T + G + APE + + +
Sbjct: 132 LAARNILVNSNLVCKVSDFGLSR-FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTS 190
Query: 210 KADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268
+DV+S+G+V+ E++S G+R + D N ++ Y+L P +
Sbjct: 191 ASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL----------PPPM------ 234
Query: 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
D Q+ L C Q D RP ++V L K
Sbjct: 235 DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-16
Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 28/200 (14%)
Query: 56 NKLGEGGFGPVFKGKLDDGREIAVKKLS-HSSNQ--GKKEFEN---EAKLLARVQHRNVV 109
LG+G +G V+ G + G+ IAVK++ +SN +KE+E E LL ++H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 110 NLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT---------------- 153
LG C + E+V S+ +L + +F K
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVH 125
Query: 154 -DIKASNILLDDKWIPKIADFGMAR---LFPEDQTHVNT--RVAGTNGYMAPEYVMHGHL 207
DIK +N++L I K+ DFG AR TH N + GT +MAPE +
Sbjct: 126 RDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGY 185
Query: 208 SVKADVFSFGVVILELISGQ 227
K+D++S G + E+ +G+
Sbjct: 186 GRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 72/287 (25%), Positives = 133/287 (46%), Gaps = 36/287 (12%)
Query: 34 AREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKE 92
++ K ++S+ K N + G G +KGK + +G + VK+++ ++ E
Sbjct: 677 SKVSKSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSE 733
Query: 93 FENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSL------------ 140
+ KL QH N+V L+G C LI+EY+ ++L +VL +L
Sbjct: 734 IADMGKL----QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGI 789
Query: 141 IKDIQILFRKKKTDIKASN-----ILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG 195
K ++ L + + N I++D K P + RL +T+ ++
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSA 843
Query: 196 YMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSL 255
Y+APE ++ K+D++ FG++++EL++G+ + V ++++WA Y D L
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH-GSIVEWARYCY-SDCHL 901
Query: 256 EI-VDPSLAASDSGDQ--IAMCIQIGLLCTQGDPQLRPTMRRVVVML 299
++ +DPS+ S +Q I + + L CT DP RP V+ L
Sbjct: 902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 47/215 (21%)
Query: 58 LGEGGFGPVFKGK---LDDGRE---IAVKKLSH-SSNQGKKEFENEAKLLARVQHRNVVN 110
+G+G FG VF+ + L +AVK L +S + +F+ EA L+A H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 111 LLGYCAHGAEKLLIYEYV----INESL----DKVLFSLIKD-----------------IQ 145
LLG CA G L++EY+ +NE L + SL Q
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 146 ILFRKKKT--------------DIKASNILLDDKWIPKIADFGMAR-LFPEDQTHVNTRV 190
+ K+ D+ N L+ + + KIADFG++R ++ D +
Sbjct: 133 LCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEND 192
Query: 191 AGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS 225
A +M PE + + + ++DV+++GVV+ E+ S
Sbjct: 193 AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 69/280 (24%), Positives = 113/280 (40%), Gaps = 57/280 (20%)
Query: 51 NFHPSNKLGEGGFG-PVFKGKLDDGREIAVKK--LSHSSNQGKKEFENEAKLLARVQHRN 107
++ P LG+G FG + +D + K+ L+ S + +++ NE +L+ +QH N
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60
Query: 108 VVNLLG-------------YC---------AHGAEKLLIYEYVINESLDKVLF------S 139
++ Y +L E V+ LF S
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVSAVS 115
Query: 140 LIKDIQILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAP 199
I IL R DIK NI L + K+ DFG++++ + + T V GT YM+P
Sbjct: 116 YIHKAGILHR----DIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSP 170
Query: 200 EYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVD 259
E + K+D+++ G V+ EL++ +R +F DA N L+ K IV
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKR--TF----DATNPLNLVVK---------IVQ 215
Query: 260 PSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299
+ S + I + Q DP+ RPT V+
Sbjct: 216 GNYTPVVSVYSSEL-ISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 47/213 (22%)
Query: 57 KLGEGGFGPVFKGKL-----DDGREIAVKKLS-HSSNQGKKEFENEAKLLARVQHRNVVN 110
+LGE FG ++KG L D + +A+K L ++ Q EF+ EA L+A + H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 111 LLGYCAHGAEKLLIYEYV---------------------------INESLDKVLFSLIKD 143
LLG +++EY+ + SLD F I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA- 130
Query: 144 IQI----------LFRKKKTDIKASNILLDDKWIPKIADFGMAR-LFPEDQTHVNTRVAG 192
IQI F K D+ A NIL+ ++ KI+D G++R ++ D V +
Sbjct: 131 IQIAAGMEYLSSHFFVHK--DLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 193 TNGYMAPEYVMHGHLSVKADVFSFGVVILELIS 225
+M PE +M+G S +D++SFGVV+ E+ S
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-16
Identities = 61/192 (31%), Positives = 99/192 (51%), Gaps = 23/192 (11%)
Query: 57 KLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCA 116
KLG G FG V+ G + ++A+K L S + F EA L+ ++QH +V L Y
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRL--YAV 69
Query: 117 HGAEKLLIY-EYVINESLDKVL-------FSLIKDI----QI----LFRKKKT----DIK 156
E + I EY+ N SL L ++ K I QI F ++K D++
Sbjct: 70 VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLR 129
Query: 157 ASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSF 216
A+NIL+ + KIADFG+ARL +++ + APE + +G ++K+DV+SF
Sbjct: 130 AANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 189
Query: 217 GVVILELISGQR 228
G+++ E+++ R
Sbjct: 190 GILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 73/262 (27%), Positives = 115/262 (43%), Gaps = 39/262 (14%)
Query: 51 NFHPSNKLGEGGFGPVFKG-KLDDGREIAVKK--LSHSSNQGKKEFENEAKLLARVQHRN 107
+F NK+G+G FG VFK + D R A+K+ LS + + ++E +EA++LA++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 108 VVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKD-----------IQILF-----RKK 151
++ + ++ EY N L K+L IQIL K
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 152 KT---DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLS 208
K DIK+ N+ LD KI D G+A+L ++ NT V GT Y++PE +
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDKPYN 179
Query: 209 VKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268
K+DV++ GVV+ E +G+ D + Q L K + V P ++ S
Sbjct: 180 EKSDVWALGVVLYECCTGK----HPFDANNQGAL--------ILKIIRGVFPPVSQMYSQ 227
Query: 269 DQIAMCIQIGLLCTQGDPQLRP 290
Q+ C D + RP
Sbjct: 228 Q----LAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 3e-16
Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 31/196 (15%)
Query: 57 KLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCA 116
KLG G FG V+ G + ++AVK L + + F EA+++ +++H +V L Y
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQL--YAV 69
Query: 117 HGAEKLLIYEYVINESLDK-VLFSLIKDIQILFRKKKT---------------------- 153
E + Y++ E + K L +KD + K
Sbjct: 70 VSEEPI----YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIH 125
Query: 154 -DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKAD 212
D++++NIL+ D + KIADFG+ARL +++ + APE ++G ++K+D
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 213 VFSFGVVILELISGQR 228
V+SFG+++ EL++ R
Sbjct: 186 VWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 3e-16
Identities = 55/196 (28%), Positives = 91/196 (46%), Gaps = 30/196 (15%)
Query: 56 NKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGK-KEFENEAKLLARVQHRNVVNLLG 113
+LG G G V K G+ +AVK + N+ K+ E +L + +V G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 114 YCAHGAEKLLIYEYVINESLDKVL----------------FSLIKDIQILFRKKKT---D 154
+ + + EY+ SLDK+L +++K + L K K D
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRD 126
Query: 155 IKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV---AGTNGYMAPEYVMHGHLSVKA 211
+K SNIL++ + K+ DFG++ VN+ GT+ YMAPE + SVK+
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQL------VNSLAKTFVGTSSYMAPERIQGNDYSVKS 180
Query: 212 DVFSFGVVILELISGQ 227
D++S G+ ++EL +G+
Sbjct: 181 DIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 4e-16
Identities = 72/273 (26%), Positives = 124/273 (45%), Gaps = 51/273 (18%)
Query: 51 NFHPSNKLGEGGFGPVFKGK-LDDGREIAVKK--LSHSSNQGKKEFENEAKLLARVQHRN 107
+F KLG+G +G V+K K L D + A+K+ L S + +++ NE ++LA V H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 108 VVN-----LLG--------YCAHG----------AEKLLIYEYVINESLDKVLFSL--IK 142
+++ L G Y G ++ LI E I ++L L +
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 143 DIQILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYV 202
+ +IL R D+K++NILL + KI D G++++ + T++ GT YMAPE
Sbjct: 121 EQKILHR----DLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQI-GTPHYMAPEVW 173
Query: 203 MHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262
S K+D++S G ++ E+ ++F +A+++ D YK+ + P +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEM------ATFAPPFEARSMQDLRYKVQRGKY------PPI 221
Query: 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRV 295
S D Q P+LRP ++
Sbjct: 222 PPIYSQDLQNFIRS----MLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 4e-16
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 33/194 (17%)
Query: 57 KLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCA 116
+LG G FG V GK ++A+K + S + EF EAK++ ++ H +V L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 117 HGAEKLLIYEYVINESL------------DKVLFSLIKDI----------QILFRKKKTD 154
++ EY+ N L L + KD+ Q + R D
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHR----D 125
Query: 155 IKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN---GYMAPEYVMHGHLSVKA 211
+ A N L+DD+ K++DFG++R +D+ T G+ + PE +++ S K+
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 212 DVFSFGVVILELIS 225
DV++FGV++ E+ S
Sbjct: 183 DVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 7e-16
Identities = 51/196 (26%), Positives = 95/196 (48%), Gaps = 31/196 (15%)
Query: 57 KLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCA 116
KLG+G FG V+ G + +A+K L + + F EA+++ +++H +V L Y
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL--YAV 69
Query: 117 HGAEKLLIYEYVINESLDK-VLFSLIK-DIQILFRKKK---------------------- 152
E + Y++ E + K L +K ++ R +
Sbjct: 70 VSEEPI----YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 125
Query: 153 TDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKAD 212
D++A+NIL+ + + K+ADFG+ARL +++ + APE ++G ++K+D
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 213 VFSFGVVILELISGQR 228
V+SFG+++ EL + R
Sbjct: 186 VWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 7e-16
Identities = 59/194 (30%), Positives = 87/194 (44%), Gaps = 26/194 (13%)
Query: 58 LGEGGFGPVFKGKLD-----DGREIAVKKL-SHSSNQGKKEFENEAKLLARVQHRNVVNL 111
LGEG FG V D G +AVK L Q ++ E +L + H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 112 LGYCAHGAEK--LLIYEYVINESLDK------------VLFS--LIKDIQILFRKK--KT 153
G C+ K LI EYV SL +LF+ + + + L +
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHR 131
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG--YMAPEYVMHGHLSVKA 211
D+ A N+LLD+ + KI DFG+A+ PE + R G + + A E + S +
Sbjct: 132 DLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYAS 191
Query: 212 DVFSFGVVILELIS 225
DV+SFGV + EL++
Sbjct: 192 DVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 35/198 (17%)
Query: 58 LGEGGFGPVFKGKL-DDGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLG 113
LG+GGFG V ++ G+ A KKL +G++ NE K+L +V R +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 114 YCAHGAEKLLIYEYVIN--------ESLDKVLFSLIKDI----------------QILFR 149
Y + L + ++N ++ + F + I +I++R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119
Query: 150 KKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSV 209
D+K N+LLDD +I+D G+A + AGT GYMAPE +
Sbjct: 120 ----DLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEVYDF 173
Query: 210 KADVFSFGVVILELISGQ 227
D F+ G + E+I+G+
Sbjct: 174 SVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 31/207 (14%)
Query: 53 HPSN-----KLGEGGFGPVFKGKLD-DGRE---IAVKKLSHS-SNQGKKEFENEAKLLAR 102
HPS+ +G G FG VF+G L GR+ +A+K L + + +++F +EA ++ +
Sbjct: 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQ 62
Query: 103 VQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVL------FSLIKDIQIL--------- 147
H N++ L G ++I EY+ N +LDK L FS + + +L
Sbjct: 63 FSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKY 122
Query: 148 ---FRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG--YMAPEYV 202
D+ A NIL++ K++DFG++R+ +D T G + APE +
Sbjct: 123 LSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 203 MHGHLSVKADVFSFGVVILELIS-GQR 228
+ + +DV+SFG+V+ E++S G+R
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGER 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 70/285 (24%), Positives = 116/285 (40%), Gaps = 56/285 (19%)
Query: 57 KLGEGGFGPV-------FKGKLDDG----------REIAVKKLSHSSNQ-GKKEFENEAK 98
KLGEG FG V + + +AVK L ++ +++F E K
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 99 LLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT----- 153
+L+R+ N+ LLG C +I EY+ N L++ L + + L K+
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 154 -----------------------DIKASNILLDDKWIPKIADFGMAR-LFPEDQTHVNTR 189
D+ N L+ + KIADFGM+R L+ D V R
Sbjct: 132 LLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGR 191
Query: 190 VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLY 249
+MA E V+ G + K+DV++FGV + E+++ R + + Q +++ A +
Sbjct: 192 APLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE-HLTDQQVIENAGHFF 250
Query: 250 KKDKSLEIVD-PSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMR 293
+ D + P D ++ L C + D + RPT R
Sbjct: 251 RDDGRQIYLPRPPNCPKD-------IYELMLECWRRDEEDRPTFR 288
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 6e-15
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 41/206 (19%)
Query: 58 LGEGGFGPVFKG------KLDDGREIAVKKLSHSSNQGKK-EFENEAKLLARVQHRNVVN 110
LG+G FG V++G K + +A+K ++ +++ ++ EF NEA ++ +VV
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 111 LLGYCAHGAEKLLIYEYVINESLDKVLFSLIKD-------------------IQI----- 146
LLG + G L++ E + L L S + +I
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 147 -LFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN----GYMAP 199
L KK D+ A N ++ + KI DFGM R E R G +MAP
Sbjct: 134 YLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE---TDYYRKGGKGLLPVRWMAP 190
Query: 200 EYVMHGHLSVKADVFSFGVVILELIS 225
E + G + K+DV+SFGVV+ E+ +
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 6e-15
Identities = 53/196 (27%), Positives = 98/196 (50%), Gaps = 31/196 (15%)
Query: 57 KLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCA 116
KLG+G FG V+ G + ++A+K L + + F EA+++ +++H +V L Y
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPL--YAV 69
Query: 117 HGAEKL-LIYEYVINESLDKVL-----------------------FSLIKDIQILFRKKK 152
E + ++ E++ SL L + I+ + + R
Sbjct: 70 VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHR--- 126
Query: 153 TDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKAD 212
D++A+NIL+ D + KIADFG+ARL +++ + APE ++G ++K+D
Sbjct: 127 -DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 213 VFSFGVVILELISGQR 228
V+SFG+++ EL++ R
Sbjct: 186 VWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 7e-15
Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 39/206 (18%)
Query: 58 LGEGGFGPVFKG-KLDDGREIAVKKLS--------HSSNQGK--KEFENEAKLLARVQHR 106
+G+G +G V+ + G +AVK++ H S Q K +E + L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 107 NVVNLLGYCAHGAEKLLIY-EYVINESLDKVL-----F--SLIKDI--QIL----FRKKK 152
N+V LG E L I+ EYV S+ L F L++ Q+L + K
Sbjct: 69 NIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127
Query: 153 ----TDIKASNILLDDKWIPKIADFGMAR----LFPEDQTHVNTRVAGTNGYMAPEYVMH 204
D+KA N+L+D I KI+DFG+++ ++ DQ N + G+ +MAPE +
Sbjct: 128 GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ---NMSMQGSVFWMAPEVIHS 184
Query: 205 GH--LSVKADVFSFGVVILELISGQR 228
S K D++S G V+LE+ +G+R
Sbjct: 185 YSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 7e-15
Identities = 58/194 (29%), Positives = 95/194 (48%), Gaps = 33/194 (17%)
Query: 58 LGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKK-EFENEAKLLARVQHRNVVNLLGYCA 116
LG+G FG VFKG L D +AVK Q K +F +EA++L + H N+V L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 117 HGAEKLLIYEYV--------INESLDK------VLFSLIKDIQILFRKKKT----DIKAS 158
++ E V + + D+ V F+L + + + K D+ A
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAAR 122
Query: 159 NILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-------YMAPEYVMHGHLSVKA 211
N L+ + + KI+DFGM+R ED + ++G + APE + +G S ++
Sbjct: 123 NCLVGENNVLKISDFGMSR--QEDDG-----IYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 212 DVFSFGVVILELIS 225
DV+S+G+++ E S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 7e-15
Identities = 61/256 (23%), Positives = 112/256 (43%), Gaps = 40/256 (15%)
Query: 57 KLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCA 116
+LG G FG V GK ++A+K ++ + +++F EAK++ ++ H +V L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 117 HGAEKLLIYEYVINESL------------DKVLFSLIKDI----QILFRKK--KTDIKAS 158
++ E++ N L +L S+ +D+ + L R D+ A
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAAR 129
Query: 159 NILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGV 218
N L+ + K++DFGM R +D+ ++ + PE S K+DV+SFGV
Sbjct: 130 NCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGV 189
Query: 219 VILELISGQR---NSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCI 275
++ E+ + + N +V ++ ++LY+ P LA+
Sbjct: 190 LMWEVFTEGKMPFEKKSNYEV--VEMISRGFRLYR---------PKLASM-------TVY 231
Query: 276 QIGLLCTQGDPQLRPT 291
++ C P+ RPT
Sbjct: 232 EVMYSCWHEKPEGRPT 247
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 7e-15
Identities = 72/256 (28%), Positives = 113/256 (44%), Gaps = 34/256 (13%)
Query: 56 NKLGEGGFGPVFKGK-LDDGREIAVKKL-SHSSNQGKKEFENEAKLLARVQHRNVVNLLG 113
N++G G G V+K GR A+K + + + +++ E ++L V H NVV
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 114 YCAHGAEKLLIYEYVINESLD-----------KVLFSLIKDIQILFRKK--KTDIKASNI 160
H E ++ E++ SL+ V ++ I L R+ DIK SN+
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNL 199
Query: 161 LLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYV----MHGHLSVKA-DVFS 215
L++ KIADFG++R+ + N+ V GT YM+PE + HG A D++S
Sbjct: 200 LINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNHGAYDGYAGDIWS 258
Query: 216 FGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCI 275
GV ILE G+ F V Q DWA + S P+ A+ + I+ C+
Sbjct: 259 LGVSILEFYLGR----FPFGVGRQG--DWASLMCAICMSQPPEAPATASREFRHFISCCL 312
Query: 276 QIGLLCTQGDPQLRPT 291
Q +P R +
Sbjct: 313 -------QREPAKRWS 321
|
Length = 353 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 8e-15
Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 34/202 (16%)
Query: 58 LGEGGFGPVFKG-KLDDGREIAVKK--LSHSSNQGKKE-------FENEAKLLARVQHRN 107
+G G FG V+ G G +AVK+ L S K E LL +QH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 108 VVNLLGYCAHGAEKLLIY-EYVINESLDKVLF-------SLIKDI--QIL-----FRKKK 152
+V LG + A+ L I+ EYV S+ +L +L+++ QIL +
Sbjct: 68 IVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126
Query: 153 T---DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVA-----GTNGYMAPEYVMH 204
DIK +NIL+D+K KI+DFG+++ + T A G+ +MAPE V
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ 186
Query: 205 GHLSVKADVFSFGVVILELISG 226
+ KAD++S G +++E+++G
Sbjct: 187 TSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 9e-15
Identities = 55/193 (28%), Positives = 96/193 (49%), Gaps = 31/193 (16%)
Query: 57 KLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCA 116
+GEG FG V +G+ G+++AVK + + + F E ++ ++ H+N+V LLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 117 HGAEKLLIYEYVINESLDKVLFS----LIKDIQIL------------FRKKK---TDIKA 157
H ++ E + +L L + L+ IQ+L KK D+ A
Sbjct: 70 HNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAA 128
Query: 158 SNILLDDKWIPKIADFGMARLFPE--DQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFS 215
NIL+ + + K++DFG+AR+ D + + + + APE + H S K+DV+S
Sbjct: 129 RNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSKSDVWS 182
Query: 216 FGVVILELISGQR 228
+GV++ E+ S R
Sbjct: 183 YGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 9e-15
Identities = 54/196 (27%), Positives = 82/196 (41%), Gaps = 33/196 (16%)
Query: 59 GEGGFGPVFKGKLDDGREI-AVK---KLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGY 114
G+G FG V + D +++ A+K K + NE ++L + H +VNL Y
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW-Y 67
Query: 115 CAHGAEKL---------------LIYEYVINESLDKV----LFSLIKDIQ---ILFRKKK 152
E + L + +E K + ++ + I+ R
Sbjct: 68 SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHR--- 124
Query: 153 TDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKAD 212
DIK NILLD++ I DF +A D + T +GT GYMAPE + SV D
Sbjct: 125 -DIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVD 181
Query: 213 VFSFGVVILELISGQR 228
+S GV E + G+R
Sbjct: 182 WWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 41/202 (20%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCA 116
LG+G +G V+ + L IA+K++ ++ + E L + ++HRN+V LG +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 117 HGAEKLLIYEYVINESLDKVLFS------------------------LIKDIQILFRKKK 152
+ E V SL +L S + D QI+ R
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR--- 132
Query: 153 TDIKASNILLDD-KWIPKIADFG----MARLFPEDQTHVNTRVAGTNGYMAPEYVMHGH- 206
DIK N+L++ + KI+DFG +A + P +T GT YMAPE + G
Sbjct: 133 -DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-----FTGTLQYMAPEVIDKGPR 186
Query: 207 -LSVKADVFSFGVVILELISGQ 227
AD++S G I+E+ +G+
Sbjct: 187 GYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 60/205 (29%), Positives = 88/205 (42%), Gaps = 35/205 (17%)
Query: 56 NKLGEGGFGPVFKGKL----DDGRE--IAVKKL-SHSSNQGKKEFENEAKLLARVQHRNV 108
LG G FG V++G D E +AVK L S Q + +F EA ++++ H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 109 VNLLGYCAHGAEKLLIYEYVINESLDKVL----------FSL-IKDIQIL---------- 147
V L+G + ++ E + L L SL +KD+
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 148 ---FRKKKTDIKASNILLDDKW---IPKIADFGMAR-LFPEDQTHVNTRVAGTNGYMAPE 200
DI A N LL K + KIADFGMAR ++ R +M PE
Sbjct: 132 LEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPE 191
Query: 201 YVMHGHLSVKADVFSFGVVILELIS 225
+ G + K DV+SFGV++ E+ S
Sbjct: 192 AFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 50 KNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQ---- 104
+ ++G G G V+K + G +AVK++ + N+ E ++L +
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-----EENKRILMDLDVVLK 69
Query: 105 -HR--NVVNLLGY---------C----AHGAEKLL--IYEYVINESLDKVLFSLIKDIQI 146
H +V GY C + +KLL I + + L K+ +++K +
Sbjct: 70 SHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHY 129
Query: 147 LFRKKKT---DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYV- 202
L K D+K SNILLD K+ DFG++ + + TR AG YMAPE +
Sbjct: 130 LKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERID 187
Query: 203 ---MHGHLSVKADVFSFGVVILELISGQ 227
+ ++ADV+S G+ ++EL +GQ
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-14
Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 46/229 (20%)
Query: 57 KLGEGGFGPVFKGKLDDGRE---------------IAVKKL-SHSSNQGKKEFENEAKLL 100
KLGEG FG V + + E +AVK L + + + +F E K++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 101 ARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVL--------FSLIKDI-------- 144
+R+++ N++ LLG C +I EY+ N L++ L F+ +I
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 145 -----QILFRKK--------KTDIKASNILLDDKWIPKIADFGMAR-LFPEDQTHVNTRV 190
QI K D+ N L+ + + KIADFGM+R L+ D + R
Sbjct: 132 LYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRA 191
Query: 191 AGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQ 239
+MA E ++ G + +DV++FGV + E+ + + ++L D Q
Sbjct: 192 VLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-14
Identities = 58/203 (28%), Positives = 88/203 (43%), Gaps = 38/203 (18%)
Query: 51 NFHPSNKLGEGGFGPVF--KGKLDDG----REIAVKKLSHSSNQGKKEFENEAKLLARVQ 104
+ K+GEG FG ++ K K D +EI + K+ + K+ + E LLA+++
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP---VKEKEASKKEVILLAKMK 57
Query: 105 HRNVVNLLGYCAHGAEKLLIYEYVINESLDK-------VLFS----------------LI 141
H N+V ++ EY L K VLFS I
Sbjct: 58 HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHI 117
Query: 142 KDIQILFRKKKTDIKASNILLD-DKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPE 200
D +IL R DIK+ NI L + + K+ DFG+AR D + GT Y++PE
Sbjct: 118 HDRKILHR----DIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE 172
Query: 201 YVMHGHLSVKADVFSFGVVILEL 223
+ + K D++S G V+ EL
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 22/192 (11%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQG--KKEFENEAKLLARVQHRNVVNLLG 113
+GEG +G V K K + G+ +A+KK S + KK E ++L +++H N+VNL+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 114 YCAHGAEKLLIYEYVINESLD---------------KVLFSLIKDIQILFRKK--KTDIK 156
L++E+V + LD K LF +++ I+ DIK
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIK 127
Query: 157 ASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKA-DVFS 215
NIL+ + K+ DFG AR VA T Y APE ++ +A D+++
Sbjct: 128 PENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA-TRWYRAPELLVGDTKYGRAVDIWA 186
Query: 216 FGVVILELISGQ 227
G ++ E+++G+
Sbjct: 187 VGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 4e-14
Identities = 73/284 (25%), Positives = 116/284 (40%), Gaps = 63/284 (22%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN---EAKLLARVQ 104
NF K+G+G F V+K L DGR +A+KK+ K ++ E LL ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 105 HRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT----------- 153
H NV+ L E ++ E L + +IK F+K+K
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSR----MIKH----FKKQKRLIPERTIWKYF 112
Query: 154 ------------------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG 195
DIK +N+ + + K+ D G+ R F T ++ V GT
Sbjct: 113 VQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPY 171
Query: 196 YMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSL 255
YM+PE + + K+D++S G ++ E+ + Q S F D NL Y L KK +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYG--DKMNL----YSLCKKIEKC 223
Query: 256 EIVDPSLAASDSGDQ----IAMCIQIGLLCTQGDPQLRPTMRRV 295
+ P L A ++ ++ CI DP+ RP + V
Sbjct: 224 DY--PPLPADHYSEELRDLVSRCINP-------DPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 4e-14
Identities = 50/189 (26%), Positives = 91/189 (48%), Gaps = 21/189 (11%)
Query: 57 KLGEGGFGPVFKG-KLDDGREIAVKK--LSHSSNQGKKEFENEAKLLARVQHRNVVNLLG 113
+G+G FG V+K + +A+K L + ++ ++ + E + L++ + + G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYITKYYG 66
Query: 114 -------------YCAHGAEKLLIYEYVINE-SLDKVLFSLIKDIQILFRKKKT--DIKA 157
YC G+ L+ ++E + +L ++ ++ L + K DIKA
Sbjct: 67 SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKA 126
Query: 158 SNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFG 217
+NILL ++ K+ADFG++ + NT V GT +MAPE + KAD++S G
Sbjct: 127 ANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEKADIWSLG 185
Query: 218 VVILELISG 226
+ +EL G
Sbjct: 186 ITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 5e-14
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 51/216 (23%)
Query: 58 LGEGGFGPVFKGK----LDDGRE---IAVKKLSH-SSNQGKKEFENEAKLLARVQHRNVV 109
LG G FG V++G L G +AVK L +++Q KKEF EA L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 110 NLLGYCAHGAEKLLIYEYVIN------------ESLDKVLFSLIKDIQILFRKKK----- 152
LLG C + +I E + E L +L + + I K
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 153 -------TDIKASNILLDDKW-----IPKIADFGMAR-LFPED------QTHVNTRVAGT 193
D+ A N L+ +K + KI DFG+AR ++ D + + R
Sbjct: 123 EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR---- 178
Query: 194 NGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQR 228
+MAPE ++ G + ++DV+SFGV++ E+++ GQ+
Sbjct: 179 --WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ 212
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 5e-14
Identities = 69/266 (25%), Positives = 121/266 (45%), Gaps = 41/266 (15%)
Query: 52 FHPSNKLGEGGFGPVFKGKLDDGREI-AVKKLSHSSNQGKKE-FENEAKLLARVQHRNVV 109
F ++G+G FG V+KG + +E+ A+K + + + E + E +L++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 110 NLLGYCAHGAEKLLIYEYVINES--------------LDKVLFSLIKDIQILFRKKKT-- 153
G G + +I EY+ S + +L ++K + L ++K
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHR 125
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADV 213
DIKA+N+LL ++ K+ADFG+A + Q NT V GT +MAPE + KAD+
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFKADI 184
Query: 214 FSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS---GDQ 270
+S G+ +EL G+ +S D+ +L L K+ P+L S +
Sbjct: 185 WSLGITAIELAKGEPPNS---DLHPMRVL----FLIPKNSP-----PTLEGQYSKPFKEF 232
Query: 271 IAMCIQIGLLCTQGDPQLRPTMRRVV 296
+ C+ DP+ RPT + ++
Sbjct: 233 VEACL-------NKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 5e-14
Identities = 54/199 (27%), Positives = 87/199 (43%), Gaps = 30/199 (15%)
Query: 56 NKLGEGGFGPVFKGK-LDDGREIAVKKLS-HSSNQGKKEFENEAKLLARVQHRNVVN--- 110
+G G V+ L + ++A+K++ E E + +++ H NVV
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 111 ----------LLGYCAHGAEKLLIYEYVINES-LDK-----VLFSLIKDIQILFRKKKT- 153
++ Y + G+ L I + LD+ VL ++K ++ L +
Sbjct: 67 SFVVGDELWLVMPYLSGGS-LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIH 125
Query: 154 -DIKASNILLDDKWIPKIADFGMARLFPED---QTHVNTRVAGTNGYMAPEYVMHGH--L 207
DIKA NILL + KIADFG++ + V GT +MAPE VM
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQVHGY 184
Query: 208 SVKADVFSFGVVILELISG 226
KAD++SFG+ +EL +G
Sbjct: 185 DFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-14
Identities = 60/196 (30%), Positives = 96/196 (48%), Gaps = 31/196 (15%)
Query: 58 LGEGGFGPVFKG-KLDDGREIAVKKLS--HSSNQGKKE---FENEAKLLARVQHRNVVNL 111
LG+G FG V+ +D GRE+AVK++ S + KKE E E +LL +QH +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 112 LGYCAHGAEKLLIY-EYV--------------INESLD-KVLFSLIKDIQILFRKK--KT 153
G C E L I+ EY+ + E++ K +++ ++ L
Sbjct: 70 YG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHR 128
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPE---DQTHVNTRVAGTNGYMAPEYVM-HGHLSV 209
DIK +NIL D K+ DFG ++ T + + V GT +M+PE + G+
Sbjct: 129 DIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPEVISGEGY-GR 186
Query: 210 KADVFSFGVVILELIS 225
KADV+S G ++E+++
Sbjct: 187 KADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 7e-14
Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 21/199 (10%)
Query: 52 FHPSNKLGEGGFGPVFKGKLDDGRE--IAVKKLSHSSNQGKKE-FENEAKLLARVQHRNV 108
F ++G+G FG VFKG +D+ + +A+K + + + E + E +L++ V
Sbjct: 6 FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 109 VNLLGYCAHGAEKLLIYEYVINES--------------LDKVLFSLIKDIQILFRKKKT- 153
G G + +I EY+ S + +L ++K + L +KK
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIH 124
Query: 154 -DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKAD 212
DIKA+N+LL ++ K+ADFG+A + Q NT V GT +MAPE + KAD
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSKAD 183
Query: 213 VFSFGVVILELISGQRNSS 231
++S G+ +EL G+ +S
Sbjct: 184 IWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 8e-14
Identities = 73/270 (27%), Positives = 123/270 (45%), Gaps = 50/270 (18%)
Query: 58 LGEGGFGPVFKGKL--DDGREI--AVKKLSHSSNQGK-KEFENEAKLLARVQHRNVVNLL 112
+G+G FG V+ G L DG++I AVK L+ ++ + ++F E ++ H NV++LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 113 GYC--------------AHGAEKLLIYEYVINESL-DKVLFSL--IKDIQILFRKK--KT 153
G C HG + I N ++ D + F L K ++ L KK
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHR 122
Query: 154 DIKASNILLDDKWIPKIADFGMAR-------LFPEDQTHVNTRVAGTNGYMAPEYVMHGH 206
D+ A N +LD+ + K+ADFG+AR + T V +MA E +
Sbjct: 123 DLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK----WMALESLQTQK 178
Query: 207 LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266
+ K+DV+SFGV++ EL++ R + DVD+ ++ + + + + DP
Sbjct: 179 FTTKSDVWSFGVLLWELMT--RGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDP------ 230
Query: 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVV 296
++ L C P++RPT +V
Sbjct: 231 -------LYEVMLSCWHPKPEMRPTFSELV 253
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 9e-14
Identities = 77/294 (26%), Positives = 123/294 (41%), Gaps = 70/294 (23%)
Query: 57 KLGEGGFGPVFKG------KLDDGREIAVKKLSHSSNQGKK-EFENEAKLLARVQHRNVV 109
+LG+G FG V++G K + +AVK ++ S++ ++ EF NEA ++ +VV
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 110 NLLGYCAHGAEKLLIYEYVINESLDKVLFSL------------------------IKDIQ 145
LLG + G L++ E + + L L SL I D
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 146 ILFRKKK---TDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-----YM 197
KK D+ A N ++ + KI DFGM R D + G G +M
Sbjct: 133 AYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWM 188
Query: 198 APEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEI 257
APE + G + +D++SFGVV+ E+ S L + Y+ ++ L+
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLKF 233
Query: 258 VDPSLAASDSG--DQIAMCIQ----IGLLCTQGDPQLRPTMRRVVVMLSKKPGP 305
V D G DQ C + + +C Q +P++RPT +V +L P
Sbjct: 234 V------MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 9e-14
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 28/200 (14%)
Query: 50 KNFHPSNKLGEGGFGPVFKG-KLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNV 108
K + K+G+G G V+ + G+E+A+K+++ K+ NE ++ +H N+
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNI 78
Query: 109 VNLLGYCAHGAEKLLIYEYVINESLDKVL--------------------FSLIKDIQILF 148
VN L G E ++ EY+ SL V+ + Q++
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIH 138
Query: 149 RKKKTDIKASNILLDDKWIPKIADFGM-ARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHL 207
R DIK+ NILL K+ DFG A++ PE Q+ +T V GT +MAPE V
Sbjct: 139 R----DIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTMV-GTPYWMAPEVVTRKAY 192
Query: 208 SVKADVFSFGVVILELISGQ 227
K D++S G++ +E++ G+
Sbjct: 193 GPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 49/214 (22%)
Query: 57 KLGEGGFGPVFKGKL------DDGREIAVKKLSHSSNQG-KKEFENEAKLLARVQHRNVV 109
+LGE FG V+KG L + + +A+K L + ++EF++EA + +R+QH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 110 NLLG-------------YCAHGAEKLLIYEYVINESL---------DKVLFSLIKDIQIL 147
LLG YC+H ++E+++ S DK + S ++ +
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSD----LHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127
Query: 148 FRKKK---------------TDIKASNILLDDKWIPKIADFGMAR-LFPEDQTHVNTRVA 191
+ D+ N+L+ DK KI+D G+ R ++ D +
Sbjct: 128 HIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSL 187
Query: 192 GTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS 225
+M+PE +M+G S+ +D++S+GVV+ E+ S
Sbjct: 188 LPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 46/212 (21%)
Query: 50 KNFHPSNKLGEGGFGPVFKGKLDDGREI-AVKKLSHSSNQGKKEFEN-----------EA 97
F N++GEG +G V++ + EI A+KK+ +N E
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKV---------RMDNERDGIPISSLREI 57
Query: 98 KLLARVQHRNVVNLL---------------GYCAHGAEKLLIYEYVIN---ESLDKVL-F 138
LL ++H N+V L YC LL + + ES K L
Sbjct: 58 TLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPTPFSESQVKCLML 115
Query: 139 SLIKDIQILFRK--KKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGY 196
L++ +Q L D+K SN+LL DK KIADFG+AR + + +V T Y
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWY 174
Query: 197 MAPEYVMHGHLSVKA-DVFSFGVVILELISGQ 227
APE ++ A D+++ G ++ EL++ +
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 35/198 (17%)
Query: 58 LGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLG 113
LG+GGFG V ++ G+ A KKL +G+ NE ++L +V R VV+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 114 YCAHGAEKLLIYEYVIN----------------ESLDKVLFSL-----IKDIQ---ILFR 149
Y + L + ++N + + ++ ++D+Q I++R
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYR 126
Query: 150 KKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSV 209
D+K NILLDD+ +I+D G+A PE +T V RV GT GYMAPE + + +
Sbjct: 127 ----DLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVINNEKYTF 180
Query: 210 KADVFSFGVVILELISGQ 227
D + G +I E+I GQ
Sbjct: 181 SPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 62/212 (29%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN--------EAKLLARVQ-HR 106
+LG+G FG V+ + + G +A+KK+ KK+F + E K L ++ H
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHP 58
Query: 107 NVVNLL-----GYCAHGAEKLLIYEYVINESL-------DKVLFS--LIKDI--QIL--- 147
N+V L + ++EY+ +L FS +I+ I QIL
Sbjct: 59 NIVKLKEVFRENDELY-----FVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGL 112
Query: 148 --------FRKKKTDIKASNILLDDKWIPKIADFGMARLF---PEDQTHVNTRVAGTNGY 196
F + D+K N+L+ + KIADFG+AR P +V+TR Y
Sbjct: 113 AHIHKHGFFHR---DLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WY 164
Query: 197 MAPEYVMH-GHLSVKADVFSFGVVILELISGQ 227
APE ++ S D+++ G ++ EL + +
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 1e-13
Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 18/195 (9%)
Query: 50 KNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNV 108
K + K+G+G G VF + G+E+A+K+++ K+ NE ++ +++ N+
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78
Query: 109 VNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKD--------------IQILFRKK--K 152
VN L G E ++ EY+ SL V+ D ++ L +
Sbjct: 79 VNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIH 138
Query: 153 TDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKAD 212
DIK+ N+LL K+ DFG +Q+ +T V GT +MAPE V K D
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197
Query: 213 VFSFGVVILELISGQ 227
++S G++ +E++ G+
Sbjct: 198 IWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 50/214 (23%)
Query: 58 LGEGGFGPVFKG------KLDDGREIAVKKLSHSSNQGK-KEFENEAKLLARV-QHRNVV 109
LGEG FG V K ++ +AVK L + + + +E +++ + +H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 110 NLLG-------------YCAHG---------AEKLLIYEYVINESLDKVL---------F 138
NLLG Y AHG ++ L +
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 139 SLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG- 195
+ + ++ L KK D+ A N+L+ + + KIADFG+AR D H++ TNG
Sbjct: 140 QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYYRKTTNGR 195
Query: 196 ----YMAPEYVMHGHLSVKADVFSFGVVILELIS 225
+MAPE + + ++DV+SFGV++ E+ +
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 73/277 (26%), Positives = 122/277 (44%), Gaps = 57/277 (20%)
Query: 58 LGEGGFGPVFKGK-LDDGREI----AVKKL-SHSSNQGKKEFENEAKLLARVQHRNVVNL 111
LG G FG V+KG + DG + A+K L ++S + KE +EA ++A V V L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 112 LGYCAHGAEKLL--------IYEYVINESLDKVL--------------FSLIKDIQILFR 149
LG C +L+ + +YV E+ D++ S +++++++ R
Sbjct: 75 LGICLTSTVQLVTQLMPYGCLLDYV-RENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHR 133
Query: 150 KKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN-GYMAPEYVMHGHLS 208
D+ A N+L+ KI DFG+ARL D+T + +MA E ++H +
Sbjct: 134 ----DLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189
Query: 209 VKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268
++DV+S+GV + EL++ + K Y + EI D L +
Sbjct: 190 HQSDVWSYGVTVWELMT------------------FGAKPYDGIPAREIPD-LLEKGERL 230
Query: 269 DQIAMCI----QIGLLCTQGDPQLRPTMRRVVVMLSK 301
Q +C I + C D + RP R +V S+
Sbjct: 231 PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSR 267
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 54/196 (27%), Positives = 85/196 (43%), Gaps = 28/196 (14%)
Query: 56 NKLGEGGFGPVFKGKLDDGREI-AVKKLSHSSNQG-KKEFENEAKLLARVQHRNVVNLLG 113
++LGEG G V K +L + I A+K ++ N +K+ E ++ + +V G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 114 YCAHGAEKLL--IYEYVINESLD-------------------KVLFSLIKDIQILFRKK- 151
+ + EY SLD K+ S++K + L +K
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKI 126
Query: 152 -KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVK 210
DIK SNILL K K+ DFG++ T GT+ YMAPE + S+
Sbjct: 127 IHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPERIQGKPYSIT 183
Query: 211 ADVFSFGVVILELISG 226
+DV+S G+ +LE+
Sbjct: 184 SDVWSLGLTLLEVAQN 199
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 61/203 (30%), Positives = 85/203 (41%), Gaps = 48/203 (23%)
Query: 36 EQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFE 94
+Q FPF VS + K+G+G FG VFK + + +A+KK+ K+ F
Sbjct: 1 DQYEFPFCDEVS---KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLM--ENEKEGFP 55
Query: 95 ----NEAKLLARVQHRNVVNL---------------------LGYCAHGAEKLLIYEYV- 128
E K+L ++H NVVNL +C H LL + V
Sbjct: 56 ITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK 115
Query: 129 -----INESLDKVLFSL--IKDIQILFRKKKTDIKASNILLDDKWIPKIADFGMARLFP- 180
I + + +L L I +IL R D+KA+NIL+ I K+ADFG+AR F
Sbjct: 116 FTLSEIKKVMKMLLNGLYYIHRNKILHR----DMKAANILITKDGILKLADFGLARAFSL 171
Query: 181 ---EDQTHVNTRVAGTNGYMAPE 200
RV T Y PE
Sbjct: 172 SKNSKPNRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 67/195 (34%), Positives = 96/195 (49%), Gaps = 28/195 (14%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKLSHSSN--QGKKEFENEAKLLARVQHRNVVNLLG 113
K+GEG +G VFK + + G+ +A+KK S + KK E ++L +++H N+VNL+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 114 YCAHGAEKLLIYEY----VINESLDK----VLFSLIKDI--QIL----FRKKKT----DI 155
+ L++EY V+NE L+K V LIK I Q L F K D+
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDV 126
Query: 156 KASNILLDDKWIPKIADFGMARLF--PEDQTHVNTRVAGTNGYMAPEY-VMHGHLSVKAD 212
K NIL+ + K+ DFG AR+ P D T T Y APE V D
Sbjct: 127 KPENILITKQGQIKLCDFGFARILTGPGDDY---TDYVATRWYRAPELLVGDTQYGPPVD 183
Query: 213 VFSFGVVILELISGQ 227
V++ G V EL++GQ
Sbjct: 184 VWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-13
Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 58 LGEGGFGPVFKGKLDD--GR----EIAVKKLSHSSNQGK-KEFENEAKLLARVQHRNVVN 110
LGEG FG V K GR +AVK L +++ + ++ +E LL +V H +V+
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 111 LLGYCAHGAEKLLIYEYVINESLDKVL--------------------------------- 137
L G C+ LLI EY SL L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 138 ------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN-T 188
+ + + +Q L K D+ A N+L+ + KI+DFG++R E+ ++V +
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS 187
Query: 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS 225
+ +MA E + + ++DV+SFGV++ E+++
Sbjct: 188 KGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 55/193 (28%), Positives = 92/193 (47%), Gaps = 27/193 (13%)
Query: 57 KLGEGGFGPVFKGKLD-DGREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGY 114
++G G FG VF G+L D +AVK + K +F EA++L + H N+V L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 115 CAHGAEKLLIYEYVIN----------------ESLDKVLFSLIKDIQILFRKK--KTDIK 156
C ++ E V + L +++ + ++ L K D+
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121
Query: 157 ASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN----GYMAPEYVMHGHLSVKAD 212
A N L+ +K + KI+DFGM+R E++ V G + APE + +G S ++D
Sbjct: 122 ARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178
Query: 213 VFSFGVVILELIS 225
V+SFG+++ E S
Sbjct: 179 VWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 35/198 (17%)
Query: 58 LGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLG 113
LG+GGFG V ++ G+ A KKL +G+ NE ++L +V R VV+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66
Query: 114 YCAHGAEKLLIYEYVIN----------------ESLDKVLFSL-----IKDI---QILFR 149
Y + L + ++N E V ++ ++D+ +I++R
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYR 126
Query: 150 KKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSV 209
D+K NILLDD +I+D G+A PE QT + RV GT GYMAPE V + +
Sbjct: 127 ----DLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYTF 180
Query: 210 KADVFSFGVVILELISGQ 227
D ++ G ++ E+I+GQ
Sbjct: 181 SPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 47/190 (24%), Positives = 92/190 (48%), Gaps = 19/190 (10%)
Query: 57 KLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNL----- 111
KLG G FG V+ + ++AVK + S + F EA ++ +QH +V L
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 112 ---LGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQ------ILFRKKKT----DIKAS 158
+ K + +++ ++ K + D + F +++ D++A+
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAA 131
Query: 159 NILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGV 218
NIL+ + KIADFG+AR+ +++ + APE + G ++K+DV+SFG+
Sbjct: 132 NILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGI 191
Query: 219 VILELISGQR 228
+++E+++ R
Sbjct: 192 LLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 5e-13
Identities = 53/226 (23%), Positives = 88/226 (38%), Gaps = 52/226 (23%)
Query: 39 HFPFEALVSATKNFHPSNKLGEGGFGPVFKGKL----DDGRE--IAVKKLSHSSNQG-KK 91
FP N LG G FG VF K ++G E + VK L + ++ +
Sbjct: 1 AFPRS-------NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS 53
Query: 92 EFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV----------INESLDKVLFS-- 139
EF E + ++ H+NVV LLG C +I EY +S D+ L
Sbjct: 54 EFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP 113
Query: 140 ------------LIKDIQILFRKKKT--DIKASNILLDDKWIPKIADFGMAR------LF 179
+ + L + D+ A N L+ + K++ +++ +
Sbjct: 114 LSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173
Query: 180 PEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS 225
+ R ++APE V S K+DV+SFGV++ E+ +
Sbjct: 174 KLRNALIPLR------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 5e-13
Identities = 60/194 (30%), Positives = 92/194 (47%), Gaps = 28/194 (14%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKLS-HSSNQGKKEFE-NEAKLLARVQHRNVVNLLG 113
K+GEG +G V+KG+ G+ +A+KK+ S +G E LL +QH N+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 114 YCAHGAEKLLIYEYV------------INESLDKVLF-SLIKDI--QILF----RKKKTD 154
+ LI+E++ + +D L S + I ILF R D
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRD 126
Query: 155 IKASNILLDDKWIPKIADFGMARLF--PEDQTHVNTRVAGTNGYMAPEYVMHGHL-SVKA 211
+K N+L+D+K + K+ADFG+AR F P V T T Y APE ++ S
Sbjct: 127 LKPQNLLIDNKGVIKLADFGLARAFGIP---VRVYTHEVVTLWYRAPEVLLGSPRYSTPV 183
Query: 212 DVFSFGVVILELIS 225
D++S G + E+ +
Sbjct: 184 DIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 5e-13
Identities = 72/281 (25%), Positives = 126/281 (44%), Gaps = 47/281 (16%)
Query: 50 KNFHPSNKLGEGGFGPV-FKGKLDDGREIAVKKLSHSSNQGKKEFEN---EAKLLARVQH 105
K F ++G G FG V F + +A+KK+S+S Q +++++ E K L R++H
Sbjct: 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84
Query: 106 RNVVNLLGYCAHGAEKLLIYEYVINESLD--KVLFSLIKDIQIL-----------FRKKK 152
N + G L+ EY + + D +V +++++I +
Sbjct: 85 PNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 153 T----DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM---HG 205
DIKA NILL + K+ADFG A + + V GT +MAPE ++ G
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAMDEG 199
Query: 206 HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265
K DV+S G+ +EL + ++ FN+ N + Y + + + P+L ++
Sbjct: 200 QYDGKVDVWSLGITCIEL-AERKPPLFNM-----NAMSALYHIAQNES------PTLQSN 247
Query: 266 DSGDQIAMCIQIGLLCTQGDPQLRPT---MRRVVVMLSKKP 303
+ D + C Q PQ RPT + + + +L ++P
Sbjct: 248 EWSDYFRNFVDS---CLQKIPQDRPTSEELLKHMFVLRERP 285
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-13
Identities = 68/260 (26%), Positives = 114/260 (43%), Gaps = 44/260 (16%)
Query: 56 NKLGEGGFGPVFKGKLDDGREI-AVKKLSHSSNQGKKEFEN---EAKLLARVQHRNVVNL 111
+++G G FG V+ E+ AVKK+S+S Q +++++ E K L +++H N +
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 112 LGYCAHGAEKLLIYEYVINESLD--KVLFSLIKDIQIL---------------FRKKKTD 154
G L+ EY + + D +V +++++I D
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 146
Query: 155 IKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM---HGHLSVKA 211
IKA NILL + K+ADFG A + V GT +MAPE ++ G K
Sbjct: 147 IKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQYDGKV 201
Query: 212 DVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271
DV+S G+ +EL + ++ FN+ N + Y + + D P+L +++ D
Sbjct: 202 DVWSLGITCIEL-AERKPPLFNM-----NAMSALYHIAQNDS------PTLQSNEWTDSF 249
Query: 272 AMCIQIGLLCTQGDPQLRPT 291
+ C Q PQ RP
Sbjct: 250 RGFVD---YCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 9e-13
Identities = 69/281 (24%), Positives = 117/281 (41%), Gaps = 58/281 (20%)
Query: 55 SNKLGEGGFGPVF----KGKLDDGRE--IAVKKLSHSSNQGKK-EFENEAKLLARVQHRN 107
S +LG+G FG V+ KG + D E +A+K ++ +++ ++ EF NEA ++ +
Sbjct: 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 108 VVNLLGYCAHGAEKLLIYEYVINESLDKVLFSL------------------------IKD 143
VV LLG + G L+I E + L L SL I D
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 144 IQILFRKKK---TDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG----- 195
K D+ A N ++ + + KI DFGM R D + G G
Sbjct: 131 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 186
Query: 196 YMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSL 255
+M+PE + G + +DV+SFGVV+ E+ + L + Y+ ++ L
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGMSNEQVL 231
Query: 256 EIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVV 296
V + M ++ +C Q +P++RP+ ++
Sbjct: 232 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 9e-13
Identities = 64/198 (32%), Positives = 94/198 (47%), Gaps = 35/198 (17%)
Query: 58 LGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNL-- 111
LG+GGFG V ++ G+ A KKL +G+ NE ++L +V R VV+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 112 -----------LGYCAHGAEKLLIYEYVINESLD--KVLFSL------IKDIQ---ILFR 149
L G K IY + N D + +F ++D+ I++R
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYN-MGNPGFDEERAVFYAAEITCGLEDLHRERIVYR 126
Query: 150 KKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSV 209
D+K NILLDD +I+D G+A PE +T + RV GT GYMAPE V + +
Sbjct: 127 ----DLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEVVKNERYTF 180
Query: 210 KADVFSFGVVILELISGQ 227
D + G +I E+I G+
Sbjct: 181 SPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 33/224 (14%)
Query: 25 NEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKG-KLDDGREIAVKKLS 83
+EE LEK+ + ++ K + K+G+G G V+ + G+E+A+K+++
Sbjct: 1 DEEILEKLRS-------IVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN 53
Query: 84 HSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVL------ 137
K+ NE ++ ++ N+VN L G E ++ EY+ SL V+
Sbjct: 54 LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD 113
Query: 138 --------------FSLIKDIQILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183
+ Q++ R DIK+ NILL K+ DFG +Q
Sbjct: 114 EGQIAAVCRECLQALDFLHSNQVIHR----DIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169
Query: 184 THVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQ 227
+ +T V GT +MAPE V K D++S G++ +E++ G+
Sbjct: 170 SKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 60/201 (29%), Positives = 93/201 (46%), Gaps = 31/201 (15%)
Query: 52 FHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLS-HSSNQGKKEFE-NEAKLLARVQ---H 105
+ ++GEG +G V+K + L+ GR +A+KK+ S +G E LL +++ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 106 RNVVNLLGYCA-----HGAEKLLIYEYV---INESLDKVLFS-----LIKDI--QIL--- 147
N+V LL C + L++E+V + L K IKD+ Q+L
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120
Query: 148 -F----RKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYV 202
F R D+K NIL+ KIADFG+AR++ T V T Y APE +
Sbjct: 121 DFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVVTLWYRAPEVL 178
Query: 203 MHGHLSVKADVFSFGVVILEL 223
+ + D++S G + EL
Sbjct: 179 LQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 45/201 (22%)
Query: 58 LGEGGFGPVFKGKL-DDGREIAVKKLS-HSSNQGKKE--FENEAKLLARVQHRNVVNLLG 113
LG GGFG V K+ R A+K + + ++ +E ++L H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 114 YCAHGAEKLLIYEYVINES-LDKVLFSLIKDI-------------------------QIL 147
Y +K Y Y++ E L L+++++D I+
Sbjct: 59 YRTFKDKK---YIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGII 115
Query: 148 FRKKKTDIKASNILLDDKWIPKIADFGMAR-LFPEDQTHVNTRVAGTNGYMAPEYVM-HG 205
+R D+K N+LLD K+ DFG A+ L +T GT Y+APE ++ G
Sbjct: 116 YR----DLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNKG 168
Query: 206 HLSVKADVFSFGVVILELISG 226
+ D +S G+++ EL++G
Sbjct: 169 Y-DFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 51/200 (25%), Positives = 84/200 (42%), Gaps = 27/200 (13%)
Query: 52 FHPSNKLGEGGFGPVFKGKLDDGREI-AVKKLSHSSNQGKKEFENEAKLLARVQHRNVVN 110
+ ++G G +G V+K + E+ A+K + + + E +L +H N+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 111 LLG-YCAHGAEKLLI-YEYVINESLD---KVLFSLIKDIQILF---------------RK 150
G Y +KL I EY SL +V + ++QI + K
Sbjct: 65 YFGSY--LRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK 122
Query: 151 KKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYV---MHGHL 207
DIK +NILL + K+ADFG++ + + GT +MAPE G
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGY 181
Query: 208 SVKADVFSFGVVILELISGQ 227
K D+++ G+ +EL Q
Sbjct: 182 DGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 66/266 (24%), Positives = 130/266 (48%), Gaps = 48/266 (18%)
Query: 58 LGEGGFGPV-FKGKLDDGREIAVKKLS--HSSNQGKKEFENEAKLLARVQHRNVVN---- 110
+G+G +G V DG++ +KKL+ ++S + +K E EA+LL++++H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 111 ----------LLGYCAHGA--EKL------LIYEYVINESLDKVLFSL--IKDIQILFRK 150
++G+C G KL L+ E + E ++ +L + + IL R
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHR- 126
Query: 151 KKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVK 210
D+K N+ L I K+ D G+AR+ E+Q + + + GT YM+PE + + K
Sbjct: 127 ---DLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLIGTPYYMSPELFSNKPYNYK 182
Query: 211 ADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQ 270
+DV++ G + E+ + + +FN A+++ Y++ +E P + D +
Sbjct: 183 SDVWALGCCVYEMATLKH--AFN----AKDMNSLVYRI------IEGKLPPM-PKDYSPE 229
Query: 271 IAMCIQIGLLCTQGDPQLRPTMRRVV 296
+ I +L + P+ RP+++ ++
Sbjct: 230 LGELIA-TMLSKR--PEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 37/199 (18%)
Query: 58 LGEGGFGPVFKGKLDD-GREIAVKKLS---HSSNQGKKEFENEAKLLARVQHRNVVNLLG 113
+G G +G V GR++A+KKLS S+ K+ + E +LL + H NV+ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLD 81
Query: 114 YCAHGAEKLLIYE--YVINESLDKVLFSLIK-------DIQILF----RKKK-------- 152
A L ++ Y++ + L +++K IQ L R K
Sbjct: 82 -VFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGII 140
Query: 153 -TDIKASNILLDDKWIPKIADFGMARLFPEDQT-HVNTRVAGTNGYMAPEYVMH--GHLS 208
D+K SNI +++ KI DFG+AR ++ T +V TR Y APE +M H +
Sbjct: 141 HRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE-IMLNWMHYN 194
Query: 209 VKADVFSFGVVILELISGQ 227
D++S G ++ EL++G+
Sbjct: 195 QTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 43/203 (21%), Positives = 87/203 (42%), Gaps = 40/203 (19%)
Query: 54 PSNKLGEGGFGPVFKG----KLDDGREIAVKKLSHSSNQGKKE-FENEAKLLARVQHRNV 108
+GEG FG V++G ++ +AVK + ++ +E F EA ++ + H ++
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69
Query: 109 VNLLGYCAHG--------------------------AEKLLIYEYVINESLDKVLFSLIK 142
V L+G L++Y Y ++ +L + ++
Sbjct: 70 VKLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTAL-----AYLE 124
Query: 143 DIQILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYV 202
+ + R DI A N+L+ K+ DFG++R ++ + ++ +MAPE +
Sbjct: 125 SKRFVHR----DIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESI 180
Query: 203 MHGHLSVKADVFSFGVVILELIS 225
+ +DV+ FGV + E++
Sbjct: 181 NFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 3e-12
Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 21/195 (10%)
Query: 52 FHPSNKLGEGGFGPVFKGKLDDGRE--IAVKKLSHSSNQGK-KEFENEAKLLARVQHRNV 108
F K+G+G FG VFKG +D+ + +A+K + + + ++ + E +L++ V
Sbjct: 6 FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 109 VNLLGYCAHGAEKLLIYEYV-------------INES-LDKVLFSLIKDIQILFRKKKT- 153
G + +I EY+ ++E+ + +L ++K + L +KK
Sbjct: 65 TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIH 124
Query: 154 -DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKAD 212
DIKA+N+LL + K+ADFG+A + Q NT V GT +MAPE + KAD
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKAD 183
Query: 213 VFSFGVVILELISGQ 227
++S G+ +EL G+
Sbjct: 184 IWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 3e-12
Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 35/225 (15%)
Query: 25 NEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKG-KLDDGREIAVKKLS 83
+EE LEK+ + ++ K + K+G+G G V+ + G+E+A+++++
Sbjct: 2 DEEILEKLRS-------IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN 54
Query: 84 HSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVL------ 137
K+ NE ++ ++ N+VN L G E ++ EY+ SL V+
Sbjct: 55 LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD 114
Query: 138 --------------FSLIKDIQILFRKKKTDIKASNILLDDKWIPKIADFGM-ARLFPED 182
+ Q++ R DIK+ NILL K+ DFG A++ PE
Sbjct: 115 EGQIAAVCRECLQALEFLHSNQVIHR----DIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170
Query: 183 QTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQ 227
+ + GT +MAPE V K D++S G++ +E+I G+
Sbjct: 171 SKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 68/259 (26%), Positives = 112/259 (43%), Gaps = 41/259 (15%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLG--- 113
LG+G FG V+K + + G A K + S + ++F E +L+ +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 114 ----------YCAHGAEKLLI--YEYVINES-LDKVLFSLIKDIQILFRKK--KTDIKAS 158
+C GA ++ E + E + V +++ + L K D+KA
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAG 132
Query: 159 NILLDDKWIPKIADFGM-ARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLS-----VKAD 212
NILL K+ADFG+ A+ Q +T + GT +MAPE V KAD
Sbjct: 133 NILLTLDGDVKLADFGVSAKNKSTLQKR-DTFI-GTPYWMAPEVVACETFKDNPYDYKAD 190
Query: 213 VFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIA 272
++S G+ ++EL + +++ +L K+ K + + PS +S D +
Sbjct: 191 IWSLGITLIELAQMEPPHH---ELNPMRVL---LKILKSE-PPTLDQPSKWSSSFNDFLK 243
Query: 273 MCIQIGLLCTQGDPQLRPT 291
C+ DP RPT
Sbjct: 244 SCL-------VKDPDDRPT 255
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 5e-12
Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 35/197 (17%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGK-KEFENEAKLLARVQH---RNVVNLL 112
+G G +G V++GK + GR +A+K ++ + + + E LL++++ N+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 113 GYCAHGAEKLLIYEY----------------------VINESLDKVLFSLIKDIQILFRK 150
G G +I EY +I E L V I + ++ R
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVL--VALKYIHKVGVIHR- 125
Query: 151 KKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHL-SV 209
DIKA+NIL+ + K+ DFG+A L ++ + +T V GT +MAPE + G
Sbjct: 126 ---DIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYYDT 181
Query: 210 KADVFSFGVVILELISG 226
KAD++S G+ I E+ +G
Sbjct: 182 KADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 52/216 (24%)
Query: 58 LGEGGFGPVF--------KGKLDDGREIAVKKL-SHSSNQGKKEFENEAKLLARV-QHRN 107
LGEG FG V K K + ++AVK L S ++ + + +E +++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 108 VVNLLGYCAHGAEKLLIYEYVINESLDKVL------------------------------ 137
++NLLG C +I EY +L + L
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 138 -FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN 194
+ + + ++ L KK D+ A N+L+ + + KIADFG+AR D H++ TN
Sbjct: 146 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKKTTN 201
Query: 195 G-----YMAPEYVMHGHLSVKADVFSFGVVILELIS 225
G +MAPE + + ++DV+SFGV++ E+ +
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 78/337 (23%), Positives = 141/337 (41%), Gaps = 79/337 (23%)
Query: 58 LGEGGFGPVF--------KGKLDDGREIAVKKLSH-SSNQGKKEFENEAKLLARV-QHRN 107
LGEG FG V K K + +AVK L ++++ + +E +++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 108 VVNLLGYCAHGAEKLLIYEYVINESLDKVL------------------------------ 137
++NLLG C ++ EY +L + L
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 138 -FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN 194
+ + + ++ L +K D+ A N+L+ + + KIADFG+AR D +++ TN
Sbjct: 140 AYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLAR----DVHNIDYYKKTTN 195
Query: 195 G-----YMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLY 249
G +MAPE + + ++DV+SFGV++ E+ + + + V+ +KL
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------LFKLL 249
Query: 250 KKDKSLEIVDPSLAASDSGDQIAMCIQ----IGLLCTQGDPQLRPTMRRVVVMLSKKPGP 305
K+ + D+ A C I C P RPT +++V L +
Sbjct: 250 KEGHRM-------------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296
Query: 306 GNLEEPTRPGVPGSRYRRARRPAALSSSTAGSSGESN 342
+ +E VP +Y P S ++ SSG+ +
Sbjct: 297 TSTDEYLDLSVPFEQY----SPGCPDSPSSCSSGDDS 329
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 51/203 (25%)
Query: 58 LGEGGFGPVFKGKLDDGREI-AVKKLSHSSNQGKKEFE---NEAKLLARVQHRNVVNLLG 113
LG G FG V + + A+K LS + K+ E NE ++L ++H +VNL G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 114 YCAHGAEKLLIYEYVI-NESLDKVLFSLIK-------------------------DIQIL 147
+ L+ EYV E LFS ++ + I+
Sbjct: 69 SFQDDSNLYLVMEYVPGGE-----LFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIV 123
Query: 148 FRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR---VAGTNGYMAPEYVMH 204
+R D+K N+LLD KI DFG A+ V R + GT Y+APE ++
Sbjct: 124 YR----DLKPENLLLDSDGYIKITDFGFAK-------RVKGRTYTLCGTPEYLAPEIILS 172
Query: 205 -GHLSVKADVFSFGVVILELISG 226
G+ D ++ G++I E+++G
Sbjct: 173 KGYGK-AVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 72/309 (23%), Positives = 124/309 (40%), Gaps = 80/309 (25%)
Query: 57 KLGEGGFGPVFKGKLDDGRE-----------------IAVKKLSHSSNQ-GKKEFENEAK 98
KLGEG FG V ++ + ++ +AVK L +N+ + +F E K
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 99 LLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKD--------------- 143
+L+R++ N++ LLG C +I EY+ N L++ L S D
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 144 -------------IQILFRKK--------KTDIKASNILLDDKWIPKIADFGMAR-LFPE 181
+QI K D+ N L+ + KIADFGM+R L+
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAG 191
Query: 182 DQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNL 241
D + R +MA E ++ G + +DV++FGV + E++ + + D Q +
Sbjct: 192 DYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ-V 250
Query: 242 LDWAYKLYKKDKSLEIVDPSLAASDSGDQI-----AMCIQ----IGLLCTQGDPQLRPTM 292
++ A + ++ D G Q+ C Q + L C D + RP+
Sbjct: 251 IENAGEFFR---------------DQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSF 295
Query: 293 RRVVVMLSK 301
+ L++
Sbjct: 296 SDIHAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 53/205 (25%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEA---------KLLARVQHR 106
K+GEG +G V+K + G +A+KK+ + E E+E LL + H
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKI-------RLETEDEGVPSTAIREISLLKELNHP 58
Query: 107 NVVNLLGYCAHGAEKL-LIYEY-----------VINESLD-----KVLFSLIKDI----- 144
N+V LL H KL L++E+ LD L+ L++ I
Sbjct: 59 NIVRLLD-VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 145 -QILFRKKKTDIKASNILLDDKWIPKIADFGMARLF--PEDQ-THVNTRVAGTNGYMAPE 200
++L R D+K N+L+D + K+ADFG+AR F P TH V T Y APE
Sbjct: 118 HRVLHR----DLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPE 169
Query: 201 YVMHG-HLSVKADVFSFGVVILELI 224
++ S D++S G + E++
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 50/211 (23%)
Query: 58 LGEGGFGPVFKGKL-DDGREI--AVKKLS-HSSNQGKKEFENEAKLLARV-QHRNVVNLL 112
+GEG FG V K ++ DG + A+K++ ++S ++F E ++L ++ H N++NLL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 113 GYCAHGAEKLLIYEYVINESL------DKVL------------FSLIKDIQIL------- 147
G C H L EY + +L +VL S + Q+L
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 148 ----FRKKKT----DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG---- 195
+ +K D+ A NIL+ + ++ KIADFG++R V T G
Sbjct: 135 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGRLPV 187
Query: 196 -YMAPEYVMHGHLSVKADVFSFGVVILELIS 225
+MA E + + + +DV+S+GV++ E++S
Sbjct: 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 58/194 (29%), Positives = 94/194 (48%), Gaps = 27/194 (13%)
Query: 58 LGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLG 113
LG+GGFG V ++ G+ A K+L +G+ NE ++L +V + VVNL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66
Query: 114 YCAHGAEKLLIYEYVINE---------------SLDKVLF---SLIKDIQILFRKKKT-- 153
Y + L + ++N ++ LF ++ ++ L R+
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYR 126
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADV 213
D+K NILLDD +I+D G+A PE ++ + RV GT GYMAPE + + ++ D
Sbjct: 127 DLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV-GTVGYMAPEVLNNQRYTLSPDY 184
Query: 214 FSFGVVILELISGQ 227
+ G +I E+I GQ
Sbjct: 185 WGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 56/190 (29%), Positives = 85/190 (44%), Gaps = 20/190 (10%)
Query: 58 LGEGGFGPVFKGKLDDGREI-AVKKLSHSS-NQGKKEFE-NEAKLLARVQHRNVVNLLGY 114
+GEG +G V K + + +EI A+KK S N+ KE E K+L ++ N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 115 CAHGAEKLLIYEYVINESL------------DKV---LFSLIKDIQILFRKK--KTDIKA 157
+ L++EYV L +KV ++ LIK I + DIK
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKP 128
Query: 158 SNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFG 217
N+L+ + K+ DFG AR E T T Y +PE ++ D++S G
Sbjct: 129 ENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVG 188
Query: 218 VVILELISGQ 227
++ EL GQ
Sbjct: 189 CILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 54/193 (27%), Positives = 95/193 (49%), Gaps = 26/193 (13%)
Query: 58 LGEGGFGPVFKGK-LDDGREI----AVKKLSH-SSNQGKKEFENEAKLLARVQHRNVVNL 111
LG G FG V+KG + +G ++ A+K+L +S + KE +EA ++A V + +V L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 112 LGYCAHGAEKLL--------IYEYVINESLDKV--------LFSLIKDIQILFRKK--KT 153
LG C +L+ + +YV E D + + K + L ++
Sbjct: 75 LGICLTSTVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHR 133
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN-GYMAPEYVMHGHLSVKAD 212
D+ A N+L+ KI DFG+A+L D+ + +MA E ++H + ++D
Sbjct: 134 DLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSD 193
Query: 213 VFSFGVVILELIS 225
V+S+GV + EL++
Sbjct: 194 VWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 56/193 (29%), Positives = 100/193 (51%), Gaps = 26/193 (13%)
Query: 58 LGEGGFGPVFKGK-LDDGREI----AVKKLSHSSN-QGKKEFENEAKLLARVQHRNVVNL 111
LG G FG V+KG + +G + A+K L+ ++ + EF +EA ++A + H ++V L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 112 LGYCAHGAEKLL--------IYEYVINESLDKVLFSLIKD--IQI----LFRKKKT---- 153
LG C +L+ + +YV +E D + L+ + +QI ++ +++
Sbjct: 75 LGVCLSPTIQLVTQLMPHGCLLDYV-HEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHR 133
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN-GYMAPEYVMHGHLSVKAD 212
D+ A N+L+ KI DFG+ARL D+ N +MA E + + + ++D
Sbjct: 134 DLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSD 193
Query: 213 VFSFGVVILELIS 225
V+S+GV I EL++
Sbjct: 194 VWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 43/210 (20%)
Query: 52 FHPSNKLGEGGFGPVFKGKLD--DGREIAVKKLSHSSNQGKKEFEN---------EAKLL 100
P +G G FG V+ D DG+ +A+KK+ + F+N E K+L
Sbjct: 2 VEPDRPIGYGAFGVVWSVT-DPRDGKRVALKKMPNV-------FQNLVSCKRVFRELKML 53
Query: 101 ARVQHRNVVNLLGYCAHGAEKLLIYEYVINE----SLDKVLFS---LIKD------IQIL 147
+H NV++ L YV+ E L K++ S L D QIL
Sbjct: 54 CFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQIL 113
Query: 148 FRKKK---------TDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMA 198
R K DIK N+L++ + KI DFG+AR+ D++ T+ T Y A
Sbjct: 114 -RGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172
Query: 199 PEYVMHG-HLSVKADVFSFGVVILELISGQ 227
PE +M H + D++S G + EL+ +
Sbjct: 173 PEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 66/267 (24%), Positives = 114/267 (42%), Gaps = 46/267 (17%)
Query: 50 KNFHPSNKLGEGGFGPV-FKGKLDDGREIAVKKLSHSSNQGKKEFEN---EAKLLARVQH 105
K F ++G G FG V F + + +A+KK+S+S Q +++++ E + L +++H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 106 RNVVNLLGYCAHGAEKLLIYEYVINESLD--KVLFSLIKDIQIL---------------F 148
N + G L+ EY + + D +V +++++I
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 149 RKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM---HG 205
D+KA NILL + + K+ DFG A + V GT +MAPE ++ G
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEG 189
Query: 206 HLSVKADVFSFGVVILELISGQRNSS-FNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264
K DV+S G+ +EL +R FN+ N + Y + + + P+L +
Sbjct: 190 QYDGKVDVWSLGITCIEL--AERKPPLFNM-----NAMSALYHIAQNES------PALQS 236
Query: 265 SDSGDQIAMCIQIGLLCTQGDPQLRPT 291
+ + C Q PQ RPT
Sbjct: 237 GHWSEYFRNFVDS---CLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 4e-11
Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 38/199 (19%)
Query: 61 GGFGPVFKGKLDDGREI-AVKKLSHSSNQGKKEFEN---EAKLLARVQHRNVVNLLGYCA 116
G +G VF K +I A+K + + K + + E +L++ Q VV L Y
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 117 HGAEKL-LIYEYVINESLDKVLFSL------------------IKDIQ---ILFRKKKTD 154
G + L L+ EY+ L +L ++ ++ + I+ R D
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHR----D 118
Query: 155 IKASNILLDDKWIPKIADFGMAR-------LFPEDQTHVNTRVAGTNGYMAPEYVMHGHL 207
+K NIL+D K+ DFG+++ + D + R+ GT Y+APE ++
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178
Query: 208 SVKADVFSFGVVILELISG 226
S D +S G ++ E + G
Sbjct: 179 SKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 52/218 (23%)
Query: 52 FHPSNKLGEGGFGPVFKGKL---DDGREIAVKKLSHSSNQGKKEFEN-------EAKLLA 101
+ +G G +G V+K K DG+E A+KK K+++ E LL
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF----KGDKEQYTGISQSACREIALLR 57
Query: 102 RVQHRNVVNLLGYCAHGAEKL--LIYEY------------------VINESLDK-VLFSL 140
++H NVV+L+ A+K L+++Y I S+ K +L+ +
Sbjct: 58 ELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117
Query: 141 IKDIQ------ILFRKKKTDIKASNILL----DDKWIPKIADFGMARLF--PEDQTHVNT 188
+ + +L R D+K +NIL+ ++ + KI D G+ARLF P
Sbjct: 118 LNGVHYLHSNWVLHR----DLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
Query: 189 RVAGTNGYMAPEYVMHGHLSVKA-DVFSFGVVILELIS 225
V T Y APE ++ KA D+++ G + EL++
Sbjct: 174 PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 33/197 (16%)
Query: 58 LGEGGFGPVFKGKLDD-GREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNL-- 111
LG+GGFG V ++ + G+ A KKL G+K E ++L +V +VNL
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 112 -----------LGYCAHGAEKLLIYEY-VINESLDKVLFSL---------IKDIQILFRK 150
+ G K IY +++V+ + + I++R
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYR- 119
Query: 151 KKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVK 210
D+K N+LLDD+ +++D G+A + +T T+ AGTNGYMAPE + S
Sbjct: 120 ---DMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSYP 174
Query: 211 ADVFSFGVVILELISGQ 227
D F+ G I E+++G+
Sbjct: 175 VDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 52/216 (24%)
Query: 58 LGEGGFGPVF--------KGKLDDGREIAVKKLSHSSNQGK-KEFENEAKLLARV-QHRN 107
LGEG FG V K K + +AVK L + + + +E +++ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 108 VVNLLGYCAHGAEKLLIYEYVINESLDKVL------------------------------ 137
++NLLG C +I EY +L + L
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 138 -FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN 194
+ + + ++ L +K D+ A N+L+ + + KIADFG+AR D +++ TN
Sbjct: 143 TYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DVNNIDYYKKTTN 198
Query: 195 G-----YMAPEYVMHGHLSVKADVFSFGVVILELIS 225
G +MAPE + + ++DV+SFGV++ E+ +
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 5e-11
Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 26/195 (13%)
Query: 58 LGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFEN---EAKLLARVQHRNVVNLLG 113
LG+GGFG V ++ G+ A KKL+ + +K +E E ++LA+V R +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 114 YCAHGAEKLLI-----------YEYVINE-----SLDKVLF---SLIKDIQILFRKK--K 152
+ L+ + Y ++E + F +I ++ L +++
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 153 TDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKAD 212
D+K N+LLD+ +I+D G+A + Q+ AGT G+MAPE + D
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG-YAGTPGFMAPELLQGEEYDFSVD 179
Query: 213 VFSFGVVILELISGQ 227
F+ GV + E+I+ +
Sbjct: 180 YFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 5e-11
Identities = 53/195 (27%), Positives = 96/195 (49%), Gaps = 31/195 (15%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVN--- 110
K+GEG FG K +DG++ +K+++ S S + ++E E +L+ ++H N+V
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 111 ----------LLGYCAHG-------AEK-LLIYEYVINESLDKVLFSL--IKDIQILFRK 150
++ YC G A++ +L E I + ++ +L + D +IL R
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHR- 125
Query: 151 KKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVK 210
DIK+ NI L K+ DFG+AR+ T + GT Y++PE + + K
Sbjct: 126 ---DIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENRPYNNK 181
Query: 211 ADVFSFGVVILELIS 225
+D+++ G V+ E+ +
Sbjct: 182 SDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 6e-11
Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 29/196 (14%)
Query: 57 KLGEGGFGPVFKGKLDD--GREI--AVKKLSHSSNQG-KKEFENEAKLLARVQHRNVVNL 111
KLG+G FG V +G+ G+ I AVK L +F EA ++ + H N++ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 112 LGYCAHGAEKLL--------IYEYVINESLDKVLFSLIKD--IQI------LFRKK--KT 153
G ++ + + + ++L L S + D +QI L K+
Sbjct: 62 YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHR 121
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTH----VNTRVAGTNGYMAPEYVMHGHLSV 209
D+ A NILL KI DFG+ R P+++ H + +V + APE + S
Sbjct: 122 DLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP--FAWCAPESLRTRTFSH 179
Query: 210 KADVFSFGVVILELIS 225
+DV+ FGV + E+ +
Sbjct: 180 ASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 6e-11
Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 33/200 (16%)
Query: 56 NKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFE----NEAKLLARVQHRNVVNL 111
++GEG +G V+K + D E+ K N+ K+ F E K+L ++ HRN+VNL
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNL 71
Query: 112 LGYCAHGAEKL----------LIYEYVINE---SLDKVLFSLIKD-IQILFRK------- 150
+ L L++EY+ ++ L+ L +D I+ ++
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNY 131
Query: 151 --KKT----DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMH 204
KK DIK SNILL++K K+ADFG+ARL+ +++ T T Y PE ++
Sbjct: 132 CHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLG 191
Query: 205 GHLSVKA-DVFSFGVVILEL 223
A DV+S G ++ EL
Sbjct: 192 EERYGPAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 7e-11
Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 26/197 (13%)
Query: 57 KLGEGGFGPVFKG---KLDDGREIAVKKLSHSSNQG--KKEFENEAKLLARVQHRNVVNL 111
+LG G FG V KG + +AVK L + +N K E EA ++ ++ + +V +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 112 LGYCAHGAEKLLIYEYV----INESLDKVLFSLIKDIQILFRKKKT-------------D 154
+G C +L+ E +N+ L K K+I L + D
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 155 IKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT--NGYMAPEYVMHGHLSVKAD 212
+ A N+LL + KI+DFG+++ D+ + + G + APE + + S K+D
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSD 180
Query: 213 VFSFGVVILELIS-GQR 228
V+SFGV++ E S GQ+
Sbjct: 181 VWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 8e-11
Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 18/189 (9%)
Query: 56 NKLGEGGFGPV-FKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGY 114
K+GEG G V GR++AVKK+ Q ++ NE ++ QH N+V +
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 115 CAHGAEKLLIYEYVINESL-DKVLFSLIKDIQI-------------LFRKK--KTDIKAS 158
G E ++ E++ +L D V + + + QI L + DIK+
Sbjct: 85 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSD 144
Query: 159 NILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGV 218
+ILL K++DFG ++ + V GT +MAPE + + D++S G+
Sbjct: 145 SILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISRLPYGTEVDIWSLGI 203
Query: 219 VILELISGQ 227
+++E++ G+
Sbjct: 204 MVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 8e-11
Identities = 49/188 (26%), Positives = 90/188 (47%), Gaps = 18/188 (9%)
Query: 57 KLGEGGFGPVFKGKL-DDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYC 115
K+GEG G V + G+ +AVKK+ Q ++ NE ++ QH NVV +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 116 AHGAEKLLIYEYV-------------INE-SLDKVLFSLIKDIQILFRKK--KTDIKASN 159
G E ++ E++ +NE + V +++K + +L + DIK+ +
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDS 146
Query: 160 ILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVV 219
ILL K++DFG ++ + V GT +MAPE + + D++S G++
Sbjct: 147 ILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVDIWSLGIM 205
Query: 220 ILELISGQ 227
++E++ G+
Sbjct: 206 VIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 47/216 (21%)
Query: 57 KLGEGGFGPV-----------------FKGKLDDGREIAVKKLSHSSNQ-GKKEFENEAK 98
KLGEG FG V + +AVK L +N+ + +F E K
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 99 LLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVL------------------FSL 140
+++R++ N++ LL C +I EY+ N L++ L +S
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 141 IKDI--QILFRKK--------KTDIKASNILLDDKWIPKIADFGMAR-LFPEDQTHVNTR 189
+ + QI K D+ N L+ + KIADFGM+R L+ D + R
Sbjct: 132 LIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGR 191
Query: 190 VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS 225
+M+ E ++ G + +DV++FGV + E+++
Sbjct: 192 AVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 59/213 (27%)
Query: 56 NKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN---------EAKLLARVQH 105
+ +GEG +G V G ++A+KK+S FE+ E K+L R +H
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKIS--------PFEHQTFCQRTLREIKILRRFKH 62
Query: 106 RNVVNLLGYCAHGAEKLLIYE-----YVINESLDKVLFSLIKD------------IQILF 148
N++ +L + +E Y++ E ++ L+ LIK QIL
Sbjct: 63 ENIIGILD-----IIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQIL- 116
Query: 149 RKKKT---------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR-----VAGTN 194
R K D+K SN+LL+ KI DFG+AR+ D H +T VA T
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEYVA-TR 173
Query: 195 GYMAPEYVMHGHLSVKA-DVFSFGVVILELISG 226
Y APE +++ KA D++S G ++ E++S
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 31/201 (15%)
Query: 51 NFHPSNKLGEGGFGPVFKGK-LDDGREIAVKK--LSHSSNQGKKEFENEAKLLARVQHRN 107
NF K+GEG +G V+K + G +A+KK L + E LL + H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 108 VVNLLGYCAHGAEKL-LIYEYVINESLDKVL---------FSLIKD--IQIL-------- 147
+V LL H KL L++E+ +++ L K + LIK Q+L
Sbjct: 61 IVKLLD-VIHTENKLYLVFEF-LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 148 FRKKKTDIKASNILLDDKWIPKIADFGMARLF--PEDQTHVNTRVAGTNGYMAPEYVMHG 205
R D+K N+L++ + K+ADFG+AR F P +T+ + V T Y APE ++
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV--TLWYRAPEILLGC 175
Query: 206 -HLSVKADVFSFGVVILELIS 225
+ S D++S G + E+++
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 53/202 (26%), Positives = 94/202 (46%), Gaps = 36/202 (17%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVKKLSH----SSNQGK--KEFENEAKLLARVQHRNVVN 110
LG G F ++ + + G +AVK++++ SS Q + + E +L+AR+ H +++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 111 LLGYCAH-------------GAEKLLIYEY------VINESLDKVL--FSLIKDIQILFR 149
+LG G+ L+ +Y VI +++L S + + QI+ R
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR 127
Query: 150 KKKTDIKASNILLDDK-WIPKIADFGMARLFPEDQTHVNT---RVAGTNGYMAPEYVMHG 205
D+K +N+L+D +IADFG A T ++ GT +MAPE +
Sbjct: 128 ----DVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE 183
Query: 206 HLSVKADVFSFGVVILELISGQ 227
DV+S G VI+E+ + +
Sbjct: 184 QYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 50/192 (26%), Positives = 94/192 (48%), Gaps = 26/192 (13%)
Query: 57 KLGEGGFGPV-FKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYC 115
K+GEG G V + G+++AVKK+ Q ++ NE ++ H NVV++
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 116 AHGAEKLLIYEYV-------------INE-SLDKVLFSLIKDIQILFRKK--KTDIKASN 159
G E ++ E++ +NE + V S+++ + L + DIK+ +
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 148
Query: 160 ILLDDKWIPKIADFG----MARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFS 215
ILL K++DFG +++ P+ ++ V GT +MAPE + + D++S
Sbjct: 149 ILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-----GTPYWMAPEVISRLPYGTEVDIWS 203
Query: 216 FGVVILELISGQ 227
G++++E+I G+
Sbjct: 204 LGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 52/193 (26%), Positives = 95/193 (49%), Gaps = 29/193 (15%)
Query: 57 KLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKE-FENEAKLLARVQHRNVVNLLGYC 115
+LG+G FG V+K K + +A K+ + ++ + E + E ++LA H +V LLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 116 AHGAEKLLIYEYVINESLDKVLFSLIK-----DIQILFRK----------KKT---DIKA 157
+ ++ E+ ++D ++ L + IQ++ R+ K D+KA
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKA 138
Query: 158 SNILLDDKWIPKIADFGMARLFPEDQTHVNTRVA--GTNGYMAPEYVMHGHLS-----VK 210
N+LL K+ADFG++ ++ + R + GT +MAPE VM + K
Sbjct: 139 GNVLLTLDGDIKLADFGVS---AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYK 195
Query: 211 ADVFSFGVVILEL 223
AD++S G+ ++E+
Sbjct: 196 ADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 19/152 (12%)
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHV---NTRVAGTNGYMAPEYVMHGHLSVK 210
D+ A NILL I KI DFG+AR D +V N R+ +MAPE + + + +
Sbjct: 239 DLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK--WMAPESIFNCVYTFE 296
Query: 211 ADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQ 270
+DV+S+G+++ E+ S + + VD++ YK+ K + ++ P A S+ D
Sbjct: 297 SDVWSYGILLWEIFSLGSSPYPGMPVDSK-----FYKMIK--EGYRMLSPECAPSEMYD- 348
Query: 271 IAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302
I C DP RPT +++V ++ ++
Sbjct: 349 ------IMKSCWDADPLKRPTFKQIVQLIEQQ 374
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 49/188 (26%), Positives = 88/188 (46%), Gaps = 18/188 (9%)
Query: 57 KLGEGGFGPV-FKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYC 115
K+GEG G V + GR++AVK + Q ++ NE ++ QH+NVV +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 116 AHGAEKLLIYEYV--------------INESLDKVLFSLIKDIQILFRKK--KTDIKASN 159
G E ++ E++ E + V S+++ + L + DIK+ +
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDS 147
Query: 160 ILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVV 219
ILL K++DFG +D + V GT +MAPE + + D++S G++
Sbjct: 148 ILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDIWSLGIM 206
Query: 220 ILELISGQ 227
++E++ G+
Sbjct: 207 VIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 67/265 (25%), Positives = 115/265 (43%), Gaps = 49/265 (18%)
Query: 58 LGEGGFGPVFKGKLDDGREIAVKKLSH--SSNQGKKEFENEAKLLARVQHRNVVNLLGYC 115
LG G G V K K + KK+ H + + +K+ E +++ + +V+ G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 116 AHGAEKLLIYEYVINESLD---------------KVLFSLIKDIQILFRKKKT---DIKA 157
+ + E++ SLD K+ ++++ + L+ + DIK
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKP 132
Query: 158 SNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFG 217
SNIL++ + K+ DFG++ E + GT+ YM+PE + G +VK+DV+S G
Sbjct: 133 SNILVNSRGQIKLCDFGVS---GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLG 189
Query: 218 VVILELISGQRNSSF-NLDVDAQNLLDWAYKLYKKDKSLEIVD----------PSLAASD 266
+ I+EL G+ +F N+D D Q D + I+D P L +SD
Sbjct: 190 ISIIELALGKFPFAFSNIDDDGQ------------DDPMGILDLLQQIVQEPPPRLPSSD 237
Query: 267 SGDQIAMCIQIGLLCTQGDPQLRPT 291
+ + + C DP RPT
Sbjct: 238 FPEDLRDFVDA---CLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 63/274 (22%), Positives = 111/274 (40%), Gaps = 41/274 (14%)
Query: 51 NFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLS---HSSNQGKKEFENEAKLLARVQHR 106
NF K+G G F V++ L DG +A+KK+ + + + E LL ++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 107 NVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKK--------------- 151
NV+ E ++ E L +++ K +++ K
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 152 ------KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG 205
DIK +N+ + + K+ D G+ R F T ++ V GT YM+PE +
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHEN 181
Query: 206 HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVD-PSLAA 264
+ K+D++S G ++ E+ + Q S F D LY K +E D P L +
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQ--SPFYGD---------KMNLYSLCKKIEQCDYPPLPS 230
Query: 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298
+++ + +C DP+ RP + V +
Sbjct: 231 DHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 37/207 (17%)
Query: 58 LGEGGFGPVFKGKL--DDGR--EIAVK--KLSHSSNQGKKEFENEAKLLARVQHRNVVNL 111
LGEG FG V +G+L DDG ++AVK KL + +EF +EA + H NV+ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 112 LGYCAHGAEK------LLIYEYVINESLDKVLFS--------------LIK---DI---- 144
+G C + ++I ++ + L L L+K DI
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 145 QILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN-GYMAPEY 201
+ L + D+ A N +L + +ADFG+++ + R+A ++A E
Sbjct: 127 EYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES 186
Query: 202 VMHGHLSVKADVFSFGVVILELIS-GQ 227
+ + K+DV++FGV + E+ + GQ
Sbjct: 187 LADRVYTSKSDVWAFGVTMWEIATRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 38/201 (18%)
Query: 58 LGEGGFGPVFKGKLD-----DGREIAVKKL------SHSSNQGKKEFENEAKLLARVQHR 106
LGEG FG V + D G ++AVK L +H ++ KKE E +L + H
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL-KKEIE----ILRNLYHE 66
Query: 107 NVVNLLGYCAHGAEK--LLIYEYVINESLDKVL----------------FSLIKDIQILF 148
N+V G C LI E++ + SL + L + K + L
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 149 RKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH--VNTRVAGTNGYMAPEYVMH 204
++ D+ A N+L++ + KI DFG+ + D+ + V + + APE ++
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 205 GHLSVKADVFSFGVVILELIS 225
+ +DV+SFGV + EL++
Sbjct: 187 SKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 43/209 (20%)
Query: 55 SNKLGEGGFGPVFKGKLDDG-----REIAVKKLS-HSSNQGKKEFENEAKLLARVQHRNV 108
S+ L EG FG +F G L D E+ VK + H+S E+ LL + H+N+
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 109 VNLLGYCAHGAEK-LLIYEYVINESL---------------------DKVLFSL--IKDI 144
+ +L C E ++Y Y+ +L V ++ +
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130
Query: 145 QILFRKK--KTDIKASNILLDDKWIPKIADFGMAR-LFPEDQTHVNTRVAGTNGY----- 196
L ++ DI A N ++D++ KI D ++R LFP D G N
Sbjct: 131 SYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY-----HCLGDNENRPVKW 185
Query: 197 MAPEYVMHGHLSVKADVFSFGVVILELIS 225
MA E +++ S +DV+SFGV++ EL++
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 55/198 (27%), Positives = 97/198 (48%), Gaps = 28/198 (14%)
Query: 57 KLGEGGFGPVFKG--KLDDGR-EIAVKKLSHSSNQG-KKEFENEAKLLARVQHRNVVNLL 112
+LG G FG V KG K+ + ++A+K L + + + + E EA+++ ++ + +V ++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 113 GYCAHGAEKL-LIYEYVINESLDKVLFSLIKDI----------QILFRKK--------KT 153
G C AE L L+ E L+K L +I Q+ K
Sbjct: 62 GVCE--AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT--NGYMAPEYVMHGHLSVKA 211
D+ A N+LL ++ KI+DFG+++ D ++ R AG + APE + S ++
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRS 179
Query: 212 DVFSFGVVILELIS-GQR 228
DV+S+G+ + E S GQ+
Sbjct: 180 DVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 50/211 (23%)
Query: 58 LGEGGFGPVFKGKLD-DGREI--AVKKL-SHSSNQGKKEFENEAKLLARV-QHRNVVNLL 112
+GEG FG V + + DG ++ A+K L +S ++F E ++L ++ H N++NLL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 113 GYCA------------------------------------HGAEKLLIYEYVINESLDKV 136
G C HG L + ++ + D
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 137 L-FSLIKDIQILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN- 194
+ + Q + R D+ A N+L+ + KIADFG++R ++ +V +
Sbjct: 130 TGMQYLSEKQFIHR----DLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLPV 182
Query: 195 GYMAPEYVMHGHLSVKADVFSFGVVILELIS 225
+MA E + + + K+DV+SFGV++ E++S
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 6e-10
Identities = 56/191 (29%), Positives = 93/191 (48%), Gaps = 23/191 (12%)
Query: 57 KLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFE-NEAKLLARVQHRNVVNLLGY 114
KLGEG + V+KGK +G+ +A+K + +G EA LL ++H N+V LL
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV-LLHD 70
Query: 115 CAHGAEKL-LIYEYV---INESLDK------------VLFSLIKDIQILFRKK--KTDIK 156
H E L L++EYV + + +DK LF L++ + + ++ D+K
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLK 130
Query: 157 ASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG-HLSVKADVFS 215
N+L+ D K+ADFG+AR +H + T Y P+ ++ S D++
Sbjct: 131 PQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWG 189
Query: 216 FGVVILELISG 226
G + +E+I G
Sbjct: 190 VGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 6e-10
Identities = 55/200 (27%), Positives = 98/200 (49%), Gaps = 34/200 (17%)
Query: 58 LGEGGFGPVFKG--KLDDGRE--IAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLL 112
LG G FG + +G KL RE +A+ L S++ ++ F EA L + H N+V L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 113 GYCAHGAEKLLIYEYVINESLDKV------------LFSLIKDI--------QILFRKKK 152
G G +++ EY+ N +LD L ++ + ++ + K
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKG 132
Query: 153 TDIKASNILLDDKWIPKIADFGMARLFPEDQTH-VNTRVAGTNG--YMAPEYVMHGHLSV 209
+ A +L++ + KI+ F R ED++ + T ++G + + APE + + H S
Sbjct: 133 --LAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSS 187
Query: 210 KADVFSFGVVILELIS-GQR 228
+DV+SFG+V+ E++S G+R
Sbjct: 188 ASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 7e-10
Identities = 46/209 (22%), Positives = 82/209 (39%), Gaps = 46/209 (22%)
Query: 58 LGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLG--- 113
+GEG +G V+K + ++ K+ ++E + E +L + H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFI 73
Query: 114 ----------------YCAHG-----AEKLL---------IYEYVINESLDKVLFSLIKD 143
C G + L Y++ E+L + + + +
Sbjct: 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY--LHE 131
Query: 144 IQILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM 203
+++ R DIK NILL K+ DFG++ NT + GT +MAPE +
Sbjct: 132 NKVIHR----DIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAPEVIA 186
Query: 204 -----HGHLSVKADVFSFGVVILELISGQ 227
++DV+S G+ +EL G+
Sbjct: 187 CDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 7e-10
Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 34/210 (16%)
Query: 57 KLGEGGFGPVFKGKLDDGREI-AVKKLS-HSSNQGKKEFE-NEAKLLARVQHRNVVNLLG 113
K+GEG +G VFK K + EI A+K++ ++G E LL ++H+N+V L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 114 YCAHGAEKL-LIYEYVINESLDK----------------VLFSLIKDIQ------ILFRK 150
H +KL L++EY ++ L K +F L+K + +L R
Sbjct: 67 -VLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHR- 123
Query: 151 KKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHL-SV 209
D+K N+L++ K+ADFG+AR F + V T Y P+ + L S
Sbjct: 124 ---DLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYST 179
Query: 210 KADVFSFGVVILELISGQRNSSFNLDVDAQ 239
D++S G + EL + R DVD Q
Sbjct: 180 SIDMWSAGCIFAELANAGRPLFPGNDVDDQ 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-10
Identities = 54/191 (28%), Positives = 86/191 (45%), Gaps = 27/191 (14%)
Query: 58 LGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAH 117
+G+G FG V G G ++AVK + + + + F EA ++ +++H N+V LLG
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 118 GAEKLLIY-EYVINESLDKVLFS-----LIKDIQILFRKK--------------KTDIKA 157
L I EY+ SL L S L D + F D+ A
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAA 130
Query: 158 SNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFG 217
N+L+ + + K++DFG+ + Q V T APE + S K+DV+SFG
Sbjct: 131 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSDVWSFG 186
Query: 218 VVILELISGQR 228
+++ E+ S R
Sbjct: 187 ILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 9e-10
Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 64/219 (29%)
Query: 51 NFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLS-HSSNQGKKEFE----NEAKLLARVQ 104
+ N++ EG +G V++ + G +A+KKL +G F E +L ++Q
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQ 62
Query: 105 HRNVVNLLGYCAHGAEKLLIYEYVINESLDKV----------LFSLIKDIQ--------- 145
H N+V + E V+ +LDK+ L SL++ ++
Sbjct: 63 HPNIVT-------------VKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVK 109
Query: 146 -----------------ILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188
IL R D+K SN+LL+++ I KI DFG+AR + T
Sbjct: 110 CLMLQLLSGVAHLHDNWILHR----DLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYT 164
Query: 189 RVAGTNGYMAPEYVM-HGHLSVKADVFSFGVVILELISG 226
++ T Y APE ++ S D++S G + EL++
Sbjct: 165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 9e-10
Identities = 53/200 (26%), Positives = 84/200 (42%), Gaps = 40/200 (20%)
Query: 56 NKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFE--------NEAKLLARVQ-H 105
K+GEG F V K + G+ A+K + KK F+ E + L R+ H
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-------KKHFKSLEQVNNLREIQALRRLSPH 57
Query: 106 RNVVNLLGYC---AHGAEKLL-------IYEYVIN-------ESLDKVLFSLIKDIQILF 148
N++ L+ G L+ +YE + + + ++ L+K + +
Sbjct: 58 PNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 149 RKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM-HG 205
R DIK NIL+ D I K+ADFG R T T Y APE ++ G
Sbjct: 118 RNGIFHRDIKPENILIKDD-ILKLADFGSCRGI--YSKPPYTEYISTRWYRAPECLLTDG 174
Query: 206 HLSVKADVFSFGVVILELIS 225
+ K D+++ G V E++S
Sbjct: 175 YYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 55/234 (23%), Positives = 103/234 (44%), Gaps = 59/234 (25%)
Query: 40 FPFEALVSATKNFHPSNKLGEGGFGPVFKGKL--------DDGREIAVKKLS-HSSNQGK 90
FP + LV LGEG FG V + + D +AVK L +++++
Sbjct: 9 FPRDRLVLG-------KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDL 61
Query: 91 KEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVL------------ 137
+ +E +L+ + +H+N++NLLG C +I EY +L + L
Sbjct: 62 ADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTF 121
Query: 138 -------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMA 176
+ + + ++ L ++ D+ A N+L+ + + KIADFG+A
Sbjct: 122 DITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 177 RLFPEDQTHVNTRVAGTNG-----YMAPEYVMHGHLSVKADVFSFGVVILELIS 225
R ++ +NG +MAPE + + ++DV+SFG+++ E+ +
Sbjct: 182 R----GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 61/199 (30%), Positives = 93/199 (46%), Gaps = 38/199 (19%)
Query: 58 LGEGGFGPVF-----KGKLDDGREIAVKKLSHSSNQGKKEF--ENEAKLLARVQHRNVVN 110
LG+G FG VF G D G+ A+K L ++ + + + E +LA V H +V
Sbjct: 4 LGQGSFGKVFLVRKITGP-DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 111 LLGYCAHGAEKL-LIYEYVINESL------------DKVLFSL---------IKDIQILF 148
L Y KL LI +++ L + V F L + + I++
Sbjct: 63 L-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121
Query: 149 RKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYV-MHGHL 207
R D+K NILLD++ K+ DFG+++ D GT YMAPE V GH
Sbjct: 122 R----DLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEVVNRRGH- 175
Query: 208 SVKADVFSFGVVILELISG 226
+ AD +SFGV++ E+++G
Sbjct: 176 TQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 58/245 (23%), Positives = 102/245 (41%), Gaps = 52/245 (21%)
Query: 11 LLKHFNLGSSREGDNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGK 70
LK+ L ++ D+ ++ ++ + + F F LG G FG V
Sbjct: 3 FLKNLQLHKKKDSDSTKEPKRKNKMKYEDFNF------------IRTLGTGSFGRVILAT 50
Query: 71 LDDGR--EIAVKKLSHSSNQGKKEFE---NEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125
+ +A+K+ S +K+ + +E K+L + H VNL G + L+
Sbjct: 51 YKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110
Query: 126 EYVINESLDKVL---------------------FSLIKDIQILFRKKKTDIKASNILLDD 164
E+VI L F ++ + I++R D+K N+LLD
Sbjct: 111 EFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYR----DLKPENLLLDK 166
Query: 165 KWIPKIADFGMARLFPEDQTHVNTR---VAGTNGYMAPEYVMHGHLSVKADVFSFGVVIL 221
K+ DFG A++ V+TR + GT Y+APE +++ AD ++ G+ I
Sbjct: 167 DGFIKMTDFGFAKV-------VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIY 219
Query: 222 ELISG 226
E++ G
Sbjct: 220 EILVG 224
|
Length = 340 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 33/219 (15%)
Query: 52 FHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN--EAKLLARVQ---H 105
+ P ++G G +G V+K + G +A+K + +N+ E LL R++ H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 106 RNVVNLLGYCA-----HGAEKLLIYEYV---INESLDKVL-----FSLIKDIQILF---- 148
N+V L+ CA + L++E+V + LDKV IKD+ F
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 149 ------RKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYV 202
D+K NIL+ K+ADFG+AR++ T V T Y APE +
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL--TPVVVTLWYRAPEVL 179
Query: 203 MHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNL 241
+ + D++S G + E+ +R F + +A L
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSEADQL 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 21/155 (13%)
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHV---NTRVAGTNGYMAPEYVMHGHLSVK 210
D+ A N+LL D + KI DFG+AR D +V N R+ +MAPE + +V+
Sbjct: 237 DVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK--WMAPESIFDCVYTVQ 294
Query: 211 ADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKS-LEIVDPSLAASDSGD 269
+DV+S+G+++ E+ S ++ + V++ K YK K ++ P A +
Sbjct: 295 SDVWSYGILLWEIFSLGKSPYPGILVNS--------KFYKMVKRGYQMSRPDFAPPEIYS 346
Query: 270 QIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKPG 304
+ MC + +P RPT ++ ++ ++ G
Sbjct: 347 IMKMCWNL-------EPTERPTFSQISQLIQRQLG 374
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 56/193 (29%), Positives = 91/193 (47%), Gaps = 26/193 (13%)
Query: 58 LGEGGFGPVFKGK-LDDGREI----AVKKLSH-SSNQGKKEFENEAKLLARVQHRNVVNL 111
LG G FG V KG + +G I A+K + S Q +E + + + H +V L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 112 LGYCAHGAEKLLIYEYVINESL--------DKVLFSLIKD--IQIL--------FRKKKT 153
LG C GA L+ + SL D + + + +QI R
Sbjct: 75 LGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHR 133
Query: 154 DIKASNILLDDKWIPKIADFGMARL-FPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKAD 212
++ A NILL I +IADFG+A L +P+D+ + + +MA E ++ G + ++D
Sbjct: 134 NLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSD 193
Query: 213 VFSFGVVILELIS 225
V+S+GV + E++S
Sbjct: 194 VWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 1e-09
Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 75/220 (34%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN---------EAKLLARVQHRN 107
+G G +G V GR++A+KK+S+ F++ E KLL ++H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 108 VVNLLGYCAHGAEKLLIYE--------YVINESLDKVLFSLIKD--------IQ------ 145
++ LL +L Y++ E ++ L +IK IQ
Sbjct: 61 IIGLL--------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQI 112
Query: 146 -----------ILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQT-------HVN 187
++ R D+K SNIL++ KI DFG+AR D+ +V
Sbjct: 113 LRGLKYLHSANVIHR----DLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 188 TRVAGTNGYMAPEYVMHGHLSVKA-DVFSFGVVILELISG 226
TR Y APE ++ KA D++S G + EL++
Sbjct: 169 TRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 23/198 (11%)
Query: 50 KNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQG--KKEFENEAKLLARVQHRN 107
+F ++LG G G V K + I +KL H + + + E ++L
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 108 VVNLLGYCAHGAEKLLIYEYVINESLDKVL---------------FSLIKDIQILFRKKK 152
+V G E + E++ SLD+VL ++++ + L K +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 124
Query: 153 T---DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSV 209
D+K SNIL++ + K+ DFG++ + + GT YM+PE + H SV
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQGTHYSV 181
Query: 210 KADVFSFGVVILELISGQ 227
++D++S G+ ++EL G+
Sbjct: 182 QSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 54/196 (27%), Positives = 84/196 (42%), Gaps = 32/196 (16%)
Query: 56 NKLGEGGFGPVFKGK-LDDGREIAVKKLSH--SSNQGKKEFENEAKLLARVQHRNVVNLL 112
+G G FG V + G+ +A+KK+ S+ K E KLL ++H N+++L
Sbjct: 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLS 75
Query: 113 GYCAHGAEKLLIYEYVINESLDKVLFSLIKD------------IQILFRKK--------K 152
E + Y + E L L L+ QIL K
Sbjct: 76 DIFISPLEDI----YFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVH 131
Query: 153 TDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGH-LSVKA 211
D+K SNIL+++ KI DFG+AR+ Q T T Y APE ++ V+
Sbjct: 132 RDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYRAPEIMLTWQKYDVEV 187
Query: 212 DVFSFGVVILELISGQ 227
D++S G + E++ G+
Sbjct: 188 DIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 51/204 (25%)
Query: 57 KLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKE-FENEAKLLARVQHRNVVNLLG-- 113
+LG+G FG V+K + + +A K+ + ++ + E + E +LA H N+V LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 114 -----------YCAHGAEKLLIYEY-----------VINESLDKVLFSLIKDIQILFRKK 151
+CA GA ++ E V ++L+ + + + + +I+ R
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNY--LHENKIIHR-- 127
Query: 152 KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV-------AGTNGYMAPEYVM- 203
D+KA NIL K+ADFG+ + NTR GT +MAPE VM
Sbjct: 128 --DLKAGNILFTLDGDIKLADFGV--------SAKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 204 ----HGHLSVKADVFSFGVVILEL 223
KADV+S G+ ++E+
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 39/207 (18%)
Query: 51 NFHPSNKLGEGGFGPVFKGKLD--DGREIAVKKLSHSSN--QGKKEFENEAKLLARVQHR 106
+ P +G G +G V +D G+++A+KK+ H+ + K E K+L +H
Sbjct: 6 RYKPIENIGSGAYGVVCSA-IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 107 NVVNLLG-YCAHGAEKLLIY---------------------EYVINESLDKVLFSL--IK 142
N++ + GA+ +Y E I L ++L L I
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124
Query: 143 DIQILFRKKKTDIKASNILLDDKWIPKIADFGMARL---FPEDQTHVNTRVAGTNGYMAP 199
++ R D+K SN+L+++ +I DFGMAR P + + T T Y AP
Sbjct: 125 SANVIHR----DLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180
Query: 200 E--YVMHGHLSVKADVFSFGVVILELI 224
E + + + D++S G + E++
Sbjct: 181 ELLLSLPEY-TTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 62/270 (22%), Positives = 110/270 (40%), Gaps = 39/270 (14%)
Query: 51 NFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLS---HSSNQGKKEFENEAKLLARVQHR 106
NF K+G G F V++ L D + +A+KK+ + +++ E LL ++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 107 NVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQIL------------------- 147
NV+ L E ++ E L +++ K +++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 148 --FRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG 205
R DIK +N+ + + K+ D G+ R F T ++ V GT YM+PE +
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHEN 181
Query: 206 HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265
+ K+D++S G ++ E+ + Q S F D NL K+ + D P L
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQ--SPFY--GDKMNLFSLCQKIEQCDY------PPLPTE 231
Query: 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMRRV 295
+++ + +C DP RP + V
Sbjct: 232 HYSEKLRELVS---MCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 65/282 (23%), Positives = 106/282 (37%), Gaps = 51/282 (18%)
Query: 56 NKLGEGGFGPVFKGKLDDGREIA---VKKLSHSSN-QGKKEFENEAKLLARVQHRNVVNL 111
+++G G FG V G+ G A VK+L S+ + F E + + H NV+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 112 LGYCAHGAEKLLIYEYVINESL------DKVLFSLIKDIQILFRKK-------------- 151
LG C LL+ E+ L ++ + + + +L R
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 152 --KTDIKASNILLDDKWIPKIADFGMA-RLFPEDQTHVNTRVAGTNGYMAPEYV--MHGH 206
+D+ N L KI D+G+A +PED A ++APE V
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQD 180
Query: 207 LSV-----KADVFSFGVVILELIS-GQRNSS--FNLDVDAQNLLDWAYKLYKKDKSLEIV 258
L K++++S GV + EL + + + V Q + + KL K L+
Sbjct: 181 LLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKY- 239
Query: 259 DPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300
SD ++ C DP+ RPT V +L+
Sbjct: 240 ------SDRWYEVMQ------FCWL-DPETRPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 59/195 (30%), Positives = 90/195 (46%), Gaps = 27/195 (13%)
Query: 58 LGEGGFGPVFKG-KLDDGREIAVKKLSH--SSNQGKKE---FENEAKLLARVQHRNVVNL 111
LG+G FG V+ +D GRE+A K++ S + KE E E +LL +QH +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 112 LGYCAHGAEKLL--IYEYVINESLD---KVLFSLIKDIQILFRKK--------------K 152
G AEK L EY+ S+ K +L + + + ++
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 153 TDIKASNILLDDKWIPKIADFGMA-RLFPEDQTHVNTR-VAGTNGYMAPEYVMHGHLSVK 210
DIK +NIL D K+ DFG + RL + R V GT +M+PE + K
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRK 189
Query: 211 ADVFSFGVVILELIS 225
ADV+S G ++E+++
Sbjct: 190 ADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 32/218 (14%)
Query: 50 KNFHPSNKLGEGGFGPVFKGK--LDDGREIAVKKLS-HSSNQGK--KEFENEAKL--LAR 102
+ + ++GEG +G VFK + + GR +A+K++ + +G A L L
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 103 VQHRNVVNLLGYCA-----HGAEKLLIYEYV---INESLDKV-------------LFSLI 141
+H NVV L C + L++E+V + LDKV +F L+
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 142 KDIQILF--RKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAP 199
+ + L R D+K NIL+ K+ADFG+AR++ T V T Y AP
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAP 178
Query: 200 EYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVD 237
E ++ + D++S G + E+ + + DVD
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 67/223 (30%), Positives = 95/223 (42%), Gaps = 41/223 (18%)
Query: 51 NFHPSNKLGEGGFGPVF----KGKLDDGREIAVKKLSHSS-NQGKKEFEN---EAKLLAR 102
NF LG G +G VF G D G+ A+K L ++ Q K E+ E ++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 103 VQHRNVVNLLGYCAHGAEKL-LIYEYVINESLDKVLFS-----------LIKDI------ 144
V+ + L Y KL LI +YV L L+ I +I
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 145 ----QILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPE 200
I++R DIK NILLD + + DFG+++ F ++ GT YMAPE
Sbjct: 121 LHQLGIIYR----DIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176
Query: 201 YVM---HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQN 240
+ GH D +S GV+ EL++G S F +D QN
Sbjct: 177 VIRGGSGGHDKA-VDWWSLGVLTFELLTGA--SPFTVD-GEQN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 37/205 (18%)
Query: 51 NFHPSNKLGEGGFGPVFKGKLDDGREI-AVKKLSHSSNQGKKEFE-NEAKLLARVQHRNV 108
NF KLGEG + V+KG+ EI A+K++ + +G E L+ ++H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 109 VNLLGYCAHGAEKL-LIYEYVINE------------SLDKVL-----FSLIKDI------ 144
V L H KL L++EY+ + +LD + L+K I
Sbjct: 61 VRLHD-VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 145 QILFRKKKTDIKASNILLDDKWIPKIADFGMARLF--PEDQTHVNTRVAGTNGYMAPEYV 202
++L R D+K N+L++ + K+ADFG+AR F P + T N V T Y AP+ +
Sbjct: 120 RVLHR----DLKPQNLLINKRGELKLADFGLARAFGIPVN-TFSNEVV--TLWYRAPDVL 172
Query: 203 MHGHL-SVKADVFSFGVVILELISG 226
+ S D++S G ++ E+I+G
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-09
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 39/211 (18%)
Query: 58 LGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKE---FENEAKLLARVQHRNVV----- 109
+G G FG V + +++ + K K E +NE ++L + H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 110 ----NLLGYCAHGAEKLLIYEYV---INESLD---------KVLFSL--IKDIQILFRKK 151
L A + EY+ N LD ++L +L + IL R
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHR-- 125
Query: 152 KTDIKASNILLDD-KWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVK 210
D+K NILLD K + KI DFG++++ ++ T V GT Y++PE + K
Sbjct: 126 --DLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYT-VVGTPCYISPELCEGKPYNQK 181
Query: 211 ADVFSFGVVILELISGQRNSSFNLDVDAQNL 241
+D+++ G V+ EL S +R +F +A NL
Sbjct: 182 SDIWALGCVLYELASLKR--AF----EAANL 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 5e-09
Identities = 46/185 (24%), Positives = 86/185 (46%), Gaps = 18/185 (9%)
Query: 58 LGEGGFGPVFKG-KLDDGREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVV------ 109
LG G G V+K L R +AVK + + + +K+ +E ++L + ++
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 110 ---NLLGYCAHGAE--KLLIYEYVINESLDKVLFSLIKDIQILFRKK--KTDIKASNILL 162
N + C + L +Y + L ++ +++K + L+ K D+K SN+L+
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV 128
Query: 163 DDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILE 222
+ + K+ DFG++ + GTN YMAPE + + +DV+S G+ +E
Sbjct: 129 NTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFME 185
Query: 223 LISGQ 227
L G+
Sbjct: 186 LALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 66/250 (26%), Positives = 99/250 (39%), Gaps = 33/250 (13%)
Query: 50 KNFHPSNKLGEGGFGPVFKGKLDDGREI-AVKKLSHSSNQGKKEFE---NEAKLLARVQH 105
K+F ++G+GG+G VF K D EI A+K++ S E E +L +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 106 RNVVNLLGYCAHGAEKL-LIYEYVINESLDKVLFSL---------------IKDIQILFR 149
+V LL Y E L L EYV +L +L + + L
Sbjct: 61 EWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHE 119
Query: 150 KKKT--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHL 207
D+K N L+D K+ DFG+++ T+ N+ V G+ YMAPE +
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANS-VVGSPDYMAPEVLRGKGY 175
Query: 208 SVKADVFSFGVVILELISGQRN-SSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266
D +S G ++ E + G S + +NL W L + DP SD
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVY----DDPRFNLSD 231
Query: 267 -SGDQIAMCI 275
+ D I I
Sbjct: 232 EAWDLITKLI 241
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 38/234 (16%)
Query: 51 NFHPSNKLGEGGFGPVFKGKL----DDGREIAVKKLSHSS-NQGKKEFEN---EAKLLAR 102
NF LG G +G VF + D G+ A+K L ++ Q K E+ E ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 103 VQHRNVVNLLGYCAHGAEKL-LIYEYVINESL-------------------DKVLFSL-- 140
++ + L Y KL LI +Y+ L +++ +L
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 141 IKDIQILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPE 200
+ + I++R DIK NILLD + DFG+++ F ED+ GT YMAP+
Sbjct: 121 LHKLGIIYR----DIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPD 176
Query: 201 YVMHGHL--SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKD 252
V G D +S GV++ EL++G S F +D + + + + ++ K +
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTG--ASPFTVDGEKNSQAEISRRILKSE 228
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 52/197 (26%), Positives = 89/197 (45%), Gaps = 23/197 (11%)
Query: 51 NFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQG--KKEFENEAKLLARVQHRNV 108
+F ++LG G G VFK I +KL H + + + E ++L +
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 109 VNLLGYCAHGAEKLLIYEYVINESLDKVL---------------FSLIKDIQILFRKKKT 153
V G E + E++ SLD+VL ++IK + L K K
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 125
Query: 154 ---DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVK 210
D+K SNIL++ + K+ DFG++ + + GT YM+PE + H SV+
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQGTHYSVQ 182
Query: 211 ADVFSFGVVILELISGQ 227
+D++S G+ ++E+ G+
Sbjct: 183 SDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 46/205 (22%)
Query: 58 LGEGGFGPVFKGKLDD-GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCA 116
+G G FG V K G +AVK++ S+ K++ L ++ + ++ +
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIR-STVDEKEQKRLLMDLDVVMRSSDCPYIVKF-- 68
Query: 117 HGA------------------EKLLIYEY-----VINES-LDKVLFSLIK-------DIQ 145
+GA +K Y Y VI E L K+ + +K +++
Sbjct: 69 YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK 128
Query: 146 ILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYV--- 202
I+ R D+K SNILLD K+ DFG++ + + TR AG YMAPE +
Sbjct: 129 IIHR----DVKPSNILLDRNGNIKLCDFGISGQLVD--SIAKTRDAGCRPYMAPERIDPS 182
Query: 203 -MHGHLSVKADVFSFGVVILELISG 226
G+ V++DV+S G+ + E+ +G
Sbjct: 183 ARDGY-DVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-09
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 42/207 (20%)
Query: 58 LGEGGFGPVFKGKLD-DGREI--AVKKL-SHSSNQGKKEFENEAKLLARV-QHRNVVNLL 112
+GEG FG V K ++ DG + A+K++ ++S ++F E ++L ++ H N++NLL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 113 GYCAHGAEKLLIYEYVINESL---------------------------DKVLFSLIKD-- 143
G C H L EY + +L + L D
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 144 --IQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN-GYMA 198
+ L +K+ D+ A NIL+ + ++ KIADFG++R + +V + +MA
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWMA 179
Query: 199 PEYVMHGHLSVKADVFSFGVVILELIS 225
E + + + +DV+S+GV++ E++S
Sbjct: 180 IESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 42/168 (25%), Positives = 73/168 (43%), Gaps = 21/168 (12%)
Query: 138 FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN- 194
F + + ++ L +K D+ A NILL + + KI DFG+AR +D +V A
Sbjct: 180 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 195 GYMAPEYVMHGHLSVKADVFSFGVVILELIS--GQRNSSFNLDVDAQNLLDWAYKLYKKD 252
+MAPE + + ++DV+SFGV++ E+ S +D + L ++ +
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPE 299
Query: 253 KSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300
+ + I L C +P+ RPT +V +L
Sbjct: 300 YATPEI----------------YSIMLDCWHNNPEDRPTFSELVEILG 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 36/206 (17%)
Query: 58 LGEGGFGPVFKGKL---DDGREIAVK--KLSHSSNQGKKEFENEAKLLARVQHRNVVNLL 112
LGEG FG V +G+L D ++AVK K++ + ++F +EA + H NV+ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 113 GYCAHGAEK--------------------LLIYE-------YVINESLDKVLFSLIKDIQ 145
G C E L+Y Y+ + L K + + ++
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 146 ILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN-GYMAPEYV 202
L K D+ A N +L++ +ADFG+++ + R+A ++A E +
Sbjct: 127 YLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESL 186
Query: 203 MHGHLSVKADVFSFGVVILELIS-GQ 227
+ K+DV+SFGV + E+ + GQ
Sbjct: 187 ADRVYTTKSDVWSFGVTMWEIATRGQ 212
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 34/201 (16%)
Query: 57 KLGEGGFGPVFKGKLDDG---REIAVKKL-SHSSNQGKKEFENEAKLLARVQHRNVVNLL 112
++G G FG V G+++ G ++ VK+L +S Q + +F EA+ +QH N++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 113 GYCAHGAEKLLIYEYVINESLDKVLFS------LIKDIQILFRKK--------------- 151
G C LL+ E+ L L S + D L R
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNF 121
Query: 152 -KTDIKASNILLDDKWIPKIADFGMARL-FPEDQTHVNTRVAGTNGYMAPEYV--MHGHL 207
+D+ N LL KI D+G++ + ED ++ ++APE V +HG+L
Sbjct: 122 IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNL 181
Query: 208 SV-----KADVFSFGVVILEL 223
V +++V+S GV I EL
Sbjct: 182 LVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 48/204 (23%), Positives = 88/204 (43%), Gaps = 34/204 (16%)
Query: 58 LGEGGFGPVFKG-KLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCA 116
LG G G VF D + +AVKK+ + Q K E K++ R+ H N+V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 117 HGAEKL---------LIYEYVINESLDKVLFSLIKDIQI-----------LFRKKK---- 152
L L Y++ E ++ L ++++ + L R K
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHS 132
Query: 153 -----TDIKASNILLD-DKWIPKIADFGMARLFPEDQTHVNTRVAG--TNGYMAPEYVMH 204
D+K +N+ ++ + + KI DFG+AR+ +H G T Y +P ++
Sbjct: 133 ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS 192
Query: 205 GHLSVKA-DVFSFGVVILELISGQ 227
+ KA D+++ G + E+++G+
Sbjct: 193 PNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 27/195 (13%)
Query: 56 NKLGEGGFGPVFKG--KLDDGREIAVKKLSHSSNQGKK-EFENEAKLLARVQHRNVVNLL 112
+KLGEG + V+KG KL D +A+K++ +G E LL ++H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 113 GYCAHGAEKLLIYEYV---INESLDKV------------LFSLIKDIQILFRKK--KTDI 155
L++EY+ + + LD LF L++ + R+K D+
Sbjct: 71 DIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDL 130
Query: 156 KASNILLDDKWIPKIADFGMARL--FPEDQTHVNTRVAGTNGYMAPEYVMHG-HLSVKAD 212
K N+L++++ K+ADFG+AR P +T+ N V T Y P+ ++ S + D
Sbjct: 131 KPQNLLINERGELKLADFGLARAKSIPT-KTYSNEVV--TLWYRPPDILLGSTDYSTQID 187
Query: 213 VFSFGVVILELISGQ 227
++ G + E+ +G+
Sbjct: 188 MWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 33/78 (42%), Positives = 47/78 (60%), Gaps = 8/78 (10%)
Query: 58 LGEGGFGPVFK------GKLDDGREIAVKKLSHSSNQGKKE-FENEAKLLARV-QHRNVV 109
LG G FG V + GK D+ +AVK L S++ ++E +E K+L+ + QH+N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 110 NLLGYCAHGAEKLLIYEY 127
NLLG C HG L+I EY
Sbjct: 106 NLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 29/84 (34%), Positives = 47/84 (55%), Gaps = 9/84 (10%)
Query: 146 ILFRKKKTDIKASNILLDDKWIPKIADFGMAR--LFPEDQTHVNTRVAGTNGYMAPEYVM 203
I++R D+K N++LD + KIADFGM + +F T GT Y+APE +
Sbjct: 122 IIYR----DLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT---FCGTPDYIAPEIIA 174
Query: 204 HGHLSVKADVFSFGVVILELISGQ 227
+ D ++FGV++ E+++GQ
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 54/231 (23%)
Query: 47 SATKNFHPSNK-LGEGGFGPVFKGK-LDDGREIAVKKLSHS--SNQGKKEFEN------- 95
S ++ + LGEG +G V K G+ +A+KK+ SN K+ +
Sbjct: 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH 64
Query: 96 -----EAKLLARVQHRNVVNLLG-YCAHGAEKLL--IYEYVINESLD-KVLFSL--IKDI 144
E K++ ++H N++ L+ Y L+ I + + +D K+ + +K I
Sbjct: 65 FTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCI 124
Query: 145 --QIL----------FRKKKTDIKASNILLDDKWIPKIADFGMARLF--------PEDQT 184
QIL F + D+ +NI ++ K I KIADFG+AR +
Sbjct: 125 LLQILNGLNVLHKWYFMHR--DLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 185 HVNTRVAGTNG-----YMAPEYVMHG---HLSVKADVFSFGVVILELISGQ 227
+ R T+ Y APE +M H +V D++S G + EL++G+
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 44/162 (27%), Positives = 75/162 (46%), Gaps = 17/162 (10%)
Query: 138 FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN- 194
F + K ++ L +K D+ A NILL + + KI DFG+AR +D +V A
Sbjct: 186 FQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 195 GYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKS 254
+MAPE + ++++DV+SFGV++ E+ S + + +D + K + ++
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRLKEGTRMRA 303
Query: 255 LEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVV 296
+ P + Q L C G+P RPT +V
Sbjct: 304 PDYTTPEM------------YQTMLDCWHGEPSQRPTFSELV 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 4e-08
Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 38/199 (19%)
Query: 57 KLGEGGFGPVFKGKLDDGRE-IAVKKLS-HSSNQGKKEFE-NEAKLLARVQHRNVVNLLG 113
K+GEG +G V+K + E IA+KK+ ++G E LL +QH N+V L
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 114 YCAHGAEKL-LIYEYV---------------INESLDKV-LFSLIKDI------QILFRK 150
H ++L L++EY+ N L K L+ +++ I ++L R
Sbjct: 69 -VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHR- 126
Query: 151 KKTDIKASNILLDDKW-IPKIADFGMARLF--PEDQTHVNTRVAGTNGYMAPEYVMHG-H 206
D+K N+L+D + K+ADFG+AR F P T T Y APE ++ H
Sbjct: 127 ---DLKPQNLLIDRRTNALKLADFGLARAFGIP---VRTFTHEVVTLWYRAPEILLGSRH 180
Query: 207 LSVKADVFSFGVVILELIS 225
S D++S G + E+++
Sbjct: 181 YSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 29/203 (14%)
Query: 51 NFHPSNKLGEGGFGPVFKG-KLDDGREIAVKKLSHS--SNQGKKE---FENEAKLLARVQ 104
N+ LG+G FG V+ D GRE+AVK++ S + KE E E +LL +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 105 HRNVVNLLGYCAHGAEKLL--IYEYVINESLDKVLFS---LIKDIQILFRKK-------- 151
H +V G E+ L E++ S+ L S L +++ + ++
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122
Query: 152 ------KTDIKASNILLDDKWIPKIADFGMARLFPE---DQTHVNTRVAGTNGYMAPEYV 202
DIK +NIL D K+ DFG ++ T + + V GT +M+PE +
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSPEVI 181
Query: 203 MHGHLSVKADVFSFGVVILELIS 225
KAD++S G ++E+++
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 48/165 (29%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 138 FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN- 194
F + + ++ L +K D+ A NILL + + KI DFG+AR +D +V A
Sbjct: 181 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 195 GYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKS 254
+MAPE + + ++DV+SFGV++ E+ S + + ++ ++ +L KD +
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----EFCQRL--KDGT 294
Query: 255 LEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299
+ P A + +I L C QGDP+ RPT +V +L
Sbjct: 295 -RMRAPENATPE-------IYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-08
Identities = 53/194 (27%), Positives = 78/194 (40%), Gaps = 29/194 (14%)
Query: 57 KLGEGGFGPVF---KGKLDDGREIAVKKLSHSSNQGKKEF---ENEAKLLARVQHRNVVN 110
+LG+G FG V+ K + V K E EA+LL+++ H +V
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 111 LLGYCAHGAEKLLIYEYVINESLDKVLFSLIKD-------------IQILF--------R 149
+I EY LD L L IQ+L R
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126
Query: 150 KKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSV 209
D+KA NI L + + KI DFG++RL + T GT YM+PE + H
Sbjct: 127 ILHRDLKAKNIFLKNN-LLKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPEALKHQGYDS 184
Query: 210 KADVFSFGVVILEL 223
K+D++S G ++ E+
Sbjct: 185 KSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-08
Identities = 54/195 (27%), Positives = 84/195 (43%), Gaps = 38/195 (19%)
Query: 58 LGEGGFGPVF--KGKLDDG----REIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVN- 110
+GEG FG + D +EI + K S + +KE A LLA+++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKE----AVLLAKMKHPNIVAF 63
Query: 111 ------------LLGYCAHG---------AEKLLIYEYVINESLDKVL-FSLIKDIQILF 148
++ YC G KL + ++ + L I + ++L
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLH 123
Query: 149 RKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLS 208
R DIK+ NI L K+ DFG ARL + T V GT Y+ PE + +
Sbjct: 124 R----DIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMPYN 178
Query: 209 VKADVFSFGVVILEL 223
K+D++S G ++ EL
Sbjct: 179 NKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 30/82 (36%), Positives = 45/82 (54%), Gaps = 5/82 (6%)
Query: 146 ILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG 205
I++R D+K N+LLD KIADFGM + + +T GT Y+APE +
Sbjct: 117 IIYR----DLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEILKGQ 171
Query: 206 HLSVKADVFSFGVVILELISGQ 227
+ D +SFGV++ E++ GQ
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-08
Identities = 29/75 (38%), Positives = 44/75 (58%), Gaps = 4/75 (5%)
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG-HLSVKAD 212
D+K +NILLD+ +I+D G+A F + + H + GT+GYMAPE + G AD
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSAD 178
Query: 213 VFSFGVVILELISGQ 227
FS G ++ +L+ G
Sbjct: 179 WFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 36/199 (18%)
Query: 58 LGEGGFGPVFK-GKLDDGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNV--VNL 111
+G GGFG V+ K D G+ A+K L QG+ NE +L+ V + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 112 LGYCAHGAEKLLIYEYVINES--------------------LDKVLFSL--IKDIQILFR 149
+ Y H +KL ++N +++ L + + +++R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 150 KKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG-HLS 208
D+K +NILLD+ +I+D G+A F + + H + GT+GYMAPE + G
Sbjct: 122 ----DLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGTAYD 174
Query: 209 VKADVFSFGVVILELISGQ 227
AD FS G ++ +L+ G
Sbjct: 175 SSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 25/194 (12%)
Query: 56 NKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKK-EFENEAKLLARVQHRNVVNLLG 113
+KLGEG + VFKG+ +A+K++ +G E LL ++H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 114 YCAHGAEKLLIYEYV---INESLDKV------------LFSLIKDIQILFRKK--KTDIK 156
L++EY+ + + LD +F L++ + ++K D+K
Sbjct: 71 IIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLK 130
Query: 157 ASNILLDDKWIPKIADFGMARL--FPEDQTHVNTRVAGTNGYMAPEYVMHG-HLSVKADV 213
N+L+++K K+ADFG+AR P +T+ N V T Y P+ ++ S D+
Sbjct: 131 PQNLLINEKGELKLADFGLARAKSVPT-KTYSNEVV--TLWYRPPDVLLGSTEYSTPIDM 187
Query: 214 FSFGVVILELISGQ 227
+ G ++ E+ +G+
Sbjct: 188 WGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 7e-08
Identities = 59/239 (24%), Positives = 98/239 (41%), Gaps = 39/239 (16%)
Query: 9 DGLLKHFNLGSSREGDNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFK 68
DG L++ + S+ E D+++D I +++ V A+ + L G G VF
Sbjct: 30 DGDLEYSDDDSASESDDDDDDGLIPTKQKA-----REVVASLGYTVIKTLTPGSEGRVFV 84
Query: 69 GKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI---- 124
+ V K+ K EA LL V H +V+ + GA ++
Sbjct: 85 ATKPGQPDPVVLKIGQ-----KGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139
Query: 125 ----YEYVINES----LDKVLFSLIKDI----------QILFRKKKTDIKASNILLDDKW 166
Y Y+ S +D+ + K I +I+ R D+K NI ++D
Sbjct: 140 SSDLYTYLTKRSRPLPIDQA-LIIEKQILEGLRYLHAQRIIHR----DVKTENIFINDVD 194
Query: 167 IPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS 225
I D G A+ FP +AGT APE + + KAD++S G+V+ E+++
Sbjct: 195 QVCIGDLGAAQ-FPVVAPA-FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 28/84 (33%), Positives = 46/84 (54%), Gaps = 9/84 (10%)
Query: 146 ILFRKKKTDIKASNILLDDKWIPKIADFGMAR--LFPEDQTHVNTRVAGTNGYMAPEYVM 203
I++R D+K N+LLD + KIADFGM + + T + GT Y+APE +
Sbjct: 117 IIYR----DLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPEILS 169
Query: 204 HGHLSVKADVFSFGVVILELISGQ 227
+ D ++ GV++ E+++GQ
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 31/204 (15%)
Query: 51 NFHPSNKLGEGGFGPVFKG-KLDDGREIAVKKL-----SHSSNQGKKEFENEAKLLARVQ 104
N+ LG G FG V+ D GRE+AVK++ S +++ E E +LL ++
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 105 HRNVVNLLGYCA--HGAEKLLIY-EYVINESLD---KVLFSLIKDIQILFRKK------- 151
H +V G C +KL I+ EY+ S+ K +L +++ + ++
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 152 -------KTDIKASNILLDDKWIPKIADFGMARLFPE---DQTHVNTRVAGTNGYMAPEY 201
DIK +NIL D K+ DFG ++ T + + V GT +M+PE
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMSPEV 180
Query: 202 VMHGHLSVKADVFSFGVVILELIS 225
+ KADV+S ++E+++
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 25/194 (12%)
Query: 56 NKLGEGGFGPVFKG--KLDDGREIAVKKLSHSSNQGKK-EFENEAKLLARVQHRNVVNLL 112
KLGEG + VFKG KL + +A+K++ +G E LL ++H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 113 GYCAHGAEKLLIYEYV---INESLDKV------------LFSLIKDIQILFRKK--KTDI 155
L++EY+ + + +D L+ +++ + R+K D+
Sbjct: 71 DIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDL 130
Query: 156 KASNILLDDKWIPKIADFGMARLFP-EDQTHVNTRVAGTNGYMAPEYVM-HGHLSVKADV 213
K N+L++++ K+ADFG+AR +T+ N V T Y P+ ++ S + D+
Sbjct: 131 KPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYSTQIDM 188
Query: 214 FSFGVVILELISGQ 227
+ G + E+ SG+
Sbjct: 189 WGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 39/204 (19%)
Query: 51 NFHPSNKLGEGGFGPVFKGKLDDGRE-IAVKKLSHSSNQGKKEFE---NEAKLLARVQHR 106
+ +G G FG V + A+K ++ K+ + NE ++L V H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 107 NVVNLLGYCAHGAEKLL--IYEYVINESLDKVL-----FS----------------LIKD 143
++ L + ++ L + EYV L L FS +
Sbjct: 62 FIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS 119
Query: 144 IQILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM 203
+I++R D+K NILLD + K+ DFG A+ D+T + GT Y+APE +
Sbjct: 120 KEIVYR----DLKPENILLDKEGHIKLTDFGFAKKL-RDRTWT---LCGTPEYLAPEVIQ 171
Query: 204 H-GHLSVKADVFSFGVVILELISG 226
GH + D ++ G++I E++ G
Sbjct: 172 SKGH-NKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 56/201 (27%), Positives = 89/201 (44%), Gaps = 38/201 (18%)
Query: 58 LGEGGFGPVFKGKL----DDGREIAVKKLSHSS---NQ-GKKEFENEAKLLARVQHRNVV 109
LG+GG+G VF+ + D G+ A+K L ++ NQ + E +L V+H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 110 NLLGYCAHGAEKLLIYEYVINESL------------DKVLFSL---------IKDIQILF 148
+L+ G + LI EY+ L D F L + I++
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIY 123
Query: 149 RKKKTDIKASNILLDDKWIPKIADFGMAR--LFPEDQTHVNTRVAGTNGYMAPEYVMHGH 206
R D+K NILLD + K+ DFG+ + + TH GT YMAPE +M
Sbjct: 124 R----DLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPEILMRSG 176
Query: 207 LSVKADVFSFGVVILELISGQ 227
D +S G ++ ++++G
Sbjct: 177 HGKAVDWWSLGALMYDMLTGA 197
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 40/207 (19%)
Query: 50 KNFHPSNKLGEGGFGPV---FKGKLDDGREIAVKKLS---HSSNQGKKEFENEAKLLARV 103
+N P +G G +G V F K G +AVKKLS S K+ + E +LL +
Sbjct: 20 QNLSP---VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHM 73
Query: 104 QHRNVVNLLG---------------YCAH--GAE--KLLIYEYVINESLDKVLFSLIKDI 144
+H NV+ LL H GA+ ++ + + ++ + +++ +++ +
Sbjct: 74 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 133
Query: 145 QILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT-HVNTRVAGTNGYMAPEY 201
+ + D+K SN+ +++ KI DFG+AR ++ T +V TR Y APE
Sbjct: 134 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 188
Query: 202 VMHG-HLSVKADVFSFGVVILELISGQ 227
+++ H + D++S G ++ EL++G+
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 29/195 (14%)
Query: 57 KLGEGGFGPVFKG-KLDDGREIAVKKLSHSSNQGKKEFE--NEAKLLARVQHRNVVNLLG 113
KLGEG + V+KG +G+ +A+K +S + +G F EA LL ++H N+V LL
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIV-LLH 69
Query: 114 YCAHGAEKL-LIYEYVINE---------------SLDKVLFSLIKDIQILFRKK--KTDI 155
H E L ++EY+ + ++ +F L++ + + + D+
Sbjct: 70 DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDL 129
Query: 156 KASNILLDDKWIPKIADFGMARL--FPEDQTHVNTRVAGTNGYMAPEYVMHG-HLSVKAD 212
K N+L+ K+ADFG+AR P QT+ + V T Y P+ ++ S D
Sbjct: 130 KPQNLLISYLGELKLADFGLARAKSIPS-QTYSSEVV--TLWYRPPDVLLGATDYSSALD 186
Query: 213 VFSFGVVILELISGQ 227
++ G + +E++ GQ
Sbjct: 187 IWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 52/200 (26%), Positives = 87/200 (43%), Gaps = 25/200 (12%)
Query: 51 NFHPSNKLGEGGFGPVFKGKLDDGREI-AVKKLSHSSNQGKKEFEN---EAKLLARVQHR 106
+F+ LG+G FG V + E+ A+K L + E E ++LA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 107 NVVNLLGYCAHGAEKL-LIYEYVINESL-------------DKVLFSLIKDIQILFRKKK 152
+ L C ++L + EYV L V ++ + + F ++
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 153 ----TDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV-AGTNGYMAPEYVMHGHL 207
D+K N++LD + KIADFGM + D V TR GT Y+APE + +
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPY 178
Query: 208 SVKADVFSFGVVILELISGQ 227
D +++GV++ E+++GQ
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 23/91 (25%)
Query: 144 IQILFRKKKTDIKASNILLDDKWIPKIADFG--------MARLFPEDQTHVNTRVAGTNG 195
+I+ R D+K SNIL++ + K+ DFG MA F GT
Sbjct: 119 HKIMHR----DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-----------VGTRS 163
Query: 196 YMAPEYVMHGHLSVKADVFSFGVVILELISG 226
YM+PE + H +V++D++S G+ ++E+ G
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 35/218 (16%)
Query: 42 FEALVSATKNFHPSNKLGEGGFGPVFK-GKLDDGREIAVKKLSHSSNQGKKEFENEAKLL 100
E+L T + +G+G +G V+K DG AVK L S+ +E E E +L
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-DEEIEAEYNIL 72
Query: 101 ARV-QHRNVVNLLGY------------------CAHGAEKLLIYEYVI-NESLDK----- 135
+ H NVV G C G+ L+ +I + LD+
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 136 VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT 193
+L+ + +Q L + D+K +NILL + K+ DFG++ + NT V GT
Sbjct: 133 ILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GT 191
Query: 194 NGYMAPEYVM-----HGHLSVKADVFSFGVVILELISG 226
+MAPE + + DV+S G+ +EL G
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 32/101 (31%), Positives = 52/101 (51%), Gaps = 9/101 (8%)
Query: 133 LDKVLFSLIKDIQILFRKKKT---DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189
L K+ S++K ++ L K D+K SN+L++ K+ DFG++ + T
Sbjct: 105 LGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV--AKTI 162
Query: 190 VAGTNGYMAPEYV----MHGHLSVKADVFSFGVVILELISG 226
AG YMAPE + VK+DV+S G+ ++EL +G
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 52/194 (26%), Positives = 85/194 (43%), Gaps = 44/194 (22%)
Query: 72 DDGREIAVKKLSHSSNQGKKE---FENEAKLLARVQHRNVVNLL--GYCAHGAEKLL--I 124
G E+A+K L + + + + F E L AR+ H N+V LL G G LL +
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG---LLFAV 57
Query: 125 YEYVINESLDKVL---------------------FSLIKDIQILFRKKKTDIKASNILL- 162
+EYV +L +VL + + I+ R D+K NI++
Sbjct: 58 FEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHR----DLKPQNIMVS 113
Query: 163 --DDKWIPKIADFGMARLFP------EDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVF 214
+ K+ DFG+ L P T V GT Y APE + ++ +D++
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 215 SFGVVILELISGQR 228
++G++ LE ++GQR
Sbjct: 174 AWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 11/92 (11%)
Query: 146 ILFRKKKTDIKASNILLDDKWIPKIADFGMAR--LFPEDQTHVNTRVAGTNGYMAPEYVM 203
I++R D+K N++LD KIADFGM + +F +++ + GT Y+APE +
Sbjct: 117 IIYR----DLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA---STFCGTPDYIAPEILQ 169
Query: 204 HGHLSVKADVFSFGVVILELISGQRNSSFNLD 235
+ D +SFGV++ E++ GQ S F+ D
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQ--SPFHGD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 29/74 (39%), Positives = 40/74 (54%), Gaps = 1/74 (1%)
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADV 213
D+K NILLD KIADFGM + T GT Y+APE ++ + D
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQKYNTSVDW 179
Query: 214 FSFGVVILELISGQ 227
+SFGV++ E++ GQ
Sbjct: 180 WSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 29/76 (38%), Positives = 45/76 (59%), Gaps = 1/76 (1%)
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQT-HVNTRVAGTNGYMAPEYVMHGHLSVKAD 212
DIK++NILL + K+ DFG ++++ + V GT Y+APE S KAD
Sbjct: 168 DIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKAD 227
Query: 213 VFSFGVVILELISGQR 228
+FS GV++ EL++ +R
Sbjct: 228 MFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 39/200 (19%)
Query: 57 KLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFE--NEAKLLARVQHRNVVNLLG 113
KLGEG + V+KG+ G+ +A+K++ +G F EA LL ++H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP-FTAIREASLLKDLKHANIV-TLH 69
Query: 114 YCAHGAEKL-LIYEYV---INESLDK------------VLFSLIKDI------QILFRKK 151
H + L L++EY+ + + +D LF L++ + ++L R
Sbjct: 70 DIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHR-- 127
Query: 152 KTDIKASNILLDDKWIPKIADFGMARL--FPEDQTHVNTRVAGTNGYMAPEYVMHG--HL 207
D+K N+L+ ++ K+ADFG+AR P +T+ N V T Y P+ V+ G
Sbjct: 128 --DLKPQNLLISERGELKLADFGLARAKSVPS-KTYSNEVV--TLWYRPPD-VLLGSTEY 181
Query: 208 SVKADVFSFGVVILELISGQ 227
S D++ G + E+ +G+
Sbjct: 182 STSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 8e-07
Identities = 59/226 (26%), Positives = 96/226 (42%), Gaps = 51/226 (22%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKK-LSHSSNQGKKEFE-NEAKLLARVQHRN-VVNLL 112
K+GEG +G V+K + + G+ +A+KK +G E LL + +V LL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 113 GYCAHGAEKL------LIYEYVINE-------------------SLDKVLFSLIKDIQ-- 145
H EK L++EY+ ++ ++ ++ L+K +
Sbjct: 68 D-VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 146 ----ILFRKKKTDIKASNILLD-DKWIPKIADFGMARLFP---EDQTHVNTRVAGTNGYM 197
++ R D+K N+L+D K + KIAD G+ R F + TH T Y
Sbjct: 127 HKHGVMHR----DLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV----TLWYR 178
Query: 198 APEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLL 242
APE ++ H S D++S G + E+ Q F D + Q LL
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ--PLFPGDSELQQLL 222
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 9e-07
Identities = 25/75 (33%), Positives = 37/75 (49%), Gaps = 5/75 (6%)
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADV 213
DIK N+L+D K+ DFG++R N + GT Y+APE ++ +D
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILGVGDDKMSDW 176
Query: 214 FSFGVVILELISGQR 228
+S G VI E + G
Sbjct: 177 WSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 9e-07
Identities = 65/217 (29%), Positives = 94/217 (43%), Gaps = 39/217 (17%)
Query: 51 NFHPSNKLGEGGFGPVF----KGKLDDGREIAVKKLSHSS-NQGKKEFEN---EAKLLAR 102
NF LG G +G VF D G+ A+K L ++ Q K E+ E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 103 VQHRNVVNLLGYCAHGAEKL-LIYEYVI------------NESLDKVLFSL--------- 140
V+ + L Y KL LI +YV N S D+V F
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 141 IKDIQILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPE 200
+ + I++R DIK NILLD + + DFG+++ F ++ GT YMAPE
Sbjct: 121 LHKLGIVYR----DIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE 176
Query: 201 YV--MHGHLSVKADVFSFGVVILELISGQRNSSFNLD 235
+ GH D +S G++I EL++G S F L+
Sbjct: 177 IIRGKGGHGKA-VDWWSLGILIFELLTGA--SPFTLE 210
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 50/216 (23%)
Query: 50 KNFHPSNKLGEGGFGPVFKGKLD--DGREIAVKKLSHSSNQGKKEFEN---------EAK 98
+ + KLG+G +G V+K +D +A+KK+ + F N E
Sbjct: 7 RKYEILQKLGKGAYGIVWKA-IDRRTKEVVALKKIFDA-------FRNATDAQRTFREIM 58
Query: 99 LLARV-QHRNVVNLLGYCAHGAEK----LLIYEYVINES-LDKVLFS-LIKDIQI----- 146
L + H N+V LL AE L++EY+ E+ L V+ + +++D+
Sbjct: 59 FLQELGDHPNIVKLLN--VIKAENDKDIYLVFEYM--ETDLHAVIRANILEDVHKRYIMY 114
Query: 147 -LFRKKK---------TDIKASNILLDDKWIPKIADFGMARLFPE-DQTHVN---TRVAG 192
L + K D+K SNILL+ K+ADFG+AR E ++ N T
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 193 TNGYMAPEYVMHGHLSVKA-DVFSFGVVILELISGQ 227
T Y APE ++ K D++S G ++ E++ G+
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 51/199 (25%), Positives = 84/199 (42%), Gaps = 36/199 (18%)
Query: 58 LGEGGFGPVFKGKLDDGREI-AVKKLSHSSNQGKKEFEN---EAKLL---ARVQHRNVVN 110
LG G FG V + E+ A+K L + E E+ E ++ +H +VN
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 111 LLG-------------YCAHGAEKLLIYEYVINESLDK-----VLFSL--IKDIQILFRK 150
L Y A G + I+ V +E V+ L + + +I++R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYR- 125
Query: 151 KKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT--RVAGTNGYMAPEYVMHGHLS 208
D+K N+LLD + KIADFG+ + E + GT ++APE + +
Sbjct: 126 ---DLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179
Query: 209 VKADVFSFGVVILELISGQ 227
D + GV+I E++ G+
Sbjct: 180 RAVDWWGLGVLIYEMLVGE 198
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 31/196 (15%)
Query: 58 LGEGGFGPVFKGKL-DDGREIAVKKLSHSSNQGKKEFE---NEAKLLARVQHRNVVNLLG 113
LG+G FG V +L + GR AVK L + E E ++L+ ++ + L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 114 YCAHGAEKLL-IYEYVINESL------------DKVLF---------SLIKDIQILFRKK 151
C ++L + E+V L + F + D I++R
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR-- 120
Query: 152 KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKA 211
D+K N+LLD + K+ADFGM + + +T GT Y+APE +
Sbjct: 121 --DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEILQEMLYGPSV 177
Query: 212 DVFSFGVVILELISGQ 227
D ++ GV++ E++ G
Sbjct: 178 DWWAMGVLLYEMLCGH 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 39/204 (19%)
Query: 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFEN---EAKLLARVQHR 106
+F LG G FG V K G A+K L K+ ++ E +L + H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 107 NVVNLLGYCAHGAEKLL--IYEYVINESL--------------------DKVL-FSLIKD 143
+VN+ C+ E + + E+V+ L + VL F +
Sbjct: 79 FIVNM--MCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS 136
Query: 144 IQILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM 203
I++R D+K N+LLD+K K+ DFG A+ P D+T + GT Y+APE +
Sbjct: 137 KDIIYR----DLKPENLLLDNKGHVKVTDFGFAKKVP-DRTFT---LCGTPEYLAPEVIQ 188
Query: 204 -HGHLSVKADVFSFGVVILELISG 226
GH D ++ GV++ E I+G
Sbjct: 189 SKGH-GKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 29/82 (35%), Positives = 46/82 (56%), Gaps = 5/82 (6%)
Query: 146 ILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG 205
I++R D+K N++LD + KIADFGM + D T GT Y+APE + +
Sbjct: 122 IIYR----DLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT-FCGTPDYIAPEIIAYQ 176
Query: 206 HLSVKADVFSFGVVILELISGQ 227
D ++FGV++ E+++GQ
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 64/279 (22%), Positives = 120/279 (43%), Gaps = 54/279 (19%)
Query: 58 LGEGGFGPVFKGKLDDGRE--IAVKKLS-HSSNQGKKEFE---------NEAKLL-ARVQ 104
LG G FG V+K + + + +A+K+++ H+ GK + E +E ++ +++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 105 HRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKD--------------IQI---- 146
H N+V ++L I +I + F+ +K+ +Q+
Sbjct: 68 HPNIVRYYKTFLEN-DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 147 --LFRKKKT---DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEY 201
L ++K+ D+ +NI+L + I DFG+A+ + T V GT Y PE
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL--TSVVGTILYSCPEI 184
Query: 202 VMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPS 261
V + KADV++FG ++ ++ F + N+L A K+ + E +
Sbjct: 185 VKNEPYGEKADVWAFGCILYQMC--TLQPPFY----STNMLSLATKIV--EAVYEPLPEG 236
Query: 262 LAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300
+ + D D I C+ D + RP + +V M+S
Sbjct: 237 MYSEDVTDVITSCLTP-------DAEARPDIIQVSAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 3e-06
Identities = 47/200 (23%), Positives = 84/200 (42%), Gaps = 32/200 (16%)
Query: 58 LGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLG--- 113
+G G +G V+KG+ ++A K+ + ++E + E +L + HRN+ G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 114 ----------------YCAHGAEKLLIYEYVIN----ESLDKVLFSLIKDIQILFRKK-- 151
+C G+ LI N E + + +++ + L + K
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVI 133
Query: 152 KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM-----HGH 206
DIK N+LL + K+ DFG++ NT + GT +MAPE +
Sbjct: 134 HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDAT 192
Query: 207 LSVKADVFSFGVVILELISG 226
K+D++S G+ +E+ G
Sbjct: 193 YDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 43/151 (28%), Positives = 71/151 (47%), Gaps = 20/151 (13%)
Query: 154 DIKASNILLDDKWIPKIADFGMAR--LFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKA 211
D+K N+LLD + K+ D+GM + L P D T + GT Y+APE +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRGEDYGFSV 177
Query: 212 DVFSFGVVILELISGQRNSSFNL----DVDAQNLLDWAY-----KLYKKDKSLEIVDPSL 262
D ++ GV++ E+++G+ S F++ D QN D+ + K + +SL + S+
Sbjct: 178 DWWALGVLMFEMMAGR--SPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASV 235
Query: 263 AAS----DSGDQIAMCIQIGLLCTQGDPQLR 289
S D +++ Q G QG P R
Sbjct: 236 LKSFLNKDPKERLGCHPQTGFADIQGHPFFR 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 67/275 (24%), Positives = 116/275 (42%), Gaps = 59/275 (21%)
Query: 58 LGEGGFGPVFKGK----LDDGR----EIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVV 109
LG+G F +FKG D G E+ +K L S + F A +++++ H+++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 110 NLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFR----------------KKKT 153
G C G E +++ EYV SLD L I I ++ K T
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLT 122
Query: 154 --DIKASNILL----DDKW----IPKIADFGMA-RLFPEDQTHVNTRVAGTNGYMAPEYV 202
++ A N+LL D K K++D G++ + P++ + R+ ++ PE +
Sbjct: 123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI--LLERIP----WVPPECI 176
Query: 203 MHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPS 261
+ +LS+ AD +SFG + E+ SG + LD KL + ++ P
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSGGDKPL--------SALDSQKKLQFYEDRHQLPAPK 228
Query: 262 LAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVV 296
++A I C +P RP+ R ++
Sbjct: 229 WT------ELANLIN---QCMDYEPDFRPSFRAII 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 27/76 (35%), Positives = 44/76 (57%), Gaps = 1/76 (1%)
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQT-HVNTRVAGTNGYMAPEYVMHGHLSVKAD 212
D+K++NI L I K+ DFG ++ + + + V + GT Y+APE S KAD
Sbjct: 194 DLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKAD 253
Query: 213 VFSFGVVILELISGQR 228
++S GV++ EL++ R
Sbjct: 254 MWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 54/206 (26%), Positives = 86/206 (41%), Gaps = 40/206 (19%)
Query: 54 PSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN---------EAKLLARV 103
P +G G +G V K + ++A+KK++++ F+N E KLL +
Sbjct: 9 PIKPIGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHL 61
Query: 104 QHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQIL------------FRKK 151
H NV+ + + Y++ E +D L +I+ Q L R
Sbjct: 62 DHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGL 121
Query: 152 K---------TDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYV 202
K D+K SN+LL+ KI DFG+AR E + V T Y APE +
Sbjct: 122 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPELL 180
Query: 203 MHGHLSVKA-DVFSFGVVILELISGQ 227
++ A DV+S G + EL+ +
Sbjct: 181 LNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 51/186 (27%), Positives = 80/186 (43%), Gaps = 44/186 (23%)
Query: 74 GREIAVKKLSHS-SNQ--GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEK--------L 122
G+ +A+KKLS N K+ + E L+ V H+N++ LL +K
Sbjct: 41 GQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLN--VFTPQKSLEEFQDVY 97
Query: 123 LIYEY-------VINESLDK-----VLFSLIKDIQ------ILFRKKKTDIKASNILLDD 164
L+ E VI LD +L+ ++ I+ I+ R D+K SNI++
Sbjct: 98 LVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHR----DLKPSNIVVKS 153
Query: 165 KWIPKIADFGMARLFPEDQT---HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVIL 221
KI DFG+AR +V TR Y APE ++ D++S G ++
Sbjct: 154 DCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMG 208
Query: 222 ELISGQ 227
E+I G
Sbjct: 209 EMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 49/203 (24%), Positives = 93/203 (45%), Gaps = 45/203 (22%)
Query: 58 LGEGGFGPVFKGKLD--DGREIAVKKLSH--SSNQGKKEFENEAKLLARVQHRNVVNLLG 113
+G G +G V LD G ++A+KKL S K E +LL ++H NV+ LL
Sbjct: 23 VGSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLD 81
Query: 114 -------------------YCAHGAEKLLIYEYVINESLDKVLFSLIKDIQ------ILF 148
+ KL+ +E + + + +++ ++K ++ I+
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIH 141
Query: 149 RKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAG---TNGYMAPEYVMHG 205
R D+K N+ +++ KI DFG+AR ++ + G T Y APE +++
Sbjct: 142 R----DLKPGNLAVNEDCELKILDFGLAR-------QTDSEMTGYVVTRWYRAPEVILNW 190
Query: 206 -HLSVKADVFSFGVVILELISGQ 227
H + D++S G ++ E+++G+
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 27/102 (26%), Positives = 39/102 (38%), Gaps = 28/102 (27%)
Query: 154 DIKASNILLDDKWIPKIADFGMA---------------------------RLFPEDQTHV 186
DIK NIL+D K+ADFG+ R Q V
Sbjct: 126 DIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRV 185
Query: 187 NTR-VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQ 227
GT Y+APE + ++ D +S GV++ E++ G
Sbjct: 186 RANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 7e-06
Identities = 54/209 (25%), Positives = 83/209 (39%), Gaps = 42/209 (20%)
Query: 58 LGEGGFGPVFKG------KLDDGREIAVKKLSHSSNQGKKE-FENEAKLLARV-QHRNVV 109
LG G FG V + K D +AVK L S++ ++E +E K+L+ + H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIV 102
Query: 110 NLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKTDIKASNILLDDKWIPK 169
NLLG C G L+I EY D+ R+K+ D PK
Sbjct: 103 NLLGACTVGGPTLVITEYCC-----------YGDLLNFLRRKR----------DSFICPK 141
Query: 170 IADFGMARLFPEDQTHVNTRVAGTNGYM----APEYVMHG----HLSVKADVFSFGVVIL 221
D A L+ N YM YV+ SV++ + V
Sbjct: 142 HEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTS 201
Query: 222 ELISGQRNSSFNLDVDAQNLLDWAYKLYK 250
E++ L +D ++LL ++Y++ K
Sbjct: 202 EILEED-----ELALDTEDLLSFSYQVAK 225
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 38/146 (26%), Positives = 64/146 (43%), Gaps = 25/146 (17%)
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN----GYMAPEYVMHGHLSV 209
D+ A N+LL I KI DFG+AR D +V+ G+ +MAPE + +
Sbjct: 262 DLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK---GSTFLPVKWMAPESIFDNLYTT 318
Query: 210 KADVFSFGVVILELIS--GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267
+DV+S+G+++ E+ S G +D N + Y++ K D + + V
Sbjct: 319 LSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEV--------- 369
Query: 268 GDQIAMCIQIGLLCTQGDPQLRPTMR 293
I + C +P+ RP+
Sbjct: 370 -------YDIMVKCWNSEPEKRPSFL 388
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 8e-06
Identities = 52/196 (26%), Positives = 86/196 (43%), Gaps = 26/196 (13%)
Query: 51 NFHPSNKLGEGGFGPVFKG-KLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVV 109
++ ++G G +G V+K L G AVK + + E ++ +H N+V
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69
Query: 110 NLLG-YCAHGAEKLLI-YEYVINESLDKV--LFSLIKDIQILFRKKKT------------ 153
G Y + EKL I EY SL + + + ++QI + ++T
Sbjct: 70 AYFGSYLSR--EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 154 ---DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM---HGHL 207
DIK +NILL D K+ADFG+A + + GT +MAPE +G
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGY 186
Query: 208 SVKADVFSFGVVILEL 223
+ D+++ G+ +EL
Sbjct: 187 NQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 8e-06
Identities = 27/83 (32%), Positives = 41/83 (49%), Gaps = 12/83 (14%)
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYV---------MH 204
DIK N+L+D K+ADFG A ++ + GT Y+APE + +
Sbjct: 127 DIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTY 186
Query: 205 GHLSVKADVFSFGVVILELISGQ 227
G V+ D +S GV+ E+I G+
Sbjct: 187 G---VECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 8e-06
Identities = 27/76 (35%), Positives = 41/76 (53%), Gaps = 5/76 (6%)
Query: 154 DIKASNILLDDKWIPKIADFGMAR--LFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKA 211
D+K NILLD + K+ADFGM + + T T GT Y+APE +
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQELEYGPSV 177
Query: 212 DVFSFGVVILELISGQ 227
D ++ GV++ E+++GQ
Sbjct: 178 DWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 8e-06
Identities = 49/199 (24%), Positives = 98/199 (49%), Gaps = 37/199 (18%)
Query: 58 LGEGGFGPV---FKGKLDDGREIAVKKLS---HSSNQGKKEFENEAKLLARVQHRNVVNL 111
+G G +G V + +L +++AVKKLS S ++ + E +LL ++H NV+ L
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGL 79
Query: 112 LGYCA-----------------HGAE--KLLIYEYVINESLDKVLFSLIKDIQILFRKK- 151
L GA+ ++ + + +E + +++ L++ ++ +
Sbjct: 80 LDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGI 139
Query: 152 -KTDIKASNILLDDKWIPKIADFGMARLFPEDQT-HVNTRVAGTNGYMAPEYVMHG-HLS 208
D+K SN+ +++ +I DFG+AR ++ T +V TR Y APE +++ H +
Sbjct: 140 IHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPEIMLNWMHYN 194
Query: 209 VKADVFSFGVVILELISGQ 227
D++S G ++ EL+ G+
Sbjct: 195 QTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 46/198 (23%), Positives = 86/198 (43%), Gaps = 36/198 (18%)
Query: 58 LGEGGFGPVFKG-KLDDGREIAVKKLS---HSSNQGKKEFENEAKLLARVQHRNVVNLL- 112
+G G +G V G ++A+KKLS S K+ + E LL +QH NV+ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLD 81
Query: 113 ----GYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT--------------- 153
+ + + L K++ + + ++ + +
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHR 141
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAG---TNGYMAPEYVMHG-HLSV 209
D+K N+ +++ KI DFG+AR H + + G T Y APE +++ H +
Sbjct: 142 DLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRAPEVILNWMHYNQ 194
Query: 210 KADVFSFGVVILELISGQ 227
D++S G ++ E+++G+
Sbjct: 195 TVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 54/201 (26%), Positives = 80/201 (39%), Gaps = 43/201 (21%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKE----FENEAKLLARVQHRNVVNLL 112
+G+G FG V K DG+ AVK L + KKE LL V+H +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 113 GYCAHGAEKL-LIYEYVINESLDKVLFSL------------------------IKDIQIL 147
Y A+KL + +YV L F L + + I+
Sbjct: 62 HYSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHSLNII 118
Query: 148 FRKKKTDIKASNILLDDKWIPKIADFGMAR--LFPEDQTHVNTRVAGTNGYMAPEYVMHG 205
+R D+K NILLD + + DFG+ + + T + GT Y+APE +
Sbjct: 119 YR----DLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT---STFCGTPEYLAPEVLRKQ 171
Query: 206 HLSVKADVFSFGVVILELISG 226
D + G V+ E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 44/195 (22%), Positives = 84/195 (43%), Gaps = 22/195 (11%)
Query: 50 KNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNV 108
++F ++G G +G V+K + ++ G A+K + + + E ++ +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 109 VNLLGYCAHGAEKLLIYEYVINESLDKV--LFSLIKDIQILFRKKKT------------- 153
V G + + E+ SL + + + + QI + ++T
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKM 128
Query: 154 --DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM---HGHLS 208
DIK +NILL D K+ADFG++ + + GT +MAPE G +
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYN 187
Query: 209 VKADVFSFGVVILEL 223
D+++ G+ +EL
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 54/196 (27%), Positives = 90/196 (45%), Gaps = 34/196 (17%)
Query: 58 LGEGGFGPVFK-GKLDDGREIAVKKLSHSSNQGKKEFEN---EAKLLARVQHRNVVNLLG 113
+G+G FG V + K D R A+K + + + E + E +LA+V +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 114 YCAHGAEKLLIYEYVINES--------------------LDKVLFSL--IKDIQILFRKK 151
+ EKL + IN ++L +L + +++R
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYR-- 117
Query: 152 KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKA 211
D+K NILLD + + DFG+ +L +D NT GT Y+APE ++ GH KA
Sbjct: 118 --DLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLL-GHGYTKA 173
Query: 212 -DVFSFGVVILELISG 226
D ++ GV++ E+++G
Sbjct: 174 VDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 40/212 (18%)
Query: 51 NFHPSNKLGEGGFGPV----FKGKLDDGREIAVKKLSHSSNQG--KKEFENEAKLLARVQ 104
+ +LG+G +G V ++ +A+KK+++ ++ K E KLL +
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEET-VAIKKITNVFSKKILAKRALRELKLLRHFR 59
Query: 105 -HRNVVNLLGY---CAHGAEKLLIYEYVINESLDKVLFS--------------------- 139
H+N+ L +L +YE ++ L +++ S
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLK 119
Query: 140 LIKDIQILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN---TRVAGTNGY 196
I +L R D+K N+L++ KI DFG+AR F E+ T T Y
Sbjct: 120 YIHSANVLHR----DLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 197 MAPEYVMHGHLSVKA-DVFSFGVVILELISGQ 227
APE ++ KA DV+S G ++ EL+ +
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 137 LFSLIKDIQILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGY 196
L L ++ I+ R D+K +N+L++ K+ DFG++ N G Y
Sbjct: 115 LKFLKEEHNIIHR----DVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI---GCQSY 167
Query: 197 MAPEYVMHGHL------SVKADVFSFGVVILELISG 226
MAPE + G +V++DV+S G+ ILE+ G
Sbjct: 168 MAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 56/201 (27%), Positives = 84/201 (41%), Gaps = 43/201 (21%)
Query: 58 LGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFEN----EAKLLARVQHRNVVNLL 112
+G+G FG V K DG AVK L + KKE + LL ++H +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 113 GYCAHGAEKL-LIYEYVINESLDKVLFSLIKD------------------------IQIL 147
Y AEKL + +YV L F L ++ + I+
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARFYAAEVASAIGYLHSLNII 118
Query: 148 FRKKKTDIKASNILLDDKWIPKIADFGMAR--LFPEDQTHVNTRVAGTNGYMAPEYVMHG 205
+R D+K NILLD + + DFG+ + + PE+ T + GT Y+APE +
Sbjct: 119 YR----DLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAPEVLRKE 171
Query: 206 HLSVKADVFSFGVVILELISG 226
D + G V+ E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 33/111 (29%), Positives = 59/111 (53%), Gaps = 16/111 (14%)
Query: 128 VINES-----LDKVLFS--LIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARL 178
+INES +D V FS + ++ L K D+ A N+L+ + + KI DFG+AR
Sbjct: 229 LINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARD 288
Query: 179 FPEDQTHVNTRVAGTN----GYMAPEYVMHGHLSVKADVFSFGVVILELIS 225
D +++ G+ +MAPE + + + +DV+SFG+++ E+ +
Sbjct: 289 IMRDSNYISK---GSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 55/267 (20%), Positives = 105/267 (39%), Gaps = 57/267 (21%)
Query: 66 VFKGKLDDGREIAVKKLSHSSNQGKK---EFENEAKLLARVQHRNVVNLLGYCAHGAEKL 122
++KG ++ +E+ ++ K ENE K L R+ N++ + G+ + L
Sbjct: 36 IYKGIFNN-KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 123 ----LIYEYVINESLDKVLFSLIKDIQILFRKKKTD----------------------IK 156
LI EY L +VL K+ + F K K D +
Sbjct: 95 PRLSLILEYCTRGYLREVLD---KEKDLSF-KTKLDMAIDCCKGLYNLYKYTNKPYKNLT 150
Query: 157 ASNILLDDKWIPKIADFGMARLFPEDQ-THVNTRVAGTNGYMAPEYV--MHGHLSVKADV 213
+ + L+ + + KI G+ ++ +VN V Y + + + + ++K D+
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDI 205
Query: 214 FSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAM 273
+S GVV+ E+ +G F ++ + + D + K+ SL++
Sbjct: 206 YSLGVVLWEIFTG--KIPFE-NLTTKEIYD---LIINKNNSLKL-------PLDCPLEIK 252
Query: 274 CIQIGLLCTQGDPQLRPTMRRVVVMLS 300
CI CT D RP ++ ++ LS
Sbjct: 253 CIVEA--CTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 34/198 (17%)
Query: 58 LGEGGFGPVFK-GKLDDGREIAVKKLSHSSNQGKKEFEN---EAKLLARVQHRN---VVN 110
+G+G FG V++ K D R A+K LS KKE + E +L R +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 111 LLGYCAHGAEKLLIYEYVINESL------------DKVLF---SLIKDIQ------ILFR 149
L ++ L+ +Y+ L D+ F L+ ++ I++R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 150 KKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSV 209
D+K NILLD + DFG+++ D NT GT Y+APE ++
Sbjct: 121 ----DLKPENILLDATGHIALCDFGLSKANLTDNKTTNT-FCGTTEYLAPEVLLDEKGYT 175
Query: 210 K-ADVFSFGVVILELISG 226
K D +S GV++ E+ G
Sbjct: 176 KHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 5e-05
Identities = 25/78 (32%), Positives = 40/78 (51%), Gaps = 6/78 (7%)
Query: 154 DIKASNILLDDKWIPKIADFGMA-RLFPEDQTHVNTRVAGTNGYMAPEYVM----HGHLS 208
D+K N+LLD K+ADFG ++ +T V GT Y++PE + G+
Sbjct: 167 DVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYG 225
Query: 209 VKADVFSFGVVILELISG 226
+ D +S GV + E++ G
Sbjct: 226 RECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 6e-05
Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 28/198 (14%)
Query: 50 KNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLS---HSSNQGKKEFENEAKLLARVQHR 106
+N P +G + LD R +A+KKLS + K+ + E L+ V H+
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 76
Query: 107 NVVNLLG-YCAHGAEKLLIYEYVINESLDK-----------------VLFSLIKDIQILF 148
N+++LL + + + Y++ E +D +L+ ++ I+ L
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 149 RKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGH 206
D+K SNI++ KI DFG+AR + + T T Y APE ++
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 207 LSVKADVFSFGVVILELI 224
D++S G ++ E++
Sbjct: 195 YKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 7e-05
Identities = 58/224 (25%), Positives = 93/224 (41%), Gaps = 39/224 (17%)
Query: 38 KHFPFEALVSATKNFHPSNKLGEGGFGPVFK-GKLDDGREIAVKKLS--HSSNQGKKEFE 94
K F++ + + +G+G +G VFK +G + AVK L H ++ E E
Sbjct: 6 KTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE---EIE 62
Query: 95 NEAKLL-ARVQHRNVVNLLG------------------YCAHGAEKLLIYEYV-----IN 130
E +L A H NVV G C G+ L+ ++ +
Sbjct: 63 AEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERME 122
Query: 131 ESLDK-VLFSLIKDIQILFRKKKT--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187
E + +L + +Q L K D+K +NILL + K+ DFG++ + N
Sbjct: 123 EPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 182
Query: 188 TRVAGTNGYMAPEYV-----MHGHLSVKADVFSFGVVILELISG 226
T V GT +MAPE + + + DV+S G+ +EL G
Sbjct: 183 TSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 7e-05
Identities = 30/98 (30%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 146 ILFRKKKTDIKASNILLDDKWIPKIADFGMAR--LFPEDQTHVNTRVAGTNGYMAPEYVM 203
I++R D+K N+LLD K+ D+GM + L P D T + GT Y+APE +
Sbjct: 117 IIYR----DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILR 169
Query: 204 HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNL 241
D ++ GV++ E+++G+ S F++ D ++
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGR--SPFDIITDNPDM 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 8e-05
Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 35/206 (16%)
Query: 57 KLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQG-KKEFENEAKLLARVQHRNVVNLLG-Y 114
K+G G +G V+K K DG++ L G E LL ++H NV++L +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 115 CAHGAEKL-LIYEYVINE-----------------------SLDKVLFSLIKDIQILFRK 150
+H K+ L+++Y ++ + +L+ ++ I L
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 151 --KKTDIKASNILL----DDKWIPKIADFGMARLF--PEDQTHVNTRVAGTNGYMAPEYV 202
D+K +NIL+ ++ KIAD G ARLF P V T Y APE +
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 187
Query: 203 MHGHLSVKA-DVFSFGVVILELISGQ 227
+ KA D+++ G + EL++ +
Sbjct: 188 LGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 9e-05
Identities = 49/176 (27%), Positives = 77/176 (43%), Gaps = 26/176 (14%)
Query: 74 GREIAVKKLS---HSSNQGKKEFENEAKLLARVQHRNVVNLLGY------CAHGAEKLLI 124
G +AVKKLS + K+ + E LL V H+N+++LL + L+
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104
Query: 125 YEY-------VINESLDK-----VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKI 170
E VI+ LD +L+ ++ I+ L D+K SNI++ KI
Sbjct: 105 MELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 164
Query: 171 ADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISG 226
DFG+AR + T T Y APE ++ D++S G ++ EL+ G
Sbjct: 165 LDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 9e-05
Identities = 48/201 (23%), Positives = 85/201 (42%), Gaps = 28/201 (13%)
Query: 50 KNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLS---HSSNQGKKEFENEAKLLARVQHR 106
+N P +G + L+ R +A+KKLS + K+ + E L+ V H+
Sbjct: 27 QNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 107 NVVNLLG-YCAHGAEKLLIYEYVINESLDK-----------------VLFSLIKDIQILF 148
N++ LL + + + Y++ E +D +L+ ++ I+ L
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 149 RKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGH 206
D+K SNI++ KI DFG+AR + + T T Y APE ++
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 207 LSVKADVFSFGVVILELISGQ 227
D++S G ++ E+I G
Sbjct: 202 YKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 44/204 (21%), Positives = 84/204 (41%), Gaps = 40/204 (19%)
Query: 58 LGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLG--- 113
+G G +G V+KG+ ++A K+ + ++E + E +L + HRN+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 114 ----------------YCAHGAEKLLIYEYVINESLDKVLFSLIKDI----------QIL 147
+C G+ L+ N + + + ++I +++
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVI 143
Query: 148 FRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM---- 203
R DIK N+LL + K+ DFG++ NT + GT +MAPE +
Sbjct: 144 HR----DIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDEN 198
Query: 204 -HGHLSVKADVFSFGVVILELISG 226
++D++S G+ +E+ G
Sbjct: 199 PDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 32/109 (29%), Positives = 58/109 (53%), Gaps = 15/109 (13%)
Query: 146 ILFRKKKTDIKASNILLDDKWIPKIADFGMAR--LFPEDQTHVNTRVAGTNGYMAPEYVM 203
I++R D+K N+LLD + K+ D+GM + + P D T + GT Y+APE +
Sbjct: 117 IIYR----DLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILR 169
Query: 204 HGHLSVKADVFSFGVVILELISGQRNSSFNL----DVDAQNLLDWAYKL 248
D ++ GV++ E+++G+ S F++ D QN D+ +++
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGR--SPFDIVGMSDNPDQNTEDYLFQV 216
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 26/79 (32%), Positives = 40/79 (50%), Gaps = 5/79 (6%)
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM-----HGHLS 208
DIK NIL+D ++ADFG ED T ++ GT Y++PE + G
Sbjct: 127 DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYG 186
Query: 209 VKADVFSFGVVILELISGQ 227
+ D +S GV + E++ G+
Sbjct: 187 PECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 4e-04
Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 35/206 (16%)
Query: 57 KLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQG-KKEFENEAKLLARVQHRNVVNLLG-Y 114
K+G G +G V+K K DG++ L G E LL ++H NV+ L +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 115 CAHGAEKL-LIYEYVINE-----------------------SLDKVLFSLIKDIQILFRK 150
+H K+ L+++Y ++ + +L+ ++ I L
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 151 --KKTDIKASNILL----DDKWIPKIADFGMARLF--PEDQTHVNTRVAGTNGYMAPEYV 202
D+K +NIL+ ++ KIAD G ARLF P V T Y APE +
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 187
Query: 203 MHGHLSVKA-DVFSFGVVILELISGQ 227
+ KA D+++ G + EL++ +
Sbjct: 188 LGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 4e-04
Identities = 52/230 (22%), Positives = 93/230 (40%), Gaps = 36/230 (15%)
Query: 57 KLGEGGFGPVFKGKLDDGREIA---VKKLSHSSN-QGKKEFENEAKLLARVQHRNVVNLL 112
++G G FG V ++ +A VK+L +++ + + EF + +QH N++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 113 GYCAHGAEKLLIYEYVINESLDKVLFS---LIKDIQILFRKK------------------ 151
G C LL++EY L L ++ Q+L ++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFL 121
Query: 152 KTDIKASNILLDDKWIPKIADFGMA-RLFPEDQTHVNTRVAGTNGYMAPEYV--MHGHL- 207
+D+ N L K+ D+G+ + ED ++APE V HG L
Sbjct: 122 HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLI 181
Query: 208 ----SVKADVFSFGVVILELI--SGQRNSSF-NLDVDAQNLLDWAYKLYK 250
+ ++V++ GV + EL + Q S + +V + D KL+K
Sbjct: 182 TAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFK 231
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 55/220 (25%), Positives = 90/220 (40%), Gaps = 53/220 (24%)
Query: 57 KLGEGGFGPVFKGKLDD---GREIAVKKLSH--SSNQG-KKEFENEAKLLARVQHRNVVN 110
+G+GG G V+ D R +A+KK+ S N KK F EAK+ A + H +V
Sbjct: 9 LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 111 LLGYCAHGAEKLLIYEYVINESLDKVLFS------LIKDIQI---------LFRK----- 150
+ C+ G Y+ +L +L S L K++ +F K
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 151 --------KKTDIKASNILLDDKWIPKIADFGMA---RLFPEDQTHVNT----------- 188
D+K NILL I D+G A +L ED ++
Sbjct: 127 EYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186
Query: 189 ---RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS 225
++ GT YMAPE ++ S D+++ GV++ ++++
Sbjct: 187 IPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 28/80 (35%), Positives = 41/80 (51%), Gaps = 7/80 (8%)
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVA-GTNGYMAPEYVM-----HGHL 207
DIK N+LLD ++ADFG D T V + VA GT Y++PE + G
Sbjct: 127 DIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRY 185
Query: 208 SVKADVFSFGVVILELISGQ 227
+ D +S GV + E++ G+
Sbjct: 186 GPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 7e-04
Identities = 25/74 (33%), Positives = 37/74 (50%), Gaps = 1/74 (1%)
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADV 213
DIK N++LD KI DFG+ + D + T GT Y+APE + D
Sbjct: 120 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDW 178
Query: 214 FSFGVVILELISGQ 227
+ GVV+ E++ G+
Sbjct: 179 WGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 8e-04
Identities = 24/76 (31%), Positives = 37/76 (48%), Gaps = 5/76 (6%)
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT--RVAGTNGYMAPEYVMHGHLSVKA 211
D+K N++LD KI DFG+ + E + T GT Y+APE +
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 212 DVFSFGVVILELISGQ 227
D + GVV+ E++ G+
Sbjct: 177 DWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 9e-04
Identities = 53/198 (26%), Positives = 78/198 (39%), Gaps = 37/198 (18%)
Query: 58 LGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKE----FENEAKLLARVQHRNVVNLL 112
+G+G FG V K DG+ AVK L +KE LL V+H +V L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 113 GYCAHGAEKLLIYEYVINESLDKVLFSLIKD------------------------IQILF 148
Y EKL +N ++ F L ++ I I++
Sbjct: 62 HYSFQTTEKLYFVLDFVNGG--ELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVY 119
Query: 149 RKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLS 208
R D+K NILLD + + DFG+ + Q+ T GT Y+APE +
Sbjct: 120 R----DLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 209 VKADVFSFGVVILELISG 226
D + G V+ E++ G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 9e-04
Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 37/207 (17%)
Query: 58 LGEGGFGPVFKG--KLDDG--REIAVKKLSHSSNQGK--KEFENEAKLLARVQHRNVVNL 111
LG+G FG V + K +DG +++AVK L +EF EA + H NV+ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 112 LGYCAHGAEK------LLIYEYVINESLDK-VLFSLIKD------IQILFR--------- 149
+G K ++I ++ + L +L S I + +Q L R
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 150 ---KKKT----DIKASNILLDDKWIPKIADFGMAR-LFPEDQTHVNTRVAGTNGYMAPEY 201
K D+ A N +L++ +ADFG+++ ++ D ++A E
Sbjct: 127 EYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALES 186
Query: 202 VMHGHLSVKADVFSFGVVILELIS-GQ 227
+ + +DV++FGV + E+++ GQ
Sbjct: 187 LADNVYTTHSDVWAFGVTMWEIMTRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 25/79 (31%), Positives = 40/79 (50%), Gaps = 5/79 (6%)
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM-----HGHLS 208
DIK N+LLD ++ADFG +D T ++ GT Y++PE + G
Sbjct: 127 DIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYG 186
Query: 209 VKADVFSFGVVILELISGQ 227
+ D +S GV + E++ G+
Sbjct: 187 PECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 24/74 (32%), Positives = 38/74 (51%), Gaps = 1/74 (1%)
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADV 213
D+K N++LD KI DFG+ + +D + T GT Y+APE + D
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDW 179
Query: 214 FSFGVVILELISGQ 227
+ GVV+ E++ G+
Sbjct: 180 WGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.001
Identities = 27/140 (19%), Positives = 50/140 (35%), Gaps = 18/140 (12%)
Query: 57 KLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVV--NLLGY 114
L G V+ D +K + S + + E E +L + + + +L
Sbjct: 5 LLKGGLTNRVYLLGTKDED-YVLKI--NPSREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 115 CAHGAEKLLIYEYVINESLDKV-------LFSLIKDIQILFRKKK------TDIKASNIL 161
L+ E++ E+LD+V + + ++ + D+ NIL
Sbjct: 62 GESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNIL 121
Query: 162 LDDKWIPKIADFGMARLFPE 181
+DD I I D+ A P
Sbjct: 122 VDDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 5/83 (6%)
Query: 145 QILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMH 204
+I++R D+K N++LD KI DFG+ + D + T GT Y+APE +
Sbjct: 115 KIVYR----DLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLED 169
Query: 205 GHLSVKADVFSFGVVILELISGQ 227
D + GVV+ E++ G+
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 42/158 (26%), Positives = 67/158 (42%), Gaps = 21/158 (13%)
Query: 96 EAKLLARVQHRNVVNLLGYCAHGAEKLLI--------YEYVINE------SLDKVLFSLI 141
EA +L + H +++ L G + LI Y Y+ + + + S++
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVL 192
Query: 142 KDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV--AGTNGYM 197
+ IQ L + DIKA NI ++ + DFG A FP D N AGT
Sbjct: 193 RAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINA-NKYYGWAGTIATN 250
Query: 198 APEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLD 235
APE + D++S G+V+ E+ + +S F D
Sbjct: 251 APELLARDPYGPAVDIWSAGIVLFEMATCH-DSLFEKD 287
|
Length = 391 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 53/242 (21%), Positives = 96/242 (39%), Gaps = 48/242 (19%)
Query: 16 NLGSSREGDNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGK-LDDG 74
N + + D E+ ++ R S K++ N +G G FG V++ +D
Sbjct: 43 NNNAGEDEDEEKMIDNDINR-----------SPNKSYKLGNIIGNGSFGVVYEAICIDTS 91
Query: 75 REIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGY----CAHGAEKLLIYEYVI- 129
++A+KK+ +E ++ + H N++ L Y C EK + V+
Sbjct: 92 EKVAIKKVLQDPQYKNREL----LIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVME 147
Query: 130 ----------------NESLDKVL-----FSLIKDIQILFRK--KKTDIKASNILLDDK- 165
N +L L + L + + + K D+K N+L+D
Sbjct: 148 FIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT 207
Query: 166 WIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELI 224
K+ DFG A+ Q V+ + Y APE ++ + + D++S G +I E+I
Sbjct: 208 HTLKLCDFGSAKNLLAGQRSVS--YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
Query: 225 SG 226
G
Sbjct: 266 LG 267
|
Length = 440 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 381 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.66 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.45 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.42 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.42 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.28 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.21 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.17 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.13 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.99 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.98 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.79 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.77 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.77 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.72 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.67 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.65 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.6 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.55 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.5 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.46 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.39 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.35 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.35 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.34 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.31 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.31 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.3 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.21 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.17 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.03 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.99 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.98 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.97 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.95 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.93 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.91 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.86 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.85 | |
| PLN02236 | 344 | choline kinase | 97.62 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.57 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.53 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.42 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.42 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.26 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.08 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.04 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.04 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.94 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.88 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.85 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.77 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.69 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.67 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.66 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.54 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.52 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.35 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.21 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.2 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.03 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.96 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.37 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 95.08 | |
| KOG3021 | 313 | consensus Predicted kinase [General function predi | 95.06 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-51 Score=381.12 Aligned_cols=267 Identities=45% Similarity=0.754 Sum_probs=233.0
Q ss_pred hCCCCChHHHHHhhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEE
Q 048280 36 EQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYC 115 (381)
Q Consensus 36 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 115 (381)
..+.|++.++..+|++|.....||+|+||.||+|...++..||||++.........+|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 57789999999999999999999999999999999998999999988665433145599999999999999999999999
Q ss_pred eeCC-eEEEEEecccCCCHHHHH-----------------HhhhhhhhHhhhhc-----cCCccccceEeCCCCCcEEee
Q 048280 116 AHGA-EKLLIYEYVINESLDKVL-----------------FSLIKDIQILFRKK-----KTDIKASNILLDDKWIPKIAD 172 (381)
Q Consensus 116 ~~~~-~~~lv~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~-----HrDlkp~NIll~~~~~~kL~D 172 (381)
.+.+ ..+||+||+++|+|.+.| .++++||.|||... |||||++|||||+++.+||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 599999999999997664 57889999999865 999999999999999999999
Q ss_pred eccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcC
Q 048280 173 FGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKD 252 (381)
Q Consensus 173 FG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (381)
||+++..........+...||.+|+|||++..+..+.|+|||||||+|+||++|+.+.+.........+..|....+...
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 99997654411111111179999999999999999999999999999999999999887666556667999998888888
Q ss_pred CcccccCCCCC-CCCCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 253 KSLEIVDPSLA-ASDSG-DQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 253 ~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
...+++|+.+. ..... .....+..++.+|++.+|.+||+|.||++.|+..
T Consensus 301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 99999999987 44443 6788899999999999999999999999999654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-51 Score=359.82 Aligned_cols=236 Identities=25% Similarity=0.397 Sum_probs=195.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC-eEEEEEe
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA-EKLLIYE 126 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~lv~E 126 (381)
.+.+.++.||+|..|+||+++++ +++.+|+|++... +...++++.+|+++++..+||+||++||.|.... .++|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 35677899999999999999876 6889999999544 4455688999999999999999999999999998 5999999
Q ss_pred cccCCCHHHHH---------------HhhhhhhhHhhh-hc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 127 YVINESLDKVL---------------FSLIKDIQILFR-KK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 127 ~~~~g~L~~~l---------------~~~~~~l~~lh~-~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
||++|+|++++ .++++||.|||. ++ ||||||+||||+..|.|||||||.++.+... ...
T Consensus 159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~ 235 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IAN 235 (364)
T ss_pred hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hcc
Confidence 99999998776 578999999996 44 9999999999999999999999999977544 445
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
+++||..|||||.+.+..|+.++||||||++++|+++|+.|+.... ....+.......+..+. .|.+...
T Consensus 236 tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~-~~~~~~~~Ll~~Iv~~p------pP~lP~~--- 305 (364)
T KOG0581|consen 236 TFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN-PPYLDIFELLCAIVDEP------PPRLPEG--- 305 (364)
T ss_pred cccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC-CCCCCHHHHHHHHhcCC------CCCCCcc---
Confidence 6889999999999999999999999999999999999999987541 11223333222222211 1222222
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.+..++..++..||++||.+||++.|++++
T Consensus 306 ~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 356678899999999999999999999863
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=367.58 Aligned_cols=231 Identities=24% Similarity=0.399 Sum_probs=195.3
Q ss_pred cCCCCCCcccccCCeeEEEEEE-CCCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKL-DDGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
..|...+.||+|||+.||.++. .+|..||+|++.+. ....++.+.+||+|+++|+|||||+++++|++.+.+|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4699999999999999999997 77999999999764 4455688999999999999999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
|+|..++|..++ .||+.|+.|||+.+ |||||..|+||+++.+|||+|||+|..+..+. ....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-Erk~ 176 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-ERKK 176 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc-cccc
Confidence 999999997654 89999999999999 99999999999999999999999999886443 2344
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
+.+||+.|+|||++.....+..+||||+|||||.||+|++||.... + ...+..-...+...|.
T Consensus 177 TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------v----kety~~Ik~~~Y~~P~------- 239 (592)
T KOG0575|consen 177 TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------V----KETYNKIKLNEYSMPS------- 239 (592)
T ss_pred eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------H----HHHHHHHHhcCccccc-------
Confidence 6899999999999999999999999999999999999999985321 1 1112211122222222
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.......+||.++|+.||.+|||+++|+..
T Consensus 240 ~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 240 HLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 334557789999999999999999999863
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=360.92 Aligned_cols=238 Identities=24% Similarity=0.364 Sum_probs=193.3
Q ss_pred hhcCCCCCCcccccCCeeEEEEEE-CCCcEEEEEEecCCCcc-------cHHHHHHHHHHHHHhCCCCcccEEEEEeeCC
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKL-DDGREIAVKKLSHSSNQ-------GKKEFENEAKLLARVQHRNVVNLLGYCAHGA 119 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 119 (381)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||++.+.... ....+.+|+++|++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 466789999999999999999975 46999999999764211 2234679999999999999999999999999
Q ss_pred eEEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCC---CCcEEeeeccceec
Q 048280 120 EKLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDK---WIPKIADFGMARLF 179 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~---~~~kL~DFG~~~~~ 179 (381)
..||||||+.||.|.+.+ +|++.++.|||+++ ||||||+|||+..+ ..+||+|||+|+..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999997655 89999999999999 99999999999765 78999999999987
Q ss_pred CCCCcccccccccCccccchhHHhhCCC---CchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCccc
Q 048280 180 PEDQTHVNTRVAGTNGYMAPEYVMHGHL---SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLE 256 (381)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (381)
.+ .....+.|||+.|.|||++.+..+ ..++||||+|||||-+++|.+||....... .+.+ ....+..
T Consensus 330 g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~e----QI~~G~y-- 399 (475)
T KOG0615|consen 330 GE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKE----QILKGRY-- 399 (475)
T ss_pred cc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHH----HHhcCcc--
Confidence 63 334557899999999999987643 347899999999999999999996543322 1111 1111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 257 IVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
.+.+.......++.++||.+||..||++|||+.|+++.-
T Consensus 400 ----~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp 438 (475)
T KOG0615|consen 400 ----AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHP 438 (475)
T ss_pred ----cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence 111234556678889999999999999999999998643
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-50 Score=342.32 Aligned_cols=237 Identities=25% Similarity=0.403 Sum_probs=193.5
Q ss_pred hcCCCCCCcccccCCeeEEEEE-ECCCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEE-EEeeCCe-EEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLG-YCAHGAE-KLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~-~~~~~~~-~~l 123 (381)
..+|++.++||.|.||.||++. ..+|..||.|.+.-. +...++.+..|+.+|++|+|||||++++ .|.+++. ++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 4468899999999999999997 457999999998643 4556678999999999999999999998 4555555 899
Q ss_pred EEecccCCCHHHHH-------------------HhhhhhhhHhhhhc------cCCccccceEeCCCCCcEEeeecccee
Q 048280 124 IYEYVINESLDKVL-------------------FSLIKDIQILFRKK------KTDIKASNILLDDKWIPKIADFGMARL 178 (381)
Q Consensus 124 v~E~~~~g~L~~~l-------------------~~~~~~l~~lh~~~------HrDlkp~NIll~~~~~~kL~DFG~~~~ 178 (381)
|||||.+|+|.+++ .|++.||..+|.+- ||||||.||+|+.+|.|||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999997665 78999999999822 999999999999999999999999998
Q ss_pred cCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCccccc
Q 048280 179 FPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
+..... .....+||+.||+||.+.+..|+.||||||+||++|||+.-..||... ++......+-..+
T Consensus 178 l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~qgd------ 244 (375)
T KOG0591|consen 178 LSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQGD------ 244 (375)
T ss_pred hcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHcCC------
Confidence 865433 344678999999999999999999999999999999999999998643 4444433332221
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 259 DPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
...-...-.+..+.+||..|+..||+.||+.-.++..+.+
T Consensus 245 ---~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 245 ---YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ---CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1111224556778899999999999999996666555543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=347.67 Aligned_cols=184 Identities=29% Similarity=0.505 Sum_probs=165.7
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
...+|.+.+.||.|+||+||+|+++ ++..||||.+.+. .....+.+..|+++|+.++|||||++++++..++.+|||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3568999999999999999999876 5899999999766 445567789999999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCC------CCcEEeeeccceecCC
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDK------WIPKIADFGMARLFPE 181 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~------~~~kL~DFG~~~~~~~ 181 (381)
||||.||+|..+| .|++.|+++||.++ ||||||+||||+.. -.+||+|||+|+.+..
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 9999999998776 79999999999999 99999999999764 5689999999999864
Q ss_pred CCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCC
Q 048280 182 DQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFN 233 (381)
Q Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 233 (381)
. ....+.+|++.|||||++....|+.|+|+||+|+|||+|++|+.||...
T Consensus 168 ~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 168 G--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred h--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 3 3345689999999999999999999999999999999999999998643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=340.95 Aligned_cols=247 Identities=26% Similarity=0.402 Sum_probs=199.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
+.|+.+.++|+|+||.||+++++ +|+.||||++..+. ..-.+-.++||++|++++|+|+|.++.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 36888999999999999999977 59999999997653 3334567899999999999999999999999999999999
Q ss_pred cccCCCH---------------HHHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 127 YVINESL---------------DKVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 127 ~~~~g~L---------------~~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
||+..-| .++++|++.++.|+|.++ ||||||+||||+.+|.+||||||+|+.+.. .....+.
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~YTD 160 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNYTD 160 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchhhh
Confidence 9966444 457799999999999999 999999999999999999999999998865 3344566
Q ss_pred cccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHH--------HHHhhcCCcc-----
Q 048280 190 VAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWA--------YKLYKKDKSL----- 255 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~----- 255 (381)
++.|.+|+|||++.+ ..|+..+||||+||++.||++|.+-|+...+.|....+... ..++......
T Consensus 161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l 240 (396)
T KOG0593|consen 161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL 240 (396)
T ss_pred hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence 789999999999988 57999999999999999999999999888777664433321 2222222111
Q ss_pred -cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 256 -EIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 256 -~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
+.-++............-+++|+..||+.||.+|++.++++.
T Consensus 241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111111112223344567889999999999999999999874
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-48 Score=354.66 Aligned_cols=239 Identities=30% Similarity=0.431 Sum_probs=193.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCccc--HHHHHHHHHHHHHhCCCCcccEEEEEeeCC-eEEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQG--KKEFENEAKLLARVQHRNVVNLLGYCAHGA-EKLLIY 125 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~lv~ 125 (381)
..+..+.+.||.|+||+||+|.+.....||||++....... .+.|.+|+.+|.+++|||||+++|+|.+.. ..+|||
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 33455567799999999999999854449999997654322 568999999999999999999999999887 799999
Q ss_pred ecccCCCHHHHH-----------------HhhhhhhhHhhhhc---cCCccccceEeCCCC-CcEEeeeccceecCCCCc
Q 048280 126 EYVINESLDKVL-----------------FSLIKDIQILFRKK---KTDIKASNILLDDKW-IPKIADFGMARLFPEDQT 184 (381)
Q Consensus 126 E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~---HrDlkp~NIll~~~~-~~kL~DFG~~~~~~~~~~ 184 (381)
||+++|+|.+++ .+++.|+.|||+.+ ||||||+||||+.++ ++||+|||+++......
T Consensus 120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999998877 57899999999887 999999999999998 99999999998764432
Q ss_pred ccccccccCccccchhHHh--hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 185 HVNTRVAGTNGYMAPEYVM--HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
...+...||+.|||||++. ...|+.|+||||||++||||+||+.||..... .+...........
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~R-------- 264 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLR-------- 264 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCC--------
Confidence 2233467999999999999 56899999999999999999999999864322 2222222222211
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
...+..+...+..|+.+||..||..||++.+|+..|+.+.
T Consensus 265 -p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 265 -PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred -CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 2222225567888999999999999999999999998653
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=356.62 Aligned_cols=238 Identities=28% Similarity=0.445 Sum_probs=200.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
.+.+..++.||+|.||.||+|.++....||+|.++... ...+.|.+|+++|++|+|+|||+++++|..+..+|||||||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 34456688999999999999999987899999997653 34478999999999999999999999999988999999999
Q ss_pred cCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 129 INESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 129 ~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
+.|+|.++| .||++|++||.+++ ||||.+.||||+++..|||+|||+++...++.......
T Consensus 284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 999998887 68999999999999 99999999999999999999999999766665555554
Q ss_pred cccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 190 VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
..-...|.|||.+..+.++.|||||||||+||||+| |+.|+......+. .+.++...+...+.
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev----------------~~~le~GyRlp~P~ 427 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV----------------LELLERGYRLPRPE 427 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH----------------HHHHhccCcCCCCC
Confidence 455778999999999999999999999999999998 6666654332221 11223334445555
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
.++..+.+|+..||+.+|++||||+.+...|+...
T Consensus 428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 67788999999999999999999999999887653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=329.89 Aligned_cols=225 Identities=23% Similarity=0.342 Sum_probs=185.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|++++.||+|+||.||.++.+ +++.+|+|++++.. ....+....|..||.+++||+||+++-.|++...+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 568999999999999999999865 59999999997652 23456788999999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
+||+.||.|...| ..++.||.|||+++ ||||||+|||||.+|+++|+|||+++....... ..
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~-~t 182 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD-AT 182 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC-cc
Confidence 9999999997655 67899999999999 999999999999999999999999996433322 33
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
.+++||+.|||||++.+..|+..+|-|||||++|||++|.+||.... ...+...+.... . ...+
T Consensus 183 ~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~I~~~k-~---------~~~p 246 (357)
T KOG0598|consen 183 RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDKILKGK-L---------PLPP 246 (357)
T ss_pred ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHHHhcCc-C---------CCCC
Confidence 45899999999999999999999999999999999999999986432 222222222211 0 0111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRP 290 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RP 290 (381)
.-......+++.+.|+.||++|.
T Consensus 247 ~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 247 GYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ccCCHHHHHHHHHHhccCHHHhc
Confidence 11334577899999999999996
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=334.62 Aligned_cols=237 Identities=22% Similarity=0.332 Sum_probs=194.1
Q ss_pred HHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCe
Q 048280 46 VSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAE 120 (381)
Q Consensus 46 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 120 (381)
....++|...+.||+|+|++|++|+.+ +++.||||++.+. .....+.+..|-.+|.+| .||.|++|+-.|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 444678999999999999999999855 6999999998654 223345677899999999 89999999999999999
Q ss_pred EEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 121 KLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
+|+|+||+++|+|.++| .+|+.+|+|||+++ ||||||+|||||+++++||+|||.++.+....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999887 58999999999999 99999999999999999999999999885432
Q ss_pred cc----------c--ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc
Q 048280 184 TH----------V--NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKK 251 (381)
Q Consensus 184 ~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 251 (381)
.. . ...++||..|.+||++.....+..+|||+||||||+|+.|.+||....+. ... ..++.
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney---liF---qkI~~- 301 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY---LIF---QKIQA- 301 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH---HHH---HHHHH-
Confidence 21 1 13589999999999999999999999999999999999999999643321 111 11111
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 252 DKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
++-.+ +..++..+.+|+.+.|..||.+|+|+.+|.+..
T Consensus 302 ------l~y~f----p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 302 ------LDYEF----PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred ------hcccC----CCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 11111 122235577899999999999999999987653
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=328.69 Aligned_cols=243 Identities=22% Similarity=0.360 Sum_probs=195.2
Q ss_pred hhcCCCCCCcccccCCeeEEEEEE-CCCcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKL-DDGREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
..+.|++.+.||.|.-++||+|+. ..+..||||++... .....+.+.+|+..|+.++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 467899999999999999999985 46899999999754 2334688999999999999999999999999999999999
Q ss_pred ecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 126 EYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 126 E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
.||.+|++.+++ +++++||.|||.++ |||||+.||||+.+|.|||+|||.+..+.......
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 999999998776 78999999999999 99999999999999999999999998765543221
Q ss_pred c---cccccCccccchhHHhh--CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCC
Q 048280 187 N---TRVAGTNGYMAPEYVMH--GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPS 261 (381)
Q Consensus 187 ~---~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (381)
. ..+.||++|||||++.. ..|+.|+||||||++..||++|..||....+... ......+... ...-..
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv------Ll~tLqn~pp-~~~t~~ 256 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV------LLLTLQNDPP-TLLTSG 256 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH------HHHHhcCCCC-Cccccc
Confidence 1 45689999999999654 4699999999999999999999999864433211 1111111111 000111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 262 LAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 262 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
+..+........+.+++..||++||.+|||+.++++
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 222333445568899999999999999999999985
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=333.35 Aligned_cols=245 Identities=26% Similarity=0.385 Sum_probs=194.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEE-CCCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeC--CeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKL-DDGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHG--AEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~l 123 (381)
.+.|+.+++||+|.||.||+|+. .+|+.||+|++.... .....-..+||.||++|+||||+++.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 45789999999999999999985 479999999997654 33345677999999999999999999988776 68999
Q ss_pred EEecccCCCH----------------HHHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 124 IYEYVINESL----------------DKVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 124 v~E~~~~g~L----------------~~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
|+|||++ +| ..++.|++.||.|+|.++ |||||.+|||||++|.+||+|||+|+++......
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~ 274 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA 274 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence 9999954 33 356689999999999999 9999999999999999999999999988766655
Q ss_pred cccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc--------CCcc-
Q 048280 186 VNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKK--------DKSL- 255 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~- 255 (381)
..+..+-|++|+|||++.|. .|+.++|+||.||||.||+.|++.|....+.++...+ +.+... ..+.
T Consensus 275 ~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kI---fklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 275 PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKI---FKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHH---HHHhCCCChhccccccCCc
Confidence 56667789999999999886 6999999999999999999999998766555443222 221111 0110
Q ss_pred -cccCCCCC-----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 256 -EIVDPSLA-----ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 256 -~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
..+.+... .+....+....++|+..+|..||.+|.|+.++++
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111100 1112344566788999999999999999999875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=339.71 Aligned_cols=235 Identities=23% Similarity=0.377 Sum_probs=200.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEE-CCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKL-DDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
...|....+||+|.-|.||.|.. .+++.||||++.......++.+.+|+.+|+..+|+|||.+++.|..++.+|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 45688889999999999999974 46899999999988888888999999999999999999999999999999999999
Q ss_pred ccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccc
Q 048280 128 VINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVA 191 (381)
Q Consensus 128 ~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~ 191 (381)
++||+|.+++ ++++.||.|||.++ |||||.+|||++.+|.+||+|||+|..+..... .....+
T Consensus 352 m~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~TmV 430 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTMV 430 (550)
T ss_pred cCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cccccc
Confidence 9999998766 67899999999999 999999999999999999999999998866554 344578
Q ss_pred cCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHH
Q 048280 192 GTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271 (381)
Q Consensus 192 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (381)
||++|||||++....|++|+||||||++++||+-|.+||.... .++..+.+...+. ..+ .......
T Consensus 431 GTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~------PlrAlyLIa~ng~-P~l-------k~~~klS 496 (550)
T KOG0578|consen 431 GTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN------PLRALYLIATNGT-PKL-------KNPEKLS 496 (550)
T ss_pred CCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC------hHHHHHHHhhcCC-CCc-------CCccccC
Confidence 9999999999999999999999999999999999999986432 2233333332221 111 2233445
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 272 AMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 272 ~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
..+.+|+.+||..|+++|+++.|||+.
T Consensus 497 ~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 497 PELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 678899999999999999999999864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-46 Score=332.42 Aligned_cols=232 Identities=25% Similarity=0.397 Sum_probs=196.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
..|...+.||+|.||.||+|.+. +++.||+|++... .....+++.+|+.+|.+++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45778899999999999999865 6899999999765 334457899999999999999999999999999999999999
Q ss_pred ccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccc
Q 048280 128 VINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV 190 (381)
Q Consensus 128 ~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 190 (381)
|.||++.+.| ++++.++.|+|..+ |||||+.|||+..+|.|||+|||++..+....... .++
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tf 171 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTF 171 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc-ccc
Confidence 9999998766 78899999999998 99999999999999999999999999876554443 568
Q ss_pred ccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHH
Q 048280 191 AGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQ 270 (381)
Q Consensus 191 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (381)
+||+.|||||++.+..|+.|+||||||++.+||++|.+|+....+.. ..-++.....+.....+
T Consensus 172 vGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------------vlflIpk~~PP~L~~~~ 235 (467)
T KOG0201|consen 172 VGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------------VLFLIPKSAPPRLDGDF 235 (467)
T ss_pred cccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------EEEeccCCCCCcccccc
Confidence 89999999999998899999999999999999999999985433321 11222222233333466
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 271 IAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 271 ~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
...+.+|+..||++||+.||++.++++.
T Consensus 236 S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 236 SPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 6779999999999999999999999853
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=335.28 Aligned_cols=230 Identities=27% Similarity=0.431 Sum_probs=194.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcc--cHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQ--GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
++|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+.... ..+.+.+|++|++.++|||||.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 47899999999999999999865 5899999999766433 34678999999999999999999999999999999999
Q ss_pred cccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 127 YVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 127 ~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
||.| +|..+| .+++.+|.|||+.+ |||+||.|||++.++.+|+||||+++.+.. +....+.
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~vlts 159 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTSVLTS 159 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc-Cceeeee
Confidence 9966 998877 67899999999998 999999999999999999999999998754 3444556
Q ss_pred cccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHH
Q 048280 190 VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGD 269 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (381)
+.||+.|||||++.+..|+..+|+||+|||||||++|++||.. ..+.+.+..+..+ |.. .+..
T Consensus 160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a------~si~~Lv~~I~~d--------~v~---~p~~ 222 (808)
T KOG0597|consen 160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA------RSITQLVKSILKD--------PVK---PPST 222 (808)
T ss_pred ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH------HHHHHHHHHHhcC--------CCC---Cccc
Confidence 8899999999999999999999999999999999999999842 2233333333222 111 1224
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 270 QIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 270 ~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
....+..++...|.+||.+|.|..+++..
T Consensus 223 ~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 223 ASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 55678889999999999999999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=330.37 Aligned_cols=239 Identities=26% Similarity=0.418 Sum_probs=189.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC-CcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC--eEEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD-GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA--EKLLIY 125 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv~ 125 (381)
..+|...+.||+|+||.||++...+ |...|||.+...+....+.+.+|+.+|.+++|||||+++|...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 3468889999999999999998764 8999999987653333677999999999999999999999754444 689999
Q ss_pred ecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCC-CCCcEEeeeccceecCC--CCc
Q 048280 126 EYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDD-KWIPKIADFGMARLFPE--DQT 184 (381)
Q Consensus 126 E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~-~~~~kL~DFG~~~~~~~--~~~ 184 (381)
||+++|+|.+++ .|+++||.|||+++ ||||||+||||+. ++.+||+|||+++.... ...
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 999999998766 78999999999988 9999999999999 79999999999987653 122
Q ss_pred ccccccccCccccchhHHhhCC-CCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC
Q 048280 185 HVNTRVAGTNGYMAPEYVMHGH-LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
.......||+.|||||++.++. ...++|||||||++.||+||+.||... .....+.......... |
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~-----P--- 242 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSL-----P--- 242 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCC-----C---
Confidence 2233578999999999998643 345999999999999999999998532 1111222222221111 1
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 264 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
..+...+....+++.+|+..||++|||+.++++...-
T Consensus 243 -~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 243 -EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred -CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 2233355668889999999999999999999986644
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=336.86 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=191.9
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHH--HHHHHHHHHHhC-CCCcccEEEEEeeCC-eE
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKE--FENEAKLLARVQ-HRNVVNLLGYCAHGA-EK 121 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-hpnIv~~~~~~~~~~-~~ 121 (381)
..-++|.++++||.|.||.||+|+.. ++..||||++++.-.. .++ -++|++.|++|+ |||||++.+++.+.+ .+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 44568999999999999999999855 5899999999765333 233 357999999998 999999999998887 99
Q ss_pred EEEEecccCCCHH----------------HHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 122 LLIYEYVINESLD----------------KVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 122 ~lv~E~~~~g~L~----------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
|+||||| ..+|. .+++|++.||+++|.+| ||||||+|||+..+..+||+|||+|+.+...
T Consensus 86 ~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk- 163 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK- 163 (538)
T ss_pred eeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC-
Confidence 9999999 44554 45689999999999999 9999999999999999999999999976433
Q ss_pred cccccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCC---------
Q 048280 184 THVNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDK--------- 253 (381)
Q Consensus 184 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 253 (381)
...+.++.|.+|+|||++.. +.|+.+.||||+|||++|+.+-++-|++..+.|+...+-.+........
T Consensus 164 -pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 164 -PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred -CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 23455788999999998765 5789999999999999999999998887665554221111100000000
Q ss_pred cccccCCCCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 254 SLEIVDPSLAA----SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 254 ~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
...+..|...+ .........+.+||.+|+.+||.+|||+.++++.-
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 00111121111 11223567788999999999999999999998754
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=332.85 Aligned_cols=273 Identities=21% Similarity=0.281 Sum_probs=205.6
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHhhhCCCCChHHHHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcc
Q 048280 10 GLLKHFNLGSSREGDNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQ 88 (381)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~ 88 (381)
.|.+.......++++..+..+.....+...+...-.....++|+++..||+|+||.||+|+.+ +|..+|+|++++..-.
T Consensus 101 ~le~~l~~~~~s~~~~~~~~~~~~~kEte~lR~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~ 180 (550)
T KOG0605|consen 101 ELEEKLASEDVSEEEQNELLKSLLSKETEYLRLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML 180 (550)
T ss_pred HHHHHHhhccccHHHHHHHHHHHhhHHHHHHHhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHH
Confidence 344444444444445555555554444444444444556889999999999999999999865 5999999999876433
Q ss_pred ---cHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCCCHHHHH---------------HhhhhhhhHhhhh
Q 048280 89 ---GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVL---------------FSLIKDIQILFRK 150 (381)
Q Consensus 89 ---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~ 150 (381)
....++.|-.+|...++|+||++|-.|.+...+||||||++||++..+| .+++.||..+|..
T Consensus 181 ~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~ 260 (550)
T KOG0605|consen 181 KKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL 260 (550)
T ss_pred hhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc
Confidence 3455778999999999999999999999999999999999999997655 6788999999999
Q ss_pred c--cCCccccceEeCCCCCcEEeeeccceecCCC----------------------Ccc-----c---------------
Q 048280 151 K--KTDIKASNILLDDKWIPKIADFGMARLFPED----------------------QTH-----V--------------- 186 (381)
Q Consensus 151 ~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~----------------------~~~-----~--------------- 186 (381)
+ ||||||+|+|||..|++||+|||++.-+... ... .
T Consensus 261 gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~n 340 (550)
T KOG0605|consen 261 GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRN 340 (550)
T ss_pred CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhh
Confidence 9 9999999999999999999999999643210 000 0
Q ss_pred ----ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccc-ccHHHHHHHHhhcCCcccccCCC
Q 048280 187 ----NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDA-QNLLDWAYKLYKKDKSLEIVDPS 261 (381)
Q Consensus 187 ----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 261 (381)
....+|||.|+|||++.+..|+..+|.||||||+||||.|.+||....+... ..+..|...+.
T Consensus 341 rr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~------------ 408 (550)
T KOG0605|consen 341 RRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK------------ 408 (550)
T ss_pred hhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc------------
Confidence 0135699999999999999999999999999999999999999976544332 22333321111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 048280 262 LAASDSGDQIAMCIQIGLLCTQGDPQLRPT---MRRVVV 297 (381)
Q Consensus 262 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~ 297 (381)
-+.......+..+||.+||. ||++|.- ++||-+
T Consensus 409 --fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 409 --FPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred --CCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 11111222567889999998 9999986 555543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=303.79 Aligned_cols=248 Identities=22% Similarity=0.308 Sum_probs=191.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcc--cHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQ--GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
.+|...++||+|.||.||+|+.. +|+.||||+++..... -.....+||+.|+.++|+||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 47888999999999999999854 6999999999765332 13467899999999999999999999999999999999
Q ss_pred cccCCCH----------------HHHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 127 YVINESL----------------DKVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 127 ~~~~g~L----------------~~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
|++ .+| ..++.++++|++|||++. ||||||.|+||+.+|.+||+|||+++.+.........
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~ 160 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH 160 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence 994 355 455688999999999998 9999999999999999999999999988755443332
Q ss_pred ccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCccc-----------
Q 048280 189 RVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLE----------- 256 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 256 (381)
.+-|.+|+|||.+.|. .|+..+||||.|||+.||+.|.+-|.+..+.++...+-........+...+
T Consensus 161 -~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~ 239 (318)
T KOG0659|consen 161 -QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ 239 (318)
T ss_pred -ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence 3578999999999875 699999999999999999999887776655544332211111111111000
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 257 IVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
...+..............++|+..||..||.+|+|+.|++++-
T Consensus 240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 0111111112334445678999999999999999999998643
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=332.43 Aligned_cols=234 Identities=25% Similarity=0.363 Sum_probs=190.1
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC----Cc-ccHHHHHHHHHHHHHhC-CCCcccEEEEEeeCC
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS----SN-QGKKEFENEAKLLARVQ-HRNVVNLLGYCAHGA 119 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 119 (381)
...++|.+.+.||+|+||.|++|+.. ++..||+|++... .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34678999999999999999999754 6899999977653 11 23456778999999998 999999999999999
Q ss_pred eEEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCC-CCcEEeeeccceecCC
Q 048280 120 EKLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDK-WIPKIADFGMARLFPE 181 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~-~~~kL~DFG~~~~~~~ 181 (381)
.+|+|||||.+|+|.+++ .|++.|++|+|+++ ||||||+|||++.+ +.+||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 999999999999997665 79999999999998 99999999999999 999999999999874
Q ss_pred CCcccccccccCccccchhHHhhCC-CC-chhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccC
Q 048280 182 DQTHVNTRVAGTNGYMAPEYVMHGH-LS-VKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVD 259 (381)
Q Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
.......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||... +.......+... ...-
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~------~~~~l~~ki~~~----~~~~ 242 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS------NVPNLYRKIRKG----EFKI 242 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc------cHHHHHHHHhcC----CccC
Confidence 2223345678999999999999977 85 7899999999999999999999652 111111111111 1111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 260 PSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 260 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
|.... ...+..|+.+||..||.+|+|+.+|+.
T Consensus 243 p~~~~------S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 243 PSYLL------SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred CCCcC------CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 11110 456888999999999999999999984
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=334.16 Aligned_cols=221 Identities=28% Similarity=0.436 Sum_probs=184.0
Q ss_pred CCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCCCHH
Q 048280 55 SNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLD 134 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~ 134 (381)
++-||.|+.|.||+|+++ ++.||||+++. .-..+|+.|++|+|||||.|.|+|.....+|||||||..|-|.
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 577999999999999998 79999999852 3345899999999999999999999999999999999999998
Q ss_pred HHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccCcccc
Q 048280 135 KVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYM 197 (381)
Q Consensus 135 ~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~ 197 (381)
.+| .+|+.++.|||.+. |||||.-||||..+..|||+|||.++.+.+. .....++||..||
T Consensus 201 ~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGTVaWM 278 (904)
T KOG4721|consen 201 EVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGTVAWM 278 (904)
T ss_pred HHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhhHhhh
Confidence 776 68999999999888 9999999999999999999999999976443 2334689999999
Q ss_pred chhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHH
Q 048280 198 APEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQI 277 (381)
Q Consensus 198 aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 277 (381)
|||++.+.+.+.|+|||||||||||||||..||..-.. .. -+|. +-...+....+..++.-+.-|
T Consensus 279 APEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds---sA------IIwG------VGsNsL~LpvPstcP~GfklL 343 (904)
T KOG4721|consen 279 APEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS---SA------IIWG------VGSNSLHLPVPSTCPDGFKLL 343 (904)
T ss_pred CHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch---he------eEEe------ccCCcccccCcccCchHHHHH
Confidence 99999999999999999999999999999999842111 00 0011 011122223344556667889
Q ss_pred HHHcccCCCCCCCCHHHHHHHhc
Q 048280 278 GLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 278 i~~cl~~dP~~RPs~~eil~~L~ 300 (381)
+++||+..|..||+|.+|+..|.
T Consensus 344 ~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 344 LKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred HHHHHhcCCCCCccHHHHHHHHh
Confidence 99999999999999999998875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=330.99 Aligned_cols=240 Identities=29% Similarity=0.462 Sum_probs=186.8
Q ss_pred hhcCCCCCCcccccCCeeEEEEEE------CCCcEEEEEEecCCCc-ccHHHHHHHHHHHHHh-CCCCcccEEEEEeeC-
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKL------DDGREIAVKKLSHSSN-QGKKEFENEAKLLARV-QHRNVVNLLGYCAHG- 118 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~- 118 (381)
..++|++.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.+++++ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 356899999999999999999974 2356899999875432 2346789999999999 899999999988764
Q ss_pred CeEEEEEecccCCCHHHHH-------------------------------------------------------------
Q 048280 119 AEKLLIYEYVINESLDKVL------------------------------------------------------------- 137 (381)
Q Consensus 119 ~~~~lv~E~~~~g~L~~~l------------------------------------------------------------- 137 (381)
...++||||+++|+|.+++
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4589999999999997654
Q ss_pred ----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc-cccccccCccccc
Q 048280 138 ----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH-VNTRVAGTNGYMA 198 (381)
Q Consensus 138 ----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~-~~~~~~gt~~y~a 198 (381)
.|++.||.|||+.+ ||||||+|||++.++.+||+|||+++.+...... ......++..|+|
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 38899999999998 9999999999999999999999999865332221 1223346678999
Q ss_pred hhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHH
Q 048280 199 PEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQI 277 (381)
Q Consensus 199 PE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 277 (381)
||++.+..++.++|||||||+||||++ |..||....... .+ ........... ........+.+|
T Consensus 245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~----~~~~~~~~~~~---------~~~~~~~~l~~l 309 (338)
T cd05102 245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EF----CQRLKDGTRMR---------APENATPEIYRI 309 (338)
T ss_pred cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HH----HHHHhcCCCCC---------CCCCCCHHHHHH
Confidence 999999999999999999999999997 999986432211 11 11111111110 111233568899
Q ss_pred HHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 278 GLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 278 i~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
+.+||+.||.+|||+.+|++.|+..
T Consensus 310 i~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 310 MLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=319.82 Aligned_cols=242 Identities=24% Similarity=0.366 Sum_probs=192.4
Q ss_pred HHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc--------------ccHHHHHHHHHHHHHhCCCCcc
Q 048280 45 LVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN--------------QGKKEFENEAKLLARVQHRNVV 109 (381)
Q Consensus 45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~hpnIv 109 (381)
-.+..++|++.+.||+|.||.|-+|+.. +++.||||++.+... ...+.+.+||.||+++.|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 3445679999999999999999999865 699999999965321 1235789999999999999999
Q ss_pred cEEEEEee--CCeEEEEEecccCCCH---------------HHHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEE
Q 048280 110 NLLGYCAH--GAEKLLIYEYVINESL---------------DKVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKI 170 (381)
Q Consensus 110 ~~~~~~~~--~~~~~lv~E~~~~g~L---------------~~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL 170 (381)
+|+.+..+ .+.+|||+|||..|.+ .+++++++.||.|||.++ ||||||+|+||+.+|+|||
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence 99999875 4679999999988776 368899999999999999 9999999999999999999
Q ss_pred eeeccceecCCCC----cccccccccCccccchhHHhhCC----CCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHH
Q 048280 171 ADFGMARLFPEDQ----THVNTRVAGTNGYMAPEYVMHGH----LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLL 242 (381)
Q Consensus 171 ~DFG~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~ 242 (381)
+|||.+..+.... ........||+.|+|||.+.++. .+.+.||||+||+||.|+.|+.||......
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~------ 325 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL------ 325 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH------
Confidence 9999998763321 11122468999999999998743 357899999999999999999998543221
Q ss_pred HHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 243 DWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
.++.. ++...+......++.+.+.+||.++|.+||++|.++.+|.....-
T Consensus 326 ----~l~~K-----Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 326 ----ELFDK-----IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred ----HHHHH-----HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 11111 122222223333566778999999999999999999999876643
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=348.32 Aligned_cols=242 Identities=27% Similarity=0.449 Sum_probs=199.6
Q ss_pred HHHhhcCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCCCcc-cHHHHHHHHHHHHHhCCCCcccEEEEEee
Q 048280 45 LVSATKNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHSSNQ-GKKEFENEAKLLARVQHRNVVNLLGYCAH 117 (381)
Q Consensus 45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 117 (381)
......+....+.||+|.||.||+|+.. +...||||.++..... .+.+|++|++++..|+|||||+++|+|.+
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 3444567778899999999999999743 3567999999876554 67899999999999999999999999999
Q ss_pred CCeEEEEEecccCCCHHHHH-----------------------------HhhhhhhhHhhhhc--cCCccccceEeCCCC
Q 048280 118 GAEKLLIYEYVINESLDKVL-----------------------------FSLIKDIQILFRKK--KTDIKASNILLDDKW 166 (381)
Q Consensus 118 ~~~~~lv~E~~~~g~L~~~l-----------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~ 166 (381)
++..++|+|||..|+|.++| .||+.|+.||-++. ||||-..|+||.++.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 99999999999999999887 58899999998877 999999999999999
Q ss_pred CcEEeeeccceecCCCCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHH
Q 048280 167 IPKIADFGMARLFPEDQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDW 244 (381)
Q Consensus 167 ~~kL~DFG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 244 (381)
.|||+|||+++.+-..... ......-.+.|||||.|..++||++||||||||||||+++ |+.|+......+
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E------- 713 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE------- 713 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------
Confidence 9999999999855333222 2223334679999999999999999999999999999997 778875433322
Q ss_pred HHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 245 AYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
+......+.. -..+..++..+..|+..||+.+|.+||+|.||-..|+..
T Consensus 714 VIe~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 714 VIECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred HHHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 1222222222 344556778899999999999999999999999999764
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=335.22 Aligned_cols=237 Identities=20% Similarity=0.271 Sum_probs=195.2
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEECCC-cEEEEEEecCCCcccHHHHHHHHHHHHHhC-CCCcccEEEE-Eee------
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLDDG-REIAVKKLSHSSNQGKKEFENEAKLLARVQ-HRNVVNLLGY-CAH------ 117 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~-~~~------ 117 (381)
....++++.+.|.+|||+.||+|+...+ ..||+|++...+....+.+.+||.+|++|+ |+|||.+++. ...
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3456788999999999999999998765 999999998888888899999999999996 9999999993 211
Q ss_pred CCeEEEEEecccCCCHHHHH-----------------HhhhhhhhHhhhhc----cCCccccceEeCCCCCcEEeeeccc
Q 048280 118 GAEKLLIYEYVINESLDKVL-----------------FSLIKDIQILFRKK----KTDIKASNILLDDKWIPKIADFGMA 176 (381)
Q Consensus 118 ~~~~~lv~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~----HrDlkp~NIll~~~~~~kL~DFG~~ 176 (381)
.-+++|+||||.+|.|-++| .++++|+.+||... |||||-+||||+.++..||||||.+
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 24678999999999997665 68899999999988 9999999999999999999999999
Q ss_pred eecCCCCccc--------ccccccCccccchhHHh---hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHH
Q 048280 177 RLFPEDQTHV--------NTRVAGTNGYMAPEYVM---HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWA 245 (381)
Q Consensus 177 ~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~ 245 (381)
.......... .-...-|+.|+|||++. +..+++|+|||+|||+||.|+....||+...
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg----------- 262 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG----------- 262 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-----------
Confidence 7432221110 11234689999999874 5678999999999999999999999986332
Q ss_pred HHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 246 YKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
...++...+.-+....+...|.+||..||+.||.+||++-+++..+..+
T Consensus 263 --------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 263 --------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred --------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 2233444444455567888999999999999999999999999887654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=315.07 Aligned_cols=243 Identities=24% Similarity=0.373 Sum_probs=186.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC-----------------CcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCccc
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD-----------------GREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVN 110 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~ 110 (381)
.++|++.+.||+|+||.||+|.+.+ +..||+|.+.... ......+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4579999999999999999997532 3469999987543 333467899999999999999999
Q ss_pred EEEEEeeCCeEEEEEecccCCCHHH----------------------------------HHHhhhhhhhHhhhhc--cCC
Q 048280 111 LLGYCAHGAEKLLIYEYVINESLDK----------------------------------VLFSLIKDIQILFRKK--KTD 154 (381)
Q Consensus 111 ~~~~~~~~~~~~lv~E~~~~g~L~~----------------------------------~l~~~~~~l~~lh~~~--HrD 154 (381)
+++++.+.+..++||||+.+++|.+ ++.|++.+|.|||+.+ |||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d 163 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 9999999999999999999999864 4467899999999999 999
Q ss_pred ccccceEeCCCCCcEEeeeccceecCCCCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhC--CCCCC
Q 048280 155 IKASNILLDDKWIPKIADFGMARLFPEDQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISG--QRNSS 231 (381)
Q Consensus 155 lkp~NIll~~~~~~kL~DFG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg--~~p~~ 231 (381)
|||+|||++.++.+||+|||+++.+...... ......++..|+|||++.++.++.++|||||||++|||+++ ..||.
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 243 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence 9999999999999999999999865433221 12234457889999999988999999999999999999975 44553
Q ss_pred CCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 232 FNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
... .................... . .....++..+.+|+.+||+.||.+|||+.+|.+.|+
T Consensus 244 ~~~---~~~~~~~~~~~~~~~~~~~~--~----~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 244 ELT---DEQVIENAGEFFRDQGRQVY--L----FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred cCC---HHHHHHHHHHHhhhcccccc--c----cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 221 12222222222211111000 0 011123356889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=317.70 Aligned_cols=232 Identities=20% Similarity=0.358 Sum_probs=195.3
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCe-EEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAE-KLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~lv~ 125 (381)
++|..++++|+|+||.+++++.+ ++..|++|++.... ...++...+|+.+++++.|||||.+.+.|..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57999999999999999999865 57899999997553 3344578899999999999999999999998888 99999
Q ss_pred ecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 126 EYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 126 E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
+||+||+|.+.| .|++.++.|||+.. |||||+.|||++.++.|||+|||+++.+..... .
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~-~ 162 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS-L 162 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh-h
Confidence 999999998665 68999999999777 999999999999999999999999998866542 3
Q ss_pred ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
...+.||+.|++||++.+.+|+.|+|||||||++|||++-+++|... +....+...... ...+.
T Consensus 163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~------~m~~Li~ki~~~----------~~~Pl 226 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS------NMSELILKINRG----------LYSPL 226 (426)
T ss_pred hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc------chHHHHHHHhhc----------cCCCC
Confidence 44578999999999999999999999999999999999999998532 222222222221 12334
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
+..+...+..|+..||+.+|+.||++.+++..
T Consensus 227 p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 227 PSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 44556778899999999999999999999865
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=313.98 Aligned_cols=228 Identities=20% Similarity=0.306 Sum_probs=182.3
Q ss_pred CCcccccCCeeEEEEEECCCcEEEEEEecCCCccc---HHHHHHHHHHHHHhCCCCcccEEEEEee----CCeEEEEEec
Q 048280 55 SNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQG---KKEFENEAKLLARVQHRNVVNLLGYCAH----GAEKLLIYEY 127 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~E~ 127 (381)
...||+|++|.||+|... |+.||||.+....... .+.+.+|+.+|++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 468999999999999984 8999999997654333 4677899999999999999999999877 4578999999
Q ss_pred ccCCCHHHHH---------------HhhhhhhhHhhhh-c--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 128 VINESLDKVL---------------FSLIKDIQILFRK-K--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 128 ~~~g~L~~~l---------------~~~~~~l~~lh~~-~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
+.+|+|.+++ .+++.++.++|.. + ||||||+|||+++++.+||+|||+++.+.... ..
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----~~ 179 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----FK 179 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----cc
Confidence 9999998776 5789999999975 4 99999999999999999999999998654322 12
Q ss_pred cccCccccchhHHhh--CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 190 VAGTNGYMAPEYVMH--GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
..|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... ..+. ......... +. .+
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---~~~~---~~i~~~~~~-----~~----~~ 244 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---KEIY---DLIINKNNS-----LK----LP 244 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---HHHH---HHHHhcCCC-----CC----CC
Confidence 457899999999976 6899999999999999999999999864321 1111 111111111 11 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
...+..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 245 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 245 LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 12345688999999999999999999999998753
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=300.73 Aligned_cols=243 Identities=24% Similarity=0.324 Sum_probs=187.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCccc--HHHHHHHHHHHHHhCCCCcccEEEEEee--CCeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQG--KKEFENEAKLLARVQHRNVVNLLGYCAH--GAEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~l 123 (381)
.++|+.++.|++|.||.||+|+++ +++.||+|+++...... --.-++||.+|.+++|||||.+-.+... -+.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 357999999999999999999876 58999999997653221 1245789999999999999999888754 357999
Q ss_pred EEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 124 IYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 124 v~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
|||||+ .+|..+| .|+++|++|||... |||||++|+|+++.|.+||+|||+|+.+.....
T Consensus 155 VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k- 232 (419)
T KOG0663|consen 155 VMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK- 232 (419)
T ss_pred eHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcc-
Confidence 999994 4665554 79999999999998 999999999999999999999999998876533
Q ss_pred cccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC--
Q 048280 186 VNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL-- 262 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 262 (381)
..+..+-|.+|+|||++.+. .|++..|+||+|||+.||+++++-|....+.++.+.+ ...... ..+.+-|.+
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~I---f~llGt--Pte~iwpg~~~ 307 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKI---FKLLGT--PSEAIWPGYSE 307 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHH---HHHhCC--CccccCCCccc
Confidence 34456679999999999886 5999999999999999999999988776665543322 221111 111111111
Q ss_pred -----------------CCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 263 -----------------AASDSGD-QIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 263 -----------------~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
....... ....-.+|+..+|..||.+|.|+.|.|+.
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0000000 33556789999999999999999999764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=298.16 Aligned_cols=220 Identities=25% Similarity=0.330 Sum_probs=182.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc---ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|++++.||.|+||.|.+++.+ +|..+|+|++.+... ...+...+|..+|+.+.||+++++++.|.+.+.+|||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 467999999999999999999976 588999999976532 2335677899999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|||++||.|..++ .+++.||+|||+.. +|||||+|||||.+|.+||+|||+++.+... .
T Consensus 123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----T 198 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----T 198 (355)
T ss_pred EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc----E
Confidence 9999999999887 57999999999999 9999999999999999999999999987443 3
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
.+.|||+.|+|||+++...|+.++|-|||||++|||+.|.+||...... . .+..+-. .++..|..
T Consensus 199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~------~-iY~KI~~---~~v~fP~~----- 263 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI------Q-IYEKILE---GKVKFPSY----- 263 (355)
T ss_pred EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH------H-HHHHHHh---CcccCCcc-----
Confidence 4579999999999999999999999999999999999999999644331 1 1111111 11222222
Q ss_pred HHHHHHHHHHHHHcccCCCCCC
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLR 289 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~R 289 (381)
....+.+|+...|+.|-.+|
T Consensus 264 --fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 264 --FSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --cCHHHHHHHHHHHhhhhHhh
Confidence 23446778888888888888
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=315.20 Aligned_cols=248 Identities=23% Similarity=0.326 Sum_probs=188.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
++|++.+.||+|+||.||+|+.+ +++.||||++.... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999876 58899999986542 2334678899999999999999999999999999999999
Q ss_pred cccCCCHHH---------------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 127 YVINESLDK---------------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 127 ~~~~g~L~~---------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
|+.++.+.. ++.|++.+|.|||..+ ||||||+|||++.++.+||+|||++..+..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccc
Confidence 998876643 3478999999999998 99999999999999999999999998764433222334
Q ss_pred cccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHH---------HHHhhcCCcccccCC
Q 048280 190 VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWA---------YKLYKKDKSLEIVDP 260 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~ 260 (381)
..|+..|+|||++.+..++.++|||||||++|||++|+.||......+........ ..............+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07848 161 YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFP 240 (287)
T ss_pred cccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccC
Confidence 56899999999999989999999999999999999999998654322211100000 000000000000001
Q ss_pred CCCCC------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 261 SLAAS------DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 261 ~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
..... ........+.+|+.+||+.||++|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 241 AVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11000 01123456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=305.38 Aligned_cols=251 Identities=22% Similarity=0.349 Sum_probs=191.0
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecC--CCcccHHHHHHHHHHHHHhCCCCcccEEEEEee-----C
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSH--SSNQGKKEFENEAKLLARVQHRNVVNLLGYCAH-----G 118 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~ 118 (381)
.....|...+.||.|+||.|+.+..+ +|..||||++.. ......++..+|+++|+.++|+||+.+++++.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34567777899999999999999865 689999999973 345556788899999999999999999998854 4
Q ss_pred CeEEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCC
Q 048280 119 AEKLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPE 181 (381)
Q Consensus 119 ~~~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~ 181 (381)
+.+|+|+|+| +.+|.++| +|++.||.|+|+.+ ||||||.|+|++.+..+||||||+|+....
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 6789999999 66776554 89999999999999 999999999999999999999999998754
Q ss_pred C-CcccccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH--------Hhhc
Q 048280 182 D-QTHVNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYK--------LYKK 251 (381)
Q Consensus 182 ~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~ 251 (381)
. .....+..+.|.+|+|||++.. ..|+...||||.|||+.||++|++-|.+....++..++..... ....
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 3 1222356778999999998865 5799999999999999999999999887655544333321110 0000
Q ss_pred CCccccc--CCCCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 252 DKSLEIV--DPSLAA----SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 252 ~~~~~~~--~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
......+ .|.... ..........++|+.+||..||.+|+|++|.++.
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000000 000000 0111223457889999999999999999999874
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=325.81 Aligned_cols=227 Identities=25% Similarity=0.398 Sum_probs=190.3
Q ss_pred cccccCCeeEEEEEECC-CcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCCCHHH
Q 048280 57 KLGEGGFGPVFKGKLDD-GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDK 135 (381)
Q Consensus 57 ~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~~ 135 (381)
+||+|.||+||.|++.+ ...+|||.+...+....+-+..||.+.++|+|.|||+++|.+.+++.+-|.||.++||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999764 67899999977766667889999999999999999999999999999999999999999998
Q ss_pred HH------------------HhhhhhhhHhhhhc--cCCccccceEeC-CCCCcEEeeeccceecCCCCcccccccccCc
Q 048280 136 VL------------------FSLIKDIQILFRKK--KTDIKASNILLD-DKWIPKIADFGMARLFPEDQTHVNTRVAGTN 194 (381)
Q Consensus 136 ~l------------------~~~~~~l~~lh~~~--HrDlkp~NIll~-~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~ 194 (381)
+| +||++||.|||.+. |||||-+||||+ -.|.+||+|||.++.+..- .....++.||.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETFTGTL 740 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETFTGTL 740 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC-Cccccccccch
Confidence 88 79999999999998 999999999996 5789999999999987433 33345688999
Q ss_pred cccchhHHhhC--CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHH
Q 048280 195 GYMAPEYVMHG--HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIA 272 (381)
Q Consensus 195 ~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (381)
.|||||++..+ .|+.++|||||||++.||.||++||..-..... ..++-+ . -..-++.+.+..+
T Consensus 741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVG--m----yKvHP~iPeelsa 806 (1226)
T KOG4279|consen 741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVG--M----YKVHPPIPEELSA 806 (1226)
T ss_pred hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhc--c----eecCCCCcHHHHH
Confidence 99999999876 589999999999999999999999853221111 011100 0 1112345677888
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 273 MCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 273 ~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.+..+|.+|+..||.+||++.+++..
T Consensus 807 eak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 807 EAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHcCCCcccCccHHHhccC
Confidence 99999999999999999999999864
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=318.32 Aligned_cols=245 Identities=22% Similarity=0.299 Sum_probs=188.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
.++|++.+.||+|+||.||+++.. ++..||+|.+.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999876 58889999987542 2334679999999999999999999999999999999999
Q ss_pred cccCCCHHHHH---------------HhhhhhhhHhhhhc---cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 127 YVINESLDKVL---------------FSLIKDIQILFRKK---KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 127 ~~~~g~L~~~l---------------~~~~~~l~~lh~~~---HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
|+++++|.+++ .+++.++.|+|+.+ ||||||+|||++.++.+||+|||++..+.... ..
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~ 160 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---AN 160 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---cc
Confidence 99999998765 57899999999853 99999999999999999999999998653322 22
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh-hc--CCcc----------
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLY-KK--DKSL---------- 255 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~--~~~~---------- 255 (381)
...|+..|+|||++.+..++.++|||||||++|||++|+.||......+ +........ .. ....
T Consensus 161 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (331)
T cd06649 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPRPRPPG 237 (331)
T ss_pred cCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCccccccc
Confidence 3568999999999999999999999999999999999999985432211 110000000 00 0000
Q ss_pred --------------------c-ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 256 --------------------E-IVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 256 --------------------~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
. +................+.+|+.+||+.||++|||+.+|++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0 0000000000112345688999999999999999999998754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=294.01 Aligned_cols=244 Identities=25% Similarity=0.323 Sum_probs=195.7
Q ss_pred HHHhhcCCCCCCcccccCCeeEEEEE-ECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeC-----
Q 048280 45 LVSATKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHG----- 118 (381)
Q Consensus 45 ~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----- 118 (381)
+.+..++|++.+.||+|||+.||+++ ..++..||+|++......+.+..++|++..++++|||+++++++...+
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 33456899999999999999999998 556899999999888878888999999999999999999999876443
Q ss_pred CeEEEEEecccCCCHHHHH-------------------HhhhhhhhHhhhhc----cCCccccceEeCCCCCcEEeeecc
Q 048280 119 AEKLLIYEYVINESLDKVL-------------------FSLIKDIQILFRKK----KTDIKASNILLDDKWIPKIADFGM 175 (381)
Q Consensus 119 ~~~~lv~E~~~~g~L~~~l-------------------~~~~~~l~~lh~~~----HrDlkp~NIll~~~~~~kL~DFG~ 175 (381)
...||+++|...|+|.+.+ .++++||+++|... ||||||.|||+.+.+.++|.|||.
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccC
Confidence 3589999999999997665 67899999999988 999999999999999999999999
Q ss_pred ceecCCCCcc--------cccccccCccccchhHHh---hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 048280 176 ARLFPEDQTH--------VNTRVAGTNGYMAPEYVM---HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDW 244 (381)
Q Consensus 176 ~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~ 244 (381)
+....-.... .......|..|+|||++. +...+.++|||||||+||+|+.|..||+....
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--------- 246 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--------- 246 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---------
Confidence 9754321111 111344789999999875 44678999999999999999999999853221
Q ss_pred HHHHhhcCC-cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 245 AYKLYKKDK-SLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 245 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
..+. ...+..+.+.-+.....++.+.+|+..||+.||.+||++.+++..+...
T Consensus 247 -----~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 247 -----QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -----cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1111 1122223333333334778899999999999999999999999988653
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=324.78 Aligned_cols=249 Identities=23% Similarity=0.376 Sum_probs=196.0
Q ss_pred CChHHHHHhhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEee
Q 048280 40 FPFEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAH 117 (381)
Q Consensus 40 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 117 (381)
.+.++..+..+...+...||+|.||+||+|++. -.||||++.... ....+.|++|+.++++-+|.||+-++|||..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 344677777788899999999999999999986 359999997653 3456789999999999999999999999998
Q ss_pred CCeEEEEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceec
Q 048280 118 GAEKLLIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLF 179 (381)
Q Consensus 118 ~~~~~lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~ 179 (381)
... .||+.+|+|.+|..+| .|++.|+.|||.++ |||||..||||.+++.|||+|||++..-
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred Cce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeee
Confidence 877 9999999999997655 78999999999999 9999999999999999999999999743
Q ss_pred CCC-CcccccccccCccccchhHHhh---CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcc
Q 048280 180 PED-QTHVNTRVAGTNGYMAPEYVMH---GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSL 255 (381)
Q Consensus 180 ~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (381)
..- .........|...|||||+++. .+|+..+||||||||+|||++|..||.... .+. -++..+...
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-~dq--------IifmVGrG~ 609 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-RDQ--------IIFMVGRGY 609 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-hhh--------eEEEecccc
Confidence 211 1111224557889999999974 368999999999999999999999986221 111 011111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 256 EIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
...|. .....++...+.+|+..||..++++||.+.+|+..|+.+.
T Consensus 610 l~pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 610 LMPDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred cCccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 11111 1223455677889999999999999999999999887654
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=321.87 Aligned_cols=236 Identities=21% Similarity=0.299 Sum_probs=188.6
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++..++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999876 48999999986542 223456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
||+++++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++..... ...
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~~ 156 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YAN 156 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----ccC
Confidence 999999998765 68999999999998 999999999999999999999999986533 223
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
...||+.|+|||++.+..++.++|||||||++|||++|..||......+ ... .......... .+.. .....
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~---~i~~~~~~~~--~~~~-~~~~~ 227 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---TWE---NLKYWKETLQ--RPVY-DDPRF 227 (333)
T ss_pred CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH---HHH---HHHhcccccc--CCCC-Ccccc
Confidence 4578999999999999999999999999999999999999986432211 111 1111000000 0111 00012
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.....+.+|+.+||..+|.+||++.++++.
T Consensus 228 ~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 228 NLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 334568899999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=324.63 Aligned_cols=232 Identities=25% Similarity=0.290 Sum_probs=191.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.+-|++.+.||.|+-|.|-+|++. +|+.+|||++.+.. ......+.+||.+|+.+.||||+++|+++++..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 356889999999999999999854 79999999997652 22345689999999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
.||+++|.|.+++ .|++.|+.|+|+.+ ||||||+|+|||..+.+||+|||+|..-..+. .-
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk--lL 168 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK--LL 168 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc--cc
Confidence 9999999998766 79999999999998 99999999999999999999999998754333 33
Q ss_pred cccccCccccchhHHhhCCC-CchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHL-SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
.+.||++.|.|||++.|.+| +.++||||+|||||.||+|+.||+. +++.....+...... ..
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD------dNir~LLlKV~~G~f-----------~M 231 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD------DNIRVLLLKVQRGVF-----------EM 231 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC------ccHHHHHHHHHcCcc-----------cC
Confidence 45789999999999999998 5789999999999999999999862 222222112111110 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
+...+.++.+|+.+||..||+.|.|++||++..
T Consensus 232 Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 232 PSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred CCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 223445688899999999999999999999754
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=320.05 Aligned_cols=229 Identities=24% Similarity=0.304 Sum_probs=185.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 357999999999999999999876 58999999986532 23346788999999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|||+.+++|.+++ .|++.+|.|||+.+ ||||||+||||+.++.+||+|||+++......
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---- 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT---- 172 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc----
Confidence 9999999997655 68899999999999 99999999999999999999999998764332
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....... .... ..+
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~-~~~~---~~p------- 235 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIYEKIL-AGRL---KFP------- 235 (329)
T ss_pred ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHHHHHh-cCCc---CCC-------
Confidence 2356899999999999999999999999999999999999998543211 1111111 1110 001
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPT-----MRRVVVM 298 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~ 298 (381)
......+.+|+.+||+.||.+||+ +.+|+..
T Consensus 236 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 236 NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 112345788999999999999997 6777644
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=311.23 Aligned_cols=231 Identities=19% Similarity=0.351 Sum_probs=192.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEE-CCCcEEEEEEecCCCcc---cHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKL-DDGREIAVKKLSHSSNQ---GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
..+|++.+.||+|.||.|-+|.. ..|+.||||.+++.... +.-.+.+||+||..|+||||+.+|.+|++.+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45799999999999999999975 67999999999876443 344678999999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|||..+|.|.+++ +||..++.|+|.++ |||||.+|||||.|+.+||+|||++.++..... .
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf--L 209 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF--L 209 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccH--H
Confidence 9999999998877 79999999999998 999999999999999999999999998755443 3
Q ss_pred cccccCccccchhHHhhCCC-CchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHL-SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
.+++|++.|.+||++.+.+| ++.+|.|||||+||.|+.|..||+... ...++ .++. .+ ....|....
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---hk~lv---rQIs-~G---aYrEP~~PS-- 277 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---HKRLV---RQIS-RG---AYREPETPS-- 277 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch---HHHHH---HHhh-cc---cccCCCCCc--
Confidence 56899999999999999988 578999999999999999999986432 22222 2221 11 122222221
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
...-||.+||..||++|.|+.+|...-
T Consensus 278 ------dA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 278 ------DASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ------hHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 244689999999999999999998654
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=320.22 Aligned_cols=236 Identities=25% Similarity=0.349 Sum_probs=184.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
.++|+..+.||+|+||.||+|+.. +++.||||++.... ......+.+|+++++.++|+||+++++++...+..++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 346778899999999999999865 58999999986543 2334678899999999999999999999999999999999
Q ss_pred cccCCCHH-----------HHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccC
Q 048280 127 YVINESLD-----------KVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT 193 (381)
Q Consensus 127 ~~~~g~L~-----------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt 193 (381)
|+.+++|. .++.|++.+|.|||..+ ||||||+|||++.++.+||+|||+++.+..... ......||
T Consensus 153 ~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~~gt 231 (353)
T PLN00034 153 FMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNSSVGT 231 (353)
T ss_pred cCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-cccccccC
Confidence 99999884 45689999999999998 999999999999999999999999987643321 12345689
Q ss_pred ccccchhHHhh-----CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 194 NGYMAPEYVMH-----GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 194 ~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
..|+|||++.. ...+.++|||||||++|||++|+.||......+ ............ . .....
T Consensus 232 ~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~------~----~~~~~ 298 (353)
T PLN00034 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAICMSQ------P----PEAPA 298 (353)
T ss_pred ccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHhccC------C----CCCCC
Confidence 99999998743 234568999999999999999999986322211 111111110000 0 11112
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.....+.+||.+||+.||++|||+.||++.
T Consensus 299 ~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 299 TASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 334568899999999999999999999875
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=315.49 Aligned_cols=228 Identities=21% Similarity=0.250 Sum_probs=184.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999876 58999999986432 123456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
||+++++|.+++ .|++.+|+|+|+.+ ||||||+|||++.++.+||+|||+++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~----~ 156 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT----W 156 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc----c
Confidence 999999997665 68999999999999 99999999999999999999999998654321 2
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ... ....... ..+ +.
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~---~~i~~~~-------~~~----~~ 219 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---GIY---EKILAGK-------LEF----PR 219 (291)
T ss_pred cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHHhCC-------cCC----Cc
Confidence 356899999999999989999999999999999999999998643211 111 1111111 001 11
Q ss_pred HHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPT-----MRRVVVM 298 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~ 298 (381)
.....+.+|+.+||+.||.+||+ +.++++.
T Consensus 220 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 220 HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 12345788999999999999995 8887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=289.42 Aligned_cols=231 Identities=26% Similarity=0.337 Sum_probs=192.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|++.+.||+|.||.||+|+.+ ++..||+|++.+.. .....++.+|++|...|+||||+++|++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 567999999999999999999865 57889999986542 23346789999999999999999999999999999999
Q ss_pred EecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 125 YEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 125 ~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
+||...|.|.+.| .|++.|+.|+|..+ ||||||+|+|++..+.+||+|||.+.... ..
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~~ 177 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SN 177 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC---CC
Confidence 9999999996544 79999999999998 99999999999999999999999998643 23
Q ss_pred cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCC
Q 048280 186 VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
...+.+||..|.+||...+..++..+|+|++|++.||++.|.+||...... ..+..-...++.+|.
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~----------etYkrI~k~~~~~p~---- 243 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS----------ETYKRIRKVDLKFPS---- 243 (281)
T ss_pred CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH----------HHHHHHHHccccCCc----
Confidence 345689999999999999999999999999999999999999998643311 111111122233332
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 266 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
.....+.++|.+|+..+|.+|.+..|++..-
T Consensus 244 ---~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 244 ---TISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred ---ccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 2234577899999999999999999998753
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=311.60 Aligned_cols=232 Identities=28% Similarity=0.351 Sum_probs=184.3
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
.|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++.+++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 4788899999999999999864 68999999986542 2223467889999999999999999999999999999999
Q ss_pred cccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 127 YVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 127 ~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|+++|+|..++ .|++.+|.|||+.+ ||||||+|||+++++.+||+|||++........ .
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~ 158 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--V 158 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe--e
Confidence 99999996543 58899999999998 999999999999999999999999987543221 2
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
....||..|+|||++.+..++.++|||||||++|+|++|+.||......... ........... ....
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~----------~~~~ 225 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKEDQ----------EEYS 225 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhccc----------ccCC
Confidence 3456899999999999999999999999999999999999998654322111 11111111000 0111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPT-----MRRVVV 297 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 297 (381)
......+.+|+.+||+.||.+||+ ++++++
T Consensus 226 ~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 226 EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 223456788999999999999997 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=326.53 Aligned_cols=238 Identities=30% Similarity=0.469 Sum_probs=186.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEE------CCCcEEEEEEecCCC-cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKL------DDGREIAVKKLSHSS-NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAE 120 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 120 (381)
.++|++.+.||+|+||.||+|.. .++..||||+++... ....+.+.+|+.++..+ +||||++++++|..++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45799999999999999999963 236689999986542 23346788999999999 89999999999999999
Q ss_pred EEEEEecccCCCHHHHH---------------------------------------------------------------
Q 048280 121 KLLIYEYVINESLDKVL--------------------------------------------------------------- 137 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l--------------------------------------------------------------- 137 (381)
.++||||+++|+|.+++
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999999999986554
Q ss_pred ---------------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc-cc
Q 048280 138 ---------------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH-VN 187 (381)
Q Consensus 138 ---------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~-~~ 187 (381)
.|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++........ ..
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 273 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence 48899999999998 9999999999999999999999999866433221 11
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
....++..|+|||++.+..++.++|||||||++|||++ |..||...... ..+. ......... ..+
T Consensus 274 ~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~----~~~~~~~~~--~~~------ 339 (375)
T cd05104 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFY----KMIKEGYRM--LSP------ 339 (375)
T ss_pred CCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHH----HHHHhCccC--CCC------
Confidence 22345667999999999999999999999999999998 78787532211 1111 111111110 011
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
...+..+.+|+.+||+.||++|||+.+|++.|++
T Consensus 340 -~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 340 -ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred -CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1123468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=319.38 Aligned_cols=242 Identities=18% Similarity=0.168 Sum_probs=182.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
..+|.+.+.||+|+||.||++... +++.||+|... ...+.+|++++++++||||+++++++......++|||+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999865 58999999753 24578899999999999999999999999999999999
Q ss_pred ccCCCHHHH---------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccc
Q 048280 128 VINESLDKV---------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV 190 (381)
Q Consensus 128 ~~~g~L~~~---------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 190 (381)
+. ++|..+ +.|++.+|.|+|+.+ ||||||+|||++.++.+||+|||+++.............
T Consensus 165 ~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 243 (391)
T PHA03212 165 YK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243 (391)
T ss_pred CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccc
Confidence 84 566543 378999999999998 999999999999999999999999975433222223346
Q ss_pred ccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccc----cHHHHHHHHhhcCC-------------
Q 048280 191 AGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQ----NLLDWAYKLYKKDK------------- 253 (381)
Q Consensus 191 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~----~~~~~~~~~~~~~~------------- 253 (381)
.||+.|+|||++.+..++.++|||||||++|||++|..||......+.. ..+...........
T Consensus 244 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~ 323 (391)
T PHA03212 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDE 323 (391)
T ss_pred cCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHH
Confidence 7999999999999999999999999999999999999887543221110 11111100000000
Q ss_pred ------cccccCCCCCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 254 ------SLEIVDPSLAAS--DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 254 ------~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
......+..... .....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 324 IYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000100000 01123457889999999999999999999985
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=307.06 Aligned_cols=237 Identities=24% Similarity=0.352 Sum_probs=187.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC----CCcEEEEEEecCCCc-ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD----DGREIAVKKLSHSSN-QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
.++|++.+.||+|+||.||+|.++ .+..||+|.+..... .....+.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457999999999999999999753 366899999876532 234578899999999999999999999999999999
Q ss_pred EEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 124 IYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 124 v~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
||||+++++|.+++ .|++.++.|+|..+ ||||||+|||++.++.+||+|||.+.........
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY 163 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchh
Confidence 99999999998665 67899999999998 9999999999999999999999987654222211
Q ss_pred cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 186 VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
......++..|+|||.+.+..++.++|||||||++|||++ |..||...... .+.. ....... .
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~----~~~~~~~---------~ 227 (266)
T cd05064 164 TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIK----AVEDGFR---------L 227 (266)
T ss_pred cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHH----HHHCCCC---------C
Confidence 1112335678999999999999999999999999999775 99998543221 1111 1111110 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
......+..+.+++.+||+.+|.+||++.+|++.|.+
T Consensus 228 ~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 228 PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 1122344568889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=310.26 Aligned_cols=244 Identities=21% Similarity=0.313 Sum_probs=183.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
.++|++.+.||.|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 357999999999999999999865 58999999986543 2234567899999999999999999999999999999999
Q ss_pred cccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 127 YVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 127 ~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
|+.+ +|.+++ .|++.+|+|||+.+ ||||||+|||++.++.+||+|||+++....... ...
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~~~ 161 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TYS 161 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-ccc
Confidence 9964 775543 68999999999999 999999999999999999999999986533221 122
Q ss_pred ccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc------------CCcc
Q 048280 189 RVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKK------------DKSL 255 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~ 255 (381)
...+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......+. .......... ....
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE---LHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHHhhccccchhhh
Confidence 3467899999999876 4689999999999999999999999864332211 1111111100 0000
Q ss_pred cccCCCCCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 256 EIVDPSLAAS----DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 256 ~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
....+..... ........+.+|+.+||+.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0111111000 00112355789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=305.10 Aligned_cols=236 Identities=25% Similarity=0.434 Sum_probs=190.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
.++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 45799999999999999999998888899999986543 23578899999999999999999999999999999999999
Q ss_pred cCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 129 INESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 129 ~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
++++|.+++ .+++.++.|||..+ ||||||+||+++.++.+||+|||++.............
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG 163 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCC
Confidence 999997655 57899999999988 99999999999999999999999998765433222223
Q ss_pred cccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 190 VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
..++..|+|||++.+..++.++|||||||++|+|++ |..||...... ..... ....... + ...
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~----~~~~~~~----~-----~~~ 227 (261)
T cd05072 164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSA----LQRGYRM----P-----RME 227 (261)
T ss_pred CccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHH----HHcCCCC----C-----CCC
Confidence 345678999999998889999999999999999998 88888542211 11111 1111100 1 111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
..+..+.+++.+||..+|++||+++++++.|+.
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 228 NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 233568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=325.17 Aligned_cols=239 Identities=30% Similarity=0.491 Sum_probs=186.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCCC-cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHSS-NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAE 120 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 120 (381)
.++|++.+.||+|+||.||+|+.. ++..||||++.... ......+.+|+.+++.+ +|+||++++++|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457999999999999999998742 24579999997543 23346788999999999 89999999999999999
Q ss_pred EEEEEecccCCCHHHHH---------------------------------------------------------------
Q 048280 121 KLLIYEYVINESLDKVL--------------------------------------------------------------- 137 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l--------------------------------------------------------------- 137 (381)
.++||||+++|+|.+++
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999999987543
Q ss_pred ----------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc-ccccccc
Q 048280 138 ----------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH-VNTRVAG 192 (381)
Q Consensus 138 ----------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~-~~~~~~g 192 (381)
.|++.+|.|||+.+ ||||||+|||+++++.+||+|||+++.+...... ......+
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~ 276 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCC
Confidence 57889999999998 9999999999999999999999999865433221 1122335
Q ss_pred CccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHH
Q 048280 193 TNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271 (381)
Q Consensus 193 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (381)
+..|+|||++.+..++.++|||||||++|||++ |+.||....... .. ........ ....+ ...+
T Consensus 277 ~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~----~~~~~~~~--~~~~~-------~~~~ 341 (374)
T cd05106 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KF----YKMVKRGY--QMSRP-------DFAP 341 (374)
T ss_pred ccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HH----HHHHHccc--CccCC-------CCCC
Confidence 668999999998899999999999999999997 999985432111 11 11111110 00011 1123
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 272 AMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 272 ~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
..+.+++.+||+.||.+|||+.+|++.|++.
T Consensus 342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 342 PEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 5688899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=314.85 Aligned_cols=235 Identities=26% Similarity=0.341 Sum_probs=183.6
Q ss_pred CCCCCCcccccCCeeEEEEEE----CCCcEEEEEEecCCC----cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKL----DDGREIAVKKLSHSS----NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEK 121 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 121 (381)
+|++.+.||+|+||.||+++. .+++.||+|++.... ....+.+.+|+.++.++ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588999999999999999975 258899999986431 22335678899999999 599999999999999999
Q ss_pred EEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 122 LLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
++||||+.+|+|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 9999999999997655 58999999999998 999999999999999999999999986543333
Q ss_pred ccccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC
Q 048280 185 HVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... ........ .++.+.
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~-------~~~~~~ 231 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRILK-------CDPPFP 231 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHhc-------CCCCCC
Confidence 333346799999999999865 47899999999999999999999986433222111 11111111 111111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 048280 264 ASDSGDQIAMCIQIGLLCTQGDPQLRP-----TMRRVVVM 298 (381)
Q Consensus 264 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 298 (381)
. .....+.+++.+||+.||++|| +++++++.
T Consensus 232 ~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 232 S----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred C----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1 2234578899999999999999 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=303.49 Aligned_cols=234 Identities=23% Similarity=0.409 Sum_probs=187.0
Q ss_pred cCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEeccc
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVI 129 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 129 (381)
++|++.+.||+|+||.||++..+++..+|+|.+.... .....+.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4688899999999999999998888889999886443 335678999999999999999999999999999999999999
Q ss_pred CCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccc
Q 048280 130 NESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVA 191 (381)
Q Consensus 130 ~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~ 191 (381)
+|+|.+++ .+++.+|.|+|..+ |+||||+||+++.++.+||+|||++...............
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~ 162 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAK 162 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCC
Confidence 99997655 57889999999999 9999999999999999999999999865433322222334
Q ss_pred cCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHH
Q 048280 192 GTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQ 270 (381)
Q Consensus 192 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (381)
++..|+|||++.+..++.++|||||||++|+|++ |+.||..... ..... .... ... ...+. ..
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~---~i~~-~~~--~~~~~-------~~ 226 (256)
T cd05114 163 FPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVE---MISR-GFR--LYRPK-------LA 226 (256)
T ss_pred CchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHH---HHHC-CCC--CCCCC-------CC
Confidence 5678999999988889999999999999999999 8888753321 11111 1111 110 11111 12
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 271 IAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 271 ~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
...+.+++.+||+.+|.+||++.+|++.|.
T Consensus 227 ~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 227 SMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 345789999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=314.24 Aligned_cols=182 Identities=28% Similarity=0.419 Sum_probs=158.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
.++|++.+.||+|+||.||++... ++..+|+|.+... .......+.+|++++++++|+||++++++|.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999876 5888999988654 22334678999999999999999999999999999999999
Q ss_pred cccCCCHHHHH---------------HhhhhhhhHhhhh-c--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 127 YVINESLDKVL---------------FSLIKDIQILFRK-K--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 127 ~~~~g~L~~~l---------------~~~~~~l~~lh~~-~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
|+.+++|.+++ .+++.++.|+|.. + |+||||+|||++.++.+||+|||++..+... ...
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---~~~ 160 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MAN 160 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---ccc
Confidence 99999998765 5789999999975 3 9999999999999999999999998755322 122
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCC
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFN 233 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 233 (381)
...|+..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred cCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 356899999999999888999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=339.41 Aligned_cols=239 Identities=30% Similarity=0.471 Sum_probs=192.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC--Cc----EEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD--GR----EIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEK 121 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 121 (381)
.++.+....||+|.||.||.|...+ +. .||||.+... +.....+|.+|..+|+.++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4456778899999999999998653 33 4899999765 455567899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHH----------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccce
Q 048280 122 LLIYEYVINESLDKVL----------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMAR 177 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l----------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~ 177 (381)
+|++|||.+|+|..+| .++++|..||+++. ||||...|+||+....|||+|||+|+
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhH
Confidence 9999999999999887 67899999999999 99999999999999999999999999
Q ss_pred ecCCCCccccccc-ccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcc
Q 048280 178 LFPEDQTHVNTRV-AGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSL 255 (381)
Q Consensus 178 ~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (381)
.+........... .-...|||||.+..+.++.|+|||||||+|||+++ |..||......+.. .......
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~------~~~~~gg--- 921 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL------LDVLEGG--- 921 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH------HHHHhCC---
Confidence 4433332222222 23468999999999999999999999999999998 66777543332211 1111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 256 EIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
+.+.+..++..+.+||.+||+.+|++||++..|++.+..+.
T Consensus 922 -------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 922 -------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred -------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 22334455677889999999999999999999999887653
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=316.16 Aligned_cols=225 Identities=20% Similarity=0.263 Sum_probs=179.8
Q ss_pred CcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCC
Q 048280 56 NKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINE 131 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g 131 (381)
+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++++++||||+++++++...+..++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 68999999987542 223356788999999999999999999999999999999999999
Q ss_pred CHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccCc
Q 048280 132 SLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN 194 (381)
Q Consensus 132 ~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~ 194 (381)
+|.+++ .|++.+|.|||+.+ ||||||+||||+.++.+||+|||+++...... .......||+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~ 159 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTP 159 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-CcccceecCc
Confidence 997654 68999999999999 99999999999999999999999987532221 1223457999
Q ss_pred cccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHH
Q 048280 195 GYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMC 274 (381)
Q Consensus 195 ~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 274 (381)
.|+|||++.+..++.++|||||||++|||++|+.||..... ..... .... .. ..+ +......+
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~---~~~~-~~------~~~----p~~~~~~~ 222 (323)
T cd05571 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFE---LILM-EE------IRF----PRTLSPEA 222 (323)
T ss_pred cccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHHH---HHHc-CC------CCC----CCCCCHHH
Confidence 99999999999999999999999999999999999853221 11111 1111 10 011 11234568
Q ss_pred HHHHHHcccCCCCCCC-----CHHHHHHH
Q 048280 275 IQIGLLCTQGDPQLRP-----TMRRVVVM 298 (381)
Q Consensus 275 ~~li~~cl~~dP~~RP-----s~~eil~~ 298 (381)
.+|+.+||+.||++|| ++.++++.
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 223 KSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 8899999999999999 78988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=318.10 Aligned_cols=262 Identities=23% Similarity=0.362 Sum_probs=219.8
Q ss_pred CCCChHHHHHHHhhhCCCCChHHHHHhhcCCCCCCcccccCCeeEEEEEEC---CC--cEEEEEEecCC-CcccHHHHHH
Q 048280 22 EGDNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLD---DG--REIAVKKLSHS-SNQGKKEFEN 95 (381)
Q Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~--~~vavK~~~~~-~~~~~~~~~~ 95 (381)
...+.+++.||........+...+..........+.||.|.||.||+|... .| -.||||..+.+ .....+.|+.
T Consensus 361 ~~~etDdYAEI~dety~~P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflq 440 (974)
T KOG4257|consen 361 TPNETDDYAEIGDETYSTPTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQ 440 (974)
T ss_pred CCCccchhhhcccccccCCCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHH
Confidence 346788889999888888887777777777888899999999999999753 23 35899999874 4556789999
Q ss_pred HHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccc
Q 048280 96 EAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKA 157 (381)
Q Consensus 96 E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp 157 (381)
|..+|++++|||||+++|+|.+ ...|||||.++-|.|..+| .|++.++.|||+.+ ||||..
T Consensus 441 Ea~iMrnfdHphIikLIGv~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAa 519 (974)
T KOG4257|consen 441 EASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAA 519 (974)
T ss_pred HHHHHHhCCCcchhheeeeeec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhh
Confidence 9999999999999999999986 4689999999999998877 78999999999999 999999
Q ss_pred cceEeCCCCCcEEeeeccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcc
Q 048280 158 SNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDV 236 (381)
Q Consensus 158 ~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~ 236 (381)
.|||+.....|||+|||+++.+..+.....+...-.+.|||||.+.-..++.+||||-|||++||++. |..||.+-...
T Consensus 520 RNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs 599 (974)
T KOG4257|consen 520 RNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS 599 (974)
T ss_pred hheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc
Confidence 99999999999999999999998776665555555778999999999999999999999999999886 88998643322
Q ss_pred ccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 237 DAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
+ ....+...-+.+.+..++..|..|+.+||..+|.+||.+.+|...|+
T Consensus 600 D----------------VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls 647 (974)
T KOG4257|consen 600 D----------------VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS 647 (974)
T ss_pred c----------------eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence 2 22223333445566677788999999999999999999999987664
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=306.91 Aligned_cols=245 Identities=23% Similarity=0.359 Sum_probs=182.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc-ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN-QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999876 588999999875432 223567889999999999999999999999999999999
Q ss_pred cccCCCHHH----------------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 127 YVINESLDK----------------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 127 ~~~~g~L~~----------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
|+. ++|.+ ++.|++.+|.|+|+.+ ||||||+|||++.++.+||+|||++........ ...
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~ 161 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH-TYS 161 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc-cCC
Confidence 995 45543 3378999999999999 999999999999999999999999976432221 223
Q ss_pred ccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCc--------ccccC
Q 048280 189 RVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKS--------LEIVD 259 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~ 259 (381)
...+++.|+|||++.+. .++.++|||||||++|+|++|..||....+. ................ .....
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchhhccccc
Confidence 35688999999998764 5889999999999999999999998643221 1111111111110000 00000
Q ss_pred CC-C---CCCCCH------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 260 PS-L---AASDSG------DQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 260 ~~-~---~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
+. . ...... .....+.+|+.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00 0 000000 11245778999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=292.45 Aligned_cols=236 Identities=22% Similarity=0.300 Sum_probs=192.8
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEE-CCCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKL-DDGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
.+.++|++.+.||+|.|+.|+++.. .+|+.+|+|++... ...+.+.+.+|++|.+.|+||||+++++.+.+....||
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 3467899999999999999999965 46999999988643 34467889999999999999999999999999999999
Q ss_pred EEecccCCCHH---------------HHHHhhhhhhhHhhhhc--cCCccccceEeCC---CCCcEEeeeccceecCCCC
Q 048280 124 IYEYVINESLD---------------KVLFSLIKDIQILFRKK--KTDIKASNILLDD---KWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 124 v~E~~~~g~L~---------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~---~~~~kL~DFG~~~~~~~~~ 183 (381)
|+|++.|++|. .++.|++++|.|+|.++ |||+||+|+||.. .--+||+|||++..+. .
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~ 165 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--D 165 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC--C
Confidence 99999999994 34589999999999999 9999999999953 3469999999999886 3
Q ss_pred cccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC
Q 048280 184 THVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 184 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
.....+..||+.|||||++...+|+..+|||+.|||||-|+.|.+||.... ...+.+.. .... -...
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~---~~rlye~I----~~g~------yd~~ 232 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYEQI----KAGA------YDYP 232 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc---HHHHHHHH----hccc------cCCC
Confidence 334456889999999999999999999999999999999999999986422 22222221 1111 1112
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 264 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
+.......+...+|+.+||..||.+|.|+.|.++
T Consensus 233 ~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 233 SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 2233344566788999999999999999999874
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=315.55 Aligned_cols=229 Identities=24% Similarity=0.312 Sum_probs=184.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC--CcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD--GREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
.++|.+.+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4579999999999999999997543 368999998643 22334578899999999999999999999999999999
Q ss_pred EEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 124 IYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 124 v~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
||||+.+|+|.+++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||++..+...
T Consensus 109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~---- 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR---- 184 (340)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC----
Confidence 99999999997665 68999999999999 9999999999999999999999999876432
Q ss_pred ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...... .. ...... ... .. +
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~---~~~i~~-~~~--~~-p------ 248 (340)
T PTZ00426 185 TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---LI---YQKILE-GII--YF-P------ 248 (340)
T ss_pred cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---HH---HHHHhc-CCC--CC-C------
Confidence 12457899999999999988999999999999999999999998643221 11 111111 110 00 1
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRP-----TMRRVVVM 298 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 298 (381)
......+.+++.+||+.||++|+ +++++++.
T Consensus 249 -~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 249 -KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11234577899999999999995 88888764
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=306.24 Aligned_cols=242 Identities=24% Similarity=0.356 Sum_probs=178.7
Q ss_pred cCCCCCCcccccCCeeEEEEEEC--CCcEEEEEEecCCC--cccHHHHHHHHHHHHHh---CCCCcccEEEEEe-----e
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD--DGREIAVKKLSHSS--NQGKKEFENEAKLLARV---QHRNVVNLLGYCA-----H 117 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~-----~ 117 (381)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.+++.+ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47999999999999999999863 46889999986542 22234567788888776 6999999999985 2
Q ss_pred CCeEEEEEecccCCCHHHH-----------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeecccee
Q 048280 118 GAEKLLIYEYVINESLDKV-----------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARL 178 (381)
Q Consensus 118 ~~~~~lv~E~~~~g~L~~~-----------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~ 178 (381)
....++||||+. ++|.++ +.|++.+|.|||+.+ ||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 456899999995 566443 478999999999999 999999999999999999999999987
Q ss_pred cCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcC---Ccc
Q 048280 179 FPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKD---KSL 255 (381)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~ 255 (381)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ........... ...
T Consensus 160 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~---~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 160 YSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPGEEDWP 234 (290)
T ss_pred ccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHHhCCCChhhch
Confidence 5433 222345689999999999988999999999999999999999999865433221 11111110000 000
Q ss_pred -------cccCCCCC---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 256 -------EIVDPSLA---ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 256 -------~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
....+... ..........+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000000 0001123356778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=303.91 Aligned_cols=236 Identities=27% Similarity=0.442 Sum_probs=192.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
..+|++.+.||.|+||.||+|...++..+++|.+..........+.+|+.+++.++|+||+++++++......++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45799999999999999999998889999999997766555678999999999999999999999999999999999999
Q ss_pred cCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 129 INESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 129 ~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
++++|.+++ .+++.++.|||..+ |+||||+|||++.++.+||+|||++......... ...
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-~~~ 163 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL-SSD 163 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc-ccC
Confidence 999997665 57899999999998 9999999999999999999999999876433222 123
Q ss_pred cccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 190 VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
..++..|+|||.+.+..++.++|||||||++|+|++ |+.||..... ...... ...... .....
T Consensus 164 ~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~----~~~~~~---------~~~~~ 227 (261)
T cd05148 164 KKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQ----ITAGYR---------MPCPA 227 (261)
T ss_pred CCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHH----HHhCCc---------CCCCC
Confidence 345678999999998899999999999999999998 7888754321 111111 111100 11112
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
..+..+.+++.+||+.||.+|||+.+|++.|+.
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 228 KCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 334568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=315.93 Aligned_cols=235 Identities=22% Similarity=0.297 Sum_probs=180.9
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
.|++++.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 6889999999999999999865 58899999996542 2234568899999999999999999999999999999999
Q ss_pred cccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc-----
Q 048280 127 YVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT----- 184 (381)
Q Consensus 127 ~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~----- 184 (381)
|+++|+|.+++ .|++.+|.|||..+ ||||||+||||+.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 99999997655 68899999999999 999999999999999999999999764311000
Q ss_pred -----------------------------------------ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHH
Q 048280 185 -----------------------------------------HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILEL 223 (381)
Q Consensus 185 -----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~el 223 (381)
.......||+.|+|||++.+..++.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el 241 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence 001235799999999999988999999999999999999
Q ss_pred HhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHH--cccCCCCCCCCHHHHHHH
Q 048280 224 ISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLL--CTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 224 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~eil~~ 298 (381)
++|..||........ ............. + ........+.+|+.+ |+..++..||++.+|+..
T Consensus 242 ltG~~Pf~~~~~~~~------~~~i~~~~~~~~~--~-----~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 242 LVGQPPFLAPTPTET------QLKVINWENTLHI--P-----PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HhCCCCCcCCCHHHH------HHHHHccccccCC--C-----CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999864332111 1111110100000 1 111123456677776 566677779999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=308.26 Aligned_cols=225 Identities=22% Similarity=0.269 Sum_probs=178.8
Q ss_pred CcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCC
Q 048280 56 NKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINE 131 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g 131 (381)
+.||+|+||.||+++.. +|..||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999865 58999999986542 223456778999999999999999999999999999999999999
Q ss_pred CHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccCc
Q 048280 132 SLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN 194 (381)
Q Consensus 132 ~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~ 194 (381)
+|..++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++....... ......||+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~gt~ 159 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGTP 159 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-ccccccCCc
Confidence 996544 68999999999999 999999999999999999999999875322211 122456899
Q ss_pred cccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHH
Q 048280 195 GYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMC 274 (381)
Q Consensus 195 ~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 274 (381)
.|+|||++.+..++.++|||||||++|||++|+.||...... ... ....... ..+ +......+
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~---~~~~~~~-------~~~----p~~~~~~~ 222 (323)
T cd05595 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLF---ELILMEE-------IRF----PRTLSPEA 222 (323)
T ss_pred CcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHH---HHHhcCC-------CCC----CCCCCHHH
Confidence 999999999999999999999999999999999998533211 111 1111111 001 11234567
Q ss_pred HHHHHHcccCCCCCCC-----CHHHHHHH
Q 048280 275 IQIGLLCTQGDPQLRP-----TMRRVVVM 298 (381)
Q Consensus 275 ~~li~~cl~~dP~~RP-----s~~eil~~ 298 (381)
.+++.+||+.||.+|| ++.++++.
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 223 KSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 8899999999999998 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=300.41 Aligned_cols=234 Identities=26% Similarity=0.412 Sum_probs=187.1
Q ss_pred cCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEeccc
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVI 129 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 129 (381)
++|++.+.||+|+||.||+|+..++..||||.+.... ...+.+.+|+.++++++||||+++++++......++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4688999999999999999988777779999986543 335678999999999999999999999999999999999999
Q ss_pred CCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccc
Q 048280 130 NESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVA 191 (381)
Q Consensus 130 ~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~ 191 (381)
+++|.+++ .|++.++.|+|..+ |+||||+|||++.++.+||+|||+++..............
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~ 162 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSK 162 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCc
Confidence 99887655 67899999999998 9999999999999999999999999876443322222334
Q ss_pred cCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHH
Q 048280 192 GTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQ 270 (381)
Q Consensus 192 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (381)
++..|+|||++.+..++.++|||||||++|+|++ |..||...... .... .. ....... .+ ...
T Consensus 163 ~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~---~~-~~~~~~~--~~-------~~~ 226 (256)
T cd05113 163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVE---KV-SQGLRLY--RP-------HLA 226 (256)
T ss_pred cChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHH---HH-hcCCCCC--CC-------CCC
Confidence 5678999999998889999999999999999998 88887533211 1111 11 1111100 01 112
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 271 IAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 271 ~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
...+.+++.+||+.||.+||++.+|++.|+
T Consensus 227 ~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 227 SEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 456889999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=315.70 Aligned_cols=227 Identities=27% Similarity=0.423 Sum_probs=183.4
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcc---cHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQ---GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
-|.-++.||.|+||.||-|++. +...||||++.-.... ..+++.+|++.|.+++|||+|.+-|+|......|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 3556788999999999999865 5788999999755333 34678999999999999999999999999999999999
Q ss_pred cccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 127 YVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 127 ~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
|| -|+-.+++ .+.+.||+|||+.+ |||||..||||++.|.|||+|||.+...... .
T Consensus 107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-----n 180 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-----N 180 (948)
T ss_pred HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch-----h
Confidence 99 55655554 67899999999998 9999999999999999999999999875433 3
Q ss_pred ccccCccccchhHHh---hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCC
Q 048280 189 RVAGTNGYMAPEYVM---HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
.++||++|||||++. .+.|+-|+||||||++..||.-.++|..... .....+.+..++ .|.+.
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN------AMSALYHIAQNe------sPtLq-- 246 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNE------SPTLQ-- 246 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch------HHHHHHHHHhcC------CCCCC--
Confidence 478999999999985 4689999999999999999999998864221 111122222221 23332
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 266 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
..+....+..|+..||++-|.+|||.+++++.
T Consensus 247 -s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 247 -SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred -CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 34556678889999999999999999998753
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=303.68 Aligned_cols=236 Identities=26% Similarity=0.460 Sum_probs=188.4
Q ss_pred cCCCCCCcccccCCeeEEEEEECC------CcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLDD------GREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 122 (381)
++|++.+.||+|+||.||+|.... ...||+|.+.... ......+.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 478999999999999999997643 2579999986543 233467899999999999999999999999999999
Q ss_pred EEEecccCCCHHHH-------------------------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcE
Q 048280 123 LIYEYVINESLDKV-------------------------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPK 169 (381)
Q Consensus 123 lv~E~~~~g~L~~~-------------------------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~k 169 (381)
++|||+++++|.++ +.|++.+|.|||..+ |+||||+|||+++++.+|
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEE
Confidence 99999999998644 467899999999999 999999999999999999
Q ss_pred EeeeccceecCCCCc-ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHH
Q 048280 170 IADFGMARLFPEDQT-HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYK 247 (381)
Q Consensus 170 L~DFG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 247 (381)
|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... .+ ..
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~----~~ 237 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EV----IE 237 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH----HH
Confidence 999999986533222 12223456788999999998899999999999999999998 99887543221 11 11
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 248 LYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
....... ......++..+.+|+.+||+.||.+||++.+|++.|++
T Consensus 238 ~i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 MIRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111111 11123445678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=309.34 Aligned_cols=224 Identities=21% Similarity=0.247 Sum_probs=177.1
Q ss_pred ccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCCCH
Q 048280 58 LGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESL 133 (381)
Q Consensus 58 lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L 133 (381)
||+|+||.||+|+.. +++.||+|++... .......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999876 5889999998643 223345678899999999999999999999999999999999999999
Q ss_pred HHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccCccc
Q 048280 134 DKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGY 196 (381)
Q Consensus 134 ~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y 196 (381)
.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++...... .......||+.|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y 159 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTPEY 159 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCCccc
Confidence 7655 68899999999999 99999999999999999999999998543222 122345799999
Q ss_pred cchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHH
Q 048280 197 MAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQ 276 (381)
Q Consensus 197 ~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 276 (381)
+|||++.+..++.++|||||||++|+|++|+.||..... ........... . .........+.+
T Consensus 160 ~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~~~-------~----~~~~~~~~~~~~ 222 (312)
T cd05585 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQEP-------L----RFPDGFDRDAKD 222 (312)
T ss_pred CCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCC-------C----CCCCcCCHHHHH
Confidence 999999999999999999999999999999999853221 11111111110 0 011123356788
Q ss_pred HHHHcccCCCCCCCCHHHHHHHh
Q 048280 277 IGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 277 li~~cl~~dP~~RPs~~eil~~L 299 (381)
++.+||+.||.+||++..+.+.|
T Consensus 223 li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 223 LLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HHHHHcCCCHHHcCCCCCHHHHH
Confidence 99999999999998654443334
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=319.38 Aligned_cols=240 Identities=25% Similarity=0.410 Sum_probs=188.6
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhC-CCCcccEEEEEeeCC
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQ-HRNVVNLLGYCAHGA 119 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 119 (381)
..++|.+.+.||+|+||.||+|... .+..||||++.... ....+.+.+|+++++++. ||||++++++|.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3668999999999999999999753 13479999996543 233467899999999996 999999999999999
Q ss_pred eEEEEEecccCCCHHHHH--------------------------------------------------------------
Q 048280 120 EKLLIYEYVINESLDKVL-------------------------------------------------------------- 137 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~~l-------------------------------------------------------------- 137 (381)
..+||||||++|+|.++|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 999999999999987554
Q ss_pred -------------------------------------------------HhhhhhhhHhhhhc--cCCccccceEeCCCC
Q 048280 138 -------------------------------------------------FSLIKDIQILFRKK--KTDIKASNILLDDKW 166 (381)
Q Consensus 138 -------------------------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~ 166 (381)
.|++.+|.|||..+ ||||||+|||++.++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC
Confidence 36889999999998 999999999999999
Q ss_pred CcEEeeeccceecCCCCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHH
Q 048280 167 IPKIADFGMARLFPEDQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDW 244 (381)
Q Consensus 167 ~~kL~DFG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 244 (381)
.+||+|||+++.+...... ......++..|+|||++.+..++.++|||||||++|||++ |..||...... ..+
T Consensus 275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~~~--- 349 (400)
T cd05105 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--STF--- 349 (400)
T ss_pred EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--HHH---
Confidence 9999999999865433221 1223456788999999999899999999999999999997 88887543211 111
Q ss_pred HHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 245 AYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
......... .......+..+.+++.+||+.||++||++.+|.+.|+..
T Consensus 350 -~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 350 -YNKIKSGYR---------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred -HHHHhcCCC---------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 111111110 011123345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=325.52 Aligned_cols=231 Identities=22% Similarity=0.305 Sum_probs=185.9
Q ss_pred CCCCCCcccccCCeeEEEEEEC-C-CcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-D-GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
.|.+.+.||+|+||.||+|... + +..||+|.+..........+.+|+.+++.++||||++++++|...+..||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4899999999999999999754 3 6788999876555444567888999999999999999999999999999999999
Q ss_pred cCCCHHHHH-------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc-cc
Q 048280 129 INESLDKVL-------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT-HV 186 (381)
Q Consensus 129 ~~g~L~~~l-------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~-~~ 186 (381)
++|+|.+++ .|++.+|.|+|+.+ ||||||+||||+.++.+||+|||+++.+..... ..
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 227 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccccc
Confidence 999996543 58899999999998 999999999999999999999999987644322 12
Q ss_pred ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ........... . .+ .
T Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~~~-~----~~-----~ 291 (478)
T PTZ00267 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLYGK-Y----DP-----F 291 (478)
T ss_pred ccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-C----CC-----C
Confidence 3346799999999999999999999999999999999999999853221 11111111111 0 00 1
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.......+.+|+.+||..||++||++.+++.
T Consensus 292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1123356889999999999999999999874
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=311.53 Aligned_cols=225 Identities=22% Similarity=0.251 Sum_probs=179.6
Q ss_pred CcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCC
Q 048280 56 NKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINE 131 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g 131 (381)
+.||+|+||.||+++.. +++.||||++.... ......+.+|+++++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999865 58999999996542 233457788999999999999999999999999999999999999
Q ss_pred CHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccCc
Q 048280 132 SLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN 194 (381)
Q Consensus 132 ~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~ 194 (381)
+|..++ .|++.+|.|||+.+ ||||||+||||+.++.+||+|||+++...... .......||+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~ 159 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFCGTP 159 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccccCCc
Confidence 996544 68999999999999 99999999999999999999999987532221 1123457999
Q ss_pred cccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHH
Q 048280 195 GYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMC 274 (381)
Q Consensus 195 ~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 274 (381)
.|+|||++.+..++.++|||||||++|+|++|+.||...... .......... ..+ +......+
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~~~~-------~~~----p~~~~~~~ 222 (328)
T cd05593 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMED-------IKF----PRTLSADA 222 (328)
T ss_pred CccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhccCC-------ccC----CCCCCHHH
Confidence 999999999999999999999999999999999998542211 1111111100 111 11234567
Q ss_pred HHHHHHcccCCCCCCC-----CHHHHHHH
Q 048280 275 IQIGLLCTQGDPQLRP-----TMRRVVVM 298 (381)
Q Consensus 275 ~~li~~cl~~dP~~RP-----s~~eil~~ 298 (381)
.+|+.+||+.||.+|+ ++.++++.
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 223 KSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 8899999999999997 89998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=316.80 Aligned_cols=239 Identities=19% Similarity=0.234 Sum_probs=188.8
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
..++|++.+.||+|+||.||+++.. +++.||+|++... .......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4568999999999999999999876 5889999998643 22233557889999999999999999999999999999
Q ss_pred EEecccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 124 IYEYVINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 124 v~E~~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
||||+++|+|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++...........
T Consensus 121 v~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~ 200 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC 200 (370)
T ss_pred EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccC
Confidence 99999999997665 68899999999999 999999999999999999999999987644333223
Q ss_pred cccccCccccchhHHhhC----CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHG----HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ............... .+
T Consensus 201 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~~~--~~--- 269 (370)
T cd05596 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMDHKNSLT--FP--- 269 (370)
T ss_pred CCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCCCcCC--CC---
Confidence 346799999999998753 478999999999999999999999864321 111111111111111 01
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHh
Q 048280 264 ASDSGDQIAMCIQIGLLCTQGDPQL--RPTMRRVVVML 299 (381)
Q Consensus 264 ~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~L 299 (381)
........+.+|+.+||+.+|.+ |+++.++++.-
T Consensus 270 --~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 270 --DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred --CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 11123456888999999999987 99999998653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=302.80 Aligned_cols=237 Identities=29% Similarity=0.479 Sum_probs=188.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCCCcc-cHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHSSNQ-GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEK 121 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 121 (381)
.++|.+.+.||+|+||.||+|... +++.||||++...... ....+.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 457889999999999999999763 2478999998765433 457899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHH-----------------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEE
Q 048280 122 LLIYEYVINESLDKVL-----------------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKI 170 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l-----------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL 170 (381)
++||||+++++|.+++ .+++.++.++|..+ ||||||+|||++.++.+||
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEE
Confidence 9999999999987654 57889999999998 9999999999999999999
Q ss_pred eeeccceecCCCCc-ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHH
Q 048280 171 ADFGMARLFPEDQT-HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKL 248 (381)
Q Consensus 171 ~DFG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 248 (381)
+|||++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||...... .....
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~~---- 236 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIEC---- 236 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----
Confidence 99999986533221 11223345788999999999999999999999999999998 99997533221 11111
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 249 YKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
....... .........+.+++.+||+.||++||++.||++.|++
T Consensus 237 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 ITQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1111110 0111234568899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=299.28 Aligned_cols=236 Identities=25% Similarity=0.403 Sum_probs=189.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
.++|++.+.||+|++|.||+|..++++.||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 46799999999999999999998778889999986543 34567899999999999999999999999999999999999
Q ss_pred cCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 129 INESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 129 ~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
.+++|.+++ .+++.++.++|..+ ||||||+||+++.++.+||+|||+++............
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG 163 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCC
Confidence 999997765 56889999999998 99999999999999999999999998775332222222
Q ss_pred cccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 190 VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
...+..|+|||++.+..++.++|||||||++|||++ |+.||..... .... ......... ....
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~----~~~~~~~~~---------~~~~ 227 (261)
T cd05068 164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVL----QQVDQGYRM---------PCPP 227 (261)
T ss_pred CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHH----HHHHcCCCC---------CCCC
Confidence 233457999999998899999999999999999999 8888753221 1111 111111100 1111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
.....+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 228 ~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 228 GCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 234568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=300.53 Aligned_cols=236 Identities=25% Similarity=0.407 Sum_probs=188.7
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
.+|.+.+.||+|+||.||+|... .+..||+|.+... ......+.+|++++++++|+||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 46888999999999999999865 4889999998644 334567899999999999999999999999999999999999
Q ss_pred cCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 129 INESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 129 ~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
++++|.+++ .|++.++.++|..+ ||||||+|||+++++.+||+|||++.............
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~ 164 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 164 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCC
Confidence 999997654 68899999999988 99999999999999999999999998764433222222
Q ss_pred cccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 190 VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
..++..|+|||.+.+..++.++|||||||++|||++ |..||..... ... ........ .+ ....
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~----~~~~~~~~-----~~----~~~~ 228 (263)
T cd05052 165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQV----YELLEKGY-----RM----ERPE 228 (263)
T ss_pred CCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHH----HHHHHCCC-----CC----CCCC
Confidence 334568999999999999999999999999999998 8888753321 111 11111110 01 1112
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
..+..+.+++.+||+.||++||++.++++.|+..
T Consensus 229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 229 GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 2345688899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=315.90 Aligned_cols=235 Identities=23% Similarity=0.303 Sum_probs=183.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999876 58999999996532 223356788999999999999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc---
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH--- 185 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~--- 185 (381)
||+.+|+|.+++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 999999997655 68999999999999 9999999999999999999999999765321100
Q ss_pred ----------------------------------cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCC
Q 048280 186 ----------------------------------VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSS 231 (381)
Q Consensus 186 ----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~ 231 (381)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 0012468999999999999999999999999999999999999986
Q ss_pred CCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 048280 232 FNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPT---MRRVVVM 298 (381)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~~ 298 (381)
..... ............... + ........+.+|+.+|+. +|.+|++ +.+++..
T Consensus 241 ~~~~~------~~~~~i~~~~~~~~~--~-----~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 241 SDNPQ------ETYRKIINWKETLQF--P-----DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCHH------HHHHHHHcCCCccCC--C-----CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 43221 111111111111110 1 011223457788989996 9999998 8888654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=314.86 Aligned_cols=241 Identities=19% Similarity=0.237 Sum_probs=187.5
Q ss_pred HHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCe
Q 048280 45 LVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAE 120 (381)
Q Consensus 45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 120 (381)
+....++|++.+.||+|+||.||+++.. +++.||+|++... .......+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3344678999999999999999999876 5889999998642 22234567889999999999999999999999999
Q ss_pred EEEEEecccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 121 KLLIYEYVINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
.|+||||+++|+|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++..+.....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 99999999999997665 68999999999999 999999999999999999999999987654333
Q ss_pred ccccccccCccccchhHHhhC----CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCC
Q 048280 185 HVNTRVAGTNGYMAPEYVMHG----HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDP 260 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... ...............
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~~---- 267 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSKIMDHKNSLN---- 267 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCcccC----
Confidence 233356799999999999764 378999999999999999999999864321 111111111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 048280 261 SLAASDSGDQIAMCIQIGLLCTQGDPQL--RPTMRRVVVM 298 (381)
Q Consensus 261 ~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~ 298 (381)
..........+.+++..||..++.+ |+++.|+++.
T Consensus 268 ---~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 ---FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111223455778888999865543 8899999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=314.48 Aligned_cols=244 Identities=21% Similarity=0.329 Sum_probs=179.7
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeC-----CeEE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHG-----AEKL 122 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~ 122 (381)
+|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|++++++++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999865 5899999998643 223345688999999999999999999988543 3579
Q ss_pred EEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc-
Q 048280 123 LIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT- 184 (381)
Q Consensus 123 lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~- 184 (381)
+||||+. ++|.+++ .|++.||.|||+.+ ||||||+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 9999994 6776544 68999999999999 999999999999999999999999986432211
Q ss_pred -ccccccccCccccchhHHhh--CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhh-----------
Q 048280 185 -HVNTRVAGTNGYMAPEYVMH--GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYK----------- 250 (381)
Q Consensus 185 -~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------- 250 (381)
.......||..|+|||++.+ ..++.++|||||||++|||++|+.||......... ........
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL---DLITDLLGTPSPETISRVR 236 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH---HHHHHHhCCCCHHHHHHhh
Confidence 11234568999999999876 67899999999999999999999998643321111 00000000
Q ss_pred cCCc---ccccCCCCCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 251 KDKS---LEIVDPSLAA---SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 251 ~~~~---~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.... ...+...... .........+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 0000000000 0001123457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=315.04 Aligned_cols=236 Identities=22% Similarity=0.294 Sum_probs=188.3
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999876 68999999986542 233467889999999999999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC-----
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ----- 183 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~----- 183 (381)
||+++++|.+++ .|++.+|.|||..+ ||||||+||||+.++.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999997655 68999999999998 99999999999999999999999998664433
Q ss_pred -----------------------cccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccccc
Q 048280 184 -----------------------THVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQN 240 (381)
Q Consensus 184 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 240 (381)
........||+.|+|||++.+..++.++|||||||+||||++|+.||......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~---- 236 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ---- 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH----
Confidence 11123456899999999999999999999999999999999999998643311
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHh
Q 048280 241 LLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPT-MRRVVVML 299 (381)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~~L 299 (381)
............ ...+. .......+.+|+.+||. ||.+||+ +.++++..
T Consensus 237 --~~~~~i~~~~~~--~~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 237 --ETYNKIINWKES--LRFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred --HHHHHHhccCCc--ccCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 111111110000 00111 11134568889999997 9999999 99998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=309.54 Aligned_cols=225 Identities=22% Similarity=0.265 Sum_probs=178.2
Q ss_pred CcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCC
Q 048280 56 NKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINE 131 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g 131 (381)
+.||+|+||.||+++.. +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+.++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999865 68999999996542 223456778999999999999999999999999999999999999
Q ss_pred CHHHHH---------------HhhhhhhhHhhh-hc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccC
Q 048280 132 SLDKVL---------------FSLIKDIQILFR-KK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT 193 (381)
Q Consensus 132 ~L~~~l---------------~~~~~~l~~lh~-~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt 193 (381)
+|..++ .|++.+|.|||+ .+ ||||||+|||++.++.+||+|||+++....... ......||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~gt 159 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTFCGT 159 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccccccCC
Confidence 997554 689999999997 55 999999999999999999999999875432221 12235699
Q ss_pred ccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHH
Q 048280 194 NGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAM 273 (381)
Q Consensus 194 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (381)
+.|+|||++.+..++.++|||||||++|+|++|..||...... ... ....... ..+. ......
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~---~~i~~~~-------~~~p----~~~~~~ 222 (325)
T cd05594 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLF---ELILMEE-------IRFP----RTLSPE 222 (325)
T ss_pred cccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHH---HHHhcCC-------CCCC----CCCCHH
Confidence 9999999999999999999999999999999999998543211 111 1111110 0111 112345
Q ss_pred HHHHHHHcccCCCCCCC-----CHHHHHHH
Q 048280 274 CIQIGLLCTQGDPQLRP-----TMRRVVVM 298 (381)
Q Consensus 274 l~~li~~cl~~dP~~RP-----s~~eil~~ 298 (381)
+.+|+.+||+.||++|+ ++.++++.
T Consensus 223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 78899999999999996 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=317.53 Aligned_cols=235 Identities=20% Similarity=0.277 Sum_probs=181.4
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++|++++.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999865 58999999986432 223456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC-----
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ----- 183 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~----- 183 (381)
||+++|+|.+++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 999999997665 68999999999998 99999999999999999999999975321000
Q ss_pred -------------------------------------cccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhC
Q 048280 184 -------------------------------------THVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISG 226 (381)
Q Consensus 184 -------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg 226 (381)
........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 0001134699999999999999999999999999999999999
Q ss_pred CCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC---CHHHHHHH
Q 048280 227 QRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRP---TMRRVVVM 298 (381)
Q Consensus 227 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~eil~~ 298 (381)
+.||......+. ............ ..........+.+++.+|+ .+|.+|+ ++.+++..
T Consensus 241 ~~Pf~~~~~~~~------~~~i~~~~~~~~-------~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 241 QPPFLADTPAET------QLKVINWETTLH-------IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCCCCCHHHH------HHHHhccCcccc-------CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999865432111 111111000000 0111122345667777766 4999999 88998765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=313.05 Aligned_cols=235 Identities=23% Similarity=0.282 Sum_probs=186.3
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++|.+.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999865 58999999997542 223456888999999999999999999999999999999
Q ss_pred ecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 126 EYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 126 E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
||+++++|.+++ .|++.+|.|+|..+ ||||||+|||++.++.+||+|||++..+........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 999999997665 57899999999998 999999999999999999999999987654433333
Q ss_pred cccccCccccchhHHh------hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCC
Q 048280 188 TRVAGTNGYMAPEYVM------HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPS 261 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (381)
....||+.|+|||++. +..++.++|||||||++|+|++|+.||...... ............... +
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~--~- 231 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFLKF--P- 231 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCccCC--C-
Confidence 3456899999999987 456789999999999999999999998543221 111111111111111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 262 LAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 262 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
........+.+|+..||. +|.+||++.+++..
T Consensus 232 ----~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 232 ----EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ----CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 111234557889999998 99999999998753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=298.18 Aligned_cols=231 Identities=27% Similarity=0.369 Sum_probs=191.8
Q ss_pred CCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccC
Q 048280 52 FHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 52 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
|.++++||+|+||.||+|.++ +|+.+|||++... .+.+++.+|+.||++++.|++|++||.+.....+|||||||-.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 677899999999999999765 5999999998543 4568899999999999999999999999999999999999999
Q ss_pred CCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccccc
Q 048280 131 ESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAG 192 (381)
Q Consensus 131 g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~g 192 (381)
|++.+++ ...+++|+|||... |||||..||||+.+|.+||+|||.+-.+.+... ...++.|
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KRNTVIG 191 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KRNTVIG 191 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH-hhCcccc
Confidence 9998776 56789999999887 999999999999999999999999987654332 2345789
Q ss_pred CccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHH
Q 048280 193 TNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIA 272 (381)
Q Consensus 193 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (381)
|+.|||||++..-.|+.++||||||++..||.-|++|+....+.... ..-...|...-..+.....
T Consensus 192 TPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI--------------FMIPT~PPPTF~KPE~WS~ 257 (502)
T KOG0574|consen 192 TPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI--------------FMIPTKPPPTFKKPEEWSS 257 (502)
T ss_pred CcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee--------------EeccCCCCCCCCChHhhhh
Confidence 99999999999999999999999999999999999998543222110 0000112222234456677
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 273 MCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 273 ~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
.+-++++.||.++|++|-|+.++++.-
T Consensus 258 ~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 258 EFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred HHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 889999999999999999999988753
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=314.99 Aligned_cols=236 Identities=22% Similarity=0.281 Sum_probs=181.3
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999865 68999999986432 223456888999999999999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc---
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH--- 185 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~--- 185 (381)
||+++|+|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999999997654 68999999999999 9999999999999999999999998633210000
Q ss_pred -------------------------------------------cccccccCccccchhHHhhCCCCchhhhHhHHHHHHH
Q 048280 186 -------------------------------------------VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILE 222 (381)
Q Consensus 186 -------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~e 222 (381)
.....+||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 0012469999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHHh
Q 048280 223 LISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLR---PTMRRVVVML 299 (381)
Q Consensus 223 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~eil~~L 299 (381)
|++|..||......+ .. ............ +. .......+.+|+.+||. +|.+| +++.+++...
T Consensus 241 lltG~~Pf~~~~~~~---~~---~~i~~~~~~~~~--p~-----~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp 306 (377)
T cd05629 241 CLIGWPPFCSENSHE---TY---RKIINWRETLYF--PD-----DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHP 306 (377)
T ss_pred hhcCCCCCCCCCHHH---HH---HHHHccCCccCC--CC-----CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCC
Confidence 999999986433211 11 111110100110 11 11123457789999997 67665 5999987653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=294.76 Aligned_cols=245 Identities=22% Similarity=0.311 Sum_probs=186.7
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc--ccHHHHHHHHHHHHHhCCCC-cccEEEEEeeCC------
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN--QGKKEFENEAKLLARVQHRN-VVNLLGYCAHGA------ 119 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~------ 119 (381)
..|..+++||+|.||+||+|+.+ +|+.||+|++..... .......+|+.+|+.++|+| |+.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 35777889999999999999865 689999999976533 23356789999999999999 999999999877
Q ss_pred eEEEEEecccC---------------C---CHHHHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceec
Q 048280 120 EKLLIYEYVIN---------------E---SLDKVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLF 179 (381)
Q Consensus 120 ~~~lv~E~~~~---------------g---~L~~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~ 179 (381)
..++||||+.. . .+..+++|++.|+.|||+++ ||||||+||||+++|.+||+|||+|+.+
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAF 170 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHh
Confidence 88999999721 1 24567799999999999999 9999999999999999999999999976
Q ss_pred CCCCcccccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcC---Ccc
Q 048280 180 PEDQTHVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKD---KSL 255 (381)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~ 255 (381)
...... .+..++|..|+|||++.+. .|+...||||+|||+.||++++.-|....+.+.. ..+....... ...
T Consensus 171 ~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql---~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 171 SIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQL---FRIFRLLGTPNEKDWP 246 (323)
T ss_pred cCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHH---HHHHHHcCCCCccCCC
Confidence 533322 3445789999999999987 7999999999999999999999888766553321 1222222111 000
Q ss_pred c-----ccCCCCCCCC-CHH-------HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 256 E-----IVDPSLAASD-SGD-------QIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 256 ~-----~~~~~~~~~~-~~~-------~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
. -......... ... ......+++.+||+.+|.+|.|++.++.+
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0 0010111100 111 11367889999999999999999999875
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=300.21 Aligned_cols=240 Identities=24% Similarity=0.349 Sum_probs=181.7
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC-----eEEEE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA-----EKLLI 124 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~lv 124 (381)
.|...+++|.|+||.||+|... ++..||||++..... --.+|+++|+.++|||||++.-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 5777899999999999999865 479999999865533 2346999999999999999998875432 34589
Q ss_pred EecccCCCHHHHH-------------------HhhhhhhhHhhhhc--cCCccccceEeCCC-CCcEEeeeccceecCCC
Q 048280 125 YEYVINESLDKVL-------------------FSLIKDIQILFRKK--KTDIKASNILLDDK-WIPKIADFGMARLFPED 182 (381)
Q Consensus 125 ~E~~~~g~L~~~l-------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~-~~~kL~DFG~~~~~~~~ 182 (381)
|||++ .+|.+++ .|+++||.|||..+ ||||||+|+|+|.+ |.+||||||.|+.+...
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 99995 4665544 79999999999988 99999999999965 99999999999987554
Q ss_pred CcccccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc-------CCc
Q 048280 183 QTHVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKK-------DKS 254 (381)
Q Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~ 254 (381)
... .....|..|+|||++.+. .|+.+.||||.|||+.||+-|++-|.+....++...+-.+...... ...
T Consensus 180 epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 180 EPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY 257 (364)
T ss_pred CCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence 333 345678999999999886 6999999999999999999999998876555443322211111000 011
Q ss_pred ccccCCCCCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 255 LEIVDPSLAAS-----DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 255 ~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.+...|.+... ..........+|+.++|+.+|.+|.++.|++.
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11112222111 23344567889999999999999999999875
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=310.14 Aligned_cols=228 Identities=22% Similarity=0.303 Sum_probs=178.3
Q ss_pred CCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHH---HhCCCCcccEEEEEeeCCeEEEE
Q 048280 52 FHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLA---RVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 52 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~---~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++. .++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999865 58999999996542 223456777776664 55799999999999999999999
Q ss_pred EecccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 125 YEYVINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 125 ~E~~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
|||+.+++|..++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~ 159 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-DRTS 159 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-Cccc
Confidence 9999999986543 78999999999999 99999999999999999999999987532221 1223
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
...|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ... ....... ... +.
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~~~---~~i~~~~-------~~~----p~ 222 (324)
T cd05589 160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---EVF---DSIVNDE-------VRY----PR 222 (324)
T ss_pred ccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---HHH---HHHHhCC-------CCC----CC
Confidence 467899999999999999999999999999999999999998643221 111 1111111 001 11
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRP-----TMRRVVV 297 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 297 (381)
.....+.+++.+||+.||.+|| ++.++++
T Consensus 223 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 223 FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 2235578899999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=297.59 Aligned_cols=233 Identities=24% Similarity=0.393 Sum_probs=185.7
Q ss_pred cCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEeccc
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVI 129 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 129 (381)
.+|++.+.||+|+||.||++.++++..+|+|++.... .....+.+|+.++++++|+||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4688999999999999999998777889999986443 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccc
Q 048280 130 NESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVA 191 (381)
Q Consensus 130 ~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~ 191 (381)
+++|.+++ .|++.++.++|..+ ||||||+||+++.++.+||+|||+++..............
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 162 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTK 162 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCCC
Confidence 99987654 67889999999998 9999999999999999999999999865433222222223
Q ss_pred cCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHH
Q 048280 192 GTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQ 270 (381)
Q Consensus 192 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (381)
++..|+|||.+.+..++.++|||||||++|+|++ |..||...... .... . ..... . . ......
T Consensus 163 ~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~---~-~~~~~--~---~----~~~~~~ 226 (256)
T cd05059 163 FPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVE---S-VSAGY--R---L----YRPKLA 226 (256)
T ss_pred CCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHH---H-HHcCC--c---C----CCCCCC
Confidence 4567999999998999999999999999999999 78887533221 1111 1 11110 0 0 111123
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 271 IAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 271 ~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
+..+.+++.+||..+|++|||+.++++.|
T Consensus 227 ~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 45688999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=296.73 Aligned_cols=235 Identities=26% Similarity=0.452 Sum_probs=187.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
.++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++++.. ...+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence 457999999999999999999988888899999875433 45679999999999999999999998854 5689999999
Q ss_pred cCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 129 INESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 129 ~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
.+++|.+++ .+++.++.|||+.+ ||||||+||++++++.+||+|||++..+..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccC
Confidence 999987665 57899999999998 99999999999999999999999998764433222222
Q ss_pred cccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 190 VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
..++..|+|||++.+..++.++|||||||++|+|++ |..||..... ..... . ..... ......
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~---~-~~~~~---------~~~~~~ 226 (260)
T cd05070 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLE---Q-VERGY---------RMPCPQ 226 (260)
T ss_pred CCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHH---H-HHcCC---------CCCCCC
Confidence 345678999999988899999999999999999999 8888753221 11111 1 11110 011122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
..+..+.+|+.+||..+|.+|||+.++++.|+.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 227 DCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 334568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=319.75 Aligned_cols=245 Identities=29% Similarity=0.406 Sum_probs=192.1
Q ss_pred HHHHHhhcCCCCCCcccccCCeeEEEEEECC--C---cEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEE
Q 048280 43 EALVSATKNFHPSNKLGEGGFGPVFKGKLDD--G---REIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGY 114 (381)
Q Consensus 43 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 114 (381)
+......++-.+.++||+|.||.||+|++.. + ..||||..+.. ......++.+|+++|++++|||||++||+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3344456677788999999999999998653 2 23899998753 34556789999999999999999999999
Q ss_pred EeeCCeEEEEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccc
Q 048280 115 CAHGAEKLLIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMA 176 (381)
Q Consensus 115 ~~~~~~~~lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~ 176 (381)
+.....++||||+|.||+|.++| .+.+.||+|||.+. ||||-.+|+|++.++.+||+|||++
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 99999999999999999999887 57899999999999 9999999999999999999999998
Q ss_pred eecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcc
Q 048280 177 RLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSL 255 (381)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (381)
+.-..-... .....-...|+|||.+..+.|+.++|||||||++||+++ |..||...... +...........
T Consensus 310 ~~~~~~~~~-~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~v~~kI~~~~~r- 381 (474)
T KOG0194|consen 310 RAGSQYVMK-KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------EVKAKIVKNGYR- 381 (474)
T ss_pred cCCcceeec-cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------HHHHHHHhcCcc-
Confidence 864311111 111124578999999999999999999999999999999 77787543322 111111121111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 256 EIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
...+...+..+..++.+||..||++||+|.++.+.|+...
T Consensus 382 --------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 382 --------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred --------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 1112234456777888999999999999999999997754
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=307.62 Aligned_cols=237 Identities=21% Similarity=0.312 Sum_probs=198.0
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEECC-CcEEEEEEecCCCcc---cHHHHHHHHHHHHHhC-CCCcccEEEEEeeCCeE
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLDD-GREIAVKKLSHSSNQ---GKKEFENEAKLLARVQ-HRNVVNLLGYCAHGAEK 121 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~ 121 (381)
.....|++.+.||.|.||.||+++.+. |+.+|+|.+.+.... ....+.+|+++|+++. |||||.++++|++...+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345679999999999999999998764 999999999766433 3468999999999998 99999999999999999
Q ss_pred EEEEecccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCC----CCCcEEeeeccceecCC
Q 048280 122 LLIYEYVINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDD----KWIPKIADFGMARLFPE 181 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~----~~~~kL~DFG~~~~~~~ 181 (381)
++|||+|.||.|.+.+ .|++.+++|+|..+ ||||||+|+|+.. ++.+|++|||++.....
T Consensus 112 ~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 9999999999997654 67899999999999 9999999999953 35899999999998765
Q ss_pred CCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCC
Q 048280 182 DQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPS 261 (381)
Q Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (381)
.......+||+.|+|||++....|+..+||||+||++|.|++|..||......... ..... . +..
T Consensus 192 --~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~------~~i~~-~------~~~ 256 (382)
T KOG0032|consen 192 --GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF------LAILR-G------DFD 256 (382)
T ss_pred --CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH------HHHHc-C------CCC
Confidence 33445689999999999999999999999999999999999999998654332211 11111 1 113
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 262 LAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 262 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
+...........+.+++..|+..||.+|+|+.++++.
T Consensus 257 f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 257 FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 3344555667788999999999999999999999985
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=296.85 Aligned_cols=236 Identities=24% Similarity=0.419 Sum_probs=187.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
.++|++.++||+|+||.||+|...++..||+|++.... ...+.+.+|++++++++|+||+++++++.. ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 45799999999999999999988777789999987543 234678999999999999999999998754 5579999999
Q ss_pred cCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 129 INESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 129 ~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
.+++|.+++ .+++.+|.++|+.+ |+||||+||++++++.+||+|||.+..+..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~ 162 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 162 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccccC
Confidence 999997665 57889999999998 99999999999999999999999998765443322223
Q ss_pred cccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 190 VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
..++..|+|||++.+..++.++|||||||++|+|++ |..||...... ... ....... ......
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~----~~~~~~~---------~~~~~~ 226 (262)
T cd05071 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVL----DQVERGY---------RMPCPP 226 (262)
T ss_pred CcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHH----HHHhcCC---------CCCCcc
Confidence 446778999999988899999999999999999999 77777533211 111 1111110 011122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
..+..+.+|+.+||+.||++||++.++++.|+..
T Consensus 227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 3456688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=310.81 Aligned_cols=247 Identities=19% Similarity=0.238 Sum_probs=191.3
Q ss_pred CChHHHHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEE
Q 048280 40 FPFEALVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYC 115 (381)
Q Consensus 40 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 115 (381)
.++.++....++|++.+.||+|+||.||+++.. +++.||+|++... .......+.+|+.+++.++||||+++++++
T Consensus 33 ~~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~ 112 (371)
T cd05622 33 NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF 112 (371)
T ss_pred hHHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 335556666789999999999999999999876 5889999998642 222335678899999999999999999999
Q ss_pred eeCCeEEEEEecccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceec
Q 048280 116 AHGAEKLLIYEYVINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLF 179 (381)
Q Consensus 116 ~~~~~~~lv~E~~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~ 179 (381)
.++...++||||+++|+|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++..+
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 113 QDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 9999999999999999997655 68999999999999 9999999999999999999999999876
Q ss_pred CCCCcccccccccCccccchhHHhhC----CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcc
Q 048280 180 PEDQTHVNTRVAGTNGYMAPEYVMHG----HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSL 255 (381)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (381)
............||+.|+|||++.+. .++.++|||||||++|||++|..||..... ..............
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~ 266 (371)
T cd05622 193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNHKNSL 266 (371)
T ss_pred CcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCcc
Confidence 54333333356799999999998754 378999999999999999999999864321 11112222111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHh
Q 048280 256 EIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQL--RPTMRRVVVML 299 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~L 299 (381)
.. .........+.+++..||..++.+ |+++.+|++..
T Consensus 267 ~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 267 TF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 11 111234456788999999844433 78999988765
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=309.12 Aligned_cols=226 Identities=25% Similarity=0.346 Sum_probs=179.1
Q ss_pred CCcccccCCeeEEEEEE----CCCcEEEEEEecCCC----cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 55 SNKLGEGGFGPVFKGKL----DDGREIAVKKLSHSS----NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
++.||+|+||.||+++. .+++.||||++.... ......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 36899999999999975 257899999986431 2233567889999999999999999999999999999999
Q ss_pred cccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 127 YVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 127 ~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
|+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 159 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHT 159 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-cccc
Confidence 99999997654 68999999999999 999999999999999999999999875432222 2234
Q ss_pred cccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHH
Q 048280 190 VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGD 269 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (381)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... ..+ +..
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~~~~-------~~~----~~~ 222 (323)
T cd05584 160 FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKILKGK-------LNL----PPY 222 (323)
T ss_pred cCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCC-------CCC----CCC
Confidence 56899999999999888999999999999999999999998643211 1111111111 001 111
Q ss_pred HHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 048280 270 QIAMCIQIGLLCTQGDPQLRP-----TMRRVVVM 298 (381)
Q Consensus 270 ~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 298 (381)
....+.+++.+||+.||++|| ++.+++..
T Consensus 223 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 223 LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 234578999999999999999 78887763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=311.61 Aligned_cols=183 Identities=24% Similarity=0.362 Sum_probs=158.4
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++.+++|+||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999865 58999999996532 223356788999999999999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc----
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT---- 184 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~---- 184 (381)
||+++|+|.+++ .|++.+|.|||+.+ ||||||+||||+.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 999999997665 68899999999999 999999999999999999999999875432110
Q ss_pred ------------------------------ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCC
Q 048280 185 ------------------------------HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSF 232 (381)
Q Consensus 185 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 232 (381)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 001235799999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=317.19 Aligned_cols=229 Identities=22% Similarity=0.298 Sum_probs=188.3
Q ss_pred HHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhC-CCCcccEEEEEeeCCe
Q 048280 46 VSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQ-HRNVVNLLGYCAHGAE 120 (381)
Q Consensus 46 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~ 120 (381)
....++|.++++||+|+||+|+++..+ +++.+|||++++.. ..+.+..+.|.+|+...+ ||.++.++..|...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 344678999999999999999999876 58899999998763 345577888999998885 9999999999999999
Q ss_pred EEEEEecccCCCHHHH--------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 121 KLLIYEYVINESLDKV--------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~--------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
+|+||||+.||++..+ ...++.||+|||.++ +||||.+|||||.+|.+||+|||+++..-. ..
T Consensus 444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~-~g 522 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG-QG 522 (694)
T ss_pred EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC-CC
Confidence 9999999999996322 257899999999999 999999999999999999999999995422 22
Q ss_pred ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 185 HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
....+++||+.|||||++.+..|+..+|-|||||+||||+.|..||....+.+. . ..+... + +
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~---F---dsI~~d----~---~---- 585 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV---F---DSIVND----E---V---- 585 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH---H---HHHhcC----C---C----
Confidence 345579999999999999999999999999999999999999999975543322 1 111111 1 1
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTM 292 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~ 292 (381)
..+...+.+.+.|+.++|..||++|.-+
T Consensus 586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1233345667889999999999999866
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=309.25 Aligned_cols=222 Identities=25% Similarity=0.281 Sum_probs=176.3
Q ss_pred CCcccccCCeeEEEEEE----CCCcEEEEEEecCCCc--ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 55 SNKLGEGGFGPVFKGKL----DDGREIAVKKLSHSSN--QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
++.||+|+||.||+++. .+++.||+|++..... .....+.+|++++++++||||+++++++..++..|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 36799999999999975 3588999999975422 23356778999999999999999999999999999999999
Q ss_pred cCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccc
Q 048280 129 INESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVA 191 (381)
Q Consensus 129 ~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~ 191 (381)
.+++|.+++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||+++....... ......
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~ 159 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAYSFC 159 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ceeccc
Confidence 999996554 68999999999999 999999999999999999999999986533221 223457
Q ss_pred cCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHH
Q 048280 192 GTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271 (381)
Q Consensus 192 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (381)
||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........... ..+....
T Consensus 160 g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~~~i~~~~~-----------~~p~~~~ 222 (318)
T cd05582 160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK------ETMTMILKAKL-----------GMPQFLS 222 (318)
T ss_pred CChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH------HHHHHHHcCCC-----------CCCCCCC
Confidence 899999999999888999999999999999999999998643211 11111111110 0111223
Q ss_pred HHHHHHHHHcccCCCCCCCCHHH
Q 048280 272 AMCIQIGLLCTQGDPQLRPTMRR 294 (381)
Q Consensus 272 ~~l~~li~~cl~~dP~~RPs~~e 294 (381)
..+.+|+.+||+.||++||++.+
T Consensus 223 ~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 223 PEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCC
Confidence 55788999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=319.22 Aligned_cols=241 Identities=21% Similarity=0.295 Sum_probs=176.4
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeC--------
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHG-------- 118 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-------- 118 (381)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3568999999999999999999875 58999999985432 2345799999999999999999887432
Q ss_pred CeEEEEEecccCCCHHHH-------------------HHhhhhhhhHhhhhc--cCCccccceEeCCCC-CcEEeeeccc
Q 048280 119 AEKLLIYEYVINESLDKV-------------------LFSLIKDIQILFRKK--KTDIKASNILLDDKW-IPKIADFGMA 176 (381)
Q Consensus 119 ~~~~lv~E~~~~g~L~~~-------------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~-~~kL~DFG~~ 176 (381)
..+++||||+++ +|.++ +.|++.||.|||+.+ ||||||+||||+.++ .+||+|||++
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 246799999965 55433 258999999999999 999999999998664 7999999999
Q ss_pred eecCCCCcccccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcC---
Q 048280 177 RLFPEDQTHVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKD--- 252 (381)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 252 (381)
+.+..... .....||+.|+|||++.+. .++.++|||||||+||||++|.+||......+. +.. ........
T Consensus 219 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~-i~~~~~~p~~~ 293 (440)
T PTZ00036 219 KNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVR-IIQVLGTPTED 293 (440)
T ss_pred hhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHHhCCCCHH
Confidence 86643221 2235689999999998764 689999999999999999999999865432211 111 11110000
Q ss_pred -------CcccccCCCCC-----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 253 -------KSLEIVDPSLA-----ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 253 -------~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.......+... ...+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000001110 00111223568899999999999999999999853
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=294.35 Aligned_cols=239 Identities=23% Similarity=0.397 Sum_probs=190.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++|++.+.||+|+||.||+|+.. +++.||||.+.... ......+.+|+.+++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999865 68999999875432 233456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHH-------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 126 EYVINESLDKVL-------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 126 E~~~~g~L~~~l-------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
||+++++|.+++ .+++.++.|+|+.+ |+||||+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 999999996544 57899999999998 999999999999999999999999987643322
Q ss_pred ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 185 HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ......... .... .+ .
T Consensus 162 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~-~~~~-----~~---~ 227 (267)
T cd08228 162 -AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKI-EQCD-----YP---P 227 (267)
T ss_pred -HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHH-hcCC-----CC---C
Confidence 12234688899999999988899999999999999999999999853221 111111111 1100 11 1
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.........+.+++.+||..+|++||++.+|++.|++.
T Consensus 228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11223446688999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=300.49 Aligned_cols=236 Identities=28% Similarity=0.452 Sum_probs=186.1
Q ss_pred cCCCCCCcccccCCeeEEEEEE-----CCCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKL-----DDGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
.+|++.+.||+|+||.||+|.. .++..|++|.+.... ......+.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4688899999999999999974 246789999987533 2334678899999999999999999999999999999
Q ss_pred EEecccCCCHHHHH--------------------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcE
Q 048280 124 IYEYVINESLDKVL--------------------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPK 169 (381)
Q Consensus 124 v~E~~~~g~L~~~l--------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~k 169 (381)
||||+.+++|.+++ .+++.++.|+|+.+ ||||||+|||++.++.+|
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~k 164 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVK 164 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEE
Confidence 99999999987654 47899999999999 999999999999999999
Q ss_pred EeeeccceecCCCCc-ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHH
Q 048280 170 IADFGMARLFPEDQT-HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYK 247 (381)
Q Consensus 170 L~DFG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 247 (381)
|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||..... .... .
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~----~ 237 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVI----E 237 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHH----H
Confidence 999999986533221 11223345678999999988889999999999999999998 8888753221 1111 1
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 248 LYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
........ .........+.+++.+||+.||.+||++.+|++.|..
T Consensus 238 ~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 MVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111 0111233568889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=306.63 Aligned_cols=231 Identities=19% Similarity=0.289 Sum_probs=179.3
Q ss_pred CcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEEEEecccC
Q 048280 56 NKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999875 58899999997542 22345678899999998 799999999999999999999999999
Q ss_pred CCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccC
Q 048280 131 ESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT 193 (381)
Q Consensus 131 g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt 193 (381)
|+|..++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++...... .......||
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt 159 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTSTFCGT 159 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC-CccccccCC
Confidence 9997554 68999999999999 99999999999999999999999987532211 122346789
Q ss_pred ccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccc--cccHHHHHHHHhhcCCcccccCCCCCCCCCHHHH
Q 048280 194 NGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVD--AQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271 (381)
Q Consensus 194 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (381)
..|+|||++.+..++.++|||||||++|+|++|+.||......+ ......+.......... .+ +....
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~----p~~~~ 229 (329)
T cd05588 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RI----PRSLS 229 (329)
T ss_pred ccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CC----CCCCC
Confidence 99999999999999999999999999999999999996422211 11112222222221111 01 11123
Q ss_pred HHHHHHHHHcccCCCCCCCC------HHHHHH
Q 048280 272 AMCIQIGLLCTQGDPQLRPT------MRRVVV 297 (381)
Q Consensus 272 ~~l~~li~~cl~~dP~~RPs------~~eil~ 297 (381)
..+.+++.+||+.||.+|++ +.++++
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 45788999999999999998 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=306.33 Aligned_cols=238 Identities=27% Similarity=0.421 Sum_probs=184.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCc----EEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGR----EIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 122 (381)
..+|++.+.||+|+||.||+|.+. ++. .||+|++.... ....+.+.+|+.+++.++||||++++++|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 357999999999999999999854 333 48999986543 33456788999999999999999999999865 578
Q ss_pred EEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 123 LIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 123 lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
+|+||+++|+|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++.+.....
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 999999999997654 58899999999999 999999999999999999999999987654322
Q ss_pred ccc-cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 185 HVN-TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 185 ~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
... ....++..|+|||++.+..++.++|||||||++|||++ |..||...... .+ .......... ..+
T Consensus 165 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~----~~~~~~~~~~--~~~-- 233 (316)
T cd05108 165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EI----SSILEKGERL--PQP-- 233 (316)
T ss_pred ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHHHhCCCCC--CCC--
Confidence 211 12234678999999999999999999999999999997 89887532211 11 1111111110 001
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
..+...+.+++.+||..||.+||++.+++..|....
T Consensus 234 -----~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 234 -----PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred -----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 112345788999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=312.03 Aligned_cols=245 Identities=24% Similarity=0.346 Sum_probs=182.6
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC-----eEE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA-----EKL 122 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~ 122 (381)
+|++.+.||+|+||.||++... +++.||||++... .......+.+|+.+++.++|+||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5888999999999999999864 6899999998643 2233467889999999999999999999998776 789
Q ss_pred EEEecccCCCHHH---------------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 123 LIYEYVINESLDK---------------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 123 lv~E~~~~g~L~~---------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
+||||+. ++|.+ ++.|++.+|.|||+.+ ||||||+|||++.++.+||+|||++.........
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 9999995 45543 3478999999999999 9999999999999999999999999865433322
Q ss_pred cccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHH----------------HHHH
Q 048280 186 VNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDW----------------AYKL 248 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~----------------~~~~ 248 (381)
......++..|+|||++.+. .++.++|||||||++|||++|+.||......+....+.. ....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 23345678999999998874 479999999999999999999999865433221111100 0000
Q ss_pred hhcC-CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 249 YKKD-KSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 249 ~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.... ...... ... ..........+.+|+.+||+.||.+|||+.|+++.
T Consensus 240 ~~~~~~~~~~~-~~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 240 ILRGPHKPPSL-PVL-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHhCCCCCCch-HHh-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000 000000 000 00111224567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=296.47 Aligned_cols=238 Identities=24% Similarity=0.340 Sum_probs=187.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++......++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 457999999999999999999864 6889999999765544556788999999999999999999999999999999999
Q ss_pred ccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccc
Q 048280 128 VINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV 190 (381)
Q Consensus 128 ~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 190 (381)
+++++|.+++ .|++.++.|+|..+ ||||||+||+++.++.+||+|||++..+..... .....
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 166 (267)
T cd06646 88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRKSF 166 (267)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc-ccCcc
Confidence 9999998764 68899999999988 999999999999999999999999986643221 12234
Q ss_pred ccCccccchhHHh---hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 191 AGTNGYMAPEYVM---HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 191 ~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
.|+..|+|||.+. ...++.++|||||||++|||++|+.||........ ... .... ....+... ..
T Consensus 167 ~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~------~~~-~~~~---~~~~~~~~--~~ 234 (267)
T cd06646 167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFL-MSKS---NFQPPKLK--DK 234 (267)
T ss_pred ccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh------hee-eecC---CCCCCCCc--cc
Confidence 6888999999884 34578899999999999999999999743221110 000 0000 00011111 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
......+.+++.+||..+|++|||+++|++.|
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 235 TKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 12346788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=323.33 Aligned_cols=238 Identities=25% Similarity=0.322 Sum_probs=187.2
Q ss_pred HHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC--
Q 048280 45 LVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA-- 119 (381)
Q Consensus 45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-- 119 (381)
.....++|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++..++|+||+++++.+....
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3444679999999999999999999854 68999999986542 333467889999999999999999988765432
Q ss_pred ------eEEEEEecccCCCHHHHH-------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEee
Q 048280 120 ------EKLLIYEYVINESLDKVL-------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIAD 172 (381)
Q Consensus 120 ------~~~lv~E~~~~g~L~~~l-------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~D 172 (381)
..++||||+.+|+|.+++ .|++.+|.|+|..+ ||||||+||||+.++.+||+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence 368999999999997654 58899999999999 999999999999999999999
Q ss_pred eccceecCCCCc-ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc
Q 048280 173 FGMARLFPEDQT-HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKK 251 (381)
Q Consensus 173 FG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 251 (381)
||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...........
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~~~~~~ 260 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHKTLAG 260 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHhcC
Confidence 999987643221 12234679999999999999999999999999999999999999985322 11111111111
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 252 DKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
. . . ..+......+.+|+.+||+.||.+||++.+++..
T Consensus 261 ~-~----~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 R-Y----D-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred C-C----C-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1 0 0 0112234568899999999999999999999864
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=300.14 Aligned_cols=233 Identities=27% Similarity=0.338 Sum_probs=184.9
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc---ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
+|++.+.||+|+||.||++... +++.||||++..... .....+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4888999999999999999865 589999999865321 223457789999999999999999999999999999999
Q ss_pred cccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 127 YVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 127 ~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|+.+++|..++ .|++.++.|+|+.+ ||||||+||++++++.++|+|||++........ .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~ 158 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--I 158 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc--c
Confidence 99999997544 68899999999998 999999999999999999999999987543222 1
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
....|+..|+|||++.+..++.++|||||||++|||++|..||....... ............. ....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~----------~~~~ 225 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKEDQ----------EEYS 225 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhcc----------cccC
Confidence 23468999999999998899999999999999999999999986432211 1111111111100 1112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRP-----TMRRVVVM 298 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 298 (381)
......+.+|+.+||+.||.+|| +++++++.
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 226 EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 23445678899999999999999 88888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=295.94 Aligned_cols=239 Identities=22% Similarity=0.329 Sum_probs=187.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 46888999999999999999864 6889999998654 223346788999999999999999999999999999999999
Q ss_pred ccCCCHHH-----------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccCc
Q 048280 128 VINESLDK-----------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN 194 (381)
Q Consensus 128 ~~~g~L~~-----------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~ 194 (381)
+++++|.. ++.|++.++.|+|+.+ |+||||+|||++.++.+||+|||++..+.... .....|+.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~ 157 (279)
T cd06619 81 MDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---AKTYVGTN 157 (279)
T ss_pred CCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---ccCCCCCh
Confidence 99998853 4588999999999999 99999999999999999999999998654321 22356899
Q ss_pred cccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHH
Q 048280 195 GYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMC 274 (381)
Q Consensus 195 ~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 274 (381)
.|+|||++.+..++.++|||||||++|+|++|+.||....................... .+.+. .......+
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~---~~~~~~~~ 229 (279)
T cd06619 158 AYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVLP---VGQFSEKF 229 (279)
T ss_pred hhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCCC---CCcCCHHH
Confidence 99999999988999999999999999999999999854322111110000011111110 01110 11123457
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 275 IQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 275 ~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
.+++.+||+.||++||+++++++..
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcCc
Confidence 8899999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=314.95 Aligned_cols=233 Identities=21% Similarity=0.283 Sum_probs=178.6
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
.|++++.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++|+||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5889999999999999999865 58899999986542 2234568889999999999999999999999999999999
Q ss_pred cccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC------
Q 048280 127 YVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ------ 183 (381)
Q Consensus 127 ~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~------ 183 (381)
||++|+|.+++ .|++.+|.|+|..+ ||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 99999997655 57899999999999 99999999999999999999999975321000
Q ss_pred ----------------------------------------cccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHH
Q 048280 184 ----------------------------------------THVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILEL 223 (381)
Q Consensus 184 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~el 223 (381)
.......+||+.|+|||++.+..++.++|||||||+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el 241 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence 0001134689999999999999999999999999999999
Q ss_pred HhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 048280 224 ISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPT---MRRVVV 297 (381)
Q Consensus 224 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~ 297 (381)
++|+.||...... .............. ..........+.+++.+|+ .+|.+|++ +.+++.
T Consensus 242 ltG~~Pf~~~~~~------~~~~~i~~~~~~~~-------~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 242 LVGQPPFLAQTPL------ETQMKVINWQTSLH-------IPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HhCCCCCCCCCHH------HHHHHHHccCCCcC-------CCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 9999998643221 11111111110000 0111122344667777765 49999997 777764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=299.89 Aligned_cols=230 Identities=30% Similarity=0.523 Sum_probs=175.8
Q ss_pred CCCcccccCCeeEEEEEEC-----CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 54 PSNKLGEGGFGPVFKGKLD-----DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 54 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
+.+.||.|.||.||+|.+. .+..|+||.+.... ....+.+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999876 36789999996542 23467899999999999999999999999988889999999
Q ss_pred ccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc-ccc
Q 048280 128 VINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT-HVN 187 (381)
Q Consensus 128 ~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~-~~~ 187 (381)
+++|+|.++| .|++.||.|||+.+ |+||+++|||++.++.+||+|||++........ ...
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~ 162 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKND 162 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEES
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999998765 68999999999998 999999999999999999999999987632222 222
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
........|+|||.+.+..++.++||||||+++|||++ |+.||... +...+. ... ....... .
T Consensus 163 ~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~---~~~~~~---~~~-~~~~~~~---------~ 226 (259)
T PF07714_consen 163 SSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY---DNEEII---EKL-KQGQRLP---------I 226 (259)
T ss_dssp TTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS---CHHHHH---HHH-HTTEETT---------S
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc---cccccc---ccc-cccccce---------e
Confidence 23456778999999999999999999999999999999 67776433 111111 111 1111111 1
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
...++..+.+++.+||..||++|||+.+|++.|
T Consensus 227 ~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112345578899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=303.11 Aligned_cols=220 Identities=23% Similarity=0.296 Sum_probs=170.9
Q ss_pred CcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHH-HHHHhCCCCcccEEEEEeeCCeEEEEEecccC
Q 048280 56 NKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAK-LLARVQHRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
+.||+|+||.||+|+.. +++.||+|++.... ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 58899999986432 122334555554 57888999999999999999999999999999
Q ss_pred CCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccC
Q 048280 131 ESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT 193 (381)
Q Consensus 131 g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt 193 (381)
++|...+ .|++.+|.|||..+ ||||||+||||+.++.+||+|||+++...... .......||
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt 159 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFCGT 159 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-CccccccCC
Confidence 9996543 68999999999998 99999999999999999999999987532221 122345789
Q ss_pred ccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHH
Q 048280 194 NGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAM 273 (381)
Q Consensus 194 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (381)
+.|+|||++.+..++.++|||||||++|||++|..||.... .......... .. . . .+......
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~-~~-~-----~----~~~~~~~~ 222 (321)
T cd05603 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQMYDNILH-KP-L-----Q----LPGGKTVA 222 (321)
T ss_pred cccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC------HHHHHHHHhc-CC-C-----C----CCCCCCHH
Confidence 99999999998899999999999999999999999985432 1111111111 10 0 0 11122345
Q ss_pred HHHHHHHcccCCCCCCCCHH
Q 048280 274 CIQIGLLCTQGDPQLRPTMR 293 (381)
Q Consensus 274 l~~li~~cl~~dP~~RPs~~ 293 (381)
+.+++.+||+.||.+||++.
T Consensus 223 ~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 223 ACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHccCCHhhcCCCC
Confidence 78899999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=306.79 Aligned_cols=224 Identities=22% Similarity=0.266 Sum_probs=177.7
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCC-CcccEEEEEeeCCeEEEEE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHR-NVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~~~~~lv~ 125 (381)
+|++.+.||+|+||.||+|+.. +++.||||++... .....+.+..|++++..++|+ +|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5889999999999999999876 4789999998653 223446678899999999764 6888999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
||+++|+|.+++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||++........ ...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~ 159 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK-TTR 159 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC-cee
Confidence 999999997654 68999999999999 999999999999999999999999875322111 223
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .... ..... .. ..+ +.
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~---~~i~~-~~------~~~----~~ 222 (324)
T cd05587 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELF---QSIME-HN------VSY----PK 222 (324)
T ss_pred eecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHH---HHHHc-CC------CCC----CC
Confidence 45689999999999999999999999999999999999999864321 1111 11111 10 111 11
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCH
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTM 292 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~ 292 (381)
.....+.+++.+||..||.+|++.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 223 SLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 223557889999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=294.61 Aligned_cols=236 Identities=26% Similarity=0.442 Sum_probs=189.1
Q ss_pred hhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
..++|++.++||+|+||.||+|..++++.||+|.+.... .....+.+|+.++++++|+||+++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 356799999999999999999998888999999986543 33568899999999999999999999875 4568999999
Q ss_pred ccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 128 VINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 128 ~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
+.+++|.+++ .+++.+|.|||..+ |+||||+||+++.++.++|+|||++............
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE 161 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccccc
Confidence 9999997654 58899999999988 9999999999999999999999999876533322223
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
...++..|+|||++.+..++.++|||||||++|||++ |+.||...... .... ........ ...
T Consensus 162 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~~~~---------~~~ 225 (260)
T cd05067 162 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQ----NLERGYRM---------PRP 225 (260)
T ss_pred CCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHH----HHHcCCCC---------CCC
Confidence 3445678999999998899999999999999999999 99998533211 1111 11111100 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
...+..+.+++.+||..+|++||++++++..|+.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1233568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=295.89 Aligned_cols=238 Identities=27% Similarity=0.428 Sum_probs=187.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC----CcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD----GREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
.++|++.+.||+|+||.||+|.+.. ...||||.+.... ......+.+|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3579999999999999999998642 4579999986543 2334678899999999999999999999999999999
Q ss_pred EEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 124 IYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 124 v~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
||||+++++|.+++ .+++.++.|||+.+ |+||||+|||++.++.+||+|||++..+......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 99999999997765 67889999999988 9999999999999999999999999977422211
Q ss_pred -cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC
Q 048280 186 -VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||...... .... ........
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~----~~~~~~~~-------- 227 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIK----AVEDGYRL-------- 227 (266)
T ss_pred eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHH----HHHcCCCC--------
Confidence 1112334678999999998899999999999999999998 98887432211 1111 11111000
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 264 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
......+..+.+|+.+||+.+|++||++.+|++.|.+.
T Consensus 228 -~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 -PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01112345688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=298.77 Aligned_cols=238 Identities=25% Similarity=0.418 Sum_probs=185.7
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCe
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAE 120 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 120 (381)
..++|++.+.||+|+||.||+|... .+..||||++.... ......+.+|+.+++.++|+||+++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999999753 25679999985432 2234568899999999999999999999999999
Q ss_pred EEEEEecccCCCHHHHH-------------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeee
Q 048280 121 KLLIYEYVINESLDKVL-------------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADF 173 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l-------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DF 173 (381)
.++||||+++++|.+++ .|++.+|.|+|..+ |+||||+|||+++++.+||+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~df 163 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 163 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCC
Confidence 99999999999987654 36889999999988 9999999999999999999999
Q ss_pred ccceecCCCCccc-ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhc
Q 048280 174 GMARLFPEDQTHV-NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKK 251 (381)
Q Consensus 174 G~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 251 (381)
|++..+....... .....++..|+|||++.+..++.++|||||||++|||++ |..||...... .... ....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~----~~~~ 236 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLR----FVME 236 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHHc
Confidence 9987654332211 112345678999999999899999999999999999999 67777533211 1111 1111
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 252 DKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
..... . .......+.+++.+||+.||++|||+.|+++.|++
T Consensus 237 ~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 237 GGLLD-----K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CCcCC-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11110 1 11223568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=300.95 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=186.4
Q ss_pred cCC-CCCCcccccCCeeEEEEEE-----CCCcEEEEEEecCCCc-ccHHHHHHHHHHHHHhCCCCcccEEEEEeeC--Ce
Q 048280 50 KNF-HPSNKLGEGGFGPVFKGKL-----DDGREIAVKKLSHSSN-QGKKEFENEAKLLARVQHRNVVNLLGYCAHG--AE 120 (381)
Q Consensus 50 ~~y-~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~ 120 (381)
++| .+.+.||+|+||.||++.. .++..||+|.+..... .....+.+|++++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 345 8899999999999988653 3578899999875432 3456788999999999999999999988653 46
Q ss_pred EEEEEecccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 121 KLLIYEYVINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
.++||||+.+++|.+++ .+++.++.|||..+ ||||||+|||++.++.+||+|||++..+.....
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred EEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 89999999999997764 68999999999999 999999999999999999999999987643322
Q ss_pred cc--ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 185 HV--NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 185 ~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|..|+...... .....................+...
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELLERGM 241 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhhhhcCC
Confidence 11 11233566799999998888999999999999999999999997532211 0000000000000000001111111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
........+..+.+++.+||+.||++|||+++|++.|+..
T Consensus 242 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 1112223456788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=304.82 Aligned_cols=226 Identities=19% Similarity=0.294 Sum_probs=175.5
Q ss_pred CcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEEEEecccC
Q 048280 56 NKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
+.||+|+||.||+|+.. +++.||+|++... .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 5889999999754 222345677899998887 799999999999999999999999999
Q ss_pred CCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccC
Q 048280 131 ESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT 193 (381)
Q Consensus 131 g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt 193 (381)
++|..++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||+++....... ......||
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~~~~gt 159 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSTFCGT 159 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-ccccccCC
Confidence 9997544 68999999999999 999999999999999999999999975322211 22345789
Q ss_pred ccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccc--cccHHHHHHHHhhcCCcccccCCCCCCCCCHHHH
Q 048280 194 NGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVD--AQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271 (381)
Q Consensus 194 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (381)
..|+|||++.+..++.++|||||||++|+|++|+.||....... ......+.......... . .+....
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~----~p~~~~ 229 (329)
T cd05618 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------R----IPRSLS 229 (329)
T ss_pred ccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------C----CCCCCC
Confidence 99999999999999999999999999999999999985322111 11112222222211110 0 111223
Q ss_pred HHHHHHHHHcccCCCCCCCCH
Q 048280 272 AMCIQIGLLCTQGDPQLRPTM 292 (381)
Q Consensus 272 ~~l~~li~~cl~~dP~~RPs~ 292 (381)
..+.+++.+||+.||.+||++
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCC
Confidence 457789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=304.23 Aligned_cols=224 Identities=25% Similarity=0.323 Sum_probs=175.1
Q ss_pred CcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEEEEecccC
Q 048280 56 NKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
+.||+|+||.||+|+.. +++.||||++.... ....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 58899999986532 22334566677777655 899999999999999999999999999
Q ss_pred CCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccC
Q 048280 131 ESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT 193 (381)
Q Consensus 131 g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt 193 (381)
|+|..++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||+++...... .......||
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt 159 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFCGT 159 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-CccccccCC
Confidence 9997654 68999999999999 99999999999999999999999998653322 222345789
Q ss_pred ccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHH
Q 048280 194 NGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAM 273 (381)
Q Consensus 194 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (381)
+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+. ..... . .+.+ +......
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~---~~i~~-~------~~~~----~~~~~~~ 222 (316)
T cd05592 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELF---DSILN-D------RPHF----PRWISKE 222 (316)
T ss_pred ccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHH---HHHHc-C------CCCC----CCCCCHH
Confidence 999999999999999999999999999999999999864321 1111 11111 1 0111 1122345
Q ss_pred HHHHHHHcccCCCCCCCCHH-HHHH
Q 048280 274 CIQIGLLCTQGDPQLRPTMR-RVVV 297 (381)
Q Consensus 274 l~~li~~cl~~dP~~RPs~~-eil~ 297 (381)
+.+++.+||+.||.+||++. ++++
T Consensus 223 ~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 223 AKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHHHc
Confidence 77899999999999999875 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=307.70 Aligned_cols=242 Identities=21% Similarity=0.302 Sum_probs=186.7
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhC-C-----CCcccEEEEEeeCCeEEE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQ-H-----RNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----pnIv~~~~~~~~~~~~~l 123 (381)
+|++.+.||+|.||.|.+|.+. +++.||||+++... .-.++...|+++|..|+ | -|||+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7899999999999999999865 69999999997553 33466778999999997 4 489999999999999999
Q ss_pred EEecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCC--CCcEEeeeccceecCCC
Q 048280 124 IYEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDK--WIPKIADFGMARLFPED 182 (381)
Q Consensus 124 v~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~--~~~kL~DFG~~~~~~~~ 182 (381)
|+|.+ ..+|.++| .|++.+|.+||..+ |+||||+||||.+. ..+||+|||.++.....
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~ 344 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR 344 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCc
Confidence 99988 66776665 79999999999988 99999999999643 37999999999976443
Q ss_pred CcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH---------------
Q 048280 183 QTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYK--------------- 247 (381)
Q Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~--------------- 247 (381)
.. ..+.+..|+|||++.|.+|+.+.||||||||+.||++|.+-|.+..+.+....+..+..
T Consensus 345 vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~k 420 (586)
T KOG0667|consen 345 VY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHK 420 (586)
T ss_pred ce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccce
Confidence 22 46678999999999999999999999999999999999888877666554332221110
Q ss_pred Hhhc-CCc--------------------------ccccCC-CC---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 048280 248 LYKK-DKS--------------------------LEIVDP-SL---AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVV 296 (381)
Q Consensus 248 ~~~~-~~~--------------------------~~~~~~-~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 296 (381)
.+.. ... .....| .. ........-..+++++.+||.+||.+|+|..+++
T Consensus 421 ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal 500 (586)
T KOG0667|consen 421 FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQAL 500 (586)
T ss_pred ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHh
Confidence 0001 000 000001 00 0011113345678999999999999999999998
Q ss_pred HH
Q 048280 297 VM 298 (381)
Q Consensus 297 ~~ 298 (381)
+.
T Consensus 501 ~H 502 (586)
T KOG0667|consen 501 NH 502 (586)
T ss_pred cC
Confidence 74
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=299.18 Aligned_cols=243 Identities=24% Similarity=0.413 Sum_probs=184.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC---------------CcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD---------------GREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLL 112 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~ 112 (381)
.++|++.+.||+|+||.||+++... ...||+|.+... .......+.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3589999999999999999987532 235899998754 233346789999999999999999999
Q ss_pred EEEeeCCeEEEEEecccCCCHHHH---------------------------HHhhhhhhhHhhhhc--cCCccccceEeC
Q 048280 113 GYCAHGAEKLLIYEYVINESLDKV---------------------------LFSLIKDIQILFRKK--KTDIKASNILLD 163 (381)
Q Consensus 113 ~~~~~~~~~~lv~E~~~~g~L~~~---------------------------l~~~~~~l~~lh~~~--HrDlkp~NIll~ 163 (381)
+++...+..++||||+.+++|.++ +.+++.+++|||..+ |+||||+|||++
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~ 163 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence 999999999999999999988654 357889999999999 999999999999
Q ss_pred CCCCcEEeeeccceecCCCCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh--CCCCCCCCCcccccc
Q 048280 164 DKWIPKIADFGMARLFPEDQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS--GQRNSSFNLDVDAQN 240 (381)
Q Consensus 164 ~~~~~kL~DFG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~p~~~~~~~~~~~ 240 (381)
.++.+||+|||++..+...... ......++..|+|||++.++.++.++|||||||++|+|++ +..||..... ..
T Consensus 164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~---~~ 240 (295)
T cd05097 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD---EQ 240 (295)
T ss_pred CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---HH
Confidence 9999999999999865332211 1122345678999999998899999999999999999998 4455532211 11
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 241 LLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
.................. ......+..+.+|+.+||+.||++|||+.+|++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 222111111111000000 011112356889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=300.19 Aligned_cols=236 Identities=27% Similarity=0.427 Sum_probs=185.4
Q ss_pred cCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCCCc-ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHSSN-QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 122 (381)
.+|++.+.||+|+||.||+|... ++..||||++..... ...+.+.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 35788899999999999999753 257899999975432 23466889999999999999999999999999999
Q ss_pred EEEecccCCCHHHHH-------------------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcE
Q 048280 123 LIYEYVINESLDKVL-------------------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPK 169 (381)
Q Consensus 123 lv~E~~~~g~L~~~l-------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~k 169 (381)
+++||+.+++|..++ .|++.+|.|+|+.+ ||||||+|||+++++.+|
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceE
Confidence 999999988887654 48999999999998 999999999999999999
Q ss_pred EeeeccceecCCCCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHH
Q 048280 170 IADFGMARLFPEDQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYK 247 (381)
Q Consensus 170 L~DFG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 247 (381)
|+|||+++........ ......+++.|+|||++.++.++.++|||||||++|||++ |..||..... .... .
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~----~ 237 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVI----E 237 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHH----H
Confidence 9999998865433221 1223345778999999998899999999999999999998 7777643211 1111 1
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 248 LYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
........ ....+.+..+.+|+.+||+.+|.+||++.+|+..|+.
T Consensus 238 ~i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111111 1112344568889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=301.16 Aligned_cols=245 Identities=29% Similarity=0.417 Sum_probs=185.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-----CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEee--CCeE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-----DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAH--GAEK 121 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~ 121 (381)
.++|++.+.||+|+||.||++... ++..||+|++........+.+.+|++++++++||||+++++++.. ....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 357899999999999999999742 578999999876655556788999999999999999999998754 3468
Q ss_pred EEEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 122 LLIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
++||||+++++|.+++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||++..+....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 9999999999998765 57899999999999 99999999999999999999999998764332
Q ss_pred ccc--ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccc---------ccHHHHHHHHhhcC
Q 048280 184 THV--NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDA---------QNLLDWAYKLYKKD 252 (381)
Q Consensus 184 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~---------~~~~~~~~~~~~~~ 252 (381)
... .....++..|+|||++.+..++.++|||||||++|||++|..++......-. ..............
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05081 163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN 242 (284)
T ss_pred cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC
Confidence 211 1112234569999999988999999999999999999998776532211000 00000000111110
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 253 KSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
............+.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus 243 ---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 243 ---------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ---------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00111122345688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=292.84 Aligned_cols=234 Identities=25% Similarity=0.435 Sum_probs=186.7
Q ss_pred cCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEeccc
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVI 129 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 129 (381)
++|++.+.||+|+||.||+|....+..+|+|.+.... ...+.+.+|++++++++|+||+++++++.. +..++||||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 5689999999999999999998777789999886543 345678999999999999999999998854 56899999999
Q ss_pred CCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccc
Q 048280 130 NESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV 190 (381)
Q Consensus 130 ~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 190 (381)
+++|.+++ .+++.+|.|+|..+ |+||||+||++++++.+||+|||++..............
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA 163 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCC
Confidence 99997665 57899999999988 999999999999999999999999987644332222233
Q ss_pred ccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHH
Q 048280 191 AGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGD 269 (381)
Q Consensus 191 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (381)
.++..|+|||.+.+..++.++|||||||++|+|++ |..||...... .... ....... ......
T Consensus 164 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~---------~~~~~~ 227 (260)
T cd05069 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLE----QVERGYR---------MPCPQG 227 (260)
T ss_pred ccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCC---------CCCCcc
Confidence 46678999999998899999999999999999999 88887543211 1111 1111100 111223
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 270 QIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 270 ~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
.+..+.+++.+||..||.+||++++|++.|+.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 228 CPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 45678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=304.98 Aligned_cols=228 Identities=21% Similarity=0.267 Sum_probs=175.0
Q ss_pred CcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHH-HHHHhCCCCcccEEEEEeeCCeEEEEEecccC
Q 048280 56 NKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAK-LLARVQHRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
+.||+|+||.||+|+.. +++.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 57889999986532 112234444444 56778999999999999999999999999999
Q ss_pred CCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccC
Q 048280 131 ESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT 193 (381)
Q Consensus 131 g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt 193 (381)
++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++....... ......||
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~~~~gt 159 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTSTFCGT 159 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-CcccccCC
Confidence 9997654 68999999999999 999999999999999999999999975432221 22345799
Q ss_pred ccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHH
Q 048280 194 NGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAM 273 (381)
Q Consensus 194 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (381)
+.|+|||++.+..++.++|||||||++|+|++|..||...... ... ....... . .. .......
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~---~~i~~~~-~--~~--------~~~~~~~ 222 (325)
T cd05602 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMY---DNILNKP-L--QL--------KPNITNS 222 (325)
T ss_pred ccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHH---HHHHhCC-c--CC--------CCCCCHH
Confidence 9999999999999999999999999999999999998643211 111 1111110 0 01 1123355
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 274 CIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 274 l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
+.+++.+||+.||.+||++.+.+..+.+
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 223 ARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred HHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 7889999999999999998755544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=290.80 Aligned_cols=229 Identities=26% Similarity=0.363 Sum_probs=181.4
Q ss_pred CcccccCCeeEEEEEECCCcEEEEEEecCCCc-ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCCCHH
Q 048280 56 NKLGEGGFGPVFKGKLDDGREIAVKKLSHSSN-QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLD 134 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~ 134 (381)
+.||+|+||.||+|...++..||+|.+..... .....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999999988889999999865432 23356889999999999999999999999999999999999999987
Q ss_pred HHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccCccc
Q 048280 135 KVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGY 196 (381)
Q Consensus 135 ~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y 196 (381)
+++ .+++.++.++|..+ |+||||+||+++.++.+||+|||++...............++..|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y 160 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKW 160 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccc
Confidence 654 57888999999988 999999999999999999999999976543322222223346679
Q ss_pred cchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHH
Q 048280 197 MAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCI 275 (381)
Q Consensus 197 ~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 275 (381)
+|||++.+..++.++|||||||++|+|++ |..||...... .. .......... ......+..+.
T Consensus 161 ~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~----~~~~~~~~~~---------~~~~~~~~~~~ 224 (250)
T cd05085 161 TAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QA----REQVEKGYRM---------SCPQKCPDDVY 224 (250)
T ss_pred cCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HH----HHHHHcCCCC---------CCCCCCCHHHH
Confidence 99999998899999999999999999998 88888533211 11 1111111110 11112345688
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 276 QIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 276 ~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
+++.+||+.+|++||++.++++.|.
T Consensus 225 ~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 225 KVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHcccCcccCCCHHHHHHHhc
Confidence 9999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=309.54 Aligned_cols=239 Identities=30% Similarity=0.454 Sum_probs=185.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCCC-cccHHHHHHHHHHHHHh-CCCCcccEEEEEee-CC
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHSS-NQGKKEFENEAKLLARV-QHRNVVNLLGYCAH-GA 119 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~-~~ 119 (381)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.++ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 457999999999999999999632 25789999986542 22335678899999999 89999999998864 45
Q ss_pred eEEEEEecccCCCHHHHH--------------------------------------------------------------
Q 048280 120 EKLLIYEYVINESLDKVL-------------------------------------------------------------- 137 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~~l-------------------------------------------------------------- 137 (381)
..+++|||+++++|.+++
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 688999999999997654
Q ss_pred --------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc-ccccccCccccchh
Q 048280 138 --------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV-NTRVAGTNGYMAPE 200 (381)
Q Consensus 138 --------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~-~~~~~gt~~y~aPE 200 (381)
.|++.+|.|+|..+ ||||||+|||++.++.+||+|||++..+....... .....++..|+|||
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 57899999999998 99999999999999999999999998754332211 22344567899999
Q ss_pred HHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHH
Q 048280 201 YVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGL 279 (381)
Q Consensus 201 ~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 279 (381)
++.+..++.++|||||||+||||++ |..||......+ .+ .......... .........+.+++.
T Consensus 246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~----~~~~~~~~~~---------~~~~~~~~~~~~l~~ 310 (337)
T cd05054 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EF----CRRLKEGTRM---------RAPEYATPEIYSIML 310 (337)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HH----HHHHhccCCC---------CCCccCCHHHHHHHH
Confidence 9999999999999999999999998 998885422111 11 1111111110 011122356889999
Q ss_pred HcccCCCCCCCCHHHHHHHhcCC
Q 048280 280 LCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 280 ~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
+||+.+|++||++.||++.|+..
T Consensus 311 ~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 311 DCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=301.11 Aligned_cols=238 Identities=27% Similarity=0.456 Sum_probs=190.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
++|.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|+.++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888999999999999999742 355689999876655556789999999999999999999999999999999
Q ss_pred EEecccCCCHHHHH-------------------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEE
Q 048280 124 IYEYVINESLDKVL-------------------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKI 170 (381)
Q Consensus 124 v~E~~~~g~L~~~l-------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL 170 (381)
||||+++++|.+++ .|++.++.|+|+.+ ||||||+|||++.++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l 164 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKI 164 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEE
Confidence 99999999987654 57899999999999 9999999999999999999
Q ss_pred eeeccceecCCCCc-ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHH
Q 048280 171 ADFGMARLFPEDQT-HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKL 248 (381)
Q Consensus 171 ~DFG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 248 (381)
+|||++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||...... ... ..
T Consensus 165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~----~~ 237 (291)
T cd05094 165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVI----EC 237 (291)
T ss_pred CCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HH
Confidence 99999986543322 11223456788999999999999999999999999999999 99887543221 111 11
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 249 YKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
........ .....+..+.+++.+||+.||.+||++.+|++.|+...
T Consensus 238 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 238 ITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred HhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 11111111 11123456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=299.60 Aligned_cols=238 Identities=26% Similarity=0.467 Sum_probs=188.4
Q ss_pred cCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
++|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|+.++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57899999999999999999742 345689999876655556789999999999999999999999999999999
Q ss_pred EEecccCCCHHHHH----------------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeee
Q 048280 124 IYEYVINESLDKVL----------------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADF 173 (381)
Q Consensus 124 v~E~~~~g~L~~~l----------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DF 173 (381)
||||+++++|.+++ .|++.+|.|+|..+ ||||||+|||+++++.+||+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~df 164 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDF 164 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccC
Confidence 99999999986554 57899999999999 9999999999999999999999
Q ss_pred ccceecCCCCc-ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhc
Q 048280 174 GMARLFPEDQT-HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKK 251 (381)
Q Consensus 174 G~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 251 (381)
|++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||...... .... ....
T Consensus 165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---~~~~----~i~~ 237 (288)
T cd05093 165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIE----CITQ 237 (288)
T ss_pred CccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHc
Confidence 99986533221 11123345778999999998899999999999999999998 88887533211 1111 1111
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 252 DKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
..... . .......+.+|+.+||+.||.+|||+.+++..|+...
T Consensus 238 ~~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 238 GRVLQ-----R----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred CCcCC-----C----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 11110 0 1112345889999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=302.41 Aligned_cols=225 Identities=24% Similarity=0.306 Sum_probs=178.1
Q ss_pred CcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEEEEecccC
Q 048280 56 NKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
+.||+|+||.||+|+.. +++.||||++.... ......+..|++++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 48899999986542 23345677899999876 799999999999999999999999999
Q ss_pred CCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccC
Q 048280 131 ESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT 193 (381)
Q Consensus 131 g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt 193 (381)
++|..++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++........ ......||
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~gt 159 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTTFCGT 159 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cccccccC
Confidence 9996544 68999999999999 999999999999999999999999985432221 22345689
Q ss_pred ccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHH
Q 048280 194 NGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAM 273 (381)
Q Consensus 194 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (381)
+.|+|||++.+..++.++|||||||++|+|++|+.||...... ... ....... ...+. .....
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~---~~i~~~~----~~~p~-------~~~~~ 222 (321)
T cd05591 160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLF---ESILHDD----VLYPV-------WLSKE 222 (321)
T ss_pred ccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHH---HHHHcCC----CCCCC-------CCCHH
Confidence 9999999999989999999999999999999999998643221 111 1111111 11111 12356
Q ss_pred HHHHHHHcccCCCCCCC-------CHHHHHHH
Q 048280 274 CIQIGLLCTQGDPQLRP-------TMRRVVVM 298 (381)
Q Consensus 274 l~~li~~cl~~dP~~RP-------s~~eil~~ 298 (381)
+.+++.+||+.||++|| ++.++++.
T Consensus 223 ~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 223 AVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 78899999999999999 77777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=299.37 Aligned_cols=235 Identities=24% Similarity=0.380 Sum_probs=190.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
.++|++.+.||+|+||.||+|... +++.|++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 468999999999999999999864 5899999999766555567889999999999999999999999999999999999
Q ss_pred ccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccc
Q 048280 128 VINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVA 191 (381)
Q Consensus 128 ~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~ 191 (381)
+++++|.+++ .|++.++.|+|..+ |+||||+|||++.++.+||+|||++........ ......
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~ 177 (296)
T cd06654 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMV 177 (296)
T ss_pred cCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-ccCccc
Confidence 9999997665 57899999999999 999999999999999999999999886533221 122346
Q ss_pred cCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHH
Q 048280 192 GTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271 (381)
Q Consensus 192 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (381)
+++.|+|||.+.+..++.++|||||||++|+|++|+.||...... .......... . +. ........
T Consensus 178 ~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~------~~~~~~~~~~-~-----~~--~~~~~~~~ 243 (296)
T cd06654 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNG-T-----PE--LQNPEKLS 243 (296)
T ss_pred CCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH------HhHHHHhcCC-C-----CC--CCCccccC
Confidence 889999999999888999999999999999999999998543221 1111111111 0 00 01122344
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 272 AMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 272 ~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
..+.+++.+||..||++||++.+|+..
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 244 AIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 568889999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=306.41 Aligned_cols=245 Identities=26% Similarity=0.428 Sum_probs=198.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcc-cHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQ-GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
.+...+.++||+|-||.|.++....+..||||+++..... .+.+|.+|+++|.+|+|||||.++|+|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 4567889999999999999999987899999999876444 458999999999999999999999999999999999999
Q ss_pred ccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCC-Ccccc
Q 048280 128 VINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPED-QTHVN 187 (381)
Q Consensus 128 ~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~-~~~~~ 187 (381)
+++|+|.+++ .|++.+++||-+.+ ||||.+.|+|++.++++||+|||+++.+-.. .....
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq 696 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ 696 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence 9999999887 68999999999988 9999999999999999999999999955433 33344
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh--CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS--GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
...+-.+.|||||.+..++++.++|||+||+++||+++ ...||....+ ...++............ ....
T Consensus 697 gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~~~~~------~~l~ 767 (807)
T KOG1094|consen 697 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRDQGRQ------VVLS 767 (807)
T ss_pred cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCCCCcc------eecc
Confidence 45566789999999999999999999999999999875 5667643221 12222222222222111 1122
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 266 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.+.-++..+.+++.+||..|-.+||++++|...|...
T Consensus 768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 768 RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 3334556788999999999999999999999988754
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=303.17 Aligned_cols=220 Identities=24% Similarity=0.287 Sum_probs=171.8
Q ss_pred CcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHH-HHHHhCCCCcccEEEEEeeCCeEEEEEecccC
Q 048280 56 NKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAK-LLARVQHRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
+.||+|+||.||+|+.. +++.||||++.... ......+.+|.. +++.++||||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999876 58999999986432 122234555554 56778999999999999999999999999999
Q ss_pred CCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccC
Q 048280 131 ESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT 193 (381)
Q Consensus 131 g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt 193 (381)
++|..++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||+++...... .......||
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt 159 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTSTFCGT 159 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-CccccccCC
Confidence 9996544 68999999999999 99999999999999999999999987532221 122345789
Q ss_pred ccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHH
Q 048280 194 NGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAM 273 (381)
Q Consensus 194 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (381)
+.|+|||++.+..++.++|||||||++|+|++|..||..... ........... ..+.. .....
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~-------~~~~~----~~~~~ 222 (323)
T cd05575 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNILNKP-------LRLKP----NISVS 222 (323)
T ss_pred hhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHHcCC-------CCCCC----CCCHH
Confidence 999999999999999999999999999999999999854321 11111111110 01111 12456
Q ss_pred HHHHHHHcccCCCCCCCCHH
Q 048280 274 CIQIGLLCTQGDPQLRPTMR 293 (381)
Q Consensus 274 l~~li~~cl~~dP~~RPs~~ 293 (381)
+.+++.+||+.||.+||++.
T Consensus 223 ~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 223 ARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHhhcCHHhCCCCC
Confidence 88899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=304.29 Aligned_cols=219 Identities=24% Similarity=0.335 Sum_probs=174.5
Q ss_pred CcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEEEEecccC
Q 048280 56 NKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
+.||+|+||.||+|+.+ +++.||||++... .......+..|+.++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999876 5889999998643 223345677899998877 699999999999999999999999999
Q ss_pred CCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccC
Q 048280 131 ESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT 193 (381)
Q Consensus 131 g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt 193 (381)
|+|..++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||+++...... .......||
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt 159 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTFCGT 159 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-CcccccccC
Confidence 9997654 68999999999999 99999999999999999999999988542221 122345789
Q ss_pred ccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHH
Q 048280 194 NGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAM 273 (381)
Q Consensus 194 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (381)
+.|+|||++.+..++.++|||||||++|+|++|+.||...... ... ..... .. ...+ ......
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~---~~i~~-~~---~~~~-------~~~~~~ 222 (320)
T cd05590 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DLF---EAILN-DE---VVYP-------TWLSQD 222 (320)
T ss_pred ccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHH---HHHhc-CC---CCCC-------CCCCHH
Confidence 9999999999989999999999999999999999998643221 111 11111 11 0111 112356
Q ss_pred HHHHHHHcccCCCCCCCCH
Q 048280 274 CIQIGLLCTQGDPQLRPTM 292 (381)
Q Consensus 274 l~~li~~cl~~dP~~RPs~ 292 (381)
+.+++.+||+.||.+||++
T Consensus 223 ~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 223 AVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHcccCHHHCCCC
Confidence 7889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=296.46 Aligned_cols=226 Identities=23% Similarity=0.339 Sum_probs=177.6
Q ss_pred ccccCCeeEEEEEEC-CCcEEEEEEecCCCc---ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCCCH
Q 048280 58 LGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESL 133 (381)
Q Consensus 58 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L 133 (381)
||+|+||.||++... +++.||||++..... ...+.+..|+++++.++|+||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999865 588999999864322 2235677899999999999999999999999999999999999999
Q ss_pred HHHH-------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccccc
Q 048280 134 DKVL-------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAG 192 (381)
Q Consensus 134 ~~~l-------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~g 192 (381)
..++ .|++.+|.|+|+.+ ||||||+|||++.++.+||+|||++..+...... .....|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~g 159 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAG 159 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccccCC
Confidence 6433 68999999999998 9999999999999999999999999866433221 234568
Q ss_pred CccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHH
Q 048280 193 TNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIA 272 (381)
Q Consensus 193 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (381)
|+.|+|||++.+..++.++|||||||++|+|++|+.||......... ......... .. .........
T Consensus 160 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~---------~~--~~~~~~~~~ 226 (280)
T cd05608 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRILN---------DS--VTYPDKFSP 226 (280)
T ss_pred CcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHhhcc---------cC--CCCcccCCH
Confidence 99999999999999999999999999999999999998643221110 000000000 00 011123445
Q ss_pred HHHHHHHHcccCCCCCCC-----CHHHHHH
Q 048280 273 MCIQIGLLCTQGDPQLRP-----TMRRVVV 297 (381)
Q Consensus 273 ~l~~li~~cl~~dP~~RP-----s~~eil~ 297 (381)
.+.+++.+||+.||++|| +++++++
T Consensus 227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 227 ASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 688899999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=299.78 Aligned_cols=237 Identities=22% Similarity=0.289 Sum_probs=181.3
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++|++.+.||+|+||.||+++.. +++.||||++... .......+.+|+.++..++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999865 5899999998642 2223456888999999999999999999999999999999
Q ss_pred ecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 126 EYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 126 E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
||+.+++|.+++ .|++.+|+|||+.+ ||||||+|||++.++.+||+|||++..+........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 999999997665 67899999999999 999999999999999999999999986644333223
Q ss_pred cccccCccccchhHHhh-----CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 188 TRVAGTNGYMAPEYVMH-----GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
....||+.|+|||++.. ..++.++|||||||++|+|++|+.||..... .+.............. +.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~~--~~- 231 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHFQF--PP- 231 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCcccC--CC-
Confidence 33568999999999873 4578899999999999999999999853221 1111112111111111 11
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCC--CCCCCHHHHHHH
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDP--QLRPTMRRVVVM 298 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP--~~RPs~~eil~~ 298 (381)
........+.+++.+||..++ ..|+++.++++.
T Consensus 232 ---~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 232 ---DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ---ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 111134556778888775433 347899998765
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=291.97 Aligned_cols=237 Identities=26% Similarity=0.453 Sum_probs=190.3
Q ss_pred hhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
..++|++.+.||+|+||.||+|..++++.||||.+.... .....+.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 356899999999999999999998878899999987543 3457899999999999999999999999998999999999
Q ss_pred ccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 128 VINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 128 ~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
+.+++|.+++ .+++.++.|+|..+ |+||||+||+++.++.+||+|||++..+.........
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 162 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE 162 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhh
Confidence 9999997654 57889999999999 9999999999999999999999999876543222222
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
...++..|+|||.+.+..++.++|||||||++|+|++ |+.||..... ...... ... .. . ....
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~---~~~-~~--~-------~~~~ 226 (261)
T cd05034 163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQ---VER-GY--R-------MPRP 226 (261)
T ss_pred ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH---HHc-CC--C-------CCCC
Confidence 3335678999999998899999999999999999998 8988753221 111111 111 10 0 0011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1124568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=307.04 Aligned_cols=250 Identities=23% Similarity=0.275 Sum_probs=184.0
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC----
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA---- 119 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---- 119 (381)
...++|++.+.||+|+||.||++... ++..||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34679999999999999999999865 5899999998643 2233467889999999999999999999986543
Q ss_pred --eEEEEEecccCCCHH------------HHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 120 --EKLLIYEYVINESLD------------KVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 120 --~~~lv~E~~~~g~L~------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
..|+||||+.++.+. .++.|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++......
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 177 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF 177 (359)
T ss_pred cceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCc
Confidence 579999999654322 24579999999999999 99999999999999999999999997643221
Q ss_pred cccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccccc------------HHH----HHHH
Q 048280 184 THVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQN------------LLD----WAYK 247 (381)
Q Consensus 184 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~------------~~~----~~~~ 247 (381)
......||..|+|||++.+..++.++|||||||++|+|++|+.||......+... +.. ....
T Consensus 178 --~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (359)
T cd07876 178 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRN 255 (359)
T ss_pred --cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 1233568999999999999999999999999999999999999986443211100 000 0000
Q ss_pred HhhcCCccc-c----cCCCCC----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 248 LYKKDKSLE-I----VDPSLA----ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 248 ~~~~~~~~~-~----~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
......... . ..+... ..........+.+|+.+||..||++|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 256 YVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000 0 000000 00111223567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=293.56 Aligned_cols=229 Identities=26% Similarity=0.365 Sum_probs=179.3
Q ss_pred CcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCCCH
Q 048280 56 NKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESL 133 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L 133 (381)
+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999875 68899999876442 23346789999999999999999999999999999999999999999
Q ss_pred HHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc-cccccCc
Q 048280 134 DKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN-TRVAGTN 194 (381)
Q Consensus 134 ~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~-~~~~gt~ 194 (381)
.+++ .|++.+|.|+|..+ ||||||+|||++.++.+||+|||++........... .....+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 160 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV 160 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCce
Confidence 7665 67899999999988 999999999999999999999999886533211111 1112345
Q ss_pred cccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHH
Q 048280 195 GYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAM 273 (381)
Q Consensus 195 ~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (381)
.|+|||.+.++.++.++|||||||++|||++ |..||...... .. ......... .......+..
T Consensus 161 ~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~----~~~~~~~~~---------~~~~~~~~~~ 224 (252)
T cd05084 161 KWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QT----REAIEQGVR---------LPCPELCPDA 224 (252)
T ss_pred eecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HH----HHHHHcCCC---------CCCcccCCHH
Confidence 6999999999899999999999999999998 87777432211 11 111111100 1111223456
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 274 CIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 274 l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
+.+|+.+||+.+|++|||+.+|++.|.
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=293.14 Aligned_cols=239 Identities=25% Similarity=0.408 Sum_probs=191.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++|++.+.||+|+||.||+|... +++.||+|.++.. .......+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 58999999999999999999876 6899999988643 2233567899999999999999999999999999999999
Q ss_pred ecccCCCHHHHH-------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 126 EYVINESLDKVL-------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 126 E~~~~g~L~~~l-------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
||+++++|.+++ .+++.++.++|+.+ |+||||+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 999999997654 57899999999998 999999999999999999999999986643322
Q ss_pred ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 185 HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.... .......... ..... +.
T Consensus 162 ~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~-~~~~~-----~~--- 227 (267)
T cd08224 162 A-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKI-EKCDY-----PP--- 227 (267)
T ss_pred c-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhh-hcCCC-----CC---
Confidence 1 223468889999999998889999999999999999999999985322 1111111111 11100 10
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.........+.+++.+||..+|++|||+.+|++.|+..
T Consensus 228 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11113445688999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=302.67 Aligned_cols=226 Identities=19% Similarity=0.265 Sum_probs=176.9
Q ss_pred CcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEEEEecccC
Q 048280 56 NKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 57899999997542 22345678899999998 699999999999999999999999999
Q ss_pred CCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccC
Q 048280 131 ESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT 193 (381)
Q Consensus 131 g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt 193 (381)
++|..++ .|++.++.|||..+ ||||||+|||++.++.+||+|||+++....... ......||
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt 159 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TTSTFCGT 159 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ceecccCC
Confidence 9996544 68999999999999 999999999999999999999999975322211 22346799
Q ss_pred ccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHH
Q 048280 194 NGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAM 273 (381)
Q Consensus 194 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (381)
+.|+|||++.+..++.++|||||||++|+|++|..||........................ . .+......
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~----~p~~~~~~ 229 (327)
T cd05617 160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------R----IPRFLSVK 229 (327)
T ss_pred cccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------C----CCCCCCHH
Confidence 9999999999999999999999999999999999999643322222222222222221110 0 11112345
Q ss_pred HHHHHHHcccCCCCCCCCH
Q 048280 274 CIQIGLLCTQGDPQLRPTM 292 (381)
Q Consensus 274 l~~li~~cl~~dP~~RPs~ 292 (381)
+.+++.+||+.||.+|+++
T Consensus 230 ~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred HHHHHHHHhccCHHHcCCC
Confidence 7789999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=322.86 Aligned_cols=240 Identities=20% Similarity=0.310 Sum_probs=183.3
Q ss_pred HHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEee--CC
Q 048280 45 LVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAH--GA 119 (381)
Q Consensus 45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~ 119 (381)
.....++|++++.||+|+||.||+|+.. ++..||+|++... .......+..|+.++++|+|||||+++++|.. ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3445678999999999999999999876 4778999988643 22334678899999999999999999998854 45
Q ss_pred eEEEEEecccCCCHHHHH-------------------HhhhhhhhHhhh---------hccCCccccceEeCC-------
Q 048280 120 EKLLIYEYVINESLDKVL-------------------FSLIKDIQILFR---------KKKTDIKASNILLDD------- 164 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~~l-------------------~~~~~~l~~lh~---------~~HrDlkp~NIll~~------- 164 (381)
.+||||||+.+++|.++| .|++.+|.|||. ..||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 789999999999997654 588999999998 339999999999954
Q ss_pred ----------CCCcEEeeeccceecCCCCcccccccccCccccchhHHhh--CCCCchhhhHhHHHHHHHHHhCCCCCCC
Q 048280 165 ----------KWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMH--GHLSVKADVFSFGVVILELISGQRNSSF 232 (381)
Q Consensus 165 ----------~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p~~~ 232 (381)
.+.+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||||||+|++|..||..
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 34589999999986543221 234578999999999865 4588999999999999999999999853
Q ss_pred CCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhcCC
Q 048280 233 NLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV--MLSKK 302 (381)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~--~L~~~ 302 (381)
... .... ....... +.+.. ......+.+||..||..+|.+||++.+++. .+...
T Consensus 246 ~~~-----~~ql-i~~lk~~-------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 246 ANN-----FSQL-ISELKRG-------PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCc-----HHHH-HHHHhcC-------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 321 1111 1111111 11100 112356888999999999999999999984 45443
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=294.27 Aligned_cols=234 Identities=23% Similarity=0.337 Sum_probs=185.6
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc-----ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN-----QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
++|.+.+.||+|++|.||++... +++.||+|.+..... .....+.+|++++++++||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57999999999999999999865 589999999864321 123568889999999999999999999999999999
Q ss_pred EEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 124 IYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 124 v~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
|+||+++++|.+++ .+++.++.+||+.+ |+||||+||+++.++.+||+|||+++.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 99999999997654 67899999999999 99999999999999999999999998654322111
Q ss_pred c--cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 187 N--TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 187 ~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
. ....++..|+|||++.+..++.++|||||||++|+|++|+.||...... ........... .+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~-----~~---- 226 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQPT-----NP---- 226 (263)
T ss_pred ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHHhccCC-----CC----
Confidence 1 2345788999999999988999999999999999999999998532111 11111111110 01
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.........+.+++.+||..+|.+|||+.++++.
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1112234557889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=304.27 Aligned_cols=224 Identities=22% Similarity=0.276 Sum_probs=177.9
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEEEE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
+|++.+.||+|+||.||+|+.. +++.||||++.... ......+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5888999999999999999876 47899999987542 22334567788888887 5899999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
||+++|+|..++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~-~~~ 159 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-TTK 159 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC-ccc
Confidence 999999997554 68999999999998 999999999999999999999999985432221 223
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. ...... .. .+.
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~---~i~~~~-------~~----~p~ 222 (323)
T cd05616 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQ---SIMEHN-------VA----YPK 222 (323)
T ss_pred cCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHH---HHHhCC-------CC----CCC
Confidence 45789999999999999999999999999999999999999864322 11111 111111 00 111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCH
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTM 292 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~ 292 (381)
.....+.+++.+||+.||.+|++.
T Consensus 223 ~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 223 SMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred cCCHHHHHHHHHHcccCHHhcCCC
Confidence 234567889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=301.23 Aligned_cols=243 Identities=21% Similarity=0.325 Sum_probs=182.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
++|.+.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57999999999999999999865 58889999986543 22335678899999999999999999999999999999999
Q ss_pred ccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 128 VINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 128 ~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
+.+ +|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++......... ...
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~ 163 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT-YSN 163 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc-ccc
Confidence 964 665433 68999999999999 9999999999999999999999999865332221 223
Q ss_pred cccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcC------------Cccc
Q 048280 190 VAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKD------------KSLE 256 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------~~~~ 256 (381)
..++..|+|||++.+ ..++.++|||||||++|+|++|+.||......+.... ........ ....
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCCHHHHhhhcchhhhhh
Confidence 457899999998875 4689999999999999999999999865432221111 11110000 0000
Q ss_pred ccCCCCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 257 IVDPSLAA----SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 257 ~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
...+.... .........+.+|+.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000 011123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=302.93 Aligned_cols=236 Identities=25% Similarity=0.391 Sum_probs=185.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecC--CCcccHHHHHHHHHHHHHhC-CCCcccEEEEEeeCCeEEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSH--SSNQGKKEFENEAKLLARVQ-HRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~ 125 (381)
...|+++++||+||-+.||++...+.+.||+|++.. .+....+-|.+|+.+|.+|+ |.+||++++|-..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 457999999999999999999988888899988753 35555678999999999994 999999999999999999999
Q ss_pred ecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 126 EYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 126 E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
||- ..+|.++| .|++.++.++|..+ |.||||.|+|+-+ |.+||+|||+|..+..+.....
T Consensus 440 E~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~ 517 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIV 517 (677)
T ss_pred ecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCcccccee
Confidence 975 55665554 78999999999999 9999999999964 6899999999998876654433
Q ss_pred -cccccCccccchhHHhhC-----------CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcc
Q 048280 188 -TRVAGTNGYMAPEYVMHG-----------HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSL 255 (381)
Q Consensus 188 -~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (381)
...+||+.||+||.+... +.+.++||||||||||+|+.|+.||... .+.......+. ..-.
T Consensus 518 kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~n~~aKl~aI~--~P~~ 590 (677)
T KOG0596|consen 518 KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----INQIAKLHAIT--DPNH 590 (677)
T ss_pred eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----HHHHHHHHhhc--CCCc
Confidence 357899999999998642 2568899999999999999999998421 11111111111 1112
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 256 EIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
++..|...... .++++++.||..||.+||++.+||+.-
T Consensus 591 ~Iefp~~~~~~------~li~~mK~CL~rdPkkR~si~eLLqhp 628 (677)
T KOG0596|consen 591 EIEFPDIPEND------ELIDVMKCCLARDPKKRWSIPELLQHP 628 (677)
T ss_pred cccccCCCCch------HHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence 22222222211 188999999999999999999998643
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=302.15 Aligned_cols=225 Identities=23% Similarity=0.291 Sum_probs=178.3
Q ss_pred CcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEEEEecccC
Q 048280 56 NKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++..+ +||||+++++++...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 48899999987542 23345677899999888 699999999999999999999999999
Q ss_pred CCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccC
Q 048280 131 ESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT 193 (381)
Q Consensus 131 g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt 193 (381)
++|..++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||+++....... ......|+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g~ 159 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTSTFCGT 159 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccceecC
Confidence 9996544 68999999999999 999999999999999999999999875322221 12235689
Q ss_pred ccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHH
Q 048280 194 NGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAM 273 (381)
Q Consensus 194 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (381)
..|+|||++.+..++.++|||||||++|+|++|+.||..... .... ....... ... +......
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~~---~~i~~~~-------~~~----~~~~~~~ 222 (318)
T cd05570 160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DELF---QSILEDE-------VRY----PRWLSKE 222 (318)
T ss_pred ccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHHH---HHHHcCC-------CCC----CCcCCHH
Confidence 999999999999999999999999999999999999854321 1111 1111111 001 1123356
Q ss_pred HHHHHHHcccCCCCCCCCH-----HHHHHH
Q 048280 274 CIQIGLLCTQGDPQLRPTM-----RRVVVM 298 (381)
Q Consensus 274 l~~li~~cl~~dP~~RPs~-----~eil~~ 298 (381)
+.+|+.+||+.||.+||++ .++++.
T Consensus 223 ~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 223 AKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 7899999999999999999 877653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=303.32 Aligned_cols=226 Identities=23% Similarity=0.282 Sum_probs=174.3
Q ss_pred CcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHH-HHHHhCCCCcccEEEEEeeCCeEEEEEecccC
Q 048280 56 NKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAK-LLARVQHRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
+.||+|+||.||+|+.. +|+.||||++.... ......+..|.. +++.++||||+++++++...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999865 58999999986542 222344555655 46778999999999999999999999999999
Q ss_pred CCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccC
Q 048280 131 ESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT 193 (381)
Q Consensus 131 g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt 193 (381)
++|..++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++...... .......||
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt 159 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTFCGT 159 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcccccCC
Confidence 9996544 78999999999999 99999999999999999999999987532221 122345789
Q ss_pred ccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHH
Q 048280 194 NGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAM 273 (381)
Q Consensus 194 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (381)
..|+|||++.+..++.++|||||||++|+|++|..||..... ........... ....+ .....
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~~~~~~---~~~~~--------~~~~~ 222 (325)
T cd05604 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------AEMYDNILHKP---LVLRP--------GASLT 222 (325)
T ss_pred hhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH------HHHHHHHHcCC---ccCCC--------CCCHH
Confidence 999999999999999999999999999999999999854321 11111111110 00111 12345
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 274 CIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 274 l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
+.+++.+||+.||.+||++.+.++.+
T Consensus 223 ~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 223 AWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred HHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 77899999999999999986544444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=325.82 Aligned_cols=239 Identities=23% Similarity=0.351 Sum_probs=186.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc---ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++|++.++||+|+||.||+|... +++.||||++..... ...+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 58999999999999999999875 589999999965422 23467899999999999999999999999999999999
Q ss_pred ecccCCCHHHHH--------------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccce
Q 048280 126 EYVINESLDKVL--------------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMAR 177 (381)
Q Consensus 126 E~~~~g~L~~~l--------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~ 177 (381)
||+++++|.+++ .|++.+|+|+|+.+ ||||||+|||++.++.+||+|||+++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999997654 47889999999999 99999999999999999999999998
Q ss_pred ecCCCC-----------------cccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccccc
Q 048280 178 LFPEDQ-----------------THVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQN 240 (381)
Q Consensus 178 ~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 240 (381)
...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k--- 238 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK--- 238 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh---
Confidence 662111 001123569999999999999999999999999999999999999985422110
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhcCC
Q 048280 241 LLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRP-TMRRVVVMLSKK 302 (381)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~~ 302 (381)
.. .. . ....+... ......+..+.+++.+||+.||++|| +++++++.|+..
T Consensus 239 i~---~~----~---~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 IS---YR----D---VILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hh---hh----h---hccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 00 0 00011000 01123345678899999999999996 566676666543
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=295.47 Aligned_cols=236 Identities=26% Similarity=0.440 Sum_probs=186.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 122 (381)
.++|...++||+|+||.||++... ++..+|+|.+..........+.+|+++++.++|+||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 357888999999999999999642 35678999987666566678999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHH------------------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEE
Q 048280 123 LIYEYVINESLDKVL------------------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKI 170 (381)
Q Consensus 123 lv~E~~~~g~L~~~l------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL 170 (381)
++|||+++++|.+++ .|++.+++|||..+ ||||||+|||+++++.+||
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEE
Confidence 999999999886543 57889999999998 9999999999999999999
Q ss_pred eeeccceecCCCCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHH
Q 048280 171 ADFGMARLFPEDQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKL 248 (381)
Q Consensus 171 ~DFG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 248 (381)
+|||++......... ......+++.|+|||++.+..++.++|||||||++|||++ |..||...... ... ...
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~---~~~ 237 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---EAI---ECI 237 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---HHH---HHH
Confidence 999999865432211 1122345678999999999999999999999999999998 88887432211 111 111
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 249 YKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
. ..... ......+..+.+|+.+||+.||.+||++.+|++.|+
T Consensus 238 ~-~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 T-QGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H-cCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1 11100 001122355789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=300.68 Aligned_cols=224 Identities=25% Similarity=0.342 Sum_probs=175.8
Q ss_pred CcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEEEEecccC
Q 048280 56 NKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
+.||+|+||.||+|+.. +++.||||++.... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 47899999986542 22345567788888765 899999999999999999999999999
Q ss_pred CCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccC
Q 048280 131 ESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT 193 (381)
Q Consensus 131 g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt 193 (381)
|+|..++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||+++....... ......||
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt 159 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCTFCGT 159 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceeeecCC
Confidence 9997655 68999999999999 999999999999999999999999875322211 22345689
Q ss_pred ccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHH
Q 048280 194 NGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAM 273 (381)
Q Consensus 194 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (381)
..|+|||++.+..++.++|||||||++|||++|..||..... ..+... .... .+... ......
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~----i~~~------~~~~~----~~~~~~ 222 (316)
T cd05619 160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQS----IRMD------NPCYP----RWLTRE 222 (316)
T ss_pred ccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHH----HHhC------CCCCC----ccCCHH
Confidence 999999999998999999999999999999999999864321 111111 1111 01111 112345
Q ss_pred HHHHHHHcccCCCCCCCCHH-HHHH
Q 048280 274 CIQIGLLCTQGDPQLRPTMR-RVVV 297 (381)
Q Consensus 274 l~~li~~cl~~dP~~RPs~~-eil~ 297 (381)
+.+++.+||+.||.+||++. +++.
T Consensus 223 ~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 223 AKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHHHHhccCHhhcCCChHHHHc
Confidence 78899999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=304.62 Aligned_cols=249 Identities=22% Similarity=0.259 Sum_probs=184.1
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeC-----
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHG----- 118 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----- 118 (381)
...++|++.+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34679999999999999999999865 58899999986542 23346778899999999999999999988643
Q ss_pred -CeEEEEEecccCCCHHH-------------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCC
Q 048280 119 -AEKLLIYEYVINESLDK-------------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPED 182 (381)
Q Consensus 119 -~~~~lv~E~~~~g~L~~-------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~ 182 (381)
...++||||+.+ +|.+ ++.|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 357999999965 4433 4579999999999999 9999999999999999999999999865332
Q ss_pred CcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccccc-HHH---------------HHH
Q 048280 183 QTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQN-LLD---------------WAY 246 (381)
Q Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~-~~~---------------~~~ 246 (381)
. ......||..|+|||++.+..++.++|||||||++|+|++|+.||......+... ... ...
T Consensus 173 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (355)
T cd07874 173 F--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_pred c--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHH
Confidence 1 2234568999999999999899999999999999999999999986432211100 000 000
Q ss_pred HHhhcCC-cccccCCCC-----C---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 247 KLYKKDK-SLEIVDPSL-----A---ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 247 ~~~~~~~-~~~~~~~~~-----~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
....... ......+.. . ..........+.+|+.+||+.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 000000000 0 00111224567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=293.45 Aligned_cols=230 Identities=26% Similarity=0.317 Sum_probs=178.6
Q ss_pred ccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCCCH
Q 048280 58 LGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESL 133 (381)
Q Consensus 58 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L 133 (381)
||+|+||.||+++.+ +|+.||+|++.... ......+..|++++++++||||+++++++..+...++||||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999865 58999999986432 12234556799999999999999999999999999999999999999
Q ss_pred HHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccCc
Q 048280 134 DKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN 194 (381)
Q Consensus 134 ~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~ 194 (381)
..++ .|++.+++|+|..+ ||||||+|||++.++.+||+|||++....... ......|+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~ 158 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTN 158 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccCCCC
Confidence 6543 58999999999998 99999999999999999999999998764332 122346899
Q ss_pred cccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHH
Q 048280 195 GYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMC 274 (381)
Q Consensus 195 ~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 274 (381)
.|+|||++.+..++.++|||||||++|||++|+.||........ ............ .. .........+
T Consensus 159 ~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~-----~~-----~~~~~~~~~~ 226 (277)
T cd05607 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLEDE-----VK-----FEHQNFTEES 226 (277)
T ss_pred CccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhccc-----cc-----cccccCCHHH
Confidence 99999999998999999999999999999999999854322111 111111111100 00 0011234567
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 275 IQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 275 ~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
.+|+.+||+.||++||++.|+++.+..
T Consensus 227 ~~li~~~L~~~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 227 KDICRLFLAKKPEDRLGSREKNDDPRK 253 (277)
T ss_pred HHHHHHHhccCHhhCCCCccchhhhhc
Confidence 899999999999999999877654443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=302.57 Aligned_cols=239 Identities=25% Similarity=0.394 Sum_probs=186.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC--------CCcEEEEEEecCCC-cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeC
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD--------DGREIAVKKLSHSS-NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHG 118 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 118 (381)
..+|.+.+.||+|+||.||+|+.. .+..||+|.+.... ......+.+|+++++++ +||||++++++|...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 357999999999999999999742 12368999886542 23346789999999999 799999999999999
Q ss_pred CeEEEEEecccCCCHHHHH-------------------------------HhhhhhhhHhhhhc--cCCccccceEeCCC
Q 048280 119 AEKLLIYEYVINESLDKVL-------------------------------FSLIKDIQILFRKK--KTDIKASNILLDDK 165 (381)
Q Consensus 119 ~~~~lv~E~~~~g~L~~~l-------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~ 165 (381)
+..+++|||+++++|.+++ .|++.+|.|||..+ ||||||+|||++.+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~ 170 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED 170 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC
Confidence 9999999999999997764 37899999999998 99999999999999
Q ss_pred CCcEEeeeccceecCCCCccc-ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHH
Q 048280 166 WIPKIADFGMARLFPEDQTHV-NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLD 243 (381)
Q Consensus 166 ~~~kL~DFG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~ 243 (381)
+.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||..... ..
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~ 244 (334)
T cd05100 171 NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------EE 244 (334)
T ss_pred CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH------HH
Confidence 999999999998664322111 112234567999999999999999999999999999998 7777743221 11
Q ss_pred HHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 244 WAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
... ......... ........+.+|+.+||+.+|.+||++.+|++.|....
T Consensus 245 ~~~-~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 245 LFK-LLKEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHH-HHHcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 111 111111111 11122356889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=321.73 Aligned_cols=237 Identities=27% Similarity=0.453 Sum_probs=198.6
Q ss_pred CCCCCCcccccCCeeEEEEEECC----CcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLDD----GREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
...|.++||.|.||.|++|+++. ...||||.++.. ....+.+|+.|+.||.+++||||++|.|+......+.||+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 34677899999999999998762 457999999865 3445678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 126 EYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 126 E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|||++|+|+.+| +.|+.|++||-..+ ||||...|||++.+..+|++|||+++.+.++.....
T Consensus 710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~y 789 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY 789 (996)
T ss_pred hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccc
Confidence 999999999887 56888999999888 999999999999999999999999998866553333
Q ss_pred ccccc--CccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 188 TRVAG--TNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 188 ~~~~g--t~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
+..-| .+.|.|||.+..++++.+|||||||+|+||.++ |.+|+-...+.+. + ..+...++.
T Consensus 790 tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV---I-------------kaIe~gyRL 853 (996)
T KOG0196|consen 790 TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---I-------------KAIEQGYRL 853 (996)
T ss_pred cccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH---H-------------HHHHhccCC
Confidence 32222 468999999999999999999999999999775 8899754433222 1 122334445
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
+.+.+++..|.+|++.||++|-.+||.|.+|+..|.+..
T Consensus 854 PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 854 PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 566778899999999999999999999999999998754
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=312.31 Aligned_cols=241 Identities=25% Similarity=0.402 Sum_probs=188.5
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCCCc-ccHHHHHHHHHHHHHhC-CCCcccEEEEEeeC
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHSSN-QGKKEFENEAKLLARVQ-HRNVVNLLGYCAHG 118 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 118 (381)
...++|.+.+.||+|+||.||+|++. .+..||||++..... ...+.+.+|+++|.++. ||||++++++|...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34557889999999999999999853 246899999975432 22457889999999997 99999999999999
Q ss_pred CeEEEEEecccCCCHHHHH-------------------------------------------------------------
Q 048280 119 AEKLLIYEYVINESLDKVL------------------------------------------------------------- 137 (381)
Q Consensus 119 ~~~~lv~E~~~~g~L~~~l------------------------------------------------------------- 137 (381)
+..++||||+.+|+|.+++
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 9999999999999997665
Q ss_pred ----------------------------------------------------HhhhhhhhHhhhhc--cCCccccceEeC
Q 048280 138 ----------------------------------------------------FSLIKDIQILFRKK--KTDIKASNILLD 163 (381)
Q Consensus 138 ----------------------------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~ 163 (381)
.|++.+|.|||..+ ||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 37888999999988 999999999999
Q ss_pred CCCCcEEeeeccceecCCCCc-ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccH
Q 048280 164 DKWIPKIADFGMARLFPEDQT-HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNL 241 (381)
Q Consensus 164 ~~~~~kL~DFG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 241 (381)
+++.+||+|||+++.+..... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~---- 349 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE---- 349 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH----
Confidence 999999999999986533221 11223456788999999998889999999999999999998 888875332111
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 242 LDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
............ ..+......+.+|+.+||..+|.+||++.+|++.|+..
T Consensus 350 --~~~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 350 --QFYNAIKRGYRM---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred --HHHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111111111100 11112245688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=294.07 Aligned_cols=243 Identities=23% Similarity=0.396 Sum_probs=185.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-----------------CCcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCccc
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-----------------DGREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVN 110 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~ 110 (381)
.++|++.+.||+|+||.||+++.. ++..||+|++... .......+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 457999999999999999998532 2346899998754 2334568999999999999999999
Q ss_pred EEEEEeeCCeEEEEEecccCCCHHHHH--------------------------HhhhhhhhHhhhhc--cCCccccceEe
Q 048280 111 LLGYCAHGAEKLLIYEYVINESLDKVL--------------------------FSLIKDIQILFRKK--KTDIKASNILL 162 (381)
Q Consensus 111 ~~~~~~~~~~~~lv~E~~~~g~L~~~l--------------------------~~~~~~l~~lh~~~--HrDlkp~NIll 162 (381)
+++++...+..++||||+.+++|.+++ .|++.++.|+|..+ |+||||+|||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili 163 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence 999999999999999999999997654 57889999999998 99999999999
Q ss_pred CCCCCcEEeeeccceecCCCCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh--CCCCCCCCCccccc
Q 048280 163 DDKWIPKIADFGMARLFPEDQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS--GQRNSSFNLDVDAQ 239 (381)
Q Consensus 163 ~~~~~~kL~DFG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~p~~~~~~~~~~ 239 (381)
+.++.+||+|||++..+...... ......++..|+|||...++.++.++|||||||++|||++ |..||..... .
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~---~ 240 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD---E 240 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh---H
Confidence 99999999999999865433221 1122334678999999988899999999999999999998 6666643221 1
Q ss_pred cHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 240 NLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
................. ..+ ....++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QVIENTGEFFRDQGRQV-YLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHHhhccccc-cCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11111111111110000 001 11123356889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=296.38 Aligned_cols=236 Identities=28% Similarity=0.413 Sum_probs=185.4
Q ss_pred CCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
+|++.+.||+|+||.||+|... ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4788999999999999999753 23568888886543 2334678899999999999999999999999999999
Q ss_pred EEecccCCCHHHHH---------------------------------------HhhhhhhhHhhhhc--cCCccccceEe
Q 048280 124 IYEYVINESLDKVL---------------------------------------FSLIKDIQILFRKK--KTDIKASNILL 162 (381)
Q Consensus 124 v~E~~~~g~L~~~l---------------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll 162 (381)
||||+.+++|.+++ .|++.+|.|||..+ ||||||+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999997653 57899999999988 99999999999
Q ss_pred CCCCCcEEeeeccceecCCCCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccccc
Q 048280 163 DDKWIPKIADFGMARLFPEDQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQN 240 (381)
Q Consensus 163 ~~~~~~kL~DFG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~ 240 (381)
++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... .
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~ 237 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE---R 237 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH---H
Confidence 99999999999999865332221 1122345678999999988899999999999999999998 88887533211 1
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 241 LLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
+ ......... ..........+.+++.+||+.+|++||++.++++.|++.
T Consensus 238 ~----~~~~~~~~~---------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 238 L----FNLLKTGYR---------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred H----HHHHhCCCC---------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 1 111111110 011122335688999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=291.18 Aligned_cols=235 Identities=28% Similarity=0.441 Sum_probs=184.1
Q ss_pred CCCCCcccccCCeeEEEEEECC-CcEEEEEEecCCCcccHH--HHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 52 FHPSNKLGEGGFGPVFKGKLDD-GREIAVKKLSHSSNQGKK--EFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 52 y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
|++.+.||+|+||+||+++... ++.||+|++......... ...+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6778999999999999999775 678999999876544332 3456999999999999999999999999999999999
Q ss_pred cCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccc
Q 048280 129 INESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVA 191 (381)
Q Consensus 129 ~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~ 191 (381)
.+++|.+++ .|++.+|.+||+.+ |+||||+|||++.++.++|+|||.+...... ........
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~ 159 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-NENFNPFV 159 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST-TSEBSSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence 998997665 68999999999999 9999999999999999999999999865222 22333466
Q ss_pred cCccccchhHHh-hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHH
Q 048280 192 GTNGYMAPEYVM-HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQ 270 (381)
Q Consensus 192 gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (381)
++..|+|||++. +..++.++||||||+++|+|++|..||......+......... ......... .....
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~-------~~~~~ 229 (260)
T PF00069_consen 160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL---KRPLPSSSQ-------QSREK 229 (260)
T ss_dssp SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH---HTHHHHHTT-------SHTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc---ccccccccc-------ccchh
Confidence 899999999998 7889999999999999999999999986541111111111111 100000000 00001
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 271 IAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 271 ~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
...+.+++.+||+.||++||++.++++
T Consensus 230 ~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 230 SEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred HHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 166889999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=300.88 Aligned_cols=223 Identities=24% Similarity=0.318 Sum_probs=175.4
Q ss_pred CcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEEEEecccC
Q 048280 56 NKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
+.||+|+||.||+|+.. ++..||+|++.... ......+..|..++..+ +||||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999876 58899999986542 23345667788888765 899999999999999999999999999
Q ss_pred CCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccC
Q 048280 131 ESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT 193 (381)
Q Consensus 131 g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt 193 (381)
++|..++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||+++...... .......||
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt 159 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTFCGT 159 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-CceeccCCC
Confidence 9997554 68999999999998 99999999999999999999999987532111 122346789
Q ss_pred ccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHH
Q 048280 194 NGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAM 273 (381)
Q Consensus 194 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (381)
..|+|||++.+..++.++|||||||++|||++|..||..... ..+.. ..... .+.+.. .....
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~----~~~~~------~~~~~~----~~~~~ 222 (316)
T cd05620 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFE----SIRVD------TPHYPR----WITKE 222 (316)
T ss_pred cCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHH----HHHhC------CCCCCC----CCCHH
Confidence 999999999999999999999999999999999999864321 11111 11111 011111 12345
Q ss_pred HHHHHHHcccCCCCCCCCHH-HHH
Q 048280 274 CIQIGLLCTQGDPQLRPTMR-RVV 296 (381)
Q Consensus 274 l~~li~~cl~~dP~~RPs~~-eil 296 (381)
+.+++.+||+.||.+||++. +++
T Consensus 223 ~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 223 SKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHHH
Confidence 77899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=290.23 Aligned_cols=239 Identities=24% Similarity=0.396 Sum_probs=190.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
.+|++.+.||.|+||.||+++.. +++.+|||.+.... ......+.+|+.+++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 47889999999999999999864 68999999876432 223457889999999999999999999999999999999
Q ss_pred ecccCCCHHHHH-------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 126 EYVINESLDKVL-------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 126 E~~~~g~L~~~l-------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
||+++++|.+++ .+++.++.|||+.+ |+||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 999999997654 57899999999998 999999999999999999999999886643322
Q ss_pred ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 185 HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
. .....++..|+|||++.+..++.++||||||+++|+|++|..||..... .......... . ...+..
T Consensus 162 ~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~-~-----~~~~~~-- 228 (267)
T cd08229 162 A-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIE-Q-----CDYPPL-- 228 (267)
T ss_pred c-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHhhhhh-c-----CCCCCC--
Confidence 1 2234688999999999988899999999999999999999999853211 1111111110 0 011111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
........+.+++.+||+.||.+|||+.+|++.+++.
T Consensus 229 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 -PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred -CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1123456788999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=296.01 Aligned_cols=234 Identities=24% Similarity=0.386 Sum_probs=189.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
.++|++.+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 468999999999999999999864 6899999999766555567789999999999999999999999999999999999
Q ss_pred ccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccc
Q 048280 128 VINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVA 191 (381)
Q Consensus 128 ~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~ 191 (381)
+++++|.+++ .+++.++.+||+.+ ||||||+|||++.++.+||+|||++......... .....
T Consensus 98 ~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~ 176 (297)
T cd06656 98 LAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMV 176 (297)
T ss_pred cCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-cCccc
Confidence 9999997665 57899999999998 9999999999999999999999999865433221 22346
Q ss_pred cCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHH
Q 048280 192 GTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271 (381)
Q Consensus 192 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (381)
+++.|+|||.+.+..++.++|||||||++|+|++|..||......... ....... .+. ........
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~------~~~~~~~------~~~--~~~~~~~~ 242 (297)
T cd06656 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNG------TPE--LQNPERLS 242 (297)
T ss_pred CCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe------eeeccCC------CCC--CCCccccC
Confidence 788999999999988999999999999999999999998543221110 0000000 000 11122334
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 272 AMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 272 ~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
..+.+++.+||+.||++||++.+|++
T Consensus 243 ~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 243 AVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 55788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=294.54 Aligned_cols=236 Identities=27% Similarity=0.398 Sum_probs=183.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEK 121 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 121 (381)
.++|.+.+.||+|+||.||+|.+. .+..|++|.+.... ......+.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 567999999999999999999865 35678999886443 23345789999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHH----------------------HhhhhhhhHhhhhc--cCCccccceEeCCCC---CcEEeeec
Q 048280 122 LLIYEYVINESLDKVL----------------------FSLIKDIQILFRKK--KTDIKASNILLDDKW---IPKIADFG 174 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l----------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~---~~kL~DFG 174 (381)
++||||+.+++|.+++ .|++.++.|||..+ ||||||+|||++.++ .+||+|||
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCc
Confidence 9999999999998654 57899999999998 999999999998654 69999999
Q ss_pred cceecCCCCccc-ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcC
Q 048280 175 MARLFPEDQTHV-NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKD 252 (381)
Q Consensus 175 ~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (381)
+++.+....... ......+..|+|||++.+..++.++|||||||++|||++ |..||...... .+.. .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~----~~~~~ 237 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVME----FVTGG 237 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHHcC
Confidence 998763322111 112233567999999999999999999999999999997 88887543221 1111 11111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 253 KSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
... ..+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 238 ~~~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 GRL---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 100 111123456888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=295.17 Aligned_cols=243 Identities=27% Similarity=0.426 Sum_probs=186.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC-----------------CcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCccc
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD-----------------GREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVN 110 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~ 110 (381)
.++|++.+.||+|+||.||+|.... +..||+|.+.... ......+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4689999999999999999987542 2458999987553 234567889999999999999999
Q ss_pred EEEEEeeCCeEEEEEecccCCCHHHHH--------------------------HhhhhhhhHhhhhc--cCCccccceEe
Q 048280 111 LLGYCAHGAEKLLIYEYVINESLDKVL--------------------------FSLIKDIQILFRKK--KTDIKASNILL 162 (381)
Q Consensus 111 ~~~~~~~~~~~~lv~E~~~~g~L~~~l--------------------------~~~~~~l~~lh~~~--HrDlkp~NIll 162 (381)
+++++..+...++||||+.+++|.+++ .|++.+|.|||+.+ |+||||+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili 163 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence 999999999999999999999887553 57889999999998 99999999999
Q ss_pred CCCCCcEEeeeccceecCCCCc-ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh--CCCCCCCCCccccc
Q 048280 163 DDKWIPKIADFGMARLFPEDQT-HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS--GQRNSSFNLDVDAQ 239 (381)
Q Consensus 163 ~~~~~~kL~DFG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~p~~~~~~~~~~ 239 (381)
+.++.++|+|||++..+..... .......++..|+|||++.+..++.++|||||||++|||++ +..||.... ..
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~---~~ 240 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT---DQ 240 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC---hH
Confidence 9999999999999986543322 11223456778999999998899999999999999999998 556654221 11
Q ss_pred cHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 240 NLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
.........+........ .......+..+.+++.+||+.||.+|||+.+|++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QVIENAGHFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHhcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 122222111111111100 0111123356899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=299.38 Aligned_cols=230 Identities=22% Similarity=0.322 Sum_probs=192.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
.+=|.+.+.||+|.|+.|-+|++. +|.+||||++.+.. ......+.+|++.|+.++|||||++|.+......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 456999999999999999999854 79999999997653 333456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEe-CCCCCcEEeeeccceecCCCCccc
Q 048280 126 EYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILL-DDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 126 E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll-~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
|+-.+|+|.++| .||+.+|.|+|... ||||||+||.+ .+-|-|||+|||++..+.....
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k-- 174 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK-- 174 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch--
Confidence 999999998876 79999999999988 99999999887 4678999999999987754432
Q ss_pred ccccccCccccchhHHhhCCCC-chhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGHLS-VKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
.++.+|++.|-|||++.+..|+ +++||||||||||-|++|+.||....+.+.. ..++|-. -.
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImDCK--Yt 237 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMDCK--YT 237 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhccc--cc
Confidence 3457899999999999999986 6899999999999999999999644332221 1111211 12
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 266 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.+.....+|.+||..||..||.+|.+.+||+.
T Consensus 238 vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 238 VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 34456678999999999999999999999975
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=305.70 Aligned_cols=248 Identities=22% Similarity=0.262 Sum_probs=183.6
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeC------
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHG------ 118 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------ 118 (381)
..++|.+.+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4678999999999999999999865 5889999998654 233346788999999999999999999987543
Q ss_pred CeEEEEEecccCCCHHH-------------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 119 AEKLLIYEYVINESLDK-------------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 119 ~~~~lv~E~~~~g~L~~-------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
...|+||||+.+ +|.+ ++.|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++......
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~ 180 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC
Confidence 357999999965 5533 4579999999999998 99999999999999999999999998653322
Q ss_pred cccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHH-H---------------HHHH
Q 048280 184 THVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLL-D---------------WAYK 247 (381)
Q Consensus 184 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~-~---------------~~~~ 247 (381)
......+|..|+|||++.+..++.++|||||||++|+|++|+.||......+..... . ....
T Consensus 181 --~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (364)
T cd07875 181 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 258 (364)
T ss_pred --cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHH
Confidence 123356899999999999999999999999999999999999998654322110000 0 0000
Q ss_pred HhhcCCcc-----cccCCCCC----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 248 LYKKDKSL-----EIVDPSLA----ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 248 ~~~~~~~~-----~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
........ ....+... ..........+.+|+.+||+.||.+|||+.++++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 00000000 00111123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=288.04 Aligned_cols=231 Identities=28% Similarity=0.407 Sum_probs=187.1
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
+|.+.+.||+|++|.||+|... ++..|++|.+... .......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 5788899999999999999875 5899999998643 334457788999999999999999999999999999999999
Q ss_pred ccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 128 VINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 128 ~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
+++++|.+++ .+++.++.|+|..+ |+||||+||+++.++.+||+|||+++.+...... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~-~~ 159 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-AN 159 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch-hh
Confidence 9999997655 57899999999988 9999999999999999999999999876543222 23
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
...|+..|+|||++.+..++.++|||||||++|+|++|+.||..... .... ... ..... + ....
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~---~~~-~~~~~-----~----~~~~ 223 (256)
T cd08529 160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALI---LKI-IRGVF-----P----PVSQ 223 (256)
T ss_pred ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHH---HHH-HcCCC-----C----CCcc
Confidence 34688999999999999999999999999999999999999864331 1111 111 11110 1 1111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.....+.+++.+||+.+|++||++.++++.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 344568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=291.69 Aligned_cols=235 Identities=23% Similarity=0.404 Sum_probs=182.4
Q ss_pred CCCCCcccccCCeeEEEEEECC----CcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCe-----
Q 048280 52 FHPSNKLGEGGFGPVFKGKLDD----GREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAE----- 120 (381)
Q Consensus 52 y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~----- 120 (381)
|.+.+.||+|+||.||+|.... +..||+|++.... ......+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6788999999999999998642 4679999987542 2334678999999999999999999998866554
Q ss_pred -EEEEEecccCCCHHHHH---------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccc
Q 048280 121 -KLLIYEYVINESLDKVL---------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMA 176 (381)
Q Consensus 121 -~~lv~E~~~~g~L~~~l---------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~ 176 (381)
.+++|||+++++|..++ .|++.+|.|+|+.+ ||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 79999999999986544 68899999999988 9999999999999999999999999
Q ss_pred eecCCCCcccc-cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCc
Q 048280 177 RLFPEDQTHVN-TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKS 254 (381)
Q Consensus 177 ~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (381)
+.......... ....++..|+|||.+.+..++.++|||||||++|||++ |..||..... ....+. ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~----~~~~~~ 233 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDY----LRHGNR 233 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHcCCC
Confidence 87643322211 12234678999999988889999999999999999999 8888753221 111111 111111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 255 LEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
. .........+.+++.+||+.||.+|||+.++++.|+..
T Consensus 234 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 L---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred C---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 11122345688999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=289.14 Aligned_cols=231 Identities=26% Similarity=0.426 Sum_probs=187.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
.++|++.+.||.|+||.||+|... ++.||||.+..... ..+.+.+|+.+++.++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 458999999999999999999876 78999999976544 4678999999999999999999999999999999999999
Q ss_pred cCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 129 INESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 129 ~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
++++|.+++ .|++.++.|+|..+ |+||||+||+++.++.+||+|||+++....... .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~----~ 158 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD----S 158 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc----c
Confidence 999997664 67899999999999 999999999999999999999999987632221 2
Q ss_pred cccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 190 VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
...+..|+|||++.+..++.++|||||||++|+|++ |..||..... ..+. ........ .....
T Consensus 159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~----~~~~~~~~---------~~~~~ 222 (256)
T cd05039 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVV----PHVEKGYR---------MEAPE 222 (256)
T ss_pred CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHH----HHHhcCCC---------CCCcc
Confidence 234668999999988889999999999999999997 8888753221 1111 11111110 01111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
..+..+.+++.+||..+|++|||+.++++.|++
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 223 GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 234668899999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=289.31 Aligned_cols=229 Identities=26% Similarity=0.371 Sum_probs=179.0
Q ss_pred cccccCCeeEEEEEEC---CCcEEEEEEecCCCc--ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCC
Q 048280 57 KLGEGGFGPVFKGKLD---DGREIAVKKLSHSSN--QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINE 131 (381)
Q Consensus 57 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g 131 (381)
.||+|+||.||+|.++ ++..+|+|++..... ...+.+.+|+.+++.++|+||+++++++.. ...++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 6899999999999643 578899999864432 234678999999999999999999999864 5678999999999
Q ss_pred CHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc--cccccc
Q 048280 132 SLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV--NTRVAG 192 (381)
Q Consensus 132 ~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~--~~~~~g 192 (381)
+|.+++ .|++.++.++|..+ ||||||.|||++.++.+||+|||++..+....... .....+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCC
Confidence 997655 68999999999999 99999999999999999999999998764432211 112234
Q ss_pred CccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHH
Q 048280 193 TNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271 (381)
Q Consensus 193 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (381)
+..|+|||.+....++.++|||||||++|||++ |..||...... .... ........ .. +...+
T Consensus 161 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~i~~~~~~-----~~----~~~~~ 224 (257)
T cd05116 161 PVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQ----MIESGERM-----EC----PQRCP 224 (257)
T ss_pred CccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHCCCCC-----CC----CCCCC
Confidence 578999999988889999999999999999998 89898543221 1111 11111111 11 11234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 272 AMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 272 ~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
..+.++|.+||+.||++||++.+|++.|++.
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 5688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=292.32 Aligned_cols=236 Identities=27% Similarity=0.433 Sum_probs=187.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC------CcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD------GREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEK 121 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 121 (381)
.++|++.+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4579999999999999999997642 4689999986543 23345788999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHH-------------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeec
Q 048280 122 LLIYEYVINESLDKVL-------------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFG 174 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l-------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG 174 (381)
++||||+++++|.+++ .|++.+|.|+|..+ ||||||+|||++.++.+||+|||
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg 164 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcc
Confidence 9999999999997654 47889999999988 99999999999999999999999
Q ss_pred cceecCCCCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcC
Q 048280 175 MARLFPEDQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKD 252 (381)
Q Consensus 175 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (381)
+++.+...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~----~~~~~ 237 (277)
T cd05032 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLK----FVIDG 237 (277)
T ss_pred cchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHH----HHhcC
Confidence 99865433221 1223446788999999998889999999999999999998 8888753221 11111 11111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 253 KSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
.... ... .....+.+++.+||+.+|++|||+.+|+..|+
T Consensus 238 ~~~~-----~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 238 GHLD-----LPE----NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCC-----CCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1111 111 12456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=293.02 Aligned_cols=237 Identities=26% Similarity=0.394 Sum_probs=182.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCc----EEEEEEecCCCc-ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGR----EIAVKKLSHSSN-QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 122 (381)
.++|++.+.||+|+||.||+|.+. +++ .|++|.+..... .....+..|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 357889999999999999999864 344 477888754322 223567788889999999999999998864 5578
Q ss_pred EEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 123 LIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 123 lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
+++||+++|+|.+++ .|++.++.|+|+.+ ||||||+|||++.++.+||+|||+++.+.....
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 999999999998665 68899999999988 999999999999999999999999987643322
Q ss_pred c-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 185 H-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 185 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
. ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... . .......... ..+..
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~----~~~~~~~~~~--~~~~~ 235 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---V----PDLLEKGERL--AQPQI 235 (279)
T ss_pred ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHCCCcC--CCCCC
Confidence 1 1223456778999999998899999999999999999998 988885432211 1 1111211111 11111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
....+.+++.+||..||.+|||+.|+++.|...
T Consensus 236 -------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 236 -------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred -------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 224567899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=296.47 Aligned_cols=244 Identities=23% Similarity=0.322 Sum_probs=185.0
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
++|++.+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++||||++++++|..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 47999999999999999999865 57889999886542 22345688999999999999999999999999999999999
Q ss_pred ccCCCHHHHH---------------HhhhhhhhHhhhh-c--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 128 VINESLDKVL---------------FSLIKDIQILFRK-K--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 128 ~~~g~L~~~l---------------~~~~~~l~~lh~~-~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
+++++|.+++ .|++.+|.|||+. + |+||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 157 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANS 157 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---ccc
Confidence 9999998765 6789999999974 4 99999999999999999999999987653221 223
Q ss_pred cccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCc---------------
Q 048280 190 VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKS--------------- 254 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------- 254 (381)
..++..|+|||++.+..++.++|||||||++|+|++|+.||........................
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM 237 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence 56889999999998888999999999999999999999998543211110000000000000000
Q ss_pred ---------ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 255 ---------LEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 255 ---------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
.....+.. ........+.+|+.+||..||++|||+.+|++..
T Consensus 238 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 238 AIFELLDYIVNEPPPKL---PSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred hHHHHHHHHhcCCCccC---cCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00000000 0011345688999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=288.65 Aligned_cols=234 Identities=24% Similarity=0.448 Sum_probs=186.5
Q ss_pred cCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEeccc
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVI 129 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 129 (381)
.+|++.+.||.|+||.||++.+.++..+|+|.+.... .....+.+|++++++++||||+++++++......++||||+.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4788899999999999999988778899999986443 234678999999999999999999999999999999999999
Q ss_pred CCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccc
Q 048280 130 NESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVA 191 (381)
Q Consensus 130 ~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~ 191 (381)
+++|.+++ .+++.++.++|+.+ |+||||+||+++.++.+||+|||++...............
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 162 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTK 162 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCc
Confidence 99987655 57889999999888 9999999999999999999999999865433222222233
Q ss_pred cCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHH
Q 048280 192 GTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQ 270 (381)
Q Consensus 192 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (381)
++..|+|||++.+..++.++|||||||++|||++ |..||...... ... ... ... .....+.. .
T Consensus 163 ~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~---~~~-~~~--~~~~~~~~-------~ 226 (256)
T cd05112 163 FPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVV---ETI-NAG--FRLYKPRL-------A 226 (256)
T ss_pred cchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHH---HHH-hCC--CCCCCCCC-------C
Confidence 5678999999998899999999999999999998 88887532211 111 111 111 01111111 2
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 271 IAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 271 ~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
...+.+|+.+||+.+|++|||+.++++.|.
T Consensus 227 ~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 227 SQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 356889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=289.25 Aligned_cols=236 Identities=23% Similarity=0.426 Sum_probs=188.3
Q ss_pred hhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
..++|++.+.||+|+||.||++...++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.. ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 356899999999999999999998778889999886543 235678899999999999999999999887 778999999
Q ss_pred ccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 128 VINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 128 ~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
+.+++|.+++ .+++.+|.++|..+ |+||||+||+++.++.+||+|||++..+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 161 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 161 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCccccc
Confidence 9999997654 58899999999988 9999999999999999999999999876443322222
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
...++..|+|||++....++.++|||||||++|+|++ |..||...... .+.. ........ ...
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~----~~~~~~~~---------~~~ 225 (260)
T cd05073 162 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIR----ALERGYRM---------PRP 225 (260)
T ss_pred CCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHhCCCCC---------CCc
Confidence 3345678999999998889999999999999999999 88887532211 1111 11111100 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
......+.+++.+||+.+|++||++.++++.|+.
T Consensus 226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 2234568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=297.72 Aligned_cols=241 Identities=26% Similarity=0.429 Sum_probs=188.2
Q ss_pred HHhhcCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCCC-cccHHHHHHHHHHHHHh-CCCCcccEEEEEee
Q 048280 46 VSATKNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHSS-NQGKKEFENEAKLLARV-QHRNVVNLLGYCAH 117 (381)
Q Consensus 46 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 117 (381)
....++|++.+.||+|+||.||++... ....+|+|.+.... ......+.+|+.+++++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 344568999999999999999999754 23679999986542 23345688999999999 89999999999999
Q ss_pred CCeEEEEEecccCCCHHHHH-------------------------------HhhhhhhhHhhhhc--cCCccccceEeCC
Q 048280 118 GAEKLLIYEYVINESLDKVL-------------------------------FSLIKDIQILFRKK--KTDIKASNILLDD 164 (381)
Q Consensus 118 ~~~~~lv~E~~~~g~L~~~l-------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~ 164 (381)
++..+++|||+++++|..++ .|++.++.|||..+ ||||||+|||++.
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 99999999999999987654 57899999999988 9999999999999
Q ss_pred CCCcEEeeeccceecCCCCccc-ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHH
Q 048280 165 KWIPKIADFGMARLFPEDQTHV-NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLL 242 (381)
Q Consensus 165 ~~~~kL~DFG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~ 242 (381)
++.+||+|||+++.+....... .....++..|+|||++.+..++.++|||||||++|||++ |..||...... ..
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~- 243 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---EL- 243 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH---HH-
Confidence 9999999999998764332211 122235678999999998899999999999999999997 88887532211 11
Q ss_pred HHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 243 DWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.......... .........+.+|+.+||+.||.+|||+.++++.|+..
T Consensus 244 ---~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 244 ---FKLLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ---HHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 1111111111 11112345688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=294.26 Aligned_cols=239 Identities=26% Similarity=0.419 Sum_probs=186.2
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCCCc-ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCe
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHSSN-QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAE 120 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 120 (381)
..++|++.+.||+|+||.||+|..+ .+..||+|.+..... .....+.+|+.+++.++|+||+++++++...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999643 245799998864432 233467889999999999999999999999999
Q ss_pred EEEEEecccCCCHHHHH-------------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeee
Q 048280 121 KLLIYEYVINESLDKVL-------------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADF 173 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l-------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DF 173 (381)
.++||||+++|+|.+++ .|++.+|.|+|+.+ ||||||+|||++.++.+||+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Df 163 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDF 163 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcC
Confidence 99999999999997665 36788999999998 9999999999999999999999
Q ss_pred ccceecCCCCccc-ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhc
Q 048280 174 GMARLFPEDQTHV-NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKK 251 (381)
Q Consensus 174 G~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 251 (381)
|+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..... ....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~~~---~~~~- 236 (288)
T cd05061 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQVLK---FVMD- 236 (288)
T ss_pred CccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH---HHHc-
Confidence 9998654322211 112345678999999999899999999999999999998 6777743211 11111 1111
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 252 DKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.... .. .......+.+++.+||+.||++|||+.++++.|.+.
T Consensus 237 ~~~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 237 GGYL-----DQ----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CCCC-----CC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1100 00 112235688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=297.47 Aligned_cols=240 Identities=25% Similarity=0.417 Sum_probs=188.2
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC--------CCcEEEEEEecCCC-cccHHHHHHHHHHHHHh-CCCCcccEEEEEee
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD--------DGREIAVKKLSHSS-NQGKKEFENEAKLLARV-QHRNVVNLLGYCAH 117 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 117 (381)
...+|.+.+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3567899999999999999999641 24579999986542 23346788999999999 89999999999999
Q ss_pred CCeEEEEEecccCCCHHHHH-------------------------------HhhhhhhhHhhhhc--cCCccccceEeCC
Q 048280 118 GAEKLLIYEYVINESLDKVL-------------------------------FSLIKDIQILFRKK--KTDIKASNILLDD 164 (381)
Q Consensus 118 ~~~~~lv~E~~~~g~L~~~l-------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~ 164 (381)
....++||||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~ 172 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTE 172 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcC
Confidence 99999999999999998765 37899999999999 9999999999999
Q ss_pred CCCcEEeeeccceecCCCCccc-ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHH
Q 048280 165 KWIPKIADFGMARLFPEDQTHV-NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLL 242 (381)
Q Consensus 165 ~~~~kL~DFG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~ 242 (381)
++.+||+|||+++.+....... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.... ..
T Consensus 173 ~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------~~ 246 (304)
T cd05101 173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------VE 246 (304)
T ss_pred CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------HH
Confidence 9999999999998764432221 122345678999999998889999999999999999998 677764321 11
Q ss_pred HHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 243 DWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
.. .......... .........+.+|+.+||+.+|.+|||+.+|++.|+++.
T Consensus 247 ~~-~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 247 EL-FKLLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred HH-HHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 11 1111111111 011123456888999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=306.59 Aligned_cols=234 Identities=21% Similarity=0.290 Sum_probs=179.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999875 58999999986432 233456888999999999999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc----
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT---- 184 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~---- 184 (381)
||+++|+|.+++ .|++.+|.|||+.+ ||||||+||||+.++.+||+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 999999997665 68899999999999 999999999999999999999999875432110
Q ss_pred ------------------------------ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCC
Q 048280 185 ------------------------------HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNL 234 (381)
Q Consensus 185 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 234 (381)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 00113569999999999999999999999999999999999999986432
Q ss_pred ccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 048280 235 DVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPT---MRRVVV 297 (381)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~ 297 (381)
... ............. ..+. ......+.+|+.+|+. ||.+|++ +.++++
T Consensus 241 ~~~------~~~~i~~~~~~~~-~p~~------~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 241 PQE------TYRKVMNWKETLV-FPPE------VPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred HHH------HHHHHHcCCCcee-cCCC------CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 211 1111111000000 1111 0123456778877764 9999996 555543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=306.82 Aligned_cols=243 Identities=20% Similarity=0.183 Sum_probs=179.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
..+|.+.+.||+|+||.||+|.+. .++.||||... ...+.+|++++++++|+|||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999876 48899999642 23467899999999999999999999999999999999
Q ss_pred ccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc-ccc
Q 048280 128 VINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH-VNT 188 (381)
Q Consensus 128 ~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~-~~~ 188 (381)
+. ++|..++ .|++.+|.|||+.+ ||||||+||||+.++.+||+|||+++.+...... ...
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 84 5665443 78999999999999 9999999999999999999999999876432211 122
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccc-cccHHHHHHHHhhcCCcc-cc---------
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVD-AQNLLDWAYKLYKKDKSL-EI--------- 257 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~-~~--------- 257 (381)
...||..|+|||++.+..++.++|||||||+||||++|..++....... .................. ..
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 4579999999999999999999999999999999999887653221111 011111111111110000 00
Q ss_pred -----------cCCCCCCCCCH---HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 258 -----------VDPSLAASDSG---DQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 258 -----------~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
..+........ .....+.+||.+||+.||.+|||+.||++.
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000000000 122357789999999999999999999875
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=290.54 Aligned_cols=234 Identities=23% Similarity=0.388 Sum_probs=179.9
Q ss_pred CCCCCcccccCCeeEEEEEECC-Cc--EEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeC------Ce
Q 048280 52 FHPSNKLGEGGFGPVFKGKLDD-GR--EIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHG------AE 120 (381)
Q Consensus 52 y~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~ 120 (381)
|.+.+.||+|+||.||+|++.. +. .||+|.+... .....+.+.+|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567899999999999998764 32 6899988654 233456788999999999999999999987532 34
Q ss_pred EEEEEecccCCCHHHHH---------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccce
Q 048280 121 KLLIYEYVINESLDKVL---------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMAR 177 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l---------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~ 177 (381)
.+++|||+.+|+|.+++ .|++.+|+|+|..+ ||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 68999999999986543 57899999999988 99999999999999999999999998
Q ss_pred ecCCCCccc-ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcc
Q 048280 178 LFPEDQTHV-NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSL 255 (381)
Q Consensus 178 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (381)
.+....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..+. .........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~----~~~~~~~~~ 233 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIY----DYLRQGNRL 233 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHH----HHHHcCCCC
Confidence 764332211 122345678999999998899999999999999999999 7888753221 1111 111111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 256 EIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
. ........+.+++.+||+.||++|||+.+|++.|+.
T Consensus 234 ~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 234 K---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred C---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0 011233558899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=295.47 Aligned_cols=237 Identities=21% Similarity=0.281 Sum_probs=181.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++|++.+.||+|+||.||+++.+ +++.||+|++... .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999876 4788999998542 1222345788999999999999999999999999999999
Q ss_pred ecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 126 EYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 126 E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
||+++|+|.+++ .|++.++.|+|+.+ ||||||+|||++.++.+||+|||++..+........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 999999997665 57889999999999 999999999999999999999999986543333223
Q ss_pred cccccCccccchhHHh-----hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 188 TRVAGTNGYMAPEYVM-----HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
....||+.|+|||++. ...++.++|||||||++|||++|+.||.... ................ .+.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~~~~--~p~- 231 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKERFQ--FPA- 231 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC------HHHHHHHHhCCCcccc--CCC-
Confidence 3457999999999986 3468899999999999999999999985332 1111122211111000 111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCC--CCCCHHHHHHH
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQ--LRPTMRRVVVM 298 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~eil~~ 298 (381)
........+.+|+.+|+..++. .|+++.++++.
T Consensus 232 ---~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 232 ---QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ---ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 1122345677888888865444 37889998765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=305.75 Aligned_cols=244 Identities=17% Similarity=0.202 Sum_probs=182.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC---CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD---DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
..+|++.+.||+|+||.||++... .+..||+|.+... ....+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999753 3678999988543 34568999999999999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc-cc
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH-VN 187 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~-~~ 187 (381)
|++. ++|.+++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||++..+...... ..
T Consensus 166 e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~ 244 (392)
T PHA03207 166 PKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244 (392)
T ss_pred hhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccc
Confidence 9985 5665443 78999999999999 9999999999999999999999999865443222 22
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCc-------------
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKS------------- 254 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------- 254 (381)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+............
T Consensus 245 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 324 (392)
T PHA03207 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKH 324 (392)
T ss_pred cccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHH
Confidence 2467999999999999999999999999999999999999998654332211111111111110000
Q ss_pred ----ccccCCCCCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 255 ----LEIVDPSLAAS---DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 255 ----~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.....+..... ........+.++|.+||..||++|||+.|++..
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 325 FKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 001123457789999999999999999999865
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=293.20 Aligned_cols=237 Identities=27% Similarity=0.424 Sum_probs=185.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEK 121 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 121 (381)
.++|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.++++++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457999999999999999999853 46789999986543 23346788999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHH-------------------------------------HhhhhhhhHhhhhc--cCCccccceEe
Q 048280 122 LLIYEYVINESLDKVL-------------------------------------FSLIKDIQILFRKK--KTDIKASNILL 162 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l-------------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll 162 (381)
++||||+++++|.+++ .+++.+|.++|..+ ||||||+|||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~ 163 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV 163 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEe
Confidence 9999999999886544 56889999999998 99999999999
Q ss_pred CCCCCcEEeeeccceecCCCCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccccc
Q 048280 163 DDKWIPKIADFGMARLFPEDQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQN 240 (381)
Q Consensus 163 ~~~~~~kL~DFG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~ 240 (381)
+.++.+||+|||++..+...... .......+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~----- 238 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH----- 238 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence 99999999999998865332211 1112334667999999998999999999999999999997 7777642211
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 241 LLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
...... ....... ......+..+.+|+.+||+.||.+|||+.||++.|++
T Consensus 239 -~~~~~~-~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 -EEVIYY-VRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -HHHHHH-HhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111111 1111111 0111234568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=296.56 Aligned_cols=176 Identities=28% Similarity=0.437 Sum_probs=144.5
Q ss_pred CCcccccCCeeEEEEEEC---CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEee--CCeEEEEEeccc
Q 048280 55 SNKLGEGGFGPVFKGKLD---DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAH--GAEKLLIYEYVI 129 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~E~~~ 129 (381)
.++||+|+||.||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 46889999986442 23567889999999999999999998854 466899999985
Q ss_pred CCCHH------------------------HHHHhhhhhhhHhhhhc--cCCccccceEe----CCCCCcEEeeeccceec
Q 048280 130 NESLD------------------------KVLFSLIKDIQILFRKK--KTDIKASNILL----DDKWIPKIADFGMARLF 179 (381)
Q Consensus 130 ~g~L~------------------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll----~~~~~~kL~DFG~~~~~ 179 (381)
+ +|. .++.|++.+|.|||+.+ ||||||+|||+ +.++.+||+|||+++.+
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 3 443 34579999999999999 99999999999 45678999999999876
Q ss_pred CCCCcc--cccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCC
Q 048280 180 PEDQTH--VNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFN 233 (381)
Q Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~ 233 (381)
...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 433211 12345789999999999874 5899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=289.47 Aligned_cols=236 Identities=22% Similarity=0.323 Sum_probs=185.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
.++|.+.+.||+|+||.||+|+.. +++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357888999999999999999865 5889999998766544456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccc
Q 048280 128 VINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV 190 (381)
Q Consensus 128 ~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 190 (381)
+++++|.+++ .|++.++.|+|..+ |+||||+||+++.++.+||+|||++..+.... ......
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 166 (267)
T cd06645 88 CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKRKSF 166 (267)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cccccc
Confidence 9999998765 67899999999998 99999999999999999999999988654322 122345
Q ss_pred ccCccccchhHHh---hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 191 AGTNGYMAPEYVM---HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 191 ~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
.|+..|+|||++. ...++.++|||||||++|+|++|..||........ ......... ..+.... .
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~~~~~~~~----~~~~~~~--~ 234 (267)
T cd06645 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFLMTKSNF----QPPKLKD--K 234 (267)
T ss_pred cCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HHhhhccCC----CCCcccc--c
Confidence 6899999999874 45688999999999999999999999753221110 011111110 0011100 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
......+.+++.+||+.+|++||++++|++
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 235 MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 122345788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=278.78 Aligned_cols=237 Identities=24% Similarity=0.334 Sum_probs=190.4
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-----cc---cHHHHHHHHHHHHHh-CCCCcccEEEEEe
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-----NQ---GKKEFENEAKLLARV-QHRNVVNLLGYCA 116 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~---~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 116 (381)
.....|...+.||.|..+.|-++.++ +|..+|+|++.... .. -++.-.+|+.||+++ .||+|+++.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34567899999999999999998654 68899999985331 11 124556799999999 5999999999999
Q ss_pred eCCeEEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceec
Q 048280 117 HGAEKLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLF 179 (381)
Q Consensus 117 ~~~~~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~ 179 (381)
.+..+++|+|.|+.|.|.++| +|+++++.|+|... ||||||+|||++++.++||+|||+++.+
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 999999999999999998776 78999999999998 9999999999999999999999999987
Q ss_pred CCCCcccccccccCccccchhHHhh------CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCC
Q 048280 180 PEDQTHVNTRVAGTNGYMAPEYVMH------GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDK 253 (381)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (381)
..... -...+||++|+|||.+.- ..|+..+|+||+|||+|.|+.|.+||.... .++ ....+.. +.
T Consensus 174 ~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-----Qml-MLR~Ime-Gk 244 (411)
T KOG0599|consen 174 EPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-----QML-MLRMIME-GK 244 (411)
T ss_pred CCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-----HHH-HHHHHHh-cc
Confidence 65433 345789999999998853 357889999999999999999999984211 111 0111111 11
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 254 SLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
-.+..+...+......+||.+||+.||.+|.|++|++..
T Consensus 245 ------yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 245 ------YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ------cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 123344556777788999999999999999999999853
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=301.90 Aligned_cols=174 Identities=23% Similarity=0.288 Sum_probs=148.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
..+|++.+.||+|+||.||+|+.. ++..||+|+.... ....|+.++++++|+||+++++++......++||||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 457999999999999999999876 4788999975332 235699999999999999999999999999999999
Q ss_pred ccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 128 VINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 128 ~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
+. ++|.+++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||+++..... .....
T Consensus 139 ~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~ 215 (357)
T PHA03209 139 YS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAFLG 215 (357)
T ss_pred cC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC--ccccc
Confidence 94 5665443 78999999999999 9999999999999999999999999753222 11234
Q ss_pred cccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCC
Q 048280 190 VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSS 231 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~ 231 (381)
..||..|+|||++.+..++.++|||||||++|||+++..++.
T Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred ccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 568999999999999999999999999999999999766653
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=298.78 Aligned_cols=238 Identities=30% Similarity=0.465 Sum_probs=186.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCCC-cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHSS-NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAE 120 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 120 (381)
.++|.+.+.||+|+||.||++... .+..||||.+.... ....+.+.+|+.+++++ +|+||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 457999999999999999999641 35579999987543 23346789999999999 79999999999999999
Q ss_pred EEEEEecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCC
Q 048280 121 KLLIYEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPE 181 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~ 181 (381)
.++||||+.+++|.+++ .+++.++.|+|+.+ |+||||+|||++.++.+||+|||+++.+..
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 99999999999997665 57899999999988 999999999999999999999999986543
Q ss_pred CCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccC
Q 048280 182 DQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVD 259 (381)
Q Consensus 182 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
.... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... .+ .........
T Consensus 194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~----~~~~~~~~~----- 262 (302)
T cd05055 194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KF----YKLIKEGYR----- 262 (302)
T ss_pred CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HH----HHHHHcCCc-----
Confidence 3221 1222345778999999999999999999999999999998 888875322111 11 111111110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 260 PSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 260 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
. .........+.+++.+||..+|++|||+.+|++.|.+
T Consensus 263 ~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 263 M----AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred C----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0 0111123568899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=292.57 Aligned_cols=232 Identities=28% Similarity=0.348 Sum_probs=182.8
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc---ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
.|++.+.||+|+||.||++... +++.||||.+..... .....+.+|+.++++++|+||+.+++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3778899999999999999865 589999999865422 223457789999999999999999999999999999999
Q ss_pred cccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 127 YVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 127 ~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|+.+++|.+++ .|++.+|.|+|..+ ||||||+||+++.++.++|+|||++........ .
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~ 158 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--I 158 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--c
Confidence 99999997654 57899999999988 999999999999999999999999986543221 1
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
....|+..|+|||++.+..++.++|||||||++|+|++|+.||........... ........ .... .
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~---~~~~~~~~------~~~~----~ 225 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKEV------QEEY----S 225 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH---HHhhhhhh------hhhc----C
Confidence 234689999999999999999999999999999999999999864322111000 01111100 0001 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPT-----MRRVVV 297 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 297 (381)
......+.+|+.+||+.||++||| +.|+++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 226 EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 122345788999999999999999 888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=294.21 Aligned_cols=241 Identities=24% Similarity=0.340 Sum_probs=177.1
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc--ccHHHHHHHHHHHHHh---CCCCcccEEEEEee-----CC
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN--QGKKEFENEAKLLARV---QHRNVVNLLGYCAH-----GA 119 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~-----~~ 119 (381)
+|++.+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5889999999999999999876 588999999865421 2234566788877766 69999999998864 34
Q ss_pred eEEEEEecccCCCHHHH-----------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecC
Q 048280 120 EKLLIYEYVINESLDKV-----------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFP 180 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~~-----------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~ 180 (381)
..++||||+.+ +|..+ +.|++.+|.|+|+.+ ||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 57999999964 66443 368999999999999 99999999999999999999999998664
Q ss_pred CCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCC---cc--
Q 048280 181 EDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDK---SL-- 255 (381)
Q Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~-- 255 (381)
... ......||..|+|||++.+..++.++|||||||++|+|++|++||......+. ............ ..
T Consensus 160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 160 CQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred Ccc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH---HHHHHHHhCCCChhhCccc
Confidence 322 12235678999999999999999999999999999999999999854332211 111111110000 00
Q ss_pred -----cccCCCC---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 256 -----EIVDPSL---AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 256 -----~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
....+.. ...........+.+|+.+||+.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000 00111123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=290.39 Aligned_cols=237 Identities=26% Similarity=0.422 Sum_probs=186.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC----CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD----DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
..+|++.+.||+|+||.||+|... .+..+|+|.+.... ......+.+|+.++++++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 357899999999999999999764 23479999986542 2334678999999999999999999999999999999
Q ss_pred EEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 124 IYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 124 v~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
||||+++++|.+++ .|++.++.++|+.+ ||||||+|||++.++.+||+|||++..+......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence 99999999997665 57889999999998 9999999999999999999999999876543222
Q ss_pred ccc--ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 186 VNT--RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 186 ~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
... ...++..|+|||.+.+..++.++|||||||++|++++ |..||...... ..... ...... .
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~----~~~~~~-----~-- 228 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKA----IEEGYR-----L-- 228 (267)
T ss_pred eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHH----HhCCCc-----C--
Confidence 111 1223567999999998899999999999999999886 99987533221 11111 111100 0
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
......+..+.+++.+||+.+|.+||++.++++.|.+
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 229 --PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred --CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 1111234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=291.70 Aligned_cols=234 Identities=22% Similarity=0.379 Sum_probs=182.5
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeC------
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHG------ 118 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~------ 118 (381)
.+.+.|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35678999999999999999999865 58899999986543 3446788999999999 699999999998753
Q ss_pred CeEEEEEecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceec
Q 048280 119 AEKLLIYEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLF 179 (381)
Q Consensus 119 ~~~~lv~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~ 179 (381)
...++||||+.+++|.+++ .|++.++.|||..+ |+||||+||++++++.+||+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 4689999999999987654 58899999999998 9999999999999999999999999865
Q ss_pred CCCCcccccccccCccccchhHHh-----hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCc
Q 048280 180 PEDQTHVNTRVAGTNGYMAPEYVM-----HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKS 254 (381)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (381)
.... .......|+..|+|||++. +..++.++|||||||++|||++|+.||....... . ..... ....
T Consensus 162 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~-~~~~~-~~~~ 233 (272)
T cd06637 162 DRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----A-LFLIP-RNPA 233 (272)
T ss_pred cccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----H-HHHHh-cCCC
Confidence 4322 1223456889999999986 3458889999999999999999999985322111 0 11111 1110
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 255 LEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
+.. ........+.+|+.+||..||.+|||+.++++
T Consensus 234 -----~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 234 -----PRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -----CCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 111 11123346889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=297.12 Aligned_cols=237 Identities=21% Similarity=0.272 Sum_probs=182.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++|++.+.||+|+||.||+++.. +++.||+|++... .......+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999876 5889999998643 1222345788999999999999999999999999999999
Q ss_pred ecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 126 EYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 126 E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
||+++|+|.+++ .|++.+|.|+|+.+ ||||||+|||++.++.+||+|||++..+........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 999999998665 57899999999998 999999999999999999999999987654433323
Q ss_pred cccccCccccchhHHhh-----CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 188 TRVAGTNGYMAPEYVMH-----GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
....||+.|+|||++.+ +.++.++|||||||+||+|++|+.||..... ............... + +
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~-~-p-- 230 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEERFQ-F-P-- 230 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCCccc-C-C--
Confidence 34569999999999876 4678999999999999999999999853321 111111111111000 0 1
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQL--RPTMRRVVVM 298 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~ 298 (381)
....+....+.+++.+||..++.+ |++++++++.
T Consensus 231 --~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 231 --SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred --CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 111223456888999998865544 4678887654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=294.21 Aligned_cols=234 Identities=24% Similarity=0.394 Sum_probs=188.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
.++|++.+.||.|+||.||+|... +++.|++|.+........+.+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 346999999999999999999854 6899999999766555567889999999999999999999999999999999999
Q ss_pred ccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccc
Q 048280 128 VINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVA 191 (381)
Q Consensus 128 ~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~ 191 (381)
+.+++|..++ .+++.++.+||+.+ |+||||+||+++.++.+||+|||++......... .....
T Consensus 98 ~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~ 176 (296)
T cd06655 98 LAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RSTMV 176 (296)
T ss_pred cCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-CCCcC
Confidence 9999997654 57889999999999 9999999999999999999999998865433221 22346
Q ss_pred cCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHH
Q 048280 192 GTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271 (381)
Q Consensus 192 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (381)
++..|+|||.+.+..++.++|||||||++|+|++|+.||....... ......... .... .......
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~~~~~~~~~-~~~~-------~~~~~~~ 242 (296)
T cd06655 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIATNG-TPEL-------QNPEKLS 242 (296)
T ss_pred CCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcC-Cccc-------CCcccCC
Confidence 8889999999998889999999999999999999999985433211 111111111 0000 0111233
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 272 AMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 272 ~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
..+.+++.+||..||.+||++.+|+.
T Consensus 243 ~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 243 PIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 56788999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=287.00 Aligned_cols=231 Identities=22% Similarity=0.302 Sum_probs=185.4
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
+|++.+.||.|+||.||++... +++.||+|.+... .....+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5888999999999999999865 5899999998643 2334567889999999999999999999999999999999999
Q ss_pred cCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 129 INESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 129 ~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
++++|.+++ .+++.++.++|..+ |+||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 159 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YACT 159 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-cccc
Confidence 999886543 68899999999998 999999999999999999999999987643322 1223
Q ss_pred cccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHH
Q 048280 190 VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGD 269 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (381)
..|+..|+|||++.+..++.++||||||+++|+|++|..||.... .......... .... .....
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~------~~~~~~~~~~-~~~~---------~~~~~ 223 (255)
T cd08219 160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS------WKNLILKVCQ-GSYK---------PLPSH 223 (255)
T ss_pred ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC------HHHHHHHHhc-CCCC---------CCCcc
Confidence 568889999999998889999999999999999999999985321 1111111111 1110 01112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 270 QIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 270 ~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
....+.+|+.+||+.||++||++.+|+..
T Consensus 224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 224 YSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 33457889999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=303.18 Aligned_cols=223 Identities=22% Similarity=0.267 Sum_probs=169.7
Q ss_pred ccccCCeeEEEEEEC-CCcEEEEEEecCCCc---ccHHHHHHHHHHHHHh---CCCCcccEEEEEeeCCeEEEEEecccC
Q 048280 58 LGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---QGKKEFENEAKLLARV---QHRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 58 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
||+|+||.||+|+.. +++.||||++..... .....+..|..++..+ +||||+++++++...+..|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999876 589999999864321 1223455677777765 699999999999999999999999999
Q ss_pred CCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccC
Q 048280 131 ESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT 193 (381)
Q Consensus 131 g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt 193 (381)
|+|..++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||++........ ......||
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt 159 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNTFCGT 159 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccCccCC
Confidence 9986543 68999999999999 999999999999999999999999875432221 22345799
Q ss_pred ccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHH
Q 048280 194 NGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIA 272 (381)
Q Consensus 194 ~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (381)
..|+|||++.+. .++.++|||||||++|+|++|+.||..... ....... ..... . +.. .....
T Consensus 160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~~~~i-~~~~~-~-----~~~---~~~~~ 223 (330)
T cd05586 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQMYRNI-AFGKV-R-----FPK---NVLSD 223 (330)
T ss_pred ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHHHHHH-HcCCC-C-----CCC---ccCCH
Confidence 999999998765 489999999999999999999999854321 1111111 11110 0 000 11234
Q ss_pred HHHHHHHHcccCCCCCCC----CHHHHHH
Q 048280 273 MCIQIGLLCTQGDPQLRP----TMRRVVV 297 (381)
Q Consensus 273 ~l~~li~~cl~~dP~~RP----s~~eil~ 297 (381)
.+.+++.+||+.||.+|| ++.++++
T Consensus 224 ~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 224 EGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 577899999999999998 4566554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=287.23 Aligned_cols=229 Identities=23% Similarity=0.362 Sum_probs=177.7
Q ss_pred cccccCCeeEEEEEEC---CCcEEEEEEecCCCc-ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCCC
Q 048280 57 KLGEGGFGPVFKGKLD---DGREIAVKKLSHSSN-QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINES 132 (381)
Q Consensus 57 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~ 132 (381)
.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.++++++|+||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999754 356799999865532 234678999999999999999999999864 56899999999999
Q ss_pred HHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc--ccccc
Q 048280 133 LDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN--TRVAG 192 (381)
Q Consensus 133 L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~--~~~~g 192 (381)
|.+++ .|++.++.|+|..+ ||||||+|||++.++.+||+|||++..+........ ....+
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCC
Confidence 98765 57899999999998 999999999999999999999999986543322111 11223
Q ss_pred CccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHH
Q 048280 193 TNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271 (381)
Q Consensus 193 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (381)
+..|+|||++.+..++.++|||||||++|+|++ |..||......+ . ......... ...+....
T Consensus 161 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~----~~~~~~~~~---------~~~~~~~~ 224 (257)
T cd05115 161 PLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---V----MSFIEQGKR---------LDCPAECP 224 (257)
T ss_pred CcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---H----HHHHHCCCC---------CCCCCCCC
Confidence 568999999988889999999999999999996 999985432211 1 111111111 11112234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 272 AMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 272 ~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
..+.+++.+||..||++||++.+|.+.|+..
T Consensus 225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 225 PEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 5688899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=286.51 Aligned_cols=232 Identities=26% Similarity=0.419 Sum_probs=187.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC-CcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD-GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
.++|++.+.||+|+||.||+|.... ++.|++|.+..... .+.+.+|++++++++|+||+++++++......++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3679999999999999999998765 88999999865433 67899999999999999999999999999999999999
Q ss_pred ccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 128 VINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 128 ~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
+.+++|.+++ .+++.++.|+|..+ |+||+|+||+++.++.+||+|||++........ ....
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 158 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNT 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-cccc
Confidence 9999997665 67899999999988 999999999999999999999999987644322 1223
Q ss_pred cccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHH
Q 048280 190 VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGD 269 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (381)
..++..|+|||++.+..++.++|||||||++|+|++|+.||........ ... .... ..+. ......
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~------~~~-~~~~-----~~~~--~~~~~~ 224 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA------IFM-IPNK-----PPPT--LSDPEK 224 (256)
T ss_pred ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh------hhh-hccC-----CCCC--CCchhh
Confidence 4578899999999998999999999999999999999999864322111 000 0000 0010 111223
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 270 QIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 270 ~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
....+.+++.+||+.||.+|||+.+|++
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 4456889999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=286.76 Aligned_cols=233 Identities=25% Similarity=0.406 Sum_probs=175.6
Q ss_pred CcccccCCeeEEEEEECC---CcEEEEEEecCCCc-ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCC
Q 048280 56 NKLGEGGFGPVFKGKLDD---GREIAVKKLSHSSN-QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINE 131 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g 131 (381)
+.||+|+||.||+|...+ +..+|+|.+..... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 468999999999997643 46799999865532 23357889999999999999999999999999999999999999
Q ss_pred CHHHHH--------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc-cc
Q 048280 132 SLDKVL--------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV-NT 188 (381)
Q Consensus 132 ~L~~~l--------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~-~~ 188 (381)
+|.+++ .|++.++.|+|..+ |+||||+||+++.++.+||+|||+++......... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD 160 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence 997654 47889999999998 99999999999999999999999997543322211 12
Q ss_pred ccccCccccchhHHhhC-------CCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCC
Q 048280 189 RVAGTNGYMAPEYVMHG-------HLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDP 260 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
...++..|+|||++.+. .++.++|||||||++|||++ |..||......+ .... ...........+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~----~~~~~~~~~~~~ 233 (269)
T cd05087 161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTY----TVREQQLKLPKP 233 (269)
T ss_pred CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHH----HhhcccCCCCCC
Confidence 34567889999988642 35789999999999999996 998985432211 1111 111111122222
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 261 SLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 261 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
..... ....+.+++..|| .+|++|||+++|+..|+
T Consensus 234 ~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 234 RLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22211 2334677889999 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=294.98 Aligned_cols=244 Identities=20% Similarity=0.313 Sum_probs=182.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
.++|++.+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 357999999999999999999865 58899999986543 2334567889999999999999999999999999999999
Q ss_pred cccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 127 YVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 127 ~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
|+. ++|.+++ .|++.+|.|||+.+ |+||||+|||++.++.+||+|||++......... ..
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~ 162 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-YS 162 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc-cc
Confidence 996 5665443 68999999999999 9999999999999999999999999764332211 12
Q ss_pred ccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc------------CCcc
Q 048280 189 RVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKK------------DKSL 255 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~ 255 (381)
...++..|+|||++.+. .++.++|||||||++|+|++|+.||...... ............ ....
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCChhhchhhhcccccc
Confidence 34568899999998764 5789999999999999999999998643221 111111111100 0000
Q ss_pred cccCCCCCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 256 EIVDPSLAAS----DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 256 ~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
....+..... ........+.+|+.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000111000 01123446788999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=303.14 Aligned_cols=234 Identities=26% Similarity=0.426 Sum_probs=197.0
Q ss_pred CCCCCCcccccCCeeEEEEEECC-CcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEeccc
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLDD-GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVI 129 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 129 (381)
+.....+||-|.||.||.|.|+. .-.||||.++.. ....++|+.|+.+|+.++|||+|+++|+|.....+|||+|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 45556799999999999999875 678999999644 4557899999999999999999999999999999999999999
Q ss_pred CCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccc
Q 048280 130 NESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV 190 (381)
Q Consensus 130 ~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 190 (381)
.|+|.+|| .||..++.||-.+. ||||...|+|+.++..||++|||+++++..+........
T Consensus 347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGA 426 (1157)
T KOG4278|consen 347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGA 426 (1157)
T ss_pred CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCc
Confidence 99999988 47889999998887 999999999999999999999999999877665554444
Q ss_pred ccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHH
Q 048280 191 AGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGD 269 (381)
Q Consensus 191 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (381)
.-.+.|.|||-+....++.|+|||+|||+|||+.| |-.||.... +..++.++.++ ++...+..
T Consensus 427 KFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-------lSqVY~LLEkg---------yRM~~PeG 490 (1157)
T KOG4278|consen 427 KFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYGLLEKG---------YRMDGPEG 490 (1157)
T ss_pred cCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-------HHHHHHHHhcc---------ccccCCCC
Confidence 45778999999999999999999999999999998 666664321 12334444433 33444556
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 270 QIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 270 ~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
++..+.+|+..||+++|.+||++.||-+.++.
T Consensus 491 CPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 491 CPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred CCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 67789999999999999999999999887754
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=293.86 Aligned_cols=235 Identities=26% Similarity=0.382 Sum_probs=181.6
Q ss_pred cCCCCCCcccccCCeeEEEEEECC-C--cEEEEEEecCC-CcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLDD-G--REIAVKKLSHS-SNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv 124 (381)
++|++.+.||+|+||.||+|...+ + ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 579999999999999999998653 3 35788887643 233346788999999999 799999999999999999999
Q ss_pred EecccCCCHHHHH-------------------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEe
Q 048280 125 YEYVINESLDKVL-------------------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIA 171 (381)
Q Consensus 125 ~E~~~~g~L~~~l-------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~ 171 (381)
|||+++++|.+++ .|++.++.++|..+ ||||||+|||++.++.+||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence 9999999986544 56888999999988 99999999999999999999
Q ss_pred eeccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhh
Q 048280 172 DFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYK 250 (381)
Q Consensus 172 DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 250 (381)
|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||...... ... .. ..
T Consensus 162 dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~~---~~-~~ 232 (297)
T cd05089 162 DFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---ELY---EK-LP 232 (297)
T ss_pred CcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH---HH-Hh
Confidence 99998643211 11111223457999999998899999999999999999997 99988533211 111 11 11
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 251 KDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
... .+ .........+.+|+.+||+.+|.+||++.+|++.|...
T Consensus 233 ~~~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 233 QGY-----RM----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred cCC-----CC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 110 01 11112335688999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=285.00 Aligned_cols=229 Identities=27% Similarity=0.379 Sum_probs=181.4
Q ss_pred CcccccCCeeEEEEEECCCcEEEEEEecCCCcc-cHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCCCHH
Q 048280 56 NKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQ-GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLD 134 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~ 134 (381)
++||.|+||.||++...+++.||+|++...... ....+.+|++++++++|+||+++++++......++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999777999999998765433 4567899999999999999999999999999999999999999997
Q ss_pred HHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc-cccccCcc
Q 048280 135 KVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN-TRVAGTNG 195 (381)
Q Consensus 135 ~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~-~~~~gt~~ 195 (381)
+++ .+++.++.++|+++ ||||||+|||++.++.+||+|||++........... ....++..
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~ 160 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK 160 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceec
Confidence 665 57788999999988 999999999999999999999999986542222111 12233567
Q ss_pred ccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHH
Q 048280 196 YMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMC 274 (381)
Q Consensus 196 y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 274 (381)
|+|||.+.+..++.++|||||||++|+|++ |..||....... .. ....... . .......+..+
T Consensus 161 y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~----~~~~~~~--~-------~~~~~~~~~~~ 224 (251)
T cd05041 161 WTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TR----ERIESGY--R-------MPAPQLCPEEI 224 (251)
T ss_pred cCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HH----HHHhcCC--C-------CCCCccCCHHH
Confidence 999999988899999999999999999999 777774332111 11 1111110 0 01112234568
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 275 IQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 275 ~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
.+++.+||..+|.+|||+.||++.|.
T Consensus 225 ~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 225 YRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHhccChhhCcCHHHHHHHhh
Confidence 89999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=295.31 Aligned_cols=236 Identities=26% Similarity=0.419 Sum_probs=181.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCc--EEEEEEecCC-CcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGR--EIAVKKLSHS-SNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l 123 (381)
.++|++.+.||+|+||.||+|.+. ++. .+++|.+... .......+.+|+.++.++ +|+||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357899999999999999999865 344 4577776543 223346788999999999 89999999999999999999
Q ss_pred EEecccCCCHHHHH-------------------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEE
Q 048280 124 IYEYVINESLDKVL-------------------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKI 170 (381)
Q Consensus 124 v~E~~~~g~L~~~l-------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL 170 (381)
||||+++++|.+++ .|++.+++|||+.+ ||||||+|||++.++.+||
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEe
Confidence 99999999887654 47889999999998 9999999999999999999
Q ss_pred eeeccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHh
Q 048280 171 ADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLY 249 (381)
Q Consensus 171 ~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 249 (381)
+|||++...... .......++..|+|||++.+..++.++|||||||++|||++ |..||...... .... ..
T Consensus 166 ~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~----~~ 236 (303)
T cd05088 166 ADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYE----KL 236 (303)
T ss_pred CccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHH----HH
Confidence 999998642111 11111234567999999988889999999999999999998 99887532211 1111 11
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 250 KKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
..... . .........+.+|+.+||+.+|++||++.+++..|...
T Consensus 237 ~~~~~-----~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 237 PQGYR-----L----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred hcCCc-----C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11100 0 01111234578899999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=286.07 Aligned_cols=229 Identities=24% Similarity=0.396 Sum_probs=182.2
Q ss_pred cCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEe-eCCeEEEEEecc
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCA-HGAEKLLIYEYV 128 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~lv~E~~ 128 (381)
++|++.+.||+|+||.||++... +..||+|.+.... ..+.+.+|+.++++++|+||+++++++. .++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 47899999999999999999776 7889999986432 3467899999999999999999999754 556789999999
Q ss_pred cCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 129 INESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 129 ~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
++++|.+++ .+++.+|+++|..+ ||||||+||+++.++.+||+|||++....... ..
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~~ 158 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DT 158 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC----CC
Confidence 999987654 57889999999998 99999999999999999999999988643322 12
Q ss_pred cccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 190 VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
..++..|+|||++.+..++.++|||||||++|+|++ |+.||.... ........ ..... + ....
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~-~~~~~-----~----~~~~ 222 (256)
T cd05082 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRV-EKGYK-----M----DAPD 222 (256)
T ss_pred CccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHH-hcCCC-----C----CCCC
Confidence 334568999999998899999999999999999997 888875321 11111111 11110 1 1112
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
..+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 234568899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=295.58 Aligned_cols=243 Identities=24% Similarity=0.395 Sum_probs=185.8
Q ss_pred cCCCCCCcccccCCeeEEEEEE-----CCCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeC--CeE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKL-----DDGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHG--AEK 121 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~ 121 (381)
+.|++++.||+|+||.||+++. .++..||+|.+.... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578999999999999999974 247889999986543 33346789999999999999999999998775 568
Q ss_pred EEEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 122 LLIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
++||||+++++|.+++ .+++.+|+|+|+.+ ||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 9999999999997665 58899999999999 99999999999999999999999998764332
Q ss_pred cc--cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcc--------ccccHHHHHHHHhhcCC
Q 048280 184 TH--VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDV--------DAQNLLDWAYKLYKKDK 253 (381)
Q Consensus 184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~--------~~~~~~~~~~~~~~~~~ 253 (381)
.. ......++..|+|||++.+..++.++|||||||++|+|++++.|+...... .................
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK 243 (284)
T ss_pred cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCc
Confidence 21 112345677899999999888999999999999999999987664321110 00000111111111111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 254 SLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
. ..........+.+|+.+||+.||.+|||+.++++.|+.
T Consensus 244 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 244 R---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred c---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 0 01111234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=288.59 Aligned_cols=238 Identities=27% Similarity=0.421 Sum_probs=186.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC-C---cEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD-G---REIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
.++|+..+.||+|+||.||+|.... + ..+|+|.+.... ....+.+.+|++++++++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4578889999999999999998652 3 379999986542 3335678899999999999999999999999999999
Q ss_pred EEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 124 IYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 124 v~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
||||+.+++|.+++ .+++.++.|+|..+ |+||||+||+++.++.+||+|||++.........
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 99999999997655 57889999999998 9999999999999999999999999866433221
Q ss_pred ccc--ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 186 VNT--RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 186 ~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
... ....+..|+|||++.+..++.++|||||||++|||++ |..||...... ... .. .....
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~~~---~~-i~~~~--------- 227 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---EVM---KA-INDGF--------- 227 (268)
T ss_pred ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHH---HH-HhcCC---------
Confidence 111 1223457999999998889999999999999999997 99998533211 111 11 11110
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
...........+.+++.+||+.+|++||++.+|++.|.+.
T Consensus 228 ~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011112345688999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=297.76 Aligned_cols=224 Identities=22% Similarity=0.283 Sum_probs=176.9
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhC-CCCcccEEEEEeeCCeEEEEE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQ-HRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~ 125 (381)
+|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+..|+.++..+. |++|+++++++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999865 58999999986532 233456778999998885 577888999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
||+++|+|..++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~-~~~ 159 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-TTR 159 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc-ccc
Confidence 999999997654 68999999999998 999999999999999999999999875432221 123
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .... ....... .. .+.
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~---~~i~~~~-------~~----~p~ 222 (323)
T cd05615 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELF---QSIMEHN-------VS----YPK 222 (323)
T ss_pred CccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHH---HHHHhCC-------CC----CCc
Confidence 45689999999999998999999999999999999999999864321 1111 1111111 00 111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCH
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTM 292 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~ 292 (381)
.....+.+++.+||+.||.+|++.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 223 SLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred cCCHHHHHHHHHHcccCHhhCCCC
Confidence 223457889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=294.57 Aligned_cols=235 Identities=25% Similarity=0.363 Sum_probs=185.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
.+.|++.+.||.|+||.||+|+.. ++..|++|.+........+.+.+|+++++.++|+||+++++++..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 467999999999999999999876 4889999999776655567889999999999999999999999999999999999
Q ss_pred ccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 128 VINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 128 ~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
+++++|..++ .|++.++.++|..+ ||||||+||+++.++.+||+|||++....... .....
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~ 169 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRRDS 169 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc-cccce
Confidence 9999986543 67899999999988 99999999999999999999999987543221 11223
Q ss_pred cccCccccchhHHh-----hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 190 VAGTNGYMAPEYVM-----HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 190 ~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
..++..|+|||++. ...++.++|||||||++|+|++|..||..... ......... ... +..
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~-~~~-----~~~-- 235 (292)
T cd06644 170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAK-SEP-----PTL-- 235 (292)
T ss_pred ecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHhc-CCC-----ccC--
Confidence 46788999999885 34578899999999999999999999753221 111111111 110 110
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.........+.+++.+||+.||++||++.++++.
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1112234567889999999999999999999753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=289.95 Aligned_cols=237 Identities=27% Similarity=0.393 Sum_probs=183.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCc----EEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGR----EIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 122 (381)
.++|++.+.||+|+||.||+|.+. ++. .||+|++.... ......+.+|+.+++.++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 457899999999999999999753 344 48999986543 3335678899999999999999999999875 4578
Q ss_pred EEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 123 LIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 123 lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
+++||+++|+|.+++ .|++.+|.|+|+.+ ||||||+|||+++++.+||+|||+++.+.....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 999999999997655 68899999999999 999999999999999999999999987643322
Q ss_pred cc-ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 185 HV-NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 185 ~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
.. .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... .+. ..........
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~----~~~~~~~~~~------ 231 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIP----DLLEKGERLP------ 231 (279)
T ss_pred eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HHHHCCCcCC------
Confidence 11 112234678999999998899999999999999999998 88887532211 111 1111111110
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
........+.+++.+||+.||++||++.++++.|...
T Consensus 232 ---~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 232 ---QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred ---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 1112334678899999999999999999999988664
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=302.89 Aligned_cols=239 Identities=30% Similarity=0.472 Sum_probs=183.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEE------CCCcEEEEEEecCCCc-ccHHHHHHHHHHHHHh-CCCCcccEEEEEee-CC
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKL------DDGREIAVKKLSHSSN-QGKKEFENEAKLLARV-QHRNVVNLLGYCAH-GA 119 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~-~~ 119 (381)
.++|++.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.++.++ +|+||+++++++.. +.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46899999999999999999973 2478899999975432 2345688999999999 68999999998865 45
Q ss_pred eEEEEEecccCCCHHHHH--------------------------------------------------------------
Q 048280 120 EKLLIYEYVINESLDKVL-------------------------------------------------------------- 137 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~~l-------------------------------------------------------------- 137 (381)
..++||||+.+|+|.+++
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999997664
Q ss_pred --------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc-cccccccCc
Q 048280 138 --------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH-VNTRVAGTN 194 (381)
Q Consensus 138 --------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~-~~~~~~gt~ 194 (381)
.|++.+|.|+|..+ ||||||+|||++.++.+||+|||++..+...... ......++.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence 37889999999998 9999999999999999999999999865332211 112234567
Q ss_pred cccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHH
Q 048280 195 GYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAM 273 (381)
Q Consensus 195 ~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (381)
.|+|||++.+..++.++|||||||++|+|++ |..||...... ..+ ........... .+. .....
T Consensus 246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~----~~~~~~~~~~~--~~~-------~~~~~ 310 (343)
T cd05103 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEF----CRRLKEGTRMR--APD-------YTTPE 310 (343)
T ss_pred ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHH----HHHHhccCCCC--CCC-------CCCHH
Confidence 8999999998899999999999999999997 88887542211 011 11111111110 011 11245
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 274 CIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 274 l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
+.+++..||+.||++|||+.+|++.|+..
T Consensus 311 ~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 311 MYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 78899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=285.18 Aligned_cols=233 Identities=24% Similarity=0.357 Sum_probs=173.0
Q ss_pred CcccccCCeeEEEEEECC---CcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCC
Q 048280 56 NKLGEGGFGPVFKGKLDD---GREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINE 131 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g 131 (381)
+.||+|+||.||+|...+ ...+++|.+.... ......+.+|+.+++.++|+||+++++++......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 468999999999997543 4568888875442 223456889999999999999999999999999999999999999
Q ss_pred CHHHHH--------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc-ccc
Q 048280 132 SLDKVL--------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH-VNT 188 (381)
Q Consensus 132 ~L~~~l--------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~-~~~ 188 (381)
+|.+++ .|++.+++|+|+.+ ||||||+|||++.++.+||+|||++......... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence 997654 57899999999999 9999999999999999999999998754322111 112
Q ss_pred ccccCccccchhHHhh-------CCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCC
Q 048280 189 RVAGTNGYMAPEYVMH-------GHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDP 260 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
...++..|+|||++.. ..++.++|||||||++|||++ |..||...... ... ..... ........+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~---~~~~~-~~~~~~~~~ 233 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QVL---KQVVR-EQDIKLPKP 233 (269)
T ss_pred CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHH---HHHhh-ccCccCCCC
Confidence 2345678999999753 356889999999999999999 67776533211 111 11111 111112222
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 261 SLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 261 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
.. .......+.+++..|| .||++|||+++|++.|.
T Consensus 234 ~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 234 QL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 22 2223455677888898 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=294.74 Aligned_cols=239 Identities=26% Similarity=0.405 Sum_probs=185.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC--------CCcEEEEEEecCCC-cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeC
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD--------DGREIAVKKLSHSS-NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHG 118 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 118 (381)
.++|.+.+.||+|+||.||+++.. +...+|+|.+.... ......+.+|+.+++++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467999999999999999999752 23579999987542 23346788899999999 799999999999999
Q ss_pred CeEEEEEecccCCCHHHHH-------------------------------HhhhhhhhHhhhhc--cCCccccceEeCCC
Q 048280 119 AEKLLIYEYVINESLDKVL-------------------------------FSLIKDIQILFRKK--KTDIKASNILLDDK 165 (381)
Q Consensus 119 ~~~~lv~E~~~~g~L~~~l-------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~ 165 (381)
+..++||||+.+++|.+++ .|++.+|+|+|+.+ ||||||+|||++.+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~ 176 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 176 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCC
Confidence 9999999999999886554 56788999999988 99999999999999
Q ss_pred CCcEEeeeccceecCCCCccc-ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHH
Q 048280 166 WIPKIADFGMARLFPEDQTHV-NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLD 243 (381)
Q Consensus 166 ~~~kL~DFG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~ 243 (381)
+.+||+|||++.......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||..... ..
T Consensus 177 ~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~------~~ 250 (307)
T cd05098 177 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------EE 250 (307)
T ss_pred CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH------HH
Confidence 999999999998654322111 112234568999999999899999999999999999998 7777743211 11
Q ss_pred HHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 244 WAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
. .......... .........+.+|+.+||..+|.+|||+.+|++.|..+.
T Consensus 251 ~-~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 251 L-FKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred H-HHHHHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1 1111111111 111123456888999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=285.78 Aligned_cols=236 Identities=23% Similarity=0.349 Sum_probs=189.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
.++|++.+.||.|+||.||+|... ++..+++|.+........+.+.+|+.++++++||||+++++++.+....+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367999999999999999999865 5788999999766555667899999999999999999999999999999999999
Q ss_pred ccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 128 VINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 128 ~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
+.+++|.+++ .|++.++.|||..+ |+||||+||+++.++.+||+|||++..+..... ....
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~ 160 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KRKS 160 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh-cccc
Confidence 9999987654 67899999999988 999999999999999999999999986543221 1223
Q ss_pred cccCccccchhHHhhC---CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 190 VAGTNGYMAPEYVMHG---HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
..++..|+|||.+.+. .++.++|||||||++|+|++|+.||........ ......... ..+. ...
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~------~~~~~~~~~----~~~~--~~~ 228 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA------LFLISKSNF----PPPK--LKD 228 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhccC----CCcc--ccc
Confidence 5678899999998776 789999999999999999999999854322111 111111100 0011 112
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.......+.+++.+||..+|.+|||+.+|+.
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2334567889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=287.90 Aligned_cols=239 Identities=23% Similarity=0.346 Sum_probs=186.4
Q ss_pred HHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 45 LVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
++..++++.....||+|+||.||+|... ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3445667777789999999999999865 578899999876655556789999999999999999999999999999999
Q ss_pred EEecccCCCHHHHH------------------HhhhhhhhHhhhhc--cCCccccceEeCC-CCCcEEeeeccceecCCC
Q 048280 124 IYEYVINESLDKVL------------------FSLIKDIQILFRKK--KTDIKASNILLDD-KWIPKIADFGMARLFPED 182 (381)
Q Consensus 124 v~E~~~~g~L~~~l------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~-~~~~kL~DFG~~~~~~~~ 182 (381)
|+||+++++|.+++ .|++.++.|||..+ ||||||+||+++. ++.+||+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 99999999997655 47889999999998 9999999999976 679999999999865432
Q ss_pred CcccccccccCccccchhHHhhCC--CCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCC
Q 048280 183 QTHVNTRVAGTNGYMAPEYVMHGH--LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDP 260 (381)
Q Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
.. ......++..|+|||++.+.. ++.++|||||||++|+|++|+.||........ ..+...... ..+
T Consensus 163 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~-------~~~ 231 (268)
T cd06624 163 NP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFK-------IHP 231 (268)
T ss_pred CC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhc-------cCC
Confidence 22 122345789999999987643 78999999999999999999999853221110 000000000 011
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 261 SLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 261 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
..+......+.+++.+||+.+|.+|||+.+++..
T Consensus 232 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 232 ----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 1122234568889999999999999999999753
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=290.16 Aligned_cols=243 Identities=26% Similarity=0.372 Sum_probs=179.7
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
+|++.+.||+|++|.||+|+.. ++..||||++.... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5888999999999999999875 58999999986542 22346788999999999999999999999999999999999
Q ss_pred ccCCCHHH------------------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 128 VINESLDK------------------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 128 ~~~g~L~~------------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
+. ++|.+ ++.|++.+|.|||+.+ |+||||+|||++.++.+||+|||++........ ..
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-VY 158 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-cc
Confidence 96 46643 3478999999999998 999999999999999999999999986543221 12
Q ss_pred cccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH-------hhcCCcc---c
Q 048280 188 TRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKL-------YKKDKSL---E 256 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~---~ 256 (381)
....+++.|+|||++.+. .++.++|||||||++|+|++|+.||......+. ........ +...... .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchhhHHHH
Confidence 233568899999988764 478999999999999999999999864322111 00000000 0000000 0
Q ss_pred ccCCCCC----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 257 IVDPSLA----ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 257 ~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
...+... ..........+.+++.+||..||.+|||+.+|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 0001113456778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=288.81 Aligned_cols=237 Identities=22% Similarity=0.357 Sum_probs=186.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC----CcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD----GREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
.++|.+.+.||+|+||.||+|...+ ...|+||...... ....+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3568899999999999999998643 3468999886554 3445689999999999999999999999875 45789
Q ss_pred EEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 124 IYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 124 v~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
||||+++++|.+++ .+++.++.|+|..+ |+||||+|||++.++.+||+|||+++........
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 163 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY 163 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccce
Confidence 99999999998765 58899999999998 9999999999999999999999999876544322
Q ss_pred cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 186 VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
......++..|+|||.+....++.++|||||||++|||++ |..||....... ... . ........
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~---~-~~~~~~~~-------- 228 (270)
T cd05056 164 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VIG---R-IENGERLP-------- 228 (270)
T ss_pred ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHH---H-HHcCCcCC--------
Confidence 2223334568999999988889999999999999999986 999985432211 111 1 11111110
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.....+..+.+++.+||..+|.+|||+.+++..|...
T Consensus 229 -~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 229 -MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1112345688899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=289.39 Aligned_cols=239 Identities=26% Similarity=0.394 Sum_probs=187.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
.++|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 357889999999999999999865 58899999886542 3345678999999999999999999999999999999999
Q ss_pred cccCCCHHHHH---------------HhhhhhhhHhhhh-c--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 127 YVINESLDKVL---------------FSLIKDIQILFRK-K--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 127 ~~~~g~L~~~l---------------~~~~~~l~~lh~~-~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
|+++++|..++ .+++.++.|+|.. + |+||||+||++++++.++|+|||++....... ..
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---~~ 160 (284)
T cd06620 84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---AD 160 (284)
T ss_pred cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---cC
Confidence 99999997654 5788999999974 3 99999999999999999999999987542221 12
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccc-----ccHHHHHHHHhhcCCcccccCCCCC
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDA-----QNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
...|+..|+|||++.+..++.++|||||||++|+|++|..||........ ..+........... .+.+
T Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~- 233 (284)
T cd06620 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------PPRL- 233 (284)
T ss_pred ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------CCCC-
Confidence 35689999999999888999999999999999999999999864432111 11111111111110 0111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 264 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
........+.+|+.+||+.||++|||+.|+++..
T Consensus 234 --~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 234 --PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred --CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1112445688999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=295.31 Aligned_cols=239 Identities=25% Similarity=0.428 Sum_probs=185.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC--------CCcEEEEEEecCCC-cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeC
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD--------DGREIAVKKLSHSS-NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHG 118 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 118 (381)
..+|.+.+.||+|+||.||+++.. ....+|+|.+.... ......+.+|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 457889999999999999999742 24578999986542 23345788999999999 699999999999999
Q ss_pred CeEEEEEecccCCCHHHHH-------------------------------HhhhhhhhHhhhhc--cCCccccceEeCCC
Q 048280 119 AEKLLIYEYVINESLDKVL-------------------------------FSLIKDIQILFRKK--KTDIKASNILLDDK 165 (381)
Q Consensus 119 ~~~~lv~E~~~~g~L~~~l-------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~ 165 (381)
...++||||+++++|.+++ .|++.+|.|+|+.+ ||||||+|||++.+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~ 170 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED 170 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCC
Confidence 9999999999999997765 47899999999998 99999999999999
Q ss_pred CCcEEeeeccceecCCCCccc-ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHH
Q 048280 166 WIPKIADFGMARLFPEDQTHV-NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLD 243 (381)
Q Consensus 166 ~~~kL~DFG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~ 243 (381)
+.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||..... ..+.
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~~~- 246 (314)
T cd05099 171 NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---EELF- 246 (314)
T ss_pred CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---HHHH-
Confidence 999999999998654322111 111234467999999999899999999999999999999 7888743221 1111
Q ss_pred HHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 244 WAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
.......... ........+.+++.+||+.||++|||+.++++.|.+..
T Consensus 247 ---~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 247 ---KLLREGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred ---HHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1111111111 11122346778999999999999999999999997753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=289.31 Aligned_cols=236 Identities=26% Similarity=0.447 Sum_probs=184.5
Q ss_pred cCCCCCCcccccCCeeEEEEEECC-C---cEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLDD-G---REIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
++|++.+.||+|+||.||+|.... + ..||||.+... .......|.+|+.++++++||||+++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 468889999999999999998653 3 36999998654 333456899999999999999999999999999999999
Q ss_pred EecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 125 YEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 125 ~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
|||+.+++|.+++ .|++.++.|+|+.+ |+||||+||+++.++.+||+|||++..........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 163 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 163 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcccc
Confidence 9999999997665 57889999999999 99999999999999999999999988654322111
Q ss_pred c-c-cc--ccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCC
Q 048280 187 N-T-RV--AGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPS 261 (381)
Q Consensus 187 ~-~-~~--~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (381)
. . .. ..+..|+|||.+.+..++.++|||||||++|||++ |..||...... ...... .... .
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i----~~~~--~----- 229 (269)
T cd05065 164 TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI----EQDY--R----- 229 (269)
T ss_pred ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH----HcCC--c-----
Confidence 1 1 11 12457999999998999999999999999999886 99887533211 111111 1110 0
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 262 LAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 262 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
.....+.+..+.+++.+||+.+|.+||++.+|+..|++
T Consensus 230 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 230 --LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred --CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 01111234557889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=286.82 Aligned_cols=233 Identities=24% Similarity=0.379 Sum_probs=187.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
++|++.+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 47889999999999999999866 58899999986543 33346788999999999999999999999999999999999
Q ss_pred ccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccc
Q 048280 128 VINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVA 191 (381)
Q Consensus 128 ~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~ 191 (381)
+.+++|.+++ .|++.++.++|..+ |+||+|+||++++++.++|+|||++..+..... ......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~~ 159 (274)
T cd06609 81 CGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KRNTFV 159 (274)
T ss_pred eCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-cccccc
Confidence 9999997655 68899999999998 999999999999999999999999987754322 223456
Q ss_pred cCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHH
Q 048280 192 GTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271 (381)
Q Consensus 192 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (381)
++..|+|||++.+..++.++|||||||++|+|++|..||...... ..... .... ..+.+... ...
T Consensus 160 ~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~------~~~~~-~~~~-----~~~~~~~~---~~~ 224 (274)
T cd06609 160 GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM------RVLFL-IPKN-----NPPSLEGN---KFS 224 (274)
T ss_pred CCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH------HHHHH-hhhc-----CCCCCccc---ccC
Confidence 888999999999888999999999999999999999998533211 11111 1111 11111111 134
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 272 AMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 272 ~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
..+.+++.+||..+|++|||++++++.
T Consensus 225 ~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 225 KPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 568889999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=290.02 Aligned_cols=232 Identities=26% Similarity=0.327 Sum_probs=181.4
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc---ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
.|+..+.||+|+||.||++... +++.||+|++..... .....+.+|++++++++|+||+.+++++..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677889999999999999865 588999999865422 223457889999999999999999999999999999999
Q ss_pred cccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 127 YVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 127 ~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|+.+++|..++ .|++.+|.|+|..+ ||||||+||++++++.+||+|||++........ .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~ 158 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--I 158 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc--c
Confidence 99999986544 68899999999998 999999999999999999999999976543221 2
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
....|+..|+|||++.+..++.++|||||||++|+|++|..||........ ............ .. ..
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~~------~~----~~ 225 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLETE------EV----YS 225 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhccc------cc----cC
Confidence 235689999999999988999999999999999999999999864322111 011111111000 00 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPT-----MRRVVV 297 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 297 (381)
......+.+|+..||+.||++||+ +.+++.
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 226 AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 122345778999999999999999 667765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=291.73 Aligned_cols=233 Identities=24% Similarity=0.322 Sum_probs=183.6
Q ss_pred CCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccC
Q 048280 52 FHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 52 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
|++.+.||.|+||.||+|... ++..+++|.+..........+.+|+++++.++|+||+++++++...+..++||||+.+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 677899999999999999876 4778899998766555567789999999999999999999999999999999999999
Q ss_pred CCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccccc
Q 048280 131 ESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAG 192 (381)
Q Consensus 131 g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~g 192 (381)
++|..++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||++........ ......+
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~ 165 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDSFIG 165 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-ccccccc
Confidence 9986543 67899999999999 999999999999999999999999876533221 1223568
Q ss_pred CccccchhHHh-----hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 193 TNGYMAPEYVM-----HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 193 t~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
+..|+|||++. +..++.++|||||||++|+|++|+.||..... ........... .... ...
T Consensus 166 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~-~~~~-------~~~ 231 (282)
T cd06643 166 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSE-PPTL-------AQP 231 (282)
T ss_pred cccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH------HHHHHHHhhcC-CCCC-------CCc
Confidence 89999999984 34578899999999999999999999753221 11111111111 0010 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
......+.+++.+||+.||.+||++.++++.-
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 22345688999999999999999999987543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=284.97 Aligned_cols=231 Identities=26% Similarity=0.412 Sum_probs=183.4
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCccc---------HHHHHHHHHHHHHhCCCCcccEEEEEeeCCe
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQG---------KKEFENEAKLLARVQHRNVVNLLGYCAHGAE 120 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 120 (381)
+|.+...||+|+||.||+|... +++.||+|.+....... .+.+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788899999999999999865 58899999886543221 2468889999999999999999999999999
Q ss_pred EEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 121 KLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
.++||||+++++|.+++ .+++.++.++|..+ ||||+|+||+++.++.+||+|||+++.+....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999986554 68899999999988 99999999999999999999999998764221
Q ss_pred cc-----cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCccccc
Q 048280 184 TH-----VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIV 258 (381)
Q Consensus 184 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
.. ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...... ........ ..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~------~~ 228 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAIFKIGE------NA 228 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHHHHHhc------cC
Confidence 11 111345788999999999888999999999999999999999998642211 11111111 11
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 259 DPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.+.. .......+.+++.+||+.||.+||++.+|++
T Consensus 229 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 229 SPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111 1223456888999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=289.26 Aligned_cols=244 Identities=24% Similarity=0.355 Sum_probs=187.0
Q ss_pred CChHHHHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHh-CCCCcccEEEEEe-
Q 048280 40 FPFEALVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLGYCA- 116 (381)
Q Consensus 40 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~- 116 (381)
+.++.+....++|++.+.||+|+||.||++... +++.+|+|++.... .....+.+|+.+++.+ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445556667889999999999999999999865 58899999886432 2235688899999999 6999999999874
Q ss_pred ----eCCeEEEEEecccCCCHHHHH-------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEe
Q 048280 117 ----HGAEKLLIYEYVINESLDKVL-------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIA 171 (381)
Q Consensus 117 ----~~~~~~lv~E~~~~g~L~~~l-------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~ 171 (381)
.++..++||||+++++|.+++ .|++.++.|+|..+ ||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence 446789999999999987543 57889999999988 99999999999999999999
Q ss_pred eeccceecCCCCcccccccccCccccchhHHhh-----CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 048280 172 DFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMH-----GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAY 246 (381)
Q Consensus 172 DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 246 (381)
|||++..+..... ......|+..|+|||++.. ..++.++|||||||++|+|++|+.||....... ...
T Consensus 167 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~------~~~ 239 (286)
T cd06638 167 DFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR------ALF 239 (286)
T ss_pred cCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH------HHh
Confidence 9999987643222 1223468999999998753 457899999999999999999999985432111 001
Q ss_pred HHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 247 KLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
.. ..........+ ......+.+|+.+||+.||++|||+.||++.+
T Consensus 240 ~~-~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 240 KI-PRNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hc-cccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 10 00100011111 11234588899999999999999999998754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=290.16 Aligned_cols=239 Identities=25% Similarity=0.345 Sum_probs=187.4
Q ss_pred hhcCCCCCCcccccCCeeEEEEEECC-----CcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEee-CCe
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLDD-----GREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAH-GAE 120 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~ 120 (381)
..++|.+.+.||+|+||.||+|.... +..|++|++... .......+.+|+.++++++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35689999999999999999998765 688999988644 23335678899999999999999999998766 567
Q ss_pred EEEEEecccCCCHHHHH-----------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeecc
Q 048280 121 KLLIYEYVINESLDKVL-----------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGM 175 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l-----------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~ 175 (381)
.++++||+.+++|.+++ .+++.+|.|||..+ |+||||+||++++++.+||+|||+
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~ 163 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL 163 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence 89999999999987654 47899999999988 999999999999999999999999
Q ss_pred ceecCCCCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCC
Q 048280 176 ARLFPEDQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDK 253 (381)
Q Consensus 176 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (381)
++.+...... ......++..|+|||++.+..++.++|||||||++||+++ |+.||..... ..+.. ......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~----~~~~~~ 236 (280)
T cd05043 164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAA----YLKDGY 236 (280)
T ss_pred cccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHH----HHHcCC
Confidence 9865433221 1122345678999999998899999999999999999999 9998854321 11111 111111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 254 SLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
. .......+..+.+++.+||..||++|||+.++++.|+..
T Consensus 237 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 237 R---------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred C---------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0 001112345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=312.38 Aligned_cols=247 Identities=20% Similarity=0.249 Sum_probs=176.6
Q ss_pred HHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCC------CcccEEEEEee
Q 048280 45 LVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHR------NVVNLLGYCAH 117 (381)
Q Consensus 45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp------nIv~~~~~~~~ 117 (381)
+....++|++.+.||+|+||.||+|... .++.||||+++... .....+..|+.+++.++|. +|+++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3345678999999999999999999865 58889999996432 2234567788888887654 58888888875
Q ss_pred C-CeEEEEEecccCCCHHHH---------------HHhhhhhhhHhhhh-c--cCCccccceEeCCCC------------
Q 048280 118 G-AEKLLIYEYVINESLDKV---------------LFSLIKDIQILFRK-K--KTDIKASNILLDDKW------------ 166 (381)
Q Consensus 118 ~-~~~~lv~E~~~~g~L~~~---------------l~~~~~~l~~lh~~-~--HrDlkp~NIll~~~~------------ 166 (381)
. ...++|||++ +++|.++ +.|++.+|.|||.. + ||||||+||||+.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 4 5789999988 6666543 47899999999974 5 999999999998665
Q ss_pred ----CcEEeeeccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHH
Q 048280 167 ----IPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLL 242 (381)
Q Consensus 167 ----~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~ 242 (381)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+
T Consensus 282 ~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred CCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 499999998764321 223467999999999999999999999999999999999999999654432221111
Q ss_pred HHHH-----------------HHhhcC-CcccccCCC----C-CC--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 243 DWAY-----------------KLYKKD-KSLEIVDPS----L-AA--SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 243 ~~~~-----------------~~~~~~-~~~~~~~~~----~-~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.... ..+... ......++. + .. .........+.+||.+||+.||++|||++|+++
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 1100 000000 000000000 0 00 000011245779999999999999999999987
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=305.47 Aligned_cols=236 Identities=23% Similarity=0.357 Sum_probs=190.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC-CcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD-GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
.+-|+|+..||.|+||.||+|..++ +-..|.|+|........++|+-||.||..++||+||++++.|...+.+||+.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 3457888999999999999998775 455677888777777788999999999999999999999999889999999999
Q ss_pred ccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 128 VINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 128 ~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
|.||-++.++ ++++.+|.|||++. |||||..|||++-+|.++|+|||.+..... .......
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkRDs 189 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKRDS 189 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh-HHhhhcc
Confidence 9999998776 68899999999998 999999999999999999999999875322 1222346
Q ss_pred cccCccccchhHHh-----hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 190 VAGTNGYMAPEYVM-----HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 190 ~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
+.||++|||||++. ..+|+.++||||||++|.||..+.+|... .+.......+...+ . |.+
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe------lnpMRVllKiaKSe-P-----PTL-- 255 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE------LNPMRVLLKIAKSE-P-----PTL-- 255 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc------cchHHHHHHHhhcC-C-----Ccc--
Confidence 88999999999874 45799999999999999999999988532 22222222222211 1 111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
..+......+.+++.+||.+||..||++.+|++.-
T Consensus 256 lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 256 LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 12334556788999999999999999999998654
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=290.53 Aligned_cols=236 Identities=25% Similarity=0.370 Sum_probs=185.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCCCcc-cHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHSSNQ-GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 122 (381)
++|++...||.|+||.||+|+.+ +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57899999999999999999854 2467999988654333 3567999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHH------------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccc
Q 048280 123 LIYEYVINESLDKVL------------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMA 176 (381)
Q Consensus 123 lv~E~~~~g~L~~~l------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~ 176 (381)
+||||+++++|.+++ .|++.+|+|||+.+ ||||||+|||++.++.++|+|||++
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~ 164 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS 164 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccc
Confidence 999999999997654 57889999999998 9999999999999999999999998
Q ss_pred eecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcc
Q 048280 177 RLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSL 255 (381)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (381)
...............++..|+|||.+.+..++.++|||||||++|+|++ |..||..... ..... .......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~----~~~~~~~- 236 (275)
T cd05046 165 KDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLN----RLQAGKL- 236 (275)
T ss_pred cccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHH----HHHcCCc-
Confidence 7543332222233456778999999988889999999999999999999 7777743211 11111 1111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 256 EIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
... .....+..+.+++.+||+.+|.+||++.+++..|.
T Consensus 237 ~~~-------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 237 ELP-------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCC-------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 000 11123356888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=296.96 Aligned_cols=243 Identities=22% Similarity=0.347 Sum_probs=179.8
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc--ccHHHHHHHHHHHHHhCCCCcccEEEEEeeC------
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN--QGKKEFENEAKLLARVQHRNVVNLLGYCAHG------ 118 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------ 118 (381)
..++|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3568999999999999999999865 588999999865422 2335677899999999999999999987543
Q ss_pred CeEEEEEecccCCCHHHH--------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCC
Q 048280 119 AEKLLIYEYVINESLDKV--------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPED 182 (381)
Q Consensus 119 ~~~~lv~E~~~~g~L~~~--------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~ 182 (381)
...+++++++ +++|.++ +.|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++.....
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence 4578999988 7787654 378999999999999 9999999999999999999999999865432
Q ss_pred CcccccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCC--------
Q 048280 183 QTHVNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDK-------- 253 (381)
Q Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 253 (381)
.....||..|+|||++.+ ..++.++|||||||++|+|++|+.||......+. ............
T Consensus 172 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ---LKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred ----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHHhcc
Confidence 233568999999999877 4689999999999999999999999864322111 111000000000
Q ss_pred ---ccccc--CCCCCCCC----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 254 ---SLEIV--DPSLAASD----SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 254 ---~~~~~--~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
..... .+...... .......+.+|+.+||+.||.+|||+.|++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00000000 00112346789999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=284.28 Aligned_cols=231 Identities=30% Similarity=0.440 Sum_probs=180.1
Q ss_pred CcccccCCeeEEEEEECC----CcEEEEEEecCCCc-ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccC
Q 048280 56 NKLGEGGFGPVFKGKLDD----GREIAVKKLSHSSN-QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
+.||+|+||.||+|.... +..||+|.+..... ...+.+.+|++++++++|+||+++++++. .+..++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997532 36899999875543 24467899999999999999999999876 4568999999999
Q ss_pred CCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc--ccc
Q 048280 131 ESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT--RVA 191 (381)
Q Consensus 131 g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~--~~~ 191 (381)
++|.+++ .|++.++.+||..+ |+||||+|||++.++.+||+|||+++.+......... ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGR 159 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCcc
Confidence 9998765 68999999999998 9999999999999999999999999876433322111 122
Q ss_pred cCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHH
Q 048280 192 GTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQ 270 (381)
Q Consensus 192 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (381)
++..|+|||.+.+..++.++|||||||++|+|++ |..||..... ..+... ....... ......
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~----~~~~~~~---------~~~~~~ 223 (257)
T cd05060 160 WPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAM----LESGERL---------PRPEEC 223 (257)
T ss_pred ccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHH----HHcCCcC---------CCCCCC
Confidence 3567999999998899999999999999999998 8988854321 111111 1111110 111123
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 271 IAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 271 ~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
...+.+++.+||..+|.+||++.+|++.|+...
T Consensus 224 ~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 224 PQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 356889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=283.17 Aligned_cols=233 Identities=24% Similarity=0.416 Sum_probs=184.4
Q ss_pred CCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCc------ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSN------QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
+|++.+.||.|+||.||+|...+++.+|||.+..... .....+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 5889999999999999999888899999999864321 1224688899999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC----
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ---- 183 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~---- 183 (381)
|||+++++|.+++ .|++.++.++|..+ |+||||+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT 160 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccc
Confidence 9999999998765 67899999999988 99999999999999999999999987653211
Q ss_pred -cccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 184 -THVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 184 -~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
........|+..|+|||++.+..++.++|||||||++|+|++|..||....... . ......... ..+.+
T Consensus 161 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~-~~~~~~~~~----~~~~~ 230 (265)
T cd06631 161 HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----A-MFYIGAHRG----LMPRL 230 (265)
T ss_pred ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----H-HHHhhhccC----CCCCC
Confidence 111123468899999999998889999999999999999999999985322111 0 011111100 11111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
. ......+.+++.+||+.+|.+||++.+++.
T Consensus 231 ~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 231 P----DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred C----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 123456788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=288.20 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=185.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47899999999999999999876 58999999886442 2234568899999999999999999999999999999999
Q ss_pred cccCCCHHHH---------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 127 YVINESLDKV---------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 127 ~~~~g~L~~~---------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
|+++++|..+ +.|++.+|.|||..+ |+||||+||+++.++.+||+|||++..+..... ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 159 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTD 159 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-cccC
Confidence 9988877644 378999999999988 999999999999999999999999987644322 1223
Q ss_pred cccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHH--------HHHhhcCCc-ccccC
Q 048280 190 VAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWA--------YKLYKKDKS-LEIVD 259 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~-~~~~~ 259 (381)
..++..|+|||++.+ ..++.++|||||||++|+|++|+.||......+........ ...+..... .....
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07847 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI 239 (286)
T ss_pred cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence 457889999999876 45789999999999999999999998654332211110000 000000000 00000
Q ss_pred CCCCCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 260 PSLAASD-----SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 260 ~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
+...... .......+.+|+.+||+.||++||++.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 1100000 1123466889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=286.51 Aligned_cols=232 Identities=26% Similarity=0.413 Sum_probs=188.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
..|+..+.||.|+||.||+|... ++..||+|.+.... ......+.+|+.++++++|+||+++++++.+++..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35788899999999999999875 58899999986543 23356788999999999999999999999999999999999
Q ss_pred ccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccc
Q 048280 128 VINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVA 191 (381)
Q Consensus 128 ~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~ 191 (381)
+.+++|.+++ .+++.++.++|..+ |+||+|+||+++.++.++|+|||++..+..... ......
T Consensus 84 ~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 162 (277)
T cd06640 84 LGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFV 162 (277)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-cccccc
Confidence 9999998755 57899999999988 999999999999999999999999987643322 122345
Q ss_pred cCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHH
Q 048280 192 GTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271 (381)
Q Consensus 192 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (381)
++..|+|||++.+..++.++|||||||++|||++|..||........ ... .. ............
T Consensus 163 ~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~-~~---------~~~~~~~~~~~~ 226 (277)
T cd06640 163 GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV------LFL-IP---------KNNPPTLTGEFS 226 (277)
T ss_pred CcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH------hhh-hh---------cCCCCCCchhhh
Confidence 78899999999988899999999999999999999999854322110 000 00 011122333456
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 272 AMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 272 ~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
..+.+++.+||+.+|++||++.+++..
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 227 KPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 778899999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=288.94 Aligned_cols=235 Identities=25% Similarity=0.358 Sum_probs=187.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
.++|++.+.||.|+||.||++... ++..||+|.+........+.+.+|++++++++|+||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 567999999999999999999875 5889999999766555567889999999999999999999999999999999999
Q ss_pred ccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 128 VINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 128 ~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
+++++|.+++ .|++.++.|+|..+ |+||||+||+++.++.++|+|||++........ ....
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~ 162 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KRDT 162 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc-ccce
Confidence 9999997654 67899999999998 999999999999999999999999876533222 1223
Q ss_pred cccCccccchhHHhh-----CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 190 VAGTNGYMAPEYVMH-----GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
..++..|+|||++.. ..++.++|||||||++|+|++|+.||...... ........ ... +.+
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~-----~~~-- 228 (280)
T cd06611 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKILK-SEP-----PTL-- 228 (280)
T ss_pred eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHHhc-CCC-----CCc--
Confidence 568899999999853 34678999999999999999999998543211 11111111 110 111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.........+.+++.+||+.+|.+||++.++++.
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1112234567889999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=285.94 Aligned_cols=229 Identities=27% Similarity=0.402 Sum_probs=181.1
Q ss_pred CcccccCCeeEEEEEECC--C--cEEEEEEecCCCc-ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccC
Q 048280 56 NKLGEGGFGPVFKGKLDD--G--REIAVKKLSHSSN-QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
+.||+|++|.||+|.+.+ + ..||||.+..... ...+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 2 3689999977655 456789999999999999999999999988 889999999999
Q ss_pred CCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc--cccc
Q 048280 131 ESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH--VNTR 189 (381)
Q Consensus 131 g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~--~~~~ 189 (381)
++|.+++ .|++.+|+++|..+ |+||||+||+++.++.+||+|||++..+...... ....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence 9997654 58899999999999 9999999999999999999999999876442211 1113
Q ss_pred cccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 190 VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
..++..|+|||.+.+..++.++|||||||++|+|++ |..||...... ... ......... . ....
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~---~~~~~~~~~--~-------~~~~ 224 (257)
T cd05040 160 LKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QIL---KKIDKEGER--L-------ERPE 224 (257)
T ss_pred CCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHH---HHHHhcCCc--C-------CCCc
Confidence 456788999999998899999999999999999998 99997532211 111 111111100 0 0111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
..+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 225 ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 23456888999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=290.47 Aligned_cols=241 Identities=22% Similarity=0.359 Sum_probs=186.7
Q ss_pred CChHHHHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHh-CCCCcccEEEEEee
Q 048280 40 FPFEALVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLGYCAH 117 (381)
Q Consensus 40 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 117 (381)
.++.++....+.|++.+.||.|+||.||+|+.. +++.||+|++.... .....+..|+.+++++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 355566667789999999999999999999875 58899999986543 2346788899999999 79999999999853
Q ss_pred ------CCeEEEEEecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEee
Q 048280 118 ------GAEKLLIYEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIAD 172 (381)
Q Consensus 118 ------~~~~~lv~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~D 172 (381)
....+++|||+.+++|.+++ .|++.++.|||+.+ |+||||+||+++.++.++|+|
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~d 164 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVD 164 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEee
Confidence 46789999999999987654 57899999999998 999999999999999999999
Q ss_pred eccceecCCCCcccccccccCccccchhHHh-----hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 048280 173 FGMARLFPEDQTHVNTRVAGTNGYMAPEYVM-----HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYK 247 (381)
Q Consensus 173 FG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 247 (381)
||++........ ......|+..|+|||++. +..++.++|||||||++|||++|..||........ ...
T Consensus 165 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~------~~~ 237 (282)
T cd06636 165 FGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA------LFL 237 (282)
T ss_pred Ccchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh------hhh
Confidence 999876532211 122356889999999886 34678899999999999999999999853221110 000
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 248 LYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
... . ..+ ..........+.+|+.+||+.||.+||++.||++
T Consensus 238 ~~~-~-----~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 IPR-N-----PPP---KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred Hhh-C-----CCC---CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000 0 001 1111234456889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=287.42 Aligned_cols=244 Identities=29% Similarity=0.466 Sum_probs=188.4
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-----CCcEEEEEEecCCCcc-cHHHHHHHHHHHHHhCCCCcccEEEEEee--CCeE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-----DGREIAVKKLSHSSNQ-GKKEFENEAKLLARVQHRNVVNLLGYCAH--GAEK 121 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~ 121 (381)
+.|.+.+.||+|+||.||+|+.. ++..||||++...... ....+.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46788899999999999999853 3678999999765443 45789999999999999999999999887 5678
Q ss_pred EEEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 122 LLIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
++||||+++++|.+++ .+++.+|.+||..+ |+||||+|||++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCC
Confidence 9999999999997665 67899999999999 99999999999999999999999998765322
Q ss_pred cc--cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccc--------cHHHHHHHHhhcCC
Q 048280 184 TH--VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQ--------NLLDWAYKLYKKDK 253 (381)
Q Consensus 184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~ 253 (381)
.. ......++..|+|||.+.+..++.++|||||||++|||++|..|+......... ..............
T Consensus 164 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05038 164 DYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243 (284)
T ss_pred cceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCC
Confidence 21 111233456799999999889999999999999999999999887543221100 00111111111111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 254 SLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
...........+.+|+.+||+.+|.+|||+.||+++|+.+
T Consensus 244 ---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 244 ---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0111122336688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=312.29 Aligned_cols=251 Identities=20% Similarity=0.251 Sum_probs=176.1
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEECC--CcEEEEEEe--------------c---CCCcccHHHHHHHHHHHHHhCCCC
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLDD--GREIAVKKL--------------S---HSSNQGKKEFENEAKLLARVQHRN 107 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~--------------~---~~~~~~~~~~~~E~~~l~~l~hpn 107 (381)
...++|++++.||+|+||.||++..+. +..+++|.+ . .........+.+|+.+|++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 345789999999999999999986532 222222211 0 011122356889999999999999
Q ss_pred cccEEEEEeeCCeEEEEEecccCCCHH--------------------HHHHhhhhhhhHhhhhc--cCCccccceEeCCC
Q 048280 108 VVNLLGYCAHGAEKLLIYEYVINESLD--------------------KVLFSLIKDIQILFRKK--KTDIKASNILLDDK 165 (381)
Q Consensus 108 Iv~~~~~~~~~~~~~lv~E~~~~g~L~--------------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~ 165 (381)
|+++++++...+..|+|+|++.+ +|. .++.|++.+|.|||+++ ||||||+||||+.+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 99999999999999999998743 332 25578999999999999 99999999999999
Q ss_pred CCcEEeeeccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCc-cccccHHHH
Q 048280 166 WIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLD-VDAQNLLDW 244 (381)
Q Consensus 166 ~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~-~~~~~~~~~ 244 (381)
+.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..++..... .....+...
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 9999999999987754433333456799999999999999999999999999999999998865432221 111111111
Q ss_pred HHHHhh-cCCcc-------cccCCC-C--CCCCCH------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 245 AYKLYK-KDKSL-------EIVDPS-L--AASDSG------DQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 245 ~~~~~~-~~~~~-------~~~~~~-~--~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
...... ..... ..++.. + ...... .....+.+++.+||+.||.+|||+.|++..
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 110000 00000 000000 0 000000 112346778999999999999999999864
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=282.03 Aligned_cols=232 Identities=23% Similarity=0.367 Sum_probs=187.2
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
+|+..+.||.|+||.||.++.. +++.+++|.+... .......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5889999999999999999854 5889999998654 234456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 128 VINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 128 ~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
+++++|.+++ .+++.++.++|+.+ |+||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~~~ 159 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-MAE 159 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-ccc
Confidence 9999997665 56889999999988 999999999999999999999999987644332 223
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
...++..|+|||++.+..++.++|||||||++|+|++|..||..... ......... .... ....
T Consensus 160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~-~~~~---------~~~~ 223 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIVQ-GNYT---------PVVS 223 (256)
T ss_pred ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHc-CCCC---------CCcc
Confidence 45689999999999888899999999999999999999999853221 111111111 1110 0112
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
.....+.+++.+||..+|.+||++.++++.+
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 224 VYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 3345688899999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=290.30 Aligned_cols=231 Identities=26% Similarity=0.447 Sum_probs=184.5
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
.|...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++|+||+++++++..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4667789999999999999865 57889999986442 233467889999999999999999999999999999999999
Q ss_pred cCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccccc
Q 048280 129 INESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAG 192 (381)
Q Consensus 129 ~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~g 192 (381)
++++|.+++ .+++.++.|+|..+ |+||+|+||++++++.+||+|||++..+..... ......+
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~ 163 (277)
T cd06642 85 GGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFVG 163 (277)
T ss_pred CCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch-hhhcccC
Confidence 999997654 68899999999988 999999999999999999999999986643322 1223457
Q ss_pred CccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHH
Q 048280 193 TNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIA 272 (381)
Q Consensus 193 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (381)
+..|+|||++.+..++.++|||||||++|||++|+.|+....... .. . ..... ..+. .......
T Consensus 164 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~---~-~~~~~-----~~~~----~~~~~~~ 227 (277)
T cd06642 164 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VL---F-LIPKN-----SPPT----LEGQYSK 227 (277)
T ss_pred cccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HH---h-hhhcC-----CCCC----CCcccCH
Confidence 889999999998899999999999999999999999975322111 00 0 01101 0111 1123345
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 273 MCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 273 ~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.+.+++.+||+.+|.+||++.++++.
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 228 PFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHh
Confidence 68899999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=286.62 Aligned_cols=231 Identities=27% Similarity=0.415 Sum_probs=175.8
Q ss_pred CcccccCCeeEEEEEEC----CCcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEe-eCCeEEEEEeccc
Q 048280 56 NKLGEGGFGPVFKGKLD----DGREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCA-HGAEKLLIYEYVI 129 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~lv~E~~~ 129 (381)
+.||+|+||.||+|.+. ....||+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999753 2457999988543 2334567889999999999999999999875 4556899999999
Q ss_pred CCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc---cccc
Q 048280 130 NESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT---HVNT 188 (381)
Q Consensus 130 ~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~---~~~~ 188 (381)
+++|.+++ .+++.++.|+|..+ ||||||+|||++.++.+||+|||+++.+..... ....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 160 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccc
Confidence 99997765 48899999999988 999999999999999999999999986533211 1111
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCC-CCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQR-NSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
...++..|+|||.+.+..++.++|||||||++|||++|.. ||.... ............. + ...
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~~~~~~~~------~----~~~ 224 (262)
T cd05058 161 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD------SFDITVYLLQGRR------L----LQP 224 (262)
T ss_pred cCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHhcCCC------C----CCC
Confidence 3345678999999988899999999999999999999654 443211 1111111111110 0 001
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
...+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus 225 ~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 225 EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 12235688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=285.32 Aligned_cols=222 Identities=24% Similarity=0.355 Sum_probs=171.4
Q ss_pred CcccccCCeeEEEEEECC-------------CcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEE
Q 048280 56 NKLGEGGFGPVFKGKLDD-------------GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 122 (381)
+.||+|+||.||+|.... ...|++|.+..........+.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997432 2358899876655445567888999999999999999999999999999
Q ss_pred EEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCC-------cEEeeeccce
Q 048280 123 LIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWI-------PKIADFGMAR 177 (381)
Q Consensus 123 lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~-------~kL~DFG~~~ 177 (381)
+||||+.+++|..++ .|++.+++|+|+.+ ||||||+|||++.++. +||+|||++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~ 160 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI 160 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence 999999999886544 68999999999998 9999999999987664 8999999987
Q ss_pred ecCCCCcccccccccCccccchhHHh-hCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcc
Q 048280 178 LFPEDQTHVNTRVAGTNGYMAPEYVM-HGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSL 255 (381)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (381)
..... ....++..|+|||.+. +..++.++|||||||++|||++ |..|+...... .. ....... .
T Consensus 161 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~-~~~~~~~--~ 226 (262)
T cd05077 161 TVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA------EK-ERFYEGQ--C 226 (262)
T ss_pred cccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh------HH-HHHHhcC--c
Confidence 54322 2245788999999887 4678999999999999999984 77776432111 10 1111111 0
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 256 EIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
... . .....+.+|+.+||+.||.+||++.+|++.|+
T Consensus 227 ~~~-----~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 227 MLV-----T----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred cCC-----C----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000 1 11345788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=291.24 Aligned_cols=176 Identities=28% Similarity=0.431 Sum_probs=143.9
Q ss_pred CCcccccCCeeEEEEEEC---CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEee--CCeEEEEEeccc
Q 048280 55 SNKLGEGGFGPVFKGKLD---DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAH--GAEKLLIYEYVI 129 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~E~~~ 129 (381)
..+||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 358999999999999865 35789999986543 23467899999999999999999998853 567899999986
Q ss_pred CCCHH------------------------HHHHhhhhhhhHhhhhc--cCCccccceEe----CCCCCcEEeeeccceec
Q 048280 130 NESLD------------------------KVLFSLIKDIQILFRKK--KTDIKASNILL----DDKWIPKIADFGMARLF 179 (381)
Q Consensus 130 ~g~L~------------------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll----~~~~~~kL~DFG~~~~~ 179 (381)
+ +|. .++.|++.+|.|||+.+ ||||||+|||+ +.++.+||+|||+++..
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 4 432 34478999999999998 99999999999 56679999999999876
Q ss_pred CCCCcc--cccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCC
Q 048280 180 PEDQTH--VNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFN 233 (381)
Q Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~ 233 (381)
...... ......||..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 443221 12245689999999998764 5899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=288.95 Aligned_cols=245 Identities=26% Similarity=0.401 Sum_probs=187.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47899999999999999999876 5889999998654 23345788999999999999999999999999999999999
Q ss_pred cccCCCHHH---------------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 127 YVINESLDK---------------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 127 ~~~~g~L~~---------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
|+.++.+.. ++.+++.++.|||..+ |+||+|+||++++++.+||+|||++.............
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence 998876653 3368999999999998 99999999999999999999999998765543323334
Q ss_pred cccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc-----------CCcc--
Q 048280 190 VAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKK-----------DKSL-- 255 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~-- 255 (381)
..++..|+|||++.+. .++.++|||||||++|+|++|+.||......+. .......... ....
T Consensus 161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ---LYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHhhhcccCccccc
Confidence 5678899999999888 889999999999999999999998864322211 1000000000 0000
Q ss_pred -cccCCCC----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 256 -EIVDPSL----AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 256 -~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
....... ...........+.+|+.+||..+|++||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000 00011122567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=287.58 Aligned_cols=233 Identities=22% Similarity=0.358 Sum_probs=182.7
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
++|++.+.||+|+||.||++... ++..||+|.+... .......+.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36899999999999999999876 6899999988654 223346788999999999999999999999999999999999
Q ss_pred ccCCCHHHHH------------------HhhhhhhhHhhhh-c--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 128 VINESLDKVL------------------FSLIKDIQILFRK-K--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 128 ~~~g~L~~~l------------------~~~~~~l~~lh~~-~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
+++++|..++ .+++.++.|||.. + |+||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc---
Confidence 9999987654 5688899999964 4 99999999999999999999999997653221
Q ss_pred ccccccCccccchhHHhhC------CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCC
Q 048280 187 NTRVAGTNGYMAPEYVMHG------HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDP 260 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
.....++..|+|||.+.+. .++.++|||||||++|+|++|+.||..... ............ .. .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~-~~-----~- 227 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY---ANIFAQLSAIVD-GD-----P- 227 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch---hhHHHHHHHHhh-cC-----C-
Confidence 2234578899999998654 358899999999999999999999854221 111111111111 10 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 261 SLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 261 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
..........+.+++.+||+.+|.+||++.+++..
T Consensus 228 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 228 ---PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ---CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11122345668889999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=290.75 Aligned_cols=242 Identities=15% Similarity=0.189 Sum_probs=176.7
Q ss_pred CCCccccc--CCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 54 PSNKLGEG--GFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 54 ~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
++++||+| +|++||++... +|+.||+|++.... ......+.+|+.+++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 78899999865 68999999986542 223356778999999999999999999999999999999999
Q ss_pred cCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc----
Q 048280 129 INESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH---- 185 (381)
Q Consensus 129 ~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~---- 185 (381)
++++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 161 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence 999987655 57899999999998 9999999999999999999999876543211110
Q ss_pred --cccccccCccccchhHHhh--CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc----------
Q 048280 186 --VNTRVAGTNGYMAPEYVMH--GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKK---------- 251 (381)
Q Consensus 186 --~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 251 (381)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ............
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcCCccccccccchhhh
Confidence 0112346778999999976 358999999999999999999999986422111 000000000000
Q ss_pred C----CcccccC-------------C----CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 252 D----KSLEIVD-------------P----SLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 252 ~----~~~~~~~-------------~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
. ......+ + .............+.+|+.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0 0000000 0 0000112233457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=290.66 Aligned_cols=233 Identities=21% Similarity=0.266 Sum_probs=184.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcc---cHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQ---GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++|++.+.||+|+||.||+|... +++.||+|.+...... ....+.+|+++++.++|+||+++++.+..+...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47889999999999999999876 4899999999765322 3457889999999999999999999999999999999
Q ss_pred ecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc-
Q 048280 126 EYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH- 185 (381)
Q Consensus 126 E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~- 185 (381)
||+.+++|.+++ .|++.+|.|||..+ |+||||+|||++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999997664 58899999999998 9999999999999999999999998755322110
Q ss_pred ---------------------------cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccc
Q 048280 186 ---------------------------VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDA 238 (381)
Q Consensus 186 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~ 238 (381)
......|+..|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~- 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE- 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH-
Confidence 0112467889999999998889999999999999999999999985432211
Q ss_pred ccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 048280 239 QNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPT----MRRVVV 297 (381)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~eil~ 297 (381)
......... ............+.+++.+||..||++||| +++++.
T Consensus 240 -----~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 240 -----TFSNILKKE---------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred -----HHHHHhcCC---------ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 011111110 000111114567889999999999999999 777765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=280.34 Aligned_cols=229 Identities=33% Similarity=0.518 Sum_probs=183.1
Q ss_pred CcccccCCeeEEEEEECC----CcEEEEEEecCCCccc-HHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccC
Q 048280 56 NKLGEGGFGPVFKGKLDD----GREIAVKKLSHSSNQG-KKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
+.||+|+||.||+|.... +..|++|.+....... .+.+.+|++++..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998653 7889999997654333 67889999999999999999999999999999999999999
Q ss_pred CCHHHHH------------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 131 ESLDKVL------------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 131 g~L~~~l------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
++|.+++ .|++.++.++|..+ |+||||+||+++.++.+||+|||.+........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 9887554 46789999999998 999999999999999999999999987654321
Q ss_pred -ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 185 -HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 185 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||..... ..+.. .......
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~----~~~~~~~-------- 225 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLE----YLRKGYR-------- 225 (262)
T ss_pred cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHH----HHHcCCC--------
Confidence 11234457889999999988899999999999999999999 5888764321 11111 1111110
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
.......+..+.+++.+||+.||.+|||+.++++.|+
T Consensus 226 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 -LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111222466889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=280.81 Aligned_cols=231 Identities=22% Similarity=0.365 Sum_probs=183.6
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEee-CCeEEEEEe
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAH-GAEKLLIYE 126 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~E 126 (381)
+|++.+.||+|++|.||++... +++.||+|++.... ....+.+.+|++++++++|+||+++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5899999999999999999865 47899999986442 2334678899999999999999999998764 456899999
Q ss_pred cccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 127 YVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 127 ~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|+++++|.+++ .+++.++.++|+.+ |+||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~ 159 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-MA 159 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC-cc
Confidence 99999986554 57889999999999 999999999999999999999999987643322 22
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
....+++.|+|||++.+..++.++|||||||++|+|++|+.||.... .......... ... + ...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~~-~~~-----~----~~~ 223 (257)
T cd08223 160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRIIE-GKL-----P----PMP 223 (257)
T ss_pred ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHh-cCC-----C----CCc
Confidence 34568899999999999999999999999999999999999985322 1111111111 111 1 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
......+.+++.+||+.||++||++.++++.
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 2344568899999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=282.10 Aligned_cols=228 Identities=26% Similarity=0.429 Sum_probs=181.5
Q ss_pred cCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEeccc
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVI 129 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 129 (381)
++|++.+.||+|+||.||++.. +++.||+|++.... ....+.+|+.++++++||||+++++++... ..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5799999999999999999975 47889999986542 346789999999999999999999998764 4799999999
Q ss_pred CCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccc
Q 048280 130 NESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV 190 (381)
Q Consensus 130 ~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 190 (381)
+++|.+++ .|++.++.++|+.+ ||||||+||+++.++.+||+|||++....... ...
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----~~~ 157 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----DNS 157 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC----CCC
Confidence 99997665 57899999999998 99999999999999999999999998643221 122
Q ss_pred ccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHH
Q 048280 191 AGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGD 269 (381)
Q Consensus 191 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (381)
..+..|+|||.+.+..++.++|||||||++|+|++ |+.||...... .. .......... .....
T Consensus 158 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~-~~~~~~~~~~---------~~~~~ 221 (254)
T cd05083 158 KLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EV-KECVEKGYRM---------EPPEG 221 (254)
T ss_pred CCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HH-HHHHhCCCCC---------CCCCc
Confidence 34568999999988899999999999999999998 88887533211 11 1111111110 11122
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 270 QIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 270 ~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
.+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 222 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 222 CPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 34567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=283.38 Aligned_cols=233 Identities=21% Similarity=0.388 Sum_probs=172.5
Q ss_pred CcccccCCeeEEEEEECCC---cEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCC
Q 048280 56 NKLGEGGFGPVFKGKLDDG---REIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINE 131 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g 131 (381)
+.||+|+||.||+++..++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.|......++||||+.+|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975433 346677765443 234568999999999999999999999999999999999999999
Q ss_pred CHHHHH-------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC-cccccc
Q 048280 132 SLDKVL-------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ-THVNTR 189 (381)
Q Consensus 132 ~L~~~l-------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~-~~~~~~ 189 (381)
+|.+++ .|++.+|.|+|+.+ ||||||+|||++.++.+||+|||++....... ......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 997654 47889999999988 99999999999999999999999986432211 112234
Q ss_pred cccCccccchhHHhh-------CCCCchhhhHhHHHHHHHHHhC-CCCCCCCCccccccHHHHHHHHhhcCCcccccCCC
Q 048280 190 VAGTNGYMAPEYVMH-------GHLSVKADVFSFGVVILELISG-QRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPS 261 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (381)
..++..|+|||++.. ..++.++|||||||++|||+++ ..||..... .... ..... .......++.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~---~~~~~-~~~~~~~~~~ 233 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---REVL---NHVIK-DQQVKLFKPQ 233 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HHHH---HHHHh-hcccccCCCc
Confidence 567889999998753 2457899999999999999975 556532211 1111 11111 1122223333
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 262 LAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 262 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
+... ....+.+++..|| .+|++||++++|++.|.
T Consensus 234 ~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 234 LELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3322 3345777888999 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=289.20 Aligned_cols=247 Identities=25% Similarity=0.424 Sum_probs=184.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc--ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN--QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47889999999999999999876 589999999865422 234578899999999999999999999999999999999
Q ss_pred cccCCCHHHH---------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 127 YVINESLDKV---------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 127 ~~~~g~L~~~---------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
|+.+++|..+ +.|++.++.|||+.+ |+||+|+||++++++.+||+|||++..+..... ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 159 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYTD 159 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-ccCc
Confidence 9998887644 368999999999999 999999999999999999999999987644332 2223
Q ss_pred cccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHH--------HHHHhhcCCc-ccccC
Q 048280 190 VAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDW--------AYKLYKKDKS-LEIVD 259 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~-~~~~~ 259 (381)
..++..|+|||++.+. .++.++|||||||++|||++|+.||......+...-... .......... .....
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence 4578899999998753 578899999999999999999988854332111000000 0000000000 00000
Q ss_pred CCCCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 260 PSLAA-----SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 260 ~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
+.... .........+.+|+.+||+.+|++||++.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 10000 001123466889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=289.01 Aligned_cols=233 Identities=23% Similarity=0.347 Sum_probs=185.1
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEeccc
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVI 129 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 129 (381)
.|+....||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++||||++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 3445568999999999999865 589999999876555556778899999999999999999999999999999999999
Q ss_pred CCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccC
Q 048280 130 NESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT 193 (381)
Q Consensus 130 ~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt 193 (381)
+++|..++ .|++.++.++|+.+ |+||||+||+++.++.+||+|||++..+..... ......|+
T Consensus 102 ~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~ 180 (297)
T cd06659 102 GGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGT 180 (297)
T ss_pred CCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccceecC
Confidence 99997654 68999999999998 999999999999999999999999976543321 12235688
Q ss_pred ccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHH
Q 048280 194 NGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAM 273 (381)
Q Consensus 194 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (381)
..|+|||++.+..++.++|||||||++|||++|+.||....... . ... ........ . .........
T Consensus 181 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~---~~~-~~~~~~~~-----~--~~~~~~~~~ 246 (297)
T cd06659 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---A---MKR-LRDSPPPK-----L--KNAHKISPV 246 (297)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHH-HhccCCCC-----c--cccCCCCHH
Confidence 99999999998899999999999999999999999986332211 1 111 11110000 0 001122345
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 274 CIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 274 l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
+.+++.+||+.+|.+||++.+|++.
T Consensus 247 l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 247 LRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhhC
Confidence 7789999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=282.39 Aligned_cols=236 Identities=26% Similarity=0.412 Sum_probs=187.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
++|++.+.||.|+||.||++..+ +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46888999999999999999876 58999999986653 33456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHH----------------HhhhhhhhHhhh-hc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 128 VINESLDKVL----------------FSLIKDIQILFR-KK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 128 ~~~g~L~~~l----------------~~~~~~l~~lh~-~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
+.+++|.+++ .+++.++.++|+ .+ |+||||+||+++.++.+||+|||.+........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---~ 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA---K 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh---h
Confidence 9989997665 578899999999 77 999999999999999999999999876532211 1
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
...++..|+|||.+.+..++.++|||||||++|+|++|..||...... ............... .+.+. ..
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~------~~~~~---~~ 227 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNEP------PPRLP---SG 227 (265)
T ss_pred cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcCC------CCCCC---hh
Confidence 256888999999999999999999999999999999999998643221 111222211111111 01111 11
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.....+.++|.+||..||++|||+.+++..
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 228 KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 145568899999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=286.24 Aligned_cols=221 Identities=25% Similarity=0.368 Sum_probs=170.1
Q ss_pred cccccCCeeEEEEEECC-------------------------CcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccE
Q 048280 57 KLGEGGFGPVFKGKLDD-------------------------GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNL 111 (381)
Q Consensus 57 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 111 (381)
.||+|+||.||+|.... ...|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 23588998865544444678889999999999999999
Q ss_pred EEEEeeCCeEEEEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCC-------
Q 048280 112 LGYCAHGAEKLLIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKW------- 166 (381)
Q Consensus 112 ~~~~~~~~~~~lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~------- 166 (381)
+++|......++||||+++++|..++ .|++.++.|+|+.+ ||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~ 161 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP 161 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence 99999999999999999999997655 68999999999998 999999999997643
Q ss_pred CcEEeeeccceecCCCCcccccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHH-hCCCCCCCCCccccccHHHH
Q 048280 167 IPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELI-SGQRNSSFNLDVDAQNLLDW 244 (381)
Q Consensus 167 ~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~ell-tg~~p~~~~~~~~~~~~~~~ 244 (381)
.+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||........ ..
T Consensus 162 ~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~- 232 (274)
T cd05076 162 FIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK---ER- 232 (274)
T ss_pred eeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH---HH-
Confidence 4799999988643221 12346788999998875 56899999999999999995 68888754322111 11
Q ss_pred HHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 245 AYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
...... ..... ....+.+++.+||+.+|++|||+.+|++.|.
T Consensus 233 ---~~~~~~-------~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 233 ---FYEKKH-------RLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HHHhcc-------CCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111100 00011 1235788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=278.76 Aligned_cols=232 Identities=31% Similarity=0.519 Sum_probs=183.6
Q ss_pred CCCCCcccccCCeeEEEEEECC-----CcEEEEEEecCCCcc-cHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 52 FHPSNKLGEGGFGPVFKGKLDD-----GREIAVKKLSHSSNQ-GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 52 y~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
+++.+.||.|+||.||+++... +..||+|++...... ....+.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4578899999999999998763 388999999655433 4578899999999999999999999999999999999
Q ss_pred ecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 126 EYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 126 E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
||+++++|.+++ .|++.++.++|+.+ |+||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 999999987655 57889999999999 99999999999999999999999998765442222
Q ss_pred ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
.....++..|+|||.+.+..++.++|||||||++|+|++ |..||.... ...... . ....... .
T Consensus 161 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~---~~~~~~---~-~~~~~~~---------~ 224 (258)
T smart00219 161 KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS---NEEVLE---Y-LKKGYRL---------P 224 (258)
T ss_pred cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHH---H-HhcCCCC---------C
Confidence 212336789999999988889999999999999999998 677764321 111111 1 1111111 0
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 266 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
........+.+++.+||..||++|||+.++++.|
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1111345688899999999999999999998765
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=285.59 Aligned_cols=234 Identities=19% Similarity=0.260 Sum_probs=187.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC-CcEEEEEEecCCCccc---HHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD-GREIAVKKLSHSSNQG---KKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.+.|++++.||.|.-|+||+++.++ +..+|+|++.+..... ..+.+.|-+||+.++||.+..||..|+.+...|+|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 4568889999999999999999874 6899999997764333 34567799999999999999999999999999999
Q ss_pred EecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCC----
Q 048280 125 YEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPE---- 181 (381)
Q Consensus 125 ~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~---- 181 (381)
||||+||+|..+. .+++.||.|||-.| .|||||+||||.++|++-|+||.++.....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 9999999997665 57899999999999 999999999999999999999998753311
Q ss_pred -----------------------------CCc----------------------ccccccccCccccchhHHhhCCCCch
Q 048280 182 -----------------------------DQT----------------------HVNTRVAGTNGYMAPEYVMHGHLSVK 210 (381)
Q Consensus 182 -----------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~ 210 (381)
... .....++||-.|+|||++.|...+.+
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA 315 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA 315 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence 000 01124679999999999999999999
Q ss_pred hhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 048280 211 ADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRP 290 (381)
Q Consensus 211 sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 290 (381)
+|-|+|||+||||+.|..||........ + .++.. ..+.-.........+.+||.+.|.+||.+|.
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~~T--l----~NIv~---------~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNKET--L----RNIVG---------QPLKFPEEPEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCchhh--H----HHHhc---------CCCcCCCCCcchhHHHHHHHHHhccChhhhh
Confidence 9999999999999999999976543221 1 11111 1111112224556789999999999999999
Q ss_pred C----HHHHHH
Q 048280 291 T----MRRVVV 297 (381)
Q Consensus 291 s----~~eil~ 297 (381)
- +.||-+
T Consensus 381 g~~rGA~eIK~ 391 (459)
T KOG0610|consen 381 GSKRGAAEIKR 391 (459)
T ss_pred ccccchHHhhc
Confidence 8 777654
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=283.25 Aligned_cols=233 Identities=22% Similarity=0.315 Sum_probs=181.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-----cccHHHHHHHHHHHHHhCCCCcccEEEEEeeC--CeE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-----NQGKKEFENEAKLLARVQHRNVVNLLGYCAHG--AEK 121 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~ 121 (381)
.+|++.+.||+|+||.||+|... ++..||||.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47899999999999999999865 58999999885432 12235788899999999999999999988763 568
Q ss_pred EEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 122 LLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
++||||+++++|.+++ .+++.+|.++|+.+ |+||||+|||++.++.+||+|||++..+.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 8999999999997665 67899999999998 999999999999999999999999986532211
Q ss_pred c--cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 185 H--VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
. ......++..|+|||++.+..++.++|||||||++|+|++|+.||..... ... ........ .
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~-~~~~~~~~---------~ 226 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-----MAA-IFKIATQP---------T 226 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-----HHH-HHHHhcCC---------C
Confidence 1 11234588899999999888899999999999999999999999853211 111 11111100 0
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
....+......+.+++.+||. +|++||++++|++.
T Consensus 227 ~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 112233445667889999995 99999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=287.45 Aligned_cols=235 Identities=25% Similarity=0.396 Sum_probs=189.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
.++|++.+.||+|+||.||++... ++..||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 468999999999999999999864 5889999998755555567789999999999999999999999999999999999
Q ss_pred ccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccc
Q 048280 128 VINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVA 191 (381)
Q Consensus 128 ~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~ 191 (381)
+++++|.+++ .+++.++.+||..+ |+||||+||+++.++.+||+|||++......... .....
T Consensus 98 ~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~-~~~~~ 176 (293)
T cd06647 98 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMV 176 (293)
T ss_pred CCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc-ccccc
Confidence 9999997654 67899999999999 9999999999999999999999998765433221 22346
Q ss_pred cCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHH
Q 048280 192 GTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271 (381)
Q Consensus 192 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (381)
+++.|+|||.+.+..++.++|||||||++|+|++|+.||......... ....... .+. ........
T Consensus 177 ~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~------~~~~~~~------~~~--~~~~~~~~ 242 (293)
T cd06647 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNG------TPE--LQNPEKLS 242 (293)
T ss_pred CChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe------eehhcCC------CCC--CCCccccC
Confidence 888999999998888999999999999999999999998643221110 0000000 001 11122334
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 272 AMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 272 ~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
..+.+++.+||..+|++||++.+++..
T Consensus 243 ~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 243 AIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 568889999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=285.34 Aligned_cols=229 Identities=27% Similarity=0.436 Sum_probs=175.9
Q ss_pred CcccccCCeeEEEEEECC-Cc--EEEEEEecCC-CcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEEEEecccC
Q 048280 56 NKLGEGGFGPVFKGKLDD-GR--EIAVKKLSHS-SNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
+.||+|+||.||+|+..+ +. .+++|.+... .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999998754 43 4688888643 233446788999999999 799999999999999999999999999
Q ss_pred CCHHHHH-------------------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccce
Q 048280 131 ESLDKVL-------------------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMAR 177 (381)
Q Consensus 131 g~L~~~l-------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~ 177 (381)
++|.+++ .+++.+++|+|..+ ||||||+|||++.++.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 9886554 46888999999988 99999999999999999999999986
Q ss_pred ecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCccc
Q 048280 178 LFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLE 256 (381)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (381)
..... ........+..|+|||++....++.++|||||||++|||++ |..||..... .... .........
T Consensus 161 ~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~----~~~~~~~~~- 230 (270)
T cd05047 161 GQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELY----EKLPQGYRL- 230 (270)
T ss_pred ccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---HHHH----HHHhCCCCC-
Confidence 32211 11111223567999999988889999999999999999997 9998853211 1111 111111000
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 257 IVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.........+.+|+.+||+.||.+|||+.+++..|...
T Consensus 231 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 231 --------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred --------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 01112234578999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=282.39 Aligned_cols=232 Identities=23% Similarity=0.343 Sum_probs=178.3
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc-----ccHHHHHHHHHHHHHhCCCCcccEEEEEee--CCeE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN-----QGKKEFENEAKLLARVQHRNVVNLLGYCAH--GAEK 121 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~ 121 (381)
.+|++.+.||+|+||.||+|... ++..|++|++..... .....+.+|+.++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 37999999999999999999865 589999998864321 223568889999999999999999998865 4678
Q ss_pred EEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 122 LLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
++++||+++++|.+++ .|++.++.+||..+ |+||||+||+++.++.+||+|||++..+.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 8999999999997654 68999999999988 999999999999999999999999986532211
Q ss_pred --ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 185 --HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 185 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
.......++..|+|||++.+..++.++|||||||++|||++|+.||..... ........... ..+.
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~-----~~~~- 229 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQP-----TNPQ- 229 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCC-----CCCC-
Confidence 111234578899999999988899999999999999999999999853211 11111111100 1111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
........+..++ .||..+|++||+++||++
T Consensus 230 ---~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 230 ---LPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1222334455666 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=283.43 Aligned_cols=229 Identities=31% Similarity=0.463 Sum_probs=178.9
Q ss_pred CcccccCCeeEEEEEECC-------CcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 56 NKLGEGGFGPVFKGKLDD-------GREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
+.||+|+||.||+|+..+ +..+|||.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999998642 2578999886543 23456789999999999999999999999999999999999
Q ss_pred ccCCCHHHHH----------------------HhhhhhhhHhhhhc--cCCccccceEeCCCC-----CcEEeeecccee
Q 048280 128 VINESLDKVL----------------------FSLIKDIQILFRKK--KTDIKASNILLDDKW-----IPKIADFGMARL 178 (381)
Q Consensus 128 ~~~g~L~~~l----------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~-----~~kL~DFG~~~~ 178 (381)
+++++|.+++ .+++.++.|+|+.+ |+||||+|||++.++ .+||+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999997654 47788999999988 999999999999877 899999999976
Q ss_pred cCCCCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCccc
Q 048280 179 FPEDQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLE 256 (381)
Q Consensus 179 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (381)
+...... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...... .... . .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~---~-~~~~~--- 230 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQ---H-VTAGG--- 230 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHH---H-HhcCC---
Confidence 5332211 1122345678999999999999999999999999999998 99888533211 1111 1 11110
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 257 IVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
........+..+.+++.+||..+|.+||++.+|++.|+
T Consensus 231 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 ------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 01111233466889999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=283.22 Aligned_cols=233 Identities=22% Similarity=0.356 Sum_probs=182.7
Q ss_pred CCCCCCcccccCCeeEEEEEECC--CcEEEEEEecCCC----------cccHHHHHHHHHHHHH-hCCCCcccEEEEEee
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLDD--GREIAVKKLSHSS----------NQGKKEFENEAKLLAR-VQHRNVVNLLGYCAH 117 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~ 117 (381)
+|++.+.||+|+||.||+|.... ++.+|+|.+.... ......+.+|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 58889999999999999998764 7889999875321 1223457778888875 699999999999999
Q ss_pred CCeEEEEEecccCCCHHHHH-------------------HhhhhhhhHhhh-hc--cCCccccceEeCCCCCcEEeeecc
Q 048280 118 GAEKLLIYEYVINESLDKVL-------------------FSLIKDIQILFR-KK--KTDIKASNILLDDKWIPKIADFGM 175 (381)
Q Consensus 118 ~~~~~lv~E~~~~g~L~~~l-------------------~~~~~~l~~lh~-~~--HrDlkp~NIll~~~~~~kL~DFG~ 175 (381)
++..++||||+++++|.+++ .|++.++.++|. .+ |+||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999987554 578999999996 44 999999999999999999999999
Q ss_pred ceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcc
Q 048280 176 ARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSL 255 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (381)
+....... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ......... ....
T Consensus 161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~ 231 (269)
T cd08528 161 AKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLATKIVE-AVYE 231 (269)
T ss_pred eeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHHHHhh-ccCC
Confidence 98764432 22345688999999999988899999999999999999999999753211 111111111 1100
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 256 EIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
+. ........+.+++.+||+.||++||++.|+..++.
T Consensus 232 ----~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 232 ----PL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ----cC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 10 01122356888999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=281.47 Aligned_cols=230 Identities=30% Similarity=0.467 Sum_probs=184.2
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-----cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-----NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
+|+..+.||+|+||.||+|... ++..|++|.+.... ....+.+.+|+.+++.++|+||+++++++.++...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4788899999999999999876 68999999986543 12346788999999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
+||+++++|.+++ .|++.++.++|..+ |+||+|+||+++.++.+||+|||++....... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~~ 158 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--FA 158 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--cc
Confidence 9999999997665 57899999999999 99999999999999999999999998754332 22
Q ss_pred cccccCccccchhHHhhCC-CCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGH-LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
....++..|+|||.+.... ++.++|||||||++|+|++|+.||..... ............. + ..
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~-----~----~~ 223 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKEL-----P----PI 223 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccC-----C----Cc
Confidence 3456889999999987776 89999999999999999999999854321 1111111110111 1 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.......+.+++.+||+.+|.+||++.+++.
T Consensus 224 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 224 PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1123455788999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=288.29 Aligned_cols=233 Identities=22% Similarity=0.375 Sum_probs=184.9
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEeccc
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVI 129 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 129 (381)
.|.....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+..++..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 4455677999999999999865 588999999876555556778999999999999999999999999999999999999
Q ss_pred CCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccC
Q 048280 130 NESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT 193 (381)
Q Consensus 130 ~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt 193 (381)
+++|.+++ .+++.++.|+|+.+ ||||||+||++++++.+||+|||++........ ......|+
T Consensus 103 ~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~ 181 (292)
T cd06658 103 GGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVGT 181 (292)
T ss_pred CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeecC
Confidence 99997654 67899999999999 999999999999999999999999876533221 12235688
Q ss_pred ccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHH
Q 048280 194 NGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAM 273 (381)
Q Consensus 194 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (381)
..|+|||.+.+..++.++|||||||++|||++|+.||....... .. .. .... ..+.... .......
T Consensus 182 ~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~---~~-~~~~-----~~~~~~~--~~~~~~~ 247 (292)
T cd06658 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AM---RR-IRDN-----LPPRVKD--SHKVSSV 247 (292)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HH-HHhc-----CCCcccc--ccccCHH
Confidence 99999999988889999999999999999999999985332211 11 11 1110 0111111 1123345
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 274 CIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 274 l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
+.+++.+||..||.+|||+.++++.
T Consensus 248 ~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 248 LRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHccCChhHCcCHHHHhhC
Confidence 7789999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=279.37 Aligned_cols=220 Identities=27% Similarity=0.433 Sum_probs=171.9
Q ss_pred CcccccCCeeEEEEEECC-C----------cEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 56 NKLGEGGFGPVFKGKLDD-G----------REIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
+.||+|+||.||+|...+ + ..|++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 468999999999998764 3 25788877554333 6788999999999999999999999988 778999
Q ss_pred EecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCC-------CcEEeeeccceec
Q 048280 125 YEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKW-------IPKIADFGMARLF 179 (381)
Q Consensus 125 ~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~-------~~kL~DFG~~~~~ 179 (381)
|||+.+++|.+++ .|++.+|+|||..+ ||||||+|||++.++ .+||+|||++...
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~ 158 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV 158 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccc
Confidence 9999999997665 58999999999988 999999999999887 7999999999865
Q ss_pred CCCCcccccccccCccccchhHHhhC--CCCchhhhHhHHHHHHHHHhC-CCCCCCCCccccccHHHHHHHHhhcCCccc
Q 048280 180 PEDQTHVNTRVAGTNGYMAPEYVMHG--HLSVKADVFSFGVVILELISG-QRNSSFNLDVDAQNLLDWAYKLYKKDKSLE 256 (381)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (381)
.. .....++..|+|||++.+. .++.++|||||||++|+|++| ..|+...... ... ..+.... .
T Consensus 159 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~---~~~----~~~~~~~--~ 224 (259)
T cd05037 159 LS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS---EKE----RFYQDQH--R 224 (259)
T ss_pred cc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch---hHH----HHHhcCC--C
Confidence 43 1223467789999999876 789999999999999999995 6665432211 111 1111110 0
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 257 IVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
. + ... ...+.+++.+||..+|.+|||+.+|++.|.
T Consensus 225 ~--~---~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 225 L--P---MPD----CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C--C---CCC----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0 000 156889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=304.54 Aligned_cols=231 Identities=27% Similarity=0.364 Sum_probs=188.1
Q ss_pred cCCCCCCcccccCCeeEEEEEECC--C--cEEEEEEecCCCcc-cHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLDD--G--REIAVKKLSHSSNQ-GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
++....++||+|.||.|++|.|.. | ..||||.++..... ...+|++|+.+|.+|+|+|+|+|||+..+ ....||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 445567889999999999998763 3 46899999766443 56899999999999999999999999987 678999
Q ss_pred EecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 125 YEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 125 ~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
||+++.|+|.+.| .|++.+++||-.++ ||||-..||||...-.|||+|||+.+.+......
T Consensus 189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 9999999996544 78999999999988 9999999999999999999999999988654332
Q ss_pred cc--cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 186 VN--TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 186 ~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
.. ....-...|+|||.+....++.++|||+|||+||||++ |..||...... . +.+.+|..-
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~---q-------------IL~~iD~~e 332 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI---Q-------------ILKNIDAGE 332 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH---H-------------HHHhccccc
Confidence 21 12233568999999999999999999999999999998 66777543221 1 122233333
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
+...+..+++.++++++.||..+|++||||..|.+
T Consensus 333 rLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred cCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 44556677889999999999999999999999974
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=285.77 Aligned_cols=244 Identities=26% Similarity=0.372 Sum_probs=184.9
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
+|++.+.||.|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5889999999999999999875 58999999987553 23346789999999999999999999999999999999999
Q ss_pred ccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 128 VINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 128 ~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
+ +++|.+++ .|++.+|.|+|..+ |+||||+||+++.++.++|+|||++.............
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 9 99997654 67899999999998 99999999999999999999999998765433222233
Q ss_pred cccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCC------------ccc
Q 048280 190 VAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDK------------SLE 256 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------------~~~ 256 (381)
..++..|+|||.+.+. .++.++|||||||++|+|++|.++|...... .............. ...
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTSLPDYNK 236 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence 5688999999988654 4689999999999999999997776533221 11111111110000 000
Q ss_pred ccCCCCC----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 257 IVDPSLA----ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 257 ~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
...+... .....+....+.+++.+||+.||.+|||+++++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 00011234678899999999999999999999764
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=285.65 Aligned_cols=244 Identities=23% Similarity=0.307 Sum_probs=180.4
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
+|++.+.||+|+||.||+|+.. +|..||+|.+.... ......+.+|+.++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4888999999999999999875 58999999986532 22235678899999999999999999999999999999999
Q ss_pred ccCCCHHHH----------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 128 VINESLDKV----------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 128 ~~~g~L~~~----------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
+. ++|.++ +.|++.+|.|||..+ ||||||+||+++.++.+||+|||+++.+...... ...
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~ 158 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-YSA 158 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC-cCC
Confidence 96 466443 368999999999999 9999999999999999999999999865432221 223
Q ss_pred cccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCC---------cccc-c
Q 048280 190 VAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDK---------SLEI-V 258 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~-~ 258 (381)
..++..|+|||++.+. .++.++|||||||++|+|++|..|+...... ............... .... .
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 4578899999998775 4789999999999999999999886432221 111111111100000 0000 0
Q ss_pred CCCCCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 259 DPSLAA-----SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 259 ~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.+.... .........+.+++.+||+.||.+|||+.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000000 0111234667899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=279.00 Aligned_cols=236 Identities=27% Similarity=0.404 Sum_probs=187.4
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
++|++.+.||.|+||.||+|... ++..+++|++.... ......+.+|+++++.++|+||+++++.+...+..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47999999999999999999865 58899999986542 22457789999999999999999999999999999999999
Q ss_pred ccCCCHHHHH------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc--
Q 048280 128 VINESLDKVL------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH-- 185 (381)
Q Consensus 128 ~~~g~L~~~l------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~-- 185 (381)
+++++|.+++ .|++.++.+||..+ |+||||+||++++++.+||+|||++..+......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 9999887654 57899999999998 9999999999999999999999999866543322
Q ss_pred -cccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC
Q 048280 186 -VNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 186 -~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
......|+..|+|||++... .++.++|||||||++|+|++|+.||....... ......... .+.+.
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~~------~~~~~ 228 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQND------PPSLE 228 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcCC------CCCcC
Confidence 12334688999999998877 78999999999999999999999985332211 011111110 01111
Q ss_pred CC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 264 AS-DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 264 ~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.. ........+.+++.+||..||++||++.+|++
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11 11244567889999999999999999999976
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=280.21 Aligned_cols=241 Identities=24% Similarity=0.315 Sum_probs=184.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc-ccHHHHHHHHHHHHHhCCCCcccEEEEEeeC--CeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN-QGKKEFENEAKLLARVQHRNVVNLLGYCAHG--AEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~ 125 (381)
++|+..+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||++++++|.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999875 588999999875432 3456789999999999999999999998653 4789999
Q ss_pred ecccCCCHHHHH-------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 126 EYVINESLDKVL-------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 126 E~~~~g~L~~~l-------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
||+++++|.+++ .+++.+|.|+|..+ |+||+|+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 999999986543 57899999999998 999999999999999999999999875432221
Q ss_pred ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 185 HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
....++..|+|||.+.+..++.++|||||||++|+|++|..||........ ...+...... ....... ... .
T Consensus 161 ---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~-~~~~~~~-~~~--~ 232 (287)
T cd06621 161 ---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIELLSYIV-NMPNPEL-KDE--P 232 (287)
T ss_pred ---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHHHHHHHh-cCCchhh-ccC--C
Confidence 234578899999999988999999999999999999999999865432111 1111111111 1111111 000 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.........+.+++.+||+.||.+|||+.||++.
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1112245678899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=281.97 Aligned_cols=222 Identities=26% Similarity=0.395 Sum_probs=171.7
Q ss_pred CcccccCCeeEEEEEECC--------CcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 56 NKLGEGGFGPVFKGKLDD--------GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
+.||.|+||.||+|.... ...|++|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997542 234888887655444456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCC--------cEEeeeccceecCC
Q 048280 128 VINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWI--------PKIADFGMARLFPE 181 (381)
Q Consensus 128 ~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~--------~kL~DFG~~~~~~~ 181 (381)
+.+|+|.+++ .|++.++.|+|+.+ ||||||+|||++.++. +||+|||++.....
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~ 160 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP 160 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence 9999997665 68899999999999 9999999999987765 59999998875432
Q ss_pred CCcccccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCC-CCCCCCCccccccHHHHHHHHhhcCCcccccC
Q 048280 182 DQTHVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQ-RNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVD 259 (381)
Q Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
. ....++..|+|||++.+. .++.++|||||||++|+|++|. .|+...... .. .......
T Consensus 161 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~------~~-~~~~~~~------- 221 (258)
T cd05078 161 K-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ------KK-LQFYEDR------- 221 (258)
T ss_pred c-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH------HH-HHHHHcc-------
Confidence 1 234578899999999864 5799999999999999999995 443221111 00 0111110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 260 PSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 260 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
..+.. .....+.+|+.+||+.||++|||+++|++.|+
T Consensus 222 ~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 HQLPA----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ccCCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01111 11245789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=287.32 Aligned_cols=237 Identities=26% Similarity=0.408 Sum_probs=182.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCc----EEEEEEecCCCc-ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGR----EIAVKKLSHSSN-QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 122 (381)
.++|++.+.||+|+||.||+|.+. ++. .||+|.+..... .....+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 457889999999999999999864 344 578888865432 2234688999999999999999999998764 467
Q ss_pred EEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 123 LIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 123 lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
+++||+++|+|.+++ .|++.+|.|+|..+ |+||||+|||++.++.+||+|||+++.+.....
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCccc
Confidence 999999999887654 58899999999998 999999999999999999999999987643322
Q ss_pred c-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 185 H-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 185 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
. ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .... ......... ..+
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~----~~~~~~~~~--~~~-- 233 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIP----DLLEKGERL--PQP-- 233 (303)
T ss_pred ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHH----HHHHCCCCC--CCC--
Confidence 1 1122345678999999998899999999999999999997 8888753221 1111 111111110 001
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
......+.+++..||..+|++||++.++++.|+..
T Consensus 234 -----~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 234 -----PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred -----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11234577899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=286.28 Aligned_cols=238 Identities=18% Similarity=0.261 Sum_probs=184.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc---ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++|++.+.||+|+||.||++... +++.|++|.+..... .....+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47899999999999999999876 478999999865432 23456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc----
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT---- 184 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~---- 184 (381)
||+++++|.+++ .+++.++.|+|+.+ ||||||+||+++.++.+||+|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 999999997665 57889999999998 999999999999999999999999874211000
Q ss_pred ----------ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCc
Q 048280 185 ----------HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKS 254 (381)
Q Consensus 185 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (381)
.......++..|+|||.+.+..++.++|||||||++|||++|..||..... ..+. .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~---~~~~---~~~~~~~-- 232 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELF---GQVISDD-- 232 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHH---HHHHhcc--
Confidence 011124578899999999888899999999999999999999999853221 1111 1111110
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 255 LEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
...+.. ....+..+.+++.+||+.||++||++.++.+.|+.
T Consensus 233 --~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 233 --IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred --cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 001111 11234557899999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=278.83 Aligned_cols=235 Identities=26% Similarity=0.372 Sum_probs=190.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc-ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN-QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
++|++.+.||+|++|.||+|... +++.|+||++..... .....+.+|+..+.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36889999999999999999876 499999999876543 3457899999999999999999999999999999999999
Q ss_pred ccCCCHHHHH---------------HhhhhhhhHhhh-hc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 128 VINESLDKVL---------------FSLIKDIQILFR-KK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 128 ~~~g~L~~~l---------------~~~~~~l~~lh~-~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
+++++|.+++ .|++.++.++|. .+ |+||+|+||+++.++.++|+|||++......... ...
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-~~~ 159 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CNT 159 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-ccc
Confidence 9999998665 578999999999 77 9999999999999999999999999876443322 123
Q ss_pred cccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHH
Q 048280 190 VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGD 269 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (381)
..++..|+|||.+.+..++.++||||||+++|+|++|..||............ ..... ... +. ....
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~---~~~~~-~~~-----~~----~~~~ 226 (264)
T cd06623 160 FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM---QAICD-GPP-----PS----LPAE 226 (264)
T ss_pred eeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH---HHHhc-CCC-----CC----CCcc
Confidence 46788999999999889999999999999999999999998644321111111 11111 100 11 1112
Q ss_pred -HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 270 -QIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 270 -~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.+..+.+++.+||..+|++||++.++++.
T Consensus 227 ~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 227 EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 44678899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=284.60 Aligned_cols=243 Identities=25% Similarity=0.359 Sum_probs=182.8
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcc-----cHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQ-----GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
+|++.+.||+|+||.||+|... +++.||||++...... ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999865 5899999999755322 234577899999999999999999999999999999
Q ss_pred EecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 125 YEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 125 ~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
|||+ +++|.+++ .|++.+|.|||..+ |+||||+|||++.++.+||+|||++.........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK- 158 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc-
Confidence 9999 88887654 68999999999999 9999999999999999999999999876443221
Q ss_pred ccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcC---------Cccc
Q 048280 187 NTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKD---------KSLE 256 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 256 (381)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..+|......+ ............ ....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHHcCCCchhhhhhcccccc
Confidence 122346788999998865 457899999999999999999977765433211 111111110000 0000
Q ss_pred ccCCCCCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 257 IVDPSLAA-----SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 257 ~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
........ .........+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000 0112234678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=284.56 Aligned_cols=244 Identities=24% Similarity=0.353 Sum_probs=188.0
Q ss_pred CCChHHHHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHh-CCCCcccEEEEEe
Q 048280 39 HFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLGYCA 116 (381)
Q Consensus 39 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 116 (381)
.+.+.++...+++|.+.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 3555667777899999999999999999999875 58899999986542 2245678899999999 8999999999987
Q ss_pred eC-----CeEEEEEecccCCCHHHHH-------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEE
Q 048280 117 HG-----AEKLLIYEYVINESLDKVL-------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKI 170 (381)
Q Consensus 117 ~~-----~~~~lv~E~~~~g~L~~~l-------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL 170 (381)
.. ...++||||+++++|.+++ .|++.++.++|..+ |+||||+||+++.++.+||
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEE
Confidence 54 3589999999999997543 57889999999998 9999999999999999999
Q ss_pred eeeccceecCCCCcccccccccCccccchhHHhhC-----CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHH
Q 048280 171 ADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG-----HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWA 245 (381)
Q Consensus 171 ~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~ 245 (381)
+|||++......... .....|+..|+|||.+... .++.++|||||||++|+|++|+.||...... ...
T Consensus 170 ~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------~~~ 242 (291)
T cd06639 170 VDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------KTL 242 (291)
T ss_pred eecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH------HHH
Confidence 999999865432221 1234678899999988643 3689999999999999999999998532211 111
Q ss_pred HHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 246 YKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.... ........+ .......+.+++.+||+.+|++||++.+|++.
T Consensus 243 ~~~~-~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 FKIP-RNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHh-cCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111 111111111 12233568899999999999999999999753
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=295.60 Aligned_cols=231 Identities=22% Similarity=0.315 Sum_probs=191.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
...|.+...||+|.|+.|.+|++. ++..||||.+.+.. ...+..+.+|+++|+.|+|||||+++.+.+....+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 457999999999999999999865 69999999998763 333456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
||+.+|.+.+++ .|+..+++|||++. |||||++||||+.+..+||+|||++..+... ....
T Consensus 135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~--~~lq 212 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG--LMLQ 212 (596)
T ss_pred EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc--cccc
Confidence 999999999887 68999999999999 9999999999999999999999999988633 2334
Q ss_pred ccccCccccchhHHhhCCC-CchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 189 RVAGTNGYMAPEYVMHGHL-SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
..+|++.|.|||++.+..| ++.+|+||+|++||-|+.|..||+...-..... . .+...+ ..+
T Consensus 213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~------r---------vl~gk~--rIp 275 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP------R---------VLRGKY--RIP 275 (596)
T ss_pred ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc------h---------heeeee--ccc
Confidence 6789999999999999876 588999999999999999999986432211100 0 000000 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
......|.+||.++|..+|.+|+++++|.+.
T Consensus 276 ~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 276 FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1223458889999999999999999999753
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=280.04 Aligned_cols=235 Identities=24% Similarity=0.409 Sum_probs=185.0
Q ss_pred CCCCCCcccccCCeeEEEEEE-CCCcEEEEEEecCCCc------ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKL-DDGREIAVKKLSHSSN------QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
+|+..+.||+|+||.||++.. .+++.||+|++..... ...+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 588899999999999999986 4689999999864321 124578899999999999999999999999999999
Q ss_pred EEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCC-CcEEeeeccceecCCCCcc
Q 048280 124 IYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKW-IPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 124 v~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~-~~kL~DFG~~~~~~~~~~~ 185 (381)
||||+.+++|.+++ .|++.++.+||..+ |+||||+||+++.++ .+||+|||++..+......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 99999999997654 78999999999999 999999999998776 5999999999876433211
Q ss_pred ---cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 186 ---VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
......++..|+|||.+.+..++.++|||||||++|+|++|..||........ ........... .
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~---------~ 228 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIASAT---------T 228 (268)
T ss_pred CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHHhccC---------C
Confidence 11234678899999999888899999999999999999999999853322111 11111111000 0
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
...........+.+++.+||..+|.+||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11222344566888999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=284.97 Aligned_cols=227 Identities=24% Similarity=0.318 Sum_probs=183.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47899999999999999999876 58999999986532 223467889999999999999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
||+.+++|.+++ .|++.+|.++|..+ |+||+|.|||++.++.+||+|||++...... ..
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~~ 156 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TY 156 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----CC
Confidence 999999997665 68999999999988 9999999999999999999999999876443 22
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
...+++.|+|||.+.+..++.++||||||+++|+|++|..||..... ........ ... ..+ +.
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~~------~~~----~~ 219 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP------IQIYEKIL-EGK------VRF----PS 219 (290)
T ss_pred CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHh-cCC------ccC----Cc
Confidence 34688999999999888889999999999999999999999854321 11111111 111 011 11
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRP-----TMRRVVV 297 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 297 (381)
.....+.+++.+||..||.+|+ +++++++
T Consensus 220 ~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 220 FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1245678899999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=289.55 Aligned_cols=249 Identities=23% Similarity=0.283 Sum_probs=184.5
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeC-----
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHG----- 118 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----- 118 (381)
...++|++.+.||+|+||.||+|... +++.||||.+... .......+.+|+.++++++|+||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 35678999999999999999999865 6899999998643 223345677899999999999999999988643
Q ss_pred -CeEEEEEecccCCCHHHH-------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCC
Q 048280 119 -AEKLLIYEYVINESLDKV-------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPED 182 (381)
Q Consensus 119 -~~~~lv~E~~~~g~L~~~-------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~ 182 (381)
...|+||||+. ++|.+. +.|++.+|.|||..+ ||||||+|||++.++.+||+|||++......
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 35799999995 466543 478999999999999 9999999999999999999999999876433
Q ss_pred CcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccH------------HHH---H-H
Q 048280 183 QTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNL------------LDW---A-Y 246 (381)
Q Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~------------~~~---~-~ 246 (381)
.. .....++..|+|||++.+..++.++|||||||++|+|++|+.||........... ... . .
T Consensus 172 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (353)
T cd07850 172 FM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR 249 (353)
T ss_pred CC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence 21 2234578899999999999999999999999999999999999864432111000 000 0 0
Q ss_pred HHhhcCCc------cccc----CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 247 KLYKKDKS------LEIV----DPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 247 ~~~~~~~~------~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
........ .... .+.............+.+++.+||+.||++|||+.|++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 0000 0000111122345667899999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=278.81 Aligned_cols=231 Identities=22% Similarity=0.352 Sum_probs=185.3
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
+|++.+.||+|+||.||++... +++.||+|.+... .......+.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5889999999999999999865 5899999998643 223345789999999999999999999999999999999999
Q ss_pred ccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 128 VINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 128 ~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
+.+++|.+++ .|++.++.++|..+ |+||+|+|||++.++.++|+|||++......... ..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~ 159 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL-AR 159 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh-hh
Confidence 9998886544 67899999999988 9999999999999999999999999876433221 22
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
...|+..|+|||++.+..++.++|||||||++|+|++|+.||..... ............ + ....
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~~~~------~----~~~~ 223 (256)
T cd08218 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKIIRGSY------P----PVSS 223 (256)
T ss_pred hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHhcCCC------C----CCcc
Confidence 34578899999999988999999999999999999999999853211 111111111110 1 1112
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.....+.+++.+||+.+|.+||++.+|++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 334568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=285.81 Aligned_cols=246 Identities=24% Similarity=0.321 Sum_probs=180.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc--ccHHHHHHHHHHHHHhCCCCcccEEEEEeeC--CeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN--QGKKEFENEAKLLARVQHRNVVNLLGYCAHG--AEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~l 123 (381)
.++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 468999999999999999999875 589999999864422 2223567899999999999999999998755 56899
Q ss_pred EEecccCCCHHH----------------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 124 IYEYVINESLDK----------------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 124 v~E~~~~g~L~~----------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
||||+.+ +|.+ ++.|++.++.|+|..+ ||||||+||+++.++.+||+|||++.........
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 164 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence 9999964 5543 3478999999999999 9999999999999999999999999876433211
Q ss_pred cccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcc---------
Q 048280 186 VNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSL--------- 255 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 255 (381)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ..............
T Consensus 165 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 165 -MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ---LDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred -CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCChhhchhhhccc
Confidence 122345788999999876 4578999999999999999999999864332211 11111111000000
Q ss_pred ---cc-cCCCCCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 256 ---EI-VDPSLAA---SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 256 ---~~-~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
.. ....... .........+.++|.+||+.||++|||+.+++..-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 00 0000000 00011245678899999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=284.33 Aligned_cols=245 Identities=22% Similarity=0.360 Sum_probs=180.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc-ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN-QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
.++|++.+.||+|++|.||+|... +++.||||.+..... .....+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 368999999999999999999876 589999999865432 223457789999999999999999999999999999999
Q ss_pred cccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 127 YVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 127 ~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
|+.+ +|.+++ .|++.+|.|+|+.+ ||||||+|||++.++.+||+|||++......... ..
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~ 161 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT-YS 161 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc-cc
Confidence 9974 776544 58999999999998 9999999999999999999999998754322111 12
Q ss_pred ccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCc------------c
Q 048280 189 RVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKS------------L 255 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------~ 255 (381)
...++..|+|||++.+ ..++.++|||||||++|+|++|+.||...... ................ .
T Consensus 162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 2346788999999876 45889999999999999999999998543311 1111111111000000 0
Q ss_pred cccCCCCCCC----C--CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 256 EIVDPSLAAS----D--SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 256 ~~~~~~~~~~----~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
....+..... . .......+.+++.+||+.+|++|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000000 0 0011256778999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=280.13 Aligned_cols=237 Identities=27% Similarity=0.405 Sum_probs=182.9
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc---c-------cHHHHHHHHHHHHHhCCCCcccEEEEEeeCC
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---Q-------GKKEFENEAKLLARVQHRNVVNLLGYCAHGA 119 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~-------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 119 (381)
+|.+.+.||.|+||.||+|... +++.||+|.+..... . ..+.+.+|+.++++++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5788999999999999999865 588999998854211 0 1245788999999999999999999999999
Q ss_pred eEEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCC
Q 048280 120 EKLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPED 182 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~ 182 (381)
..++||||+++++|.+++ .|++.++.++|+.+ |+||+|+||+++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 999999999999987654 67899999999998 9999999999999999999999999865332
Q ss_pred Ccc-cccccccCccccchhHHhhCC--CCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccC
Q 048280 183 QTH-VNTRVAGTNGYMAPEYVMHGH--LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVD 259 (381)
Q Consensus 183 ~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
... ......++..|+|||.+.... ++.++||||||+++|+|++|..||..... ............ .
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~-----~ 230 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMFKLGNKRS-----A 230 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHHHhhcccc-----C
Confidence 111 122345788999999987654 88999999999999999999999842211 111111111111 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 260 PSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 260 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
+.............+.+++.+||..+|.+||++.+|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 231 PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111111222345678899999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=277.22 Aligned_cols=234 Identities=29% Similarity=0.476 Sum_probs=186.0
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcc--cHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQ--GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
+|.+.+.||+|+||.||+|... +++.|++|.+...... ....+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999865 6899999998765443 557889999999999999999999999999999999999
Q ss_pred ccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc--
Q 048280 128 VINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT-- 188 (381)
Q Consensus 128 ~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~-- 188 (381)
+++++|.+++ .+++.++.++|..+ |+||+|+||+++.++.+||+|||++............
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 160 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccc
Confidence 9999998765 67899999999988 9999999999999999999999999876543332211
Q ss_pred -ccccCccccchhHHhhCC---CCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 189 -RVAGTNGYMAPEYVMHGH---LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 189 -~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
...++..|+|||++.+.. ++.++|||||||++|+|++|+.||...... ......... .. .+.+.
T Consensus 161 ~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~~~~-~~-----~~~~~- 228 (264)
T cd06626 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFHVGA-GH-----KPPIP- 228 (264)
T ss_pred cCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHHHhc-CC-----CCCCC-
Confidence 345788999999998766 889999999999999999999998532211 111111111 10 11111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
........+.+++.+||+.+|.+||++.+++.
T Consensus 229 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 229 -DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11122455778999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=282.30 Aligned_cols=235 Identities=23% Similarity=0.365 Sum_probs=183.4
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCC-----
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGA----- 119 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~----- 119 (381)
..+++|++.+.||.|++|.||+|... +++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35689999999999999999999875 578999999865543 346789999999999 7999999999997644
Q ss_pred -eEEEEEecccCCCHHHHH-------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccce
Q 048280 120 -EKLLIYEYVINESLDKVL-------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMAR 177 (381)
Q Consensus 120 -~~~lv~E~~~~g~L~~~l-------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~ 177 (381)
..++||||+.+++|.+++ .|++.+|.|+|+.+ |+||+|+||+++.++.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 489999999999886543 57999999999998 99999999999999999999999998
Q ss_pred ecCCCCcccccccccCccccchhHHhh-----CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcC
Q 048280 178 LFPEDQTHVNTRVAGTNGYMAPEYVMH-----GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKD 252 (381)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (381)
....... ......|+..|+|||++.. ..++.++|||||||++|+|++|+.||...... ........ .
T Consensus 162 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~ 233 (275)
T cd06608 162 QLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM------RALFKIPR-N 233 (275)
T ss_pred ecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH------HHHHHhhc-c
Confidence 6543221 2233568899999998854 34678999999999999999999998532111 11111111 1
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 253 KSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
. .+.. .........+.+|+.+||..||++|||+.+|++
T Consensus 234 ~-----~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 234 P-----PPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred C-----CCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 1111 112234567889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=282.12 Aligned_cols=237 Identities=29% Similarity=0.427 Sum_probs=184.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC-Cc----EEEEEEecCCCc-ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD-GR----EIAVKKLSHSSN-QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 122 (381)
..+|++.+.||+|+||.||+|.... +. .||+|.+..... .....+.+|+.++++++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3578999999999999999998642 33 589998865532 334678899999999999999999999987 7889
Q ss_pred EEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 123 LIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 123 lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
+||||+++|+|.+++ .|++.++.|||..+ |+||||+|||++.++.+||+|||+++.+.....
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 164 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence 999999999997665 67899999999988 999999999999999999999999987643322
Q ss_pred ccc-cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 185 HVN-TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 185 ~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
... ....++..|+|||.+....++.++|||||||++|||++ |+.||...... .+.. ....... ...+
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~~~--~~~~-- 233 (279)
T cd05057 165 EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPD----LLEKGER--LPQP-- 233 (279)
T ss_pred ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHH----HHhCCCC--CCCC--
Confidence 111 11223568999999988899999999999999999998 99998543211 1111 1111110 0111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
......+.+++.+||..||.+||++.++++.|...
T Consensus 234 -----~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 234 -----PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred -----CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11223577899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=282.05 Aligned_cols=231 Identities=26% Similarity=0.427 Sum_probs=184.6
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
-|++.+.||.|+||.||+|... ++..||||.+.... ......+.+|+.++.+++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3778899999999999999865 58899999986442 233467889999999999999999999999999999999999
Q ss_pred cCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccccc
Q 048280 129 INESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAG 192 (381)
Q Consensus 129 ~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~g 192 (381)
.+++|.+++ .+++.++.++|..+ |+||||+||+++.++.++|+|||++..+..... ......+
T Consensus 85 ~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~ 163 (277)
T cd06641 85 GGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNTFVG 163 (277)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-hhccccC
Confidence 999997665 67899999999998 999999999999999999999999987643322 1223457
Q ss_pred CccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHH
Q 048280 193 TNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIA 272 (381)
Q Consensus 193 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (381)
+..|+|||.+.+..++.++|||||||++|+|++|..||...... ...... .... .+. .......
T Consensus 164 ~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~-~~~~-----~~~----~~~~~~~ 227 (277)
T cd06641 164 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFLI-PKNN-----PPT----LEGNYSK 227 (277)
T ss_pred CccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHHH-hcCC-----CCC----CCcccCH
Confidence 88999999998888999999999999999999999998532211 111111 1110 011 1122345
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 273 MCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 273 ~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.+.+++.+||+.+|.+||++.++++.
T Consensus 228 ~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 228 PLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHhC
Confidence 67889999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=285.33 Aligned_cols=246 Identities=22% Similarity=0.319 Sum_probs=180.7
Q ss_pred CCCCCCcccccCCeeEEEEEEC---CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeC--CeEE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD---DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHG--AEKL 122 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~ 122 (381)
+|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4888999999999999999865 47899999997632 33346788899999999999999999999988 8899
Q ss_pred EEEecccCCCHH--------------------HHHHhhhhhhhHhhhhc--cCCccccceEeCC----CCCcEEeeeccc
Q 048280 123 LIYEYVINESLD--------------------KVLFSLIKDIQILFRKK--KTDIKASNILLDD----KWIPKIADFGMA 176 (381)
Q Consensus 123 lv~E~~~~g~L~--------------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~----~~~~kL~DFG~~ 176 (381)
+||||+.+ +|. .++.|++.++.|||..+ ||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999964 443 24468999999999999 9999999999999 999999999999
Q ss_pred eecCCCCc--ccccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccc------cHHHHHHH
Q 048280 177 RLFPEDQT--HVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQ------NLLDWAYK 247 (381)
Q Consensus 177 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~------~~~~~~~~ 247 (381)
..+..... .......++..|+|||++.+. .++.++|||||||++|+|++|+.||......... ........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 87643322 112245678899999988764 5789999999999999999999998654332200 00000000
Q ss_pred HhhcC------------Cccc----ccCCCCCCCCCH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 248 LYKKD------------KSLE----IVDPSLAASDSG-------DQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 248 ~~~~~------------~~~~----~~~~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
..... .... ............ .....+.+++.+||+.||++|||+.|++.
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 0000 000000000000 22346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=279.36 Aligned_cols=232 Identities=24% Similarity=0.411 Sum_probs=184.3
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC-CcccHHHHHHHHHHHHHhC---CCCcccEEEEEeeCCeEEEEE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS-SNQGKKEFENEAKLLARVQ---HRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~lv~ 125 (381)
.|++.+.||.|+||.||+|... +++.||+|.+... .......+.+|+.++++++ ||||+++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 5788999999999999999864 6899999998654 2334567889999999997 999999999999999999999
Q ss_pred ecccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 126 EYVINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 126 E~~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
||+.+++|.+++ .+++.++.++|..+ |+||+|+||+++.++.++|+|||++..+..... ....
T Consensus 82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~ 160 (277)
T cd06917 82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-KRST 160 (277)
T ss_pred ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-cccc
Confidence 999999997665 57899999999999 999999999999999999999999987654332 2233
Q ss_pred cccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 190 VAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
..|+..|+|||.+.++ .++.++|||||||++|+|++|..||...... ..... .... ..+.+...
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~------~~~~~-~~~~-----~~~~~~~~--- 225 (277)
T cd06917 161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF------RAMML-IPKS-----KPPRLEDN--- 225 (277)
T ss_pred ccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh------hhhhc-cccC-----CCCCCCcc---
Confidence 4688999999988754 4689999999999999999999998533211 11110 0000 11111111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.....+.+++.+||+.||++||++.+++..
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 226 GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 134568889999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=283.20 Aligned_cols=242 Identities=24% Similarity=0.353 Sum_probs=179.0
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
+|++.+.||.|++|.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5889999999999999999875 58999999986542 22335788999999999999999999999999999999999
Q ss_pred ccCCCHHHH-----------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 128 VINESLDKV-----------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 128 ~~~g~L~~~-----------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
+. ++|..+ +.|++.+++|||..+ |+||+|+||+++.++.+||+|||++..+...... ..
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~-~~ 158 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YT 158 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc-cc
Confidence 95 466543 367899999999998 9999999999999999999999998865432211 22
Q ss_pred ccccCccccchhHHhhCC-CCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCc---------c--c
Q 048280 189 RVAGTNGYMAPEYVMHGH-LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKS---------L--E 256 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~--~ 256 (381)
...++..|+|||++.+.. ++.++|||||||++|+|++|+.||......+ ...... ........ . .
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIF-RTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHH-HHhCCCChhhhhhhhHHHHHH
Confidence 234678899999887644 6889999999999999999999986433211 111110 00000000 0 0
Q ss_pred ccCCCCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 257 IVDPSLAA----SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 257 ~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
...+.... .........+.+++.+||+.||.+|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000 001112345778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=323.71 Aligned_cols=238 Identities=26% Similarity=0.342 Sum_probs=190.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
+-++.....||.|.||.||.|... +|...|+|.+.... ......+.+|++++..|+|||+|+++|+-...+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 457778899999999999999854 58889999886543 333467889999999999999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc--
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV-- 186 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~-- 186 (381)
|||.+|+|.+++ .|++.|+.|||..+ ||||||+||||+.+|.+|++|||.|..+.......
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 999999998776 68999999999999 99999999999999999999999999876543221
Q ss_pred -ccccccCccccchhHHhhCC---CCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 187 -NTRVAGTNGYMAPEYVMHGH---LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 187 -~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
-....||+.|||||++.+.. ...+.||||||||+.||+||++||...... .+..+.. ..+ -
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-----~aIMy~V-~~g---------h 1458 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-----WAIMYHV-AAG---------H 1458 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-----hHHHhHH-hcc---------C
Confidence 12567999999999998643 467899999999999999999998532211 1111111 111 1
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
.+..+......-.+++.+||..||++|.++.||++.-..
T Consensus 1459 ~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1459 KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcc
Confidence 122333355667789999999999999999998876543
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=275.52 Aligned_cols=230 Identities=22% Similarity=0.352 Sum_probs=182.8
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
+|++.+.||+|+||.||++... +++.+|||.+.... ......+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999865 58899999986542 23356788999999999999999999999999999999999
Q ss_pred ccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCC-CCcEEeeeccceecCCCCcccc
Q 048280 128 VINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDK-WIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 128 ~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~-~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
+++++|.+++ .+++.++.++|.++ |+||||+||+++.+ +.+||+|||++........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~ 158 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK--A 158 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--c
Confidence 9999987654 57899999999988 99999999999854 4689999999987643321 2
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ........... ... ..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~------~~~~~~~~~~~-~~~---------~~ 222 (256)
T cd08220 159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL------PALVLKIMSGT-FAP---------IS 222 (256)
T ss_pred cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch------HHHHHHHHhcC-CCC---------CC
Confidence 234678899999999988899999999999999999999999853321 11111111110 001 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
......+.+++.+||+.||.+|||+.|++..
T Consensus 223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1234558899999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=278.86 Aligned_cols=235 Identities=22% Similarity=0.368 Sum_probs=180.4
Q ss_pred CCCCCcccccCCeeEEEEEEC----CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC------
Q 048280 52 FHPSNKLGEGGFGPVFKGKLD----DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA------ 119 (381)
Q Consensus 52 y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------ 119 (381)
|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 677889999999999999753 36889999986542 233567889999999999999999999886532
Q ss_pred eEEEEEecccCCCHHHH---------------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccc
Q 048280 120 EKLLIYEYVINESLDKV---------------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMA 176 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~~---------------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~ 176 (381)
..++++||+.+++|..+ +.|++.+++|+|+.+ ||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 34788999999988544 367889999999998 9999999999999999999999999
Q ss_pred eecCCCCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCc
Q 048280 177 RLFPEDQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKS 254 (381)
Q Consensus 177 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (381)
+........ ......++..|++||.+.+..++.++|||||||++|+|++ |..||..... ..+... ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~----~~~~~~ 233 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNY----LIKGNR 233 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHH----HHcCCc
Confidence 865432211 1122345678999999998899999999999999999999 7777753221 111111 111110
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 255 LEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.. ........+.+++.+||+.+|++||++.++++.|+++
T Consensus 234 ~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 LK---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0112345688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=279.93 Aligned_cols=232 Identities=23% Similarity=0.351 Sum_probs=184.9
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEeccc
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVI 129 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 129 (381)
.|...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++|+||+++++++...+..++|+||+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 4555689999999999999864 688999999876555555678899999999999999999999999999999999999
Q ss_pred CCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccC
Q 048280 130 NESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT 193 (381)
Q Consensus 130 ~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt 193 (381)
+++|.+++ .|++.++.++|+.+ ||||+|+||+++.++.++|+|||++........ ......|+
T Consensus 100 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~ 178 (285)
T cd06648 100 GGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLVGT 178 (285)
T ss_pred CCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccccccCC
Confidence 99997654 67899999999999 999999999999999999999998876543222 12234688
Q ss_pred ccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHH
Q 048280 194 NGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAM 273 (381)
Q Consensus 194 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (381)
..|+|||.+.+..++.++|||||||++|+|++|+.||..... ......... ... +... ........
T Consensus 179 ~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~~-~~~-----~~~~--~~~~~~~~ 244 (285)
T cd06648 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIRD-NLP-----PKLK--NLHKVSPR 244 (285)
T ss_pred ccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHh-cCC-----CCCc--ccccCCHH
Confidence 999999999888899999999999999999999999853221 111111111 110 1110 11113356
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 048280 274 CIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 274 l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
+.+++.+||+.+|++||++.++++
T Consensus 245 l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 245 LRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHcccChhhCcCHHHHcc
Confidence 889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=282.67 Aligned_cols=231 Identities=24% Similarity=0.362 Sum_probs=175.4
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc-ccHHHHHHHHHH-HHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN-QGKKEFENEAKL-LARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
++|++.+.||+|+||.||+++.. +|+.||||++..... .....+..|+.+ ++.++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47899999999999999999876 589999999875432 233456667665 555689999999999999999999999
Q ss_pred cccCCCHHHH-------------------HHhhhhhhhHhhhh-c--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 127 YVINESLDKV-------------------LFSLIKDIQILFRK-K--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 127 ~~~~g~L~~~-------------------l~~~~~~l~~lh~~-~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
|++ ++|.++ +.|++.++.|+|.. + ||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 158 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV- 158 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 995 565433 36889999999987 5 99999999999999999999999998653322
Q ss_pred ccccccccCccccchhHHhh----CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCC
Q 048280 185 HVNTRVAGTNGYMAPEYVMH----GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDP 260 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||..... . ......... .. .+
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~-~~~~~~~~~-~~-----~~ 226 (283)
T cd06617 159 -AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT----P-FQQLKQVVE-EP-----SP 226 (283)
T ss_pred -ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc----C-HHHHHHHHh-cC-----CC
Confidence 1223457889999998865 4568899999999999999999999853211 0 111111111 10 01
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 261 SLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 261 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
... ....+..+.+++.+||..+|.+||++.+|++
T Consensus 227 ~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 227 QLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 1123456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=281.53 Aligned_cols=244 Identities=23% Similarity=0.322 Sum_probs=181.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcc--cHHHHHHHHHHHHHhCCCCcccEEEEEeeC--CeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQ--GKKEFENEAKLLARVQHRNVVNLLGYCAHG--AEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~l 123 (381)
.++|++.+.||.|+||.||+|... +++.+++|.++..... ....+.+|+.++.+++||||+++++++... +..++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 357999999999999999999876 5889999998654322 234567899999999999999999999877 89999
Q ss_pred EEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 124 IYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 124 v~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
||||+. ++|.+++ .|++.+|.|||..+ |+||||+|||++.++.+||+|||++..+......
T Consensus 84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 162 (293)
T cd07843 84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162 (293)
T ss_pred EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence 999996 4775443 68999999999999 9999999999999999999999999876543221
Q ss_pred cccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhh-----------c--
Q 048280 186 VNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYK-----------K-- 251 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~-- 251 (381)
.....++..|+|||.+.+. .++.++|||||||++|+|++|..||......+. ......... .
T Consensus 163 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 163 -YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ---LNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred -cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchHHHHHhhccc
Confidence 2234578899999998765 468999999999999999999999864432211 111110000 0
Q ss_pred ----CCcccccCCCCCCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 252 ----DKSLEIVDPSLAASDSGD-QIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 252 ----~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
..........+....... ....+.+++.+||+.||++|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000000111111 2456788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=277.83 Aligned_cols=231 Identities=23% Similarity=0.351 Sum_probs=183.2
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEee--CCeEEEEE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAH--GAEKLLIY 125 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~ 125 (381)
+|++.+.||.|+||.||++... ++..||+|.+... .....+.+.+|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5888999999999999999865 5889999998643 23334678899999999999999999998754 45689999
Q ss_pred ecccCCCHHHHH-------------------HhhhhhhhHhh-----hhc--cCCccccceEeCCCCCcEEeeeccceec
Q 048280 126 EYVINESLDKVL-------------------FSLIKDIQILF-----RKK--KTDIKASNILLDDKWIPKIADFGMARLF 179 (381)
Q Consensus 126 E~~~~g~L~~~l-------------------~~~~~~l~~lh-----~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~ 179 (381)
||+++++|.+++ .+++.++.++| ..+ |+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999987554 57899999999 656 9999999999999999999999999876
Q ss_pred CCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccC
Q 048280 180 PEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVD 259 (381)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
...... .....++..|+|||.+.+..++.++||||||+++|+|++|..||..... ..+. ........
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~----~~~~~~~~----- 227 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLA----SKIKEGKF----- 227 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHH----HHHhcCCC-----
Confidence 543321 2234689999999999988899999999999999999999999864321 1111 11111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 260 PSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 260 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
..........+.+++.+||+.+|.+||++.+|++.
T Consensus 228 ----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 ----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11122344668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=280.86 Aligned_cols=235 Identities=26% Similarity=0.379 Sum_probs=179.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhC-CCCcccEEEEEeeCCeEEEEEe
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQ-HRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~E 126 (381)
++|+..+.||+|+||.||++... +++.||+|++.... ......+.+|+.++.++. |+||+++++++......+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35667789999999999999865 58999999986543 234567889999999996 9999999999999999999999
Q ss_pred cccCCCHH--------------------HHHHhhhhhhhHhhhh-c--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 127 YVINESLD--------------------KVLFSLIKDIQILFRK-K--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 127 ~~~~g~L~--------------------~~l~~~~~~l~~lh~~-~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
|+.. +|. .++.+++.++.|+|+. + ||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 9853 332 2336789999999975 5 99999999999999999999999997653322
Q ss_pred cccccccccCccccchhHHhhC---CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCC
Q 048280 184 THVNTRVAGTNGYMAPEYVMHG---HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDP 260 (381)
Q Consensus 184 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
. .....|+..|+|||++.+. .++.++|||||||++|+|++|+.||.... ............ ..+
T Consensus 163 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~------~~~ 229 (288)
T cd06616 163 A--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKG------DPP 229 (288)
T ss_pred c--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCC------CCC
Confidence 1 1233578899999999776 68999999999999999999999985332 111111111111 111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 261 SLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 261 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.+...........+.+|+.+||+.||++|||+++|++.
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 12222223345678899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=322.12 Aligned_cols=244 Identities=25% Similarity=0.475 Sum_probs=193.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
...|...+.||+|+||.||+|+.. ++..||||++...... ...|++++++++|||||+++++|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 356788899999999999999874 6899999998644322 23568899999999999999999999999999999
Q ss_pred ccCCCHHHHH------------HhhhhhhhHhhhh---c--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccc
Q 048280 128 VINESLDKVL------------FSLIKDIQILFRK---K--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV 190 (381)
Q Consensus 128 ~~~g~L~~~l------------~~~~~~l~~lh~~---~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 190 (381)
+++|+|.+++ .+++.|++|+|.. + ||||||+||+++.++.+++. ||........ ...
T Consensus 765 ~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~ 838 (968)
T PLN00113 765 IEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKC 838 (968)
T ss_pred CCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCc
Confidence 9999998765 6789999999943 3 99999999999999888876 6665433211 123
Q ss_pred ccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC--CCCH
Q 048280 191 AGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA--SDSG 268 (381)
Q Consensus 191 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 268 (381)
.+|..|+|||++.+..++.++|||||||++|||++|+.||..... .......|.............+++.+.. ....
T Consensus 839 ~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (968)
T PLN00113 839 FISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917 (968)
T ss_pred cccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence 578999999999999999999999999999999999999854322 2234555555444333334445554432 2345
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
.....+.+++.+||+.||++|||+.|+++.|++..
T Consensus 918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred HHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 66677889999999999999999999999998753
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=281.16 Aligned_cols=246 Identities=21% Similarity=0.271 Sum_probs=180.5
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc-ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN-QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++++|.+.+.||+|+||.||+|... ++..||+|.+..... .....+.+|+.+++.++|+||+++++++..+...++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999865 588999999865432 22346788999999999999999999999999999999
Q ss_pred ecccCCCHHHH----------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 126 EYVINESLDKV----------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 126 E~~~~g~L~~~----------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
||+. ++|... +.|++.+|.|+|+.+ |+||||+|||++.++.+||+|||+++........ .
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~ 160 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT-Y 160 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-C
Confidence 9995 555432 368999999999999 9999999999999999999999999764332211 1
Q ss_pred cccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc------------CCc
Q 048280 188 TRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKK------------DKS 254 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~ 254 (381)
....++..|+|||++.+. .++.++|||||||++|+|++|..||...... ...+......... ...
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 234578899999988764 5789999999999999999999998643221 1111111110000 000
Q ss_pred ccccCCCCCCCC------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 255 LEIVDPSLAASD------SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 255 ~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.....+...... .......+.+++.+|+..||.+|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000 0011345778999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=277.63 Aligned_cols=230 Identities=25% Similarity=0.311 Sum_probs=184.9
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc---ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
+|++.+.||.|+||.||+|+.. ++..||+|++..... ...+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999876 589999999975432 335688999999999999999999999999999999999
Q ss_pred cccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 127 YVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 127 ~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
|+.+++|.+++ .+++.++.|||..+ |+||+|+||++++++.++|+|||++....... ....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~ 158 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTS 158 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cccc
Confidence 99999987654 67999999999998 99999999999999999999999998764332 1223
Q ss_pred cccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHH
Q 048280 190 VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGD 269 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (381)
..|+..|+|||.+.+..++.++|||||||++|+|++|..||........ ......... . . + ..+..
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~--~-~---~----~~~~~ 224 (258)
T cd05578 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIRAKQET--A-D---V----LYPAT 224 (258)
T ss_pred cCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHHHHhcc--c-c---c----cCccc
Confidence 5678899999999888899999999999999999999999865432211 111111110 0 0 1 11112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 048280 270 QIAMCIQIGLLCTQGDPQLRPTM--RRVV 296 (381)
Q Consensus 270 ~~~~l~~li~~cl~~dP~~RPs~--~eil 296 (381)
.+..+.+++.+||+.||.+||++ .|++
T Consensus 225 ~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 225 WSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 33668899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=270.40 Aligned_cols=232 Identities=28% Similarity=0.446 Sum_probs=187.4
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEeccc
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVI 129 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 129 (381)
+|++.+.||+|++|.||++... ++..+++|++..........+.+|++++++++|+||+++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4788999999999999999876 688999999976655456789999999999999999999999999999999999999
Q ss_pred CCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccc
Q 048280 130 NESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVA 191 (381)
Q Consensus 130 ~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~ 191 (381)
+++|.+++ .+++.++.++|..+ |+||+|+||+++.++.++|+|||.+........ .....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 158 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMV 158 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cccee
Confidence 99997654 67899999999988 999999999999999999999999987654332 23456
Q ss_pred cCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHH
Q 048280 192 GTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271 (381)
Q Consensus 192 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (381)
++..|+|||.+.+..++.++||||||+++|+|++|..||...... ....... ......... .....
T Consensus 159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~~~~-------~~~~~ 224 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------KALFKIA-TNGPPGLRN-------PEKWS 224 (253)
T ss_pred cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHH-hcCCCCcCc-------ccccC
Confidence 888999999998888999999999999999999999998533211 1111111 111111111 11124
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 272 AMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 272 ~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
..+.+++.+||+.||.+|||+.++++.
T Consensus 225 ~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 225 DEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 568899999999999999999999753
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=288.52 Aligned_cols=247 Identities=21% Similarity=0.315 Sum_probs=180.9
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeC-----Ce
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHG-----AE 120 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~ 120 (381)
.+++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++|+||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3578999999999999999999865 68999999986432 22345688899999999999999999987644 35
Q ss_pred EEEEEecccCCCHHHH--------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 121 KLLIYEYVINESLDKV--------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~--------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
.++|+||+. ++|.++ +.|++.+|.+||+.+ ||||||+|||++.++.+||+|||++........
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 161 (336)
T cd07849 83 VYIVQELME-TDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161 (336)
T ss_pred EEEEehhcc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence 799999995 466543 468999999999999 999999999999999999999999986543221
Q ss_pred c--cccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCc---cccc
Q 048280 185 H--VNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKS---LEIV 258 (381)
Q Consensus 185 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 258 (381)
. ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... .............. ..+.
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHHHHHHhh
Confidence 1 1123568899999998765 468999999999999999999999985432111 11111110000000 0000
Q ss_pred C----------CCCCC-C---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 259 D----------PSLAA-S---DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 259 ~----------~~~~~-~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
. +.... . ........+.+++.+||+.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00000 0 001224568899999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=279.81 Aligned_cols=243 Identities=23% Similarity=0.339 Sum_probs=181.5
Q ss_pred CCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeC--CeEEEEEe
Q 048280 52 FHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHG--AEKLLIYE 126 (381)
Q Consensus 52 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~E 126 (381)
|++.+.||.|+||.||+|... +++.+|+|++.... ......+.+|+.++++++|+||+++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999876 48899999997653 33345788999999999999999999999888 89999999
Q ss_pred cccCCCHHHH----------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 127 YVINESLDKV----------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 127 ~~~~g~L~~~----------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
|+.+ +|..+ +.+++.++.+||..+ |+||||+|||+++++.+||+|||++............
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 9964 66543 378999999999998 9999999999999999999999999876544322223
Q ss_pred ccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcc---c--------
Q 048280 189 RVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSL---E-------- 256 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~-------- 256 (381)
...++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ............... .
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhccccccchhhh
Confidence 3456888999997765 457899999999999999999999985433211 111111111000000 0
Q ss_pred ccCCC------CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 257 IVDPS------LAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 257 ~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
...+. +.......+...+.+++.+||+.+|.+||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000 0000001125678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=282.86 Aligned_cols=230 Identities=27% Similarity=0.416 Sum_probs=180.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc---ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.+.|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||++++++|...+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356889999999999999999865 589999999864422 2235688999999999999999999999999999999
Q ss_pred EecccCCCHHH----------------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 125 YEYVINESLDK----------------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 125 ~E~~~~g~L~~----------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
|||+. |+|.+ ++.|++.+|.|+|..+ |+||+|+||+++.++.+||+|||++......
T Consensus 94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---- 168 (307)
T cd06607 94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---- 168 (307)
T ss_pred HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence 99996 45433 3368999999999988 9999999999999999999999999765322
Q ss_pred ccccccCccccchhHHh---hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVM---HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
....++..|+|||++. ...++.++|||||||++|||++|..||..... ........... .+..
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~------~~~~~~~~~~~------~~~~- 234 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQND------SPTL- 234 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH------HHHHHHHhcCC------CCCC-
Confidence 2345788999999874 35688999999999999999999999753221 11111111110 0111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 264 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
........+.+++.+||+.||++||++.+|+...
T Consensus 235 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 235 --SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred --CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 1122455688999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=276.77 Aligned_cols=235 Identities=24% Similarity=0.394 Sum_probs=188.3
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
.++.|++.+.||+|++|.||+|... ++..|++|++..... ....+.+|++++++++|+||+++++++......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4667999999999999999999876 588999999976544 45678899999999999999999999999999999999
Q ss_pred cccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 127 YVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 127 ~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
|+.+++|.+++ .+++.++.++|..+ |+||+|+||+++.++.+||+|||++........ ...
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~ 174 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRN 174 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhc
Confidence 99999997665 67889999999988 999999999999999999999999876543221 122
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
...++..|+|||.+.+..++.++|||||||++|+|++|+.||....... ....... ...... ....
T Consensus 175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~------~~~~~~~-~~~~~~-------~~~~ 240 (286)
T cd06614 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR------ALFLITT-KGIPPL-------KNPE 240 (286)
T ss_pred cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-cCCCCC-------cchh
Confidence 3457889999999988889999999999999999999999985322211 1111111 111000 1111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.....+.+++.+||+.+|.+||++.+|++.
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred hCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 234568899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=273.65 Aligned_cols=231 Identities=23% Similarity=0.366 Sum_probs=183.4
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
+|.+.+.||.|+||.||++..+ ++..||+|.+.... ....+.+.+|+.++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788999999999999999876 48899999986542 23446788999999999999999999999999999999999
Q ss_pred ccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCC-CcEEeeeccceecCCCCcccc
Q 048280 128 VINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKW-IPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 128 ~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~-~~kL~DFG~~~~~~~~~~~~~ 187 (381)
+++++|.+++ .+++.++.|+|..+ |+||||+||++++++ .+||+|||.+........ ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~~ 159 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-LA 159 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-cc
Confidence 9999987654 57899999999988 999999999998875 469999999987643322 12
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
....|+..|+|||++.+..++.++|||||||++|+|++|..||.... ........... . .. ...
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~-~----~~-----~~~ 223 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQG-Y----FA-----PIS 223 (257)
T ss_pred cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhcc-c----CC-----CCC
Confidence 23458889999999988889999999999999999999999985321 11222211111 1 10 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
......+.+++.+||..+|++|||+.+|++.
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 224 PNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1223568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=287.29 Aligned_cols=244 Identities=24% Similarity=0.347 Sum_probs=181.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeC-----Ce
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHG-----AE 120 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~ 120 (381)
.++|.+.+.||+|+||.||+|+.. ++..||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 468999999999999999999865 5899999998653 222345677899999999999999999987644 35
Q ss_pred EEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 121 KLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
.++|+||+. ++|.+++ .|++.++.|||..+ ||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 799999995 5665443 68999999999999 99999999999999999999999998764332
Q ss_pred cccccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc-----------
Q 048280 184 THVNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKK----------- 251 (381)
Q Consensus 184 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 251 (381)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ...........
T Consensus 163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 163 -DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred -ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCChHHhhhcCc
Confidence 11223457889999998875 468999999999999999999999986432111 11100000000
Q ss_pred CCc-------ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 252 DKS-------LEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 252 ~~~-------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
... .....+.. ..........+.+++.+||+.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 239 EKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000 00000000 00111234668899999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=264.63 Aligned_cols=234 Identities=25% Similarity=0.415 Sum_probs=179.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhC-CCCcccEEEEEeeCCeEEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQ-HRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~ 125 (381)
.++.+.+..||.|..|.||+++.. +|...|||.+.... ....++++..+.++..-+ .|+||+++|+|..+..+++.|
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 345667889999999999999876 48999999997664 344567888888877764 899999999999999999999
Q ss_pred ecccCCCHHHHH----------------HhhhhhhhHhhhhc---cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 126 EYVINESLDKVL----------------FSLIKDIQILFRKK---KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 126 E~~~~g~L~~~l----------------~~~~~~l~~lh~~~---HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
|.| ..-+++++ ..++++|.||-.+. |||+||+|||+|+.|.+||||||++-.+.+...
T Consensus 171 elM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-- 247 (391)
T KOG0983|consen 171 ELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-- 247 (391)
T ss_pred HHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc--
Confidence 987 22333332 56788888886555 999999999999999999999999987755433
Q ss_pred ccccccCccccchhHHhh---CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMH---GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
.+...|-+.|||||.+.- ..|+.++||||||++|+||+||..||..... +. +.......++ .|.+.
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t-dF----e~ltkvln~e------PP~L~ 316 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT-DF----EVLTKVLNEE------PPLLP 316 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc-cH----HHHHHHHhcC------CCCCC
Confidence 334568899999998864 3688999999999999999999999865321 11 1111122211 13332
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 264 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
... .+...+.+++..||.+|+.+||...++++.
T Consensus 317 ~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 317 GHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 221 156678899999999999999999999764
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=275.86 Aligned_cols=242 Identities=24% Similarity=0.375 Sum_probs=181.1
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc-ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN-QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
+|++.+.||.|++|.||+|+.. ++..||||++..... .....+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5889999999999999999976 588999999876532 23466788999999999999999999999999999999999
Q ss_pred cCCCHHHH------------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 129 INESLDKV------------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 129 ~~g~L~~~------------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
.+ +|.++ +.|++.++.|+|..+ ||||||+||++++++.+||+|||++........ ...
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~ 158 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFS 158 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-ccc
Confidence 75 66543 368899999999998 999999999999999999999999976533221 112
Q ss_pred ccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcC--------CcccccC
Q 048280 189 RVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKD--------KSLEIVD 259 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~ 259 (381)
...++..|++||++.+. .++.++|||||||++|+|++|+.||......+ ............ .......
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED---QLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 34568899999988664 57899999999999999999999986443221 111111110000 0000000
Q ss_pred CCCC-------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 260 PSLA-------ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 260 ~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.... ..........+.+++.+||+.||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 0011123456789999999999999999999974
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=274.88 Aligned_cols=241 Identities=15% Similarity=0.179 Sum_probs=169.1
Q ss_pred hhcCCCCCCcccccCCeeEEEEEECC----CcEEEEEEecCCCcccH-----------HHHHHHHHHHHHhCCCCcccEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLDD----GREIAVKKLSHSSNQGK-----------KEFENEAKLLARVQHRNVVNLL 112 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpnIv~~~ 112 (381)
..++|.+.+.||+|+||.||+|...+ +..+|+|+......... .....+...+..+.|+||++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34689999999999999999998654 34566665432221110 0112233445556899999999
Q ss_pred EEEeeCC----eEEEEEecccCCCH---------------HHHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEe
Q 048280 113 GYCAHGA----EKLLIYEYVINESL---------------DKVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIA 171 (381)
Q Consensus 113 ~~~~~~~----~~~lv~E~~~~g~L---------------~~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~ 171 (381)
+++.... ..++++|++.. ++ ..++.|++.++.|+|+.+ ||||||+|||++.++.+||+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEE
Confidence 9765543 34778887632 33 235588999999999998 99999999999999999999
Q ss_pred eeccceecCCCCc------ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHH
Q 048280 172 DFGMARLFPEDQT------HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWA 245 (381)
Q Consensus 172 DFG~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~ 245 (381)
|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~~~~~~ 246 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--NLIHAA 246 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--HHHHHh
Confidence 9999987643221 11123469999999999999999999999999999999999999996442211 111111
Q ss_pred H-HHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 246 Y-KLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 246 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
. ........ +... .......+.+++..||+.+|++||++.+|++.|
T Consensus 247 ~~~~~~~~~~-----~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 247 KCDFIKRLHE-----GKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHHHhhh-----hhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1 11111000 0000 011235688899999999999999999999876
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=276.99 Aligned_cols=229 Identities=23% Similarity=0.359 Sum_probs=182.0
Q ss_pred CCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCCC
Q 048280 54 PSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINES 132 (381)
Q Consensus 54 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~ 132 (381)
....||+|+||.||++... ++..||||++..........+.+|+.+++.++|+||+++++++..++..++||||+++++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 3468999999999999875 689999999865555556678999999999999999999999999999999999999999
Q ss_pred HHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccCccc
Q 048280 133 LDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGY 196 (381)
Q Consensus 133 L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y 196 (381)
|.+++ .|++.+++|+|+.+ |+||||+||+++.++.++|+|||++........ ......|+..|
T Consensus 104 L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y 182 (292)
T cd06657 104 LTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGTPYW 182 (292)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccccCccc
Confidence 97654 68999999999998 999999999999999999999999876543221 12235688999
Q ss_pred cchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHH
Q 048280 197 MAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQ 276 (381)
Q Consensus 197 ~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 276 (381)
+|||.+.+..++.++|||||||++|+|++|..||....... .... ..... .+.+. ........+.+
T Consensus 183 ~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~~~~----~~~~~-----~~~~~--~~~~~~~~l~~ 248 (292)
T cd06657 183 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKM----IRDNL-----PPKLK--NLHKVSPSLKG 248 (292)
T ss_pred cCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----HHhhC-----CcccC--CcccCCHHHHH
Confidence 99999988889999999999999999999999985432211 1111 11100 01100 01112345778
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 048280 277 IGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 277 li~~cl~~dP~~RPs~~eil~ 297 (381)
++.+||+.||.+||++.+++.
T Consensus 249 li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 249 FLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHhCCcccCcCHHHHhc
Confidence 999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=279.33 Aligned_cols=247 Identities=25% Similarity=0.347 Sum_probs=181.5
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC----
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA---- 119 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---- 119 (381)
...++|++.+.||+|+||.||+|..+ +++.||+|++.... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34678999999999999999999876 58899999986542 223356788999999999999999999987654
Q ss_pred ------eEEEEEecccCCCHHH----------------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeecc
Q 048280 120 ------EKLLIYEYVINESLDK----------------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGM 175 (381)
Q Consensus 120 ------~~~lv~E~~~~g~L~~----------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~ 175 (381)
..++|+||+.+ +|.. ++.|++.+|+|||..+ |+||||+||++++++.+||+|||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence 78999999976 4432 3478999999999999 999999999999999999999999
Q ss_pred ceecCCCCcccccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCc
Q 048280 176 ARLFPEDQTHVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKS 254 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (381)
+..+............++..|+|||.+.+. .++.++|||||||++|+|++|+.||....... ..............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~ 239 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA---QLELISRLCGSPCP 239 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCh
Confidence 987644332222223467889999988654 57899999999999999999999886432211 11111111111000
Q ss_pred ---ccc--------cCCCC-----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 255 ---LEI--------VDPSL-----AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 255 ---~~~--------~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
... .++.. ........+..+.+++.+||+.||.+||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 00000 00001123466889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=274.94 Aligned_cols=225 Identities=25% Similarity=0.342 Sum_probs=174.9
Q ss_pred ccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCCCH
Q 048280 58 LGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESL 133 (381)
Q Consensus 58 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L 133 (381)
||+|+||.||++... +++.||+|.+.... ......+.+|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999865 58999999986432 22345667899999999999999999999999999999999999999
Q ss_pred HHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccCc
Q 048280 134 DKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN 194 (381)
Q Consensus 134 ~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~ 194 (381)
.+++ .|++.++.|+|..+ |+||+|+||++++++.+||+|||++....... ......++.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~ 158 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTP 158 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccccCCC
Confidence 7654 57899999999999 99999999999999999999999988654321 122345788
Q ss_pred cccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHH
Q 048280 195 GYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMC 274 (381)
Q Consensus 195 ~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 274 (381)
.|+|||.+.+..++.++|||||||++|+|++|+.||............ . . .... .. ..........+
T Consensus 159 ~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~---~-~~~~--~~----~~~~~~~~~~~ 225 (277)
T cd05577 159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL---K---R-RTLE--MA----VEYPDKFSPEA 225 (277)
T ss_pred CcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH---H---h-cccc--cc----ccCCccCCHHH
Confidence 999999998888999999999999999999999998643321111000 0 0 0000 00 01111234567
Q ss_pred HHHHHHcccCCCCCCC-----CHHHHHH
Q 048280 275 IQIGLLCTQGDPQLRP-----TMRRVVV 297 (381)
Q Consensus 275 ~~li~~cl~~dP~~RP-----s~~eil~ 297 (381)
.+++.+||+.||.+|| ++.+++.
T Consensus 226 ~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 226 KDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHccCChhHccCCCcccHHHHHh
Confidence 8999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=293.29 Aligned_cols=237 Identities=26% Similarity=0.381 Sum_probs=178.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeC------CeE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHG------AEK 121 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~~ 121 (381)
..|...+.||+|+||.||+|+++ +|+.||||.+... ....++...+|+++|++++|+|||+++++-++. ...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 34667889999999999999955 6999999999764 334567889999999999999999999886543 356
Q ss_pred EEEEecccCCCHHHHH------------------HhhhhhhhHhhhhc--cCCccccceEeC----CCCCcEEeeeccce
Q 048280 122 LLIYEYVINESLDKVL------------------FSLIKDIQILFRKK--KTDIKASNILLD----DKWIPKIADFGMAR 177 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l------------------~~~~~~l~~lh~~~--HrDlkp~NIll~----~~~~~kL~DFG~~~ 177 (381)
.+|||||.+|+|.++| .++..|+.|||.++ ||||||.||++. ..-..||+|||.|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 8999999999998766 57889999999988 999999999993 23368999999999
Q ss_pred ecCCCCcccccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcc-
Q 048280 178 LFPEDQTHVNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSL- 255 (381)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 255 (381)
.+.+.. ....++||..|++||++.. +.|+..+|.|||||++|+++||..||.............| .........
T Consensus 173 el~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~--~~~tkkp~~v 248 (732)
T KOG4250|consen 173 ELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMW--HIITKKPSGV 248 (732)
T ss_pred cCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhh--hhhccCCCce
Confidence 886554 4556889999999999984 8899999999999999999999999954332211111112 111111110
Q ss_pred -cccCCC----------C--CCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 048280 256 -EIVDPS----------L--AASDSGDQIAMCIQIGLLCTQGDPQLRP 290 (381)
Q Consensus 256 -~~~~~~----------~--~~~~~~~~~~~l~~li~~cl~~dP~~RP 290 (381)
....+. + ...........+-..+..+|..+|++|-
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 001111 1 1112334455666777788888999998
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=277.16 Aligned_cols=242 Identities=23% Similarity=0.327 Sum_probs=179.1
Q ss_pred CCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 52 FHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 52 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
|++.+.||.|++|.||+|... +|..||+|++.... ......+.+|+.++++++||||+++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 678899999999999999865 69999999986543 223356889999999999999999999999999999999999
Q ss_pred cCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 129 INESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 129 ~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
. ++|.+++ .|++.+|.|||..+ |+||+|+||+++.++.+||+|||++......... ...
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~ 158 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-YTH 158 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-cCc
Confidence 4 5776544 67899999999998 9999999999999999999999999765332211 122
Q ss_pred cccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcC--------Cccc----
Q 048280 190 VAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKD--------KSLE---- 256 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~---- 256 (381)
..++..|+|||++.+. .++.++|||||||++|+|++|+.||......+. +........... ....
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 3468899999987664 578999999999999999999999864322111 111000000000 0000
Q ss_pred c--cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 257 I--VDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 257 ~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
. ................+.+++.+||+.||.+|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 0000000111223356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=279.97 Aligned_cols=248 Identities=24% Similarity=0.323 Sum_probs=177.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC------
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA------ 119 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------ 119 (381)
.++|++.+.||+|+||.||+|... +++.||||.+.... ......+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457999999999999999999875 58999999986442 222345678999999999999999999987654
Q ss_pred --eEEEEEecccCCCHHH----------------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceec
Q 048280 120 --EKLLIYEYVINESLDK----------------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLF 179 (381)
Q Consensus 120 --~~~lv~E~~~~g~L~~----------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~ 179 (381)
..++||||+. ++|.+ ++.|++.++.|||..+ |+||||+||+++.++.+||+|||++..+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 4599999995 45543 3478999999999999 9999999999999999999999999866
Q ss_pred CCCCcc---cccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCC--
Q 048280 180 PEDQTH---VNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDK-- 253 (381)
Q Consensus 180 ~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 253 (381)
...... ......++..|+|||.+.+. .++.++|||||||++|+|++|..||...........+...........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP 249 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 432211 11234578899999988765 478899999999999999999998864432211111111100000000
Q ss_pred ---cccccCC-CCCCCC---------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 254 ---SLEIVDP-SLAASD---------SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 254 ---~~~~~~~-~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.....+. ...... .......+.+|+.+||..||.+|||++++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000000 000000 0001245678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=275.78 Aligned_cols=241 Identities=24% Similarity=0.365 Sum_probs=183.2
Q ss_pred CCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcc--cHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 52 FHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQ--GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 52 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
|++.+.||.|++|.||+|... +++.+++|.+...... ....+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 678899999999999999875 5889999998655322 3467889999999999999999999999999999999999
Q ss_pred cCCCHHHH----------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccc
Q 048280 129 INESLDKV----------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV 190 (381)
Q Consensus 129 ~~g~L~~~----------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 190 (381)
.+ +|.++ +.+++.++.+||..+ |+||||+||+++.++.+||+|||.+....... ......
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~~ 158 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHY 158 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccCc
Confidence 65 66543 368999999999999 99999999999999999999999998775443 112234
Q ss_pred ccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCC---cccc---------
Q 048280 191 AGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDK---SLEI--------- 257 (381)
Q Consensus 191 ~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--------- 257 (381)
.++..|+|||.+.+. .++.++|||||||++|+|++|+.||......+. ............ ....
T Consensus 159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSLARNYKF 235 (283)
T ss_pred cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhhhhhhhh
Confidence 578899999998877 789999999999999999999998864432211 111111000000 0000
Q ss_pred cCCCC----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 258 VDPSL----AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 258 ~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
..+.. ...........+.+++.+||+.||.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000 01112234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=266.94 Aligned_cols=234 Identities=27% Similarity=0.387 Sum_probs=188.6
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc--ccHHHHHHHHHHHHHhCCCCcccEEEEEeeC--CeEEEEE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN--QGKKEFENEAKLLARVQHRNVVNLLGYCAHG--AEKLLIY 125 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~ 125 (381)
+|.+.+.||+|++|.||+|... ++..|++|++..... ...+.+.+|+.++++++|+||+++++++... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999876 689999999865542 3457889999999999999999999999988 8999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc-cc
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH-VN 187 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~-~~ 187 (381)
||+.+++|.+++ .+++.++.+||+.+ |+||+|+||+++.++.+||+|||.+......... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 999999997654 67899999999988 9999999999999999999999999876544321 12
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
....++..|+|||.+.+..++.++||||||+++|+|++|..||.... +.......... ........
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~---------~~~~~~~~ 226 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGS---------SGEPPEIP 226 (260)
T ss_pred cCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccc---------cCCCcCCC
Confidence 23568889999999988889999999999999999999999986443 11111111111 00111122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
......+.+++.+||..||.+||++.+++..
T Consensus 227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 2235678899999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=269.09 Aligned_cols=225 Identities=21% Similarity=0.323 Sum_probs=179.5
Q ss_pred ccccCCeeEEEEEEC-CCcEEEEEEecCCCc---ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCCCH
Q 048280 58 LGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESL 133 (381)
Q Consensus 58 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L 133 (381)
||.|+||.||+++.. +++.||+|++..... ...+.+.+|+++++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999876 489999999865422 2346789999999999999999999999999999999999999999
Q ss_pred HHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccCccc
Q 048280 134 DKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGY 196 (381)
Q Consensus 134 ~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y 196 (381)
.+++ .|++.+|.++|..+ |+||||+||+++.++.+||+|||++....... ......++..|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~ 158 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTPEY 158 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCcCc
Confidence 8665 57899999999988 99999999999999999999999998764432 12234678899
Q ss_pred cchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHH
Q 048280 197 MAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQ 276 (381)
Q Consensus 197 ~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 276 (381)
++||.+.+..++.++|||||||++|+|++|..||..... +.............. ...+......+.+
T Consensus 159 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~ 225 (262)
T cd05572 159 VAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE----DPMEIYNDILKGNGK---------LEFPNYIDKAAKD 225 (262)
T ss_pred cChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC----CHHHHHHHHhccCCC---------CCCCcccCHHHHH
Confidence 999999888899999999999999999999999864432 111111111110000 0111112456889
Q ss_pred HHHHcccCCCCCCCC-----HHHHHH
Q 048280 277 IGLLCTQGDPQLRPT-----MRRVVV 297 (381)
Q Consensus 277 li~~cl~~dP~~RPs-----~~eil~ 297 (381)
++.+||..||++||+ +.|+++
T Consensus 226 ~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 226 LIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHccCChhhCcCCcccCHHHHhc
Confidence 999999999999999 788765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=275.80 Aligned_cols=235 Identities=26% Similarity=0.361 Sum_probs=182.0
Q ss_pred CCCCCCcccccCCeeEEEEEE----CCCcEEEEEEecCCC----cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKL----DDGREIAVKKLSHSS----NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEK 121 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 121 (381)
+|++.+.||+|+||.||+++. .+|..||+|++.... ....+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 488899999999999999985 368899999986532 12346678899999999 599999999999999999
Q ss_pred EEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 122 LLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
++||||+++++|.+++ .|++.+|.++|..+ ||||||+|||++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 9999999999998765 48999999999998 999999999999999999999999987644332
Q ss_pred ccccccccCccccchhHHhhC--CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 185 HVNTRVAGTNGYMAPEYVMHG--HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
.......|+..|+|||.+.+. .++.++|||||||++|+|++|..||...... .............. +..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~-------~~~ 231 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSE-------PPY 231 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccC-------CCC
Confidence 222345688999999998753 4678999999999999999999998532211 11111111111111 111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRP-----TMRRVVVM 298 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 298 (381)
.......+.+++.+||+.||.+|| ++.+++..
T Consensus 232 ----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 232 ----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 112335678899999999999997 67777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=274.55 Aligned_cols=240 Identities=24% Similarity=0.319 Sum_probs=177.1
Q ss_pred CCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhC-CCCcccEEEEEeeC--CeEEEEEe
Q 048280 52 FHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQ-HRNVVNLLGYCAHG--AEKLLIYE 126 (381)
Q Consensus 52 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~--~~~~lv~E 126 (381)
|++.+.||+|+||.||+|... +++.||+|++.... ........+|+.++.++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 678899999999999999865 58899999986542 222234457999999985 99999999999987 88999999
Q ss_pred cccCCCHHHH----------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 127 YVINESLDKV----------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 127 ~~~~g~L~~~----------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
|+.+ +|.+. +.|++.+|.+||..+ ||||||+||+++. +.+||+|||++..+..... ..
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~--~~ 156 (282)
T cd07831 81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP--YT 156 (282)
T ss_pred cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC--cC
Confidence 9964 55433 378999999999999 9999999999999 9999999999987643322 12
Q ss_pred ccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh-----------hcCCccc
Q 048280 189 RVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLY-----------KKDKSLE 256 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~ 256 (381)
...++..|+|||++.. ..++.++|||||||++|||++|..||......+ ......... .......
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhccccccc
Confidence 3457889999998754 457899999999999999999999986533221 111111111 0000001
Q ss_pred ccCCCCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 257 IVDPSLAA----SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 257 ~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
...+.... ......+..+.+|+.+||+.||++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00111000 0112345778999999999999999999999753
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=276.99 Aligned_cols=242 Identities=24% Similarity=0.342 Sum_probs=177.6
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc--ccHHHHHHHHHHHHHhC-CCCcccEEEEEeeCCe-----
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN--QGKKEFENEAKLLARVQ-HRNVVNLLGYCAHGAE----- 120 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~----- 120 (381)
++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+.+++.+. |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47899999999999999999875 589999998865422 23357888999999995 6999999999887665
Q ss_pred EEEEEecccCCCHHHH--------------------HHhhhhhhhHhhhhc--cCCccccceEeCC-CCCcEEeeeccce
Q 048280 121 KLLIYEYVINESLDKV--------------------LFSLIKDIQILFRKK--KTDIKASNILLDD-KWIPKIADFGMAR 177 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~--------------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~-~~~~kL~DFG~~~ 177 (381)
.|+||||+.+ +|.++ +.|++.+|.|||..+ ||||||+||+++. ++.+||+|||++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999975 66443 367899999999999 9999999999998 8899999999998
Q ss_pred ecCCCCcccccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCccc
Q 048280 178 LFPEDQTHVNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLE 256 (381)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (381)
.+...... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||........ ... ......... ..
T Consensus 160 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~-~~~~~~~~~-~~ 234 (295)
T cd07837 160 AFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLH-IFKLLGTPT-EQ 234 (295)
T ss_pred ecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHH-HHHHhCCCC-hh
Confidence 65332111 122346788999998865 4579999999999999999999999864322111 111 001000000 00
Q ss_pred cc-----------CCCCC----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 257 IV-----------DPSLA----ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 257 ~~-----------~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.. .+... ..........+.++|.+||..||.+||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 00000 0011124466889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=280.70 Aligned_cols=230 Identities=27% Similarity=0.396 Sum_probs=179.4
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc---ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
.|...+.||+|+||.||+++.. ++..||+|++..... .....+.+|++++++++|+|++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3777899999999999999865 588999999864422 223568889999999999999999999999999999999
Q ss_pred cccCCCHHHH----------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 127 YVINESLDKV----------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 127 ~~~~g~L~~~----------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
|+.+ +|.++ +.+++.++.|+|..+ ||||+|+||+++.++.+||+|||++...... .
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-----~ 179 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-----N 179 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc-----c
Confidence 9964 55443 367899999999998 9999999999999999999999998754322 2
Q ss_pred ccccCccccchhHHh---hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCC
Q 048280 189 RVAGTNGYMAPEYVM---HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
...++..|+|||++. .+.++.++|||||||++|+|++|+.||..... ............ + ..
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~~------~---~~ 244 (317)
T cd06635 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNES------P---TL 244 (317)
T ss_pred cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHhccC------C---CC
Confidence 345788999999974 45688999999999999999999999753211 111111111111 0 01
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 266 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
........+.+++.+||+.+|.+||++.+|++.+..
T Consensus 245 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 245 QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 111234567889999999999999999999986544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=277.69 Aligned_cols=242 Identities=25% Similarity=0.345 Sum_probs=179.4
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc--ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN--QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
++|++.+.||+|++|.||+|... +++.||+|++..... .....+.+|++++++++|+||+++++++.++...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999876 688999999865422 234578899999999999999999999999999999999
Q ss_pred cccCCCHHH-----------------HHHhhhhhhhHhhhhc--cCCccccceEeCC-CCCcEEeeeccceecCCCCccc
Q 048280 127 YVINESLDK-----------------VLFSLIKDIQILFRKK--KTDIKASNILLDD-KWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 127 ~~~~g~L~~-----------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~-~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
|+. ++|.+ ++.|++.+|.|||..+ |+||||+||+++. ++.+||+|||++........ .
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~-~ 159 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR-T 159 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-c
Confidence 995 45533 3368999999999999 9999999999985 56799999999986533211 1
Q ss_pred ccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccc--------
Q 048280 187 NTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEI-------- 257 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 257 (381)
.....++..|+|||++.+. .++.++|||||||++|+|++|..||......+ ............ ....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~---~~~~~~~~~~~~-~~~~~~~~~~~~ 235 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID---ELFKIFRILGTP-NEETWPGVTSLP 235 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCC-Chhhccccccch
Confidence 1234568899999998764 57899999999999999999999986432211 111111111000 0000
Q ss_pred ----cCCCCCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 258 ----VDPSLAAS----DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 258 ----~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
..+..... ........+.+++.+||+.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000 01123355788999999999999999999986
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=272.07 Aligned_cols=226 Identities=23% Similarity=0.287 Sum_probs=171.1
Q ss_pred cccccCCeeEEEEEEC-CCcEEEEEEecCCCc---ccHHHHHHHHHHHHH---hCCCCcccEEEEEeeCCeEEEEEeccc
Q 048280 57 KLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---QGKKEFENEAKLLAR---VQHRNVVNLLGYCAHGAEKLLIYEYVI 129 (381)
Q Consensus 57 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~hpnIv~~~~~~~~~~~~~lv~E~~~ 129 (381)
.||+|+||.||++... +++.||+|.+..... .....+.+|..++.. .+||||+.+++++...+..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 588999998865421 112334455544444 369999999999999999999999999
Q ss_pred CCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccccc
Q 048280 130 NESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAG 192 (381)
Q Consensus 130 ~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~g 192 (381)
+++|.+++ .|++.++.|+|..+ ||||||+|||++.++.+||+|||++....... .....|
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~ 157 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVG 157 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccCcCC
Confidence 99997654 67899999999998 99999999999999999999999987553322 123468
Q ss_pred CccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHH
Q 048280 193 TNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271 (381)
Q Consensus 193 t~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (381)
+..|+|||.+.+ ..++.++|||||||++|+|++|..||..........+ ..... ..... .+....
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~------~~~~~----~~~~~~ 223 (279)
T cd05633 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTL------TVNVE----LPDSFS 223 (279)
T ss_pred CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH----HHHhh------cCCcC----CccccC
Confidence 999999999864 5689999999999999999999999864332211111 11000 00111 122234
Q ss_pred HHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 048280 272 AMCIQIGLLCTQGDPQLRP-----TMRRVVVML 299 (381)
Q Consensus 272 ~~l~~li~~cl~~dP~~RP-----s~~eil~~L 299 (381)
..+.+++.+||+.||.+|| +++++++..
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 224 PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 5688899999999999999 599988753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=275.51 Aligned_cols=238 Identities=24% Similarity=0.318 Sum_probs=184.3
Q ss_pred CCCCCCcccccCCeeEEEEEEC----CCcEEEEEEecCCC----cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD----DGREIAVKKLSHSS----NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEK 121 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 121 (381)
+|++.+.||+|+||.||+++.. ++..||||.+.... ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788999999999999999742 47889999986432 22335678999999999 599999999999999999
Q ss_pred EEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 122 LLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
++||||+.+++|.+++ .|++.+|.+||..+ |+||||+||+++.++.++|+|||++..+.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 9999999999997654 58999999999988 999999999999999999999999886544332
Q ss_pred ccccccccCccccchhHHhhCC--CCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 185 HVNTRVAGTNGYMAPEYVMHGH--LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
.......|+..|+|||.+.+.. .+.++||||||+++|+|++|..||........ ........... .+..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~-------~~~~ 231 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKS-------KPPF 231 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHcc-------CCCC
Confidence 2223356889999999987665 78899999999999999999999853321111 11111111111 0111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
.......+.+++.+||+.||++|||+.++.+.|+.
T Consensus 232 ----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 232 ----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 11123457889999999999999999888887765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=306.93 Aligned_cols=236 Identities=27% Similarity=0.391 Sum_probs=173.6
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEee-------
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAH------- 117 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------- 117 (381)
....+|+.++.||+||||.||+++.+ +|+.||||+|.... ......+.+|++.|++|+|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34568999999999999999999987 89999999997553 2334568899999999999999996542100
Q ss_pred --------------------------------------------------------------------------------
Q 048280 118 -------------------------------------------------------------------------------- 117 (381)
Q Consensus 118 -------------------------------------------------------------------------------- 117 (381)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CeEEEEEecccCCCHHHHH----------------HhhhhhhhHhhh
Q 048280 118 ------------------------G--------AEKLLIYEYVINESLDKVL----------------FSLIKDIQILFR 149 (381)
Q Consensus 118 ------------------------~--------~~~~lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~ 149 (381)
. ..+||-||||+..+|.+++ ++|+.|+.|+|.
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 1247788999777765544 789999999999
Q ss_pred hc--cCCccccceEeCCCCCcEEeeeccceecC------C-----------CCcccccccccCccccchhHHhhCC---C
Q 048280 150 KK--KTDIKASNILLDDKWIPKIADFGMARLFP------E-----------DQTHVNTRVAGTNGYMAPEYVMHGH---L 207 (381)
Q Consensus 150 ~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~------~-----------~~~~~~~~~~gt~~y~aPE~~~~~~---~ 207 (381)
++ ||||||.||||+.++.|||+|||+++... . ......+..+||..|+|||++.+.. |
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 99 99999999999999999999999998621 0 0111334678999999999997654 9
Q ss_pred CchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048280 208 SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQ 287 (381)
Q Consensus 208 ~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 287 (381)
+.|+|+|||||||+||+. ||.... +.... ....+...... + ..........=..+|.++++.||.
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~TsM--ERa~i----L~~LR~g~iP~---~---~~f~~~~~~~e~slI~~Ll~hdP~ 860 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGTSM--ERASI----LTNLRKGSIPE---P---ADFFDPEHPEEASLIRWLLSHDPS 860 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCchH--HHHHH----HHhcccCCCCC---C---cccccccchHHHHHHHHHhcCCCc
Confidence 999999999999999986 343211 11111 11111111111 1 111222223344689999999999
Q ss_pred CCCCHHHHHH
Q 048280 288 LRPTMRRVVV 297 (381)
Q Consensus 288 ~RPs~~eil~ 297 (381)
+|||+.|+|.
T Consensus 861 kRPtA~eLL~ 870 (1351)
T KOG1035|consen 861 KRPTATELLN 870 (1351)
T ss_pred cCCCHHHHhh
Confidence 9999999974
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=282.93 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=182.1
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeC--CeE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHG--AEK 121 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--~~~ 121 (381)
..++|++.+.||+|+||.||+|... ++..+|||++... .......+.+|+.+++++ +|+||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4568999999999999999999876 5889999988543 223345677899999999 999999999998643 468
Q ss_pred EEEEecccCCCHHHH--------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 122 LLIYEYVINESLDKV--------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~--------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
++||||+. ++|..+ +.|++.+|.|||..+ |+||||+|||++.++.+||+|||++..+......
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 85 YLVFEYME-TDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred EEEecccc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 99999996 477553 478899999999998 9999999999999999999999999866433221
Q ss_pred ----cccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHH--------HHhhcC
Q 048280 186 ----VNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAY--------KLYKKD 252 (381)
Q Consensus 186 ----~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~ 252 (381)
......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||......+......... ......
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP 243 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence 2224568899999998765 457899999999999999999999986433221100000000 000000
Q ss_pred CcccccC----CC--CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 253 KSLEIVD----PS--LAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 253 ~~~~~~~----~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.....++ .. ............+.+++.+||+.||.+|||+.++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000 00 0001111134668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=271.92 Aligned_cols=232 Identities=23% Similarity=0.320 Sum_probs=180.3
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC-----CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeC--CeE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS-----SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHG--AEK 121 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~ 121 (381)
.+|++.+.||+|+||.||+|... ++..||+|.+... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999865 5899999987432 122345788999999999999999999998764 568
Q ss_pred EEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 122 LLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
++|+||+++++|.+++ .+++.++.++|+.+ |+||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 8999999999997654 58999999999998 999999999999999999999999986532111
Q ss_pred --ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 185 --HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 185 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
.......++..|+|||++.+..++.++|||||||++|+|++|+.||..... ........... ..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~-----~~--- 227 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA------MAAIFKIATQP-----TK--- 227 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH------HHHHHHHHcCC-----CC---
Confidence 111234688999999999988899999999999999999999999853211 11111111110 01
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
...+......+.+++.+||+ +|..||++.+++.
T Consensus 228 -~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 228 -PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11222344668889999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=277.10 Aligned_cols=237 Identities=19% Similarity=0.305 Sum_probs=175.2
Q ss_pred Cccccc--CCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccC
Q 048280 56 NKLGEG--GFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 56 ~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
..||.| +||+||++++. +++.||+|++.... ....+.+.+|+.+++.++||||++++++|..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999875 69999999986542 22346788999999999999999999999999999999999999
Q ss_pred CCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc-----
Q 048280 131 ESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV----- 186 (381)
Q Consensus 131 g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~----- 186 (381)
++|.+++ .|++.+|.|+|+.+ ||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 9987654 67899999999988 99999999999999999999998654332111100
Q ss_pred -ccccccCccccchhHHhhC--CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCC----------
Q 048280 187 -NTRVAGTNGYMAPEYVMHG--HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDK---------- 253 (381)
Q Consensus 187 -~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------- 253 (381)
.....++..|+|||++.+. .++.++|||||||++|+|++|+.||........ .. .......
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~----~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LL----QKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HH----HHhcCCCCCCccccccc
Confidence 0112345679999999764 478999999999999999999999864321110 00 0000000
Q ss_pred --------------------------cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 254 --------------------------SLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 254 --------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
........+.......+...+.+|+.+||+.||++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000011111122233456778999999999999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=268.79 Aligned_cols=229 Identities=27% Similarity=0.392 Sum_probs=185.4
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
+|++.+.||.|+||.||++... +++.+++|.+.... ......+.+|++++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5888999999999999999765 58899999986542 23345778899999999999999999999999999999999
Q ss_pred ccCCCHHHHH-------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 128 VINESLDKVL-------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 128 ~~~g~L~~~l-------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
+++++|.+++ .+++.++.++|+.+ |+||+|+||+++.++.+||+|||++...... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---M 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---C
Confidence 9999997654 47899999999998 9999999999999999999999999876543 1
Q ss_pred ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... .+. .. ..... ....
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~---~~-~~~~~---------~~~~ 221 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLR---YK-VQRGK---------YPPI 221 (256)
T ss_pred cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HH-HhcCC---------CCCC
Confidence 22345788999999999888999999999999999999999998543221 111 11 11111 1111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.......+.+++.+||+.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 22445668999999999999999999999753
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=268.69 Aligned_cols=233 Identities=20% Similarity=0.242 Sum_probs=177.6
Q ss_pred hHHHHHhhcCCCCCCcc--cccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHh-CCCCcccEEEEEee
Q 048280 42 FEALVSATKNFHPSNKL--GEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLGYCAH 117 (381)
Q Consensus 42 ~~~~~~~~~~y~~~~~l--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 117 (381)
..+.....++|++.+.+ |+|+||.||+++.+ ++..+|+|.+....... .|+.....+ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence 34445556788888877 99999999999865 58889999986432211 133333323 79999999999999
Q ss_pred CCeEEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCC-CcEEeeeccceec
Q 048280 118 GAEKLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKW-IPKIADFGMARLF 179 (381)
Q Consensus 118 ~~~~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~-~~kL~DFG~~~~~ 179 (381)
.+..++||||+++++|.+++ .|++.++.++|+.+ ||||||+||+++.++ .++|+|||++...
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 99999999999999997665 68999999999999 999999999999988 9999999999865
Q ss_pred CCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccC
Q 048280 180 PEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVD 259 (381)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
.... ...++..|+|||++.+..++.++|||||||++|+|++|+.||....... .....+.... .. .
T Consensus 161 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~---~~--~--- 226 (267)
T PHA03390 161 GTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ---QK--K--- 226 (267)
T ss_pred CCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh---cc--c---
Confidence 4322 2357899999999999899999999999999999999999986332211 1111111111 00 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 048280 260 PSLAASDSGDQIAMCIQIGLLCTQGDPQLRPT-MRRVVV 297 (381)
Q Consensus 260 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~ 297 (381)
..........+.+++.+||+.||.+||+ ++++++
T Consensus 227 ----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 ----LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0111134456889999999999999996 698874
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=282.37 Aligned_cols=247 Identities=20% Similarity=0.336 Sum_probs=182.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEee----CCeE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAH----GAEK 121 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~ 121 (381)
.++|++.+.||.|+||.||+|... ++..||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 468999999999999999999865 58999999987542 2334677889999999999999999998753 3568
Q ss_pred EEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 122 LLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
++||||+. ++|.+++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||++........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999994 5776544 68999999999998 999999999999999999999999986543322
Q ss_pred c---cccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc---------
Q 048280 185 H---VNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKK--------- 251 (381)
Q Consensus 185 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 251 (381)
. ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ..........
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~---~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ---LKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH---HHHHHHHhCCChhHhhhhh
Confidence 1 1123468899999999866 4588999999999999999999999864322111 0000000000
Q ss_pred --CCcccccC--CCCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 252 --DKSLEIVD--PSLAA----SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 252 --~~~~~~~~--~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
........ +.... .........+.+++.+||+.+|.+||++.+++...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 00000000 00000 01122356789999999999999999999998743
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=280.94 Aligned_cols=250 Identities=22% Similarity=0.331 Sum_probs=183.6
Q ss_pred HHHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEee-CC
Q 048280 44 ALVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAH-GA 119 (381)
Q Consensus 44 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~ 119 (381)
++..++++|++.+.||.|+||.||+|... +++.||||++... .......+.+|+.++++++||||++++++|.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34556889999999999999999999865 6899999988643 22334678899999999999999999999865 56
Q ss_pred eEEEEEecccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 120 EKLLIYEYVINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
..++|+||+ +++|.+++ .|++.+|.+||..+ ||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~ 162 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM 162 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCCc
Confidence 789999998 56775543 68899999999999 99999999999999999999999998543221
Q ss_pred cccccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHH--------HHHhhcCCc
Q 048280 184 THVNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWA--------YKLYKKDKS 254 (381)
Q Consensus 184 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~ 254 (381)
....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||............... .........
T Consensus 163 ----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 163 ----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred ----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 23457889999998766 56899999999999999999999998654321111000000 000000000
Q ss_pred ccccCC-CCCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 255 LEIVDP-SLAA-----SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 255 ~~~~~~-~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
...... .... .........+.+++.+||+.+|++||++.+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0000 0011234668899999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=262.27 Aligned_cols=249 Identities=21% Similarity=0.293 Sum_probs=192.1
Q ss_pred ChHHHHHhhcCCCCCCcccccCCeeEEEEE-ECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhC-CCCcccEEEEEeeC
Q 048280 41 PFEALVSATKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQ-HRNVVNLLGYCAHG 118 (381)
Q Consensus 41 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 118 (381)
.++++.+.+ .+.||+|+|+.|-.+. +.+|..||||++.+.....+.++.+|++++.+.+ |+||+.++++|+++
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 366666666 4789999999999986 5679999999999888888899999999999994 99999999999999
Q ss_pred CeEEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCC---CcEEeeecccee
Q 048280 119 AEKLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKW---IPKIADFGMARL 178 (381)
Q Consensus 119 ~~~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~---~~kL~DFG~~~~ 178 (381)
...|||||-|.||.|...| .+++.+|.+||.++ ||||||+|||..... -||||||.+..-
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG 228 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccc
Confidence 9999999999999996554 67899999999999 999999999996554 489999988764
Q ss_pred cCCCC------cccccccccCccccchhHHh-----hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccc----cHHH
Q 048280 179 FPEDQ------THVNTRVAGTNGYMAPEYVM-----HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQ----NLLD 243 (381)
Q Consensus 179 ~~~~~------~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~----~~~~ 243 (381)
+.... .....+.+|+..|||||+.. ...|+.++|.||||||||-|++|.+||......+.. ....
T Consensus 229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr 308 (463)
T KOG0607|consen 229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR 308 (463)
T ss_pred cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence 32111 11123567899999999874 236899999999999999999999999765543331 1111
Q ss_pred HH-HHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 244 WA-YKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 244 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.. ..++..-.... -.+........+....+++...|..|+.+|.++.+++.
T Consensus 309 ~CQ~~LFesIQEGk---YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 309 VCQNKLFESIQEGK---YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHHHHhccC---CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11 11111110001 11223344566677888999999999999999999876
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=265.67 Aligned_cols=230 Identities=28% Similarity=0.481 Sum_probs=185.6
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc--ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN--QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
+|++.+.||+|++|.||++... +++.|++|.+..... .....+.+|++++.+++|+|++++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5888999999999999999866 588999999976543 3456789999999999999999999999999999999999
Q ss_pred ccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccc
Q 048280 128 VINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV 190 (381)
Q Consensus 128 ~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 190 (381)
+.+++|.+++ .+++.++.++|+.+ |+||||+||+++.++.+||+|||++......... ....
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~ 159 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DASV 159 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-cccc
Confidence 9999997654 68899999999999 9999999999999999999999999876543322 2234
Q ss_pred ccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHH
Q 048280 191 AGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQ 270 (381)
Q Consensus 191 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (381)
.++..|+|||.+.+..++.++||||||+++|+|++|..||..... . ........ .. .+.. ....
T Consensus 160 ~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~-~~~~~~~~-~~-----~~~~----~~~~ 223 (254)
T cd06627 160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----M-AALFRIVQ-DD-----HPPL----PEGI 223 (254)
T ss_pred ccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----H-HHHHHHhc-cC-----CCCC----CCCC
Confidence 678899999999888889999999999999999999999853221 1 11111111 10 1111 1122
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 271 IAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 271 ~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
...+.+++.+||..+|++|||+.+++.
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 224 SPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 456788999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=268.32 Aligned_cols=227 Identities=21% Similarity=0.255 Sum_probs=172.6
Q ss_pred CcccccCCeeEEEEEEC-CCcEEEEEEecCCCcc---cHHHHHHHHHHHH-HhCCCCcccEEEEEeeCCeEEEEEecccC
Q 048280 56 NKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQ---GKKEFENEAKLLA-RVQHRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
+.||.|+||.||+|... +++.||||.+...... ....+..|..++. ..+|+||+++++++..++..++|+||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999865 5889999998654321 1223445555443 44899999999999999999999999999
Q ss_pred CCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccC
Q 048280 131 ESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT 193 (381)
Q Consensus 131 g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt 193 (381)
++|.+++ .|++.+|.|+|..+ |+||+|+||+++.++.+||+|||++..... .....++
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~~~ 156 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFVGT 156 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCCCC
Confidence 9997665 68999999999998 999999999999999999999999886432 2234578
Q ss_pred ccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHH
Q 048280 194 NGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAM 273 (381)
Q Consensus 194 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (381)
..|+|||.+.+..++.++||||||+++|+|++|..||...... ... ..... ... .............
T Consensus 157 ~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~---~~~~~-~~~------~~~~~~~~~~~~~ 223 (260)
T cd05611 157 PDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---AVF---DNILS-RRI------NWPEEVKEFCSPE 223 (260)
T ss_pred cCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---HHH---HHHHh-ccc------CCCCcccccCCHH
Confidence 8999999998888999999999999999999999998543211 111 11111 100 0001111123456
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 274 CIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 274 l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
+.+++.+||+.||++||++.++.+.|.
T Consensus 224 ~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 224 AVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred HHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 889999999999999997765555553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=283.20 Aligned_cols=244 Identities=23% Similarity=0.323 Sum_probs=184.3
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC-----eEE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA-----EKL 122 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~ 122 (381)
+|++.+.||.|+||.||+|+.. ++..||||++.... ....+.+.+|+.+++.++|+||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999876 48999999987653 334467889999999999999999999988765 789
Q ss_pred EEEecccCCCHHHH---------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc-
Q 048280 123 LIYEYVINESLDKV---------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT- 184 (381)
Q Consensus 123 lv~E~~~~g~L~~~---------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~- 184 (381)
+||||+. ++|.++ +.+++.+|.+||..+ |+||||+|||++.++.++|+|||++........
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 9999996 466543 478999999999999 999999999999999999999999997654321
Q ss_pred -ccccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCC---------
Q 048280 185 -HVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDK--------- 253 (381)
Q Consensus 185 -~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 253 (381)
.......++..|+|||++.+. .++.++|||||||++|+|++|..||........ ............
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ---LNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHhcCCCChhHhhhccc
Confidence 112334578899999999887 789999999999999999999999865432211 111111000000
Q ss_pred --cccccC---CCC---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 254 --SLEIVD---PSL---AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 254 --~~~~~~---~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
....+. ... ...........+.+++.+||+.+|.+||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000 000 000011234668899999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=280.86 Aligned_cols=246 Identities=22% Similarity=0.316 Sum_probs=179.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeC------C
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHG------A 119 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~ 119 (381)
.++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+++.++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999865 68999999986532 22335688999999999999999999998654 3
Q ss_pred eEEEEEecccCCCHHH-------------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 120 EKLLIYEYVINESLDK-------------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~-------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
..++|+||+. .+|.. ++.|++.+++|+|..+ ||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-- 170 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-- 170 (342)
T ss_pred eEEEEecccc-cCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC--
Confidence 4699999985 35543 4478999999999998 9999999999999999999999998764322
Q ss_pred ccccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhh-----------cC
Q 048280 185 HVNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYK-----------KD 252 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~~ 252 (381)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .......... ..
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07879 171 --MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGPEFVQKLEDK 245 (342)
T ss_pred --CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHHHHHHhccc
Confidence 123457889999999876 468899999999999999999999986432111 1111110000 00
Q ss_pred CcccccC--CCCCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hcCC
Q 048280 253 KSLEIVD--PSLAAS----DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM--LSKK 302 (381)
Q Consensus 253 ~~~~~~~--~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~ 302 (381)
....... +..... ........+.+|+.+||+.||.+||++.+++.. ++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0000000 000000 001123457899999999999999999999853 5443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=266.43 Aligned_cols=231 Identities=23% Similarity=0.414 Sum_probs=186.7
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc--ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN--QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
+|++.+.||.|+||.||++... ++..|++|++..... .....+.+|+++++.++|+|++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5888999999999999999876 588999999875533 4456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHH-------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 128 VINESLDKVL-------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 128 ~~~g~L~~~l-------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
+++++|.+++ .+++.++.++|..+ |+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 159 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DL 159 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-ce
Confidence 9999986554 57899999999999 99999999999999999999999998765443 12
Q ss_pred ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||..... ......... ... +.+
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-~~~-----~~~---- 223 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKILK-GQY-----PPI---- 223 (258)
T ss_pred ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHHhc-CCC-----CCC----
Confidence 2335688899999999888899999999999999999999999853321 111111111 111 111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.......+.+++.+||..+|++|||+.++++.
T Consensus 224 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11234568889999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=276.33 Aligned_cols=230 Identities=27% Similarity=0.422 Sum_probs=178.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
..|...+.||+|+||.||+|+.. ++..||+|.+... .......+.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777899999999999999865 5788999998643 2223356788999999999999999999999999999999
Q ss_pred ecccCCCHHHH----------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 126 EYVINESLDKV----------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 126 E~~~~g~L~~~----------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
||+. ++|.++ +.+++.++.|+|..+ ||||||+|||++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-----
Confidence 9996 566443 367899999999988 9999999999999999999999998865432
Q ss_pred cccccCccccchhHHh---hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVM---HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
....++..|+|||.+. ...++.++|||||||++|+|++|..||...... .......... . +..
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~-~-----~~~-- 234 (308)
T cd06634 169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNE-S-----PAL-- 234 (308)
T ss_pred ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HHHHHHhhcC-C-----CCc--
Confidence 2345788999999985 346788999999999999999999997432111 1111111111 0 111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
........+.+|+.+||+.+|.+||++.+++....
T Consensus 235 -~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 235 -QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred -CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 11233456788999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=280.17 Aligned_cols=248 Identities=19% Similarity=0.291 Sum_probs=178.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeC---------
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHG--------- 118 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--------- 118 (381)
.++|.+.+.||.|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 468999999999999999999865 5899999998766655667889999999999999999999776543
Q ss_pred -----CeEEEEEecccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeC-CCCCcEEeeeccc
Q 048280 119 -----AEKLLIYEYVINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLD-DKWIPKIADFGMA 176 (381)
Q Consensus 119 -----~~~~lv~E~~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~-~~~~~kL~DFG~~ 176 (381)
...++||||+. ++|.+++ .|++.++.|||..+ ||||||+||+++ .++.+||+|||++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~ 162 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA 162 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccc
Confidence 35789999996 5775443 78999999999999 999999999997 4567899999999
Q ss_pred eecCCCCcc--cccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHH--------
Q 048280 177 RLFPEDQTH--VNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWA-------- 245 (381)
Q Consensus 177 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~-------- 245 (381)
..+...... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07854 163 RIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242 (342)
T ss_pred eecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 865332111 1122357889999998765 46889999999999999999999998643321110000000
Q ss_pred -HHH---hhcCCcccccCCCCC-CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 246 -YKL---YKKDKSLEIVDPSLA-ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 246 -~~~---~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
... ...........+... ..........+.+|+.+||+.||.+|||+.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 243 RNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 000000000000000 0001123356788999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=270.61 Aligned_cols=228 Identities=22% Similarity=0.320 Sum_probs=179.2
Q ss_pred ccccCCeeEEEEEECC-CcEEEEEEecCCCc---ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCCCH
Q 048280 58 LGEGGFGPVFKGKLDD-GREIAVKKLSHSSN---QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESL 133 (381)
Q Consensus 58 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L 133 (381)
||.|+||.||+++... ++.|++|.+..... .....+.+|++++++++|+||+++++.+..+...++||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999774 89999999865433 3456788999999999999999999999999999999999999998
Q ss_pred HHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc-------ccccc
Q 048280 134 DKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT-------HVNTR 189 (381)
Q Consensus 134 ~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~-------~~~~~ 189 (381)
.+++ .|++.+|+++|..+ |+||+|+||+++.++.+||+|||++........ .....
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 7554 78999999999999 999999999999999999999999876433211 12223
Q ss_pred cccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHH
Q 048280 190 VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGD 269 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (381)
..++..|+|||.+.+..++.++||||||+++|+|++|..||...... ........ ... . .+. ...
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~-~~~-~--~~~-----~~~ 225 (265)
T cd05579 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQNILN-GKI-E--WPE-----DVE 225 (265)
T ss_pred cccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhc-CCc-C--CCc-----ccc
Confidence 45788999999998888999999999999999999999998543211 11111111 100 0 000 001
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 270 QIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 270 ~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
....+.+++.+||+.+|.+|||+.++.+.|+
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 226 VSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 2466889999999999999999966665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=278.37 Aligned_cols=248 Identities=22% Similarity=0.308 Sum_probs=181.5
Q ss_pred hhcCCCC-CCcccccCCeeEEEEEEC-CCcEEEEEEecCCCccc--------------HHHHHHHHHHHHHhCCCCcccE
Q 048280 48 ATKNFHP-SNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQG--------------KKEFENEAKLLARVQHRNVVNL 111 (381)
Q Consensus 48 ~~~~y~~-~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~hpnIv~~ 111 (381)
..++|.. .+.||.|+||.||+|... +++.||||++....... ...+.+|++++++++|+||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 3567765 577999999999999865 58999999986542221 1257789999999999999999
Q ss_pred EEEEeeCCeEEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeec
Q 048280 112 LGYCAHGAEKLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFG 174 (381)
Q Consensus 112 ~~~~~~~~~~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG 174 (381)
++++...+..++||||+. ++|.+++ .|++.++.+||..+ |+||||+||+++.++.+||+|||
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 999999999999999996 5776544 68999999999999 99999999999999999999999
Q ss_pred cceecCCCC-------------cccccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccccc
Q 048280 175 MARLFPEDQ-------------THVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQN 240 (381)
Q Consensus 175 ~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 240 (381)
++....... ........++..|+|||.+.+. .++.++|||||||++|+|++|..||......+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~--- 241 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID--- 241 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---
Confidence 998664111 0111123467889999998764 46899999999999999999999986443221
Q ss_pred HHHHHHHHhhcCCcc---c--------ccC---CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 241 LLDWAYKLYKKDKSL---E--------IVD---PSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 241 ~~~~~~~~~~~~~~~---~--------~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
............... . ... +.............+.+++.+||+.+|++|||+++++...
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 111111111100000 0 000 0000001112245688999999999999999999998643
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=268.47 Aligned_cols=258 Identities=23% Similarity=0.372 Sum_probs=197.7
Q ss_pred hCCCCChHHHHHhhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHh--CCCCcccEEE
Q 048280 36 EQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARV--QHRNVVNLLG 113 (381)
Q Consensus 36 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~~~~ 113 (381)
.....++--.+...++..+.+.||+|.||.||+|++. |..||||++...+ ...+.+|.+|.+.+ +|+||+.+++
T Consensus 197 SGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIa 272 (513)
T KOG2052|consen 197 SGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIA 272 (513)
T ss_pred CCCCchhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhh
Confidence 4456666667777889999999999999999999998 8999999996443 46788999998875 9999999998
Q ss_pred EEeeC----CeEEEEEecccCCCHHHHH--------------HhhhhhhhHhhhhc----------cCCccccceEeCCC
Q 048280 114 YCAHG----AEKLLIYEYVINESLDKVL--------------FSLIKDIQILFRKK----------KTDIKASNILLDDK 165 (381)
Q Consensus 114 ~~~~~----~~~~lv~E~~~~g~L~~~l--------------~~~~~~l~~lh~~~----------HrDlkp~NIll~~~ 165 (381)
.-..+ .++|||++|-+.|+|.++| +.++.||++||... |||||..|||+.++
T Consensus 273 aD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn 352 (513)
T KOG2052|consen 273 ADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 352 (513)
T ss_pred ccccCCCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence 75433 3689999999999999988 67889999999654 99999999999999
Q ss_pred CCcEEeeeccceecCCCCcc---cccccccCccccchhHHhhCC----C-C-chhhhHhHHHHHHHHHhC----------
Q 048280 166 WIPKIADFGMARLFPEDQTH---VNTRVAGTNGYMAPEYVMHGH----L-S-VKADVFSFGVVILELISG---------- 226 (381)
Q Consensus 166 ~~~kL~DFG~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~-~-~~sDvwSlGvvl~elltg---------- 226 (381)
+.+.|+|+|+|......... .....+||..|||||++.... + + ..+||||||.|+||++..
T Consensus 353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 99999999999876544222 223568999999999986532 2 2 359999999999999863
Q ss_pred CCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 227 QRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS-DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 227 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
+.||....+.+.. ...+.+-...+.+.|..... .....+..+.+|++.||..||.-|-|+-.|-+.|.+..
T Consensus 433 ~~Pyyd~Vp~DPs------~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 433 QLPYYDVVPSDPS------FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred cCCcccCCCCCCC------HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 3565443333321 11122222223333444333 34466788899999999999999999999988887653
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=277.90 Aligned_cols=245 Identities=26% Similarity=0.357 Sum_probs=177.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcc--cHHHHHHHHHHHHHhCCCCcccEEEEEeeC-------
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQ--GKKEFENEAKLLARVQHRNVVNLLGYCAHG------- 118 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------- 118 (381)
.++|++.+.||+|+||.||+|... +++.||||++...... ....+.+|++++++++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999865 5899999998644222 234677899999999999999999987543
Q ss_pred -CeEEEEEecccCCCHH----------------HHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceec
Q 048280 119 -AEKLLIYEYVINESLD----------------KVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLF 179 (381)
Q Consensus 119 -~~~~lv~E~~~~g~L~----------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~ 179 (381)
...++||||+.+ +|. .++.|++.+|.|+|..+ |+||||+|||+++++.+||+|||++...
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 356999999854 443 24478999999999999 9999999999999999999999999865
Q ss_pred CCCCcc----------cccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 048280 180 PEDQTH----------VNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKL 248 (381)
Q Consensus 180 ~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 248 (381)
...... ......++..|+|||.+.+. .++.++|||||||++|||++|+.||........ .......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~---~~~~~~~ 242 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ---LHLIFKL 242 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHH
Confidence 432211 11234568889999988764 588999999999999999999999864333211 1111111
Q ss_pred hhcCC---------ccc----ccCCCCCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 249 YKKDK---------SLE----IVDPSLAA---SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 249 ~~~~~---------~~~----~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
..... ... ........ .........+.+++.+||+.||.+|||+.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 10000 000 00000000 000112256789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=287.61 Aligned_cols=227 Identities=21% Similarity=0.309 Sum_probs=176.3
Q ss_pred CCCCcccccCCeeEEEEEEC-CCcEEEEEEecC----CCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCe--EEEEE
Q 048280 53 HPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSH----SSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAE--KLLIY 125 (381)
Q Consensus 53 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--~~lv~ 125 (381)
+....||+|.|-+||+|.+. +|..||--.++. ......++|..|+.+|+.|+|||||++|.++.+... .-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 44678999999999999865 477777433321 133345889999999999999999999999887655 77899
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc----cCCccccceEeCC-CCCcEEeeeccceecCCCCcc
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK----KTDIKASNILLDD-KWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~----HrDlkp~NIll~~-~~~~kL~DFG~~~~~~~~~~~ 185 (381)
|.+..|+|..|+ +||++||.|||++. |||||.+||||+. .|.|||+|+|+|.......
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-- 200 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-- 200 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence 999999998776 79999999999998 9999999999974 5899999999999864432
Q ss_pred cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCC
Q 048280 186 VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
...+.|||.|||||++. ..|+..+||||||++++||+|+..||..-. ....+...+....+......+-|
T Consensus 201 -aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~--n~AQIYKKV~SGiKP~sl~kV~d------ 270 (632)
T KOG0584|consen 201 -AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT--NPAQIYKKVTSGIKPAALSKVKD------ 270 (632)
T ss_pred -cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC--CHHHHHHHHHcCCCHHHhhccCC------
Confidence 23478999999999776 789999999999999999999999984221 12222222221111111112222
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 266 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
..+.+||.+||.. ..+|||+.|+|..
T Consensus 271 ------Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 271 ------PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 3467899999999 9999999999863
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=272.52 Aligned_cols=243 Identities=18% Similarity=0.196 Sum_probs=175.0
Q ss_pred CCCCcccccCCeeEEEEEECCCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccC
Q 048280 53 HPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 53 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
.+.+.+|.|+++.|+++.. +++.||||++... .......+.+|+.+++.++|+||+++++++...+..+++|||+.+
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3444455555555555444 5899999998754 334456899999999999999999999999999999999999999
Q ss_pred CCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc------c
Q 048280 131 ESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT------H 185 (381)
Q Consensus 131 g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~------~ 185 (381)
++|.+++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||.+..+..... .
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 9997654 68999999999998 999999999999999999999999875532211 1
Q ss_pred cccccccCccccchhHHhhC--CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh----hcCC------
Q 048280 186 VNTRVAGTNGYMAPEYVMHG--HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLY----KKDK------ 253 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~------ 253 (381)
......++..|+|||++.+. .++.++|||||||++|||++|..||...... ....+...... ....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhhhcC
Confidence 11234567889999998763 5889999999999999999999998643211 11111100000 0000
Q ss_pred -ccc----ccCCC----CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 254 -SLE----IVDPS----LAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 254 -~~~----~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
... ..++. ............+.+|+.+||+.||++|||+.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 00000 0011223345678899999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=268.92 Aligned_cols=240 Identities=24% Similarity=0.316 Sum_probs=178.3
Q ss_pred CCCCCcccccCCeeEEEEEECC-CcEEEEEEecCCCc--ccHHHHHHHHHHHHHh---CCCCcccEEEEEeeCCe-----
Q 048280 52 FHPSNKLGEGGFGPVFKGKLDD-GREIAVKKLSHSSN--QGKKEFENEAKLLARV---QHRNVVNLLGYCAHGAE----- 120 (381)
Q Consensus 52 y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~----- 120 (381)
|++.+.||+|+||.||+|+.+. ++.||+|.+..... .....+.+|+.+++++ +|+||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6788999999999999999764 89999999964422 2234566788888777 59999999999988776
Q ss_pred EEEEEecccCCCHHHH-----------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCC
Q 048280 121 KLLIYEYVINESLDKV-----------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPE 181 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~-----------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~ 181 (381)
.+++|||+.+ +|.++ +.|++.+|.+||..+ |+||+|+||+++.++.+||+|||++..+..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 9999999964 56443 378999999999998 999999999999999999999999987643
Q ss_pred CCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcc------
Q 048280 182 DQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSL------ 255 (381)
Q Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 255 (381)
.... ....++..|+|||++.+..++.++|||||||++|+|++|..||......+ ...............
T Consensus 160 ~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 160 EMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD---QLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred Cccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH---HHHHHHHHcCCCChHhcCCCc
Confidence 3221 22347889999999999999999999999999999999988876433211 111111111000000
Q ss_pred ----cccCCCC---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 256 ----EIVDPSL---AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 256 ----~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
....... ...........+.+++.+||+.||.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000 01112234567789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=275.08 Aligned_cols=250 Identities=21% Similarity=0.320 Sum_probs=183.4
Q ss_pred CChHHHHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEe
Q 048280 40 FPFEALVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCA 116 (381)
Q Consensus 40 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 116 (381)
....++....++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 334556667789999999999999999999854 68899999986542 223456788999999999999999999886
Q ss_pred eC------CeEEEEEecccCCCHHHH--------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeec
Q 048280 117 HG------AEKLLIYEYVINESLDKV--------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFG 174 (381)
Q Consensus 117 ~~------~~~~lv~E~~~~g~L~~~--------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG 174 (381)
.. ...+++++++ +++|.++ +.|++.+++|+|+.+ ||||||+||+++.++.+||+|||
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg 165 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG 165 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccc
Confidence 43 3467888877 7777643 478999999999999 99999999999999999999999
Q ss_pred cceecCCCCcccccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc--
Q 048280 175 MARLFPEDQTHVNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKK-- 251 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 251 (381)
++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ...........
T Consensus 166 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~ 238 (345)
T cd07877 166 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPG 238 (345)
T ss_pred cccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCC
Confidence 98864322 223467889999999876 468899999999999999999999985432211 11100000000
Q ss_pred ---------CC-------cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 252 ---------DK-------SLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 252 ---------~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.. ......... ..........+.+++.+||+.||.+||++.+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 239 AELLKKISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHhhcccHhHHHHHHHhcccCCcch-hhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 000000000 00000123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=261.25 Aligned_cols=250 Identities=23% Similarity=0.326 Sum_probs=181.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC---C--CcEEEEEEecCCCc-cc-HHHHHHHHHHHHHhCCCCcccEEEEEee-CCe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD---D--GREIAVKKLSHSSN-QG-KKEFENEAKLLARVQHRNVVNLLGYCAH-GAE 120 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~---~--~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~ 120 (381)
...|+.+..||+|.||.||+|.-+ + ...+|||+++.... .+ .....+|+.+++.++||||+.+..+|.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 457999999999999999999532 2 33789999975522 11 2467789999999999999999999887 788
Q ss_pred EEEEEecccCCCHH--------------------HHHHhhhhhhhHhhhhc--cCCccccceEeCCC----CCcEEeeec
Q 048280 121 KLLIYEYVINESLD--------------------KVLFSLIKDIQILFRKK--KTDIKASNILLDDK----WIPKIADFG 174 (381)
Q Consensus 121 ~~lv~E~~~~g~L~--------------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~----~~~kL~DFG 174 (381)
+++++||.+. +|. .+|.|++.|+.|||++- ||||||.||||..+ |+|||+|||
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999999854 443 45589999999999987 99999999999877 899999999
Q ss_pred cceecCCCCccc--ccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccc-c-----cHHHHH
Q 048280 175 MARLFPEDQTHV--NTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDA-Q-----NLLDWA 245 (381)
Q Consensus 175 ~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-~-----~~~~~~ 245 (381)
+++.+...-... ...++-|..|+|||++.|. .|+.+.||||+|||+.||++-.+-|......-. . +.++..
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 999886553332 2356779999999999886 699999999999999999998877754322111 1 112222
Q ss_pred HHHhhcCCcccccC----CCC-----------CCCC-CHH-------HHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 246 YKLYKKDKSLEIVD----PSL-----------AASD-SGD-------QIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 246 ~~~~~~~~~~~~~~----~~~-----------~~~~-~~~-------~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
..+..........+ |.. .... ... -.....+|+.++|..||.+|.|+++.++..
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 22211110000000 000 0000 000 011256899999999999999999998754
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=269.22 Aligned_cols=231 Identities=23% Similarity=0.320 Sum_probs=184.7
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhC-CCCcccEEEEEeeCCeEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQ-HRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv 124 (381)
++|.+.+.||.|+||.||+|... +++.||+|++.... ......+.+|+.++++++ |+||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999875 68999999986532 223456888999999998 99999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc---
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT--- 184 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~--- 184 (381)
|||+.+++|.+++ .|++.++.+||+.+ |+||||+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 9999999997665 68999999999999 999999999999999999999999987644332
Q ss_pred ----------------ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 048280 185 ----------------HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKL 248 (381)
Q Consensus 185 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 248 (381)
.......++..|+|||++.+..++.++|||||||++|+|++|..||...... ... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~---~~~ 234 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---LTF---QKI 234 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---HHH---HHH
Confidence 1122345788999999998888999999999999999999999998643211 001 111
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 048280 249 YKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTM----RRVVV 297 (381)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~eil~ 297 (381)
.... . .........+.+++.+||+.+|.+||++ .+++.
T Consensus 235 ~~~~-------~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 235 LKLE-------Y----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HhcC-------C----CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1100 0 1111224568899999999999999999 77754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=274.14 Aligned_cols=242 Identities=22% Similarity=0.336 Sum_probs=179.5
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC-----
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA----- 119 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----- 119 (381)
..++|++.+.||+|+||.||++... ++..||||++.... ......+.+|+.++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999855 68999999986432 223356889999999999999999999987653
Q ss_pred -eEEEEEecccCCCHHHH--------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCC
Q 048280 120 -EKLLIYEYVINESLDKV--------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPED 182 (381)
Q Consensus 120 -~~~lv~E~~~~g~L~~~--------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~ 182 (381)
..++||||+ +++|.++ +.|++.++.|+|+.+ ||||||+||+++.++.+||+|||++......
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 458999998 7777654 378999999999999 9999999999999999999999999865332
Q ss_pred CcccccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh-----------h
Q 048280 183 QTHVNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLY-----------K 250 (381)
Q Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~ 250 (381)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..||........ ........ .
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 172 ----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ---LMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred ----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHHHHHhhc
Confidence 123457889999999876 4588999999999999999999999864322110 00000000 0
Q ss_pred cCCccccc--CCCCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 251 KDKSLEIV--DPSLAA----SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 251 ~~~~~~~~--~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
........ -+.... .........+.+++.+||+.||.+|||+.+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 000000 001122345789999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=272.88 Aligned_cols=226 Identities=28% Similarity=0.408 Sum_probs=175.4
Q ss_pred CCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc---ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 52 FHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 52 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
|...+.||+|+||.||+|+.. ++..|++|++..... .....+.+|+.+++.++||||+++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666788999999999999865 588999999864422 2235678899999999999999999999999999999999
Q ss_pred ccCCCHHH----------------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 128 VINESLDK----------------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 128 ~~~g~L~~----------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
+. ++|.+ ++.|++.++.|||..+ |+||||+||+++.++.+||+|||++..... ...
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~~~ 176 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----ANS 176 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----CCC
Confidence 95 45543 3368999999999999 999999999999999999999999864322 123
Q ss_pred cccCccccchhHHh---hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 190 VAGTNGYMAPEYVM---HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 190 ~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
..|+..|+|||++. ...++.++|||||||++|+|++|..||...... .......... . +...
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~-~-----~~~~--- 241 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQND-S-----PTLQ--- 241 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcC-C-----CCCC---
Confidence 46888999999984 356889999999999999999999997533211 1111111111 1 1111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.......+.+|+.+||+.+|.+||++.+++..
T Consensus 242 ~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11223457889999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=269.57 Aligned_cols=235 Identities=26% Similarity=0.415 Sum_probs=178.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC-CcEEEEEEecCCCc-ccHHHHHHHHHHHHHhC-CCCcccEEEEEeeCCeEEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD-GREIAVKKLSHSSN-QGKKEFENEAKLLARVQ-HRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~ 125 (381)
.++|++.+.||+|+||.||+|..+. ++.||||.+..... .....+.+|+.++.++. |+||+++++++.+....++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4679999999999999999999875 89999999975432 23455677887777774 999999999999999999999
Q ss_pred ecccCCCHH----------------HHHHhhhhhhhHhhhh-c--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 126 EYVINESLD----------------KVLFSLIKDIQILFRK-K--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 126 E~~~~g~L~----------------~~l~~~~~~l~~lh~~-~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
||+.+ +|. .++.+++.++.|||.. + ||||+|+||++++++.+||+|||++..+......
T Consensus 94 e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~- 171 (296)
T cd06618 94 ELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK- 171 (296)
T ss_pred eccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc-
Confidence 99853 443 3457899999999974 5 9999999999999999999999998765432221
Q ss_pred ccccccCccccchhHHhhCC----CCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGH----LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
....++..|+|||.+.+.. ++.++|||||||++|+|++|+.||...... .+......... .. ..
T Consensus 172 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-~~-----~~ 239 (296)
T cd06618 172 -TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE-PP-----SL 239 (296)
T ss_pred -cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC-CC-----CC
Confidence 2235778999999987654 789999999999999999999998532110 11111111111 00 01
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
. ........+.+|+.+||..||.+||++.+++...
T Consensus 240 ~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 240 P--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred C--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 0 0112345688999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=261.91 Aligned_cols=236 Identities=22% Similarity=0.314 Sum_probs=178.4
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc-ccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEEEEe
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN-QGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
.+.+-+..||.|.||+|++-.++ .|+..|||+++.... ....+++.|.....+- +.||||++||.+..++..||.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 34556788999999999998765 699999999976643 4456788888776555 79999999999999999999999
Q ss_pred cccCCCHHHHH--------------------HhhhhhhhHhhhhc---cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 127 YVINESLDKVL--------------------FSLIKDIQILFRKK---KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 127 ~~~~g~L~~~l--------------------~~~~~~l~~lh~~~---HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
+| ..+|+.+- ...+.||.||-... ||||||+||||+..|.+||||||++-.+...
T Consensus 144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S- 221 (361)
T KOG1006|consen 144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS- 221 (361)
T ss_pred HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH-
Confidence 99 56775443 22467778885544 9999999999999999999999999866432
Q ss_pred cccccccccCccccchhHHhh--CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCC
Q 048280 184 THVNTRVAGTNGYMAPEYVMH--GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPS 261 (381)
Q Consensus 184 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (381)
...+.-.|-..|||||.+.. ..|+.+|||||||++|||++||+.|+..... ..++......... ..+..
T Consensus 222 -iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~gdp-p~l~~-- 292 (361)
T KOG1006|consen 222 -IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIGDP-PILLF-- 292 (361)
T ss_pred -HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcCCC-CeecC--
Confidence 22334568889999999864 3589999999999999999999999864322 3333333332221 11111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 262 LAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 262 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
..........+..+|..||.+|-.+||...++.++
T Consensus 293 --~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 --DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred --cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 12223455678899999999999999999998754
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=266.20 Aligned_cols=225 Identities=23% Similarity=0.297 Sum_probs=170.6
Q ss_pred cccccCCeeEEEEEEC-CCcEEEEEEecCCCcc---cHHHHHHHHHH---HHHhCCCCcccEEEEEeeCCeEEEEEeccc
Q 048280 57 KLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQ---GKKEFENEAKL---LARVQHRNVVNLLGYCAHGAEKLLIYEYVI 129 (381)
Q Consensus 57 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~---l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 129 (381)
.||+|+||.||+|... +++.||+|.+...... ....+..|..+ ++...||||+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999865 5889999998654211 11234444443 444579999999999999999999999999
Q ss_pred CCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccccc
Q 048280 130 NESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAG 192 (381)
Q Consensus 130 ~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~g 192 (381)
+++|..++ .|++.++.|+|+.+ ||||||+||+++.++.+||+|||++..+.... .....|
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~ 157 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVG 157 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcCcCC
Confidence 99997654 68899999999988 99999999999999999999999987653321 123468
Q ss_pred CccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHH
Q 048280 193 TNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271 (381)
Q Consensus 193 t~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (381)
+..|+|||++.++ .++.++|||||||++|+|++|+.||............ ..... ..+.+. ....
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~------~~~~~~----~~~s 223 (278)
T cd05606 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLT------MAVELP----DSFS 223 (278)
T ss_pred CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HHhhc------cCCCCC----CcCC
Confidence 9999999998754 6899999999999999999999998644222111110 00000 111111 1124
Q ss_pred HHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 048280 272 AMCIQIGLLCTQGDPQLRP-----TMRRVVVM 298 (381)
Q Consensus 272 ~~l~~li~~cl~~dP~~RP-----s~~eil~~ 298 (381)
..+.+++.+||..+|.+|| ++.++++.
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 224 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 5688899999999999999 99999854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=278.74 Aligned_cols=226 Identities=25% Similarity=0.370 Sum_probs=182.7
Q ss_pred CCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCC
Q 048280 55 SNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINE 131 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g 131 (381)
.+.||+|.||+||-|.++ +|+.||||++.+. .......+.+|+.||+++.||.||.+-..|+..+.+++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 478999999999999765 6999999999765 2334478899999999999999999999999999999999999655
Q ss_pred CHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCC---CCCcEEeeeccceecCCCCccccccc
Q 048280 132 SLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDD---KWIPKIADFGMARLFPEDQTHVNTRV 190 (381)
Q Consensus 132 ~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~---~~~~kL~DFG~~~~~~~~~~~~~~~~ 190 (381)
-|.-+| .||+.+|.|||.++ |+||||+||||.. -.++||||||+++.+.+... ...+
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF--RrsV 726 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF--RRSV 726 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh--hhhh
Confidence 554333 69999999999998 9999999999964 34899999999999876544 3457
Q ss_pred ccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHH
Q 048280 191 AGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQ 270 (381)
Q Consensus 191 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (381)
+||+.|+|||++++..|+..-|+||.|||+|.-++|..||....+ ..+.++.+. .+ +......+.
T Consensus 727 VGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAa----------FM---yPp~PW~ei 791 (888)
T KOG4236|consen 727 VGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAA----------FM---YPPNPWSEI 791 (888)
T ss_pred cCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccc----------cc---cCCCchhhc
Confidence 899999999999999999999999999999999999999864322 111111111 11 112334555
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 271 IAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 271 ~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
....++||...|+..-.+|-|.+..+.
T Consensus 792 s~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 792 SPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred CHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 667888999999999999999887653
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=240.50 Aligned_cols=244 Identities=21% Similarity=0.310 Sum_probs=179.7
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc--ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN--QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
+|...++||+|.||+||+|+.. +++.||+|.++..+. .......+||-+++.++|.|||+++++...++.+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 5777889999999999999865 588999999876532 2345788999999999999999999999999999999999
Q ss_pred ccCCCHH----------------HHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 128 VINESLD----------------KVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 128 ~~~g~L~----------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
| ..+|. .++.|+++++.++|++. ||||||.|+||+.+|.+||+|||+++.+.-...... .
T Consensus 83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys-a 160 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS-A 160 (292)
T ss_pred h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee-c
Confidence 9 33443 45689999999999998 999999999999999999999999998765443322 2
Q ss_pred cccCccccchhHHhhCC-CCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhh---cCCcc---cccCCCC
Q 048280 190 VAGTNGYMAPEYVMHGH-LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYK---KDKSL---EIVDPSL 262 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~---~~~~~~~ 262 (381)
.+-|..|++|.++.+.. |++..|+||-||++.|+.....|.....+.+ +.+........ ++... ...|-..
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd--dqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH--HHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 34689999999998864 8999999999999999998666643222222 22222222221 11111 1111111
Q ss_pred CCCC---------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 263 AASD---------SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 263 ~~~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.+.. .+.....=.+|+...|.-+|.+|.++++.++.
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1100 11122233567888888899999999988653
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=300.60 Aligned_cols=247 Identities=21% Similarity=0.262 Sum_probs=196.6
Q ss_pred CCChHHHHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEE
Q 048280 39 HFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGY 114 (381)
Q Consensus 39 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 114 (381)
.-.+.+++-..++|++++.||+|+||.|.+++.+ +++.||+|++.+. ......-|..|-.+|..-+.+=|+.++-.
T Consensus 64 v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA 143 (1317)
T KOG0612|consen 64 VKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA 143 (1317)
T ss_pred HHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH
Confidence 3345556666789999999999999999999876 5889999999763 33444678889999999899999999999
Q ss_pred EeeCCeEEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccce
Q 048280 115 CAHGAEKLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMAR 177 (381)
Q Consensus 115 ~~~~~~~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~ 177 (381)
|.+..++|+||||++||+|-.+| ..++.||.-+|+.| ||||||+|||||..|++||+|||.+-
T Consensus 144 FQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 144 FQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred hcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHH
Confidence 99999999999999999997665 57888999999999 99999999999999999999999999
Q ss_pred ecCCCCcccccccccCccccchhHHhh-----CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcC
Q 048280 178 LFPEDQTHVNTRVAGTNGYMAPEYVMH-----GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKD 252 (381)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (381)
.+..++.......+|||.|++||++.. +.|+..+|-||+||++|||+.|..||.. ..+..-...+....
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslveTY~KIm~hk 297 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVETYGKIMNHK 297 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHHHHHHHhchh
Confidence 888777766677889999999999863 5789999999999999999999999852 22332222232222
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHHh
Q 048280 253 KSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPT---MRRVVVML 299 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~~L 299 (381)
....+. ...+.+....+||.+.+. +|+.|.. ++++-...
T Consensus 298 ~~l~FP-------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 298 ESLSFP-------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred hhcCCC-------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 222211 112244556667766554 8889988 88886543
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=269.66 Aligned_cols=241 Identities=22% Similarity=0.346 Sum_probs=178.9
Q ss_pred CCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc-ccHHHHHHHHHHHHHhC-CCCcccEEEEEeeCCeEEEEEecc
Q 048280 52 FHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN-QGKKEFENEAKLLARVQ-HRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 52 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
|.+.+.||.|++|.||+|... +++.|+||++..... .......+|+..+++++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 678899999999999999976 478899999865432 22334567999999998 999999999999999999999999
Q ss_pred cCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 129 INESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 129 ~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
+++|.+++ .|++.+|.|||..+ |+||+|+||+++.++.++|+|||++........ ...
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~ 157 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--YTD 157 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--cCC
Confidence 77876543 68899999999998 999999999999999999999999986643222 223
Q ss_pred cccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc------------CCccc
Q 048280 190 VAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKK------------DKSLE 256 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~~ 256 (381)
..++..|+|||++.+ ..++.++||||||+++|+|++|+.||......+.. ......... .....
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQL---YKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHH---HHHHHhcCCCChhhhhhHhhhhcccc
Confidence 457889999998754 45789999999999999999999988654322110 000000000 00000
Q ss_pred ccCCCCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 257 IVDPSLAA----SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 257 ~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
...+.... .........+.+++.+||+.||++|||+.|++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000 0001113568899999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=259.23 Aligned_cols=235 Identities=19% Similarity=0.192 Sum_probs=185.0
Q ss_pred hhcCCCCC-CcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHh-CCCCcccEEEEEee----CCe
Q 048280 48 ATKNFHPS-NKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLGYCAH----GAE 120 (381)
Q Consensus 48 ~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~----~~~ 120 (381)
++++|.+. ++||-|-.|.|-.+..+ +++.+|+|++.. .....+|+++.-.. .|||||.++++|++ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 46788774 68999999999999765 699999999843 35567899988777 59999999998864 467
Q ss_pred EEEEEecccCCCHHH-----------------HHHhhhhhhhHhhhhc--cCCccccceEeCC---CCCcEEeeecccee
Q 048280 121 KLLIYEYVINESLDK-----------------VLFSLIKDIQILFRKK--KTDIKASNILLDD---KWIPKIADFGMARL 178 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~-----------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~---~~~~kL~DFG~~~~ 178 (381)
+.+|||.++||.|.. ++.||..+++|||+.. ||||||+|+|... |..+||+|||+++.
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence 889999999999964 4589999999999998 9999999999964 55799999999996
Q ss_pred cCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCccccc
Q 048280 179 FPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
-.... ...+.+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||........ ..-....+..+
T Consensus 214 t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---spgMk~rI~~g------ 282 (400)
T KOG0604|consen 214 TQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKRRIRTG------ 282 (400)
T ss_pred cCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC---ChhHHhHhhcc------
Confidence 54322 22346789999999999999999999999999999999999999965433211 11111111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 259 DPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.-.+..+.....++...++|+.+|+.+|.+|.|+.+++..
T Consensus 283 qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 283 QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1123344556777888999999999999999999999864
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=274.92 Aligned_cols=243 Identities=22% Similarity=0.294 Sum_probs=175.0
Q ss_pred CCCCCCcccccCCeeEEEEEEC-C--CcEEEEEEecCCC--cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeC----Ce
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-D--GREIAVKKLSHSS--NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHG----AE 120 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~----~~ 120 (381)
+|++.+.||+|+||.||+++.. . +..||+|++.... ......+.+|+.+++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 5788999999999999999865 3 6789999986432 22345788899999999 599999999875432 45
Q ss_pred EEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 121 KLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
.++++||+. ++|.+++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||+++.+....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 788999884 5675543 78999999999999 99999999999999999999999998654322
Q ss_pred cc---cccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhh---------
Q 048280 184 TH---VNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYK--------- 250 (381)
Q Consensus 184 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------- 250 (381)
.. ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||....... ..........
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPDEETLSR 236 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCCHHHHHh
Confidence 21 1123568999999998876 468999999999999999999999986432111 1110000000
Q ss_pred --cCCc------ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 251 --KDKS------LEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 251 --~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.... ...................+.+++.+||+.||.+|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 0000000000000112356889999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=266.51 Aligned_cols=241 Identities=26% Similarity=0.366 Sum_probs=181.4
Q ss_pred CCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 52 FHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 52 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
|++.+.||+|++|.||+|... +++.||+|++.... ......+.+|+.++++++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 667889999999999999876 48999999987653 233467788999999999999999999999999999999999
Q ss_pred cCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccc
Q 048280 129 INESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV 190 (381)
Q Consensus 129 ~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 190 (381)
. ++|.+++ .+++.+|.+||..+ ||||+|+||++++++.+||+|||++......... ....
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~~~~ 158 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHE 158 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-cCcc
Confidence 6 5776554 67899999999998 9999999999999999999999999876433221 2223
Q ss_pred ccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhh-----------cCCccccc
Q 048280 191 AGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYK-----------KDKSLEIV 258 (381)
Q Consensus 191 ~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~ 258 (381)
.++..|+|||.+.+. .++.++|||||||++|||++|..||......+. ......... ........
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhccccccccc
Confidence 457789999998776 789999999999999999999988854332111 111111000 00000000
Q ss_pred CCCCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 259 DPSLAA----SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 259 ~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.+.... .........+.+++.+||..||++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 011100 111122456899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=275.43 Aligned_cols=243 Identities=23% Similarity=0.376 Sum_probs=180.9
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCe----
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAE---- 120 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---- 120 (381)
..++|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++|+||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3678999999999999999999876 5889999998653 22233567789999999999999999988766554
Q ss_pred --EEEEEecccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCC
Q 048280 121 --KLLIYEYVINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPED 182 (381)
Q Consensus 121 --~~lv~E~~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~ 182 (381)
.++|+||+ +++|.+++ .|++.++.++|+.+ ||||||+||+++.++.+||+|||++......
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 89999998 67886654 68999999999998 9999999999999999999999999865432
Q ss_pred CcccccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCC--------
Q 048280 183 QTHVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDK-------- 253 (381)
Q Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 253 (381)
.....++..|+|||.+.+. .++.++|||||||++|+|++|+.||....... .............
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred ----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCCHHHHhhcc
Confidence 2234578899999998763 67899999999999999999999986432211 1111111000000
Q ss_pred ---cccccC--CCCC-C---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 254 ---SLEIVD--PSLA-A---SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 254 ---~~~~~~--~~~~-~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
....+. +... . .........+.+++.+||+.||.+|||+.+|+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000 0000 0 0001124678899999999999999999999753
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=272.91 Aligned_cols=229 Identities=27% Similarity=0.361 Sum_probs=184.6
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
+.|+.-++||+||||.||-++.+ +|+.+|+|++.+. ........++|-.+|.+++.+.||.+--.|+..+.+++||
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 46888999999999999999865 6999999998654 2334456789999999999999999999999999999999
Q ss_pred ecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 126 EYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 126 E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
..|.||+|.-.| .+|+.||.+||+.+ .|||||+|||||+.|+++|+|+|+|..+.+....
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~- 343 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI- 343 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCcc-
Confidence 999999995333 68899999999998 9999999999999999999999999987655433
Q ss_pred ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
...+||.+|||||++.+..|+...|-|||||+||||+.|+.||..........-++.. .. -++ ...
T Consensus 344 -~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr---~~-------~~~---~ey 409 (591)
T KOG0986|consen 344 -RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRR---TL-------EDP---EEY 409 (591)
T ss_pred -ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHH---Hh-------cch---hhc
Confidence 3348999999999999999999999999999999999999999654433222111110 00 111 122
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMR 293 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~ 293 (381)
+..+.+.+..|....|.+||.+|.-..
T Consensus 410 ~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 410 SDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred ccccCHHHHHHHHHHHccCHHHhccCC
Confidence 344556677788889999999997543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=268.34 Aligned_cols=247 Identities=26% Similarity=0.384 Sum_probs=182.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHh--CCCCcccEEEEEeeCC----eEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARV--QHRNVVNLLGYCAHGA----EKL 122 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~~~~~~~~~~----~~~ 122 (381)
.......++||+|.||.||+|.+. ++.||||++.. ...+.|.+|-.|.+.. +|+||++++++-..+. .++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 445667889999999999999988 59999999953 3457788888888765 7999999999876655 899
Q ss_pred EEEecccCCCHHHHH--------------HhhhhhhhHhhhhc-----------cCCccccceEeCCCCCcEEeeeccce
Q 048280 123 LIYEYVINESLDKVL--------------FSLIKDIQILFRKK-----------KTDIKASNILLDDKWIPKIADFGMAR 177 (381)
Q Consensus 123 lv~E~~~~g~L~~~l--------------~~~~~~l~~lh~~~-----------HrDlkp~NIll~~~~~~kL~DFG~~~ 177 (381)
||+||.+.|+|.++| ..+++||+|||.-. |||||..||||.+++++.|+|||+|.
T Consensus 285 LVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred EEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999999888 56899999999754 99999999999999999999999999
Q ss_pred ecCCCCccc-ccccccCccccchhHHhhCC-CC-----chhhhHhHHHHHHHHHhCCCCCC------CCCcccc----cc
Q 048280 178 LFPEDQTHV-NTRVAGTNGYMAPEYVMHGH-LS-----VKADVFSFGVVILELISGQRNSS------FNLDVDA----QN 240 (381)
Q Consensus 178 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-~~-----~~sDvwSlGvvl~elltg~~p~~------~~~~~~~----~~ 240 (381)
.+....... ....+||..|||||++.+.. +. .+.||||+|.|||||++...-+. +..++.. ..
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 876443221 12468999999999998753 22 35899999999999998654332 1111110 00
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 241 LLDWAYKLYKKDKSLEIVDPSLAASD-SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
-++..+......+ ..|.+.... ....+..+.+.+..||..||+.|.|+.=+.+.+....
T Consensus 445 t~e~mq~~VV~kK----~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 445 TLEEMQELVVRKK----QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred CHHHHHHHHHhhc----cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 1111111111111 112222111 1134567888999999999999999988888776653
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=262.68 Aligned_cols=231 Identities=22% Similarity=0.283 Sum_probs=182.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHH---HHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKE---FENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
-++|+.+++||+|.||.|-+++.+ +++.+|+|++++.-...+++ -+.|-++|+..+||.+..+--.|...+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 357899999999999999999865 69999999998764444433 45688999999999999998889999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|||+.||.|.-.| ..|+.+|.|||+++ .||||.+|+|||++|++||+|||+++.--.. ....
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~-g~t~ 325 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY-GDTT 325 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc-ccee
Confidence 9999999995443 57899999999988 9999999999999999999999999853222 2234
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
.+++||+.|+|||++....|+.++|-|.+|||+|||++|+.||..... ..+..... .. ++..|
T Consensus 326 kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---~kLFeLIl--~e-----d~kFP------- 388 (516)
T KOG0690|consen 326 KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---EKLFELIL--ME-----DLKFP------- 388 (516)
T ss_pred ccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---hHHHHHHH--hh-----hccCC-------
Confidence 578999999999999999999999999999999999999999853222 11111110 11 11112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRP-----TMRRVVV 297 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 297 (381)
.....+...|+...|.+||.+|. .+.||.+
T Consensus 389 r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 389 RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 22233466788899999999996 3555553
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=262.94 Aligned_cols=230 Identities=25% Similarity=0.374 Sum_probs=177.5
Q ss_pred CCCCCCcccccCCeeEEEEEECC-CcEEEEEEecCC-----CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLDD-GREIAVKKLSHS-----SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
+|.+.+.||+|+||.||+++... +..+++|.++.. .......+..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58889999999999999998653 445666655432 122234577899999999999999999999999999999
Q ss_pred EecccCCCHHHHH-------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 125 YEYVINESLDKVL-------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 125 ~E~~~~g~L~~~l-------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
|||+++++|..++ .|++.++.++|+.+ |+||||+||+++. +.+||+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 9999999997544 57899999999998 9999999999975 569999999998764332
Q ss_pred cccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC
Q 048280 184 THVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 184 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.... .......... . ..+
T Consensus 160 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~-~-----~~~--- 223 (260)
T cd08222 160 D-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVE-G-----PTP--- 223 (260)
T ss_pred c-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHc-C-----CCC---
Confidence 2 2223557889999999988889999999999999999999999985321 1111111111 1 011
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 264 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.........+.+++.+||+.||++||++.++++.
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 -SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1123445678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=291.09 Aligned_cols=129 Identities=22% Similarity=0.385 Sum_probs=115.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc---ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|.+.+.||+|+||.||+|.+. +++.||||++..... .....+.+|+.+++.++|+||+++++++......|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 368999999999999999999876 589999999965432 2236788899999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccce
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMAR 177 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~ 177 (381)
|||+.+++|.+++ .|++.+|.|||..+ ||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999997665 67999999999998 99999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=255.82 Aligned_cols=219 Identities=24% Similarity=0.308 Sum_probs=175.2
Q ss_pred ccccCCeeEEEEEEC-CCcEEEEEEecCCCcc---cHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCCCH
Q 048280 58 LGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQ---GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESL 133 (381)
Q Consensus 58 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L 133 (381)
||.|+||.||++... +++.+|+|.+...... ....+.+|+.++++++|+||+++++.+..+...++||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999876 4899999998655322 345788999999999999999999999999999999999999999
Q ss_pred HHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccCccc
Q 048280 134 DKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGY 196 (381)
Q Consensus 134 ~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y 196 (381)
.+++ .|++.++.++|..+ |+||+|+||+++.++.++|+|||++....... .......++..|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ 159 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTPEY 159 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCccc
Confidence 7665 67999999999988 99999999999999999999999998764332 122345678899
Q ss_pred cchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHH
Q 048280 197 MAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQ 276 (381)
Q Consensus 197 ~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 276 (381)
+|||.+.+...+.++|+||||+++|+|++|..||..... ..... .... . . . ..+......+.+
T Consensus 160 ~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~---~~~~-~---~---~----~~~~~~~~~l~~ 222 (250)
T cd05123 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYE---KILK-D---P---L----RFPEFLSPEARD 222 (250)
T ss_pred cChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHH---HHhc-C---C---C----CCCCCCCHHHHH
Confidence 999999888899999999999999999999999854322 11111 1111 0 0 0 011111456788
Q ss_pred HHHHcccCCCCCCCCHHH
Q 048280 277 IGLLCTQGDPQLRPTMRR 294 (381)
Q Consensus 277 li~~cl~~dP~~RPs~~e 294 (381)
++.+||..||++||++.+
T Consensus 223 ~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 223 LISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHhcCCHhhCCCccc
Confidence 999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=277.04 Aligned_cols=226 Identities=22% Similarity=0.238 Sum_probs=182.7
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++..|++...+|.|+|+.|-.+... +++..++|++.... .+..+|+.++... +||||+++++++.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3678999999999999999999755 68999999997652 2345678777766 7999999999999999999999
Q ss_pred ecccCCCHHH--------------HHHhhhhhhhHhhhhc--cCCccccceEe-CCCCCcEEeeeccceecCCCCccccc
Q 048280 126 EYVINESLDK--------------VLFSLIKDIQILFRKK--KTDIKASNILL-DDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 126 E~~~~g~L~~--------------~l~~~~~~l~~lh~~~--HrDlkp~NIll-~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
|.+.++-|.+ ++.+++.++.|||+++ ||||||+|||+ ++.++++|+|||.++..... ..
T Consensus 396 e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~ 471 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CD 471 (612)
T ss_pred hhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh----hc
Confidence 9998887743 4578999999999998 99999999999 68999999999999976544 22
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
..+-|..|.|||++....|+.++|+||||++||+|++|+.||...... .++ ...... +....
T Consensus 472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei----~~~i~~------------~~~s~ 533 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI----HTRIQM------------PKFSE 533 (612)
T ss_pred ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH----HHhhcC------------Ccccc
Confidence 345688999999999999999999999999999999999998643332 111 111111 11123
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
..+....+|+.+||+.||.+||++.++...-
T Consensus 534 ~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 534 CVSDEAKDLLQQLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred ccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence 4456688899999999999999999997543
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=289.25 Aligned_cols=242 Identities=29% Similarity=0.420 Sum_probs=188.8
Q ss_pred HHHhhcCCCCCCcccccCCeeEEEEEEC--------CCcEEEEEEecCC-CcccHHHHHHHHHHHHHh-CCCCcccEEEE
Q 048280 45 LVSATKNFHPSNKLGEGGFGPVFKGKLD--------DGREIAVKKLSHS-SNQGKKEFENEAKLLARV-QHRNVVNLLGY 114 (381)
Q Consensus 45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~ 114 (381)
.+...++..+.+.||+|.||.|++|... ....||||.++.. .....+.+..|+++|+.+ .|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3334455567779999999999999743 1457999998755 334567899999999999 69999999999
Q ss_pred EeeCCeEEEEEecccCCCHHHHH-------------------------------HhhhhhhhHhhhhc--cCCccccceE
Q 048280 115 CAHGAEKLLIYEYVINESLDKVL-------------------------------FSLIKDIQILFRKK--KTDIKASNIL 161 (381)
Q Consensus 115 ~~~~~~~~lv~E~~~~g~L~~~l-------------------------------~~~~~~l~~lh~~~--HrDlkp~NIl 161 (381)
|......++|+||+..|+|.+++ .|++.|++||++.. ||||-..|||
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVL 450 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEE
Confidence 99999999999999999886554 57889999999988 9999999999
Q ss_pred eCCCCCcEEeeeccceecCCCCccccccccc--CccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccc
Q 048280 162 LDDKWIPKIADFGMARLFPEDQTHVNTRVAG--TNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDA 238 (381)
Q Consensus 162 l~~~~~~kL~DFG~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~ 238 (381)
+.++..+||+|||+++..............+ ...|||||.+....|+.|+|||||||+||||++ |..|+..... .
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--~ 528 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--T 528 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--H
Confidence 9999999999999999654444333222222 446999999999999999999999999999998 5666643110 1
Q ss_pred ccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 239 QNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
.++ ......+ .+...+..+...+.++++.||+.+|++||++.++.+.+..
T Consensus 529 ~~l----~~~l~~G---------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 529 EEL----LEFLKEG---------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HHH----HHHHhcC---------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 111 1122222 2223333445678899999999999999999999999876
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=264.49 Aligned_cols=250 Identities=21% Similarity=0.320 Sum_probs=186.9
Q ss_pred hHHHHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCC--C----CcccEEEE
Q 048280 42 FEALVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQH--R----NVVNLLGY 114 (381)
Q Consensus 42 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--p----nIv~~~~~ 114 (381)
++.....+++|.+...+|+|.||.|-.+.+. .+..||||+++.-. ..+++.+-|+++|+++.+ | -+|.+.+|
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 3333445789999999999999999999765 47899999986443 345677789999999942 2 37788889
Q ss_pred EeeCCeEEEEEecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeC------------
Q 048280 115 CAHGAEKLLIYEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLD------------ 163 (381)
Q Consensus 115 ~~~~~~~~lv~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~------------ 163 (381)
|.-.++.|||+|.+ |-++.++| .|+++++++||..+ |-||||+|||+.
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence 99999999999988 76777666 69999999999999 999999999992
Q ss_pred --------CCCCcEEeeeccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCc
Q 048280 164 --------DKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLD 235 (381)
Q Consensus 164 --------~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~ 235 (381)
++..+||+|||.+....+.. ..++.|..|+|||++.+-.++..+||||+||||+||++|..-|....+
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 13458999999998754433 446789999999999999999999999999999999999988765443
Q ss_pred cccccHHHHHH--------------HHhhcCCccc------------ccCCCC----CCCCCHHHHHHHHHHHHHcccCC
Q 048280 236 VDAQNLLDWAY--------------KLYKKDKSLE------------IVDPSL----AASDSGDQIAMCIQIGLLCTQGD 285 (381)
Q Consensus 236 ~~~~~~~~~~~--------------~~~~~~~~~~------------~~~~~~----~~~~~~~~~~~l~~li~~cl~~d 285 (381)
.+...+.+.+. ..+..+ ..+ ..++.. .......+...|.+|+.+||..|
T Consensus 315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 32211111110 000001 000 000000 01123345567999999999999
Q ss_pred CCCCCCHHHHHHH
Q 048280 286 PQLRPTMRRVVVM 298 (381)
Q Consensus 286 P~~RPs~~eil~~ 298 (381)
|.+|+|+.|++..
T Consensus 394 P~~RiTl~EAL~H 406 (415)
T KOG0671|consen 394 PARRITLREALSH 406 (415)
T ss_pred ccccccHHHHhcC
Confidence 9999999999753
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=264.33 Aligned_cols=237 Identities=25% Similarity=0.353 Sum_probs=179.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEE-CCCcEEEEEEecCCCc--c-----cHHHHHHHHHHHHHhCCCCcccEEEEEe-eCC
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKL-DDGREIAVKKLSHSSN--Q-----GKKEFENEAKLLARVQHRNVVNLLGYCA-HGA 119 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~-----~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~ 119 (381)
.++|-++.+||+|||+.||+|.+ ...+.||||+-..+.. . ..+...+|.+|.+.|+||.||++|++|. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 46788899999999999999974 4588999998643311 1 1234568999999999999999999985 556
Q ss_pred eEEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc----cCCccccceEeC---CCCCcEEeeeccce
Q 048280 120 EKLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK----KTDIKASNILLD---DKWIPKIADFGMAR 177 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~----HrDlkp~NIll~---~~~~~kL~DFG~~~ 177 (381)
.+|-|+|||+|.+|+-+| .|++.+|.||.... |-||||.||||. ..|.+||+|||+++
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 789999999999996544 68999999999887 999999999994 45789999999999
Q ss_pred ecCCCCcc------cccccccCccccchhHHhhC----CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 048280 178 LFPEDQTH------VNTRVAGTNGYMAPEYVMHG----HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYK 247 (381)
Q Consensus 178 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 247 (381)
.+..+... ......||.+|++||.+.-+ .++.|+||||+|||+|..+.|+.||..+. ..+++++...-
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq--sQQdILqeNTI 699 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ--SQQDILQENTI 699 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch--hHHHHHhhhch
Confidence 88655432 23467899999999987543 47899999999999999999999986432 22333332111
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 048280 248 LYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVV 296 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 296 (381)
+. ..++-.|.. +.......++|.+||++.-++|....++.
T Consensus 700 -lk---AtEVqFP~K-----PvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 700 -LK---ATEVQFPPK-----PVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -hc---ceeccCCCC-----CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 11 111111111 12234567899999999999999888764
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=276.25 Aligned_cols=243 Identities=21% Similarity=0.354 Sum_probs=195.1
Q ss_pred CChHHHHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHh-CCCCcccEEEEEee
Q 048280 40 FPFEALVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLGYCAH 117 (381)
Q Consensus 40 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 117 (381)
..++.+...++.|++.+.||.|.+|.||+++.. +++..|+|+...... ..++++.|.++|+.+ .|||++.++|+|..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 344555556788999999999999999999854 588899999865543 346788899999988 69999999999853
Q ss_pred -----CCeEEEEEecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeee
Q 048280 118 -----GAEKLLIYEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADF 173 (381)
Q Consensus 118 -----~~~~~lv~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DF 173 (381)
++.+|||||||.+|+..+++ +.++.++++||... |||||-.|||++.++.|||+||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeee
Confidence 57899999999999997765 67889999999988 9999999999999999999999
Q ss_pred ccceecCCCCcccccccccCccccchhHHhh-----CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 048280 174 GMARLFPEDQTHVNTRVAGTNGYMAPEYVMH-----GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKL 248 (381)
Q Consensus 174 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 248 (381)
|++..+...... ..+..||+.|||||++.- ..|+..+|+||||++..||.-|.+|+....+. ..+
T Consensus 168 GvSaQldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm---------raL 237 (953)
T KOG0587|consen 168 GVSAQLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM---------RAL 237 (953)
T ss_pred eeeeeeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh---------hhh
Confidence 999877544333 335789999999999864 35788999999999999999999997533221 111
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 249 YKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
+. ..-.|......+......+.++|..||.+|-++||++.++++.
T Consensus 238 F~-----IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 238 FL-----IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred cc-----CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11 1112333334566778889999999999999999999998753
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=251.79 Aligned_cols=202 Identities=19% Similarity=0.155 Sum_probs=159.3
Q ss_pred cCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCCCHHHHH--
Q 048280 61 GGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVL-- 137 (381)
Q Consensus 61 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~~~l-- 137 (381)
|.||.||+++.. +++.||+|++.... .+.+|...+....||||+++++++.+.+..++||||+++++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999875 58999999996543 2344555566667999999999999999999999999999997654
Q ss_pred -------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccCccccchhHH
Q 048280 138 -------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYV 202 (381)
Q Consensus 138 -------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 202 (381)
.|++.++.|+|..+ ||||||+||+++.++.++|+|||.+..+.... ....++..|+|||.+
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~aPE~~ 154 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYCAPEVG 154 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccccCCccc
Confidence 67899999999988 99999999999999999999999887653321 223456789999999
Q ss_pred hhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcc
Q 048280 203 MHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCT 282 (381)
Q Consensus 203 ~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 282 (381)
.+..++.++||||+||++|||++|..|+...... .... .. ...+......+.+++.+||
T Consensus 155 ~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~~~--~~-------~~~~~~~~~~~~~li~~~l 213 (237)
T cd05576 155 GISEETEACDWWSLGAILFELLTGKTLVECHPSG------------INTH--TT-------LNIPEWVSEEARSLLQQLL 213 (237)
T ss_pred CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------cccc--cc-------cCCcccCCHHHHHHHHHHc
Confidence 8888999999999999999999999876421110 0000 00 0111123456788999999
Q ss_pred cCCCCCCCCH
Q 048280 283 QGDPQLRPTM 292 (381)
Q Consensus 283 ~~dP~~RPs~ 292 (381)
+.||++||++
T Consensus 214 ~~dp~~R~~~ 223 (237)
T cd05576 214 QFNPTERLGA 223 (237)
T ss_pred cCCHHHhcCC
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=279.32 Aligned_cols=233 Identities=26% Similarity=0.361 Sum_probs=186.8
Q ss_pred CCCCCcccccCCeeEEEEEE-CC----CcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 52 FHPSNKLGEGGFGPVFKGKL-DD----GREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 52 y~~~~~lg~G~~g~V~~~~~-~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
.+..++||+|+||+||+|.+ .+ .-+||||++... ......+++.|+-+|.+++|||+++++++|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34568999999999999964 33 347899998654 3344578999999999999999999999998766 88999
Q ss_pred ecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 126 EYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 126 E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
+|++.|+|.+++ .||++|+.|||.++ ||||-..||||.....+||.|||+++.+..+.....
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 999999998876 79999999999988 999999999999999999999999998866554433
Q ss_pred c-ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCC
Q 048280 188 T-RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265 (381)
Q Consensus 188 ~-~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
. ...-.+.|||=|.+....|+.++|||||||++||++| |..|+......+. ...++.. .+..
T Consensus 857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-------~dlle~g---------eRLs 920 (1177)
T KOG1025|consen 857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-------PDLLEKG---------ERLS 920 (1177)
T ss_pred ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-------hHHHhcc---------ccCC
Confidence 2 2223568999999999999999999999999999998 7788754333222 2222222 1223
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 266 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
.+.-+.-.++.++.+||..|+..||+++++...+.+
T Consensus 921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 334445568889999999999999999999877654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=276.31 Aligned_cols=240 Identities=20% Similarity=0.261 Sum_probs=157.5
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-C----CcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEE------Ee
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-D----GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGY------CA 116 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~------~~ 116 (381)
..++|++.+.||+|+||.||+|.+. + +..||||++..... .+.+.+| .+....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4678999999999999999999875 4 68999998754321 1111111 1122223333322211 24
Q ss_pred eCCeEEEEEecccCCCHHHH-----------------------------------HHhhhhhhhHhhhhc--cCCccccc
Q 048280 117 HGAEKLLIYEYVINESLDKV-----------------------------------LFSLIKDIQILFRKK--KTDIKASN 159 (381)
Q Consensus 117 ~~~~~~lv~E~~~~g~L~~~-----------------------------------l~~~~~~l~~lh~~~--HrDlkp~N 159 (381)
.+...++||||+.+++|.++ +.|++.+|.|+|+.+ ||||||+|
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 56789999999999988543 356789999999998 99999999
Q ss_pred eEeCC-CCCcEEeeeccceecCCCCcccccccccCccccchhHHhhC----------------------CCCchhhhHhH
Q 048280 160 ILLDD-KWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG----------------------HLSVKADVFSF 216 (381)
Q Consensus 160 Ill~~-~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDvwSl 216 (381)
||++. ++.+||+|||+++.+............+++.|+|||.+... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99985 67999999999986644433334456789999999976432 23456799999
Q ss_pred HHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCc----ccccCCCCCCC------CCHHHHHHHHHHHHHcccCCC
Q 048280 217 GVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKS----LEIVDPSLAAS------DSGDQIAMCIQIGLLCTQGDP 286 (381)
Q Consensus 217 Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP 286 (381)
||+||||+++..++... .............. .....+..... .........++|+.+||+.||
T Consensus 366 GviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred HHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 99999999977654311 11111100000000 00001110000 000112235689999999999
Q ss_pred CCCCCHHHHHHH
Q 048280 287 QLRPTMRRVVVM 298 (381)
Q Consensus 287 ~~RPs~~eil~~ 298 (381)
++|||+.++++.
T Consensus 439 ~kR~ta~e~L~H 450 (566)
T PLN03225 439 RQRISAKAALAH 450 (566)
T ss_pred ccCCCHHHHhCC
Confidence 999999999874
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=248.67 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=181.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc--ccHHHHHHHHHHHHHhCCCCcccEEEEEee--------
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN--QGKKEFENEAKLLARVQHRNVVNLLGYCAH-------- 117 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-------- 117 (381)
.+.|+-..+||+|.||.||+|+.+ +|+.||+|++..... .--....+|+++|..++|+|++.++.+|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 456888899999999999999865 588899988754321 122456789999999999999999988743
Q ss_pred CCeEEEEEecccCCCH----------------HHHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceec
Q 048280 118 GAEKLLIYEYVINESL----------------DKVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLF 179 (381)
Q Consensus 118 ~~~~~lv~E~~~~g~L----------------~~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~ 179 (381)
...+|+||.+|+. +| .+++.+++.||.|+|+.. |||+|++|+||+.+|.+||+|||+++.+
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 2458999999854 33 356688999999999998 9999999999999999999999999876
Q ss_pred CCCCcc---cccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCC--
Q 048280 180 PEDQTH---VNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDK-- 253 (381)
Q Consensus 180 ~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 253 (381)
...... ..+..+-|..|++||.+.+. .|+++.|||.-|||+.||.++.+-+..+.+.....++.........+.
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP 254 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP 254 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence 543322 12344569999999999875 689999999999999999999887765554443333322211111111
Q ss_pred ------cccccC-CCCCCCC---CHHHH------HHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 254 ------SLEIVD-PSLAASD---SGDQI------AMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 254 ------~~~~~~-~~~~~~~---~~~~~------~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
..+.+. +.+.... ..+.. ....+|+..++..||.+|+++++++..-
T Consensus 255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 011110 1011111 11111 2456899999999999999999998654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=265.63 Aligned_cols=233 Identities=21% Similarity=0.304 Sum_probs=187.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCc-EEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGR-EIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
..+++++..||-||||.|-+++.+... .+|+|++++. +....+.+..|-.||..++.|.||++|-.|.+...+|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 346777889999999999999877533 4888888765 333445678899999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
||-|-||.|..+| ..+++++.|||+++ .|||||+|++|+.+|-+||.|||+++.+..... .
T Consensus 499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K--T 576 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK--T 576 (732)
T ss_pred HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc--e
Confidence 9999999998887 35789999999999 999999999999999999999999998755432 3
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
-+++||+.|.|||++.+...+.++|.||||+++|||++|.+||....+...-+++- +.-... ..+
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL------kGid~i---------~~P 641 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL------KGIDKI---------EFP 641 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH------hhhhhh---------hcc
Confidence 36899999999999999999999999999999999999999997654433322221 111111 122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPT-----MRRVVVM 298 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~ 298 (381)
........+||++.+..+|.+|.- +.+|-+.
T Consensus 642 r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 642 RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 233345677888999999999976 5566543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=238.01 Aligned_cols=221 Identities=25% Similarity=0.361 Sum_probs=176.2
Q ss_pred CCeeEEEEEECC-CcEEEEEEecCCCccc-HHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCCCHHHHH--
Q 048280 62 GFGPVFKGKLDD-GREIAVKKLSHSSNQG-KKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVL-- 137 (381)
Q Consensus 62 ~~g~V~~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~~~l-- 137 (381)
+||.||+|.... ++.+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999764 8999999997665444 678999999999999999999999999999999999999998987654
Q ss_pred -------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccCccccchhHH
Q 048280 138 -------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYV 202 (381)
Q Consensus 138 -------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 202 (381)
.+++.++.++|..+ |+||+|.||+++.++.++|+|||.+....... ......++..|++||.+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAPEVL 158 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCHHHH
Confidence 57889999999998 99999999999999999999999998765432 22345678899999999
Q ss_pred hhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcc
Q 048280 203 MHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCT 282 (381)
Q Consensus 203 ~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 282 (381)
.+..++.++||||||+++|+|++|..||..... ..... .......... ..........+.+++.+||
T Consensus 159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~----~~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l 225 (244)
T smart00220 159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELF----KKIGKPKPPF-------PPPEWKISPEAKDLIRKLL 225 (244)
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHH----HHHhccCCCC-------ccccccCCHHHHHHHHHHc
Confidence 888899999999999999999999999854211 11111 1111111000 0000003456888999999
Q ss_pred cCCCCCCCCHHHHHH
Q 048280 283 QGDPQLRPTMRRVVV 297 (381)
Q Consensus 283 ~~dP~~RPs~~eil~ 297 (381)
..+|++||++.++++
T Consensus 226 ~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 226 VKDPEKRLTAEEALQ 240 (244)
T ss_pred cCCchhccCHHHHhh
Confidence 999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=262.63 Aligned_cols=244 Identities=18% Similarity=0.246 Sum_probs=164.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEE-----------------CCCcEEEEEEecCCCcccHHH--------------HHHHH
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKL-----------------DDGREIAVKKLSHSSNQGKKE--------------FENEA 97 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E~ 97 (381)
.++|++.++||+|+||.||+|.. ..++.||||++........+. ...|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 67899999999999999999963 235689999986543322233 33477
Q ss_pred HHHHHhCCCCc-----ccEEEEEee--------CCeEEEEEecccCCCHHHHH---------------------------
Q 048280 98 KLLARVQHRNV-----VNLLGYCAH--------GAEKLLIYEYVINESLDKVL--------------------------- 137 (381)
Q Consensus 98 ~~l~~l~hpnI-----v~~~~~~~~--------~~~~~lv~E~~~~g~L~~~l--------------------------- 137 (381)
.++.+++|.++ ++++++|.. ....+|||||+.+++|.+++
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77778876654 667777653 35689999999998886544
Q ss_pred ------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccCccccchhHHh
Q 048280 138 ------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM 203 (381)
Q Consensus 138 ------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 203 (381)
.|++.++.|+|..+ ||||||+|||++.++.+||+|||++...............+++.|+|||.+.
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 46788999999988 9999999999999999999999999765432221111223478999999875
Q ss_pred hCC--------------------C--CchhhhHhHHHHHHHHHhCCC-CCCCCCccccccHH--HHHHHHhhcCCccccc
Q 048280 204 HGH--------------------L--SVKADVFSFGVVILELISGQR-NSSFNLDVDAQNLL--DWAYKLYKKDKSLEIV 258 (381)
Q Consensus 204 ~~~--------------------~--~~~sDvwSlGvvl~elltg~~-p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 258 (381)
... + ..+.||||+||++|+|++|.. |+.....+.. .+. ......+....... .
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-~~~~~~~~~~~~r~~~~~~-~ 461 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-ELRQYDNDLNRWRMYKGQK-Y 461 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-HHhhccchHHHHHhhcccC-C
Confidence 432 1 134799999999999999875 5432111110 000 00001111100000 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCC---CCCCCHHHHHHH
Q 048280 259 DPSLAASDSGDQIAMCIQIGLLCTQGDP---QLRPTMRRVVVM 298 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~eil~~ 298 (381)
+ ...........++|+.+||..+| .+|+|+.|++++
T Consensus 462 ~----~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 462 D----FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred C----cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0 01112234567889999999766 689999999864
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=251.59 Aligned_cols=225 Identities=23% Similarity=0.262 Sum_probs=177.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc---ccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---QGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l 123 (381)
..+|..+.+||+|+||.|.+|..+ +.+.+|||++++.-. .+.+--+.|-++|... +-|.+++++.+|..-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 457999999999999999999765 477899999977522 2234445677888776 57899999999999999999
Q ss_pred EEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 124 IYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 124 v~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
||||+.||+|--.| ..++-+|-+||.++ .||||.+|||||.+|++||+|||+++.---. ...
T Consensus 428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~-~~T 506 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD-GVT 506 (683)
T ss_pred EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC-Ccc
Confidence 99999999996555 45788999999999 9999999999999999999999999842211 222
Q ss_pred ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
..+++||+.|+|||++...+|+..+|-|||||+||||+.|++||+...+. .+.+. +.... ...
T Consensus 507 TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~---elF~a---I~ehn-----------vsy 569 (683)
T KOG0696|consen 507 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQA---IMEHN-----------VSY 569 (683)
T ss_pred eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHH---HHHcc-----------CcC
Confidence 34689999999999999999999999999999999999999999754332 22211 11111 123
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCC
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPT 291 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs 291 (381)
+...+.+...+....|.+.|.+|.-
T Consensus 570 PKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 570 PKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred cccccHHHHHHHHHHhhcCCccccC
Confidence 3344556677888888999999954
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=249.20 Aligned_cols=273 Identities=23% Similarity=0.285 Sum_probs=200.1
Q ss_pred CCCCCCChHHHHHHHhhhCCCCChHHHHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHH
Q 048280 19 SSREGDNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEA 97 (381)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~ 97 (381)
..+..+++|+.++|-....+...+.+... .++|.+.++||.|.|++||++.+. ..+.||+|+++.. ....+..+.||
T Consensus 48 ~g~~~~eqE~~~dY~kGGYHpV~IGD~F~-~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEI 125 (590)
T KOG1290|consen 48 LGSDDEEQEDPEDYRKGGYHPVRIGDVFN-GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEI 125 (590)
T ss_pred ccCCcccccChhhhhcCCCceeecccccc-CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHH
Confidence 34455788888888888888777666533 368999999999999999999865 4788999998543 44557788999
Q ss_pred HHHHHhC-----C---CCcccEEEEEe----eCCeEEEEEecccCCCHHHHH-----------------HhhhhhhhHhh
Q 048280 98 KLLARVQ-----H---RNVVNLLGYCA----HGAEKLLIYEYVINESLDKVL-----------------FSLIKDIQILF 148 (381)
Q Consensus 98 ~~l~~l~-----h---pnIv~~~~~~~----~~~~~~lv~E~~~~g~L~~~l-----------------~~~~~~l~~lh 148 (381)
++|++++ | .+||+|++.|. ++.++|||+|++ |.+|.++| +|++.||.|||
T Consensus 126 klL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH 204 (590)
T KOG1290|consen 126 KLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLH 204 (590)
T ss_pred HHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHH
Confidence 9999994 3 36999999986 467899999998 77776554 79999999999
Q ss_pred hhc---cCCccccceEeCCC------------------------------------------------------------
Q 048280 149 RKK---KTDIKASNILLDDK------------------------------------------------------------ 165 (381)
Q Consensus 149 ~~~---HrDlkp~NIll~~~------------------------------------------------------------ 165 (381)
+.. |-||||+|||+..+
T Consensus 205 ~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~ 284 (590)
T KOG1290|consen 205 RECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKL 284 (590)
T ss_pred HhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhh
Confidence 987 99999999999100
Q ss_pred --------------------------------------------------------------------------------
Q 048280 166 -------------------------------------------------------------------------------- 165 (381)
Q Consensus 166 -------------------------------------------------------------------------------- 165 (381)
T Consensus 285 ~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~ 364 (590)
T KOG1290|consen 285 EASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGS 364 (590)
T ss_pred hhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhccccccccccc
Confidence
Q ss_pred --------------------------CCcEEeeeccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHH
Q 048280 166 --------------------------WIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVV 219 (381)
Q Consensus 166 --------------------------~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvv 219 (381)
-+|||+|||.|+..... .+.-..|..|+|||++.+..|++.+||||++|+
T Consensus 365 ~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~kh----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~ 440 (590)
T KOG1290|consen 365 LSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKH----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACM 440 (590)
T ss_pred ccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhhh----hchhhhhhhccCcceeecCCCCCchhHHHHHHH
Confidence 01566677766654322 222346889999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCcccc---ccHHHHHHHHhhc--------C-CcccccCCC--------C-----------CCCCCH
Q 048280 220 ILELISGQRNSSFNLDVDA---QNLLDWAYKLYKK--------D-KSLEIVDPS--------L-----------AASDSG 268 (381)
Q Consensus 220 l~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~--------~-~~~~~~~~~--------~-----------~~~~~~ 268 (381)
+|||+||...|......+. .+.+..+..+... + ...++++.. + .-.+..
T Consensus 441 ~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~ 520 (590)
T KOG1290|consen 441 AFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSE 520 (590)
T ss_pred HHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCH
Confidence 9999999988754322211 1222222111111 1 111111110 0 123566
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
+....+.+++.-||+.+|++|||+.++++.
T Consensus 521 e~A~~fsdFL~PmLef~PeKR~tA~~cl~h 550 (590)
T KOG1290|consen 521 EDAQQFSDFLSPMLEFDPEKRPTAAQCLKH 550 (590)
T ss_pred HHHHHHHHHHHHHHhcCccccccHHHHhcC
Confidence 788889999999999999999999999864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-34 Score=241.45 Aligned_cols=249 Identities=23% Similarity=0.346 Sum_probs=180.0
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeC-----CeEE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHG-----AEKL 122 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~ 122 (381)
+.+..+.||.|.||.||.+.+. +|+.||+|++..- .-...+.+.+|+++|..++|.|++..+++..-. .++|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 5566789999999999999865 6999999998543 223346788999999999999999988876433 2356
Q ss_pred EEEecccCCCHHH---------------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 123 LIYEYVINESLDK---------------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 123 lv~E~~~~g~L~~---------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
+++|.+ ..+|.+ +++||++||+|||+.+ ||||||.|+|++.|..+||||||+++....+...
T Consensus 134 V~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 134 VLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 777776 445554 4489999999999998 9999999999999999999999999976655555
Q ss_pred cccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHH--------HHHHhhcCCccc
Q 048280 186 VNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDW--------AYKLYKKDKSLE 256 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~ 256 (381)
..+..+-|.+|+|||++.|. .|+.+.||||.|||+.||+..+.-|....+....+++.. .....-++....
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H 292 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH 292 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence 55555678899999999875 699999999999999999998877755444433222211 000000111111
Q ss_pred ccCCCCCC---------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 257 IVDPSLAA---------SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 257 ~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
++...... ......-.....++..++..||++|.+..+.+..+.
T Consensus 293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11111110 011122234556778899999999999999887653
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-33 Score=225.33 Aligned_cols=185 Identities=27% Similarity=0.397 Sum_probs=150.8
Q ss_pred HHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC-CcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeE
Q 048280 45 LVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS-SNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEK 121 (381)
Q Consensus 45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 121 (381)
+....+....+..||+|+||.|-+-++. +|...|+|.+... ......+.++|+.+..+. .+|.+|.+||.......+
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 3344556667889999999999888765 5899999999755 233346678888887665 699999999999999999
Q ss_pred EEEEecccCCCHHHH-------------------HHhhhhhhhHhhhhc---cCCccccceEeCCCCCcEEeeeccceec
Q 048280 122 LLIYEYVINESLDKV-------------------LFSLIKDIQILFRKK---KTDIKASNILLDDKWIPKIADFGMARLF 179 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~-------------------l~~~~~~l~~lh~~~---HrDlkp~NIll~~~~~~kL~DFG~~~~~ 179 (381)
+|.||.| ..+|..+ ...+++++.|||++- |||+||+||||+.+|+||+||||++-.+
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 9999988 4555433 257889999999987 9999999999999999999999999887
Q ss_pred CCCCcccccccccCccccchhHHhh----CCCCchhhhHhHHHHHHHHHhCCCCCCC
Q 048280 180 PEDQTHVNTRVAGTNGYMAPEYVMH----GHLSVKADVFSFGVVILELISGQRNSSF 232 (381)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvvl~elltg~~p~~~ 232 (381)
.+.... +...|-..|||||.+.. ..|+.|+||||||+++.||++++.|++.
T Consensus 200 ~dSiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 200 VDSIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred hhhhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 543221 22457788999998854 3689999999999999999999999864
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=264.28 Aligned_cols=225 Identities=27% Similarity=0.389 Sum_probs=175.2
Q ss_pred CCCCCcccccCCee-EEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEEEEeccc
Q 048280 52 FHPSNKLGEGGFGP-VFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLLIYEYVI 129 (381)
Q Consensus 52 y~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~ 129 (381)
|...+.+|.|+-|+ ||+|... ++.||||.+-.. ......+||..|+.- +|||||++|+.-.+....||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 34456789998875 7999887 899999998532 235678999999988 5999999999999999999999998
Q ss_pred CCCHHHHH-------------------HhhhhhhhHhhhhc--cCCccccceEeCC-----CCCcEEeeeccceecCCCC
Q 048280 130 NESLDKVL-------------------FSLIKDIQILFRKK--KTDIKASNILLDD-----KWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 130 ~g~L~~~l-------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~-----~~~~kL~DFG~~~~~~~~~ 183 (381)
..+|.+++ .|++.|+++||..+ ||||||.||||+. ..+++|+|||+++.+....
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 55665544 68899999999988 9999999999965 2579999999999886544
Q ss_pred cc--cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhC-CCCCCCCCccccccHHHHHHHHhhcCCcccccCC
Q 048280 184 TH--VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISG-QRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDP 260 (381)
Q Consensus 184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
.. ...+..||-+|+|||++....-+.++||||||||+|+.++| ..||......+ ..+.........+.+
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--------~NIl~~~~~L~~L~~ 737 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--------ANILTGNYTLVHLEP 737 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--------hhhhcCccceeeecc
Confidence 32 23367899999999999998888999999999999999997 88886433221 222222222222211
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 261 SLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 261 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
. .++ ...+||.+|+..+|..||++.+|+.
T Consensus 738 ~------~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 738 L------PDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred C------chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1 111 5778999999999999999999973
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=252.61 Aligned_cols=188 Identities=24% Similarity=0.349 Sum_probs=157.4
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccH---HHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGK---KEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
.-|..++.||-|+||.|.+++.. +...||+|.+++.+--.+ ..++.|-.||..-+.+-||+||-.|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 45888999999999999999754 467789999977643333 34667999999999999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecC--------
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFP-------- 180 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~-------- 180 (381)
+|++||++-.+| ..+..++.+.|..+ ||||||+|||||.+|++||+|||+|.-+.
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 999999997665 46678999999999 99999999999999999999999996331
Q ss_pred -CCCcc--------------------------------cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCC
Q 048280 181 -EDQTH--------------------------------VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQ 227 (381)
Q Consensus 181 -~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~ 227 (381)
+.... .....+||+.|+|||++....|+..+|-||.|||||||+.|+
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence 00000 011356999999999999999999999999999999999999
Q ss_pred CCCCCCCccc
Q 048280 228 RNSSFNLDVD 237 (381)
Q Consensus 228 ~p~~~~~~~~ 237 (381)
.||.......
T Consensus 869 ~pf~~~tp~~ 878 (1034)
T KOG0608|consen 869 PPFLADTPGE 878 (1034)
T ss_pred CCccCCCCCc
Confidence 9997655443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-33 Score=253.07 Aligned_cols=259 Identities=20% Similarity=0.264 Sum_probs=194.4
Q ss_pred hhCCCCChHHHHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhC------CCC
Q 048280 35 REQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQ------HRN 107 (381)
Q Consensus 35 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------hpn 107 (381)
--..+|.+......-++|.+....|+|-|++|.+|... .|+.||||+|..+... ...=+.|++||++|+ --|
T Consensus 417 DaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 417 DAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred cccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhH
Confidence 34456777777777889999999999999999999865 4889999999766432 244568999999996 358
Q ss_pred cccEEEEEeeCCeEEEEEecccCCCHHHHH------------------HhhhhhhhHhhhhc--cCCccccceEeCCC-C
Q 048280 108 VVNLLGYCAHGAEKLLIYEYVINESLDKVL------------------FSLIKDIQILFRKK--KTDIKASNILLDDK-W 166 (381)
Q Consensus 108 Iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~-~ 166 (381)
+++++-.|...+++|||||-+ ..+|.++| .|+..+|..|-..+ |.||||+|||+++. .
T Consensus 496 clrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 496 CLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc
Confidence 999999999999999999987 66777766 67888888888777 99999999999864 5
Q ss_pred CcEEeeeccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 048280 167 IPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAY 246 (381)
Q Consensus 167 ~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 246 (381)
.+||||||.|....+.... .+.-+..|.|||++.|..|+...|+||.||+||||.||+..|++........+...+.
T Consensus 575 iLKLCDfGSA~~~~eneit---PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENEIT---PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred eeeeccCcccccccccccc---HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 7899999999877554332 2334567999999999999999999999999999999999887654433222111100
Q ss_pred -----HHhhcCC---------------------------cccccCCC------C-----CCCCCHHHHHHHHHHHHHccc
Q 048280 247 -----KLYKKDK---------------------------SLEIVDPS------L-----AASDSGDQIAMCIQIGLLCTQ 283 (381)
Q Consensus 247 -----~~~~~~~---------------------------~~~~~~~~------~-----~~~~~~~~~~~l~~li~~cl~ 283 (381)
.++.... .+..+.|. + ...........|.+|+..||.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 0000000 00011110 0 122334556788899999999
Q ss_pred CCCCCCCCHHHHHHH
Q 048280 284 GDPQLRPTMRRVVVM 298 (381)
Q Consensus 284 ~dP~~RPs~~eil~~ 298 (381)
.||++|.|..+.|..
T Consensus 732 LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 732 LDPEKRITVNQALKH 746 (752)
T ss_pred cChhhcCCHHHHhcC
Confidence 999999999998754
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=236.56 Aligned_cols=233 Identities=18% Similarity=0.264 Sum_probs=182.0
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 122 (381)
..++|+++.+||.|+|+.|.+++++ +.+.+|+|++++. +..+.+-++.|-.+..+. +||.+|.++.+|.....++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3578999999999999999999865 5889999999764 344455667788888777 7999999999999999999
Q ss_pred EEEecccCCCHHHH---------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 123 LIYEYVINESLDKV---------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 123 lv~E~~~~g~L~~~---------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
+|.||++||+|--. -..++.+|.|||+++ .||||.+|||||..|.+||+|+|+++.--... .
T Consensus 328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g-d 406 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG-D 406 (593)
T ss_pred EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCC-c
Confidence 99999999999322 256889999999999 99999999999999999999999998533222 2
Q ss_pred cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCc-cccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 186 VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLD-VDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
...+++||+.|.|||++.+..|...+|-|+|||+++||+.|+.||+.-.. ....+-.++..+.+-+.... -|.
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir---ipr--- 480 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR---IPR--- 480 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc---ccc---
Confidence 34568999999999999999999999999999999999999999964321 22233334433333222111 111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCC
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPT 291 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs 291 (381)
........+++.-|.+||.+|..
T Consensus 481 ----slsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 481 ----SLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ----eeehhhHHHHHHhhcCCcHHhcC
Confidence 11223445777889999999853
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=228.32 Aligned_cols=261 Identities=20% Similarity=0.312 Sum_probs=191.5
Q ss_pred ChHHHHHHHhhhCCCCChHHHHHhhcCCCCCCcccccCCeeEEEEE-ECCCcEEEEEEecCCCcccHHHHHHHHHHHHHh
Q 048280 25 NEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARV 103 (381)
Q Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l 103 (381)
+++-.+++.+.+.....+. ..++|++.+++|.|.|+.||.|. ..+++.++||+++.- ....+.+|++||..|
T Consensus 17 n~~rp~eYWdYE~~~i~wg----~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL 89 (338)
T KOG0668|consen 17 NEERPREYWDYESLVIDWG----NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNL 89 (338)
T ss_pred cccCchhhcchhheeeecc----ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhc
Confidence 3444566666665555544 36789999999999999999997 456889999999643 346789999999999
Q ss_pred C-CCCcccEEEEEeeC--CeEEEEEecccCCCHH------------HHHHhhhhhhhHhhhhc--cCCccccceEeCCC-
Q 048280 104 Q-HRNVVNLLGYCAHG--AEKLLIYEYVINESLD------------KVLFSLIKDIQILFRKK--KTDIKASNILLDDK- 165 (381)
Q Consensus 104 ~-hpnIv~~~~~~~~~--~~~~lv~E~~~~g~L~------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~- 165 (381)
. ||||++++++..+. ....||+||+.+.+.. -++.+++++|.|+|+.| |||+||.|++||..
T Consensus 90 ~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~ 169 (338)
T KOG0668|consen 90 RGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHEL 169 (338)
T ss_pred cCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhh
Confidence 7 99999999998764 4567999999876654 35689999999999999 99999999999854
Q ss_pred CCcEEeeeccceecCCCCcccccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 048280 166 WIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDW 244 (381)
Q Consensus 166 ~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~ 244 (381)
-.++|+|+|+|.+....... .-.+.+..|--||++..- .|+..-|+|||||+|..|+..+.||....+.. +.++..
T Consensus 170 rkLrlIDWGLAEFYHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~-DQLVkI 246 (338)
T KOG0668|consen 170 RKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVKI 246 (338)
T ss_pred ceeeeeecchHhhcCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH-HHHHHH
Confidence 47999999999887543322 223567889999988764 58899999999999999999999986543322 222221
Q ss_pred HHH--------HhhcCCcccccCCCCC---------------CCCCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 245 AYK--------LYKKDKSLEIVDPSLA---------------ASDSG-DQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 245 ~~~--------~~~~~~~~~~~~~~~~---------------~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
+.- ...... -.++|.+. ..... -...+.++|+...|..|-.+|+|++|.+.
T Consensus 247 akVLGt~el~~Yl~KY~--i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 247 AKVLGTDELYAYLNKYQ--IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHhChHHHHHHHHHHc--cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 110 000000 01222211 11111 12356788999999999999999999875
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=239.61 Aligned_cols=243 Identities=23% Similarity=0.304 Sum_probs=190.6
Q ss_pred HHHHHhhcCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEE
Q 048280 43 EALVSATKNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYC 115 (381)
Q Consensus 43 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 115 (381)
.++.....+++....+-+|.||.||.|.+. +.+.|.+|.++.. ++.....++.|.-.+..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 344445567888999999999999999543 3456778877644 344457788999999999999999999998
Q ss_pred ee-CCeEEEEEecccCCCHHHHH-----------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcE
Q 048280 116 AH-GAEKLLIYEYVINESLDKVL-----------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPK 169 (381)
Q Consensus 116 ~~-~~~~~lv~E~~~~g~L~~~l-----------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~k 169 (381)
.+ ....++++.++.-|+|..+| .|+..++.++|+++ |.||...|++||+..+||
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVk 436 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVK 436 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEE
Confidence 55 45678889999999999887 47888999999999 999999999999999999
Q ss_pred EeeeccceecCCCCcccc-cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHH
Q 048280 170 IADFGMARLFPEDQTHVN-TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYK 247 (381)
Q Consensus 170 L~DFG~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 247 (381)
|+|=.+++.+-......- ........||+||.+.+..|+.++|||||||+||||+| |+.|+..-.+++. ..
T Consensus 437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm-------~~ 509 (563)
T KOG1024|consen 437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM-------EH 509 (563)
T ss_pred eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH-------HH
Confidence 999999986543333222 22335678999999999999999999999999999998 7778754333322 11
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 248 LYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
..++ ..+...+.+++.++..++..||..+|++||++++++..|..
T Consensus 510 ylkd---------GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 510 YLKD---------GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHhc---------cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1221 22233444567789999999999999999999999998865
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=257.51 Aligned_cols=236 Identities=23% Similarity=0.312 Sum_probs=187.1
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
..++|+.+..+|.|.||.||++++. ++...|+|+++........-+.+|+-+++..+|||||.++|.+...+..|+.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3568999999999999999999865 689999999988776777788899999999999999999999999999999999
Q ss_pred cccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 127 YVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 127 ~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
||.+|+|.++- +..+.++.|+|.++ |||||-.|||+++.|.+||+|||.+..+.... .....
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~Krks 171 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AKRKS 171 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh-hhhhc
Confidence 99999997643 66789999999999 99999999999999999999999997664332 23346
Q ss_pred cccCccccchhHH---hhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 190 VAGTNGYMAPEYV---MHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 190 ~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
+.||++|||||+. ..+.|..++|||++|++..|+.--++|-..-.+ ..+..+.... ..+|.. ...
T Consensus 172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-------mr~l~LmTkS----~~qpp~-lkD 239 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-------MRALFLMTKS----GFQPPT-LKD 239 (829)
T ss_pred ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-------HHHHHHhhcc----CCCCCc-ccC
Confidence 7899999999976 356799999999999999999877766321100 1111111111 111111 112
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVV 296 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil 296 (381)
.......+.+|++.||.++|++||+++.++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 223456688899999999999999987764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=231.37 Aligned_cols=246 Identities=25% Similarity=0.302 Sum_probs=180.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeC------C
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHG------A 119 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~ 119 (381)
..+|.-++.+|.|.- .|..+.+. .++.||+|++... .....++..+|..++..++|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 457888899999988 66666433 5899999998644 233346778999999999999999999988532 4
Q ss_pred eEEEEEecccCCCH-------------HHHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 120 EKLLIYEYVINESL-------------DKVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 120 ~~~lv~E~~~~g~L-------------~~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
..|+|||++ ..+| ..+++|++.+++++|+.+ ||||||+||++..++.+||.|||+++.....
T Consensus 95 e~y~v~e~m-~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~-- 171 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD-- 171 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc--
Confidence 579999998 4444 455689999999999999 9999999999999999999999999864333
Q ss_pred ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHH----------------HHHHHH
Q 048280 185 HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLL----------------DWAYKL 248 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~----------------~~~~~~ 248 (381)
...+..+.|..|.|||++.+..+.+.+||||+||++.||++|+.-|.+....+.-... ..+...
T Consensus 172 ~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~y 251 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNY 251 (369)
T ss_pred cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHH
Confidence 3556678899999999999988999999999999999999999887644333221111 001111
Q ss_pred hhcCC------cccc-cCCCCCC--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 249 YKKDK------SLEI-VDPSLAA--SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 249 ~~~~~------~~~~-~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
..... ..+. .|..+.. ....-....+.+++.+||..||++|.+++++|+.
T Consensus 252 v~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 252 VENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 11000 0000 0111111 1112234556789999999999999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-29 Score=214.83 Aligned_cols=193 Identities=32% Similarity=0.567 Sum_probs=166.5
Q ss_pred ccccCCeeEEEEEECC-CcEEEEEEecCCCcc-cHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCCCHHH
Q 048280 58 LGEGGFGPVFKGKLDD-GREIAVKKLSHSSNQ-GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDK 135 (381)
Q Consensus 58 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~~ 135 (381)
||+|.+|.||++.... ++.+++|++...... ....+.+|++.++.++|++|+++++++......++++||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998764 899999998755432 34679999999999999999999999999999999999999899876
Q ss_pred HH----------------HhhhhhhhHhhhhc--cCCccccceEeCC-CCCcEEeeeccceecCCCCcccccccccCccc
Q 048280 136 VL----------------FSLIKDIQILFRKK--KTDIKASNILLDD-KWIPKIADFGMARLFPEDQTHVNTRVAGTNGY 196 (381)
Q Consensus 136 ~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~-~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y 196 (381)
++ .+++.++.++|..+ |+||+|.||+++. ++.++|+|||.+........ ......+...|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ 159 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGTPAY 159 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCCCCc
Confidence 64 57889999999999 9999999999999 89999999999987644321 12234577889
Q ss_pred cchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHH
Q 048280 197 MAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCI 275 (381)
Q Consensus 197 ~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 275 (381)
++||.+... .++.++|+|+||+++++| ..+.
T Consensus 160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------~~~~ 191 (215)
T cd00180 160 MAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------PELK 191 (215)
T ss_pred cChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------HHHH
Confidence 999999877 888999999999999999 3477
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHh
Q 048280 276 QIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 276 ~li~~cl~~dP~~RPs~~eil~~L 299 (381)
+++..|++.||.+||++.++++.+
T Consensus 192 ~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 192 DLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHhhCCcccCcCHHHHhhCC
Confidence 899999999999999999998643
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=238.76 Aligned_cols=180 Identities=21% Similarity=0.323 Sum_probs=151.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC-CcEEEEEEecCCCcc--------cHHHHHHHHHHHHHhC---CCCcccEEEEEe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD-GREIAVKKLSHSSNQ--------GKKEFENEAKLLARVQ---HRNVVNLLGYCA 116 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~---hpnIv~~~~~~~ 116 (381)
..+|..++.||+|+||.|++|.++. ...|+||.+.+...- ..-.+-.||+||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 4479999999999999999998775 667888988654211 1112446999999997 999999999999
Q ss_pred eCCeEEEEEecc-cCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeecccee
Q 048280 117 HGAEKLLIYEYV-INESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARL 178 (381)
Q Consensus 117 ~~~~~~lv~E~~-~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~ 178 (381)
+++.+||+||-- ++.+|.++| +|++.++++||.++ |||||-+||.++.+|.+||+|||.+.+
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 999999999964 455666655 89999999999999 999999999999999999999999987
Q ss_pred cCCCCcccccccccCccccchhHHhhCCC-CchhhhHhHHHHHHHHHhCCCCCC
Q 048280 179 FPEDQTHVNTRVAGTNGYMAPEYVMHGHL-SVKADVFSFGVVILELISGQRNSS 231 (381)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~ 231 (381)
..... ...++||..|.|||++.|..| +..-|||++|++||.++....||.
T Consensus 720 ~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 720 TKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 64433 335789999999999999887 456899999999999999888873
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-30 Score=216.90 Aligned_cols=245 Identities=18% Similarity=0.291 Sum_probs=177.6
Q ss_pred HHHHhhhCCCCChHHHHHhhcCCCCCCcccccCCeeEEEEEECC-CcEEEEEEecCCCcccHHHHHHHHHHHHHh-CCCC
Q 048280 30 EKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLDD-GREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRN 107 (381)
Q Consensus 30 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpn 107 (381)
+-|+..+...+.+ .+.|.+.+.||+|.||.+.+++++. ...+++|.+... .....+|.+|...--.| .|.|
T Consensus 10 h~I~~~el~kv~l------~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~h 82 (378)
T KOG1345|consen 10 HLIPMEELKKVDL------EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQH 82 (378)
T ss_pred cccccccccccch------hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchh
Confidence 3444444555555 4478999999999999999999874 778899988544 34467899998877667 4899
Q ss_pred cccEEEE-EeeCCeEEEEEecccCCCHHHH--------------HHhhhhhhhHhhhhc--cCCccccceEeC--CCCCc
Q 048280 108 VVNLLGY-CAHGAEKLLIYEYVINESLDKV--------------LFSLIKDIQILFRKK--KTDIKASNILLD--DKWIP 168 (381)
Q Consensus 108 Iv~~~~~-~~~~~~~~lv~E~~~~g~L~~~--------------l~~~~~~l~~lh~~~--HrDlkp~NIll~--~~~~~ 168 (381)
|+.-|++ |+..+.+++++||++.|+|..- ..|++.+|.|+|++. |||||.+||||- +..+|
T Consensus 83 Ii~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rv 162 (378)
T KOG1345|consen 83 IIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRV 162 (378)
T ss_pred hhHHHHHHhhcCceEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEE
Confidence 9998865 6777888999999999999654 379999999999999 999999999993 34489
Q ss_pred EEeeeccceecCCCCcccccccccCccccchhHHhhC-----CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHH
Q 048280 169 KIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG-----HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLD 243 (381)
Q Consensus 169 kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~ 243 (381)
||||||+....+.... ...-+..|.+||+.... ...+.+|||.||+++|.++||+.||..... +... -
T Consensus 163 KlcDFG~t~k~g~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~--Y 235 (378)
T KOG1345|consen 163 KLCDFGLTRKVGTTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKP--Y 235 (378)
T ss_pred EeeecccccccCceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCch--H
Confidence 9999999986433221 12246679999987543 246789999999999999999999963221 1222 2
Q ss_pred HHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 048280 244 WAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRR 294 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 294 (381)
|.+..+........ | .....+...+..+.++-|..++++|--..+
T Consensus 236 ~~~~~w~~rk~~~~--P----~~F~~fs~~a~r~Fkk~lt~~~~drcki~~ 280 (378)
T KOG1345|consen 236 WEWEQWLKRKNPAL--P----KKFNPFSEKALRLFKKSLTPRFKDRCKIWT 280 (378)
T ss_pred HHHHHHhcccCccC--c----hhhcccCHHHHHHHHHhcCCcccccchhHH
Confidence 22333333322211 1 122234456777888899999999943333
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=213.81 Aligned_cols=180 Identities=32% Similarity=0.509 Sum_probs=155.8
Q ss_pred CCCCCcccccCCeeEEEEEECC-CcEEEEEEecCCCcc-cHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEeccc
Q 048280 52 FHPSNKLGEGGFGPVFKGKLDD-GREIAVKKLSHSSNQ-GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVI 129 (381)
Q Consensus 52 y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 129 (381)
|.+.+.||.|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5678899999999999998775 899999999766544 56789999999999999999999999999999999999999
Q ss_pred CCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccc
Q 048280 130 NESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVA 191 (381)
Q Consensus 130 ~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~ 191 (381)
+++|.+++ .+++.++.++|..+ |+||+|.||+++.++.++|+|||.+...............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 160 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVK 160 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccccee
Confidence 98887654 56788999999998 9999999999999999999999999877544211223346
Q ss_pred cCccccchhHH-hhCCCCchhhhHhHHHHHHHHHhCCCCCC
Q 048280 192 GTNGYMAPEYV-MHGHLSVKADVFSFGVVILELISGQRNSS 231 (381)
Q Consensus 192 gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg~~p~~ 231 (381)
++..|++||.+ ....++.++|||+||+++++|++|+.||.
T Consensus 161 ~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 161 GTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 78889999998 66678889999999999999999999984
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=217.55 Aligned_cols=251 Identities=25% Similarity=0.342 Sum_probs=182.5
Q ss_pred HHhhcCCCCCCcccccCCeeEEEEEEC----CCcEEEEEEecCCCcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCe
Q 048280 46 VSATKNFHPSNKLGEGGFGPVFKGKLD----DGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAE 120 (381)
Q Consensus 46 ~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 120 (381)
....+.|..+++||+|.|++||++.+. ..+.||+|.+..... ..++.+|+++|..+ -+.||+++.+++..++.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 344667999999999999999999632 478899999876543 36689999999999 59999999999999999
Q ss_pred EEEEEecccCCCHH------------HHHHhhhhhhhHhhhhc--cCCccccceEeCC-CCCcEEeeeccceecCCC---
Q 048280 121 KLLIYEYVINESLD------------KVLFSLIKDIQILFRKK--KTDIKASNILLDD-KWIPKIADFGMARLFPED--- 182 (381)
Q Consensus 121 ~~lv~E~~~~g~L~------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~-~~~~kL~DFG~~~~~~~~--- 182 (381)
+.+|+||++..... .+++.++.+|.++|.++ ||||||+|+|.+. .+.-.|.|||++......
T Consensus 110 v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~ 189 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQT 189 (418)
T ss_pred eEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhh
Confidence 99999999876654 45588999999999999 9999999999974 567899999999721000
Q ss_pred -------------------------------Cccc---------ccccccCccccchhHHhhC-CCCchhhhHhHHHHHH
Q 048280 183 -------------------------------QTHV---------NTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVIL 221 (381)
Q Consensus 183 -------------------------------~~~~---------~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~ 221 (381)
.... .....||++|+|||++... .-++++||||.|||++
T Consensus 190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~L 269 (418)
T KOG1167|consen 190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILL 269 (418)
T ss_pred hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceee
Confidence 0000 0135699999999998765 4689999999999999
Q ss_pred HHHhCCCCCCCCCccccccHHHHHH-----------HHhhc------CCc---------ccccC-CCC--------CCC-
Q 048280 222 ELISGQRNSSFNLDVDAQNLLDWAY-----------KLYKK------DKS---------LEIVD-PSL--------AAS- 265 (381)
Q Consensus 222 elltg~~p~~~~~~~~~~~~~~~~~-----------~~~~~------~~~---------~~~~~-~~~--------~~~- 265 (381)
-+++++.||....+ +...+.+.+. ..... ... .+.++ ... ...
T Consensus 270 slls~~~PFf~a~d-d~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~ 348 (418)
T KOG1167|consen 270 SLLSRRYPFFKAKD-DADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI 348 (418)
T ss_pred hhhccccccccCcc-ccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence 99999999854322 2222221110 00000 000 00010 000 001
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 266 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
........+++|+.+|+..||.+|.|+++.|+.-
T Consensus 349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 349 GSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred ccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 1112334789999999999999999999998643
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-27 Score=244.15 Aligned_cols=177 Identities=16% Similarity=0.198 Sum_probs=120.3
Q ss_pred HhCC-CCcccEEEEE-------eeCCeEEEEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCc
Q 048280 102 RVQH-RNVVNLLGYC-------AHGAEKLLIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDI 155 (381)
Q Consensus 102 ~l~h-pnIv~~~~~~-------~~~~~~~lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDl 155 (381)
.++| +||++++++| .....++++|||+ +++|.++| .|++.||.|||+++ ||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3445 5788888877 2234567778877 66786655 69999999999998 9999
Q ss_pred cccceEeCC-------------------CCCcEEeeeccceecCCCCc---------------ccccccccCccccchhH
Q 048280 156 KASNILLDD-------------------KWIPKIADFGMARLFPEDQT---------------HVNTRVAGTNGYMAPEY 201 (381)
Q Consensus 156 kp~NIll~~-------------------~~~~kL~DFG~~~~~~~~~~---------------~~~~~~~gt~~y~aPE~ 201 (381)
||+||||+. ++.+||+|||+++....... .......||+.|+|||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999954 44566666666653211000 00112357889999999
Q ss_pred HhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHc
Q 048280 202 VMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLC 281 (381)
Q Consensus 202 ~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 281 (381)
+.+..++.++|||||||+||||++|..|+.... ... ..... . ...+.. .........++.+|
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~---~~~~~-~----~~~~~~-----~~~~~~~~~~~~~~ 248 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTM---SSLRH-R----VLPPQI-----LLNWPKEASFCLWL 248 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHH---HHHHH-h----hcChhh-----hhcCHHHHHHHHHh
Confidence 999999999999999999999999887753110 000 01100 0 011111 01123355788899
Q ss_pred ccCCCCCCCCHHHHHH
Q 048280 282 TQGDPQLRPTMRRVVV 297 (381)
Q Consensus 282 l~~dP~~RPs~~eil~ 297 (381)
|+.||.+||++.||++
T Consensus 249 L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 249 LHPEPSCRPSMSELLQ 264 (793)
T ss_pred CCCChhhCcChHHHhh
Confidence 9999999999999975
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-26 Score=209.59 Aligned_cols=169 Identities=18% Similarity=0.213 Sum_probs=131.6
Q ss_pred HHHHHhhcCCCCCCcccccCCeeEEEEEEC--CCcEEEEEEecCC-----CcccHHHHHHHHHHHHHhCCCCcccEEEEE
Q 048280 43 EALVSATKNFHPSNKLGEGGFGPVFKGKLD--DGREIAVKKLSHS-----SNQGKKEFENEAKLLARVQHRNVVNLLGYC 115 (381)
Q Consensus 43 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 115 (381)
..+....++|.+.+.||+|+||.||+|++. +++.||||++... .......+.+|+++|++++|+||+..+..
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~- 89 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA- 89 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence 344556778999999999999999999865 4777899987532 12234668999999999999999963322
Q ss_pred eeCCeEEEEEecccCCCHH--------HHHHhhhhhhhHhhhhc--cCCc-cccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 116 AHGAEKLLIYEYVINESLD--------KVLFSLIKDIQILFRKK--KTDI-KASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 116 ~~~~~~~lv~E~~~~g~L~--------~~l~~~~~~l~~lh~~~--HrDl-kp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
.+..|+||||+++++|. .++.+++.+|.|+|+.+ |||| ||+|||++.++.+||+|||+++.+.....
T Consensus 90 --~~~~~LVmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~ 167 (365)
T PRK09188 90 --TGKDGLVRGWTEGVPLHLARPHGDPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGA 167 (365)
T ss_pred --cCCcEEEEEccCCCCHHHhCccchHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcc
Confidence 24579999999999885 45678999999999998 9999 99999999999999999999997754331
Q ss_pred ccc-------cccccCccccchhHHhhCC------CCchhhhH
Q 048280 185 HVN-------TRVAGTNGYMAPEYVMHGH------LSVKADVF 214 (381)
Q Consensus 185 ~~~-------~~~~gt~~y~aPE~~~~~~------~~~~sDvw 214 (381)
... ....+++.|+|||.+.... .+..+|-|
T Consensus 168 ~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 168 LYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred hhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 111 3566888999999886432 23446666
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=188.33 Aligned_cols=149 Identities=20% Similarity=0.234 Sum_probs=109.8
Q ss_pred CHHHHHHhhhhhhhHhhhhccCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccCccccchhHHhhCCCCchh
Q 048280 132 SLDKVLFSLIKDIQILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKA 211 (381)
Q Consensus 132 ~L~~~l~~~~~~l~~lh~~~HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s 211 (381)
.+..++.|++.||.|+|+.+ ||+|||++.++.+|+ ||++....... ..||+.|+|||++.+..++.++
T Consensus 18 ~~~~i~~qi~~~L~~lH~~~----kp~Nil~~~~~~~~~--fG~~~~~~~~~------~~g~~~y~aPE~~~~~~~~~~~ 85 (176)
T smart00750 18 EIWAVCLQCLRALRELHRQA----KSGNILLTWDGLLKL--DGSVAFKTPEQ------SRVDPYFMAPEVIQGQSYTEKA 85 (176)
T ss_pred HHHHHHHHHHHHHHHHHhcC----CcccEeEcCccceee--ccceEeecccc------CCCcccccChHHhcCCCCcchh
Confidence 34567799999999999976 999999999999999 99998754322 2588999999999999999999
Q ss_pred hhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHH--HHHHHHHHcccCCCCCC
Q 048280 212 DVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIA--MCIQIGLLCTQGDPQLR 289 (381)
Q Consensus 212 DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~l~~li~~cl~~dP~~R 289 (381)
|||||||++|||++|+.||...... ............. ..+.. ......... .+.+++.+||..||.+|
T Consensus 86 DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~------~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~R 156 (176)
T smart00750 86 DIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPA------DDPRD-RSNLESVSAARSFADFMRVCASRLPQRR 156 (176)
T ss_pred hHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhcc------CCccc-cccHHHHHhhhhHHHHHHHHHhcccccc
Confidence 9999999999999999998533211 1111111111110 00000 011122223 58999999999999999
Q ss_pred CCHHHHHHHhcC
Q 048280 290 PTMRRVVVMLSK 301 (381)
Q Consensus 290 Ps~~eil~~L~~ 301 (381)
|++.++++.+..
T Consensus 157 p~~~~ll~~~~~ 168 (176)
T smart00750 157 EAANHYLAHCRA 168 (176)
T ss_pred cCHHHHHHHHHH
Confidence 999999988754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=193.32 Aligned_cols=239 Identities=19% Similarity=0.204 Sum_probs=176.1
Q ss_pred CCCCCCcccccCCeeEEEEEECCC--cEEEEEEecCCCcccHHHHHHHHHHHHHhCC----CCcccEEEEE-eeCCeEEE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLDDG--REIAVKKLSHSSNQGKKEFENEAKLLARVQH----RNVVNLLGYC-AHGAEKLL 123 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----pnIv~~~~~~-~~~~~~~l 123 (381)
+|.+.+.||+|+||.||++..... ..+|+|............+..|+.++..+.. .++..+++.. ......|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999987653 4788888765533333378889999999973 6889999888 57788999
Q ss_pred EEecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCC-----CCcEEeeeccce--
Q 048280 124 IYEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDK-----WIPKIADFGMAR-- 177 (381)
Q Consensus 124 v~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~-----~~~kL~DFG~~~-- 177 (381)
||+.+ |.+|.++. .|++.+|.++|+.+ ||||||+|+++... ..+.|.|||+++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 99988 88887655 58999999999999 99999999999765 469999999998
Q ss_pred ecCCCCcc------c-ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhh
Q 048280 178 LFPEDQTH------V-NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYK 250 (381)
Q Consensus 178 ~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 250 (381)
.+...... . ...+.||..|+++.+..+...+.+.|+||++.++.+++.|..||......... ........
T Consensus 178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~---~~~~~~~~ 254 (322)
T KOG1164|consen 178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK---SKFEKDPR 254 (322)
T ss_pred cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH---HHHHHHhh
Confidence 32222111 1 12456999999999999999999999999999999999999998543322221 11111111
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 251 KDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
... ... .....+..+.++...+-..+...+|....+...|...
T Consensus 255 ~~~----~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 255 KLL----TDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred hhc----ccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 100 000 1111223344555555668999999999998887554
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=186.49 Aligned_cols=161 Identities=14% Similarity=0.178 Sum_probs=129.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHH---------HHHHHHHHHHHhCCCCcccEEEEEeeC-
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKK---------EFENEAKLLARVQHRNVVNLLGYCAHG- 118 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~---------~~~~E~~~l~~l~hpnIv~~~~~~~~~- 118 (381)
.++|++++.||.|+||.||++.. ++..+|||.+......... .+.+|++.+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 67899999999999999999766 5778999999755332222 268999999999999999999886643
Q ss_pred -------CeEEEEEecccCCCHHHH-------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCC
Q 048280 119 -------AEKLLIYEYVINESLDKV-------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPED 182 (381)
Q Consensus 119 -------~~~~lv~E~~~~g~L~~~-------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~ 182 (381)
...+|||||++|.+|.++ +.+++.++..+|+.+ ||||||+||+++.++ ++|+|||......+.
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~ 187 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQR 187 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccch
Confidence 357899999999999654 578999999999999 999999999999988 999999988754322
Q ss_pred CcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHH
Q 048280 183 QTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELI 224 (381)
Q Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ell 224 (381)
... ..++....|..++||||||+++..+.
T Consensus 188 ~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 188 KAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred hhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 111 11345556778999999999987654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-22 Score=184.31 Aligned_cols=241 Identities=27% Similarity=0.413 Sum_probs=181.3
Q ss_pred CCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcc---cHHHHHHHHHHHHHhCCC-CcccEEEEEeeCCeEEEEEec
Q 048280 52 FHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQ---GKKEFENEAKLLARVQHR-NVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 52 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~~~~~lv~E~ 127 (381)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +|+++++++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 778899999999999999877 78899998765333 367899999999999988 799999999877778999999
Q ss_pred ccCCCHHHHH------------------HhhhhhhhHhhhhc--cCCccccceEeCCCC-CcEEeeeccceecCCCCcc-
Q 048280 128 VINESLDKVL------------------FSLIKDIQILFRKK--KTDIKASNILLDDKW-IPKIADFGMARLFPEDQTH- 185 (381)
Q Consensus 128 ~~~g~L~~~l------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~-~~kL~DFG~~~~~~~~~~~- 185 (381)
+.+++|.+++ .+++.++.++|..+ ||||||+||+++..+ .++++|||++..+......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS 159 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc
Confidence 9998887433 57788899999998 999999999999988 7999999999866544322
Q ss_pred ----cccccccCccccchhHHhh---CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCccccc
Q 048280 186 ----VNTRVAGTNGYMAPEYVMH---GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIV 258 (381)
Q Consensus 186 ----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
......|+..|+|||.+.+ ..++...|+||+|++++++++|..||...... ................ ..
T Consensus 160 ~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~-~~ 235 (384)
T COG0515 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP-SL 235 (384)
T ss_pred cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc-cc
Confidence 2345789999999999987 57899999999999999999999996543321 0011111111111110 00
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 259 DPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
...............+.+++..|+..+|..|.+..+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000000002223567788999999999999999887754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-25 Score=217.19 Aligned_cols=236 Identities=22% Similarity=0.252 Sum_probs=172.1
Q ss_pred CCCCcccccCCeeEEEEEEC-CCcEEEEEEecC---CCcccH---HHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 53 HPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSH---SSNQGK---KEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 53 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~---~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
.....+|.|.+|.|+.+... .....+.|.+.. ...... ..+..|+-+-..+.|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45788999999988877543 334344443321 111111 12556777778889999988877776666666669
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc---c
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT---H 185 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~---~ 185 (381)
|||++ +|..++ .|++.|++|+|..+ |||||++|+++..+|.+||+|||.+..+..... .
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~ 479 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH 479 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence 99988 876544 79999999999999 999999999999999999999999987654433 3
Q ss_pred cccccccCccccchhHHhhCCCCc-hhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 186 VNTRVAGTNGYMAPEYVMHGHLSV-KADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
....++|+..|+|||++.+..|.+ ..||||.|+++..|++|+.||......+... .........-...-..
T Consensus 480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--------~~~~~~~~~~~~~~~~ 551 (601)
T KOG0590|consen 480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--------KTNNYSDQRNIFEGPN 551 (601)
T ss_pred hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--------hhhccccccccccChH
Confidence 455788999999999999999875 4899999999999999999986554433321 0000000000111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.....++.....+|.+||+.||.+|.|+++|++
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 233455677788999999999999999999986
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-23 Score=173.16 Aligned_cols=236 Identities=18% Similarity=0.237 Sum_probs=174.1
Q ss_pred hcCCCCCCcccccCCeeEEEEE-ECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCC-CCcccEEEEEeeCCeEEEEEe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQH-RNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~E 126 (381)
.++|.++++||+|+||.+|+|. ..+|..||||.-..... ..++..|.++...|++ ..|..+..+..+...-.+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 5689999999999999999997 55799999998754432 2467789999999975 677777778888889999999
Q ss_pred cccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCC---CCCcEEeeeccceecCCCCcc
Q 048280 127 YVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDD---KWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 127 ~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~---~~~~kL~DFG~~~~~~~~~~~ 185 (381)
.+ |.+|++++ -|++..+.|+|.++ ||||||+|+|..- ...+.|+|||+++.+.+....
T Consensus 92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 98 99998775 58899999999999 9999999999953 346899999999976443221
Q ss_pred ------cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccC
Q 048280 186 ------VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVD 259 (381)
Q Consensus 186 ------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
......||..|.+-....+..-+.+.|+-|+|.+|.++..|..||..-.........+. +.+.+. ...-
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk----I~EkK~-s~~i 245 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK----ISEKKM-STPI 245 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH----HHHhhc-CCCH
Confidence 22356799999998888888888999999999999999999999965443322221111 111110 0011
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 048280 260 PSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVV 296 (381)
Q Consensus 260 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 296 (381)
..+.. ..+.++.-.+.-|-..--++-|...-|.
T Consensus 246 e~LC~----G~P~EF~myl~Y~R~L~F~E~Pdy~ylr 278 (341)
T KOG1163|consen 246 EVLCK----GFPAEFAMYLNYCRGLGFEEKPDYMYLR 278 (341)
T ss_pred HHHhC----CCcHHHHHHHHHHhhcCCCCCCcHHHHH
Confidence 11122 2334455666677777777777754443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.2e-24 Score=179.71 Aligned_cols=228 Identities=21% Similarity=0.330 Sum_probs=172.6
Q ss_pred CCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
+..+.-+|.+...|..|+|++. |..+++|++.... ....++|..|.-.|+-+.||||+.++|.|.......++..|+
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 3445567888999999999997 5667777775432 222367888999999999999999999999999999999999
Q ss_pred cCCCHHHHH-----------------HhhhhhhhHhhhhc----cCCccccceEeCCCCCcEEe--eeccceecCCCCcc
Q 048280 129 INESLDKVL-----------------FSLIKDIQILFRKK----KTDIKASNILLDDKWIPKIA--DFGMARLFPEDQTH 185 (381)
Q Consensus 129 ~~g~L~~~l-----------------~~~~~~l~~lh~~~----HrDlkp~NIll~~~~~~kL~--DFG~~~~~~~~~~~ 185 (381)
+.|+|..+| .+++++++|||+.. .--|....|+||++.+++|. |--++..
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq------- 342 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------- 342 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-------
Confidence 999998877 67899999999987 34688889999999988775 3221111
Q ss_pred cccccccCccccchhHHhhCCC---CchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 186 VNTRVAGTNGYMAPEYVMHGHL---SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
.....-.+.||+||.++..+- -.++|+|||.++||||.|...||....+.+.. . .+.-..+
T Consensus 343 -e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg------m---------kialegl 406 (448)
T KOG0195|consen 343 -EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG------M---------KIALEGL 406 (448)
T ss_pred -ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh------h---------hhhhccc
Confidence 112234688999999987653 35799999999999999999998654433221 1 1111223
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
+...++.....+.+|+.-|+..||.+||.++.|+-.|++.
T Consensus 407 rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 3334444556678899999999999999999999888763
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=169.18 Aligned_cols=182 Identities=23% Similarity=0.389 Sum_probs=154.3
Q ss_pred hcCCCCCCcccccCCeeEEEEE-ECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhC-CCCcccEEEEEeeCCeEEEEEe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQ-HRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~E 126 (381)
.-.|++.++||+|+||.++.|. +-+++.||||.-...+ ...++..|.+..+.|. .++|..+|-+-.++.+-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 4479999999999999999997 3468999999864332 3357788999999985 7999999988888889999999
Q ss_pred cccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCC-----CcEEeeeccceecCCCC
Q 048280 127 YVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKW-----IPKIADFGMARLFPEDQ 183 (381)
Q Consensus 127 ~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~-----~~kL~DFG~~~~~~~~~ 183 (381)
++ |.+|++++ .|++..++++|.+. .|||||+|+||...+ .+.|+|||+++.+.+..
T Consensus 105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 98 99998776 68999999999988 899999999996443 58999999999775543
Q ss_pred cc------cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCC
Q 048280 184 TH------VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFN 233 (381)
Q Consensus 184 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 233 (381)
.. ......||..||+-....+..-+.+.|+-|||-|+++.|-|..||..-
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 32 233567999999999999999999999999999999999999999653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=201.23 Aligned_cols=232 Identities=23% Similarity=0.287 Sum_probs=166.2
Q ss_pred CCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCC-cccHHHHHHHHHH--HHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSS-NQGKKEFENEAKL--LARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
+|...+.||.+.|=.|.+|+++.|. |+||++-+.+ ....+.|.++++- ...++|||++.+.-+...+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6888999999999999999998777 9999986554 4444555544433 4445899999998887777888888888
Q ss_pred ccCCCHHHH---------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccce--ecCCCCccccc
Q 048280 128 VINESLDKV---------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMAR--LFPEDQTHVNT 188 (381)
Q Consensus 128 ~~~g~L~~~---------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~--~~~~~~~~~~~ 188 (381)
+ ..+|.+. ++|++.++..+|..+ |||||.+||||+.-.-+.|+||..-+ ++.+++....+
T Consensus 103 v-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~ 181 (1431)
T KOG1240|consen 103 V-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFT 181 (1431)
T ss_pred H-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccce
Confidence 8 4455443 389999999999999 99999999999999999999998776 33444332222
Q ss_pred ----ccccCccccchhHHhhC----------C-CCchhhhHhHHHHHHHHHhC-CCCCCCCCccccccHHHHHHH-Hhhc
Q 048280 189 ----RVAGTNGYMAPEYVMHG----------H-LSVKADVFSFGVVILELISG-QRNSSFNLDVDAQNLLDWAYK-LYKK 251 (381)
Q Consensus 189 ----~~~gt~~y~aPE~~~~~----------~-~~~~sDvwSlGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~-~~~~ 251 (381)
+...-.+|+|||.+... . .+++-||||+|||+.||++- +++|.. ..+..+... ....
T Consensus 182 fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 182 FFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAYRSGNADDP 255 (1431)
T ss_pred EEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhHhccCccCH
Confidence 22233589999988542 1 57889999999999999985 555532 111111110 0000
Q ss_pred CCcc-cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 252 DKSL-EIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 252 ~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
+... .+-| ..+..++..|++.||.+|.++++.|+.-.+.
T Consensus 256 e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 256 EQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred HHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 0000 1111 1366899999999999999999999876553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.8e-20 Score=156.38 Aligned_cols=175 Identities=16% Similarity=0.122 Sum_probs=134.6
Q ss_pred CCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCccc----HHHHHHHHHHHHHhC-CCCcccEEEEEeeCCeEEEEEe
Q 048280 52 FHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQG----KKEFENEAKLLARVQ-HRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 52 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~E 126 (381)
+.+...|++|+||+||.+.. .+.+++.+.+....... ...+.+|+++|++|. |++|.+++++ +..+++||
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 34578899999999998765 57888888776543321 235889999999995 5889999886 34699999
Q ss_pred cccCCCHHH--------HHHhhhhhhhHhhhhc--cCCc-cccceEeCCCCCcEEeeeccceecCCCCcc----c-----
Q 048280 127 YVINESLDK--------VLFSLIKDIQILFRKK--KTDI-KASNILLDDKWIPKIADFGMARLFPEDQTH----V----- 186 (381)
Q Consensus 127 ~~~~g~L~~--------~l~~~~~~l~~lh~~~--HrDl-kp~NIll~~~~~~kL~DFG~~~~~~~~~~~----~----- 186 (381)
|+.|.+|.+ ++.+++.++.++|+.+ |||| ||+|||++.++.++|+|||++......... .
T Consensus 79 yI~G~~L~~~~~~~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~ 158 (218)
T PRK12274 79 YLAGAAMYQRPPRGDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLR 158 (218)
T ss_pred eecCccHHhhhhhhhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHH
Confidence 999998853 4578889999999999 9999 799999999999999999999865443310 0
Q ss_pred ---ccccccCccccchhHHhhC-CCC-chhhhHhHHHHHHHHHhCCCCCC
Q 048280 187 ---NTRVAGTNGYMAPEYVMHG-HLS-VKADVFSFGVVILELISGQRNSS 231 (381)
Q Consensus 187 ---~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwSlGvvl~elltg~~p~~ 231 (381)
......++.|++|+...-- ..+ ...+-++-|+-+|.++|+..++-
T Consensus 159 ~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 159 HLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0122357788888865432 333 56677799999999999998753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-21 Score=184.77 Aligned_cols=215 Identities=25% Similarity=0.264 Sum_probs=167.4
Q ss_pred cccccCCeeEEEEEE----CCCcEEEEEEecCCCccc--HHHHHHHHHHHHHhC-CCCcccEEEEEeeCCeEEEEEeccc
Q 048280 57 KLGEGGFGPVFKGKL----DDGREIAVKKLSHSSNQG--KKEFENEAKLLARVQ-HRNVVNLLGYCAHGAEKLLIYEYVI 129 (381)
Q Consensus 57 ~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~E~~~ 129 (381)
.+|+|.||.|++++. ..+..+|+|+.++..... +.....|..++..++ ||.+|+++-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998752 347788999886553221 124556888888886 9999999999999999999999999
Q ss_pred CCCHHH---------------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccccc
Q 048280 130 NESLDK---------------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAG 192 (381)
Q Consensus 130 ~g~L~~---------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~g 192 (381)
+|.|.. ++..++-++..+|..+ +||+|++||+++.+|.+|+.|||+++..-+.... +|
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-----cg 155 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-----CG 155 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-----cc
Confidence 988853 3467888999999998 9999999999999999999999999965433322 89
Q ss_pred CccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHH
Q 048280 193 TNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIA 272 (381)
Q Consensus 193 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (381)
|..|||||++. .....+|-||||++++||++|..||.. +....+.. .....+.....
T Consensus 156 t~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~-----------~~~~~p~~l~~ 212 (612)
T KOG0603|consen 156 TYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILK-----------AELEMPRELSA 212 (612)
T ss_pred chhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhh-----------hccCCchhhhH
Confidence 99999999988 567889999999999999999999853 11111111 11234555666
Q ss_pred HHHHHHHHcccCCCCCCCCH--HHHHHHh
Q 048280 273 MCIQIGLLCTQGDPQLRPTM--RRVVVML 299 (381)
Q Consensus 273 ~l~~li~~cl~~dP~~RPs~--~eil~~L 299 (381)
.+..++..++..+|.+|.-. ..+.+..
T Consensus 213 ~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 213 EARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred HHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 77788889999999999765 3444443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.1e-21 Score=161.76 Aligned_cols=123 Identities=17% Similarity=0.200 Sum_probs=94.5
Q ss_pred CCcccccCCeeEEEEEECCCcEEEEEEecCCCcc--c-------H-----------------HHHHHHHHHHHHhCCCCc
Q 048280 55 SNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQ--G-------K-----------------KEFENEAKLLARVQHRNV 108 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~hpnI 108 (381)
.+.||+|+||.||+|...+|+.||||+++..... . . ....+|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 5789999999999999878999999999754211 1 0 122459999999988877
Q ss_pred ccEEEEEeeCCeEEEEEecccCCCHH---------------HHHHhhhhhhhHh-hhhc--cCCccccceEeCCCCCcEE
Q 048280 109 VNLLGYCAHGAEKLLIYEYVINESLD---------------KVLFSLIKDIQIL-FRKK--KTDIKASNILLDDKWIPKI 170 (381)
Q Consensus 109 v~~~~~~~~~~~~~lv~E~~~~g~L~---------------~~l~~~~~~l~~l-h~~~--HrDlkp~NIll~~~~~~kL 170 (381)
.....+... ..+|||||+.++++. +++.|++.+|.++ |+.+ ||||||+|||++ ++.++|
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~L 158 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYI 158 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEE
Confidence 544333222 238999999876553 3347889999999 5766 999999999998 478999
Q ss_pred eeeccceecC
Q 048280 171 ADFGMARLFP 180 (381)
Q Consensus 171 ~DFG~~~~~~ 180 (381)
+|||++....
T Consensus 159 iDFG~a~~~~ 168 (190)
T cd05147 159 IDVSQSVEHD 168 (190)
T ss_pred EEccccccCC
Confidence 9999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.4e-21 Score=180.29 Aligned_cols=197 Identities=23% Similarity=0.409 Sum_probs=148.2
Q ss_pred HHHhCCCCcccEEEEEeeCCeEEEEEecccCCCHHHHH----------------HhhhhhhhHhhhhc---cCCccccce
Q 048280 100 LARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVL----------------FSLIKDIQILFRKK---KTDIKASNI 160 (381)
Q Consensus 100 l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~---HrDlkp~NI 160 (381)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+++ +++++++.|+|... |+.|+..|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 35678999999999999999999999999999998876 68999999999877 999999999
Q ss_pred EeCCCCCcEEeeeccceecCCC-CcccccccccCccccchhHHhhCC-------CCchhhhHhHHHHHHHHHhCCCCCCC
Q 048280 161 LLDDKWIPKIADFGMARLFPED-QTHVNTRVAGTNGYMAPEYVMHGH-------LSVKADVFSFGVVILELISGQRNSSF 232 (381)
Q Consensus 161 ll~~~~~~kL~DFG~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDvwSlGvvl~elltg~~p~~~ 232 (381)
++|..+.+||+|||+....... .........-...|.|||.+.+.. .+.+.||||||++++|+++...||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 9999999999999999876421 111111222456799999987641 46779999999999999999999975
Q ss_pred CCcccc-ccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 233 NLDVDA-QNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 233 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
...... ..++..+.. .......|.+.... +....+..++..||..+|.+||++++|-..++...
T Consensus 161 ~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 433222 222222111 11122223322111 33446889999999999999999999988876643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-20 Score=164.48 Aligned_cols=213 Identities=18% Similarity=0.203 Sum_probs=135.0
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc---ccHHHHHHHHHHHHHhC----------CCCcccEEEEEe
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---QGKKEFENEAKLLARVQ----------HRNVVNLLGYCA 116 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~----------hpnIv~~~~~~~ 116 (381)
.+...+.||.|+++.||.+.+. +++.+|||++..... ...+.+.+|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3455789999999999999977 489999999854432 22345555553333321 222333333221
Q ss_pred ---------eCC--------eEEEEEecccCCCHHHHH----------------------HhhhhhhhHhhhhc--cCCc
Q 048280 117 ---------HGA--------EKLLIYEYVINESLDKVL----------------------FSLIKDIQILFRKK--KTDI 155 (381)
Q Consensus 117 ---------~~~--------~~~lv~E~~~~g~L~~~l----------------------~~~~~~l~~lh~~~--HrDl 155 (381)
... ..+++|+-+ .++|.+++ .|+++.++++|+.+ |+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 111 235677766 66776553 57788899999999 9999
Q ss_pred cccceEeCCCCCcEEeeeccceecCCCCcccccccccCccccchhHHhhC--------CCCchhhhHhHHHHHHHHHhCC
Q 048280 156 KASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG--------HLSVKADVFSFGVVILELISGQ 227 (381)
Q Consensus 156 kp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~sDvwSlGvvl~elltg~ 227 (381)
||+|+|++.+|.++|+||+.....+..... ...+..|.+||..... .++.+.|.|+||+++|.|.++.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999999999999888764332111 2345789999977542 4789999999999999999999
Q ss_pred CCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 048280 228 RNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLR 289 (381)
Q Consensus 228 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 289 (381)
.||........... ....+. +.++.+..||..+|+.||.+|
T Consensus 248 lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99875433211110 112334 777889999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.2e-20 Score=156.08 Aligned_cols=125 Identities=20% Similarity=0.242 Sum_probs=99.0
Q ss_pred CCCcccccCCeeEEEEEECCCcEEEEEEecCCCcc---------------------c-----HHHHHHHHHHHHHhCCCC
Q 048280 54 PSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQ---------------------G-----KKEFENEAKLLARVQHRN 107 (381)
Q Consensus 54 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~hpn 107 (381)
+...||+|+||.||+|...+|+.||||++...... . ...+.+|.+.+.++.|++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 35789999999999999778999999998765211 0 112457999999999998
Q ss_pred cccEEEEEeeCCeEEEEEecccCCCHH---------------HHHHhhhhhhhHhhh-hc--cCCccccceEeCCCCCcE
Q 048280 108 VVNLLGYCAHGAEKLLIYEYVINESLD---------------KVLFSLIKDIQILFR-KK--KTDIKASNILLDDKWIPK 169 (381)
Q Consensus 108 Iv~~~~~~~~~~~~~lv~E~~~~g~L~---------------~~l~~~~~~l~~lh~-~~--HrDlkp~NIll~~~~~~k 169 (381)
|.....+.... .+|||||+.++++. .++.+++.++.++|. .+ ||||||+|||++ ++.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 86555444332 48999999887432 334789999999999 77 999999999999 78999
Q ss_pred EeeeccceecCC
Q 048280 170 IADFGMARLFPE 181 (381)
Q Consensus 170 L~DFG~~~~~~~ 181 (381)
|+|||++..+..
T Consensus 158 liDFG~a~~~~~ 169 (190)
T cd05145 158 IIDVSQAVELDH 169 (190)
T ss_pred EEEcccceecCC
Confidence 999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-20 Score=168.59 Aligned_cols=180 Identities=21% Similarity=0.253 Sum_probs=123.1
Q ss_pred CCCCcccEEEEEee---------------------------CCeEEEEEecccCCCHHHHH--------------Hhhhh
Q 048280 104 QHRNVVNLLGYCAH---------------------------GAEKLLIYEYVINESLDKVL--------------FSLIK 142 (381)
Q Consensus 104 ~hpnIv~~~~~~~~---------------------------~~~~~lv~E~~~~g~L~~~l--------------~~~~~ 142 (381)
+|||||+++++|.+ +..+|+||.-+ ..+|..++ .|+++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRHRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCCCchHHHHHHHHHHHH
Confidence 49999999887643 24578999876 45666554 79999
Q ss_pred hhhHhhhhc--cCCccccceEe--CCCC--CcEEeeeccceecCCCCcc-----cccccccCccccchhHHhhCC-----
Q 048280 143 DIQILFRKK--KTDIKASNILL--DDKW--IPKIADFGMARLFPEDQTH-----VNTRVAGTNGYMAPEYVMHGH----- 206 (381)
Q Consensus 143 ~l~~lh~~~--HrDlkp~NIll--~~~~--~~kL~DFG~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~----- 206 (381)
++.+||.++ |||+|.+|||| |+++ .++|+|||++-........ ......|.-.-||||+....+
T Consensus 353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av 432 (598)
T KOG4158|consen 353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV 432 (598)
T ss_pred HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence 999999999 99999999999 3443 5789999998654332111 112345778899999876432
Q ss_pred -CCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCC
Q 048280 207 -LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGD 285 (381)
Q Consensus 207 -~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 285 (381)
.-.|+|.|+.|.+.||++....||....+..- +. ..+.+. --|.+... ++..+.+|+...|+.|
T Consensus 433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-~~-----r~Yqe~-----qLPalp~~----vpp~~rqlV~~lL~r~ 497 (598)
T KOG4158|consen 433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-DT-----RTYQES-----QLPALPSR----VPPVARQLVFDLLKRD 497 (598)
T ss_pred eccchhhhhhhhhhHHHHhccCCcccccchhee-ch-----hhhhhh-----hCCCCccc----CChHHHHHHHHHhcCC
Confidence 13689999999999999999999864221110 00 001111 11222222 2344677888899999
Q ss_pred CCCCCCHHHHHHHh
Q 048280 286 PQLRPTMRRVVVML 299 (381)
Q Consensus 286 P~~RPs~~eil~~L 299 (381)
|.+|++..-....|
T Consensus 498 pskRvsp~iAANvl 511 (598)
T KOG4158|consen 498 PSKRVSPNIAANVL 511 (598)
T ss_pred ccccCCccHHHhHH
Confidence 99999976554444
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=154.45 Aligned_cols=124 Identities=20% Similarity=0.328 Sum_probs=97.4
Q ss_pred CCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHh-----CCCCcccEEEEEeeCC---e-EE
Q 048280 52 FHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARV-----QHRNVVNLLGYCAHGA---E-KL 122 (381)
Q Consensus 52 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~---~-~~ 122 (381)
+.-.+.||+|+||.||. .-.++.. +||++........+.+.+|+++++.+ +||||++++|+++++. . +.
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34568999999999996 3233444 79998765444567899999999999 5799999999998873 4 34
Q ss_pred EEEec--ccCCCHHHHH------------Hhhhhhh-hHhhhhc--cCCccccceEeCC----CCCcEEeeeccce
Q 048280 123 LIYEY--VINESLDKVL------------FSLIKDI-QILFRKK--KTDIKASNILLDD----KWIPKIADFGMAR 177 (381)
Q Consensus 123 lv~E~--~~~g~L~~~l------------~~~~~~l-~~lh~~~--HrDlkp~NIll~~----~~~~kL~DFG~~~ 177 (381)
+|+|| +.+++|.+++ .+++.++ .|||+.+ ||||||+|||++. ++.++|+||+.+.
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~~~e~~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCRYEEDVAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred EEecCCCCcchhHHHHHHcccccHhHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 78999 5578997765 4667677 8999999 9999999999974 3489999954443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.6e-18 Score=173.13 Aligned_cols=182 Identities=18% Similarity=0.240 Sum_probs=141.8
Q ss_pred HHHHhhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhC---CCCcccEEEEEeeCCe
Q 048280 44 ALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQ---HRNVVNLLGYCAHGAE 120 (381)
Q Consensus 44 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~ 120 (381)
++......|.|.+.||+|+||.||+|...+|+.||+|+-+...... |.--.+++.+|+ -+-|+.+...+.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 3444567899999999999999999998889999999976654332 111223333443 2455566555566677
Q ss_pred EEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeC-------CCCCcEEeeeccc
Q 048280 121 KLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLD-------DKWIPKIADFGMA 176 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~-------~~~~~kL~DFG~~ 176 (381)
-+||+||.+.|+|.+++ .|++.-+..||..+ |+||||+|+||. .+..++|+|||.+
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 89999999999998876 68999999999999 999999999993 2346899999998
Q ss_pred eecCCC-CcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCC
Q 048280 177 RLFPED-QTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQR 228 (381)
Q Consensus 177 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~ 228 (381)
--+.-- ........++|-.+-.+|+..|..++..+|-|.|..+++-||.|+.
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 643211 1123446778999999999999999999999999999999999973
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.7e-19 Score=176.31 Aligned_cols=202 Identities=17% Similarity=0.269 Sum_probs=137.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC-CcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD-GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
..+|+.++.|..|+||.||.++++. .+.+|+| +.+.. .+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----hhhhc--cccccCCccee------------------
Confidence 4689999999999999999998774 6778884 33221 11111 22223344443
Q ss_pred ccCCCHHHHH----HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc--------------ccc
Q 048280 128 VINESLDKVL----FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT--------------HVN 187 (381)
Q Consensus 128 ~~~g~L~~~l----~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~--------------~~~ 187 (381)
-+..+|.+.+ .+++.+++|+|+.+ |||+||+|.+|+.-|.+|++|||+++....... ...
T Consensus 136 gDc~tllk~~g~lPvdmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~d 215 (1205)
T KOG0606|consen 136 GDCATLLKNIGPLPVDMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQD 215 (1205)
T ss_pred chhhhhcccCCCCcchhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhh
Confidence 1111222211 34478999999999 999999999999999999999999975422111 112
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
..++||+.|+|||++....|...+|-|++|+|+||.+.|..||....+.. ++.. .+...... .+..
T Consensus 216 KqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee---lfg~---visd~i~w--------pE~d 281 (1205)
T KOG0606|consen 216 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFGQ---VISDDIEW--------PEED 281 (1205)
T ss_pred ccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH---HHhh---hhhhhccc--------cccC
Confidence 36789999999999999999999999999999999999999987543322 1111 11111000 1111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRP 290 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RP 290 (381)
.....+..+++.+.|+.+|..|-
T Consensus 282 ea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 282 EALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred cCCCHHHHHHHHHHHHhChHhhc
Confidence 22234566788889999999995
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-19 Score=166.14 Aligned_cols=103 Identities=28% Similarity=0.434 Sum_probs=88.9
Q ss_pred eEEEEEecccCCCHHHHH------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceec
Q 048280 120 EKLLIYEYVINESLDKVL------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLF 179 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~~l------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~ 179 (381)
..||.|++|...+|.++| .|+..++.| ++ |+|+||.||++..+..+||+|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 578999999999998887 466666666 33 9999999999999999999999999876
Q ss_pred CCCC-----cccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh
Q 048280 180 PEDQ-----THVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS 225 (381)
Q Consensus 180 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt 225 (381)
.... ....+...||..||+||.+.+..|+.|+||||||++|+||+.
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 5444 223456789999999999999999999999999999999997
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.4e-17 Score=143.62 Aligned_cols=121 Identities=21% Similarity=0.340 Sum_probs=100.1
Q ss_pred cccccCCeeEEEEEECCCcEEEEEEecCCCc-c-------cHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 57 KLGEGGFGPVFKGKLDDGREIAVKKLSHSSN-Q-------GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 57 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~-------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
.||+|+||.||+|... +..|++|+...... . ....+.+|++++..+.|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999854 78899998653311 1 1255778999999999887766666666677789999999
Q ss_pred cCCCHH--------HHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceec
Q 048280 129 INESLD--------KVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLF 179 (381)
Q Consensus 129 ~~g~L~--------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~ 179 (381)
+|++|. .++.+++.++.++|..+ |+|++|.||+++ ++.++|+|||++...
T Consensus 80 ~g~~l~~~~~~~~~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGNDELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999997 45678899999999999 999999999999 789999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=144.01 Aligned_cols=134 Identities=20% Similarity=0.233 Sum_probs=105.2
Q ss_pred HHHHhhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcc----------------------cHHHHHHHHHHHH
Q 048280 44 ALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQ----------------------GKKEFENEAKLLA 101 (381)
Q Consensus 44 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~ 101 (381)
++......|.+.+.||+|+||.||++...+|+.||||++...... ....+.+|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 444444458889999999999999999888999999987543210 1123677999999
Q ss_pred HhCCCC--cccEEEEEeeCCeEEEEEecccCCCHHH---------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCc
Q 048280 102 RVQHRN--VVNLLGYCAHGAEKLLIYEYVINESLDK---------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIP 168 (381)
Q Consensus 102 ~l~hpn--Iv~~~~~~~~~~~~~lv~E~~~~g~L~~---------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~ 168 (381)
.+.|++ +...++. ...++||||+.+++|.. ++.+++.++.++|..+ ||||||+||+++.++.+
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 998874 4445442 34589999999988754 4478889999999988 99999999999999999
Q ss_pred EEeeeccceecCC
Q 048280 169 KIADFGMARLFPE 181 (381)
Q Consensus 169 kL~DFG~~~~~~~ 181 (381)
+|+|||++..+..
T Consensus 165 ~liDfg~~~~~~~ 177 (198)
T cd05144 165 YIIDWPQMVSTDH 177 (198)
T ss_pred EEEECCccccCCC
Confidence 9999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.5e-18 Score=149.82 Aligned_cols=133 Identities=17% Similarity=0.224 Sum_probs=102.2
Q ss_pred HHHHHhhcCCCCCCcccccCCeeEEEEE--ECCCcEEEEEEecCCCcc------------------------cHHHHHHH
Q 048280 43 EALVSATKNFHPSNKLGEGGFGPVFKGK--LDDGREIAVKKLSHSSNQ------------------------GKKEFENE 96 (381)
Q Consensus 43 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E 96 (381)
..+......|.+.+.||+|+||.||+|. ..+|+.||||++...... ....+.+|
T Consensus 21 ~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 100 (237)
T smart00090 21 YSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKE 100 (237)
T ss_pred HHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHH
Confidence 3344444468899999999999999998 457999999998754210 01235689
Q ss_pred HHHHHHhCCCC--cccEEEEEeeCCeEEEEEecccCCCHH---------------HHHHhhhhhhhHhhhhc---cCCcc
Q 048280 97 AKLLARVQHRN--VVNLLGYCAHGAEKLLIYEYVINESLD---------------KVLFSLIKDIQILFRKK---KTDIK 156 (381)
Q Consensus 97 ~~~l~~l~hpn--Iv~~~~~~~~~~~~~lv~E~~~~g~L~---------------~~l~~~~~~l~~lh~~~---HrDlk 156 (381)
+.+++++.+.. +.+++++ . ..++||||+.+.+|. .++.|++.++.++|..+ |||||
T Consensus 101 ~~~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dik 176 (237)
T smart00090 101 FRNLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLS 176 (237)
T ss_pred HHHHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCC
Confidence 99999997532 3344432 2 358999999887652 45688999999999887 99999
Q ss_pred ccceEeCCCCCcEEeeeccceecC
Q 048280 157 ASNILLDDKWIPKIADFGMARLFP 180 (381)
Q Consensus 157 p~NIll~~~~~~kL~DFG~~~~~~ 180 (381)
|+||+++ ++.++|+|||.+....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999 8899999999988543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.8e-17 Score=144.20 Aligned_cols=122 Identities=18% Similarity=0.291 Sum_probs=102.6
Q ss_pred CCcccccCCeeEEEEEECCCcEEEEEEecCCCcc--------cHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 55 SNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQ--------GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
++.||+|++|.||+|.. .+..|++|+....... ....+.+|+.++..+.|++|.....++......++|||
T Consensus 1 ~~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred CcccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 36799999999999987 5788999986543211 12457889999999999999888888777788899999
Q ss_pred cccCCCHHHHH-----------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeecccee
Q 048280 127 YVINESLDKVL-----------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARL 178 (381)
Q Consensus 127 ~~~~g~L~~~l-----------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~ 178 (381)
|++|++|.+++ .+++.++.++|..+ |+|++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGMEELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999997544 67888999999998 999999999999 78899999998874
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-17 Score=163.84 Aligned_cols=136 Identities=19% Similarity=0.273 Sum_probs=108.0
Q ss_pred hHHHHHhhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEec-CC-Cc------ccHHHHHHHHHHHHHhCCCCcccEEE
Q 048280 42 FEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLS-HS-SN------QGKKEFENEAKLLARVQHRNVVNLLG 113 (381)
Q Consensus 42 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~-~~-~~------~~~~~~~~E~~~l~~l~hpnIv~~~~ 113 (381)
+.........|...+.||+|+||.||++.+... .+++|+.. .. .. ...+.+.+|+++++.++|++|+....
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~ 403 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI 403 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence 333334445567789999999999999987643 44444322 11 11 11356889999999999999999888
Q ss_pred EEeeCCeEEEEEecccCCCHHHHH-------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceec
Q 048280 114 YCAHGAEKLLIYEYVINESLDKVL-------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLF 179 (381)
Q Consensus 114 ~~~~~~~~~lv~E~~~~g~L~~~l-------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~ 179 (381)
++......++||||+++++|.+++ .+++.++.++|..+ ||||||+|||+ .++.++|+|||+++..
T Consensus 404 ~~~~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 404 YDVDPEEKTIVMEYIGGKDLKDVLEGNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEeCCCCEEEEEecCCCcHHHHHHHHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 887777889999999999998765 78999999999998 99999999999 6778999999999853
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=7.3e-18 Score=166.25 Aligned_cols=237 Identities=22% Similarity=0.313 Sum_probs=175.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC--CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhC-CCCcccEEEEEeeCCeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD--DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQ-HRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~l 123 (381)
...|.+.+.||+|.|+.|-..... ....+|+|.+.... .........|..+-+.+. |.|++++++...+....++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 457888999999999999988753 34566777665443 222344556888888887 9999999999999999999
Q ss_pred EEecccCCCHH-----------------HHHHhhhhhhhHhh-hhc--cCCccccceEeCCCC-CcEEeeeccceecCC-
Q 048280 124 IYEYVINESLD-----------------KVLFSLIKDIQILF-RKK--KTDIKASNILLDDKW-IPKIADFGMARLFPE- 181 (381)
Q Consensus 124 v~E~~~~g~L~-----------------~~l~~~~~~l~~lh-~~~--HrDlkp~NIll~~~~-~~kL~DFG~~~~~~~- 181 (381)
+++|..++++. .++.|+..++.|+| ..+ |+||||+|.+++..+ ..|++|||++..+..
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99998887774 34578999999999 555 999999999999999 999999999987755
Q ss_pred C-Cccccccccc-CccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCccccc
Q 048280 182 D-QTHVNTRVAG-TNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIV 258 (381)
Q Consensus 182 ~-~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
. ........+| ++.|+|||...+. ......|+||.|+++.-+++|..|+......+.. +..+.....
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~------~~~~~~~~~---- 248 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR------YSSWKSNKG---- 248 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc------ceeeccccc----
Confidence 2 2222335677 9999999998874 4578899999999999999999998765443321 011111110
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 259 DPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
...............+++.+++..+|..|.+.+++..
T Consensus 249 --~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 --RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0011112223344667888899999999999988753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=9.4e-16 Score=130.74 Aligned_cols=121 Identities=22% Similarity=0.300 Sum_probs=91.4
Q ss_pred CCcccccCCeeEEEEEECCCcEEEEEEecCCCccc--HHH----------------------HHHHHHHHHHhCCCC--c
Q 048280 55 SNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQG--KKE----------------------FENEAKLLARVQHRN--V 108 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~hpn--I 108 (381)
.+.||+|+||.||+|...+++.||||++....... ... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 57899999999999998889999999986542111 111 135667777775443 4
Q ss_pred ccEEEEEeeCCeEEEEEecccCC-----CH---------HHHHHhhhhhhhHhhh-hc--cCCccccceEeCCCCCcEEe
Q 048280 109 VNLLGYCAHGAEKLLIYEYVINE-----SL---------DKVLFSLIKDIQILFR-KK--KTDIKASNILLDDKWIPKIA 171 (381)
Q Consensus 109 v~~~~~~~~~~~~~lv~E~~~~g-----~L---------~~~l~~~~~~l~~lh~-~~--HrDlkp~NIll~~~~~~kL~ 171 (381)
.+++++ ...++||||++++ .| ..++.+++.++.++|. .+ |+||||+||+++ ++.++|+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~li 156 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYII 156 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEE
Confidence 555543 2358999999883 33 3456789999999999 76 999999999999 8899999
Q ss_pred eeccceecC
Q 048280 172 DFGMARLFP 180 (381)
Q Consensus 172 DFG~~~~~~ 180 (381)
|||.+....
T Consensus 157 Dfg~a~~~~ 165 (187)
T cd05119 157 DVPQAVEID 165 (187)
T ss_pred ECccccccc
Confidence 999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.1e-15 Score=132.04 Aligned_cols=123 Identities=17% Similarity=0.183 Sum_probs=97.3
Q ss_pred CCccc-ccCCeeEEEEEECCCcEEEEEEecCCC-------------cccHHHHHHHHHHHHHhCCCCc--ccEEEEEeeC
Q 048280 55 SNKLG-EGGFGPVFKGKLDDGREIAVKKLSHSS-------------NQGKKEFENEAKLLARVQHRNV--VNLLGYCAHG 118 (381)
Q Consensus 55 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~hpnI--v~~~~~~~~~ 118 (381)
...|| .||.|+||.+... +..++||.+.... ......+.+|+.++.+|.|++| +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35677 8899999998876 7789999874321 1223567889999999998875 6677764432
Q ss_pred -C---eEEEEEecccC-CCHHHH----------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeecccee
Q 048280 119 -A---EKLLIYEYVIN-ESLDKV----------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARL 178 (381)
Q Consensus 119 -~---~~~lv~E~~~~-g~L~~~----------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~ 178 (381)
. ..++|||++++ .+|.++ +.+++.++.++|+.+ ||||||+|||++.++.++|+|||.+..
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 2 23599999997 688765 467899999999999 999999999999988999999998875
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.1e-15 Score=121.68 Aligned_cols=122 Identities=22% Similarity=0.237 Sum_probs=104.4
Q ss_pred CCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCC--CCcccEEEEEeeCCeEEEEEecccCC
Q 048280 54 PSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQH--RNVVNLLGYCAHGAEKLLIYEYVINE 131 (381)
Q Consensus 54 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~lv~E~~~~g 131 (381)
+.+.||.|.++.||++...+ ..+++|....... ...+.+|+.++..+.| .++.++++++...+..+++|||+.++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 46789999999999999864 7899999865433 5678999999999976 59999999988888899999999888
Q ss_pred CHH--------HHHHhhhhhhhHhhhh---c--cCCccccceEeCCCCCcEEeeecccee
Q 048280 132 SLD--------KVLFSLIKDIQILFRK---K--KTDIKASNILLDDKWIPKIADFGMARL 178 (381)
Q Consensus 132 ~L~--------~~l~~~~~~l~~lh~~---~--HrDlkp~NIll~~~~~~kL~DFG~~~~ 178 (381)
.+. .+..+++.++..+|.. + |+||+|+||++++.+.++|+|||.+..
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 664 4557888999999984 2 999999999999989999999998874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.1e-13 Score=132.62 Aligned_cols=127 Identities=20% Similarity=0.294 Sum_probs=89.5
Q ss_pred CCcccccCCeeEEEEEECCCcEEEEEEecCCCcccH----------------------------------------HHHH
Q 048280 55 SNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGK----------------------------------------KEFE 94 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~ 94 (381)
.+.||.|++|.||+|++++|+.||||+.+....... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 468999999999999999999999999865421100 0244
Q ss_pred HHHHHHHHhC----CCCcccEEEEE-eeCCeEEEEEecccCCCHHHHHH-------------hhhh-hhhHhhhhc--cC
Q 048280 95 NEAKLLARVQ----HRNVVNLLGYC-AHGAEKLLIYEYVINESLDKVLF-------------SLIK-DIQILFRKK--KT 153 (381)
Q Consensus 95 ~E~~~l~~l~----hpnIv~~~~~~-~~~~~~~lv~E~~~~g~L~~~l~-------------~~~~-~l~~lh~~~--Hr 153 (381)
+|++.+.++. |.+-+.+-.++ ......+|||||++|++|.++.. .++. .+..+|..+ |+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g~~H~ 281 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDGFFHA 281 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCceeC
Confidence 5666666653 22223332222 22345789999999998876542 1222 245667777 99
Q ss_pred CccccceEeCCCCCcEEeeeccceecCC
Q 048280 154 DIKASNILLDDKWIPKIADFGMARLFPE 181 (381)
Q Consensus 154 Dlkp~NIll~~~~~~kL~DFG~~~~~~~ 181 (381)
|+||.||+++.++.++|+|||++..+..
T Consensus 282 D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 282 DLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.1e-13 Score=131.14 Aligned_cols=231 Identities=23% Similarity=0.279 Sum_probs=164.8
Q ss_pred hcCCCCCCcccc--cCCeeEEEEEE--C-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCe
Q 048280 49 TKNFHPSNKLGE--GGFGPVFKGKL--D-DGREIAVKKLSHS--SNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAE 120 (381)
Q Consensus 49 ~~~y~~~~~lg~--G~~g~V~~~~~--~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 120 (381)
.+.|.+.+.+|. |.+|.||.+.. . ++..+|+|+-+.. .......-.+|+....++ .|+|.++.+..++.++.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 346778899999 99999999976 3 5888999984333 223333445677777777 49999999999999999
Q ss_pred EEEEEecccCCCHHHHH----------------Hhhhh----hhhHhhhhc--cCCccccceEeCCC-CCcEEeeeccce
Q 048280 121 KLLIYEYVINESLDKVL----------------FSLIK----DIQILFRKK--KTDIKASNILLDDK-WIPKIADFGMAR 177 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l----------------~~~~~----~l~~lh~~~--HrDlkp~NIll~~~-~~~kL~DFG~~~ 177 (381)
.++-+|+| +.+|..+. .+... |+..+|... |-|+||.||++..+ ...+++|||+..
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred ceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 99999988 46665443 45555 899999888 99999999999998 889999999999
Q ss_pred ecCCCCcccc----cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCC
Q 048280 178 LFPEDQTHVN----TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDK 253 (381)
Q Consensus 178 ~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (381)
.+........ ....|...|++||.. .+.++...|||++|.++.+..++...+...... . |......
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~-------W~~~r~~- 341 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS-S-------WSQLRQG- 341 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC-C-------ccccccc-
Confidence 8876543222 223577889999955 557899999999999999999987665322100 0 0001100
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 254 SLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
. +...+ .......+...+..+++.+|..|++++.+..
T Consensus 342 --~-ip~e~----~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 342 --Y-IPLEF----CEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --c-Cchhh----hcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0 11111 1111122334788899999999999887753
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.4e-13 Score=131.92 Aligned_cols=132 Identities=20% Similarity=0.281 Sum_probs=89.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC-CcEEEEEEecCCCccc----------------------------------HH--
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD-GREIAVKKLSHSSNQG----------------------------------KK-- 91 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~-- 91 (381)
...|+. +.||+|++|.||+|++++ |+.||||+++..-... .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 799999999999999887 9999999997542100 01
Q ss_pred ----HHHHHHHHHHHhC----CCCcccEEEEEee-CCeEEEEEecccCCCHHHHH--Hh-------hhhh-----hhHhh
Q 048280 92 ----EFENEAKLLARVQ----HRNVVNLLGYCAH-GAEKLLIYEYVINESLDKVL--FS-------LIKD-----IQILF 148 (381)
Q Consensus 92 ----~~~~E~~~l~~l~----hpnIv~~~~~~~~-~~~~~lv~E~~~~g~L~~~l--~~-------~~~~-----l~~lh 148 (381)
++.+|+..+.++. +.+.+.+-.++.+ ....+|||||+.|+.|.++. .. ++.. +..++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 2344555555552 3444444344332 45578999999999997642 11 1111 11223
Q ss_pred hhc--cCCccccceEeCCCC----CcEEeeeccceecCC
Q 048280 149 RKK--KTDIKASNILLDDKW----IPKIADFGMARLFPE 181 (381)
Q Consensus 149 ~~~--HrDlkp~NIll~~~~----~~kL~DFG~~~~~~~ 181 (381)
..+ |+|+||.||+++.++ .++++|||++..+..
T Consensus 278 ~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 344 999999999999887 999999999987754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.42 E-value=1e-12 Score=110.03 Aligned_cols=119 Identities=18% Similarity=0.169 Sum_probs=93.5
Q ss_pred CCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcc-cEEEEEeeCCeEEEEEecccCCCH
Q 048280 55 SNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVV-NLLGYCAHGAEKLLIYEYVINESL 133 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~lv~E~~~~g~L 133 (381)
++.|+.|.++.||+++.. +..|++|....... ....+.+|+.+++.+.+.+++ +++.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 467899999999999876 78899999754432 223567899999999765544 455443 2345899999999888
Q ss_pred H-------HHHHhhhhhhhHhhhh-------ccCCccccceEeCCCCCcEEeeecccee
Q 048280 134 D-------KVLFSLIKDIQILFRK-------KKTDIKASNILLDDKWIPKIADFGMARL 178 (381)
Q Consensus 134 ~-------~~l~~~~~~l~~lh~~-------~HrDlkp~NIll~~~~~~kL~DFG~~~~ 178 (381)
. ..+.+++..++.+|.. .|+|++|.||+++ ++.++|+|||.+..
T Consensus 79 ~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTEDFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6 3567899999999987 3999999999999 66899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.4e-11 Score=118.26 Aligned_cols=155 Identities=16% Similarity=0.215 Sum_probs=117.1
Q ss_pred EECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCCC--HH--------HHHHh
Q 048280 70 KLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINES--LD--------KVLFS 139 (381)
Q Consensus 70 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~--L~--------~~l~~ 139 (381)
+..++.+|.|+..+...........+-++.|+.++||||+++++.++.....|||+|-+.--. |. --|+|
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~~~lk~l~~~~v~~Gl~q 112 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRPLETVLKELGKEEVCLGLFQ 112 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccccHHHHHHHhHHHHHHHHHHH
Confidence 344688999999876655445667888999999999999999999999999999999874322 11 12489
Q ss_pred hhhhhhHhhhhc---cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhH
Q 048280 140 LIKDIQILFRKK---KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSF 216 (381)
Q Consensus 140 ~~~~l~~lh~~~---HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 216 (381)
|+.+|.+||..+ |++|.-+.|+|+..|..||++|.++........ ......---.|..|+.+.... -..|.|-|
T Consensus 113 Il~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s~D~~~L 189 (690)
T KOG1243|consen 113 ILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WSIDSWGL 189 (690)
T ss_pred HHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cchhhhhH
Confidence 999999999766 999999999999999999999998875432221 011111223466676543222 45799999
Q ss_pred HHHHHHHHhCC
Q 048280 217 GVVILELISGQ 227 (381)
Q Consensus 217 Gvvl~elltg~ 227 (381)
||+++|++.|.
T Consensus 190 g~li~el~ng~ 200 (690)
T KOG1243|consen 190 GCLIEELFNGS 200 (690)
T ss_pred HHHHHHHhCcc
Confidence 99999999993
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=4e-12 Score=111.94 Aligned_cols=179 Identities=18% Similarity=0.287 Sum_probs=119.5
Q ss_pred HHHhCCCCcccEEEEEeeC-----CeEEEEEecccCCCHHHHH-------------------HhhhhhhhHhhhhc----
Q 048280 100 LARVQHRNVVNLLGYCAHG-----AEKLLIYEYVINESLDKVL-------------------FSLIKDIQILFRKK---- 151 (381)
Q Consensus 100 l~~l~hpnIv~~~~~~~~~-----~~~~lv~E~~~~g~L~~~l-------------------~~~~~~l~~lh~~~---- 151 (381)
+-++.|.|||+++.|+.+. ....+++||+..|+|.++| -|++.+|.|||+..
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 4455699999999987543 4578999999999997666 58999999999988
Q ss_pred cCCccccceEeCCCCCcEEeeeccc--eecCCC-CcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCC
Q 048280 152 KTDIKASNILLDDKWIPKIADFGMA--RLFPED-QTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQR 228 (381)
Q Consensus 152 HrDlkp~NIll~~~~~~kL~DFG~~--~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~ 228 (381)
|+++..+-|++..+|-+|++--.-. ...-.. .........+-++|.+||.-.....+..+|||+||+..++|..+..
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 9999999999999998887531111 100000 0011112346688999997777778889999999999999998774
Q ss_pred CCCCCC-ccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 229 NSSFNL-DVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 229 p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
-..... ......-.. ......-++.- ..++..|++..|..||+|.+++..
T Consensus 281 q~tnseS~~~~ee~ia--------~~i~~len~lq------------r~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 281 QSTNSESKVEVEENIA--------NVIIGLENGLQ------------RGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred ccCCCcceeehhhhhh--------hheeeccCccc------------cCcCcccccCCCCCCcchhhhhcC
Confidence 321111 000000000 00000111111 137778999999999999998643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.6e-11 Score=116.74 Aligned_cols=231 Identities=19% Similarity=0.183 Sum_probs=160.1
Q ss_pred HHHhhcCCCCCCcccccCCeeEEEEEEC--CCcEEEEEEecCCCcccHHH--HHHHHHHHHHh-CCCCcccEEEEEeeCC
Q 048280 45 LVSATKNFHPSNKLGEGGFGPVFKGKLD--DGREIAVKKLSHSSNQGKKE--FENEAKLLARV-QHRNVVNLLGYCAHGA 119 (381)
Q Consensus 45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 119 (381)
......+|..+..||.|.|+.|+....+ ++..|++|.+.........+ -..|+.+...+ .|.+++..+..+....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3444668999999999999999998644 57889999886653333222 24577777766 5899999887777777
Q ss_pred eEEEEEecccCCCHHH---------------HHHhhhhhhhHhhhhc--cCCccccceEeCCC-CCcEEeeeccceecCC
Q 048280 120 EKLLIYEYVINESLDK---------------VLFSLIKDIQILFRKK--KTDIKASNILLDDK-WIPKIADFGMARLFPE 181 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~---------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~-~~~kL~DFG~~~~~~~ 181 (381)
..|+=.|||.++++.. .+.|++.++.++|... |+|+||+||++..+ +..+++|||....+.-
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence 7889999999988753 2378889999999888 99999999999886 7889999999874211
Q ss_pred CCcccccccccCcccc--chhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccC
Q 048280 182 DQTHVNTRVAGTNGYM--APEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVD 259 (381)
Q Consensus 182 ~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
.. ........+. +++......+..+.|++|||..+.+.+++..-..... ....+.
T Consensus 420 ~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------------------~~~~i~ 476 (524)
T KOG0601|consen 420 SS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------------------QSLTIR 476 (524)
T ss_pred ec----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc-------------------cceeee
Confidence 11 1112233333 5665666778899999999999999999874321100 000001
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 260 PSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 260 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
......... ....+..+...+...++..||.+.++....
T Consensus 477 ~~~~p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 477 SGDTPNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred cccccCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence 111111111 114466677788899999999998876543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.3e-10 Score=95.23 Aligned_cols=121 Identities=15% Similarity=0.189 Sum_probs=88.7
Q ss_pred CCcccccCCeeEEEEEECC-------CcEEEEEEecCCCc----------------------ccHHHHH----HHHHHHH
Q 048280 55 SNKLGEGGFGPVFKGKLDD-------GREIAVKKLSHSSN----------------------QGKKEFE----NEAKLLA 101 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~----------------------~~~~~~~----~E~~~l~ 101 (381)
...||.|.-+.||.|...+ +..+|||+.+.... ..+..+. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999997543 47999998753210 0122333 7999999
Q ss_pred HhCC--CCcccEEEEEeeCCeEEEEEecccCC-----CH----------HHHHHhhhhhhhHh-hhhc--cCCccccceE
Q 048280 102 RVQH--RNVVNLLGYCAHGAEKLLIYEYVINE-----SL----------DKVLFSLIKDIQIL-FRKK--KTDIKASNIL 161 (381)
Q Consensus 102 ~l~h--pnIv~~~~~~~~~~~~~lv~E~~~~g-----~L----------~~~l~~~~~~l~~l-h~~~--HrDlkp~NIl 161 (381)
++.. -++.+.+++ ..-+|||||+.+. .| .+++.+++..+..+ |..+ |+||++.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9953 466666654 4568999999653 12 33457888888888 6666 9999999999
Q ss_pred eCCCCCcEEeeeccceecC
Q 048280 162 LDDKWIPKIADFGMARLFP 180 (381)
Q Consensus 162 l~~~~~~kL~DFG~~~~~~ 180 (381)
++ ++.+.|+|||.+....
T Consensus 158 ~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EE-CCcEEEEECCCceeCC
Confidence 97 4679999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=9.1e-10 Score=90.33 Aligned_cols=121 Identities=21% Similarity=0.302 Sum_probs=92.2
Q ss_pred CcccccCCeeEEEEEECCCcEEEEEEecCCC-c-------ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 56 NKLGEGGFGPVFKGKLDDGREIAVKKLSHSS-N-------QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~-------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
..+++|+-+.+|.+.+. |..+++|.-.... . -...+..+|++++.++.--.|-.-+=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46789999999999765 4556677532221 1 1124567899999999765655555566677778999999
Q ss_pred ccCCCHHHHH--------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeecccee
Q 048280 128 VINESLDKVL--------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARL 178 (381)
Q Consensus 128 ~~~g~L~~~l--------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~ 178 (381)
++|..|.+++ ..+-..+.-||..+ |+||.++||++.... +.++|||++..
T Consensus 81 I~G~~lkd~l~~~~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEARPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhcchHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888555 55667778899998 999999999998765 99999999984
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.04 E-value=8e-10 Score=96.56 Aligned_cols=124 Identities=16% Similarity=0.279 Sum_probs=92.7
Q ss_pred CCcccccCCeeEEEEEECCCcEEEEEEecCCCc-ccHHHHHHHHHHHHHhCC--CCcccEEEEEeeCC---eEEEEEecc
Q 048280 55 SNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSN-QGKKEFENEAKLLARVQH--RNVVNLLGYCAHGA---EKLLIYEYV 128 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~---~~~lv~E~~ 128 (381)
.+.|+.|..+.||++...+|..+++|....... .....+.+|+++++.+.+ .++.+++.+..... ..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 367899999999999887678999999765432 134678899999999975 45677888776542 568999999
Q ss_pred cCCCHHH--------------HHHhhhhhhhHhhhh--------------------------------------------
Q 048280 129 INESLDK--------------VLFSLIKDIQILFRK-------------------------------------------- 150 (381)
Q Consensus 129 ~~g~L~~--------------~l~~~~~~l~~lh~~-------------------------------------------- 150 (381)
+|.++.. ++.+++..+..+|+.
T Consensus 83 ~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (223)
T cd05154 83 DGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR 162 (223)
T ss_pred CCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence 8876643 234555555555420
Q ss_pred ----------c----cCCccccceEeCC--CCCcEEeeecccee
Q 048280 151 ----------K----KTDIKASNILLDD--KWIPKIADFGMARL 178 (381)
Q Consensus 151 ----------~----HrDlkp~NIll~~--~~~~kL~DFG~~~~ 178 (381)
. |+|+++.||+++. ++.+.|+||+.+..
T Consensus 163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 0 9999999999998 56789999988764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.3e-09 Score=86.09 Aligned_cols=124 Identities=19% Similarity=0.270 Sum_probs=93.5
Q ss_pred CCCcccccCCeeEEEEEECCCcEEEEEEecCC--------CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 54 PSNKLGEGGFGPVFKGKLDDGREIAVKKLSHS--------SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 54 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
....|-+|+-+.|+++.+. |+.++||.-... ..-.+.+..+|+++|.++.--.|..-.=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5778899999999999887 788788753221 1122456788999999997656665555666777788999
Q ss_pred ecccC-CCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCC---CcEEeeecccee
Q 048280 126 EYVIN-ESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKW---IPKIADFGMARL 178 (381)
Q Consensus 126 E~~~~-g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~---~~kL~DFG~~~~ 178 (381)
||+++ .++.+++ ..+-..+.-||... |+||..+||+|..++ .+.|+|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 2454444 56677788899888 999999999996544 458999999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.1e-10 Score=115.08 Aligned_cols=234 Identities=17% Similarity=0.207 Sum_probs=156.4
Q ss_pred HHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeE
Q 048280 46 VSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEK 121 (381)
Q Consensus 46 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 121 (381)
+...+++.+.+.+-.|.++.++.+.-. .|...++|...... ....+....+-.++-...||.++....-+......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 345677888899999999999988643 34444444433221 11122333344444444567666655555556778
Q ss_pred EEEEecccCCCHHHHH---------------HhhhhhhhHhhhh--ccCCccccceEeCCCCCcEEeeeccceecCCC--
Q 048280 122 LLIYEYVINESLDKVL---------------FSLIKDIQILFRK--KKTDIKASNILLDDKWIPKIADFGMARLFPED-- 182 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~--~HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~-- 182 (381)
+||++|+.+++|...| ..+...+++||.. .|+|++|.|+|+..++..+++|||........
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 9999999888887654 5567788999988 39999999999999999999999843321100
Q ss_pred -----------------------Cc-----ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCC
Q 048280 183 -----------------------QT-----HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNL 234 (381)
Q Consensus 183 -----------------------~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 234 (381)
.. .......||+.|.+||...+......+|.|++|++++|.++|..||....
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 00 01224678999999999999999999999999999999999999986443
Q ss_pred ccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 048280 235 DVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMR 293 (381)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 293 (381)
.... +.......+.-+ ...........+++...+..+|.+|-.+.
T Consensus 1040 pq~~----------f~ni~~~~~~~p----~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1040 PQQI----------FENILNRDIPWP----EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhh----------hhccccCCCCCC----CCccccChhhhhhhhhhhccCchhccCcc
Confidence 3211 111111111111 11222233455677788888999998776
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.79 E-value=7.9e-08 Score=90.31 Aligned_cols=149 Identities=19% Similarity=0.295 Sum_probs=113.2
Q ss_pred CeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEe----eCCeEEEEEecccC-CC----
Q 048280 63 FGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCA----HGAEKLLIYEYVIN-ES---- 132 (381)
Q Consensus 63 ~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----~~~~~~lv~E~~~~-g~---- 132 (381)
-.+.|++..+ +|..|++|++.............-+++++++.|.|||++.++|. .+..+++|++|.++ ++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3567888754 79999999995443333344556788999999999999998876 34568899999754 23
Q ss_pred --------------------------HHHHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 133 --------------------------LDKVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 133 --------------------------L~~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
|+.++.|+..+|.++|+.| -+-|.+.+||++.+.+++|+..|....+..+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~ 448 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT 448 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCCC
Confidence 3456689999999999999 778999999999999999998888876654431
Q ss_pred ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCC
Q 048280 185 HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRN 229 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p 229 (381)
. .+.. -.+-|.=.||.+++.|.||...
T Consensus 449 ~---------------~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 449 E---------------PLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred c---------------chhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 1 1111 2356888899999999999643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.77 E-value=8.8e-08 Score=80.85 Aligned_cols=111 Identities=26% Similarity=0.340 Sum_probs=73.2
Q ss_pred eEEEEEECCCcEEEEEEecCCCcc--------------------------cHHHHHHHHHHHHHhCCC--CcccEEEEEe
Q 048280 65 PVFKGKLDDGREIAVKKLSHSSNQ--------------------------GKKEFENEAKLLARVQHR--NVVNLLGYCA 116 (381)
Q Consensus 65 ~V~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~hp--nIv~~~~~~~ 116 (381)
.||.|...+|..+|||+.+..... ......+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999888999999987542100 013466799999999755 566666542
Q ss_pred eCCeEEEEEeccc--CCCH-------------HHHHHhhhhhhhH-hhhhc--cCCccccceEeCCCCCcEEeeecccee
Q 048280 117 HGAEKLLIYEYVI--NESL-------------DKVLFSLIKDIQI-LFRKK--KTDIKASNILLDDKWIPKIADFGMARL 178 (381)
Q Consensus 117 ~~~~~~lv~E~~~--~g~L-------------~~~l~~~~~~l~~-lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~ 178 (381)
.-+|||||+. |..+ ..++.+++..+.. +|..+ |+||.+.|||++++ .+.|+|||.+..
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCccee
Confidence 3479999997 4333 3445566665555 45777 99999999999887 899999999886
Q ss_pred cC
Q 048280 179 FP 180 (381)
Q Consensus 179 ~~ 180 (381)
..
T Consensus 156 ~~ 157 (188)
T PF01163_consen 156 SS 157 (188)
T ss_dssp TT
T ss_pred cC
Confidence 43
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=9.1e-08 Score=83.39 Aligned_cols=124 Identities=21% Similarity=0.285 Sum_probs=95.8
Q ss_pred CCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCc----------------------ccHHHHHHHHHHHHHhCCC--
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSN----------------------QGKKEFENEAKLLARVQHR-- 106 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~hp-- 106 (381)
=+.+...||-|.-+.||.|....|.++|||.=+.... ..+...++|.++|.+|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 4567889999999999999999999999996432110 1124567899999999644
Q ss_pred CcccEEEEEeeCCeEEEEEecccCCCH----------HHHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeec
Q 048280 107 NVVNLLGYCAHGAEKLLIYEYVINESL----------DKVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFG 174 (381)
Q Consensus 107 nIv~~~~~~~~~~~~~lv~E~~~~g~L----------~~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG 174 (381)
.+.+.+++ +.-.+||||+.|-.| ..++..++..+..+.+.+ |+|+.+-||+++++|.+.++||-
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwP 247 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWP 247 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCc
Confidence 67777654 556899999876444 455667777777777666 99999999999999999999996
Q ss_pred ccee
Q 048280 175 MARL 178 (381)
Q Consensus 175 ~~~~ 178 (381)
-+..
T Consensus 248 Q~v~ 251 (304)
T COG0478 248 QAVP 251 (304)
T ss_pred cccc
Confidence 6553
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=3.2e-09 Score=102.69 Aligned_cols=147 Identities=18% Similarity=0.220 Sum_probs=98.8
Q ss_pred HhhhhhhhHhhhhc---cCCccccceEeCCCCCcEEeeeccceecCCCCccc--------ccccccCccccchhHHhhCC
Q 048280 138 FSLIKDIQILFRKK---KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV--------NTRVAGTNGYMAPEYVMHGH 206 (381)
Q Consensus 138 ~~~~~~l~~lh~~~---HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~ 206 (381)
.+...|+.++|+.. |++|.|++|.++.++..||+.|+++.......... ..-......|.|||++.+..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 44558999999987 99999999999999999999999987554311110 01122456899999999988
Q ss_pred CCchhhhHhHHHHHHHHHhCCCC-CCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCC
Q 048280 207 LSVKADVFSFGVVILELISGQRN-SSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGD 285 (381)
Q Consensus 207 ~~~~sDvwSlGvvl~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 285 (381)
.+.++|+||+||++|.+..|..+ +........ +..... .+..-........+.++.+=+.+++..+
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-----~~~~~~--------~~~~~~~~~s~~~p~el~~~l~k~l~~~ 252 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-----YSFSRN--------LLNAGAFGYSNNLPSELRESLKKLLNGD 252 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcch-----hhhhhc--------ccccccccccccCcHHHHHHHHHHhcCC
Confidence 89999999999999999955544 221111000 000000 0111111122444566777777889999
Q ss_pred CCCCCCHHHHHH
Q 048280 286 PQLRPTMRRVVV 297 (381)
Q Consensus 286 P~~RPs~~eil~ 297 (381)
+..||++.++..
T Consensus 253 ~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 253 SAVRPTLDLLLS 264 (700)
T ss_pred cccCcchhhhhc
Confidence 999998877653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.7e-07 Score=90.90 Aligned_cols=149 Identities=21% Similarity=0.302 Sum_probs=94.2
Q ss_pred HHHHHHHhhhCCCCChHHHHHhhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccH----------------
Q 048280 27 EDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGK---------------- 90 (381)
Q Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---------------- 90 (381)
+..+++...+... +++++....+ ...|+.++-|.||+|++++|+.||||+.+..-....
T Consensus 107 ~~~~~iie~eLG~-~iee~F~eF~----~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~ 181 (517)
T COG0661 107 EEAERIIEEELGR-PIEELFSEFE----PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKR 181 (517)
T ss_pred HHHHHHHHHHhCC-CHHHHHHHcC----CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHH
Confidence 3344444444443 5555544332 378999999999999999999999999875421100
Q ss_pred ------------------------HHHHHHHHHHHHhC-----CCCcccEEEEE-eeCCeEEEEEecccCCCHHHHH--H
Q 048280 91 ------------------------KEFENEAKLLARVQ-----HRNVVNLLGYC-AHGAEKLLIYEYVINESLDKVL--F 138 (381)
Q Consensus 91 ------------------------~~~~~E~~~l~~l~-----hpnIv~~~~~~-~~~~~~~lv~E~~~~g~L~~~l--~ 138 (381)
-++.+|..-+.+++ .+++ ++=.+| +-.....|+|||++|-.+.++. .
T Consensus 182 ~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~ 260 (517)
T COG0661 182 LPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALK 260 (517)
T ss_pred cCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHH
Confidence 02334555555552 2222 222222 2345678999999998876653 1
Q ss_pred -------hhhhhh-----hHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCC
Q 048280 139 -------SLIKDI-----QILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPE 181 (381)
Q Consensus 139 -------~~~~~l-----~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~ 181 (381)
.++..+ ..+-..+ |.|..|.||+++.+|.+.+.|||+...+..
T Consensus 261 ~~g~d~k~ia~~~~~~f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 261 SAGIDRKELAELLVRAFLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 111111 1112222 999999999999999999999999987654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=4.1e-07 Score=81.41 Aligned_cols=122 Identities=12% Similarity=0.086 Sum_probs=84.3
Q ss_pred CcccccCCeeEEEEEECCCcEEEEEEecCCCcc-----------cHHHHHHHHHHHHHhCCCC--cccEEEEEee-----
Q 048280 56 NKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQ-----------GKKEFENEAKLLARVQHRN--VVNLLGYCAH----- 117 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~----- 117 (381)
+.+-.-....|.++... |+.|.||........ ....+.+|...+.+|..-+ ....+++.+.
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 33443444456676664 788999976433211 1124779999999985433 3344555543
Q ss_pred CCeEEEEEecccCC-CHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCC-------CCCcEE
Q 048280 118 GAEKLLIYEYVINE-SLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDD-------KWIPKI 170 (381)
Q Consensus 118 ~~~~~lv~E~~~~g-~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~-------~~~~kL 170 (381)
....+||||++++. +|.+++ .+++..+..+|..+ |+||++.|||++. ++.+.|
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L 186 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSV 186 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEE
Confidence 23578999999875 675543 46778888999999 9999999999975 468999
Q ss_pred eeecccee
Q 048280 171 ADFGMARL 178 (381)
Q Consensus 171 ~DFG~~~~ 178 (381)
+||+.+..
T Consensus 187 IDl~r~~~ 194 (268)
T PRK15123 187 IDLHRAQI 194 (268)
T ss_pred EECCcccc
Confidence 99998863
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=5.6e-07 Score=82.76 Aligned_cols=241 Identities=16% Similarity=0.147 Sum_probs=137.9
Q ss_pred CCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHh-CCCCcccEEEEE-------eeCCeEEEE
Q 048280 53 HPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLGYC-------AHGAEKLLI 124 (381)
Q Consensus 53 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~-------~~~~~~~lv 124 (381)
.....||+|+-+.+|-.-.- +..+.|++.........+. +..|... .||-+-.-+.|= ..+...-++
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchh--hchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 34678999999999975321 2245677765543322222 2233333 455433311110 111224556
Q ss_pred EecccCCC-H---------------------HHHHHhhhhhhhHhhhhcc--CCccccceEeCCCCCcEEeeeccceecC
Q 048280 125 YEYVINES-L---------------------DKVLFSLIKDIQILFRKKK--TDIKASNILLDDKWIPKIADFGMARLFP 180 (381)
Q Consensus 125 ~E~~~~g~-L---------------------~~~l~~~~~~l~~lh~~~H--rDlkp~NIll~~~~~~kL~DFG~~~~~~ 180 (381)
|..+.+.. + ...-+.++.+.+-+|..+| +|+.++|+|+.+++.|.|.|=..-...
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~- 167 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN- 167 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec-
Confidence 66554421 1 1122567888889999995 899999999999999999985443332
Q ss_pred CCCcccccccccCccccchhHHh-----hCCCCchhhhHhHHHHHHHHHhC-CCCCCCCCccc-cccHHHHHH--H--Hh
Q 048280 181 EDQTHVNTRVAGTNGYMAPEYVM-----HGHLSVKADVFSFGVVILELISG-QRNSSFNLDVD-AQNLLDWAY--K--LY 249 (381)
Q Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg-~~p~~~~~~~~-~~~~~~~~~--~--~~ 249 (381)
.+.......+|...|.+||... +..-+...|.|.||+++++|+.| +.||....... .-+..+... . .+
T Consensus 168 -~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y 246 (637)
T COG4248 168 -ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY 246 (637)
T ss_pred -cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence 2222233457889999999765 23456789999999999999997 88886532211 111111000 0 00
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHHhcC
Q 048280 250 KKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQG--DPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~eil~~L~~ 301 (381)
....... ..+.-......-....+..|..+|+.. ++.-|||++..+..|..
T Consensus 247 a~~~~~g-~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 247 ASDQRRG-LKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred chhccCC-CCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 0010000 111111112223345567788888875 35689999988776644
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.55 E-value=9.7e-07 Score=75.43 Aligned_cols=128 Identities=13% Similarity=0.204 Sum_probs=88.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHH---------HHHHHHHHHHhCC---CCcccEEEEEe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKE---------FENEAKLLARVQH---RNVVNLLGYCA 116 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h---pnIv~~~~~~~ 116 (381)
.++|.+.+.+-......|.+...+ |..+++|..+.......+. ..+++..+.++.. ..+..++.+.+
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 567888888888888888887776 7889999876543222222 2344454555532 22333232222
Q ss_pred -----eCCeEEEEEecccCCCHHHH-------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeecccee
Q 048280 117 -----HGAEKLLIYEYVINESLDKV-------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARL 178 (381)
Q Consensus 117 -----~~~~~~lv~E~~~~g~L~~~-------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~ 178 (381)
-....+|+|||++|..|.++ ...+...+..+|..| |+|+.|.|+++++++ ++++||+..+.
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~i~e~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIEDIDEDLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchhcCHHHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECccccc
Confidence 22445789999999887542 245778899999999 999999999998665 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.6e-06 Score=75.91 Aligned_cols=117 Identities=17% Similarity=0.223 Sum_probs=82.7
Q ss_pred CcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCC--cccEEEEEeeCCeEEEEEecccCCC-
Q 048280 56 NKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRN--VVNLLGYCAHGAEKLLIYEYVINES- 132 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~~lv~E~~~~g~- 132 (381)
..||.|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||++.|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 25567888875432 3456789999999996433 4677888888888899999998864
Q ss_pred HH-----------HHHHhhhhhhhHhhh---------------------------------------hc------cCCcc
Q 048280 133 LD-----------KVLFSLIKDIQILFR---------------------------------------KK------KTDIK 156 (381)
Q Consensus 133 L~-----------~~l~~~~~~l~~lh~---------------------------------------~~------HrDlk 156 (381)
+. .+...++..+.-+|. .. |+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21 111112222222221 00 99999
Q ss_pred ccceEeCCCCCcEEeeecccee
Q 048280 157 ASNILLDDKWIPKIADFGMARL 178 (381)
Q Consensus 157 p~NIll~~~~~~kL~DFG~~~~ 178 (381)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999988763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.9e-06 Score=73.40 Aligned_cols=151 Identities=19% Similarity=0.278 Sum_probs=104.1
Q ss_pred ChHHHHHHHhhhCCCCChHHHHHhhcCCCCCCccc---ccCCeeEEEEEECCCcEEEEEEecCCCccc------------
Q 048280 25 NEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLG---EGGFGPVFKGKLDDGREIAVKKLSHSSNQG------------ 89 (381)
Q Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg---~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------------ 89 (381)
+..+.-.+.....-..++..+.....+..+....| .|.-+.||+|...++..+|||+++......
T Consensus 20 Kd~~~~k~~~~v~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~R 99 (268)
T COG1718 20 KDKEDRKVVDEVFDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPR 99 (268)
T ss_pred hcchHhhhhhhhhhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChh
Confidence 34444455556667778888888888887766555 566668999998889999999986542111
Q ss_pred -------HHH-----HHHHHHHHHHhC--CCCcccEEEEEeeCCeEEEEEecccCC-----CH----------HHHHHhh
Q 048280 90 -------KKE-----FENEAKLLARVQ--HRNVVNLLGYCAHGAEKLLIYEYVINE-----SL----------DKVLFSL 140 (381)
Q Consensus 90 -------~~~-----~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv~E~~~~g-----~L----------~~~l~~~ 140 (381)
... ..+|.+-|+++. +-.+.+-+++.. -.|||||+... .| ..+..++
T Consensus 100 f~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~ 175 (268)
T COG1718 100 FRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDV 175 (268)
T ss_pred hhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHH
Confidence 111 335788888874 445555555543 46899998432 12 2334566
Q ss_pred hhhhhHhhhhc---cCCccccceEeCCCCCcEEeeeccceecC
Q 048280 141 IKDIQILFRKK---KTDIKASNILLDDKWIPKIADFGMARLFP 180 (381)
Q Consensus 141 ~~~l~~lh~~~---HrDlkp~NIll~~~~~~kL~DFG~~~~~~ 180 (381)
+..+.-|.... |+||..-|||+. ++.+.|+|||-+....
T Consensus 176 v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 176 VEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 77777666633 999999999999 7889999999887654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.9e-08 Score=94.48 Aligned_cols=171 Identities=18% Similarity=0.126 Sum_probs=128.8
Q ss_pred hhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCC-cccEEEEEeeCCeEEEEEe
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRN-VVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~E 126 (381)
-++-|.....+++|+++.+++.+....+....+.+... ....-++++|.+++||| .+..++-+..+...+++++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 34556666778999999999987544444446655432 34455889999999999 7777777777888999999
Q ss_pred cccCC-CH-----------H-----HHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 127 YVINE-SL-----------D-----KVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 127 ~~~~g-~L-----------~-----~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
++.++ +. . ..++.-.+.++++|+.- |+| ||+..+ +..|++||+....+.... ..
T Consensus 315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~ 387 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KP 387 (829)
T ss_pred hhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc--cc
Confidence 99777 21 1 12245567888888873 888 777765 578999999988765443 23
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNS 230 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~ 230 (381)
....+++.++|||+.....+..+.|+|++|+--.+|.-|.+|-
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 4567899999999999999999999999998877887777664
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.35 E-value=3.1e-06 Score=74.37 Aligned_cols=78 Identities=21% Similarity=0.302 Sum_probs=57.8
Q ss_pred CCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCC--CcccEEEEEee---CCeEEEEEeccc
Q 048280 55 SNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHR--NVVNLLGYCAH---GAEKLLIYEYVI 129 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~~~~---~~~~~lv~E~~~ 129 (381)
++.|+.|..+.||++...+ ..+++|..... .....+.+|..+++.+... .+.+++.+... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4578999999999999886 69999997544 3456788999999998533 35567765433 345789999998
Q ss_pred CCCHHH
Q 048280 130 NESLDK 135 (381)
Q Consensus 130 ~g~L~~ 135 (381)
+..+..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 887765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.35 E-value=6.1e-06 Score=73.32 Aligned_cols=74 Identities=18% Similarity=0.203 Sum_probs=53.8
Q ss_pred cccccCC-eeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhC-CCCcccEEEEEeeCCeEEEEEecccCCCHH
Q 048280 57 KLGEGGF-GPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQ-HRNVVNLLGYCAHGAEKLLIYEYVINESLD 134 (381)
Q Consensus 57 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~ 134 (381)
.|..|.. ..||+.... +..++||+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3445555 789999765 4778888875432 345778999999884 444667788777666789999999987775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.34 E-value=4.9e-06 Score=71.87 Aligned_cols=106 Identities=23% Similarity=0.218 Sum_probs=75.7
Q ss_pred CcEEEEEEecCCC-------cccHHHHHHHHHHHHHhCC--CCcccEEEEEeeC----CeEEEEEecccCC-CHHHHH--
Q 048280 74 GREIAVKKLSHSS-------NQGKKEFENEAKLLARVQH--RNVVNLLGYCAHG----AEKLLIYEYVINE-SLDKVL-- 137 (381)
Q Consensus 74 ~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~----~~~~lv~E~~~~g-~L~~~l-- 137 (381)
++.+.+|...... ........+|...+..|.. -.+.+.+++.+.. ...+||+|++++. +|.+++
T Consensus 32 ~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~ 111 (206)
T PF06293_consen 32 GRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ 111 (206)
T ss_pred ceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh
Confidence 5566666543211 1234567889998888853 3455566665542 2458999999774 665544
Q ss_pred -------------HhhhhhhhHhhhhc--cCCccccceEeCCCC---CcEEeeeccceec
Q 048280 138 -------------FSLIKDIQILFRKK--KTDIKASNILLDDKW---IPKIADFGMARLF 179 (381)
Q Consensus 138 -------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~---~~kL~DFG~~~~~ 179 (381)
.+++..+.-||..+ |+|+++.|||++.+. .+.|+||+-++..
T Consensus 112 ~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 112 WEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 56777888999999 999999999998887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=5.8e-06 Score=67.71 Aligned_cols=120 Identities=23% Similarity=0.338 Sum_probs=83.9
Q ss_pred CCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCccc-EEEEEeeCCeEEEEEecccC
Q 048280 52 FHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVN-LLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 52 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~-~~~~~~~~~~~~lv~E~~~~ 130 (381)
-+..+.|++|.+|.||++.+. |..+|+|+-+.. ..+..+..|+++|..+.--++.. +|.|- ..++.|||+.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G 96 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDG 96 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcC
Confidence 455789999999999999988 668999986544 34578999999999998666654 44432 23456999998
Q ss_pred CCHHHH--------HHhhhhhhhHhhhhc--cCCcc-ccceEeCCCCCcEEeeecccee
Q 048280 131 ESLDKV--------LFSLIKDIQILFRKK--KTDIK-ASNILLDDKWIPKIADFGMARL 178 (381)
Q Consensus 131 g~L~~~--------l~~~~~~l~~lh~~~--HrDlk-p~NIll~~~~~~kL~DFG~~~~ 178 (381)
..|.+. +..+++.--.|-..+ |+.|. |..++|.++..+.|+||..|+.
T Consensus 97 ~~L~~~~~~~~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIGGDRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhcccHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 788544 344555533333334 66664 4444444455899999998874
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.31 E-value=5.7e-06 Score=69.92 Aligned_cols=133 Identities=22% Similarity=0.368 Sum_probs=100.1
Q ss_pred HhhhCCCCChHHHHHhhcCCCCCCcccccCC-eeEEEEEECCCcEEEEEEecC---CCc------------------ccH
Q 048280 33 AAREQKHFPFEALVSATKNFHPSNKLGEGGF-GPVFKGKLDDGREIAVKKLSH---SSN------------------QGK 90 (381)
Q Consensus 33 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~---~~~------------------~~~ 90 (381)
.....+.|+. -+.+++.++.||.|.- |.||+++.. |+.+|+|.+.. ... ...
T Consensus 25 ~gPKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~ 98 (207)
T PF13095_consen 25 PGPKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYA 98 (207)
T ss_pred CCCCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhc
Confidence 3345556665 2378999999999999 999999987 78999999321 100 112
Q ss_pred HHHHHHHHHHHHhC---CCCc--ccEEEEEeeC------------------CeEEEEEecccCCC--HHHHHHhhhhhhh
Q 048280 91 KEFENEAKLLARVQ---HRNV--VNLLGYCAHG------------------AEKLLIYEYVINES--LDKVLFSLIKDIQ 145 (381)
Q Consensus 91 ~~~~~E~~~l~~l~---hpnI--v~~~~~~~~~------------------~~~~lv~E~~~~g~--L~~~l~~~~~~l~ 145 (381)
..|..|.+...+|+ +.++ |+++||..-. ....||.||++... -.+-+.++++.+.
T Consensus 99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~~~~~~~~~~~~~dl~ 178 (207)
T PF13095_consen 99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDPPLQIRDIPQMLRDLK 178 (207)
T ss_pred ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCccccchhHHHHHHHHHH
Confidence 35788999998885 4566 9999997322 13468999998776 4556788999999
Q ss_pred Hhhhhc--cCCccccceEeCCCCCcEEeeeccc
Q 048280 146 ILFRKK--KTDIKASNILLDDKWIPKIADFGMA 176 (381)
Q Consensus 146 ~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~ 176 (381)
.+|..+ -+|+++.|.. .-||+|||.+
T Consensus 179 ~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 999988 8999999987 3599999864
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.30 E-value=7.6e-06 Score=69.74 Aligned_cols=119 Identities=14% Similarity=0.195 Sum_probs=85.7
Q ss_pred ccccCCeeEEEEEECCCcEEEEEEecCC------CcccHHHHHHHHHHHHHhCCC--CcccEEEEEee-----CCeEEEE
Q 048280 58 LGEGGFGPVFKGKLDDGREIAVKKLSHS------SNQGKKEFENEAKLLARVQHR--NVVNLLGYCAH-----GAEKLLI 124 (381)
Q Consensus 58 lg~G~~g~V~~~~~~~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~~~~-----~~~~~lv 124 (381)
-|.||.+.|+..... |..+-+|.-... .......|.+|+..+.+|..- .+.++. ++.. .-..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 467999999998776 457888876421 133567899999999999532 244444 3221 1235789
Q ss_pred EecccC-CCHH-----------------HHHHhhhhhhhHhhhhc--cCCccccceEeCCCCC--cEEeeecccee
Q 048280 125 YEYVIN-ESLD-----------------KVLFSLIKDIQILFRKK--KTDIKASNILLDDKWI--PKIADFGMARL 178 (381)
Q Consensus 125 ~E~~~~-g~L~-----------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~--~kL~DFG~~~~ 178 (381)
+|-+.+ .+|. .++.+++..++-+|..+ |+|+-+.|||++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 986632 3443 45567888999999999 9999999999986666 99999977653
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.4e-05 Score=75.91 Aligned_cols=126 Identities=17% Similarity=0.251 Sum_probs=81.6
Q ss_pred CCcccccCCeeEEEEEECCCcEEEEEEecCCCccc-------------------------------------HHHHHHHH
Q 048280 55 SNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQG-------------------------------------KKEFENEA 97 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~~~~E~ 97 (381)
.+.||.-+.|.||+|+.++|+.||||+-+..-... .-+|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 47899999999999999999999999876532111 00234455
Q ss_pred HHHHHh----CCCC------cccEEEEEeeCCeEEEEEecccCCCHHHHH---------Hhhhhhh-------hHhhhhc
Q 048280 98 KLLARV----QHRN------VVNLLGYCAHGAEKLLIYEYVINESLDKVL---------FSLIKDI-------QILFRKK 151 (381)
Q Consensus 98 ~~l~~l----~hpn------Iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l---------~~~~~~l-------~~lh~~~ 151 (381)
+-..++ .|-+ |.++|-. -.....|+||||+|..+.++- ..++..+ -+.|..-
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~Gff 323 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKTGFF 323 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhcCCc
Confidence 443333 3555 3333322 234578999999998775432 1122111 1112222
Q ss_pred cCCccccceEeC----CCCCcEEeeeccceecCCC
Q 048280 152 KTDIKASNILLD----DKWIPKIADFGMARLFPED 182 (381)
Q Consensus 152 HrDlkp~NIll~----~~~~~kL~DFG~~~~~~~~ 182 (381)
|+|=.|.||++. .++.+.+.|||+...+...
T Consensus 324 HaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 324 HADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred cCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 999999999998 3678999999999876443
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.5e-05 Score=71.44 Aligned_cols=116 Identities=16% Similarity=0.157 Sum_probs=73.5
Q ss_pred cccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCc-ccEEEEEeeCCeEEEEEecccCCCHHH
Q 048280 57 KLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNV-VNLLGYCAHGAEKLLIYEYVINESLDK 135 (381)
Q Consensus 57 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~E~~~~g~L~~ 135 (381)
.+..|-.+.+|+... ++..+++|..........-...+|.++++.+....+ .+++..+. -++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 456677889998874 467888887644322211235789999999964333 34444432 368999998876531
Q ss_pred -------HHHhhhhhhhHhhh---------------------------------------h----------ccCCccccc
Q 048280 136 -------VLFSLIKDIQILFR---------------------------------------K----------KKTDIKASN 159 (381)
Q Consensus 136 -------~l~~~~~~l~~lh~---------------------------------------~----------~HrDlkp~N 159 (381)
.+.++++.+.-+|+ . .|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 12111111111110 0 199999999
Q ss_pred eEeCCCCCcEEeeecccee
Q 048280 160 ILLDDKWIPKIADFGMARL 178 (381)
Q Consensus 160 Ill~~~~~~kL~DFG~~~~ 178 (381)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999988764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.03 E-value=4.1e-05 Score=70.05 Aligned_cols=120 Identities=14% Similarity=0.129 Sum_probs=78.4
Q ss_pred CCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCC--cccEEEE------EeeCCeEEEEEe
Q 048280 55 SNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRN--VVNLLGY------CAHGAEKLLIYE 126 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~------~~~~~~~~lv~E 126 (381)
++.|..|....+|+....+ ..+++|+... .....+..|++++..+.+.+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 5677788888999987654 5688898754 23456778999998885332 4444431 233456789999
Q ss_pred cccCCCHHH----HHHhhhhh----------------------------------------------hhHhhh-------
Q 048280 127 YVINESLDK----VLFSLIKD----------------------------------------------IQILFR------- 149 (381)
Q Consensus 127 ~~~~g~L~~----~l~~~~~~----------------------------------------------l~~lh~------- 149 (381)
|++|..+.. .+.++.+. +.++-.
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998876521 11111111 111111
Q ss_pred --hccCCccccceEeCCCCCcEEeeecccee
Q 048280 150 --KKKTDIKASNILLDDKWIPKIADFGMARL 178 (381)
Q Consensus 150 --~~HrDlkp~NIll~~~~~~kL~DFG~~~~ 178 (381)
..|+|+.|.|||+++++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 11999999999999887778999988763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.99 E-value=6.7e-05 Score=66.17 Aligned_cols=74 Identities=15% Similarity=0.181 Sum_probs=49.6
Q ss_pred CCcccccCCeeEEEEEECC--CcEEEEEEecCCCcccHHHHHHHHHHHHHhCC-CCcccEEEEEeeCCeEEEEEecccCC
Q 048280 55 SNKLGEGGFGPVFKGKLDD--GREIAVKKLSHSSNQGKKEFENEAKLLARVQH-RNVVNLLGYCAHGAEKLLIYEYVINE 131 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~E~~~~g 131 (381)
++.|..|-...+|+....+ +..|++|+....... .-...+|+.+++.+.. .-..++++.+. -.+||||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 4567788888999998664 678999977543221 1234579999999853 33445554432 24799999886
Q ss_pred CH
Q 048280 132 SL 133 (381)
Q Consensus 132 ~L 133 (381)
++
T Consensus 78 ~l 79 (235)
T cd05157 78 TL 79 (235)
T ss_pred cC
Confidence 65
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00015 Score=67.11 Aligned_cols=75 Identities=12% Similarity=0.080 Sum_probs=47.8
Q ss_pred CCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCC--cccEEE------EEeeCCeEEEEEe
Q 048280 55 SNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRN--VVNLLG------YCAHGAEKLLIYE 126 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~------~~~~~~~~~lv~E 126 (381)
.+.|+.|....+|+....+| .+++|++. . .....+..|+.++..|...+ +.+++. +....+..+++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 45677788889999887655 68889875 2 22345556777777774222 333332 1233556789999
Q ss_pred cccCCCH
Q 048280 127 YVINESL 133 (381)
Q Consensus 127 ~~~~g~L 133 (381)
|++|..+
T Consensus 103 ~l~G~~~ 109 (319)
T PRK05231 103 FLEGKWP 109 (319)
T ss_pred ecCCCCC
Confidence 9988643
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00018 Score=61.26 Aligned_cols=117 Identities=15% Similarity=0.280 Sum_probs=81.9
Q ss_pred CCCcccccCCeeEEEEEECCCcEEEEEEecCCC----------------cccHHHHHHHHHHHHHhC------CCCcccE
Q 048280 54 PSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSS----------------NQGKKEFENEAKLLARVQ------HRNVVNL 111 (381)
Q Consensus 54 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------hpnIv~~ 111 (381)
-...||+|+.-.||. +.++....||+..... ....++..+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356899999999997 4456667888886554 223466778888887776 7899999
Q ss_pred EEEEeeCCeEEEEEecccC------CCHHHHHH------hhhhhh----hHhhhhc--cCCccccceEeCCCC----CcE
Q 048280 112 LGYCAHGAEKLLIYEYVIN------ESLDKVLF------SLIKDI----QILFRKK--KTDIKASNILLDDKW----IPK 169 (381)
Q Consensus 112 ~~~~~~~~~~~lv~E~~~~------g~L~~~l~------~~~~~l----~~lh~~~--HrDlkp~NIll~~~~----~~k 169 (381)
+|+.+++.-.-+|+|.+.+ .+|.+++. .+..+| .++.+.. .+||+|.||++.... .+.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lv 162 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTEELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLV 162 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccHHHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEE
Confidence 9999999889999998632 35666652 122222 2332222 689999999995322 577
Q ss_pred Eee
Q 048280 170 IAD 172 (381)
Q Consensus 170 L~D 172 (381)
|+|
T Consensus 163 lID 165 (199)
T PF10707_consen 163 LID 165 (199)
T ss_pred EEe
Confidence 777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00016 Score=66.62 Aligned_cols=76 Identities=13% Similarity=0.089 Sum_probs=49.0
Q ss_pred CCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCC--CcccEEEE------EeeCCeEEEEEe
Q 048280 55 SNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHR--NVVNLLGY------CAHGAEKLLIYE 126 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~------~~~~~~~~lv~E 126 (381)
++.++.|....+|+....++ .+++|+..... ..+.+..|++++..|... .+.+++.. ....+..+++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 56677787789999876544 57788775422 234566788888888422 24444432 122456789999
Q ss_pred cccCCCH
Q 048280 127 YVINESL 133 (381)
Q Consensus 127 ~~~~g~L 133 (381)
|++|..+
T Consensus 104 ~i~G~~~ 110 (307)
T TIGR00938 104 FLQGLSV 110 (307)
T ss_pred eCCCCCC
Confidence 9987543
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00033 Score=66.16 Aligned_cols=76 Identities=17% Similarity=0.220 Sum_probs=55.6
Q ss_pred CCcccccCCeeEEEEEECCC-cEEEEEEecCC-----C--cccHHHHHHHHHHHHHhC---CCCcccEEEEEeeCCeEEE
Q 048280 55 SNKLGEGGFGPVFKGKLDDG-REIAVKKLSHS-----S--NQGKKEFENEAKLLARVQ---HRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~l 123 (381)
.+.||.|.+..||++...+| +.|+||.-... . ....+++..|.+.|..+. ..++.+++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46899999999999998876 58999985311 1 224567788888888873 3457777766 3355789
Q ss_pred EEecccCCC
Q 048280 124 IYEYVINES 132 (381)
Q Consensus 124 v~E~~~~g~ 132 (381)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999997644
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00015 Score=66.36 Aligned_cols=77 Identities=13% Similarity=0.096 Sum_probs=57.7
Q ss_pred CCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCC---CCcccEEEEEeeC---CeEEEEEec
Q 048280 54 PSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQH---RNVVNLLGYCAHG---AEKLLIYEY 127 (381)
Q Consensus 54 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pnIv~~~~~~~~~---~~~~lv~E~ 127 (381)
-.+.||.|..+.||+....++ .+.+|..+. ......+..|...|+.|.- -.+.++++++..+ +..+||||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 357899999999999976655 466677432 1123688999999999953 4678888887543 668999999
Q ss_pred ccCCCH
Q 048280 128 VINESL 133 (381)
Q Consensus 128 ~~~g~L 133 (381)
+++.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 988754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00011 Score=64.94 Aligned_cols=73 Identities=21% Similarity=0.316 Sum_probs=46.9
Q ss_pred CCcccccCCe-eEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCC---CcccEEEEEeeC---CeEEEEEec
Q 048280 55 SNKLGEGGFG-PVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHR---NVVNLLGYCAHG---AEKLLIYEY 127 (381)
Q Consensus 55 ~~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~~~~~~~~~---~~~~lv~E~ 127 (381)
++.|+.|+.. .||+. +..+++|..... .....+.+|.+++..+... .+.++++..... ...+++|++
T Consensus 2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 2 IEPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred ceeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 4567877776 58975 235777765432 2345788999999988532 344444443322 234889999
Q ss_pred ccCCCH
Q 048280 128 VINESL 133 (381)
Q Consensus 128 ~~~g~L 133 (381)
++|.++
T Consensus 76 i~G~~l 81 (235)
T cd05155 76 LEGETA 81 (235)
T ss_pred ecCCCC
Confidence 988776
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00012 Score=76.37 Aligned_cols=78 Identities=21% Similarity=0.397 Sum_probs=57.9
Q ss_pred CCcccccCCeeEEEEEECCC---cEEEEEEecCCC-cccHHHHHHHHHHHHHhC-CCCc--ccEEEEEeeC---CeEEEE
Q 048280 55 SNKLGEGGFGPVFKGKLDDG---REIAVKKLSHSS-NQGKKEFENEAKLLARVQ-HRNV--VNLLGYCAHG---AEKLLI 124 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnI--v~~~~~~~~~---~~~~lv 124 (381)
+..|+.|.+..+|+.....+ ..+++|+..... ......+.+|+++|+.+. |.+| .+++.+|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 57789999999999876643 467777764332 123457889999999995 6665 7788888664 457899
Q ss_pred EecccCCC
Q 048280 125 YEYVINES 132 (381)
Q Consensus 125 ~E~~~~g~ 132 (381)
|||++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998754
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00046 Score=64.53 Aligned_cols=74 Identities=19% Similarity=0.225 Sum_probs=49.1
Q ss_pred CCcccccCCeeEEEEEECC-----CcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcc-cEEEEEeeCCeEEEEEecc
Q 048280 55 SNKLGEGGFGPVFKGKLDD-----GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVV-NLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~lv~E~~ 128 (381)
+..|-.|-...+|++...+ ++.|++|+.........+ -.+|..+++.+..-++. ++++.+..+ .|.+|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 4566668888999987542 367899987654333223 36799999999644443 566665433 578888
Q ss_pred cCCCH
Q 048280 129 INESL 133 (381)
Q Consensus 129 ~~g~L 133 (381)
++.+|
T Consensus 116 ~g~~l 120 (344)
T PLN02236 116 HARTL 120 (344)
T ss_pred CCCCC
Confidence 77665
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.57 E-value=1.8e-05 Score=83.49 Aligned_cols=137 Identities=9% Similarity=0.046 Sum_probs=101.3
Q ss_pred HHHHHHHHHHhCCCCcccEEEEEe--eCCeEEEEEecccCCCHHHHHH------------------hh-hhhhhHhhhhc
Q 048280 93 FENEAKLLARVQHRNVVNLLGYCA--HGAEKLLIYEYVINESLDKVLF------------------SL-IKDIQILFRKK 151 (381)
Q Consensus 93 ~~~E~~~l~~l~hpnIv~~~~~~~--~~~~~~lv~E~~~~g~L~~~l~------------------~~-~~~l~~lh~~~ 151 (381)
...|...++...|+++.....-.. +....+.+++|+.+|.+..+|. ++ +....-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 344555555667888877654432 2345688999999999988772 11 22233333332
Q ss_pred -------cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHH
Q 048280 152 -------KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELI 224 (381)
Q Consensus 152 -------HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ell 224 (381)
|++||+-|.+|..+..+|++++|+.+... ......+...+++.|+.|++...-.++.++|+|..|+-+|++.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn-p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN-PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccC-chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 89999999999999999999999999432 3333344567888999999998889999999999999999998
Q ss_pred hCCCCC
Q 048280 225 SGQRNS 230 (381)
Q Consensus 225 tg~~p~ 230 (381)
-|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 887664
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0005 Score=62.26 Aligned_cols=74 Identities=20% Similarity=0.320 Sum_probs=49.5
Q ss_pred CCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhC---CCCcccEEEEEeeCCeEEEEEecccC
Q 048280 54 PSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQ---HRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 54 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
-.+.++.|....+|+.. .+++.+.||+-. ......|..|..-|+.|. --.+.+++++....+..+|||||++.
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 35678889999999987 558889999875 233467888999999883 44577888888777778999999977
Q ss_pred C
Q 048280 131 E 131 (381)
Q Consensus 131 g 131 (381)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 6
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00079 Score=69.90 Aligned_cols=178 Identities=16% Similarity=0.197 Sum_probs=114.1
Q ss_pred HHHHHHHHHHhCCCCcccEEEEEeeCCeEE----EEEecccCCCHHHHH---------------HhhhhhhhHhhhhccC
Q 048280 93 FENEAKLLARVQHRNVVNLLGYCAHGAEKL----LIYEYVINESLDKVL---------------FSLIKDIQILFRKKKT 153 (381)
Q Consensus 93 ~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~----lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~Hr 153 (381)
...|+..+.++.|+|++.++.|-......- +..++|..-++...+ .+.++++.++|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~--- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL--- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh---
Confidence 344677788889999999999876543332 334666666654443 5678899999985
Q ss_pred CccccceEe----------CCCCCcEEe--eeccceecCCCCcccccccccCccccchhHHhhCCCCc--hhhhHhHHHH
Q 048280 154 DIKASNILL----------DDKWIPKIA--DFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSV--KADVFSFGVV 219 (381)
Q Consensus 154 Dlkp~NIll----------~~~~~~kL~--DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~sDvwSlGvv 219 (381)
+..|+.+ +..+.+.++ ||+.++.+....... ....+..|.++|......+.. ..|+|.+|..
T Consensus 306 --~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 306 --SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred --ccceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 4444444 344556666 888887664433221 123355678888776665544 4799999999
Q ss_pred HHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 220 ILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 220 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
+..+..|..+...... ....+ ..... ..+.+...+|+..++++|+++.+++...
T Consensus 382 ~~~~~~~~~i~~~~~~------------------~~~~l-----~~~~~---~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAV------------------PVSLL-----DVLST---SELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred HhhhhhcCcccccccc------------------hhhhh-----ccccc---hhhhhhhhhhcchhhhhccchhhhhhch
Confidence 9999988755321000 00000 00000 0355677889999999999999999877
Q ss_pred cCCC
Q 048280 300 SKKP 303 (381)
Q Consensus 300 ~~~~ 303 (381)
....
T Consensus 436 f~~~ 439 (1351)
T KOG1035|consen 436 FLRF 439 (1351)
T ss_pred hccc
Confidence 5544
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00083 Score=61.66 Aligned_cols=73 Identities=26% Similarity=0.351 Sum_probs=48.3
Q ss_pred CcccccCCeeEEEEEECC-------CcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCc-ccEEEEEeeCCeEEEEEec
Q 048280 56 NKLGEGGFGPVFKGKLDD-------GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNV-VNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~E~ 127 (381)
+.|..|--..+|+....+ ++.+++|+..... .......+|.+++..+....+ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667777899987654 5789999975443 222456789999999853333 355655532 357888
Q ss_pred ccCCCH
Q 048280 128 VINESL 133 (381)
Q Consensus 128 ~~~g~L 133 (381)
++|..+
T Consensus 79 i~G~~l 84 (302)
T cd05156 79 IPSRTL 84 (302)
T ss_pred eCCCcC
Confidence 877655
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0021 Score=55.66 Aligned_cols=100 Identities=20% Similarity=0.310 Sum_probs=56.4
Q ss_pred CcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCc-ccEEEEEeeCCeEEEEEecccCCCHH-------HHHHhhhhhhh
Q 048280 74 GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNV-VNLLGYCAHGAEKLLIYEYVINESLD-------KVLFSLIKDIQ 145 (381)
Q Consensus 74 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~E~~~~g~L~-------~~l~~~~~~l~ 145 (381)
++.|+|++..... ...-.-.+|..+++.+..-++ .++++++.++ +|.+|+.+..|. .++..++..|+
T Consensus 2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHH
Confidence 4678888886553 334566789999999864444 5566665432 577998776652 12222222222
Q ss_pred Hhhh---------------------------------------------------------h-c------cCCccccceE
Q 048280 146 ILFR---------------------------------------------------------K-K------KTDIKASNIL 161 (381)
Q Consensus 146 ~lh~---------------------------------------------------------~-~------HrDlkp~NIl 161 (381)
-+|. . . |+||.+.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 2221 0 0 9999999999
Q ss_pred e-CCCCCcEEeeecccee
Q 048280 162 L-DDKWIPKIADFGMARL 178 (381)
Q Consensus 162 l-~~~~~~kL~DFG~~~~ 178 (381)
+ +.++.++|+||..+..
T Consensus 157 ~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp ETSSSSCEEE--GTT-EE
T ss_pred eccCCCeEEEecHHHHhh
Confidence 9 8889999999988764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0051 Score=58.14 Aligned_cols=74 Identities=15% Similarity=0.127 Sum_probs=52.1
Q ss_pred CCCcccccCCeeEEEEEECCCcEEEEEEecCC-----C--cccHHHHHHHHHHHHHhC---CCCcccEEEEEeeCCeEEE
Q 048280 54 PSNKLGEGGFGPVFKGKLDDGREIAVKKLSHS-----S--NQGKKEFENEAKLLARVQ---HRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 54 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~l 123 (381)
..+.||.|....||+.... +..++||+-... . .....+-..|...|+.+. ..++.+++.++.+ ..++
T Consensus 36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vl 112 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALI 112 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEE
Confidence 3678899999999998865 567999975411 1 123445555677777664 3578888888873 4678
Q ss_pred EEecccC
Q 048280 124 IYEYVIN 130 (381)
Q Consensus 124 v~E~~~~ 130 (381)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 8999966
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0043 Score=57.68 Aligned_cols=74 Identities=15% Similarity=0.279 Sum_probs=47.5
Q ss_pred CCcccccCCeeEEEEEECC----CcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCc-ccEEEEEeeCCeEEEEEeccc
Q 048280 55 SNKLGEGGFGPVFKGKLDD----GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNV-VNLLGYCAHGAEKLLIYEYVI 129 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~E~~~ 129 (381)
++.|..|-...+|+....+ +..|++|+........ -.-.+|..+++.+..-++ .++++++..+ +|.+|++
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~ 93 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFIN 93 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeCCc----Eeehhhc
Confidence 3455557777899886543 2478899875543322 233679999999965554 3566665322 5888887
Q ss_pred CCCH
Q 048280 130 NESL 133 (381)
Q Consensus 130 ~g~L 133 (381)
+..|
T Consensus 94 g~~l 97 (330)
T PLN02421 94 ARTL 97 (330)
T ss_pred CCCC
Confidence 7655
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0013 Score=59.47 Aligned_cols=125 Identities=16% Similarity=0.129 Sum_probs=87.9
Q ss_pred CCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCc----------------------ccHHHHHHHHHHHHHhC-CC-
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSN----------------------QGKKEFENEAKLLARVQ-HR- 106 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~-hp- 106 (381)
=+.+.++||-|.-+.||.+-...|+..++|.-+.... -.+-...+|...|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 4678899999999999999998899999985322110 01224567999999884 32
Q ss_pred CcccEEEEEeeCCeEEEEEecccCCCHHHH---------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeecc
Q 048280 107 NVVNLLGYCAHGAEKLLIYEYVINESLDKV---------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGM 175 (381)
Q Consensus 107 nIv~~~~~~~~~~~~~lv~E~~~~g~L~~~---------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~ 175 (381)
-+.+.+++ +..++|||++.+-.|.++ ...++.-+.-|...+ |+|..--||++++++.++++||--
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQ 248 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechH
Confidence 24444443 456889999888776432 123333344455555 999999999999999999999976
Q ss_pred ceec
Q 048280 176 ARLF 179 (381)
Q Consensus 176 ~~~~ 179 (381)
+...
T Consensus 249 mvS~ 252 (465)
T KOG2268|consen 249 MVST 252 (465)
T ss_pred hhcc
Confidence 5543
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.002 Score=61.56 Aligned_cols=47 Identities=19% Similarity=0.300 Sum_probs=37.2
Q ss_pred HHHHHHHHHHHHhCCCCcccEEEEEeeC-CeEEEEEecccCCCHHHHHH
Q 048280 91 KEFENEAKLLARVQHRNVVNLLGYCAHG-AEKLLIYEYVINESLDKVLF 138 (381)
Q Consensus 91 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~E~~~~g~L~~~l~ 138 (381)
.++.-...+++.+.|+|...++++.... ....+|+|++ +.+|.+++.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~ 74 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILK 74 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHH
Confidence 4566678889999999999999887543 3478899998 788888773
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0018 Score=54.93 Aligned_cols=82 Identities=27% Similarity=0.340 Sum_probs=61.7
Q ss_pred HHHHHHHHHhCC-CCcccEEEEEeeCCeEEEEEecccCCCH-------H-----------HHHHhhhhhhhHhhhhc---
Q 048280 94 ENEAKLLARVQH-RNVVNLLGYCAHGAEKLLIYEYVINESL-------D-----------KVLFSLIKDIQILFRKK--- 151 (381)
Q Consensus 94 ~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~E~~~~g~L-------~-----------~~l~~~~~~l~~lh~~~--- 151 (381)
.+|.-+++.+.+ +++.+++|+|- .++|.||...+++ . ++..++++.+.+++..-
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888888875 69999999994 3678999876533 2 23356666666665533
Q ss_pred --cCCccccceEeCCCCCcEEeeeccceec
Q 048280 152 --KTDIKASNILLDDKWIPKIADFGMARLF 179 (381)
Q Consensus 152 --HrDlkp~NIll~~~~~~kL~DFG~~~~~ 179 (381)
-.|++++|+-+++++.+|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 4799999999999999999999877643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.011 Score=55.03 Aligned_cols=72 Identities=19% Similarity=0.202 Sum_probs=48.5
Q ss_pred cccccCCeeEEEEEECCC-cEEEEEEecC-------CCcccHHHHHHHHHHHHHhC--CC-CcccEEEEEeeCCeEEEEE
Q 048280 57 KLGEGGFGPVFKGKLDDG-REIAVKKLSH-------SSNQGKKEFENEAKLLARVQ--HR-NVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 57 ~lg~G~~g~V~~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--hp-nIv~~~~~~~~~~~~~lv~ 125 (381)
.||.|....||++...++ +.|+||.-.. .-....++...|...|+... -| .+.++|.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997654 6899997421 11334456667888887763 34 44455443 445567999
Q ss_pred ecccC
Q 048280 126 EYVIN 130 (381)
Q Consensus 126 E~~~~ 130 (381)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99855
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.016 Score=52.47 Aligned_cols=44 Identities=20% Similarity=0.101 Sum_probs=29.6
Q ss_pred cccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhC
Q 048280 59 GEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQ 104 (381)
Q Consensus 59 g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 104 (381)
++|-...|+.....+|+.+++|.-... .....+.+|.++|..+.
T Consensus 20 ~~g~~~~v~~i~~~~g~~~VlR~p~~~--~~~~~l~rE~~vL~~L~ 63 (276)
T cd05152 20 ESGLDFQVVFAKDTDGVPWVLRIPRRP--DVSERAAAEKRVLALVR 63 (276)
T ss_pred CCcceeEEEEEEcCCCCeEEEEecCCH--HHHHHHHHHHHHHHHHH
Confidence 444445566665556888998886422 22456789999999985
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.018 Score=52.68 Aligned_cols=127 Identities=17% Similarity=0.282 Sum_probs=78.7
Q ss_pred CCCCCcccccCCeeEEEEEECCCcEEEEEEec-CCCcccHHHHHHHHHHHHHhCC--CCcccEEEEEeeCC--eEEEEEe
Q 048280 52 FHPSNKLGEGGFGPVFKGKLDDGREIAVKKLS-HSSNQGKKEFENEAKLLARVQH--RNVVNLLGYCAHGA--EKLLIYE 126 (381)
Q Consensus 52 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~--~~~lv~E 126 (381)
..+++.+..|---.+|..... ++.+++.+-. ...........+|..+++.+.- --+-..+++|.++. ..|.||+
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred CceeeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 444555534433445554444 7778887211 1222334567788888888743 23445567777665 6799999
Q ss_pred cccCCCH---------H-HHHH-hhhhhhhHhhh----------------------------------------------
Q 048280 127 YVINESL---------D-KVLF-SLIKDIQILFR---------------------------------------------- 149 (381)
Q Consensus 127 ~~~~g~L---------~-~~l~-~~~~~l~~lh~---------------------------------------------- 149 (381)
|+.|..+ . ++.. .+...|.-||+
T Consensus 106 ~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~ 185 (321)
T COG3173 106 WVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK 185 (321)
T ss_pred EecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence 9977332 2 2332 33333333332
Q ss_pred ----hc----------cCCccccceEeCCCCCcEEeeeccceec
Q 048280 150 ----KK----------KTDIKASNILLDDKWIPKIADFGMARLF 179 (381)
Q Consensus 150 ----~~----------HrDlkp~NIll~~~~~~kL~DFG~~~~~ 179 (381)
.. |+|+.+.||+|+...-+=|.||+++..-
T Consensus 186 Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 186 WLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 11 9999999999998888999999998753
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.0087 Score=56.31 Aligned_cols=74 Identities=14% Similarity=0.194 Sum_probs=51.4
Q ss_pred CCcccccCCeeEEEEEECC-CcEEEEEEecC------CCcccHHHHHHHHHHHHHhC--CC-CcccEEEEEeeCCeEEEE
Q 048280 55 SNKLGEGGFGPVFKGKLDD-GREIAVKKLSH------SSNQGKKEFENEAKLLARVQ--HR-NVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--hp-nIv~~~~~~~~~~~~~lv 124 (381)
++.||.|.-..||++...+ ++.|+||.-.. .-.-..++...|.++|+.+. -| .+.++|.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 6788999999999998753 56899997421 11334567777888888773 34 45556543 44556789
Q ss_pred EecccC
Q 048280 125 YEYVIN 130 (381)
Q Consensus 125 ~E~~~~ 130 (381)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999854
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.0079 Score=51.49 Aligned_cols=145 Identities=19% Similarity=0.167 Sum_probs=88.5
Q ss_pred CCeeEEEEEECCCcEEEEEEecCCCcc-cHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCCC--HHHHHH
Q 048280 62 GFGPVFKGKLDDGREIAVKKLSHSSNQ-GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINES--LDKVLF 138 (381)
Q Consensus 62 ~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~--L~~~l~ 138 (381)
+-++.-.+..+- ....+|++....-. ...-|.++.++++++. .|+++..- ++-.+-++.|+|-... ...++.
T Consensus 74 gNsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~~~N~i~ 148 (308)
T PF07387_consen 74 GNSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKINFSNFIT 148 (308)
T ss_pred CceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccchhHHHH
Confidence 334444443332 23455665433222 3356778889988874 46666521 3345668899885433 344555
Q ss_pred hhhhhhhHhhhhc----cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccccCccccchhHHhhCCCCchhhhH
Q 048280 139 SLIKDIQILFRKK----KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVF 214 (381)
Q Consensus 139 ~~~~~l~~lh~~~----HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvw 214 (381)
.-+++|.-.|+.. |+|..|+||+-|+.|.+||.|-+.--. .+..|.-- .....+.++.+-
T Consensus 149 agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~-------------~~V~~vN~---~Y~~lT~~aE~~ 212 (308)
T PF07387_consen 149 AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE-------------NQVNMVNI---EYESLTQEAEVK 212 (308)
T ss_pred HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhhhh-------------heeeEEee---eccccChHHHHH
Confidence 5578888899655 999999999999999999999764321 11122221 112356677777
Q ss_pred hHHHHHHHHHhCC
Q 048280 215 SFGVVILELISGQ 227 (381)
Q Consensus 215 SlGvvl~elltg~ 227 (381)
+|=.-++++....
T Consensus 213 ~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 213 VFVKSCLKLVEKQ 225 (308)
T ss_pred HHHHHHHHHHHHH
Confidence 7777777776543
|
The function of this family is unknown. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.024 Score=52.42 Aligned_cols=70 Identities=23% Similarity=0.330 Sum_probs=46.3
Q ss_pred CCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCC------cccEEE----EEeeCCeEEEEEecccCC
Q 048280 62 GFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRN------VVNLLG----YCAHGAEKLLIYEYVINE 131 (381)
Q Consensus 62 ~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~~~~----~~~~~~~~~lv~E~~~~g 131 (381)
.-..||+....+|+. ++|+.... ....++..|+..|..|.-.. |..+=| ....+...+-+++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 456789998887666 88888655 45577888999998884221 222211 112223778899999887
Q ss_pred CHH
Q 048280 132 SLD 134 (381)
Q Consensus 132 ~L~ 134 (381)
.+.
T Consensus 114 ~~~ 116 (331)
T COG2334 114 PLE 116 (331)
T ss_pred CcC
Confidence 776
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.044 Score=50.41 Aligned_cols=64 Identities=14% Similarity=0.218 Sum_probs=40.7
Q ss_pred eEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCC--CcccEEEE------EeeCCeEEEEEecccCCCH
Q 048280 65 PVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHR--NVVNLLGY------CAHGAEKLLIYEYVINESL 133 (381)
Q Consensus 65 ~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~------~~~~~~~~lv~E~~~~g~L 133 (381)
.||+....+| .+++|++... ...+..|+.++..|... .+.+++.. ...++..++|+||++|..+
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~~----~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~ 82 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINYP----PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC 82 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence 4899886655 5888987422 24456677777777433 34444432 2335678999999977543
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.024 Score=52.39 Aligned_cols=124 Identities=18% Similarity=0.211 Sum_probs=81.8
Q ss_pred CCCCcccccCCeeEEEEEECCCcEEEEEEecCCCc----------------------ccHH----HHHHHHHHHHHhCCC
Q 048280 53 HPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSN----------------------QGKK----EFENEAKLLARVQHR 106 (381)
Q Consensus 53 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~----~~~~E~~~l~~l~hp 106 (381)
++...|..|.-+-||.|...+|..+|||+++.+-. ..+. -...|++-|++|+..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 45567888999999999988999999999864310 0011 134688888888755
Q ss_pred CcccEEEEEeeCCeEEEEEecccCC---------------CHHHHHHhhhhhhhHhhhhc---cCCccccceEeCCCCCc
Q 048280 107 NVVNLLGYCAHGAEKLLIYEYVINE---------------SLDKVLFSLIKDIQILFRKK---KTDIKASNILLDDKWIP 168 (381)
Q Consensus 107 nIv~~~~~~~~~~~~~lv~E~~~~g---------------~L~~~l~~~~~~l~~lh~~~---HrDlkp~NIll~~~~~~ 168 (381)
.|..---+.. ..-.|||+|+-.. .+..+-.+++..+..|.... |.||.--|+|+. +|.+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~l 303 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKL 303 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEE
Confidence 5432222222 1246899997321 12233355666666665554 999999999996 4579
Q ss_pred EEeeeccceec
Q 048280 169 KIADFGMARLF 179 (381)
Q Consensus 169 kL~DFG~~~~~ 179 (381)
.|+|-+-+...
T Consensus 304 yiIDVSQSVE~ 314 (520)
T KOG2270|consen 304 YIIDVSQSVEH 314 (520)
T ss_pred EEEEccccccC
Confidence 99998877644
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.17 Score=46.94 Aligned_cols=72 Identities=15% Similarity=0.163 Sum_probs=46.6
Q ss_pred ccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCC--CcccEE---E--EEeeCCeEEEEEecccCCC
Q 048280 60 EGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHR--NVVNLL---G--YCAHGAEKLLIYEYVINES 132 (381)
Q Consensus 60 ~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~---~--~~~~~~~~~lv~E~~~~g~ 132 (381)
.+.-..||+....++..+++|+..... .....+..|++.+..|... .++... | +...++..+.|+++++|..
T Consensus 35 ~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 35 NSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 345567999988778889999875332 3456778899888888421 122211 1 2233456788999987654
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.095 Score=48.23 Aligned_cols=27 Identities=19% Similarity=0.239 Sum_probs=24.9
Q ss_pred cCCccccceEeCCCCCcEEeeecccee
Q 048280 152 KTDIKASNILLDDKWIPKIADFGMARL 178 (381)
Q Consensus 152 HrDlkp~NIll~~~~~~kL~DFG~~~~ 178 (381)
|+|+.+.|||++.++.+.++||..+..
T Consensus 200 HgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 200 HGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred CCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 999999999999998999999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.061 Score=46.51 Aligned_cols=75 Identities=19% Similarity=0.219 Sum_probs=50.6
Q ss_pred CcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhC---CCCcccEEEEEeeCCeEEEEEecccCCC
Q 048280 56 NKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQ---HRNVVNLLGYCAHGAEKLLIYEYVINES 132 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~lv~E~~~~g~ 132 (381)
+.+.-|..-..|...+. ...+-||+-. ......|..|+.-|..|. .-++.+++.+-.+..+.|+||||++.+.
T Consensus 22 ~~v~gG~inea~~v~dg-~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRDG-TDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeecC-CcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 34444444444554433 5677888642 233466788887777774 4567788888888999999999998876
Q ss_pred HH
Q 048280 133 LD 134 (381)
Q Consensus 133 L~ 134 (381)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 64
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.1 Score=55.93 Aligned_cols=77 Identities=18% Similarity=0.241 Sum_probs=47.4
Q ss_pred CcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhC--CCC--cccEEE--------EEee-CC--e
Q 048280 56 NKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQ--HRN--VVNLLG--------YCAH-GA--E 120 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hpn--Iv~~~~--------~~~~-~~--~ 120 (381)
+.|+ |..-.+|+....++..+++|+..... .......|.++|..|. ++. +.+++- .... ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4564 45688899988888899999987542 2345556677777663 222 222221 1111 12 4
Q ss_pred EEEEEecccCCCHHH
Q 048280 121 KLLIYEYVINESLDK 135 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~ 135 (381)
.+.+++|++|..|.+
T Consensus 108 ~vrLl~~l~G~~l~~ 122 (1013)
T PRK06148 108 LLRLLSWLPGTPLAE 122 (1013)
T ss_pred EEEEEeccCCCcHHh
Confidence 677899999877754
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.22 Score=48.18 Aligned_cols=75 Identities=15% Similarity=0.185 Sum_probs=46.9
Q ss_pred CCCcccccCCeeEEEEEECC---------CcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcc-cEEEEEeeCCeEEE
Q 048280 54 PSNKLGEGGFGPVFKGKLDD---------GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVV-NLLGYCAHGAEKLL 123 (381)
Q Consensus 54 ~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~l 123 (381)
.++.|..|-.-.+|++...+ ++.|.+++.......-. .-.+|..+++.+..-+|- ++++.+. -+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~ 183 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGR 183 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCE
Confidence 35566677777889987542 45788888754432222 345688888888654444 4555543 235
Q ss_pred EEecccCCCH
Q 048280 124 IYEYVINESL 133 (381)
Q Consensus 124 v~E~~~~g~L 133 (381)
|.||++|.+|
T Consensus 184 I~efi~g~~l 193 (442)
T PTZ00296 184 IEEWLYGDPL 193 (442)
T ss_pred EEEeeCCccC
Confidence 7788876543
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.08 E-value=0.14 Score=46.70 Aligned_cols=70 Identities=11% Similarity=0.166 Sum_probs=42.6
Q ss_pred cccCCeeEEEEEEC-----C----CcEEEEEEecCCCc-----ccHHHHHHHHHHHHHhC---------C----CCcccE
Q 048280 59 GEGGFGPVFKGKLD-----D----GREIAVKKLSHSSN-----QGKKEFENEAKLLARVQ---------H----RNVVNL 111 (381)
Q Consensus 59 g~G~~g~V~~~~~~-----~----~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---------h----pnIv~~ 111 (381)
|.|-.|.+|++... + ...++||....... .....|.+|+.+...+- + ..+.++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 77888999988641 1 23578888752211 12246788888777652 1 223455
Q ss_pred EEEEeeCCeEEEEEecc
Q 048280 112 LGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 112 ~~~~~~~~~~~lv~E~~ 128 (381)
+....+....+||||-+
T Consensus 82 ~~~~~~~~~~~lvlEDL 98 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDL 98 (294)
T ss_pred EEeccCCCceeeehhhh
Confidence 55554445678999865
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >KOG3021 consensus Predicted kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.18 Score=43.15 Aligned_cols=82 Identities=23% Similarity=0.259 Sum_probs=56.0
Q ss_pred cCCCCCCcccccCCeeEEEEEE--CCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccE---EEEEee-CCeEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKL--DDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNL---LGYCAH-GAEKLL 123 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~---~~~~~~-~~~~~l 123 (381)
-+-..++.+|.-+-|.+-.++. .+.-.|-||+-.. ..++.|.-|+.-|..+..-+.|.+ +.+..- +...++
T Consensus 9 l~~~~vr~~gs~gggcI~~~r~ydtDaG~~FvK~nr~---~~~~mfeGE~~sLeAi~sT~tv~vprpikvid~p~Ggs~l 85 (313)
T KOG3021|consen 9 LGLNNVRALGSVGGGCISDGRHYDTDAGKVFVKVNRS---IARDMFEGELASLEAIQSTETVLVPRPIKVIDLPGGGSSL 85 (313)
T ss_pred cCcceeeeecCCCCceeccccccccCCccEEEEeccc---cchHHHhhHHHHHHHHHhcCceecCCceeeEecCCCceee
Confidence 3445567788766677777752 3455688887533 556889999999988876655543 455444 566789
Q ss_pred EEecccCCCHH
Q 048280 124 IYEYVINESLD 134 (381)
Q Consensus 124 v~E~~~~g~L~ 134 (381)
||||+.-+.|.
T Consensus 86 ime~idf~~lr 96 (313)
T KOG3021|consen 86 IMEHIDFQGLR 96 (313)
T ss_pred eeehhhcccch
Confidence 99999777663
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 381 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-45 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-45 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-34 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-33 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-30 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-30 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-29 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-27 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-18 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-18 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-18 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-18 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-17 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-17 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-17 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-17 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-17 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-17 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-17 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-06 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-05 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-05 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-04 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-04 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-04 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-04 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-04 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-04 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 379 bits (975), Expect = e-131
Identities = 110/302 (36%), Positives = 159/302 (52%), Gaps = 27/302 (8%)
Query: 25 NEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSH 84
E+ ++ + K F L A+ NF N LG GGFG V+KG+L DG +AVK+L
Sbjct: 5 PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKE 64
Query: 85 SSNQG-KKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKD 143
QG + +F+ E ++++ HRN++ L G+C E+LL+Y Y+ N S+ L +
Sbjct: 65 ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPES 124
Query: 144 IQIL---FRKK------------------KT---DIKASNILLDDKWIPKIADFGMARLF 179
L R++ K D+KA+NILLD+++ + DFG+A+L
Sbjct: 125 QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184
Query: 180 PEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQ 239
THV T V GT G++APEY+ G S K DVF +GV++LELI+GQR +
Sbjct: 185 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
Query: 240 --NLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297
LLDW L K+ K +VD L + +++ IQ+ LLCTQ P RP M VV
Sbjct: 245 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
Query: 298 ML 299
ML
Sbjct: 305 ML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 366 bits (942), Expect = e-127
Identities = 96/311 (30%), Positives = 159/311 (51%), Gaps = 45/311 (14%)
Query: 26 EEDLEKIAAREQKHFPFEALVSATKNFHP------SNKLGEGGFGPVFKGKLDDGREIAV 79
E +++ F F L + T NF NK+GEGGFG V+KG ++ +AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAV 59
Query: 80 KKLSH----SSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDK 135
KKL+ ++ + K++F+ E K++A+ QH N+V LLG+ + G + L+Y Y+ N SL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 136 VLFSLIK------------------------DIQILFRKKKTDIKASNILLDDKWIPKIA 171
L L + + R DIK++NILLD+ + KI+
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHR----DIKSANILLDEAFTAKIS 175
Query: 172 DFGMARLFPE-DQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNS 230
DFG+AR + QT + +R+ GT YMAPE + G ++ K+D++SFGVV+LE+I+G
Sbjct: 176 DFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV 234
Query: 231 SFNLDVDAQNLLDWAYKLYKKDKSLE-IVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLR 289
+ + Q LLD ++ ++K++E +D + +DS + + C R
Sbjct: 235 DEHR--EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADS-TSVEAMYSVASQCLHEKKNKR 291
Query: 290 PTMRRVVVMLS 300
P +++V +L
Sbjct: 292 PDIKKVQQLLQ 302
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 354 bits (911), Expect = e-122
Identities = 97/308 (31%), Positives = 157/308 (50%), Gaps = 33/308 (10%)
Query: 18 GSSREGDNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREI 77
S + + L + P L AT NF +G G FG V+KG L DG ++
Sbjct: 10 NSINDALSSSYLVPFESY---RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 78 AVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVL 137
A+K+ + S+QG +EFE E + L+ +H ++V+L+G+C E +LIY+Y+ N +L + L
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 138 FSLIKDIQIL-------------------------FRKKKTDIKASNILLDDKWIPKIAD 172
+ + R D+K+ NILLD+ ++PKI D
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHR----DVKSINILLDENFVPKITD 182
Query: 173 FGMARLFPE-DQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSS 231
FG+++ E DQTH++T V GT GY+ PEY + G L+ K+DV+SFGVV+ E++ +
Sbjct: 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
Query: 232 FNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPT 291
+L + NL +WA + + + +IVDP+LA + + + C + RP+
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
Query: 292 MRRVVVML 299
M V+ L
Sbjct: 303 MGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 2e-71
Identities = 63/305 (20%), Positives = 108/305 (35%), Gaps = 44/305 (14%)
Query: 39 HFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAK 98
E L + G FG V+K +L +AVK Q + E E
Sbjct: 13 DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSW-QNEYEVY 70
Query: 99 LLARVQHRNVVNLLGYCAHG----AEKLLIYEYVINESLDKVL----------FSLIKDI 144
L ++H N++ +G G + LI + SL L + + +
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETM 130
Query: 145 --------QILFRKKKT--------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188
+ + K DIK+ N+LL + IADFG+A F ++ +T
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190
Query: 189 -RVAGTNGYMAPEYVMHGHL-----SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLL 242
GT YMAPE + ++ D+++ G+V+ EL S + +D
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250
Query: 243 DWAYKLYKKDKSLEIV-----DPSLAAS-DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVV 296
+ + + E+V P L +AM + C D + R + V
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310
Query: 297 VMLSK 301
+++
Sbjct: 311 ERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-54
Identities = 58/317 (18%), Positives = 103/317 (32%), Gaps = 59/317 (18%)
Query: 40 FPFEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAK- 98
N +G G +G V+KG LD R +AVK S ++ F NE
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFS---FANRQNFINEKNI 58
Query: 99 -LLARVQHRNVVNLLGYCAHG-----AEKLLIYEYVINESLDKVLFSLIKDIQILFR--- 149
+ ++H N+ + E LL+ EY N SL K L D R
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH 118
Query: 150 ------------------KKKT----DIKASNILLDDKWIPKIADFGMARLF-------P 180
K D+ + N+L+ + I+DFG++ P
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 181 EDQTHVNTRVAGTNGYMAPEYVM-------HGHLSVKADVFSFGVVILELISGQRNSSFN 233
++ + GT YMAPE + + D+++ G++ E+ +
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238
Query: 234 LDVDAQNL--LDWAYKLYKKDKSLEIVD-----PSLAASDSGDQIAMCIQIGLL--CTQG 284
V + + +V P + + +A+ + C
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298
Query: 285 DPQLRPTMRRVVVMLSK 301
D + R T + +++
Sbjct: 299 DAEARLTAQXAEERMAE 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-46
Identities = 71/272 (26%), Positives = 122/272 (44%), Gaps = 49/272 (18%)
Query: 56 NKLGEGGFGPVFKGKLDDGREIAVKKL--SHSSNQGKKEFENEAKLLARVQHRNVVNLLG 113
K+G G FG V + + G ++AVK L + EF E ++ R++H N+V +G
Sbjct: 43 EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 114 YCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT-------------------- 153
++ EY+ SL ++L Q+ R++ +
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 154 --DIKASNILLDDKWIPKIADFGMARLFPEDQTHVN-TRVAGTNGYMAPEYVMHGHLSVK 210
++K+ N+L+D K+ K+ DFG++RL + T ++ AGT +MAPE + + K
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219
Query: 211 ADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEI---VDPSLAASDS 267
+DV+SFGV++ EL + Q+ NL N + K K LEI ++P +A
Sbjct: 220 SDVYSFGVILWELATLQQPWG-NL-----NPAQVVAAVGFKCKRLEIPRNLNPQVA---- 269
Query: 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299
I C +P RP+ ++ +L
Sbjct: 270 -AIIEGCW-------TNEPWKRPSFATIMDLL 293
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-45
Identities = 63/322 (19%), Positives = 107/322 (33%), Gaps = 66/322 (20%)
Query: 56 NKLGEGGFGPVFKGKL-DDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGY 114
LG+G FG K + G + +K+L + ++ F E K++ ++H NV+ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 115 CAHGAEKLLIYEYVINESLDKVL------FSLIKDIQILF----------------RKKK 152
I EY+ +L ++ + + + R
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHR--- 132
Query: 153 TDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR-------------VAGTNGYMAP 199
D+ + N L+ + +ADFG+ARL +++T V G +MAP
Sbjct: 133 -DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 200 EYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEI-- 257
E + K DVFSFG+V+ E+I L L+ +
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-----VRGFLDRYCPP 246
Query: 258 -VDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKPGPGNLEEPTRPGV 316
PS I + C DP+ RP+ ++ L L +
Sbjct: 247 NCPPSFF------------PITVRCCDLDPEKRPSFVKLEHWLET------LRMHLAGHL 288
Query: 317 PGSRYRRARRPAALSSSTAGSS 338
P + G S
Sbjct: 289 PLGPQLEQLDRGFWETYRRGES 310
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-44
Identities = 65/275 (23%), Positives = 107/275 (38%), Gaps = 57/275 (20%)
Query: 56 NKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYC 115
+G G FG V K K +++A+K++ S +K F E + L+RV H N+V L G C
Sbjct: 14 EVVGRGAFGVVCKAKWR-AKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 116 AHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT---------------------- 153
+ L+ EY SL VL +
Sbjct: 71 LN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 154 -DIKASNILLDDKW-IPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKA 211
D+K N+LL + KI DFG A D T G+ +MAPE + S K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKC 184
Query: 212 DVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEI---VDPSLAASDSG 268
DVFS+G+++ E+I+ ++ + A ++ + + + + +
Sbjct: 185 DVFSWGIILWEVITRRKPFD-EIGGPAFRIMWAVH----NGTRPPLIKNLPKPIES---- 235
Query: 269 DQIAMCIQIGLL--CTQGDPQLRPTMRRVVVMLSK 301
L+ C DP RP+M +V +++
Sbjct: 236 ----------LMTRCWSKDPSQRPSMEEIVKIMTH 260
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-42
Identities = 73/287 (25%), Positives = 112/287 (39%), Gaps = 70/287 (24%)
Query: 56 NKLGEGGFGPVFKGKLDDGREIAVKKL----SHSSNQGKKEFENEAKLLARVQHRNVVNL 111
+G GGFG V++ G E+AVK +Q + EAKL A ++H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 112 LGYCAHGAEKLLIYEYVINESLDKVL----------FSLIKDI-------------QILF 148
G C L+ E+ L++VL + I I+
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 149 RKKKTDIKASNILLDDK--------WIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPE 200
R D+K+SNIL+ K I KI DFG+AR + AG +MAPE
Sbjct: 132 R----DLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAPE 184
Query: 201 YVMHGHLSVKADVFSFGVVILELISGQ---RNSSFNLDVDAQNLLDWAYKLYKKDKSLEI 257
+ S +DV+S+GV++ EL++G+ R L AY + +L I
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---------LAVAYGVAMNKLALPI 235
Query: 258 ---VDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
A ++ C DP RP+ ++ L+
Sbjct: 236 PSTCPEPFA------------KLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 9e-42
Identities = 63/286 (22%), Positives = 113/286 (39%), Gaps = 68/286 (23%)
Query: 56 NKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGK-------KEFENEAKLLARVQHRN 107
++G+GGFG V KG+ + D +A+K L ++G+ +EF+ E +++ + H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 108 VVNLLGYCAHGAEKLLIYEYVINESLDKVL------------FSLIKDI----------- 144
+V L G + ++ E+V L L L+ DI
Sbjct: 85 IVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN 142
Query: 145 -QILFRKKKTDIKASNILLDDKW-----IPKIADFGMARLFPEDQTHVNTRVAGTNGYMA 198
I+ R D+++ NI L K+ADFG+++ H + + G +MA
Sbjct: 143 PPIVHR----DLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMA 194
Query: 199 PE--YVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLE 256
PE + KAD +SF +++ +++G+ + + + ++
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-EYSYGK---IKFINMIREEGLRPT 250
Query: 257 I---VDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299
I P L + LC GDP+ RP +V L
Sbjct: 251 IPEDCPPRLR------------NVIELCWSGDPKKRPHFSYIVKEL 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-41
Identities = 53/284 (18%), Positives = 99/284 (34%), Gaps = 70/284 (24%)
Query: 56 NKLGEGGFGPVFKGKLDDGREIAVKKL--SHSSNQGKKEFENEAKLLARVQHRNVVNLLG 113
KL E G ++KG+ G +I VK L S + ++F E L H NV+ +LG
Sbjct: 16 TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 114 YCAHGAEKLL--IYEYVINESLDKVL-------------FSLIKDI------------QI 146
C I ++ SL VL D+ I
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLI 134
Query: 147 LFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMH-- 204
+ + ++++D+ +I+ + F + ++APE +
Sbjct: 135 PRH----ALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPEALQKKP 184
Query: 205 -GHLSVKADVFSFGVVILELISGQ---RNSSFNLDVDAQNLLDWAYKLYKKDKSLEI--- 257
AD++SF V++ EL++ + + S ++ K+ + I
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPFADLSN---------MEIGMKVALEGLRPTIPPG 235
Query: 258 VDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
+ P ++ ++ +C DP RP +V +L K
Sbjct: 236 ISPHVS------------KLMKICMNEDPAKRPKFDMIVPILEK 267
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-40
Identities = 57/283 (20%), Positives = 104/283 (36%), Gaps = 59/283 (20%)
Query: 56 NKLGEGGFGPVFKGKLDDGREIAVKKL--SHSSNQGKKEFENEAKLLARVQHRNVVNLLG 113
+G+G FG V+ G+ E+A++ + + K F+ E + +H NVV +G
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 114 YCAHGAEKLLIYEYVINESLDKVL------FSLIKDIQI----------LFRKK--KTDI 155
C +I +L V+ + K QI L K D+
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDL 156
Query: 156 KASNILLDDKWIPKIADFGMARL----FPEDQTHVNTRVAGTNGYMAPEYVMHG------ 205
K+ N+ D+ + I DFG+ + + G ++APE +
Sbjct: 157 KSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEE 215
Query: 206 ---HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVD--- 259
S +DVF+ G + EL + + W +K + + +
Sbjct: 216 DKLPFSKHSDVFALGTIWYELHARE----------------WPFKTQPAEAIIWQMGTGM 259
Query: 260 -PSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
P+L+ G +I+ + C + + RPT +++ ML K
Sbjct: 260 KPNLSQIGMGKEISDILL---FCWAFEQEERPTFTKLMDMLEK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-39
Identities = 66/296 (22%), Positives = 106/296 (35%), Gaps = 60/296 (20%)
Query: 56 NKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAK--LLARVQHRNVVNLLG 113
++G+G +G V+ GK G ++AVK + + E + ++H N++ +
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 114 YCAHGAEK----LLIYEYVINESLDKVL----------FSLIKDI---------QILFRK 150
G LI +Y N SL L L +I +
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 151 KKT-----DIKASNILLDDKWIPKIADFGMARLFPEDQTHV---NTRVAGTNGYMAPEYV 202
K D+K+ NIL+ IAD G+A F D V GT YM PE V
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE-V 217
Query: 203 MHGHLSV-------KADVFSFGVVILELISGQRNSS---------FNLDVDAQNLLDWAY 246
+ L+ AD++SFG+++ E+ + +L + D
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMRE 277
Query: 247 KLYKKDKSLEIVDPSLAASDSGD-QIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
+ K P+ +SD Q+ + C +P R T RV L+K
Sbjct: 278 IVCIKKLRPSF--PNRWSSDECLRQMGKLMTE---CWAHNPASRLTALRVKKTLAK 328
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-38
Identities = 64/272 (23%), Positives = 115/272 (42%), Gaps = 46/272 (16%)
Query: 56 NKLGEGGFGPVFKGKLDDGREIAVKKL--SHSSNQGKKEFENEAKLLARVQHRNVVNLLG 113
++G G FG V+KGK ++AVK L + + Q + F+NE +L + +H N++ +G
Sbjct: 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 114 YCAHGAEKL-LIYEYVINESLDKVL------FSLIKDIQI----------LFRKKKT--D 154
Y +L ++ ++ SL L F + K I I L K D
Sbjct: 88 YSTA--PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRD 145
Query: 155 IKASNILLDDKWIPKIADFGMARLFPEDQ-THVNTRVAGTNGYMAPE---YVMHGHLSVK 210
+K++NI L + KI DFG+A +H +++G+ +MAPE S +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 211 ADVFSFGVVILELISGQ---RNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267
+DV++FG+V+ EL++GQ N + + + K +
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRDQIIEM--VGRGSLSPDLSKVRSNCPKRMK---- 259
Query: 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299
++ C + RP+ R++ +
Sbjct: 260 --------RLMAECLKKKRDERPSFPRILAEI 283
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-37
Identities = 61/297 (20%), Positives = 114/297 (38%), Gaps = 62/297 (20%)
Query: 56 NKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKL--LARVQHRNVVNLLG 113
+G+G +G V++G G +AVK S ++ +K + E +L ++H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 114 YCAHGAEK----LLIYEYVINESLDKVL----------FSLIKDI---------QILFRK 150
LI Y SL L ++ I +I +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 151 KKT-----DIKASNILLDDKWIPKIADFGMARLFPEDQTHV---NTRVAGTNGYMAPEYV 202
K D+K+ NIL+ IAD G+A + + + N GT YMAPE V
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE-V 188
Query: 203 MHGHLSV-------KADVFSFGVVILELISGQRNSS---------FNLDVDAQNLLDWAY 246
+ + V + D+++FG+V+ E+ ++ +++ + + D
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRK 248
Query: 247 KLYKKDKSLEIVDPSLAASDSGDQIAMC--IQIGLLCTQGDPQLRPTMRRVVVMLSK 301
+ + I P+ SD ++ ++ C +P R T R+ L+K
Sbjct: 249 VVCVDQQRPNI--PNRWFSDPTLT-SLAKLMK---ECWYQNPSARLTALRIKKTLTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-35
Identities = 59/297 (19%), Positives = 111/297 (37%), Gaps = 62/297 (20%)
Query: 56 NKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAK--LLARVQHRNVVNLLG 113
+G+G FG V++GK G E+AVK S ++ ++ + EA+ ++H N++ +
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 114 YCAHGAEK----LLIYEYVINESLDKVL----------FSLIKDI---------QILFRK 150
L+ +Y + SL L L +I+ +
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 151 KKT-----DIKASNILLDDKWIPKIADFGMARLF---PEDQTHVNTRVAGTNGYMAPEYV 202
K D+K+ NIL+ IAD G+A + GT YMAPE V
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-V 222
Query: 203 MHGHLSV-------KADVFSFGVVILELISGQRNSS---------FNLDVDAQNLLDWAY 246
+ +++ +AD+++ G+V E+ ++L ++ +
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 282
Query: 247 KLYKKDKSLEIVDPSLAASDSGDQIAMC--IQIGLLCTQGDPQLRPTMRRVVVMLSK 301
+ ++ I P+ S + M ++ C + R T R+ LS+
Sbjct: 283 VVCEQKLRPNI--PNRWQSCEALR-VMAKIMR---ECWYANGAARLTALRIKKTLSQ 333
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 54/264 (20%), Positives = 100/264 (37%), Gaps = 49/264 (18%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVK--KLSHSSNQGKKEFENEAKLLARVQHRNVVNLLG 113
++G G F V+KG + E+A + + ++ F+ EA++L +QH N+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 114 YCAHGAEK---LLIY-EYVINESLDKVL-------FSLIKDI--QILF------RKKKT- 153
+ +++ E + + +L L +++ QIL +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 154 ---DIKASNILLDDK-WIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSV 209
D+K NI + KI D G+A L V GT +MAPE +
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEEKY-DE 208
Query: 210 KADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKK--DKSLEIVDPSLAASDS 267
DV++FG+ +LE+ + + S AQ +Y++ +A +
Sbjct: 209 SVDVYAFGMCMLEMATSEYPYS-ECQNAAQ--------IYRRVTSGVKPASFDKVAIPEV 259
Query: 268 GDQIAMCIQIGLLCTQGDPQLRPT 291
+ I CI+ + R +
Sbjct: 260 KEIIEGCIRQ-------NKDERYS 276
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 64/200 (32%), Positives = 96/200 (48%), Gaps = 33/200 (16%)
Query: 56 NKLGEGGFGPVFKGKLD-----DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVN 110
+LG+G FG V + D G +AVKKL HS+ + ++FE E ++L +QH N+V
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 111 LLGYCAHGAEK--LLIYEYVINESLDKVL------FSLIKDI----QI------LFRKKK 152
G C + LI EY+ SL L IK + QI L K+
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 135
Query: 153 T--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-----YMAPEYVMHG 205
D+ NIL++++ KI DFG+ ++ P+D+ G + APE +
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF---KVKEPGESPIFWYAPESLTES 192
Query: 206 HLSVKADVFSFGVVILELIS 225
SV +DV+SFGVV+ EL +
Sbjct: 193 KFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 33/200 (16%)
Query: 56 NKLGEGGFGPVFKGKLD-----DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVN 110
+LG+G FG V + D G +AVKKL HS+ + ++FE E ++L +QH N+V
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 111 LLGYCAHGAEK--LLIYEYVINESLDKVL------FSLIKDI----QI------LFRKKK 152
G C + LI EY+ SL L IK + QI L K+
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 166
Query: 153 T--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-----YMAPEYVMHG 205
D+ NIL++++ KI DFG+ ++ P+D+ + G + APE +
Sbjct: 167 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY---KVKEPGESPIFWYAPESLTES 223
Query: 206 HLSVKADVFSFGVVILELIS 225
SV +DV+SFGVV+ EL +
Sbjct: 224 KFSVASDVWSFGVVLYELFT 243
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 8e-32
Identities = 63/259 (24%), Positives = 105/259 (40%), Gaps = 41/259 (15%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCA 116
LG+G +G V+ G+ L + IA+K++ ++ + E L ++H+N+V LG +
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 117 HGAEKLLIY-EYVINESLDKVLF----------SLIKDI--QILF-----RKKKT---DI 155
+ I+ E V SL +L I QIL + DI
Sbjct: 90 EN-GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDI 148
Query: 156 KASNILLDDKW-IPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHL--SVKAD 212
K N+L++ + KI+DFG ++ T GT YMAPE + G AD
Sbjct: 149 KGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYGKAAD 207
Query: 213 VFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIA 272
++S G I+E+ +G+ L + +K+ EI P ++++ I
Sbjct: 208 IWSLGCTIIEMATGKPPFY-ELGEPQAAM----FKVGMFKVHPEI--PESMSAEAKAFIL 260
Query: 273 MCIQIGLLCTQGDPQLRPT 291
C + DP R
Sbjct: 261 KCFEP-------DPDKRAC 272
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-31
Identities = 63/276 (22%), Positives = 104/276 (37%), Gaps = 56/276 (20%)
Query: 57 KLGEGGFGPVFKGKL-DDGREIAVKKL-SHSSNQGKKEFENEAKLLARVQHRNVVNLLGY 114
++G G FG VF G+L D +AVK K +F EA++L + H N+V L+G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 115 CAHGAEKLLIYEYVINESLDKVL------FSLIKDIQILFR---------KKKT---DIK 156
C ++ E V L + +Q++ K D+
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLA 240
Query: 157 ASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGY----MAPEYVMHGHLSVKAD 212
A N L+ +K + KI+DFGM+R + G APE + +G S ++D
Sbjct: 241 ARNCLVTEKNVLKISDFGMSREEADGVY---AASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 213 VFSFGVVILELIS-------GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265
V+SFG+++ E S N + ++ +L P L
Sbjct: 298 VWSFGILLWETFSLGASPYPNLSNQ------QTREFVEKGGRLPC---------PELCP- 341
Query: 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
D + ++ C +P RP+ + L
Sbjct: 342 ---DAVF---RLMEQCWAYEPGQRPSFSTIYQELQS 371
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-31
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 41/204 (20%)
Query: 56 NKLGEGGFGPVFKGKLD-----DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVN 110
++LG+G FG V + D G +AVK+L HS +++F+ E ++L + +V
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 111 LLGYCAHGAEK--LLIYEYVINESLDKVL------FSLIKDIQILF-------------- 148
G + L+ EY+ + L L + +
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 148
Query: 149 --RKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-----YMAPEY 201
R D+ A NIL++ + KIADFG+A+L P D+ + V G + APE
Sbjct: 149 VHR----DLAARNILVESEAHVKIADFGLAKLLPLDK---DYYVVREPGQSPIFWYAPES 201
Query: 202 VMHGHLSVKADVFSFGVVILELIS 225
+ S ++DV+SFGVV+ EL +
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 58/206 (28%), Positives = 88/206 (42%), Gaps = 33/206 (16%)
Query: 56 NKLGEGGFGPVFKGKLD---DGREI--AVKKL-SHSSNQGKKEFENEAKLLARVQHRNVV 109
LGEG FG V D DG AVK L + + Q + ++ E +L + H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 110 NLLGYCAHGAEK--LLIYEYVINESLDKVL----FSLIKDI----QI------LFRKKKT 153
G C L+ EYV SL L L + + QI L +
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYI 156
Query: 154 --DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-----YMAPEYVMHGH 206
D+ A N+LLD+ + KI DFG+A+ PE + +G + APE +
Sbjct: 157 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY---RVREDGDSPVFWYAPECLKEYK 213
Query: 207 LSVKADVFSFGVVILELIS-GQRNSS 231
+DV+SFGV + EL++ + S
Sbjct: 214 FYYASDVWSFGVTLYELLTHCDSSQS 239
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-31
Identities = 65/273 (23%), Positives = 110/273 (40%), Gaps = 43/273 (15%)
Query: 50 KNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKL---SHSSNQGKKEFENEAKLLARVQH 105
NF K+G G F V++ L DG +A+KK+ + + + E LL ++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 106 RNVVNLLGYCAHGAEKLLIY-EYVINESLDKVLFSLIKD-------------IQILF--- 148
NV+ +L I E L +++ K +Q+
Sbjct: 92 PNVIKYYASFIED-NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 149 ---RKKKT--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM 203
++ DIK +N+ + + K+ D G+ R F T ++ V GT YM+PE +
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 209
Query: 204 HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263
+ K+D++S G ++ E+ + Q F D NL K+ + D + PS
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQS--PFY--GDKMNLYSLCKKIEQCDYP-PL--PSDH 262
Query: 264 ASDSG-DQIAMCIQIGLLCTQGDPQLRPTMRRV 295
S+ + MCI DP+ RP + V
Sbjct: 263 YSEELRQLVNMCINP-------DPEKRPDVTYV 288
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-31
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 35/208 (16%)
Query: 56 NKLGEGGFGPVFKGKLD-----DGREIAVKKL-SHSSNQGKKEFENEAKLLARVQHRNVV 109
LGEG FG V + D G ++AVK L S + + E ++L + H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 110 NLLGYCAHGAEK--LLIYEYVINESLDKVL------FSLIKDI----QI------LFRKK 151
G C LI E++ + SL + L +L + + QI L ++
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 152 KT--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-----YMAPEYVMH 204
D+ A N+L++ + KI DFG+ + D+ + + + + APE +M
Sbjct: 147 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK---DDRDSPVFWYAPECLMQ 203
Query: 205 GHLSVKADVFSFGVVILELIS-GQRNSS 231
+ +DV+SFGV + EL++ +SS
Sbjct: 204 SKFYIASDVWSFGVTLHELLTYCDSDSS 231
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-31
Identities = 53/191 (27%), Positives = 92/191 (48%), Gaps = 25/191 (13%)
Query: 56 NKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYC 115
+LG G FG V GK ++A+K + S + EF EAK++ + H +V L G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 116 AHGAEKLLIYEYVINESLDKVL------FSLIKDIQILFR---------KKKT---DIKA 157
+I EY+ N L L F + +++ K+ D+ A
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAA 148
Query: 158 SNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN---GYMAPEYVMHGHLSVKADVF 214
N L++D+ + K++DFG++R +D+ T G+ + PE +M+ S K+D++
Sbjct: 149 RNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 215 SFGVVILELIS 225
+FGV++ E+ S
Sbjct: 206 AFGVLMWEIYS 216
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 63/258 (24%), Positives = 107/258 (41%), Gaps = 54/258 (20%)
Query: 11 LLKHFNLGSSREGDNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGK 70
L GS +G E+ + + H +V +LGEG FG VF +
Sbjct: 9 LSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIV-------LKWELGEGAFGKVFLAE 61
Query: 71 LDDGRE------IAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124
+ +AVK L +S +++F+ EA+LL +QH+++V G C G L++
Sbjct: 62 CHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV 121
Query: 125 YEYVINESLDKVLFSLIKDIQILFRKKKT------------------------------- 153
+EY+ + L++ L S D ++L +
Sbjct: 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVH 181
Query: 154 -DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-----YMAPEYVMHGHL 207
D+ N L+ + KI DFGM+R RV G +M PE +++
Sbjct: 182 RDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRV-GGRTMLPIRWMPPESILYRKF 237
Query: 208 SVKADVFSFGVVILELIS 225
+ ++DV+SFGVV+ E+ +
Sbjct: 238 TTESDVWSFGVVLWEIFT 255
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 59/268 (22%), Positives = 92/268 (34%), Gaps = 52/268 (19%)
Query: 50 KNFHPSNKLGEGGFGPVFKG-KLDDGREIAVK--KLSHSSNQGKKEFENEAKLLARV-QH 105
++F ++LG G +G VFK +DGR AVK + + E +V QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 106 RNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT------------ 153
V L G L Y+ E L + + +
Sbjct: 117 PCCVRLEQAWEEG-GIL----YLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA 171
Query: 154 ----------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM 203
D+K +NI L + K+ DFG+ + G YMAPE +
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG-EVQE-GDPRYMAPELLQ 229
Query: 204 HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263
+ ADVFS G+ ILE+ + W +L + E +
Sbjct: 230 GSY-GTAADVFSLGLTILEVACNME-LPHGGE-------GWQ-QLRQGYLPPEF--TAGL 277
Query: 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPT 291
+S+ + M ++ DP+LR T
Sbjct: 278 SSELRSVLVMMLEP-------DPKLRAT 298
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-30
Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 25/191 (13%)
Query: 56 NKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYC 115
++G G FG V G + ++A+K + +++F EA+++ ++ H +V L G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 116 AHGAEKLLIYEYVINESLDKVL------FSLIKDIQILFR---------KKKT---DIKA 157
A L+ E++ + L L F+ + + + D+ A
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAA 132
Query: 158 SNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN---GYMAPEYVMHGHLSVKADVF 214
N L+ + + K++DFGM R +DQ T GT + +PE S K+DV+
Sbjct: 133 RNCLVGENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVKWASPEVFSFSRYSSKSDVW 189
Query: 215 SFGVVILELIS 225
SFGV++ E+ S
Sbjct: 190 SFGVLMWEVFS 200
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-30
Identities = 51/190 (26%), Positives = 85/190 (44%), Gaps = 25/190 (13%)
Query: 57 KLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCA 116
+LG G FG V GK ++AVK + S + EF EA+ + ++ H +V G C+
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 117 HGAEKLLIYEYVINESLDKVL------FSLIKDIQILFR---------KKKT---DIKAS 158
++ EY+ N L L + +++ + + D+ A
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAAR 133
Query: 159 NILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN---GYMAPEYVMHGHLSVKADVFS 215
N L+D K++DFGM R +DQ GT + APE + S K+DV++
Sbjct: 134 NCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA 190
Query: 216 FGVVILELIS 225
FG+++ E+ S
Sbjct: 191 FGILMWEVFS 200
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-30
Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 48/214 (22%)
Query: 56 NKLGEGGFGPVFKGKLDDGRE------IAVKKLSHSSNQGKKEFENEAKLLARVQHRNVV 109
+LGEG FG VF + + +AVK L + +K+F+ EA+LL +QH ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 110 NLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT---------------- 153
G C G ++++EY+ + L+K L + D IL +
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 154 -----------------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG- 195
D+ N L+ + KI DFGM+R + G +
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RVGGHTM 196
Query: 196 ----YMAPEYVMHGHLSVKADVFSFGVVILELIS 225
+M PE +M+ + ++DV+SFGV++ E+ +
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 61/276 (22%), Positives = 107/276 (38%), Gaps = 48/276 (17%)
Query: 47 SATKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKK--LSHSSNQGKKEFENEAKLLARV 103
S +++ +G G +G K + DG+ + K+ + K+ +E LL +
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 104 QHRNVVNLLG-YCAHGAEKLLIY-EYVINESLDKVLFSLIKD-------------IQILF 148
+H N+V L I EY L V+ K+ Q+
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 149 ------RKKKT-------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG 195
R+ D+K +N+ LD K K+ DFG+AR+ D + T V GT
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPY 181
Query: 196 YMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSL 255
YM+PE + + K+D++S G ++ EL + F A + + A K+ ++ K
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP--PF----TAFSQKELAGKI-REGKFR 234
Query: 256 EIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPT 291
I P + + + I + + RP+
Sbjct: 235 RI--PYRYSDELNEIITRMLNL-------KDYHRPS 261
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 40/206 (19%)
Query: 56 NKLGEGGFGPVFKGKL--DDGREI--AVKKL-SHSSNQGKKEFENEAKLLARVQHRNVVN 110
+G G G V G+L R++ A+K L + + + +++F +EA ++ + H N++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 111 LLGYCAHGAEKLLIYEYVINESLDKVL------FSLIKDIQILF---------------- 148
L G G +++ EY+ N SLD L F++++ + +L
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVH 174
Query: 149 RKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-----YMAPEYVM 203
R D+ A N+L+D + K++DFG++R+ +D T T G + APE +
Sbjct: 175 R----DLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT---TGGKIPIRWTAPEAIA 227
Query: 204 HGHLSVKADVFSFGVVILELIS-GQR 228
S +DV+SFGVV+ E+++ G+R
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 61/224 (27%), Positives = 109/224 (48%), Gaps = 40/224 (17%)
Query: 41 PFEALVSATKNFHPSN-----KLGEGGFGPVFKGKLDDGRE-----IAVKKL-SHSSNQG 89
P +A++ T HPS +G G FG V+KG L +A+K L + + +
Sbjct: 30 PNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ 89
Query: 90 KKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVL------FSLIKD 143
+ +F EA ++ + H N++ L G + ++I EY+ N +LDK L FS+++
Sbjct: 90 RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL 149
Query: 144 IQILF----------------RKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187
+ +L R D+ A NIL++ + K++DFG++R+ +D
Sbjct: 150 VGMLRGIAAGMKYLANMNYVHR----DLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 205
Query: 188 TRVAGTNGY--MAPEYVMHGHLSVKADVFSFGVVILELIS-GQR 228
T G APE + + + +DV+SFG+V+ E+++ G+R
Sbjct: 206 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 39/223 (17%)
Query: 41 PFEALVSATKNFHPSN-----KLGEGGFGPVFKG--KLDDGREI--AVKKL-SHSSNQGK 90
P + + K +N +G G FG V G KL +EI A+K L + + +
Sbjct: 31 PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 91 KEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVL------FSLIKDI 144
++F EA ++ + H N++ L G +++ EY+ N SLD L F++I+ +
Sbjct: 91 RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 145 QILF----------------RKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188
+L R D+ A NIL++ + K++DFG+ R+ +D T
Sbjct: 151 GMLRGIASGMKYLSDMGYVHR----DLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT 206
Query: 189 RVAGTNGY--MAPEYVMHGHLSVKADVFSFGVVILELIS-GQR 228
G +PE + + + +DV+S+G+V+ E++S G+R
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 62/267 (23%), Positives = 113/267 (42%), Gaps = 38/267 (14%)
Query: 56 NKLGEGGFGPVFKGKL-DDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGY 114
+KLG G +G V++G +AVK L + + +EF EA ++ ++H N+V LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 115 CAHGAEKLLIYEYVINESLDKVL-------FSLIKDIQILFR---------KKKT---DI 155
C +I E++ +L L S + + + + KK ++
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNL 344
Query: 156 KASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFS 215
A N L+ + + K+ADFG++RL D + + APE + + S+K+DV++
Sbjct: 345 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 404
Query: 216 FGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMC 274
FGV++ E+ + G LL+ Y++ + + E V
Sbjct: 405 FGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY--------------- 449
Query: 275 IQIGLLCTQGDPQLRPTMRRVVVMLSK 301
++ C Q +P RP+ +
Sbjct: 450 -ELMRACWQWNPSDRPSFAEIHQAFET 475
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-29
Identities = 61/282 (21%), Positives = 98/282 (34%), Gaps = 63/282 (22%)
Query: 50 KNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNV 108
+F +G GGFG VFK K DG+ +K++ ++ ++ E E K LA++ H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNI 66
Query: 109 VNLLGYCAHGAEKLLIYEYVINESLDKV------------LFSLIKD------------- 143
V+ G + S K L I+
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 144 --IQILF------RKKKT--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT 193
QI KK D+K SNI L D KI DFG+ D TR GT
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSKGT 184
Query: 194 NGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDK 253
YM+PE + + D+++ G+++ EL+ ++F K + +
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-TAFETS-----------KFFTDLR 232
Query: 254 SLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRV 295
I + + + P+ RP +
Sbjct: 233 DGII--SDIFDKKEKTLLQKLLSK-------KPEDRPNTSEI 265
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 41/204 (20%)
Query: 56 NKLGEGGFGPVFKGKL--DDGREI--AVKKL-SHSSNQGKKEFENEAKLLARVQHRNVVN 110
+G G FG V+ G L +DG++I AVK L + +F E ++ H NV++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 111 LLGYCAHGAEKLL-IYEYVINESLDKVL------FSLIKDIQILF--------------- 148
LLG C L + Y+ + L + ++ I
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 150
Query: 149 -RKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG------YMAPEY 201
R D+ A N +LD+K+ K+ADFG+AR + + + V G +MA E
Sbjct: 151 HR----DLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAKLPVKWMALES 203
Query: 202 VMHGHLSVKADVFSFGVVILELIS 225
+ + K+DV+SFGV++ EL++
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 49/215 (22%)
Query: 56 NKLGEGGFGPVFKGKLDDGRE------IAVKKL-SHSSNQGKKEFENEAKLLARVQHRNV 108
+LGE FG V+KG L +A+K L + ++EF +EA L AR+QH NV
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 109 VNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT--------------- 153
V LLG +I+ Y + L + L +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 154 ------------------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG 195
D+ N+L+ DK KI+D G+ R + N
Sbjct: 135 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY----KLLGNS 190
Query: 196 -----YMAPEYVMHGHLSVKADVFSFGVVILELIS 225
+MAPE +M+G S+ +D++S+GVV+ E+ S
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 67/330 (20%), Positives = 135/330 (40%), Gaps = 56/330 (16%)
Query: 50 KNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKK--LSHSSNQGKKEFENEAKLLARVQHR 106
+ + K+GEG FG K +DGR+ +K+ +S S++ ++E E +LA ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 107 NVVN-------------LLGYCAHG--------AEKLLIYEYVINESLDKVLFSL--IKD 143
N+V ++ YC G + +L E I + ++ +L + D
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 144 IQILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM 203
+IL R DIK+ NI L ++ DFG+AR+ + GT Y++PE
Sbjct: 144 RKILHR----DIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICE 198
Query: 204 HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263
+ + K+D+++ G V+ EL + + +F +A ++ + K+ +
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKH--AF----EAGSMKNLVLKI-ISGSFPPV--SLHY 249
Query: 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPT---------MRRVVVMLSKKPGPGNLEEPTRP 314
+ D ++ + +P+ RP+ + + +
Sbjct: 250 SYDLRSLVSQLFKR-------NPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTF 302
Query: 315 GVPGSRYRRARRPAALSSSTAGSSGESNSR 344
GS+ A+RPA+ +S + + ++
Sbjct: 303 SKFGSQPIPAKRPASGQNSISVMPAQKITK 332
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 62/290 (21%), Positives = 112/290 (38%), Gaps = 59/290 (20%)
Query: 42 FEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVK--KLSHSSNQGKKEFENEAKL 99
F+++ + + ++G GG VF+ + + A+K L + NQ + NE
Sbjct: 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 100 LARVQHRN--VVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKD-------------I 144
L ++Q + ++ L Y ++ E + L S +K
Sbjct: 80 LNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-----LNSWLKKKKSIDPWERKSYWK 134
Query: 145 QIL-----FRKKKT---DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR-VAGTNG 195
+L + D+K +N L+ D + K+ DFG+A D T V GT
Sbjct: 135 NMLEAVHTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVN 193
Query: 196 YMAPEYVM-----------HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDW 244
YM PE + +S K+DV+S G ++ + G+ F Q +++
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PF------QQIINQ 245
Query: 245 AYKLYKK-DKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMR 293
KL+ D + EI P + D D + C++ DP+ R ++
Sbjct: 246 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR-------DPKQRISIP 288
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 51/192 (26%), Positives = 91/192 (47%), Gaps = 27/192 (14%)
Query: 56 NKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYC 115
KLG G FG V+ + ++AVK + + + F EA ++ +QH +V L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 116 AHGAEKLLIYEYVINESLDKVLFSLIKD-----------IQI------LFRKKKT--DIK 156
+I E++ SL L S QI + ++ D++
Sbjct: 253 TKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR 311
Query: 157 ASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG---YMAPEYVMHGHLSVKADV 213
A+NIL+ + KIADFG+AR+ +++ T G + APE + G ++K+DV
Sbjct: 312 AANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFTIKSDV 368
Query: 214 FSFGVVILELIS 225
+SFG++++E+++
Sbjct: 369 WSFGILLMEIVT 380
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 61/307 (19%), Positives = 102/307 (33%), Gaps = 52/307 (16%)
Query: 13 KHFNLGSSREGDNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGK-L 71
+ R G ED E + E+ ++G G FG V + K
Sbjct: 21 SSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDK 80
Query: 72 DDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY-EYVIN 130
G + AVKK+ + E A + +V L G G + I+ E +
Sbjct: 81 QTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREG-PWVNIFMELLEG 134
Query: 131 ESLDKVL-----F--SLIKDI--QILF------RKKKT--DIKASNILLDDKWIP-KIAD 172
SL +++ Q L ++ D+KA N+LL + D
Sbjct: 135 GSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCD 194
Query: 173 FGMARLFPEDQTHVNTR----VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQR 228
FG A D + + GT +MAPE VM K D++S ++L +++G
Sbjct: 195 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
Query: 229 -NSSFNLDVDAQNLLDWA--YKLYKKDK-SLEIVDPSLAASDSGDQIAMCIQIGLLCTQG 284
+ + K+ + EI P A + I ++
Sbjct: 255 PWTQYF---------RGPLCLKIASEPPPIREI--PPSCAPLTAQAIQEGLRK------- 296
Query: 285 DPQLRPT 291
+P R +
Sbjct: 297 EPVHRAS 303
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 56/214 (26%), Positives = 89/214 (41%), Gaps = 48/214 (22%)
Query: 56 NKLGEGGFGPVFKGKLDDGRE------IAVKKL-SHSSNQGKKEFENEAKLLARV-QHRN 107
LG G FG V + + +AVK L S + K+ +E K+++ + QH N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 108 VVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT-------------- 153
+VNLLG C HG L+I EY L L + ++
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 154 -----------------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG- 195
D+ A N+LL + + KI DFG+AR D + + N
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY----IVKGNAR 227
Query: 196 ----YMAPEYVMHGHLSVKADVFSFGVVILELIS 225
+MAPE + +V++DV+S+G+++ E+ S
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 63/292 (21%), Positives = 101/292 (34%), Gaps = 68/292 (23%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRN 107
+F LG+G FG V K + D R A+KK+ H+ + +E LLA + H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 108 VVNLLGYCAHGAEKLLIYEYVINESLDKV-----------LFSLIKDIQILFRKKKT--- 153
VV Y A + + + + L+ LI + ++ +
Sbjct: 64 VVRY--YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 154 -------------------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVN------- 187
D+K NI +D+ KI DFG+A+ +
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 188 ------TRVAGTNGYMAPEYVMHG--HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQ 239
T GT Y+A E V+ G H + K D++S G++ E+I F+ ++
Sbjct: 182 GSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIYP-----FSTGMERV 235
Query: 240 NLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPT 291
N+L KL I + I DP RP
Sbjct: 236 NILK---KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDH-------DPNKRPG 277
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 50/202 (24%), Positives = 92/202 (45%), Gaps = 31/202 (15%)
Query: 53 HPSNKLGEGGFGPVFKGKLDDGRE----IAVKKL-SHSSNQGKKEFENEAKLLARVQHRN 107
H +G+G FG V+ G+ D + A+K L + Q + F E L+ + H N
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 108 VVNLLGYCAHGAE-KLLIYEYVINESLDKVLFSLIKDI----------QI------LFRK 150
V+ L+G ++ Y+ + L + + S ++ Q+ L +
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ 143
Query: 151 KKT--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-----YMAPEYVM 203
K D+ A N +LD+ + K+ADFG+AR D+ + + + + + A E +
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQ-QHRHARLPVKWTALESLQ 201
Query: 204 HGHLSVKADVFSFGVVILELIS 225
+ K+DV+SFGV++ EL++
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLT 223
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 59/266 (22%), Positives = 116/266 (43%), Gaps = 38/266 (14%)
Query: 56 NKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYC 115
KLG+G FG V+ G + +A+K L + F EA+++ +++H +V L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 116 AHGAEKLLIYEYVINESLDKVL------FSLIKD-----IQI------LFRKKKT--DIK 156
++ EY+ SL L + + QI + R D++
Sbjct: 249 -SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 307
Query: 157 ASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSF 216
A+NIL+ + + K+ADFG+ARL +++ + APE ++G ++K+DV+SF
Sbjct: 308 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 367
Query: 217 GVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCI 275
G+++ EL + G+ ++ + + ++ Y++ + E +
Sbjct: 368 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH---------------- 411
Query: 276 QIGLLCTQGDPQLRPTMRRVVVMLSK 301
+ C + +P+ RPT + L
Sbjct: 412 DLMCQCWRKEPEERPTFEYLQAFLED 437
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 52/207 (25%), Positives = 88/207 (42%), Gaps = 43/207 (20%)
Query: 56 NKLGEGGFGPVFKGKLDDGRE-----IAVKKL-SHSSNQGKKEFENEAKLLARVQHRNVV 109
LG G FG V+KG E +A+K+L +S + KE +EA ++A V + +V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 110 NLLGYCAHGAEKLLIYEYVINESLDKVL------FSLIKDIQILF--------------- 148
LLG C + LI + + L + +
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLV 139
Query: 149 -RKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-----YMAPEYV 202
R D+ A N+L+ KI DFG+A+L ++ + G +MA E +
Sbjct: 140 HR----DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA----EGGKVPIKWMALESI 191
Query: 203 MHGHLSVKADVFSFGVVILELIS-GQR 228
+H + ++DV+S+GV + EL++ G +
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-28
Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 31/195 (15%)
Query: 56 NKLGEGGFGPVFKGKL-DDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGY 114
+KLG G +G V++G +AVK L + + +EF EA ++ ++H N+V LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 115 CAHGAEKLLIYEYVINESLDKVL-------FSLIKDIQILFR---------KKKT---DI 155
C +I E++ +L L S + + + + KK D+
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 156 KASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-----YMAPEYVMHGHLSVK 210
A N L+ + + K+ADFG++RL D A + APE + + S+K
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDTY-----TAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 211 ADVFSFGVVILELIS 225
+DV++FGV++ E+ +
Sbjct: 193 SDVWAFGVLLWEIAT 207
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 61/282 (21%), Positives = 108/282 (38%), Gaps = 59/282 (20%)
Query: 50 KNFHPSNKLGEGGFGPVFKGKLDDGREIAVK--KLSHSSNQGKKEFENEAKLLARVQH-- 105
+ + ++G GG VF+ + + A+K L + NQ + NE L ++Q
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 106 RNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKD-------------IQILF---- 148
++ L Y ++ E + L S +K +L
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECGNID-----LNSWLKKKKSIDPWERKSYWKNMLEAVHT 123
Query: 149 -RKKKT---DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR-VAGTNGYMAPEYVM 203
+ D+K +N L+ D + K+ DFG+A D T V GT YM PE +
Sbjct: 124 IHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 204 -----------HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKK- 251
+S K+DV+S G ++ + G+ + F Q +++ KL+
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPF------QQIINQISKLHAII 234
Query: 252 DKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMR 293
D + EI P + D D + C++ DP+ R ++
Sbjct: 235 DPNHEIEFPDIPEKDLQDVLKCCLKR-------DPKQRISIP 269
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-28
Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 43/209 (20%)
Query: 56 NKLGEGGFGPVFKGKLDDGRE------IAVKKL-SHSSNQGKKEFENEAKLLARVQHRNV 108
+LG+G FG V++G + +A+K + +S + + EF NEA ++ +V
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 109 VNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKD-------------------IQI--- 146
V LLG + G L+I E + L L SL +I
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 147 ---LFRKKKT--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGY----- 196
L K D+ A N ++ + + KI DFGM R E + G G
Sbjct: 151 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLPVRW 206
Query: 197 MAPEYVMHGHLSVKADVFSFGVVILELIS 225
M+PE + G + +DV+SFGVV+ E+ +
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-28
Identities = 57/218 (26%), Positives = 81/218 (37%), Gaps = 52/218 (23%)
Query: 56 NKLGEGGFGPVFKGKL------DDGREIAVKKL-SHSSNQGKKEFENEAKLLARV-QHRN 107
LG G FG V + D +AVK L + ++ +E K+L+ + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 108 VVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT-------------- 153
+VNLLG C G L+I EY L L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 154 ---------------------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAG 192
D+ A NILL I KI DFG+AR D + V
Sbjct: 149 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND----SNYVVK 204
Query: 193 TNG-----YMAPEYVMHGHLSVKADVFSFGVVILELIS 225
N +MAPE + + + ++DV+S+G+ + EL S
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 56/193 (29%), Positives = 97/193 (50%), Gaps = 29/193 (15%)
Query: 56 NKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYC 115
+LG G FG V+ G + ++AVK L + F EA L+ ++QH+ +V L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 116 AHGAEKLLI-YEYVINESLDKVL-------FSLIKDIQILFR---------KKKT---DI 155
E + I EY+ N SL L ++ K + + + ++ D+
Sbjct: 78 TQ--EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135
Query: 156 KASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN---GYMAPEYVMHGHLSVKAD 212
+A+NIL+ D KIADFG+ARL +++ T G + APE + +G ++K+D
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 213 VFSFGVVILELIS 225
V+SFG+++ E+++
Sbjct: 193 VWSFGILLTEIVT 205
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 42/205 (20%)
Query: 57 KLGEGGFGPVFKGKLDDGR---EIAVK--KLSHSSNQGKKEFENEAKLLARVQHRNVVNL 111
+LG G FG V KG + +AVK K + K E EA ++ ++ + +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 112 LGYCAHGAEKL-LIYEYVINESLDKVL-----FSLIKDIQILF----------------R 149
+G C AE L+ E L+K L I+++ R
Sbjct: 84 IGICE--AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 141
Query: 150 KKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-----YMAPEYVMH 204
D+ A N+LL + KI+DFG+++ D+ + A T+G + APE + +
Sbjct: 142 ----DLAARNVLLVTQHYAKISDFGLSKALRADENYY---KAQTHGKWPVKWYAPECINY 194
Query: 205 GHLSVKADVFSFGVVILELIS-GQR 228
S K+DV+SFGV++ E S GQ+
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 46/201 (22%), Positives = 82/201 (40%), Gaps = 35/201 (17%)
Query: 57 KLGEGGFGPVFKG--KLDDGREI--AVKKL-SHSSNQGKKEFENEAKLLARVQHRNVVNL 111
+GEG FG V +G + + A+K + +S+ +++F EA + + H ++V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 112 LGYCAHGAEKLLIYEYVINESLDKVL------FSLIKDIQILFR---------KKKT--- 153
+G +I E L L L I ++ K+
Sbjct: 82 IGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 140
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-----YMAPEYVMHGHLS 208
DI A N+L+ K+ DFG++R + + G +MAPE + +
Sbjct: 141 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-----YKASKGKLPIKWMAPESINFRRFT 195
Query: 209 VKADVFSFGVVILELIS-GQR 228
+DV+ FGV + E++ G +
Sbjct: 196 SASDVWMFGVCMWEILMHGVK 216
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-27
Identities = 64/313 (20%), Positives = 115/313 (36%), Gaps = 59/313 (18%)
Query: 19 SSREGDNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIA 78
R+ + DL + E + + + ++G GG VF+ + + A
Sbjct: 25 FERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYA 84
Query: 79 VK--KLSHSSNQGKKEFENEAKLLARVQH--RNVVNLLGYCAHGAEKLLIYEYVINESLD 134
+K L + NQ + NE L ++Q ++ L Y ++ E +
Sbjct: 85 IKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID--- 141
Query: 135 KVLFSLIKD-------------IQIL-----FRKKKT---DIKASNILLDDKWIPKIADF 173
L S +K +L + D+K +N L+ D + K+ DF
Sbjct: 142 --LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGML-KLIDF 198
Query: 174 GMARLFPEDQTHVNTR-VAGTNGYMAPEYVM-----------HGHLSVKADVFSFGVVIL 221
G+A D T V G YM PE + +S K+DV+S G ++
Sbjct: 199 GIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 258
Query: 222 ELISGQRNSSFNLDVDAQNLLDWAYKLYKK-DKSLEIVDPSLAASDSGDQIAMCIQIGLL 280
+ G+ + F Q +++ KL+ D + EI P + D D + C++
Sbjct: 259 YMTYGK--TPF------QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR--- 307
Query: 281 CTQGDPQLRPTMR 293
DP+ R ++
Sbjct: 308 ----DPKQRISIP 316
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 54/223 (24%), Positives = 88/223 (39%), Gaps = 57/223 (25%)
Query: 56 NKLGEGGFGPVFKGKLDDGRE------IAVKKL-SHSSNQGKKEFENEAKLLARVQHRNV 108
LGEG FG V K + +AVK L ++S ++ +E +L +V H +V
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 109 VNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT--------------- 153
+ L G C+ LLI EY SL L K +
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 154 --------------------------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187
D+ A NIL+ + KI+DFG++R E+ ++
Sbjct: 149 MGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY-- 206
Query: 188 TRVAGTNG-----YMAPEYVMHGHLSVKADVFSFGVVILELIS 225
V + G +MA E + + ++DV+SFGV++ E+++
Sbjct: 207 --VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 34/201 (16%)
Query: 57 KLGEGGFGPVFKGKLDDGRE---IAVKKL-SHSSNQGKKEFENEAKLLARVQHRNVVNLL 112
+LG G FG V +G ++ +A+K L + +E EA+++ ++ + +V L+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 113 GYCAHGAEKLLIYEYVINESLDKVL------FSLIKDIQILF----------------RK 150
G C +L+ E L K L + ++L R
Sbjct: 77 GVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR- 134
Query: 151 KKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN--GYMAPEYVMHGHLS 208
D+ A N+LL ++ KI+DFG+++ D ++ R AG + APE + S
Sbjct: 135 ---DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 209 VKADVFSFGVVILELIS-GQR 228
++DV+S+GV + E +S GQ+
Sbjct: 192 SRSDVWSYGVTMWEALSYGQK 212
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 39/203 (19%)
Query: 56 NKLGEGGFGPVFKGKL--DDGREI--AVKKL-SHSSNQGKKEFENEAKLLARVQHRNVVN 110
+G G FG V+ G L +DG++I AVK L + +F E ++ H NV++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 111 LLGYCAHGAEKLL-IYEYVINESLDKVL------FSLIKDIQILF--------------- 148
LLG C L + Y+ + L + ++ I
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 214
Query: 149 -RKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-----YMAPEYV 202
R D+ A N +LD+K+ K+ADFG+AR D+ + T +MA E +
Sbjct: 215 HR----DLAARNCMLDEKFTVKVADFGLARDM-YDKEFDSVH-NKTGAKLPVKWMALESL 268
Query: 203 MHGHLSVKADVFSFGVVILELIS 225
+ K+DV+SFGV++ EL++
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMT 291
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 53/226 (23%), Positives = 83/226 (36%), Gaps = 54/226 (23%)
Query: 49 TKNFHPSNKLGEGGFGPVFKG-KLDDGREIAVKK--LSHSSNQGKKEFENEAKLLARV-Q 104
T FH K+G G FG VFK K DG A+K+ + + ++ E A + Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 105 HRNVVNLLGYCAHGAEKLLIY-EYVINESLDKVLF-----------SLIKDI--QILF-- 148
H +VV A + +LI EY SL + + +KD+ Q+
Sbjct: 70 HSHVVRYFSAWAED-DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 149 ----RKKKT--DIKASNILLD-------------------DKWIPKIADFGMARLFPEDQ 183
DIK SNI + +K + KI D G Q
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 184 THVNTRVAGTNGYMAPEYVM--HGHLSVKADVFSFGVVILELISGQ 227
G + ++A E + + HL KAD+F+ + ++ +
Sbjct: 189 VEE-----GDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAE 228
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 46/205 (22%), Positives = 81/205 (39%), Gaps = 43/205 (20%)
Query: 57 KLGEGGFGPVFKGKL--DDGREI--AVKKL-SHSSNQGKKEFENEAKLLARVQHRNVVNL 111
LGEG FG V++G G +I AVK + K++F +EA ++ + H ++V L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 112 LGYCAHGAEKLLIYEYVINESLDKVL------FSLIKDIQILF----------------R 149
+G +I E L L ++ + R
Sbjct: 79 IGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHR 137
Query: 150 KKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-----YMAPEYVMH 204
DI NIL+ K+ DFG++R ++ + +M+PE +
Sbjct: 138 ----DIAVRNILVASPECVKLGDFGLSRYIEDEDY-----YKASVTRLPIKWMSPESINF 188
Query: 205 GHLSVKADVFSFGVVILELIS-GQR 228
+ +DV+ F V + E++S G++
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 57/266 (21%), Positives = 116/266 (43%), Gaps = 38/266 (14%)
Query: 56 NKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYC 115
KLG+G FG V+ G + +A+K L + F EA+++ +++H +V L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 116 AHGAEKLLIYEYVINESLDKVL-------FSLIKDIQILFR---------KKKT---DIK 156
++ EY+ SL L L + + + + + D++
Sbjct: 332 -SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 390
Query: 157 ASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSF 216
A+NIL+ + + K+ADFG+ARL +++ + APE ++G ++K+DV+SF
Sbjct: 391 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 450
Query: 217 GVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCI 275
G+++ EL + G+ ++ + + ++ Y++ + E +
Sbjct: 451 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH---------------- 494
Query: 276 QIGLLCTQGDPQLRPTMRRVVVMLSK 301
+ C + +P+ RPT + L
Sbjct: 495 DLMCQCWRKEPEERPTFEYLQAFLED 520
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 51/209 (24%), Positives = 85/209 (40%), Gaps = 43/209 (20%)
Query: 56 NKLGEGGFGPVFKGKLDDGRE----IAVK--KLSHSSNQGKKEFENEAKLLARVQHRNVV 109
LGEG FG V +G L +AVK KL +SS + +EF +EA + H NV+
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 110 NLLGYC-----AHGAEKLLIYEYVINESLDKVLFSL----------IKD-----IQI--- 146
LLG C + ++I ++ L L ++ + I
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 147 ---LFRKKKT--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-----Y 196
L + D+ A N +L D +ADFG+++ + G +
Sbjct: 160 MEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMPVKW 215
Query: 197 MAPEYVMHGHLSVKADVFSFGVVILELIS 225
+A E + + K+DV++FGV + E+ +
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 34/201 (16%)
Query: 57 KLGEGGFGPVFKGKL-DDGREI--AVKKL-SHSSNQGKKEFENEAKLLARVQHRNVVNLL 112
+LG G FG V +G ++I A+K L + +E EA+++ ++ + +V L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 113 GYCAHGAEKLLIYEYVINESLDKVL------FSLIKDIQILF----------------RK 150
G C +L+ E L K L + ++L R
Sbjct: 403 GVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR- 460
Query: 151 KKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGY--MAPEYVMHGHLS 208
++ A N+LL ++ KI+DFG+++ D ++ R AG APE + S
Sbjct: 461 ---NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 209 VKADVFSFGVVILELIS-GQR 228
++DV+S+GV + E +S GQ+
Sbjct: 518 SRSDVWSYGVTMWEALSYGQK 538
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 43/210 (20%), Positives = 79/210 (37%), Gaps = 44/210 (20%)
Query: 56 NKLGEGGFGPVFKGKLDDGRE----IAVK--KLSHSSNQGKKEFENEAKLLARVQHRNVV 109
LG+G FG V + +L +AVK K ++ +EF EA + H +V
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 110 NLLGYC------AHGAEKLLIYEYVINESLDKVLFSLIKD---------------IQI-- 146
L+G ++I ++ + L L + + I
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 147 ----LFRKKKT--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG----- 195
L + D+ A N +L + +ADFG++R + G
Sbjct: 149 GMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCASKLPVK 204
Query: 196 YMAPEYVMHGHLSVKADVFSFGVVILELIS 225
++A E + +V +DV++FGV + E+++
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 53/213 (24%), Positives = 84/213 (39%), Gaps = 51/213 (23%)
Query: 56 NKLGEGGFGPVFKGKL----DDGREI--AVKKL-SHSSNQGKKEFENEAKLLARVQHRNV 108
LG G FG V++G++ +D + AVK L S Q + +F EA ++++ H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 109 VNLLGYCAHGAEKLLIYEYVINESLDKVL------------FSLIKDIQILF-------- 148
V +G + ++ E + L L +++ + +
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 149 --------RKKKTDIKASNILLDDKW---IPKIADFGMARLFPEDQTHVNTRVAGTNGY- 196
R DI A N LL + KI DFGMAR + G
Sbjct: 197 LEENHFIHR----DIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY----RKGGCAML 248
Query: 197 ----MAPEYVMHGHLSVKADVFSFGVVILELIS 225
M PE M G + K D +SFGV++ E+ S
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-27
Identities = 53/223 (23%), Positives = 87/223 (39%), Gaps = 57/223 (25%)
Query: 56 NKLGEGGFGPVFKGKLDDGRE------IAVKKL-SHSSNQGKKEFENEAKLLARVQHRNV 108
+GEG FG VF+ + +AVK L +S + +F+ EA L+A + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 109 VNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT--------------- 153
V LLG CA G L++EY+ L++ L S+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 154 --------------------------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187
D+ N L+ + + KIADFG++R +
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY-- 230
Query: 188 TRVAGTNGY-----MAPEYVMHGHLSVKADVFSFGVVILELIS 225
A N M PE + + + ++DV+++GVV+ E+ S
Sbjct: 231 --KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 45/193 (23%), Positives = 83/193 (43%), Gaps = 33/193 (17%)
Query: 56 NKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYC 115
+G+G FG V G G ++AVK + + + + F EA ++ +++H N+V LLG
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 116 AHGAEKL-LIYEYVINESLDKVL-------FSLIKDIQILFR---------KKKT---DI 155
L ++ EY+ SL L ++ D+
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 315
Query: 156 KASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTN---GYMAPEYVMHGHLSVKAD 212
A N+L+ + + K++DFG+ + ++ + APE + S K+D
Sbjct: 316 AARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTKSD 368
Query: 213 VFSFGVVILELIS 225
V+SFG+++ E+ S
Sbjct: 369 VWSFGILLWEIYS 381
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-27
Identities = 53/213 (24%), Positives = 83/213 (38%), Gaps = 51/213 (23%)
Query: 56 NKLGEGGFGPVFKGKLDDGR------EIAVKKL-SHSSNQGKKEFENEAKLLARVQHRNV 108
LG G FG V++G++ ++AVK L S Q + +F EA ++++ H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 109 VNLLGYCAHGAEKLLIYEYVINESLDKVL------------FSLIKDIQILF-------- 148
V +G + ++ E + L L +++ + +
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 149 --------RKKKTDIKASNILLDDKW---IPKIADFGMARLFPEDQTHVNTRVAGTNGY- 196
R DI A N LL + KI DFGMAR R G
Sbjct: 156 LEENHFIHR----DIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY---YRK-GGCAML 207
Query: 197 ----MAPEYVMHGHLSVKADVFSFGVVILELIS 225
M PE M G + K D +SFGV++ E+ S
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-27
Identities = 51/196 (26%), Positives = 93/196 (47%), Gaps = 18/196 (9%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRN 107
K + K+G+G G V+ + G+E+A+++++ K+ NE ++ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 108 VVNLLG-------------YCAHGAEKLLIYEYVINES-LDKVLFSLIKDIQILFRKKKT 153
+VN L Y A G+ ++ E ++E + V ++ ++ L +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 154 --DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKA 211
DIK+ NILL K+ DFG +Q+ +T V GT +MAPE V K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 212 DVFSFGVVILELISGQ 227
D++S G++ +E+I G+
Sbjct: 198 DIWSLGIMAIEMIEGE 213
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-27
Identities = 54/239 (22%), Positives = 100/239 (41%), Gaps = 23/239 (9%)
Query: 11 LLKHFNLGSSREGDNEEDLEKIAA--REQKHFPFEALVSA---TKNFHPSNKLGEGGFGP 65
+ H + S + E + EQ +V K+GEG G
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGI 60
Query: 66 VFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLG----------- 113
V + GR++AVK + Q ++ NE ++ QH NVV +
Sbjct: 61 VCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL 120
Query: 114 --YCAHGAEKLLIYEYVINES-LDKVLFSLIKDIQILFRKKKT--DIKASNILLDDKWIP 168
+ GA ++ + +NE + V ++++ + L + DIK+ +ILL
Sbjct: 121 MEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRV 180
Query: 169 KIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQ 227
K++DFG +D + V GT +MAPE + + + D++S G++++E++ G+
Sbjct: 181 KLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-27
Identities = 42/214 (19%), Positives = 81/214 (37%), Gaps = 60/214 (28%)
Query: 57 KLGEGGFGPVFKGKL--------DDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNV 108
LG+G F +FKG E+ +K L + + F A +++++ H+++
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 109 VNLLGYCAHGAEKLLIYEYVINESLDKVL------FSLIKDIQILF-------------- 148
V G C G E +L+ E+V SLD L +++ +++
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL 134
Query: 149 --RKKKTDIKASNILLDDKWIP--------KIADFGMARLFPEDQTHVNTRVAGTNGY-- 196
++ A NILL + K++D G++
Sbjct: 135 IHG----NVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------ILQE 179
Query: 197 ----MAPEYVMHG-HLSVKADVFSFGVVILELIS 225
+ PE + + +L++ D +SFG + E+ S
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-27
Identities = 50/218 (22%), Positives = 87/218 (39%), Gaps = 52/218 (23%)
Query: 56 NKLGEGGFGPVFKGKL--------DDGREIAVKKL-SHSSNQGKKEFENEAKLLARV-QH 105
LGEG FG V + + +AVK L ++ + + +E +++ + +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 106 RNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT------------ 153
+N++NLLG C +I EY +L + L +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 154 ---------------------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAG 192
D+ A N+L+ + + KIADFG+AR +
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI----DYYKKT 216
Query: 193 TNG-----YMAPEYVMHGHLSVKADVFSFGVVILELIS 225
TNG +MAPE + + ++DV+SFGV++ E+ +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 64/287 (22%), Positives = 102/287 (35%), Gaps = 63/287 (21%)
Query: 50 KNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQ-GKKEFENEAKLLARVQHRN 107
+F P LG GGFG VF+ K D A+K++ + + +++ E K LA+++H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 108 VV---------NLLGYCAHGAEKLLIY---EYVINESLDKVL----------FSLIKDI- 144
+V N + K+ +Y + E+L + S+ I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 145 -QILF------RKKKT--DIKASNILLDDKWIPKIADFGMARLF-----------PEDQT 184
QI K D+K SNI + K+ DFG+ P
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 185 HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDW 244
+T GT YM+PE + S K D+FS G+++ EL+ F Q
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-----YPF----STQMER-- 233
Query: 245 AYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPT 291
+ ++L+ P L + M P RP
Sbjct: 234 -VRTLTDVRNLKF--PPLFTQKYPCEYVMVQD----MLSPSPMERPE 273
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 47/195 (24%), Positives = 81/195 (41%), Gaps = 37/195 (18%)
Query: 56 NKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYC 115
+G+G FG V G G ++AVK + + + + F EA ++ +++H N+V LLG
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 116 AHGAEKLLI-YEYVINESLDKVL-------FSLIKDIQILFR---------KKKT---DI 155
L I EY+ SL L ++ D+
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 143
Query: 156 KASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-----YMAPEYVMHGHLSVK 210
A N+L+ + + K++DFG+ + G + APE + S K
Sbjct: 144 AARNVLVSEDNVAKVSDFGLTK---------EASSTQDTGKLPVKWTAPEALREKKFSTK 194
Query: 211 ADVFSFGVVILELIS 225
+DV+SFG+++ E+ S
Sbjct: 195 SDVWSFGILLWEIYS 209
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 51/218 (23%), Positives = 89/218 (40%), Gaps = 52/218 (23%)
Query: 56 NKLGEGGFGPVFKGKL--------DDGREIAVKKL-SHSSNQGKKEFENEAKLLARV-QH 105
LGEG FG V + + ++AVK L S ++ + + +E +++ + +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 106 RNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT------------ 153
+N++NLLG C +I EY +L + L +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 154 ---------------------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAG 192
D+ A N+L+ + + KIADFG+AR +
Sbjct: 195 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY----KKT 250
Query: 193 TNG-----YMAPEYVMHGHLSVKADVFSFGVVILELIS 225
TNG +MAPE + + ++DV+SFGV++ E+ +
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 50/213 (23%)
Query: 56 NKLGEGGFGPVFKGKLDDGRE---IAVKKL-SHSSNQGKKEFENEAKLLARV-QHRNVVN 110
+ +GEG FG V K ++ A+K++ ++S ++F E ++L ++ H N++N
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 111 LLGYCAHGAEKLLIYEYVINESLDKVL-----FSLIKDIQILFRKKKT------------ 153
LLG C H L EY + +L L I T
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 154 ----------------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-- 195
D+ A NIL+ + ++ KIADFG++R V T G
Sbjct: 151 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGRL 203
Query: 196 ---YMAPEYVMHGHLSVKADVFSFGVVILELIS 225
+MA E + + + +DV+S+GV++ E++S
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 66/310 (21%), Positives = 111/310 (35%), Gaps = 51/310 (16%)
Query: 33 AAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKK 91
+ RE +F ++ K++ KLGEGGF V + L DG A+K++ Q ++
Sbjct: 12 SGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE 71
Query: 92 EFENEAKLLARVQHRNVVNLLGYC----AHGAEKLLIYEYVINESLDKVL------FSLI 141
E + EA + H N++ L+ YC E L+ + +L + + +
Sbjct: 72 EAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFL 131
Query: 142 KDIQIL--FR----------KKKT---DIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186
+ QIL K D+K +NILL D+ P + D G
Sbjct: 132 TEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGS 191
Query: 187 NTRVA--------GTNGYMAPEYV---MHGHLSVKADVFSFGVVILELISGQRNSSFNLD 235
+ T Y APE H + + DV+S G V+ ++ G+ +
Sbjct: 192 RQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE--GPY--- 246
Query: 236 VDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRV 295
D + L L I +S + + + DP RP + +
Sbjct: 247 -DMVFQKGDSVAL-AVQNQLSIPQSPRHSSALWQLLNSMMTV-------DPHQRPHIPLL 297
Query: 296 VVMLSKKPGP 305
+ L P
Sbjct: 298 LSQLEALQPP 307
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 51/217 (23%)
Query: 56 NKLGEGGFGPVFKGKL------DDGREIAVKKL-SHSSNQGKKEFENEAKLLARV-QHRN 107
LG G FG V + R +AVK L +++ + +E K+L + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 108 VVNLLGYC-AHGAEKLLIYEYVINESLDKVL-------FSLIKDIQILFRKKKT------ 153
VVNLLG C G ++I E+ +L L + L++ T
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 154 --------------------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGT 193
D+ A NILL +K + KI DFG+AR +D V
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----PDYVRKG 208
Query: 194 NG-----YMAPEYVMHGHLSVKADVFSFGVVILELIS 225
+ +MAPE + ++++DV+SFGV++ E+ S
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 53/223 (23%), Positives = 89/223 (39%), Gaps = 57/223 (25%)
Query: 56 NKLGEGGFGPVFKGKLDDGRE------IAVKKL-SHSSNQGKKEFENEAKLLARV-QHRN 107
LG G FG V + +AVK L + + ++ +E K++ ++ H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 108 VVNLLGYCAHGAEKLLIYEYVINESL-------------------DKVLFSLIKDIQILF 148
+VNLLG C LI+EY L ++ +D+ +L
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 149 RKKKT---------------------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187
+ D+ A N+L+ + KI DFG+AR D +
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD----S 226
Query: 188 TRVAGTNG-----YMAPEYVMHGHLSVKADVFSFGVVILELIS 225
V N +MAPE + G ++K+DV+S+G+++ E+ S
Sbjct: 227 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 50/203 (24%), Positives = 83/203 (40%), Gaps = 35/203 (17%)
Query: 56 NKLGEGGFGPVFKGKLDDGRE-----IAVKKL-SHSSNQGKKEFENEAKLLARVQHRNVV 109
LG G FG V KG E + +K + S Q + + + + H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 110 NLLGYCAHGAEKLLIYEYVINESLDKVL------FSLIKDI----QI------LFRKKKT 153
LLG C G+ L+ +Y+ SL + + QI L
Sbjct: 79 RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV 137
Query: 154 --DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-----YMAPEYVMHGH 206
++ A N+LL ++ADFG+A L P D + + +MA E + G
Sbjct: 138 HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY----SEAKTPIKWMALESIHFGK 193
Query: 207 LSVKADVFSFGVVILELIS-GQR 228
+ ++DV+S+GV + EL++ G
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAE 216
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 45/218 (20%), Positives = 82/218 (37%), Gaps = 39/218 (17%)
Query: 41 PFEALVSATKNFHPSN-----KLGEGGFGPVFKG--KLDDGREI--AVKKL-SHSSNQGK 90
+ + +GEG FG V +G + + A+K + +S+ +
Sbjct: 376 TYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR 435
Query: 91 KEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVL------FSLIKDI 144
++F EA + + H ++V L+G +I E L L L I
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLI 494
Query: 145 QILFR---------KKKT---DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAG 192
++ K+ DI A N+L+ K+ DFG++R +
Sbjct: 495 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-----YKA 549
Query: 193 TNG-----YMAPEYVMHGHLSVKADVFSFGVVILELIS 225
+ G +MAPE + + +DV+ FGV + E++
Sbjct: 550 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 50/218 (22%), Positives = 87/218 (39%), Gaps = 52/218 (23%)
Query: 56 NKLGEGGFGPVFKGKL--------DDGREIAVKKL-SHSSNQGKKEFENEAKLLARV-QH 105
LGEG FG V + + +AVK L ++ + + +E +++ + +H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 106 RNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT------------ 153
+N++NLLG C +I EY +L + L +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 154 ---------------------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAG 192
D+ A N+L+ + + KIADFG+AR +
Sbjct: 207 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI----DYYKKT 262
Query: 193 TNG-----YMAPEYVMHGHLSVKADVFSFGVVILELIS 225
TNG +MAPE + + ++DV+SFGV++ E+ +
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 35/203 (17%)
Query: 56 NKLGEGGFGPVFKGKLDDGRE-----IAVKKL-SHSSNQGKKEFENEAKLLARVQHRNVV 109
LG G FG V+KG E +A+K+L +S + KE +EA ++A V + +V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 110 NLLGYCAHGAEKLLIYEYVINESLDKVL------FSLIKDI----QI------LFRKKKT 153
LLG C + LI + + L + + QI L ++
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLV 139
Query: 154 --DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-----YMAPEYVMHGH 206
D+ A N+L+ KI DFG+A+L ++ + G +MA E ++H
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA----EGGKVPIKWMALESILHRI 195
Query: 207 LSVKADVFSFGVVILELIS-GQR 228
+ ++DV+S+GV + EL++ G +
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 52/207 (25%), Positives = 81/207 (39%), Gaps = 43/207 (20%)
Query: 57 KLGEGGFGPVFKG--KLDDGREI--AVKKL---SHSSNQGKKEFENEAKLLARVQHRNVV 109
KLG+G FG V +G G+ + AVK L S + +F E + + HRN++
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 110 NLLGYCAHGAEKLLIYEYVINESLDKVL------FSLIKDIQILF--------------- 148
L G ++ E SL L F L +
Sbjct: 85 RLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFI 143
Query: 149 -RKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-----YMAPEYV 202
R D+ A N+LL + + KI DFG+ R P++ + V + + APE +
Sbjct: 144 HR----DLAARNLLLATRDLVKIGDFGLMRALPQND---DHYVMQEHRKVPFAWCAPESL 196
Query: 203 MHGHLSVKADVFSFGVVILELIS-GQR 228
S +D + FGV + E+ + GQ
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 28/221 (12%)
Query: 27 EDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKL-DDGREIAVKKLSHS 85
+ LE ++QK + +F ++LG G G VFK G +A K +
Sbjct: 15 KRLEAFLTQKQKVGELKD-----DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE 69
Query: 86 SNQGK-KEFENEAKLLARVQHRNVVNLLG-------------YCAHG-AEKLLIYEYVIN 130
+ E ++L +V G + G +++L I
Sbjct: 70 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP 129
Query: 131 ES-LDKVLFSLIKDIQILFRKKKT---DIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186
E L KV ++IK + L K K D+K SNIL++ + K+ DFG++ +
Sbjct: 130 EQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMA 187
Query: 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQ 227
N+ V GT YM+PE + H SV++D++S G+ ++E+ G+
Sbjct: 188 NSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-23
Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 19/197 (9%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKE-FENEAKLLARVQHR 106
+ F K+G+G FG VFKG + +A+K + + + E + E +L++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 107 NVVNLLG-------------YCAHGAEKLLIYEYVINES-LDKVLFSLIKDIQILFRKKK 152
V G Y G+ L+ ++E+ + +L ++K + L +KK
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 153 T--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVK 210
DIKA+N+LL + K+ADFG+A + Q NT V GT +MAPE + K
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSK 199
Query: 211 ADVFSFGVVILELISGQ 227
AD++S G+ +EL G+
Sbjct: 200 ADIWSLGITAIELARGE 216
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 58/281 (20%), Positives = 98/281 (34%), Gaps = 60/281 (21%)
Query: 51 NFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVV 109
+F P + LG G G + + D R++AVK++ + E +LL +H NV+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA---DREVQLLRESDEHPNVI 81
Query: 110 NLLGYCAHGAEKLLIYEYVINESLDKVL-----------FSLIKDI----------QILF 148
+ + E + V +L++ I+
Sbjct: 82 RYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVH 141
Query: 149 RKKKTDIKASNILLDDK-----WIPKIADFGMARLFPEDQTHVNTR--VAGTNGYMAPEY 201
R D+K NIL+ I+DFG+ + + + R V GT G++APE
Sbjct: 142 R----DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 202 V---MHGHLSVKADVFSFGVVILELISGQR---NSSFNLDVDAQNLLDWAYKLYKKDKSL 255
+ + + D+FS G V +IS S + SL
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL----------LGACSL 247
Query: 256 EIVDPSLAASDSG-DQIAMCIQIGLLCTQGDPQLRPTMRRV 295
+ + P + I I + DPQ RP+ + V
Sbjct: 248 DCLHPEKHEDVIARELIEKMIAM-------DPQKRPSAKHV 281
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-23
Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 22/198 (11%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRN 107
+ F KLGEG +G V+K + G+ +A+K++ +E E ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPH 85
Query: 108 VVNLLGYCAHGAEKLLIYEY-----------VINESLDK-----VLFSLIKDIQILFRKK 151
VV G + ++ EY + N++L + +L S +K ++ L +
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 152 KT--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSV 209
K DIKA NILL+ + K+ADFG+A + NT + GT +MAPE + +
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNC 204
Query: 210 KADVFSFGVVILELISGQ 227
AD++S G+ +E+ G+
Sbjct: 205 VADIWSLGITAIEMAEGK 222
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-23
Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 25/203 (12%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRN 107
+ + +LG+G FG V+K K + G A K + S + +++ E ++LA H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 108 VVNLLG-------------YCAHGA--EKLLIYEYVINES-LDKVLFSLIKDIQILFRKK 151
+V LLG +C GA +L + + E + V +++ + L K+
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 152 KT--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLS- 208
D+KA N+L+ + ++ADFG++ + ++ + GT +MAPE VM +
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKD 196
Query: 209 ----VKADVFSFGVVILELISGQ 227
KAD++S G+ ++E+ +
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIE 219
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 5e-23
Identities = 42/200 (21%), Positives = 79/200 (39%), Gaps = 40/200 (20%)
Query: 57 KLGEGGFGPVFKGKLD---DGREIAVKKLSHSSNQGKKE-FENEAKLLARVQHRNVVNLL 112
+ GG G ++ D +GR + +K L HS + + E + LA V H ++V +
Sbjct: 87 CIAHGGLGWIYLAL-DRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 113 GYCAHGAEKL-----LIYEYVINESLDKVL---------FSLIKDI----------QILF 148
+ H ++ EYV +SL + + + +I +++
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVY 205
Query: 149 RKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLS 208
D+K NI+L ++ + K+ D G + + GT G+ APE V +
Sbjct: 206 N----DLKPENIMLTEEQL-KLIDLGAVSRI--NSFGY---LYGTPGFQAPEIVR-TGPT 254
Query: 209 VKADVFSFGVVILELISGQR 228
V D+++ G + L
Sbjct: 255 VATDIYTVGRTLAALTLDLP 274
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 99.4 bits (247), Expect = 7e-23
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 33/209 (15%)
Query: 51 NFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKE-FENEAKLLARVQHRNV 108
+ +LG GGFG V + D G ++A+K+ + +E + E +++ ++ H NV
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 109 VNLL------GYCAHGAEKLLIYEYV-----------------INESLDKVLFS-LIKDI 144
V+ A LL EY + E + L S + +
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 145 QILFRKKKT--DIKASNILLD---DKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAP 199
+ L + D+K NI+L + I KI D G A+ + + V GT Y+AP
Sbjct: 135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTEFV-GTLQYLAP 192
Query: 200 EYVMHGHLSVKADVFSFGVVILELISGQR 228
E + +V D +SFG + E I+G R
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-22
Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKLSHSSN-QGKKEFENEAK-LLARVQHRNVVNLLG 113
++G G +G V K G+ +AVK++ + + + +K+ + ++ +V G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 114 -------------YCAHGAEKLLIYEY-----VINES-LDKVLFSLIKDIQILFRKKKT- 153
+ +K Y Y VI E L K+ + +K + L K
Sbjct: 89 ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKII 148
Query: 154 --DIKASNILLDDKWIPKIADFGM-ARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHL--- 207
DIK SNILLD K+ DFG+ +L + TR AG YMAPE +
Sbjct: 149 HRDIKPSNILLDRSGNIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPERIDPSASRQG 205
Query: 208 -SVKADVFSFGVVILELISGQ 227
V++DV+S G+ + EL +G+
Sbjct: 206 YDVRSDVWSLGITLYELATGR 226
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 62/237 (26%), Positives = 98/237 (41%), Gaps = 38/237 (16%)
Query: 18 GSSREGDNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGK-LDDGRE 76
GSS + I + + E + ++G G G V+K + G
Sbjct: 1 GSSGSSGKQTGYLTI---GGQRYQAEI-----NDLENLGEMGSGTCGQVWKMRFRKTGHV 52
Query: 77 IAVKKLSHSSNQGK-KEFENEAKLLAR-VQHRNVVNLLG-------------YCAHGAEK 121
IAVK++ S N+ + K + ++ + +V G AEK
Sbjct: 53 IAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEK 112
Query: 122 L-LIYEYVINES-LDKVLFSLIKDIQILFRKKKT---DIKASNILLDDKWIPKIADFGM- 175
L + I E L K+ +++K + L K D+K SNILLD++ K+ DFG+
Sbjct: 113 LKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172
Query: 176 ARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHL-----SVKADVFSFGVVILELISGQ 227
RL R AG YMAPE + ++ADV+S G+ ++EL +GQ
Sbjct: 173 GRLV---DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-22
Identities = 49/200 (24%), Positives = 82/200 (41%), Gaps = 30/200 (15%)
Query: 56 NKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSN-QGKKEFENEAK-LLARVQHRNVVNLL 112
+LG G +G V K + + G+ +AVK++ + N Q +K + + V V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 113 G-------------YCAHGAEKLLIYEY----VINES-LDKVLFSLIKDIQILFRKKKT- 153
G +K I E L K+ S++K ++ L K
Sbjct: 73 GALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVI 132
Query: 154 --DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPE----YVMHGHL 207
D+K SN+L++ K+ DFG++ AG YMAPE +
Sbjct: 133 HRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPYMAPERINPELNQKGY 190
Query: 208 SVKADVFSFGVVILELISGQ 227
SVK+D++S G+ ++EL +
Sbjct: 191 SVKSDIWSLGITMIELAILR 210
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 6e-22
Identities = 58/297 (19%), Positives = 103/297 (34%), Gaps = 51/297 (17%)
Query: 47 SATKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKE-FENEAKLLARVQ 104
++ + S+ LG+G VF+G+ G A+K ++ S + E ++L ++
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 105 HRNVVNLLGY--CAHGAEKLLIYEYVINESLDKVLFSLI-----------KDIQILFR-- 149
H+N+V L K+LI E+ SL ++++ + I+ R
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSL----YTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 150 --------KKKT---DIKASNILL----DDKWIPKIADFGMARLFPEDQTHVNTRVAGTN 194
+ +IK NI+ D + + K+ DFG AR +D+ + GT
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLY-GTE 179
Query: 195 GYMAPEYVMHGHL--------SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAY 246
Y+ P+ L D++S GV +G F + + Y
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL--PFRPFEGPRRNKEVMY 237
Query: 247 KLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303
K+ S I A + D L L P + +L
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLAN---ILEADQ 291
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 46/210 (21%)
Query: 52 FHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFEN-EAKLLARVQHRNVVN 110
+ +G G FG VF+ KL + E+A+KK+ K F+N E +++ V+H NVV+
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVD 96
Query: 111 LLGYCAHGAEKL------LIYEYVINESLDKVLFSLIKDIQI------------LFRKKK 152
L + +K L+ EYV E++ + K Q L R
Sbjct: 97 LKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 153 T---------DIKASNILLD-DKWIPKIADFGMARLFPEDQTHVN---TRVAGTNGYMAP 199
DIK N+LLD + K+ DFG A++ + +V+ +R Y AP
Sbjct: 156 YIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAP 210
Query: 200 EYVMHG--HLSVKADVFSFGVVILELISGQ 227
E ++ G + + D++S G V+ EL+ GQ
Sbjct: 211 E-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 2e-21
Identities = 59/297 (19%), Positives = 102/297 (34%), Gaps = 51/297 (17%)
Query: 47 SATKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKE-FENEAKLLARVQ 104
++ + S+ LG+G VF+G+ G A+K ++ S + E ++L ++
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 105 HRNVVNLLGY--CAHGAEKLLIYEYVINESLDKVLFSLI-----------KDIQILFR-- 149
H+N+V L K+LI E+ SL ++++ + I+ R
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSL----YTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 150 --------KKKT---DIKASNILL----DDKWIPKIADFGMARLFPEDQTHVNTRVAGTN 194
+ +IK NI+ D + + K+ DFG AR ED + GT
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSLY-GTE 179
Query: 195 GYMAPEYVMHGHL--------SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAY 246
Y+ P+ L D++S GV +G F + + Y
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL--PFRPFEGPRRNKEVMY 237
Query: 247 KLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303
K+ S I A + D L L P + +L
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLAN---ILEADQ 291
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-21
Identities = 58/212 (27%), Positives = 88/212 (41%), Gaps = 45/212 (21%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKE-FENEAKLLARVQHR 106
F KLG G FG V + G E +K ++ +Q E E E ++L + H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 107 NVVNLLG-------------YCAHGAEKLLIYEYVINESLDKVLFS------LIKDI--- 144
N++ + C G E + E +++ S L+K +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCE-GGE---LLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 145 -------QILFRKKKTDIKASNILLDDK---WIPKIADFGMARLFPEDQTHVNTRVAGTN 194
++ + D+K NIL D KI DFG+A LF D+ T AGT
Sbjct: 137 LAYFHSQHVVHK----DLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTA 190
Query: 195 GYMAPEYVMHGHLSVKADVFSFGVVILELISG 226
YMAPE V ++ K D++S GVV+ L++G
Sbjct: 191 LYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-21
Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 37/201 (18%)
Query: 57 KLGEGGFGPVFKGK---LDDGREIAVK--KLSHSSNQG-KKEFENEAKLLARVQHRNVVN 110
KLG GG V+ + L+ ++A+K + + K FE E +++ H+N+V+
Sbjct: 18 KLGGGGMSTVYLAEDTILN--IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 111 LLGYCAHGAEKLLIYEYV--------INE----SLDKVLFSLIKDI----------QILF 148
++ L+ EY+ I S+D + + I +I+
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAI-NFTNQILDGIKHAHDMRIVH 134
Query: 149 RKKKTDIKASNILLDDKWIPKIADFGMARLFPED-QTHVNTRVAGTNGYMAPEYVMHGHL 207
R DIK NIL+D KI DFG+A+ E T N V GT Y +PE
Sbjct: 135 R----DIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAKGEAT 189
Query: 208 SVKADVFSFGVVILELISGQR 228
D++S G+V+ E++ G+
Sbjct: 190 DECTDIYSIGIVLYEMLVGEP 210
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 6e-21
Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 29/203 (14%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFE---NEAKLLARVQ 104
K F ++G G FG V+ + + + +A+KK+S+S Q ++++ E + L +++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 105 HRNVVNLLG-------------YCAHGAEKLL-IYEYVINES-LDKVLFSLIKDIQILFR 149
H N + G YC A LL +++ + E + V ++ + L
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 150 KKKT--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHL 207
D+KA NILL + + K+ DFG A + + V GT +MAPE ++
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDE 227
Query: 208 S---VKADVFSFGVVILELISGQ 227
K DV+S G+ +EL +
Sbjct: 228 GQYDGKVDVWSLGITCIELAERK 250
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 8e-21
Identities = 45/203 (22%), Positives = 80/203 (39%), Gaps = 32/203 (15%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKLS-HSSNQGKKEFENEAKLLARVQHRNVVNLLG- 113
+G G V ++A+K+++ E E + +++ H N+V+
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 114 ------------YCAHGAEKLLIYEYVINESLDK----------VLFSLIKDIQILFRKK 151
+ G+ +I V +L +++ ++ L +
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 141
Query: 152 KT--DIKASNILLDDKWIPKIADFGM-ARLFPEDQTHVNTR---VAGTNGYMAPEYVMHG 205
+ D+KA NILL + +IADFG+ A L N GT +MAPE +
Sbjct: 142 QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV 201
Query: 206 HL-SVKADVFSFGVVILELISGQ 227
KAD++SFG+ +EL +G
Sbjct: 202 RGYDFKADIWSFGITAIELATGA 224
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 35/206 (16%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVK---KLSHSSNQGKKEFENEAKLLARVQ 104
+ + LG+G FG V K G+E AVK K K+ E +LL ++
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 105 HRNVVNLLGYCAHGAEKLLIYEYVI-NESLDKVL----FS------LIKDI--------- 144
H N++ L + L+ E E D+++ FS +I+ +
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 144
Query: 145 -QILFRKKKTDIKASNILLDDKW---IPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPE 200
+I+ R D+K N+LL+ K +I DFG++ F + GT Y+APE
Sbjct: 145 NKIVHR----DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTAYYIAPE 198
Query: 201 YVMHGHLSVKADVFSFGVVILELISG 226
V+HG K DV+S GV++ L+SG
Sbjct: 199 -VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-20
Identities = 42/195 (21%), Positives = 75/195 (38%), Gaps = 32/195 (16%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYC 115
+G G +G V A KK+ + F+ E +++ + H N++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 116 AHGAEKLLIYEYVIN-ESLDKVL----FS------LIKDI----------QILFRKKKTD 154
+ L+ E E ++V+ F ++KD+ + R D
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHR----D 131
Query: 155 IKASNILLDDK---WIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKA 211
+K N L K+ DFG+A F + GT Y++P+ V+ G +
Sbjct: 132 LKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQ-VLEGLYGPEC 188
Query: 212 DVFSFGVVILELISG 226
D +S GV++ L+ G
Sbjct: 189 DEWSAGVMMYVLLCG 203
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 51/207 (24%), Positives = 88/207 (42%), Gaps = 34/207 (16%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVK--KLSHSSNQGKKEFENEAKLLARVQH 105
++ + KLG G +G V + E A+K + + S + E +L + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 106 RNVVNLLGYCAHGAEKLLIYEYVI-NESLDKVL----FS------LIKDI---------- 144
N++ L + L+ E E D+++ F+ +IK +
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 145 QILFRKKKTDIKASNILLDDKW---IPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEY 201
I+ R D+K N+LL+ K + KI DFG++ +F + GT Y+APE
Sbjct: 156 NIVHR----DLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPE- 208
Query: 202 VMHGHLSVKADVFSFGVVILELISGQR 228
V+ K DV+S GV++ L++G
Sbjct: 209 VLRKKYDEKCDVWSIGVILFILLAGYP 235
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 47/212 (22%), Positives = 85/212 (40%), Gaps = 39/212 (18%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVK-----KLSHSSNQGKKEFENEAKLLAR 102
+ +G+G F V + + G++ AVK K + S ++ + EA +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 103 VQHRNVVNLLGYCAHGAEKLLIYEYV---------INESLDKVLFS------LIKDI--- 144
++H ++V LL + +++E++ + + ++S ++ I
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 145 -------QILFRKKKTDIKASNILLDDKWIP---KIADFGMARLFPEDQTHVNTRVAGTN 194
I+ R D+K +LL K K+ FG+A E RV GT
Sbjct: 143 LRYCHDNNIIHR----DVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTP 197
Query: 195 GYMAPEYVMHGHLSVKADVFSFGVVILELISG 226
+MAPE V DV+ GV++ L+SG
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-20
Identities = 58/260 (22%), Positives = 96/260 (36%), Gaps = 39/260 (15%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVKKLSHSS--NQGKKE-FENEAKLLARVQHRNVVNLLG 113
LG+GGF F+ D A K + S ++E E + + H++VV G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 114 YCAHGAEKLLIYEYVINESLDKVLFS---------------LIKDIQILFRKKKT--DIK 156
+ ++ E SL ++ ++ Q L R + D+K
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 157 ASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSF 216
N+ L++ KI DFG+A D + GT Y+APE + S + DV+S
Sbjct: 143 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFEVDVWSI 201
Query: 217 GVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQ 276
G ++ L+ G + L + Y + K E P + I +Q
Sbjct: 202 GCIMYTLLVG------KPPFETSCLKE----TYLRIKKNEYSIPKHINPVAASLIQKMLQ 251
Query: 277 IGLLCTQGDPQLRPTMRRVV 296
DP RPT+ ++
Sbjct: 252 T-------DPTARPTINELL 264
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 34/205 (16%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVK--KLSHSSNQGKKEFENEAKLLARVQH 105
+ ++ LG+G FG V K K +E AVK + + N+ E +LL ++ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 106 RNVVNLLGYCAHGAEKLLIYEYVI-NESLDKVL----FS------LIKDI---------- 144
N++ L + ++ E E D+++ FS +IK +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 145 QILFRKKKTDIKASNILLDDKW---IPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEY 201
I+ R D+K NILL+ K KI DFG++ F ++ GT Y+APE
Sbjct: 141 NIVHR----DLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPE- 193
Query: 202 VMHGHLSVKADVFSFGVVILELISG 226
V+ G K DV+S GV++ L+SG
Sbjct: 194 VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 47/237 (19%), Positives = 84/237 (35%), Gaps = 35/237 (14%)
Query: 19 SSREGDNEEDLEKIAAREQKHFPFEALVSATKNFHP----SNKLGEGGFGPVFKGK-LDD 73
+G + + K + + + + +LG G FG V +
Sbjct: 122 VRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERAT 181
Query: 74 GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVIN-ES 132
G A K + K+ E + ++ ++H +VNL E ++IYE++ E
Sbjct: 182 GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 241
Query: 133 LDKVL-----FS------LIKDI----------QILFRKKKTDIKASNILLDDKWIP--K 169
+KV S ++ + + D+K NI+ K K
Sbjct: 242 FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHL----DLKPENIMFTTKRSNELK 297
Query: 170 IADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISG 226
+ DFG+ Q+ GT + APE + D++S GV+ L+SG
Sbjct: 298 LIDFGLTAHLDPKQSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-20
Identities = 47/203 (23%), Positives = 85/203 (41%), Gaps = 41/203 (20%)
Query: 57 KLGEGGFGPVFKGKLDD---GREIAVKKLS--HSSNQGKKE-FENEAKLLARVQHRNVVN 110
+G GG G V++ + D R +A+K +S SS+ + + EA+ R+Q +VV
Sbjct: 41 LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 111 LLGYCAHGAEKLLIY---EYVINESLDKVL-----------FSLIKDI----------QI 146
+ + G +Y + L +L ++++ I
Sbjct: 99 IHDF---GEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGA 155
Query: 147 LFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQ-THVNTRVAGTNGYMAPEYVMHG 205
R D+K NIL+ + DFG+A +++ T + GT YMAPE
Sbjct: 156 THR----DVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSES 210
Query: 206 HLSVKADVFSFGVVILELISGQR 228
H + +AD+++ V+ E ++G
Sbjct: 211 HATYRADIYALTCVLYECLTGSP 233
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 4e-20
Identities = 51/237 (21%), Positives = 88/237 (37%), Gaps = 35/237 (14%)
Query: 19 SSREGDNEEDLEKIAAREQKHFPFEALVSATKNFHP----SNKLGEGGFGPVFKGK-LDD 73
+G D +K K + + + + + +LG G FG V +
Sbjct: 16 GKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKAT 75
Query: 74 GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVI-NES 132
GR K ++ K +NE ++ ++ H ++NL E +LI E++ E
Sbjct: 76 GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 135
Query: 133 LDKVL-----FS------LIKDI----------QILFRKKKTDIKASNILLDDKWIP--K 169
D++ S ++ I+ DIK NI+ + K K
Sbjct: 136 FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHL----DIKPENIMCETKKASSVK 191
Query: 170 IADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISG 226
I DFG+A D+ T + APE V + D+++ GV+ L+SG
Sbjct: 192 IIDFGLATKLNPDEIV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 4e-20
Identities = 49/206 (23%), Positives = 86/206 (41%), Gaps = 41/206 (19%)
Query: 57 KLGEGGFGPVFKGK---LDDGREIAVK--KLSHSSNQG-KKEFENEAKLLARVQHRNVVN 110
LG GG V + R++AVK + + + F EA+ A + H +V
Sbjct: 19 ILGFGGMSEVHLARDLRDH--RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 111 LLGY-CAHGAEKLLIY---EYVINESLDKVL-----FSLIKDIQILF------------- 148
+ A L Y EYV +L ++ + + I+++
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG 136
Query: 149 ---RKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR---VAGTNGYMAPEYV 202
R D+K +NI++ K+ DFG+AR + V T+ V GT Y++PE
Sbjct: 137 IIHR----DVKPANIMISATNAVKVMDFGIARAIADSGNSV-TQTAAVIGTAQYLSPEQA 191
Query: 203 MHGHLSVKADVFSFGVVILELISGQR 228
+ ++DV+S G V+ E+++G+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-20
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 34/205 (16%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKE--FENEAKLLARVQH 105
+ ++ LG+G FG V K K +E AVK ++ +S + K E +LL ++ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 106 RNVVNLLGYCAHGAEKLLIYEYVIN-ESLDKVL----FS------LIKDI---------- 144
N++ L + ++ E E D+++ FS +IK +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 145 QILFRKKKTDIKASNILLDDK---WIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEY 201
I+ R D+K NILL+ K KI DFG++ F ++ GT Y+APE
Sbjct: 141 NIVHR----DLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPE- 193
Query: 202 VMHGHLSVKADVFSFGVVILELISG 226
V+ G K DV+S GV++ L+SG
Sbjct: 194 VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 5e-20
Identities = 55/265 (20%), Positives = 102/265 (38%), Gaps = 50/265 (18%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLG 113
LG+G F V++ + + G E+A+K + + +NE K+ +++H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 114 YCAHGAEKL-LIYEYVINESLDKVLFSLIKDIQILFRKKKT------------------- 153
Y + + L+ E N + +K+ F + +
Sbjct: 79 Y-FEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGI 133
Query: 154 ---DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVK 210
D+ SN+LL KIADFG+A T + GT Y++PE ++
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGLE 192
Query: 211 ADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQ 270
+DV+S G + L+ G D + + K + PS + ++ D
Sbjct: 193 SDVWSLGCMFYTLLIG------RPPFDTDTVKN----TLNKVVLADYEMPSFLSIEAKDL 242
Query: 271 IAMCIQIGLLCTQGDPQLRPTMRRV 295
I LL + +P R ++ V
Sbjct: 243 IH-----QLL--RRNPADRLSLSSV 260
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 6e-20
Identities = 50/227 (22%), Positives = 90/227 (39%), Gaps = 36/227 (15%)
Query: 34 AREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKE 92
AR AL F +G G +G V+KG+ + G+ A+K + + ++E
Sbjct: 8 ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEE 66
Query: 93 FENEAKLLARV-QHRNVVNLLG-------------------YCAHGAEKLLIYEYVINES 132
+ E +L + HRN+ G +C G+ + + +
Sbjct: 67 IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGS-VTDLIKNTKGNT 125
Query: 133 LDK-----VLFSLIKDIQILFRKKKT--DIKASNILLDDKWIPKIADFGMARLFPEDQTH 185
L + + +++ + L + K DIK N+LL + K+ DFG++
Sbjct: 126 LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 185
Query: 186 VNTRVAGTNGYMAPEYVMHGHLS-----VKADVFSFGVVILELISGQ 227
NT GT +MAPE + K+D++S G+ +E+ G
Sbjct: 186 RNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 8e-20
Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 37/204 (18%)
Query: 51 NFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVV 109
+ LG G FG V K + G ++A K + + K+E +NE ++ ++ H N++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 110 NLLGYCAHGAEKLLIYEYV--------INESLDKVLFS------LIKDI----------Q 145
L + +L+ EYV I + + + +K I
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY 207
Query: 146 ILFRKKKTDIKASNILL---DDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYV 202
IL D+K NIL D K I KI DFG+AR + + + GT ++APE V
Sbjct: 208 ILHL----DLKPENILCVNRDAKQI-KIIDFGLARRYKPREK-LKVNF-GTPEFLAPEVV 260
Query: 203 MHGHLSVKADVFSFGVVILELISG 226
+ +S D++S GV+ L+SG
Sbjct: 261 NYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 9e-20
Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 49/215 (22%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGKL-DDGREIAVKK-LSHSSNQGKKEFEN-EAKLLARVQH 105
++ + +G G FG V++ KL D G +A+KK L K F+N E +++ ++ H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDH 106
Query: 106 RNVVNLLGYCAHGAEKL------LIYEYVINESLDKVLFSLIKDIQI------------L 147
N+V L + EK L+ +YV E++ +V + Q L
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 148 FRKKKT---------DIKASNILLD-DKWIPKIADFGMARLFPEDQ--TH-VNTRVAGTN 194
FR DIK N+LLD D + K+ DFG A+ + + +R
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---- 221
Query: 195 GYMAPEYVMHG--HLSVKADVFSFGVVILELISGQ 227
Y APE ++ G + DV+S G V+ EL+ GQ
Sbjct: 222 -YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 9e-20
Identities = 39/235 (16%), Positives = 77/235 (32%), Gaps = 43/235 (18%)
Query: 34 AREQKHFPFEALVSATKNFHPS-------NKLGEG--GFGPVFKGK-LDDGREIAVKK-- 81
A H +F P +G+G V + G + V++
Sbjct: 2 AHHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN 61
Query: 82 LSHSSNQGKKEFENEAKLLARVQHRNVVNLLG-------------YCAHGAEKLLIYEYV 128
L SN+ + E + H N+V + A+G+ K LI
Sbjct: 62 LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI-CTH 120
Query: 129 INESLDK-----VLFSLIKDIQILFRKKK--TDIKASNILLDDKWIPKIADFGMARLFPE 181
+ +++ +L ++K + + +KAS+IL+ ++
Sbjct: 121 FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180
Query: 182 DQTHVNTR------VAGTNGYMAPEYVMHGHLS---VKADVFSFGVVILELISGQ 227
+++PE V+ +L K+D++S G+ EL +G
Sbjct: 181 HGQRQRVVHDFPKYSVKVLPWLSPE-VLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 60/261 (22%), Positives = 98/261 (37%), Gaps = 41/261 (15%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVKKLSHSS--NQGKKE-FENEAKLLARVQHRNVVNLLG 113
LG+GGF F+ D A K + S ++E E + + H++VV G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 114 YCAHGAEKLLIYEYVINESLDKVLFS---------------LIKDIQILFRKKKT--DIK 156
+ ++ E SL ++ ++ Q L R + D+K
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 157 ASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMH-GHLSVKADVFS 215
N+ L++ KI DFG+A D + GT Y+APE + GH S + DV+S
Sbjct: 169 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH-SFEVDVWS 226
Query: 216 FGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCI 275
G ++ L+ G + L + Y + K E P + I +
Sbjct: 227 IGCIMYTLLVG------KPPFETSCLKE----TYLRIKKNEYSIPKHINPVAASLIQKML 276
Query: 276 QIGLLCTQGDPQLRPTMRRVV 296
Q DP RPT+ ++
Sbjct: 277 QT-------DPTARPTINELL 290
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 36/200 (18%)
Query: 58 LGEGGFGPVFKGKLDDGREI-AVKKLSHSSNQGKKEFE---NEAKLLARVQHRNVVNLLG 113
LG GGFG VF ++ ++ A KKL+ + +K ++ E K+LA+V R +V+L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251
Query: 114 YCAHGAEKL-LIYEYV---------INESLDKVLFSLIK----------------DIQIL 147
Y L L+ + N D F + I+
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII 311
Query: 148 FRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHL 207
+R D+K N+LLDD +I+D G+A QT GT G+MAPE ++
Sbjct: 312 YR----DLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEY 366
Query: 208 SVKADVFSFGVVILELISGQ 227
D F+ GV + E+I+ +
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 1e-19
Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 44/205 (21%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVK-----KLSHSSNQGKKE-FENEAKLLARVQHRNVV 109
+LG G F V K + G+E A K +LS S +E E E +L ++H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 110 NLLGYCAHGAEKLLIYEYV--------INESLDKVLFS------LIKDI----------Q 145
L + + +LI E V + +K + +K I +
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYLHSKR 128
Query: 146 ILFRKKKTDIKASNILLDDKWIP----KIADFGMARLFPEDQTHVNTRVAGTNGYMAPEY 201
I D+K NI+L DK +P K+ DFG+A + GT ++APE
Sbjct: 129 IAHF----DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEI 182
Query: 202 VMHGHLSVKADVFSFGVVILELISG 226
V + L ++AD++S GV+ L+SG
Sbjct: 183 VNYEPLGLEADMWSIGVITYILLSG 207
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 60/197 (30%), Positives = 90/197 (45%), Gaps = 33/197 (16%)
Query: 58 LGEGGFGPVFKGKLDDGREI-AVKKLSHSSNQGKKEFE---NEAKLLARVQHRNVVNLLG 113
LG+GGFG V ++ ++ A KKL + +K NE ++L +V R VV+L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 250
Query: 114 YCAHGAEKL-LIYEYVINESLDKVLFSLIKDIQILFRKKKT------------------- 153
Y + L L+ + L F + Q F + +
Sbjct: 251 YAYETKDALCLVLTLMNGGDL---KFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI 307
Query: 154 ---DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVK 210
D+K NILLDD +I+D G+A PE QT + RV GT GYMAPE V + +
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYTFS 365
Query: 211 ADVFSFGVVILELISGQ 227
D ++ G ++ E+I+GQ
Sbjct: 366 PDWWALGCLLYEMIAGQ 382
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-19
Identities = 55/215 (25%), Positives = 87/215 (40%), Gaps = 56/215 (26%)
Query: 51 NFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN---------EAKLL 100
+ K+GEG +G VFK + D G+ +A+KK + ++ E ++L
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-------LESEDDPVIKKIALREIRML 56
Query: 101 ARVQHRNVVNLLGYCAHGAEKL-LIYEYVINESLDKVLFSLIKDIQILFRKKKT------ 153
+++H N+VNLL +L L++EY D + + Q +
Sbjct: 57 KQLKHPNLVNLLEVF-RRKRRLHLVFEY-----CDHTVLHELDRYQRGVPEHLVKSITWQ 110
Query: 154 ----------------DIKASNILLDDKWIPKIADFGMARLF--PEDQ-TH-VNTRVAGT 193
D+K NIL+ + K+ DFG ARL P D V TR
Sbjct: 111 TLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR---- 166
Query: 194 NGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQ 227
Y +PE ++ DV++ G V EL+SG
Sbjct: 167 -WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-19
Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 54/214 (25%)
Query: 51 NFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN---------EAKLL 100
+ +GEG +G V K + D GR +A+KK + ++ E KLL
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-------LESDDDKMVKKIAMREIKLL 78
Query: 101 ARVQHRNVVNLLGYCAHGAEKL-LIYEYV----------INESLD-----KVLFSLIKDI 144
+++H N+VNLL C ++ L++E+V LD K LF +I I
Sbjct: 79 KQLRHENLVNLLEVC-KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI 137
Query: 145 Q------ILFRKKKTDIKASNILLDDKWIPKIADFGMARLF--PEDQ-TH-VNTRVAGTN 194
I+ R DIK NIL+ + K+ DFG AR P + V TR
Sbjct: 138 GFCHSHNIIHR----DIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR----- 188
Query: 195 GYMAPEYVMHG-HLSVKADVFSFGVVILELISGQ 227
Y APE ++ DV++ G ++ E+ G+
Sbjct: 189 WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-19
Identities = 45/241 (18%), Positives = 88/241 (36%), Gaps = 47/241 (19%)
Query: 33 AAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKK 91
+ R+Q F + + L EGGF V++ + + GRE A+K+L + + +
Sbjct: 11 SGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR 70
Query: 92 EFENEAKLLARVQ-HRNVVNLLGYCA-------HGAEKLLIYEY--------VINESLDK 135
E + ++ H N+V + G + L+ + + +
Sbjct: 71 AIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR 130
Query: 136 VLFSLIKDIQILFR----------KKKT-----DIKASNILLDDKWIPKIADFGMARLF- 179
S + +F ++K D+K N+LL ++ K+ DFG A
Sbjct: 131 GPLS-CDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS 189
Query: 180 --PEDQTHVNTRVA--------GTNGYMAPEYV-MHGHLSV--KADVFSFGVVILELISG 226
P+ R T Y PE + ++ + + K D+++ G ++ L
Sbjct: 190 HYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249
Query: 227 Q 227
Q
Sbjct: 250 Q 250
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 87.0 bits (215), Expect = 4e-19
Identities = 35/228 (15%), Positives = 72/228 (31%), Gaps = 58/228 (25%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGKLDD------GREIAVKKLSHSSNQGKKEFENEAKLLAR 102
+K + + LGEG F V++ D ++ +K ++ EF +L+ R
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMER 120
Query: 103 VQ---HRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT------ 153
++ + +L+ E +L + I + K
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL----LNAINLYKNTPEKVMPQGLVIS 176
Query: 154 --------------------DIKASNILLDDKWIP-----------KIADFGMA---RLF 179
DIK N +L + ++ + D G + +LF
Sbjct: 177 FAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF 236
Query: 180 PEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQ 227
P+ T T+G+ E + + + + D F + ++ G
Sbjct: 237 PKGTI--FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 5e-19
Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 55/218 (25%)
Query: 47 SATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFEN---------EA 97
+ + K+GEG +G V+K K GR +A+K++ + + E+ E
Sbjct: 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRI-------RLDAEDEGIPSTAIREI 70
Query: 98 KLLARVQHRNVVNLLGYCAHGAEKL-LIYEYV-------INESLDKVLFSLIKDI----- 144
LL + H N+V+L+ H L L++E++ ++E+ + S IK
Sbjct: 71 SLLKELHHPNIVSLID-VIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLL 129
Query: 145 ---------QILFRKKKTDIKASNILLDDKWIPKIADFGMARLF--PEDQ-TH-VNTRVA 191
+IL R D+K N+L++ K+ADFG+AR F P TH V T
Sbjct: 130 RGVAHCHQHRILHR----DLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTL-- 183
Query: 192 GTNGYMAPEYVMHG--HLSVKADVFSFGVVILELISGQ 227
Y AP+ V+ G S D++S G + E+I+G+
Sbjct: 184 ---WYRAPD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-19
Identities = 57/202 (28%), Positives = 86/202 (42%), Gaps = 38/202 (18%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVK-----KLSHSSNQGKKE-FENEAKLLARVQHRNVV 109
+LG G F V K + G + A K + S +E E E +L +QH NV+
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 110 NLLGYCAHGAEKLLIYEYVI-NESLDKVL----FS------LIKDI----------QILF 148
L + + +LI E V E D + + +K I QI
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 149 RKKKTDIKASNILLDDKWIP----KIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMH 204
D+K NI+L D+ +P KI DFG+A + GT ++APE V +
Sbjct: 138 F----DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIVNY 191
Query: 205 GHLSVKADVFSFGVVILELISG 226
L ++AD++S GV+ L+SG
Sbjct: 192 EPLGLEADMWSIGVITYILLSG 213
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-19
Identities = 60/210 (28%), Positives = 88/210 (41%), Gaps = 38/210 (18%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVK-----KLSHSSNQGKKE-FENEAKLLA 101
+ +LG G F V K + G E A K + S +E E E +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 102 RVQHRNVVNLLGYCAHGAEKLLIYEYVIN-ESLDKVL----FS------LIKDI------ 144
+V H NV+ L + + +LI E V E D + S IK I
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 145 ----QILFRKKKTDIKASNILLDDKWIP----KIADFGMARLFPEDQTHVNTRVAGTNGY 196
+I D+K NI+L DK IP K+ DFG+A + + GT +
Sbjct: 131 LHTKKIAHF----DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEF 184
Query: 197 MAPEYVMHGHLSVKADVFSFGVVILELISG 226
+APE V + L ++AD++S GV+ L+SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-19
Identities = 63/269 (23%), Positives = 106/269 (39%), Gaps = 45/269 (16%)
Query: 50 KNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLS----HSSNQGKKEFENEAKLLARVQ 104
++F LG+G FG V+ + +A+K L + + E ++ + ++
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLR 67
Query: 105 HRNVVNLLGYCAHGAEKL-LIYEYVINESLDKVL-----FS----------LIKDIQILF 148
H N++ L GY H A ++ LI EY ++ + L F L +
Sbjct: 68 HPNILRLYGYF-HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 149 RKKKT--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGH 206
K+ DIK N+LL KIADFG + P + + GT Y+ PE +
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPEMIEGRM 183
Query: 207 LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266
K D++S GV+ E + G +A + YK+ +E P
Sbjct: 184 HDEKVDLWSLGVLCYEFLVG------KPPFEANTYQ----ETYKRISRVEFTFPDFVTEG 233
Query: 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRV 295
+ D I+ ++ +P RP +R V
Sbjct: 234 ARDLISRLLKH-------NPSQRPMLREV 255
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 6e-19
Identities = 59/210 (28%), Positives = 88/210 (41%), Gaps = 38/210 (18%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVK-----KLSHSSNQGKKE-FENEAKLLA 101
+ +LG G F V K + G E A K + S +E E E +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 102 RVQHRNVVNLLGYCAHGAEKLLIYEYVIN-ESLDKVL----FS------LIKDI------ 144
+V H N++ L + + +LI E V E D + S IK I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 145 ----QILFRKKKTDIKASNILLDDKWIP----KIADFGMARLFPEDQTHVNTRVAGTNGY 196
+I D+K NI+L DK IP K+ DFG+A + + GT +
Sbjct: 131 LHTKKIAHF----DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEF 184
Query: 197 MAPEYVMHGHLSVKADVFSFGVVILELISG 226
+APE V + L ++AD++S GV+ L+SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 7e-19
Identities = 50/220 (22%), Positives = 84/220 (38%), Gaps = 48/220 (21%)
Query: 47 SATKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLS-HSSNQGKKEFENEA------- 97
AT + P ++G G +G V+K + G +A+K + + G
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 98 KLLARVQHRNVVNLL----GYCAHGAEKL-LIYEYV------INESLDKVLFS--LIKDI 144
+ L +H NVV L+ K+ L++E+V + IKD+
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 145 --------------QILFRKKKTDIKASNILLDDKWIPKIADFGMARLF--PEDQTH-VN 187
I+ R D+K NIL+ K+ADFG+AR++ T V
Sbjct: 126 MRQFLRGLDFLHANCIVHR----DLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV 181
Query: 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQ 227
T Y APE ++ + D++S G + E+ +
Sbjct: 182 TL-----WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 45/216 (20%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLS-------------HSSNQGKKEFE 94
+++ KLG G +G V K + E A+K + + + +E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 95 NEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVI-NESLDKVL----FS------LIKD 143
NE LL + H N++ L L+ E+ E ++++ F ++K
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154
Query: 144 I----------QILFRKKKTDIKASNILLDDK---WIPKIADFGMARLFPEDQTHVNTRV 190
I I+ R DIK NILL++K KI DFG++ F +D
Sbjct: 155 ILSGICYLHKHNIVHR----DIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL--RDR 208
Query: 191 AGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISG 226
GT Y+APE V+ + K DV+S GV++ L+ G
Sbjct: 209 LGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 1e-18
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 47/216 (21%)
Query: 47 SATKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN-----EAKLL 100
S K + + LGEG F V+K + + + +A+KK+ K+ N E KLL
Sbjct: 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLL 66
Query: 101 ARVQHRNVVNLLGYCAHGAEKL-LIYEYVINESLDKVLFSLIKDIQILFRKK--KT---- 153
+ H N++ LL + L++++ ++ L +IKD ++ K
Sbjct: 67 QELSHPNIIGLLD-AFGHKSNISLVFDF-----METDLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 154 ----------------DIKASNILLDDKWIPKIADFGMARLF--PEDQ-TH-VNTRVAGT 193
D+K +N+LLD+ + K+ADFG+A+ F P TH V TR
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR---- 176
Query: 194 NGYMAPEYVMHG--HLSVKADVFSFGVVILELISGQ 227
Y APE ++ G V D+++ G ++ EL+
Sbjct: 177 -WYRAPE-LLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-18
Identities = 40/204 (19%), Positives = 76/204 (37%), Gaps = 34/204 (16%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRN 107
+ + + LG G FG V + + K + + + E +L +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRN 62
Query: 108 VVNLLGYCAHGAEKLLIYEYVI-NESLDKVL-----FS------LIKDI----------Q 145
+++L E ++I+E++ + +++ + + +
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 146 ILFRKKKTDIKASNILLDDK---WIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYV 202
I DI+ NI+ + I KI +FG AR + Y APE
Sbjct: 123 IGHF----DIRPENIIYQTRRSSTI-KIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVH 175
Query: 203 MHGHLSVKADVFSFGVVILELISG 226
H +S D++S G ++ L+SG
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSG 199
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 60/297 (20%), Positives = 97/297 (32%), Gaps = 69/297 (23%)
Query: 50 KNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNV 108
LG G G V GR +AVK++ E KLL H NV
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNV 71
Query: 109 VNLLG-------------YCAHGAEKLLIYEYVINESLDKVLFSLIKDI--QILF----- 148
+ C + L+ + V +E+L + QI
Sbjct: 72 IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 149 -------RKKKTDIKASNILLDDKWIP-------------KIADFGMARLFPEDQTHVNT 188
R D+K NIL+ I+DFG+ + Q+ T
Sbjct: 132 HSLKIIHR----DLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 189 R---VAGTNGYMAPE-------YVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDA 238
+GT+G+ APE L+ D+FS G V ++S ++ +
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
Query: 239 QNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRV 295
N++ + L ++ + +++ D I+ I DP RPT +V
Sbjct: 248 SNIIRGIFSL----DEMKCLHDRSLIAEATDLISQMIDH-------DPLKRPTAMKV 293
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 2e-18
Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 55/215 (25%)
Query: 50 KNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFEN---------EAKLL 100
+ +H K+GEG +G V+K + + G A+KK+ + E E+ E +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKI-------RLEKEDEGIPSTTIREISIL 54
Query: 101 ARVQHRNVVNLLGYCAHGAEKL-LIYEYV-------INESLDKVLFSLIKDI-------- 144
++H N+V L H ++L L++E++ ++ + K
Sbjct: 55 KELKHSNIVKLYDVI-HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 145 ------QILFRKKKTDIKASNILLDDKWIPKIADFGMARLF--PEDQ-TH-VNTRVAGTN 194
++L R D+K N+L++ + KIADFG+AR F P + TH + T
Sbjct: 114 AYCHDRRVLHR----DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL----- 164
Query: 195 GYMAPEYVMHG--HLSVKADVFSFGVVILELISGQ 227
Y AP+ V+ G S D++S G + E+++G
Sbjct: 165 WYRAPD-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-18
Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 33/205 (16%)
Query: 49 TKNFHPSNKLGEGGFGPVFKG-KLDDGREIAVKKL--SHSSNQGKKEFENEAKLLARVQH 105
+ N+ +LG+G F V + G E A K + S + ++ E EA++ ++QH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 106 RNVVNLLGYCAHGAEKLLIYEYVIN-ESLDKVL----FS------LIKDI---------- 144
N+V L + L+++ V E + ++ +S I+ I
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 145 QILFRKKKTDIKASNILLDDKWIP---KIADFGMARLFPEDQTHVNTRVAGTNGYMAPEY 201
I+ R ++K N+LL K K+ADFG+A + + AGT GY++PE
Sbjct: 125 GIVHR----NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEV 178
Query: 202 VMHGHLSVKADVFSFGVVILELISG 226
+ S D+++ GV++ L+ G
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVG 203
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-18
Identities = 51/217 (23%), Positives = 91/217 (41%), Gaps = 56/217 (25%)
Query: 50 KNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN---------EAKL 99
+ + K+GEG +G VFK K + +A+K++ + + ++ E L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-------RLDDDDEGVPSSALREICL 54
Query: 100 LARVQHRNVVNLLGYCAHGAEKL-LIYEYV-------INESLDKVLFSLIKDI------- 144
L ++H+N+V L H +KL L++E+ + + ++K
Sbjct: 55 LKELKHKNIVRLHD-VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 145 -------QILFRKKKTDIKASNILLDDKWIPKIADFGMARLF--PEDQ-TH-VNTRVAGT 193
+L R D+K N+L++ K+A+FG+AR F P + V T
Sbjct: 114 LGFCHSRNVLHR----DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTL---- 165
Query: 194 NGYMAPEYVMHG--HLSVKADVFSFGVVILELISGQR 228
Y P+ V+ G S D++S G + EL + R
Sbjct: 166 -WYRPPD-VLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 4e-18
Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 38/200 (19%)
Query: 58 LGEGGFGPVFKG-KLDDGREIAVKKLSHSSNQGKKEFE---NEAKLLARV---QHRNVVN 110
+G GGFG V+ K D G+ A+K L + K+ NE +L+ V +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 111 LLGYCAHGAEKL-LIYEYV--------------INESLDK-----VLFSL--IKDIQILF 148
+ Y H +KL I + + +E+ + ++ L + + +++
Sbjct: 257 M-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 149 RKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLS 208
R D+K +NILLD+ +I+D G+A F + + H V GT+GYMAPE + G
Sbjct: 316 R----DLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGVAY 368
Query: 209 VKA-DVFSFGVVILELISGQ 227
+ D FS G ++ +L+ G
Sbjct: 369 DSSADWFSLGCMLFKLLRGH 388
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 6e-18
Identities = 49/199 (24%), Positives = 82/199 (41%), Gaps = 40/199 (20%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYC 115
LG G F VF K G+ A+K + S ENE +L +++H N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 116 AHGAEKLLIYEYV--------INESLDKVLFS------LIKDI----------QILFRKK 151
L+ + V I L++ +++ +I+ + I+ R
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRI---LERGVYTEKDASLVIQQVLSAVKYLHENGIVHR-- 130
Query: 152 KTDIKASNILL----DDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHL 207
D+K N+L ++ I I DFG++++ + GT GY+APE +
Sbjct: 131 --DLKPENLLYLTPEENSKI-MITDFGLSKMEQNGIM---STACGTPGYVAPEVLAQKPY 184
Query: 208 SVKADVFSFGVVILELISG 226
S D +S GV+ L+ G
Sbjct: 185 SKAVDCWSIGVITYILLCG 203
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 7e-18
Identities = 49/214 (22%), Positives = 94/214 (43%), Gaps = 53/214 (24%)
Query: 50 KNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN--------EAKLL 100
+ + +KLGEG + V+KGK +A+K++ + E E E LL
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-------RLEHEEGAPCTAIREVSLL 54
Query: 101 ARVQHRNVVNLLGYCAHGAEKL-LIYEYV-------INESLDKVLFSLIKDI-------- 144
++H N+V L H + L L++EY+ +++ + + +K
Sbjct: 55 KDLKHANIVTLHD-IIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 145 ------QILFRKKKTDIKASNILLDDKWIPKIADFGMARLF---PEDQTHVNTRVAGTNG 195
++L R D+K N+L++++ K+ADFG+AR + + V T
Sbjct: 114 AYCHRQKVLHR----DLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TLW 165
Query: 196 YMAPEYVMHG--HLSVKADVFSFGVVILELISGQ 227
Y P+ ++ G S + D++ G + E+ +G+
Sbjct: 166 YRPPD-ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 8e-18
Identities = 50/223 (22%), Positives = 84/223 (37%), Gaps = 45/223 (20%)
Query: 42 FEALVSATKNFHPSNKLGEGGFGPVFKGKL-DDGREIAVKKLSHSSNQGKKEFENEAKLL 100
E F G+G FG V GK G +A+KK+ +E + + L
Sbjct: 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDL 73
Query: 101 ARVQHRNVVNLLGYCAHGAEK-------LLIYEYVINESLDKVLFSLIKDIQIL------ 147
A + H N+V L Y E+ ++ EYV ++L + + +
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIK 132
Query: 148 ------FRKKKT-----------DIKASNILLD-DKWIPKIADFGMARLFPEDQTHVN-- 187
R DIK N+L++ K+ DFG A+ + +V
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 188 -TRVAGTNGYMAPEYVMHG--HLSVKADVFSFGVVILELISGQ 227
+R Y APE ++ G H + D++S G + E++ G+
Sbjct: 193 CSRY-----YRAPE-LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 1e-17
Identities = 54/225 (24%), Positives = 93/225 (41%), Gaps = 62/225 (27%)
Query: 46 VSATKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN--------E 96
+S++ F KLG G + V+KG G +A+K++ K + E E
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV-------KLDSEEGTPSTAIRE 53
Query: 97 AKLLARVQHRNVVNLLGYCAHGAEKL-LIYEYVINESLDKVLFSLIKDIQILFRKK---- 151
L+ ++H N+V L H KL L++E+ +D L + + +
Sbjct: 54 ISLMKELKHENIVRLYDVI-HTENKLTLVFEF-----MDNDLKKYMDSRTVGNTPRGLEL 107
Query: 152 ---KT--------------------DIKASNILLDDKWIPKIADFGMARLF--PEDQ-TH 185
K D+K N+L++ + K+ DFG+AR F P + +
Sbjct: 108 NLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS 167
Query: 186 -VNTRVAGTNGYMAPEYVMHG--HLSVKADVFSFGVVILELISGQ 227
V T Y AP+ V+ G S D++S G ++ E+I+G+
Sbjct: 168 EVVTL-----WYRAPD-VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 42/222 (18%), Positives = 81/222 (36%), Gaps = 63/222 (28%)
Query: 57 KLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEF-----------------ENEAKL 99
L +G F + + D + A+KK S + K++F +NE ++
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 100 LARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT------ 153
+ +++ + G + E +IYEY+ N+S+ + +L +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSI----LKFDEYFFVLDKNYTCFIPIQV 152
Query: 154 ------------------------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189
D+K SNIL+D K++DFG + + +
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--G- 209
Query: 190 VAGTNGYMAPEYVM-----HGHLSVKADVFSFGVVILELISG 226
GT +M PE+ +G K D++S G+ + +
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMFYN 248
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 50/221 (22%), Positives = 88/221 (39%), Gaps = 60/221 (27%)
Query: 51 NFHPSNKLGEGGFGPVFKGK--LDDGREIAVKKLSHSSNQGKKEFENEA----------- 97
+ ++GEG +G VFK + + GR +A+K++ + + E
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-------RVQTGEEGMPLSTIREVAV 64
Query: 98 -KLLARVQHRNVVNLL----GYCAHGAEKL-LIYEYV------INESLDKVLFS--LIKD 143
+ L +H NVV L KL L++E+V + + + IKD
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 124
Query: 144 I--------------QILFRKKKTDIKASNILLDDKWIPKIADFGMARLF--PEDQTH-V 186
+ +++ R D+K NIL+ K+ADFG+AR++ T V
Sbjct: 125 MMFQLLRGLDFLHSHRVVHR----DLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 180
Query: 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQ 227
T Y APE ++ + D++S G + E+ +
Sbjct: 181 VTL-----WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 66/226 (29%)
Query: 51 NFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEA-----------K 98
+ K+G+G FG VFK + G+++A+KK+ ENE K
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV---------LMENEKEGFPITALREIK 68
Query: 99 LLARVQHRNVVNLLGYCAHGAEKL--------LIYEYV-------INESLDKVLFSLIKD 143
+L ++H NVVNL+ C A L++++ ++ L K S IK
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 128
Query: 144 I--------------QILFRKKKTDIKASNILLDDKWIPKIADFGMARLF-------PED 182
+ +IL R D+KA+N+L+ + K+ADFG+AR F P
Sbjct: 129 VMQMLLNGLYYIHRNKILHR----DMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 183 QTHVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQ 227
T+ RV T Y PE ++ D++ G ++ E+ +
Sbjct: 185 YTN---RVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 58/260 (22%), Positives = 107/260 (41%), Gaps = 43/260 (16%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLG 113
LG+G FG V+ + + +A+K L S + + E ++ + ++H N++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 114 YCAHGAEKL-LIYEYVINESLDKVL-----FS----------LIKDIQILFRKKKT--DI 155
Y H +++ L+ E+ L K L F L + +K DI
Sbjct: 82 YF-HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDI 140
Query: 156 KASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFS 215
K N+L+ K KIADFG + P + T + GT Y+ PE + K D++
Sbjct: 141 KPENLLMGYKGELKIADFGWSVHAPSLRRR--T-MCGTLDYLPPEMIEGKTHDEKVDLWC 197
Query: 216 FGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCI 275
GV+ E + G D+ + + +++ ++++ P + S D I+
Sbjct: 198 AGVLCYEFLVG------MPPFDSPSHT----ETHRRIVNVDLKFPPFLSDGSKDLIS--- 244
Query: 276 QIGLLCTQGDPQLRPTMRRV 295
LL + P R ++ V
Sbjct: 245 --KLL--RYHPPQRLPLKGV 260
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 39/208 (18%)
Query: 49 TKNFHPSNKLGEGGFGPVFKG-KLDDGREIAVKKLSHS--SNQGKKEFENEAKLLARVQH 105
+ N+ +LG+G F V + G E A K ++ S + ++ E EA++ ++QH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 106 RNVVNLLGYCAHGAEKLLIYEYV--------INESLDKVLFS------LIKDI------- 144
N+V L + L+++ V I + +S I+ I
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYC 144
Query: 145 ---QILFRKKKTDIKASNILLDDKWIP---KIADFGMARLFPEDQTHVNTRVAGTNGYMA 198
I+ R ++K N+LL K K+ADFG+A + + AGT GY++
Sbjct: 145 HSNGIVHR----NLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLS 198
Query: 199 PEYVMHGHLSVKADVFSFGVVILELISG 226
PE + S D+++ GV++ L+ G
Sbjct: 199 PEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 8e-17
Identities = 47/204 (23%), Positives = 79/204 (38%), Gaps = 34/204 (16%)
Query: 49 TKNFHPSNKLGEGGFGPVFKG-KLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRN 107
T + +G G + + E AVK + S +E LL QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77
Query: 108 VVNLLGYCAHGAEKLLIYEYVIN-ESLDKVL----FS------LIKDI----------QI 146
++ L G ++ E + E LDK+L FS ++ I +
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 147 LFRKKKTDIKASNILL----DDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYV 202
+ R D+K SNIL + +I DFG A+ + + T T ++APE +
Sbjct: 138 VHR----DLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEVL 192
Query: 203 MHGHLSVKADVFSFGVVILELISG 226
D++S GV++ +++G
Sbjct: 193 ERQGYDAACDIWSLGVLLYTMLTG 216
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 9e-17
Identities = 50/216 (23%), Positives = 82/216 (37%), Gaps = 44/216 (20%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVK-----KLSHSSNQGKKE----FENEAK 98
+N+ P LG G V + +E AVK S + +E E
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 99 LLARV-QHRNVVNLLGYCAHGAEKLLIYEYVIN-ESLDKVL----FS------LIKDI-- 144
+L +V H N++ L L+++ + E D + S +++ +
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 145 --------QILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGY 196
I+ R D+K NILLDD K+ DFG + + V GT Y
Sbjct: 136 VICALHKLNIVHR----DLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSY 189
Query: 197 MAPE------YVMHGHLSVKADVFSFGVVILELISG 226
+APE H + D++S GV++ L++G
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 24/273 (8%), Positives = 60/273 (21%), Gaps = 66/273 (24%)
Query: 17 LGSSREGDNEEDLEKIAAREQKHFPFEALVS-------ATKNFHPSNKLGEGGFGPVFKG 69
+G RE +E + A +P A + + L G VF
Sbjct: 22 IGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLV 81
Query: 70 K-LDDGREIAVKKLSHSSNQGKKE---FENEAKLLARVQHRNVVNLLGYC---------- 115
+ ++ + A+K + + + E AR+ +
Sbjct: 82 RDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141
Query: 116 -----------AHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT----------- 153
+ + ++ + L L + ++ +
Sbjct: 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTA 201
Query: 154 -----------------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGY 196
N+ + + D + Y
Sbjct: 202 QLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTY 257
Query: 197 MAPEYVMHGHLSV--KADVFSFGVVILELISGQ 227
E++ + + + G+ I +
Sbjct: 258 APREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-16
Identities = 49/196 (25%), Positives = 77/196 (39%), Gaps = 34/196 (17%)
Query: 57 KLGEGGFGPVFKG-KLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQ-HRNVVNLLGY 114
LGEG F K + AVK +S + + E L + H N+V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74
Query: 115 CAHGAEKLLIYEYVIN-ESLDKVL----FS------LIKDI----------QILFRKKKT 153
L+ E + E +++ FS +++ + ++ R
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR---- 130
Query: 154 DIKASNILLDDKW---IPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVK 210
D+K N+L D+ KI DFG ARL P D + T T Y APE +
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNGYDES 189
Query: 211 ADVFSFGVVILELISG 226
D++S GV++ ++SG
Sbjct: 190 CDLWSLGVILYTMLSG 205
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 50/244 (20%), Positives = 94/244 (38%), Gaps = 46/244 (18%)
Query: 25 NEEDLEKIAAREQKHFPFEALVSATKNFHPSN---------KLGEGGFGPVFKGK-LDDG 74
N ++ K F F L ++ +P LG G G V
Sbjct: 101 NNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTC 160
Query: 75 REIAVK-----KLSHSSNQGKKE---FENEAKLLARVQHRNVVNLLGYCAHGAEKL-LIY 125
+++A++ K + S + E E ++L ++ H ++ + + AE ++
Sbjct: 161 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--AEDYYIVL 218
Query: 126 EYV--------------INESLDKVLFS-LIKDIQILFRKKKT--DIKASNILLDDKWIP 168
E + + E+ K+ F ++ +Q L D+K N+LL +
Sbjct: 219 ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 278
Query: 169 ---KIADFGMARLFPEDQTHVNTRVAGTNGYMAPE---YVMHGHLSVKADVFSFGVVILE 222
KI DFG +++ + + + T GT Y+APE V + D +S GV++
Sbjct: 279 CLIKITDFGHSKIL-GETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFI 336
Query: 223 LISG 226
+SG
Sbjct: 337 CLSG 340
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 48/205 (23%), Positives = 88/205 (42%), Gaps = 32/205 (15%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVK--KLSHSSNQGKKEFENEAKLLARVQH 105
T+ + +LG+G F V + + G+E A S + ++ E EA++ ++H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 106 RNVVNLLGYCAHGAEKLLIYEYVIN-ESLDKVL----FS------LIKDI---------- 144
N+V L + LI++ V E + ++ +S I+ I
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 145 QILFRKKKTDIKASNILLDDKWIP---KIADFGMARLFPEDQTHVNTRVAGTNGYMAPEY 201
++ R ++K N+LL K K+ADFG+A +Q GT GY++PE
Sbjct: 130 GVVHR----NLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEV 184
Query: 202 VMHGHLSVKADVFSFGVVILELISG 226
+ D+++ GV++ L+ G
Sbjct: 185 LRKDPYGKPVDLWACGVILYILLVG 209
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 59/218 (27%), Positives = 88/218 (40%), Gaps = 58/218 (26%)
Query: 51 NFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN---------EAKLL 100
+ KLGEG +G V+K +A+K++ + E E E LL
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-------RLEHEEEGVPGTAIREVSLL 87
Query: 101 ARVQHRNVVNLLGYCAHGAEKL-LIYEYV-------------INESLDKV-LFSLIKDIQ 145
+QHRN++ L H +L LI+EY ++ + K L+ LI +
Sbjct: 88 KELQHRNIIELKSVI-HHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 146 ------ILFRKKKTDIKASNILLDDKWIP-----KIADFGMARLF--PEDQ-THVNTRVA 191
L R D+K N+LL KI DFG+AR F P Q TH +
Sbjct: 147 FCHSRRCLHR----DLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII 199
Query: 192 GTNGYMAPEYVMHG--HLSVKADVFSFGVVILELISGQ 227
T Y PE ++ G H S D++S + E++
Sbjct: 200 -TLWYRPPE-ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 4e-16
Identities = 51/200 (25%), Positives = 80/200 (40%), Gaps = 36/200 (18%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVK--KLSHSSNQGKKEFENEAKLLARVQHR-NVVNLL 112
+LG G F V + G+E A K K + E +E +L + V+NL
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 113 GYCAHGAEKLLIYEYVIN-ESLDKVL------FS------LIKDI----------QILFR 149
+ +E +LI EY E L S LIK I I+
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHL 155
Query: 150 KKKTDIKASNILLDDKWIP---KIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGH 206
D+K NILL + KI DFGM+R + + GT Y+APE + +
Sbjct: 156 ----DLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIM-GTPEYLAPEILNYDP 209
Query: 207 LSVKADVFSFGVVILELISG 226
++ D+++ G++ L++
Sbjct: 210 ITTATDMWNIGIIAYMLLTH 229
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-16
Identities = 48/246 (19%), Positives = 95/246 (38%), Gaps = 43/246 (17%)
Query: 18 GSSREGDNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGK-LDDGRE 76
++ E + E + + A + + P + +G G V + G E
Sbjct: 62 NDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHE 121
Query: 77 IAVKKLSHSSNQGKKE--------FENEAKLLARV-QHRNVVNLLGYCAHGAEKLLIYEY 127
AVK + ++ + E E +L +V H +++ L+ + L+++
Sbjct: 122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDL 181
Query: 128 VIN-ESLDKVL----FS------LIKDI----------QILFRKKKTDIKASNILLDDKW 166
+ E D + S +++ + I+ R D+K NILLDD
Sbjct: 182 MRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHR----DLKPENILLDDNM 237
Query: 167 IPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPE------YVMHGHLSVKADVFSFGVVI 220
+++DFG + + + GT GY+APE H + D+++ GV++
Sbjct: 238 QIRLSDFGFSCHLEPGEK-LRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
Query: 221 LELISG 226
L++G
Sbjct: 296 FTLLAG 301
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 9e-16
Identities = 64/268 (23%), Positives = 101/268 (37%), Gaps = 49/268 (18%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVK-----KLSHSSNQGKKEFENEAKLLARVQHRNVVNL 111
LGEG +G V + + AVK KL N + E +LL R++H+NV+ L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEAN-VKKEIQLLRRLRHKNVIQL 71
Query: 112 LGYCAHGAEKLLIY---EYV---INESLDKV------------LFS-LIKDIQILFRKKK 152
+ + EK +Y EY + E LD V F LI ++ L +
Sbjct: 72 VDVL-YNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGI 130
Query: 153 T--DIKASNILLDDKWIPKIADFGMARLF-PEDQTHVNTRVAGTNGYMAPEYVM--HGHL 207
DIK N+LL KI+ G+A P G+ + PE
Sbjct: 131 VHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFS 190
Query: 208 SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267
K D++S GV + + +G + N+ YKL++ P
Sbjct: 191 GFKVDIWSAGVTLYNITTGL------YPFEGDNI----YKLFENIGKGSYAIPGDCGPPL 240
Query: 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRV 295
D + G+L +P R ++R++
Sbjct: 241 SDLLK-----GMLEY--EPAKRFSIRQI 261
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-15
Identities = 49/203 (24%), Positives = 80/203 (39%), Gaps = 44/203 (21%)
Query: 58 LGEGGFGPVFKGKL-DDGREIAVKKLSHSSNQGKKEFE---NEAKLLARVQHRNVVNLLG 113
LGEG F V + RE A+K L + + E +++R+ H V L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 114 YCAHGAEKL-LIYEYVIN-ESLDKVLFSLIKDIQ-------------------------I 146
+ EKL Y N E L I+ I I
Sbjct: 97 FTFQDDEKLYFGLSYAKNGE-----LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 147 LFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR-VAGTNGYMAPEYVMHG 205
+ R D+K NILL++ +I DFG A++ + GT Y++PE ++
Sbjct: 152 IHR----DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LLTE 206
Query: 206 HLSVKA-DVFSFGVVILELISGQ 227
+ K+ D+++ G +I +L++G
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGL 229
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 67/222 (30%)
Query: 57 KLGEGGFGPVFKGKLDD---GREIAVKKLSHSSNQGKKEFEN-------EAKLLARVQHR 106
K+G G +G V+K K D ++ A+K++ E E LL ++H
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQI---------EGTGISMSACREIALLRELKHP 78
Query: 107 NVVNLLG-YCAHGAEKL-LIYEYVINESLDKVLFSLIKDIQILFRKKKT----------- 153
NV++L + +H K+ L+++Y + L+ +IK + KK
Sbjct: 79 NVISLQKVFLSHADRKVWLLFDY-----AEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 154 -------------------DIKASNILL----DDKWIPKIADFGMARLF---PEDQTHVN 187
D+K +NIL+ ++ KIAD G ARLF + ++
Sbjct: 134 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193
Query: 188 TRVAGTNGYMAPEYVMHG--HLSVKADVFSFGVVILELISGQ 227
V T Y APE ++ G H + D+++ G + EL++ +
Sbjct: 194 PVVV-TFWYRAPE-LLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 35/204 (17%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRN 107
+ F ++LG G V++ K + A+K L + + KK E +L R+ H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPN 109
Query: 108 VVNLLGYCAHGAEKLLIYEYVI-NESLDKVL----FS------LIKDI----------QI 146
++ L E L+ E V E D+++ +S +K I I
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169
Query: 147 LFRKKKTDIKASNILL----DDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYV 202
+ R D+K N+L D + KIADFG++++ V GT GY APE +
Sbjct: 170 VHR----DLKPENLLYATPAPDAPL-KIADFGLSKIVEHQVLM--KTVCGTPGYCAPEIL 222
Query: 203 MHGHLSVKADVFSFGVVILELISG 226
+ D++S G++ L+ G
Sbjct: 223 RGCAYGPEVDMWSVGIITYILLCG 246
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 48/207 (23%), Positives = 79/207 (38%), Gaps = 43/207 (20%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQ-HRNVVNLLGYC 115
LGEG V L +E AVK + + E ++L + Q HRNV+ L+ +
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 116 AHGAEKLLIYEYVINESL-----DKVLFS------LIKDI----------QILFRKKKTD 154
L++E + S+ + F+ +++D+ I R D
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR----D 136
Query: 155 IKASNILLDDKWIP---KIADFGMARLFPEDQTHVNTR------VAGTNGYMAPEYVMHG 205
+K NIL + KI DF + + G+ YMAPE V+
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE-VVEA 195
Query: 206 HLSV------KADVFSFGVVILELISG 226
+ D++S GV++ L+SG
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 49/198 (24%), Positives = 80/198 (40%), Gaps = 32/198 (16%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN------EAKLLARVQHR--NV 108
LG GGFG V+ G + D +A+K + E N E LL +V V
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 109 VNLLGYCAHGAEKLLIYEYV---------------INESLDKVLFS-LIKDIQILFRKKK 152
+ LL + +LI E + E L + F +++ ++
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGV 170
Query: 153 T--DIKASNILLD-DKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM-HGHLS 208
DIK NIL+D ++ K+ DFG L + GT Y PE++ H +
Sbjct: 171 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD---FDGTRVYSPPEWIRYHRYHG 227
Query: 209 VKADVFSFGVVILELISG 226
A V+S G+++ +++ G
Sbjct: 228 RSAAVWSLGILLYDMVCG 245
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 33/149 (22%), Positives = 52/149 (34%), Gaps = 29/149 (19%)
Query: 154 DIKASNILLDDKWIPKIADFGMAR-----------LFPEDQTHVNTRVAGTNGYMAPEYV 202
D+K SNI + K+ DFG+ L P +T GT YM+PE +
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248
Query: 203 MHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262
+ S K D+FS G+++ EL+ ++ ++L+ P L
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLYSFSTQM------------ERVRIITDVRNLKF--PLL 294
Query: 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPT 291
+ M P RP
Sbjct: 295 FTQKYPQEHMMVQD----MLSPSPTERPE 319
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 23/130 (17%), Positives = 42/130 (32%), Gaps = 7/130 (5%)
Query: 50 KNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQG-KKEFENEAKLLARVQHRN 107
+F P +G GGFG VF+ K D A+K++ + + +++ E K LA+++H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 108 VVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKTDIKASNILLDDKWI 167
+V + E D+ D + +D
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDE-----STDWPLSSPSPMDAPSVKIRRMDPFST 120
Query: 168 PKIADFGMAR 177
Sbjct: 121 KNTVGQLQPS 130
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 43/203 (21%), Positives = 87/203 (42%), Gaps = 35/203 (17%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQ-HR 106
++ KLG G + VF+ + + ++ VK L KK+ + E K+L ++
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGP 91
Query: 107 NVVNLLGYCAHGAEK--LLIYEYVINESLDKVLFSL-IKDIQ-----------------I 146
N++ L + L++E+V N ++ +L DI+ I
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGI 151
Query: 147 LFRKKKTDIKASNILLD-DKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG 205
+ R D+K N+++D + ++ D+G+A + Q + N RVA + + PE ++
Sbjct: 152 MHR----DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA-SRYFKGPE-LLVD 204
Query: 206 --HLSVKADVFSFGVVILELISG 226
D++S G ++ +I
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFR 227
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 56/250 (22%), Positives = 103/250 (41%), Gaps = 54/250 (21%)
Query: 16 NLGSSREGDNEEDLEKIAAREQKHFPFEALVSATKNFHPSN-----KLGEGGFGPVFKGK 70
N ++++G +E +++ A+ ++ F + + LG G FG V K
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 71 L-DDGREIAVKKLSHSSNQGKKEFE---NEAKLLARVQHRNVVNLLGYCAHGAEKL-LIY 125
+ G A+K L K+ E NE ++L V +V L + L ++
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNSNLYMVM 120
Query: 126 EYVI-NESLDKVLFSLIKDIQ-------------------------ILFRKKKTDIKASN 159
EYV E +FS ++ I +++R D+K N
Sbjct: 121 EYVAGGE-----MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR----DLKPEN 171
Query: 160 ILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMH-GH-LSVKADVFSFG 217
+L+D + ++ DFG A+ + T + GT +APE ++ G+ +V D ++ G
Sbjct: 172 LLIDQQGYIQVTDFGFAK---RVKGRTWT-LCGTPEALAPEIILSKGYNKAV--DWWALG 225
Query: 218 VVILELISGQ 227
V+I E+ +G
Sbjct: 226 VLIYEMAAGY 235
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 47/216 (21%), Positives = 80/216 (37%), Gaps = 42/216 (19%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKE--FEN---------EA 97
+ + G +G V G +G +A+K++ ++ + G+ + E
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 98 KLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQI----------- 146
+LL H N++ L H E + Y++ E + L +I D +I
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 147 --LFRKKKT---------DIKASNILLDDKWIPKIADFGMARLFPEDQT---HVNTRVAG 192
+ D+ NILL D I DF +AR D +V R
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW-- 198
Query: 193 TNGYMAPEYVM-HGHLSVKADVFSFGVVILELISGQ 227
Y APE VM + D++S G V+ E+ + +
Sbjct: 199 ---YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 48/206 (23%)
Query: 58 LGEGGFGPVFKG-KLDDGREIAVKKLSHSSNQGKKEFEN---EAKLLARVQHRNVVNLLG 113
+G+G FG V K D + A+K ++ + E N E +++ ++H +VNL
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81
Query: 114 YCAHGAEKL-LIYEYVIN-ESLDKVLFSLIK-------------------------DIQI 146
Y E + ++ + ++ + L ++ + +I
Sbjct: 82 YSFQDEEDMFMVVDLLLGGD-----LRYHLQQNVHFKEETVKLFICELVMALDYLQNQRI 136
Query: 147 LFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM--- 203
+ R D+K NILLD+ I DF +A + P + T +AGT YMAPE
Sbjct: 137 IHR----DMKPDNILLDEHGHVHITDFNIAAMLPRETQI--TTMAGTKPYMAPEMFSSRK 190
Query: 204 -HGHLSVKADVFSFGVVILELISGQR 228
G+ S D +S GV EL+ G+R
Sbjct: 191 GAGY-SFAVDWWSLGVTAYELLRGRR 215
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 63/263 (23%), Positives = 111/263 (42%), Gaps = 48/263 (18%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVK-----KLSHSSNQGKKEFENEAKLLARVQHRNVVNL 111
+G+G F V + + GRE+A+K +L+ +S ++ E +++ + H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS---LQKLFREVRIMKILNHPNIVKL 79
Query: 112 LGYCAHGAEKLLIYEYV--------------INESLDKVLFS-LIKDIQILFRKKKT--D 154
LI EY + E + F ++ +Q +K+ D
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRD 139
Query: 155 IKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSV--KAD 212
+KA N+LLD KIADFG + F ++ G Y APE + G + D
Sbjct: 140 LKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFC-GAPPYAAPE-LFQGKKYDGPEVD 196
Query: 213 VFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIA 272
V+S GV++ L+SG L D QNL +L ++ + P ++D + +
Sbjct: 197 VWSLGVILYTLVSGS------LPFDGQNL----KELRERVLRGKYRIPFYMSTDCENLLK 246
Query: 273 MCIQIGLLCTQGDPQLRPTMRRV 295
+ + +P R T+ ++
Sbjct: 247 RFLVL-------NPIKRGTLEQI 262
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 6e-15
Identities = 51/200 (25%), Positives = 85/200 (42%), Gaps = 34/200 (17%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN------EAKLLARV----QHR 106
LG+GGFG VF G L D ++A+K + + G + E LL +V H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 107 NVVNLLGYCAHGAEKLLIYEYVIN---------------ESLDKVLFS-LIKDIQILFRK 150
V+ LL + +L+ E + E + F ++ IQ +
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR 158
Query: 151 KKT--DIKASNILLD-DKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM-HGH 206
DIK NIL+D + K+ DFG L ++ GT Y PE++ H +
Sbjct: 159 GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD---FDGTRVYSPPEWISRHQY 215
Query: 207 LSVKADVFSFGVVILELISG 226
++ A V+S G+++ +++ G
Sbjct: 216 HALPATVWSLGILLYDMVCG 235
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 19/229 (8%), Positives = 52/229 (22%), Gaps = 59/229 (25%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVKKLSHS---SNQGKKEFENEAKLLAR----------- 102
LG+ + + G V + + K+ + E L
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 103 -----------VQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKK 151
V+ ++ + ++ + + + L + + +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 152 KT----------------------------DIKASNILLDDKWIPKIADFGMARLFPEDQ 183
K+ ++ +I+LD + + F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASA 265
Query: 184 THVNTRVAGTNGYMAPEYV-----MHGHLSVKADVFSFGVVILELISGQ 227
R A + ++ D ++ G+ I +
Sbjct: 266 VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 19/234 (8%), Positives = 55/234 (23%), Gaps = 70/234 (29%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN------EAKLLARVQH----- 105
LG+ + + G V + + +LL +++
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 106 --------------RNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKK 151
++ + ++ + + + L + + +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 152 KT----------------------------DIKASNILLDDKWIPKIADFGMARLFPEDQ 183
K+ ++ +I+LD + + F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARV 260
Query: 184 THVNTRVAGTNGYMAPEYVMH-----------GHLSVKADVFSFGVVILELISG 226
+ + G+ PE ++ D ++ G+VI +
Sbjct: 261 V-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 55/246 (22%), Positives = 91/246 (36%), Gaps = 79/246 (32%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN-EAKLLARVQHR 106
+K + LG G FG V + ++ G+ A+KK+ ++N E ++ + H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHV 60
Query: 107 NVVNLLGYCAHGAEKL--------------------------------------LIYEYV 128
N++ L+ Y ++ +I EYV
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 129 INESLDKVLFSLIKDIQIL------------FRKKKT---------DIKASNILLD-DKW 166
++L KVL S I+ + + FR DIK N+L++
Sbjct: 121 -PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 167 IPKIADFGMARLFPEDQTHVN---TRVAGTNGYMAPEYVMHG--HLSVKADVFSFGVVIL 221
K+ DFG A+ + V +R Y APE +M G + D++S G V
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPE-LMLGATEYTPSIDLWSIGCVFG 233
Query: 222 ELISGQ 227
ELI G+
Sbjct: 234 ELILGK 239
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 47/216 (21%), Positives = 83/216 (38%), Gaps = 47/216 (21%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVK-----KLSHSSNQGKKE---FENEAKL 99
+ S LG G G V +++A+K K + S + E E ++
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 100 LARVQHRNVVNLLGYCAHGAEKL-LIYEYVIN-ESLDKVL----FS------LIKDI--- 144
L ++ H ++ + + AE ++ E + E DKV+ +
Sbjct: 69 LKKLNHPCIIKIKNF--FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 126
Query: 145 -------QILFRKKKTDIKASNILLDDKWIP---KIADFGMARLFPEDQTHVNTRVAGTN 194
I+ R D+K N+LL + KI DFG +++ E + + GT
Sbjct: 127 VQYLHENGIIHR----DLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTP 180
Query: 195 GYMAPEYVMHGHL----SVKADVFSFGVVILELISG 226
Y+APE V+ + D +S GV++ +SG
Sbjct: 181 TYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 50/212 (23%), Positives = 89/212 (41%), Gaps = 46/212 (21%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN---------EAK 98
K + +G G +G V G ++A+KKLS + F++ E
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELL 75
Query: 99 LLARVQHRNVVNLLG-YCAHGAEKLLIYEYVINESLDKVLFSLIKDI-----------QI 146
LL +QH NV+ LL + + + Y++ + L ++ Q+
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQM 135
Query: 147 LFRKKKT---------DIKASNILLDDKWIPKIADFGMARLFPEDQTH-VNTRVAGTNGY 196
L + K D+K N+ +++ KI DFG+AR + T V TR Y
Sbjct: 136 L-KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----Y 189
Query: 197 MAPEYVM-HGHLSVKADVFSFGVVILELISGQ 227
APE ++ H + D++S G ++ E+++G+
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 52/244 (21%), Positives = 83/244 (34%), Gaps = 63/244 (25%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVKKLS----------------HSSNQGKKEFENEAKLL 100
+G+G +G V +D A+K LS + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 101 ARVQ----------HRNVVNLLGYCA-HGAEKLLIY---EYVIN-ESLDKV--------- 136
+V H NVV L + +Y E V ++
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ 138
Query: 137 ---LFS-LIKDIQILFRKKKT--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV 190
F LIK I+ L +K DIK SN+L+ + KIADFG++ F ++
Sbjct: 139 ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN-T 197
Query: 191 AGTNGYMAPEYVMHGHLSV---KADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYK 247
GT +MAPE + DV++ GV + + GQ + ++
Sbjct: 198 VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ------CPFMDERIMC---- 247
Query: 248 LYKK 251
L+ K
Sbjct: 248 LHSK 251
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 45/202 (22%), Positives = 77/202 (38%), Gaps = 44/202 (21%)
Query: 57 KLGEGGFGPVFKG-KLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQ-HRNVVNLLGY 114
LG G G V + G++ A+K L + E + ++V +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCILDV 90
Query: 115 C---AHGAEKL-LIYEYVIN-ESLDKVL------FS------LIKDI----------QIL 147
HG L +I E + E ++ F+ +++DI I
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIA 150
Query: 148 FRKKKTDIKASNILLDDK---WIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMH 204
R D+K N+L K + K+ DFG A+ ++ + T T Y+APE +
Sbjct: 151 HR----DVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYYVAPEVLGP 203
Query: 205 GHLSVKADVFSFGVVILELISG 226
D++S GV++ L+ G
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCG 225
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 67/262 (25%), Positives = 108/262 (41%), Gaps = 46/262 (17%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVK-----KLSHSSNQGKKEFENEAKLLARVQHRNVVNL 111
LGEG FG V +++A+K L S + E E L ++H +++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR--VEREISYLKLLRHPHIIKL 74
Query: 112 LGYCAHGAEKLLIYEYVINESLDKV-------------LFS-LIKDIQILFRKKKT--DI 155
+ +++ EY E D + F +I I+ R K D+
Sbjct: 75 YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDL 134
Query: 156 KASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHL--SVKADV 213
K N+LLDD KIADFG++ + + + T G+ Y APE V++G L + DV
Sbjct: 135 KPENLLLDDNLNVKIADFGLSNIMTDGN-FLKT-SCGSPNYAAPE-VINGKLYAGPEVDV 191
Query: 214 FSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAM 273
+S G+V+ ++ G L D + + L+KK S V P + + I
Sbjct: 192 WSCGIVLYVMLVG------RLPFDDEFIP----NLFKKVNSCVYVMPDFLSPGAQSLIRR 241
Query: 274 CIQIGLLCTQGDPQLRPTMRRV 295
I DP R T++ +
Sbjct: 242 MIVA-------DPMQRITIQEI 256
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 6e-14
Identities = 46/201 (22%), Positives = 82/201 (40%), Gaps = 38/201 (18%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVK--------KLSHSSNQGKKEFENEAKLLARVQHRNV 108
LG G FG V+ + +E+ VK + + + E +L+RV+H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 109 VNLLG-------------YCAHGAEKLLIYEYVI-----NESLDKVLFS-LIKDIQILFR 149
+ +L G + ++ ++ +E L +F L+ + L
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLD---LFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL 148
Query: 150 KKKT--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHL 207
K DIK NI++ + + K+ DFG A + T GT Y APE V+ G+
Sbjct: 149 KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYT-FCGTIEYCAPE-VLMGNP 205
Query: 208 --SVKADVFSFGVVILELISG 226
+ +++S GV + L+
Sbjct: 206 YRGPELEMWSLGVTLYTLVFE 226
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 7e-14
Identities = 51/212 (24%), Positives = 84/212 (39%), Gaps = 45/212 (21%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN---------EAK 98
K + +G G G V R +A+KKLS + F+N E
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113
Query: 99 LLARVQHRNVVNLLG-YCAHGAEKLLIYEYVINESLDKVLFSLIKD-----------IQI 146
L+ V H+N+++LL + + Y++ E +D L +I+ Q+
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 173
Query: 147 LFRKKKT--------DIKASNILLDDKWIPKIADFGMARLFPEDQT---HVNTRVAGTNG 195
L K D+K SNI++ KI DFG+AR +V TR
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----- 228
Query: 196 YMAPEYVMHGHLSVKADVFSFGVVILELISGQ 227
Y APE ++ D++S G ++ E++ +
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 1e-13
Identities = 60/262 (22%), Positives = 107/262 (40%), Gaps = 45/262 (17%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVK-----KLSHSSNQGKKEFENEAKLLARVQHRNVVNL 111
LG G FG V G+ G ++AVK K+ GK + E + L +H +++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGK--IKREIQNLKLFRHPHIIKL 76
Query: 112 LGYCAHGAEKLLIYEYV--------------INESLDKVLFS-LIKDIQILFRKKKT--D 154
+ + ++ EYV + E + LF ++ + R D
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRD 136
Query: 155 IKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM-HGHLSVKADV 213
+K N+LLD KIADFG++ + + + + T G+ Y APE + + + D+
Sbjct: 137 LKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRT-SCGSPNYAAPEVISGRLYAGPEVDI 194
Query: 214 FSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAM 273
+S GV++ L+ G L D +++ L+KK + P +
Sbjct: 195 WSCGVILYALLCGT------LPFDDEHVP----TLFKKIRGGVFYIPEYLNRSVATLLMH 244
Query: 274 CIQIGLLCTQGDPQLRPTMRRV 295
+Q+ DP R T++ +
Sbjct: 245 MLQV-------DPLKRATIKDI 259
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 53/257 (20%), Positives = 98/257 (38%), Gaps = 46/257 (17%)
Query: 8 FDGLLKHFNLGSSREGDNEEDLEKIAAREQKHFPFEALVSATK----NFHPSNKLGEGGF 63
D L+ ++ ++ E+++ + + PF + V + +F +G G F
Sbjct: 31 LDILICLYDECNNSPLRREKNILEYLEWAK---PFTSKVKQMRLHREDFEILKVIGRGAF 87
Query: 64 GPVFKGKLDDGREI-AVKKLSHSSNQGKKE---FENEAKLLARVQHRNVVNLLGYCAHGA 119
G V KL + ++ A+K L+ + E F E +L + + L Y
Sbjct: 88 GEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDD 146
Query: 120 EKL-LIYEYVIN-ESLDKVLFSLIKDIQILFRKKKT----------------------DI 155
L L+ +Y + + L +L+ + ++ DI
Sbjct: 147 NNLYLVMDYYVGGD-----LLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDI 201
Query: 156 KASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVK----- 210
K NIL+D ++ADFG ED T ++ GT Y++PE +
Sbjct: 202 KPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPE 261
Query: 211 ADVFSFGVVILELISGQ 227
D +S GV + E++ G+
Sbjct: 262 CDWWSLGVCMYEMLYGE 278
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 52/210 (24%), Positives = 84/210 (40%), Gaps = 41/210 (19%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN---------EAK 98
K + +G G G V R +A+KKLS + F+N E
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76
Query: 99 LLARVQHRNVVNLLG-YCAHGAEKLLIYEYVINESLDKVLFSLIKD-----------IQI 146
L+ V H+N++ LL + + + Y++ E +D L +I+ Q+
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 136
Query: 147 LFRKKKT---------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYM 197
L K D+K SNI++ KI DFG+AR + + T T Y
Sbjct: 137 L-CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 193
Query: 198 APEYVMHGHLSVKADVFSFGVVILELISGQ 227
APE ++ D++S G ++ E+I G
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 4e-13
Identities = 52/194 (26%), Positives = 82/194 (42%), Gaps = 29/194 (14%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVK-----KLSHSSNQGKKEFENEAKLLARVQHRNVVNL 111
LGEG +G V +AVK + KKE + H NVV
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI----NKMLNHENVVKF 70
Query: 112 LGYCAHGAEKLLIYEYV--------------INESLDKVLFS-LIKDIQILFRKKKT--D 154
G+ G + L EY + E + F L+ + L T D
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 155 IKASNILLDDKWIPKIADFGMARLF-PEDQTHVNTRVAGTNGYMAPEYVMH-GHLSVKAD 212
IK N+LLD++ KI+DFG+A +F ++ + ++ GT Y+APE + + D
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 213 VFSFGVVILELISG 226
V+S G+V+ +++G
Sbjct: 191 VWSCGIVLTAMLAG 204
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 7e-13
Identities = 45/203 (22%), Positives = 76/203 (37%), Gaps = 45/203 (22%)
Query: 57 KLGEGGFGPVFKG-KLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQ-HRNVVNLLGY 114
LG G G V + + A+K L + E +L R ++V ++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV 123
Query: 115 C--AHGAEK--LLIYEYV--------INESLDKVLFS------LIKDI----------QI 146
+ K L++ E + I + D+ F+ ++K I I
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHSINI 182
Query: 147 LFRKKKTDIKASNILLDDK---WIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM 203
R D+K N+L K I K+ DFG A+ + + T T Y+APE +
Sbjct: 183 AHR----DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYYVAPEVLG 236
Query: 204 HGHLSVKADVFSFGVVILELISG 226
D++S GV++ L+ G
Sbjct: 237 PEKYDKSCDMWSLGVIMYILLCG 259
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 8e-13
Identities = 64/263 (24%), Positives = 108/263 (41%), Gaps = 47/263 (17%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVK-----KLSHSSNQGKKEFENEAKLLARVQHRNVVNL 111
LG G FG V GK G ++AVK K+ GK E + L +H +++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK--IRREIQNLKLFRHPHIIKL 81
Query: 112 LGYCAHGAEKLLIYEYV--------------INESLDKVLFS-LIKDIQILFRKKKT--D 154
+ ++ ++ EYV ++E + LF ++ + R D
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRD 141
Query: 155 IKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHL--SVKAD 212
+K N+LLD KIADFG++ + + + + T G+ Y APE V+ G L + D
Sbjct: 142 LKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSC-GSPNYAAPE-VISGRLYAGPEVD 198
Query: 213 VFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIA 272
++S GV++ L+ G L D ++ L+KK P +
Sbjct: 199 IWSSGVILYALLCG------TLPFDDDHVP----TLFKKICDGIFYTPQYLNPSVISLLK 248
Query: 273 MCIQIGLLCTQGDPQLRPTMRRV 295
+Q+ DP R T++ +
Sbjct: 249 HMLQV-------DPMKRATIKDI 264
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 48/213 (22%), Positives = 87/213 (40%), Gaps = 47/213 (22%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN---------EAK 98
+ +G G +G V G ++A+KKL + F++ E +
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELR 76
Query: 99 LLARVQHRNVVNLLG-YCAHGAEKLLIYEYVINESLDKVLFSLIKD------------IQ 145
LL ++H NV+ LL + Y++ + L L+K Q
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 136
Query: 146 ILFRKKKT---------DIKASNILLDDKWIPKIADFGMARLFPEDQT-HVNTRVAGTNG 195
+L + + D+K N+ +++ KI DFG+AR + T +V TR
Sbjct: 137 ML-KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----- 190
Query: 196 YMAPEYVM-HGHLSVKADVFSFGVVILELISGQ 227
Y APE ++ + D++S G ++ E+I+G+
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 35/292 (11%), Positives = 80/292 (27%), Gaps = 69/292 (23%)
Query: 57 KLGEGGFGPVFKGKLDD--GREIAVKKLSHSSN---QGKKEFENEAKLLARVQHRNVVNL 111
G ++ D R++A+ + +E + L+R+ V +
Sbjct: 38 FHGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 112 LGYCAHGAEKLLIYEYVINESLDKVL---------FSLIKDI----------QILFRKKK 152
L A L++ E++ SL +V ++ + +
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALS--- 153
Query: 153 TDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKAD 212
S + + +A M + + D
Sbjct: 154 -IDHPSRVRVSIDGDVVLAYP---------------------ATMPDA-------NPQDD 184
Query: 213 VFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIA 272
+ G + L+ + ++ L A +D + + ++P+ D QI+
Sbjct: 185 IRGIGASLYALLVNRW--PLPEA-GVRSGLAPAE----RDTAGQPIEPADIDRDIPFQIS 237
Query: 273 MCIQIGLLCTQGDPQLRP--TMRRVVVMLSKKPGPGNLEEPTRPGVPGSRYR 322
QGD +R T+ ++ + + P + R
Sbjct: 238 AVA---ARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPIDEAPVSAAPR 286
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 44/227 (19%), Positives = 88/227 (38%), Gaps = 62/227 (27%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN---------EAK 98
+ LG GG G VF D + +A+KK+ + E K
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 99 LLARVQHRNVVNLL-------GYCAHGAEKLLIYE--YVINESLDKVLFSLIK-----DI 144
++ R+ H N+V + L Y++ E ++ L ++++ +
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120
Query: 145 QI------LFRKKKT---------DIKASNILLDDKWIP-KIADFGMARLFPEDQTH--- 185
L R K D+K +N+ ++ + + KI DFG+AR+ +H
Sbjct: 121 HARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 186 ----VNTRVAGTNGYMAPEYVMHGHLSVKA-DVFSFGVVILELISGQ 227
+ T+ Y +P ++ + KA D+++ G + E+++G+
Sbjct: 181 LSEGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 52/195 (26%), Positives = 83/195 (42%), Gaps = 31/195 (15%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVK-----KLSHSSNQGKKEFENEAKLLARVQHRNVVNL 111
LGEG +G V +AVK + KKE + H NVV
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI----NKMLNHENVVKF 70
Query: 112 LGYCAHGAEKLLIYEYV--------------INESLDKVLFS-LIKDIQILFRKKKT--D 154
G+ G + L EY + E + F L+ + L T D
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 155 IKASNILLDDKWIPKIADFGMARLF-PEDQTHVNTRVAGTNGYMAPEYVMHGHL--SVKA 211
IK N+LLD++ KI+DFG+A +F ++ + ++ GT Y+APE ++ +
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-LLKRREFHAEPV 189
Query: 212 DVFSFGVVILELISG 226
DV+S G+V+ +++G
Sbjct: 190 DVWSCGIVLTAMLAG 204
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 4e-12
Identities = 28/77 (36%), Positives = 45/77 (58%), Gaps = 9/77 (11%)
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG-----YMAPEYVMHGHLS 208
D+ A NILL +K + KI DFG+AR +D + V + +MAPE + +
Sbjct: 218 DLAARNILLSEKNVVKICDFGLARDIYKDPDY----VRKGDARLPLKWMAPETIFDRVYT 273
Query: 209 VKADVFSFGVVILELIS 225
+++DV+SFGV++ E+ S
Sbjct: 274 IQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 28/91 (30%), Positives = 41/91 (45%), Gaps = 9/91 (9%)
Query: 56 NKLGEGGFGPVFKGKL------DDGREIAVKKL-SHSSNQGKKEFENEAKLLARV-QHRN 107
LG G FG V + R +AVK L +++ + +E K+L + H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 108 VVNLLGYC-AHGAEKLLIYEYVINESLDKVL 137
VVNLLG C G ++I E+ +L L
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 53/219 (24%), Positives = 94/219 (42%), Gaps = 55/219 (25%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN---------EAK 98
+ + +GEG +G V + +A+KK+S FE+ E K
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS--------PFEHQTYCQRTLREIK 77
Query: 99 LLARVQHRNVVNLLGYCAHGAEKLLIYE--YVINESLDKVLFSLIK-----DIQI----- 146
+L R +H N++ + A + + Y++ + ++ L+ L+K + I
Sbjct: 78 ILLRFRHENIIGIND--IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 135
Query: 147 -LFRKKKT---------DIKASNILLDDKWIPKIADFGMARLFPEDQTH-------VNTR 189
+ R K D+K SN+LL+ KI DFG+AR+ D H V TR
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 190 VAGTNGYMAPEYVMHGHLSVKA-DVFSFGVVILELISGQ 227
Y APE +++ K+ D++S G ++ E++S +
Sbjct: 196 -----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 45/212 (21%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN---------EAK 98
+ + + +G G +G V G +AVKKLS + F++ E +
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELR 80
Query: 99 LLARVQHRNVVNLLG-YCAHGAEKLLIYEYVINESLDKVLFSLIK-----DIQI------ 146
LL ++H NV+ LL + + + Y++ + L +++K D +
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 147 LFRKKKT---------DIKASNILLDDKWIPKIADFGMARLFPEDQT-HVNTRVAGTNGY 196
+ R K D+K SN+ +++ KI DFG+AR ++ T +V TR Y
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----Y 195
Query: 197 MAPEYVM-HGHLSVKADVFSFGVVILELISGQ 227
APE ++ H + D++S G ++ EL++G+
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 9e-12
Identities = 54/237 (22%), Positives = 89/237 (37%), Gaps = 40/237 (16%)
Query: 18 GSSREGDNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREI 77
GS + E++E A+ + F LG+G FG V K
Sbjct: 123 GSPSDNSGAEEMEVSLAKPKHRVTMN-------EFEYLKLLGKGTFGKVILVKEKATGRY 175
Query: 78 -AVKKLSHSSNQGKKEFEN---EAKLLARVQHRNVVNLLGYCAHGAEKL-LIYEYV---- 128
A+K L K E + E ++L +H + L Y ++L + EY
Sbjct: 176 YAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGE 234
Query: 129 ----------INESLDKV--------LFSLIKDIQILFRKKKTDIKASNILLDDKWIPKI 170
+E + L L + +++R D+K N++LD KI
Sbjct: 235 LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR----DLKLENLMLDKDGHIKI 290
Query: 171 ADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQ 227
DFG+ + +D + T GT Y+APE + D + GVV+ E++ G+
Sbjct: 291 TDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 45/206 (21%), Positives = 72/206 (34%), Gaps = 43/206 (20%)
Query: 58 LGEGGFGPVFKGKLDDGREI-AVKKLSHSSNQGKKE---FENEAKLLARVQHRNVVNLLG 113
+G G F V K+ ++ A+K ++ + E F E +L R + L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127
Query: 114 YCAHGAEKL-LIYEYVIN-ESLDKVLFSLIKDIQILFRKKKT------------------ 153
+ L L+ EY + + L +L+ +
Sbjct: 128 FAFQDENYLYLVMEYYVGGD-----LLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182
Query: 154 ----DIKASNILLDDKWIPKIADFGMA-RLFPEDQTHVNTRVAGTNGYMAPE-------Y 201
DIK NILLD ++ADFG +L + V GT Y++PE
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGG 241
Query: 202 VMHGHLSVKADVFSFGVVILELISGQ 227
G + D ++ GV E+ GQ
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 1e-11
Identities = 55/204 (26%), Positives = 86/204 (42%), Gaps = 51/204 (25%)
Query: 58 LGEGGFGPVFKGKLDDGREI-AVKKLSHSSNQGKKEFE---NEAKLLARVQHRNVVNLLG 113
LG G FG V + A+K L K+ E +E +L+ V H ++ +
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW- 72
Query: 114 YCAHGAEKL-LIYEYVI-NESLDKVLFSLIKDIQ-------------------------I 146
A+++ +I +Y+ E LFSL++ Q I
Sbjct: 73 GTFQDAQQIFMIMDYIEGGE-----LFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 127
Query: 147 LFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM--- 203
++R D+K NILLD KI DFG A+ T + GT Y+APE V
Sbjct: 128 IYR----DLKPENILLDKNGHIKITDFGFAK---YVPDVTYT-LCGTPDYIAPEVVSTKP 179
Query: 204 HGHLSVKADVFSFGVVILELISGQ 227
+ S+ D +SFG++I E+++G
Sbjct: 180 YNK-SI--DWWSFGILIYEMLAGY 200
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 50/198 (25%), Positives = 76/198 (38%), Gaps = 40/198 (20%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN---EAKLLARVQHRNVVNL-- 111
+G G FG + +AVK + +G EN E ++H N+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI----ERGAAIDENVQREIINHRSLRHPNIVRFKE 83
Query: 112 -----------LGYCAHGAEKLLIYEYVIN-----ESLDKVLFS-LIKDIQILFRKKKT- 153
+ Y + G E +YE + N E + F L+ + +
Sbjct: 84 VILTPTHLAIIMEYASGG-E---LYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139
Query: 154 -DIKASNILLDDKWIP--KIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHL--S 208
D+K N LLD P KI DFG ++ + V GT Y+APE V+
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV-GTPAYIAPE-VLLRQEYDG 196
Query: 209 VKADVFSFGVVILELISG 226
ADV+S GV + ++ G
Sbjct: 197 KIADVWSCGVTLYVMLVG 214
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 51/200 (25%), Positives = 82/200 (41%), Gaps = 36/200 (18%)
Query: 58 LGEGGFGPVFKGKLDDGREI-AVKKLSHSSNQGKKE---FENEAKLLARVQHRNVVNLLG 113
+G G FG V + R++ A+K LS + + F E ++A VV L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 135
Query: 114 YCAHGAEKL-LIYEYV-------------INESLDK------VL-FSLIKDIQILFRKKK 152
Y L ++ EY+ + E + VL I + + R
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHR--- 192
Query: 153 TDIKASNILLDDKWIPKIADFGMA-RLFPEDQTHVNTRVAGTNGYMAPEYVM----HGHL 207
D+K N+LLD K+ADFG ++ E +T V GT Y++PE + G+
Sbjct: 193 -DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYY 250
Query: 208 SVKADVFSFGVVILELISGQ 227
+ D +S GV + E++ G
Sbjct: 251 GRECDWWSVGVFLYEMLVGD 270
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 3e-11
Identities = 53/223 (23%), Positives = 84/223 (37%), Gaps = 56/223 (25%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN---------EAK 98
+ +F + LGEG +G V G +A+KK+ F+ E K
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE--------PFDKPLFALRTLREIK 61
Query: 99 LLARVQHRNVVNLLGYCAHGAEKLLIYE--YVINESLDKVLFSLIK-----DI------- 144
+L +H N++ + + + Y+I E + L +I D
Sbjct: 62 ILKHFKHENIITIFN--IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY 119
Query: 145 QILFRKKKT---------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG 195
Q L R K D+K SN+L++ K+ DFG+AR+ E + +G
Sbjct: 120 QTL-RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 196 ---------YMAPEYVM--HGHLSVKADVFSFGVVILELISGQ 227
Y APE VM S DV+S G ++ EL +
Sbjct: 179 MVEFVATRWYRAPE-VMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 49/261 (18%), Positives = 92/261 (35%), Gaps = 64/261 (24%)
Query: 26 EEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSH 84
+ RE +F V N+ + +G G +G V+ + + +A+KK++
Sbjct: 2 HHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN- 60
Query: 85 SSNQGKKEFEN---------EAKLLARVQHRNVVNLLGYCAHGAEKLLIYE--YVINESL 133
+ FE+ E +L R++ ++ L + LL ++ Y++ E
Sbjct: 61 ------RMFEDLIDCKRILREITILNRLKSDYIIRLYD--LIIPDDLLKFDELYIVLEIA 112
Query: 134 DKVLFSLIKDIQIL------------FRKKKT---------DIKASNILLDDKWIPKIAD 172
D L L K L + D+K +N LL+ K+ D
Sbjct: 113 DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCD 172
Query: 173 FGMARLFPEDQTHVNTRVAGTNG---------------------YMAPEYVMHGHLSVKA 211
FG+AR ++ N Y APE ++ K+
Sbjct: 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKS 232
Query: 212 -DVFSFGVVILELISGQRNSS 231
D++S G + EL++ ++
Sbjct: 233 IDIWSTGCIFAELLNMLQSHI 253
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 9e-11
Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 36/199 (18%)
Query: 58 LGEGGFGPVF----KGKLDDGREIAVKKLSHSSNQGKKEFE--NEAKLLARVQHRNVVNL 111
LG+G FG VF D + A+K L ++ + + E +L V H +V L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 112 LGYCAHGAEKL-LIYEYVINESL-----DKVLFS----------LIKDIQ------ILFR 149
Y KL LI +++ L +V+F+ L + I++R
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYR 150
Query: 150 KKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM-HGHLS 208
D+K NILLD++ K+ DFG+++ + + + GT YMAPE V GH +
Sbjct: 151 ----DLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVNRRGH-T 204
Query: 209 VKADVFSFGVVILELISGQ 227
AD +SFGV++ E+++G
Sbjct: 205 QSADWWSFGVLMFEMLTGT 223
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 25/81 (30%), Positives = 40/81 (49%), Gaps = 9/81 (11%)
Query: 154 DIKASNILLDDK--WIPKIADFGMARLFP---EDQTHVNTRVAGTNGYMAPEYVMHGHL- 207
DIK N L + K+ DFG+++ F + + T AGT ++APE V++
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-VLNTTNE 251
Query: 208 --SVKADVFSFGVVILELISG 226
K D +S GV++ L+ G
Sbjct: 252 SYGPKCDAWSAGVLLHLLLMG 272
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 20/104 (19%), Positives = 40/104 (38%), Gaps = 6/104 (5%)
Query: 31 KIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVK-----KLSH 84
+ RE +F +L+ K +H +G+G +G V A+K K+
Sbjct: 7 HSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ 66
Query: 85 SSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128
+ + + + E +L+ ++ H N+ L L+ E
Sbjct: 67 INPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELC 110
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 47/196 (23%), Positives = 78/196 (39%), Gaps = 32/196 (16%)
Query: 58 LGEGGFGPVFKGKLDDGREI-AVKKLSHSSNQGKKEFEN---EAKLLARVQHRNVVNLLG 113
LG+G FG V + A+K L K E + E+++L +H + L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 114 YCAHGAEKL-LIYEYVINESL-----DKVLFSLIK----------------DIQILFRKK 151
Y ++L + EY L + +F+ + +++R
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR-- 129
Query: 152 KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKA 211
DIK N++LD KI DFG+ + D + T GT Y+APE +
Sbjct: 130 --DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRAV 186
Query: 212 DVFSFGVVILELISGQ 227
D + GVV+ E++ G+
Sbjct: 187 DWWGLGVVMYEMMCGR 202
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 36/220 (16%), Positives = 69/220 (31%), Gaps = 44/220 (20%)
Query: 18 GSSREGDNEEDLEKIAAREQKHFPFEALVSATKNFH------PSNKLGEGGFGPVFKGK- 70
G+ + + + P ++ ++ + +G G +G V +
Sbjct: 15 GTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYD 74
Query: 71 LDDGREIAVKKLSHSSNQGKKEFEN---------EAKLLARVQHRNVVNLLGYCAHGAEK 121
+ R +A+KK+ + FE+ E +L R+ H +VV +L +
Sbjct: 75 KLEKRVVAIKKIL-------RVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE 127
Query: 122 LLIYEYVINESLDKVLFSLIKDIQIL------------FRKKKT---------DIKASNI 160
YV+ E D L + L K D+K +N
Sbjct: 128 KFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANC 187
Query: 161 LLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPE 200
L++ K+ DFG+AR + +
Sbjct: 188 LVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 9e-10
Identities = 55/216 (25%), Positives = 81/216 (37%), Gaps = 54/216 (25%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVK---KLSHSSNQGKKEFENEAKLLARVQHRNVVNLL 112
KLG G F V+ K + + +A+K + + E KLL RV +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE----IKLLQRVNDADNTKED 81
Query: 113 GYCAHGAEKLLIYEYVIN----------ESLDKVLFSLIKD---------------IQIL 147
A+ KLL + E L + L +LIK Q+L
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 141
Query: 148 F------RKKK---TDIKASNILLDD------KWIPKIADFGMARLFPEDQT-HVNTRVA 191
R+ TDIK N+L++ KIAD G A + E T + TR
Sbjct: 142 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE- 200
Query: 192 GTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQ 227
Y +PE ++ AD++S +I ELI+G
Sbjct: 201 ----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 52/197 (26%), Positives = 82/197 (41%), Gaps = 33/197 (16%)
Query: 58 LGEGGFGPVFKGKLDDGREI-AVKKLSHSSNQGKKEFE---NEAKLLARV-QHRNVVNLL 112
LG+G FG V + E+ AVK L + E E ++LA + + L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 113 GYCAHGAEKL-LIYEYVINESL-----DKVLFSL----------------IKDIQILFRK 150
C ++L + EYV L F ++ I++R
Sbjct: 409 -SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR- 466
Query: 151 KKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVK 210
D+K N++LD + KIADFGM + D T GT Y+APE + +
Sbjct: 467 ---DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQPYGKS 522
Query: 211 ADVFSFGVVILELISGQ 227
D ++FGV++ E+++GQ
Sbjct: 523 VDWWAFGVLLYEMLAGQ 539
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 1e-09
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 48/206 (23%)
Query: 58 LGEGGFGPVF----KGKLDDGREIAVKKLSHSS-NQGKKEFEN---EAKLLARVQHRNVV 109
LG+GG+G VF + G+ A+K L + + K+ + E +L V+H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 110 NLLGYCAHGAEKL-LIYEYVIN-ESLDKVLFSLIK------------------------- 142
+L+ Y KL LI EY+ E LF ++
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGE-----LFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 143 DIQILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYV 202
I++R D+K NI+L+ + K+ DFG+ + D T +T GT YMAPE +
Sbjct: 139 QKGIIYR----DLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYMAPEIL 193
Query: 203 M-HGHLSVKADVFSFGVVILELISGQ 227
M GH + D +S G ++ ++++G
Sbjct: 194 MRSGH-NRAVDWWSLGALMYDMLTGA 218
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 59/209 (28%), Positives = 87/209 (41%), Gaps = 50/209 (23%)
Query: 58 LGEGGFGPVF----KGKLDDGREIAVKKLSHSS-NQGKKEFE---NEAKLLARVQHRN-V 108
LG G +G VF D G+ A+K L ++ Q K E E ++L ++ +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 109 VNLLGYCAHGAEKL-LIYEYVIN-ESLDKVLFSLIK------------------------ 142
V L Y KL LI +Y+ E LF+ +
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGE-----LFTHLSQRERFTEHEVQIYVGEIVLALEHL 175
Query: 143 -DIQILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEY 201
+ I++R DIK NILLD + DFG+++ F D+T GT YMAP+
Sbjct: 176 HKLGIIYR----DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231
Query: 202 VM---HGHLSVKADVFSFGVVILELISGQ 227
V GH D +S GV++ EL++G
Sbjct: 232 VRGGDSGH-DKAVDWWSLGVLMYELLTGA 259
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 52/199 (26%), Positives = 82/199 (41%), Gaps = 37/199 (18%)
Query: 58 LGEGGFGPVFKGKLDDGREI-AVKKLSHSSNQGKKEFEN---EAKLLARV-QHRNVVNLL 112
LG+G FG V + E+ AVK L + E E ++LA + + L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 113 GYCAHGAEKL-LIYEYVINESL-----DKVLFSLIK----------------DIQILFRK 150
C ++L + EYV L F I++R
Sbjct: 88 -SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR- 145
Query: 151 KKTDIKASNILLDDKWIPKIADFGMAR--LFPEDQTHVNTRVAGTNGYMAPEYVMHGHLS 208
D+K N++LD + KIADFGM + ++ T T GT Y+APE + +
Sbjct: 146 ---DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KT-FCGTPDYIAPEIIAYQPYG 199
Query: 209 VKADVFSFGVVILELISGQ 227
D ++FGV++ E+++GQ
Sbjct: 200 KSVDWWAFGVLLYEMLAGQ 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 48/197 (24%), Positives = 80/197 (40%), Gaps = 33/197 (16%)
Query: 58 LGEGGFGPVFKGKLDDGREI-AVKKLSHSSNQGKKEFEN---EAKLLARV-QHRNVVNLL 112
LG+G FG V ++ + ++ AVK L + E E ++L+ H + L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 113 GYCAHGAEKL-LIYEYVINESL-----DKVLFSLIK----------------DIQILFRK 150
C ++L + E+V L F + D I++R
Sbjct: 91 -CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYR- 148
Query: 151 KKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVK 210
D+K N+LLD + K+ADFGM + + T GT Y+APE +
Sbjct: 149 ---DLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIAPEILQEMLYGPA 204
Query: 211 ADVFSFGVVILELISGQ 227
D ++ GV++ E++ G
Sbjct: 205 VDWWAMGVLLYEMLCGH 221
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 47/204 (23%)
Query: 58 LGEGGFGPVFKGKLDDGREI-AVKKLSHSSNQGKKEFEN---EAKLLARV-QHRNVVNLL 112
LG+G FG VF + + A+K L + E E ++L+ +H + ++
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 113 GYCAHGAEKL-LIYEYVIN-ESLDKVLFSLIK-------------------------DIQ 145
E L + EY+ + L I+
Sbjct: 85 -CTFQTKENLFFVMEYLNGGD-----LMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 138
Query: 146 ILFRKKKTDIKASNILLDDKWIPKIADFGMAR--LFPEDQTHVNTRVAGTNGYMAPEYVM 203
I++R D+K NILLD KIADFGM + + + +T NT GT Y+APE ++
Sbjct: 139 IVYR----DLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NT-FCGTPDYIAPEILL 191
Query: 204 HGHLSVKADVFSFGVVILELISGQ 227
+ D +SFGV++ E++ GQ
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 54/237 (22%), Positives = 95/237 (40%), Gaps = 74/237 (31%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFEN---------EAK 98
+ + KLG+G +G V+K G +AVKK+ F+N E
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60
Query: 99 LLARVQ-HRNVVNLLGYCAHGAEKLLIYE-----YVINESLDKVLFSLIK-----DI--- 144
+L + H N+VNLL +L + Y++ + ++ L ++I+ +
Sbjct: 61 ILTELSGHENIVNLL--------NVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQ 112
Query: 145 ----QILFRKKKT---------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVA 191
Q++ + K D+K SNILL+ + K+ADFG++R F + N
Sbjct: 113 YVVYQLI-KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 192 GTNG--------------------YMAPEYVMHGHLSVKA-DVFSFGVVILELISGQ 227
N Y APE ++ K D++S G ++ E++ G+
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 49/197 (24%), Positives = 82/197 (41%), Gaps = 33/197 (16%)
Query: 58 LGEGGFGPVFKGKLDDGREI-AVKKLSHSSNQGKKEFE---NEAKLLAR-VQHRNVVNLL 112
+G+G FG V + AVK L + KKE + +E +L + V+H +V L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 113 GYCAHGAEKL-LIYEYVINESL-----DKVLFSLIK----------------DIQILFRK 150
+ A+KL + +Y+ L + F + + I++R
Sbjct: 106 -FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR- 163
Query: 151 KKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVK 210
D+K NILLD + + DFG+ + E + +T GT Y+APE +
Sbjct: 164 ---DLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYLAPEVLHKQPYDRT 219
Query: 211 ADVFSFGVVILELISGQ 227
D + G V+ E++ G
Sbjct: 220 VDWWCLGAVLYEMLYGL 236
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 6e-08
Identities = 45/199 (22%), Positives = 78/199 (39%), Gaps = 37/199 (18%)
Query: 58 LGEGGFGPVFKGKLDDGREI-AVKKLSHSSNQGKKEFE---NEAKLLARV-QHRNVVNLL 112
+G G + V +L I A+K + ++ + E + + H +V L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 113 GYCAHGAEKL-LIYEYVINESL-----DKVLFSLIK----------------DIQILFRK 150
C +L + EYV L + + I++R
Sbjct: 77 -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR- 134
Query: 151 KKTDIKASNILLDDKWIPKIADFGMAR--LFPEDQTHVNTRVAGTNGYMAPEYVMHGHLS 208
D+K N+LLD + K+ D+GM + L P D T T GT Y+APE +
Sbjct: 135 ---DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS--T-FCGTPNYIAPEILRGEDYG 188
Query: 209 VKADVFSFGVVILELISGQ 227
D ++ GV++ E+++G+
Sbjct: 189 FSVDWWALGVLMFEMMAGR 207
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 40/197 (20%), Positives = 75/197 (38%), Gaps = 33/197 (16%)
Query: 58 LGEGGFGPVFKGKLDDGREI-AVKKLSHSSNQGKKEFE---NEAKLLARV-QHRNVVNLL 112
+G G + V +L I A++ + ++ + E + + H +V L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 113 GYCAHGAEKL-LIYEYVINESL-----DKVLFSLIK----------------DIQILFRK 150
C +L + EYV L + + I++R
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR- 177
Query: 151 KKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVK 210
D+K N+LLD + K+ D+GM + +T GT Y+APE +
Sbjct: 178 ---DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEILRGEDYGFS 233
Query: 211 ADVFSFGVVILELISGQ 227
D ++ GV++ E+++G+
Sbjct: 234 VDWWALGVLMFEMMAGR 250
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 40/222 (18%), Positives = 78/222 (35%), Gaps = 56/222 (25%)
Query: 57 KLGEGGFGPVFKGKLDDGREIAVK-----KLSHSSNQ------------GKKEFENEAKL 99
+G+GGFG ++ ++ + K+ S N K E +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 100 LARVQHRNVVNLLGYCAHGAEKLLIYEYVIN---ESLDKVL------FSLIKD-----IQ 145
++++ V G H +++ L K+ FS K ++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSR-KTVLQLSLR 160
Query: 146 ILFRKKKT--------DIKASNILLDDKWIPKI--ADFGMARLFPEDQTHV------NTR 189
IL + DIKASN+LL+ K ++ D+G+A + + H
Sbjct: 161 ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRC 220
Query: 190 VAGTNGYMAPEYVMHGHL----SVKADVFSFGVVILELISGQ 227
GT + + + H S + D+ G +++ ++G
Sbjct: 221 HDGTIEFTS----IDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 1e-07
Identities = 43/323 (13%), Positives = 97/323 (30%), Gaps = 88/323 (27%)
Query: 5 KKFFDGLLK---HFNLGSSREGDNEEDLEK---IAAREQ---------KHF-----PFEA 44
+KF + +L+ F + + + + I R++ K+ P+
Sbjct: 80 QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLK 139
Query: 45 LVSATKNFHPSNKL---GEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFE------- 94
L A P+ + G G G K + A+ Q K +F+
Sbjct: 140 LRQALLELRPAKNVLIDGVLGSG---KTWV------ALDVCLSYKVQCKMDFKIFWLNLK 190
Query: 95 ---NEAKLLARVQ---HRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILF 148
+ +L +Q ++ N H + + I+ + ++ L
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSN----IKLRIHSIQAE--------LRRLL 238
Query: 149 RKKKTDIKASNILLDDKWIPKIAD-FGMARLFPED---QTHVNTRVAGTNGYMAPEYVMH 204
+ K + ++L + K + F + + + TR +++ H
Sbjct: 239 KSK--PYENCLLVLLNVQNAKAWNAF--------NLSCKILLTTRFKQVTDFLSAATTTH 288
Query: 205 GHLSVKADVFS-----------FGVVILEL-ISGQRNSSFNLDVDAQNLLDWA-----YK 247
L + + +L + L + A+++ D +K
Sbjct: 289 ISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWK 348
Query: 248 LYKKDKSLEIVDPSLAASDSGDQ 270
DK I++ SL + +
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEY 371
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 44/207 (21%), Positives = 79/207 (38%), Gaps = 46/207 (22%)
Query: 56 NKLGEGGFGPVFKGK-LDDGREIAVK---KLSHSSNQGKKEFENEAKLLARVQHR----- 106
+ +G+G FG V K + +A+K NQ + E +LL +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE----VRLLELMNKHDTEMK 115
Query: 107 -NVVNLLGYCAHGA------EKLLI--YEYVINESLDKVLFSLIKDI--QIL----FRKK 151
+V+L + E L Y+ + N + V +L + Q+ F
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 152 K------TDIKASNILL--DDKWIPKIADFGMARLFPEDQTH---VNTRVAGTNGYMAPE 200
D+K NILL + KI DFG + Q + +R Y +PE
Sbjct: 176 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRF-----YRSPE 228
Query: 201 YVMHGHLSVKADVFSFGVVILELISGQ 227
++ + D++S G +++E+ +G+
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 45/207 (21%), Positives = 86/207 (41%), Gaps = 44/207 (21%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQH-RNVVNLLGY 114
++GEG FG +F+G L + +++A+K + +E + + + N+ +
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 115 CAHGAEKLLIYEYVINESLDKVL------FSLIKD-----IQILFRKKKT--------DI 155
G +L+ + + SL+ +L FS+ K Q+L R + DI
Sbjct: 75 GQEGLHNVLVIDL-LGPSLEDLLDLCGRKFSV-KTVAMAAKQMLARVQSIHEKSLVYRDI 132
Query: 156 KASNILLDDKWIPK-----IADFGMARLF--PEDQTHV----NTRVAGTNGYMAPEYVMH 204
K N L+ + DFGM + + P + H+ ++GT YM+ ++
Sbjct: 133 KPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS----IN 188
Query: 205 GHL----SVKADVFSFGVVILELISGQ 227
HL S + D+ + G V + + G
Sbjct: 189 THLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 40/202 (19%), Positives = 65/202 (32%), Gaps = 64/202 (31%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLG- 113
LG G G V + + A+K L + E +L R Q ++V ++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 79
Query: 114 YCAHGAEKLLIY---EYVIN-ESLDKVL------FS------LIKDI----------QIL 147
Y A + + E + E ++ F+ ++K I I
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 139
Query: 148 FRKKKTDIKASNILLDDKW---IPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMH 204
R D+K N+L K I K+ DFG A E
Sbjct: 140 HR----DVKPENLLYTSKRPNAILKLTDFGFA---KE--------------------TTG 172
Query: 205 GHLSVKADVFSFGVVILELISG 226
D++S GV++ L+ G
Sbjct: 173 EKYDKSCDMWSLGVIMYILLCG 194
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 46/204 (22%), Positives = 80/204 (39%), Gaps = 40/204 (19%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQH-RNVVNLLGY 114
K+G G FG ++ G + G E+A+K + E+K+ +Q + +
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 115 CAHGAEKLLIYEYVINESLDKVL------FSL----------IKDIQILFRK--KKTDIK 156
A G +++ E + SL+ + FSL I I+ + K D+K
Sbjct: 74 GAEGDYNVMVMEL-LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVK 132
Query: 157 ASNILLDDKWIPK---IADFGMARLF--PEDQTHVNTR----VAGTNGYMAPEYVMHGHL 207
N L+ I DFG+A+ + H+ R + GT Y + ++ HL
Sbjct: 133 PDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS----INTHL 188
Query: 208 ----SVKADVFSFGVVILELISGQ 227
S + D+ S G V++ G
Sbjct: 189 GIEQSRRDDLESLGYVLMYFNLGS 212
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 17/65 (26%), Positives = 27/65 (41%), Gaps = 4/65 (6%)
Query: 164 DKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILEL 223
+K KIAD G A + T T Y + E ++ + AD++S + EL
Sbjct: 231 EKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNTPADIWSTACMAFEL 286
Query: 224 ISGQR 228
+G
Sbjct: 287 ATGDY 291
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 44/207 (21%), Positives = 74/207 (35%), Gaps = 52/207 (25%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVKKLSHSS---NQGKKEFE-----NEA---------KL 99
+G+G FG V K + +A+K + + Q +E + +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 100 LARVQHRN----VVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDI--QIL-----F 148
L RN LL +YE + L++ IL
Sbjct: 165 LENFTFRNHICMTFELLSMN--------LYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 149 RKKK---TDIKASNILLDDKWIP--KIADFGMARLFPEDQTH---VNTRVAGTNGYMAPE 200
K + D+K NILL + K+ DFG + E Q + +R Y APE
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTYIQSRF-----YRAPE 269
Query: 201 YVMHGHLSVKADVFSFGVVILELISGQ 227
++ + D++S G ++ EL++G
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 43/219 (19%), Positives = 76/219 (34%), Gaps = 53/219 (24%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQ---------HR 106
K+G GGFG ++ + + A + Q +E K RV R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVK-VEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 107 NVVNLLG-----YCAHGAEKLLIYEYVINESLDKVLFSLIKD-------------IQILF 148
++ LG K Y +++ E L L + I++L
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLD 162
Query: 149 RKKKT--------DIKASNILLDDKWIPKI--ADFGMARLFPEDQTHV------NTRVAG 192
+ DIKA+N+LL K ++ AD+G++ + + H G
Sbjct: 163 VLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNG 222
Query: 193 TNGYMAPEYVMHGHL----SVKADVFSFGVVILELISGQ 227
T + + + H S ++DV G +L + G+
Sbjct: 223 TIEFTS----LDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 44/204 (21%), Positives = 82/204 (40%), Gaps = 40/204 (19%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQ-HRNVVNLLGY 114
K+G G FG ++ G + E+A+K + + + E+K+ +Q + N+ +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 115 CAHGAEKLLIYEYVINESLDKVL------FSL----------IKDIQILFRKK--KTDIK 156
G +L+ + + SL+ + SL I ++ + K DIK
Sbjct: 72 GVEGDYNVLVMDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
Query: 157 ASNILLDDKWIPK---IADFGMARLF--PEDQTHVNTR----VAGTNGYMAPEYVMHGHL 207
N L+ I DFG+A+ + H+ R + GT Y + ++ HL
Sbjct: 131 PDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS----VNTHL 186
Query: 208 ----SVKADVFSFGVVILELISGQ 227
S + D+ S G V++ + G
Sbjct: 187 GIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 6e-06
Identities = 47/213 (22%), Positives = 83/213 (38%), Gaps = 44/213 (20%)
Query: 51 NFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQH-RNV 108
NF K+G G FG + GK L +A+K S + E + ++ +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGI 67
Query: 109 VNLLGYCAHGAEKLLIYEYVINESLDKVL------FSLIKD-----IQILFRKKKT---- 153
+ + G ++ E + SL+ + FSL K IQ++ R +
Sbjct: 68 PQVYYFGPCGKYNAMVLEL-LGPSLEDLFDLCDRTFSL-KTVLMIAIQLISRMEYVHSKN 125
Query: 154 ----DIKASNILLDDKWIPK-----IADFGMARLF--PEDQTHVNTR----VAGTNGYMA 198
D+K N L+ I DF +A+ + PE + H+ R + GT YM+
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS 185
Query: 199 PEYVMHGHL----SVKADVFSFGVVILELISGQ 227
++ HL S + D+ + G + + + G
Sbjct: 186 ----INTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 32/232 (13%), Positives = 74/232 (31%), Gaps = 62/232 (26%)
Query: 50 KNFHPSNKLGEGGFGPVFKGK---------LDDGREIAVKKLSHSS----------NQGK 90
+ + + G +++ ++ ++K + K
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 91 KEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKD------- 143
N+ K L + +G+ H + Y +++ SL + L S +
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDK----YRFLVLPSLGRSLQSALDVSPKHVLS 157
Query: 144 --------IQILFRKKKT--------DIKASNILLDDKWIPKI--ADFGMARLFPEDQTH 185
++L + ++ A NI +D + ++ A +G A + H
Sbjct: 158 ERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217
Query: 186 V------NTRVAGTNGYMAPEYVMHGHL----SVKADVFSFGVVILELISGQ 227
V + G +++ M H S ++D+ S G +L+ + G
Sbjct: 218 VAYVEGSRSPHEGDLEFIS----MDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 40/226 (17%), Positives = 69/226 (30%), Gaps = 70/226 (30%)
Query: 57 KLGEGGFGPVFKG--KLDDGREIAVK---KLSHSSNQGKKEFE-----NEA--------- 97
LGEG FG V + ++A+K + + E E
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCV 85
Query: 98 KLLARVQHRN----VVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDI--QIL---- 147
+ LLG +E++ + ++ + Q+
Sbjct: 86 LMSDWFNFHGHMCIAFELLGKN--------TFEFLKENNFQPYPLPHVRHMAYQLCHALR 137
Query: 148 -FRKKK---TDIKASNILLDDKWIP-------------------KIADFGMARLFPEDQT 184
+ + TD+K NIL + ++ADFG A + +
Sbjct: 138 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEH 195
Query: 185 H---VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQ 227
H V TR Y PE ++ + DV+S G ++ E G
Sbjct: 196 HTTIVATRH-----YRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 55/230 (23%), Positives = 86/230 (37%), Gaps = 74/230 (32%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVK---KLSHSSNQGKKEFE-----NEA--------KL 99
K+G+G FG V + +D+ + AVK + + K E + K
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101
Query: 100 LARVQHRN----VVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDI--QIL-----F 148
+ + + + LG +YE + + + IK +IL
Sbjct: 102 HGKFMYYDHMCLIFEPLGPS--------LYEIITRNNYNGFHIEDIKLYCIEILKALNYL 153
Query: 149 RKKK---TDIKASNILLDDKWIP-------------------------KIADFGMARLFP 180
RK TD+K NILLDD + K+ DFG A F
Sbjct: 154 RKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA-TF- 211
Query: 181 EDQTH---VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQ 227
+ H +NTR Y APE +++ V +D++SFG V+ EL +G
Sbjct: 212 KSDYHGSIINTRQ-----YRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 2e-04
Identities = 14/43 (32%), Positives = 21/43 (48%), Gaps = 2/43 (4%)
Query: 40 FPFEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKL 82
PF + T+ K+GEG FG VF+ D +A+K +
Sbjct: 11 VPFSHCLP-TEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKII 51
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 52/226 (23%), Positives = 77/226 (34%), Gaps = 70/226 (30%)
Query: 57 KLGEGGFGPVFKGK--LDDGREIAVKKL-SHSS--NQGKKEFE-----NEA--------- 97
LGEG FG V + GR +AVK + + + E + N
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80
Query: 98 KLLARVQHRN----VVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDI--QIL---- 147
++L +H V LLG Y+++ I+ + QI
Sbjct: 81 QMLEWFEHHGHICIVFELLGLS--------TYDFIKENGFLPFRLDHIRKMAYQICKSVN 132
Query: 148 -FRKKK---TDIKASNILLDDKWIP-------------------KIADFGMARLFPEDQT 184
K TD+K NIL K+ DFG A +D+
Sbjct: 133 FLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEH 190
Query: 185 H---VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQ 227
H V+TR Y APE ++ S DV+S G +++E G
Sbjct: 191 HSTLVSTRH-----YRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 381 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.69 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.42 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.01 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.92 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.74 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.52 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.46 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.34 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.29 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.21 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.16 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.14 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.02 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.01 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.88 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.72 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.72 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.7 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.56 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.46 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.39 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.37 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.22 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.13 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.1 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.51 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.91 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.37 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 90.45 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.22 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-58 Score=423.86 Aligned_cols=231 Identities=23% Similarity=0.363 Sum_probs=186.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
++|++++.||+|+||.||+|++. +|+.||||++... .....+.+.+|+++|++|+|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999875 5999999999754 23345789999999999999999999999999999999999
Q ss_pred cccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 127 YVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 127 ~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
||+||+|.++| .|++.||.|||+++ ||||||+||||+.++.+||+|||+|+.+.... ...
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 182 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-ELA 182 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-HHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-ccc
Confidence 99999997665 68999999999999 99999999999999999999999998764321 223
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
...+||+.|||||++.+..|+.++||||||||||||++|+.||.... ..+.......... +.. .
T Consensus 183 ~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~~~------~~~----~ 246 (350)
T 4b9d_A 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKIISGSF------PPV----S 246 (350)
T ss_dssp HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHTCC------CCC----C
T ss_pred cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcCCC------CCC----C
Confidence 35689999999999999999999999999999999999999996432 2222222222211 111 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
...+..+.+||.+||+.||++|||+.|+++
T Consensus 247 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 247 LHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 123456889999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-57 Score=414.17 Aligned_cols=233 Identities=22% Similarity=0.339 Sum_probs=195.3
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
+.|++.++||+|+||.||+|++. +|+.||||++........+.+.+|+++|++++|||||+++++|.+.+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999876 69999999997666566678899999999999999999999999999999999999
Q ss_pred cCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccccc
Q 048280 129 INESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAG 192 (381)
Q Consensus 129 ~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~g 192 (381)
++|+|.+++ .|++.||.|||+++ ||||||+||||+.++.+||+|||+|+.+..... .....+|
T Consensus 154 ~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~G 232 (346)
T 4fih_A 154 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVG 232 (346)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCCCS
T ss_pred CCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-ccccccc
Confidence 999998765 78999999999999 999999999999999999999999998754332 2345789
Q ss_pred CccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHH
Q 048280 193 TNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIA 272 (381)
Q Consensus 193 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (381)
|+.|||||++.+..|+.++|||||||+||||++|+.||...... +....... ... +.+ ........
T Consensus 233 Tp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~~-~~~-----~~~--~~~~~~s~ 298 (346)
T 4fih_A 233 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKMIRD-NLP-----PRL--KNLHKVSP 298 (346)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHH-SSC-----CCC--SCGGGSCH
T ss_pred CcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHc-CCC-----CCC--CccccCCH
Confidence 99999999999999999999999999999999999998643221 11111111 111 111 11223346
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 273 MCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 273 ~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.+.+||.+||+.||++|||+.|+++
T Consensus 299 ~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 299 SLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhc
Confidence 6889999999999999999999986
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-57 Score=410.72 Aligned_cols=238 Identities=28% Similarity=0.418 Sum_probs=194.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 122 (381)
.++++.++||+|+||.||+|++. +++.||||+++.. .....+.|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45677899999999999999863 4688999999654 3344678999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHH-------------------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcE
Q 048280 123 LIYEYVINESLDKVL-------------------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPK 169 (381)
Q Consensus 123 lv~E~~~~g~L~~~l-------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~k 169 (381)
||||||++|+|.++| .|++.|+.|||+++ ||||||+||||++++.+|
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~K 185 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVK 185 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEE
Confidence 999999999998766 47899999999998 999999999999999999
Q ss_pred EeeeccceecCCCC-cccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHH
Q 048280 170 IADFGMARLFPEDQ-THVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYK 247 (381)
Q Consensus 170 L~DFG~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 247 (381)
|+|||+++.+.... ....+...||+.|||||++.++.|+.++|||||||+||||+| |..||..... ..+..
T Consensus 186 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~~---- 258 (308)
T 4gt4_A 186 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVVE---- 258 (308)
T ss_dssp ECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHHH----
T ss_pred ECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHHH----
Confidence 99999998664322 222345679999999999999999999999999999999998 8899864322 12221
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 248 LYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
........ ..+..++..+.+|+.+||+.||++||||.||++.|+...
T Consensus 259 ~i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 259 MIRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 12222111 112234566889999999999999999999999998753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-57 Score=411.69 Aligned_cols=238 Identities=26% Similarity=0.468 Sum_probs=194.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 122 (381)
.++|.+.+.||+|+||.||+|++. ++..||||+++.......+.|.+|+++|++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 357888999999999999999863 47789999998776666788999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHH----------------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEee
Q 048280 123 LIYEYVINESLDKVL----------------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIAD 172 (381)
Q Consensus 123 lv~E~~~~g~L~~~l----------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~D 172 (381)
||||||++|+|.++| .|++.||.|||+++ ||||||+||||+.++.+||+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECC
Confidence 999999999998765 58899999999998 999999999999999999999
Q ss_pred eccceecCCCCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhh
Q 048280 173 FGMARLFPEDQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYK 250 (381)
Q Consensus 173 FG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 250 (381)
||+|+........ ......||+.|||||++.+..|+.++|||||||+||||+| |+.||..... ..+.. . ..
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~---~-i~ 244 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIE---C-IT 244 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHH---H-HH
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH---H-HH
Confidence 9999866443222 2234569999999999999999999999999999999998 8999864322 11221 1 11
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 251 KDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
..... ..+..++..+.+|+.+||+.||++|||+.+|++.|++.
T Consensus 245 ~~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 245 QGRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 12111 11122345688999999999999999999999999764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=412.97 Aligned_cols=238 Identities=27% Similarity=0.450 Sum_probs=189.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 122 (381)
.++|.+.++||+|+||.||+|++. +++.||||+++.......+.|.+|+++|++++|||||+++|+|.+.+..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 356778899999999999999864 47889999998777666788999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHH------------------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEE
Q 048280 123 LIYEYVINESLDKVL------------------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKI 170 (381)
Q Consensus 123 lv~E~~~~g~L~~~l------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL 170 (381)
||||||++|+|.++| .|++.||.|||+.+ ||||||+||||++++.+||
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki 199 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKI 199 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEE
Confidence 999999999997654 58999999999998 9999999999999999999
Q ss_pred eeeccceecCCCCc-ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHH
Q 048280 171 ADFGMARLFPEDQT-HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKL 248 (381)
Q Consensus 171 ~DFG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 248 (381)
+|||+++.+..... .......||+.|||||++.+..|+.++|||||||+||||+| |+.||..... ..+.. .
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~---~- 272 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAID---C- 272 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHHH---H-
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHHH---H-
Confidence 99999987644332 22345679999999999999999999999999999999999 8999864322 11221 1
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 249 YKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
....... ..+..++..+.+|+.+||+.||++|||+.||++.|+.+
T Consensus 273 i~~g~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 273 ITQGREL---------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp HHHTCCC---------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred HHcCCCC---------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 1111111 11122345688999999999999999999999999765
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-55 Score=414.10 Aligned_cols=234 Identities=22% Similarity=0.340 Sum_probs=196.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
.+.|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|+.+|++++|||||+++++|.+++.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 356999999999999999999876 5999999999877666677899999999999999999999999999999999999
Q ss_pred ccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccc
Q 048280 128 VINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVA 191 (381)
Q Consensus 128 ~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~ 191 (381)
|.||+|.+++ .|++.||.|||+++ ||||||+||||+.+|.+||+|||+|+.+..... .....+
T Consensus 230 ~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~ 308 (423)
T 4fie_A 230 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV 308 (423)
T ss_dssp CTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CBCCCE
T ss_pred CCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-cccccc
Confidence 9999998765 78999999999999 999999999999999999999999998754432 234578
Q ss_pred cCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHH
Q 048280 192 GTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271 (381)
Q Consensus 192 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (381)
||+.|||||++.+..|+.++|||||||+||||++|+.||..... ......... ... +.+ .......
T Consensus 309 GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~-~~~-----~~~--~~~~~~s 374 (423)
T 4fie_A 309 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKMIRD-NLP-----PRL--KNLHKVS 374 (423)
T ss_dssp ECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHH-SCC-----CCC--SCTTSSC
T ss_pred cCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHc-CCC-----CCC--cccccCC
Confidence 99999999999999999999999999999999999999864322 111112111 111 111 1111234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 272 AMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 272 ~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
..+.+||.+||+.||++|||+.||++
T Consensus 375 ~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 375 PSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 56889999999999999999999986
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=401.08 Aligned_cols=241 Identities=24% Similarity=0.388 Sum_probs=187.1
Q ss_pred hhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
..++|++.++||+|+||+||+|+++ ..||||+++... ....+.|.+|+++|++++|||||+++|++.+ +..+|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 3567889999999999999999875 359999986543 3345789999999999999999999999865 5689999
Q ss_pred ecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc-cc
Q 048280 126 EYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT-HV 186 (381)
Q Consensus 126 E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~-~~ 186 (381)
|||++|+|.++| .|++.||.|||+++ ||||||+||||++++.+||+|||+|+....... ..
T Consensus 111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~ 190 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ 190 (307)
T ss_dssp ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence 999999998776 68999999999998 999999999999999999999999987643322 22
Q ss_pred ccccccCccccchhHHhh---CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMH---GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
....+||+.|||||++.+ +.|+.++|||||||+||||+||+.||....... .......... ..|.+
T Consensus 191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~----~~p~~- 259 (307)
T 3omv_A 191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGY----ASPDL- 259 (307)
T ss_dssp ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTC----CCCCS-
T ss_pred ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCC----CCCCc-
Confidence 345689999999999974 358999999999999999999999986432211 1111121111 11111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 264 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
......++..+.+|+.+||+.||++|||+.||++.|+.+
T Consensus 260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 112223456688999999999999999999999888654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-56 Score=402.11 Aligned_cols=230 Identities=21% Similarity=0.283 Sum_probs=192.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++|++.+.||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+++|++++|||||++++++.+.+.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999875 6999999999653 2344578999999999999999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc-ccc
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT-HVN 187 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~-~~~ 187 (381)
|||+||+|.++| .|++.||.|||+++ ||||||+||||+.++.+||+|||+|+.+..... ...
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~ 191 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 191 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCB
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccc
Confidence 999999998766 78999999999999 999999999999999999999999998754332 233
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
...+||+.|||||++.+..|+.++|||||||+||||++|+.||..... ........... ..+..
T Consensus 192 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~~-------~~~p~--- 255 (311)
T 4aw0_A 192 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFAKIIKLE-------YDFPE--- 255 (311)
T ss_dssp CCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTC-------CCCCT---
T ss_pred cCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCC-------CCCCc---
Confidence 467899999999999999999999999999999999999999964321 11112222211 11111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVV 296 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil 296 (381)
.....+.+||.+||+.||++|||++|++
T Consensus 256 -~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 256 -KFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 2235688999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=399.30 Aligned_cols=234 Identities=21% Similarity=0.250 Sum_probs=188.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
.+.|++.++||+|+||.||+|++. +|+.||||+++.... ..+|+.+|++++|||||++++++.+++.+||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356788889999999999999976 599999999975432 24799999999999999999999999999999999
Q ss_pred ccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCC-CcEEeeeccceecCCCCcc----
Q 048280 128 VINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKW-IPKIADFGMARLFPEDQTH---- 185 (381)
Q Consensus 128 ~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~-~~kL~DFG~~~~~~~~~~~---- 185 (381)
|+||+|.++| .|++.||.|||+++ ||||||+||||+.++ .+||+|||+|+.+......
T Consensus 132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 9999998776 68999999999999 999999999999987 6999999999987543221
Q ss_pred cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCC
Q 048280 186 VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
....++||+.|||||++.+..|+.++|||||||+||||++|+.||........ .. .......... .
T Consensus 212 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~---~i~~~~~~~~--------~ 277 (336)
T 4g3f_A 212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CL---KIASEPPPIR--------E 277 (336)
T ss_dssp --CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HH---HHHHSCCGGG--------G
T ss_pred cCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HH---HHHcCCCCch--------h
Confidence 12246799999999999999999999999999999999999999965433221 11 1111111111 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 266 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
.+...+..+.+||.+||+.||.+|||+.||++.|..
T Consensus 278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 112234568889999999999999999999987754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=386.96 Aligned_cols=228 Identities=21% Similarity=0.318 Sum_probs=175.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++|++.+.||+|+||.||+|+.. +|+.||||++.+. .......+.+|+++|++++|||||++++++.+.+..||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999865 6999999999654 2334567999999999999999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
||| +|+|.+++ .|++.||.|+|+++ ||||||+||||+.++.+||+|||+|+...... ...
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--~~~ 169 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--FLK 169 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC--ccC
Confidence 999 67887655 78999999999999 99999999999999999999999998764332 233
Q ss_pred ccccCccccchhHHhhCCC-CchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 189 RVAGTNGYMAPEYVMHGHL-SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
..+||+.|||||++.+..+ +.++|||||||+||+|++|+.||.... ............ . .+.
T Consensus 170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~~~~~~i~~~~-~------~~p---- 232 (275)
T 3hyh_A 170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IPVLFKNISNGV-Y------TLP---- 232 (275)
T ss_dssp -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTC-C------CCC----
T ss_pred CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHcCC-C------CCC----
Confidence 5689999999999998876 589999999999999999999996432 111111111111 0 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
...+..+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 233 KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 122356889999999999999999999987
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-54 Score=387.82 Aligned_cols=227 Identities=24% Similarity=0.360 Sum_probs=180.3
Q ss_pred CCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEee----CCeEEEEE
Q 048280 53 HPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAH----GAEKLLIY 125 (381)
Q Consensus 53 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~ 125 (381)
++.+.||+|+||.||+|.+. +++.||||++... .....+.|.+|+++|++++|||||+++++|.+ ...+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 66778999999999999876 5899999998644 33345679999999999999999999999875 35689999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc----cCCccccceEeCC-CCCcEEeeeccceecCCCCcc
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK----KTDIKASNILLDD-KWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~----HrDlkp~NIll~~-~~~~kL~DFG~~~~~~~~~~~ 185 (381)
|||++|+|.+++ .|++.||.|||+++ ||||||+||||+. ++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~--- 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--- 185 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT---
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC---
Confidence 999999998766 68999999999875 9999999999974 789999999999864322
Q ss_pred cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCC
Q 048280 186 VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
.....+||+.|||||++.+ .|+.++|||||||+||||+||+.||...... .. ..............+ .
T Consensus 186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-----~~-~~~~i~~~~~~~~~~----~- 253 (290)
T 3fpq_A 186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQ-IYRRVTSGVKPASFD----K- 253 (290)
T ss_dssp SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HH-HHHHHTTTCCCGGGG----G-
T ss_pred ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-----HH-HHHHHHcCCCCCCCC----c-
Confidence 2345789999999998865 6999999999999999999999998543221 11 111122111111111 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 266 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
..+..+.+||.+||+.||++|||+.|+++
T Consensus 254 ---~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 254 ---VAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11245788999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=393.87 Aligned_cols=230 Identities=23% Similarity=0.271 Sum_probs=181.0
Q ss_pred cCCCCCCcccccCCeeEEEEEEC----CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD----DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
++|++++.||+|+||.||+|+.. +++.||||++.... ......+.+|+++|++++|||||++++++.+++..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999853 47899999997542 2233568899999999999999999999999999999
Q ss_pred EEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 124 IYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 124 v~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
|||||+||+|.+++ .|++.||.|||+++ ||||||+|||++.++.+||+|||+|+....... .
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 182 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-K 182 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C-C
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc-c
Confidence 99999999998765 68999999999999 999999999999999999999999986543322 2
Q ss_pred ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
....+||+.|||||++.+..|+.++|||||||+||||++|+.||..... .+.......... ..
T Consensus 183 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~~~-------~~---- 245 (304)
T 3ubd_A 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR------KETMTMILKAKL-------GM---- 245 (304)
T ss_dssp CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC-------CC----
T ss_pred ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH------HHHHHHHHcCCC-------CC----
Confidence 3357899999999999999999999999999999999999999964322 111122222110 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTM-----RRVVV 297 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~ 297 (381)
+...+..+.+||.+||+.||++|||+ +|+++
T Consensus 246 p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 246 PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 11234568899999999999999984 67764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-54 Score=400.59 Aligned_cols=244 Identities=29% Similarity=0.430 Sum_probs=195.5
Q ss_pred HHHHhhcCCCCCCcccccCCeeEEEEEECC------CcEEEEEEecCCC-cccHHHHHHHHHHHHHhCC-CCcccEEEEE
Q 048280 44 ALVSATKNFHPSNKLGEGGFGPVFKGKLDD------GREIAVKKLSHSS-NQGKKEFENEAKLLARVQH-RNVVNLLGYC 115 (381)
Q Consensus 44 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~ 115 (381)
..+...++|++.+.||+|+||.||+|++.. ++.||||++.... ....+.|.+|+++|.+++| ||||+++|+|
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 344556789999999999999999998542 3679999997653 2345679999999999965 8999999999
Q ss_pred eeC-CeEEEEEecccCCCHHHHH-------------------------------HhhhhhhhHhhhhc--cCCccccceE
Q 048280 116 AHG-AEKLLIYEYVINESLDKVL-------------------------------FSLIKDIQILFRKK--KTDIKASNIL 161 (381)
Q Consensus 116 ~~~-~~~~lv~E~~~~g~L~~~l-------------------------------~~~~~~l~~lh~~~--HrDlkp~NIl 161 (381)
.+. +.++||||||++|+|.++| .|++.|+.|||+++ ||||||+|||
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 764 5789999999999998876 47899999999999 9999999999
Q ss_pred eCCCCCcEEeeeccceecCCCCc-ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccc
Q 048280 162 LDDKWIPKIADFGMARLFPEDQT-HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQ 239 (381)
Q Consensus 162 l~~~~~~kL~DFG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~ 239 (381)
|++++.+||+|||+|+.+..... .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.......
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-- 295 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-- 295 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH--
Confidence 99999999999999997654433 23345679999999999999999999999999999999998 899986432211
Q ss_pred cHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 240 NLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.+ ........... .+...+..+.+|+.+||+.||++|||+.||++.|+..
T Consensus 296 ~~----~~~i~~g~~~~---------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 296 EF----CRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp HH----HHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH----HHHHHcCCCCC---------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 11 12222221111 1112345688999999999999999999999988653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-53 Score=388.32 Aligned_cols=248 Identities=23% Similarity=0.314 Sum_probs=184.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC----eEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA----EKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~lv 124 (381)
.++|.+.+.||+|+||.||+|+++ |+.||||++..... ....++.|+..+.+++|||||+++++|.+.+ .+|||
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 356888899999999999999985 89999999964422 1123345666667889999999999998654 57999
Q ss_pred EecccCCCHHHHH--------------HhhhhhhhHhhhh--------c--cCCccccceEeCCCCCcEEeeeccceecC
Q 048280 125 YEYVINESLDKVL--------------FSLIKDIQILFRK--------K--KTDIKASNILLDDKWIPKIADFGMARLFP 180 (381)
Q Consensus 125 ~E~~~~g~L~~~l--------------~~~~~~l~~lh~~--------~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~ 180 (381)
||||++|+|.++| .|++.||.|+|+. + ||||||+||||+.++.+||+|||+++...
T Consensus 80 ~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred ecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 9999999998776 6899999999976 3 99999999999999999999999998765
Q ss_pred CCCccc---ccccccCccccchhHHhhC------CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccc--------ccHHH
Q 048280 181 EDQTHV---NTRVAGTNGYMAPEYVMHG------HLSVKADVFSFGVVILELISGQRNSSFNLDVDA--------QNLLD 243 (381)
Q Consensus 181 ~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~--------~~~~~ 243 (381)
...... ....+||+.|||||++.+. .++.++|||||||+||||+||..||........ .....
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 433221 2246799999999999764 367899999999999999999877643221110 00111
Q ss_pred HHHHHhhcCCcccccCCCCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 244 WAYKLYKKDKSLEIVDPSLAAS-DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
......... ..+|.+... ...+....+.+|+.+||+.||++||||.||++.|+++
T Consensus 240 ~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 240 EMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 111111111 122222211 1235667789999999999999999999999999764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=389.46 Aligned_cols=231 Identities=23% Similarity=0.357 Sum_probs=174.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC-------
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA------- 119 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------- 119 (381)
.++|++++.||+|+||.||+|+.+ +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 346999999999999999999876 68999999996543 334567899999999999999999999987544
Q ss_pred -----eEEEEEecccCCCHHHHH------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeec
Q 048280 120 -----EKLLIYEYVINESLDKVL------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFG 174 (381)
Q Consensus 120 -----~~~lv~E~~~~g~L~~~l------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG 174 (381)
.+|||||||.+|+|.+++ .|++.||.|||+++ ||||||+||||+.++.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 379999999999997654 68999999999999 99999999999999999999999
Q ss_pred cceecCCCCcc-----------cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHH
Q 048280 175 MARLFPEDQTH-----------VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLD 243 (381)
Q Consensus 175 ~~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~ 243 (381)
+|+.+...... ..+..+||+.|||||++.+..|+.++|||||||+||||++ ||... .....
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~~~ 235 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----MERVR 235 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHHHH
Confidence 99876543221 1234679999999999999999999999999999999996 65321 11111
Q ss_pred HHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 244 WAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.... ...... +.........+.+|+.+||+.||.+|||+.||++
T Consensus 236 ~~~~-~~~~~~---------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 TLTD-VRNLKF---------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHH-HHTTCC---------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHH-HhcCCC---------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 111110 1112233345678999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=381.12 Aligned_cols=245 Identities=18% Similarity=0.279 Sum_probs=185.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEee------CC
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAH------GA 119 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------~~ 119 (381)
.++|++++.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 357999999999999999999875 69999999997543 2334678899999999999999999999764 36
Q ss_pred eEEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCC
Q 048280 120 EKLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPED 182 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~ 182 (381)
.+|||||||. |+|.+++ .|++.||.|||+++ ||||||+|||++.++.+||+|||+++.+...
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 7899999995 6786554 79999999999999 9999999999999999999999999876432
Q ss_pred C---cccccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCccccc
Q 048280 183 Q---THVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIV 258 (381)
Q Consensus 183 ~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
. .......+||+.|+|||++.+. .++.++||||+|||+|||++|+.||......+. +........... ....
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~---l~~I~~~~g~p~-~~~~ 287 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ---LQLIMMVLGTPS-PAVI 287 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH---HHHHHHHHCCCC-GGGT
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhcCCCC-hHHh
Confidence 2 1223457899999999998875 569999999999999999999999975433222 111111111000 0000
Q ss_pred --------------CCCCCCCC----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 259 --------------DPSLAASD----SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 259 --------------~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.+...... .......+.+||.+||..||.+|||+.|+++.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 01123567899999999999999999999863
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=374.83 Aligned_cols=184 Identities=25% Similarity=0.368 Sum_probs=158.0
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC----CCcEEEEEEecCCCcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD----DGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 122 (381)
..+.|++.+.||+|+||.||+|+.+ +++.||||++.... ....+.+|+++|+.+ +|||||+++++|.+.+.+|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4678999999999999999999753 47889999986543 346788999999999 6999999999999999999
Q ss_pred EEEecccCCCHHHHH------------HhhhhhhhHhhhhc--cCCccccceEeCCC-CCcEEeeeccceecCCCCcc--
Q 048280 123 LIYEYVINESLDKVL------------FSLIKDIQILFRKK--KTDIKASNILLDDK-WIPKIADFGMARLFPEDQTH-- 185 (381)
Q Consensus 123 lv~E~~~~g~L~~~l------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~-~~~kL~DFG~~~~~~~~~~~-- 185 (381)
||||||++|+|.+++ .|++.||.|||+++ ||||||+||||+.+ +.+||+|||+|+........
T Consensus 97 lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~ 176 (361)
T 4f9c_A 97 IAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELL 176 (361)
T ss_dssp EEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGG
T ss_pred EEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccc
Confidence 999999999997655 79999999999999 99999999999876 79999999999865433211
Q ss_pred -------------------------cccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCC
Q 048280 186 -------------------------VNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFN 233 (381)
Q Consensus 186 -------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~ 233 (381)
.....+||+.|+|||++.+. .|+.++||||+|||+|||++|+.||...
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 177 KFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp GGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 11245799999999999876 5899999999999999999999998543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=364.41 Aligned_cols=267 Identities=35% Similarity=0.602 Sum_probs=229.0
Q ss_pred hCCCCChHHHHHhhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEE
Q 048280 36 EQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYC 115 (381)
Q Consensus 36 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 115 (381)
....+++.++...+++|++.+.||+|+||.||+|++.+++.||||++........+.+.+|+.++++++||||+++++++
T Consensus 25 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 104 (321)
T 2qkw_B 25 ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC 104 (321)
T ss_dssp -----CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred cceeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34567777777889999999999999999999999888999999999776666678899999999999999999999999
Q ss_pred eeCCeEEEEEecccCCCHHH-------------------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeec
Q 048280 116 AHGAEKLLIYEYVINESLDK-------------------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFG 174 (381)
Q Consensus 116 ~~~~~~~lv~E~~~~g~L~~-------------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG 174 (381)
...+..++||||+.+++|.+ ++.|++.+|.|||..+ ||||||+|||++.++.+||+|||
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999988854 4478999999999999 99999999999999999999999
Q ss_pred cceecCCCC-cccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCC
Q 048280 175 MARLFPEDQ-THVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDK 253 (381)
Q Consensus 175 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (381)
+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+......+.........
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 998754322 2222345689999999999999999999999999999999999999987766666667766666666666
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 254 SLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
....+++.............+.+++.+||+.||++|||+.|+++.|+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 6667777777777888999999999999999999999999999999753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=391.01 Aligned_cols=235 Identities=22% Similarity=0.277 Sum_probs=194.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
.++|++.+.||+|+||.||+|+.+ +|+.||||++........+.+.+|+++|+.++|||||+++++|.+.+.+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999876 5999999999877666677899999999999999999999999999999999999
Q ss_pred ccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCC--CCcEEeeeccceecCCCCcccc
Q 048280 128 VINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDK--WIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 128 ~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~--~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|.||+|.++| .|++.||.|||+++ ||||||+||||+.+ +.+||+|||+++.+..... .
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~--~ 313 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--V 313 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE--E
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc--e
Confidence 9999997655 78999999999999 99999999999854 8999999999998754332 3
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
...+||+.|||||++.+..|+.++|||||||+||||++|..||...... ............ .. ....
T Consensus 314 ~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~------~~~~~i~~~~~~---~~----~~~~ 380 (573)
T 3uto_A 314 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCDWN---MD----DSAF 380 (573)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTCCC---CC----SGGG
T ss_pred eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHhCCCC---CC----cccc
Confidence 3468999999999999999999999999999999999999998643221 111122111110 00 1111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
......+.+||.+||+.||.+|||+.|+++.
T Consensus 381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 381 SGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1234568899999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=365.30 Aligned_cols=272 Identities=40% Similarity=0.680 Sum_probs=228.6
Q ss_pred HHhhhCCCCChHHHHHhhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCc-ccHHHHHHHHHHHHHhCCCCccc
Q 048280 32 IAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSN-QGKKEFENEAKLLARVQHRNVVN 110 (381)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~ 110 (381)
+.....+.|++.++....++|++.+.||+|+||.||+|+..+++.||||++..... .....+.+|++++++++||||++
T Consensus 12 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 91 (326)
T 3uim_A 12 VHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 91 (326)
T ss_dssp ---CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCC
T ss_pred cccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccc
Confidence 33456678999999999999999999999999999999988899999999975432 22346899999999999999999
Q ss_pred EEEEEeeCCeEEEEEecccCCCHHHHH-------------------HhhhhhhhHhhhh---c--cCCccccceEeCCCC
Q 048280 111 LLGYCAHGAEKLLIYEYVINESLDKVL-------------------FSLIKDIQILFRK---K--KTDIKASNILLDDKW 166 (381)
Q Consensus 111 ~~~~~~~~~~~~lv~E~~~~g~L~~~l-------------------~~~~~~l~~lh~~---~--HrDlkp~NIll~~~~ 166 (381)
+++++...+..++||||+.+++|.+++ .|++.+|.|||+. + ||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~ 171 (326)
T 3uim_A 92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171 (326)
T ss_dssp CCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred eEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence 999999999999999999999997655 6788999999998 6 999999999999999
Q ss_pred CcEEeeeccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCC--ccccccHHHH
Q 048280 167 IPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNL--DVDAQNLLDW 244 (381)
Q Consensus 167 ~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~--~~~~~~~~~~ 244 (381)
.+||+|||++...............||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .........+
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251 (326)
T ss_dssp CEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred CEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence 99999999999876554444455679999999999999999999999999999999999999985321 1222344455
Q ss_pred HHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 245 AYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
..............+..............+.+++.+||+.||.+|||+.+|++.|+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 55555555556666677777788889999999999999999999999999999998754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=384.02 Aligned_cols=232 Identities=23% Similarity=0.285 Sum_probs=184.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHH---HHHHHHhCCCCcccEEEEEeeCCeE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENE---AKLLARVQHRNVVNLLGYCAHGAEK 121 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~hpnIv~~~~~~~~~~~~ 121 (381)
.++|++.+.||+|+||.||+|+.. +|+.||||++.+.. ......+.+| +.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 467999999999999999999876 59999999996431 1223344444 5555666899999999999999999
Q ss_pred EEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 122 LLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
|||||||.||+|..+| .|++.||.|||+++ ||||||+||||+.+|.+||+|||+|+.+....
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~- 346 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 346 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC-
Confidence 9999999999998766 78999999999999 99999999999999999999999999765432
Q ss_pred ccccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC
Q 048280 185 HVNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
....+||+.|||||++.+ ..|+.++|||||||+||||++|..||......+...+. ....... ..+
T Consensus 347 --~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~---~~i~~~~-------~~~- 413 (689)
T 3v5w_A 347 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTLTMA-------VEL- 413 (689)
T ss_dssp --CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH---HHHHHCC-------CCC-
T ss_pred --CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HhhcCCC-------CCC-
Confidence 234689999999999975 57999999999999999999999999643322221111 1111111 111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 048280 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPT-----MRRVVV 297 (381)
Q Consensus 264 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 297 (381)
+......+.+||.+||+.||.+|++ ++||++
T Consensus 414 ---p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 414 ---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ---CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ---CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1123456889999999999999998 678764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=342.36 Aligned_cols=236 Identities=24% Similarity=0.373 Sum_probs=195.5
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
..++|++.+.||+|+||.||+|... +++.||||++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 3578999999999999999999864 689999999977666667889999999999999999999999999999999999
Q ss_pred cccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccc
Q 048280 127 YVINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV 190 (381)
Q Consensus 127 ~~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 190 (381)
|+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++........ .....
T Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 176 (297)
T 3fxz_A 98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTM 176 (297)
T ss_dssp CCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCC
T ss_pred CCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-ccCCc
Confidence 99999998765 68999999999999 999999999999999999999999987654332 23346
Q ss_pred ccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHH
Q 048280 191 AGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQ 270 (381)
Q Consensus 191 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (381)
.||+.|+|||++.+..++.++|||||||++|+|++|..||...... ............ . .......
T Consensus 177 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~-~-------~~~~~~~ 242 (297)
T 3fxz_A 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP-E-------LQNPEKL 242 (297)
T ss_dssp CSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC-C-------CSCGGGS
T ss_pred cCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC-C-------CCCcccc
Confidence 7999999999999999999999999999999999999998543221 111111111110 0 0112233
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 271 IAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 271 ~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
...+.+|+.+||+.||.+|||+.|+++.
T Consensus 243 ~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 243 SAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 4568899999999999999999999863
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=339.13 Aligned_cols=240 Identities=24% Similarity=0.374 Sum_probs=194.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
.++|.+.+.||+|+||.||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 468999999999999999999876 5899999999776666778899999999999999999999999999999999999
Q ss_pred ccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc--
Q 048280 128 VINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN-- 187 (381)
Q Consensus 128 ~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~-- 187 (381)
+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++..........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 168 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence 9999998765 68999999999999 999999999999999999999999987644332211
Q ss_pred -----------cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCccc
Q 048280 188 -----------TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLE 256 (381)
Q Consensus 188 -----------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (381)
....||+.|+|||++.+..++.++|||||||++|+|++|..|+.............. .......
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-~~~~~~~---- 243 (310)
T 3s95_A 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-RGFLDRY---- 243 (310)
T ss_dssp -----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-HHHHHHT----
T ss_pred ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-hcccccc----
Confidence 145799999999999999999999999999999999999999865433221100000 0000000
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 257 IVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.. ...+..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 244 -~~--------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 244 -CP--------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp -CC--------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CC--------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00 11123478899999999999999999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=342.85 Aligned_cols=247 Identities=26% Similarity=0.395 Sum_probs=186.9
Q ss_pred CChHHHHHhhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEee
Q 048280 40 FPFEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAH 117 (381)
Q Consensus 40 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 117 (381)
+....+....++|++.+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|++++++++||||+++++++.+
T Consensus 27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp -----CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCcccccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 444444455778999999999999999999874 8899999987553 2334678999999999999999999999999
Q ss_pred CCeEEEEEecccCCCHHHHH------------------HhhhhhhhHhhhhc----cCCccccceEeCCCCCcEEeeecc
Q 048280 118 GAEKLLIYEYVINESLDKVL------------------FSLIKDIQILFRKK----KTDIKASNILLDDKWIPKIADFGM 175 (381)
Q Consensus 118 ~~~~~lv~E~~~~g~L~~~l------------------~~~~~~l~~lh~~~----HrDlkp~NIll~~~~~~kL~DFG~ 175 (381)
....++||||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 99999999999999997665 58899999999976 999999999999999999999999
Q ss_pred ceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcc
Q 048280 176 ARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSL 255 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (381)
++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ... ..........
T Consensus 186 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~---~~~~~~~~~~ 258 (309)
T 3p86_A 186 SRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA---QVV---AAVGFKCKRL 258 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH---HHH---HHHHHSCCCC
T ss_pred Cccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHHhcCCCC
Confidence 98653322 2223467999999999999999999999999999999999999998643221 111 1111111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 256 EIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
.........+.+|+.+||+.||.+|||+.+|++.|+...
T Consensus 259 ---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 259 ---------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111123356889999999999999999999999997653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=338.39 Aligned_cols=248 Identities=23% Similarity=0.347 Sum_probs=200.8
Q ss_pred hCCCCChHHHHHhhcC----------CCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhC
Q 048280 36 EQKHFPFEALVSATKN----------FHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQ 104 (381)
Q Consensus 36 ~~~~~~~~~~~~~~~~----------y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 104 (381)
....++++++..+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++
T Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 100 (321)
T 2c30_A 21 QSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ 100 (321)
T ss_dssp ----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC
T ss_pred cCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC
Confidence 4456888888777754 677789999999999999976 69999999998776667788999999999999
Q ss_pred CCCcccEEEEEeeCCeEEEEEecccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCc
Q 048280 105 HRNVVNLLGYCAHGAEKLLIYEYVINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIP 168 (381)
Q Consensus 105 hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~ 168 (381)
||||+++++++...+..++||||+.+++|.+++ .|++.+|.|||..+ ||||||+|||++.++.+
T Consensus 101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~ 180 (321)
T 2c30_A 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRV 180 (321)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCE
T ss_pred CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcE
Confidence 999999999999999999999999999998765 78999999999999 99999999999999999
Q ss_pred EEeeeccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 048280 169 KIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKL 248 (381)
Q Consensus 169 kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 248 (381)
||+|||++..+..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ......
T Consensus 181 kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~------~~~~~~ 253 (321)
T 2c30_A 181 KLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV------QAMKRL 253 (321)
T ss_dssp EECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHH
T ss_pred EEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH
Confidence 9999999987654322 223467999999999999999999999999999999999999998643221 111111
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 249 YKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
. .... +.+ .........+.+++.+||+.||++|||+.++++.
T Consensus 254 ~-~~~~-----~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 254 R-DSPP-----PKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp H-HSSC-----CCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred h-cCCC-----CCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 1111 111 1111234568899999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=331.55 Aligned_cols=264 Identities=33% Similarity=0.566 Sum_probs=211.3
Q ss_pred hhhCCCCChHHHHHhhcCCCCC------CcccccCCeeEEEEEECCCcEEEEEEecCCC----cccHHHHHHHHHHHHHh
Q 048280 34 AREQKHFPFEALVSATKNFHPS------NKLGEGGFGPVFKGKLDDGREIAVKKLSHSS----NQGKKEFENEAKLLARV 103 (381)
Q Consensus 34 ~~~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l 103 (381)
......|++.++..++++|... +.||+|+||.||+|.. +++.||||++.... ....+.+.+|+.+++++
T Consensus 9 ~~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l 87 (307)
T 2nru_A 9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC 87 (307)
T ss_dssp --CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC
T ss_pred CCCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc
Confidence 3456789999999999999877 8999999999999987 48899999986532 23357899999999999
Q ss_pred CCCCcccEEEEEeeCCeEEEEEecccCCCHHHHH------------------HhhhhhhhHhhhhc--cCCccccceEeC
Q 048280 104 QHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVL------------------FSLIKDIQILFRKK--KTDIKASNILLD 163 (381)
Q Consensus 104 ~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~~~l------------------~~~~~~l~~lh~~~--HrDlkp~NIll~ 163 (381)
+||||+++++++.+.+..++||||+++++|.+++ .|++.+|.|||..+ ||||||+|||++
T Consensus 88 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 88 QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD 167 (307)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred CCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEc
Confidence 9999999999999999999999999999997655 57899999999998 999999999999
Q ss_pred CCCCcEEeeeccceecCCCCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHH
Q 048280 164 DKWIPKIADFGMARLFPEDQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLL 242 (381)
Q Consensus 164 ~~~~~kL~DFG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~ 242 (381)
.++.+||+|||++......... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||......... .
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~ 244 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL--L 244 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT--T
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH--H
Confidence 9999999999999876543222 2234578999999998765 5899999999999999999999998754432221 1
Q ss_pred HHHHHHhhcC-CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 243 DWAYKLYKKD-KSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 243 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.......... .....+++.+ ..........+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1111111111 1122233322 345677788899999999999999999999999999764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=346.63 Aligned_cols=238 Identities=26% Similarity=0.415 Sum_probs=192.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC--------CCcEEEEEEecCCC-cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeC
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD--------DGREIAVKKLSHSS-NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHG 118 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 118 (381)
.++|++.+.||+|+||.||+|++. ++..||||++.... ....+.+.+|+.+++++ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999752 35679999997653 23456789999999999 899999999999999
Q ss_pred CeEEEEEecccCCCHHHHH-------------------------------HhhhhhhhHhhhhc--cCCccccceEeCCC
Q 048280 119 AEKLLIYEYVINESLDKVL-------------------------------FSLIKDIQILFRKK--KTDIKASNILLDDK 165 (381)
Q Consensus 119 ~~~~lv~E~~~~g~L~~~l-------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~ 165 (381)
+..|+||||+.+|+|.+++ .|++.+|.|||+.+ ||||||+||||+.+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 239 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN 239 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCC
Confidence 9999999999999997654 57899999999999 99999999999999
Q ss_pred CCcEEeeeccceecCCCCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHH
Q 048280 166 WIPKIADFGMARLFPEDQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLD 243 (381)
Q Consensus 166 ~~~kL~DFG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~ 243 (381)
+.+||+|||+++.+...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||...... .+..
T Consensus 240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~~~~ 316 (370)
T 2psq_A 240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---ELFK 316 (370)
T ss_dssp CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH
T ss_pred CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH
Confidence 99999999999976543322 2233457889999999999999999999999999999999 99998643221 2221
Q ss_pred HHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 244 WAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
....... ...+..+...+.+|+.+||+.||.+|||+.||++.|+.+
T Consensus 317 ----~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 317 ----LLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp ----HHHTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111111 111122345688999999999999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=339.08 Aligned_cols=232 Identities=23% Similarity=0.321 Sum_probs=190.7
Q ss_pred hhcCCCCCCcccccCCeeEEEEEE-CCCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKL-DDGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
..++|++.+.||+|+||.||+|++ .+|+.||||++... .....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 357899999999999999999987 46999999999654 333456788999999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|||+++++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++....... ..
T Consensus 93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~ 170 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KL 170 (328)
T ss_dssp ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--GG
T ss_pred EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--cc
Confidence 9999999997665 78999999999999 99999999999999999999999998664332 23
Q ss_pred cccccCccccchhHHhhCCCC-chhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLS-VKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
...+||+.|+|||++.+..+. .++|||||||++|+|++|+.||..... ............. .|
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~~----~p------ 234 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KELRERVLRGKYR----IP------ 234 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC----CC------
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC----CC------
Confidence 456799999999999988875 899999999999999999999864321 1111122211110 01
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
......+.+|+.+||..||.+|||+.|+++.
T Consensus 235 -~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 235 -FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1123557889999999999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=330.14 Aligned_cols=239 Identities=25% Similarity=0.395 Sum_probs=197.4
Q ss_pred hhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
..++|++.+.||+|+||.||+|+..++..||||++.... ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 356899999999999999999999888899999996543 3457799999999999999999999999999999999999
Q ss_pred ccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 128 VINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 128 ~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
+++++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++.............
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 164 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG 164 (268)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCS
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccC
Confidence 9999997665 68899999999999 99999999999999999999999999776554444445
Q ss_pred cccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 190 VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
..+|+.|+|||++.+..++.++|||||||++|+|++ |..||....... ......... ....+.
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~---~~~~~~------- 228 (268)
T 3sxs_A 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VVLKVSQGH---RLYRPH------- 228 (268)
T ss_dssp CCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHTTC---CCCCCT-------
T ss_pred CCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH------HHHHHHcCC---CCCCCC-------
Confidence 567788999999999999999999999999999999 999985432211 111111111 111111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
.....+.+++.+||+.||.+|||+.++++.|+...
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 229 LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 12346888999999999999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=331.88 Aligned_cols=237 Identities=24% Similarity=0.399 Sum_probs=194.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
.++|++.+.||+|+||.||+|+..+++.||+|++.... ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 46799999999999999999999888999999997553 34578999999999999999999999999999999999999
Q ss_pred cCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccc
Q 048280 129 INESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV 190 (381)
Q Consensus 129 ~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 190 (381)
++++|.+++ .|++.++.+||+.+ ||||||+|||++.++.+||+|||++..............
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 167 (269)
T 4hcu_A 88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 167 (269)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccccCc
Confidence 999998765 68899999999998 999999999999999999999999987654333333345
Q ss_pred ccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHH
Q 048280 191 AGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGD 269 (381)
Q Consensus 191 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (381)
.+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... ........ .. ....+ ..
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~~~~~~-~~--~~~~~-------~~ 231 (269)
T 4hcu_A 168 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDIST-GF--RLYKP-------RL 231 (269)
T ss_dssp TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHT-TC--CCCCC-------TT
T ss_pred ccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHhc-Cc--cCCCC-------Cc
Confidence 67788999999999999999999999999999999 89888643221 11111111 10 11111 11
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 270 QIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 270 ~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
....+.+++.+||+.||.+|||+.++++.|+..
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 232 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 235688999999999999999999999999764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=335.97 Aligned_cols=243 Identities=23% Similarity=0.328 Sum_probs=190.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc---ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 568999999999999999999865 589999999865432 3346788999999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|||+++++|.+++ .|++.+|.|+|+.+ ||||||+|||++.++.+||+|||++...........
T Consensus 90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 169 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169 (294)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccccc
Confidence 9999999998765 68999999999999 999999999999999999999999987654443334
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ........... . .......
T Consensus 170 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~-~-----~~~~~~~ 237 (294)
T 4eqm_A 170 NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQDSV-P-----NVTTDVR 237 (294)
T ss_dssp -----CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSSCC-C-----CHHHHSC
T ss_pred CccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhccC-C-----Ccchhcc
Confidence 4567999999999999999999999999999999999999998643221 11111111111 0 0000111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhcCCC
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRP-TMRRVVVMLSKKP 303 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~~~ 303 (381)
...+..+.+++.+||+.||.+|| +++++.+.|....
T Consensus 238 ~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 238 KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 12345688899999999999999 9999999998764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=340.55 Aligned_cols=238 Identities=25% Similarity=0.408 Sum_probs=190.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC----CCcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD----DGREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
.++|++.+.||+|+||.||+|++. .+..||||++... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467899999999999999999874 3456999999764 33445679999999999999999999999999999999
Q ss_pred EEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 124 IYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 124 v~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
||||+.+++|.+++ .|++.+|.|||+.+ ||||||+||||+.++.+||+|||+++.+......
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 207 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----C
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccc
Confidence 99999999998765 67899999999999 9999999999999999999999999977543222
Q ss_pred --cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 186 --VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... ... .. ......
T Consensus 208 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~---~~-~~~~~~-------- 272 (325)
T 3kul_A 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVI---SS-VEEGYR-------- 272 (325)
T ss_dssp CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHH---HH-HHTTCC--------
T ss_pred eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHH---HH-HHcCCC--------
Confidence 1223446778999999999999999999999999999999 99998543221 111 11 111110
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.......+..+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 273 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 273 -LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111122345688999999999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=354.66 Aligned_cols=243 Identities=23% Similarity=0.395 Sum_probs=197.7
Q ss_pred HHHHhhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 44 ALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 44 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
......++|++.+.||+|+||.||+|.++++..||||++.... ...+.+.+|+.+|++++||||+++++++. ....++
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 3445567899999999999999999999888999999997644 45688999999999999999999999987 567899
Q ss_pred EEecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 124 IYEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 124 v~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
||||+.+|+|.+++ .|++.+|.|||+++ ||||||+||||+.++.+||+|||+++.......
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999998765 68899999999999 999999999999999999999999987643322
Q ss_pred ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC
Q 048280 185 HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
.......++..|+|||++....++.++|||||||+||||++ |+.||...... .... . ......
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~---~-i~~~~~--------- 403 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIR---A-LERGYR--------- 403 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH---H-HHHTCC---------
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHH---H-HHcCCC---------
Confidence 22233456788999999999999999999999999999999 99998643221 1111 1 111111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 048280 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKPG 304 (381)
Q Consensus 264 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 304 (381)
...+..++..+.+|+.+||+.||++|||+.+|++.|+....
T Consensus 404 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 01112234568899999999999999999999999988753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=339.90 Aligned_cols=237 Identities=23% Similarity=0.313 Sum_probs=187.2
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc-ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN-QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
..++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 3578999999999999999999876 689999999865432 23466889999999999999999999999999999999
Q ss_pred ecccCCCHHH---------------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc-ccc
Q 048280 126 EYVINESLDK---------------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT-HVN 187 (381)
Q Consensus 126 E~~~~g~L~~---------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~-~~~ 187 (381)
||+.+++|.+ ++.|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++.+..... ...
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 164 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (323)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence 9999988854 4589999999999999 999999999999999999999999986543222 122
Q ss_pred cccccCccccchhHHhhCCC-CchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHL-SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ... .+..... ....
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~-----~~~~~~~--------~~~~ 230 (323)
T 3tki_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYS-----DWKEKKT--------YLNP 230 (323)
T ss_dssp CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHH-----HHHTTCT--------TSTT
T ss_pred CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHH-----HHhcccc--------cCCc
Confidence 34679999999999988776 7899999999999999999999964432211 111 1111100 0011
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.......+.+|+.+||+.||.+|||+.|+++.
T Consensus 231 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 12234567889999999999999999999764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=340.60 Aligned_cols=249 Identities=23% Similarity=0.301 Sum_probs=192.1
Q ss_pred hhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC----eEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA----EKLL 123 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~l 123 (381)
..++|++.+.||+|+||.||+|+.. ++.||||++.... .....+.+|+.++++++||||+++++++.... ..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3578999999999999999999887 7999999996543 23345677999999999999999999998744 4799
Q ss_pred EEecccCCCHHHHH--------------HhhhhhhhHhhhh----------c--cCCccccceEeCCCCCcEEeeeccce
Q 048280 124 IYEYVINESLDKVL--------------FSLIKDIQILFRK----------K--KTDIKASNILLDDKWIPKIADFGMAR 177 (381)
Q Consensus 124 v~E~~~~g~L~~~l--------------~~~~~~l~~lh~~----------~--HrDlkp~NIll~~~~~~kL~DFG~~~ 177 (381)
||||+++|+|.+++ .|++.+|.|||+. + ||||||+|||++.++.+||+|||+++
T Consensus 100 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~ 179 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179 (322)
T ss_dssp EEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccc
Confidence 99999999998765 6899999999988 6 99999999999999999999999998
Q ss_pred ecCCCCcc-cccccccCccccchhHHhhC-----CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHH--------
Q 048280 178 LFPEDQTH-VNTRVAGTNGYMAPEYVMHG-----HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLD-------- 243 (381)
Q Consensus 178 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~-------- 243 (381)
.+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..........+..
T Consensus 180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (322)
T 3soc_A 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL 259 (322)
T ss_dssp EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCH
T ss_pred ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCch
Confidence 76543322 22345799999999999873 45678999999999999999999986543322211111
Q ss_pred -HHHHHhhcCCcccccCCCCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 244 -WAYKLYKKDKSLEIVDPSLAAS-DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 244 -~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.......... ..+.+... ........+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 260 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 260 EDMQEVVVHKK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp HHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhhhhhhccc----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0111111111 11111111 1224566799999999999999999999999999754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=330.45 Aligned_cols=238 Identities=25% Similarity=0.395 Sum_probs=192.0
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
...++|++.+.||+|+||.||++.+.++..||||++.... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 3467899999999999999999999888899999997553 345789999999999999999999999999999999999
Q ss_pred cccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 127 YVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 127 ~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
|+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++............
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (283)
T 3gen_A 100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 179 (283)
T ss_dssp CCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTT
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccccccc
Confidence 99999997765 68899999999999 9999999999999999999999999876443333333
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
...+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...... ........ .. ....+
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------~~~~~~~~-~~--~~~~~------- 243 (283)
T 3gen_A 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEHIAQ-GL--RLYRP------- 243 (283)
T ss_dssp STTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHT-TC--CCCCC-------
T ss_pred CCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------HHHHHHhc-cc--CCCCC-------
Confidence 4557788999999999999999999999999999998 99998643221 11111111 10 01111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
......+.+|+.+||+.||.+|||+.++++.|..
T Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 244 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 1123568889999999999999999999999865
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=341.22 Aligned_cols=245 Identities=28% Similarity=0.429 Sum_probs=189.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEE-----CCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEee--CCeE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKL-----DDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAH--GAEK 121 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~ 121 (381)
.++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 56899999999999999999984 2588999999987766666789999999999999999999999864 3568
Q ss_pred EEEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 122 LLIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
++||||+++++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++.......
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC------
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCc
Confidence 9999999999998765 68999999999999 99999999999999999999999998764432
Q ss_pred cc--cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcc---------ccccHHHHHHHHhhcC
Q 048280 184 TH--VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDV---------DAQNLLDWAYKLYKKD 252 (381)
Q Consensus 184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~---------~~~~~~~~~~~~~~~~ 252 (381)
.. ......++..|+|||++.+..++.++|||||||++|+|++|..|+...... ................
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (295)
T 3ugc_A 169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248 (295)
T ss_dssp -------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhcc
Confidence 21 122345677899999999999999999999999999999999887532110 0000000111111111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 253 KSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
. ........+..+.+|+.+||+.||++|||+.||++.|+.+
T Consensus 249 ~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 249 G---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp C---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred C---------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1 1111223346688999999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=334.77 Aligned_cols=245 Identities=24% Similarity=0.334 Sum_probs=187.2
Q ss_pred hhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCc--ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSN--QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
..++|++.+.||+|+||.||+|+..+++.||||++..... .....+.+|++++++++||||+++++++.+....++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 3578999999999999999999998899999999965422 23467889999999999999999999999999999999
Q ss_pred ecccCCCHHHH----------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 126 EYVINESLDKV----------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 126 E~~~~g~L~~~----------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
||+.+ +|.++ +.|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++....... ..
T Consensus 99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~ 176 (311)
T 3niz_A 99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SY 176 (311)
T ss_dssp ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-cc
Confidence 99975 55443 478999999999999 999999999999999999999999987643322 22
Q ss_pred cccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccc---------
Q 048280 188 TRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEI--------- 257 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 257 (381)
....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+. ................
T Consensus 177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhhhhccchh
Confidence 34568999999999977 4689999999999999999999999975443322 2222222111110000
Q ss_pred ---cCCCCCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 258 ---VDPSLAAS----DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 258 ---~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
........ ........+.+|+.+||+.||.+|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000 01112356789999999999999999999987
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=329.28 Aligned_cols=251 Identities=22% Similarity=0.273 Sum_probs=198.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC--eEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA--EKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv 124 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999876 48999999997543 334577889999999999999999999998765 78999
Q ss_pred EecccCCCHHHHH------------------HhhhhhhhHhhhhc--cCCccccceEe----CCCCCcEEeeeccceecC
Q 048280 125 YEYVINESLDKVL------------------FSLIKDIQILFRKK--KTDIKASNILL----DDKWIPKIADFGMARLFP 180 (381)
Q Consensus 125 ~E~~~~g~L~~~l------------------~~~~~~l~~lh~~~--HrDlkp~NIll----~~~~~~kL~DFG~~~~~~ 180 (381)
|||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||| +.++.+||+|||+++.+.
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 9999999997665 68899999999999 99999999999 788889999999999765
Q ss_pred CCCcccccccccCccccchhHHh--------hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcC
Q 048280 181 EDQTHVNTRVAGTNGYMAPEYVM--------HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKD 252 (381)
Q Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (381)
.... .....||..|+|||++. +..++.++|||||||++|||++|+.||......... ...........
T Consensus 168 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~ 243 (319)
T 4euu_A 168 DDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIITGK 243 (319)
T ss_dssp TTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHHHHHC
T ss_pred CCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHHhcCC
Confidence 4432 23456899999999987 467899999999999999999999998643322221 11112222211
Q ss_pred Cc---ccc---------cCC--CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 253 KS---LEI---------VDP--SLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 253 ~~---~~~---------~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
.. ... ..+ .............+.+|+.+||+.||++|||++|+++......
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 10 000 000 1112345778888999999999999999999999999987643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=340.04 Aligned_cols=236 Identities=24% Similarity=0.308 Sum_probs=190.7
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc------ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCe
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN------QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAE 120 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 120 (381)
..+.|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3568999999999999999999876 589999999975432 235789999999999999999999999999999
Q ss_pred EEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCC----CcEEeeeccceec
Q 048280 121 KLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKW----IPKIADFGMARLF 179 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~----~~kL~DFG~~~~~ 179 (381)
.++||||+.+|+|.+++ .|++.+|.|||..+ ||||||+|||++.++ .+||+|||+++.+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 99999999999998765 78999999999999 999999999998777 7999999999976
Q ss_pred CCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccC
Q 048280 180 PEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVD 259 (381)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .. .......... .+
T Consensus 170 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~~---~~~i~~~~~~---~~ 238 (361)
T 2yab_A 170 EDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ET---LANITAVSYD---FD 238 (361)
T ss_dssp CTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HH---HHHHHTTCCC---CC
T ss_pred CCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HH---HHHHHhcCCC---CC
Confidence 5432 223467999999999999999999999999999999999999998643221 11 1111111100 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 260 PSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 260 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
+.. .......+.+||.+||..||.+|||+.|+++.
T Consensus 239 ~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 239 EEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 01123568899999999999999999999863
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=334.86 Aligned_cols=232 Identities=22% Similarity=0.270 Sum_probs=189.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999876 5899999999653 233456788999999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|||+++|+|..++ .|++.+|.|||+++ ||||||+|||++.++.+||+|||+++....... ..
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~-~~ 162 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 162 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-CB
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC-cc
Confidence 9999999997654 68999999999999 999999999999999999999999986432222 23
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ......... .+ +
T Consensus 163 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~---~~~i~~~~~-------~~----p 225 (337)
T 1o6l_A 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERL---FELILMEEI-------RF----P 225 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHH---HHHHHHCCC-------CC----C
T ss_pred cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH---HHH---HHHHHcCCC-------CC----C
Confidence 356799999999999999999999999999999999999999864321 111 111111110 01 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRP-----TMRRVVVM 298 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 298 (381)
......+.+||.+||+.||.+|| ++.||++.
T Consensus 226 ~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 12335688999999999999999 89999764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=346.89 Aligned_cols=240 Identities=25% Similarity=0.351 Sum_probs=192.0
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
...++|++.+.||+|+||.||+|++. +++.||||++.... ......+.+|++++++++||||+++++++...+..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 34567889999999999999999986 68999999987542 22335688999999999999999999999999999999
Q ss_pred EecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 125 YEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 125 ~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
|||+++|+|.+++ .|++.++.|||+.+ ||||||+|||++.++.+||+|||+++.........
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 9999999997665 67899999999999 99999999999999999999999998754332211
Q ss_pred c-cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 187 N-TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 187 ~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
. ....+++.|+|||++.+..++.++|||||||++|||++ |..||....... . ..........
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~----~~~~~~~~~~--------- 334 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---T----REFVEKGGRL--------- 334 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---H----HHHHHTTCCC---------
T ss_pred cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCCCC---------
Confidence 1 12235678999999999999999999999999999998 998886432211 1 1111111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
..+...+..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 335 PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 11112345688999999999999999999999998753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=343.63 Aligned_cols=238 Identities=25% Similarity=0.426 Sum_probs=181.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC----CCcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD----DGREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
.++|++.+.||+|+||.||+|+.. ++..||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 468999999999999999999864 4778999999754 33345679999999999999999999999999999999
Q ss_pred EEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 124 IYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 124 v~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
||||+++++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++........
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 203 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence 99999999998765 67899999999998 9999999999999999999999999876543221
Q ss_pred cc--cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 186 VN--TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 186 ~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
.. ....+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .... .......
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~~----~i~~~~~-------- 268 (373)
T 2qol_A 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVIK----AVDEGYR-------- 268 (373)
T ss_dssp ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHHH----HHHTTEE--------
T ss_pred ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCC--------
Confidence 11 12345778999999999999999999999999999998 99998543221 1111 1111110
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.......+..+.+|+.+||+.||.+||++.+|++.|+..
T Consensus 269 -~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 269 -LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp -CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 111122345688999999999999999999999999765
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=354.45 Aligned_cols=239 Identities=25% Similarity=0.396 Sum_probs=197.5
Q ss_pred hhcCCCCCCcccccCCeeEEEEEECC-CcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLDD-GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
..++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.|.+|+.+|++++||||++++++|......+||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 45678889999999999999999874 8899999997543 346789999999999999999999999999999999999
Q ss_pred cccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 127 YVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 127 ~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|+.+|+|.+++ .|++.+|.|||+++ ||||||+||||+.++.+||+|||+++..........
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 376 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 376 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECC
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeec
Confidence 99999998766 58899999999998 999999999999999999999999997754443333
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
....+++.|+|||++.+..++.++|||||||+||||++ |..||...... .+.. ...... ....
T Consensus 377 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~---------~~~~ 440 (495)
T 1opk_A 377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYE----LLEKDY---------RMER 440 (495)
T ss_dssp TTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH----HHHTTC---------CCCC
T ss_pred CCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCC---------CCCC
Confidence 34556789999999999999999999999999999999 88888643322 2221 111111 1111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
+..++..+.+||.+||+.||.+|||+.+|++.|+...
T Consensus 441 ~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 2233456889999999999999999999999998764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=339.42 Aligned_cols=233 Identities=19% Similarity=0.300 Sum_probs=183.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l 123 (381)
.++|++.+.||+|+||.||+|+.+ +++.||||++.+.. ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 568999999999999999999876 58899999997542 22334688899999988 89999999999999999999
Q ss_pred EEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 124 IYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 124 v~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
||||+.+|+|..++ .|++.+|.|||+.+ ||||||+||||+.++.+||+|||+++...... ..
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~~ 209 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 209 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CC
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC-Cc
Confidence 99999999997654 68999999999999 99999999999999999999999998633222 22
Q ss_pred ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccc--ccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDA--QNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ................ .+
T Consensus 210 ~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~-- 281 (396)
T 4dc2_A 210 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RI-- 281 (396)
T ss_dssp BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------CC--
T ss_pred cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------CC--
Confidence 3456899999999999999999999999999999999999999964322111 1111111221111110 11
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTM 292 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~ 292 (381)
+......+.+||.+||+.||.+||++
T Consensus 282 --p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 282 --PRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp --CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred --CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11233568899999999999999996
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=348.53 Aligned_cols=240 Identities=23% Similarity=0.403 Sum_probs=190.1
Q ss_pred HHhhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 46 VSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 46 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
....++|++.+.||+|+||.||+|.++.+..||||++.... ...+.+.+|+++|++++||||+++++++.+ +..++||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 34467788999999999999999999888889999997554 345789999999999999999999999876 6789999
Q ss_pred ecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 126 EYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 126 E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
||+.+|+|.+++ .|++.+|.|||+++ ||||||+|||++.++.+||+|||+++.........
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 999999998765 58899999999998 99999999999999999999999998765433333
Q ss_pred ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||...... ... ........ ..
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~----~~i~~~~~---------~~ 401 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVL----DQVERGYR---------MP 401 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH----HHHHTTCC---------CC
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCC---------CC
Confidence 334557889999999999999999999999999999999 89998643221 111 11111111 11
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 266 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
.+..++..+.+|+.+||+.||++|||+.+|++.|+...
T Consensus 402 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 12233456889999999999999999999999998865
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=346.24 Aligned_cols=238 Identities=20% Similarity=0.266 Sum_probs=189.5
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc--ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN--QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
...++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34678999999999999999999865 689999999975532 234678999999999999999999999999999999
Q ss_pred EEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeC---CCCCcEEeeeccceecCCCC
Q 048280 124 IYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLD---DKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 124 v~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~---~~~~~kL~DFG~~~~~~~~~ 183 (381)
||||+.+|+|.+.+ .|++.+|.|||+.+ ||||||+|||++ .++.+||+|||++.......
T Consensus 88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 99999999996544 78999999999999 999999999998 56789999999998765432
Q ss_pred cccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC
Q 048280 184 THVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 184 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..+. ..... ... ...
T Consensus 168 ~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~---~~~~---~~i~~-~~~-~~~----- 233 (444)
T 3soa_A 168 Q-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---HRLY---QQIKA-GAY-DFP----- 233 (444)
T ss_dssp C-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH---HHHHH-TCC-CCC-----
T ss_pred c-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---HHHH---HHHHh-CCC-CCC-----
Confidence 2 22346799999999999999999999999999999999999999854321 1111 11111 110 001
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 264 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
..........+.+|+.+||+.||.+|||+.|+++.
T Consensus 234 ~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 234 SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11111234568899999999999999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=347.61 Aligned_cols=244 Identities=20% Similarity=0.244 Sum_probs=194.5
Q ss_pred HHHHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeC
Q 048280 43 EALVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHG 118 (381)
Q Consensus 43 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 118 (381)
.++....++|++.+.||+|+||.||+|+.. +++.||+|++... .......+.+|+.+++.++||||++++++|.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344555789999999999999999999976 5889999998642 112234578999999999999999999999999
Q ss_pred CeEEEEEecccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCC
Q 048280 119 AEKLLIYEYVINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPED 182 (381)
Q Consensus 119 ~~~~lv~E~~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~ 182 (381)
...|+||||+++|+|.+++ .|++.+|.|||+.+ ||||||+||||+.++.+||+|||+++.+...
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 9999999999999998765 68999999999999 9999999999999999999999999987655
Q ss_pred CcccccccccCccccchhHHhhCC----CCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCccccc
Q 048280 183 QTHVNTRVAGTNGYMAPEYVMHGH----LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIV 258 (381)
Q Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
........+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... ..............
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~-- 293 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKNSLT-- 293 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTHHHHCC--
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------hHHHHHHhcccccc--
Confidence 444444678999999999998765 889999999999999999999998643221 11111111100000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHh
Q 048280 259 DPSLAASDSGDQIAMCIQIGLLCTQGDPQL--RPTMRRVVVML 299 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~L 299 (381)
.|. .......+.+||.+||..+|.+ ||+++||++.-
T Consensus 294 ~p~-----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 294 FPD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp CCT-----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred CCC-----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 011 0112356888999999999988 99999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=336.67 Aligned_cols=232 Identities=22% Similarity=0.353 Sum_probs=183.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC-------
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA------- 119 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------- 119 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||++++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467999999999999999999986 69999999997543 334578999999999999999999999986543
Q ss_pred --------------------------------------------------eEEEEEecccCCCHHHHH------------
Q 048280 120 --------------------------------------------------EKLLIYEYVINESLDKVL------------ 137 (381)
Q Consensus 120 --------------------------------------------------~~~lv~E~~~~g~L~~~l------------ 137 (381)
..++|||||.+++|.+++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 379999999999997654
Q ss_pred ------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc-----------ccccccccCccccc
Q 048280 138 ------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT-----------HVNTRVAGTNGYMA 198 (381)
Q Consensus 138 ------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~-----------~~~~~~~gt~~y~a 198 (381)
.|++.+|.|||+.+ ||||||+||||+.++.+||+|||+++....... .......||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 68999999999999 999999999999999999999999997754421 11234579999999
Q ss_pred hhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHH
Q 048280 199 PEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIG 278 (381)
Q Consensus 199 PE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 278 (381)
||++.+..++.++|||||||++|+|++|..|+. ..... ........ ...........+.+|+
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~~-~~~~~~~~---------~~~~~~~~~~~~~~li 306 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVRI-ITDVRNLK---------FPLLFTQKYPQEHMMV 306 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHHH-HHHHHTTC---------CCHHHHHHCHHHHHHH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHHH-HHHhhccC---------CCcccccCChhHHHHH
Confidence 999999999999999999999999999876531 00111 11111110 0111233445678999
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 048280 279 LLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 279 ~~cl~~dP~~RPs~~eil~~ 298 (381)
.+||+.||.+|||+.|+++.
T Consensus 307 ~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 307 QDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHCSSGGGSCCHHHHHHS
T ss_pred HHHccCCCCcCCCHHHHhhc
Confidence 99999999999999999863
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=333.32 Aligned_cols=235 Identities=24% Similarity=0.320 Sum_probs=189.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc------ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN------QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEK 121 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 121 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 457999999999999999999876 589999999865422 2467899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCC----CcEEeeeccceecC
Q 048280 122 LLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKW----IPKIADFGMARLFP 180 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~----~~kL~DFG~~~~~~ 180 (381)
++||||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++ .+||+|||+++.+.
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 9999999999998765 78999999999998 999999999998877 89999999998764
Q ss_pred CCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCC
Q 048280 181 EDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDP 260 (381)
Q Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ... .........
T Consensus 170 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~---~~~~~~~~~------ 235 (326)
T 2y0a_A 170 FGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETL---ANVSAVNYE------ 235 (326)
T ss_dssp TTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHH---HHHHHTCCC------
T ss_pred CCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHH---HHHHhcCCC------
Confidence 3322 23457999999999999999999999999999999999999998643221 111 111111100
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 261 SLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 261 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
............+.+|+.+||+.||.+|||+.++++.
T Consensus 236 -~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 236 -FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000001123567889999999999999999999874
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=338.35 Aligned_cols=231 Identities=23% Similarity=0.294 Sum_probs=184.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l 123 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.+++.+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 578999999999999999999876 5899999999653 223456788999999998 79999999999999999999
Q ss_pred EEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 124 IYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 124 v~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
||||+.+|+|..++ .|++.+|.|||+.+ ||||||+||||+.++.+||+|||+++...... ..
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~-~~ 180 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG-VT 180 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC-cc
Confidence 99999999997655 68999999999999 99999999999999999999999998543222 22
Q ss_pred ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........... ..|
T Consensus 181 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~~~----~~p------ 244 (353)
T 3txo_A 181 TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILNDEV----VYP------ 244 (353)
T ss_dssp -----CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC----CCC------
T ss_pred ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCC----CCC------
Confidence 33567999999999999999999999999999999999999998643221 11122222111 111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTM------RRVVV 297 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~------~eil~ 297 (381)
......+.+|+.+||+.||.+||++ .+|++
T Consensus 245 -~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 245 -TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1123557889999999999999998 77765
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=328.90 Aligned_cols=244 Identities=24% Similarity=0.361 Sum_probs=188.1
Q ss_pred hhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHH--hCCCCcccEEEEEee----CCeE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLAR--VQHRNVVNLLGYCAH----GAEK 121 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~----~~~~ 121 (381)
..++|++.+.||+|+||.||+|+. +++.||||++... ....+.+|.+++.. ++||||+++++++.. ....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 467899999999999999999988 4899999998643 34566778888877 789999999998754 3568
Q ss_pred EEEEecccCCCHHHHH--------------HhhhhhhhHhh--------hhc--cCCccccceEeCCCCCcEEeeeccce
Q 048280 122 LLIYEYVINESLDKVL--------------FSLIKDIQILF--------RKK--KTDIKASNILLDDKWIPKIADFGMAR 177 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l--------------~~~~~~l~~lh--------~~~--HrDlkp~NIll~~~~~~kL~DFG~~~ 177 (381)
++||||+.+|+|.+++ .|++.+|.||| +.+ ||||||+|||++.++.+||+|||+++
T Consensus 82 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 161 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 161 (301)
T ss_dssp EEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCee
Confidence 9999999999998765 68999999999 666 99999999999999999999999998
Q ss_pred ecCCCCccc---ccccccCccccchhHHhhC------CCCchhhhHhHHHHHHHHHhC----------CCCCCCCCcccc
Q 048280 178 LFPEDQTHV---NTRVAGTNGYMAPEYVMHG------HLSVKADVFSFGVVILELISG----------QRNSSFNLDVDA 238 (381)
Q Consensus 178 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg----------~~p~~~~~~~~~ 238 (381)
......... .....||+.|+|||++.+. .++.++|||||||++|||++| ..||........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~ 241 (301)
T 3q4u_A 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241 (301)
T ss_dssp EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc
Confidence 764433221 2234799999999999876 456799999999999999999 777754333222
Q ss_pred ccHHHHHHHHhhcCCcccccCCCCCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 239 QNLLDWAYKLYKKDKSLEIVDPSLAA-SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
. .... ........ ..+.... .........+.+|+.+||+.||.+|||+.+|++.|++
T Consensus 242 ~-~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 242 S-FEDM-RKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp C-HHHH-HHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred c-hhhh-hHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 1 1111 11111111 1111111 1223567789999999999999999999999999975
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=338.58 Aligned_cols=234 Identities=21% Similarity=0.273 Sum_probs=187.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC-----CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS-----SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 122 (381)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 457999999999999999999875 5899999998532 1224678999999999999999999999999999999
Q ss_pred EEEecccCCCHHHH-------------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCC---cEEeeecccee
Q 048280 123 LIYEYVINESLDKV-------------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWI---PKIADFGMARL 178 (381)
Q Consensus 123 lv~E~~~~g~L~~~-------------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~---~kL~DFG~~~~ 178 (381)
+||||+.+++|.++ +.|++.+|.|||+.+ ||||||+|||++.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 99999999999643 368999999999999 9999999999976554 99999999987
Q ss_pred cCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCccccc
Q 048280 179 FPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+. ......... .
T Consensus 183 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~---~~i~~~~~~---~ 251 (351)
T 3c0i_A 183 LGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLF---EGIIKGKYK---M 251 (351)
T ss_dssp CCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHH---HHHHHTCCC---C
T ss_pred ecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHH---HHHHcCCCC---C
Confidence 754332 2334579999999999999999999999999999999999999986421 1111 111111100 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 259 DPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.+.. .......+.+|+.+||+.||.+|||+.++++
T Consensus 252 ~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 252 NPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Cccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000 0112356889999999999999999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=333.61 Aligned_cols=235 Identities=18% Similarity=0.254 Sum_probs=190.6
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
..++|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 3578999999999999999999876 58899999986543 345678899999999999999999999999999999999
Q ss_pred cccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCC--CCCcEEeeeccceecCCCCccc
Q 048280 127 YVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDD--KWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 127 ~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~--~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
|+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++. ++.+||+|||++..+.....
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~-- 159 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-- 159 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE--
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc--
Confidence 99999997655 78999999999999 9999999999987 78999999999998754322
Q ss_pred ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ............. .. ..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~~---~~----~~ 226 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEYTF---DE----EA 226 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCC---CH----HH
T ss_pred cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHcCCCCC---Ch----hh
Confidence 23457899999999999888999999999999999999999998643221 1111111111100 00 00
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
....+..+.+|+.+||..||.+|||+.|+++.
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01223568899999999999999999999973
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=337.48 Aligned_cols=237 Identities=21% Similarity=0.307 Sum_probs=189.9
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
...++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34568999999999999999999876 58999999997543 2334678899999999999999999999999999999
Q ss_pred EEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCC---CCcEEeeeccceecCCCC
Q 048280 124 IYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDK---WIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 124 v~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~---~~~kL~DFG~~~~~~~~~ 183 (381)
||||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.+ +.+||+|||++.......
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 99999999996554 78999999999999 99999999999765 459999999998765332
Q ss_pred cccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC
Q 048280 184 THVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 184 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..+. ........ . ..
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~---~~i~~~~~--~-----~~ 250 (362)
T 2bdw_A 186 --AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLY---AQIKAGAY--D-----YP 250 (362)
T ss_dssp --SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHHHTCC--C-----CC
T ss_pred --ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHH---HHHHhCCC--C-----CC
Confidence 22346799999999999999999999999999999999999999854321 1111 11111110 0 00
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 264 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
..........+.+|+.+||+.||.+|||+.++++.
T Consensus 251 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 251 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11112234568899999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=325.21 Aligned_cols=234 Identities=28% Similarity=0.445 Sum_probs=180.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCc----ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSN----QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|++.+.||+|+||.||+|.+. ++.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 468999999999999999999976 88999999865422 2346789999999999999999999999999999999
Q ss_pred EecccCCCHHHHH--------------HhhhhhhhHhhhhc-----cCCccccceEeCC--------CCCcEEeeeccce
Q 048280 125 YEYVINESLDKVL--------------FSLIKDIQILFRKK-----KTDIKASNILLDD--------KWIPKIADFGMAR 177 (381)
Q Consensus 125 ~E~~~~g~L~~~l--------------~~~~~~l~~lh~~~-----HrDlkp~NIll~~--------~~~~kL~DFG~~~ 177 (381)
|||+.+++|.+++ .|++.++.|||+.+ ||||||+|||++. ++.+||+|||++.
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp EECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred EEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 9999999997664 78999999999988 9999999999986 7789999999998
Q ss_pred ecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccc
Q 048280 178 LFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEI 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (381)
....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ............
T Consensus 165 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~--- 232 (271)
T 3dtc_A 165 EWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AVAYGVAMNKLA--- 232 (271)
T ss_dssp --------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHTSCCC---
T ss_pred ccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHhhhcCCCC---
Confidence 6543322 2356899999999999999999999999999999999999998643211 111111111110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 258 VDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
..........+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 233 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 233 ------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11112234568899999999999999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=342.36 Aligned_cols=238 Identities=26% Similarity=0.384 Sum_probs=189.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEK 121 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 121 (381)
.++|++.+.||+|+||.||+|++. +++.||||++... .......+.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467999999999999999999843 4678999999654 333445788999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHH----------------------HhhhhhhhHhhhhc--cCCccccceEeCCCC---CcEEeeec
Q 048280 122 LLIYEYVINESLDKVL----------------------FSLIKDIQILFRKK--KTDIKASNILLDDKW---IPKIADFG 174 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l----------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~---~~kL~DFG 174 (381)
++||||+.+|+|.+++ .|++.+|.|||+.+ ||||||+||||+.++ .+||+|||
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG 229 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 229 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCc
Confidence 9999999999997655 67899999999999 999999999998554 59999999
Q ss_pred cceecCCCC-cccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcC
Q 048280 175 MARLFPEDQ-THVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKD 252 (381)
Q Consensus 175 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (381)
+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++ |..||...... .+. ......
T Consensus 230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~----~~i~~~ 302 (367)
T 3l9p_A 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVL----EFVTSG 302 (367)
T ss_dssp HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHH----HHHHTT
T ss_pred cccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcC
Confidence 997542221 112224567899999999999999999999999999999998 99998643221 111 111111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 253 KSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
... .........+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 303 ~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 303 GRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp CCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC---------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111 11112335688999999999999999999999999764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=328.51 Aligned_cols=244 Identities=25% Similarity=0.355 Sum_probs=184.4
Q ss_pred cCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
++|++.+.||+|+||.||+|+..+++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999998889999999996543 22346788999999999999999999999999999999999
Q ss_pred ccCCCHHHH----------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 128 VINESLDKV----------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 128 ~~~g~L~~~----------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
+.+ +|.++ +.|++.+|.|||+.+ ||||||+|||++.++.+||+|||++........ ....
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 159 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTH 159 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-cccc
Confidence 965 66544 478999999999999 999999999999999999999999987643222 2233
Q ss_pred cccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCc--------ccccCC
Q 048280 190 VAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKS--------LEIVDP 260 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~ 260 (381)
..||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+ .............. ....++
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHHCCCChhhchhhhccccccc
Confidence 5689999999999764 58999999999999999999999986533221 11111111111000 000011
Q ss_pred CCC-------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 261 SLA-------ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 261 ~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
... ..........+.+|+.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 110 00111234567899999999999999999999863
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=346.64 Aligned_cols=247 Identities=20% Similarity=0.266 Sum_probs=195.5
Q ss_pred CChHHHHHhhcCCCCCCcccccCCeeEEEEEECC-CcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEE
Q 048280 40 FPFEALVSATKNFHPSNKLGEGGFGPVFKGKLDD-GREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYC 115 (381)
Q Consensus 40 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 115 (381)
+.+.++....++|++.+.||+|+||.||+|+... ++.||||++.... ......+.+|+.++..++||||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3455666677899999999999999999999774 7899999986431 12223488999999999999999999999
Q ss_pred eeCCeEEEEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccce
Q 048280 116 AHGAEKLLIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMAR 177 (381)
Q Consensus 116 ~~~~~~~lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~ 177 (381)
.+.+..|+||||+.+|+|.+++ .|++.+|.|||+.+ ||||||+||||+.++.+||+|||+++
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL 223 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence 9999999999999999997765 67899999999999 99999999999999999999999998
Q ss_pred ecCCCCcccccccccCccccchhHHh-----hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcC
Q 048280 178 LFPEDQTHVNTRVAGTNGYMAPEYVM-----HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKD 252 (381)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (381)
.+...........+||+.|+|||++. ...++.++|||||||++|||++|+.||......+ .. .......
T Consensus 224 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~---~~---~~i~~~~ 297 (437)
T 4aw2_A 224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE---TY---GKIMNHK 297 (437)
T ss_dssp ECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHHTHH
T ss_pred hcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH---HH---Hhhhhcc
Confidence 77655444444568999999999997 4568999999999999999999999986432211 11 1111110
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 048280 253 KSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQL--RPTMRRVVVM 298 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~ 298 (381)
. ....|.... .....+.+||.+||..+|++ ||+++||++.
T Consensus 298 ~--~~~~p~~~~----~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 298 E--RFQFPTQVT----DVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp H--HCCCCSSCC----CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred c--cccCCcccc----cCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0 001111111 12355788999999988888 9999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=330.99 Aligned_cols=241 Identities=17% Similarity=0.212 Sum_probs=191.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEEEEe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++..... .+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 568999999999999999999864 689999999865432 24688999999999 99999999999999999999999
Q ss_pred cccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCC-----cEEeeeccceecCCCC
Q 048280 127 YVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWI-----PKIADFGMARLFPEDQ 183 (381)
Q Consensus 127 ~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~-----~kL~DFG~~~~~~~~~ 183 (381)
|+ +++|.+++ .|++.+|.|||+.+ ||||||+|||++.++. +||+|||+++.+....
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 99 99998765 68999999999999 9999999999998887 9999999999764432
Q ss_pred cc------cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccc
Q 048280 184 TH------VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEI 257 (381)
Q Consensus 184 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (381)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+................ ...
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-~~~ 243 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP-IEV 243 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC-HHH
T ss_pred CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC-HHH
Confidence 21 12356799999999999999999999999999999999999999976433322222222111111100 000
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 258 VDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.. . ..+ .+.+|+..||+.||.+||++.+|++.|+..
T Consensus 244 ~~----~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 244 LC----E----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HT----T----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred Hh----c----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 00 0 112 688999999999999999999999988643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=330.40 Aligned_cols=245 Identities=22% Similarity=0.355 Sum_probs=174.0
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
..++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 3568999999999999999999865 58999999997543 234477889999999999999999999999999999999
Q ss_pred ecccCCCHHHHH---------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCC
Q 048280 126 EYVINESLDKVL---------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPED 182 (381)
Q Consensus 126 E~~~~g~L~~~l---------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~ 182 (381)
||+. ++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 9997 5776554 48999999999999 9999999999999999999999999876433
Q ss_pred CcccccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCC--c-----
Q 048280 183 QTHVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDK--S----- 254 (381)
Q Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~----- 254 (381)
.. ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+ ............. .
T Consensus 162 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 162 VN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp CC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCGGGG
T ss_pred cc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhhhhh
Confidence 22 22345689999999999864 68999999999999999999999986543221 1222111111000 0
Q ss_pred -ccccCCCCC---CC---------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 255 -LEIVDPSLA---AS---------DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 255 -~~~~~~~~~---~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.....+... .. ........+.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000000000 00 00112356889999999999999999999976
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=341.70 Aligned_cols=249 Identities=28% Similarity=0.431 Sum_probs=196.3
Q ss_pred CCChHHHHHhhcCCCCCCcccccCCeeEEEEEE------CCCcEEEEEEecCCC-cccHHHHHHHHHHHHHh-CCCCccc
Q 048280 39 HFPFEALVSATKNFHPSNKLGEGGFGPVFKGKL------DDGREIAVKKLSHSS-NQGKKEFENEAKLLARV-QHRNVVN 110 (381)
Q Consensus 39 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~ 110 (381)
.+.........++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+++++++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 445555666788999999999999999999973 246889999997643 23346799999999999 7999999
Q ss_pred EEEEEeeCC-eEEEEEecccCCCHHHHH----------------------------------------------------
Q 048280 111 LLGYCAHGA-EKLLIYEYVINESLDKVL---------------------------------------------------- 137 (381)
Q Consensus 111 ~~~~~~~~~-~~~lv~E~~~~g~L~~~l---------------------------------------------------- 137 (381)
+++++.+.+ ..++||||+.+|+|.+++
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999998755 489999999999987654
Q ss_pred -----------------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc-c
Q 048280 138 -----------------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT-H 185 (381)
Q Consensus 138 -----------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~-~ 185 (381)
.|++.+|.|||+.+ ||||||+||||+.++.+||+|||+++.+..... .
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence 47899999999999 999999999999999999999999987644322 2
Q ss_pred cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 186 VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
......||+.|+|||++.+..++.++|||||||++|||++ |..||....... .. ...........
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~----~~~~~~~~~~~-------- 316 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EF----CRRLKEGTRMR-------- 316 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HH----HHHHHHTCCCC--------
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HH----HHHHHcCCCCC--------
Confidence 2335678899999999999999999999999999999998 999986433221 11 11111111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
........+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 317 -~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 317 -APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1111235688899999999999999999999999753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=338.76 Aligned_cols=235 Identities=21% Similarity=0.265 Sum_probs=191.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
.++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 568999999999999999999876 5899999999776555567899999999999999999999999999999999999
Q ss_pred ccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCC--CCCcEEeeeccceecCCCCcccc
Q 048280 128 VINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDD--KWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 128 ~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~--~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++. ++.+||+|||++..+..... .
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~--~ 207 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--V 207 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--E
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc--e
Confidence 9999997554 78999999999998 9999999999974 57899999999997654322 2
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ............ ..+ ...
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~i~~~~~~---~~~----~~~ 274 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKRCDWE---FDE----DAF 274 (387)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHCCCC---CCS----STT
T ss_pred eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC---CCc----ccc
Confidence 3357999999999999999999999999999999999999998643221 111111111100 111 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
......+.+||.+||+.||.+|||+.|+++.
T Consensus 275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 275 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 2234568899999999999999999999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=327.92 Aligned_cols=238 Identities=26% Similarity=0.423 Sum_probs=193.8
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
...++|++.+.||+|+||.||+|...++..||||++.... ...+.+.+|++++++++||||+++++++.. +..++|||
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence 3457899999999999999999998888899999996543 346789999999999999999999999874 55899999
Q ss_pred cccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 127 YVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 127 ~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|+.+++|.+++ .|++.+|.+||+.+ ||||||+|||++.++.+||+|||++...........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence 99999997654 68999999999999 999999999999999999999999998765443333
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
....++..|+|||++.+..++.++|||||||++|+|++ |..||...... ... .. ...... . ..
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~---~~-~~~~~~-----~----~~ 231 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVI---QN-LERGYR-----M----VR 231 (279)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH---HH-HHTTCC-----C----CC
T ss_pred cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHH---HH-HhcccC-----C----CC
Confidence 44567889999999999999999999999999999999 88888543221 111 11 111110 0 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.......+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 232 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 112345688999999999999999999999998764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=327.79 Aligned_cols=238 Identities=25% Similarity=0.401 Sum_probs=196.6
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEECC-CcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLDD-GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
...++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 356789999999999999999998764 8899999996543 34578999999999999999999999999999999999
Q ss_pred ecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 126 EYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 126 E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
||+.+++|.+++ .+++.+|.|||+.+ ||||||+|||++.++.+||+|||++..........
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 168 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 168 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEE
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcccc
Confidence 999999997665 58899999999999 99999999999999999999999998776554444
Q ss_pred ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
.....+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... ..... ...... ..
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~~----~~~~~~---------~~ 232 (288)
T 3kfa_A 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYEL----LEKDYR---------ME 232 (288)
T ss_dssp ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH----HHTTCC---------CC
T ss_pred ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HhccCC---------CC
Confidence 445667889999999999999999999999999999999 88888643322 11111 111110 11
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 266 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
.....+..+.+|+.+||+.||.+|||+.++++.|+.
T Consensus 233 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 112234568899999999999999999999998865
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=324.94 Aligned_cols=246 Identities=21% Similarity=0.285 Sum_probs=187.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc--ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN--QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999876 589999999975432 234678899999999999999999999999999999999
Q ss_pred cccCCCHH---------------HHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 127 YVINESLD---------------KVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 127 ~~~~g~L~---------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
|+.++.+. .++.|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++....... ....
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 160 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSA 160 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-CCCS
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-cccC
Confidence 99754332 24479999999999999 999999999999999999999999987643322 2234
Q ss_pred cccCccccchhHHhhCC-CCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccc------c----
Q 048280 190 VAGTNGYMAPEYVMHGH-LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEI------V---- 258 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~---- 258 (381)
..||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... .................... .
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 57899999999998766 89999999999999999999988643322 11222222221111100000 0
Q ss_pred -----CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 259 -----DPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 259 -----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
...............+.+|+.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000011122344668899999999999999999999863
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=325.61 Aligned_cols=238 Identities=22% Similarity=0.343 Sum_probs=179.3
Q ss_pred hhcCCCCCCcccccCCeeEEEEEECC----CcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLDD----GREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 122 (381)
..++|++.+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 45689999999999999999998642 4579999986543 334567899999999999999999999985 46689
Q ss_pred EEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 123 LIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 123 lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
+||||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171 (281)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccc
Confidence 999999999997665 68999999999999 999999999999999999999999987654433
Q ss_pred ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC
Q 048280 185 HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
.......+++.|+|||++.+..++.++|||||||++|||++ |..||......+ .... .......
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~----i~~~~~~-------- 236 (281)
T 1mp8_A 172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGR----IENGERL-------- 236 (281)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HHTTCCC--------
T ss_pred cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHH----HHcCCCC--------
Confidence 33334457789999999999999999999999999999997 888986543221 2111 1111110
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 264 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
......+..+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 237 -PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11122345688999999999999999999999998753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=338.53 Aligned_cols=233 Identities=21% Similarity=0.332 Sum_probs=188.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.+++.++||||++++++|.+....|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999876 5889999998643 233457788999999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|||+.+|+|..++ .|++.+|.|||+.+ ||||||+||||+.++.+||+|||+++.+.... ..
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~ 171 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--QI 171 (384)
T ss_dssp ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC--CB
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC--ce
Confidence 9999999997655 68999999999999 99999999999999999999999999764332 23
Q ss_pred cccccCccccchhHHhh---CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMH---GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
...+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............. ... .. .
T Consensus 172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~---~~~-~~------~---- 237 (384)
T 4fr4_A 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT---FET-TV------V---- 237 (384)
T ss_dssp CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH---HHH-CC------C----
T ss_pred eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH---Hhh-cc------c----
Confidence 45679999999999864 4589999999999999999999999965443332222211 111 10 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPT-MRRVVV 297 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~ 297 (381)
..+......+.+||.+||+.||.+||+ +.+|++
T Consensus 238 ~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 011122356889999999999999998 777764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=327.35 Aligned_cols=228 Identities=24% Similarity=0.313 Sum_probs=188.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467999999999999999999876 58999999986531 23456788999999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|||+.+|+|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++..... .
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~----~ 160 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----T 160 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----B
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc----c
Confidence 9999999998765 68999999999999 9999999999999999999999999876432 2
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
...+||+.|+|||++.+..++.++|||||||++|||++|..||..... ............ .+ +
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~-------~~----p 223 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAEL-------RF----P 223 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCCC-------CC----C
T ss_pred ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC-------CC----C
Confidence 346799999999999999999999999999999999999999864321 111122222110 01 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRP-----TMRRVVV 297 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 297 (381)
......+.+|+.+||..||.+|| ++++|++
T Consensus 224 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 224 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 12235688999999999999999 8999875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=333.03 Aligned_cols=237 Identities=19% Similarity=0.243 Sum_probs=180.1
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
..++|++.+.||+|+||.||+++.. +++.||||++..... ..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3578999999999999999999976 689999999975543 33678899999999999999999999999999999999
Q ss_pred cccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCC--cEEeeeccceecCCCCcccc
Q 048280 127 YVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWI--PKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 127 ~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~--~kL~DFG~~~~~~~~~~~~~ 187 (381)
|+.+|+|.+++ .|++.+|.|||+.+ ||||||+||||+.++. +||+|||+++...... ..
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~--~~ 174 (361)
T 3uc3_A 97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 174 (361)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--CC
Confidence 99999997655 78999999999999 9999999999987765 9999999997532221 22
Q ss_pred cccccCccccchhHHhhCCCCch-hhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVK-ADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||....... .............. . ...
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~~~--~-------~~~ 243 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILSVKY--S-------IPD 243 (361)
T ss_dssp ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHTTCC--C-------CCT
T ss_pred CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhcCCC--C-------CCC
Confidence 34579999999999998888666 899999999999999999986533221 22222222211110 0 001
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.......+.+|+.+||+.||.+|||+.|+++.
T Consensus 244 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11123567899999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=329.70 Aligned_cols=238 Identities=18% Similarity=0.286 Sum_probs=187.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l 123 (381)
.++|++.+.||+|+||.||+|+.+ +++.||||++.... ....+.+.+|+.++.++ +||||+++++++.+.+..|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 457999999999999999999976 58899999997542 22345688999999998 89999999999999999999
Q ss_pred EEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 124 IYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 124 v~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
||||+.+|+|..++ .|++.+|.|||+.+ ||||||+||||+.++.+||+|||+++...... ..
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-~~ 166 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 166 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-CC
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC-Cc
Confidence 99999999997655 68999999999999 99999999999999999999999998643222 22
Q ss_pred ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccc--cHHHHHHHHhhcCCcccccCCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQ--NLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ............... .+
T Consensus 167 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~-- 238 (345)
T 3a8x_A 167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RI-- 238 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------CC--
T ss_pred ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------CC--
Confidence 33567999999999999999999999999999999999999999642211110 111111111111110 11
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTM------RRVVV 297 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~------~eil~ 297 (381)
+......+.+|+.+||+.||.+||++ .+|++
T Consensus 239 --p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 239 --PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp --CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred --CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 11233568889999999999999996 56654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=332.06 Aligned_cols=237 Identities=26% Similarity=0.405 Sum_probs=183.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCc----EEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGR----EIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 122 (381)
.++|++.+.||+|+||.||+|++. +++ .||+|.+... .....+.+.+|+.++++++||||++++++|..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 467999999999999999999864 344 4688887543 3345678999999999999999999999998765 78
Q ss_pred EEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 123 LIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 123 lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
+|+||+.+|+|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++.+.....
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence 999999999997655 68999999999999 999999999999999999999999987654332
Q ss_pred c-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 185 H-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 185 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
. ......+|..|+|||++.+..++.++|||||||++|||++ |+.||....... +.. .......
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~----~~~~~~~-------- 237 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGER-------- 237 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCC--------
T ss_pred cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHH----HHHcCCC--------
Confidence 2 2223456889999999999999999999999999999999 999986543322 111 1111110
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
..........+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 238 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 238 -LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp -CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred -CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111122335688899999999999999999999998764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=332.76 Aligned_cols=242 Identities=21% Similarity=0.370 Sum_probs=177.9
Q ss_pred HHHhhcCCCCCCcccccCCeeEEEEEECC-C---cEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeC
Q 048280 45 LVSATKNFHPSNKLGEGGFGPVFKGKLDD-G---REIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHG 118 (381)
Q Consensus 45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 118 (381)
+....++|++.+.||+|+||.||+|++.. + ..||||++... .....+.+.+|++++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 33446789999999999999999998654 3 27999999754 334457899999999999999999999999877
Q ss_pred CeE------EEEEecccCCCHHHHH---------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcE
Q 048280 119 AEK------LLIYEYVINESLDKVL---------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPK 169 (381)
Q Consensus 119 ~~~------~lv~E~~~~g~L~~~l---------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~k 169 (381)
... ++||||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+|
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence 655 9999999999997654 67899999999999 999999999999999999
Q ss_pred EeeeccceecCCCCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHH
Q 048280 170 IADFGMARLFPEDQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYK 247 (381)
Q Consensus 170 L~DFG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 247 (381)
|+|||+++........ ......+++.|+|||++.+..++.++|||||||++|+|++ |..||....... ....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~--- 251 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYNY--- 251 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH---
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHHH---
Confidence 9999999876443222 2223456789999999999999999999999999999999 898886443221 1111
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 248 LYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
... ... .......+..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus 252 ~~~-~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 252 LIG-GNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp HHT-TCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred Hhc-CCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111 110 011112335688999999999999999999999998765
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=343.62 Aligned_cols=232 Identities=24% Similarity=0.375 Sum_probs=189.1
Q ss_pred hhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC-eEEEEEe
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA-EKLLIYE 126 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~lv~E 126 (381)
..++|++.+.||+|+||.||+|... ++.||||+++... ..+.+.+|+++|++++||||+++++++.... ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3567899999999999999999886 7899999997543 4578999999999999999999999987665 7999999
Q ss_pred cccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 127 YVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 127 ~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|+.+|+|.+++ .|++.+|.|||+++ ||||||+|||++.++.+||+|||+++......
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 343 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 343 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc----
Confidence 99999997665 68899999999999 99999999999999999999999998643221
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
....++..|+|||++.+..++.++|||||||+||||++ |..||......+ .... ...... ...
T Consensus 344 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~----i~~~~~---------~~~ 407 (450)
T 1k9a_A 344 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKGYK---------MDA 407 (450)
T ss_dssp ---CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHH----HHTTCC---------CCC
T ss_pred cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcCCC---------CCC
Confidence 12357889999999999999999999999999999998 999986543221 2211 111111 111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
+..++..+.+||.+||+.||.+|||+.+|++.|+.+
T Consensus 408 p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 223346688999999999999999999999998754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=330.89 Aligned_cols=243 Identities=20% Similarity=0.252 Sum_probs=190.3
Q ss_pred HHHHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC-----CcccHHHHHHHHHHHHHhCCCCcccEEEEEe
Q 048280 43 EALVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS-----SNQGKKEFENEAKLLARVQHRNVVNLLGYCA 116 (381)
Q Consensus 43 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 116 (381)
.++....++|++.+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 98 (345)
T 3hko_A 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE 98 (345)
T ss_dssp BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence 445667889999999999999999999875 5889999998643 2344578999999999999999999999999
Q ss_pred eCCeEEEEEecccCCCHHH-------------------------------------------------------HHHhhh
Q 048280 117 HGAEKLLIYEYVINESLDK-------------------------------------------------------VLFSLI 141 (381)
Q Consensus 117 ~~~~~~lv~E~~~~g~L~~-------------------------------------------------------~l~~~~ 141 (381)
+.+..++||||+++|+|.+ ++.|++
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 9999999999999999865 446899
Q ss_pred hhhhHhhhhc--cCCccccceEeCCCC--CcEEeeeccceecCCCCc---ccccccccCccccchhHHhh--CCCCchhh
Q 048280 142 KDIQILFRKK--KTDIKASNILLDDKW--IPKIADFGMARLFPEDQT---HVNTRVAGTNGYMAPEYVMH--GHLSVKAD 212 (381)
Q Consensus 142 ~~l~~lh~~~--HrDlkp~NIll~~~~--~~kL~DFG~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~sD 212 (381)
.+|.|||+.+ ||||||+||||+.++ .+||+|||++..+..... .......||+.|+|||++.+ ..++.++|
T Consensus 179 ~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 179 SALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 9999999999 999999999998766 899999999986533221 12235679999999999975 67899999
Q ss_pred hHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 048280 213 VFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTM 292 (381)
Q Consensus 213 vwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 292 (381)
||||||++|+|++|+.||...... .............. ..........+.+|+.+||+.||.+|||+
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 325 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLCFE-------NPNYNVLSPLARDLLSNLLNRNVDERFDA 325 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCTT-------SGGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred HHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcccccC-------CcccccCCHHHHHHHHHHcCCChhHCCCH
Confidence 999999999999999998643321 11122222111110 01111234568899999999999999999
Q ss_pred HHHHHH
Q 048280 293 RRVVVM 298 (381)
Q Consensus 293 ~eil~~ 298 (381)
.++++.
T Consensus 326 ~~~l~h 331 (345)
T 3hko_A 326 MRALQH 331 (345)
T ss_dssp HHHHHS
T ss_pred HHHhcC
Confidence 999873
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=322.27 Aligned_cols=237 Identities=24% Similarity=0.387 Sum_probs=193.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
.++|++.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 467999999999999999999998889999999976543 4578999999999999999999999999999999999999
Q ss_pred cCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccc
Q 048280 129 INESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV 190 (381)
Q Consensus 129 ~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 190 (381)
++++|.+++ .|++.+|.+||+.+ ||||||+|||++.++.+||+|||++..............
T Consensus 86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 165 (267)
T 3t9t_A 86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 165 (267)
T ss_dssp TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccccccc
Confidence 999998765 68899999999999 999999999999999999999999987643322222345
Q ss_pred ccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHH
Q 048280 191 AGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGD 269 (381)
Q Consensus 191 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (381)
.++..|+|||++.+..++.++|||||||++|+|++ |..||...... ........ ... ...+ ..
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~i~~-~~~--~~~~-------~~ 229 (267)
T 3t9t_A 166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDIST-GFR--LYKP-------RL 229 (267)
T ss_dssp TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHT-TCC--CCCC-------TT
T ss_pred cccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------HHHHHHhc-CCc--CCCC-------cc
Confidence 57788999999999999999999999999999999 88888543211 11111111 110 0111 11
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 270 QIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 270 ~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
....+.+++.+||+.||.+|||+.++++.|+..
T Consensus 230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 230 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 235688899999999999999999999999764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=333.43 Aligned_cols=192 Identities=29% Similarity=0.411 Sum_probs=168.8
Q ss_pred hCCCCChHHHHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhC-----CCCcc
Q 048280 36 EQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQ-----HRNVV 109 (381)
Q Consensus 36 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv 109 (381)
+...+++.+.....++|++.+.||+|+||.||+|+.. +++.||||++... ......+..|+.+++.+. ||||+
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 4567888888888999999999999999999999875 5899999999643 233467788999999996 99999
Q ss_pred cEEEEEeeCCeEEEEEecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCC------
Q 048280 110 NLLGYCAHGAEKLLIYEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDD------ 164 (381)
Q Consensus 110 ~~~~~~~~~~~~~lv~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~------ 164 (381)
++++++...+..++||||+ +++|.+++ .|++.+|.|||+.+ ||||||+||||+.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEE
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccc
Confidence 9999999999999999999 88987654 68999999999999 9999999999975
Q ss_pred -------------------CCCcEEeeeccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh
Q 048280 165 -------------------KWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS 225 (381)
Q Consensus 165 -------------------~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt 225 (381)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 7899999999998754322 34578999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 048280 226 GQRNSSFN 233 (381)
Q Consensus 226 g~~p~~~~ 233 (381)
|+.||...
T Consensus 255 g~~pf~~~ 262 (360)
T 3llt_A 255 GSLLFRTH 262 (360)
T ss_dssp SSCSCCCS
T ss_pred CCCCCCCC
Confidence 99999654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=334.93 Aligned_cols=242 Identities=26% Similarity=0.401 Sum_probs=193.8
Q ss_pred HHhhcCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeC
Q 048280 46 VSATKNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHG 118 (381)
Q Consensus 46 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 118 (381)
....++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 345678999999999999999999874 34889999997553 33356789999999999999999999999999
Q ss_pred CeEEEEEecccCCCHHHHH---------------------------------------HhhhhhhhHhhhhc--cCCccc
Q 048280 119 AEKLLIYEYVINESLDKVL---------------------------------------FSLIKDIQILFRKK--KTDIKA 157 (381)
Q Consensus 119 ~~~~lv~E~~~~g~L~~~l---------------------------------------~~~~~~l~~lh~~~--HrDlkp 157 (381)
+..++||||+.+++|.+++ .|++.+|.|||+.+ ||||||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 202 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 9999999999999997654 57899999999999 999999
Q ss_pred cceEeCCCCCcEEeeeccceecCCCCc-ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCc
Q 048280 158 SNILLDDKWIPKIADFGMARLFPEDQT-HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLD 235 (381)
Q Consensus 158 ~NIll~~~~~~kL~DFG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~ 235 (381)
+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 999999999999999999986543221 12234567899999999999999999999999999999999 9989854321
Q ss_pred cccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 236 VDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
. .. ... ........ .....+..+.+|+.+||+.||.+|||+.+|++.|+...
T Consensus 283 ~---~~---~~~-~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 283 E---EV---IYY-VRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp H---HH---HHH-HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred H---HH---HHH-HhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 1 11 111 11111111 11123356889999999999999999999999998764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=334.35 Aligned_cols=230 Identities=22% Similarity=0.312 Sum_probs=186.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|++.+.||+|+||.||+|++. +++.||||++... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 468999999999999999999974 6899999998643 122346789999999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|||+ +|+|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++....... ..
T Consensus 88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--~~ 164 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--FL 164 (336)
T ss_dssp ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--TT
T ss_pred EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--cc
Confidence 9999 67776554 78999999999999 99999999999999999999999998764332 22
Q ss_pred cccccCccccchhHHhhCCC-CchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHL-SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
...+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ...+... ....
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~~~-~~~~ 227 (336)
T 3h4j_B 165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKVNSC-VYVM 227 (336)
T ss_dssp CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCCCSS-CCCC
T ss_pred ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHHcC-CCCC
Confidence 34579999999999988776 7899999999999999999999864322111 0000000 0011
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
+......+.+|+.+||+.||.+|||+.||++.
T Consensus 228 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 228 PDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 12234568899999999999999999999863
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=322.49 Aligned_cols=243 Identities=18% Similarity=0.255 Sum_probs=194.1
Q ss_pred hhcCCCCCCcccccCCeeEEEEEE-CCCcEEEEEEecCCCcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKL-DDGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+|+.+++++ +|+||+++++++......++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 356899999999999999999986 468999999986543 234688999999999 7999999999999999999999
Q ss_pred ecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCC-----cEEeeeccceecCCC
Q 048280 126 EYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWI-----PKIADFGMARLFPED 182 (381)
Q Consensus 126 E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~-----~kL~DFG~~~~~~~~ 182 (381)
||+ +++|.+++ .|++.+|.|||+.+ ||||||+|||++.++. +||+|||+++.....
T Consensus 86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 999 99998765 68999999999998 9999999999987765 999999999876543
Q ss_pred Ccc------cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCccc
Q 048280 183 QTH------VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLE 256 (381)
Q Consensus 183 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (381)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..........................
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 244 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHH
Confidence 221 12356799999999999999999999999999999999999999976443333222222211111111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 257 IVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
. . . ..+..+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 245 ~-~----~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 245 L-C----A----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp H-T----T----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred H-H----h----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 0 0 1 1235688999999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=337.04 Aligned_cols=239 Identities=26% Similarity=0.423 Sum_probs=192.4
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC--------CCcEEEEEEecCCC-cccHHHHHHHHHHHHHh-CCCCcccEEEEEee
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD--------DGREIAVKKLSHSS-NQGKKEFENEAKLLARV-QHRNVVNLLGYCAH 117 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 117 (381)
..++|.+.+.||+|+||.||+|+.. .+..||||++.... ......+.+|+++++++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4578999999999999999999852 24579999997553 33346789999999999 89999999999999
Q ss_pred CCeEEEEEecccCCCHHHHH-------------------------------HhhhhhhhHhhhhc--cCCccccceEeCC
Q 048280 118 GAEKLLIYEYVINESLDKVL-------------------------------FSLIKDIQILFRKK--KTDIKASNILLDD 164 (381)
Q Consensus 118 ~~~~~lv~E~~~~g~L~~~l-------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~ 164 (381)
.+..++||||+.+|+|.+++ .|++.+|.|||+.+ ||||||+||||+.
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 226 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 226 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcC
Confidence 99999999999999997654 57899999999999 9999999999999
Q ss_pred CCCcEEeeeccceecCCCCc-ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHH
Q 048280 165 KWIPKIADFGMARLFPEDQT-HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLL 242 (381)
Q Consensus 165 ~~~~kL~DFG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~ 242 (381)
++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... .+
T Consensus 227 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~---~~- 302 (382)
T 3tt0_A 227 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---EL- 302 (382)
T ss_dssp TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HH-
T ss_pred CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HH-
Confidence 99999999999987654322 22234457889999999999999999999999999999999 99998543211 11
Q ss_pred HHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 243 DWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
........... ........+.+|+.+||+.||.+|||+.+|++.|+++
T Consensus 303 ---~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 303 ---FKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp ---HHHHHTTCCCC---------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHcCCCCC---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11122111111 1112335688999999999999999999999999765
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=326.01 Aligned_cols=233 Identities=24% Similarity=0.318 Sum_probs=181.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc--------------------------ccHHHHHHHHHHHH
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN--------------------------QGKKEFENEAKLLA 101 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 101 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999875 588999999865421 11356889999999
Q ss_pred HhCCCCcccEEEEEee--CCeEEEEEecccCCCHH--------------HHHHhhhhhhhHhhhhc--cCCccccceEeC
Q 048280 102 RVQHRNVVNLLGYCAH--GAEKLLIYEYVINESLD--------------KVLFSLIKDIQILFRKK--KTDIKASNILLD 163 (381)
Q Consensus 102 ~l~hpnIv~~~~~~~~--~~~~~lv~E~~~~g~L~--------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~ 163 (381)
+++||||+++++++.+ ....++||||+.+++|. .++.|++.+|.|||+.+ ||||||+|||++
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 171 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG 171 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC
Confidence 9999999999999986 57899999999988874 45689999999999999 999999999999
Q ss_pred CCCCcEEeeeccceecCCCCcccccccccCccccchhHHhhCC---CCchhhhHhHHHHHHHHHhCCCCCCCCCcccccc
Q 048280 164 DKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGH---LSVKADVFSFGVVILELISGQRNSSFNLDVDAQN 240 (381)
Q Consensus 164 ~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 240 (381)
.++.+||+|||++..+..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.....
T Consensus 172 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----- 245 (298)
T 2zv2_A 172 EDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI----- 245 (298)
T ss_dssp TTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH-----
T ss_pred CCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH-----
Confidence 999999999999987654322 223457999999999987665 47889999999999999999999854321
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 241 LLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
......... ... .. + ........+.+|+.+||+.||++|||+.||++
T Consensus 246 -~~~~~~~~~-~~~-~~--~-----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 -MCLHSKIKS-QAL-EF--P-----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp -HHHHHHHHH-CCC-CC--C-----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -HHHHHHHhc-ccC-CC--C-----CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 111111111 110 00 1 01122356889999999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=328.61 Aligned_cols=239 Identities=28% Similarity=0.410 Sum_probs=193.4
Q ss_pred hhcCCCCCCcccccCCeeEEEEEE------CCCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCe
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKL------DDGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAE 120 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 120 (381)
..++|.+.+.||+|+||.||+|.. .++..||||++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 467899999999999999999975 235789999997543 3345678999999999999999999999999999
Q ss_pred EEEEEecccCCCHHHHH---------------------------------------HhhhhhhhHhhhhc--cCCccccc
Q 048280 121 KLLIYEYVINESLDKVL---------------------------------------FSLIKDIQILFRKK--KTDIKASN 159 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l---------------------------------------~~~~~~l~~lh~~~--HrDlkp~N 159 (381)
.++||||+.+++|.+++ .|++.+|.|||+.+ ||||||+|
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~N 180 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARN 180 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchhe
Confidence 99999999999997654 47899999999999 99999999
Q ss_pred eEeCCCCCcEEeeeccceecCCCCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccc
Q 048280 160 ILLDDKWIPKIADFGMARLFPEDQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVD 237 (381)
Q Consensus 160 Ill~~~~~~kL~DFG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~ 237 (381)
||++.++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~- 259 (314)
T 2ivs_A 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE- 259 (314)
T ss_dssp EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 99999999999999999876543322 2224457889999999999999999999999999999999 99998644322
Q ss_pred cccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 238 AQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.+.. ........ .........+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 260 --~~~~----~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 260 --RLFN----LLKTGHRM---------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp --GHHH----HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHH----HhhcCCcC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111 11111111 11122345688999999999999999999999998753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=346.78 Aligned_cols=245 Identities=21% Similarity=0.247 Sum_probs=182.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeC------C
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHG------A 119 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~ 119 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999866 5899999999754 333456788999999999999999999999654 4
Q ss_pred eEEEEEecccCCCHH------------HHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 120 EKLLIYEYVINESLD------------KVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
..|+||||+.++.+. .++.|++.+|.|||+.+ ||||||+||||+.++.+||+|||+++......
T Consensus 141 ~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-- 218 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-- 218 (464)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CC--
T ss_pred eEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc--
Confidence 679999999765332 35589999999999999 99999999999999999999999998764332
Q ss_pred cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhh---------------
Q 048280 186 VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYK--------------- 250 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------------- 250 (381)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .........
T Consensus 219 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~---~~~i~~~lg~p~~~~~~~~~~~~~ 295 (464)
T 3ttj_A 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ---WNKVIEQLGTPCPEFMKKLQPTVR 295 (464)
T ss_dssp CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHHHHHHcchhhh
Confidence 23446799999999999999999999999999999999999999965432221 111111100
Q ss_pred ----cCCc-c-----cccCCCCCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 251 ----KDKS-L-----EIVDPSLAAS---DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 251 ----~~~~-~-----~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.... . ......+... ........+.+|+.+||+.||.+|||+.|+++.
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0 0000000000 011225678999999999999999999999874
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=336.03 Aligned_cols=249 Identities=14% Similarity=0.187 Sum_probs=188.3
Q ss_pred hhcCCCCCCccccc--CCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEE
Q 048280 48 ATKNFHPSNKLGEG--GFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 48 ~~~~y~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 122 (381)
..++|++.+.||+| +||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 46789999999999 99999999976 69999999997542 333467888999999999999999999999999999
Q ss_pred EEEecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 123 LIYEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 123 lv~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
+||||+.+++|.+++ .|++.+|.|||+.+ ||||||+||||+.++.+||+|||++.......
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 999999999997765 68999999999999 99999999999999999999999987542221
Q ss_pred c------ccccccccCccccchhHHhh--CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc----
Q 048280 184 T------HVNTRVAGTNGYMAPEYVMH--GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKK---- 251 (381)
Q Consensus 184 ~------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 251 (381)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +..........
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLDT 260 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC-----------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCccccc
Confidence 1 11123468999999999987 5799999999999999999999999965332221 10000000000
Q ss_pred -----CC-------------ccccc---CC------CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 252 -----DK-------------SLEIV---DP------SLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 252 -----~~-------------~~~~~---~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.. ..... .+ .............+.+|+.+||+.||.+|||+.|+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 00000 00 00001122334668899999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=331.96 Aligned_cols=233 Identities=23% Similarity=0.318 Sum_probs=188.4
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeE
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEK 121 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 121 (381)
...++|++.+.||+|+||.||+|+.+ +++.||||++.... ......+.+|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34678999999999999999999976 58999999996542 23456788899999987 899999999999999999
Q ss_pred EEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 122 LLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
|+||||+++|+|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++......
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 172 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 172 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC-
Confidence 9999999999997665 68999999999999 99999999999999999999999998643222
Q ss_pred ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 185 HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
......+||+.|+|||++.+..++.++|||||||++|||++|..||..... ..+. ....... +.+.
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~---~~i~~~~-------~~~p- 238 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELF---HSIRMDN-------PFYP- 238 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHHHCC-------CCCC-
T ss_pred CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---HHHH---HHHHhCC-------CCCC-
Confidence 123456799999999999999999999999999999999999999864322 1111 1111111 1111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMR-RVVV 297 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~ 297 (381)
......+.+|+.+||..||.+||++. +|++
T Consensus 239 ---~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 239 ---RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ---TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---cccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 11335688999999999999999997 6653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=340.00 Aligned_cols=247 Identities=21% Similarity=0.240 Sum_probs=194.1
Q ss_pred CCChHHHHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEE
Q 048280 39 HFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGY 114 (381)
Q Consensus 39 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 114 (381)
.+.+.+.....++|++.+.||+|+||.||+|+.+ +++.||||++.+.. ......+.+|+.++..++||||++++++
T Consensus 50 ~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 3455566666789999999999999999999976 69999999996432 1223457889999999999999999999
Q ss_pred EeeCCeEEEEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccc
Q 048280 115 CAHGAEKLLIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMA 176 (381)
Q Consensus 115 ~~~~~~~~lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~ 176 (381)
+.+.+..|+||||+++|+|.+++ .|++.+|.|||+.+ ||||||+||||+.++.+||+|||++
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhh
Confidence 99999999999999999998765 57899999999998 9999999999999999999999999
Q ss_pred eecCCCCcccccccccCccccchhHHhh-------CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh
Q 048280 177 RLFPEDQTHVNTRVAGTNGYMAPEYVMH-------GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLY 249 (381)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 249 (381)
+.+...........+||+.|+|||++.. ..++.++|||||||++|||++|+.||....... .. ....
T Consensus 210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~---~~i~ 283 (412)
T 2vd5_A 210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE---TY---GKIV 283 (412)
T ss_dssp EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHH
T ss_pred eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH---HH---HHHH
Confidence 9875544433345689999999999973 568999999999999999999999986432211 11 1111
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 048280 250 KKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLR---PTMRRVVVM 298 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~eil~~ 298 (381)
..... ...|.. ....+..+.+||.+||. +|.+| |+++||++.
T Consensus 284 ~~~~~--~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 284 HYKEH--LSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp THHHH--CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred hcccC--cCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 10000 001111 11234568899999999 99998 589998764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=330.76 Aligned_cols=235 Identities=21% Similarity=0.279 Sum_probs=174.7
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4678999999999999999999976 48899999997543 34678899999999999999999999999999999999
Q ss_pred cccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCC---CCCcEEeeeccceecCCCCccc
Q 048280 127 YVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDD---KWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 127 ~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~---~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
|+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++. ++.+||+|||+++...... .
T Consensus 129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~ 206 (349)
T 2w4o_A 129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--L 206 (349)
T ss_dssp CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc--c
Confidence 99999997655 78999999999998 9999999999975 8899999999998754322 2
Q ss_pred ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
.....||+.|+|||++.+..++.++|||||||++|||++|..||....... ... ....... . ... ...
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~---~~i~~~~-~-~~~-----~~~ 274 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMF---RRILNCE-Y-YFI-----SPW 274 (349)
T ss_dssp ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHH---HHHHTTC-C-CCC-----TTT
T ss_pred cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHH---HHHHhCC-C-ccC-----Cch
Confidence 234578999999999999999999999999999999999999985432211 011 1111111 0 001 111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.......+.+|+.+||+.||++|||+.++++.
T Consensus 275 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 275 WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 12234568899999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=353.08 Aligned_cols=241 Identities=24% Similarity=0.406 Sum_probs=195.4
Q ss_pred HHHhhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 45 LVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.....++|++.+.||+|+||.||+|.+..+..||||++.... ...+.|.+|+++|++++||||+++++++.+ ...+||
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 334566788999999999999999999888889999997654 345789999999999999999999999876 678999
Q ss_pred EecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 125 YEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 125 ~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
|||+.+|+|.+++ .|++.+|.|||+++ ||||||+||||+.++.+||+|||+++.+......
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 9999999997765 58899999999998 9999999999999999999999999876432222
Q ss_pred cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 186 VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
......++..|+|||++.+..++.++|||||||+||||++ |+.||...... .+.. ....... .
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~----~i~~~~~---------~ 483 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD----QVERGYR---------M 483 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHH----HHHTTCC---------C
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCC---------C
Confidence 2233456789999999999999999999999999999999 89888643221 1111 1111111 1
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
.....+...+.+||.+||+.||++|||+.+|++.|+...
T Consensus 484 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111233456889999999999999999999999998865
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=330.17 Aligned_cols=229 Identities=21% Similarity=0.247 Sum_probs=189.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 468999999999999999999976 58999999986432 23456788999999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|||+++|+|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++..... .
T Consensus 120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----~ 195 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----T 195 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----B
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC----c
Confidence 9999999997665 68999999999999 9999999999999999999999999976432 2
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
...+||+.|+|||++.+..++.++|||||||++|||++|..||..... ........... . .+.
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~-~------~~p---- 258 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGK-V------RFP---- 258 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC-C------CCC----
T ss_pred ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHHHHcCC-C------CCC----
Confidence 346799999999999999999999999999999999999999864321 11111222111 0 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPT-----MRRVVVM 298 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~ 298 (381)
......+.+||.+||+.||.+||+ +.+|++.
T Consensus 259 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 122356889999999999999998 8888753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=322.72 Aligned_cols=234 Identities=24% Similarity=0.381 Sum_probs=188.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC-C-------cEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD-G-------REIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAE 120 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 120 (381)
.++|.+.+.||+|+||.||+|+... + ..||+|++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 5689999999999999999997653 3 4799999977666667889999999999999999999999999999
Q ss_pred EEEEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCC--------cEEeeec
Q 048280 121 KLLIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWI--------PKIADFG 174 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~--------~kL~DFG 174 (381)
.++||||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++. +||+|||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg 166 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCc
Confidence 99999999999998765 68999999999999 9999999999988877 9999999
Q ss_pred cceecCCCCcccccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCC
Q 048280 175 MARLFPEDQTHVNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDK 253 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (381)
++..... .....||..|+|||++.+ ..++.++|||||||++|+|++|..|+....... .. ........
T Consensus 167 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-----~~-~~~~~~~~ 235 (289)
T 4fvq_A 167 ISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-----RK-LQFYEDRH 235 (289)
T ss_dssp SCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HH-HHHHHTTC
T ss_pred ccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-----HH-HHHhhccC
Confidence 9875422 123457899999999987 678999999999999999999766553322111 11 11111111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 048280 254 SLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKPG 304 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 304 (381)
. ..... ...+.+|+.+||+.||.+|||+.++++.|+....
T Consensus 236 ~---~~~~~--------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 236 Q---LPAPK--------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp C---CCCCS--------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred C---CCCCC--------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 0 00111 1236789999999999999999999999998753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=333.64 Aligned_cols=242 Identities=27% Similarity=0.403 Sum_probs=192.6
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEE------CCCcEEEEEEecCC-CcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeC
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKL------DDGREIAVKKLSHS-SNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHG 118 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 118 (381)
...++|++.+.||+|+||.||+|.. .++..||||++... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3467899999999999999999985 24668999999754 233457899999999999 899999999999999
Q ss_pred CeEEEEEecccCCCHHHHH--------------------------------------HhhhhhhhHhhhhc--cCCcccc
Q 048280 119 AEKLLIYEYVINESLDKVL--------------------------------------FSLIKDIQILFRKK--KTDIKAS 158 (381)
Q Consensus 119 ~~~~lv~E~~~~g~L~~~l--------------------------------------~~~~~~l~~lh~~~--HrDlkp~ 158 (381)
+..++||||+++|+|.+++ .|++.+|.|||..+ ||||||+
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 201 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence 9999999999999997654 57899999999999 9999999
Q ss_pred ceEeCCCCCcEEeeeccceecCCCCc-ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcc
Q 048280 159 NILLDDKWIPKIADFGMARLFPEDQT-HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDV 236 (381)
Q Consensus 159 NIll~~~~~~kL~DFG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~ 236 (381)
||||+.++.+||+|||++..+..... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 99999999999999999986643322 22234567889999999999999999999999999999998 99998644321
Q ss_pred ccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 237 DAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
. .+ ......... + .........+.+|+.+||+.||.+|||+.+|++.|+...
T Consensus 282 ~--~~----~~~~~~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 282 A--NF----YKLIQNGFK-----M----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp H--HH----HHHHHTTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred H--HH----HHHHhcCCC-----C----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1 11 111111111 1 111122456888999999999999999999999997653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=335.89 Aligned_cols=246 Identities=26% Similarity=0.351 Sum_probs=195.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEE-----CCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEe--eCCeE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKL-----DDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCA--HGAEK 121 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~~~~ 121 (381)
.++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46899999999999999999984 358899999998776666678999999999999999999999986 45678
Q ss_pred EEEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 122 LLIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
++||||+++++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++.......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 181 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCC
Confidence 9999999999998765 58899999999999 99999999999999999999999999775443
Q ss_pred cc--cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccc--------cccHHHHHHHHhhcCC
Q 048280 184 TH--VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVD--------AQNLLDWAYKLYKKDK 253 (381)
Q Consensus 184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~--------~~~~~~~~~~~~~~~~ 253 (381)
.. ......||..|+|||++.+..++.++|||||||++|+|++|..||....... ...............
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 260 (327)
T 3lxl_A 182 DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG- 260 (327)
T ss_dssp SEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT-
T ss_pred ccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc-
Confidence 22 2224567888999999999999999999999999999999999975321100 000011111111111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 254 SLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
............+.+|+.+||+.||.+|||+.+|++.|+...
T Consensus 261 --------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 261 --------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred --------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111122234466889999999999999999999999998764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=327.35 Aligned_cols=232 Identities=24% Similarity=0.318 Sum_probs=179.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEE----CCCcEEEEEEecCCC----cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKL----DDGREIAVKKLSHSS----NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAE 120 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 120 (381)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999986 468999999997542 2234567889999999999999999999999999
Q ss_pred EEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 121 KLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
.|+||||+.+++|.+++ .|++.+|.|||+.+ ||||||+||||+.++.+||+|||+++......
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 175 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG 175 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-------
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCC
Confidence 99999999999997654 68999999999999 99999999999999999999999998643222
Q ss_pred cccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC
Q 048280 184 THVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 184 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ........... .+
T Consensus 176 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~-------~~- 240 (327)
T 3a62_A 176 T-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKILKCKL-------NL- 240 (327)
T ss_dssp ----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTCC-------CC-
T ss_pred c-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCC-------CC-
Confidence 1 223457999999999999999999999999999999999999998643221 11111211110 01
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 048280 264 ASDSGDQIAMCIQIGLLCTQGDPQLRP-----TMRRVVVM 298 (381)
Q Consensus 264 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 298 (381)
+......+.+|+.+||+.||.+|| ++.++++.
T Consensus 241 ---p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 241 ---PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ---CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ---CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 112235688999999999999999 78888764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=323.79 Aligned_cols=244 Identities=24% Similarity=0.375 Sum_probs=190.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEE-----CCCcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeC--Ce
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKL-----DDGREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHG--AE 120 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~ 120 (381)
.+.|++.+.||+|+||.||+|++ .+++.||||++... .....+.+.+|++++++++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 45689999999999999999983 35899999999754 334457899999999999999999999999876 67
Q ss_pred EEEEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCC
Q 048280 121 KLLIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPED 182 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~ 182 (381)
.++||||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++......
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 89999999999998765 68999999999999 9999999999999999999999999987544
Q ss_pred Cc--ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCc--------cccccHHHHHHHHhhcC
Q 048280 183 QT--HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLD--------VDAQNLLDWAYKLYKKD 252 (381)
Q Consensus 183 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~--------~~~~~~~~~~~~~~~~~ 252 (381)
.. .......||..|+|||++.+..++.++|||||||++|+|++|..|+..... .................
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT
T ss_pred CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc
Confidence 32 222345688889999999999999999999999999999999987532110 00111111111111111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 253 KSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
. ........+..+.+|+.+||+.||.+|||+.++++.|+.
T Consensus 260 ~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 260 K---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp C---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred C---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 1 111122334668899999999999999999999999865
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=331.73 Aligned_cols=244 Identities=26% Similarity=0.382 Sum_probs=190.4
Q ss_pred cCC-CCCCcccccCCeeEEEEEEC-----CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEee--CCe
Q 048280 50 KNF-HPSNKLGEGGFGPVFKGKLD-----DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAH--GAE 120 (381)
Q Consensus 50 ~~y-~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~ 120 (381)
++| ++.+.||+|+||.||++.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+ ...
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 345 99999999999999998642 58899999997653 2345678999999999999999999999987 467
Q ss_pred EEEEEecccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 121 KLLIYEYVINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
.++||||+++++|.+++ .|++.+|.+||+.+ ||||||+|||++.++.+||+|||++........
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 89999999999997654 78999999999999 999999999999999999999999998754432
Q ss_pred c--cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccc--------cccHHHHHHHHhhcCCc
Q 048280 185 H--VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVD--------AQNLLDWAYKLYKKDKS 254 (381)
Q Consensus 185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~ 254 (381)
. ......+|..|+|||++.+..++.++|||||||++|+|++|..||....... ...............
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 267 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG-- 267 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT--
T ss_pred ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc--
Confidence 1 2234567888999999999999999999999999999999999975321100 000000011111111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 255 LEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.........+..+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 268 -------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 268 -------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11112223346788999999999999999999999998764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=333.84 Aligned_cols=234 Identities=21% Similarity=0.329 Sum_probs=180.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCC--CCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSS--NQGKKEFENEAKLLARVQH--RNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~lv 124 (381)
.++|++.+.||+|+||.||++...+++.||||++.... ....+.+.+|+.++++++| +||+++++++......++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 56799999999999999999998889999999986543 3334678999999999986 9999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc-c
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH-V 186 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~-~ 186 (381)
||+ .+++|.+++ .|++.+|.|||..+ ||||||+||||+ ++.+||+|||+++.+...... .
T Consensus 88 ~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~ 165 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVV 165 (343)
T ss_dssp ECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--------
T ss_pred EeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccccc
Confidence 995 578887654 78999999999999 999999999997 578999999999876443322 2
Q ss_pred ccccccCccccchhHHhh-----------CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcc
Q 048280 187 NTRVAGTNGYMAPEYVMH-----------GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSL 255 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (381)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... .............
T Consensus 166 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~~~~~-- 238 (343)
T 3dbq_A 166 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPNH-- 238 (343)
T ss_dssp ----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHCTTS--
T ss_pred CCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHHhcCCc--
Confidence 234679999999999976 6789999999999999999999999854221 1111111111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 256 EIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
....+......+.+|+.+||+.||.+|||+.|+++.
T Consensus 239 -------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 239 -------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111111112457889999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=331.63 Aligned_cols=228 Identities=25% Similarity=0.342 Sum_probs=177.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc--ccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN--QGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|++.++||+|+||+||+|+.. +++.||||++..... .....+..|+..+.++ +||||++++++|.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999986 699999999865432 2334556677777666 899999999999999999999
Q ss_pred EecccCCCHHHH----------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 125 YEYVINESLDKV----------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 125 ~E~~~~g~L~~~----------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
|||+ +++|.++ +.|++.+|.|||+.+ ||||||+||||+.++.+||+|||++....... .
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~--~ 212 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG--A 212 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC--C
Confidence 9999 6777654 368999999999998 99999999999999999999999998764332 2
Q ss_pred ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
.....||+.|+|||++.+ .++.++|||||||++|||++|..|+.... . .......... +..
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----~-----~~~~~~~~~~----~~~---- 273 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----G-----WQQLRQGYLP----PEF---- 273 (311)
T ss_dssp --CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----H-----HHHHTTTCCC----HHH----
T ss_pred CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----H-----HHHHhccCCC----ccc----
Confidence 234568999999998875 79999999999999999999977653211 0 1111111110 000
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.......+.+|+.+||+.||++|||+.|+++.
T Consensus 274 ~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 274 TAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 11123568899999999999999999999863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=337.90 Aligned_cols=248 Identities=24% Similarity=0.352 Sum_probs=177.4
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhC-CCCcccEEEEEeeCC--e
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQ-HRNVVNLLGYCAHGA--E 120 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~--~ 120 (381)
...++|++.+.||+|+||.||+|.+. +++.||||++... .......+.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34678999999999999999999875 5899999998644 2334567889999999997 999999999997544 7
Q ss_pred EEEEEecccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC-
Q 048280 121 KLLIYEYVINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ- 183 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~- 183 (381)
.|+||||+. ++|.+++ .|++.+|.|||+.+ ||||||+||||+.++.+||+|||+++.+....
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EEEEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 899999996 5776554 68999999999999 99999999999999999999999998753311
Q ss_pred -------------------cccccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHH
Q 048280 184 -------------------THVNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLD 243 (381)
Q Consensus 184 -------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~ 243 (381)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+. ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~ 241 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ---LE 241 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH
Confidence 111234679999999999987 6789999999999999999999999975433221 11
Q ss_pred HHHHHhhcCCcccc--c-C-----------------CCCCCCCCH-------------HHHHHHHHHHHHcccCCCCCCC
Q 048280 244 WAYKLYKKDKSLEI--V-D-----------------PSLAASDSG-------------DQIAMCIQIGLLCTQGDPQLRP 290 (381)
Q Consensus 244 ~~~~~~~~~~~~~~--~-~-----------------~~~~~~~~~-------------~~~~~l~~li~~cl~~dP~~RP 290 (381)
.............. + . ......... .....+.+|+.+||+.||.+||
T Consensus 242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 321 (388)
T 3oz6_A 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI 321 (388)
T ss_dssp HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence 11111110000000 0 0 000000000 1234688999999999999999
Q ss_pred CHHHHHHH
Q 048280 291 TMRRVVVM 298 (381)
Q Consensus 291 s~~eil~~ 298 (381)
|+.|+++.
T Consensus 322 t~~e~l~H 329 (388)
T 3oz6_A 322 SANDALKH 329 (388)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhCC
Confidence 99999865
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=324.33 Aligned_cols=232 Identities=28% Similarity=0.430 Sum_probs=180.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
.++|++.+.||+|+||.||+|+.. ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 467999999999999999999886 788999998643 345789999999999999999999998874 479999999
Q ss_pred cCCCHHHHH------------------HhhhhhhhHhhh---hc--cCCccccceEeCCCCC-cEEeeeccceecCCCCc
Q 048280 129 INESLDKVL------------------FSLIKDIQILFR---KK--KTDIKASNILLDDKWI-PKIADFGMARLFPEDQT 184 (381)
Q Consensus 129 ~~g~L~~~l------------------~~~~~~l~~lh~---~~--HrDlkp~NIll~~~~~-~kL~DFG~~~~~~~~~~ 184 (381)
++++|.+++ .|++.+|.|||. .+ ||||||+|||++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 999998766 478899999999 55 9999999999998886 799999999865332
Q ss_pred ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 185 HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ......... ... +..
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~-~~~-----~~~-- 225 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAVHN-GTR-----PPL-- 225 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHHHT-TCC-----CCC--
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHHhc-CCC-----CCc--
Confidence 123468999999999999999999999999999999999999986432211 111111111 111 111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
....+..+.+|+.+||+.||.+|||+.+|++.|+...
T Consensus 226 --~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 226 --IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp --BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred --ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 1123356888999999999999999999999987643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=326.12 Aligned_cols=244 Identities=21% Similarity=0.256 Sum_probs=184.6
Q ss_pred hcCCCCC-CcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEEEE
Q 048280 49 TKNFHPS-NKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 49 ~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
.+.|++. +.||+|+||.||+|+.. +++.||||++..........+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4578885 78999999999999865 6899999999876666678899999999995 7999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCC---cEEeeeccceecCCCCc-
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWI---PKIADFGMARLFPEDQT- 184 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~---~kL~DFG~~~~~~~~~~- 184 (381)
||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++. +||+|||++........
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170 (316)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence 999999997665 68999999999999 9999999999988775 99999999986532211
Q ss_pred -----ccccccccCccccchhHHhh-----CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccH--------HHHHH
Q 048280 185 -----HVNTRVAGTNGYMAPEYVMH-----GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNL--------LDWAY 246 (381)
Q Consensus 185 -----~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~--------~~~~~ 246 (381)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+.... .....
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 250 (316)
T 2ac3_A 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250 (316)
T ss_dssp -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence 11123468999999999975 5688999999999999999999999975433221000 01111
Q ss_pred HHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 247 KLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
........ .. + ..........+.+|+.+||+.||.+|||+.|+++.
T Consensus 251 ~~i~~~~~-~~--~---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 251 ESIQEGKY-EF--P---DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHCCC-CC--C---HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhccCc-cc--C---chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11111110 00 0 00001123568899999999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=327.76 Aligned_cols=240 Identities=31% Similarity=0.470 Sum_probs=193.3
Q ss_pred hhcCCCCCCcccccCCeeEEEEEE------CCCcEEEEEEecCCCc-ccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCC
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKL------DDGREIAVKKLSHSSN-QGKKEFENEAKLLARV-QHRNVVNLLGYCAHGA 119 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 119 (381)
..++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.+++++ +||||+++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 356899999999999999999985 2468899999975532 3457799999999999 9999999999999999
Q ss_pred eEEEEEecccCCCHHHHH---------------------------------HhhhhhhhHhhhhc--cCCccccceEeCC
Q 048280 120 EKLLIYEYVINESLDKVL---------------------------------FSLIKDIQILFRKK--KTDIKASNILLDD 164 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~~l---------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~ 164 (381)
..++||||+++|+|.+++ .|++.+|.|||+.+ ||||||+|||++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcC
Confidence 999999999999997654 47889999999999 9999999999999
Q ss_pred CCCcEEeeeccceecCCCCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHH
Q 048280 165 KWIPKIADFGMARLFPEDQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLL 242 (381)
Q Consensus 165 ~~~~kL~DFG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~ 242 (381)
++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||....... ..
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~- 257 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--KF- 257 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--HH-
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--HH-
Confidence 999999999999876544322 2234557889999999999999999999999999999999 999886433211 11
Q ss_pred HHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 243 DWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
......... . ......+..+.+|+.+||+.||.+|||+.+|++.|++.
T Consensus 258 ---~~~~~~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 258 ---YKMIKEGFR-----M----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp ---HHHHHHTCC-----C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHhccCCC-----C----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 111111110 0 01112335688999999999999999999999999753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=329.33 Aligned_cols=235 Identities=22% Similarity=0.302 Sum_probs=186.0
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
..++|++.+.||+|+||.||+|..+ +++.||||++...... ..+|++++.++ +||||+++++++.++...|+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4568999999999999999999876 5899999999765432 35788899888 7999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCC----CCcEEeeeccceecCCCCc
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDK----WIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~----~~~kL~DFG~~~~~~~~~~ 184 (381)
||+.+|+|.+++ .|++.+|.|||+.+ ||||||+|||+... +.+||+|||+++.......
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 999999997654 78999999999999 99999999998433 3599999999987644322
Q ss_pred ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 185 HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||..........+.. .... .... +..
T Consensus 176 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~---~i~~-~~~~------~~~ 244 (342)
T 2qr7_A 176 -LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA---RIGS-GKFS------LSG 244 (342)
T ss_dssp -CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH---HHHH-CCCC------CCS
T ss_pred -ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH---HHcc-CCcc------cCc
Confidence 2234678999999999998889999999999999999999999996533222222221 1111 1110 111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.........+.+|+.+||..||++|||+.++++
T Consensus 245 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 245 GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111233456889999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=326.00 Aligned_cols=249 Identities=25% Similarity=0.383 Sum_probs=184.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc--ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN--QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 468999999999999999999976 489999999865432 22467889999999999999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
||+.+++|..++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++......... ..
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~ 160 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY-YD 160 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc-cC
Confidence 999998886543 68999999999999 9999999999999999999999999876533222 23
Q ss_pred ccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHH--------HHHhhcCCc---cc
Q 048280 189 RVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWA--------YKLYKKDKS---LE 256 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~---~~ 256 (381)
...||..|+|||++.+ ..++.++|||||||++|+|++|..||......+........ ...+..... ..
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240 (311)
T ss_dssp -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence 4568999999999987 56899999999999999999999998654433221111100 000000000 00
Q ss_pred ccCCCCCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 257 IVDPSLAAS---DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 257 ~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
..++..... ........+.+|+.+||+.||.+|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 011100000 001234568899999999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=320.30 Aligned_cols=237 Identities=24% Similarity=0.367 Sum_probs=186.6
Q ss_pred hhcCCCCCCcccccCCeeEEEEEECC----CcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLDD----GREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 122 (381)
..++|++.+.||+|+||.||+|++.. +..||||++... .....+.+.+|+.++++++||||+++++++.++ ..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 35789999999999999999998542 346999998765 333457899999999999999999999998754 568
Q ss_pred EEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 123 LIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 123 lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
+||||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++........
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence 999999999997765 58899999999998 999999999999999999999999987654433
Q ss_pred ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC
Q 048280 185 HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
.......+++.|+|||++.+..++.++|||||||++|+|++ |+.||......+ ..... .......
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~----~~~~~~~------- 234 (281)
T 3cc6_A 169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVL----EKGDRLP------- 234 (281)
T ss_dssp ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHH----HHTCCCC-------
T ss_pred cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHH----hcCCCCC-------
Confidence 33344567889999999999999999999999999999998 999986433322 22111 1111100
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 264 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
........+.+++.+||+.||.+|||+.++++.|+.
T Consensus 235 --~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 270 (281)
T 3cc6_A 235 --KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270 (281)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence 011123568899999999999999999999999865
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=330.18 Aligned_cols=231 Identities=23% Similarity=0.267 Sum_probs=187.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC-CcEEEEEEecCC---CcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD-GREIAVKKLSHS---SNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l 123 (381)
.++|++.+.||+|+||.||+|+... ++.||||++... .....+.+.+|..++..+ +||||+++++++.+.+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 5689999999999999999999874 889999999654 223456788999999988 79999999999999999999
Q ss_pred EEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 124 IYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 124 v~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
||||+++|+|.+++ .|++.+|.|||+.+ ||||||+||||+.++.+||+|||+++....... .
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~-~ 177 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-T 177 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-C
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc-c
Confidence 99999999997665 68999999999999 999999999999999999999999986432222 2
Q ss_pred ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+. ........ .+
T Consensus 178 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~---~~i~~~~~-------~~---- 240 (353)
T 2i0e_A 178 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELF---QSIMEHNV-------AY---- 240 (353)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHHHCCC-------CC----
T ss_pred cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH---HHHH---HHHHhCCC-------CC----
Confidence 3356799999999999999999999999999999999999999864321 1111 12222110 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPT-----MRRVVV 297 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 297 (381)
+......+.+|+.+||+.||.+||+ +.+|++
T Consensus 241 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 241 PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1123456889999999999999995 577764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=324.49 Aligned_cols=257 Identities=25% Similarity=0.363 Sum_probs=193.8
Q ss_pred hCCCCChHHHHHhhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHh--CCCCcccEEE
Q 048280 36 EQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARV--QHRNVVNLLG 113 (381)
Q Consensus 36 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~~~~ 113 (381)
.....+........++|++.+.||+|+||.||+|+.. ++.||||++... ....+.+|.+++..+ +||||+++++
T Consensus 23 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~ 98 (337)
T 3mdy_A 23 SGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIA 98 (337)
T ss_dssp SCSSSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred CCCCCCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEE
Confidence 4445666666677789999999999999999999887 899999998543 234555666666655 8999999999
Q ss_pred EEeeC----CeEEEEEecccCCCHHHHH--------------HhhhhhhhHhhhh--------c--cCCccccceEeCCC
Q 048280 114 YCAHG----AEKLLIYEYVINESLDKVL--------------FSLIKDIQILFRK--------K--KTDIKASNILLDDK 165 (381)
Q Consensus 114 ~~~~~----~~~~lv~E~~~~g~L~~~l--------------~~~~~~l~~lh~~--------~--HrDlkp~NIll~~~ 165 (381)
++... ...++||||+.+|+|.+++ .|++.+|.|||.. + ||||||+|||++.+
T Consensus 99 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178 (337)
T ss_dssp EEEESCGGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred EEccCCCCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC
Confidence 99887 7899999999999998765 6889999999987 5 99999999999999
Q ss_pred CCcEEeeeccceecCCCCccc---ccccccCccccchhHHhhCCCCch------hhhHhHHHHHHHHHhC----------
Q 048280 166 WIPKIADFGMARLFPEDQTHV---NTRVAGTNGYMAPEYVMHGHLSVK------ADVFSFGVVILELISG---------- 226 (381)
Q Consensus 166 ~~~kL~DFG~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------sDvwSlGvvl~elltg---------- 226 (381)
+.+||+|||++..+....... .....||+.|+|||++.+..++.+ +|||||||++|||++|
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 999999999998764433221 124579999999999988766654 9999999999999999
Q ss_pred CCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 227 QRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS-DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 227 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
..||......... . ........... ..+..... ....+...+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 259 ~~p~~~~~~~~~~-~-~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 259 QLPYHDLVPSDPS-Y-EDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CCTTTTTSCSSCC-H-HHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cccHhhhcCCCCc-h-hhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 5565433222211 1 11111111111 11111111 1236678899999999999999999999999999764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=332.39 Aligned_cols=239 Identities=25% Similarity=0.354 Sum_probs=190.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEE----CCCcEEEEEEecCCC----cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCC
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKL----DDGREIAVKKLSHSS----NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGA 119 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 119 (381)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46899999999999999999987 368999999986532 23345677899999999 6999999999999999
Q ss_pred eEEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCC
Q 048280 120 EKLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPED 182 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~ 182 (381)
..++||||+.+++|.+++ .|++.+|.|||+.+ ||||||+||||+.++.+||+|||+++.+...
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 212 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence 999999999999998765 58999999999998 9999999999999999999999999876544
Q ss_pred CcccccccccCccccchhHHhhC--CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCC
Q 048280 183 QTHVNTRVAGTNGYMAPEYVMHG--HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDP 260 (381)
Q Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
.........||+.|+|||++.+. .++.++|||||||+||||++|+.||........ ............ +
T Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~-------~ 283 (355)
T 1vzo_A 213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE-------P 283 (355)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHCC-------C
T ss_pred CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhccC-------C
Confidence 33334456799999999999863 478999999999999999999999864433222 111111111111 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHhc
Q 048280 261 SLAASDSGDQIAMCIQIGLLCTQGDPQLRP-----TMRRVVVMLS 300 (381)
Q Consensus 261 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~ 300 (381)
.. .......+.+|+.+||..||.+|| ++.++++...
T Consensus 284 ~~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 284 PY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred CC----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 11 112335678899999999999999 9999987653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=328.96 Aligned_cols=233 Identities=24% Similarity=0.257 Sum_probs=164.7
Q ss_pred CCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhC-CCCcccEEEEEeeCCeEEEEEecccCCC
Q 048280 55 SNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQ-HRNVVNLLGYCAHGAEKLLIYEYVINES 132 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~E~~~~g~ 132 (381)
.+.||+|+||.||+|... +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+.+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999876 5899999999643 3467889999999997 9999999999999999999999999999
Q ss_pred HHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCC---CcEEeeeccceecCCCCccccccccc
Q 048280 133 LDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKW---IPKIADFGMARLFPEDQTHVNTRVAG 192 (381)
Q Consensus 133 L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~---~~kL~DFG~~~~~~~~~~~~~~~~~g 192 (381)
|.+++ .|++.+|.|||+.+ ||||||+|||++.++ .+||+|||+++....... ......|
T Consensus 93 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~ 171 (325)
T 3kn6_A 93 LFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLKTPCF 171 (325)
T ss_dssp HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cccccCC
Confidence 97655 78999999999999 999999999997665 899999999987644322 2234568
Q ss_pred CccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccc-ccHHHHHHHHhhcCCcccccCCCCCCCCCHHHH
Q 048280 193 TNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDA-QNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271 (381)
Q Consensus 193 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (381)
|+.|+|||++.+..++.++|||||||++|+|++|..||........ ......... ...... ...........
T Consensus 172 t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-i~~~~~------~~~~~~~~~~s 244 (325)
T 3kn6_A 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK-IKKGDF------SFEGEAWKNVS 244 (325)
T ss_dssp ------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH-HTTTCC------CCCSHHHHTSC
T ss_pred CcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH-HHcCCC------CCCcccccCCC
Confidence 9999999999999999999999999999999999999965432211 111111111 111110 00111112234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 272 AMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 272 ~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
..+.+|+.+||+.||.+|||+.++++.
T Consensus 245 ~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 245 QEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 678899999999999999999998753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=329.53 Aligned_cols=238 Identities=24% Similarity=0.402 Sum_probs=185.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcE----EEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGRE----IAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 122 (381)
.++|++.+.||+|+||.||+|++. +++. ||+|.+.... ......+.+|+.++++++||||+++++++.. ...+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccE
Confidence 468999999999999999999865 3443 7888875432 2334567889999999999999999999874 5689
Q ss_pred EEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 123 LIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 123 lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
+||||+.+|+|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++.+.....
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 999999999997665 68999999999999 999999999999999999999999997654432
Q ss_pred c-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 185 H-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 185 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
. ......+|..|+|||++.+..++.++|||||||++|+|++ |..||....... .. ......... ..+..
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~~~~~--~~~~~ 241 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VP----DLLEKGERL--AQPQI 241 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HH----HHHHTTCBC--CCCTT
T ss_pred cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HH----HHHHcCCCC--CCCCc
Confidence 2 2234567889999999999999999999999999999999 999986533221 11 111111111 11111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
....+.+|+.+||+.||.+|||+.++++.|+...
T Consensus 242 -------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 242 -------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp -------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred -------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1123667999999999999999999999998753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=333.79 Aligned_cols=228 Identities=23% Similarity=0.299 Sum_probs=180.7
Q ss_pred CCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCCCH
Q 048280 55 SNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESL 133 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L 133 (381)
.+.||+|+||.||+|... +++.||||++........+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 567999999999999875 5899999999876655667899999999999999999999999999999999999999998
Q ss_pred HHHH----------------HhhhhhhhHhhhhc--cCCccccceEe--CCCCCcEEeeeccceecCCCCcccccccccC
Q 048280 134 DKVL----------------FSLIKDIQILFRKK--KTDIKASNILL--DDKWIPKIADFGMARLFPEDQTHVNTRVAGT 193 (381)
Q Consensus 134 ~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll--~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt 193 (381)
.+++ .|++.+|.|||+.+ ||||||+|||+ +.++.+||+|||+++.+..... .....||
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~~~gt 251 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVNFGT 251 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCCCCSS
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cccccCC
Confidence 6554 68999999999999 99999999999 6678999999999997654332 2335699
Q ss_pred ccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHH
Q 048280 194 NGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAM 273 (381)
Q Consensus 194 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (381)
+.|+|||++.+..++.++|||||||++|||++|..||...... ............ . .+ .........
T Consensus 252 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~~--~-~~----~~~~~~~~~ 318 (373)
T 2x4f_A 252 PEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACRWD--L-ED----EEFQDISEE 318 (373)
T ss_dssp CTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCC--S-CS----GGGTTSCHH
T ss_pred CcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccCC--C-Ch----hhhccCCHH
Confidence 9999999999989999999999999999999999998643221 111112211110 0 00 011123456
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 048280 274 CIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 274 l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
+.+|+.+||+.||.+|||+.|+++
T Consensus 319 ~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 319 AKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHhc
Confidence 889999999999999999999987
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=319.54 Aligned_cols=234 Identities=25% Similarity=0.418 Sum_probs=185.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCccc-------HHHHHHHHHHHHHhCCCCcccEEEEEeeCCe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQG-------KKEFENEAKLLARVQHRNVVNLLGYCAHGAE 120 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 120 (381)
.++|++.+.||+|+||.||+|++. +++.||||++....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 578999999999999999999875 68999999986543221 167899999999999999999999997665
Q ss_pred EEEEEecccCCCHHHHH----------------HhhhhhhhHhhhhc----cCCccccceEeCCCCC-----cEEeeecc
Q 048280 121 KLLIYEYVINESLDKVL----------------FSLIKDIQILFRKK----KTDIKASNILLDDKWI-----PKIADFGM 175 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~----HrDlkp~NIll~~~~~-----~kL~DFG~ 175 (381)
++||||+.+++|.+.+ .|++.+|.|||..+ ||||||+|||++.++. +||+|||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 7999999999996544 78999999999976 9999999999987776 99999999
Q ss_pred ceecCCCCcccccccccCccccchhHHh--hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCC
Q 048280 176 ARLFPEDQTHVNTRVAGTNGYMAPEYVM--HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDK 253 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (381)
++.... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||........ ...........
T Consensus 176 ~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~ 247 (287)
T 4f0f_A 176 SQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KFINMIREEGL 247 (287)
T ss_dssp CBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HHHHHHHHSCC
T ss_pred cccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HHHHHHhccCC
Confidence 985432 233467899999999984 45678999999999999999999999864332211 11111111111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 254 SLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
.+. .....+..+.+|+.+||+.||.+|||+.+|++.|++
T Consensus 248 -----~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 248 -----RPT----IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp -----CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -----CCC----CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 111 112234568899999999999999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=317.05 Aligned_cols=235 Identities=21% Similarity=0.300 Sum_probs=188.6
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4678999999999999999999876 58999999986542 23346788999999999999999999999999999999
Q ss_pred EecccCCCHHHH---------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCC---cEEeeeccceecCCCCc
Q 048280 125 YEYVINESLDKV---------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWI---PKIADFGMARLFPEDQT 184 (381)
Q Consensus 125 ~E~~~~g~L~~~---------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~---~kL~DFG~~~~~~~~~~ 184 (381)
|||+.+++|.+. +.|++.+|.|||+.+ ||||||+|||++.++. +||+|||++........
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 999999999654 378999999999999 9999999999976654 99999999987654322
Q ss_pred ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 185 HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ... ..... ... ... .
T Consensus 164 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~---~~~~~-~~~-~~~-----~ 228 (284)
T 3kk8_A 164 --WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLY---AQIKA-GAY-DYP-----S 228 (284)
T ss_dssp --CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHH-TCC-CCC-----T
T ss_pred --ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHH---HHHHh-ccc-cCC-----c
Confidence 23457899999999999999999999999999999999999998543221 111 11111 110 000 1
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.........+.+|+.+||+.||.+|||+.|+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 229 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111123356889999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=329.06 Aligned_cols=248 Identities=24% Similarity=0.393 Sum_probs=196.9
Q ss_pred CChHHHHHhhcCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEE
Q 048280 40 FPFEALVSATKNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLL 112 (381)
Q Consensus 40 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~ 112 (381)
+...+.....++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 444455566789999999999999999999754 36789999997543 23345788999999999999999999
Q ss_pred EEEeeCCeEEEEEecccCCCHHHHH-------------------------HhhhhhhhHhhhhc--cCCccccceEeCCC
Q 048280 113 GYCAHGAEKLLIYEYVINESLDKVL-------------------------FSLIKDIQILFRKK--KTDIKASNILLDDK 165 (381)
Q Consensus 113 ~~~~~~~~~~lv~E~~~~g~L~~~l-------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~ 165 (381)
+++.+.+..++||||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 174 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC
Confidence 9999999999999999999997655 47889999999999 99999999999999
Q ss_pred CCcEEeeeccceecCCCCc-ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHH
Q 048280 166 WIPKIADFGMARLFPEDQT-HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLD 243 (381)
Q Consensus 166 ~~~kL~DFG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~ 243 (381)
+.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... ...
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~- 250 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVL- 250 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHH-
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---HHH-
Confidence 9999999999986543222 12223457889999999999999999999999999999999 78887543211 111
Q ss_pred HHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 244 WAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
.. ....... ......+..+.+|+.+||+.||.+|||+.++++.|+...
T Consensus 251 --~~-~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 251 --RF-VMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp --HH-HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred --HH-HHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 11 1111111 111123456888999999999999999999999998753
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=331.84 Aligned_cols=247 Identities=22% Similarity=0.313 Sum_probs=190.6
Q ss_pred HHHHHhhcCCCCCCcccccCCeeEEEEEE-CCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEee----
Q 048280 43 EALVSATKNFHPSNKLGEGGFGPVFKGKL-DDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAH---- 117 (381)
Q Consensus 43 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---- 117 (381)
+.+....++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++..
T Consensus 22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 33444567899999999999999999987 4689999999876666667789999999999999999999999863
Q ss_pred CCeEEEEEecccCCCHHHHH-------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccc
Q 048280 118 GAEKLLIYEYVINESLDKVL-------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMA 176 (381)
Q Consensus 118 ~~~~~lv~E~~~~g~L~~~l-------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~ 176 (381)
....++||||+.+++|.+++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 34789999999999997654 68899999999999 9999999999999999999999998
Q ss_pred eecCCCCcc--------cccccccCccccchhHHhhCC---CCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHH
Q 048280 177 RLFPEDQTH--------VNTRVAGTNGYMAPEYVMHGH---LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWA 245 (381)
Q Consensus 177 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~ 245 (381)
......... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....... .....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~-- 258 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVAL-- 258 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-SCHHH--
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-chhhH--
Confidence 865321111 012345799999999987554 6899999999999999999999984211110 01111
Q ss_pred HHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 246 YKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
..... ............+.+|+.+||+.||.+|||+.+|++.|+...
T Consensus 259 --~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 259 --AVQNQ---------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp --HHHCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred --Hhhcc---------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 01110 000111223456889999999999999999999999998864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=337.26 Aligned_cols=234 Identities=20% Similarity=0.325 Sum_probs=181.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCC--cccHHHHHHHHHHHHHhC--CCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSS--NQGKKEFENEAKLLARVQ--HRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|+.++++++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 34699999999999999999998889999999986543 334577899999999996 59999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc-c
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH-V 186 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~-~ 186 (381)
|| +.+++|.+++ .|++.+|.|||..+ ||||||+||||+ ++.+||+|||+++.+...... .
T Consensus 135 ~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~ 212 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVV 212 (390)
T ss_dssp EE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--------
T ss_pred Ee-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcccc
Confidence 99 5588887655 68999999999999 999999999996 578999999999876443222 2
Q ss_pred ccccccCccccchhHHhh-----------CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcc
Q 048280 187 NTRVAGTNGYMAPEYVMH-----------GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSL 255 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (381)
.....||+.|+|||++.+ ..++.++|||||||+||||++|+.||..... ..............
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~~~~~~- 286 (390)
T 2zmd_A 213 KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPNHE- 286 (390)
T ss_dssp -CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHHCTTSC-
T ss_pred CCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHhCcccc-
Confidence 234679999999999875 3689999999999999999999999864321 11111112111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 256 EIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
...+......+.+|+.+||+.||.+|||+.||++.
T Consensus 287 --------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 287 --------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp --------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 00111113467889999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=326.93 Aligned_cols=239 Identities=26% Similarity=0.422 Sum_probs=191.8
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC--------CCcEEEEEEecCCC-cccHHHHHHHHHHHHHh-CCCCcccEEEEEee
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD--------DGREIAVKKLSHSS-NQGKKEFENEAKLLARV-QHRNVVNLLGYCAH 117 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 117 (381)
..++|++.+.||+|+||.||+|+.. ++..||||++.... ......+.+|+++++++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3578999999999999999999863 46789999997543 23456789999999999 89999999999999
Q ss_pred CCeEEEEEecccCCCHHHHH-------------------------------HhhhhhhhHhhhhc--cCCccccceEeCC
Q 048280 118 GAEKLLIYEYVINESLDKVL-------------------------------FSLIKDIQILFRKK--KTDIKASNILLDD 164 (381)
Q Consensus 118 ~~~~~lv~E~~~~g~L~~~l-------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~ 164 (381)
.+..++||||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcC
Confidence 99999999999999997664 47899999999999 9999999999999
Q ss_pred CCCcEEeeeccceecCCCCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHH
Q 048280 165 KWIPKIADFGMARLFPEDQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLL 242 (381)
Q Consensus 165 ~~~~kL~DFG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~ 242 (381)
++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... .+.
T Consensus 193 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~ 269 (334)
T 2pvf_A 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---ELF 269 (334)
T ss_dssp TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHH
T ss_pred CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---HHH
Confidence 999999999999876543322 1223457889999999999999999999999999999999 99998643211 111
Q ss_pred HHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 243 DWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
......... .. .......+.+|+.+||+.||.+|||+.+|++.|+++
T Consensus 270 ----~~~~~~~~~-----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 270 ----KLLKEGHRM-----DK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp ----HHHHHTCCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHhcCCCC-----CC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111111111 11 112335688899999999999999999999998764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=324.97 Aligned_cols=240 Identities=22% Similarity=0.301 Sum_probs=180.0
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc---ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC----
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---QGKKEFENEAKLLARVQHRNVVNLLGYCAHGA---- 119 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---- 119 (381)
..++|++.+.||+|+||.||+|++. +++.||||++..... .....+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 3578999999999999999999874 689999999976532 23457889999999999999999999987654
Q ss_pred eEEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCC
Q 048280 120 EKLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPED 182 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~ 182 (381)
..|+||||+++++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++..+...
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 349999999999998765 68999999999999 9999999999999999999999999876443
Q ss_pred Ccc--cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCC
Q 048280 183 QTH--VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDP 260 (381)
Q Consensus 183 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .................
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~~~~-- 241 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIPPSA-- 241 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCCHHH--
T ss_pred ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCCCccc--
Confidence 221 22345689999999999999999999999999999999999999864322 11112222211111000
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH-Hhc
Q 048280 261 SLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV-MLS 300 (381)
Q Consensus 261 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~-~L~ 300 (381)
.....+..+.+|+.+||+.||.+||++.+++. .|.
T Consensus 242 -----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 242 -----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp -----HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -----ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 00112356888999999999999997766553 443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=317.01 Aligned_cols=244 Identities=18% Similarity=0.280 Sum_probs=187.7
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEE-CCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEE-eeCCeEEEE
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKL-DDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYC-AHGAEKLLI 124 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~~~~~lv 124 (381)
...++|++.+.||+|+||.||+|+. .+++.||||++...... ..+.+|+.+++.++|++++..+.++ ......++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3467899999999999999999986 46899999987544322 4578899999999988877766655 677888999
Q ss_pred EecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEe---CCCCCcEEeeeccceecCCCC
Q 048280 125 YEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILL---DDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 125 ~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll---~~~~~~kL~DFG~~~~~~~~~ 183 (381)
|||+ +++|.+++ .|++.+|.|||+.+ ||||||+|||+ +.++.+||+|||+++......
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 9999 99998765 58999999999999 99999999999 788999999999998765433
Q ss_pred cc------cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccc
Q 048280 184 TH------VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEI 257 (381)
Q Consensus 184 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (381)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......................... .
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~ 241 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-V 241 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-H
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh-h
Confidence 21 1234678999999999999999999999999999999999999997654443333333222211111100 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 258 VDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.. . ..+..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 242 ~~----~----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 242 LC----K----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HT----T----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hh----c----cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 00 0 1135688999999999999999999999998764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=332.76 Aligned_cols=233 Identities=21% Similarity=0.222 Sum_probs=177.8
Q ss_pred hcCCCCC-CcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHh-CCCCcccEEEEEee----CCeE
Q 048280 49 TKNFHPS-NKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLGYCAH----GAEK 121 (381)
Q Consensus 49 ~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~----~~~~ 121 (381)
.++|.+. +.||+|+||.||+|... +++.||||++.. ...+.+|+.++.++ +||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 4567776 68999999999999876 589999999853 25677899988655 89999999999876 5678
Q ss_pred EEEEecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCC---CCCcEEeeeccceec
Q 048280 122 LLIYEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDD---KWIPKIADFGMARLF 179 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~---~~~~kL~DFG~~~~~ 179 (381)
|||||||.+|+|.+++ .|++.+|.|||+.+ ||||||+||||+. ++.+||+|||+++..
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~ 214 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence 9999999999997655 68899999999998 9999999999987 789999999999876
Q ss_pred CCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccc-cHHHHHHHHhhcCCccccc
Q 048280 180 PEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQ-NLLDWAYKLYKKDKSLEIV 258 (381)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 258 (381)
.... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ....... .... ..
T Consensus 215 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~~-~~- 286 (400)
T 1nxk_A 215 TSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQY-EF- 286 (400)
T ss_dssp C-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTCC-CC-
T ss_pred CCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCcc-cC-
Confidence 4322 223467899999999999999999999999999999999999999654432211 1111111 1100 00
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 259 DPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
+ ..........+.+||.+||+.||.+|||+.||++.
T Consensus 287 -~---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 287 -P---NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -C---TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -C---CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 11112234568899999999999999999999974
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=323.73 Aligned_cols=235 Identities=25% Similarity=0.312 Sum_probs=189.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc------ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN------QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEK 121 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 121 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 567999999999999999999876 589999999865432 1367899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCC----CcEEeeeccceecC
Q 048280 122 LLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKW----IPKIADFGMARLFP 180 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~----~~kL~DFG~~~~~~ 180 (381)
++||||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++ .+||+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 9999999999998765 68999999999998 999999999999887 79999999998765
Q ss_pred CCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCC
Q 048280 181 EDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDP 260 (381)
Q Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........... ...+
T Consensus 171 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~~---~~~~ 239 (321)
T 2a2a_A 171 DGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANITSVSY---DFDE 239 (321)
T ss_dssp TTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTCC---CCCH
T ss_pred cccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhccc---ccCh
Confidence 4322 23456899999999999999999999999999999999999998643221 11111111100 0000
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 261 SLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 261 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
... ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 240 ~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 240 EFF----SHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred hhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 1123558899999999999999999999874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=323.22 Aligned_cols=245 Identities=25% Similarity=0.338 Sum_probs=183.6
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-----cccHHHHHHHHHHHHHhC---CCCcccEEEEEeeC
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-----NQGKKEFENEAKLLARVQ---HRNVVNLLGYCAHG 118 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~ 118 (381)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4679999999999999999999964 68999999986432 122356778888888775 99999999999876
Q ss_pred C-----eEEEEEecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeec
Q 048280 119 A-----EKLLIYEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFG 174 (381)
Q Consensus 119 ~-----~~~lv~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG 174 (381)
. ..++||||+. ++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 5 5899999996 5876543 78999999999999 99999999999999999999999
Q ss_pred cceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCc
Q 048280 175 MARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKS 254 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (381)
+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+ ..............
T Consensus 166 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 166 LARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIGLPPE 240 (308)
T ss_dssp CTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHHHCCCCT
T ss_pred cccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCh
Confidence 9986643322 234678999999999999999999999999999999999999986543221 12222221111100
Q ss_pred cccc---------CCCCCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 255 LEIV---------DPSLAAS----DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 255 ~~~~---------~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.... .+..... ........+.+|+.+||+.||.+|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0000 0000000 011234568899999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=340.47 Aligned_cols=232 Identities=22% Similarity=0.262 Sum_probs=178.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999875 5899999998643 223345678899999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhh-hc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFR-KK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~-~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
|||+.+++|..++ .|++.+|.|||+ .+ ||||||+||||+.++.+||+|||+++....... .
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~ 305 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 305 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc-c
Confidence 9999999997654 689999999998 65 999999999999999999999999986433222 2
Q ss_pred ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
....+||+.|+|||++.+..++.++|||||||+||||++|+.||...... .+. ........ .+
T Consensus 306 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~---~~i~~~~~-------~~---- 368 (446)
T 4ejn_A 306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLF---ELILMEEI-------RF---- 368 (446)
T ss_dssp -CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHCCC-------CC----
T ss_pred cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHH---HHHHhCCC-------CC----
Confidence 33467999999999999999999999999999999999999998543221 111 11111110 01
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRP-----TMRRVVVM 298 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 298 (381)
+......+.+||.+||+.||.+|| ++.|+++.
T Consensus 369 p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 369 PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 111235688999999999999999 99999863
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=317.31 Aligned_cols=234 Identities=19% Similarity=0.254 Sum_probs=189.2
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
..++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 4567999999999999999999876 478999999977666667889999999999999999999999999999999999
Q ss_pred cccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEe---CCCCCcEEeeeccceecCCCCccc
Q 048280 127 YVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILL---DDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 127 ~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll---~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
|+.+++|.+++ .|++.+|.|||+.+ ||||||+|||+ +.++.+||+|||++........
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~-- 164 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-- 164 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC--
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc--
Confidence 99999996654 78999999999999 99999999999 7889999999999987654322
Q ss_pred ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
.....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... ............. + ...
T Consensus 165 ~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~----~---~~~ 230 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS------EVMLKIREGTFTF----P---EKD 230 (277)
T ss_dssp BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCC----C---HHH
T ss_pred hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCCCC----C---chh
Confidence 234568999999998865 4999999999999999999999998643221 1111111111000 0 000
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.......+.+|+.+||+.||.+|||+.++++
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 231 WLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0012356889999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=331.36 Aligned_cols=250 Identities=22% Similarity=0.272 Sum_probs=195.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC--eEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA--EKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv 124 (381)
.++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467999999999999999999876 48999999997543 334577889999999999999999999998765 78999
Q ss_pred EecccCCCHHHHH------------------HhhhhhhhHhhhhc--cCCccccceEe----CCCCCcEEeeeccceecC
Q 048280 125 YEYVINESLDKVL------------------FSLIKDIQILFRKK--KTDIKASNILL----DDKWIPKIADFGMARLFP 180 (381)
Q Consensus 125 ~E~~~~g~L~~~l------------------~~~~~~l~~lh~~~--HrDlkp~NIll----~~~~~~kL~DFG~~~~~~ 180 (381)
|||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||+ +.++.+||+|||+++...
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 9999999987654 68999999999999 99999999999 778889999999998764
Q ss_pred CCCcccccccccCccccchhHHhh--------CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcC
Q 048280 181 EDQTHVNTRVAGTNGYMAPEYVMH--------GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKD 252 (381)
Q Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (381)
... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||......... ...........
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~~~~~ 243 (396)
T 4eut_A 168 DDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIITGK 243 (396)
T ss_dssp CGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHHHHSC
T ss_pred CCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHHhcCC
Confidence 432 2234579999999999875 56788999999999999999999998643322111 11112222211
Q ss_pred Cccc---c---------cCC--CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 253 KSLE---I---------VDP--SLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 253 ~~~~---~---------~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.... . ... .............+.+++.+||+.||++||++.++++.+..+
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 1100 0 000 111234577888899999999999999999999999887653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=318.75 Aligned_cols=242 Identities=23% Similarity=0.385 Sum_probs=182.5
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEE
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 122 (381)
...++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++...+..+
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 34568999999999999999999864 68999999997532 334567889999999999999999999999999999
Q ss_pred EEEecccCCCHHHHH-------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCC
Q 048280 123 LIYEYVINESLDKVL-------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPE 181 (381)
Q Consensus 123 lv~E~~~~g~L~~~l-------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~ 181 (381)
+||||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999997655 58899999999999 999999999999999999999999986643
Q ss_pred CCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCC
Q 048280 182 DQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPS 261 (381)
Q Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (381)
... ......|+..|+|||++.+..++.++|||||||++|+|++|..||..... ......... ...... .
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~-~~~~~~-----~ 257 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKI-EQCDYP-----P 257 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHHH-HTTCSC-----C
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHHh-hcccCC-----C
Confidence 322 12245689999999999999999999999999999999999999853321 111111111 111111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 262 LAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 262 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
. ........+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 258 ~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 258 L---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp C---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1 1112345688999999999999999999999999775
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=325.54 Aligned_cols=248 Identities=17% Similarity=0.196 Sum_probs=183.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC----CCcEEEEEEecCCCcc-----------cHHHHHHHHHHHHHhCCCCcccEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD----DGREIAVKKLSHSSNQ-----------GKKEFENEAKLLARVQHRNVVNLLG 113 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpnIv~~~~ 113 (381)
.++|++.+.||+|+||.||+|... ++..||||++...... ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999875 5788999998755321 1234667888899999999999999
Q ss_pred EEee----CCeEEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCC--CcEE
Q 048280 114 YCAH----GAEKLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKW--IPKI 170 (381)
Q Consensus 114 ~~~~----~~~~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~--~~kL 170 (381)
++.. ....++||||+ +++|.+++ .|++.+|.|||+.+ ||||||+||||+.++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 9988 78899999999 99997654 78999999999999 999999999998877 9999
Q ss_pred eeeccceecCCCCc------ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 048280 171 ADFGMARLFPEDQT------HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDW 244 (381)
Q Consensus 171 ~DFG~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~ 244 (381)
+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~~ 272 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV--AVQT 272 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH--HHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH--HHHH
Confidence 99999987643211 112345799999999999999999999999999999999999999853221111 1111
Q ss_pred HHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 245 AYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
.......... ..+..... ....+..+.+|+.+||+.||.+|||+.+|++.|+...
T Consensus 273 ~~~~~~~~~~-~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 273 AKTNLLDELP-QSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHTTT-HHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHhhccccc-HHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 1111111100 00000000 0022356889999999999999999999999998754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=317.81 Aligned_cols=237 Identities=23% Similarity=0.351 Sum_probs=190.1
Q ss_pred hcCCCCCC-cccccCCeeEEEEEEC---CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 49 TKNFHPSN-KLGEGGFGPVFKGKLD---DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 49 ~~~y~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
.++|.+.+ .||+|+||.||+|.+. ++..||||++.... ....+.+.+|++++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 45677776 9999999999999753 57889999997653 33457799999999999999999999999 4566899
Q ss_pred EEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 124 IYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 124 v~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
||||+.+++|.+++ .|++.+|.+||+.+ ||||||+|||++.++.+||+|||++.........
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 99999999998765 68999999999999 9999999999999999999999999977543322
Q ss_pred c--ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 186 V--NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 186 ~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
. .....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||......+ .. ........ +
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~----~~i~~~~~-----~-- 232 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM----AFIEQGKR-----M-- 232 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HH----HHHHTTCC-----C--
T ss_pred eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HH----HHHhcCCc-----C--
Confidence 1 123456889999999999999999999999999999998 999986433211 11 11111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
......+..+.+|+.+||+.||.+||++.++++.|+..
T Consensus 233 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 233 --ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp --CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11122345688999999999999999999999998764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=339.84 Aligned_cols=230 Identities=23% Similarity=0.351 Sum_probs=189.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|.+.+.||+|+||.||+|++. +|+.||||++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 468999999999999999999876 69999999996432 23356789999999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++........ .
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~--~ 172 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF--L 172 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC--B
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc--c
Confidence 9999999997654 78999999999999 999999999999999999999999997654322 2
Q ss_pred cccccCccccchhHHhhCCC-CchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHL-SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
...+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... .+. ..... ... ..+
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~---~~i~~-~~~---~~p------ 236 (476)
T 2y94_A 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLF---KKICD-GIF---YTP------ 236 (476)
T ss_dssp CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHH---HHHHT-TCC---CCC------
T ss_pred cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHH---HHHhc-CCc---CCC------
Confidence 34579999999999988776 78999999999999999999998643221 111 11111 110 001
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
......+.+|+.+||+.||.+|||+.+|++
T Consensus 237 -~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 237 -QYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 112345888999999999999999999996
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=325.28 Aligned_cols=238 Identities=26% Similarity=0.401 Sum_probs=183.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcE----EEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGRE----IAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 122 (381)
.++|++.+.||+|+||.||+|++. +++. ||+|.+... .......+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 468999999999999999999865 3443 577777543 3445678999999999999999999999998765 78
Q ss_pred EEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 123 LIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 123 lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
+|+||+.+|+|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++.+.....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence 999999999997655 68999999999999 999999999999999999999999987643322
Q ss_pred c-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 185 H-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 185 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
. ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||....... +.. .......
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~----~~~~~~~-------- 237 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGER-------- 237 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCC--------
T ss_pred cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCCC--------
Confidence 2 2223456889999999999999999999999999999999 999986543322 111 1111110
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
..........+.+|+.+||+.||.+|||+.||++.|+...
T Consensus 238 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 238 -LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1111123346888999999999999999999999998753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=332.48 Aligned_cols=248 Identities=17% Similarity=0.224 Sum_probs=183.6
Q ss_pred hhcCCCCCCcccccCCeeEEEEEECC------CcEEEEEEecCCCccc-----------HHHHHHHHHHHHHhCCCCccc
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLDD------GREIAVKKLSHSSNQG-----------KKEFENEAKLLARVQHRNVVN 110 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpnIv~ 110 (381)
..++|++.+.||+|+||.||+|.+.. ++.||||++....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35589999999999999999998754 4789999986543211 112334555566667999999
Q ss_pred EEEEEeeC----CeEEEEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeC--CCC
Q 048280 111 LLGYCAHG----AEKLLIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLD--DKW 166 (381)
Q Consensus 111 ~~~~~~~~----~~~~lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~--~~~ 166 (381)
+++++... ...+|||||+ +++|.+++ .|++.+|.|||+.+ ||||||+||||+ .++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 99998764 5589999999 99997765 68999999999999 999999999998 889
Q ss_pred CcEEeeeccceecCCCCcc------cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccccc
Q 048280 167 IPKIADFGMARLFPEDQTH------VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQN 240 (381)
Q Consensus 167 ~~kL~DFG~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 240 (381)
.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~--~~ 269 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD--PK 269 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC--HH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC--HH
Confidence 9999999999876432211 112345999999999999999999999999999999999999998642221 11
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 241 LLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.......... ......+++.+.. ...+..+.+|+..||+.||.+||++.+|++.|+..
T Consensus 270 ~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 270 YVRDSKIRYR-ENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp HHHHHHHHHH-HCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHhh-hhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 1111111111 1111122221111 11235688899999999999999999999988653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=315.04 Aligned_cols=243 Identities=19% Similarity=0.289 Sum_probs=191.3
Q ss_pred hhcCCCCCCcccccCCeeEEEEEE-CCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEE-eeCCeEEEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKL-DDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYC-AHGAEKLLIY 125 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~~~~~lv~ 125 (381)
..++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+|+.+++.++|++++..+.++ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999999987 4689999999865433 24688999999999988877666555 6778889999
Q ss_pred ecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEe---CCCCCcEEeeeccceecCCCCc
Q 048280 126 EYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILL---DDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 126 E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll---~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
||+ +++|.+++ .|++.+|.|||+.+ ||||||+|||+ +.++.+||+|||++........
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 999 99997765 68999999999999 99999999999 4888999999999987654432
Q ss_pred c------cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCccccc
Q 048280 185 H------VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIV 258 (381)
Q Consensus 185 ~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........................ ...
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 242 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-EVL 242 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-HHH
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-HHH
Confidence 1 123467999999999999999999999999999999999999999764443333333222221111110 000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 259 DPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
. . ..+..+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 243 ~----~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 243 C----K----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp T----T----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred H----h----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 0 1 1235588899999999999999999999999764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=343.69 Aligned_cols=235 Identities=28% Similarity=0.349 Sum_probs=190.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|++.+.||+|+||.||+|+.. +|+.||||++... .......+.+|+.+|++++||||+++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999876 6999999998643 223456788999999999999999999999999999999
Q ss_pred EecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 125 YEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 125 ~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
|||+++|+|..++ .|++.+|.|||+++ ||||||+||||+.++.+||+|||+++.+.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~- 341 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 341 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCcc-
Confidence 9999999997655 68899999999999 999999999999999999999999997654322
Q ss_pred cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCC
Q 048280 186 VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+ ........ ..+
T Consensus 342 -~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i---~~~i~~~~------~~~--- 408 (576)
T 2acx_A 342 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKEVP------EEY--- 408 (576)
T ss_dssp -EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH---HHHHHHCC------CCC---
T ss_pred -ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH---HHHhhccc------ccC---
Confidence 23457999999999999989999999999999999999999999754332211111 11111110 111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 048280 266 DSGDQIAMCIQIGLLCTQGDPQLRP-----TMRRVVVM 298 (381)
Q Consensus 266 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 298 (381)
.......+.+||.+||+.||.+|| ++.||++.
T Consensus 409 -p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 409 -SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 112335688999999999999999 78888753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=324.70 Aligned_cols=238 Identities=25% Similarity=0.416 Sum_probs=183.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC-----CcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD-----GREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 122 (381)
.++|.+.+.||+|+||.||+|.... +..||||++.... ......+.+|+.++++++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4578888999999999999998642 2469999997543 334467899999999999999999999999999999
Q ss_pred EEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 123 LIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 123 lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
+||||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++........
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 202 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence 999999999997765 67899999999998 999999999999999999999999987644322
Q ss_pred cc--ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCC
Q 048280 185 HV--NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPS 261 (381)
Q Consensus 185 ~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (381)
.. .....+|..|+|||++.+..++.++|||||||++|||++ |..||...... .+. ........
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~----~~~~~~~~------- 268 (333)
T 1mqb_A 203 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVM----KAINDGFR------- 268 (333)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH----HHHHTTCC-------
T ss_pred cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHH----HHHHCCCc-------
Confidence 11 123346788999999999999999999999999999999 99998543221 111 11111110
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 262 LAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 262 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
..........+.+|+.+||+.||.+||++.+|++.|+..
T Consensus 269 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 269 --LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp --CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011112345688999999999999999999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=324.24 Aligned_cols=249 Identities=28% Similarity=0.428 Sum_probs=196.6
Q ss_pred CCChHHHHHhhcCCCCCCcccccCCeeEEEEEE------CCCcEEEEEEecCCCc-ccHHHHHHHHHHHHHh-CCCCccc
Q 048280 39 HFPFEALVSATKNFHPSNKLGEGGFGPVFKGKL------DDGREIAVKKLSHSSN-QGKKEFENEAKLLARV-QHRNVVN 110 (381)
Q Consensus 39 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~ 110 (381)
.+.........++|++.+.||+|+||.||+|++ .+++.||||++..... .....+.+|+.+++++ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 455555666678999999999999999999974 2468899999976532 3346789999999999 7999999
Q ss_pred EEEEEeeCC-eEEEEEecccCCCHHHHH-------------------------------HhhhhhhhHhhhhc--cCCcc
Q 048280 111 LLGYCAHGA-EKLLIYEYVINESLDKVL-------------------------------FSLIKDIQILFRKK--KTDIK 156 (381)
Q Consensus 111 ~~~~~~~~~-~~~lv~E~~~~g~L~~~l-------------------------------~~~~~~l~~lh~~~--HrDlk 156 (381)
+++++...+ ..++||||+.+++|.+++ .|++.+|.|||+.+ |||||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dik 175 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 175 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCc
Confidence 999987754 589999999999997765 47899999999999 99999
Q ss_pred ccceEeCCCCCcEEeeeccceecCCCCc-ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCC
Q 048280 157 ASNILLDDKWIPKIADFGMARLFPEDQT-HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNL 234 (381)
Q Consensus 157 p~NIll~~~~~~kL~DFG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~ 234 (381)
|+|||++.++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999987644332 22234567899999999999999999999999999999998 999986432
Q ss_pred ccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 235 DVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
... .+. .......... . .......+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 256 ~~~--~~~----~~~~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 256 IDE--EFC----RRLKEGTRMR-----A----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CSH--HHH----HHHHHTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhH--HHH----HHhccCccCC-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 211 111 1111111111 1 111235688899999999999999999999998753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=324.23 Aligned_cols=249 Identities=22% Similarity=0.318 Sum_probs=181.8
Q ss_pred HHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcc-----cHHHHHHHHHHHHHhCCCCcccEEEEEeeCC
Q 048280 46 VSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQ-----GKKEFENEAKLLARVQHRNVVNLLGYCAHGA 119 (381)
Q Consensus 46 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 119 (381)
....++|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+|++++++++||||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 344678999999999999999999876 5899999999653221 1246789999999999999999999999999
Q ss_pred eEEEEEecccCCCHHHH----------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCC
Q 048280 120 EKLLIYEYVINESLDKV----------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPE 181 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~~----------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~ 181 (381)
..++||||+.+ +|..+ +.|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++.+..
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 99999999965 66544 478999999999999 999999999999999999999999987643
Q ss_pred CCcccccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccc---
Q 048280 182 DQTHVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEI--- 257 (381)
Q Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 257 (381)
... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+ .................
T Consensus 165 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~---~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 165 PNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp CCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSST
T ss_pred Ccc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHcCCCChhhhhhh
Confidence 322 22345789999999999764 58999999999999999999998886443211 11111111111100000
Q ss_pred ------cCCCCCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 258 ------VDPSLAASDS-----GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 258 ------~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
+......... ......+.+|+.+||+.||.+|||+.|+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 0000000001 12336788999999999999999999998754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=329.45 Aligned_cols=229 Identities=26% Similarity=0.422 Sum_probs=183.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc---ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.+.|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 345889999999999999999864 689999999975432 2235788999999999999999999999999999999
Q ss_pred EecccCCCHHHH----------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 125 YEYVINESLDKV----------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 125 ~E~~~~g~L~~~----------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
|||+. |+|.++ +.|++.+|.|||+.+ ||||||+|||++.++.+||+|||++......
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---- 207 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 207 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC----
Confidence 99996 566543 368999999999999 9999999999999999999999999865432
Q ss_pred ccccccCccccchhHHh---hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVM---HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
....||+.|+|||++. +..++.++|||||||++|||++|+.||..... ............ +...
T Consensus 208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~~~------~~~~ 274 (348)
T 1u5q_A 208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNES------PALQ 274 (348)
T ss_dssp -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC------CCCC
T ss_pred -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCC------CCCC
Confidence 2357899999999985 46789999999999999999999999854321 111122222111 1111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 264 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.......+.+|+.+||+.||.+|||+.++++.
T Consensus 275 ---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 275 ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11223557889999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=317.01 Aligned_cols=230 Identities=24% Similarity=0.356 Sum_probs=184.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|++.+.||+|+||.||+|+.. ++..||||++... .......+.+|+.++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 568999999999999999999876 4779999998543 222356788999999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|||+++++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++....... .
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~---~ 164 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---R 164 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--------
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc---c
Confidence 9999999987554 78999999999998 99999999999999999999999986543222 2
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...... .......... ... +
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~-------~~~----~ 227 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVE-------FTF----P 227 (279)
T ss_dssp ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTC-------CCC----C
T ss_pred cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH------HHHHHHHhCC-------CCC----C
Confidence 3457899999999999999999999999999999999999998643211 1111111111 011 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
......+.+|+.+||+.||.+|||+.||++.
T Consensus 228 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 228 DFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1123557889999999999999999999974
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=337.18 Aligned_cols=177 Identities=24% Similarity=0.399 Sum_probs=138.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEee-----CCe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAH-----GAE 120 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~ 120 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+++|++++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999866 6899999999654 23345678999999999999999999999843 357
Q ss_pred EEEEEecccCCCHHHH---------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 121 KLLIYEYVINESLDKV---------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~---------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
.|+||||+ +++|.++ +.|++.+|.|||+.+ ||||||+||||+.++.+||+|||+++......
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred EEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 89999998 5677654 478999999999999 99999999999999999999999998764321
Q ss_pred c--------------------------ccccccccCccccchhHHh-hCCCCchhhhHhHHHHHHHHHhC
Q 048280 184 T--------------------------HVNTRVAGTNGYMAPEYVM-HGHLSVKADVFSFGVVILELISG 226 (381)
Q Consensus 184 ~--------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg 226 (381)
. ...+..+||+.|+|||++. +..++.++||||||||||||++|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 1 1123467899999999874 56799999999999999999993
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=317.68 Aligned_cols=242 Identities=24% Similarity=0.411 Sum_probs=180.8
Q ss_pred hhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
..++|++.+.||+|+||.||+|+.. ..||||++.... ....+.+.+|+.++++++||||+++++++. ....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEE
Confidence 3678999999999999999999865 359999986543 333467899999999999999999999764 55689999
Q ss_pred ecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC-ccc
Q 048280 126 EYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ-THV 186 (381)
Q Consensus 126 E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~-~~~ 186 (381)
||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++....... ...
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (289)
T 3og7_A 99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178 (289)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccccc
Confidence 999999997654 68999999999999 99999999999999999999999998654321 122
Q ss_pred ccccccCccccchhHHh---hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVM---HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
.....||+.|+|||++. +..++.++|||||||++|+|++|+.||......+ .+ .............
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~----~~~~~~~~~~~~~----- 247 (289)
T 3og7_A 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QI----IEMVGRGSLSPDL----- 247 (289)
T ss_dssp -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HH----HHHHHHTSCCCCT-----
T ss_pred ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HH----HHHhcccccCcch-----
Confidence 23457899999999986 5678999999999999999999999986433211 11 1111111111110
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 264 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
......++..+.+|+.+||+.||.+|||+.+|++.|+...
T Consensus 248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1111233466889999999999999999999999998753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=331.08 Aligned_cols=233 Identities=21% Similarity=0.261 Sum_probs=178.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc---ccHHHHHHHHHH-HHHhCCCCcccEEEEEeeCCeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---QGKKEFENEAKL-LARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
.++|++.+.||+|+||.||+|+.+ +++.||||++..... .....+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 468999999999999999999976 488999999975432 223456677776 467899999999999999999999
Q ss_pred EEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 124 IYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 124 v~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
||||+.+|+|..++ .|++.+|.|||+++ ||||||+||||+.++.+||+|||+++...... ..
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-~~ 195 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-ST 195 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-CC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC-Cc
Confidence 99999999997654 68999999999999 99999999999999999999999998643222 12
Q ss_pred ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
....+||+.|+|||++.+..++.++|||||||++|||++|..||..... ............ .+..
T Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~-------~~~~-- 260 (373)
T 2r5t_A 196 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNKPL-------QLKP-- 260 (373)
T ss_dssp CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHHSCC-------CCCS--
T ss_pred cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhccc-------CCCC--
Confidence 3356799999999999999999999999999999999999999864321 111112222110 0111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
.....+.+|+.+||+.||.+||++.+.+..+
T Consensus 261 --~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 261 --NITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp --SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred --CCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 1235588899999999999999985444333
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=328.03 Aligned_cols=227 Identities=22% Similarity=0.280 Sum_probs=186.1
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc--------ccHHHHHHHHHHHHHhCCCCcccEEEEEeeC
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN--------QGKKEFENEAKLLARVQHRNVVNLLGYCAHG 118 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 118 (381)
..++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3568999999999999999999865 588999999975431 1234677899999999999999999999999
Q ss_pred CeEEEEEecccCC-CHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecC
Q 048280 119 AEKLLIYEYVINE-SLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFP 180 (381)
Q Consensus 119 ~~~~lv~E~~~~g-~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~ 180 (381)
+..++||||+.+| +|.+++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||++....
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 9999999999776 886544 78999999999999 99999999999999999999999999765
Q ss_pred CCCcccccccccCccccchhHHhhCCC-CchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccC
Q 048280 181 EDQTHVNTRVAGTNGYMAPEYVMHGHL-SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVD 259 (381)
Q Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
.... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .. .....
T Consensus 182 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------~~----~~~~~ 243 (335)
T 3dls_A 182 RGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------VE----AAIHP 243 (335)
T ss_dssp TTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------TT----TCCCC
T ss_pred CCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------Hh----hccCC
Confidence 4332 234579999999999998877 88999999999999999999998531110 00 00000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 260 PSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 260 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
+ ......+.+|+.+||+.||.+|||+.++++.-
T Consensus 244 ~-------~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 244 P-------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp S-------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred C-------cccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 1 11235688999999999999999999998753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=328.17 Aligned_cols=242 Identities=30% Similarity=0.463 Sum_probs=192.9
Q ss_pred HHHhhcCCCCCCcccccCCeeEEEEEECC-C-----cEEEEEEecCCC-cccHHHHHHHHHHHHHh-CCCCcccEEEEEe
Q 048280 45 LVSATKNFHPSNKLGEGGFGPVFKGKLDD-G-----REIAVKKLSHSS-NQGKKEFENEAKLLARV-QHRNVVNLLGYCA 116 (381)
Q Consensus 45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 116 (381)
.....++|++.+.||+|+||.||+|.... + ..||+|++.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 44456789999999999999999998642 2 479999997553 23456789999999999 8999999999999
Q ss_pred eCCeEEEEEecccCCCHHHHH-----------------------------HhhhhhhhHhhhhc--cCCccccceEeCCC
Q 048280 117 HGAEKLLIYEYVINESLDKVL-----------------------------FSLIKDIQILFRKK--KTDIKASNILLDDK 165 (381)
Q Consensus 117 ~~~~~~lv~E~~~~g~L~~~l-----------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~ 165 (381)
..+..++||||+++|+|.+++ .|++.+|.|||+.+ ||||||+|||++.+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 999999999999999997765 47899999999999 99999999999999
Q ss_pred CCcEEeeeccceecCCCCc-ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHH
Q 048280 166 WIPKIADFGMARLFPEDQT-HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLD 243 (381)
Q Consensus 166 ~~~kL~DFG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~ 243 (381)
+.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||....... ..
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~-- 276 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KF-- 276 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--HH--
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--HH--
Confidence 9999999999986543322 22234557889999999999999999999999999999998 888886433211 11
Q ss_pred HHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 244 WAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
.......... .. ....+..+.+|+.+||+.||.+|||+.+|++.|+.
T Consensus 277 --~~~~~~~~~~--~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 277 --YKLVKDGYQM--AQ-------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp --HHHHHHTCCC--CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --HHHHhcCCCC--CC-------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 1111111110 01 11123568889999999999999999999999865
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=312.16 Aligned_cols=232 Identities=24% Similarity=0.342 Sum_probs=181.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
.++|.+.+.||+|+||.||+|+.. ++..||+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 467999999999999999999875 58999999986543 3456789999999999999999999999999999999999
Q ss_pred cccCCCHHHHH-------------------HhhhhhhhHhhhhc--cCCccccceEe---CCCCCcEEeeeccceecCCC
Q 048280 127 YVINESLDKVL-------------------FSLIKDIQILFRKK--KTDIKASNILL---DDKWIPKIADFGMARLFPED 182 (381)
Q Consensus 127 ~~~~g~L~~~l-------------------~~~~~~l~~lh~~~--HrDlkp~NIll---~~~~~~kL~DFG~~~~~~~~ 182 (381)
|+.+++|.+++ .|++.+|.|||+.+ ||||||+|||+ +.++.+||+|||++..+...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 99999987554 68899999999999 99999999999 45678999999999865433
Q ss_pred CcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 183 QTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
. ......||+.|+|||++. ..++.++|||||||++|+|++|+.||...... ................
T Consensus 181 ~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~~~---- 247 (285)
T 3is5_A 181 E--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------EVQQKATYKEPNYAVE---- 247 (285)
T ss_dssp --------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCCCC-----
T ss_pred c--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH------HHHhhhccCCcccccc----
Confidence 2 223456899999999875 57899999999999999999999998643211 1111111111110000
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
... ....+.+|+.+||+.||.+|||+.||++
T Consensus 248 ~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 248 CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011 2355788999999999999999999985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=327.47 Aligned_cols=248 Identities=27% Similarity=0.437 Sum_probs=184.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc--ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN--QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 568999999999999999999876 489999999865432 23456889999999999999999999999999999999
Q ss_pred ecccCCCHHHH---------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 126 EYVINESLDKV---------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 126 E~~~~g~L~~~---------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
||+.+++|..+ +.|++.+|.|||+.+ ||||||+|||++.++.+||+|||++..+..... ...
T Consensus 104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 182 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYD 182 (331)
T ss_dssp ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------------
T ss_pred ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-ccC
Confidence 99998887654 478999999999999 999999999999999999999999986543322 223
Q ss_pred ccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHH--------HHHHhhcCC-ccccc
Q 048280 189 RVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDW--------AYKLYKKDK-SLEIV 258 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~-~~~~~ 258 (381)
...||..|+|||++.+. .++.++|||||||++|+|++|+.||......+....... ....+.... .....
T Consensus 183 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
T 4aaa_A 183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262 (331)
T ss_dssp -CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCC
T ss_pred CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccccc
Confidence 45689999999999876 789999999999999999999999865433221110000 000011110 00111
Q ss_pred CCCCCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 259 DPSLAASDS-----GDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 259 ~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.+....... ......+.+|+.+||+.||.+|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111111111 123467889999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=318.36 Aligned_cols=240 Identities=18% Similarity=0.212 Sum_probs=182.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcc---cHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQ---GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 578999999999999999999876 6889999999754322 246788999999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++...........
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 192 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL 192 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccc
Confidence 9999999997765 68899999999998 999999999999999999999999987654433333
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCC-cccccCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDK-SLEIVDPSLAASD 266 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 266 (381)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...... .......... .....
T Consensus 193 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~-------- 257 (309)
T 2h34_A 193 GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPRPSTV-------- 257 (309)
T ss_dssp ----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCCGGGT--------
T ss_pred cccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCCcccc--------
Confidence 4567899999999999889999999999999999999999998643211 1111111111 11111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhcCCC
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRP-TMRRVVVMLSKKP 303 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~~~ 303 (381)
....+..+.+|+.+||+.||++|| +++++++.|+...
T Consensus 258 ~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 258 RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 112234578899999999999999 9999999998754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=319.48 Aligned_cols=239 Identities=26% Similarity=0.353 Sum_probs=188.1
Q ss_pred HhhcCCCCCC-cccccCCeeEEEEEEC---CCcEEEEEEecCCCc--ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCe
Q 048280 47 SATKNFHPSN-KLGEGGFGPVFKGKLD---DGREIAVKKLSHSSN--QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAE 120 (381)
Q Consensus 47 ~~~~~y~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 120 (381)
...++|.+.+ .||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++++++||||+++++++ ..+.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 3456888888 9999999999999542 478899999975532 2356799999999999999999999999 5677
Q ss_pred EEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 121 KLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
.++||||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++.......
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 89999999999997665 68999999999999 99999999999999999999999998775443
Q ss_pred cccc--cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCC
Q 048280 184 THVN--TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDP 260 (381)
Q Consensus 184 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
.... ....+++.|+|||++.+..++.++|||||||++|+|++ |+.||...... .. ......... +
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~-----~ 239 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EV----TAMLEKGER-----M 239 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH----HHHHHTTCC-----C
T ss_pred CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HH----HHHHHcCCC-----C
Confidence 3221 23346788999999999999999999999999999999 99998643221 11 111111111 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 261 SLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 261 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
......+..+.+++.+||+.||.+||++.+|++.|+..
T Consensus 240 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 240 ----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11122345688999999999999999999999999763
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=334.35 Aligned_cols=242 Identities=18% Similarity=0.255 Sum_probs=190.0
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCC-CCcccEEEEEeeCCeEEEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQH-RNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~ 125 (381)
..++|++.+.||+|+||.||+|++. +++.||||++...... ..+.+|+++++.++| ++|..+..++......+|||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 3578999999999999999999864 6899999988654332 457899999999976 56666777778889999999
Q ss_pred ecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEe---CCCCCcEEeeeccceecCCCCc
Q 048280 126 EYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILL---DDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 126 E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll---~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
||+ +++|.+++ .|++.+|.|||..+ ||||||+|||| +.++.+||+|||+++.+.....
T Consensus 83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 999 99997765 68999999999999 99999999999 6889999999999997654332
Q ss_pred c------cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCccccc
Q 048280 185 H------VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIV 258 (381)
Q Consensus 185 ~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
. ......||..|+|||++.+..++.++||||||||||||++|+.||............................
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALC 241 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHH
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHh
Confidence 1 1225679999999999999999999999999999999999999997654433322222221111111110000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 259 DPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
. .++..+.+|+..||+.||++||++.+|++.|+.
T Consensus 242 -----~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 275 (483)
T 3sv0_A 242 -----R----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD 275 (483)
T ss_dssp -----T----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred -----c----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 0 123568899999999999999999999988764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=323.23 Aligned_cols=245 Identities=20% Similarity=0.282 Sum_probs=192.3
Q ss_pred CCChHHHHHhhcCCCCC-CcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHh-CCCCcccEEE
Q 048280 39 HFPFEALVSATKNFHPS-NKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARV-QHRNVVNLLG 113 (381)
Q Consensus 39 ~~~~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~~~~ 113 (381)
...++.+....+.|.+. +.||+|+||.||+|+.. +++.||||++... .......+.+|+.+++++ +||||+++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 45556667778889888 89999999999999876 5899999998754 334467899999999999 5699999999
Q ss_pred EEeeCCeEEEEEecccCCCHHH-----------------HHHhhhhhhhHhhhhc--cCCccccceEeCC---CCCcEEe
Q 048280 114 YCAHGAEKLLIYEYVINESLDK-----------------VLFSLIKDIQILFRKK--KTDIKASNILLDD---KWIPKIA 171 (381)
Q Consensus 114 ~~~~~~~~~lv~E~~~~g~L~~-----------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~---~~~~kL~ 171 (381)
++.+....++||||+.+++|.+ ++.|++.+|.|||..+ ||||||+|||++. ++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred EEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEe
Confidence 9999999999999999988754 3478999999999999 9999999999987 7899999
Q ss_pred eeccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc
Q 048280 172 DFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKK 251 (381)
Q Consensus 172 DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 251 (381)
|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ........
T Consensus 177 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~ 248 (327)
T 3lm5_A 177 DFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE------TYLNISQV 248 (327)
T ss_dssp CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHT
T ss_pred eCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHHHHHhc
Confidence 9999997643322 234579999999999999999999999999999999999999986432211 11111111
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 252 DKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
. ..............+.+|+.+||+.||.+|||+.++++.
T Consensus 249 ~-------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 N-------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp C-------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred c-------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 1 001111112234568899999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=331.02 Aligned_cols=267 Identities=23% Similarity=0.231 Sum_probs=192.2
Q ss_pred CChHHHHHHHhhhCCCCChHHHHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHH
Q 048280 24 DNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLAR 102 (381)
Q Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~ 102 (381)
+++|+++.+.......+...+ ...++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.+++.
T Consensus 13 ~~~e~~~~~~~~~~~~~~~g~--~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~ 89 (397)
T 1wak_A 13 DEQEDPNDYCKGGYHLVKIGD--LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKS 89 (397)
T ss_dssp ---------CC--CCSSCTTC--EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHH
T ss_pred ccccccccCCCCCceEEehhh--hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHH
Confidence 344444444444444444333 34678999999999999999999865 5889999999643 3345678899999999
Q ss_pred hC--------CCCcccEEEEEe----eCCeEEEEEecccCCCHHH-----------------HHHhhhhhhhHhhhh-c-
Q 048280 103 VQ--------HRNVVNLLGYCA----HGAEKLLIYEYVINESLDK-----------------VLFSLIKDIQILFRK-K- 151 (381)
Q Consensus 103 l~--------hpnIv~~~~~~~----~~~~~~lv~E~~~~g~L~~-----------------~l~~~~~~l~~lh~~-~- 151 (381)
++ |+||+++++++. .....++||||+ +++|.+ ++.|++.+|.|||++ +
T Consensus 90 l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~gi 168 (397)
T 1wak_A 90 VRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRI 168 (397)
T ss_dssp HHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCE
T ss_pred HhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCE
Confidence 96 788999999987 556889999999 555533 347899999999998 7
Q ss_pred -cCCccccceEeCCCC-------------------------------------------------CcEEeeeccceecCC
Q 048280 152 -KTDIKASNILLDDKW-------------------------------------------------IPKIADFGMARLFPE 181 (381)
Q Consensus 152 -HrDlkp~NIll~~~~-------------------------------------------------~~kL~DFG~~~~~~~ 181 (381)
||||||+||||+.++ .+||+|||++.....
T Consensus 169 vHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~ 248 (397)
T 1wak_A 169 IHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK 248 (397)
T ss_dssp ECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB
T ss_pred ecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc
Confidence 999999999998775 799999999987643
Q ss_pred CCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccccc---HHHHHHHHhhcC------
Q 048280 182 DQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQN---LLDWAYKLYKKD------ 252 (381)
Q Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~---~~~~~~~~~~~~------ 252 (381)
. .....||+.|+|||++.+..++.++|||||||+||||++|+.||.......... ............
T Consensus 249 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 324 (397)
T 1wak_A 249 H----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324 (397)
T ss_dssp C----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHH
T ss_pred c----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhh
Confidence 2 233568999999999999999999999999999999999999997544332211 111111111100
Q ss_pred ---CcccccCC--------CC-----------CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 253 ---KSLEIVDP--------SL-----------AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 253 ---~~~~~~~~--------~~-----------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
........ .. ...........+.+|+.+||+.||++|||+.||++.
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 325 AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp HCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00000000 00 012346677889999999999999999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=326.39 Aligned_cols=247 Identities=23% Similarity=0.323 Sum_probs=178.0
Q ss_pred HHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc--ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEE
Q 048280 46 VSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN--QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 46 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 122 (381)
....++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++||||+++++++.+....+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 344678999999999999999999865 689999999965432 22456789999999999999999999999999999
Q ss_pred EEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEe-----CCCCCcEEeeeccceecC
Q 048280 123 LIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILL-----DDKWIPKIADFGMARLFP 180 (381)
Q Consensus 123 lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll-----~~~~~~kL~DFG~~~~~~ 180 (381)
+||||+. ++|.+++ .|++.+|.|||+.+ ||||||+|||| +.++.+||+|||++..+.
T Consensus 110 lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9999996 4776544 78999999999999 99999999999 455569999999998764
Q ss_pred CCCcccccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcc----
Q 048280 181 EDQTHVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSL---- 255 (381)
Q Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---- 255 (381)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+ ...............
T Consensus 189 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 189 IPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID---QLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSTT
T ss_pred Cccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH---HHHHHHHHhCCCchhhhhh
Confidence 3322 22345689999999999875 48999999999999999999999986543221 111111111100000
Q ss_pred -------cccCCCCCCCCCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 256 -------EIVDPSLAASDSG-----DQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 256 -------~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
....+........ .....+.+|+.+||+.||.+|||+.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000111111111 12356789999999999999999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=315.49 Aligned_cols=232 Identities=22% Similarity=0.366 Sum_probs=187.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeC--CeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHG--AEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv 124 (381)
.++|++.+.||+|+||.||+|++. ++.||||++.... ....+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 468999999999999999999986 8899999997553 33346799999999999999999999999887 788999
Q ss_pred EecccCCCHHHHH-----------------HhhhhhhhHhhhhc----cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 125 YEYVINESLDKVL-----------------FSLIKDIQILFRKK----KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 125 ~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~----HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
|||+++++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-- 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-- 165 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc--
Confidence 9999999998765 68899999999865 999999999999999999999998764322
Q ss_pred cccccccccCccccchhHHhhCCCCc---hhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCC
Q 048280 184 THVNTRVAGTNGYMAPEYVMHGHLSV---KADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDP 260 (381)
Q Consensus 184 ~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
....||+.|+|||++.+..++. ++|||||||++|+|++|+.||...... ............ +
T Consensus 166 ----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~-----~ 230 (271)
T 3kmu_A 166 ----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALEGLR-----P 230 (271)
T ss_dssp ----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHHHSCCC-----C
T ss_pred ----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHHhcCCC-----C
Confidence 2246899999999998765544 899999999999999999998643221 111112211111 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 261 SLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 261 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.. .......+.+++.+||+.||.+|||+.++++.|+..
T Consensus 231 ~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 231 TI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 11 122345688999999999999999999999999764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=321.24 Aligned_cols=256 Identities=23% Similarity=0.337 Sum_probs=198.1
Q ss_pred CCCCChHHHHHhhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHH--hCCCCcccEEEE
Q 048280 37 QKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLAR--VQHRNVVNLLGY 114 (381)
Q Consensus 37 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~ 114 (381)
....++.......++|++.+.||+|+||.||+|+.. ++.||||++... ....+.+|++++.. ++||||++++++
T Consensus 29 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~ 104 (342)
T 1b6c_B 29 GSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAA 104 (342)
T ss_dssp CSSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEE
T ss_pred CCCCceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEee
Confidence 345666666677889999999999999999999985 899999998543 34678889999988 689999999999
Q ss_pred EeeCC----eEEEEEecccCCCHHHHH--------------HhhhhhhhHhh--------hhc--cCCccccceEeCCCC
Q 048280 115 CAHGA----EKLLIYEYVINESLDKVL--------------FSLIKDIQILF--------RKK--KTDIKASNILLDDKW 166 (381)
Q Consensus 115 ~~~~~----~~~lv~E~~~~g~L~~~l--------------~~~~~~l~~lh--------~~~--HrDlkp~NIll~~~~ 166 (381)
+.... ..++||||+.+|+|.+++ .|++.+|.||| ..+ ||||||+||||+.++
T Consensus 105 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp EECCCSSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS
T ss_pred ecccCCccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC
Confidence 98876 789999999999998765 68999999999 666 999999999999999
Q ss_pred CcEEeeeccceecCCCCcc---cccccccCccccchhHHhhCC------CCchhhhHhHHHHHHHHHhC----------C
Q 048280 167 IPKIADFGMARLFPEDQTH---VNTRVAGTNGYMAPEYVMHGH------LSVKADVFSFGVVILELISG----------Q 227 (381)
Q Consensus 167 ~~kL~DFG~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvvl~elltg----------~ 227 (381)
.+||+|||++......... ......||+.|+|||++.+.. ++.++|||||||++|||++| .
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 9999999999876544322 123457899999999997752 34789999999999999999 6
Q ss_pred CCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 228 RNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS-DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 228 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.||......+. ....... ...... ..+.+... ........+.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus 265 ~p~~~~~~~~~-~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 265 LPYYDLVPSDP-SVEEMRK-VVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CTTTTTSCSSC-CHHHHHH-HHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCccccCcCcc-cHHHHHH-HHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 67654322211 1111111 111111 11111111 1235667899999999999999999999999999764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=339.46 Aligned_cols=235 Identities=24% Similarity=0.340 Sum_probs=189.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++.+....|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999976 59999999996432 23456788999999999999999999999999999999
Q ss_pred EecccCCCHHHHH-------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 125 YEYVINESLDKVL-------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 125 ~E~~~~g~L~~~l-------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
|||+.+|+|..++ .|++.+|.|||+.+ ||||||+||||+.++.+||+|||+++.+....
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 9999999997654 68999999999999 99999999999999999999999999765433
Q ss_pred cccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC
Q 048280 184 THVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 184 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ............. .
T Consensus 344 ~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~~~~~-------~-- 411 (543)
T 3c4z_A 344 TK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVLEQAV-------T-- 411 (543)
T ss_dssp CC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHHHCCC-------C--
T ss_pred cc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHhhccc-------C--
Confidence 22 2345799999999999999999999999999999999999999965432211 1111111111110 0
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 048280 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPTM-----RRVVV 297 (381)
Q Consensus 264 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~ 297 (381)
.+......+.+|+.+||+.||.+||++ .+|++
T Consensus 412 --~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 412 --YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred --CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 111234568889999999999999965 66664
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=330.63 Aligned_cols=245 Identities=28% Similarity=0.424 Sum_probs=191.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEE-----CCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC--eE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKL-----DDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA--EK 121 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~ 121 (381)
.++|++.+.||+|+||.||+|+. .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45799999999999999999984 358899999998766666678999999999999999999999987644 68
Q ss_pred EEEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 122 LLIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
++||||+++++|.+++ .|++.+|.+||..+ ||||||+|||++.++.+||+|||++.......
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence 9999999999998765 68899999999998 99999999999999999999999999875443
Q ss_pred ccc--ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCc---------cccccHHHHHHHHhhcC
Q 048280 184 THV--NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLD---------VDAQNLLDWAYKLYKKD 252 (381)
Q Consensus 184 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~---------~~~~~~~~~~~~~~~~~ 252 (381)
... .....++..|+|||++.+..++.++|||||||++|+|++|..|+..... .................
T Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (326)
T 2w1i_A 200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279 (326)
T ss_dssp SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC
Confidence 221 2234567789999999999999999999999999999999988742110 00000000111111111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 253 KSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
. ........+..+.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus 280 ~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 280 G---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp C---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred C---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 0111222346688999999999999999999999998753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=328.85 Aligned_cols=241 Identities=22% Similarity=0.322 Sum_probs=180.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeC------C
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHG------A 119 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~ 119 (381)
.++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 568999999999999999999875 69999999996542 23346788999999999999999999999765 3
Q ss_pred eEEEEEecccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 120 EKLLIYEYVINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
..|+||||+ +++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 181 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE- 181 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred eEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc-
Confidence 469999999 88887654 68999999999999 9999999999999999999999999976432
Q ss_pred cccccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCC---------
Q 048280 184 THVNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDK--------- 253 (381)
Q Consensus 184 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 253 (381)
.....+|..|+|||++.+ ..++.++|||||||++|||++|+.||......+. ............
T Consensus 182 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 182 ---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ---LKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp ---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHHTCSC
T ss_pred ---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHHHHHHhhh
Confidence 234578999999999987 6799999999999999999999999865432221 111111100000
Q ss_pred ---------cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 254 ---------SLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 254 ---------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
........+ ..........+.+|+.+||..||.+|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000000 01111234568899999999999999999999984
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=325.70 Aligned_cols=243 Identities=21% Similarity=0.363 Sum_probs=191.7
Q ss_pred ChHHHHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcc--------cHHHHHHHHHHHHHh-CCCCccc
Q 048280 41 PFEALVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQ--------GKKEFENEAKLLARV-QHRNVVN 110 (381)
Q Consensus 41 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~hpnIv~ 110 (381)
.+.......++|++.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+.+++++ +||||++
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 33445556678999999999999999999986 6999999998654311 135678999999999 7999999
Q ss_pred EEEEEeeCCeEEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeee
Q 048280 111 LLGYCAHGAEKLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADF 173 (381)
Q Consensus 111 ~~~~~~~~~~~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DF 173 (381)
+++++......++||||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+||
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~Df 244 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDF 244 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEec
Confidence 999999999999999999999997655 68999999999999 9999999999999999999999
Q ss_pred ccceecCCCCcccccccccCccccchhHHhhC------CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 048280 174 GMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG------HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYK 247 (381)
Q Consensus 174 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 247 (381)
|++..+..... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...... ... ..
T Consensus 245 G~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~---~~ 316 (365)
T 2y7j_A 245 GFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---LML---RM 316 (365)
T ss_dssp TTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HH
T ss_pred CcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---HHH---HH
Confidence 99987654322 2346799999999998743 5889999999999999999999998543211 111 11
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 248 LYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
......... .+.. ......+.+|+.+||+.||.+|||+.++++.
T Consensus 317 i~~~~~~~~--~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 317 IMEGQYQFS--SPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHTCCCCC--HHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhCCCCCC--Cccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111110000 0000 0123458889999999999999999999873
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=329.60 Aligned_cols=237 Identities=24% Similarity=0.360 Sum_probs=186.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
.++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 568999999999999999999876 6899999999765 33345678999999999999999999999999999999999
Q ss_pred cccCCCHHHHH---------------HhhhhhhhHhhhh-c--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 127 YVINESLDKVL---------------FSLIKDIQILFRK-K--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 127 ~~~~g~L~~~l---------------~~~~~~l~~lh~~-~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
|+++++|.+++ .+++.+|.|||.. + ||||||+|||++.++.+||+|||++...... ...
T Consensus 112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~ 188 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MAN 188 (360)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C--
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---ccc
Confidence 99999997665 6889999999986 5 9999999999999999999999998754221 122
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHH--------------------------
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLL-------------------------- 242 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~-------------------------- 242 (381)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||............
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (360)
T 3eqc_A 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268 (360)
T ss_dssp --CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------------
T ss_pred CCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccc
Confidence 457899999999999999999999999999999999999998653322111000
Q ss_pred ----------HHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 243 ----------DWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 243 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
....... ... .+ ..........+.+|+.+||+.||.+|||+.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~-~~~-----~~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 269 MDSRPPMAIFELLDYIV-NEP-----PP---KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -----CCCHHHHHHHHH-HSC-----CC---CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cCCCCcccchhhhhHHh-ccC-----CC---CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000000 000 00 0011123456889999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=315.12 Aligned_cols=231 Identities=23% Similarity=0.380 Sum_probs=181.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeC-CeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHG-AEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~E~ 127 (381)
.++|++.+.||+|+||.||+++.. ++.||||++.... ..+.+.+|++++++++||||+++++++... +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 568999999999999999999876 8899999986543 457899999999999999999999997654 478999999
Q ss_pred ccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 128 VINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 128 ~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
+.+++|.+++ .|++.++.+||+.+ ||||||+|||++.++.+||+|||++....... .
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~----~ 172 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----D 172 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc----c
Confidence 9999997655 68899999999998 99999999999999999999999998653321 2
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
...++..|+|||++.+..++.++|||||||++|+|++ |..||...... .... ...... . ....
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~----~~~~~~-----~----~~~~ 236 (278)
T 1byg_A 173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP----RVEKGY-----K----MDAP 236 (278)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHH----HHTTTC-----C----CCCC
T ss_pred CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHhcCC-----C----CCCc
Confidence 2357889999999999999999999999999999998 99998643221 1111 111111 0 1111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 237 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 22345688999999999999999999999998754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=329.79 Aligned_cols=236 Identities=28% Similarity=0.442 Sum_probs=176.1
Q ss_pred CCCCCCcccccCCeeEEEEEEC--C--CcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEee-CCeEEEE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD--D--GREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAH-GAEKLLI 124 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~--~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv 124 (381)
.|++.+.||+|+||.||+|... + +..||||.+... .....+.+.+|+.++++++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4677889999999999999853 2 246899998654 33445789999999999999999999998754 5678999
Q ss_pred EecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc-
Q 048280 125 YEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH- 185 (381)
Q Consensus 125 ~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~- 185 (381)
|||+.+|+|.+++ .|++.+|.|||+.+ ||||||+||||+.++.+||+|||+++.+......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 249 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 249 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccccc
Confidence 9999999998766 58999999999999 9999999999999999999999999865433211
Q ss_pred --cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 186 --VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+ .... ... ... ...+
T Consensus 250 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~---~~~-~~~--~~~p-- 318 (373)
T 3c1x_A 250 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY---LLQ-GRR--LLQP-- 318 (373)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHH---HHT-TCC--CCCC--
T ss_pred ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHH---HHc-CCC--CCCC--
Confidence 1223457789999999999999999999999999999999 566665432222 1111 111 110 0111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
...+..+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 319 -----~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 319 -----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp -----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 12335688999999999999999999999999764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=318.31 Aligned_cols=234 Identities=23% Similarity=0.325 Sum_probs=187.2
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
..++|.+.+.||+|+||.||+|+.. +++.||||++..........+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3568999999999999999999876 689999999986655455678999999999999999999999999999999999
Q ss_pred cccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEe---CCCCCcEEeeeccceecCCCCccc
Q 048280 127 YVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILL---DDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 127 ~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll---~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
|+.+++|.+++ .|++.+|.|||..+ ||||||+|||+ +.++.+||+|||++...... .
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---~ 163 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---I 163 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB---T
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC---c
Confidence 99999997654 68999999999999 99999999999 78899999999999764322 2
Q ss_pred ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ... ......... .. ...
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~---~~i~~~~~~---~~----~~~ 230 (304)
T 2jam_A 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLF---EKIKEGYYE---FE----SPF 230 (304)
T ss_dssp THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH---HHHHHCCCC---CC----TTT
T ss_pred cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHH---HHHHcCCCC---CC----ccc
Confidence 23456899999999999999999999999999999999999998643221 111 111111100 00 111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.......+.+|+.+||+.||.+|||+.++++
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 231 WDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1223456889999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=332.96 Aligned_cols=181 Identities=22% Similarity=0.381 Sum_probs=150.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeC-----Ce
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHG-----AE 120 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~ 120 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+++|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 578999999999999999999876 5889999999754 233456789999999999999999999999766 57
Q ss_pred EEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 121 KLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
.|+||||+. ++|.+++ .|++.+|.|||+.+ ||||||+||||+.++.+||+|||+++......
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 183 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred EEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence 899999985 5886554 78999999999999 99999999999999999999999999765432
Q ss_pred cc---------------------cccccccCccccchhHHh-hCCCCchhhhHhHHHHHHHHHhCCCCC
Q 048280 184 TH---------------------VNTRVAGTNGYMAPEYVM-HGHLSVKADVFSFGVVILELISGQRNS 230 (381)
Q Consensus 184 ~~---------------------~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~p~ 230 (381)
.. .....+||+.|+|||++. +..++.++|||||||++|||++|..||
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 11 124567999999999874 556999999999999999999865444
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=325.97 Aligned_cols=249 Identities=22% Similarity=0.315 Sum_probs=182.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHH--HHHhCCCCcccEEEEEee-----CCeE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKL--LARVQHRNVVNLLGYCAH-----GAEK 121 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~hpnIv~~~~~~~~-----~~~~ 121 (381)
.++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 56899999999999999999987 48999999986432 3444555554 445799999999986543 2367
Q ss_pred EEEEecccCCCHHHHH--------------HhhhhhhhHhhhh---------c--cCCccccceEeCCCCCcEEeeeccc
Q 048280 122 LLIYEYVINESLDKVL--------------FSLIKDIQILFRK---------K--KTDIKASNILLDDKWIPKIADFGMA 176 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l--------------~~~~~~l~~lh~~---------~--HrDlkp~NIll~~~~~~kL~DFG~~ 176 (381)
++||||+++|+|.+++ .|++.+|.|||.. + ||||||+||||+.++.+||+|||++
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a 167 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccce
Confidence 8999999999998765 6899999999988 6 9999999999999999999999999
Q ss_pred eecCCCCc-------ccccccccCccccchhHHhh-------CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccc-cH
Q 048280 177 RLFPEDQT-------HVNTRVAGTNGYMAPEYVMH-------GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQ-NL 241 (381)
Q Consensus 177 ~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~-~~ 241 (381)
+.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||......... ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~ 247 (336)
T 3g2f_A 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247 (336)
T ss_dssp EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence 87653321 11224569999999999986 35678999999999999999998776433221110 00
Q ss_pred ----------HHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 242 ----------LDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 242 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
................+... ..........+.+|+.+||+.||++|||+.|+++.|+.+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcccCCCchHHHHHhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 00111111111111111111 1123346678999999999999999999999999987643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=317.82 Aligned_cols=231 Identities=23% Similarity=0.344 Sum_probs=189.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|.+.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 568999999999999999999876 4889999998654 223456788999999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++........ ..
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~ 198 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RK 198 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-cc
Confidence 9999999997654 78999999999999 999999999999999999999999987643322 22
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
....||..|+|||++.+..++.++|||||||++|+|++|+.||...... ........... .+..
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~-------~~~~--- 262 (335)
T 2owb_A 199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIKKNEY-------SIPK--- 262 (335)
T ss_dssp CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCC-------CCCT---
T ss_pred cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHhcCCC-------CCCc---
Confidence 3456899999999999999999999999999999999999998643221 11111111110 0111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.....+.+|+.+||+.||.+|||+.|+++
T Consensus 263 -~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 263 -HINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12345788999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=347.48 Aligned_cols=229 Identities=23% Similarity=0.351 Sum_probs=181.1
Q ss_pred cccccCCeeEEEEEEC---CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccCCC
Q 048280 57 KLGEGGFGPVFKGKLD---DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINES 132 (381)
Q Consensus 57 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~ 132 (381)
.||+|+||.||+|.+. ++..||||+++... ....+.+.+|+++|++++|||||+++++|.. +..++||||+.+|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999764 46679999997653 3456789999999999999999999999976 56899999999999
Q ss_pred HHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc--cccccc
Q 048280 133 LDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV--NTRVAG 192 (381)
Q Consensus 133 L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~--~~~~~g 192 (381)
|.+++ .|++.+|.|||+++ ||||||+||||+.++.+||+|||+++.+....... .....+
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~ 501 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 501 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCC
Confidence 98765 68999999999998 99999999999999999999999998764332211 122345
Q ss_pred CccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHH
Q 048280 193 TNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271 (381)
Q Consensus 193 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (381)
++.|+|||++.+..++.++|||||||+||||++ |+.||......+ +. ........ ...+..++
T Consensus 502 ~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~----~~i~~~~~---------~~~p~~~~ 565 (613)
T 2ozo_A 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM----AFIEQGKR---------MECPPECP 565 (613)
T ss_dssp CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HH----HHHHTTCC---------CCCCTTCC
T ss_pred ccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcCCC---------CCCCCcCC
Confidence 689999999999999999999999999999998 999986543221 11 11221111 11122334
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 272 AMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 272 ~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
..+.+||.+||+.||++||++.+|++.|+..
T Consensus 566 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 566 PELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 6688999999999999999999999998763
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=315.02 Aligned_cols=232 Identities=22% Similarity=0.334 Sum_probs=189.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467999999999999999999976 48899999986542 23456788999999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|||+.+++|.+++ .|++.++.|||+.+ ||||||+|||++.++.+||+|||++........ ..
T Consensus 94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~ 172 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RK 172 (294)
T ss_dssp EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc-cc
Confidence 9999999997654 68999999999999 999999999999999999999999987643322 22
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .......... . ...
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~-~------~~~---- 235 (294)
T 2rku_A 173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIKKNE-Y------SIP---- 235 (294)
T ss_dssp CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTC-C------CCC----
T ss_pred ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhhcc-C------CCc----
Confidence 3456899999999999989999999999999999999999998643221 1111111111 0 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
......+.+|+.+||+.||++|||+.++++.
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 236 KHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1223457889999999999999999999863
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=324.17 Aligned_cols=246 Identities=23% Similarity=0.335 Sum_probs=184.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc--ccHHHHHHHHHHHHHhCCCCcccEEEEEee--------
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN--QGKKEFENEAKLLARVQHRNVVNLLGYCAH-------- 117 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-------- 117 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 468999999999999999999975 689999999865432 234678899999999999999999999987
Q ss_pred CCeEEEEEecccCCCHH----------------HHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceec
Q 048280 118 GAEKLLIYEYVINESLD----------------KVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLF 179 (381)
Q Consensus 118 ~~~~~lv~E~~~~g~L~----------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~ 179 (381)
.+..++||||+.+ +|. .++.|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++.+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 4568999999965 443 34478999999999999 9999999999999999999999999876
Q ss_pred CCCCc---ccccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCc-
Q 048280 180 PEDQT---HVNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKS- 254 (381)
Q Consensus 180 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 254 (381)
..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ .............
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLCGSITPE 251 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTT
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChh
Confidence 53221 12234578999999999976 4589999999999999999999999865432221 1111111111000
Q ss_pred --ccc--------cCC-CCCCCCCHHH------HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 255 --LEI--------VDP-SLAASDSGDQ------IAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 255 --~~~--------~~~-~~~~~~~~~~------~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
... ... .......... ...+.+|+.+||+.||.+|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 000 000 0000001111 2457899999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=312.76 Aligned_cols=234 Identities=24% Similarity=0.374 Sum_probs=183.4
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
++|.....||+|+||.||+|... +++.||||++........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34566669999999999999865 58899999998766666688999999999999999999999999999999999999
Q ss_pred cCCCHHHHH------------------HhhhhhhhHhhhhc--cCCccccceEeCC-CCCcEEeeeccceecCCCCcccc
Q 048280 129 INESLDKVL------------------FSLIKDIQILFRKK--KTDIKASNILLDD-KWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 129 ~~g~L~~~l------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~-~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
++++|.+++ .|++.+|.|||..+ |+||||+|||++. ++.+||+|||++........ ..
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~ 180 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CT 180 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-cc
Confidence 999987654 58899999999999 9999999999987 89999999999987643321 22
Q ss_pred cccccCccccchhHHhhCC--CCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGH--LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....... .......... ..+.+
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~-----~~~~~--- 247 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-----AAMFKVGMFK-----VHPEI--- 247 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-----HHHHHHHHHC-----CCCCC---
T ss_pred cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-----HHHHhhcccc-----ccccc---
Confidence 3456899999999998754 8899999999999999999999985321111 0011110000 11111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 266 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.......+.+|+.+||+.||++|||+.++++.
T Consensus 248 -~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 248 -PESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11233568889999999999999999999863
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=316.89 Aligned_cols=238 Identities=27% Similarity=0.427 Sum_probs=184.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC----CcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEe-eCCeEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD----GREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCA-HGAEKL 122 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~ 122 (381)
..+|++.+.||+|+||.||+|+..+ ...||+|.+.... ....+.+.+|+.++++++||||+++++++. .++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4578999999999999999998642 3368999987543 334567899999999999999999999864 456789
Q ss_pred EEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 123 LIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 123 lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
+||||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++.......
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 999999999998765 58999999999999 999999999999999999999999986643321
Q ss_pred ---ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCC-CCCCCCccccccHHHHHHHHhhcCCcccccCC
Q 048280 185 ---HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQR-NSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDP 260 (381)
Q Consensus 185 ---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
.......+|+.|+|||.+.+..++.++|||||||++|+|++|.. ||...... ..... ...... ...+
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~~---~~~~~~---~~~~ 254 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVY---LLQGRR---LLQP 254 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---THHHH---HHTTCC---CCCC
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---HHHHH---HhcCCC---CCCC
Confidence 11224567889999999999999999999999999999999554 44332221 11111 111110 0111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 261 SLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 261 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
...+..+.+++.+||+.||.+|||+.++++.|+..
T Consensus 255 -------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 255 -------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp -------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11235688999999999999999999999999764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=316.12 Aligned_cols=233 Identities=26% Similarity=0.423 Sum_probs=190.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
.+.|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 457999999999999999999865 58999999997553 3446789999999999999999999999999999999999
Q ss_pred cccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccc
Q 048280 127 YVINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV 190 (381)
Q Consensus 127 ~~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 190 (381)
|+.+++|.+++ .|++.+|.+||..+ ||||||+|||++.++.+||+|||++........ .....
T Consensus 101 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 179 (303)
T 3a7i_A 101 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNTF 179 (303)
T ss_dssp CCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CBCCC
T ss_pred eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc-ccCcc
Confidence 99999997655 78999999999999 999999999999999999999999987644322 22345
Q ss_pred ccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHH
Q 048280 191 AGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQ 270 (381)
Q Consensus 191 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (381)
.||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....... ... .+.+.. ..
T Consensus 180 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~-----~~~~~~----~~ 243 (303)
T 3a7i_A 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------KVLFLIP-KNN-----PPTLEG----NY 243 (303)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH-HSC-----CCCCCS----SC
T ss_pred CCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH------HHHHHhh-cCC-----CCCCcc----cc
Confidence 7899999999999999999999999999999999999998643221 1111111 111 111111 22
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 271 IAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 271 ~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
...+.+|+.+||+.||.+|||+.+|++.
T Consensus 244 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 244 SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 3458899999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=322.51 Aligned_cols=238 Identities=26% Similarity=0.387 Sum_probs=185.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEE------CCCcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKL------DDGREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEK 121 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 121 (381)
.++|++.+.||+|+||.||+|++ .+++.||||++... .......+.+|+.++++++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 57899999999999999999983 24778999999644 333456789999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHH----------------------HhhhhhhhHhhhhc--cCCccccceEeCC---CCCcEEeeec
Q 048280 122 LLIYEYVINESLDKVL----------------------FSLIKDIQILFRKK--KTDIKASNILLDD---KWIPKIADFG 174 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l----------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~---~~~~kL~DFG 174 (381)
++||||+++++|.+++ .|++.+|.|||+.+ ||||||+|||++. +..+||+|||
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg 188 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccc
Confidence 9999999999997665 57899999999998 9999999999984 4569999999
Q ss_pred cceecCCCCc-ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcC
Q 048280 175 MARLFPEDQT-HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKD 252 (381)
Q Consensus 175 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (381)
++........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||...... ... ......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~----~~~~~~ 261 (327)
T 2yfx_A 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVL----EFVTSG 261 (327)
T ss_dssp HHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHH----HHHHTT
T ss_pred cccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHH----HHHhcC
Confidence 9975533222 12234567899999999999999999999999999999998 88888543211 111 111111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 253 KSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
... . ........+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 262 ~~~-----~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 262 GRM-----D----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp CCC-----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC-----C----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111 0 1112335688999999999999999999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=321.09 Aligned_cols=242 Identities=24% Similarity=0.375 Sum_probs=181.1
Q ss_pred HHHhhcCCCCCCcccccCCeeEEEEEEC----CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeC
Q 048280 45 LVSATKNFHPSNKLGEGGFGPVFKGKLD----DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHG 118 (381)
Q Consensus 45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 118 (381)
+....++|.+.+.||+|+||.||+|... ++..||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 3345678999999999999999999754 34589999986542 23346789999999999999999999999775
Q ss_pred C-----eEEEEEecccCCCHHHHH---------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEE
Q 048280 119 A-----EKLLIYEYVINESLDKVL---------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKI 170 (381)
Q Consensus 119 ~-----~~~lv~E~~~~g~L~~~l---------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL 170 (381)
. ..++||||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence 5 359999999999997665 68899999999999 9999999999999999999
Q ss_pred eeeccceecCCCCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHH
Q 048280 171 ADFGMARLFPEDQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKL 248 (381)
Q Consensus 171 ~DFG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 248 (381)
+|||++..+...... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...... ..... .
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~---~ 262 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYDY---L 262 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH---H
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHHH---H
Confidence 999999866433221 1223457889999999999999999999999999999999 88887643322 11111 1
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 249 YKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.. ... + ......+..+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 263 ~~-~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 263 LH-GHR-----L----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp HT-TCC-----C----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred Hc-CCC-----C----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 111 1 11122335688999999999999999999999998764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=317.34 Aligned_cols=244 Identities=18% Similarity=0.282 Sum_probs=187.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhC-CCCcccEEEEEee--CCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQ-HRNVVNLLGYCAH--GAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~--~~~~~lv 124 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++... ..+.+.+|+.++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 578999999999999999999864 6899999998643 3578899999999997 9999999999987 6778999
Q ss_pred EecccCCCHHHH------------HHhhhhhhhHhhhhc--cCCccccceEeCCCC-CcEEeeeccceecCCCCcccccc
Q 048280 125 YEYVINESLDKV------------LFSLIKDIQILFRKK--KTDIKASNILLDDKW-IPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 125 ~E~~~~g~L~~~------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~-~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
|||+.+++|.++ +.|++.+|.|||+.+ ||||||+|||++.++ .+||+|||+++....... ...
T Consensus 112 ~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~ 189 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNV 189 (330)
T ss_dssp EECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--CCS
T ss_pred EeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc--ccc
Confidence 999999999764 478999999999999 999999999999776 899999999987654332 234
Q ss_pred cccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHH--------HHhhcCC-------
Q 048280 190 VAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAY--------KLYKKDK------- 253 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~------- 253 (381)
..||..|+|||++.+ ..++.++|||||||++|+|++|+.||........ .+..... .......
T Consensus 190 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (330)
T 3nsz_A 190 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYIDKYNIELDPRF 268 (330)
T ss_dssp CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHHHHTTCCCCTHH
T ss_pred ccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhHHHHhccccccch
Confidence 568999999999987 6789999999999999999999999854322111 1111000 0000000
Q ss_pred -------cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 254 -------SLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 254 -------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
....................+.+|+.+||+.||.+|||+.|+++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 269 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000001111122245678899999999999999999999873
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=313.91 Aligned_cols=234 Identities=24% Similarity=0.340 Sum_probs=185.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc------ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN------QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEK 121 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 121 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999976 589999999865421 2367899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCC----CcEEeeeccceecC
Q 048280 122 LLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKW----IPKIADFGMARLFP 180 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~----~~kL~DFG~~~~~~ 180 (381)
++||||+.+++|.+++ .|++.+|.+||+.+ ||||||+|||++.++ .+||+|||++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 9999999999997765 68999999999998 999999999998877 89999999998764
Q ss_pred CCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCC
Q 048280 181 EDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDP 260 (381)
Q Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
.... .....|++.|+|||++.+..++.++|||||||++|+|++|..||...... ............ ..+
T Consensus 164 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~---~~~ 232 (283)
T 3bhy_A 164 AGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ------ETLTNISAVNYD---FDE 232 (283)
T ss_dssp ----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTCCC---CCH
T ss_pred CCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH------HHHHHhHhcccC---Ccc
Confidence 4322 23456899999999999999999999999999999999999998643221 111111111000 000
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 261 SLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 261 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.. .......+.+|+.+||+.||.+|||+.++++
T Consensus 233 ~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 233 EY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00 0112355888999999999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=315.26 Aligned_cols=231 Identities=22% Similarity=0.347 Sum_probs=167.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 467999999999999999999874 68999999986432 22346789999999999999999999999999999999
Q ss_pred EecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 125 YEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 125 ~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
|||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++.........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 168 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK- 168 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc-
Confidence 9999999987654 68999999999999 9999999999999999999999999876433221
Q ss_pred ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ . ....... .. .
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~-------~~~~~~~---~~----~ 231 (278)
T 3cok_A 169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---L-------NKVVLAD---YE----M 231 (278)
T ss_dssp -----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------CCSSC---CC----C
T ss_pred ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---H-------HHHhhcc---cC----C
Confidence 2235689999999999998999999999999999999999999864332111 0 0000000 01 1
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
+......+.+|+.+||+.||.+|||+.++++
T Consensus 232 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 232 PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1123356789999999999999999999976
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=337.16 Aligned_cols=235 Identities=23% Similarity=0.312 Sum_probs=187.0
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
..++|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4568999999999999999999876 6899999998643 233467899999999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeC---CCCCcEEeeeccceecCCCCc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLD---DKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~---~~~~~kL~DFG~~~~~~~~~~ 184 (381)
||||.+++|.+.+ .|++.+|.|||+.+ ||||||+|||++ .++.+||+|||+++.+....
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~- 178 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC-
Confidence 9999999996544 78999999999999 999999999995 45679999999998664332
Q ss_pred ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 185 HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||...... ... ........... .
T Consensus 179 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~---~~i~~~~~~~~-------~ 243 (486)
T 3mwu_A 179 -KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DIL---KRVETGKYAFD-------L 243 (486)
T ss_dssp ----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHTCCCSC-------S
T ss_pred -ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHHhCCCCCC-------C
Confidence 2234579999999998875 5999999999999999999999998643221 111 11111111000 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
......+..+.+||.+||+.||.+|||+.++++.
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1112234568899999999999999999999974
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=327.34 Aligned_cols=247 Identities=22% Similarity=0.308 Sum_probs=168.9
Q ss_pred cCCCC-CCcccccCCeeEEEEEEC---CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEee--CCeEEE
Q 048280 50 KNFHP-SNKLGEGGFGPVFKGKLD---DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAH--GAEKLL 123 (381)
Q Consensus 50 ~~y~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~l 123 (381)
+.|++ .++||+|+||.||+|+.. +++.||||++.... ....+.+|+.+|++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34666 458999999999999865 47899999996543 23578899999999999999999999954 678999
Q ss_pred EEecccCCCHHH------------------------HHHhhhhhhhHhhhhc--cCCccccceEe----CCCCCcEEeee
Q 048280 124 IYEYVINESLDK------------------------VLFSLIKDIQILFRKK--KTDIKASNILL----DDKWIPKIADF 173 (381)
Q Consensus 124 v~E~~~~g~L~~------------------------~l~~~~~~l~~lh~~~--HrDlkp~NIll----~~~~~~kL~DF 173 (381)
||||+.+ +|.+ ++.|++.+|.|||+.+ ||||||+|||| +.++.+||+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 9999964 5543 3468999999999999 99999999999 67889999999
Q ss_pred ccceecCCCCc--ccccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccc------cccHHHH
Q 048280 174 GMARLFPEDQT--HVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVD------AQNLLDW 244 (381)
Q Consensus 174 G~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~------~~~~~~~ 244 (381)
|+++.+..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... ....+..
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~ 256 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence 99987643321 222346789999999999874 58999999999999999999999996543210 0111111
Q ss_pred HHHHhhcCCcccc--c--------------CCCCCCCCCH--------HHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 245 AYKLYKKDKSLEI--V--------------DPSLAASDSG--------DQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 245 ~~~~~~~~~~~~~--~--------------~~~~~~~~~~--------~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
............. + .......... .....+.+||.+||+.||.+|||+.|+++.-
T Consensus 257 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 1111110000000 0 0000000000 0034578899999999999999999999743
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=328.29 Aligned_cols=243 Identities=22% Similarity=0.325 Sum_probs=178.3
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCccc-HHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQG-KKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
++|++.+.||+|+||.||+|+.. +++.||||++....... ...+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999976 68999999996543221 12456799999999999999999999999999999999
Q ss_pred ccCCCHHHH----------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 128 VINESLDKV----------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 128 ~~~g~L~~~----------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
+. ++|.++ +.|++.+|.|||+.+ ||||||+|||++.++.+||+|||++........ ....
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 159 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYDN 159 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-cccc
Confidence 96 466544 368999999999999 999999999999999999999999986543322 2234
Q ss_pred cccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcc---cc--------
Q 048280 190 VAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSL---EI-------- 257 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-------- 257 (381)
..||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ ............... ..
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 568999999999987 568999999999999999999999986543222 222222211111000 00
Q ss_pred -cCCCCCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 258 -VDPSLAAS----DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 258 -~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
..+..... ........+.+|+.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000000 00122356789999999999999999999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=319.31 Aligned_cols=237 Identities=25% Similarity=0.393 Sum_probs=184.8
Q ss_pred CCCCCCcccccCCeeEEEEEECC-C---cEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeE-EEE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLDD-G---REIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEK-LLI 124 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~-~lv 124 (381)
.|.+.+.||+|+||.||+|++.+ + ..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 46667999999999999998532 2 379999987543 23457789999999999999999999999876655 999
Q ss_pred EecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc--
Q 048280 125 YEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT-- 184 (381)
Q Consensus 125 ~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~-- 184 (381)
|||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++.+.....
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS 181 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence 9999999998765 68999999999999 999999999999999999999999986543221
Q ss_pred -ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC
Q 048280 185 -HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 185 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
.......++..|+|||.+.+..++.++|||||||++|+|++|..|+..... ....... ......
T Consensus 182 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~~----~~~~~~--------- 246 (298)
T 3pls_A 182 VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTHF----LAQGRR--------- 246 (298)
T ss_dssp SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHHH----HHTTCC---------
T ss_pred cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHHH----hhcCCC---------
Confidence 112245678899999999999999999999999999999997666533222 1112111 111110
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 264 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
..........+.+|+.+||+.||.+|||+.++++.|+..
T Consensus 247 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 247 LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011112235688999999999999999999999998764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=311.57 Aligned_cols=229 Identities=24% Similarity=0.372 Sum_probs=187.2
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEee---------
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAH--------- 117 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--------- 117 (381)
..++|++.+.||+|+||.||+|+.. +++.||||++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3567999999999999999999986 69999999996543 356789999999999999999998864
Q ss_pred -------CCeEEEEEecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEe
Q 048280 118 -------GAEKLLIYEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIA 171 (381)
Q Consensus 118 -------~~~~~lv~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~ 171 (381)
....++||||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 45589999999999997765 68899999999999 99999999999999999999
Q ss_pred eeccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc
Q 048280 172 DFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKK 251 (381)
Q Consensus 172 DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 251 (381)
|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..|+.. .. . .......
T Consensus 165 Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-----~~---~-~~~~~~~ 233 (284)
T 2a19_B 165 DFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-----TS---K-FFTDLRD 233 (284)
T ss_dssp CCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-----HH---H-HHHHHHT
T ss_pred cchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-----HH---H-HHHHhhc
Confidence 9999987654322 2335689999999999999999999999999999999999987521 10 1 1111111
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 252 DKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
.. ... .....+.+|+.+||+.||.+|||+.|+++.|....
T Consensus 234 ~~--------~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 234 GI--------ISD----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp TC--------CCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred cc--------ccc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 11 111 12345788999999999999999999999997754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=337.07 Aligned_cols=233 Identities=23% Similarity=0.343 Sum_probs=182.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
.++|++.+.||+|+||.||+|+.. ++..||||++.... ......+.+|+.+++.++||||++++++|.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999976 58899999997542 334578899999999999999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCC---CCCcEEeeeccceecCCCCcc
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDD---KWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~---~~~~kL~DFG~~~~~~~~~~~ 185 (381)
|||.+|+|.+.+ .|++.+|.|||+.+ ||||||+|||++. ++.+||+|||++..+....
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-- 193 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-- 193 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB--
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc--
Confidence 999999996543 78999999999999 9999999999976 4559999999998764332
Q ss_pred cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCC
Q 048280 186 VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
......||+.|+|||++. ..++.++|||||||++|+|++|..||...... .+. ......... ...+
T Consensus 194 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~---~~i~~~~~~--~~~~----- 259 (494)
T 3lij_A 194 KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EIL---RKVEKGKYT--FDSP----- 259 (494)
T ss_dssp CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHTCCC--CCSG-----
T ss_pred cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHHhCCCC--CCch-----
Confidence 223457999999999876 56999999999999999999999998643321 111 111111110 0001
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 266 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.....+..+.+|+.+||+.||.+|||+.++++
T Consensus 260 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 260 EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 11123356889999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=338.34 Aligned_cols=234 Identities=24% Similarity=0.328 Sum_probs=189.5
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3568999999999999999999876 68999999986542 3456789999999999999999999999999999999
Q ss_pred EEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEe---CCCCCcEEeeeccceecCCCC
Q 048280 124 IYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILL---DDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 124 v~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll---~~~~~~kL~DFG~~~~~~~~~ 183 (381)
||||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||+ +.++.+||+|||++..+....
T Consensus 104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 183 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183 (484)
T ss_dssp EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence 99999999996544 78999999999999 99999999999 567899999999998765433
Q ss_pred cccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC
Q 048280 184 THVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 184 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
. .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...... ... ...........
T Consensus 184 ~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~---~~i~~~~~~~~------- 247 (484)
T 3nyv_A 184 K--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DIL---KKVEKGKYTFE------- 247 (484)
T ss_dssp S--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHCCCCCC-------
T ss_pred c--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHH---HHHHcCCCCCC-------
Confidence 2 234579999999998876 6999999999999999999999998643221 111 11111111100
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 264 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.......+..+.+|+.+||+.||.+|||+.|+++
T Consensus 248 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 248 LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0111223456889999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=313.97 Aligned_cols=227 Identities=23% Similarity=0.316 Sum_probs=183.0
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l 123 (381)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3568999999999999999999876 69999999987542 33456788999999999 99999999999999999999
Q ss_pred EEecccCCCHHHHH-------------------HhhhhhhhHhhhhc--cCCccccceEeCC------------------
Q 048280 124 IYEYVINESLDKVL-------------------FSLIKDIQILFRKK--KTDIKASNILLDD------------------ 164 (381)
Q Consensus 124 v~E~~~~g~L~~~l-------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~------------------ 164 (381)
||||+++++|.+++ .|++.+|.|||+.+ ||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 99999999997665 68899999999999 9999999999984
Q ss_pred -CCCcEEeeeccceecCCCCcccccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHH
Q 048280 165 -KWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLL 242 (381)
Q Consensus 165 -~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~ 242 (381)
...+||+|||++....... ...||..|+|||++.+. .++.++|||||||++|+|++|..++.... .
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------~- 236 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------Q- 236 (289)
T ss_dssp -CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------H-
T ss_pred CceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------H-
Confidence 4479999999998765432 23589999999999876 56789999999999999999987753211 1
Q ss_pred HHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 243 DWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
......... +.+.. .....+.+|+.+||+.||.+|||+.++++.
T Consensus 237 ---~~~~~~~~~-----~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 ---WHEIRQGRL-----PRIPQ----VLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ---HHHHHTTCC-----CCCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---HHHHHcCCC-----CCCCc----ccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111111111 11111 223568899999999999999999999764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=317.53 Aligned_cols=243 Identities=21% Similarity=0.353 Sum_probs=183.8
Q ss_pred CCCChHHHHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHh-CCCCcccEEEEE
Q 048280 38 KHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLGYC 115 (381)
Q Consensus 38 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~ 115 (381)
..+.+.++....++|++.+.||+|+||.||+|+.. +++.||||++.... .....+.+|+.+++++ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 33445555566889999999999999999999875 68999999986543 3457889999999999 799999999999
Q ss_pred ee------CCeEEEEEecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEE
Q 048280 116 AH------GAEKLLIYEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKI 170 (381)
Q Consensus 116 ~~------~~~~~lv~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL 170 (381)
.. ....++||||+.+++|.+++ .|++.+|.|||..+ ||||||+|||++.++.+||
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEE
Confidence 87 56889999999999997665 68899999999999 9999999999999999999
Q ss_pred eeeccceecCCCCcccccccccCccccchhHHh-----hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHH
Q 048280 171 ADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM-----HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWA 245 (381)
Q Consensus 171 ~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~ 245 (381)
+|||++........ ......||+.|+|||++. +..++.++|||||||++|+|++|..||...... ...
T Consensus 171 ~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~ 243 (326)
T 2x7f_A 171 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RAL 243 (326)
T ss_dssp CCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHH
T ss_pred eeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHH
Confidence 99999986543221 223456899999999986 567899999999999999999999998543221 111
Q ss_pred HHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 246 YKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
..... ....... .......+.+|+.+||..||.+|||+.++++
T Consensus 244 ~~~~~-~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 244 FLIPR-NPAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHH-SCCCCCS--------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhhc-CccccCC--------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11111 1111111 1112356888999999999999999999987
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=314.65 Aligned_cols=237 Identities=22% Similarity=0.309 Sum_probs=188.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEee--CCeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAH--GAEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~l 123 (381)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 568999999999999999999876 58999999997543 3345678999999999999999999998854 678999
Q ss_pred EEecccCCCHHHHH-------------------HhhhhhhhHhhhhc-------cCCccccceEeCCCCCcEEeeeccce
Q 048280 124 IYEYVINESLDKVL-------------------FSLIKDIQILFRKK-------KTDIKASNILLDDKWIPKIADFGMAR 177 (381)
Q Consensus 124 v~E~~~~g~L~~~l-------------------~~~~~~l~~lh~~~-------HrDlkp~NIll~~~~~~kL~DFG~~~ 177 (381)
||||+++++|.+++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999997665 57899999999853 99999999999999999999999998
Q ss_pred ecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccc
Q 048280 178 LFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEI 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (381)
....... ......||..|+|||++.+..++.++|||||||++|+|++|..||..... ..+. .. .......
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~---~~-i~~~~~~-- 234 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELA---GK-IREGKFR-- 234 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HH-HHHTCCC--
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHH---HH-Hhhcccc--
Confidence 7643322 22345689999999999999999999999999999999999999864321 1111 11 1111111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 258 VDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.+ .......+.+++.+||+.||.+|||+.||++.+...
T Consensus 235 ---~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 235 ---RI----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp ---CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred ---cC----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 11 112345688999999999999999999999877654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=334.09 Aligned_cols=222 Identities=13% Similarity=0.139 Sum_probs=174.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEE-CCCcEEEEEEecCC---CcccHHHHHHHH---HHHHHhCCCCcccEE-------EE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKL-DDGREIAVKKLSHS---SNQGKKEFENEA---KLLARVQHRNVVNLL-------GY 114 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~hpnIv~~~-------~~ 114 (381)
.++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+ +++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999996 46999999999743 333457889999 455555899999998 77
Q ss_pred EeeCCe-----------------EEEEEecccCCCHHHH----------------------HHhhhhhhhHhhhhc--cC
Q 048280 115 CAHGAE-----------------KLLIYEYVINESLDKV----------------------LFSLIKDIQILFRKK--KT 153 (381)
Q Consensus 115 ~~~~~~-----------------~~lv~E~~~~g~L~~~----------------------l~~~~~~l~~lh~~~--Hr 153 (381)
+.+.+. .|+||||+ +|+|.++ +.|++.+|.|||+.+ ||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 665532 78999999 6788643 368899999999999 99
Q ss_pred CccccceEeCCCCCcEEeeeccceecCCCCcccccccccCccccchhHHhhC-----------CCCchhhhHhHHHHHHH
Q 048280 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG-----------HLSVKADVFSFGVVILE 222 (381)
Q Consensus 154 Dlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlGvvl~e 222 (381)
||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||++||
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 9999999999999999999999986432 2234567 999999999987 89999999999999999
Q ss_pred HHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 223 LISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 223 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
|++|+.||........ ..... ... . .....+.+|+.+||+.||.+|||+.++++
T Consensus 306 lltg~~Pf~~~~~~~~---------------~~~~~-~~~-~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 306 IWCADLPITKDAALGG---------------SEWIF-RSC-K----NIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHSSCCC------CC---------------SGGGG-SSC-C----CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHCCCCCcccccccc---------------hhhhh-hhc-c----CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999853322111 00000 100 1 12356888999999999999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=327.35 Aligned_cols=251 Identities=20% Similarity=0.270 Sum_probs=182.5
Q ss_pred hHHHHHhhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcc-----------cHHHHHHHHHHHHHhCCCCccc
Q 048280 42 FEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQ-----------GKKEFENEAKLLARVQHRNVVN 110 (381)
Q Consensus 42 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpnIv~ 110 (381)
+.++....++|++.+.||+|+||.||+|...+++.||||++...... ..+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 56777888999999999999999999999888999999998543211 1367899999999999999999
Q ss_pred EEEEEee-----CCeEEEEEecccCCCHHHH----------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCC
Q 048280 111 LLGYCAH-----GAEKLLIYEYVINESLDKV----------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWI 167 (381)
Q Consensus 111 ~~~~~~~-----~~~~~lv~E~~~~g~L~~~----------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~ 167 (381)
+++++.. ....++||||+. |+|.++ +.|++.+|.|||..+ ||||||+|||++.++.
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 172 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND 172 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC
Confidence 9999854 346899999996 566543 478999999999999 9999999999999999
Q ss_pred cEEeeeccceecCCCCcccccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 048280 168 PKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAY 246 (381)
Q Consensus 168 ~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 246 (381)
+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+. .....
T Consensus 173 ~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~ 247 (362)
T 3pg1_A 173 ITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ---LNKIV 247 (362)
T ss_dssp EEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHH
T ss_pred EEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHH
Confidence 9999999998543322 2234578999999999987 6789999999999999999999999865432211 11111
Q ss_pred HHhhcCCcc-----------cccCC---CCCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 247 KLYKKDKSL-----------EIVDP---SLAAS----DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 247 ~~~~~~~~~-----------~~~~~---~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
......... ..... ..... ........+.+|+.+||+.||.+|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 111000000 00000 00000 011223568899999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=312.82 Aligned_cols=229 Identities=22% Similarity=0.297 Sum_probs=187.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467999999999999999999876 5788999998643 123346789999999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|||+++++|.+++ .|++.++.|||+.+ ||||||+|||++.++.+||+|||++....... .
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~---~ 169 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---R 169 (284)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC---B
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc---c
Confidence 9999999997654 68999999999999 99999999999999999999999998654322 2
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
....|++.|+|||++.+..++.++|||||||++|+|++|..||....... ......... ..+.
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~-------~~~~---- 232 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------THRRIVNVD-------LKFP---- 232 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTTC-------CCCC----
T ss_pred ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------HHHHHhccc-------cCCC----
Confidence 34568999999999999999999999999999999999999986432211 111111111 1111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
......+.+|+.+||+.||.+|||+.++++
T Consensus 233 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 233 PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 122356788999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=322.81 Aligned_cols=244 Identities=22% Similarity=0.265 Sum_probs=178.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC------
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA------ 119 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------ 119 (381)
.++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 578999999999999999999875 5889999999654 2333467889999999999999999999997664
Q ss_pred eEEEEEecccCCCHHH-------------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 120 EKLLIYEYVINESLDK-------------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~-------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
..++||||+.+ +|.+ ++.|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++......
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 181 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF- 181 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---------
T ss_pred ceEEEEEcCCC-CHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc-
Confidence 78999999965 5644 4479999999999999 99999999999999999999999998654322
Q ss_pred ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH-----------------
Q 048280 185 HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYK----------------- 247 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~----------------- 247 (381)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+. ......
T Consensus 182 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 182 -MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ---WNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp ---------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHC-CCCCCHHHHTTSCHHH
T ss_pred -ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHHHhhhHH
Confidence 22345789999999999999999999999999999999999999865432111 100000
Q ss_pred --HhhcCCcc-----cccCCCC-CCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 248 --LYKKDKSL-----EIVDPSL-AAS---DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 248 --~~~~~~~~-----~~~~~~~-~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
........ ....+.. ... ........+.+|+.+||+.||.+|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000 0000000 000 112335678999999999999999999999873
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=313.18 Aligned_cols=237 Identities=23% Similarity=0.321 Sum_probs=188.5
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3568999999999999999999876 68999999986443 234577899999999999999999999999999999999
Q ss_pred ecccCCCHHH---------------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc-ccc
Q 048280 126 EYVINESLDK---------------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT-HVN 187 (381)
Q Consensus 126 E~~~~g~L~~---------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~-~~~ 187 (381)
||+.+++|.+ ++.|++.+|.+||+.+ ||||||+||+++.++.+||+|||++..+..... ...
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 9999888854 4478999999999999 999999999999999999999999986543221 112
Q ss_pred cccccCccccchhHHhhCCC-CchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHL-SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
....||..|+|||++.+..+ +.++|||||||++|+|++|..||........ .. ..+...... . ..
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~-----~~~~~~~~~--~------~~ 230 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EY-----SDWKEKKTY--L------NP 230 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HH-----HHHHTTCTT--S------TT
T ss_pred cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HH-----HHhhhcccc--c------Cc
Confidence 34578999999999987765 7899999999999999999999865432211 11 111111100 0 01
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.......+.+|+.+||+.||.+|||+.+|++.
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 11234567889999999999999999999763
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=318.96 Aligned_cols=244 Identities=21% Similarity=0.327 Sum_probs=170.5
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
...++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34678999999999999999999864 68999999986542 33456788999999999999999999999999999999
Q ss_pred EecccCCCHHHHH-----------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceec
Q 048280 125 YEYVINESLDKVL-----------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLF 179 (381)
Q Consensus 125 ~E~~~~g~L~~~l-----------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~ 179 (381)
|||+.+++|.+++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||++...
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 9999999987665 47899999999998 9999999999999999999999999865
Q ss_pred CCCCc----ccccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCc
Q 048280 180 PEDQT----HVNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKS 254 (381)
Q Consensus 180 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (381)
..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ . ....... .
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~---~~~~~~~-~ 244 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---L---MLTLQND-P 244 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---H---HHHHTSS-C
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---H---HHHhccC-C
Confidence 43221 11224568999999999876 5789999999999999999999999865433221 1 1111111 1
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 255 LEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
...................+.+|+.+||+.||.+|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0000000000111122356888999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=344.88 Aligned_cols=229 Identities=26% Similarity=0.379 Sum_probs=180.1
Q ss_pred CcccccCCeeEEEEEEC---CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccC
Q 048280 56 NKLGEGGFGPVFKGKLD---DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
+.||+|+||.||+|.+. .++.||||+++... ....+.+.+|+++|++++|||||++++++.. +..++||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 37999999999999653 46789999997542 3345789999999999999999999999965 558899999999
Q ss_pred CCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc--ccccccc
Q 048280 131 ESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT--HVNTRVA 191 (381)
Q Consensus 131 g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~--~~~~~~~ 191 (381)
|+|.+++ .|++.+|.|||+.+ ||||||+||||+.++.+||+|||+++.+..... .......
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 533 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 533 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCC
Confidence 9997665 68999999999999 999999999999999999999999987654332 1222345
Q ss_pred cCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHH
Q 048280 192 GTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQ 270 (381)
Q Consensus 192 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (381)
+|+.|+|||++.+..++.++|||||||+||||++ |+.||....... + .......... ..+..+
T Consensus 534 ~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~----~~~i~~~~~~---------~~p~~~ 597 (635)
T 4fl3_A 534 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---V----TAMLEKGERM---------GCPAGC 597 (635)
T ss_dssp -CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H----HHHHHTTCCC---------CCCTTC
T ss_pred CceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCCCC---------CCCCCC
Confidence 6789999999999999999999999999999998 999986433211 1 1112211111 111223
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 271 IAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 271 ~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
+..+.+||.+||+.||++||++.+|++.|+.
T Consensus 598 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 598 PREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 4668899999999999999999999999865
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=327.33 Aligned_cols=236 Identities=12% Similarity=0.029 Sum_probs=170.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc---ccHHHHHHHHHHHHHh--CCCCcccEE-------EEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---QGKKEFENEAKLLARV--QHRNVVNLL-------GYC 115 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~hpnIv~~~-------~~~ 115 (381)
..+|.+.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345999999999999999999976 689999999976542 2345677886666666 599988755 555
Q ss_pred eeC-----------------CeEEEEEecccCCCHHHHH----------------------HhhhhhhhHhhhhc--cCC
Q 048280 116 AHG-----------------AEKLLIYEYVINESLDKVL----------------------FSLIKDIQILFRKK--KTD 154 (381)
Q Consensus 116 ~~~-----------------~~~~lv~E~~~~g~L~~~l----------------------~~~~~~l~~lh~~~--HrD 154 (381)
... ...++||||+. ++|.+++ .|++.+|.|||+++ |||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 433 33799999997 8886543 68899999999999 999
Q ss_pred ccccceEeCCCCCcEEeeeccceecCCCCcccccccccCccccchhHHhh--CCCCchhhhHhHHHHHHHHHhCCCCCCC
Q 048280 155 IKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMH--GHLSVKADVFSFGVVILELISGQRNSSF 232 (381)
Q Consensus 155 lkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p~~~ 232 (381)
|||+||||+.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||+||||++|+.||..
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999764321 13456799999999987 6799999999999999999999999865
Q ss_pred CCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 233 NLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
........ +........................+.+|+.+||+.||++|||+.++++
T Consensus 296 ~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 296 VTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred cCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 43221100 0000000111111111112234567889999999999999999999974
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=335.83 Aligned_cols=234 Identities=26% Similarity=0.331 Sum_probs=184.8
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc-------------ccHHHHHHHHHHHHHhCCCCcccEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN-------------QGKKEFENEAKLLARVQHRNVVNLLG 113 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpnIv~~~~ 113 (381)
..++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4678999999999999999999876 588999999865421 23567899999999999999999999
Q ss_pred EEeeCCeEEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCC---CcEEeee
Q 048280 114 YCAHGAEKLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKW---IPKIADF 173 (381)
Q Consensus 114 ~~~~~~~~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~---~~kL~DF 173 (381)
++.+....++|||||.+|+|.+++ .|++.+|.|||+.+ ||||||+|||++.++ .+||+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 999999999999999999996544 78999999999999 999999999998776 6999999
Q ss_pred ccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCC
Q 048280 174 GMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDK 253 (381)
Q Consensus 174 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (381)
|++..+.... ......||+.|+|||++. +.++.++|||||||++|+|++|..||...... .+. ........
T Consensus 194 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~---~~i~~~~~ 264 (504)
T 3q5i_A 194 GLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DII---KKVEKGKY 264 (504)
T ss_dssp TTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHCCC
T ss_pred CCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHHcCCC
Confidence 9999765432 223457999999999876 56999999999999999999999998643221 111 11111110
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 254 SLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.... .........+.+|+.+||+.||.+|||+.|+++
T Consensus 265 ~~~~-------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 265 YFDF-------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CCCH-------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCc-------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000 000112356889999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=313.34 Aligned_cols=235 Identities=23% Similarity=0.366 Sum_probs=183.5
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
..++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4678999999999999999999986 589999999987766677889999999999999999999999999999999999
Q ss_pred cccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 127 YVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 127 ~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
|+++++|.+++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||++...... .....
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 175 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQKRD 175 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HHC--
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-ccccc
Confidence 99999997654 68999999999999 9999999999999999999999987532111 01112
Q ss_pred ccccCccccchhHHh-----hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC
Q 048280 189 RVAGTNGYMAPEYVM-----HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
...||..|+|||++. +..++.++|||||||++|+|++|..||...... ........... ...
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~-~~~------ 242 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSDP-PTL------ 242 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCC-CCC------
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHhccCC-ccc------
Confidence 356899999999984 567899999999999999999999998643221 11111111111 111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 264 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.........+.+|+.+||+.||.+|||+.+|++
T Consensus 243 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 -LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111223456889999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=311.77 Aligned_cols=233 Identities=24% Similarity=0.358 Sum_probs=184.3
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
..++|++.+.||+|+||.||+|... +++.||||++.... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3568999999999999999999876 48999999997543 34778999999999999999999999999999999999
Q ss_pred cccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 127 YVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 127 ~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
|+.+++|.+++ .+++.+|.|||..+ |+||||+|||++.++.+||+|||++........ ...
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~ 183 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRN 183 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-CBC
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-ccC
Confidence 99999997665 67899999999998 999999999999999999999999987643322 223
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
...||..|+|||++.+..++.++|||||||++|+|++|..||...... ........ ...... ....
T Consensus 184 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~~-------~~~~ 249 (314)
T 3com_A 184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIFMIPT-NPPPTF-------RKPE 249 (314)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHH-SCCCCC-------SSGG
T ss_pred ccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhc-CCCccc-------CCcc
Confidence 456899999999999999999999999999999999999998643221 11111111 111111 1111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.....+.+|+.+||+.||.+|||+.++++
T Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 250 LWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 22456889999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=319.48 Aligned_cols=234 Identities=15% Similarity=0.160 Sum_probs=185.9
Q ss_pred HHHHhhcCCCCCCcccccCCeeEEEEE------ECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhC---CCCcccEEEE
Q 048280 44 ALVSATKNFHPSNKLGEGGFGPVFKGK------LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQ---HRNVVNLLGY 114 (381)
Q Consensus 44 ~~~~~~~~y~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~ 114 (381)
++....++|.+.+.||+|+||.||+|. ..+++.||||++... ....+.+|+++++.++ |+||++++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 334456789999999999999999994 346899999999654 3467888999998886 9999999999
Q ss_pred EeeCCeEEEEEecccCCCHHHHH--------------------HhhhhhhhHhhhhc--cCCccccceEeCC--------
Q 048280 115 CAHGAEKLLIYEYVINESLDKVL--------------------FSLIKDIQILFRKK--KTDIKASNILLDD-------- 164 (381)
Q Consensus 115 ~~~~~~~~lv~E~~~~g~L~~~l--------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~-------- 164 (381)
+...+..++||||+.+|+|.+++ .|++.+|.|||+.+ ||||||+||||+.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 99999999999999999998765 57899999999998 9999999999998
Q ss_pred ---CCCcEEeeeccceecCCC-CcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccccc
Q 048280 165 ---KWIPKIADFGMARLFPED-QTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQN 240 (381)
Q Consensus 165 ---~~~~kL~DFG~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 240 (381)
++.+||+|||+++.+... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 899999999999865321 2223345679999999999999999999999999999999999999984221110
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHhcC
Q 048280 241 LLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLR-PTMRRVVVMLSK 301 (381)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~eil~~L~~ 301 (381)
..+...+.... ....+.+++..||+.+|.+| |++.++.+.|+.
T Consensus 293 ---------------~~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 293 ---------------CKPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp ---------------EEECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred ---------------eeechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 00111111111 13456678889999999998 577777776654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=323.01 Aligned_cols=242 Identities=15% Similarity=0.185 Sum_probs=186.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC---------CcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCccc---------
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD---------GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVN--------- 110 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~--------- 110 (381)
.++|++.+.||+|+||.||+|+... ++.||||++... ..+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4789999999999999999998763 789999998644 46789999999999999887
Q ss_pred ------EEEEEee-CCeEEEEEecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCC
Q 048280 111 ------LLGYCAH-GAEKLLIYEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDD 164 (381)
Q Consensus 111 ------~~~~~~~-~~~~~lv~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~ 164 (381)
+++++.. +...++||||+ +++|.+++ .|++.+|.|||+.+ ||||||+|||++.
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDP 194 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEET
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcC
Confidence 6777776 78899999999 99998765 68899999999999 9999999999999
Q ss_pred CC--CcEEeeeccceecCCCCcc------cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcc
Q 048280 165 KW--IPKIADFGMARLFPEDQTH------VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDV 236 (381)
Q Consensus 165 ~~--~~kL~DFG~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~ 236 (381)
++ .+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 98 9999999999866432211 112357999999999999999999999999999999999999998643211
Q ss_pred ccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 237 DAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
...+......... . .......... .......+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 275 -~~~~~~~~~~~~~-~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 275 -TEDIMKQKQKFVD-K-PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp -HHHHHHHHHHHHH-S-CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred -HHHHHHHHHhccC-C-hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 1112221111111 1 1111111100 011235688899999999999999999999998764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=310.65 Aligned_cols=237 Identities=21% Similarity=0.274 Sum_probs=182.5
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC----cccHHHHHHHHHHHHHhCCCCcccEEEEE--eeCCe
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS----NQGKKEFENEAKLLARVQHRNVVNLLGYC--AHGAE 120 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~--~~~~~ 120 (381)
..++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++ .+...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3578999999999999999999875 58899999996532 23457799999999999999999999998 44567
Q ss_pred EEEEEecccCCCHHH-----------------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCC
Q 048280 121 KLLIYEYVINESLDK-----------------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPE 181 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~-----------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~ 181 (381)
.++||||+.++ |.+ ++.|++.+|.|||+.+ ||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 89999999776 433 3478999999999999 999999999999999999999999987643
Q ss_pred CCc-ccccccccCccccchhHHhhCC--CCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCccccc
Q 048280 182 DQT-HVNTRVAGTNGYMAPEYVMHGH--LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIV 258 (381)
Q Consensus 182 ~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... ......... ...
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~i~~-~~~---- 230 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YKLFENIGK-GSY---- 230 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHH-CCC----
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HHHHHHHhc-CCC----
Confidence 221 2223456899999999987654 47899999999999999999999864321 111111111 110
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhcCC
Q 048280 259 DPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV--MLSKK 302 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~--~L~~~ 302 (381)
.... .....+.+|+.+||+.||.+|||+.++++ .+...
T Consensus 231 --~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 231 --AIPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp --CCCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred --CCCC----ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 1111 22356788999999999999999999996 34443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=323.66 Aligned_cols=181 Identities=20% Similarity=0.335 Sum_probs=156.4
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHh------CCCCcccEEEEEeeCCe
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARV------QHRNVVNLLGYCAHGAE 120 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~~~~~~~~~~~ 120 (381)
...+|++.+.||+|+||.||+|... +++.||||++... ......+.+|+++++.+ +|+||+++++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 3567999999999999999999876 4899999999653 23346788899999988 46799999999999999
Q ss_pred EEEEEecccCCCHHHH-----------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCC--cEEeeeccceec
Q 048280 121 KLLIYEYVINESLDKV-----------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWI--PKIADFGMARLF 179 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~-----------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~--~kL~DFG~~~~~ 179 (381)
.++||||+. ++|.++ +.|++.+|.|||+.+ ||||||+||||+.++. +||+|||++...
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 999999995 577554 378999999999999 9999999999999887 999999999865
Q ss_pred CCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCC
Q 048280 180 PEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNL 234 (381)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 234 (381)
.... ....||+.|+|||++.+..++.++|||||||+||||++|..||....
T Consensus 253 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 253 HQRV----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TCCC----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCcc----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 4322 23578999999999999999999999999999999999999986543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=323.65 Aligned_cols=244 Identities=22% Similarity=0.296 Sum_probs=174.3
Q ss_pred CChHHHHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhC-CCCcccEEEEEe-
Q 048280 40 FPFEALVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQ-HRNVVNLLGYCA- 116 (381)
Q Consensus 40 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~- 116 (381)
+.-..+.....+|++.+.||+|+||.||+|++. +++.||||++..........+.+|+.+++++. ||||+++++++.
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 97 (337)
T 3ll6_A 18 FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI 97 (337)
T ss_dssp STTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred hhcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence 333344444568999999999999999999975 68999999987666566678999999999996 999999999994
Q ss_pred -------eCCeEEEEEecccCCCHHHHH------------------HhhhhhhhHhhhhc----cCCccccceEeCCCCC
Q 048280 117 -------HGAEKLLIYEYVINESLDKVL------------------FSLIKDIQILFRKK----KTDIKASNILLDDKWI 167 (381)
Q Consensus 117 -------~~~~~~lv~E~~~~g~L~~~l------------------~~~~~~l~~lh~~~----HrDlkp~NIll~~~~~ 167 (381)
.....++||||+. |+|.+++ .|++.+|.|||..+ ||||||+||||+.++.
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC
T ss_pred cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC
Confidence 3445899999995 6775544 68899999999875 9999999999999999
Q ss_pred cEEeeeccceecCCCCccc-----------ccccccCccccchhHH---hhCCCCchhhhHhHHHHHHHHHhCCCCCCCC
Q 048280 168 PKIADFGMARLFPEDQTHV-----------NTRVAGTNGYMAPEYV---MHGHLSVKADVFSFGVVILELISGQRNSSFN 233 (381)
Q Consensus 168 ~kL~DFG~~~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 233 (381)
+||+|||+++......... .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 9999999998765432211 1134589999999998 5667899999999999999999999998532
Q ss_pred CccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 234 LDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
.... ....... ..........+.+|+.+||+.||.+|||+.|+++.|+...
T Consensus 257 ~~~~----------~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 257 AKLR----------IVNGKYS---------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp -------------------CC---------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHH----------hhcCccc---------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2110 0000000 0000111233778999999999999999999999997653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=316.14 Aligned_cols=239 Identities=26% Similarity=0.375 Sum_probs=181.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC--CCc--EEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD--DGR--EIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEK 121 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 121 (381)
.++|++.+.||+|+||.||+|++. +++ .||||++... .....+.+.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 568999999999999999999853 233 6899998654 2234578899999999999999999999998765 8
Q ss_pred EEEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 122 LLIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
++||||+.+++|.+++ .|++.+|.+||+.+ ||||||+|||++.++.+||+|||++.......
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence 9999999999997655 68999999999999 99999999999999999999999998775443
Q ss_pred cc--cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCC
Q 048280 184 TH--VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDP 260 (381)
Q Consensus 184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
.. ......+|..|+|||++.+..++.++|||||||++|+|++ |..||...... ............
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~------ 243 (291)
T 1u46_A 176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGER------ 243 (291)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCC------
T ss_pred cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHccCCC------
Confidence 22 1223457888999999999999999999999999999999 99998643221 111111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 261 SLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 261 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
.......+..+.+++.+||+.||.+|||+.++++.|++..
T Consensus 244 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 244 ---LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ---CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 0111223466889999999999999999999999998753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=327.13 Aligned_cols=242 Identities=24% Similarity=0.339 Sum_probs=179.1
Q ss_pred HHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEee-------
Q 048280 46 VSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAH------- 117 (381)
Q Consensus 46 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------- 117 (381)
....++|++.+.||+|+||.||+|+.. +++.||||++..... ...+|+++++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 345678999999999999999999864 689999999865432 23479999999999999999999844
Q ss_pred -------------------------------CCeEEEEEecccCCCHHHH-------------------HHhhhhhhhHh
Q 048280 118 -------------------------------GAEKLLIYEYVINESLDKV-------------------LFSLIKDIQIL 147 (381)
Q Consensus 118 -------------------------------~~~~~lv~E~~~~g~L~~~-------------------l~~~~~~l~~l 147 (381)
....++||||++ ++|.+. +.|++.+|.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334889999997 465433 36899999999
Q ss_pred hhhc--cCCccccceEeC-CCCCcEEeeeccceecCCCCcccccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHH
Q 048280 148 FRKK--KTDIKASNILLD-DKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILEL 223 (381)
Q Consensus 148 h~~~--HrDlkp~NIll~-~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~el 223 (381)
|+.+ ||||||+|||++ .++.+||+|||+++.+..... .....||..|+|||++.+. .++.++|||||||++|||
T Consensus 158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 9999 999999999997 688999999999997644322 2345689999999998875 489999999999999999
Q ss_pred HhCCCCCCCCCccccccHHHHHHHHhhc----------CCcccccCCCCCCC-----CCHHHHHHHHHHHHHcccCCCCC
Q 048280 224 ISGQRNSSFNLDVDAQNLLDWAYKLYKK----------DKSLEIVDPSLAAS-----DSGDQIAMCIQIGLLCTQGDPQL 288 (381)
Q Consensus 224 ltg~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~ 288 (381)
++|+.||......+. .......... ........+..... .....+..+.+|+.+||+.||.+
T Consensus 236 l~g~~pf~~~~~~~~---~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 236 ILGKPLFSGETSIDQ---LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 999999875433221 1111111000 00001111111111 11123456889999999999999
Q ss_pred CCCHHHHHH
Q 048280 289 RPTMRRVVV 297 (381)
Q Consensus 289 RPs~~eil~ 297 (381)
|||+.|+++
T Consensus 313 R~t~~e~l~ 321 (383)
T 3eb0_A 313 RINPYEAMA 321 (383)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhc
Confidence 999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=309.47 Aligned_cols=236 Identities=22% Similarity=0.301 Sum_probs=188.5
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc---------ccHHHHHHHHHHHHHhC-CCCcccEEEEE
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---------QGKKEFENEAKLLARVQ-HRNVVNLLGYC 115 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-hpnIv~~~~~~ 115 (381)
...++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34678999999999999999999876 589999999965431 22456889999999995 99999999999
Q ss_pred eeCCeEEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeecccee
Q 048280 116 AHGAEKLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARL 178 (381)
Q Consensus 116 ~~~~~~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~ 178 (381)
......++||||+.+++|.+++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||++..
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 9999999999999999997765 68999999999999 999999999999999999999999987
Q ss_pred cCCCCcccccccccCccccchhHHh------hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcC
Q 048280 179 FPEDQTHVNTRVAGTNGYMAPEYVM------HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKD 252 (381)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (381)
...... .....|++.|+|||++. ...++.++|||||||++|+|++|..||...... ..........
T Consensus 174 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~ 245 (298)
T 1phk_A 174 LDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------LMLRMIMSGN 245 (298)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC
T ss_pred cCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH------HHHHHHhcCC
Confidence 654322 23456899999999986 346889999999999999999999998543211 1111111111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 253 KSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.. ............+.+|+.+||+.||.+|||+.++++
T Consensus 246 ~~-------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 246 YQ-------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CC-------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cc-------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 10 011111234466889999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=308.05 Aligned_cols=232 Identities=22% Similarity=0.333 Sum_probs=180.7
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
..++|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3578999999999999999999976 6899999998643 22345678999999999999999999999999999999
Q ss_pred EEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 124 IYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 124 v~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
||||+.+++|.+++ .|++.+|.+||+.+ |+||||+|||++.++.+||+|||++........
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 166 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-- 166 (276)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred EEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc--
Confidence 99999999997665 68999999999999 999999999999999999999999987643321
Q ss_pred ccccccCccccchhHHhhCCC-CchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCC
Q 048280 187 NTRVAGTNGYMAPEYVMHGHL-SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
.....|++.|+|||++.+..+ +.++|||||||++|+|++|..||..... .... .. ...... ..
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~---~~-~~~~~~------~~--- 230 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---PTLF---KK-IRGGVF------YI--- 230 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HH-HHHCCC------CC---
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHH---HH-hhcCcc------cC---
Confidence 223568999999999988765 6899999999999999999999864321 1111 11 111110 01
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 266 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
+......+.+++.+||+.||.+|||+.+|++.
T Consensus 231 -~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 -PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11123457889999999999999999999974
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=319.16 Aligned_cols=236 Identities=26% Similarity=0.420 Sum_probs=184.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcE--EEEEEecCC-CcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGRE--IAVKKLSHS-SNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l 123 (381)
.++|++.+.||+|+||.||+|+.. ++.. ||||.+... .....+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 468999999999999999999865 4554 499988653 233456789999999999 89999999999999999999
Q ss_pred EEecccCCCHHHHH-------------------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEE
Q 048280 124 IYEYVINESLDKVL-------------------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKI 170 (381)
Q Consensus 124 v~E~~~~g~L~~~l-------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL 170 (381)
||||+++++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL 183 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 183 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEE
Confidence 99999999997654 57889999999998 9999999999999999999
Q ss_pred eeeccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHh
Q 048280 171 ADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLY 249 (381)
Q Consensus 171 ~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 249 (381)
+|||+++..... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...... .. ....
T Consensus 184 ~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~-~~~~ 254 (327)
T 1fvr_A 184 ADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------EL-YEKL 254 (327)
T ss_dssp CCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HH-HHHG
T ss_pred cccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH------HH-HHHh
Confidence 999999843221 11223456889999999999999999999999999999998 99998543211 11 1111
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 250 KKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
..... . .........+.+|+.+||+.||.+|||+.++++.|...
T Consensus 255 ~~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 255 PQGYR-----L----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp GGTCC-----C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCC-----C----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11110 1 11112345688999999999999999999999988754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=308.90 Aligned_cols=232 Identities=23% Similarity=0.342 Sum_probs=182.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEee----CCeE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAH----GAEK 121 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~ 121 (381)
...|++.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 345788899999999999999875 5889999998654 33345678999999999999999999999875 4568
Q ss_pred EEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc----cCCccccceEeC-CCCCcEEeeeccceecCC
Q 048280 122 LLIYEYVINESLDKVL---------------FSLIKDIQILFRKK----KTDIKASNILLD-DKWIPKIADFGMARLFPE 181 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~----HrDlkp~NIll~-~~~~~kL~DFG~~~~~~~ 181 (381)
++||||+.+++|.+++ .|++.+|.|||..+ ||||||+|||++ .++.+||+|||++.....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 9999999999997665 68999999999875 999999999997 789999999999976433
Q ss_pred CCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCC
Q 048280 182 DQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPS 261 (381)
Q Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (381)
.. .....||+.|+|||++. +.++.++|||||||++|+|++|+.||...... ... ..............
T Consensus 185 ~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~-~~~~~~~~~~~~~~-- 252 (290)
T 1t4h_A 185 SF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQI-YRRVTSGVKPASFD-- 252 (290)
T ss_dssp TS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHH-HHHHTTTCCCGGGG--
T ss_pred cc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HHH-HHHHhccCCccccC--
Confidence 22 23456899999999776 46999999999999999999999998643221 111 11111111111111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 262 LAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 262 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
......+.+|+.+||+.||.+|||+.++++.
T Consensus 253 ------~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 253 ------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ------CCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1112458899999999999999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=327.43 Aligned_cols=241 Identities=24% Similarity=0.338 Sum_probs=180.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC------eEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA------EKL 122 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------~~~ 122 (381)
..+|++.+.||+|+||.||+|+...+..||+|++...... ..+|+++++.++||||++++++|.... ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 4579999999999999999999887777999998654322 237999999999999999999996543 378
Q ss_pred EEEecccCCCHH------------------HHHHhhhhhhhHhhhhc--cCCccccceEeC-CCCCcEEeeeccceecCC
Q 048280 123 LIYEYVINESLD------------------KVLFSLIKDIQILFRKK--KTDIKASNILLD-DKWIPKIADFGMARLFPE 181 (381)
Q Consensus 123 lv~E~~~~g~L~------------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~-~~~~~kL~DFG~~~~~~~ 181 (381)
+||||+.++.+. .++.|++.+|.|||+.+ ||||||+||||+ .++.+||+|||+++.+..
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 999999765432 34479999999999999 999999999999 799999999999987643
Q ss_pred CCcccccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc---------
Q 048280 182 DQTHVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKK--------- 251 (381)
Q Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 251 (381)
... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+. ..........
T Consensus 195 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 195 GEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ---LVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp TCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHHHH
T ss_pred CCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHHhh
Confidence 322 2345789999999999775 589999999999999999999999975432221 1111111000
Q ss_pred -CCcccccCCCCCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 252 -DKSLEIVDPSLAAS-----DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 252 -~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
........+..... ........+.+|+.+||+.||.+|||+.|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000111111111 111234578899999999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=329.85 Aligned_cols=237 Identities=20% Similarity=0.310 Sum_probs=176.2
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--------cccHHHHHHHHHHHHHhCCCCcccEEEEEee
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--------NQGKKEFENEAKLLARVQHRNVVNLLGYCAH 117 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 117 (381)
...++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34678999999999999999999876 58999999986432 111235789999999999999999999985
Q ss_pred CCeEEEEEecccCCCHHH---------------HHHhhhhhhhHhhhhc--cCCccccceEeCCC---CCcEEeeeccce
Q 048280 118 GAEKLLIYEYVINESLDK---------------VLFSLIKDIQILFRKK--KTDIKASNILLDDK---WIPKIADFGMAR 177 (381)
Q Consensus 118 ~~~~~lv~E~~~~g~L~~---------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~---~~~kL~DFG~~~ 177 (381)
....++||||+.+++|.+ ++.|++.+|.|||+.+ ||||||+|||++.+ +.+||+|||+++
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 456899999999999864 3479999999999998 99999999999654 459999999998
Q ss_pred ecCCCCcccccccccCccccchhHHhh---CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCc
Q 048280 178 LFPEDQTHVNTRVAGTNGYMAPEYVMH---GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKS 254 (381)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (381)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... .+... ......
T Consensus 291 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~----i~~~~~ 362 (419)
T 3i6u_A 291 ILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ----ITSGKY 362 (419)
T ss_dssp SCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHH----HHTTCC
T ss_pred ecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHH----HhcCCC
Confidence 764332 2234679999999999853 578899999999999999999999986433221 11111 111110
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 255 LEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.. .+. ........+.+|+.+||+.||.+|||+.|+++.
T Consensus 363 ~~--~~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 363 NF--IPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CC--CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CC--Cch----hhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 000 001123568899999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=316.97 Aligned_cols=249 Identities=19% Similarity=0.293 Sum_probs=187.3
Q ss_pred HHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeC-----
Q 048280 46 VSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHG----- 118 (381)
Q Consensus 46 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----- 118 (381)
....++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...
T Consensus 23 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 23 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp CCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred ccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 334678999999999999999999876 58899999997543 23346788999999999999999999999765
Q ss_pred CeEEEEEecccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCC
Q 048280 119 AEKLLIYEYVINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPED 182 (381)
Q Consensus 119 ~~~~lv~E~~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~ 182 (381)
...++||||+. ++|.+++ .|++.+|.|||+.+ ||||||+||||+.++.+||+|||++......
T Consensus 103 ~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 103 KDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp CCEEEEEECCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred ceEEEEEcccC-cCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 46899999996 5776543 78999999999999 9999999999999999999999999876433
Q ss_pred Cccc--ccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcc----
Q 048280 183 QTHV--NTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSL---- 255 (381)
Q Consensus 183 ~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---- 255 (381)
.... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+. ..............
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQEDLNC 258 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHHHHHCSCCHHHHHT
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHHHhCCCCHHHHHH
Confidence 2211 2345799999999987654 589999999999999999999999965443322 11111111100000
Q ss_pred -----------cccCCCCC--CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 256 -----------EIVDPSLA--ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 256 -----------~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
....+... ..........+.+|+.+||+.||.+|||+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 00001123568899999999999999999999874
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=323.14 Aligned_cols=241 Identities=22% Similarity=0.361 Sum_probs=171.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeC------C
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHG------A 119 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~ 119 (381)
.++|++.+.||+|+||.||+|... +|+.||||++... .......+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 578999999999999999999865 5899999999654 223456788999999999999999999998654 5
Q ss_pred eEEEEEecccCCCHHH--------------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 120 EKLLIYEYVINESLDK--------------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~--------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
..++||||+ +++|.+ ++.|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++.....
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~- 185 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE- 185 (367)
T ss_dssp CCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----------
T ss_pred eEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc-
Confidence 689999998 666644 4579999999999998 9999999999999999999999999865432
Q ss_pred cccccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccC---
Q 048280 184 THVNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVD--- 259 (381)
Q Consensus 184 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 259 (381)
.....||..|+|||++.+ ..++.++|||||||++|||++|+.||......+. ........... ....+.
T Consensus 186 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~p-~~~~~~~~~ 258 (367)
T 2fst_X 186 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTP-GAELLKKIS 258 (367)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSC-CHHHHTTCC
T ss_pred ---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCC-CHHHHHHhh
Confidence 234578999999999987 6789999999999999999999999865433221 11111111100 000000
Q ss_pred -----------CCCCCCCC----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 260 -----------PSLAASDS----GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 260 -----------~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
+....... ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000000 1123567899999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=344.04 Aligned_cols=232 Identities=22% Similarity=0.245 Sum_probs=188.6
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 122 (381)
..++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+..|..++..+ +||||+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3568999999999999999999876 5889999998643 223456788899999988 7999999999999999999
Q ss_pred EEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 123 LIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 123 lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
|||||+.+|+|..++ .|++.+|.|||+.+ ||||||+||||+.++.+||+|||+++.......
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~- 497 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV- 497 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC-
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCc-
Confidence 999999999997665 68999999999999 999999999999999999999999986433322
Q ss_pred cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCC
Q 048280 186 VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
.....+||+.|+|||++.+..++.++|||||||+||||++|..||..... ......+..... .
T Consensus 498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~-------~---- 560 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHNV-------A---- 560 (674)
T ss_dssp CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHSSCC-------C----
T ss_pred ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCCC-------C----
Confidence 23457899999999999999999999999999999999999999864322 111122221110 0
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 048280 266 DSGDQIAMCIQIGLLCTQGDPQLRPTM-----RRVVV 297 (381)
Q Consensus 266 ~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~ 297 (381)
.+......+.+||.+||+.||.+||++ +||++
T Consensus 561 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 561 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 111234568899999999999999998 67764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=313.45 Aligned_cols=235 Identities=21% Similarity=0.298 Sum_probs=180.6
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc--------ccHHHHHHHHHHHHHhCCCCcccEEEEEeeC
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN--------QGKKEFENEAKLLARVQHRNVVNLLGYCAHG 118 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 118 (381)
..++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3568999999999999999999876 588999999865321 1234588999999999999999999998766
Q ss_pred CeEEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCC---cEEeeecccee
Q 048280 119 AEKLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWI---PKIADFGMARL 178 (381)
Q Consensus 119 ~~~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~---~kL~DFG~~~~ 178 (381)
. .++||||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++. +||+|||++..
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 5 89999999999987654 78999999999999 9999999999987654 99999999987
Q ss_pred cCCCCcccccccccCccccchhHHh---hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcc
Q 048280 179 FPEDQTHVNTRVAGTNGYMAPEYVM---HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSL 255 (381)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (381)
..... ......||+.|+|||++. ...++.++|||||||++|+|++|..||....... .+..... .....
T Consensus 167 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~----~~~~~ 238 (322)
T 2ycf_A 167 LGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQIT----SGKYN 238 (322)
T ss_dssp CCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHH----HTCCC
T ss_pred ccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHH----hCccc
Confidence 64332 223456899999999985 4578999999999999999999999986433221 1221111 11100
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 256 EIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
..+.. .......+.+|+.+||+.||.+|||+.++++
T Consensus 239 --~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 239 --FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --cCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00000 0112356889999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=322.81 Aligned_cols=239 Identities=24% Similarity=0.350 Sum_probs=177.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeC------CeEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHG------AEKL 122 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~~~ 122 (381)
.+|++.+.||+|+||.||+|++. +++.||||++.... ..+.+|+++|++++||||++++++|... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46999999999999999999986 58999999986543 2234799999999999999999998542 2367
Q ss_pred EEEecccCCCHH-------------------HHHHhhhhhhhHhhhhc--cCCccccceEeCCC-CCcEEeeeccceecC
Q 048280 123 LIYEYVINESLD-------------------KVLFSLIKDIQILFRKK--KTDIKASNILLDDK-WIPKIADFGMARLFP 180 (381)
Q Consensus 123 lv~E~~~~g~L~-------------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~-~~~kL~DFG~~~~~~ 180 (381)
+||||+.+ +|. .++.|++.+|.|||+.+ ||||||+||||+.+ +.+||+|||+++.+.
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 99999975 433 23479999999999998 99999999999955 578999999999764
Q ss_pred CCCcccccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhh---------
Q 048280 181 EDQTHVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYK--------- 250 (381)
Q Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------- 250 (381)
.... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||......+. +... .....
T Consensus 209 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i-~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 209 RGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEI-IKVLGTPTREQIRE 283 (420)
T ss_dssp TTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH-HHHHCSCCHHHHHH
T ss_pred cCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH-HHHhCCCCHHHHHh
Confidence 3322 2345789999999999775 789999999999999999999999875432221 1111 11100
Q ss_pred -cCCcccccCCCCCCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 251 -KDKSLEIVDPSLAASD-----SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 251 -~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.........+...... .......+.+|+.+||+.||.+|||+.|+++.
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0001111111111110 11224668899999999999999999999863
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=318.31 Aligned_cols=245 Identities=20% Similarity=0.335 Sum_probs=183.9
Q ss_pred CCCChHHHHHhhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCC--cccHHHHHHHHHHHHHhC--CCCcccEEE
Q 048280 38 KHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSS--NQGKKEFENEAKLLARVQ--HRNVVNLLG 113 (381)
Q Consensus 38 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--hpnIv~~~~ 113 (381)
+.+.++.+....++|++.+.||+|+||.||++...+++.||||++.... ....+.+.+|++++++++ |+||+++++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 3455555556678899999999999999999998889999999996542 334577899999999997 599999999
Q ss_pred EEeeCCeEEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccc
Q 048280 114 YCAHGAEKLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMA 176 (381)
Q Consensus 114 ~~~~~~~~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~ 176 (381)
++...+..++||| +.+++|.+++ .|++.+|.|||+.+ ||||||+|||+++ +.+||+|||++
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~ 173 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIA 173 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeecccc
Confidence 9999999999999 5578887655 68999999999999 9999999999965 88999999999
Q ss_pred eecCCCCcc-cccccccCccccchhHHhh-----------CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 048280 177 RLFPEDQTH-VNTRVAGTNGYMAPEYVMH-----------GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDW 244 (381)
Q Consensus 177 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~ 244 (381)
..+...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ...
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~ 248 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISK 248 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHH
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HHH
Confidence 876433221 1224568999999999875 46889999999999999999999998543221 111
Q ss_pred HHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 245 AYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.......... ..........+.+|+.+||+.||.+|||+.|+++.
T Consensus 249 ~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 249 LHAIIDPNHE---------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHCTTSC---------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhcccc---------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1111111111 01111113568889999999999999999999863
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=313.62 Aligned_cols=242 Identities=21% Similarity=0.296 Sum_probs=187.3
Q ss_pred hhcCCCCCCcccccCCeeEEEEEE-C-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCC------cccEEEEEeeCC
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKL-D-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRN------VVNLLGYCAHGA 119 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~~~~~~~~~~ 119 (381)
..++|++.+.||+|+||.||+|.. . +++.||||++.... ...+.+.+|+++++.++|+| |+++++++...+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 357899999999999999999986 3 58899999996442 33567889999999997654 999999999999
Q ss_pred eEEEEEecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCC----------------
Q 048280 120 EKLLIYEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDD---------------- 164 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~---------------- 164 (381)
..++||||+ +++|.+++ .|++.+|.|||+.+ ||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 999999999 88886554 78999999999999 9999999999987
Q ss_pred ---CCCcEEeeeccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccH
Q 048280 165 ---KWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNL 241 (381)
Q Consensus 165 ---~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 241 (381)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||......+..
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-- 243 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL-- 243 (339)
T ss_dssp EESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH--
T ss_pred cccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH--
Confidence 678999999999875432 22357899999999999999999999999999999999999998754332211
Q ss_pred HHHHHHHhhcC--------Cccccc---------------------CCC-CCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 048280 242 LDWAYKLYKKD--------KSLEIV---------------------DPS-LAASDSGDQIAMCIQIGLLCTQGDPQLRPT 291 (381)
Q Consensus 242 ~~~~~~~~~~~--------~~~~~~---------------------~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 291 (381)
.......... ...... .+. ............+.+|+.+||+.||.+|||
T Consensus 244 -~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 244 -AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp -HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred -HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 1111111000 000000 000 001122345677899999999999999999
Q ss_pred HHHHHHH
Q 048280 292 MRRVVVM 298 (381)
Q Consensus 292 ~~eil~~ 298 (381)
+.|+++.
T Consensus 323 ~~ell~h 329 (339)
T 1z57_A 323 LREALKH 329 (339)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999753
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=308.90 Aligned_cols=233 Identities=24% Similarity=0.345 Sum_probs=168.6
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcc-c-HHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQ-G-KKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
..++|++.+.||+|+||.||+|+.. +++.||||++...... . .+.+.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3578999999999999999999875 6899999999754222 2 23344455557778999999999999999999999
Q ss_pred EecccCCCHHH-------------------HHHhhhhhhhHhhhh-c--cCCccccceEeCCCCCcEEeeeccceecCCC
Q 048280 125 YEYVINESLDK-------------------VLFSLIKDIQILFRK-K--KTDIKASNILLDDKWIPKIADFGMARLFPED 182 (381)
Q Consensus 125 ~E~~~~g~L~~-------------------~l~~~~~~l~~lh~~-~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~ 182 (381)
|||+.+ +|.+ ++.|++.+|.|||+. + ||||||+|||++.++.+||+|||++......
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 163 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence 999964 6643 347899999999998 7 9999999999999999999999999876443
Q ss_pred CcccccccccCccccchhHH----hhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCccccc
Q 048280 183 QTHVNTRVAGTNGYMAPEYV----MHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIV 258 (381)
Q Consensus 183 ~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
.. .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||...... ............ ..
T Consensus 164 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~-~~-- 233 (290)
T 3fme_A 164 VA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVVEEPS-PQ-- 233 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHHHSCC-CC--
T ss_pred cc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHhccCC-CC--
Confidence 22 2234689999999996 4567899999999999999999999998642211 111111121111 11
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 259 DPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
. ........+.+|+.+||+.||.+|||+.|+++
T Consensus 234 ---~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 ---L---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ---C---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---c---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1 01122356889999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=315.16 Aligned_cols=189 Identities=21% Similarity=0.274 Sum_probs=158.9
Q ss_pred CChHHHHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhC-CC-----CcccEE
Q 048280 40 FPFEALVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQ-HR-----NVVNLL 112 (381)
Q Consensus 40 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----nIv~~~ 112 (381)
+.+.......++|++.+.||+|+||.||+|+.. +++.||||++... ......+.+|+.+++.++ |+ +|++++
T Consensus 44 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred EEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 445555566789999999999999999999876 5889999999643 233467788999999985 55 499999
Q ss_pred EEEeeCCeEEEEEecccCCCHHHHH-----------------HhhhhhhhHhhh--hc--cCCccccceEeC--CCCCcE
Q 048280 113 GYCAHGAEKLLIYEYVINESLDKVL-----------------FSLIKDIQILFR--KK--KTDIKASNILLD--DKWIPK 169 (381)
Q Consensus 113 ~~~~~~~~~~lv~E~~~~g~L~~~l-----------------~~~~~~l~~lh~--~~--HrDlkp~NIll~--~~~~~k 169 (381)
+++...+..++||||+. ++|.+++ .|++.+|.|||. .+ ||||||+||||+ .++.+|
T Consensus 123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred eeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEE
Confidence 99999999999999995 5876554 688999999995 34 999999999994 578899
Q ss_pred EeeeccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCC
Q 048280 170 IADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNL 234 (381)
Q Consensus 170 L~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 234 (381)
|+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 202 L~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 202 IVDFGSSCQLGQRI----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp ECCCTTCEETTCCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEeccCceeccccc----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999998764332 23578999999999999999999999999999999999999987543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=310.24 Aligned_cols=235 Identities=25% Similarity=0.374 Sum_probs=177.4
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEee---------
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAH--------- 117 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--------- 117 (381)
..++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3568999999999999999999975 6899999998543 2345678899999999999999999998865
Q ss_pred ----CCeEEEEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeecc
Q 048280 118 ----GAEKLLIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGM 175 (381)
Q Consensus 118 ----~~~~~lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~ 175 (381)
....++||||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 35689999999999997665 68899999999999 999999999999999999999999
Q ss_pred ceecCCCC-------------cccccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccH
Q 048280 176 ARLFPEDQ-------------THVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNL 241 (381)
Q Consensus 176 ~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 241 (381)
+....... ........||..|+|||++.+. .++.++|||||||++|+|++ ||... . ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--~---~~ 234 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--M---ER 234 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--H---HH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--h---hH
Confidence 98654321 1112345689999999999865 68999999999999999998 43211 1 11
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 242 LDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
...... .... ...............+.+|+.+||+.||.+|||+.++++.
T Consensus 235 ~~~~~~-~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 235 VNILKK-LRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHH-HHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHh-cccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111111 1111 0111122223334567889999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=341.37 Aligned_cols=241 Identities=22% Similarity=0.338 Sum_probs=187.3
Q ss_pred HHHhhcCCCCCCcccccCCeeEEEEEECC----CcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC
Q 048280 45 LVSATKNFHPSNKLGEGGFGPVFKGKLDD----GREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA 119 (381)
Q Consensus 45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 119 (381)
.....++|++.+.||+|+||.||+|.+.. +..||||++.... ....+.+.+|+.++++++||||+++++++.+ +
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-C
Confidence 33445678889999999999999998642 4679999986543 3334779999999999999999999999854 5
Q ss_pred eEEEEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCC
Q 048280 120 EKLLIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPE 181 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~ 181 (381)
..++||||+.+|+|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++....
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 689999999999997765 68999999999999 999999999999999999999999987654
Q ss_pred CCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCC
Q 048280 182 DQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDP 260 (381)
Q Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
..........+|+.|+|||++.+..++.++|||||||++|||++ |..||...... .... .... ....
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~---~i~~-~~~~----- 611 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIG---RIEN-GERL----- 611 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH---HHHH-TCCC-----
T ss_pred CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHH---HHHc-CCCC-----
Confidence 43333334557889999999999999999999999999999997 88888643221 1111 1111 1111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 261 SLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 261 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
. .+...+..+.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus 612 ~----~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 612 P----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 1112345688999999999999999999999998653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=312.88 Aligned_cols=244 Identities=25% Similarity=0.354 Sum_probs=184.3
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC--CCcEEEEEEecCCC--cccHHHHHHHHHHHHHh---CCCCcccEEEEEe----
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD--DGREIAVKKLSHSS--NQGKKEFENEAKLLARV---QHRNVVNLLGYCA---- 116 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~---- 116 (381)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4678999999999999999999973 58899999986432 12234567888888777 8999999999987
Q ss_pred -eCCeEEEEEecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccc
Q 048280 117 -HGAEKLLIYEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMA 176 (381)
Q Consensus 117 -~~~~~~lv~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~ 176 (381)
.....++||||+. ++|.+++ .|++.+|.|||..+ ||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 5567899999996 6886654 68899999999999 9999999999999999999999999
Q ss_pred eecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCccc
Q 048280 177 RLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLE 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (381)
...... .......||..|+|||++.+..++.++|||||||++|+|++|+.||......+ ................
T Consensus 168 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 168 RIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEED 242 (326)
T ss_dssp CCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCGGG
T ss_pred ccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCCCccc
Confidence 865322 12334578999999999999999999999999999999999999986543221 1111111111000000
Q ss_pred c----------cC---CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 257 I----------VD---PSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 257 ~----------~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
. .. ..............+.+|+.+||+.||.+|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 00 00000111223456889999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=316.93 Aligned_cols=250 Identities=22% Similarity=0.287 Sum_probs=175.7
Q ss_pred HHHHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCe-
Q 048280 43 EALVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAE- 120 (381)
Q Consensus 43 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~- 120 (381)
.......++|++.+.||+|+||.||+|+.. +++.||||++..... ....+.++++.+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 445566789999999999999999999875 589999999865432 33566788899999999999999999976433
Q ss_pred ------EEEEEecccCCCHH------------------HHHHhhhhhhhHhh--hhc--cCCccccceEeCC-CCCcEEe
Q 048280 121 ------KLLIYEYVINESLD------------------KVLFSLIKDIQILF--RKK--KTDIKASNILLDD-KWIPKIA 171 (381)
Q Consensus 121 ------~~lv~E~~~~g~L~------------------~~l~~~~~~l~~lh--~~~--HrDlkp~NIll~~-~~~~kL~ 171 (381)
.++||||+.++.+. .++.|++.++.|+| ..+ ||||||+||||+. ++.+||+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 78999999764221 23478999999999 777 9999999999996 8999999
Q ss_pred eeccceecCCCCcccccccccCccccchhHHhhCC-CCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhh
Q 048280 172 DFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGH-LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYK 250 (381)
Q Consensus 172 DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 250 (381)
|||+++.+..... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........ .........
T Consensus 175 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~ 249 (360)
T 3e3p_A 175 DFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ---LHEIVRVLG 249 (360)
T ss_dssp CCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHC
T ss_pred eCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH---HHHHHHHcC
Confidence 9999987654322 23456899999999997654 89999999999999999999999865432211 111111100
Q ss_pred cC------------CcccccCCC------CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 251 KD------------KSLEIVDPS------LAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 251 ~~------------~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.. ......... ............+.+|+.+||+.||.+|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 000000000 0011112245678999999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=316.42 Aligned_cols=247 Identities=22% Similarity=0.291 Sum_probs=184.4
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeC-----Ce
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHG-----AE 120 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~ 120 (381)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4678999999999999999999876 58999999996543 23346788999999999999999999998754 67
Q ss_pred EEEEEecccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 121 KLLIYEYVINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
.++||||+. ++|.+++ .|++.+|.|||+.+ ||||||+|||++.++.+||+|||++..+.....
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence 899999996 5776544 78999999999999 999999999999999999999999987653321
Q ss_pred cc---------ccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCc
Q 048280 185 HV---------NTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKS 254 (381)
Q Consensus 185 ~~---------~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (381)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ..............
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 244 (353)
T 2b9h_A 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFGIIGTPHS 244 (353)
T ss_dssp ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCS
T ss_pred cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCch
Confidence 11 123568999999998875 678999999999999999999999986543211 11111111110000
Q ss_pred cccc--------------CCCCCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 255 LEIV--------------DPSLAAS----DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 255 ~~~~--------------~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.... .+..... ........+.+|+.+||+.||.+|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 0000000 001234567899999999999999999999873
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=314.50 Aligned_cols=244 Identities=24% Similarity=0.281 Sum_probs=183.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhC-----------CCCcccEEEEEe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQ-----------HRNVVNLLGYCA 116 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~~~~~~~ 116 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++... ......+.+|++++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 468999999999999999999874 6899999999643 234567889999999986 899999999987
Q ss_pred eCC----eEEEEEecccCCCHHHHH-----------------HhhhhhhhHhhhh-c--cCCccccceEeC------CCC
Q 048280 117 HGA----EKLLIYEYVINESLDKVL-----------------FSLIKDIQILFRK-K--KTDIKASNILLD------DKW 166 (381)
Q Consensus 117 ~~~----~~~lv~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~-~--HrDlkp~NIll~------~~~ 166 (381)
..+ ..++||||+ +++|.+++ .|++.+|.|||++ + ||||||+||||+ ..+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence 654 789999999 88887654 6899999999998 7 999999999994 445
Q ss_pred CcEEeeeccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccH---HH
Q 048280 167 IPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNL---LD 243 (381)
Q Consensus 167 ~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~---~~ 243 (381)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||........... ..
T Consensus 176 ~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 251 (373)
T 1q8y_A 176 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251 (373)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHH
Confidence 8999999999876432 2235689999999999999999999999999999999999999965432211111 11
Q ss_pred HHHHHhhcC------------------CcccccCCC----------CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 048280 244 WAYKLYKKD------------------KSLEIVDPS----------LAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRV 295 (381)
Q Consensus 244 ~~~~~~~~~------------------~~~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 295 (381)
......... .....+... ............+.+||.+||+.||.+|||+.||
T Consensus 252 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 331 (373)
T 1q8y_A 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 331 (373)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHH
Confidence 111111000 000000000 0112346677889999999999999999999999
Q ss_pred HHH
Q 048280 296 VVM 298 (381)
Q Consensus 296 l~~ 298 (381)
++.
T Consensus 332 l~h 334 (373)
T 1q8y_A 332 VNH 334 (373)
T ss_dssp HTC
T ss_pred hhC
Confidence 873
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=309.01 Aligned_cols=245 Identities=19% Similarity=0.317 Sum_probs=178.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC-CcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEe-----------
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD-GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCA----------- 116 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----------- 116 (381)
.++|++.+.||+|+||.||+|.... ++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 5789999999999999999999774 8999999997766666678999999999999999999999873
Q ss_pred ---eCCeEEEEEecccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeC-CCCCcEEeeeccc
Q 048280 117 ---HGAEKLLIYEYVINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLD-DKWIPKIADFGMA 176 (381)
Q Consensus 117 ---~~~~~~lv~E~~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~-~~~~~kL~DFG~~ 176 (381)
.....++||||+. ++|.+++ .|++.+|.|||+.+ ||||||+|||++ .++.+||+|||++
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~ 168 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA 168 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred cccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccc
Confidence 4467899999996 5886654 78999999999999 999999999997 5679999999999
Q ss_pred eecCCCCc--ccccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc--
Q 048280 177 RLFPEDQT--HVNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKK-- 251 (381)
Q Consensus 177 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 251 (381)
+....... .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||........ ..........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~ 245 (320)
T 2i6l_A 169 RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ---MQLILESIPVVH 245 (320)
T ss_dssp BCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHSCCCC
T ss_pred cccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCc
Confidence 87643211 11223457899999998876 6789999999999999999999999865432211 1111100000
Q ss_pred --------CCcc-----cccCCCCC-CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 252 --------DKSL-----EIVDPSLA-ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 252 --------~~~~-----~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.... ....+... ..........+.+|+.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0000 00000000 0000123456889999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=316.94 Aligned_cols=241 Identities=24% Similarity=0.330 Sum_probs=181.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeE----
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEK---- 121 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~---- 121 (381)
.++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 578999999999999999999876 58999999997542 22346788999999999999999999999877654
Q ss_pred --EEEEecccCCCHHH-------------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 122 --LLIYEYVINESLDK-------------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 122 --~lv~E~~~~g~L~~-------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
++||||+. ++|.+ ++.|++.+|.|||+.+ ||||||+|||++.++.+||+|||+++.....
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-- 197 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-- 197 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--------
T ss_pred eEEEEEcccc-ccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC--
Confidence 99999996 56654 4579999999999999 9999999999999999999999999865332
Q ss_pred ccccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCccccc-----
Q 048280 185 HVNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIV----- 258 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 258 (381)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ ............ .....
T Consensus 198 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~-~~~~~~~~~~ 271 (371)
T 4exu_A 198 --MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVP-GTEFVQKLND 271 (371)
T ss_dssp ----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC-CHHHHTTCSC
T ss_pred --cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCC-cHHHHHHhhh
Confidence 234578999999999987 678999999999999999999999986433211 111111100000 00000
Q ss_pred ---------CCCCCCCC----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 259 ---------DPSLAASD----SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 259 ---------~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.+...... .......+.+|+.+||+.||.+|||+.|+++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000000 01224568899999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=317.19 Aligned_cols=240 Identities=21% Similarity=0.332 Sum_probs=187.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCccc-----------------HHHHHHHHHHHHHhCCCCcccE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQG-----------------KKEFENEAKLLARVQHRNVVNL 111 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~hpnIv~~ 111 (381)
.++|++.+.||+|+||.||+|+. +++.||||++....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 57899999999999999999998 89999999986432111 1789999999999999999999
Q ss_pred EEEEeeCCeEEEEEecccCCCHHH-----------------------HHHhhhhhhhHhhh-hc--cCCccccceEeCCC
Q 048280 112 LGYCAHGAEKLLIYEYVINESLDK-----------------------VLFSLIKDIQILFR-KK--KTDIKASNILLDDK 165 (381)
Q Consensus 112 ~~~~~~~~~~~lv~E~~~~g~L~~-----------------------~l~~~~~~l~~lh~-~~--HrDlkp~NIll~~~ 165 (381)
++++.+.+..++||||+++++|.+ ++.|++.+|.|||. .+ ||||||+|||++.+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN 188 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence 999999999999999999988754 44789999999998 77 99999999999999
Q ss_pred CCcEEeeeccceecCCCCcccccccccCccccchhHHhhC-CCCc-hhhhHhHHHHHHHHHhCCCCCCCCCccccccHHH
Q 048280 166 WIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG-HLSV-KADVFSFGVVILELISGQRNSSFNLDVDAQNLLD 243 (381)
Q Consensus 166 ~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~ 243 (381)
+.+||+|||++...... ......||..|+|||++.+. .++. ++|||||||++|+|++|..||...... ....
T Consensus 189 ~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~- 262 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VELF- 262 (348)
T ss_dssp SCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HHHH-
T ss_pred CcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHH-
Confidence 99999999999876433 23345789999999999887 6666 999999999999999999998644321 1111
Q ss_pred HHHHHhhcCCcccccC------CC---CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 244 WAYKLYKKDKSLEIVD------PS---LAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.. ........... +. ............+.+|+.+||+.||.+|||+.|+++.
T Consensus 263 --~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 263 --NN-IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp --HH-HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred --HH-HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 11111100000 00 0000012344678899999999999999999999863
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=313.28 Aligned_cols=245 Identities=22% Similarity=0.306 Sum_probs=186.3
Q ss_pred ChHHHHHhhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeC
Q 048280 41 PFEALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHG 118 (381)
Q Consensus 41 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 118 (381)
...+.....++|++.+.||+|+||.||+|+... .||+|++.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 344445557899999999999999999998763 49999986542 23345678899999999999999999999999
Q ss_pred CeEEEEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecC
Q 048280 119 AEKLLIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFP 180 (381)
Q Consensus 119 ~~~~lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~ 180 (381)
+..++||||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++ ++.+||+|||++....
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 9999999999999987654 78999999999999 999999999998 6799999999987543
Q ss_pred CCC----cccccccccCccccchhHHhh---------CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 048280 181 EDQ----THVNTRVAGTNGYMAPEYVMH---------GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYK 247 (381)
Q Consensus 181 ~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 247 (381)
... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~ 254 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------AIIWQ 254 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------HHHHH
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH
Confidence 211 111223458999999999874 35789999999999999999999998643221 11111
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 248 LYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
. ........... .....+.+|+.+||..||.+|||+.+|++.|+...
T Consensus 255 ~-~~~~~~~~~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 255 M-GTGMKPNLSQI--------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp H-HTTCCCCCCCS--------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred h-ccCCCCCCCcC--------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 1 11111111110 11234788999999999999999999999998865
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=319.70 Aligned_cols=231 Identities=24% Similarity=0.266 Sum_probs=177.3
Q ss_pred CCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEEEEeccc
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLLIYEYVI 129 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~ 129 (381)
.|.+.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+.+..++|||||.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 44556889999999998877777999999998643 245678999999987 89999999999999999999999995
Q ss_pred CCCHHH----------------------HHHhhhhhhhHhhhhc--cCCccccceEeCCC-------------CCcEEee
Q 048280 130 NESLDK----------------------VLFSLIKDIQILFRKK--KTDIKASNILLDDK-------------WIPKIAD 172 (381)
Q Consensus 130 ~g~L~~----------------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~-------------~~~kL~D 172 (381)
|+|.+ ++.|++.||.|||+.+ ||||||+||||+.+ +.+||+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 57754 4478999999999998 99999999999654 4899999
Q ss_pred eccceecCCCCcc---cccccccCccccchhHHhh-------CCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccH
Q 048280 173 FGMARLFPEDQTH---VNTRVAGTNGYMAPEYVMH-------GHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNL 241 (381)
Q Consensus 173 FG~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 241 (381)
||+++.+...... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.......
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---- 247 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE---- 247 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH----
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH----
Confidence 9999987543322 1224579999999999976 578999999999999999999 899985432211
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 242 LDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
......... .+.............+.+|+.+||+.||.+|||+.+|++
T Consensus 248 ----~~i~~~~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 ----SNIIRGIFS----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ----HHHHHTCCC----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHHhcCCCC----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111111111 111122234567788999999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=310.95 Aligned_cols=235 Identities=25% Similarity=0.384 Sum_probs=161.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHH-HHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAK-LLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
.++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 578999999999999999999875 68999999997543 223345666666 666679999999999999999999999
Q ss_pred ecccCCCHHH--------------------HHHhhhhhhhHhhhh-c--cCCccccceEeCCCCCcEEeeeccceecCCC
Q 048280 126 EYVINESLDK--------------------VLFSLIKDIQILFRK-K--KTDIKASNILLDDKWIPKIADFGMARLFPED 182 (381)
Q Consensus 126 E~~~~g~L~~--------------------~l~~~~~~l~~lh~~-~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~ 182 (381)
||+.+ +|.+ ++.+++.+|.|||.. + ||||||+|||++.++.+||+|||+++.....
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 179 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence 99975 5543 347889999999998 6 9999999999999999999999999866433
Q ss_pred CcccccccccCccccchhHH----hhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCccccc
Q 048280 183 QTHVNTRVAGTNGYMAPEYV----MHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIV 258 (381)
Q Consensus 183 ~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
.. .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||....... .... ......
T Consensus 180 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------~~~~--~~~~~~ 246 (327)
T 3aln_A 180 IA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF---------DQLT--QVVKGD 246 (327)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------C--CCCCSC
T ss_pred cc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH---------HHHH--HHhcCC
Confidence 21 2234689999999998 45678999999999999999999999986432110 0000 000111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 259 DPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.+.+...........+.+|+.+||+.||.+|||+.+|++
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111111111223456889999999999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=299.02 Aligned_cols=234 Identities=24% Similarity=0.337 Sum_probs=185.8
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
..++|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|++++++++||||+++++++...+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3568999999999999999999976 6899999998654 234567899999999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCC---CCcEEeeeccceecCCCCc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDK---WIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~---~~~kL~DFG~~~~~~~~~~ 184 (381)
|||+.+++|.+++ .|++.+|.+||..+ ||||||+|||++.+ +.+||+|||++........
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~ 179 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (287)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence 9999999996554 78999999999998 99999999999754 4799999999986643322
Q ss_pred ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 185 HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||...... ... ............ +
T Consensus 180 --~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~---~~~~~~~~~~~~--~---- 244 (287)
T 2wei_A 180 --MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DIL---KRVETGKYAFDL--P---- 244 (287)
T ss_dssp --CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHCCCCCCS--G----
T ss_pred --cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHH---HHHHcCCCCCCc--h----
Confidence 223458899999998865 5899999999999999999999998643221 111 111111110000 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
........+.+|+.+||+.||.+|||+.++++
T Consensus 245 -~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 245 -QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 01122356889999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=314.65 Aligned_cols=241 Identities=22% Similarity=0.292 Sum_probs=181.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCe-----
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAE----- 120 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~----- 120 (381)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999875 58999999996542 2234678899999999999999999999987654
Q ss_pred -EEEEEecccCCCHH-------------HHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 121 -KLLIYEYVINESLD-------------KVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 121 -~~lv~E~~~~g~L~-------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
.++||||+. ++|. .++.|++.+|.|||+.+ ||||||+|||++.++.+||+|||++......
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-- 179 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-- 179 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC------
T ss_pred eEEEEecccc-CCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC--
Confidence 499999996 4664 35589999999999999 9999999999999999999999999865322
Q ss_pred ccccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcC-----------
Q 048280 185 HVNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKD----------- 252 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 252 (381)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ ............
T Consensus 180 --~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~ 254 (353)
T 3coi_A 180 --MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGTEFVQKLNDK 254 (353)
T ss_dssp ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HHHHHHHHHCBCCHHHHTTCSCH
T ss_pred --ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHHHHhhH
Confidence 234568999999999987 678999999999999999999999986433211 111111110000
Q ss_pred -------CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 253 -------KSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 253 -------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.......+.+ ..........+.+|+.+||+.||.+|||+.++++.
T Consensus 255 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 255 AAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000001 11112335678899999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=308.16 Aligned_cols=229 Identities=23% Similarity=0.396 Sum_probs=176.3
Q ss_pred HHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcc------cHHHHHHHHHHHHHh----CCCCcccEEE
Q 048280 45 LVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQ------GKKEFENEAKLLARV----QHRNVVNLLG 113 (381)
Q Consensus 45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~hpnIv~~~~ 113 (381)
.....++|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 4455778999999999999999999865 5889999999655321 223466799999999 8999999999
Q ss_pred EEeeCCeEEEEEec-ccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeC-CCCCcEEeeec
Q 048280 114 YCAHGAEKLLIYEY-VINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLD-DKWIPKIADFG 174 (381)
Q Consensus 114 ~~~~~~~~~lv~E~-~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~-~~~~~kL~DFG 174 (381)
++...+..++|||| +.+++|.+++ .|++.+|.|||+.+ ||||||+|||++ .++.+||+|||
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 99999999999999 7889997665 68999999999999 999999999999 88999999999
Q ss_pred cceecCCCCcccccccccCccccchhHHhhCCCC-chhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCC
Q 048280 175 MARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLS-VKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDK 253 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (381)
++....... .....||..|+|||++.+..+. .++|||||||++|+|++|+.||.... ......
T Consensus 186 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~~~~~~- 249 (312)
T 2iwi_A 186 SGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------EILEAE- 249 (312)
T ss_dssp SCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHTC-
T ss_pred hhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------HHhhhc-
Confidence 998765432 2345689999999999887764 58999999999999999999985210 011110
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048280 254 SLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 299 (381)
..+ .......+.+|+.+||+.||++|||+.|+++.-
T Consensus 250 ------~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 250 ------LHF----PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp ------CCC----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred ------cCC----cccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 001 112235678899999999999999999999743
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=308.83 Aligned_cols=232 Identities=21% Similarity=0.233 Sum_probs=157.2
Q ss_pred hcCCCCCC-cccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHH-HHHHHhCCCCcccEEEEEee----CCeE
Q 048280 49 TKNFHPSN-KLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEA-KLLARVQHRNVVNLLGYCAH----GAEK 121 (381)
Q Consensus 49 ~~~y~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~hpnIv~~~~~~~~----~~~~ 121 (381)
.++|.+.+ .||+|+||.||+|+.. +++.||||++... ....+|+ ..++.+.||||+++++++.. ....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 67899965 6999999999999877 5899999998643 2223333 34566699999999999876 4568
Q ss_pred EEEEecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCC---CCCcEEeeeccceec
Q 048280 122 LLIYEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDD---KWIPKIADFGMARLF 179 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~---~~~~kL~DFG~~~~~ 179 (381)
++||||+.+|+|.+++ .|++.+|.|||..+ ||||||+|||++. ++.+||+|||++...
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 9999999999997665 68899999999999 9999999999976 456999999999875
Q ss_pred CCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccC
Q 048280 180 PEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVD 259 (381)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||............ ....... .
T Consensus 182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~------~ 249 (336)
T 3fhr_A 182 TQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIRLG------Q 249 (336)
T ss_dssp -------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------------
T ss_pred cccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhhcc------c
Confidence 4322 22456899999999998888999999999999999999999998543322110000 0000000 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 260 PSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 260 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
..............+.+|+.+||+.||.+|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 250 YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00111111233456889999999999999999999997
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=308.23 Aligned_cols=242 Identities=19% Similarity=0.271 Sum_probs=184.9
Q ss_pred HhhcCCCCCCcccccCCeeEEEEEEC-CC-cEEEEEEecCCCcccHHHHHHHHHHHHHhCCCC------cccEEEEEeeC
Q 048280 47 SATKNFHPSNKLGEGGFGPVFKGKLD-DG-REIAVKKLSHSSNQGKKEFENEAKLLARVQHRN------VVNLLGYCAHG 118 (381)
Q Consensus 47 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~~~~~~~~~ 118 (381)
...++|++.+.||+|+||.||+|... ++ +.||||++... ....+.+.+|+.++++++|++ ++.+++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 34679999999999999999999875 34 68999999643 234567889999999998766 89999999999
Q ss_pred CeEEEEEecccCCCHHH-----------------HHHhhhhhhhHhhhhc--cCCccccceEe-----------------
Q 048280 119 AEKLLIYEYVINESLDK-----------------VLFSLIKDIQILFRKK--KTDIKASNILL----------------- 162 (381)
Q Consensus 119 ~~~~lv~E~~~~g~L~~-----------------~l~~~~~~l~~lh~~~--HrDlkp~NIll----------------- 162 (381)
+..++||||+ +++|.+ ++.|++.+|.|||+.+ ||||||+||||
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999999 555543 3378999999999999 99999999999
Q ss_pred --CCCCCcEEeeeccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccccc
Q 048280 163 --DDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQN 240 (381)
Q Consensus 163 --~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 240 (381)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-- 247 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH-- 247 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--
T ss_pred cccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH--
Confidence 567899999999998754322 335789999999999999999999999999999999999999865432211
Q ss_pred HHHHHHHHhhcC--------Ccccc-cCC---------------------CCCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 048280 241 LLDWAYKLYKKD--------KSLEI-VDP---------------------SLAASDSGDQIAMCIQIGLLCTQGDPQLRP 290 (381)
Q Consensus 241 ~~~~~~~~~~~~--------~~~~~-~~~---------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 290 (381)
........... ..... ... .............+.+|+.+||+.||.+||
T Consensus 248 -~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 248 -LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp -HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred -HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 11111111000 00000 000 000112234456788999999999999999
Q ss_pred CHHHHHH
Q 048280 291 TMRRVVV 297 (381)
Q Consensus 291 s~~eil~ 297 (381)
|+.|+++
T Consensus 327 t~~e~l~ 333 (355)
T 2eu9_A 327 TLAEALL 333 (355)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=309.83 Aligned_cols=231 Identities=22% Similarity=0.363 Sum_probs=183.9
Q ss_pred hHHHHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcc------cHHHHHHHHHHHHHhC--CCCcccEE
Q 048280 42 FEALVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQ------GKKEFENEAKLLARVQ--HRNVVNLL 112 (381)
Q Consensus 42 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpnIv~~~ 112 (381)
..+.....++|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++++++ |+||++++
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 3444556788999999999999999999865 6899999998654221 2245778999999996 59999999
Q ss_pred EEEeeCCeEEEEEecccC-CCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeC-CCCCcEEeee
Q 048280 113 GYCAHGAEKLLIYEYVIN-ESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLD-DKWIPKIADF 173 (381)
Q Consensus 113 ~~~~~~~~~~lv~E~~~~-g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~-~~~~~kL~DF 173 (381)
+++...+..++|||++.+ ++|.+++ .|++.+|.|||+.+ ||||||+|||++ +++.+||+||
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999999999976 7887654 68999999999999 999999999999 7889999999
Q ss_pred ccceecCCCCcccccccccCccccchhHHhhCCC-CchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcC
Q 048280 174 GMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHL-SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKD 252 (381)
Q Consensus 174 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (381)
|++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ......
T Consensus 195 g~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~~~~~~ 259 (320)
T 3a99_A 195 GSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQ 259 (320)
T ss_dssp TTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCC
T ss_pred cccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------hhhccc
Confidence 9998765432 234568999999999988776 688999999999999999999985311 111111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 253 KSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
. . ... .....+.+|+.+||+.||.+|||+.+|++.
T Consensus 260 ~---~----~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 260 V---F----FRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp C---C----CSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c---c----ccc----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0 111 123568899999999999999999999873
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=318.18 Aligned_cols=231 Identities=23% Similarity=0.339 Sum_probs=173.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
..+|.+.+.||+|+||+||.....+++.||||++..... ..+.+|+++++++ +|||||++++++.+....|+||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 456899999999999997766666799999999965432 2356899999999 799999999999999999999999
Q ss_pred ccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCC-----CCCcEEeeeccceecCCCCc
Q 048280 128 VINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDD-----KWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 128 ~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~-----~~~~kL~DFG~~~~~~~~~~ 184 (381)
|. |+|.+++ .|++.||.|||+.+ ||||||+||||+. ...+||+|||+++.+.....
T Consensus 100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 95 5776544 78999999999999 9999999999943 33678999999987653321
Q ss_pred --ccccccccCccccchhHHh---hCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCccccc
Q 048280 185 --HVNTRVAGTNGYMAPEYVM---HGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIV 258 (381)
Q Consensus 185 --~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (381)
.......||+.|+|||++. ...++.++|||||||++|||++ |..||....... .............
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~--------~~~~~~~~~~~~~ 250 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--------ANILLGACSLDCL 250 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH--------HHHHTTCCCCTTS
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH--------HHHHhccCCcccc
Confidence 2233567999999999987 4567889999999999999999 888874322110 1111111111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 259 DPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.........+.+|+.+||+.||.+|||+.+|++
T Consensus 251 ------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 251 ------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 112234556789999999999999999999984
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=299.70 Aligned_cols=233 Identities=24% Similarity=0.380 Sum_probs=163.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcc-c-HHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQ-G-KKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
.++|++.+.||+|+||.||+|+.. +++.||||++...... . .+.+..+..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467999999999999999999976 6899999999755322 2 233444556677889999999999999999999999
Q ss_pred ecccCCCHH----------------HHHHhhhhhhhHhhhh-c--cCCccccceEeCCCCCcEEeeeccceecCCCCccc
Q 048280 126 EYVINESLD----------------KVLFSLIKDIQILFRK-K--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV 186 (381)
Q Consensus 126 E~~~~g~L~----------------~~l~~~~~~l~~lh~~-~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~ 186 (381)
||+ ++.+. .++.|++.+|.|||.. + ||||||+|||++.++.+||+|||++..+.... .
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~ 180 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK--A 180 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc--c
Confidence 999 44443 3447899999999985 6 99999999999999999999999998654332 1
Q ss_pred ccccccCccccchhHHh-----hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCC
Q 048280 187 NTRVAGTNGYMAPEYVM-----HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPS 261 (381)
Q Consensus 187 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (381)
.....||+.|+|||++. ...++.++|||||||++|+|++|+.||...... ............ ..
T Consensus 181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~-~~----- 249 (318)
T 2dyl_A 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEEP-PL----- 249 (318)
T ss_dssp ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSCC-CC-----
T ss_pred ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccCC-CC-----
Confidence 23456899999999984 557899999999999999999999998642211 111112222111 10
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 262 LAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 262 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.. ........+.+|+.+||+.||.+|||+.+|++
T Consensus 250 ~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 250 LP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00 00112355888999999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=296.93 Aligned_cols=215 Identities=14% Similarity=0.053 Sum_probs=171.2
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcc---cHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQ---GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
..++|++.+.||+|+||.||+|++. +++.||||++...... ..+.+.+|+.++.+++||||+++++++...+..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 3468999999999999999999976 4899999999765332 24678999999999999999999999999999999
Q ss_pred EEecccCCCHHHHH-------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 124 IYEYVINESLDKVL-------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 124 v~E~~~~g~L~~~l-------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
||||+.+++|.+++ .|++.+|.|||+.+ ||||||+||||+.++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-------------- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------------- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--------------
T ss_pred EEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--------------
Confidence 99999999998765 78999999999999 99999999999999999998543
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC--CCC
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA--ASD 266 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 266 (381)
|++ .++.++|||||||++|||++|+.||.......... ........... ...
T Consensus 175 -------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------------~~~~~~~~~~~~~~~~ 228 (286)
T 3uqc_A 175 -------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------------PAERDTAGQPIEPADI 228 (286)
T ss_dssp -------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------------ECCBCTTSCBCCHHHH
T ss_pred -------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------------HHHHHhccCCCChhhc
Confidence 333 36899999999999999999999997543322100 00000000000 001
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 267 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
....+..+.+|+.+||+.||.+| |+.|+++.|+...
T Consensus 229 ~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 229 DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 11234568899999999999999 9999999998753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=325.50 Aligned_cols=240 Identities=24% Similarity=0.316 Sum_probs=181.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEee------CCe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAH------GAE 120 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------~~~ 120 (381)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++.. ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 478999999999999999999875 5899999998754 33445678999999999999999999998765 677
Q ss_pred EEEEEecccCCCHHHHH------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCC---cEEeeeccce
Q 048280 121 KLLIYEYVINESLDKVL------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWI---PKIADFGMAR 177 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~---~kL~DFG~~~ 177 (381)
.++||||+.+++|.+++ .+++.+|.|||+.+ ||||||+|||++.++. +||+|||++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 89999999999997765 67899999999998 9999999999987664 8999999998
Q ss_pred ecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH--------h
Q 048280 178 LFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKL--------Y 249 (381)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--------~ 249 (381)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..|.... .
T Consensus 173 ~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 173 ELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSNEHIV 245 (676)
T ss_dssp BTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC------CC
T ss_pred ccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccchhhh
Confidence 7654322 23457899999999999999999999999999999999999998643111 0000000 0
Q ss_pred hcCCccc-c-cCC--CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 048280 250 KKDKSLE-I-VDP--SLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRV 295 (381)
Q Consensus 250 ~~~~~~~-~-~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 295 (381)
....... . ... .............+.+|+.+||..||.+|||+.++
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 0000000 0 000 11122344567889999999999999999999663
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=327.23 Aligned_cols=223 Identities=22% Similarity=0.347 Sum_probs=179.1
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC--CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCe----
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD--DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAE---- 120 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---- 120 (381)
..++|++.+.||+|+||.||+|.+. +++.||||++.... ......+.+|++++++++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3578999999999999999999875 58999999986542 3345678899999999999999999999987665
Q ss_pred -EEEEEecccCCCHHH-------------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 121 -KLLIYEYVINESLDK-------------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 121 -~~lv~E~~~~g~L~~-------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
.||||||+++++|.+ ++.|++.+|.|+|+++ ||||||+||||+.+ .+||+|||+++.....
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~-- 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF-- 234 (681)
T ss_dssp EEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC--
T ss_pred eeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC--
Confidence 799999999988864 3489999999999999 99999999999885 8999999999976443
Q ss_pred ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 185 HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
....||+.|+|||++.+.. +.++|||||||+||+|++|..||....... + + ..
T Consensus 235 ---~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------------~-~--~~ 287 (681)
T 2pzi_A 235 ---GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------------L-P--ED 287 (681)
T ss_dssp ---SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------------C-C--TT
T ss_pred ---CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc--------------------c-c--cc
Confidence 3457999999999987764 899999999999999999988764211000 0 0 00
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHhc
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPT-MRRVVVMLS 300 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~~L~ 300 (381)
.........+.+||.+||+.||.+||+ ++++...|.
T Consensus 288 ~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 288 DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 111123356889999999999999995 555555543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=285.54 Aligned_cols=211 Identities=19% Similarity=0.194 Sum_probs=162.5
Q ss_pred hcCCCCC-CcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHH-HHhCCCCcccEEEEEee----CCeE
Q 048280 49 TKNFHPS-NKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLL-ARVQHRNVVNLLGYCAH----GAEK 121 (381)
Q Consensus 49 ~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~~~~~~~~----~~~~ 121 (381)
.++|.+. +.||+|+||.||+|... +++.||||++.. ...+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4678877 78999999999999875 689999999853 25678899998 44589999999999987 6788
Q ss_pred EEEEecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCC---CCCcEEeeeccceec
Q 048280 122 LLIYEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDD---KWIPKIADFGMARLF 179 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~---~~~~kL~DFG~~~~~ 179 (381)
++||||+.+++|.+++ .|++.+|.|||+.+ ||||||+|||++. ++.+||+|||++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 170 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence 9999999999997665 68899999999999 9999999999998 789999999998754
Q ss_pred CCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccC
Q 048280 180 PEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVD 259 (381)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
. +..++.++|||||||++|+|++|..||........ . .........
T Consensus 171 ~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~----------~-~~~~~~~~~ 216 (299)
T 3m2w_A 171 T-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----------S-PGMKTRIRM 216 (299)
T ss_dssp T-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSSCT
T ss_pred c-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh----------h-HHHHHHHhh
Confidence 2 13467899999999999999999999854322110 0 000000000
Q ss_pred CCCCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 260 PSLAAS--DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 260 ~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
...... ........+.+|+.+||+.||.+|||+.|+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 217 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000000 001234668899999999999999999999873
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=304.16 Aligned_cols=220 Identities=12% Similarity=0.105 Sum_probs=162.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc---ccHHHHHHHHHHHHHhCC-CCc---------ccEE---
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---QGKKEFENEAKLLARVQH-RNV---------VNLL--- 112 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-pnI---------v~~~--- 112 (381)
.+|...+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.+++.++| +|+ +..+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45778889999999999999965 699999999874322 235789999999999977 221 1111
Q ss_pred ---------EEEee-----CCeEEEEEecccCCCHHHHH----------------------HhhhhhhhHhhhhc--cCC
Q 048280 113 ---------GYCAH-----GAEKLLIYEYVINESLDKVL----------------------FSLIKDIQILFRKK--KTD 154 (381)
Q Consensus 113 ---------~~~~~-----~~~~~lv~E~~~~g~L~~~l----------------------~~~~~~l~~lh~~~--HrD 154 (381)
.++.. ....+++|+++ +++|.+++ .|++.+|.|||+++ |||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 11111 22357777765 67776555 68999999999999 999
Q ss_pred ccccceEeCCCCCcEEeeeccceecCCCCcccccccccCccccchhHH----------hhCCCCchhhhHhHHHHHHHHH
Q 048280 155 IKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYV----------MHGHLSVKADVFSFGVVILELI 224 (381)
Q Consensus 155 lkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwSlGvvl~ell 224 (381)
|||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|||+
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999999999875432 334567 999999999 4445888999999999999999
Q ss_pred hCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 048280 225 SGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVV 296 (381)
Q Consensus 225 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 296 (381)
+|+.||......... ...+.. . . ..+..+.+|+.+||+.||++||++.+++
T Consensus 312 tg~~Pf~~~~~~~~~---------------~~~~~~-~-~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 312 CADLPNTDDAALGGS---------------EWIFRS-C-K----NIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HSSCCCCTTGGGSCS---------------GGGGSS-C-C----CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HCCCCCCCcchhhhH---------------HHHHhh-c-c----cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999998643321110 001110 0 0 1235688999999999999999977764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=296.69 Aligned_cols=225 Identities=15% Similarity=0.156 Sum_probs=171.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCC--------cccHHHHHHHHHHHHHhC---------CCCcccE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSS--------NQGKKEFENEAKLLARVQ---------HRNVVNL 111 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------hpnIv~~ 111 (381)
.++|++.+.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999998 58999999997542 233478999999999996 8888888
Q ss_pred EEEEe------------------------------eCCeEEEEEecccCCCHH--------------HHHHhhhhhhhHh
Q 048280 112 LGYCA------------------------------HGAEKLLIYEYVINESLD--------------KVLFSLIKDIQIL 147 (381)
Q Consensus 112 ~~~~~------------------------------~~~~~~lv~E~~~~g~L~--------------~~l~~~~~~l~~l 147 (381)
++++. .....||||||+.+|++. .++.|++.||.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence 77643 267899999999888542 4558999999999
Q ss_pred h-hhc--cCCccccceEeCCCC--------------------CcEEeeeccceecCCCCcccccccccCccccchhHHhh
Q 048280 148 F-RKK--KTDIKASNILLDDKW--------------------IPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMH 204 (381)
Q Consensus 148 h-~~~--HrDlkp~NIll~~~~--------------------~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 204 (381)
| +.+ ||||||+||||+.++ .+||+|||+++..... ...||+.|+|||++.+
T Consensus 178 H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGGGCC
T ss_pred HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhhhcC
Confidence 9 777 999999999999887 8999999999876432 3479999999999987
Q ss_pred CCCCchhhhHhHHHH-HHHHHhCCCCCCCCCccccccHHHHHH-HHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcc
Q 048280 205 GHLSVKADVFSFGVV-ILELISGQRNSSFNLDVDAQNLLDWAY-KLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCT 282 (381)
Q Consensus 205 ~~~~~~sDvwSlGvv-l~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 282 (381)
.. +.++||||||++ .+++++|..||.. ........ ....... ................+.+||.+||
T Consensus 252 ~~-~~~~Diwsl~~~~~~~~~~g~~p~~~------~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~s~~~~dli~~~L 320 (336)
T 2vuw_A 252 DG-DYQFDIYRLMKKENNNRWGEYHPYSN------VLWLHYLTDKMLKQMT----FKTKCNTPAMKQIKRKIQEFHRTML 320 (336)
T ss_dssp CS-SHHHHHHHHHHHHHTTCTTSCCTHHH------HHHHHHHHHHHHHTCC----CSSCCCSHHHHHHHHHHHHHHHHGG
T ss_pred CC-ccceehhhhhCCCCcccccccCCCcc------hhhhhHHHHhhhhhhc----cCcccchhhhhhcCHHHHHHHHHHh
Confidence 66 899999998777 7778889888621 00001111 1111100 0111111223457788999999999
Q ss_pred cCCCCCCCCHHHHH
Q 048280 283 QGDPQLRPTMRRVV 296 (381)
Q Consensus 283 ~~dP~~RPs~~eil 296 (381)
+.| |+.|++
T Consensus 321 ~~d-----sa~e~l 329 (336)
T 2vuw_A 321 NFS-----SATDLL 329 (336)
T ss_dssp GSS-----SHHHHH
T ss_pred ccC-----CHHHHH
Confidence 977 999998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=270.90 Aligned_cols=169 Identities=18% Similarity=0.150 Sum_probs=118.2
Q ss_pred ccccCCeeEEEEE-ECCCcEEEEEEecCCC----------cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEEEE
Q 048280 58 LGEGGFGPVFKGK-LDDGREIAVKKLSHSS----------NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 58 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++.|++|.+..++ .-.|+.|+||++.... ....++|.+|+++|+++ .|+||++++++++++...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 3445555555443 2247889999986541 12235799999999999 7999999999999999999999
Q ss_pred ecccCCCHHHHH------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccc
Q 048280 126 EYVINESLDKVL------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVA 191 (381)
Q Consensus 126 E~~~~g~L~~~l------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~ 191 (381)
||++|++|.++| .|++.+|.|+|+++ ||||||+||||+.+|.+||+|||+++....... .....+
T Consensus 322 Eyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~-~~~t~v 400 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS-WPTNLV 400 (569)
T ss_dssp ECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C-CSHHHH
T ss_pred ecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc-cccCce
Confidence 999999998765 79999999999999 999999999999999999999999997654432 234568
Q ss_pred cCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCC
Q 048280 192 GTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQR 228 (381)
Q Consensus 192 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~ 228 (381)
||+.|+|||++.+ .+..++|+||+|+++++|.++..
T Consensus 401 GTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 401 QSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp HHHHHHHHHHC------------------CCCCTTHH
T ss_pred echhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 9999999998875 46778999999999888766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-28 Score=237.80 Aligned_cols=175 Identities=15% Similarity=0.201 Sum_probs=137.1
Q ss_pred CCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcc--------cHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 53 HPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQ--------GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 53 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
...+.||+|+||.||+|... ++.+++|+....... ..+.+.+|++++++++||||+++..++...+..|||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 44678999999999999544 788999986543211 134589999999999999999666666677788999
Q ss_pred EecccCCCHHHH-------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc------ccc
Q 048280 125 YEYVINESLDKV-------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV------NTR 189 (381)
Q Consensus 125 ~E~~~~g~L~~~-------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~------~~~ 189 (381)
|||+++++|.++ +.|++.+|.|||+++ ||||||+|||++. .+||+|||+++......... ...
T Consensus 418 mE~~~ggsL~~~l~~~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~ 495 (540)
T 3en9_A 418 MSYINGKLAKDVIEDNLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKA 495 (540)
T ss_dssp EECCCSEEHHHHSTTCTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHH
T ss_pred EECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhh
Confidence 999999999865 578999999999999 9999999999998 99999999999875432211 235
Q ss_pred cccCccccchhHHhh--CCCCchhhhHhHHHHHHHHHhCCCCC
Q 048280 190 VAGTNGYMAPEYVMH--GHLSVKADVFSFGVVILELISGQRNS 230 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p~ 230 (381)
..||+.|+|||++.. ..|+..+|+||..+-..+.+.++.+|
T Consensus 496 ~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 496 VLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred hcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 679999999999987 56888899999999988888877654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9.1e-25 Score=197.25 Aligned_cols=136 Identities=18% Similarity=0.159 Sum_probs=111.0
Q ss_pred cCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCc------------------ccHHHHHHHHHHHHHhCCCCcccE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSN------------------QGKKEFENEAKLLARVQHRNVVNL 111 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~hpnIv~~ 111 (381)
..|.+.+.||+|+||.||+|...+|+.||||++..... .....+.+|+.++++++ | +++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 33445599999999999999997799999999964321 12456889999999999 4 666
Q ss_pred EEEEeeCCeEEEEEecccCCCHH--------HHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCC
Q 048280 112 LGYCAHGAEKLLIYEYVINESLD--------KVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPE 181 (381)
Q Consensus 112 ~~~~~~~~~~~lv~E~~~~g~L~--------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~ 181 (381)
++++.. +..++||||+++++|. .++.|++.++.++|+.+ ||||||+|||++ ++.+||+|||+++.
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~l~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~--- 241 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE--- 241 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEE---
T ss_pred CeEEec-cceEEEEEecCCCcHHHcchhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeE---
Confidence 665544 4569999999998885 46689999999999998 999999999999 99999999999973
Q ss_pred CCcccccccccCccccchhHHhh
Q 048280 182 DQTHVNTRVAGTNGYMAPEYVMH 204 (381)
Q Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~ 204 (381)
+..|+|||++.+
T Consensus 242 -----------~~~~~a~e~l~r 253 (282)
T 1zar_A 242 -----------VGEEGWREILER 253 (282)
T ss_dssp -----------TTSTTHHHHHHH
T ss_pred -----------CCCCCHHHHHHH
Confidence 345789998754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-19 Score=161.55 Aligned_cols=123 Identities=21% Similarity=0.272 Sum_probs=96.9
Q ss_pred CCCCCCcccccCCeeEEEEEE-CCCcE--EEEEEecCCCcc------------------------cHHHHHHHHHHHHHh
Q 048280 51 NFHPSNKLGEGGFGPVFKGKL-DDGRE--IAVKKLSHSSNQ------------------------GKKEFENEAKLLARV 103 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 103 (381)
-|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.+|.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999987 67888 999997543211 013678999999999
Q ss_pred CCCCc--ccEEEEEeeCCeEEEEEecccC-C----CHH------------HHHHhhhhhhhHhh-hhc--cCCccccceE
Q 048280 104 QHRNV--VNLLGYCAHGAEKLLIYEYVIN-E----SLD------------KVLFSLIKDIQILF-RKK--KTDIKASNIL 161 (381)
Q Consensus 104 ~hpnI--v~~~~~~~~~~~~~lv~E~~~~-g----~L~------------~~l~~~~~~l~~lh-~~~--HrDlkp~NIl 161 (381)
.|++| ..++++ ...+|||||+.+ | +|. .++.|++.++.++| ..+ ||||||+|||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NIL 203 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIM 203 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEE
Confidence 98864 444443 346899999942 3 454 44578999999999 777 9999999999
Q ss_pred eCCCCCcEEeeeccceec
Q 048280 162 LDDKWIPKIADFGMARLF 179 (381)
Q Consensus 162 l~~~~~~kL~DFG~~~~~ 179 (381)
++. .++|+|||++...
T Consensus 204 l~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 204 YID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ESS--SEEECCCTTCEET
T ss_pred EcC--cEEEEECcccccC
Confidence 998 8999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=8.3e-17 Score=149.39 Aligned_cols=127 Identities=13% Similarity=0.123 Sum_probs=95.0
Q ss_pred CCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcc--------------cHH--------HHHHHHHHHHHhCCCCc
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQ--------------GKK--------EFENEAKLLARVQHRNV 108 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------~~~--------~~~~E~~~l~~l~hpnI 108 (381)
=|++.+.||.|+||.||+|...+|+.||||+++..... ... ...+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 48999999999999999999988999999987542110 011 12356777777755544
Q ss_pred ccEEEEEeeCCeEEEEEecccCCCHH---------HHHHhhhhhhhHhhhhc--cCCccccceEeCCCC----------C
Q 048280 109 VNLLGYCAHGAEKLLIYEYVINESLD---------KVLFSLIKDIQILFRKK--KTDIKASNILLDDKW----------I 167 (381)
Q Consensus 109 v~~~~~~~~~~~~~lv~E~~~~g~L~---------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~----------~ 167 (381)
.-..-+.... .+|||||+.|+.|. .++.|++.++.++|+.+ ||||||.|||+++++ .
T Consensus 176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~ 253 (397)
T 4gyi_A 176 PVPEPIAQSR--HTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLT 253 (397)
T ss_dssp SCCCEEEEET--TEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEE
T ss_pred CCCeeeeccC--ceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccc
Confidence 3222222222 37999999887764 46689999999999998 999999999998776 3
Q ss_pred cEEeeeccceec
Q 048280 168 PKIADFGMARLF 179 (381)
Q Consensus 168 ~kL~DFG~~~~~ 179 (381)
+.|+||+-+...
T Consensus 254 ~~iID~~Q~V~~ 265 (397)
T 4gyi_A 254 PIIIXFPQMVSM 265 (397)
T ss_dssp EEECCCTTCEET
T ss_pred eEEEEeCCcccC
Confidence 889999987754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=9.6e-13 Score=117.05 Aligned_cols=132 Identities=13% Similarity=0.127 Sum_probs=107.4
Q ss_pred HHhhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhC-CCCcccEEEEEeeCCeEEEE
Q 048280 46 VSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQ-HRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 46 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv 124 (381)
.....+|++...++.|+.+.||++... ++.+++|+...........+.+|+++++.+. +.++.++++++...+..|+|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 344568988899999999999999765 6899999986432223346889999999994 67788999999999999999
Q ss_pred EecccCCCHHH----------HHHhhhhhhhHhhh---------------------------------------------
Q 048280 125 YEYVINESLDK----------VLFSLIKDIQILFR--------------------------------------------- 149 (381)
Q Consensus 125 ~E~~~~g~L~~----------~l~~~~~~l~~lh~--------------------------------------------- 149 (381)
|||++|.+|.+ ++.++...+..||+
T Consensus 89 ~e~i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 89 MSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp EECCSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred EEecCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 99999998865 35678888888888
Q ss_pred --------------hc--cCCccccceEeCCCCCcEEeeecccee
Q 048280 150 --------------KK--KTDIKASNILLDDKWIPKIADFGMARL 178 (381)
Q Consensus 150 --------------~~--HrDlkp~NIll~~~~~~kL~DFG~~~~ 178 (381)
.. |+|++|.|||++++..+.|+||+.+..
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 11 999999999998766667999987753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.35 E-value=1.5e-12 Score=115.41 Aligned_cols=127 Identities=14% Similarity=0.133 Sum_probs=97.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCC--cccEEEEEeeCCeEEEEEe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRN--VVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~~lv~E 126 (381)
..+|.+....+.|..+.||++...+|..+++|+.... ....+.+|+.+++.+.+.+ +.+++++...++..++|||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 4456654444466679999998777888999997543 2245788999999996544 5568888888788999999
Q ss_pred cccCCCHH-------HHHHhhhhhhhHhhhh-------------------------------------------------
Q 048280 127 YVINESLD-------KVLFSLIKDIQILFRK------------------------------------------------- 150 (381)
Q Consensus 127 ~~~~g~L~-------~~l~~~~~~l~~lh~~------------------------------------------------- 150 (381)
|++|.+|. .++.++...+..+|+.
T Consensus 96 ~i~G~~l~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 96 EVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp CCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred ecCCcccCcCcCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 99998885 5666666667766641
Q ss_pred -----------ccCCccccceEeCCCCCcEEeeecccee
Q 048280 151 -----------KKTDIKASNILLDDKWIPKIADFGMARL 178 (381)
Q Consensus 151 -----------~HrDlkp~NIll~~~~~~kL~DFG~~~~ 178 (381)
.|+|++|.|||++++..+.|+|||.+..
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 2999999999998776677999998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.01 E-value=8.9e-10 Score=102.45 Aligned_cols=125 Identities=15% Similarity=0.255 Sum_probs=94.0
Q ss_pred CCCCcccccCCeeEEEEEECCCcEEEEEEec--CCC-cccHHHHHHHHHHHHHhC--CCCcccEEEEEeeC---CeEEEE
Q 048280 53 HPSNKLGEGGFGPVFKGKLDDGREIAVKKLS--HSS-NQGKKEFENEAKLLARVQ--HRNVVNLLGYCAHG---AEKLLI 124 (381)
Q Consensus 53 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~---~~~~lv 124 (381)
..++.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..|+|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 34678999999999999876 4678888875 322 122357889999999997 45688999998776 448999
Q ss_pred EecccCCCHH-------------HHHHhhhhhhhHhhhh-----------------------------------------
Q 048280 125 YEYVINESLD-------------KVLFSLIKDIQILFRK----------------------------------------- 150 (381)
Q Consensus 125 ~E~~~~g~L~-------------~~l~~~~~~l~~lh~~----------------------------------------- 150 (381)
|||++|..+. .++.+++..|..||..
T Consensus 120 me~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (359)
T 3dxp_A 120 MEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS 199 (359)
T ss_dssp EECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred EEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence 9999987762 3467788888888861
Q ss_pred -----------------c--cCCccccceEeCCCCC--cEEeeecccee
Q 048280 151 -----------------K--KTDIKASNILLDDKWI--PKIADFGMARL 178 (381)
Q Consensus 151 -----------------~--HrDlkp~NIll~~~~~--~kL~DFG~~~~ 178 (381)
. |+|+++.|||++.++. +.|+||+.+..
T Consensus 200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 2 9999999999987653 68999998875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.92 E-value=9.2e-10 Score=99.92 Aligned_cols=165 Identities=21% Similarity=0.220 Sum_probs=106.1
Q ss_pred CCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhC-CCC--cccEEEEEeeCC---eEEEEEecc
Q 048280 55 SNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQ-HRN--VVNLLGYCAHGA---EKLLIYEYV 128 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpn--Iv~~~~~~~~~~---~~~lv~E~~ 128 (381)
++.++.|....||++. ..+++|+.... .....+.+|+++|+.+. +.. +.+++....... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 5678999999999863 56889986432 33467899999999984 333 345555443333 348899999
Q ss_pred cCCCHHH-------------HHHhhhhhhhHhhh----------------------------------------------
Q 048280 129 INESLDK-------------VLFSLIKDIQILFR---------------------------------------------- 149 (381)
Q Consensus 129 ~~g~L~~-------------~l~~~~~~l~~lh~---------------------------------------------- 149 (381)
+|.+|.. +..++...+..+|+
T Consensus 99 ~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 178 (304)
T 3sg8_A 99 KGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYR 178 (304)
T ss_dssp CCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHH
T ss_pred CCeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHH
Confidence 9877753 23444444444443
Q ss_pred --------------hccCCccccceEeCC--CCCcEEeeeccceecCCCCcccccccccCccc---cchhHHhh-----C
Q 048280 150 --------------KKKTDIKASNILLDD--KWIPKIADFGMARLFPEDQTHVNTRVAGTNGY---MAPEYVMH-----G 205 (381)
Q Consensus 150 --------------~~HrDlkp~NIll~~--~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~-----~ 205 (381)
..|+|++|.||+++. ...+.|+||+.+..-... .... ....+ ..|+.... +
T Consensus 179 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~----~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 179 DILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFI----SLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHH----TTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHH----HHHhhccccCHHHHHHHHHHcC
Confidence 019999999999988 556889999998764221 1100 01111 23332211 1
Q ss_pred C---------CCchhhhHhHHHHHHHHHhCCCCC
Q 048280 206 H---------LSVKADVFSFGVVILELISGQRNS 230 (381)
Q Consensus 206 ~---------~~~~sDvwSlGvvl~elltg~~p~ 230 (381)
. .....+.|++|.++|.+.+|..+|
T Consensus 254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1 122368999999999999998654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.5e-06 Score=77.13 Aligned_cols=124 Identities=14% Similarity=0.150 Sum_probs=87.2
Q ss_pred CCCCCCcccccCCe-eEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhC-CCCcccEEEEEeeCCeEEEEEec
Q 048280 51 NFHPSNKLGEGGFG-PVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQ-HRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 51 ~y~~~~~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
+|+. +.+..|..+ .||+.... ++..+++|+-... ....+.+|..+|+.+. +--+-++++++.+.+..++|||+
T Consensus 26 g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~ 101 (272)
T 4gkh_A 26 GYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTA 101 (272)
T ss_dssp TCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred CCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEe
Confidence 4443 344455544 68988765 4677899986432 3457888999999884 33467889999999999999999
Q ss_pred ccCCCHHHHH-----------HhhhhhhhHhhhh----------------------------------------------
Q 048280 128 VINESLDKVL-----------FSLIKDIQILFRK---------------------------------------------- 150 (381)
Q Consensus 128 ~~~g~L~~~l-----------~~~~~~l~~lh~~---------------------------------------------- 150 (381)
++|.++.+.. .++...+..||..
T Consensus 102 l~G~~~~~~~~~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 102 IPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp CCSEEHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred eCCccccccccCCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 9998775432 2233333333321
Q ss_pred --------------ccCCccccceEeCCCCCcEEeeecccee
Q 048280 151 --------------KKTDIKASNILLDDKWIPKIADFGMARL 178 (381)
Q Consensus 151 --------------~HrDlkp~NIll~~~~~~kL~DFG~~~~ 178 (381)
.|+|+.+.|||++.++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 0999999999999877777999988764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=3.4e-06 Score=76.31 Aligned_cols=75 Identities=19% Similarity=0.185 Sum_probs=55.5
Q ss_pred CCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCC---CcccEEEEEe-eCCeEEEEEecccC
Q 048280 55 SNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHR---NVVNLLGYCA-HGAEKLLIYEYVIN 130 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~~~~~~~-~~~~~~lv~E~~~~ 130 (381)
++.++.|....||+. +..+++|+... ......+.+|.++|+.+.+. .+.+++.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888888899988 57788888532 23346789999999999753 3556676664 34567899999999
Q ss_pred CCHHH
Q 048280 131 ESLDK 135 (381)
Q Consensus 131 g~L~~ 135 (381)
..|..
T Consensus 98 ~~l~~ 102 (306)
T 3tdw_A 98 QILGE 102 (306)
T ss_dssp EECHH
T ss_pred eECch
Confidence 87754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=4.3e-06 Score=78.51 Aligned_cols=75 Identities=15% Similarity=0.152 Sum_probs=51.0
Q ss_pred CCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc-------ccHHHHHHHHHHHHHhCC--CC-cccEEEEEeeCCeEEE
Q 048280 55 SNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN-------QGKKEFENEAKLLARVQH--RN-VVNLLGYCAHGAEKLL 123 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--pn-Iv~~~~~~~~~~~~~l 123 (381)
.+.||.|..+.||++... +++.++||....... ...+.+..|.++++.+.. +. +.+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 568999999999999754 468899998643211 223567889999998842 33 4456654 3455689
Q ss_pred EEecccCC
Q 048280 124 IYEYVINE 131 (381)
Q Consensus 124 v~E~~~~g 131 (381)
|||++.+.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.16 E-value=7.4e-06 Score=73.33 Aligned_cols=78 Identities=21% Similarity=0.230 Sum_probs=58.6
Q ss_pred CCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhC-C--CCcccEEEEEeeCCeEEEEEecc
Q 048280 52 FHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQ-H--RNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 52 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--pnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
..-++.+|.|..+.||+.+..+|+.|++|+...........|..|+..|+.|. . -.+.+++++. ..++||||+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l 92 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence 44467899999999999999999999999876554444567889999999984 2 2345555542 247899998
Q ss_pred cCCCH
Q 048280 129 INESL 133 (381)
Q Consensus 129 ~~g~L 133 (381)
.++..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 76553
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=2.9e-06 Score=78.43 Aligned_cols=79 Identities=8% Similarity=0.038 Sum_probs=55.7
Q ss_pred CCcc-cccCCeeEEEEEEC-------CCcEEEEEEecCCC---cccHHHHHHHHHHHHHhC-C--CCcccEEEEEeeC--
Q 048280 55 SNKL-GEGGFGPVFKGKLD-------DGREIAVKKLSHSS---NQGKKEFENEAKLLARVQ-H--RNVVNLLGYCAHG-- 118 (381)
Q Consensus 55 ~~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--pnIv~~~~~~~~~-- 118 (381)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88888999998754 26678898864432 111246788999999884 3 3577888887665
Q ss_pred -CeEEEEEecccCCCH
Q 048280 119 -AEKLLIYEYVINESL 133 (381)
Q Consensus 119 -~~~~lv~E~~~~g~L 133 (381)
+..++||||++|..+
T Consensus 105 ~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TSSCEEEEECCCCBCC
T ss_pred cCCceEEEEecCCCCh
Confidence 356899999987553
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.02 E-value=2.9e-05 Score=70.96 Aligned_cols=74 Identities=18% Similarity=0.327 Sum_probs=44.5
Q ss_pred CCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCC--CCcccEEE------EEeeCCeEEEEEe
Q 048280 55 SNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQH--RNVVNLLG------YCAHGAEKLLIYE 126 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~------~~~~~~~~~lv~E 126 (381)
++.|+.|..+.||++...++ .+++|+.... ...+..|+.+++.|.. -.+.+++. +....+..++||+
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34566677899999987654 5899998642 2445566777766631 12333332 1234677899999
Q ss_pred cccCCCH
Q 048280 127 YVINESL 133 (381)
Q Consensus 127 ~~~~g~L 133 (381)
|++|..+
T Consensus 112 ~i~G~~~ 118 (346)
T 2q83_A 112 WIEGRPF 118 (346)
T ss_dssp CCCCBCC
T ss_pred eecCccC
Confidence 9987543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.01 E-value=3.6e-05 Score=69.58 Aligned_cols=75 Identities=21% Similarity=0.187 Sum_probs=60.8
Q ss_pred CCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhC---CCCcccEEEEEeeCCeEEEEEecccCC
Q 048280 55 SNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQ---HRNVVNLLGYCAHGAEKLLIYEYVINE 131 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~lv~E~~~~g 131 (381)
.+.|+.|....+|+.... +..+++|+.... ....+..|...|+.|. ...+.+++.++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 567899999999998764 678889987532 3567889999999984 367888999888888899999999887
Q ss_pred CH
Q 048280 132 SL 133 (381)
Q Consensus 132 ~L 133 (381)
.+
T Consensus 117 ~~ 118 (312)
T 3jr1_A 117 KN 118 (312)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.88 E-value=7.7e-05 Score=67.67 Aligned_cols=91 Identities=9% Similarity=0.040 Sum_probs=53.1
Q ss_pred CChHHHHHhhcCCCC-----CCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCC--cccEE
Q 048280 40 FPFEALVSATKNFHP-----SNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRN--VVNLL 112 (381)
Q Consensus 40 ~~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~ 112 (381)
++.+++......|.+ .+.|+.|....+|+....++ .+++|+..... ....+..|+.++..+.... +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 444455555555544 34567788899999987655 68899886521 2245667888888874222 23333
Q ss_pred EE------EeeCCeEEEEEecccCCCH
Q 048280 113 GY------CAHGAEKLLIYEYVINESL 133 (381)
Q Consensus 113 ~~------~~~~~~~~lv~E~~~~g~L 133 (381)
.. ....+..+++|+|++|..+
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~ 110 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWL 110 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCC
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCC
Confidence 11 1234567899999987543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00014 Score=68.66 Aligned_cols=74 Identities=15% Similarity=0.160 Sum_probs=47.1
Q ss_pred CCCcccccCCeeEEEEEECCCcEEEEEEecCC------C-c--ccHHHHHHHHHHHHH-hCCCCcccEEEEEeeCCeEEE
Q 048280 54 PSNKLGEGGFGPVFKGKLDDGREIAVKKLSHS------S-N--QGKKEFENEAKLLAR-VQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 54 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~------~-~--~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~l 123 (381)
.++.||.|..+.||++.. +++.++||..... . . .....+..|+..+.. .....+.+++.+. ....++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 356889999999999965 4678999953211 1 1 123344444433322 2335667777765 466799
Q ss_pred EEecc-cC
Q 048280 124 IYEYV-IN 130 (381)
Q Consensus 124 v~E~~-~~ 130 (381)
||||+ ++
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.72 E-value=0.0003 Score=63.84 Aligned_cols=75 Identities=13% Similarity=0.137 Sum_probs=50.6
Q ss_pred CcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCC--cccEEEE-----EeeCCeEEEEEecc
Q 048280 56 NKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRN--VVNLLGY-----CAHGAEKLLIYEYV 128 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~-----~~~~~~~~lv~E~~ 128 (381)
..|+ |....||+....+|+.+++|...... .....+..|..++..+.... +.+++.. ....+..++||+++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 88889999877777789999986332 23467778999988884222 3344332 22355678899999
Q ss_pred cCCC
Q 048280 129 INES 132 (381)
Q Consensus 129 ~~g~ 132 (381)
+|..
T Consensus 110 ~G~~ 113 (328)
T 1zyl_A 110 GGRQ 113 (328)
T ss_dssp CCEE
T ss_pred CCCC
Confidence 7744
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00015 Score=67.28 Aligned_cols=74 Identities=18% Similarity=0.199 Sum_probs=47.2
Q ss_pred CCcccccCCeeEEEEEEC--------CCcEEEEEEecCCCcccHHHHHHHHHHHHHhC-CCCcccEEEEEeeCCeEEEEE
Q 048280 55 SNKLGEGGFGPVFKGKLD--------DGREIAVKKLSHSSNQGKKEFENEAKLLARVQ-HRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++.|..|-...+|++... +++.+++|+.... ......+.+|.++++.+. +.-..++++++.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 457777888899999864 2478999986332 234566779999999985 4334567776653 2899
Q ss_pred ecccCCCH
Q 048280 126 EYVINESL 133 (381)
Q Consensus 126 E~~~~g~L 133 (381)
||++|.+|
T Consensus 130 e~i~G~~l 137 (379)
T 3feg_A 130 QYIPSRPL 137 (379)
T ss_dssp ECCSEEEC
T ss_pred EEecCccC
Confidence 99977554
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00039 Score=65.84 Aligned_cols=72 Identities=13% Similarity=0.244 Sum_probs=50.4
Q ss_pred CCcccccCCeeEEEEEECC--------CcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCc-ccEEEEEeeCCeEEEEE
Q 048280 55 SNKLGEGGFGPVFKGKLDD--------GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNV-VNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~ 125 (381)
++.|+.|....||++...+ ++.+++|+.... .....+.+|..+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 5678888889999998653 578999988432 112556689999999853333 567776543 3899
Q ss_pred ecccCCC
Q 048280 126 EYVINES 132 (381)
Q Consensus 126 E~~~~g~ 132 (381)
||++|.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9987633
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00017 Score=64.75 Aligned_cols=116 Identities=15% Similarity=0.102 Sum_probs=74.8
Q ss_pred CCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCc-ccEEEEEeeCCeEEEEEecc-cCC
Q 048280 54 PSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNV-VNLLGYCAHGAEKLLIYEYV-INE 131 (381)
Q Consensus 54 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~E~~-~~g 131 (381)
-++.|+.|....+|+. ..+++|+........ ....+|+.+++.+....+ .++++++ ...-++|+||+ ++.
T Consensus 22 ~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 22 GPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp SCEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred ceeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 3788999999999998 568888875432111 123568888888853333 4666543 33357899999 665
Q ss_pred CHHH--------HHHhhhhhhhHhhhh-----------------------------------------------------
Q 048280 132 SLDK--------VLFSLIKDIQILFRK----------------------------------------------------- 150 (381)
Q Consensus 132 ~L~~--------~l~~~~~~l~~lh~~----------------------------------------------------- 150 (381)
+|.. ++.+++..|+-+|..
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 5421 233333333333320
Q ss_pred --ccCCccccceEeCCCCCcEEeeecccee
Q 048280 151 --KKTDIKASNILLDDKWIPKIADFGMARL 178 (381)
Q Consensus 151 --~HrDlkp~NIll~~~~~~kL~DFG~~~~ 178 (381)
.|+|+.+.||+ ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 19999999999 5566789999998875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00079 Score=64.16 Aligned_cols=74 Identities=14% Similarity=0.091 Sum_probs=48.3
Q ss_pred CCcccccCCeeEEEEEECC-CcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCc-ccEEEEEeeCCeEEEEEecccCCC
Q 048280 55 SNKLGEGGFGPVFKGKLDD-GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNV-VNLLGYCAHGAEKLLIYEYVINES 132 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~E~~~~g~ 132 (381)
++.|+.|-...+|++...+ +..+++|+........ -...+|..++..|...++ .++++++. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4568888889999998765 4788899874432111 112589999999965444 56777763 2 25999987644
Q ss_pred H
Q 048280 133 L 133 (381)
Q Consensus 133 L 133 (381)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00043 Score=64.08 Aligned_cols=73 Identities=11% Similarity=0.126 Sum_probs=45.5
Q ss_pred CCcccccCCeeEEEEEECC---------CcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCC-cccEEEEEeeCCeEEEE
Q 048280 55 SNKLGEGGFGPVFKGKLDD---------GREIAVKKLSHSSNQGKKEFENEAKLLARVQHRN-VVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv 124 (381)
.+.|+.|....+|++...+ ++.+++|+....... ......|..+++.+...+ +.++++.+ . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 4577888888999998653 268888887543221 112467888998885334 44677654 2 3689
Q ss_pred EecccCCC
Q 048280 125 YEYVINES 132 (381)
Q Consensus 125 ~E~~~~g~ 132 (381)
|||++|..
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0018 Score=59.11 Aligned_cols=67 Identities=6% Similarity=0.071 Sum_probs=43.9
Q ss_pred ccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCC---CCcccEEEE------EeeCCeEEEEEecccC
Q 048280 60 EGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQH---RNVVNLLGY------CAHGAEKLLIYEYVIN 130 (381)
Q Consensus 60 ~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pnIv~~~~~------~~~~~~~~lv~E~~~~ 130 (381)
.|....||+....+| .+++|+...... ..|+.++..|.. +++.+++.. ....+..++||+|++|
T Consensus 33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 33 ADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp SCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred CccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 333679999987766 899998755431 456777776631 224444432 2335678999999988
Q ss_pred CCH
Q 048280 131 ESL 133 (381)
Q Consensus 131 g~L 133 (381)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 655
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0043 Score=56.34 Aligned_cols=75 Identities=9% Similarity=0.045 Sum_probs=40.7
Q ss_pred CCcccccCCee-EEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCC--CCcccEEEEEeeCCeEEEEEecccCC
Q 048280 55 SNKLGEGGFGP-VFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQH--RNVVNLLGYCAHGAEKLLIYEYVINE 131 (381)
Q Consensus 55 ~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~lv~E~~~~g 131 (381)
.+.|+.|.... +|+....++..+++|....... ..+..|+.+++.+.. -.+.+++.+....+ +++||++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 34565554444 6777654467787876543221 334567888877742 23556777644333 7899998765
Q ss_pred CHH
Q 048280 132 SLD 134 (381)
Q Consensus 132 ~L~ 134 (381)
.+.
T Consensus 98 ~l~ 100 (333)
T 3csv_A 98 LFT 100 (333)
T ss_dssp BHH
T ss_pred chH
Confidence 553
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0068 Score=56.98 Aligned_cols=74 Identities=12% Similarity=0.096 Sum_probs=49.0
Q ss_pred CCcccccCCeeEEEEEECC--------CcEEEEEEecCCCcccHHHHHHHHHHHHHhC-CCCcccEEEEEeeCCeEEEEE
Q 048280 55 SNKLGEGGFGPVFKGKLDD--------GREIAVKKLSHSSNQGKKEFENEAKLLARVQ-HRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++.|..|-...+|+....+ ++.+++++....... .-...+|.++++.+. +.-..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 4567778888999998753 578999986443222 123467999998885 333455665432 27899
Q ss_pred ecccCCCH
Q 048280 126 EYVINESL 133 (381)
Q Consensus 126 E~~~~g~L 133 (381)
||++|..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99977553
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.91 E-value=0.12 Score=48.20 Aligned_cols=27 Identities=30% Similarity=0.420 Sum_probs=23.3
Q ss_pred cCCccccceEe------CCCCCcEEeeecccee
Q 048280 152 KTDIKASNILL------DDKWIPKIADFGMARL 178 (381)
Q Consensus 152 HrDlkp~NIll------~~~~~~kL~DFG~~~~ 178 (381)
|+|+.+.|||+ +++..++++||..|..
T Consensus 248 HnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 248 HNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp CSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred EecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 99999999999 4567799999988864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.37 E-value=0.1 Score=43.84 Aligned_cols=61 Identities=15% Similarity=0.053 Sum_probs=36.3
Q ss_pred CccccceEeCCCCCcEEeeeccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCC
Q 048280 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRN 229 (381)
Q Consensus 154 Dlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p 229 (381)
=+.|..|+|..+|.|-+.+ +.+. .....+.|||... ...+.+.=|||||++||.-+--..|
T Consensus 75 i~~~~~i~l~~dG~V~f~~-~~s~-------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 75 VRSAAQIRVWRDGAVTLAP-AADD-------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp CCSGGGEEEETTSCEEECC-C-------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ecCCcceEEecCCceeccc-cccc-------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 3456889999999887663 1111 1123466887542 3456788899999999998875544
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=90.45 E-value=0.032 Score=53.14 Aligned_cols=62 Identities=10% Similarity=0.089 Sum_probs=19.3
Q ss_pred CCCCcccccCCeeEEEEEECC-CcEEEE------EEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEee
Q 048280 53 HPSNKLGEGGFGPVFKGKLDD-GREIAV------KKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAH 117 (381)
Q Consensus 53 ~~~~~lg~G~~g~V~~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 117 (381)
.+.+.|| ||.||+|.+.. ..+||| |..... .......+.+|..+++.++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 4566776 99999998764 467888 665432 22233568889999999999999999887643
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.22 E-value=4.9 Score=33.47 Aligned_cols=103 Identities=4% Similarity=0.057 Sum_probs=63.8
Q ss_pred CCCCcccEEEEEeeCCeEEEEEeccc---------CCCHH---HHHHhhhhhhhHhhhhccCCccccceEeCCCCCcEEe
Q 048280 104 QHRNVVNLLGYCAHGAEKLLIYEYVI---------NESLD---KVLFSLIKDIQILFRKKKTDIKASNILLDDKWIPKIA 171 (381)
Q Consensus 104 ~hpnIv~~~~~~~~~~~~~lv~E~~~---------~g~L~---~~l~~~~~~l~~lh~~~HrDlkp~NIll~~~~~~kL~ 171 (381)
.||+++.. .+-.+.+.+.+.++.-. ..++. .++..++....+++..-|--|.|+||+++.++.+++.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~~~~~eKlr~l~ni~~l~~~~~~r~tf~L~P~NL~f~~~~~p~i~ 121 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKSFTKNEKLRYLLNIKNLEEVNRTRYTFVLAPDELFFTRDGLPIAK 121 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGGSCHHHHHHHHHHGGGGGGGGGSSEECCCSGGGEEECTTSCEEES
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHhcCHHHHHHHHHHHHHHHHHhcCceEEEEecceEEEcCCCCEEEE
Confidence 58888877 56666666666665432 12222 2334555544444444588999999999999999999
Q ss_pred eeccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCC
Q 048280 172 DFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNS 230 (381)
Q Consensus 172 DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~ 230 (381)
-.|+-..+... =+.+|.+ .-.+=|++..+++++..|
T Consensus 122 ~RGik~~l~P~-------------~~~ee~f----------L~qyKAliiall~~K~~F 157 (215)
T 4ann_A 122 TRGLQNVVDPL-------------PVSEAEF----------LTRYKALVICAFNEKQSF 157 (215)
T ss_dssp CCEETTTBSCC-------------CCCHHHH----------HHHHHHHHHHHHCTTCCH
T ss_pred EccCccCCCCC-------------CCCHHHH----------HHHHHHHHHHHHcCCCCH
Confidence 87764432111 0122222 235667888889988765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 381 | ||||
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-59 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-58 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-50 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-48 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-47 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-47 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-47 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-47 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-46 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-46 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-45 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-45 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-41 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-40 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-40 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-37 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-37 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-34 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-33 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-33 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-30 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-30 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-29 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-17 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-60
Identities = 58/270 (21%), Positives = 110/270 (40%), Gaps = 34/270 (12%)
Query: 50 KNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVV 109
++G G FG V G + ++A+K + + +++F EA+++ ++ H +V
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 110 NLLGYCAHGAEKLLIYEYVINESLD----------------KVLFSLIKDIQILFRKK-- 151
L G C A L++E++ + L + + + + L
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123
Query: 152 KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKA 211
D+ A N L+ + + K++DFGM R +DQ +T + +PE S K+
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 212 DVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271
DV+SFGV++ E+ S + N + + P LA++
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSEV--------VEDISTGFRLYKPRLASTH----- 230
Query: 272 AMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
QI C + P+ RP R++ L++
Sbjct: 231 --VYQIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 9e-59
Identities = 60/268 (22%), Positives = 105/268 (39%), Gaps = 34/268 (12%)
Query: 50 KNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVV 109
K+ +LG G FG V GK ++A+K + S + EF EAK++ + H +V
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 110 NLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKK------------------ 151
L G C +I EY+ N L L + Q +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122
Query: 152 KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKA 211
D+ A N L++D+ + K++DFG++R +D+ + + PE +M+ S K+
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 212 DVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271
D+++FGV++ E+ S + + L + P LA+
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSET--------AEHIAQGLRLYRPHLASEK----- 229
Query: 272 AMCIQIGLLCTQGDPQLRPTMRRVVVML 299
I C RPT + ++ +
Sbjct: 230 --VYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 6e-58
Identities = 64/269 (23%), Positives = 115/269 (42%), Gaps = 36/269 (13%)
Query: 50 KNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVV 109
+ +LG G FG V+ G + ++AVK L S F EA L+ ++QH+ +V
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 110 NLLGYCAHGAEKLLIYEYVINESLDKVLFS-----------------LIKDIQILFRKKK 152
L +I EY+ N SL L + + + + + +
Sbjct: 72 RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 153 T--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVK 210
D++A+NIL+ D KIADFG+ARL +++ + APE + +G ++K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 211 ADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQ 270
+DV+SFG+++ E+++ R + + ++ +V P +
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEV--------IQNLERGYRMVRPDNCPEE---- 238
Query: 271 IAMCIQIGLLCTQGDPQLRPTMRRVVVML 299
Q+ LC + P+ RPT + +L
Sbjct: 239 ---LYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 3e-57
Identities = 57/273 (20%), Positives = 114/273 (41%), Gaps = 34/273 (12%)
Query: 51 NFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVN 110
++G G FG V+KGK + + ++ + Q + F+NE +L + +H N++
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 111 LLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT----------------- 153
+GY + ++ ++ SL L + +++
Sbjct: 69 FMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH 127
Query: 154 -DIKASNILLDDKWIPKIADFGMARLFPEDQ-THVNTRVAGTNGYMAPEYVMH---GHLS 208
D+K++NI L + KI DFG+A + +H +++G+ +MAPE + S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 209 VKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268
++DV++FG+V+ EL++GQ N D + + + P L+ S
Sbjct: 188 FQSDVYAFGIVLYELMTGQLP------YSNINNRDQIIFMVGR----GYLSPDLSKVRSN 237
Query: 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
AM ++ C + RP +++ +
Sbjct: 238 CPKAM-KRLMAECLKKKRDERPLFPQILASIEL 269
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-56
Identities = 61/285 (21%), Positives = 120/285 (42%), Gaps = 38/285 (13%)
Query: 50 KNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVV 109
++ KLG+G FG V+ G + +A+K L + F EA+++ +++H +V
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 110 NLLGYCAHGAEKLLIYEYVINESLD-----------------KVLFSLIKDIQILFRKK- 151
L + ++ EY+ SL + + + + R
Sbjct: 76 QLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134
Query: 152 -KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVK 210
D++A+NIL+ + + K+ADFG+ARL +++ + APE ++G ++K
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 194
Query: 211 ADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQ 270
+DV+SFG+++ EL + R + + +LD + Y+ E +
Sbjct: 195 SDVWSFGILLTELTTKGRV--PYPGMVNREVLDQVERGYRMPCPPECPES---------- 242
Query: 271 IAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKPGPGNLEEPTRPG 315
+ C + +P+ RPT + L + + E +PG
Sbjct: 243 ---LHDLMCQCWRKEPEERPTFEYLQAFL--EDYFTSTEPQYQPG 282
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 3e-54
Identities = 63/276 (22%), Positives = 111/276 (40%), Gaps = 42/276 (15%)
Query: 53 HPSNKLGEGGFGPVFKGKLDD----GREIAVKKLSHSSNQGK-KEFENEAKLLARVQHRN 107
H + +G G FG V+ G L D AVK L+ ++ G+ +F E ++ H N
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 108 VVNLLGYCAHG-AEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT------------- 153
V++LLG C L++ Y+ + L + + + +
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149
Query: 154 -----DIKASNILLDDKWIPKIADFGMARLFPEDQ---THVNTRVAGTNGYMAPEYVMHG 205
D+ A N +LD+K+ K+ADFG+AR + + H T +MA E +
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 209
Query: 206 HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265
+ K+DV+SFGV++ EL++ N D L + + ++ P
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGRR---LLQPEYCPD 261
Query: 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
++ L C ++RP+ +V +S
Sbjct: 262 P-------LYEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 178 bits (451), Expect = 7e-54
Identities = 66/298 (22%), Positives = 121/298 (40%), Gaps = 51/298 (17%)
Query: 40 FPFEALVSATKNFHPS---------NKLGEGGFGPVFKGKL----DDGREIAVKKL-SHS 85
F FE A + F +G G FG V G L +A+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 86 SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQ 145
+ + +++F +EA ++ + H NV++L G ++I E++ N SLD L
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 146 ILFRKKKT------------------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187
++ D+ A NIL++ + K++DFG++R +D +
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 186
Query: 188 TRVA----GTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLD 243
A + APE + + + +DV+S+G+V+ E++S + D+ Q++++
Sbjct: 187 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW--DMTNQDVIN 244
Query: 244 WAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
+ Y+ ++ Q+ L C Q D RP ++V L K
Sbjct: 245 AIEQDYRLPPPMDCPSA-------------LHQLMLDCWQKDRNHRPKFGQIVNTLDK 289
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 3e-53
Identities = 63/284 (22%), Positives = 116/284 (40%), Gaps = 46/284 (16%)
Query: 49 TKNFHPS-----NKLGEGGFGPVFKGKLDDG-----REIAVKKLSHSSNQG-KKEFENEA 97
T HPS +G G FG V+KG L +A+K L + + +F EA
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 98 KLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT---- 153
++ + H N++ L G + ++I EY+ N +LDK L + +L
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 154 --------------DIKASNILLDDKWIPKIADFGMARLFPEDQ--THVNTRVAGTNGYM 197
D+ A NIL++ + K++DFG++R+ +D T+ + +
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 198 APEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEI 257
APE + + + +DV+SFG+V+ E+++ + L ++
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---------------MKA 225
Query: 258 VDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
++ D + Q+ + C Q + RP +V +L K
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 176 bits (446), Expect = 3e-53
Identities = 63/272 (23%), Positives = 113/272 (41%), Gaps = 36/272 (13%)
Query: 50 KNFHPSNKLGEGGFGPVFKGKL-DDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNV 108
+ +KLG G +G V++G +AVK L + + +EF EA ++ ++H N+
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 109 VNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKD-----------IQILFRKKK----- 152
V LLG C +I E++ +L L + QI +
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 135
Query: 153 ---TDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSV 209
D+ A N L+ + + K+ADFG++RL D + + APE + + S+
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 210 KADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGD 269
K+DV++FGV++ E+ + + +D L Y+L +KD +E +
Sbjct: 196 KSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLEKDYRMERPE---------G 240
Query: 270 QIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
++ C Q +P RP+ +
Sbjct: 241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 8e-52
Identities = 59/272 (21%), Positives = 107/272 (39%), Gaps = 42/272 (15%)
Query: 50 KNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVV 109
K +G+G FG V G G ++AVK + + + + F EA ++ +++H N+V
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 110 NLLGYCAHGAEKL-LIYEYVINESLDKVLFS-----------------LIKDIQILFRKK 151
LLG L ++ EY+ SL L S + + ++ L
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 123
Query: 152 KT--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSV 209
D+ A N+L+ + + K++DFG+ + Q + APE + S
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALREKKFST 179
Query: 210 KADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGD 269
K+DV+SFG+++ E+ S R + L +K ++ D A
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRVEKGYKMDAPDGCPPA----- 228
Query: 270 QIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
++ C D +RP+ ++ L
Sbjct: 229 ----VYEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 9e-52
Identities = 57/287 (19%), Positives = 104/287 (36%), Gaps = 44/287 (15%)
Query: 57 KLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYC- 115
+G+G FG V++GK G E+AVK S + E E ++H N++ +
Sbjct: 10 SIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 116 ---AHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKK-------------------- 152
+ L+ +Y + SL L ++ + +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 127
Query: 153 ----TDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN---TRVAGTNGYMAPEY---- 201
D+K+ NIL+ IAD G+A ++ GT YMAPE
Sbjct: 128 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187
Query: 202 --VMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQ----NLLDWAYKLYKKDKSL 255
+ H +AD+++ G+V E+ + D D + + +K
Sbjct: 188 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 247
Query: 256 EIVDPSLAAS-DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
+ + P++ S + + + +I C + R T R+ LS+
Sbjct: 248 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (426), Expect = 4e-50
Identities = 61/300 (20%), Positives = 110/300 (36%), Gaps = 64/300 (21%)
Query: 51 NFHPSNKLGEGGFGPVFKGKL------DDGREIAVKKLS-HSSNQGKKEFENEAKLLARV 103
N +GEG FG VF+ + + +AVK L +S + +F+ EA L+A
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 104 QHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT---------- 153
+ N+V LLG CA G L++EY+ L++ L S+
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 154 -------------------------------DIKASNILLDDKWIPKIADFGMAR-LFPE 181
D+ N L+ + + KIADFG++R ++
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 182 DQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNL 241
D + A +M PE + + + ++DV+++GVV+ E+ S + +
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH----- 248
Query: 242 LDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
+ + L + + + LC P RP+ + +L +
Sbjct: 249 -EEVIYYVRDGNILACPE---------NCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 8e-50
Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 23/198 (11%)
Query: 51 NFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQG-KKEFENEAKLLARVQHRNV 108
+F ++LG G G VFK G +A K + + + E ++L +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 109 VNLLGYCAHGAEKLLIYEYVINESLD---------------KVLFSLIKDIQILFRKKKT 153
V G E + E++ SLD KV ++IK + L K K
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 154 ---DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVK 210
D+K SNIL++ + K+ DFG++ + GT YM+PE + H SV+
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHYSVQ 183
Query: 211 ADVFSFGVVILELISGQR 228
+D++S G+ ++E+ G+
Sbjct: 184 SDIWSMGLSLVEMAVGRY 201
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 8e-49
Identities = 61/268 (22%), Positives = 107/268 (39%), Gaps = 40/268 (14%)
Query: 56 NKLGEGGFGPVFKGKLDD---GREIAVKKLSHSSNQG--KKEFENEAKLLARVQHRNVVN 110
+LG G FG V KG + +AVK L + +N K E EA ++ ++ + +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 111 LLGYCAHGAEKLLIYEYVINESLDKVLFSL--IKDIQILF---------------RKKKT 153
++G C +L+ E L+K L +KD I+
Sbjct: 73 MIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131
Query: 154 DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR--VAGTNGYMAPEYVMHGHLSVKA 211
D+ A N+LL + KI+DFG+++ D+ + + + APE + + S K+
Sbjct: 132 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 191
Query: 212 DVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271
DV+SFGV++ E S + + + +K + + P+ +
Sbjct: 192 DVWSFGVLMWEAFSYGQKPYRGMKG------SEVTAMLEKGERMGC--PAGCPRE----- 238
Query: 272 AMCIQIGLLCTQGDPQLRPTMRRVVVML 299
+ LC D + RP V + L
Sbjct: 239 --MYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-48
Identities = 61/277 (22%), Positives = 101/277 (36%), Gaps = 42/277 (15%)
Query: 50 KNFHPSNKLGEGGFGPVFKGKLD----DGREIAVKKLSH---SSNQGKKEFENEAKLLAR 102
K+ KLG+G FG V +G+ D +AVK L S + +F E +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 103 VQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKK----------- 151
+ HRN++ L G K ++ E SL L + +
Sbjct: 68 LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 152 -------KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH--VNTRVAGTNGYMAPEYV 202
D+ A N+LL + + KI DFG+ R P++ H + + APE +
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 203 MHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262
S +D + FGV + E+ + + L N +K+ K+ + L +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-----NGSQILHKIDKEGERLPRPE--- 238
Query: 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299
D + + C P+ RPT + L
Sbjct: 239 ------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 2e-47
Identities = 55/280 (19%), Positives = 106/280 (37%), Gaps = 41/280 (14%)
Query: 45 LVSATKNFHPSN-KLGEGGFGPVFKGKL---DDGREIAVKKLSHSSNQG-KKEFENEAKL 99
L N ++ +LG G FG V +G ++A+K L + + +E EA++
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 100 LARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT------ 153
+ ++ + +V L+G C +L+ E L K L ++I + +
Sbjct: 63 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121
Query: 154 ------------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR--VAGTNGYMAP 199
D+ A N+LL ++ KI+DFG+++ D ++ R + AP
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181
Query: 200 EYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVD 259
E + S ++DV+S+GV + E +S + + ++ K +E
Sbjct: 182 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKRMEC-- 233
Query: 260 PSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299
P + + C + RP V +
Sbjct: 234 PPECPPE-------LYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 4e-47
Identities = 53/268 (19%), Positives = 104/268 (38%), Gaps = 45/268 (16%)
Query: 56 NKLGEGGFGPVFKGKL-DDGREIAVKKLS--HSSNQGKKEFENEAKLLARVQHRNVVNLL 112
++G G F V+KG + E+A +L + ++ F+ EA++L +QH N+V
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 113 GYCAHGAEK----LLIYEYVINESLDKVLFS---------------LIKDIQILFRKKKT 153
+ +L+ E + + +L L ++K +Q L +
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 134
Query: 154 ----DIKASNILLDDK-WIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLS 208
D+K NI + KI D G+A L V GT +MAPE +
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPE-MYEEKYD 190
Query: 209 VKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268
DV++FG+ +LE+ + + ++ +A + K ++ P +
Sbjct: 191 ESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRVTSGVKPASFDKVAIPEVK----- 243
Query: 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVV 296
+I C + + R +++ ++
Sbjct: 244 -------EIIEGCIRQNKDERYSIKDLL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (406), Expect = 4e-47
Identities = 62/272 (22%), Positives = 109/272 (40%), Gaps = 44/272 (16%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGK---KEFENEAKLLARVQ 104
K F ++G G FG V+ + + + +A+KK+S+S Q ++ E + L +++
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 105 HRNVVNLLGYCAHGAEKLLIYEYVINESLD---------------KVLFSLIKDIQILFR 149
H N + G L+ EY + + D V ++ + L
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 150 KK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM---H 204
D+KA NILL + + K+ DFG A + + V GT +MAPE ++
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDE 188
Query: 205 GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264
G K DV+S G+ +EL + + N + Y + + + P+L +
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPP------LFNMNAMSALYHIAQNE------SPALQS 236
Query: 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVV 296
+ + C Q PQ RPT ++
Sbjct: 237 GHWSEYFRNFVD---SCLQKIPQDRPTSEVLL 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 5e-47
Identities = 63/274 (22%), Positives = 109/274 (39%), Gaps = 39/274 (14%)
Query: 52 FHPSNKLGEGGFGPVFKGK-LDDGRE----IAVKKLSHS-SNQGKKEFENEAKLLARVQH 105
F LG G FG V+KG + +G + +A+K+L + S + KE +EA ++A V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 106 RNVVNLLGYCAHGAEKLLIYEYVINESLD-----------KVLFSLIKDI----QILFRK 150
+V LLG C +L+ LD + L + I L +
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 151 K--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT-RVAGTNGYMAPEYVMHGHL 207
+ D+ A N+L+ KI DFG+A+L ++ + +MA E ++H
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 208 SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267
+ ++DV+S+GV + EL++ Y + I++
Sbjct: 191 THQSDVWSYGVTVWELMTFGS---------------KPYDGIPASEISSILEKGERLPQP 235
Query: 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
I + C D RP R +++ SK
Sbjct: 236 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 6e-47
Identities = 68/291 (23%), Positives = 127/291 (43%), Gaps = 45/291 (15%)
Query: 25 NEEDLEKIAAREQKHFPFEALVSA---TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVK 80
+EE LEK+ ++VS K + K+G+G G V+ + G+E+A++
Sbjct: 2 DEEILEKL----------RSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIR 51
Query: 81 KLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFS- 139
+++ K+ NE ++ ++ N+VN L G E ++ EY+ SL V+
Sbjct: 52 QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 111
Query: 140 -------------LIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184
++ ++ L + DIK+ NILL K+ DFG +Q+
Sbjct: 112 CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171
Query: 185 HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDW 244
+T V GT +MAPE V K D++S G++ +E+I G+ +N L
Sbjct: 172 KRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP------YLNENPLRA 224
Query: 245 AYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRV 295
Y + + + E+ +P ++ D + C+ + D + R + + +
Sbjct: 225 LYLI-ATNGTPELQNPEKLSAIFRDFLNRCLDM-------DVEKRGSAKEL 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 6e-47
Identities = 62/290 (21%), Positives = 119/290 (41%), Gaps = 55/290 (18%)
Query: 50 KNFHPSNKLGEGGFGPVFKGKLDDG---REIAVKKLS-HSSNQGKKEFENEAKLLARV-Q 104
+ + +GEG FG V K ++ + A+K++ ++S ++F E ++L ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 105 HRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFS------------------------- 139
H N++NLLG C H L EY + +L L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 140 ------LIKDIQILFRKKKT--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVA 191
+ + + L +K+ D+ A NIL+ + ++ KIADFG++R T
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGR 187
Query: 192 GTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKK 251
+MA E + + + +DV+S+GV++ E++S + +LY+K
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---------ELYEK 238
Query: 252 DKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
++ L D + C + P RP+ +++V L++
Sbjct: 239 LPQGYRLEKPLNCDDE------VYDLMRQCWREKPYERPSFAQILVSLNR 282
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 2e-46
Identities = 55/271 (20%), Positives = 103/271 (38%), Gaps = 43/271 (15%)
Query: 50 KNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLS-HSSNQGKKEFENEAKLLARVQHRN 107
+++ LGEG +G V +AVK + + + + E + + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 108 VVNLLGYCAHGAEKLLIYEYVINESLDKVLFS-----------LIKDI----------QI 146
VV G+ G + L EY L + + I
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 147 LFRKKKTDIKASNILLDDKWIPKIADFGMARLF-PEDQTHVNTRVAGTNGYMAPEYVMHG 205
R DIK N+LLD++ KI+DFG+A +F ++ + ++ GT Y+APE +
Sbjct: 125 THR----DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 206 HL-SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264
+ DV+S G+V+ +++G+ D + Y +K+ K+ + +
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELP------WDQPSDSCQEYSDWKEKKTYLNPWKKIDS 234
Query: 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRV 295
+ + + +P R T+ +
Sbjct: 235 A--------PLALLHKILVENPSARITIPDI 257
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-46
Identities = 64/292 (21%), Positives = 116/292 (39%), Gaps = 50/292 (17%)
Query: 50 KNFHPSNKLGEGGFGPVFKGKL------DDGREIAVKKLSHS-SNQGKKEFENEAKLLAR 102
+ S +LG+G FG V++G + +A+K ++ + S + + EF NEA ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 103 VQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKK---------- 152
+VV LLG + G L+I E + L L SL +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 153 -----------------TDIKASNILLDDKWIPKIADFGMARLFPE-DQTHVNTRVAGTN 194
D+ A N ++ + + KI DFGM R E D +
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199
Query: 195 GYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKS 254
+M+PE + G + +DV+SFGVV+ E+ + L + + +
Sbjct: 200 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVLRFVMEGGL 253
Query: 255 LEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKPGPG 306
L+ D + M ++ +C Q +P++RP+ ++ + ++ PG
Sbjct: 254 LDKPD---------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 2e-46
Identities = 57/282 (20%), Positives = 105/282 (37%), Gaps = 50/282 (17%)
Query: 47 SATKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSN--QGKKEFENEAKLLARV 103
S +++ +G G +G K + DG+ + K+L + S K+ +E LL +
Sbjct: 1 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 104 QHRNVVNLLGYCAHGAEKLL--IYEYVINESLDKVLFSLIKDIQILFRKKKT-------- 153
+H N+V L + EY L V+ K+ Q L +
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 154 ------------------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNG 195
D+K +N+ LD K K+ DFG+AR+ D + GT
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPY 179
Query: 196 YMAPEYVMHGHLSVKADVFSFGVVILELISGQR-NSSFNLDVDAQNLLDWAYKLYKKDKS 254
YM+PE + + K+D++S G ++ EL + ++F+ A + + ++ S
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 239
Query: 255 LEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVV 296
E+ + I RP++ ++
Sbjct: 240 DELNE-----------------IITRMLNLKDYHRPSVEEIL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-45
Identities = 60/272 (22%), Positives = 107/272 (39%), Gaps = 49/272 (18%)
Query: 50 KNFHPSNKLGEGGFGPVFKGKL-DDGREIAVKKLSHS---SNQGKKEFENEAKLLARVQH 105
++F LG+G FG V+ + +A+K L + + + E ++ + ++H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 106 RNVVNLLGYCAHGAEKLLIYEYVINESLDKVLF-----------SLIKDI---------- 144
N++ L GY LI EY ++ + L + I ++
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 145 QILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMH 204
+++ R DIK N+LL KIADFG + P + + GT Y+ PE +
Sbjct: 126 RVIHR----DIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEG 178
Query: 205 GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264
K D++S GV+ E + G+ N + YK+ +E P
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----------TYKRISRVEFTFPDFVT 228
Query: 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVV 296
+ D I+ ++ +P RP +R V+
Sbjct: 229 EGARDLISRLLKH-------NPSQRPMLREVL 253
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-45
Identities = 73/295 (24%), Positives = 110/295 (37%), Gaps = 58/295 (19%)
Query: 51 NFHPSNKLGEGGFGPVFKGKL------DDGREIAVKKLSHSSNQG-KKEFENEAKLLARV 103
LG G FG V + D +AVK L S++ ++ +E K+L+ +
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 104 -QHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT--------- 153
H N+VNLLG C G L+I EY L L
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 154 --------------------------DIKASNILLDDKWIPKIADFGMARLFPEDQTH-V 186
D+ A NILL I KI DFG+AR D + V
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 187 NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAY 246
+MAPE + + + ++DV+S+G+ + EL S + + VD Y
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-----SKFY 258
Query: 247 KLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
K+ K+ + P A ++ I C DP RPT +++V ++ K
Sbjct: 259 KMIKEGFRMLS--PEHAPAE-------MYDIMKTCWDADPLKRPTFKQIVQLIEK 304
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 5e-45
Identities = 58/277 (20%), Positives = 108/277 (38%), Gaps = 45/277 (16%)
Query: 49 TKNFHPS------NKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLA 101
T++ +P +LG+G FG V+K + + A K + S + +++ E +LA
Sbjct: 5 TRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILA 64
Query: 102 RVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT-------- 153
H N+V LL + ++ E+ ++D V+ L + + +
Sbjct: 65 SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 124
Query: 154 ----------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM 203
D+KA NIL K+ADFG++ ++ + GT +MAPE VM
Sbjct: 125 YLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVM 183
Query: 204 -----HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIV 258
KADV+S G+ ++E+ + + K + +
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-------VLLKIAKSEPPTLA 236
Query: 259 DPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRV 295
PS +S+ D + C++ + R T ++
Sbjct: 237 QPSRWSSNFKDFLKKCLEK-------NVDARWTTSQL 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 5e-45
Identities = 78/332 (23%), Positives = 122/332 (36%), Gaps = 70/332 (21%)
Query: 17 LGSSREGDNEEDLEKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKG------K 70
GSS D + + FP E N LG G FG V K
Sbjct: 11 TGSSDNEYFYVDFREYEYDLKWEFPRE-------NLEFGKVLGSGAFGKVMNATAYGISK 63
Query: 71 LDDGREIAVKKLSHSSNQG-KKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLLIYEYV 128
++AVK L ++ ++ +E K++ ++ H N+VNLLG C LI+EY
Sbjct: 64 TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYC 123
Query: 129 INESLDKVLFS---LIKDIQILFRKKKT-------------------------------- 153
L L S + +I + +K
Sbjct: 124 CYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK 183
Query: 154 -----DIKASNILLDDKWIPKIADFGMARLFPEDQTH-VNTRVAGTNGYMAPEYVMHGHL 207
D+ A N+L+ + KI DFG+AR D + V +MAPE + G
Sbjct: 184 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 243
Query: 208 SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267
++K+DV+S+G+++ E+ S N + VDA YKL + ++ P A +
Sbjct: 244 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN-----FYKLIQNGFKMDQ--PFYATEE- 295
Query: 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVML 299
I C D + RP+ + L
Sbjct: 296 ------IYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 5e-45
Identities = 52/274 (18%), Positives = 96/274 (35%), Gaps = 39/274 (14%)
Query: 51 NFHPSNKLGEGGFGPVFKGKL----DDGREIAVKKLSHSSNQGKKE-FENEAKLLARVQH 105
+GEG FG V +G + +A+K + ++ +E F EA + + H
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 106 RNVVNLLGYCAHGAEKLLIYEYVINESLD----------------KVLFSLIKDIQILFR 149
++V L+G +I E L + L + L
Sbjct: 68 PHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 150 KKKT--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHL 207
K+ DI A N+L+ K+ DFG++R + + ++ +MAPE +
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 208 SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267
+ +DV+ FGV + E++ + + + + L + P+ +
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKN------NDVIGRIENGERLPM-PPNCPPT-- 237
Query: 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
+ C DP RP + LS
Sbjct: 238 ------LYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-41
Identities = 70/294 (23%), Positives = 108/294 (36%), Gaps = 57/294 (19%)
Query: 51 NFHPSNKLGEGGFGPVFKG------KLDDGREIAVKKLSHSSNQG-KKEFENEAKLLAR- 102
LG G FG V + K R +AVK L + + +E K+L
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 103 VQHRNVVNLLGYCAHGAEKLLI-YEYVINESLDKVLFSLIKD------------------ 143
H NVVNLLG C L++ E+ +L L S +
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 144 -------IQIL--------FRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN- 187
Q+ + D+ A NILL +K + KI DFG+AR +D +V
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYK 247
+MAPE + ++++DV+SFGV++ E+ S + + + +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCR 248
Query: 248 LYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
K+ + D + Q L C G+P RPT +V L
Sbjct: 249 RLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-40
Identities = 55/271 (20%), Positives = 94/271 (34%), Gaps = 47/271 (17%)
Query: 51 NFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHR 106
+F LGEG F V + L RE A+K L E +++R+ H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 107 NVVNLLGYCAHGAEKLLIYEYVINESLDKVLF-------SLIKDI--------------Q 145
V L + Y N L K + + +
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 146 ILFRKKKTDIKASNILLDDKWIPKIADFGMARLF-PEDQTHVNTRVAGTNGYMAPEYVMH 204
I+ R D+K NILL++ +I DFG A++ PE + GT Y++PE +
Sbjct: 129 IIHR----DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 205 GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264
+D+++ G +I +L++G F + +++K LE P
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYL--------IFQKIIKLEYDFPEKFF 234
Query: 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRV 295
+ D + + + D R +
Sbjct: 235 PKARDLVEKLLVL-------DATKRLGCEEM 258
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 143 bits (362), Expect = 4e-40
Identities = 65/322 (20%), Positives = 112/322 (34%), Gaps = 43/322 (13%)
Query: 51 NFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVV 109
++ +LG G FG V + G A K + K+ E + ++ ++H +V
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 110 NLLGYCAHGAEKLLIYEYVINESLDKVLFS----------------LIKDIQILFRKKKT 153
NL E ++IYE++ L + + + K + +
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 146
Query: 154 --DIKASNILLDDKW--IPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSV 209
D+K NI+ K K+ DFG+ Q+ T GT + APE +
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGY 204
Query: 210 KADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGD 269
D++S GV+ L+SG F +N + + D +++ S + D D
Sbjct: 205 YTDMWSVGVLSYILLSGLS--PF----GGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258
Query: 270 QIAMCIQIGLLCTQGDPQLRPTMRRVVVM--LSKKPGPGNLEEPTRPGVPGSRYRRARRP 327
I + DP R T+ + + L+ PG + +P SRY + R
Sbjct: 259 FIRKLLLA-------DPNTRMTIHQALEHPWLTPGNAPGRDSQ-----IPSSRYTKIRDS 306
Query: 328 AALSSSTAGSSGESNSRTYTSS 349
R S
Sbjct: 307 IKTKYDAWPEPLPPLGRISNYS 328
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 3e-38
Identities = 60/295 (20%), Positives = 111/295 (37%), Gaps = 59/295 (20%)
Query: 51 NFHPSNKLGEGGFGPVFKGKL--------DDGREIAVKKL-SHSSNQGKKEFENEAKLLA 101
LGEG FG V + + ++AVK L S ++ + + +E +++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 102 RV-QHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT------- 153
+ +H+N++NLLG C +I EY +L + L +
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 154 --------------------------DIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187
D+ A N+L+ + + KIADFG+AR +
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 188 TRVA-GTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAY 246
T +MAPE + + ++DV+SFGV++ E+ + + + V + +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------EELF 247
Query: 247 KLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
KL K+ ++ + + C P RPT +++V L +
Sbjct: 248 KLLKEGHRMDKPS---------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 2e-37
Identities = 53/286 (18%), Positives = 106/286 (37%), Gaps = 39/286 (13%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQG-KKEFENEAKLLARVQHR 106
+ + +GEG +G V + +A+KK+S +Q + E K+L R +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 107 NVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKD------------------IQILF 148
N++ + + + Y++ + L+ L+K ++ +
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 149 RKKKT--DIKASNILLDDKWIPKIADFGMARLFPEDQTH--VNTRVAGTNGYMAPEYVMH 204
D+K SN+LL+ KI DFG+AR+ D H T T Y APE +++
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 205 GHL-SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLL----------DWAYKLYKKDK 253
+ D++S G ++ E++S + +D N + D + K +
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
Query: 254 SLEIVDPSLAASDSGDQI----AMCIQIGLLCTQGDPQLRPTMRRV 295
+ + P + + + +P R + +
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 135 bits (342), Expect = 3e-37
Identities = 54/260 (20%), Positives = 98/260 (37%), Gaps = 36/260 (13%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYC 115
+LG G FG V + GR K ++ K +NE ++ ++ H ++NL
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 116 AHGAEKLLIYEYVINESLDKVLFS----------------LIKDIQILFRKK--KTDIKA 157
E +LI E++ L + + + ++ + DIK
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKP 155
Query: 158 SNILLDDKWIP--KIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFS 215
NI+ + K KI DFG+A D+ T T + APE V + D+++
Sbjct: 156 ENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGFYTDMWA 213
Query: 216 FGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCI 275
GV+ L+SG ++ L+ + + D + S + ++ D I +
Sbjct: 214 IGVLGYVLLSGLSP------FAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLL 267
Query: 276 QIGLLCTQGDPQLRPTMRRV 295
Q +P+ R T+
Sbjct: 268 QK-------EPRKRLTVHDA 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 133 bits (336), Expect = 3e-37
Identities = 56/274 (20%), Positives = 102/274 (37%), Gaps = 48/274 (17%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGK---KEFENEAKLLARVQ 104
+ + LG GG V + L R++AVK L + F EA+ A +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 105 HRNVVNLLGYCAH----GAEKLLIYEYVINESLDKVL-----------FSLIKDI----- 144
H +V + G ++ EYV +L ++ +I D
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 145 -----QILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN--TRVAGTNGYM 197
I+ R D+K +NI++ K+ DFG+AR + V V GT Y+
Sbjct: 126 FSHQNGIIHR----DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 198 APEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEI 257
+PE + ++DV+S G V+ E+++G+ + + AY+ ++D
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP------FTGDSPVSVAYQHVREDPIPPS 235
Query: 258 VDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPT 291
++D + + +P+ R
Sbjct: 236 ARHEGLSADLDAVVLKALAK-------NPENRYQ 262
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 134 bits (337), Expect = 6e-37
Identities = 59/266 (22%), Positives = 100/266 (37%), Gaps = 42/266 (15%)
Query: 50 KNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHS---SNQGKKEFENEAKLLARVQH 105
++F LG G FG V + +GR A+K L + + +E +L+ V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 106 RNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKD---------IQILFRKKKT--- 153
++ + G + +I +Y+ L +L + ++ +
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 154 -----DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLS 208
D+K NILLD KI DFG A+ P+ + GT Y+APE V +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTKPYN 179
Query: 209 VKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268
D +SFG++I E+++G F + Y+K + E+ P D
Sbjct: 180 KSIDWWSFGILIYEMLAGYT--PFYDSNTMK--------TYEKILNAELRFPPFFNEDVK 229
Query: 269 DQIAMCIQIGLLCTQGDPQLRPTMRR 294
D ++ I D R +
Sbjct: 230 DLLSRLITR-------DLSQRLGNLQ 248
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 6e-37
Identities = 61/296 (20%), Positives = 113/296 (38%), Gaps = 38/296 (12%)
Query: 56 NKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKE-----FENEAKLLARVQHRNVV 109
+ LGEG F V+K + + + +A+KK+ K+ E KLL + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 110 NLLGYCAHGAEKLLIYEYVINESLD---------------KVLFSLIKDIQILFRKKK-- 152
LL H + L+++++ + + ++ ++ L +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123
Query: 153 TDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM-HGHLSVKA 211
D+K +N+LLD+ + K+ADFG+A+ F +V T Y APE + V
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGARMYGVGV 182
Query: 212 DVFSFGVVILELISGQRNSSFNLDVDAQNLL----------DWAYKLYKKDKSLEIVDPS 261
D+++ G ++ EL+ + D+D + W D P
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242
Query: 262 LAASDSGDQI-AMCIQIGLLCTQGDPQLRPTMRRVVVM--LSKKPGPGNLEEPTRP 314
+ + + +P R T + + M S +PGP + RP
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRP 298
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (336), Expect = 6e-37
Identities = 55/269 (20%), Positives = 99/269 (36%), Gaps = 37/269 (13%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKE-FENEAKLLARVQHR 106
+ + LG G F V + + +A+K ++ + +GK+ ENE +L +++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 107 NVVNLLGYCAHGAEKLLIYEYVINESLDKVLFS-----------LIKDI---------QI 146
N+V L G LI + V L + LI +
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 147 LFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGH 206
+ + LD+ I+DFG++++ ED V + GT GY+APE +
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQKP 185
Query: 207 LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASD 266
S D +S GV+ L+ G +N ++ K + + +
Sbjct: 186 YSKAVDCWSIGVIAYILLCGYPP------FYDENDAKLFEQILKAEYEFDSPYWDDISDS 239
Query: 267 SGDQIAMCIQIGLLCTQGDPQLRPTMRRV 295
+ D I ++ DP+ R T +
Sbjct: 240 AKDFIRHLMEK-------DPEKRFTCEQA 261
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-36
Identities = 60/267 (22%), Positives = 104/267 (38%), Gaps = 43/267 (16%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQG------KKEFENEAKLLARVQHRNVV 109
+LG G F V K + G + A K + + +++ E E +L +QH NV+
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 110 NLLGYCAHGAEKLLIYEYVINESLD---------------KVLFSLIKDIQILFRKK--K 152
L + + +LI E V L + L ++ + L +
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 136
Query: 153 TDIKASNILLDDKWIP----KIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLS 208
D+K NI+L D+ +P KI DFG+A + GT ++APE V + L
Sbjct: 137 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLG 194
Query: 209 VKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268
++AD++S GV+ L+SG + + + E S ++ +
Sbjct: 195 LEADMWSIGVITYILLSGASP------FLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248
Query: 269 DQIAMCIQIGLLCTQGDPQLRPTMRRV 295
D I + DP+ R T++
Sbjct: 249 DFIRRLLVK-------DPKKRMTIQDS 268
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 131 bits (330), Expect = 3e-36
Identities = 53/276 (19%), Positives = 100/276 (36%), Gaps = 31/276 (11%)
Query: 51 NFHPSNKLGEGGFGPVFKGKLDDGREIAVKKL--SHSSNQGKKEFENEAKLLARVQHRNV 108
+H K+GEG +G V+K + + G A+KK+ E +L ++H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 109 VNLLGYCAHGAEKLLIYEYVINESLDKVLFS---------------LIKDIQILFRKK-- 151
V L +L++E++ + + L+ I ++
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL 122
Query: 152 KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKA 211
D+K N+L++ + KIADFG+AR F + + S
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 212 DVFSFGVVILELISGQRNSSFNLDVDAQNLL----------DWA--YKLYKKDKSLEIVD 259
D++S G + E+++G + D + +W +L K D + + +
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 260 PSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRV 295
P S I + + DP R T ++
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (323), Expect = 4e-35
Identities = 44/273 (16%), Positives = 90/273 (32%), Gaps = 39/273 (14%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYC 115
K+G G FG ++ G + G E+A+K + + E+K+ +Q + + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 116 AHGAEKLLIYEYVINESLD----------------KVLFSLIKDIQILFRKKK--TDIKA 157
+ ++ ++ SL+ + +I I+ + K D+K
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKP 131
Query: 158 SNIL---LDDKWIPKIADFGMARLFPEDQTHV------NTRVAGTNGYMAPEYVMHGHLS 208
N L + I DFG+A+ + + +TH N + GT Y + + S
Sbjct: 132 DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS 191
Query: 209 VKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268
+ D+ S G V++ G + + + K + L
Sbjct: 192 RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-----KKMSTPIEVLCKGYPS 246
Query: 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
+ C +P + +
Sbjct: 247 E----FATYLNFCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 130 bits (327), Expect = 4e-35
Identities = 56/269 (20%), Positives = 101/269 (37%), Gaps = 42/269 (15%)
Query: 51 NFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHS---SNQGKKEFENE---AKLLARV 103
+F +G GGFG V+ + D G+ A+K L QG+ NE L++
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 104 QHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFS---------------LIKDIQILF 148
+V + + I + + L L +I ++ +
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 149 RKKKT--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG- 205
+ D+K +NILLD+ +I+D G+A F + + H GT+GYMAPE + G
Sbjct: 125 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQKGV 181
Query: 206 HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265
AD FS G ++ +L+ G + D +++ + ++ + P +
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------KHEIDRMTLTMAVELPDSFSP 234
Query: 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMRR 294
+ + +Q D R
Sbjct: 235 ELRSLLEGLLQR-------DVNRRLGCLG 256
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 1e-34
Identities = 59/265 (22%), Positives = 100/265 (37%), Gaps = 40/265 (15%)
Query: 51 NFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHS---SNQGKKEFENEAKLLARV-QH 105
+F LG+G FG VF + + A+K L + + E ++L+ +H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 106 RNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFS---------------LIKDIQILFRK 150
+ ++ + EY+ L + S +I +Q L K
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 151 KKT--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLS 208
D+K NILLD KIADFGM + NT GT Y+APE ++ +
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQKYN 181
Query: 209 VKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268
D +SFGV++ E++ GQ F+ + + L+ + P ++
Sbjct: 182 HSVDWWSFGVLLYEMLIGQS--PFHGQDEEE--------LFHSIRMDNPFYPRWLEKEAK 231
Query: 269 DQIAMCIQIGLLCTQGDPQLRPTMR 293
D + +P+ R +R
Sbjct: 232 DLLVKLFVR-------EPEKRLGVR 249
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 125 bits (316), Expect = 2e-34
Identities = 53/279 (18%), Positives = 95/279 (34%), Gaps = 49/279 (17%)
Query: 51 NFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSN---------QGKKEFENEAKLL 100
N+ P LG G V + +E AVK + + + ++ E +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 101 ARVQ-HRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFS---------------LIKDI 144
+V H N++ L L+++ + L L L++ I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 145 QILFRKKKT--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYV 202
L + D+K NILLDD K+ DFG + + V GT Y+APE +
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLAPEII 181
Query: 203 M------HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLE 256
H + D++S GV++ L++G + + + +
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQMLMLRMIMSGNYQFG 235
Query: 257 IVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRV 295
+ + D ++ + + PQ R T
Sbjct: 236 SPEWDDYSDTVKDLVSRFLVV-------QPQKRYTAEEA 267
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 6e-34
Identities = 55/278 (19%), Positives = 101/278 (36%), Gaps = 33/278 (11%)
Query: 51 NFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSN--QGKKEFENEAKLLARVQHRN 107
NF K+GEG +G V+K + G +A+KK+ + E LL + H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 108 VVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQILFRKKKT-------------- 153
+V LL + L++E++ + + S + I + K
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 154 ----DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSV 209
D+K N+L++ + K+ADFG+AR F V + + S
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 210 KADVFSFGVVILELISGQRNSSFNLDVDA-----QNLLDWAYKLYKKDKSLEIVDPSLAA 264
D++S G + E+++ + + ++D + L ++ S+ PS
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242
Query: 265 SDSGDQIAMCIQIG-----LL--CTQGDPQLRPTMRRV 295
D + + LL DP R + +
Sbjct: 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 6e-34
Identities = 50/328 (15%), Positives = 105/328 (32%), Gaps = 42/328 (12%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYC 115
LG G FG V + + K + + + E +L +HRN+++L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 116 AHGAEKLLIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKA 157
E ++I+E++ + + + + + +Q L DI+
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRP 130
Query: 158 SNILLDDK--WIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFS 215
NI+ + KI +FG AR + Y APE H +S D++S
Sbjct: 131 ENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDVVSTATDMWS 188
Query: 216 FGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCI 275
G ++ L+SG A+ + + + + + ++ D + +
Sbjct: 189 LGTLVYVLLSGINP------FLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLL 242
Query: 276 QIGLLCTQGDPQLRPTMRRVVVMLSKKPGPGNLEEPTRPGVPGSRYRRARRPAALSSSTA 335
+ + R T + K + + RY L+ +
Sbjct: 243 VK-------ERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVS 295
Query: 336 GSSGESNSRTYTSSLNTNTGTASASTSA 363
+ + ++ + G + A
Sbjct: 296 -----AARISCGGAIRSQKGVSVAKVKV 318
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 1e-33
Identities = 57/295 (19%), Positives = 104/295 (35%), Gaps = 50/295 (16%)
Query: 45 LVSATKNFHPSNKLGEGGFGPVFKGK--LDDGREIAVKKLSHSSNQGKKEFE-----NEA 97
L A + + ++GEG +G VFK + + GR +A+K++ + +
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 98 KLLARVQHRNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKDIQ------------ 145
+ L +H NVV L C ++ E +D+ L + + +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 146 ---------------ILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV 190
++ R D+K NIL+ K+ADFG+AR++ T V
Sbjct: 122 MFQLLRGLDFLHSHRVVHR----DLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSV 175
Query: 191 AGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLL-------- 242
T Y APE ++ + D++S G + E+ + + DVD +
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235
Query: 243 --DWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRV 295
DW + ++ D + + L C +P R +
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 124 bits (312), Expect = 1e-33
Identities = 40/282 (14%), Positives = 94/282 (33%), Gaps = 41/282 (14%)
Query: 50 KNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNV 108
++ ++GEG FG +F+G L + +++A+K S+ + +E + +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 109 VNLLGYCAHGAEKLLIYEYVINESLDKVLFSL-----IKDIQILFRKKKT---------- 153
+ + Y ++ ++ SL+ +L +K + + ++
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 122
Query: 154 ---DIKASNILLDDKWIP-----KIADFGMARLFPEDQTHVN------TRVAGTNGYMAP 199
DIK N L+ + DFGM + + + T + ++GT YM+
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 200 EYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVD 259
+ S + D+ + G V + + G + + + + E+
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242
Query: 260 PSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301
++ + P + + SK
Sbjct: 243 ------GFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSK 275
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 2e-32
Identities = 53/268 (19%), Positives = 94/268 (35%), Gaps = 55/268 (20%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKE------FENEAKLLARVQ--HRN 107
LG GGFG V+ G + D +A+K + E E LL +V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 108 VVNLLGYCAHGAEKLLIYEYVINESLD----------------KVLFSLIKDIQILFRKK 151
V+ LL + +LI E + +++ ++
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130
Query: 152 K--TDIKASNILLD-DKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM-HGHL 207
DIK NIL+D ++ K+ DFG L + T GT Y PE++ H +
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWIRYHRYH 187
Query: 208 SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267
A V+S G+++ +++ G ++ ++ ++ +S+
Sbjct: 188 GRSAAVWSLGILLYDMVCGDI----------------PFEHDEEIIRGQVFFRQRVSSEC 231
Query: 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRV 295
I C+ + P RPT +
Sbjct: 232 QHLIRWCLAL-------RPSDRPTFEEI 252
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 9e-32
Identities = 57/292 (19%), Positives = 109/292 (37%), Gaps = 47/292 (16%)
Query: 51 NFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGK--KEFENEAKLLARVQHRN 107
+ K+G+G FG VFK + G+++A+KK+ + + E K+L ++H N
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 108 VVNLLGYCAHGAEKLLIYE---YVINESLDKVLFSLIKDIQILFRKKKT----------- 153
VVNL+ C A + Y++ + + L L+ ++ + F +
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 130
Query: 154 -----------DIKASNILLDDKWIPKIADFGMARLFPEDQT---HVNTRVAGTNGYMAP 199
D+KA+N+L+ + K+ADFG+AR F + + T T Y P
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 200 EYVMHGHL-SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLL--------------DW 244
E ++ D++ G ++ E+ + N + L+
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250
Query: 245 AYKLYKKDKSLEIVDPSLAASDSGDQI-AMCIQIGLLCTQGDPQLRPTMRRV 295
Y+LY+K + ++ + + + DP R
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-31
Identities = 54/287 (18%), Positives = 95/287 (33%), Gaps = 49/287 (17%)
Query: 50 KNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKL--SHSSNQGKKEFENEAKLLARVQHR 106
+ + K+GEG +G VFK K + +A+K++ E LL ++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 107 NVVNLLGYCAHGAEKLLIYEYVINESLD---------------KVLFSLIKDIQILFRKK 151
N+V L + L++E+ + LF L+K + +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 152 --KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSV 209
D+K N+L++ K+A+FG+AR F + V S
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 210 KADVFSFGVVILELISGQR---------------------NSSFNLDVDAQNLLDWAYKL 248
D++S G + EL + R + + Y +
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 249 YKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRV 295
Y SL V P L A D + ++ +P R +
Sbjct: 242 YPATTSLVNVVPKLNA-TGRDLLQNLLKC-------NPVQRISAEEA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 6e-30
Identities = 57/266 (21%), Positives = 91/266 (34%), Gaps = 39/266 (14%)
Query: 50 KNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKE---FENEAKLLARVQH 105
+F LG+G FG V + GR A+K L K E E+++L +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 106 RNVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIKD---------IQIL--------F 148
+ L + EY L L +I+
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 149 RKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLS 208
DIK N++LD KI DFG+ + D + T GT Y+APE +
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYG 183
Query: 209 VKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268
D + GVV+ E++ G+ F + L++ EI P + ++
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLP--FYNQDHER--------LFELILMEEIRFPRTLSPEAK 233
Query: 269 DQIAMCIQIGLLCTQGDPQLRPTMRR 294
+A ++ DP+ R
Sbjct: 234 SLLAGLLKK-------DPKQRLGGGP 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 9e-30
Identities = 50/266 (18%), Positives = 94/266 (35%), Gaps = 44/266 (16%)
Query: 58 LGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLGYC 115
LG G G V + + A+K L Q + E +L R Q ++V ++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 116 AHGAEK----LLIYEYVINESLDKVLFS-----------------LIKDIQILFRKKKT- 153
+ L++ E + L + + + IQ L
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 134
Query: 154 -DIKASNILLDDKW---IPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSV 209
D+K N+L K I K+ DFG A+ + T Y+APE +
Sbjct: 135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEKYDK 192
Query: 210 KADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGD 269
D++S GV++ L+ G + + L + + + + + P+ S+ +
Sbjct: 193 SCDMWSLGVIMYILLCGYPP------FYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 246
Query: 270 QIAMCIQIGLLCTQGDPQLRPTMRRV 295
++ M I+ + +P R T+
Sbjct: 247 EVKMLIR---NLLKTEPTQRMTITEF 269
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 3e-29
Identities = 56/283 (19%), Positives = 94/283 (33%), Gaps = 45/283 (15%)
Query: 51 NFHPSNKLGEGGFGPVFKGKL-DDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVV 109
++ + +G G FG V++ KL D G +A+KK+ Q K+ E +++ ++ H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 76
Query: 110 NLLGYCAHGAEK------LLIYEYVINESLDKVLFSLIKDIQILFRKKKT---------- 153
L + EK L+ +YV + K
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 154 ----------DIKASNILLD-DKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYV 202
DIK N+LLD D + K+ DFG A+ + + + +
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRAPELIF 195
Query: 203 MHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNL------------LDWAYKLYK 250
+ DV+S G V+ EL+ GQ + VD + Y
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255
Query: 251 KDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMR 293
+ K +I I + + P R T
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 112 bits (280), Expect = 9e-29
Identities = 39/217 (17%), Positives = 91/217 (41%), Gaps = 28/217 (12%)
Query: 35 REQKHFPFEALVSATKN---FHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGK 90
R ++++ +E+ V N + KLG G + VF+ + + ++ VK L K
Sbjct: 17 RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---K 73
Query: 91 KEFENEAKLLARVQ-HRNVVNLLGYCAHGAEKL--LIYEYVINESLDK------------ 135
K+ + E K+L ++ N++ L + L++E+V N +
Sbjct: 74 KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF 133
Query: 136 VLFSLIKDIQILFRKK--KTDIKASNILLD-DKWIPKIADFGMARLFPEDQTHVNTRVAG 192
++ ++K + D+K N+++D + ++ D+G+A + Q +
Sbjct: 134 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVA 191
Query: 193 TNGYMAPEYVM-HGHLSVKADVFSFGVVILELISGQR 228
+ + PE ++ + D++S G ++ +I +
Sbjct: 192 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 109 bits (273), Expect = 1e-27
Identities = 63/305 (20%), Positives = 115/305 (37%), Gaps = 47/305 (15%)
Query: 16 NLGSSREGDNEEDLEKIAAREQKHFPFEALVSATK-----NFHPSNKLGEGGFGPVFKGK 70
N ++++G +E +++ A+ ++ F + + F LG G FG V K
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 71 -LDDGREIAVKKLSHSSNQGKKE---FENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126
+ G A+K L K+ NE ++L V +V L + ++ E
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121
Query: 127 YVINESLDKVLFS---------------LIKDIQILFRKK--KTDIKASNILLDDKWIPK 169
YV + L ++ + L D+K N+L+D + +
Sbjct: 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181
Query: 170 IADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRN 229
+ DFG A+ + GT +APE ++ + D ++ GV+I E+ +G
Sbjct: 182 VTDFGFAKRVKGRTWTLC----GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP- 236
Query: 230 SSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLR 289
F D Q +Y+K S ++ PS +SD D + +Q+ D R
Sbjct: 237 -PFFADQPIQ--------IYEKIVSGKVRFPSHFSSDLKDLLRNLLQV-------DLTKR 280
Query: 290 PTMRR 294
+
Sbjct: 281 FGNLK 285
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 8e-27
Identities = 62/277 (22%), Positives = 106/277 (38%), Gaps = 49/277 (17%)
Query: 50 KNFHPSNKLGEGGFGPVFKGKL----DDGREIAVKKLSHSS----NQGKKEFENEAKLLA 101
+NF LG G +G VF + D G+ A+K L ++ + + E ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 102 RVQHR-NVVNLLGYCAHGAEKLLIYEYVINESLDKVLFSLIK------------------ 142
++ +V L + LI +Y+ L L +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 143 ---DIQILFRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAP 199
+ I++R DIK NILLD + DFG+++ F D+T GT YMAP
Sbjct: 144 HLHKLGIIYR----DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 200 EYVMHGH--LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEI 257
+ V G D +S GV++ EL++G F +D + + ++ ++ E
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGAS--PFTVDGEKNSQ----AEISRRILKSEP 253
Query: 258 VDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRR 294
P ++ + D I + DP+ R
Sbjct: 254 PYPQEMSALAKDLIQRLLMK-------DPKKRLGCGP 283
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 3e-26
Identities = 47/203 (23%), Positives = 80/203 (39%), Gaps = 29/203 (14%)
Query: 50 KNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKL--SHSSNQGKKEFENEAKLLARVQHR 106
+ +G G +G V G ++A+KKL S K E +LL ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 107 NVVNLLGYCAHGAEKLLIYE-YVINESLDKVLFSLIKD------------IQIL------ 147
NV+ LL + Y++ + L L+K Q+L
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 148 --FRKKKTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVM-H 204
D+K N+ +++ KI DFG+AR + T T Y APE ++
Sbjct: 138 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG----YVVTRWYRAPEVILNW 193
Query: 205 GHLSVKADVFSFGVVILELISGQ 227
+ D++S G ++ E+I+G+
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGK 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 1e-25
Identities = 46/201 (22%), Positives = 77/201 (38%), Gaps = 25/201 (12%)
Query: 50 KNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLS--HSSNQGKKEFENEAKLLARVQHR 106
K + +G G G V R +A+KKLS + K E L+ V H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 107 NVVNLLGYCAH------GAEKLLIYEYVINESLD------------KVLFSLIKDIQILF 148
N+++LL + L+ E + +L+ ++ I+ L
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 149 RKKKT--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGH 206
D+K SNI++ KI DFG+AR T T Y APE ++
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRAPEVILGMG 194
Query: 207 LSVKADVFSFGVVILELISGQ 227
D++S G ++ E++ +
Sbjct: 195 YKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 3e-24
Identities = 42/203 (20%), Positives = 82/203 (40%), Gaps = 27/203 (13%)
Query: 49 TKNFHPSNKLGEGGFGPVFKGK-LDDGREIAVKKLS--HSSNQGKKEFENEAKLLARVQH 105
+ + + +G G +G V G +AVKKLS S K E +LL ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 106 RNVVNLLGYCAHGA-----EKLLIYEYVINESLDKVLFS--------------LIKDIQI 146
NV+ LL + + +++ L+ ++ +++ ++
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 147 LFRKKKT--DIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMH 204
+ D+K SN+ +++ KI DFG+AR + VA +
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNW 193
Query: 205 GHLSVKADVFSFGVVILELISGQ 227
H + D++S G ++ EL++G+
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 94.7 bits (234), Expect = 3e-22
Identities = 42/208 (20%), Positives = 73/208 (35%), Gaps = 38/208 (18%)
Query: 57 KLGEGGFGPVFKGK-LDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYC 115
KLG G F V+ K + + +A+K + + E+E KLL RV +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 116 AHGAEKLLIYEYVINESLD-------------------------------KVLFSLIKDI 144
A+ KLL + + ++ L+ +
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 145 QILFRKKK---TDIKASNILLD-DKWIPKIADFGMARLFPEDQTHVNTR-VAGTNGYMAP 199
+ R+ TDIK N+L++ + +A L + T Y +P
Sbjct: 139 DYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSP 198
Query: 200 EYVMHGHLSVKADVFSFGVVILELISGQ 227
E ++ AD++S +I ELI+G
Sbjct: 199 EVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 76.4 bits (187), Expect = 5e-17
Identities = 34/193 (17%), Positives = 64/193 (33%), Gaps = 33/193 (17%)
Query: 56 NKLGEGGFGPVFKGKLDDGREIAVK----------KLSHSSNQGKKEFENEAKLLARVQH 105
+GEG VF + E VK K+ + G F A AR +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 106 RNVVNLLGYCAHGA----EKLLIYEYVINE--------SLDKVLFSLIKDIQILFRKK-- 151
R + L G ++ E + + + D+VL +++++ + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIV 125
Query: 152 KTDIKASNILLDDKWIPKIADFGMARLF--PEDQTHVNTRVAGTNGYMAPEYVMHGHLSV 209
D+ N+L+ + I DF + + + V Y + Y
Sbjct: 126 HGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTY------RT 178
Query: 210 KADVFSFGVVILE 222
+ D+ S IL+
Sbjct: 179 EKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 381 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.72 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.38 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.71 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.61 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.43 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.21 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=392.09 Aligned_cols=234 Identities=24% Similarity=0.382 Sum_probs=195.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
.++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..||||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 357999999999999999999865 6999999999876666678899999999999999999999999999999999999
Q ss_pred ccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccc
Q 048280 128 VINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVA 191 (381)
Q Consensus 128 ~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~ 191 (381)
|++|+|.+++ .|++.||.|||+++ ||||||+||||+.++.+||+|||+++.+..... .....+
T Consensus 99 ~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~~~ 177 (293)
T d1yhwa1 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMV 177 (293)
T ss_dssp CTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCC
T ss_pred cCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-cccccc
Confidence 9999997654 79999999999999 999999999999999999999999998754332 234567
Q ss_pred cCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHH
Q 048280 192 GTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQI 271 (381)
Q Consensus 192 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (381)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ............ .. .......
T Consensus 178 gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~-~~-------~~~~~~s 243 (293)
T d1yhwa1 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP-EL-------QNPEKLS 243 (293)
T ss_dssp SCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC-CC-------SSGGGSC
T ss_pred cCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCC-CC-------CCcccCC
Confidence 999999999999999999999999999999999999998543221 111222222111 10 1112334
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 272 AMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 272 ~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
..+.+||.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 244 AIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 66889999999999999999999975
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-55 Score=398.33 Aligned_cols=245 Identities=25% Similarity=0.410 Sum_probs=201.4
Q ss_pred HHHHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeE
Q 048280 43 EALVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEK 121 (381)
Q Consensus 43 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 121 (381)
++.+...++|++.+.||+|+||.||+|++. +++.||||++.... ...+.|.+|+++|++++|||||+++++|.+++..
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 333445678999999999999999999876 58899999986543 4567899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCC
Q 048280 122 LLIYEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPED 182 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~ 182 (381)
++|||||++|+|.+++ .|++.||.|||+++ ||||||+||||+.++.+||+|||+++.....
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 9999999999997665 68999999999999 9999999999999999999999999987655
Q ss_pred CcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 183 QTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
.........|++.|+|||++.+..++.++|||||||++|||++|..||...... ..+ .........
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~~----~~~i~~~~~-------- 234 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQV----YELLEKDYR-------- 234 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHH----HHHHHTTCC--------
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--HHH----HHHHhcCCC--------
Confidence 555455567899999999999999999999999999999999987776433221 111 122222111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
...+...+..+.+|+.+||+.||++|||+.||++.|+...
T Consensus 235 -~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 235 -MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1112223456889999999999999999999999997653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-55 Score=391.63 Aligned_cols=238 Identities=24% Similarity=0.397 Sum_probs=184.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
.++|++.+.||+|+||.||+|++.+++.||||++.... ...+.|.+|++++++++|||||+++|+|...+..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 35789999999999999999999888899999997543 44678999999999999999999999999999999999999
Q ss_pred cCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccc
Q 048280 129 INESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV 190 (381)
Q Consensus 129 ~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 190 (381)
++|+|.+++ .|++.||.|+|+.+ ||||||+||||++++.+||+|||+++.............
T Consensus 83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 162 (263)
T d1sm2a_ 83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 162 (263)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeecce
Confidence 999998765 78999999999999 999999999999999999999999987755544444456
Q ss_pred ccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHH
Q 048280 191 AGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQ 270 (381)
Q Consensus 191 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (381)
.||+.|+|||++.+..++.++|||||||++|||+|+..|+..... ...+... ... .. ....| ...
T Consensus 163 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~---i~~-~~--~~~~p-------~~~ 227 (263)
T d1sm2a_ 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVED---IST-GF--RLYKP-------RLA 227 (263)
T ss_dssp --CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHH---HHH-TC--CCCCC-------TTS
T ss_pred ecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHHHH---HHh-cC--CCCCc-------ccc
Confidence 789999999999999999999999999999999996555432211 1112211 111 11 11111 122
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 271 IAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 271 ~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
...+.+|+.+||+.||++|||++||++.|+++
T Consensus 228 ~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 35688999999999999999999999999754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-55 Score=388.71 Aligned_cols=235 Identities=23% Similarity=0.319 Sum_probs=187.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
.++|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 468999999999999999999875 68999999996543 2334678999999999999999999999999999999999
Q ss_pred cccCCCHHHH---------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc-cccc
Q 048280 127 YVINESLDKV---------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT-HVNT 188 (381)
Q Consensus 127 ~~~~g~L~~~---------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~-~~~~ 188 (381)
||.+|+|.++ +.|++.||.|||+++ ||||||+||||+.++.+||+|||+|+.+..... ....
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~ 163 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 163 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccccc
Confidence 9999999644 489999999999999 999999999999999999999999997643322 2234
Q ss_pred ccccCccccchhHHhhCCC-CchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 189 RVAGTNGYMAPEYVMHGHL-SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
..+||+.|+|||++.+..+ +.++|||||||+||||++|+.||........ .. ......... ....
T Consensus 164 ~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~----~~~~~~~~~--------~~~~ 229 (271)
T d1nvra_ 164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EY----SDWKEKKTY--------LNPW 229 (271)
T ss_dssp CCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--HH----HHHHTTCTT--------STTG
T ss_pred ceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--HH----HHHhcCCCC--------CCcc
Confidence 5689999999999998876 5789999999999999999999965432211 11 111111100 0111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
......+.+|+.+||+.||++|||++|+++
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 230 KKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 223456788999999999999999999965
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-55 Score=392.03 Aligned_cols=237 Identities=26% Similarity=0.431 Sum_probs=193.9
Q ss_pred hhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
..++|++.+.||+|+||.||+|++++++.||||++.... ...+.|.+|++++++++|||||++++++.+ +..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 356899999999999999999999888999999997543 446789999999999999999999998865 557999999
Q ss_pred ccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 128 VINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 128 ~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
+++|+|.+++ .|++.||.|||+++ ||||||+||||++++.+||+|||+++.+.........
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcccccc
Confidence 9999997543 78999999999999 9999999999999999999999999987665544455
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
...||+.|+|||++.++.++.++|||||||+||||+||..|+...... ..+. .. ...... + ..+.
T Consensus 169 ~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~---~~-i~~~~~-----~----~~p~ 233 (272)
T d1qpca_ 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVI---QN-LERGYR-----M----VRPD 233 (272)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHH---HH-HHTTCC-----C----CCCT
T ss_pred ccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHH---HH-HHhcCC-----C----CCcc
Confidence 667999999999999999999999999999999999976665332211 1111 11 111111 1 1112
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
..+..+.+|+.+||+.||++|||+++|++.|+.
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 234568899999999999999999999998864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-54 Score=380.08 Aligned_cols=235 Identities=25% Similarity=0.400 Sum_probs=197.1
Q ss_pred cCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEeccc
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVI 129 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 129 (381)
++|++.+.||+|+||.||+|++++++.||||+++... ...+.|.+|++++++++||||++++|+|.+.+..++||||+.
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6899999999999999999999888899999997654 346789999999999999999999999999999999999999
Q ss_pred CCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccccc
Q 048280 130 NESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRVA 191 (381)
Q Consensus 130 ~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~ 191 (381)
+|+|..++ .|++.||.|||+.+ ||||||+||||+.++.+||+|||+++.+............
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 162 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 162 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccC
Confidence 99997654 78999999999999 9999999999999999999999999877655444444567
Q ss_pred cCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHH
Q 048280 192 GTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQ 270 (381)
Q Consensus 192 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (381)
||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+. ... ..... ...| ...
T Consensus 163 ~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~---~~i-~~~~~--~~~p-------~~~ 226 (258)
T d1k2pa_ 163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETA---EHI-AQGLR--LYRP-------HLA 226 (258)
T ss_dssp CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHH---HHH-HTTCC--CCCC-------TTC
T ss_pred CCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHH---HHH-HhCCC--CCCc-------ccc
Confidence 8999999999999999999999999999999998 78888543221 111 111 11111 1111 123
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 271 IAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 271 ~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
+..+.+|+.+||+.||++|||+++|++.|..
T Consensus 227 ~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 227 SEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 3568899999999999999999999999854
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-54 Score=383.86 Aligned_cols=228 Identities=24% Similarity=0.363 Sum_probs=190.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++|++.+.||+|+||.||+|+.+ +++.||||++... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999976 5899999998643 2334577899999999999999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
|||++|+|.+++ .|++.||.|||+++ ||||||+||||+.++.+||+|||+++...... ..
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~---~~ 162 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RT 162 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC---CE
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc---cc
Confidence 999999997665 79999999999999 99999999999999999999999998764332 23
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
...||+.|+|||++.+..++.++|||||||+||||++|+.||..... ........... ..+ +.
T Consensus 163 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~-------~~~----p~ 225 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRISRVE-------FTF----PD 225 (263)
T ss_dssp ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTC-------CCC----CT
T ss_pred ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH------HHHHHHHHcCC-------CCC----Cc
Confidence 46799999999999999999999999999999999999999864321 11111111111 111 11
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
..+..+.+|+.+||+.||++|||++|+++
T Consensus 226 ~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 226 FVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 23456889999999999999999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=384.11 Aligned_cols=233 Identities=24% Similarity=0.326 Sum_probs=191.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
+.|++.+.||+|+||.||+|++. +++.||||++........+.+.+|+++|++++|||||++++++.+.+..+||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999875 58999999998776666788999999999999999999999999999999999999
Q ss_pred cCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccc
Q 048280 129 INESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV 190 (381)
Q Consensus 129 ~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 190 (381)
++|+|.+++ .|++.||.|||+++ ||||||+||||+.++.+||+|||+++...... ......
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~~~ 170 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSF 170 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHTCC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cccccc
Confidence 999997665 78999999999999 99999999999999999999999998653221 122356
Q ss_pred ccCccccchhHHh-----hCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCC
Q 048280 191 AGTNGYMAPEYVM-----HGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265 (381)
Q Consensus 191 ~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
.||+.|+|||++. +..|+.++|||||||+||||++|+.||......+ .. ....... .... .
T Consensus 171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~---~~i~~~~-~~~~-------~ 236 (288)
T d2jfla1 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VL---LKIAKSE-PPTL-------A 236 (288)
T ss_dssp CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HH---HHHHHSC-CCCC-------S
T ss_pred ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HH---HHHHcCC-CCCC-------C
Confidence 7999999999984 4568999999999999999999999986543222 11 1112111 1111 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 266 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.....+..+.+||.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12233466889999999999999999999976
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=382.27 Aligned_cols=240 Identities=25% Similarity=0.408 Sum_probs=186.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
.++|++.+.||+|+||.||+|+.+ ..||||+++.. .....+.|.+|+.+|++++|||||++++++.+ +..+||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 578999999999999999999865 35999998654 33445789999999999999999999998765 56899999
Q ss_pred cccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc-ccc
Q 048280 127 YVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT-HVN 187 (381)
Q Consensus 127 ~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~-~~~ 187 (381)
||++|+|.+++ .|++.||.|||+++ ||||||+||||+.++.+||+|||+++....... ...
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~ 163 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccc
Confidence 99999998766 68999999999999 999999999999999999999999987654322 223
Q ss_pred cccccCccccchhHHhhC---CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHG---HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
....||+.|+|||++.+. .|+.++|||||||+||||+||+.||........ ........... |.+ .
T Consensus 164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~~~~~~~~~~----p~~-~ 232 (276)
T d1uwha_ 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGYLS----PDL-S 232 (276)
T ss_dssp --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHHTSCC----CCG-G
T ss_pred cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH------HHHHHhcCCCC----Ccc-h
Confidence 456799999999999753 589999999999999999999999864322111 11111111111 110 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.....++..+.+|+.+||+.||.+|||+.||++.|+.+
T Consensus 233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11122345688999999999999999999999998764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-54 Score=383.88 Aligned_cols=232 Identities=23% Similarity=0.332 Sum_probs=179.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEee--CCeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAH--GAEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~l 123 (381)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+ ++.+||
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 367999999999999999999875 68999999997653 3345678999999999999999999999864 456899
Q ss_pred EEecccCCCHHHHH-------------------HhhhhhhhHhhhhc-------cCCccccceEeCCCCCcEEeeeccce
Q 048280 124 IYEYVINESLDKVL-------------------FSLIKDIQILFRKK-------KTDIKASNILLDDKWIPKIADFGMAR 177 (381)
Q Consensus 124 v~E~~~~g~L~~~l-------------------~~~~~~l~~lh~~~-------HrDlkp~NIll~~~~~~kL~DFG~~~ 177 (381)
|||||++|+|.+++ .|++.||.|||+.+ ||||||+||||+.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999997654 68999999999853 99999999999999999999999999
Q ss_pred ecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccc
Q 048280 178 LFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEI 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (381)
.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+. .. ........
T Consensus 163 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~~---~~-i~~~~~~~- 233 (269)
T d2java1 163 ILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELA---GK-IREGKFRR- 233 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH---HH-HHHTCCCC-
T ss_pred ecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HHHH---HH-HHcCCCCC-
Confidence 7654332 23356799999999999999999999999999999999999999864322 1111 11 11111111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 258 VDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
+ +...+..+.+|+.+||+.||.+|||+.||++
T Consensus 234 ----~----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 ----I----PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ----C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----C----CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1 1123456889999999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-53 Score=386.32 Aligned_cols=238 Identities=26% Similarity=0.424 Sum_probs=181.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC-C---cEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD-G---REIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
.++|++.+.||+|+||.||+|++.. + ..||||++... .....+.|.+|+++|++++|||||+++|+|...+..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 3568888999999999999998753 3 35889988654 33445679999999999999999999999999999999
Q ss_pred EEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 124 IYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 124 v~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
|||||++|+|.+++ .|++.||.|||+++ ||||||+||||+.++.+||+|||+++.+......
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 184 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence 99999999997655 78999999999999 9999999999999999999999999876543222
Q ss_pred c----ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCC
Q 048280 186 V----NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDP 260 (381)
Q Consensus 186 ~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
. .....||+.|+|||++.++.++.++|||||||+||||+| |+.||...... .+.. . ......
T Consensus 185 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~---~-i~~~~~------ 251 (299)
T d1jpaa_ 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVIN---A-IEQDYR------ 251 (299)
T ss_dssp -----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH---H-HHTTCC------
T ss_pred ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHH---H-HHcCCC------
Confidence 1 123457899999999999999999999999999999998 89898543221 1111 1 111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 261 SLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 261 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
...+...+..+.+|+.+||+.||++|||+.||++.|+++
T Consensus 252 ---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 252 ---LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111223446688999999999999999999999998764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-54 Score=393.67 Aligned_cols=247 Identities=24% Similarity=0.325 Sum_probs=188.7
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
..++|++++.||+|+||+||+|+.. +|+.||+|++.... ....+.+.+|+.+|++++|||||+++++|.+.+..||||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999975 68999999997553 333568899999999999999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhh-c--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRK-K--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~-~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|||++|+|.+++ .|++.||.|||++ + ||||||+||||+.++.+||+|||+|+.+... ..
T Consensus 84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---~~ 160 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 160 (322)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---TC
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC---cc
Confidence 999999998765 6899999999974 5 9999999999999999999999999865322 22
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCC----------cc-c
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDK----------SL-E 256 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------~~-~ 256 (381)
...+||+.|+|||++.+..|+.++|||||||++|||++|+.||....................... .. .
T Consensus 161 ~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240 (322)
T ss_dssp ---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------------
T ss_pred ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccc
Confidence 356899999999999999999999999999999999999999965432211000000000000000 00 0
Q ss_pred ----------------ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 257 ----------------IVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 257 ----------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.................+.+|+.+||+.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00000000001112356889999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=384.21 Aligned_cols=231 Identities=21% Similarity=0.283 Sum_probs=187.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+++|++++|||||++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999875 6899999998643 2334577999999999999999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc-ccc
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT-HVN 187 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~-~~~ 187 (381)
|||++|+|.+++ .|++.||.|+|+.+ ||||||+||||++++.+||+|||+++.+..... ...
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~ 167 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccccc
Confidence 999999997665 78999999999999 999999999999999999999999998754332 223
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
...+||+.|+|||++.+..++.++|||||||+||||++|+.||..... ........... ..+.
T Consensus 168 ~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~~~-------~~~p---- 230 (288)
T d1uu3a_ 168 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------YLIFQKIIKLE-------YDFP---- 230 (288)
T ss_dssp --CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHTTC-------CCCC----
T ss_pred ccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH------HHHHHHHHcCC-------CCCC----
Confidence 356799999999999999999999999999999999999999864321 11111222111 1111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
......+.+||.+||+.||.+|||++|++.
T Consensus 231 ~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 231 EKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 123356889999999999999999998743
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-53 Score=379.65 Aligned_cols=238 Identities=24% Similarity=0.410 Sum_probs=188.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecc
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYV 128 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 128 (381)
.++|++.+.||+|+||.||+|++++++.||||++.... ...+.|.+|+.++++++|||||+++++|.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 46899999999999999999999888899999996543 456789999999999999999999999865 5689999999
Q ss_pred cCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 129 INESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 129 ~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
++|+|..++ .|++.||+|||..+ ||||||+||||+.++.+||+|||+++.+..........
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 173 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 173 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceeecc
Confidence 999987554 78999999999998 99999999999999999999999998775554444455
Q ss_pred cccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHH
Q 048280 190 VAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGD 269 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (381)
..||+.|+|||++.++.++.++|||||||+||||++|..|+...... ..+... ...... ......
T Consensus 174 ~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~----i~~~~~---------~~~~~~ 238 (285)
T d1fmka3 174 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQ----VERGYR---------MPCPPE 238 (285)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHH----HHTTCC---------CCCCTT
T ss_pred ccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHH----HHhcCC---------CCCCcc
Confidence 67999999999999999999999999999999999987776433221 111111 111111 111222
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 270 QIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 270 ~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
.+..+.+|+.+||+.||++|||+++|+++|+...
T Consensus 239 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 3456889999999999999999999999998764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=377.95 Aligned_cols=236 Identities=23% Similarity=0.353 Sum_probs=189.8
Q ss_pred hcCCCCCCc-ccccCCeeEEEEEEC---CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 49 TKNFHPSNK-LGEGGFGPVFKGKLD---DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~-lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
.++|.+.+. ||+|+||.||+|.++ ++..||||++.... ....+.|.+|+++|++++|||||+++|++.. +..||
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 345667774 999999999999764 35579999997543 3445789999999999999999999999975 45899
Q ss_pred EEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 124 IYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 124 v~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
|||||++|+|.+++ .|++.||.|||+++ ||||||+||||+.++.+||+|||+++.+......
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 165 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence 99999999998765 78999999999999 9999999999999999999999999987554332
Q ss_pred c--ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 186 V--NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 186 ~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
. .....||+.|+|||++.++.++.++|||||||++|||+| |+.||...... .+. .........
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~----~~i~~~~~~------- 231 (285)
T d1u59a_ 166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVM----AFIEQGKRM------- 231 (285)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHH----HHHHTTCCC-------
T ss_pred cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCCC-------
Confidence 2 224568999999999999999999999999999999998 89998643321 111 112222111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
..+...+..+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 232 --~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 232 --ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp --CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1112334568899999999999999999999998864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-52 Score=380.73 Aligned_cols=236 Identities=22% Similarity=0.308 Sum_probs=176.3
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
..+.|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+++|++++|||||++++++.+++..||||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3467999999999999999999876 58999999997543 223456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeC---CCCCcEEeeeccceecCCCCcc
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLD---DKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~---~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
|||++|+|.+++ .|++.||.|||+++ ||||||+|||+. +++.+||+|||+++......
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-- 164 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-- 164 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC--
Confidence 999999998765 78999999999999 999999999994 57899999999998764332
Q ss_pred cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCC
Q 048280 186 VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
.....+||+.|+|||++.+..|+.++|||||||+||||++|+.||...... ............ ....
T Consensus 165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~~~~~-------~~~~ 231 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA------KLFEQILKAEYE-------FDSP 231 (307)
T ss_dssp --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHTTCCC-------CCTT
T ss_pred eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHhccCCC-------CCCc
Confidence 223467999999999999999999999999999999999999998643221 111122221111 1111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 266 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 232 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 232 YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 122334568899999999999999999999874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.5e-52 Score=386.41 Aligned_cols=235 Identities=21% Similarity=0.265 Sum_probs=194.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
.++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..||||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 468999999999999999999875 6899999999877666677899999999999999999999999999999999999
Q ss_pred ccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeC--CCCCcEEeeeccceecCCCCcccc
Q 048280 128 VINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLD--DKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 128 ~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~--~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|++|+|.+++ .|++.||.|||+++ ||||||+||||+ .++.+||+|||+++.+..... .
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~--~ 182 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--V 182 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC--E
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc--c
Confidence 9999997665 79999999999999 999999999995 467899999999998754332 3
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .+........... ......
T Consensus 183 ~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~-------~~~~~~ 249 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCDWN-------MDDSAF 249 (350)
T ss_dssp EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCC-------SCCGGG
T ss_pred ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC-------CCcccc
Confidence 346799999999999999999999999999999999999999864321 1111222211110 001111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
...+..+.+||.+||+.||++|||+.|+++.
T Consensus 250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 250 SGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2234568899999999999999999999874
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-53 Score=380.97 Aligned_cols=239 Identities=25% Similarity=0.421 Sum_probs=184.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC-C----cEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD-G----REIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKL 122 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~-~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 122 (381)
.+.|++.++||+|+||.||+|.++. + ..||||++.... ......|.+|++++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 3568889999999999999998653 2 479999996543 333457899999999999999999999999999999
Q ss_pred EEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 123 LIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 123 lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
+|||||.+++|.+++ .|++.|+.|||+.+ ||||||+||||+.++.+||+|||+++.+.....
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 999999999886544 78999999999999 999999999999999999999999987644322
Q ss_pred c--cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCC
Q 048280 185 H--VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSL 262 (381)
Q Consensus 185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (381)
. ......||+.|+|||++.++.++.++|||||||++|||++|..|+...... ..+. .......
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~----~~i~~~~--------- 230 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVM----KAINDGF--------- 230 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHH----HHHHTTC---------
T ss_pred cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHH----HHHhccC---------
Confidence 1 223456899999999999999999999999999999999977776433221 1111 1122111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 263 AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 263 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
....+...+..+.+|+.+||+.||++|||+.||++.|+++
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 231 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 1112223446688999999999999999999999998754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=385.61 Aligned_cols=237 Identities=28% Similarity=0.422 Sum_probs=190.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC-C-----cEEEEEEecCC-CcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD-G-----REIAVKKLSHS-SNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAE 120 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 120 (381)
.++|++.+.||+|+||.||+|++.. + ..||+|++... .......+.+|+.+|.++ +|||||+++++|.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4679999999999999999998642 2 36999998654 334456899999999999 89999999999999999
Q ss_pred EEEEEecccCCCHHHHH--------------------------------------HhhhhhhhHhhhhc--cCCccccce
Q 048280 121 KLLIYEYVINESLDKVL--------------------------------------FSLIKDIQILFRKK--KTDIKASNI 160 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l--------------------------------------~~~~~~l~~lh~~~--HrDlkp~NI 160 (381)
.++|||||++|+|.++| .|++.||.|||+++ ||||||+||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni 195 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence 99999999999998765 58999999999999 999999999
Q ss_pred EeCCCCCcEEeeeccceecCCCCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccc
Q 048280 161 LLDDKWIPKIADFGMARLFPEDQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDA 238 (381)
Q Consensus 161 ll~~~~~~kL~DFG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~ 238 (381)
|++.++.+||+|||+|+........ ......||+.|+|||++.++.++.++|||||||+||||++ |..||.......
T Consensus 196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~- 274 (325)
T d1rjba_ 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA- 274 (325)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH-
Confidence 9999999999999999876443322 2335678999999999999999999999999999999998 899986432211
Q ss_pred ccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048280 239 QNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLS 300 (381)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 300 (381)
.+ ......... ...+...+..+.+||.+||+.||++|||++||++.|.
T Consensus 275 -~~----~~~~~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 275 -NF----YKLIQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp -HH----HHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -HH----HHHHhcCCC---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 11 122222211 1112223456889999999999999999999999984
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=374.14 Aligned_cols=229 Identities=26% Similarity=0.371 Sum_probs=181.5
Q ss_pred CcccccCCeeEEEEEEC---CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEecccC
Q 048280 56 NKLGEGGFGPVFKGKLD---DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEYVIN 130 (381)
Q Consensus 56 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 130 (381)
++||+|+||.||+|.+. .++.||||++.... ....+.|.+|+++|++++|||||+++++|.. +..+||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999754 35689999996542 2335679999999999999999999999965 457899999999
Q ss_pred CCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccc--ccccc
Q 048280 131 ESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHV--NTRVA 191 (381)
Q Consensus 131 g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~--~~~~~ 191 (381)
|+|.+++ .|++.||.|||+.+ ||||||+||||+.++.+||+|||+++.+....... .....
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 171 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----C
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccC
Confidence 9998765 68999999999999 99999999999999999999999999775443322 23457
Q ss_pred cCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHH
Q 048280 192 GTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQ 270 (381)
Q Consensus 192 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (381)
||+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+ .......... ..+..+
T Consensus 172 gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~----~~~i~~~~~~---------~~p~~~ 235 (277)
T d1xbba_ 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EV----TAMLEKGERM---------GCPAGC 235 (277)
T ss_dssp CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH----HHHHHTTCCC---------CCCTTC
T ss_pred CCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HH----HHHHHcCCCC---------CCCccc
Confidence 8999999999999999999999999999999998 89998643221 11 1122222111 111223
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 271 IAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 271 ~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
+..+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 4568899999999999999999999988754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.2e-52 Score=385.13 Aligned_cols=235 Identities=21% Similarity=0.263 Sum_probs=193.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
.++|++++.||+|+||.||+|+.. +|+.||||++..........+.+|+++|++++|||||+++++|.+++..||||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 467999999999999999999875 6999999999876655667889999999999999999999999999999999999
Q ss_pred ccCCCHHHH----------------HHhhhhhhhHhhhhc--cCCccccceEeC--CCCCcEEeeeccceecCCCCcccc
Q 048280 128 VINESLDKV----------------LFSLIKDIQILFRKK--KTDIKASNILLD--DKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 128 ~~~g~L~~~----------------l~~~~~~l~~lh~~~--HrDlkp~NIll~--~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|++|+|.++ +.|++.||.|||+++ ||||||+||||+ .++.+||+|||+++.+..... .
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~--~ 185 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--V 185 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--E
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc--e
Confidence 999999654 479999999999999 999999999997 678999999999998754432 3
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
....||+.|+|||++.+..++.++|||||||+||+|++|+.||...... .. ......... .......
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~---~~~i~~~~~-------~~~~~~~ 252 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ET---LQNVKRCDW-------EFDEDAF 252 (352)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HH---HHHHHHCCC-------CCCSSTT
T ss_pred eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HH---HHHHHhCCC-------CCCcccc
Confidence 3467999999999999999999999999999999999999998643221 11 111211111 0111111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
...+..+.+||.+||+.||.+|||+.|+++.
T Consensus 253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2234568899999999999999999999874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=368.90 Aligned_cols=227 Identities=24% Similarity=0.357 Sum_probs=179.6
Q ss_pred CCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEee----CCeEEEEE
Q 048280 53 HPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAH----GAEKLLIY 125 (381)
Q Consensus 53 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~ 125 (381)
++.++||+|+||+||+|++. +++.||+|++... .....+.+.+|+++|++++|||||++++++.+ ...+|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56778999999999999876 5889999998654 33345678999999999999999999999875 45689999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc----cCCccccceEeC-CCCCcEEeeeccceecCCCCcc
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK----KTDIKASNILLD-DKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~----HrDlkp~NIll~-~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
|||++|+|.+++ .|++.||.|||+++ ||||||+||||+ .++.+||+|||+++.....
T Consensus 92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~--- 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--- 168 (270)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT---
T ss_pred eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC---
Confidence 999999997765 78999999999875 999999999996 5789999999999864332
Q ss_pred cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCC
Q 048280 186 VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
.....+||+.|+|||++.+ .++.++|||||||++|||++|+.||...... ... .............+ .
T Consensus 169 ~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-----~~~-~~~i~~~~~~~~~~----~- 236 (270)
T d1t4ha_ 169 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQI-YRRVTSGVKPASFD----K- 236 (270)
T ss_dssp SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHH-HHHHTTTCCCGGGG----G-
T ss_pred ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-----HHH-HHHHHcCCCCcccC----c-
Confidence 2235689999999998865 6999999999999999999999998543221 111 11111111111111 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 266 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.....+.+|+.+||+.||++|||+.||++
T Consensus 237 ---~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 237 ---VAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---cCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 12245788999999999999999999976
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-52 Score=380.78 Aligned_cols=228 Identities=26% Similarity=0.425 Sum_probs=185.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc---ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---QGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
+.|+.++.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++|++++|||||++++++.+.+..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 34899999999999999999865 688999999975532 23456889999999999999999999999999999999
Q ss_pred ecccCCCHHHH---------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 126 EYVINESLDKV---------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 126 E~~~~g~L~~~---------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
|||.+|+|..+ +.|++.||.|||+++ ||||||+||||+.++.+||+|||+++..... .
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-----~ 169 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----N 169 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----C
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC-----C
Confidence 99999988643 489999999999999 9999999999999999999999999865332 2
Q ss_pred ccccCccccchhHHhh---CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCC
Q 048280 189 RVAGTNGYMAPEYVMH---GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAAS 265 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
...||+.|+|||++.+ +.|+.++|||||||++|||++|..||..... ............ +...
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~i~~~~~------~~~~-- 235 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNES------PALQ-- 235 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC------CCCS--
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCC------CCCC--
Confidence 4579999999999864 4589999999999999999999999854321 111122222111 1111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 266 DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 266 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 236 -~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 -SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1122356889999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=373.24 Aligned_cols=234 Identities=24% Similarity=0.316 Sum_probs=190.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC------cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS------NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEK 121 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 121 (381)
.+.|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999975 68999999986432 22357899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCC----CcEEeeeccceecC
Q 048280 122 LLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKW----IPKIADFGMARLFP 180 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~----~~kL~DFG~~~~~~ 180 (381)
|||||||++|+|.+++ .|++.||.|||+.+ ||||||+|||++.++ .+||+|||++..+.
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 9999999999998765 78999999999999 999999999998776 59999999999875
Q ss_pred CCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCC
Q 048280 181 EDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDP 260 (381)
Q Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +...........
T Consensus 169 ~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~~~~~------ 234 (293)
T d1jksa_ 169 FGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANVSAVNYE------ 234 (293)
T ss_dssp TSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHTTCCC------
T ss_pred CCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH------HHHHHHHhcCCC------
Confidence 4332 23457899999999999999999999999999999999999998643221 111111111100
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 261 SLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 261 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.........+..+.+||.+||+.||.+|||++|+++
T Consensus 235 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 -FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000112356789999999999999999999987
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-51 Score=374.80 Aligned_cols=231 Identities=22% Similarity=0.277 Sum_probs=190.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|++++.||+|+||.||+|+.+ +|+.||||++.+. .....+.+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 457999999999999999999875 6999999999653 233457789999999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
||||++|+|.+++ .|++.||.|+|+++ ||||||+||||+.+|.+||+|||+++....... ..
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~-~~ 162 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 162 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-CB
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc-cc
Confidence 9999999997655 78999999999999 999999999999999999999999987643322 23
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
...+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ..+. ..... .. ..+ +
T Consensus 163 ~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~---~~i~~-~~------~~~----p 225 (337)
T d1o6la_ 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLF---ELILM-EE------IRF----P 225 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHHH-CC------CCC----C
T ss_pred ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---HHHH---HHHhc-CC------CCC----C
Confidence 457899999999999999999999999999999999999999864322 1111 11111 11 111 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPT-----MRRVVV 297 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 297 (381)
...+..+.+||.+||+.||.+|++ +.||++
T Consensus 226 ~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 123356889999999999999995 788875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.6e-51 Score=372.00 Aligned_cols=229 Identities=24% Similarity=0.312 Sum_probs=190.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
.++|++++.||+|+||.||+|+.+ +|+.||||++... .....+.+.+|+.+|++++|||||++++++.+.+..|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 357999999999999999999975 5999999999643 233457899999999999999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
||||.+|+|..++ .|++.||.|+|+++ ||||||+||||+.++.+||+|||+++.+... .
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~----~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----T 158 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----B
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc----c
Confidence 9999999996554 79999999999999 9999999999999999999999999986433 2
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
...+||+.|+|||++.+..|+.++|||||||+||||++|+.||..... ............ ...
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~~~-------~~p---- 221 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAEL-------RFP---- 221 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCCC-------CCC----
T ss_pred ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------HHHHHHHHcCCC-------CCC----
Confidence 346899999999999999999999999999999999999999864322 111122222111 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRP-----TMRRVVVM 298 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 298 (381)
......+.+++.+||..||.+|+ |+++|++.
T Consensus 222 ~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 222 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 11235588899999999999996 89999863
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=368.28 Aligned_cols=236 Identities=22% Similarity=0.348 Sum_probs=179.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC----CcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD----GREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
.++|++.+.||+|+||.||+|++.. +..||||++... .....+.+.+|+++|++++|||||++++++.+ +..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 4689999999999999999998642 456899998654 33345679999999999999999999999964 67899
Q ss_pred EEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 124 IYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 124 v~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
||||+++|+|.+++ .|++.||.|+|+.+ ||||||+|||++.++.+||+|||+++.+......
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~ 164 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 164 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcce
Confidence 99999999997654 78999999999999 9999999999999999999999999977554444
Q ss_pred cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCC
Q 048280 186 VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAA 264 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (381)
......||+.|+|||++.+..++.++|||||||++|||++ |..||...... .+... .......
T Consensus 165 ~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~----i~~~~~~--------- 228 (273)
T d1mp8a_ 165 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR----IENGERL--------- 228 (273)
T ss_dssp ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH----HHTTCCC---------
T ss_pred eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHH----HHcCCCC---------
Confidence 4455678999999999999999999999999999999998 78887654332 22221 1111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 265 SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 265 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
..+...+..+.+||.+||+.||++|||+.||++.|+.
T Consensus 229 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 229 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1112234568899999999999999999999998865
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-51 Score=375.55 Aligned_cols=242 Identities=26% Similarity=0.400 Sum_probs=193.5
Q ss_pred HHHhhcCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCCCc-ccHHHHHHHHHHHHHhCCCCcccEEEEEee
Q 048280 45 LVSATKNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHSSN-QGKKEFENEAKLLARVQHRNVVNLLGYCAH 117 (381)
Q Consensus 45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 117 (381)
+....++|++.+.||+|+||.||+|+.+ +++.||||++..... ...+.|.+|+++|++++||||++++++|..
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 3344678999999999999999999864 357899999975432 335679999999999999999999999999
Q ss_pred CCeEEEEEecccCCCHHHHH---------------------------------------HhhhhhhhHhhhhc--cCCcc
Q 048280 118 GAEKLLIYEYVINESLDKVL---------------------------------------FSLIKDIQILFRKK--KTDIK 156 (381)
Q Consensus 118 ~~~~~lv~E~~~~g~L~~~l---------------------------------------~~~~~~l~~lh~~~--HrDlk 156 (381)
.+..++||||+.+|+|.+++ .|++.||+|+|.++ |||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK 167 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence 99999999999999998765 57899999999998 99999
Q ss_pred ccceEeCCCCCcEEeeeccceecCCCCc-ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCC-CCCCCC
Q 048280 157 ASNILLDDKWIPKIADFGMARLFPEDQT-HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQR-NSSFNL 234 (381)
Q Consensus 157 p~NIll~~~~~~kL~DFG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~-p~~~~~ 234 (381)
|+||||+.++.+||+|||+++.+..... ...+...||+.|+|||.+.+..++.++|||||||++|||++|.. ||....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 9999999999999999999986643322 22335678999999999999999999999999999999999965 554322
Q ss_pred ccccccHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 235 DVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
.. .+. .. ....... ..+...+..+.+|+.+||+.||++||||.||++.|+++
T Consensus 248 ~~---e~~---~~-v~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 248 HE---EVI---YY-VRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp HH---HHH---HH-HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HH---HHH---HH-HHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11 111 11 2222111 11122335688999999999999999999999999865
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=367.83 Aligned_cols=245 Identities=22% Similarity=0.297 Sum_probs=183.5
Q ss_pred CCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcc-----cHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 54 PSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQ-----GKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 54 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
.+++||+|+||+||+|++. +|+.||||++...... ..+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4678999999999999975 5899999998654322 124688999999999999999999999999999999999
Q ss_pred ccCCCHH---------------HHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccc
Q 048280 128 VINESLD---------------KVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV 190 (381)
Q Consensus 128 ~~~g~L~---------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 190 (381)
+.++++. .++.|++.||.|||+++ ||||||+|||++.++.+||+|||+++........ ....
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-~~~~ 160 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-YTHQ 160 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-CCCS
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc-ccce
Confidence 9887764 34589999999999999 9999999999999999999999999876544322 2345
Q ss_pred ccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccC---------C
Q 048280 191 AGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVD---------P 260 (381)
Q Consensus 191 ~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~ 260 (381)
+||+.|+|||++.+. .++.++|||||||++|||++|..||......+. .................+ -
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred ecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH---HHHHHHhcCCCChhhccchhccchhhhh
Confidence 799999999998755 579999999999999999999999865433221 221122111100000000 0
Q ss_pred CCCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhcCC
Q 048280 261 SLAASDS-----GDQIAMCIQIGLLCTQGDPQLRPTMRRVVV--MLSKK 302 (381)
Q Consensus 261 ~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~--~L~~~ 302 (381)
....... ......+.+|+.+||+.||++|||+.|+++ .++..
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0000011 122356889999999999999999999987 35443
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-51 Score=361.76 Aligned_cols=231 Identities=23% Similarity=0.387 Sum_probs=181.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEee-CCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAH-GAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~E~ 127 (381)
.++|++.+.||+|+||.||+|+++ |..||||+++.. ...+.+.+|++++++++||||++++|+|.+ .+..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 457889999999999999999986 789999999654 345789999999999999999999999865 4568999999
Q ss_pred ccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 128 VINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 128 ~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
+++|+|.++| .|++.|+.|||+.+ ||||||+|||++.++.+||+|||+++...... .
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~----~ 158 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----D 158 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCC----c
Confidence 9999998766 68999999999998 99999999999999999999999998654322 2
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
...+|..|+|||++.+..++.++|||||||++|||++ |+.||.... ...+.... .... .+. .+
T Consensus 159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~---~~~~~~~i----~~~~-----~~~----~~ 222 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPRV----EKGY-----KMD----AP 222 (262)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC---GGGHHHHH----TTTC-----CCC----CC
T ss_pred cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC---HHHHHHHH----HcCC-----CCC----CC
Confidence 3467899999999999999999999999999999998 566664332 22222221 1111 111 12
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
......+.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus 223 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 22335688999999999999999999999999754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=369.69 Aligned_cols=236 Identities=27% Similarity=0.406 Sum_probs=184.0
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCc----EEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGR----EIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 123 (381)
.+|++++.||+|+||+||+|++. +|+ .||+|++... .....+.|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999865 343 6899988654 344567899999999999999999999999875 4678
Q ss_pred EEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 124 IYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 124 v~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
++||+.+++|.+++ .|++.||.|||+++ ||||||+||||+.++.+||+|||+++.+......
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~ 167 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC-
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccccc
Confidence 88999999986544 79999999999998 9999999999999999999999999977544332
Q ss_pred c-ccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC
Q 048280 186 V-NTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 186 ~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
. .....||+.|+|||++.++.++.++|||||||+||||+| |..||...... .+... .......
T Consensus 168 ~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~~~----i~~~~~~-------- 232 (317)
T d1xkka_ 168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSI----LEKGERL-------- 232 (317)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHHHH----HHHTCCC--------
T ss_pred ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HHHHH----HHcCCCC--------
Confidence 2 234568999999999999999999999999999999998 77777543322 22221 1111111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 264 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
..+..++..+.+|+.+||+.||.+|||+.||++.|...
T Consensus 233 -~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 233 -PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 11122345688999999999999999999999988654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=365.71 Aligned_cols=237 Identities=26% Similarity=0.380 Sum_probs=180.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC--CC--cEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD--DG--REIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEK 121 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 121 (381)
.++|++.+.||+|+||.||+|+.. ++ ..||||++... .....+.|.+|+++|++++|||||+++|+|.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 467999999999999999999853 22 47899998654 22334679999999999999999999999976 467
Q ss_pred EEEEecccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 122 LLIYEYVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
++||||+++|+|.+++ .|++.||.|||+++ ||||||+||||+.++.+||+|||+++.+....
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 8999999999987544 78999999999999 99999999999999999999999999875543
Q ss_pred cc--cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcCCcccccCC
Q 048280 184 TH--VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDP 260 (381)
Q Consensus 184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
.. ......|+..|+|||++.+..++.++|||||||++|||++ |+.||..... .+............
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~------~~~~~~i~~~~~~~----- 234 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEGERL----- 234 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSCCCC-----
T ss_pred CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH------HHHHHHHHhCCCCC-----
Confidence 32 2234567889999999999999999999999999999998 8999853322 11122222221111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 261 SLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 261 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
......+..+.+|+.+||+.||++|||+.+|++.|.+
T Consensus 235 ----~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 235 ----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1112233568899999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9e-50 Score=358.88 Aligned_cols=240 Identities=22% Similarity=0.303 Sum_probs=185.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCc---ccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC----e
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSN---QGKKEFENEAKLLARVQHRNVVNLLGYCAHGA----E 120 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~ 120 (381)
.++|++.+.||+|+||.||+|++. +++.||||++..... .....+.+|++++++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999875 699999999975532 33457899999999999999999999987653 4
Q ss_pred EEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCC
Q 048280 121 KLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~ 183 (381)
.|||||||++++|.+++ .|++.||.|||+++ ||||||+||||+.++.++|+|||.+.......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 79999999999997554 79999999999998 99999999999999999999999998664332
Q ss_pred c--ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCC
Q 048280 184 T--HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPS 261 (381)
Q Consensus 184 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (381)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+..............
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~~~~---- 235 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIPPS---- 235 (277)
T ss_dssp -------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCCGG----
T ss_pred ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCCCCc----
Confidence 2 223356799999999999999999999999999999999999999864322 1222222222211110
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhcC
Q 048280 262 LAASDSGDQIAMCIQIGLLCTQGDPQLRP-TMRRVVVMLSK 301 (381)
Q Consensus 262 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~ 301 (381)
......+..+.+||.+||+.||.+|| |++++++.|.+
T Consensus 236 ---~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 236 ---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ---GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 11112335688999999999999999 89999888865
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.4e-50 Score=358.68 Aligned_cols=235 Identities=22% Similarity=0.289 Sum_probs=190.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcc---------cHHHHHHHHHHHHHhC-CCCcccEEEEEee
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQ---------GKKEFENEAKLLARVQ-HRNVVNLLGYCAH 117 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~ 117 (381)
.++|++.+.||+|+||+||+|+.. +++.||||++...... ..+.+.+|+.++++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 468999999999999999999875 6899999999754321 1246889999999997 9999999999999
Q ss_pred CCeEEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecC
Q 048280 118 GAEKLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFP 180 (381)
Q Consensus 118 ~~~~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~ 180 (381)
++..|||||||++|+|.++| .|++.||.|||.++ ||||||+||||+.++.+||+|||+++.+.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999998766 79999999999999 99999999999999999999999999875
Q ss_pred CCCcccccccccCccccchhHHhh------CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCc
Q 048280 181 EDQTHVNTRVAGTNGYMAPEYVMH------GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKS 254 (381)
Q Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (381)
.... .....||..|+|||.+.+ ..++.++||||+||+||||++|+.||...... ............
T Consensus 162 ~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~------~~~~~i~~~~~~ 233 (277)
T d1phka_ 162 PGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------LMLRMIMSGNYQ 233 (277)
T ss_dssp TTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCC
T ss_pred CCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH------HHHHHHHhCCCC
Confidence 4332 344679999999999864 34688999999999999999999998643221 111112221111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 255 LEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
.........+..+.+|+.+||+.||.+|||++||++.
T Consensus 234 -------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 234 -------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp -------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred -------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111222344678899999999999999999999763
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.2e-50 Score=370.44 Aligned_cols=227 Identities=21% Similarity=0.250 Sum_probs=189.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++|++++.||+|+||.||+|+++ +|+.||||++... .....+.+.+|+++|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999875 6999999998643 2334567899999999999999999999999999999999
Q ss_pred ecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 126 EYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 126 E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
||+.+|+|..++ .|++.||.|||+++ ||||||+||||+.++.+||+|||+++.+... ..
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~----~~ 196 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TW 196 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----BC
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc----cc
Confidence 999999997654 78999999999999 9999999999999999999999999976432 23
Q ss_pred ccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 048280 189 RVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDSG 268 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
...||+.|+|||++.+..++.++|||||||+||||++|+.||.... ............. .. +.
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~~~-------~~----p~ 259 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIVSGKV-------RF----PS 259 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCC-------CC----CT
T ss_pred cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC------HHHHHHHHhcCCC-------CC----Cc
Confidence 4679999999999999999999999999999999999999986432 1111122222110 11 11
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 048280 269 DQIAMCIQIGLLCTQGDPQLRP-----TMRRVVV 297 (381)
Q Consensus 269 ~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 297 (381)
.....+.+||.+||+.||.+|+ |+++|++
T Consensus 260 ~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred cCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 2335688999999999999994 8999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.1e-50 Score=372.42 Aligned_cols=232 Identities=23% Similarity=0.303 Sum_probs=183.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC---cccHHHHHHH---HHHHHHhCCCCcccEEEEEeeCCeE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS---NQGKKEFENE---AKLLARVQHRNVVNLLGYCAHGAEK 121 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~hpnIv~~~~~~~~~~~~ 121 (381)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+| +++++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 368999999999999999999976 59999999985431 2223344555 5556666799999999999999999
Q ss_pred EEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 122 LLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
|+|||||++|+|.++| .|++.||.|||+++ ||||||+||||+.++.+||+|||+++.+....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~- 161 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 161 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc-
Confidence 9999999999998766 68999999999999 99999999999999999999999999765432
Q ss_pred ccccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCC
Q 048280 185 HVNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLA 263 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (381)
.....||+.|+|||++.+ ..|+.++|||||||+||||++|+.||......+.. . ......... ...
T Consensus 162 --~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~----~~~~~~~~~---~~~- 228 (364)
T d1omwa3 162 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---E----IDRMTLTMA---VEL- 228 (364)
T ss_dssp --CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH---H----HHHHSSSCC---CCC-
T ss_pred --ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH---H----HHHhcccCC---CCC-
Confidence 234579999999999975 46899999999999999999999999654332221 1 111111111 111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 048280 264 ASDSGDQIAMCIQIGLLCTQGDPQLRPT-----MRRVVV 297 (381)
Q Consensus 264 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 297 (381)
+...+..+.+||.+||+.||.+||| ++||++
T Consensus 229 ---~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 229 ---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ---CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ---CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1123356889999999999999999 688875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=362.66 Aligned_cols=234 Identities=27% Similarity=0.432 Sum_probs=185.6
Q ss_pred CCcccccCCeeEEEEEECC----CcEEEEEEecCC-CcccHHHHHHHHHHHHHhCCCCcccEEEEEee-CCeEEEEEecc
Q 048280 55 SNKLGEGGFGPVFKGKLDD----GREIAVKKLSHS-SNQGKKEFENEAKLLARVQHRNVVNLLGYCAH-GAEKLLIYEYV 128 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~E~~ 128 (381)
.++||+|+||+||+|++.+ ...||||+++.. .....++|.+|+++|++++|||||+++|++.. +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5789999999999998653 236899999753 44445789999999999999999999999876 46899999999
Q ss_pred cCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc---cc
Q 048280 129 INESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH---VN 187 (381)
Q Consensus 129 ~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~---~~ 187 (381)
.+|+|.+++ .|++.||.|+|..+ ||||||+||||++++.+||+|||+++.+...... ..
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 191 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceec
Confidence 999997655 78999999999999 9999999999999999999999999976543322 22
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
....||+.|+|||.+.++.++.++|||||||++|||++|+.||...... ..+.. .... .... ..|
T Consensus 192 ~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~---~i~~-g~~~--~~p------- 256 (311)
T d1r0pa_ 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITV---YLLQ-GRRL--LQP------- 256 (311)
T ss_dssp TCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHH---HHHT-TCCC--CCC-------
T ss_pred ccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHH---HHHc-CCCC--CCc-------
Confidence 2456899999999999999999999999999999999988887543211 11111 1111 1111 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKKP 303 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 303 (381)
......+.+|+.+||+.||++|||+.||++.|+++.
T Consensus 257 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 257 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 122356889999999999999999999999997753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=364.80 Aligned_cols=233 Identities=18% Similarity=0.257 Sum_probs=189.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
.++|++.+.||+|+||+||+|.+. +++.||||++.... .....+.+|+++|++++|||||++++++.+.+.+||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 568999999999999999999876 58899999997654 3345688999999999999999999999999999999999
Q ss_pred ccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCC--CCCcEEeeeccceecCCCCcccc
Q 048280 128 VINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDD--KWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 128 ~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~--~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
|.+|+|.+++ .|++.||.|||+++ ||||||+|||++. .+.+||+|||+++....... .
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~--~ 160 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--F 160 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE--E
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCc--c
Confidence 9999997665 78999999999999 9999999999984 45899999999997644322 3
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
....+|+.|+|||.+.+..++.++|||||||++|+|++|..||...... +............. . ...
T Consensus 161 ~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~~~~~~~---~----~~~ 227 (321)
T d1tkia_ 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEYTFD---E----EAF 227 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCCC---H----HHH
T ss_pred cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCCC---h----hhc
Confidence 3457899999999999999999999999999999999999998643321 11122222111000 0 000
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
......+.+|+.+||..||.+|||+.|+++
T Consensus 228 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 228 KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 012355889999999999999999999987
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=366.08 Aligned_cols=233 Identities=20% Similarity=0.214 Sum_probs=183.9
Q ss_pred hcCCCCCC-cccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHh-CCCCcccEEEEEee----CCeE
Q 048280 49 TKNFHPSN-KLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARV-QHRNVVNLLGYCAH----GAEK 121 (381)
Q Consensus 49 ~~~y~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~----~~~~ 121 (381)
.++|++.. .||+|+||.||+|++. +++.||||++.. ...+.+|+.++.++ +|||||+++++|.+ ...+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46898875 5999999999999874 689999999853 35678899998766 89999999999876 4678
Q ss_pred EEEEecccCCCHHHHH-----------------HhhhhhhhHhhhhc--cCCccccceEeCC---CCCcEEeeeccceec
Q 048280 122 LLIYEYVINESLDKVL-----------------FSLIKDIQILFRKK--KTDIKASNILLDD---KWIPKIADFGMARLF 179 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~l-----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~---~~~~kL~DFG~~~~~ 179 (381)
|||||||+||+|.++| .|++.||.|||+.+ ||||||+|||++. .+.+||+|||+++..
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeec
Confidence 9999999999998766 78999999999999 9999999999975 567999999999976
Q ss_pred CCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccC
Q 048280 180 PEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVD 259 (381)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
..... .....||+.|+|||++.+..|+.++|||||||+||+|++|+.||......... .. ...... ...
T Consensus 165 ~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~---~~~~i~---~~~ 233 (335)
T d2ozaa1 165 TSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PG---MKTRIR---MGQ 233 (335)
T ss_dssp CCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------CCC---SCS
T ss_pred cCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HH---HHHHHh---cCC
Confidence 54332 23467999999999999999999999999999999999999999643322110 00 000000 000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 260 PSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 260 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
..+........+..+.+||.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111122345577899999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=368.43 Aligned_cols=236 Identities=25% Similarity=0.399 Sum_probs=185.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC-Cc--EEEEEEecCC-CcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCCeEEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD-GR--EIAVKKLSHS-SNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l 123 (381)
.++|++.+.||+|+||.||+|++++ +. .||||++... .....+.+.+|+++|+++ +|||||+++++|.+.+..++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 3689999999999999999998753 44 5788887543 334456799999999999 79999999999999999999
Q ss_pred EEecccCCCHHHHH-------------------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEE
Q 048280 124 IYEYVINESLDKVL-------------------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKI 170 (381)
Q Consensus 124 v~E~~~~g~L~~~l-------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL 170 (381)
||||+++|+|.++| .|++.|+.|+|+.+ ||||||+|||++.++.+||
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEE
Confidence 99999999998765 58999999999999 9999999999999999999
Q ss_pred eeeccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCC-CCCCCccccccHHHHHHHHh
Q 048280 171 ADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRN-SSFNLDVDAQNLLDWAYKLY 249 (381)
Q Consensus 171 ~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p-~~~~~~~~~~~~~~~~~~~~ 249 (381)
+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|..| |... +..+.... .
T Consensus 169 ~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~------~~~~~~~~-i 239 (309)
T d1fvra_ 169 ADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM------TCAELYEK-L 239 (309)
T ss_dssp CCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHH-G
T ss_pred cccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC------CHHHHHHH-H
Confidence 99999986533222 2245689999999999999999999999999999999997654 4322 11111111 1
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 250 KKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
..... ...+...+..+.+||.+||+.||++|||+.||++.|+++
T Consensus 240 ~~~~~---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 240 PQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp GGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11111 111223346788999999999999999999999988765
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=363.18 Aligned_cols=230 Identities=24% Similarity=0.325 Sum_probs=187.4
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC---CcccHHHHHHHHHHHH-HhCCCCcccEEEEEeeCCeEEEE
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS---SNQGKKEFENEAKLLA-RVQHRNVVNLLGYCAHGAEKLLI 124 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~lv 124 (381)
++|++.+.||+|+||+||+|++. +++.||||++.+. .....+.+.+|+.++. .++|||||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999876 6999999999643 2234566777887766 57999999999999999999999
Q ss_pred EecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccc
Q 048280 125 YEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVN 187 (381)
Q Consensus 125 ~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~ 187 (381)
||||++|+|.+++ .|++.||.|||+++ ||||||+|||+++++.+||+|||+++....... ..
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~-~~ 160 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KT 160 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-CB
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc-cc
Confidence 9999999998766 78999999999999 999999999999999999999999986543322 23
Q ss_pred cccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCCCCCCCCC
Q 048280 188 TRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDPSLAASDS 267 (381)
Q Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ..... .. +...
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~---~~i~~-~~------~~~p---- 223 (320)
T d1xjda_ 161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELF---HSIRM-DN------PFYP---- 223 (320)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHH-CC------CCCC----
T ss_pred cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HHH---HHHHc-CC------CCCC----
Confidence 4467999999999999999999999999999999999999999643221 111 11111 11 1111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 048280 268 GDQIAMCIQIGLLCTQGDPQLRPTMR-RVVV 297 (381)
Q Consensus 268 ~~~~~~l~~li~~cl~~dP~~RPs~~-eil~ 297 (381)
...+..+.+|+.+||+.||.+|||+. +|++
T Consensus 224 ~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 224 RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 12245688999999999999999995 6754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=363.83 Aligned_cols=240 Identities=31% Similarity=0.477 Sum_probs=193.1
Q ss_pred hhcCCCCCCcccccCCeeEEEEEE------CCCcEEEEEEecCCC-cccHHHHHHHHHHHHHh-CCCCcccEEEEEeeCC
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKL------DDGREIAVKKLSHSS-NQGKKEFENEAKLLARV-QHRNVVNLLGYCAHGA 119 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 119 (381)
..++|++.+.||+|+||.||+|++ .+++.||||++.... ......+.+|+.+++++ +|||||+++++|.+..
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 457899999999999999999975 246789999997543 33456789999999999 6999999999999999
Q ss_pred eEEEEEecccCCCHHHHH---------------------------------HhhhhhhhHhhhhc--cCCccccceEeCC
Q 048280 120 EKLLIYEYVINESLDKVL---------------------------------FSLIKDIQILFRKK--KTDIKASNILLDD 164 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~~l---------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~ 164 (381)
..++|||||++|+|.+++ .|++.|++|||+++ ||||||+|||++.
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~ 180 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccc
Confidence 999999999999987654 78999999999999 9999999999999
Q ss_pred CCCcEEeeeccceecCCCCc-ccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHH
Q 048280 165 KWIPKIADFGMARLFPEDQT-HVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLD 243 (381)
Q Consensus 165 ~~~~kL~DFG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~ 243 (381)
++.+||+|||+++....... .......||+.|+|||++.++.++.++|||||||++|||+|+..|+........ .
T Consensus 181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~--~-- 256 (311)
T d1t46a_ 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--K-- 256 (311)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--H--
T ss_pred cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH--H--
Confidence 99999999999997754433 333456899999999999999999999999999999999996555433222211 1
Q ss_pred HHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 244 WAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
........... ..+...+..+.+||.+||+.||.+|||+.+|+++|++
T Consensus 257 -~~~~i~~~~~~---------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 257 -FYKMIKEGFRM---------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp -HHHHHHHTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHHHhcCCCC---------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11222221111 1111234568899999999999999999999999975
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-50 Score=366.48 Aligned_cols=239 Identities=25% Similarity=0.391 Sum_probs=192.4
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCe
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAE 120 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 120 (381)
..++|++.+.||+|+||.||+|.++ ++..||||+++... ......|.+|+.++++++|||||+++++|...+.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 3468899999999999999999763 25789999997543 3334568999999999999999999999999999
Q ss_pred EEEEEecccCCCHHHHH-------------------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeee
Q 048280 121 KLLIYEYVINESLDKVL-------------------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADF 173 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l-------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DF 173 (381)
.++||||+.+|+|.+++ .+++.||.|||.++ ||||||+||||+.++++||+||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DF 177 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 177 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeec
Confidence 99999999999997654 68899999999998 9999999999999999999999
Q ss_pred ccceecCCCCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCC-CCCCCCCccccccHHHHHHHHhhc
Q 048280 174 GMARLFPEDQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQ-RNSSFNLDVDAQNLLDWAYKLYKK 251 (381)
Q Consensus 174 G~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~ 251 (381)
|+++.+...... ......||+.|+|||.+.+..++.++|||||||++|||+||. .||... +..+...... .
T Consensus 178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~------~~~~~~~~i~-~ 250 (308)
T d1p4oa_ 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL------SNEQVLRFVM-E 250 (308)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS------CHHHHHHHHH-T
T ss_pred ccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC------CHHHHHHHHH-h
Confidence 999876443322 223456899999999999999999999999999999999986 454322 1111112222 1
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 252 DKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
..... .+..++..+.+|+.+||+.||++|||+.+|++.|++.
T Consensus 251 ~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 251 GGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp TCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred CCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11111 1122345689999999999999999999999999875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-49 Score=358.37 Aligned_cols=249 Identities=23% Similarity=0.344 Sum_probs=188.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
++|++++.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58999999999999999999875 68999999996542 2335789999999999999999999999999999999999
Q ss_pred cccCCCHH----------------HHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccc
Q 048280 127 YVINESLD----------------KVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNT 188 (381)
Q Consensus 127 ~~~~g~L~----------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~ 188 (381)
|+.++.+. .++.|++.||+|||+++ ||||||+|||++.++.+||+|||+++....... ...
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-~~~ 160 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYT 160 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-CTT
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc-cce
Confidence 99665443 34489999999999999 999999999999999999999999987654332 233
Q ss_pred ccccCccccchhHHhhCC-CCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCC---cccc-----cC
Q 048280 189 RVAGTNGYMAPEYVMHGH-LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDK---SLEI-----VD 259 (381)
Q Consensus 189 ~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-----~~ 259 (381)
...||+.|+|||++.... ++.++|||||||++|+|++|+.||......+ ............. .... ..
T Consensus 161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH---HHHHHHHhcCCCchhhccccccccccc
Confidence 457999999999987766 5789999999999999999999986432211 1111111111000 0000 00
Q ss_pred ---CCCCCCC----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hcCC
Q 048280 260 ---PSLAASD----SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM--LSKK 302 (381)
Q Consensus 260 ---~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~ 302 (381)
+...... .......+.+|+.+||+.||++|||+.||++. ++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0000000 01223568899999999999999999999974 5544
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=358.87 Aligned_cols=239 Identities=29% Similarity=0.433 Sum_probs=181.0
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC------CCcEEEEEEecCC-CcccHHHHHHHHHHHHHh-CCCCcccEEEEEeeC-
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD------DGREIAVKKLSHS-SNQGKKEFENEAKLLARV-QHRNVVNLLGYCAHG- 118 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~- 118 (381)
..++|++.+.||+|+||.||+|++. +++.||||++... .....+.+.+|+.++.++ +|+||+.+++++...
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 3468999999999999999999853 2468999998654 233456788899988888 689999999998664
Q ss_pred CeEEEEEecccCCCHHHHH-------------------------------HhhhhhhhHhhhhc--cCCccccceEeCCC
Q 048280 119 AEKLLIYEYVINESLDKVL-------------------------------FSLIKDIQILFRKK--KTDIKASNILLDDK 165 (381)
Q Consensus 119 ~~~~lv~E~~~~g~L~~~l-------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~ 165 (381)
...++|||||++|+|.+++ .|++.||.|||+++ ||||||+||||+++
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 5689999999999998765 47899999999999 99999999999999
Q ss_pred CCcEEeeeccceecCCCCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCC-CCCCCCccccccHHH
Q 048280 166 WIPKIADFGMARLFPEDQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQR-NSSFNLDVDAQNLLD 243 (381)
Q Consensus 166 ~~~kL~DFG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~-p~~~~~~~~~~~~~~ 243 (381)
+.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|.. ||...... ..+
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~~~-- 246 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEF-- 246 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--HHH--
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--HHH--
Confidence 99999999999876543322 2335679999999999999999999999999999999999754 55432211 111
Q ss_pred HHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 244 WAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
........... . +...+..+.+|+.+||+.||++|||+.||++.|++
T Consensus 247 --~~~~~~~~~~~-----~----~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 247 --CRRLKEGTRMR-----A----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp --HHHHHHTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --HHHHhcCCCCC-----C----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11222221111 1 11223568899999999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=360.16 Aligned_cols=238 Identities=26% Similarity=0.410 Sum_probs=187.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEECC--------CcEEEEEEecCCCc-ccHHHHHHHHHHHHHh-CCCCcccEEEEEeeC
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDD--------GREIAVKKLSHSSN-QGKKEFENEAKLLARV-QHRNVVNLLGYCAHG 118 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 118 (381)
.++|++.+.||+|+||.||+|+... +..||||++..... .....+.+|...+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 5689999999999999999997532 24799999976533 3457788999999999 799999999999999
Q ss_pred CeEEEEEecccCCCHHHHH-------------------------------HhhhhhhhHhhhhc--cCCccccceEeCCC
Q 048280 119 AEKLLIYEYVINESLDKVL-------------------------------FSLIKDIQILFRKK--KTDIKASNILLDDK 165 (381)
Q Consensus 119 ~~~~lv~E~~~~g~L~~~l-------------------------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~ 165 (381)
+..++|||||.+|+|.++| .|++.||+|+|+.+ ||||||+|||++.+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~ 171 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 171 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCC
Confidence 9999999999999997765 58999999999999 99999999999999
Q ss_pred CCcEEeeeccceecCCCCcc-cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccccccHHH
Q 048280 166 WIPKIADFGMARLFPEDQTH-VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELIS-GQRNSSFNLDVDAQNLLD 243 (381)
Q Consensus 166 ~~~kL~DFG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~ 243 (381)
+.+||+|||+++........ ......||+.|+|||.+.++.|+.++||||||||+|||++ |..||...... .
T Consensus 172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~--- 245 (299)
T d1fgka_ 172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E--- 245 (299)
T ss_dssp CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H---
T ss_pred CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---H---
Confidence 99999999999976543322 2234678999999999999999999999999999999998 67776432211 1
Q ss_pred HHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 244 WAYKLYKKDKSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
....+....... . +...+..+.+|+.+||+.||.+|||+.||++.|+++
T Consensus 246 -~~~~i~~~~~~~-----~----p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 246 -LFKLLKEGHRMD-----K----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp -HHHHHHTTCCCC-----C----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHcCCCCC-----C----CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 122222221111 1 112345688999999999999999999999999764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=355.51 Aligned_cols=246 Identities=23% Similarity=0.324 Sum_probs=182.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHH--HHHHHHHhCCCCcccEEEEEeeCC----eEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFEN--EAKLLARVQHRNVVNLLGYCAHGA----EKL 122 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~hpnIv~~~~~~~~~~----~~~ 122 (381)
..+|.+.+.||+|+||.||+|+++ |+.||||++.... ...+.+ |+..+.+++|||||+++++|.+.+ ..+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 356788899999999999999875 8999999986432 234444 555556789999999999997654 689
Q ss_pred EEEecccCCCHHHHH--------------HhhhhhhhHhhhh--------c--cCCccccceEeCCCCCcEEeeecccee
Q 048280 123 LIYEYVINESLDKVL--------------FSLIKDIQILFRK--------K--KTDIKASNILLDDKWIPKIADFGMARL 178 (381)
Q Consensus 123 lv~E~~~~g~L~~~l--------------~~~~~~l~~lh~~--------~--HrDlkp~NIll~~~~~~kL~DFG~~~~ 178 (381)
+|||||++|+|.++| .+++.++.|+|.. + ||||||+||||+.++.+||+|||+++.
T Consensus 78 lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999998776 6889999999974 3 999999999999999999999999997
Q ss_pred cCCCCcc---cccccccCccccchhHHhhCC------CCchhhhHhHHHHHHHHHhCCCCCCCCCcccc--------ccH
Q 048280 179 FPEDQTH---VNTRVAGTNGYMAPEYVMHGH------LSVKADVFSFGVVILELISGQRNSSFNLDVDA--------QNL 241 (381)
Q Consensus 179 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~--------~~~ 241 (381)
....... ......||+.|+|||++.+.. ++.++|||||||+||||+||..||........ ...
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 7543322 223567999999999987643 67899999999999999999887643221110 001
Q ss_pred HHHHHHHhhcCCcccccCCCCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 048280 242 LDWAYKLYKKDKSLEIVDPSLAAS-DSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSKK 302 (381)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 302 (381)
........... ...|.+... ........+.+|+.+||+.||++|||+.||++.|+++
T Consensus 238 ~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 238 VEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 11111111111 112222111 1234567788999999999999999999999998753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8e-49 Score=354.41 Aligned_cols=244 Identities=24% Similarity=0.325 Sum_probs=185.9
Q ss_pred cCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEec
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYEY 127 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 127 (381)
++|++++.||+|+||+||+|++++|+.||||++.... ....+.+.+|+.+|++++|||||++++++...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999999999999999996542 33357899999999999999999999999999999999999
Q ss_pred ccCCCHHH---------------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCccccccc
Q 048280 128 VINESLDK---------------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTRV 190 (381)
Q Consensus 128 ~~~g~L~~---------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 190 (381)
+.++.+.. ++.|++.||+|||+.+ ||||||+||||+.++.+||+|||++......... ....
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~ 160 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-YTHE 160 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccc-ccee
Confidence 97776643 3479999999999998 9999999999999999999999999876543322 2345
Q ss_pred ccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCccc-------------
Q 048280 191 AGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLE------------- 256 (381)
Q Consensus 191 ~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------------- 256 (381)
.|++.|+|||.+.+. .++.++|||||||++|||++|+.||......+ ................
T Consensus 161 ~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred cccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 689999999999765 56899999999999999999999986443221 1111111111100000
Q ss_pred --ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 257 --IVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 257 --~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
...+.............+.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000111223356889999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-49 Score=352.97 Aligned_cols=223 Identities=23% Similarity=0.375 Sum_probs=180.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcc------cHHHHHHHHHHHHHhC--CCCcccEEEEEeeCC
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQ------GKKEFENEAKLLARVQ--HRNVVNLLGYCAHGA 119 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~ 119 (381)
.++|++.+.||+|+||.||+|+.. +|+.||||++...... ....+.+|+.+|++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 468999999999999999999875 6899999998643211 1234678999999996 899999999999999
Q ss_pred eEEEEEecccC-CCHHHH---------------HHhhhhhhhHhhhhc--cCCccccceEeCC-CCCcEEeeeccceecC
Q 048280 120 EKLLIYEYVIN-ESLDKV---------------LFSLIKDIQILFRKK--KTDIKASNILLDD-KWIPKIADFGMARLFP 180 (381)
Q Consensus 120 ~~~lv~E~~~~-g~L~~~---------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~-~~~~kL~DFG~~~~~~ 180 (381)
..++||||+.+ +++.++ +.|++.||.|||+++ ||||||+|||++. ++.+||+|||+++...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999976 566543 379999999999999 9999999999985 5799999999998754
Q ss_pred CCCcccccccccCccccchhHHhhCCC-CchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccC
Q 048280 181 EDQTHVNTRVAGTNGYMAPEYVMHGHL-SVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVD 259 (381)
Q Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .......
T Consensus 163 ~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~~~------ 221 (273)
T d1xwsa_ 163 DTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQV------ 221 (273)
T ss_dssp SSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCC------
T ss_pred ccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhccc------
Confidence 332 335679999999999988776 577999999999999999999985311 1111110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 260 PSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 260 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
.... ..+..+.+|+.+||+.||++|||++|+++
T Consensus 222 -~~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 -FFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -CCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCC----CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0111 12356889999999999999999999987
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=354.52 Aligned_cols=245 Identities=23% Similarity=0.332 Sum_probs=183.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-C-CcEEEEEEecCC--CcccHHHHHHHHHHHHHh---CCCCcccEEEEEee----
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-D-GREIAVKKLSHS--SNQGKKEFENEAKLLARV---QHRNVVNLLGYCAH---- 117 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~---- 117 (381)
.++|++++.||+|+||+||+|++. + ++.||||++... .......+.+|+.+|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 578999999999999999999874 4 667999998643 222234567888888776 79999999999853
Q ss_pred -CCeEEEEEecccCCCHH----------------HHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeecccee
Q 048280 118 -GAEKLLIYEYVINESLD----------------KVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARL 178 (381)
Q Consensus 118 -~~~~~lv~E~~~~g~L~----------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~ 178 (381)
....+++|||+.++.+. .++.|++.||+|||+++ ||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 35689999999887663 34589999999999999 999999999999999999999999986
Q ss_pred cCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCccc--
Q 048280 179 FPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLE-- 256 (381)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 256 (381)
.... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||......+ ................
T Consensus 166 ~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 166 YSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCGGGSC
T ss_pred hccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCCchhccc
Confidence 4322 23345789999999999999999999999999999999999999996543222 1111111111000000
Q ss_pred -------ccC----CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 257 -------IVD----PSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 257 -------~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
... ..............+.+|+.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 000001112234567889999999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=348.82 Aligned_cols=247 Identities=22% Similarity=0.318 Sum_probs=182.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCC--CcccHHHHHHHHHHHHHhCCCCcccEEEEEee--------
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHS--SNQGKKEFENEAKLLARVQHRNVVNLLGYCAH-------- 117 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-------- 117 (381)
.++|++++.||+|+||+||+|++. +|+.||||++... .......+.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 468999999999999999999975 6999999998654 33345778999999999999999999998855
Q ss_pred CCeEEEEEecccCCCHH---------------HHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecC
Q 048280 118 GAEKLLIYEYVINESLD---------------KVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFP 180 (381)
Q Consensus 118 ~~~~~lv~E~~~~g~L~---------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~ 180 (381)
.+..++||||+.++.+. .++.|++.||.|||+.+ ||||||+||||+.++.+||+|||+++.+.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 34689999999776663 34589999999999998 99999999999999999999999998765
Q ss_pred CCCcc---cccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcc-
Q 048280 181 EDQTH---VNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSL- 255 (381)
Q Consensus 181 ~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 255 (381)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ..............
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLCGSITPEV 245 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTT
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH---HHHHHHhcCCCChhh
Confidence 43222 22245799999999999865 689999999999999999999999864332221 11111111110000
Q ss_pred --ccc--------C-CCCCCCCCHH------HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 256 --EIV--------D-PSLAASDSGD------QIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 256 --~~~--------~-~~~~~~~~~~------~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
... . .......... ....+++|+.+||+.||++|||++|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000 0 0000000111 12456789999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=347.96 Aligned_cols=236 Identities=25% Similarity=0.346 Sum_probs=189.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC----CCcEEEEEEecCC----CcccHHHHHHHHHHHHHhCC-CCcccEEEEEeeCC
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD----DGREIAVKKLSHS----SNQGKKEFENEAKLLARVQH-RNVVNLLGYCAHGA 119 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~ 119 (381)
.++|++++.||+|+||+||+|+.. +|+.||||++... +....+.+.+|+++|++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 367999999999999999999752 4789999998643 22334678899999999976 89999999999999
Q ss_pred eEEEEEecccCCCHHHHH---------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCC
Q 048280 120 EKLLIYEYVINESLDKVL---------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPED 182 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~~~l---------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~ 182 (381)
..++||||+.+|+|.+++ .|++.|+.|+|+.+ ||||||+||||+.++.+||+|||+++.+...
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 999999999999997665 79999999999998 9999999999999999999999999977555
Q ss_pred CcccccccccCccccchhHHhhC--CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccCC
Q 048280 183 QTHVNTRVAGTNGYMAPEYVMHG--HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVDP 260 (381)
Q Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (381)
.........|++.|+|||.+.+. .++.++|||||||+||+|++|+.||......+....+. ....... +
T Consensus 183 ~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~--~~~~~~~-------~ 253 (322)
T d1vzoa_ 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRILKSE-------P 253 (322)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHHHHCC-------C
T ss_pred ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--HhcccCC-------C
Confidence 44444567899999999999765 46889999999999999999999997554433322111 1111111 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 048280 261 SLAASDSGDQIAMCIQIGLLCTQGDPQLRP-----TMRRVVV 297 (381)
Q Consensus 261 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 297 (381)
. .+......+.+|+.+||+.||.+|| |++|+++
T Consensus 254 ~----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 P----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp C----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred C----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1 1122346788999999999999999 4788876
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=348.28 Aligned_cols=249 Identities=20% Similarity=0.298 Sum_probs=181.2
Q ss_pred hhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC-----
Q 048280 48 ATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA----- 119 (381)
Q Consensus 48 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----- 119 (381)
..++|++++.||+|+||+||+|.+. +|+.||||++.... ....+.+.+|+++|++++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3578999999999999999999875 59999999997542 233467889999999999999999999997654
Q ss_pred -eEEEEEecccCCCHHH--------------HHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCC
Q 048280 120 -EKLLIYEYVINESLDK--------------VLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPED 182 (381)
Q Consensus 120 -~~~lv~E~~~~g~L~~--------------~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~ 182 (381)
.+|+||||+ +.+|.. ++.|++.||.|||+++ ||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~ 174 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred ceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc
Confidence 579999999 666654 3489999999999999 9999999999999999999999999976443
Q ss_pred CcccccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH-----HhhcC----
Q 048280 183 QTHVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYK-----LYKKD---- 252 (381)
Q Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-----~~~~~---- 252 (381)
. +...||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+.......... .....
T Consensus 175 ~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
T d1cm8a_ 175 M----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250 (346)
T ss_dssp C----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred c----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence 2 346799999999999875 568999999999999999999999865432221111000000 00000
Q ss_pred ------CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hcCC
Q 048280 253 ------KSLEIVDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM--LSKK 302 (381)
Q Consensus 253 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~ 302 (381)
.........+ ..........+.+||.+||..||.+|||+.||++. ++..
T Consensus 251 ~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 251 AKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0000000000 00111223457889999999999999999999974 5543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=348.45 Aligned_cols=238 Identities=24% Similarity=0.325 Sum_probs=178.4
Q ss_pred CCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCcccEEEEEeeC------CeEEE
Q 048280 51 NFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNVVNLLGYCAHG------AEKLL 123 (381)
Q Consensus 51 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~~~l 123 (381)
+|+..++||+|+||+||+|++. +|+.||||++..... ...+|+++|++++||||++++++|... ..++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888999999999999999976 599999999975432 234799999999999999999998543 35799
Q ss_pred EEecccCCCHH------------------HHHHhhhhhhhHhhhhc--cCCccccceEeCCCC-CcEEeeeccceecCCC
Q 048280 124 IYEYVINESLD------------------KVLFSLIKDIQILFRKK--KTDIKASNILLDDKW-IPKIADFGMARLFPED 182 (381)
Q Consensus 124 v~E~~~~g~L~------------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~-~~kL~DFG~~~~~~~~ 182 (381)
|||||.++.+. .++.|++.||.|||+++ ||||||+||||+.++ .+||+|||+++.+...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 99999766432 23479999999999999 999999999999775 8999999999976543
Q ss_pred CcccccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhh----------c
Q 048280 183 QTHVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYK----------K 251 (381)
Q Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------~ 251 (381)
.. .....||..|+|||.+.+. .++.++|||||||++|||++|+.||......+. ......... .
T Consensus 177 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~---l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 177 EP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ---LVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp SC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH---HHHHHHHHCCCCHHHHHHHC
T ss_pred cc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH---HHHHHHHhCCChHHhhhhhc
Confidence 32 2345799999999988764 689999999999999999999999865433221 111111000 0
Q ss_pred CCcccccCCCC-----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 252 DKSLEIVDPSL-----AASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 252 ~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
........+.. ...........+.+|+.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000 00111223456889999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-46 Score=337.23 Aligned_cols=245 Identities=21% Similarity=0.292 Sum_probs=189.4
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCCeEEEEEe
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 126 (381)
++|++++.||+|+||+||+|++. +++.||||+++... ......+.+|+.+|++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999975 68999999986543 2345788999999999999999999999999999999999
Q ss_pred cccCCCHHHH---------------HHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcccccc
Q 048280 127 YVINESLDKV---------------LFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTHVNTR 189 (381)
Q Consensus 127 ~~~~g~L~~~---------------l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~~~~~ 189 (381)
++.+++|..+ +.|++.||+|||+++ ||||||+|||++.++.+||+|||.++........ ...
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~-~~~ 160 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSA 160 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC-CCS
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc-cee
Confidence 9988887644 489999999999998 9999999999999999999999999987544322 233
Q ss_pred cccCccccchhHHhhCC-CCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcc------cc-----
Q 048280 190 VAGTNGYMAPEYVMHGH-LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSL------EI----- 257 (381)
Q Consensus 190 ~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~----- 257 (381)
..++..|+|||++.+.. ++.++|||||||++|||++|+.||...... ................. ..
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH--HHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 45788999999988765 689999999999999999999997433221 11222211111110000 00
Q ss_pred ---c-CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 258 ---V-DPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 258 ---~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
. ...............+.+|+.+||+.||.+|||++||++
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000011122233456889999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-47 Score=349.61 Aligned_cols=247 Identities=20% Similarity=0.291 Sum_probs=181.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC-cccHHHHHHHHHHHHHhCCCCcccEEEEEeeCC----eEE
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS-NQGKKEFENEAKLLARVQHRNVVNLLGYCAHGA----EKL 122 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~ 122 (381)
+.+|++++.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 568999999999999999999865 79999999997543 333567899999999999999999999997643 234
Q ss_pred EEEecccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc-
Q 048280 123 LIYEYVINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH- 185 (381)
Q Consensus 123 lv~E~~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~- 185 (381)
++++|+.+|+|.+++ .|++.||.|||+++ ||||||+||||++++.+||+|||+++........
T Consensus 87 ~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~ 166 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 166 (345)
T ss_dssp EEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBC
T ss_pred EEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccc
Confidence 455566799998765 79999999999999 9999999999999999999999999876433221
Q ss_pred -cccccccCccccchhHHhh-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcc--------
Q 048280 186 -VNTRVAGTNGYMAPEYVMH-GHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSL-------- 255 (381)
Q Consensus 186 -~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 255 (381)
.....+||+.|+|||++.. ..++.++||||+||++|+|++|+.||......+.... ...........
T Consensus 167 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH---ILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCHHHHHTCCCH
T ss_pred eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHH---HhhhccCCChhhhhhhhhh
Confidence 2235679999999999854 4678999999999999999999999865432221111 11100000000
Q ss_pred -----cccCCCCCCCC----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 256 -----EIVDPSLAASD----SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 256 -----~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
....+...... .......+.+|+.+||+.||.+|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000000 01122468899999999999999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.4e-46 Score=336.62 Aligned_cols=241 Identities=19% Similarity=0.253 Sum_probs=181.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCc-ccEEEEEeeCCeEEEEEe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNV-VNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~E 126 (381)
.++|++.+.||+|+||.||+|++. +|+.||||++...... ..+.+|++++++++|+|+ +.+.+++.+++..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 457999999999999999999875 5899999998654322 457889999999987665 455566688889999999
Q ss_pred cccCCCHHHH----------------HHhhhhhhhHhhhhc--cCCccccceEeC---CCCCcEEeeeccceecCCCCcc
Q 048280 127 YVINESLDKV----------------LFSLIKDIQILFRKK--KTDIKASNILLD---DKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 127 ~~~~g~L~~~----------------l~~~~~~l~~lh~~~--HrDlkp~NIll~---~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
|+ +++|... +.|++.+|+|||+++ ||||||+|||++ .+..+||+|||+++.+......
T Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 99 5565433 368999999999999 999999999985 4557999999999987543321
Q ss_pred ------cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccccC
Q 048280 186 ------VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEIVD 259 (381)
Q Consensus 186 ------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (381)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........................ .
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~--- 238 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-E--- 238 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH-H---
T ss_pred cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh-h---
Confidence 223567999999999999999999999999999999999999999754443332222111111111100 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 260 PSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 260 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
.+.. ..+..+.+|+..||+.||++||++.+|.+.|+.
T Consensus 239 -~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 239 -VLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp -HHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred -Hhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 0011 123558889999999999999999998877764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.7e-45 Score=338.93 Aligned_cols=259 Identities=18% Similarity=0.267 Sum_probs=191.1
Q ss_pred HHHHhhhCCCCChHHHHHhhcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhC-CCC
Q 048280 30 EKIAAREQKHFPFEALVSATKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQ-HRN 107 (381)
Q Consensus 30 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpn 107 (381)
.++...+.....+.. .++|+++++||+|+||+||+|+.. +++.||||+++.. ..+.+.+|+.+|++++ |||
T Consensus 19 ~~~~~~~~~~~~~~~----~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpn 91 (328)
T d3bqca1 19 REYWDYESHVVEWGN----QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPN 91 (328)
T ss_dssp HHHHCGGGCCCCCCC----GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTT
T ss_pred CccchhhhcccCCCC----CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCC
Confidence 334443444444332 368999999999999999999975 6899999998643 3567899999999995 999
Q ss_pred cccEEEEEee--CCeEEEEEecccCCCHH------------HHHHhhhhhhhHhhhhc--cCCccccceEeCCCC-CcEE
Q 048280 108 VVNLLGYCAH--GAEKLLIYEYVINESLD------------KVLFSLIKDIQILFRKK--KTDIKASNILLDDKW-IPKI 170 (381)
Q Consensus 108 Iv~~~~~~~~--~~~~~lv~E~~~~g~L~------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~-~~kL 170 (381)
|+++++++.. ....++|||||.+++|. .++.|++.||.|||+++ ||||||+||||+.++ .+||
T Consensus 92 Iv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl 171 (328)
T d3bqca1 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 171 (328)
T ss_dssp BCCEEEEEECTTTCSEEEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEE
T ss_pred CcEEEEEEEecCCCceeEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeee
Confidence 9999999974 45689999999999985 45589999999999999 999999999998655 6999
Q ss_pred eeeccceecCCCCcccccccccCccccchhHHhhC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHH-HH----
Q 048280 171 ADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHG-HLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLL-DW---- 244 (381)
Q Consensus 171 ~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~-~~---- 244 (381)
+|||+++.+..... .....+|+.|+|||.+.+. .++.++|||||||++|+|++|+.||............ ..
T Consensus 172 ~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~ 249 (328)
T d3bqca1 172 IDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 249 (328)
T ss_dssp CCGGGCEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCH
T ss_pred cccccceeccCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCC
Confidence 99999997654322 2345789999999998876 4799999999999999999999998654332111000 00
Q ss_pred --HHHHhhc---CCcc---ccc--------CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 245 --AYKLYKK---DKSL---EIV--------DPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 245 --~~~~~~~---~~~~---~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
....... .... ... ...............+.+||.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 250 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 0000 000 000111112233456889999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.4e-45 Score=332.17 Aligned_cols=241 Identities=18% Similarity=0.276 Sum_probs=189.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhCC-CCcccEEEEEeeCCeEEEEEe
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQH-RNVVNLLGYCAHGAEKLLIYE 126 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~E 126 (381)
.++|++.+.||+|+||.||+|++. +|+.||||++..... ...+.+|+++++.++| +||+.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999976 589999999865432 2457889999999965 899999999999999999999
Q ss_pred cccCCCHHHHH----------------HhhhhhhhHhhhhc--cCCccccceEeCC-----CCCcEEeeeccceecCCCC
Q 048280 127 YVINESLDKVL----------------FSLIKDIQILFRKK--KTDIKASNILLDD-----KWIPKIADFGMARLFPEDQ 183 (381)
Q Consensus 127 ~~~~g~L~~~l----------------~~~~~~l~~lh~~~--HrDlkp~NIll~~-----~~~~kL~DFG~~~~~~~~~ 183 (381)
|+ +++|.+++ .|++.+|.|+|+++ ||||||+||||+. ++.+||+|||+++.+....
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 99 78887654 78999999999999 9999999999964 5689999999999765432
Q ss_pred cc------cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccc
Q 048280 184 TH------VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEI 257 (381)
Q Consensus 184 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (381)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........................+
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~- 239 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE- 239 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH-
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH-
Confidence 21 22356799999999999999999999999999999999999999975444333222222211111111111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 048280 258 VDPSLAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVMLSK 301 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 301 (381)
+... .+..+.+++..||..+|++||+++.+.+.|+.
T Consensus 240 ----l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 240 ----LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp ----HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ----hcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 1111 23458889999999999999999888777654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=342.38 Aligned_cols=248 Identities=21% Similarity=0.226 Sum_probs=179.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEee------CC
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAH------GA 119 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------~~ 119 (381)
.++|+++++||+|+||+||+|++. +|+.||||++.... ......+.+|+.++++++|||||+++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 478999999999999999999976 59999999997542 3334578899999999999999999999963 46
Q ss_pred eEEEEEecccCCCHH------------HHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCcc
Q 048280 120 EKLLIYEYVINESLD------------KVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQTH 185 (381)
Q Consensus 120 ~~~lv~E~~~~g~L~------------~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~~ 185 (381)
..|+|||||.++.+. .++.|++.||.|||+.+ ||||||+|||++.++.+||+|||+++......
T Consensus 96 ~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~-- 173 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-- 173 (355)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred eeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccc--
Confidence 889999999766553 34589999999999999 99999999999999999999999998654332
Q ss_pred cccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHH----------------HHHHHh
Q 048280 186 VNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLD----------------WAYKLY 249 (381)
Q Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~----------------~~~~~~ 249 (381)
......+|+.|+|||++.+..++.++||||+||++|+|++|+.||............. ......
T Consensus 174 ~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 253 (355)
T d2b1pa1 174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253 (355)
T ss_dssp -------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHH
T ss_pred ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHh
Confidence 2345678999999999999999999999999999999999999986443211110000 000000
Q ss_pred hcCCc------ccccCCCCCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048280 250 KKDKS------LEIVDPSLAA---SDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVVM 298 (381)
Q Consensus 250 ~~~~~------~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 298 (381)
..... .......... .........+.+|+.+||..||++|||++||++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 10000 0000000111 1123456778999999999999999999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=336.40 Aligned_cols=245 Identities=21% Similarity=0.328 Sum_probs=181.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCC--cccHHHHHHHHHHHHHhCCCCcccEEEEEeeC-----Ce
Q 048280 49 TKNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSS--NQGKKEFENEAKLLARVQHRNVVNLLGYCAHG-----AE 120 (381)
Q Consensus 49 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~ 120 (381)
.++|++++.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 568999999999999999999865 69999999997543 23345788999999999999999999998643 33
Q ss_pred EEEEEecccCCCHHHHH--------------HhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 121 KLLIYEYVINESLDKVL--------------FSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 121 ~~lv~E~~~~g~L~~~l--------------~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
.+++|+|+.+|+|.+++ .|++.||.|||+++ ||||||+|||++.++.+||+|||++.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~--- 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--- 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG---
T ss_pred eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc---
Confidence 46667778899998765 79999999999999 999999999999999999999999975432
Q ss_pred ccccccccCccccchhHHhhCC-CCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcCCcccc------
Q 048280 185 HVNTRVAGTNGYMAPEYVMHGH-LSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAYKLYKKDKSLEI------ 257 (381)
Q Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 257 (381)
......||..|+|||++.+.. ++.++|||||||++|+|++|+.||........... ........ ....
T Consensus 174 -~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~---i~~~~~~~-~~~~~~~~~~ 248 (348)
T d2gfsa1 174 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL---ILRLVGTP-GAELLKKISS 248 (348)
T ss_dssp -GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCC-CHHHHTTCCC
T ss_pred -ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCCC-ChHHhhhccc
Confidence 233467899999999887764 68999999999999999999999865432222111 11110000 0000
Q ss_pred ------c--CCCCCCCC----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhcC
Q 048280 258 ------V--DPSLAASD----SGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV--MLSK 301 (381)
Q Consensus 258 ------~--~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~--~L~~ 301 (381)
. .+...... .......+.+||.+||+.||.+|||+.|+++ .+.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 0 00000000 0112356789999999999999999999987 4544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.4e-40 Score=304.57 Aligned_cols=244 Identities=23% Similarity=0.229 Sum_probs=177.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEC-CCcEEEEEEecCCCcccHHHHHHHHHHHHHhC-----------CCCcccEEEEEee
Q 048280 50 KNFHPSNKLGEGGFGPVFKGKLD-DGREIAVKKLSHSSNQGKKEFENEAKLLARVQ-----------HRNVVNLLGYCAH 117 (381)
Q Consensus 50 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~~~~~~~~ 117 (381)
++|+++++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 45999999999999999999975 69999999997543 23467889999998885 5789999988754
Q ss_pred --CCeEEEEEecccCCCH------------------HHHHHhhhhhhhHhhh-hc--cCCccccceEeCCCC------Cc
Q 048280 118 --GAEKLLIYEYVINESL------------------DKVLFSLIKDIQILFR-KK--KTDIKASNILLDDKW------IP 168 (381)
Q Consensus 118 --~~~~~lv~E~~~~g~L------------------~~~l~~~~~~l~~lh~-~~--HrDlkp~NIll~~~~------~~ 168 (381)
....+++|+++..+.. ..++.|++.|+.|||+ .+ ||||||+||||+.++ .+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 4566777776644332 3456899999999997 65 999999999997655 38
Q ss_pred EEeeeccceecCCCCcccccccccCccccchhHHhhCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccccccHHHHHH--
Q 048280 169 KIADFGMARLFPEDQTHVNTRVAGTNGYMAPEYVMHGHLSVKADVFSFGVVILELISGQRNSSFNLDVDAQNLLDWAY-- 246 (381)
Q Consensus 169 kL~DFG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~-- 246 (381)
||+|||.+....... ....||+.|+|||++.+..++.++||||+||++++|++|+.||................
T Consensus 172 kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 172 KIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp EECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred eEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence 999999998654322 34579999999999999999999999999999999999999986443222211111111
Q ss_pred -HHhhc------------------CCcccccCCC----------CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048280 247 -KLYKK------------------DKSLEIVDPS----------LAASDSGDQIAMCIQIGLLCTQGDPQLRPTMRRVVV 297 (381)
Q Consensus 247 -~~~~~------------------~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 297 (381)
..... ......+... ............+.+|+.+||..||.+|||++|+++
T Consensus 248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11000 0000000000 012234667788999999999999999999999987
Q ss_pred H
Q 048280 298 M 298 (381)
Q Consensus 298 ~ 298 (381)
.
T Consensus 328 H 328 (362)
T d1q8ya_ 328 H 328 (362)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=2.3e-24 Score=181.44 Aligned_cols=154 Identities=18% Similarity=0.204 Sum_probs=115.4
Q ss_pred CCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcc------------------cHHHHHHHHHHHHHhCCCCcccEEEE
Q 048280 53 HPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQ------------------GKKEFENEAKLLARVQHRNVVNLLGY 114 (381)
Q Consensus 53 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~hpnIv~~~~~ 114 (381)
.+.++||+|+||.||+|+..+|+.||||+++..... ......+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 457899999999999999888999999987532110 01234568899999999999998866
Q ss_pred EeeCCeEEEEEecccCCCH--------HHHHHhhhhhhhHhhhhc--cCCccccceEeCCCCCcEEeeeccceecCCCCc
Q 048280 115 CAHGAEKLLIYEYVINESL--------DKVLFSLIKDIQILFRKK--KTDIKASNILLDDKWIPKIADFGMARLFPEDQT 184 (381)
Q Consensus 115 ~~~~~~~~lv~E~~~~g~L--------~~~l~~~~~~l~~lh~~~--HrDlkp~NIll~~~~~~kL~DFG~~~~~~~~~~ 184 (381)
.. .+++|||+.+..+ ..++.|++.++.+||+.+ ||||||+|||+++++ ++|+|||++........
T Consensus 83 ~~----~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~~~ 157 (191)
T d1zara2 83 EG----NAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGW 157 (191)
T ss_dssp ET----TEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTCEETTSTTH
T ss_pred cC----CEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCcccCCCCCc
Confidence 32 3799999977554 467899999999999999 999999999999765 89999999987543322
Q ss_pred ccccccccCccccch--h---HHhhCCCCchhhhHhHHHHH
Q 048280 185 HVNTRVAGTNGYMAP--E---YVMHGHLSVKADVFSFGVVI 220 (381)
Q Consensus 185 ~~~~~~~gt~~y~aP--E---~~~~~~~~~~sDvwSlGvvl 220 (381)
. .|... + .+..+.|+.++||||+.--+
T Consensus 158 ~---------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 158 R---------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp H---------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred H---------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 1 11111 1 01245688999999986443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.72 E-value=3.5e-08 Score=85.15 Aligned_cols=135 Identities=13% Similarity=0.125 Sum_probs=96.3
Q ss_pred HHHHHhhcCCCCCCcccccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhC-CCCcccEEEEEeeCCeE
Q 048280 43 EALVSATKNFHPSNKLGEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQ-HRNVVNLLGYCAHGAEK 121 (381)
Q Consensus 43 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~ 121 (381)
.++......|++.+..+.++.+.||+... +++.++||+...........+.+|...+..+. +--+.+++.++..++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 45566667888777766566678999864 46778889876554444456788999988884 44467788888889999
Q ss_pred EEEEecccCCCHHHH----------HHhhhhhhhHhhhh-----------------------------------------
Q 048280 122 LLIYEYVINESLDKV----------LFSLIKDIQILFRK----------------------------------------- 150 (381)
Q Consensus 122 ~lv~E~~~~g~L~~~----------l~~~~~~l~~lh~~----------------------------------------- 150 (381)
++||++++|.++.+. ..++...+..+|+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred EEEEEecccccccccccccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence 999999988776432 22333333333320
Q ss_pred --------------------ccCCccccceEeCCCCCcEEeeecccee
Q 048280 151 --------------------KKTDIKASNILLDDKWIPKIADFGMARL 178 (381)
Q Consensus 151 --------------------~HrDlkp~NIll~~~~~~kL~DFG~~~~ 178 (381)
.|+|+.|.|||+++++.+-|+||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 0999999999999876667999987763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.38 E-value=8.4e-07 Score=75.73 Aligned_cols=119 Identities=16% Similarity=0.172 Sum_probs=83.1
Q ss_pred cccccC-CeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCC--CCcccEEEEEeeCCeEEEEEecccCCCH
Q 048280 57 KLGEGG-FGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQH--RNVVNLLGYCAHGAEKLLIYEYVINESL 133 (381)
Q Consensus 57 ~lg~G~-~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~lv~E~~~~g~L 133 (381)
.+..|. -+.||+....++..+++|....... ..+..|...++.+.. -.+.+++.+..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 444454 3679999888788889998654432 346788888888843 3356788888888889999999988665
Q ss_pred H-------HHHHhhhhhhhHhhh---------------------------------------------------h-----
Q 048280 134 D-------KVLFSLIKDIQILFR---------------------------------------------------K----- 150 (381)
Q Consensus 134 ~-------~~l~~~~~~l~~lh~---------------------------------------------------~----- 150 (381)
. +.+.++...+..||+ .
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 2 223233333333331 0
Q ss_pred ----ccCCccccceEeCCCCCcEEeeecccee
Q 048280 151 ----KKTDIKASNILLDDKWIPKIADFGMARL 178 (381)
Q Consensus 151 ----~HrDlkp~NIll~~~~~~kL~DFG~~~~ 178 (381)
.|+|+.|.|||++.+..+-|+||+.+..
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 0999999999999876678999987763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.71 E-value=9e-05 Score=67.12 Aligned_cols=76 Identities=16% Similarity=0.147 Sum_probs=50.4
Q ss_pred CCcccccCCeeEEEEEECC-CcEEEEEEecCC-------CcccHHHHHHHHHHHHHhC-C--CCcccEEEEEeeCCeEEE
Q 048280 55 SNKLGEGGFGPVFKGKLDD-GREIAVKKLSHS-------SNQGKKEFENEAKLLARVQ-H--RNVVNLLGYCAHGAEKLL 123 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--pnIv~~~~~~~~~~~~~l 123 (381)
.+.||.|....||++...+ ++.|+||.-... .....++...|.+.|+.+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 5578999999999998654 678999975321 1123345667888888773 3 345566654 4455689
Q ss_pred EEecccCCC
Q 048280 124 IYEYVINES 132 (381)
Q Consensus 124 v~E~~~~g~ 132 (381)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.61 E-value=0.00012 Score=64.56 Aligned_cols=69 Identities=13% Similarity=0.113 Sum_probs=48.2
Q ss_pred CeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCc--ccEE-----EEEeeCCeEEEEEecccCCC
Q 048280 63 FGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNV--VNLL-----GYCAHGAEKLLIYEYVINES 132 (381)
Q Consensus 63 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI--v~~~-----~~~~~~~~~~lv~E~~~~g~ 132 (381)
--.||++...+|..|++|+.+... ...+++..|+..+..|....| +..+ ..+......+.+++++.|..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 358999999999999999986542 345778889999988853222 1111 12345677889999987644
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.43 E-value=0.00036 Score=63.04 Aligned_cols=73 Identities=12% Similarity=0.191 Sum_probs=50.9
Q ss_pred CCcccccCCeeEEEEEECC--------CcEEEEEEecCCCcccHHHHHHHHHHHHHhC-CCCcccEEEEEeeCCeEEEEE
Q 048280 55 SNKLGEGGFGPVFKGKLDD--------GREIAVKKLSHSSNQGKKEFENEAKLLARVQ-HRNVVNLLGYCAHGAEKLLIY 125 (381)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~ 125 (381)
++.|+.|---.+|++...+ .+.|.+++.. . ........+|..+++.+. +.-..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 4678888889999998653 3457777764 2 223345678999999985 4434578887753 6899
Q ss_pred ecccCCCH
Q 048280 126 EYVINESL 133 (381)
Q Consensus 126 E~~~~g~L 133 (381)
||++|..|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99977544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.21 E-value=0.0016 Score=56.54 Aligned_cols=90 Identities=7% Similarity=0.017 Sum_probs=50.5
Q ss_pred CChHHHHHhhcCCCCCCcc-----cccCCeeEEEEEECCCcEEEEEEecCCCcccHHHHHHHHHHHHHhCCCCc-----c
Q 048280 40 FPFEALVSATKNFHPSNKL-----GEGGFGPVFKGKLDDGREIAVKKLSHSSNQGKKEFENEAKLLARVQHRNV-----V 109 (381)
Q Consensus 40 ~~~~~~~~~~~~y~~~~~l-----g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v 109 (381)
.+.+++.....+|.+.+.. ..|---+.|+....+|+ +++|++.... ..+.+..|++++..|...++ +
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 4556677777778765443 35556788999887654 8999885432 23456667888888753222 2
Q ss_pred cEE---EEEeeCCeEEEEEecccCCC
Q 048280 110 NLL---GYCAHGAEKLLIYEYVINES 132 (381)
Q Consensus 110 ~~~---~~~~~~~~~~lv~E~~~~g~ 132 (381)
... .+.........++.++.+..
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~ 105 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMW 105 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBC
T ss_pred eecCCCcceeeecccceeeeeccccc
Confidence 110 01223455666677665533
|